PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Prasetyo, M; Moniqa, R; Tulaar, A; Prihartono, J; Setiawan, SI				Prasetyo, Marcel; Moniqa, Ratna; Tulaar, Angela; Prihartono, Joedo; Setiawan, Stefanus Imanuel			Correlation between Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score and Hemophilia Joint Health Score (HJHS) in patients with hemophilic arthropathy	PLOS ONE			English	Article								Background Hemophilic arthropathy, a condition manifested as joint destruction due to spontaneous joint bleeding, is one complication of hemophiliac patients. Early detection and intervention may improve the outcome, in which ultrasonography can be an ideal modality with the introduction of HEAD-US (Hemophilia Early Arthropathy Detection with Ultrasound) protocol. Studies have shown US benefit in hemophiliac patients, including its potential as an alternative for the Hemophiliac Joint Health Score (HJHS) system. However, many of the studies were conducted in countries with better management of hemophilia using prophylaxis treatment. It is unclear whether HEAD-US has a correlation with HJHS in countries using episodic treatment only, like in Indonesia. Purpose This study aimed to explore the correlation between HEAD-US and HJHS in hemophiliac patients with joint problems in Indonesia. Materials and methods A cross-sectional correlation study between HEAD-US and HJHS was performed with primary data collected from 120 hemophilic patients. US examination was performed on elbow, knee and ankle joints using the HEAD-US scoring method by a musculoskeletal radiologist. HJHS examination was conducted by a trained physiotherapist and a medical rehabilitation specialist. All examiner is member of multidisciplinary Hemophiliac Management Team in Cipto Mangunkusumo General Hospital in Jakarta, Indonesia. Results The mean age of the participant was 9.3 (5-14) years old. The median score of HEAD-US was 8 (1-28) with most of the joint abnormalities found on the ankles. The median score of HJHS was 3 (0-35), with most joint abnormalities found on the knees. There was a moderate correlation between HEAD-US and HJHS score (p < 0.05, r = 0.65). Conclusion HEAD-US shows a moderate correlation to HJHS in hemophiliac patients who received episodic treatment. HEAD-US can provide additional value in the anatomical evaluation of the joint and could be complementary to HJHS in assessing the joint status in hemophilic patient	[Prasetyo, Marcel; Moniqa, Ratna; Setiawan, Stefanus Imanuel] Univ Indonesia, Dr Cipto Mangunkusumo Natl Cent Gen Hosp, Fac Med, Dept Radiol, Jakarta, Indonesia; [Tulaar, Angela] Univ Indonesia, Dr Cipto Mangunkusumo Natl Cent Gen Hosp, Fac Med, Dept Med Rehabil, Jakarta, Indonesia; [Prihartono, Joedo] Univ Indonesia, Fac Med, Dept Community Med, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia	Prasetyo, M (corresponding author), Univ Indonesia, Dr Cipto Mangunkusumo Natl Cent Gen Hosp, Fac Med, Dept Radiol, Jakarta, Indonesia.	marcel71@ui.ac.id		Prasetyo, Marcel/0000-0002-7796-3871; Setiawan, Stefanus Imanuel/0000-0003-1371-2894				Acharya SS, 2008, J THROMB HAEMOST, V6, P2055, DOI 10.1111/j.1538-7836.2008.03160.x; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Altisent C, 2016, HAEMOPHILIA, V22, P218, DOI 10.1111/hae.12792; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Chozie NA, 2019, HAEMOPHILIA, V25, P633, DOI 10.1111/hae.13770; De la Corte-Rodriguez H, 2020, BLOOD COAGUL FIBRIN, V31, P387, DOI 10.1097/MBC.0000000000000934; Di Minno MND., 2015, EUR J HAEMATOL, V95, P1; Doria AS, 2010, HAEMOPHILIA, V16, P107, DOI 10.1111/j.1365-2516.2010.02307.x; Foppen W, 2016, HAEMOPHILIA, V22, P121, DOI 10.1111/hae.12769; Jansen NWD, 2008, BRIT J HAEMATOL, V143, P632, DOI 10.1111/j.1365-2141.2008.07386.x; Klukowska A, 2001, HAEMOPHILIA, V7, P286, DOI 10.1046/j.1365-2516.2001.00509.x; Knobe Karin, 2011, J Comorb, V1, P51; Martinoli C, 2013, THROMB HAEMOSTASIS, V109, P1170, DOI 10.1160/TH12-11-0874; Melchiorre D, 2011, HAEMOPHILIA, V17, P112, DOI 10.1111/j.1365-2516.2010.02380.x; Oldenburg J, 2015, BLOOD, V125, P2038, DOI 10.1182/blood-2015-01-528414; Pipe SW, 2007, HAEMOPHILIA, V13, P1, DOI 10.1111/j.1365-2516.2007.01552.x; Rodriguez-Merchan E Carlos, 2010, HSS J, V6, P37, DOI 10.1007/s11420-009-9140-9; Roosendaal G, 2006, HAEMOPHILIA, V12, P117, DOI 10.1111/j.1365-2516.2006.01268.x; Sari TT, 2017, MED J INDONES, V26, P47, DOI [10.13181/mji.v26i1.1494, 10.13181]; Seuser A., 2015, ECR 2015 EUR C RAD; Aisa CS, 2014, HAEMOPHILIA, V20, pE51, DOI 10.1111/hae.12268; Sluiter D, 2014, HAEMOPHILIA, V20, P282, DOI 10.1111/hae.12290; Timmer MA, 2017, HAEMOPHILIA, V23, pE141, DOI 10.1111/hae.13147	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0248952	10.1371/journal.pone.0248952	http://dx.doi.org/10.1371/journal.pone.0248952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826621	Green Published, gold			2022-12-26	WOS:000638119900006
J	Baena-Raya, A; Soriano-Maldonado, A; Rodriguez-Perez, MA; Garcia-de-Alcaraz, A; Ortega-Becerra, M; Jimenez-Reyes, P; Garcia-Ramos, A				Baena-Raya, Andres; Soriano-Maldonado, Alberto; Rodriguez-Perez, Manuel A.; Garcia-de-Alcaraz, Antonio; Ortega-Becerra, Manuel; Jimenez-Reyes, Pedro; Garcia-Ramos, Amador			The force-velocity profile as determinant of spike and serve ball speed in top-level male volleyball players	PLOS ONE			English	Article								Understanding the relationship between mechanical variables derived from actions such as jumping, sprinting, or ballistic bench press throwing and sport-specific performance moves is of scientific and practical interest for strength and conditioning coaches for improving training programs. We examined the association between mechanical variables derived from the force-velocity (FV) profiles of the aforementioned actions and spike and serve ball speeds in elite volleyball players. Twenty-two male elite volleyball players (age: 24.3 +/- 4.5 years; height: 1.89 +/- 0.06 m; body mass: 86.3 +/- 8.6 kg) were tested in two sessions. Squatting, sprinting, and bench press throwing FV profiles were determined in the first session, while spike and serve ball speeds were assessed in the second session. The theoretical maximal force (F-0) of vertical jumping, the theoretical maximal velocity of sprinting, and the F-0 of bench press throwing in ascending order, were strongly associated (r(s) range 0.53-0.84; p<0.05) with spike and serve ball speeds. These mechanical variables explained 20%-36% of the variability in spike and serve ball speeds, with a greater influence on the serve speed. These results suggest that assessing jumping, sprinting, and bench press throwing force-velocity profiles might help provide player-specific training programs and optimize performance in these technical-tactical actions in male elite volleyball players.	[Baena-Raya, Andres; Soriano-Maldonado, Alberto; Rodriguez-Perez, Manuel A.; Garcia-de-Alcaraz, Antonio] Univ Almeria, Fac Educ Sci, Dept Educ, Almeria, Spain; [Baena-Raya, Andres; Soriano-Maldonado, Alberto; Rodriguez-Perez, Manuel A.; Garcia-de-Alcaraz, Antonio] Univ Almeria, CERNEP Res Ctr, SPORT Res Grp CTS 1024, Almeria, Spain; [Ortega-Becerra, Manuel] Pablo Olavide Univ, Phys Performance & Sports Res Ctr, Seville, Spain; [Jimenez-Reyes, Pedro] Rey Juan Carlos Univ, Ctr Sport Studies, Madrid, Spain; [Garcia-Ramos, Amador] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia-Ramos, Amador] Univ Catolica Santisima Concepcion, Fac Educ, Dept Sports Sci & Phys Conditioning, Concepcion, Chile	Universidad de Almeria; Universidad de Almeria; Universidad Pablo de Olavide; Universidad Rey Juan Carlos; University of Granada; Universidad Catolica de la Santisima Concepcion	Rodriguez-Perez, MA (corresponding author), Univ Almeria, Fac Educ Sci, Dept Educ, Almeria, Spain.; Rodriguez-Perez, MA (corresponding author), Univ Almeria, CERNEP Res Ctr, SPORT Res Grp CTS 1024, Almeria, Spain.	manolo.rodriguez@ual.es	Soriano-Maldonado, Alberto/I-6379-2015; Baena-Raya, Andrés/AAO-1550-2020; Ortega-Becerra, Manuel/AAL-7127-2020; Ramos, Amador Garcia/S-6982-2016; Rodríguez-Pérez, Manuel A./AAU-6670-2021	Soriano-Maldonado, Alberto/0000-0002-4626-420X; Baena-Raya, Andrés/0000-0002-6590-6773; Ortega-Becerra, Manuel/0000-0003-4117-2397; Ramos, Amador Garcia/0000-0003-0608-8755; Rodríguez-Pérez, Manuel A./0000-0002-1336-5979				Beato M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01288; Challoumas D, 2018, INT J SPORT PHYSIOL, V13, P1230, DOI 10.1123/ijspp.2018-0125; Chelly MS, 2010, J STRENGTH COND RES, V24, P1480, DOI 10.1519/JSC.0b013e3181d32fbf; Coleman S. G. S., 1993, Journal of Sports Sciences, V11, P295; Drikos S, 2011, INT J PERF ANAL SPOR, V11, P85, DOI 10.1080/24748668.2011.11868531; Forthomme B, 2005, AM J SPORT MED, V33, P1513, DOI 10.1177/0363546505274935; Fuchs PX, 2019, J SCI MED SPORT, V22, P833, DOI 10.1016/j.jsams.2019.01.002; Garcia-Ramos A, 2021, SPORT BIOMECH, V20, P274, DOI 10.1080/14763141.2018.1545044; Garcia-Ramos A, 2018, J STRENGTH COND RES, V32, P2701, DOI 10.1519/JSC.0000000000002616; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Hicks DS, 2020, STRENGTH COND J, V42, P45, DOI 10.1519/SSC.0000000000000519; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jimenez-Reyes P, 2017, INT J SPORT PHYSIOL, V12, P36, DOI [10.1123/ijspp.2015-0484, 10.1123/IJSPP.2015-0484]; Jimenez-Reyes P, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00677; Gonzalez-Badillo JJ, 2014, EUR J SPORT SCI, V14, P772, DOI 10.1080/17461391.2014.905987; Marcelino R, 2009, J SPORT SCI MED, V8, P352; Marcote-Pequeno R, 2019, INT J SPORT PHYSIOL, V14, P209, DOI 10.1123/ijspp.2018-0233; Marques MC, 2009, J STRENGTH COND RES, V23, P1106, DOI 10.1519/JSC.0b013e31819b78c4; Marques MC, 2008, J STRENGTH COND RES, V22, P1147, DOI 10.1519/JSC.0b013e31816a42d0; Morin JB, 2019, SPORTS MED, V49, P999, DOI 10.1007/s40279-019-01073-1; Morin JB, 2016, INT J SPORT PHYSIOL, V11, P267, DOI 10.1123/ijspp.2015-0638; Palao JM., 2004, INT J PERF ANAL SPOR, V4, P50, DOI 10.1080/24748668.2004.11868304; Palao JM, 2009, STRENGTH COND J, V31, P47, DOI 10.1519/SSC.0b013e3181c21b3f; Perez-Castilla A, 2018, J STRENGTH COND RES, V32, P2025, DOI 10.1519/JSC.0000000000002583; Reeser JC, 2010, SPORTS HEALTH, V2, P368, DOI 10.1177/1941738110374624; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Samozino P, 2014, INT J SPORTS MED, V35, P505, DOI 10.1055/s-0033-1354382; Samozino P, 2008, J BIOMECH, V41, P2940, DOI 10.1016/j.jbiomech.2008.07.028; Sattler T, 2015, J STRENGTH COND RES, V29, P1486, DOI 10.1519/JSC.0000000000000781; Sheppard JM, 2008, J STRENGTH COND RES, V22, P758, DOI 10.1519/JSC.0b013e31816a8440; Valades Cerrato D, 2018, J SPORT MED PHYS FIT, V58, P1423, DOI 10.23736/S0022-4707.17.07527-2; Voelzke M, 2012, J SCI MED SPORT, V15, P457, DOI 10.1016/j.jsams.2012.02.004; Wagner H, 2014, SCAND J MED SCI SPOR, V24, P345, DOI 10.1111/j.1600-0838.2012.01503.x; Wagner H, 2009, INT J SPORTS MED, V30, P760, DOI 10.1055/s-0029-1224177	35	8	8	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249612	10.1371/journal.pone.0249612	http://dx.doi.org/10.1371/journal.pone.0249612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798256	gold, Green Published			2022-12-26	WOS:000636737700028
J	Sattler, LM; Schniewind, HA; Minich, WB; Haudum, CW; Niklowitz, P; Munzker, J; Kovacs, GL; Reinehr, T; Obermayer-Pietsch, B; Schomburg, L				Sattler, Lisa-Marie; Schniewind, Hanna A.; Minich, Waldemar B.; Haudum, Christoph W.; Niklowitz, Petra; Muenzker, Julia; Kovacs, Gabor L.; Reinehr, Thomas; Obermayer-Pietsch, Barbara; Schomburg, Lutz			Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome	PLOS ONE			English	Article								Context Polycystic ovarian syndrome (PCOS) is a complex disease with different subtypes and unclear etiology. Among the frequent comorbidities are autoimmune diseases, suggesting that autoantibodies (aAb) may be involved in PCOS pathogenesis. Objective As the gonadal axis often is dysregulated, we tested the hypothesis that aAb to the gonadotropin-releasing hormone receptor (GnRH-R) are of diagnostic value in PCOS. Design An in vitro assay for quantifying aAb to the GnRH-R (GnRH-R-aAb) was established by using a recombinant fusion protein of full-length human GnRH-R and firefly luciferase. A commercial rabbit antiserum to human GnRH-R was used for standardization. Serum samples of control subjects and different cohorts of European PCOS patients (n = 1051) were analyzed. Results The novel GnRH-R-aAb assay was sensitive, and signals were linear on dilution when tested with the commercial GnRH-R antiserum. Natural GnRH-R-aAb were detected in one control (0.25%) and two PCOS samples (0.31%), and 12 samples were slightly above the threshold of positivity. The identification of samples with positive GnRH-R-aAb was reproducible and the signals showed no matrix interferences. Conclusion Natural GnRH-R-aAb are present in a very small fraction of adult control and PCOS subjects of European decent. Our results do not support the hypothesis that the GnRH-R constitutes a relevant autoantigen in PCOS.	[Sattler, Lisa-Marie; Schniewind, Hanna A.; Minich, Waldemar B.; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; [Sattler, Lisa-Marie; Schniewind, Hanna A.; Minich, Waldemar B.; Schomburg, Lutz] Free Univ Berlin, Berlin, Germany; [Sattler, Lisa-Marie; Schniewind, Hanna A.; Minich, Waldemar B.; Schomburg, Lutz] Humboldt Univ, Berlin, Germany; [Sattler, Lisa-Marie; Schniewind, Hanna A.; Minich, Waldemar B.; Schomburg, Lutz] Berlin Inst Hlth, Berlin, Germany; [Haudum, Christoph W.; Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Internal Med, Graz, Austria; [Haudum, Christoph W.; Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Gynecol & Obstet, Endocrinol Lab Platform, Graz, Austria; [Haudum, Christoph W.] Ctr Biomarker Res Med CBmed, Graz, Austria; [Niklowitz, Petra; Reinehr, Thomas] Univ Witten Herdecke, Dept Pediat Endocrinol, Vest Kinder & Jugendklin, Datteln, Germany; [Muenzker, Julia] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med, Leipzig, Germany; [Kovacs, Gabor L.] Flor Ferenc Hosp, Dept Internal Med 1, Kistarcsa, Hungary	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Medical University of Graz; Medical University of Graz; Witten Herdecke University; Leipzig University	Schomburg, L (corresponding author), Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany.; Schomburg, L (corresponding author), Free Univ Berlin, Berlin, Germany.; Schomburg, L (corresponding author), Humboldt Univ, Berlin, Germany.; Schomburg, L (corresponding author), Berlin Inst Hlth, Berlin, Germany.	lutz.schomburg@charite.de	Schomburg, Lutz/D-8096-2013	Schomburg, Lutz/0000-0001-9445-1555	Deutsche Forschungsgemeinschaft (DFG) [FOR- 2558, Scho 849/6-1]; Austrian Research Promotion Agency FFG [FFG844609]; Open Access Publication Fund of Charite - Universitatsmedizin Berlin; Center for Biomarker Research in Medicine (CBmed) in Graz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Research Promotion Agency FFG; Open Access Publication Fund of Charite - Universitatsmedizin Berlin; Center for Biomarker Research in Medicine (CBmed) in Graz	The research has been funded by the Deutsche Forschungsgemeinschaft (DFG), Research Unit FOR- 2558 "TraceAge" (Scho 849/6-1), by the Austrian Research Promotion Agency FFG (FFG844609), the Center for Biomarker Research in Medicine (CBmed) in Graz, and we acknowledge financial support by the Open Access Publication Fund of Charite - Universitatsmedizin Berlin.	Alborzi S, 2009, FERTIL STERIL, V91, P1159, DOI 10.1016/j.fertnstert.2008.01.038; Arduc A, 2015, ENDOCR RES, V40, P204, DOI 10.3109/07435800.2015.1015730; Barber TM, 2016, CLIN MED, V16, P262, DOI 10.7861/clinmedicine.16-3-262; Becker NP, 2019, FRONT BIOSCI-LANDMRK, V24, P48, DOI 10.2741/4709; Becker NP, 2017, AUTOIMMUN REV, V16, P269, DOI 10.1016/j.autrev.2017.01.012; Bednarska S, 2017, ADV CLIN EXP MED, V26, P359, DOI 10.17219/acem/59380; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Boege F, 2017, J AM COLL CARDIOL, V70, P807, DOI 10.1016/j.jacc.2017.03.617; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Brix TH, 2014, CLIN ENDOCRINOL, V81, P440, DOI 10.1111/cen.12434; Brown RJ, 2017, J CLIN ENDOCR METAB, V102, P1789, DOI 10.1210/jc.2016-3674; Caburet S, 2017, EUR J ENDOCRINOL, V176, pK9, DOI 10.1530/EJE-16-0968; Chaudhari N, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0354-x; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Craig LB, 2017, FERTIL STERIL, V108, pE259, DOI 10.1016/j.fertnstert.2017.07.774; Davies TF, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0184-y; Eleftheriadou AM, 2020, EUR J ENDOCRINOL, V183, P571, DOI 10.1530/EJE-20-0566; Endo T, 1996, BIOCHEM BIOPH RES CO, V224, P92, DOI 10.1006/bbrc.1996.0989; Engmann L, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.003; Franks S, 2006, J CLIN ENDOCR METAB, V91, P786, DOI 10.1210/jc.2005-2501; Gibson-Helm M, 2017, J CLIN ENDOCR METAB, V102, P604, DOI 10.1210/jc.2016-2963; Glintborg D, 2017, CURR OPIN OBSTET GYN, V29, P390, DOI 10.1097/GCO.0000000000000410; GOUDSWAARD J, 1978, SCAND J IMMUNOL, V8, P21, DOI 10.1111/j.1365-3083.1978.tb00492.x; Hefler-Frischmuth K, 2010, FERTIL STERIL, V93, P2291, DOI 10.1016/j.fertnstert.2009.01.056; John GK, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030167; Kahaly GJ, 2020, ENDOCR PRACT, V26, P97, DOI 10.4158/EP-2019-0363; Kem DC, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa078; Lass N, 2011, J CLIN ENDOCR METAB, V96, P3533, DOI 10.1210/jc.2011-1609; Lerchbaum E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108263; de Andrade VHL, 2016, REV ASSOC MED BRAS, V62, P867, DOI 10.1590/1806-9282.62.09.867; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Minich WB, 2013, J CLIN ENDOCR METAB, V98, P752, DOI 10.1210/jc.2012-1771; Minich WB, 2004, CLIN EXP IMMUNOL, V136, P129, DOI 10.1111/j.1365-2249.2004.02417.x; Mobeen H, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/4071735; Munzker J, 2015, J CLIN ENDOCR METAB, V100, P653, DOI 10.1210/jc.2014-2523; Petrikova J, 2015, BIOMED PAP, V159, P302, DOI 10.5507/bp.2014.062; Petrikova J, 2012, AUTOIMMUN REV, V11, pA471, DOI 10.1016/j.autrev.2011.11.010; Rapoport B, 2018, HORM METAB RES, V50, P840, DOI 10.1055/a-0725-9297; Rosenfield RL, 2016, ENDOCR REV, V37, P467, DOI 10.1210/er.2015-1104; Schwiebert C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020463; Spritzer PM, 2016, CURR PHARM DESIGN, V22, P5603, DOI 10.2174/1381612822666160720151243; Torchen LC, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0956-2; Tozzoli R, 2020, AUTOIMMUN HIGHLIGHTS, V11, DOI 10.1186/s13317-019-0125-5; Wang J, 2019, LIFE SCI, V236, DOI 10.1016/j.lfs.2019.116940; Yoshida A, 2009, J CLIN ENDOCR METAB, V94, P442, DOI 10.1210/jc.2008-1732; Zophel K, 2010, AUTOIMMUN REV, V9, P695, DOI 10.1016/j.autrev.2010.05.021	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249639	10.1371/journal.pone.0249639	http://dx.doi.org/10.1371/journal.pone.0249639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798258	gold, Green Published			2022-12-26	WOS:000636737700044
J	Khan, MA; Khan, ST; Sequeira, MC; Faheem, SM; Rais, N				Khan, Munawwar Ali; Khan, Shams Tabrez; Sequeira, Milred Cedric; Faheem, Sultan Mohammad; Rais, Naushad			Illumina sequencing of 16S rRNA genes reveals a unique microbial community in three anaerobic sludge digesters of Dubai	PLOS ONE			English	Article							SP-NOV.; SPEC-NOV; WATER; ENERGY; ARCHAEON; LINEAGE; NEXUS	Understanding the microbial communities in anaerobic digesters, especially bacteria and archaea, is key to its better operation and regulation. Microbial communities in the anaerobic digesters of the Gulf region where climatic conditions and other factors may impact the incoming feed are not documented. Therefore, Archaeal and Bacterial communities of three full-scale anaerobic digesters, namely AD1, AD3, and AD5 of the Jebel Ali Sewage water Treatment Plant (JASTP) were analyzed by Illumina sequencing of 16S rRNA genes. Among bacteria, the most abundant genus was fermentative bacteria Acetobacteroides (Blvii28). Other predominant bacterial genera in the digesters included thermophilic bacteria (Fervidobacterium and Coprothermobacter) and halophilic bacteria like Haloterrigena and Sediminibacter. This can be correlated with the climatic condition in Dubai, where the bacteria in the incoming feed may be thermophilic or halophilic as much of the water used in the country is desalinated seawater. The predominant Archaea include mainly the members of the phyla Euryarchaeota and Crenarchaeota belonging to the genus Methanocorpusculum, Metallosphaera, Methanocella, and Methanococcus. The highest population of Methanocorpusculum (more than 50% of total Archaea), and other hydrogenotrophic archaea, is in agreement with the high population of bacterial genera Acetobacteroides (Blvii28) and Fervidobacterium, capable of fermenting organic substrates into acetate and H-2. Coprothermobacter, which is known to improve protein degradation by establishing syntrophy with hydrogenotrophic archaea, is also one of the digesters' dominant genera. The results suggest that the microbial community in three full-scale anaerobic digesters is different. To best of our knowledge this is the first detailed report from the UAE.	[Khan, Munawwar Ali] Zayed Univ, Dept Life & Environm Sci, Coll Nat & Hlth Sci, Dubai, U Arab Emirates; [Khan, Shams Tabrez] Aligarh Muslim Univ, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India; [Sequeira, Milred Cedric; Faheem, Sultan Mohammad; Rais, Naushad] Manipal Acad Higher Educ, Sch Life Sci, Dubai, U Arab Emirates	Zayed University; Aligarh Muslim University	Khan, ST (corresponding author), Aligarh Muslim Univ, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India.	shamsalig75@gmail.com	Khan, Munawwar Ali/O-8086-2014; Khan, Shams/AAM-3333-2020	Khan, Munawwar Ali/0000-0001-5683-300X; Khan, Shams/0000-0003-4963-4998	Zayed University Microbial Diversity and Ecogenomics Research Cluster Project [R16092]	Zayed University Microbial Diversity and Ecogenomics Research Cluster Project	This work was supported by Zayed University Microbial Diversity and Ecogenomics Research Cluster Project (Grant code: R16092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelidaki I, 2003, ADV BIOCHEM ENG BIOT, V82, P1; Bond T, 2011, ENERGY SUSTAIN DEV, V15, P347, DOI 10.1016/j.esd.2011.09.003; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Daebeler A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00193; Dawoud M.A., 2012, INT J ENV SUSTAINABI, V1, DOI 10.24102/ijes.v1i3.96; De Vrieze J, 2017, WATER RES, V111, P109, DOI 10.1016/j.watres.2016.12.042; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FitzGerald JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142603; Gagliano MC, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv018; Garcia-Ruiz MJ, 2020, AICHE J, V66, DOI 10.1002/aic.16807; Glansdorff N., 2006, ALKALINE ENV BIODIVE; Goux X, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0309-9; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ju F, 2017, ENVIRON SCI TECHNOL, V51, P3982, DOI 10.1021/acs.est.6b06344; Karakashev D, 2005, APPL ENVIRON MICROB, V71, P331, DOI 10.1128/AEM.71.1.331-338.2005; Kessler PS, 2001, J BACTERIOL, V183, P882, DOI 10.1128/JB.183.3.882-889.2001; Khan MA, 2020, SOIL-GERMANY, V6, P513, DOI 10.5194/soil-6-513-2020; Khan MA, 2019, J SUSTAIN DEV ENERGY, V7, P385, DOI 10.13044/j.sdewes.d6.0222; Khan Munawwar A, 2018, Open Microbiol J, V12, P123, DOI 10.2174/1874285801812010123; Khan ST, 2007, INT J SYST EVOL MICR, V57, P265, DOI 10.1099/ijs.0.64628-0; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/ngeo1955, 10.1038/NGEO1955]; Kolbl D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01918; Lin L, 2018, RENEW SUST ENERG REV, V89, P151, DOI 10.1016/j.rser.2018.03.025; Liu L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00354; Maclean H., 2013, ANAEROBIC DIGESTERS, P139; Meegoda JN, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102224; Muvhiiwa R, 2017, ENERGY SUSTAIN SOC, V7, DOI 10.1186/s13705-017-0122-3; Paolini V, 2018, J ENVIRON SCI HEAL A, V53, P899, DOI 10.1080/10934529.2018.1459076; PATEL BKC, 1985, ARCH MICROBIOL, V141, P63, DOI 10.1007/BF00446741; Paul P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040364; Perrotta AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171369; Praveckova M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00933; Regueiro L, 2012, MICROBIOL RES, V167, P581, DOI 10.1016/j.micres.2012.06.002; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shrestha N, 2018, BIORESOURCE TECHNOL, V255, P318, DOI 10.1016/j.biortech.2018.01.151; Silvestre G, 2015, ENERG CONVERS MANAGE, V101, P255, DOI 10.1016/j.enconman.2015.05.033; Sorokin DY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02359; Stolze Y, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0565-3; Su XL, 2014, INT J SYST EVOL MICR, V64, P2986, DOI 10.1099/ijs.0.063917-0; Suryawanshi PC, 2010, CRIT REV BIOTECHNOL, V30, P31, DOI 10.3109/07388550903330505; Svensson K, 2018, BIORESOURCE TECHNOL, V269, P276, DOI 10.1016/j.biortech.2018.08.096; Vanwonterghem I, 2014, CURR OPIN BIOTECH, V27, P55, DOI 10.1016/j.copbio.2013.11.004; Walter A, 2019, WATER ENVIRON J, V33, P214, DOI 10.1111/wej.12392; Wang SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01298-y; Yang Y, 2014, APPL MICROBIOL BIOT, V98, P5709, DOI 10.1007/s00253-014-5648-0; ZELLNER G, 1987, ARCH MICROBIOL, V147, P13, DOI 10.1007/BF00492898	48	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249023	10.1371/journal.pone.0249023	http://dx.doi.org/10.1371/journal.pone.0249023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793629	gold, Green Published			2022-12-26	WOS:000636467000095
J	Lind, A; Akbarian, E; Olsson, S; Nasell, H; Skoldenberg, O; Razavian, AS; Gordon, M				Lind, Anna; Akbarian, Ehsan; Olsson, Simon; Nasell, Hans; Skoldenberg, Olof; Razavian, Ali Sharif; Gordon, Max			Artificial intelligence for the classification of fractures around the knee in adults according to the 2018 AO/OTA classification system	PLOS ONE			English	Article								Background Fractures around the knee joint are inherently complex in terms of treatment; complication rates are high, and they are difficult to diagnose on a plain radiograph. An automated way of classifying radiographic images could improve diagnostic accuracy and would enable production of uniformly classified records of fractures to be used in researching treatment strategies for different fracture types. Recently deep learning, a form of artificial intelligence (AI), has shown promising results for interpreting radiographs. In this study, we aim to evaluate how well an AI can classify knee fractures according to the detailed 2018 AO-OTA fracture classification system. Methods We selected 6003 radiograph exams taken at Danderyd University Hospital between the years 2002-2016, and manually categorized them according to the AO/OTA classification system and by custom classifiers. We then trained a ResNet-based neural network on this data. We evaluated the performance against a test set of 600 exams. Two senior orthopedic surgeons had reviewed these exams independently where we settled exams with disagreement through a consensus session. Results We captured a total of 49 nested fracture classes. Weighted mean AUC was 0.87 for proximal tibia fractures, 0.89 for patella fractures and 0.89 for distal femur fractures. Almost 3/4 of AUC estimates were above 0.8, out of which more than half reached an AUC of 0.9 or above indicating excellent performance. Conclusion Our study shows that neural networks can be used not only for fracture identification but also for more detailed classification of fractures around the knee joint.	[Lind, Anna; Akbarian, Ehsan; Olsson, Simon; Nasell, Hans; Skoldenberg, Olof; Razavian, Ali Sharif; Gordon, Max] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet	Gordon, M (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden.	max.gordon@ki.se	Gordon, Max/M-4330-2014	Gordon, Max/0000-0002-8080-5815	Region Stockholm (ALF project); Karolinska Institute	Region Stockholm (ALF project); Karolinska Institute(Karolinska Institutet)	This project was supported by grants provided by Region Stockholm (ALF project), and by the Karolinska Institute. Salaries and computational resources were funded through these grants. DeepMed AB provided no financial or intellectual property for this study.	Bengio Y, 2014, FITNETS HINTS THIN D; Chung SW, 2018, ACTA ORTHOP, V89, P468, DOI 10.1080/17453674.2018.1453714; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Frenay B, 2014, IEEE T NEUR NET LEAR, V25, P845, DOI 10.1109/TNNLS.2013.2292894; Gale W, 2017, DETECTING HIP FRACTU; Gan KF, 2019, ACTA ORTHOP, V90, P394, DOI 10.1080/17453674.2019.1600125; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hallas P, 2006, BMC EMERG MED, V6, DOI 10.1186/1471-227X-6-4; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hua KL, 2015, ONCOTARGETS THER, V8, P2015, DOI 10.2147/OTT.S80733; Izmailov Pavel, 2018, 34 C UNC ART INT 201; Kellam JF, 2018, J ORTHOP TRAUMA, V32, pS1, DOI [10.1097/BOT.0000000000001062, 10.1097/BOT.0000000000001063]; Kim DH, 2018, CLIN RADIOL, V73, P439, DOI 10.1016/j.crad.2017.11.015; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Langerhuizen DWG, 2019, CLIN ORTHOP RELAT R, V477, P2482, DOI 10.1097/CORR.0000000000000848; Li Fangyu, 2018, Shanghai Arch Psychiatry, V30, P207, DOI 10.11919/j.issn.1002-0829.218052; Lindsey R, 2018, P NATL ACAD SCI USA, V115, P11591, DOI 10.1073/pnas.1806905115; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Olczak J, 2020, ACTA ORTHOP, V92, P102, DOI 10.1080/17453674.2020.1837420; Olczak J, 2017, ACTA ORTHOP, V88, P581, DOI 10.1080/17453674.2017.1344459; Pranata YD, 2019, COMPUT METH PROG BIO, V171, P27, DOI 10.1016/j.cmpb.2019.02.006; Saleh H, 2016, WORLD J ORTHOP, V7, P584, DOI 10.5312/wjo.v7.i9.584; Smailagic A, 2018, 2018 17 IEEE INT C M; Sundararajan M, 2017, PR MACH LEARN RES, V70; te Stroet MAJ, 2011, EMERG RADIOL, V18, P279, DOI 10.1007/s10140-010-0932-5; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Urakawa T, 2019, SKELETAL RADIOL, V48, P239, DOI 10.1007/s00256-018-3016-3; Waite S, 2017, AM J ROENTGENOL, V208, P739, DOI 10.2214/AJR.16.16963; Wasserstein D, 2014, J BONE JOINT SURG AM, V96A, P144, DOI 10.2106/JBJS.L.01691; Zhu XQ, 2004, ARTIF INTELL REV, V22, P177, DOI 10.1007/s10462-004-0751-8	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248809	10.1371/journal.pone.0248809	http://dx.doi.org/10.1371/journal.pone.0248809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793601	Green Published, gold			2022-12-26	WOS:000636467000041
J	Inbaraj, LR; George, CE; Chandrasingh, S				Inbaraj, Leeberk Raja; George, Carolin Elizabeth; Chandrasingh, Sindhulina			Seroprevalence of COVID-19 infection in a rural district of South India: A population-based seroepidemiological study	PLOS ONE			English	Article								Objectives We aimed to estimate the seroprevalence of COVID-19 in a rural district of South India, six months after the index case. Methodology We conducted a cross-sectional study of 509 adults aged more than 18 years. From all the four subdistricts, two grampanchayats (administrative cluster of 5-8 villages) were randomly selected followed by one village through convenience. The participants were invited for the study to the community-based study kiosk set up in all the eight villages through village health committees. We collected socio-demographic characteristics and symptoms using a mobile application-based questionnaire, and we tested samples for the presence of IgG antibodies for SARS CoV-2 using an electro chemiluminescent immunoassay. We calculated age-gender adjusted and test performance adjusted seroprevalence. Results The age-and gender-adjusted seroprevalence was 8.5% (95% CI 6.9%- 10.8%). The unadjusted seroprevalence among participants with hypertension and diabetes was 16.3% (95% CI:9.2-25.8) and 10.7% (95% CI: 5.5-18.3) respectively. When we adjusted for the test performance, the seroprevalence was 6.1% (95% CI 4.02-8.17). The study estimated 7 (95% CI 1:4.5-1:9) undetected infected individuals for every RT-PCR confirmed case. Infection Fatality Rate (IFR) was calculated as 12.38 per 10000 infections as on 22 October 2020. History of self-reported symptoms and education were significantly associated with positive status (p < 0.05) Conclusion A significant proportion of the rural population in a district of south India remains susceptible to COVID-19. A higher proportion of susceptible, relatively higher IFR and a poor tertiary healthcare network stress the importance of sustaining the public health measures and promoting early access to the vaccine are crucial to preserving the health of this population. Low population density, good housing, adequate ventilation, limited urbanisation combined with public, private and local health leadership are critical components of curbing future respiratory pandemics.	[Inbaraj, Leeberk Raja; George, Carolin Elizabeth] Bangalore Baptist Hosp, Div Community Hlth & Family Med, Bangalore, Karnataka, India; [Chandrasingh, Sindhulina] Bangalore Baptist Hosp, Dept Microbiol, Bangalore, Karnataka, India		George, CE (corresponding author), Bangalore Baptist Hosp, Div Community Hlth & Family Med, Bangalore, Karnataka, India.	carolinelizabethj@gmail.com	Chandrasingh, Sindhulina/AAF-9473-2022; Inbaraj, Leeberk Raja/AAY-9266-2020; Chandrasingh, Sindhulina/AFK-2194-2022	Chandrasingh, Sindhulina/0000-0001-8149-5727; Inbaraj, Leeberk Raja/0000-0001-8642-1348; Chandrasingh, Sindhulina/0000-0001-8149-5727	Azim Premji Foundation	Azim Premji Foundation	Authors were supported by Azim Premji Foundation (https://azimpremjifoundation.org/) This was not a research grant but a philanthropic support for COVID response. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, POPULATION BASED AGE; [Anonymous], 2020, KARNATAKA COVID 19 D; [Anonymous], 2020, WHO INDIAN SITUATION; [Anonymous], 2020, WHO CORONAVIRUS DIS; [Anonymous], 2019, WHO CHARACTERIZES CO; Babu GR., 2020, MEDRXIV, DOI [10.1101/2020.12.04.20243949, DOI 10.1101/2020.12.04.20243949]; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; George CE, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821000273; Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142; Khan SMS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239303; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Malani A, 2021, LANCET GLOB HEALTH, V9, pE110, DOI 10.1016/S2214-109X(20)30467-8; Mallapaty S, 2020, NATURE, V582, P467, DOI 10.1038/d41586-020-01738-2; Murhekar MV, 2020, INDIAN J MED RES, V152, P48, DOI 10.4103/ijmr.IJMR_3290_20; Stoesser N, 2020, LANCET INFECT DIS, V20, P1390, DOI 10.1016/S1473-3099(20)30634-4; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849; World Health Organization, 2020, COORDINATED GLOBAL R; Yanes-Lane M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241536; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	19	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249247	10.1371/journal.pone.0249247	http://dx.doi.org/10.1371/journal.pone.0249247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788873	gold, Green Published			2022-12-26	WOS:000636354600014
J	Wasana, KGP; Attanayake, AP; Weerarathna, TP; Jayatilaka, KAPW				Wasana, Keddagoda Gamage Piyumi; Attanayake, Anoja Priyadarshani; Weerarathna, Thilak Priyantha; Jayatilaka, Kamani Ayoma Perera Wijewardana			Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; GLUCOSE-TOLERANCE; SENSITIVITY; RATIO; TRIGLYCERIDE; ASSOCIATIONS; INFLAMMATION; INDEXES	Background Insulin resistance (IR) has been considered as a therapeutic target in the management of type 2 diabetes mellitus (T2DM). Readily available, simple and low cost measures to identify individuals with IR is of utmost importance for clinicians to plan optimal management strategies. Research on the associations between surrogate markers of IR and routine clinical and lipid parameters have not been carried out in Sri Lanka, a developing country with rising burden of T2DM with inadequate resources. Therefore, we aimed to study the utility of readily available clinical parameters such as age, body mass index (BMI), waist circumference (WC) and triglyceride to high density lipoprotein cholesterol ratio (TG/HDL-C) in the fasting lipid profile in predicting IR in a cohort of patients with newly diagnosed T2DM in Sri Lanka. Methods and findings We conducted a community based cross sectional study involving of 147 patients (age 30-60 years) with newly diagnosed T2DM in a suburban locality in Galle district, Sri Lanka. Data on age, BMI, WC, fasting plasma glucose (FPG) concentration, fasting insulin concentration and serum lipid profile were collected from each subject. The indirect IR indices namely homeostasis model assessment (HOMA), quantitative insulin sensitivity check index (QUICKI) and McAuley index (MCA) were estimated. Both clinical and biochemical parameters across the lowest and the highest fasting insulin quartiles were compared using independent sample t-test. Linear correlation analysis was performed to assess the correlation between selected clinical parameters and indirect IR indices. The area under the receiver operating characteristic (ROC) curve was obtained to calculate optimal cut-off values for the clinical markers to differentiate IR. BMI (p<0.001) and WC (p = 0.01) were significantly increased whereas age (p = 0.06) was decreased and TG/HDL-C (p = 0.28) was increased across the insulin quartiles. BMI and WC were significantly correlated (p<0.05) with HOMA, QUICKI and MCA. Out of the clinical parameters, age showed a borderline significant correlation with QUICKI and TG/HDL-C showed a significant correlation only with MCA. The area under ROC of BMI was 0.728 (95% CI 0.648-0.809; p<0.001) and for WC, it was 0.646 (95% CI 0.559-0.734; p = 0.003). The optimized cut-off value for BMI and WC were 24.91 kg/m(2) and 81.5 cm respectively to differentiate the patients with IR or ID. Study limitations include small sample size due to recruitment of patients only from a limited geographical locality of the country and not totally excluding of the possibility of inclusion of some patients with slowly progressive type 1 DM or Latent onset diabetes of adulthood from the study population. Conclusions The results revealed that there was a significant positive correlation between BMI, WC and HOMA while a significant negative correlation with QUICKI and MCA among the cohort of patients with newly diagnosed T2DM. The cut-off values of BMI and WC as 24.91 kg/m(2) and 81.5 cm respectively could be used as simple clinical parameters to identify IR in newly diagnosed patients with T2DM. Our results could be beneficial in rational decision making in the management of newly diagnosed patients with T2DM in limited resource settings.	[Wasana, Keddagoda Gamage Piyumi; Attanayake, Anoja Priyadarshani; Jayatilaka, Kamani Ayoma Perera Wijewardana] Univ Ruhuna, Dept Biochem, Fac Med, Galle, Sri Lanka; [Weerarathna, Thilak Priyantha] Univ Ruhuna, Dept Med, Fac Med, Galle, Sri Lanka	University Ruhuna; University Ruhuna	Weerarathna, TP (corresponding author), Univ Ruhuna, Dept Med, Fac Med, Galle, Sri Lanka.	thilak.priyantha@yahoo.com	Jayatilaka, Kamani Ayoma Perera Wijewardena/AGY-8938-2022	Weerarathna, Thilak/0000-0003-0047-6669	National Research Council, Sri Lanka (NRC) [17-029]	National Research Council, Sri Lanka (NRC)	This work was supported by National Research Council, Sri Lanka (NRC grant number, 17-029). The funder provided support in the form of stipend for the author KGPW, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; ANDERSEN L, 1993, CLIN CHEM, V39, P578; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; ASSMANN G, 1983, CLIN CHEM, V29, P2026; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Brogna A, 2006, AGING CLIN EXP RES, V18, P493; Bryhni B, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-21; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Cheng YH, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000008126, 10.1097/md.0000000000008126]; Chung JO, 2012, KOREAN J INTERN MED, V27, P66, DOI 10.3904/kjim.2012.27.1.66; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Gong Yuan, 2014, Sichuan Da Xue Xue Bao Yi Xue Ban, V45, P524; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Gutch Manish, 2015, Indian J Endocrinol Metab, V19, P160, DOI 10.4103/2230-8210.146874; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; International Diabetes Federation, 2021, IDF DIAB ATL TEB; Iwani AKNZ, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/8586167; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Mirzaalian Yaser, 2019, Arch Med Sci Atheroscler Dis, V4, pe32, DOI 10.5114/amsad.2019.84411; ROESCHLA.P, 1974, Z KLIN CHEM KLIN BIO, V12, P226; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Stanimirovic J, 2015, CLIN LIPIDOL, V10, P167, DOI 10.2217/CLP.15.8; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; Thong EP, 2020, LANCET DIABETES ENDO, V8, P134, DOI 10.1016/S2213-8587(19)30345-6; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Wahlefeld AW., 1974, METHOD ENZYMATIC ANA, P1825; Miralles CSW, 2015, NUTR HOSP, V31, P2115, DOI 10.3305/nh.2015.31.5.7773; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248469	10.1371/journal.pone.0248469	http://dx.doi.org/10.1371/journal.pone.0248469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788827	Green Published, gold			2022-12-26	WOS:000636354600046
J	Madec, M; Rosati, E; Lallement, C				Madec, Morgan; Rosati, Elise; Lallement, Christophe			Feasibility and reliability of sequential logic with gene regulatory networks	PLOS ONE			English	Article							DESIGN AUTOMATION; CONSTRUCTION; SIMULATION; REDUNDANCY; WORKFLOW	Gene regulatory networks exhibiting Boolean behaviour, e.g. AND, OR or XOR, have been routinely designed for years. However, achieving more sophisticated functions, such as control or computation, usually requires sequential circuits or so-called state machines. For such a circuit, outputs depend both on inputs and the current state of the system. Although it is still possible to design such circuits by analogy with digital electronics, some particularities of biology make the task trickier. The impact of two of them, namely the stochasticity of biological processes and the inhomogeneity in the response of regulation mechanisms, are assessed in this paper. Numerical simulations performed in two use cases point out high risks of malfunctions even for designed GRNs functional from a theoretical point of view. Several solutions to improve reliability of such systems are also discussed.	[Madec, Morgan; Rosati, Elise; Lallement, Christophe] Univ Strasbourg, Lab Engn Sci Comp Sci & Imaging, CNRS, UMR 7357, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Madec, M (corresponding author), Univ Strasbourg, Lab Engn Sci Comp Sci & Imaging, CNRS, UMR 7357, Illkirch Graffenstaden, France.	morgan.madec@unistra.fr		LALLEMENT, christophe/0000-0002-0708-7212				Alon U., 2006, INTRO SYSTEMS BIOL D; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Andrews LB, 2018, SCIENCE, V361, P1217, DOI 10.1126/science.aap8987; Ashenden P.J., 2010, DESIGNERS GUIDE VHDL, V3rd; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Beal J, 2012, ACS SYNTH BIOL, V1, P317, DOI 10.1021/sb300030d; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Chuang CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-63; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fernandez-Nino M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180155; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fritz Georg, 2007, Syst Synth Biol, V1, P89, DOI 10.1007/s11693-007-9006-8; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goerlich R., 2018, EDP SCI, P39; Groves B, 2016, NAT NANOTECHNOL, V11, P287, DOI [10.1038/NNANO.2015.278, 10.1038/nnano.2015.278]; Guodong Wang, 2009, 2009 Asia-Pacific Conference on Computational Intelligence and Industrial Applications (PACIIA 2009), P123, DOI 10.1109/PACIIA.2009.5406480; Hassoun S, 2012, DES AUT TEST EUROPE, P242; Hillenbrand P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068345; Horowitz P., 2015, ART ELECT; Hoteit I, 2012, BIOSYSTEMS, V109, P57, DOI 10.1016/j.biosystems.2012.01.004; Jiang H, 2011, DES AUT CON, P836; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Khanin R, 2007, LECT NOTES COMPUT SC, V4695, P1; Konkoli Z, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-10; Koren I., 2010, FAULT TOLERANT SYSTE; Lala P. K, 2001, SELF CHECKING FAULT; Lin CL, 2018, J BIOL ENG, V12, DOI 10.1186/s13036-018-0109-4; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Madec M, 2016, J COMPUT BIOL, V23, P841, DOI 10.1089/cmb.2015.0229; Mardanlou V, 2014, IEEE DECIS CONTR P, P4605, DOI 10.1109/CDC.2014.7040108; Meister Arwen, 2014, Quant Biol, V2, P1; Micheli GDe, 1994, SYNTHESIS OPTIMIZATI; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Oishi K, 2014, ACS SYNTH BIOL, V3, P652, DOI 10.1021/sb4001799; Padirac A, 2012, P NATL ACAD SCI USA, V109, pE3212, DOI 10.1073/pnas.1212069109; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rodrigo Guillermo, 2007, Syst Synth Biol, V1, P183, DOI 10.1007/s11693-008-9017-0; Rosati E, 2016, LECT NOTES COMPUT SC, V9597, P184, DOI 10.1007/978-3-319-31204-0_13; Ruijters E, 2015, COMPUT SCI REV, V15-16, P29, DOI 10.1016/j.cosrev.2015.03.001; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shin J, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199401; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Varde P.V., 2015, DIGITAL AVIONICS HDB; Wang BJ, 2013, BIOSENS BIOELECTRON, V40, P368, DOI 10.1016/j.bios.2012.08.011; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhang JZ, 2012, ADV EXP MED BIOL, V751, P279, DOI 10.1007/978-1-4614-3567-9_13	54	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249234	10.1371/journal.pone.0249234	http://dx.doi.org/10.1371/journal.pone.0249234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784367	Green Published, gold			2022-12-26	WOS:000636359600057
J	Neate-Clegg, MHC; Stuart, SN; Mtui, D; Sekercioglu, CH; Newmark, WD				Neate-Clegg, Montague H. C.; Stuart, Simon N.; Mtui, Devolent; Sekercioglu, Cagan H.; Newmark, William D.			Afrotropical montane birds experience upslope shifts and range contractions along a fragmented elevational gradient in response to global warming	PLOS ONE			English	Article							CLIMATE-CHANGE; INTERSPECIFIC AGGRESSION; HABITAT FRAGMENTATION; EXTINCTION; MOUNTAINS; IMPACT; DISTRIBUTIONS; BIODIVERSITY; COMMUNITIES; SONGBIRDS	Global warming is predicted to result in upslope shifts in the elevational ranges of bird species in montane habitats. Yet few studies have examined changes over time in the elevational distribution of species along fragmented gradients in response to global warming. Here, we report on a resurvey of an understory bird community in the Usambara Mountains in Tanzania, along a forested elevational gradient that has been fragmented over the last 200 years. In 2019, we resurveyed seven sites, ranging in elevation from 360 m to 2110 m, that were originally surveyed between 1979 and 1981. We calculated differences in mean elevation and lower and upper range limits for 29 species between the two time periods and corrected for possible differences in elevation due to chance. Over four decades, we documented a significant mean upslope shift across species of 93 m. This shift was smaller than the 125 m expected shift due to local climate warming. Of the 29 focal species, 19 shifted upslope, eight downslope, and two remained unchanged. Mean upslope shifts in species were driven largely by contracting lower range limits which moved significantly upslope on average across species by 183 m, while upper range limits shifted non-significantly upslope by 72 m, leading to a mean range contraction of 114 m across species. Community composition of understory bird species also shifted over time, with current communities resembling communities found historically at lower elevations. Past forest fragmentation in combination with the limited gap-crossing ability of many tropical understory bird species are very likely important contributory factors to the observed asymmetrical shifts in lower and upper elevational range limits. Re-establishing forested linkages among the largest and closest forest fragments in the Eastern Arc Mountains are critical to permitting species to shift upslope and to reduce further elevational range contractions over time.	[Neate-Clegg, Montague H. C.; Sekercioglu, Cagan H.] Univ Utah, Sch Biol Sci, Salt Lake City, UT 84112 USA; [Stuart, Simon N.] Synchron Earth, London, England; [Stuart, Simon N.] Rocha Int, London, England; [Stuart, Simon N.] IUCN SSC, David Attenborough Bldg, Cambridge, England; [Mtui, Devolent] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Sekercioglu, Cagan H.] Koc Univ, Fac Sci, Istanbul, Turkey; [Newmark, William D.] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Koc University; Utah System of Higher Education; University of Utah	Neate-Clegg, MHC (corresponding author), Univ Utah, Sch Biol Sci, Salt Lake City, UT 84112 USA.	monte.neate-clegg@utah.edu		Neate-Clegg, Montague/0000-0001-9753-6765; Sekercioglu, Cagan H./0000-0003-3193-0377; Newmark, William/0000-0002-0359-9763	JRS Biodiversity Foundation [60708_TAWIRI]; University of Utah Global Change & Sustainability Center	JRS Biodiversity Foundation; University of Utah Global Change & Sustainability Center	WDN received a JRS Biodiversity Foundation grant (#60708_TAWIRI; jrsbiodiversity. org). MHCNC received a research grant from the University of Utah Global Change & Sustainability Center (environment.utah.edu/programs-projects/student-funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe AF, 2019, ECOL EVOL, V9, P9609, DOI 10.1002/ece3.5491; Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boyce AJ, 2019, BEHAV ECOL, V30, P541, DOI 10.1093/beheco/ary194; Brodie JF, 2019, AM NAT, V193, P748, DOI 10.1086/702589; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Campos-Cerqueira M, 2017, ECOL EVOL, V7, P9914, DOI 10.1002/ece3.3520; CRU, 2019, CLIM RES UN U E ANGL; Avalos VD, 2015, GLOB ECOL CONSERV, V4, P459, DOI 10.1016/j.gecco.2015.08.004; Dulle HI, 2016, DIVERS DISTRIB, V22, P288, DOI 10.1111/ddi.12405; Elsen PR, 2018, P NATL ACAD SCI USA, V115, P6004, DOI 10.1073/pnas.1720141115; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Freeman BG, 2019, ECOGRAPHY, V42, P1832, DOI 10.1111/ecog.04606; Freeman BG, 2018, GLOBAL ECOL BIOGEOGR, V27, P1268, DOI 10.1111/geb.12774; Freeman BG, 2018, P NATL ACAD SCI USA, V115, P11982, DOI 10.1073/pnas.1804224115; Freeman BG, 2016, IBIS, V158, P726, DOI 10.1111/ibi.12384; Freeman BG, 2016, DIVERS DISTRIB, V22, P309, DOI 10.1111/ddi.12409; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Halley JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12283; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; Harris JBC, 2012, RAFFLES B ZOOL, P197; Harris JBC, 2011, IBIS, V153, P877, DOI 10.1111/j.1474-919X.2011.01166.x; International Union for Conservation of Nature (IUCN), 2013, GUID REINTR OTH CONS; Jankowski JE, 2013, J BIOGEOGR, V40, P950, DOI 10.1111/jbi.12041; Jankowski JE, 2013, ECOGRAPHY, V36, DOI 10.1111/j.1600-0587.2012.07785.x; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jarzyna MA, 2015, GLOBAL CHANGE BIOL, V21, P2942, DOI 10.1111/gcb.12885; Jones SEI, 2020, IBIS, V162, P814, DOI 10.1111/ibi.12793; Korfanta NM, 2012, ECOLOGY, V93, P2548, DOI 10.1890/11-1345.1; La Sorte FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098361; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Lister BC, 2018, P NATL ACAD SCI USA, V115, pE10397, DOI 10.1073/pnas.1722477115; Londono GA, 2017, FUNCT ECOL, V31, P204, DOI 10.1111/1365-2435.12697; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; McSweeney C., 2013, UNDP CTRY PROFILES T, V1, P27; Moller AP, 2010, GLOBAL CHANGE BIOL, V16, P1158, DOI 10.1111/j.1365-2486.2009.02035.x; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2015, AVIAN RES, V6, DOI 10.1186/s40657-015-0017-y; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neate-Clegg MHC, 2021, GLOBAL CHANGE BIOL, V27, P2254, DOI 10.1111/gcb.15567; Neate-Clegg MHC, 2018, BIOTROPICA, V50, P805, DOI 10.1111/btp.12596; Newmark WD, 2010, ANIM CONSERV, V13, P474, DOI 10.1111/j.1469-1795.2010.00366.x; Newmark W. D., 2002, CONSERVING BIODIVERS; NEWMARK WD, 1991, CONSERV BIOL, V5, P67, DOI 10.1111/j.1523-1739.1991.tb00389.x; Newmark WD, 2018, BIODIVERS CONSERV, V27, P1387, DOI 10.1007/s10531-018-1498-x; Newmark WD, 2017, P NATL ACAD SCI USA, V114, P9635, DOI 10.1073/pnas.1705834114; Newmark WD, 2011, P NATL ACAD SCI USA, V108, P11488, DOI 10.1073/pnas.1104955108; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Paxton EH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600029; Pfeifer M, 2017, NATURE, V551, P187, DOI 10.1038/nature24457; R Core Team, 2020, R LANG ENV STAT COMP; Rahbek C, 2019, SCIENCE, V365, P1108, DOI 10.1126/science.aax0149; REED JM, 1993, TRENDS ECOL EVOL, V8, P253, DOI 10.1016/0169-5347(93)90201-Y; Rosselli L, 2017, J FIELD ORNITHOL, V88, P211, DOI 10.1111/jofo.12204; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Salisbury CL, 2012, ECOL LETT, V15, P847, DOI 10.1111/j.1461-0248.2012.01806.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2019, P NATL ACAD SCI USA, V116, P9903, DOI 10.1073/pnas.1802732116; Sheard C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16313-6; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stouffer PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020543; Stuart SN, 1983, THESIS U CAMBRIDGE; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; van der Hoek Y, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2866; Ward MP, 2004, CONSERV BIOL, V18, P519, DOI 10.1111/j.1523-1739.2004.00494.x; White RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121849; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026; Garamszegi LZ, 2010, J PARASITOL, V96, P1197, DOI 10.1645/GE-2531.1	74	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248712	10.1371/journal.pone.0248712	http://dx.doi.org/10.1371/journal.pone.0248712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784307	Green Published, gold			2022-12-26	WOS:000636359600003
J	Sing'oei, V; Ochola, J; Owuoth, J; Otieno, J; Rono, E; Andagalu, B; Otieno, L; Nwoga, C; Copeland, NK; Lawlor, J; Yates, A; Imbach, M; Crowell, TA; Eller, LA; Kamau, E; Modjarrad, K; Cowden, J; Ake, J; Robb, ML; Polyak, CS				Sing'oei, Valentine; Ochola, Jew; Owuoth, John; Otieno, June; Rono, Eric; Andagalu, Ben; Otieno, Lucas; Nwoga, Chiaka; Copeland, Nathanial K.; Lawlor, John; Yates, Adam; Imbach, Michelle; Crowell, Trevor A.; Eller, Leigh Anne; Kamau, Edwin; Modjarrad, Kayvon; Cowden, Jessica; Ake, Julie; Robb, Merlin L.; Polyak, Christina S.			Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; LYMPHOCYTE SUBSETS; HEALTHY-ADULTS; CELL COUNT; POPULATION; WOMEN; AGE; HEMOGLOBIN; SEX	Background Clinical laboratory reference intervals (RIs) are essential for diagnosing and managing patients in routine clinical care as well as establishing eligibility criteria and defining adverse events in clinical trials, but may vary by age, gender, genetics, nutrition and geographic location. It is, therefore, critical to establish region-specific reference values in order to inform clinical decision-making. Methods We analyzed data from a prospective observational HIV incidence cohort study in Kombewa, Kenya. Study participants were healthy males and females, aged 18-35 years, without HIV. Median and 95% reference values (2.5(th) percentile to 97.5(th) percentile) were calculated for laboratory parameters including hematology, chemistry studies, and CD4 T cell count. Standard Deviation Ratios (SDR) and Bias Ratios (BR) are presented as measures of effect magnitude. Findings were compared with those from the United States and other Kenyan studies. Results A total of 299 participants were analyzed with a median age of 24 years (interquartile range: 21-28). Ratio of males to females was 0.9:1. Hemoglobin range (2.5(th)-97.5(th) percentiles) was 12.0-17.9 g/dL and 9.5-15.3 g/dL in men and women respectively. In the cohort, MCV range was 59-95fL, WBC 3.7-9.2x10(3)/mu L, and platelet 154-401x10(3)/mu L. Chemistry values were higher in males; the creatinine RI was 59-103 mu mol/L in males vs. 46-76 mu mol/L in females (BRUL>.3); and the alanine transferase range was 8.8-45.3 U/L in males vs. 7.5-36.8 U/L in females (SDR>.3). The overall CD4 T cell count RI was 491-1381 cells/mu L. Some parameters including hemoglobin, neutrophil, creatinine and ALT varied with that from prior studies in Kenya and the US. Conclusion This study not only provides clinical reference intervals for a population in Kisumu County but also highlights the variations in comparable settings, accentuating the requirement for region-specific reference values to improve patient care, scientific validity, and quality of clinical trials in Africa.	[Sing'oei, Valentine; Ochola, Jew; Owuoth, John] HJF Med Res Int, Kisumu, Kenya; [Sing'oei, Valentine; Ochola, Jew; Owuoth, John; Otieno, June; Rono, Eric; Andagalu, Ben; Otieno, Lucas; Copeland, Nathanial K.; Cowden, Jessica] US Army Med Res Directorate Africa, Kisumu, Kenya; [Otieno, June; Rono, Eric; Andagalu, Ben; Otieno, Lucas] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Nwoga, Chiaka; Lawlor, John; Yates, Adam; Imbach, Michelle; Crowell, Trevor A.; Eller, Leigh Anne; Kamau, Edwin; Ake, Julie; Polyak, Christina S.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Nwoga, Chiaka; Lawlor, John; Yates, Adam; Imbach, Michelle; Crowell, Trevor A.; Eller, Leigh Anne; Robb, Merlin L.; Polyak, Christina S.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Modjarrad, Kayvon] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Silver Spring, MD USA	Kenya Medical Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Polyak, CS (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Polyak, CS (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	cpolyak@hivresearch.org	Crowell, Trevor A./W-3904-2019	Crowell, Trevor A./0000-0001-5947-265X; Sing'oei, Valentine/0000-0001-9434-9630; Nwoga, Chiaka/0000-0002-4514-330X	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174, W81XWH-18-2-0040]; U.S. Department of Defense (DOD) [W81XWH-11-2-0174, W81XWH-18-2-0040]; U.S. National Institute of Allergy and Infectious Diseases	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement (W81XWH-11-2-0174; W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). This research was funded, in part, by the U.S. National Institute of Allergy and Infectious Diseases. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25.	Afolabi J K, 2017, J Int Assoc Provid AIDS Care, V16, P359, DOI 10.1177/2325957414530472; Ake JA, 2019, CLIN INFECT DIS, V69, P639, DOI 10.1093/cid/ciy981; Alemnji GA., 2010, OPEN CLIN CHEM J, V3, P66; [Anonymous], WHOCDSTB201915, P1392; [Anonymous], 2019 Kenya Population and Housing Census Results-Kenya National Bureau of Statistics; Bachtiar M., 2013, CURR GENET MED REP, V1, P162, DOI DOI 10.1007/S40142-013-0017-3; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1985, SCAND J HAEMATOL, V35, P77; Baz H., BIORXIV PREPRINT, DOI [10.1101/2020.07.15.204057, DOI 10.1101/2020.07.15.204057]; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; Crampin A C, 2011, Open AIDS J, V5, P74, DOI 10.2174/1874613601105010074; DiPiro JT, 2007, AMA MANUAL STYLE, V10th; DiPiro JT, 2014, PEDIAT NEONATAL DOSA, V21st; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Farhangi MA, 2013, J HEALTH POPUL NUTR, V31, P58; Handzel T, 2003, AM J TROP MED HYG, V69, P318, DOI 10.4269/ajtmh.2003.69.318; Hensley LE, 2005, CURR MOL MED, V5, P761, DOI 10.2174/156652405774962344; Ichihara K, 2010, CLIN CHEM LAB MED, V48, P1537, DOI 10.1515/CCLM.2010.319; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kenyan Ministry of Public Health, 2015, KENYA NATL STRATEG; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Klose N, 2007, CLIN VACCINE IMMUNOL, V14, P782, DOI 10.1128/CVI.00044-07; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Kulnigg-dabsch S., 2013, INFLAMM BOWEL DIS, V0, P1; Lee EH, 2021, AM J TROP MED HYG, V104, P12, DOI 10.4269/ajtmh.20-0541; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maini MK, 1996, GENITOURIN MED, V72, P27; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; NAETS JP, 1966, AM J PHYSIOL, V210, P315, DOI 10.1152/ajplegacy.1966.210.2.315; National AIDS and STI Control Programs (NASCOP), KENYA HIV ESTIMATES; National Malaria Control Programme M of H, 2015, KENYA MALARIA INDICA, P2; NCCLS, 2000, DEF DET REF INT CLIN, V20; null J.W, 1977, EXPLORATORY DATA ANA; Nyirenda MJ, 2016, INT HEALTH, V8, P157, DOI 10.1093/inthealth/ihw021; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Odhiambo GO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002784; Oh RC, 2017, AM FAM PHYSICIAN, V96, P709; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; Omuse G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235234; Omuse G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198444; Park MJ, 2013, PLATELETS, V24, P348, DOI 10.3109/09537104.2012.699641; Puppalwar G, 2015, OPEN ACCESS J CLIN T, V7, P23, DOI 10.2147/OAJCT.S77316; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Santagostino A, 1999, HAEMATOLOGICA, V84, P499; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Sheet F, 2019, PEOPLE GLOBAL HIV ST; Tembe N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097391; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	62	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249259	10.1371/journal.pone.0249259	http://dx.doi.org/10.1371/journal.pone.0249259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784358	Green Published, gold			2022-12-26	WOS:000636359600033
J	Steiner, W; Scholl, EM; Leisch, F; Hacklander, K				Steiner, Wolfgang; Schoell, Eva Maria; Leisch, Friedrich; Hacklaender, Klaus			Temporal patterns of roe deer traffic accidents: Effects of season, daytime and lunar phase	PLOS ONE			English	Article								Wildlife-related accidents, especially deer-vehicle accidents, pose a serious problem for road safety and animal protection in many countries. Knowledge of spatial and temporal patterns of deer-vehicle accidents is inevitable for accident analysis and mitigation efforts with temporal deer-vehicle accident data being much more difficult to obtain in sufficient data quality. We described the temporal patterns of roe deer (Capreolus capreolus) roadkills occurring in the period 2002-2006 in southeastern Austria. Using a comprehensive dataset, consisting of 11.771 data points, we examined the influence of different time units (i.e. season, month, day of week, day of year), illumination categories (coarse and fine temporal resolution) and lunar phases on deer-vehicle accidents by performing linear and generalized additive models. Thereby, we identified peak accident periods within the analyzed time units. Highest frequencies of deer-vehicle accidents occurred in November, May and October, on Fridays, and during nights. Relationships between lunar phases and roe deer-vehicle accidents were analysed, providing evidence for high frequencies of deer-vehicle accidents during full moon phases. We suggest that deer-vehicle accidents are dependent both on human activity in traffic and wildlife activity, which is in turn affected by phenology, intra- and interspecific competition, climatic and astronomical events. Our results highlight, that short-term mitigation measures (e.g. traffic controls and speed limits) can be highly effective to reduce deer-vehicle accidents, but should be flexibly adapted to specific temporal periods.	[Steiner, Wolfgang; Schoell, Eva Maria; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Boku, Austria; [Leisch, Friedrich] Univ Nat Resources & Life Sci, Inst Stat, Vienna, Boku, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steiner, W (corresponding author), Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Boku, Austria.	wolfgang.steiner@boku.ac.at	Leisch, Friedrich/A-6977-2013; Schöll, Eva Maria/AAR-2523-2020	Leisch, Friedrich/0000-0001-7278-1983; Schöll, Eva Maria/0000-0003-3096-5885	University of Natural Resources and Life Sciences, Vienna; Hunting Association of Burgenland (Burgenlandischer Jagdverband)	University of Natural Resources and Life Sciences, Vienna; Hunting Association of Burgenland (Burgenlandischer Jagdverband)	The publication was supported by the Open Access Publication Fund of the University of Natural Resources and Life Sciences, Vienna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ursula Nopp-Mayr for providing helpful comments on the original draft of the manuscript. We thank the Hunting Association of Burgenland (Burgenlandischer Jagdverband) for support.	ALLEN RE, 1976, J WILDLIFE MANAGE, V40, P317, DOI 10.2307/3800431; [Anonymous], 1996, KLIM KLIM BURG; [Anonymous], STAT JAGDJ 2002 2003; [Anonymous], ZAMG ZENTRALANSTALT; [Anonymous], TIME DATE MONDPHASEN; [Anonymous], BLJV. Burgenlandischer Landesjagdverband; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2015, INNOVATION TECHNOLOG; [Anonymous], USNO THE US NAVAL OB; [Anonymous], bmvit-Bundesministerium fur Verkehr Innovation und Technologie. Osterreich unterwegs 2013/2014: Ergebnisbericht zur osterreichweiten Mobilitatserhebung "Osterreich unterwegs; Apollonio M., 2010, EUROPEAN UNGULATES T; Barrientos R, 2020, ANIM CONSERV, V23, P343, DOI 10.1111/acv.12547; BEIER P, 1990, WILDLIFE MONOGR, P5; Benten A, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-019-1312-4; Bil M, 2020, J NAT CONSERV, V54, DOI 10.1016/j.jnc.2020.125798; Bil M, 2019, J ENVIRON MANAGE, V237, P297, DOI 10.1016/j.jenvman.2019.02.076; Bil M, 2017, BIOL CONSERV, V213, P167, DOI 10.1016/j.biocon.2017.07.012; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; BUSS IO, 1950, J MAMMAL, V31, P426, DOI 10.2307/1375111; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Canal D, 2019, BIODIVERS CONSERV, V28, P3239, DOI 10.1007/s10531-019-01817-5; CARBAUGH B, 1975, J WILDLIFE MANAGE, V39, P570, DOI 10.2307/3800400; CEDERLUND G, 1989, HOLARCTIC ECOL, V12, P39; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; D'Angelo GJ, 2006, WILDLIFE SOC B, V34, P1175, DOI 10.2193/0091-7648(2006)34[1175:EOWWRF]2.0.CO;2; Dal Compare L, 2007, ITAL J ANIM SCI, V6, P848, DOI 10.4081/ijas.2007.1s.848; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Decker D.J., 1990, Transactions of the Northeast Section of the Wildlife Society, V47, P21; Diaz-Varela ER, 2011, TRANSPORT RES D-TR E, V16, P281, DOI 10.1016/j.trd.2011.01.002; Donaldson BM, 2010, TRANSP RES RECORD, P18, DOI 10.3141/2147-03; Eiberle K., 1972, Schweizerische Zeitschrift fur Forstwesen, V123, P201; Ellenberg H., 1978, POPULATIONSOKOLOG S2; Englefield B, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100752; Finder RA, 1999, LANDSCAPE URBAN PLAN, V44, P77, DOI 10.1016/S0169-2046(99)00006-7; Forbes C., 2011, STAT DISTRIBUTIONS; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Gill RMA, 1990, GEMS INFORM SERIES; Gleason Jeffrey S., 1993, Prairie Naturalist, V25, P281; Graber R., 2019, WILD JAGD LANDESJAGD, P30; Griffin PC, 2005, BEHAV ECOL, V16, P938, DOI 10.1093/beheco/ari074; Gundersen H, 1998, WILDLIFE BIOL, V4, P103, DOI 10.2981/wlb.1998.007; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Gunson KE, 2003, P INT C EC TRANSP N, P355; Haikonen H, 2001, AM J PREV MED, V21, P209, DOI 10.1016/S0749-3797(01)00352-X; HARTWIG D, 1991, Z JAGDWISS, V37, P55, DOI 10.1007/BF02241648; Heigl F, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100832; Henke SE, 1997, WILDLIFE SOC B, V25, P291; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029510; Hubbard MW, 2000, J WILDLIFE MANAGE, V64, P707, DOI 10.2307/3802740; Hussain Anwar, 2007, Human-Wildlife Conflicts, V1, P89; Kammermayer KE, 1975, THESIS U GEORGIA; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; Knoflacher HM, 1980, STRASSENFORSCHUNG, V138; Kofler H, 1985, INT S ROUT FAUN SAUV, P93; KUFELD RC, 1988, J RANGE MANAGE, V41, P70, DOI 10.2307/3898794; Lagos L, 2012, EUR J WILDLIFE RES, V58, P661, DOI 10.1007/s10344-012-0614-6; Langbein J, 2006, NATL DEER VEHICLE CO; Langbein J., 2007, NATL DEER VEHICLE CO; Lavsund Sten, 1991, Alces, V27, P118; Lemon J., 2006, R R NEWS; Madsen AB, 2002, WILDLIFE BIOL, V8, P55, DOI 10.2981/wlb.2002.008; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Marcoux A, THESIS MICHIGAN STAT; McShea W.J., 1997, SCI OVERABUNDANCE DE; MICHAEL ED, 1970, TEX J SCI, V21, P417; Munoz-Delgado J, 2000, SALUD MENT, V23, P33; Myers WL, 2008, 7011 WARD WASH DEP F; Naugle DE, 1997, CAN FIELD NAT, V111, P595; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; Olsson MPO, 2008, LANDSCAPE URBAN PLAN, V85, P133, DOI 10.1016/j.landurbplan.2007.10.006; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; Perelberg A, 2003, J WILDLIFE MANAGE, V67, P485, DOI 10.2307/3802706; Pierce AM, 2010, THESIS U TENNESSEE; Pokorny Bostjan, 2006, Veterinarski Arhiv, V76, pS177; Ramakrishnan U., 2005, P 2005 INT C EC TRAN, P478; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Riginos C, 2018, WILDLIFE SOC B, V42, P119, DOI 10.1002/wsb.862; Riley S.J., 2006, RC1475 MICH DEP TRAN; Rodriguez-Morales B, 2013, ACCIDENT ANAL PREV, V60, P121, DOI 10.1016/j.aap.2013.07.032; ROOT BG, 1988, WILDLIFE SOC B, V16, P145; ROST GR, 1979, J WILDLIFE MANAGE, V43, P634, DOI 10.2307/3808741; Said S, 2009, OIKOS, V118, P1299, DOI 10.1111/j.1600-0706.2009.17346.x; Sarkar D, 2008, USE R, P1; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Sielecki LE, 2001, P INT C EC TRANSP CT, P473; Skolving H., 1987, P317; Snow NP, 2015, BIOL CONSERV, V181, P44, DOI 10.1016/j.biocon.2014.10.030; Steiner W, 2011, FORSCHUNGSARBEITEN O; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Thomas KP, 1966, THESIS SO ILLINOIS U; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Trouwborst A., 2018, N AM WILDLIFE POLICY, P425; Venables WN., 2002, MODERN APPL STAT S 4; Verkehr S, 2009, STRASSENVERWALTUNGEN; VINCENT JP, 1988, Z JAGDWISS, V34, P63, DOI 10.1007/BF02241282; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WAHLSTROM LK, 1995, J ZOOL, V235, P455, DOI 10.1111/j.1469-7998.1995.tb01762.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	101	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249082	10.1371/journal.pone.0249082	http://dx.doi.org/10.1371/journal.pone.0249082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784325	Green Published			2022-12-26	WOS:000636359600017
J	Diehl, RM; Gourevitch, JD; Drago, S; Wemple, BC				Diehl, Rebecca M.; Gourevitch, Jesse D.; Drago, Stephanie; Wemple, Beverley C.			Improving flood hazard datasets using a low-complexity, probabilistic floodplain mapping approach	PLOS ONE			English	Article							INUNDATION; RISK; HAND; UNCERTAINTY; RESOLUTION; DEM; MODELS	As runoff patterns shift with a changing climate, it is critical to effectively communicate current and future flood risks, yet existing flood hazard maps are insufficient. Modifying, extending, or updating flood inundation extents is difficult, especially over large scales, because traditional floodplain mapping approaches are data and resource intensive. Low-complexity floodplain mapping techniques are promising alternatives, but their simplistic representation of process falls short of capturing inundation patterns in all situations or settings. To address these needs and deficiencies, we formalize and extend the functionality of the Height Above Nearest Drainage (i.e., HAND) floodplain mapping approach into the probHAND model by incorporating an uncertainty analysis. With publicly available datasets, the probHAND model can produce probabilistic floodplain maps for large areas relatively rapidly. We describe the modeling approach and then provide an example application in the Lake Champlain Basin, Vermont, USA. Uncertainties translate to on-the-ground changes to inundated areas, or floodplain widths, in the study area by an average of 40%. We found that the spatial extent of probable inundation captured the distribution of observed and modeled flood extents well, suggesting that low-complexity models may be sufficient for representing inundation extents in support of flood risk and conservation mapping applications, especially when uncertainties in parameter inputs and process simplifications are accounted for. To improve the accuracy of flood hazard datasets, we recommend investing limited resources in accurate topographic datasets and improved flood frequency analyses. Such investments will have the greatest impact on decreasing model output variability, therefore increasing the certainty of flood inundation extents.	[Diehl, Rebecca M.; Wemple, Beverley C.] Univ Vermont, Dept Geog, Burlington, VT USA; [Diehl, Rebecca M.; Gourevitch, Jesse D.; Wemple, Beverley C.] Univ Vermont, Gund Inst Environm, Burlington, VT USA; [Gourevitch, Jesse D.; Drago, Stephanie] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Diehl, RM (corresponding author), Univ Vermont, Dept Geog, Burlington, VT USA.; Diehl, RM (corresponding author), Univ Vermont, Gund Inst Environm, Burlington, VT USA.	Rebecca.Diehl@uvm.edu			Lake Champlain Basin Program Technical Grant [L-2018-017]; Gund Institute for Environment at the University of Vermont; Nature Conservancy Vermont; National Science Foundation under VT EPSCoR Grant [NSF OIA 1556770]	Lake Champlain Basin Program Technical Grant; Gund Institute for Environment at the University of Vermont; Nature Conservancy Vermont; National Science Foundation under VT EPSCoR Grant	This work was funded by a Lake Champlain Basin Program Technical Grant to RMD and BCW (Project Code: L-2018-017; www.lcbp.org).Additional funding was provided to RMD by the Gund Institute for Environment at the University of Vermont (www.uvm.edu/gund). SD was supported in part by a grant from the Nature Conservancy Vermont (www.nature.org). JDG and BCW were supported in part by the National Science Foundation under VT EPSCoR Grant (NSF OIA 1556770; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari S, 2018, J HYDROL, V556, P539, DOI 10.1016/j.jhydrol.2017.11.036; Alfonso L, 2016, WATER RESOUR RES, V52, P1026, DOI 10.1002/2015WR017378; Annis A, 2019, HYDROLOG SCI J, V64, P525, DOI 10.1080/02626667.2019.1591623; [Anonymous], 2013, HIGH WATER MARKS FLO; [Anonymous], 2018, LIDAR BASE SPECIFICA, DOI [DOI 10.3133/TM11B4, 10.3133/tm11b4]; [Anonymous], 2002, FLOW FREQUENCY CHARA; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Brody SD, 2013, NAT HAZARDS REV, V14, P89, DOI [10.1061/(ASCE)NH.1527-6996.0000091, 10.1061/(ASCE)NH.1527-6996.8888891]; Burby R. J., 2001, Environmental Hazards, V3, P111; Cook A, 2009, J HYDROL, V377, P131, DOI 10.1016/j.jhydrol.2009.08.015; De Roo APJ, 2000, HYDROL PROCESS, V14, P1981, DOI [10.1002/1099-1085(20000815/30)14:11/12<1981::AID-HYP49>3.0.CO;2-F, 10.1002/1099-1085(20000815/30)14:11/12&lt;1981::AID-]; DuBois and King, 2017, FLOOD STUDY MAD RIVE; Ferencevic MV, 2012, RIVER RES APPL, V28, P1394, DOI 10.1002/rra.1523; Garousi-Nejad I, 2019, WATER RESOUR RES, V55, P7983, DOI 10.1029/2019WR024837; Godbout L, 2019, J AM WATER RESOUR AS, V55, P952, DOI 10.1111/1752-1688.12783; Gourevitch JD, 2020, GLOBAL ENVIRON CHANG, V61, DOI 10.1016/j.gloenvcha.2020.102050; Hall JW, 2005, J HYDRAUL ENG-ASCE, V131, P117, DOI 10.1061/(ASCE)0733-9429(2005)131:2(117); Highfield WE, 2013, RISK ANAL, V33, P186, DOI 10.1111/j.1539-6924.2012.01840.x; Horritt MS, 2002, J HYDROL, V268, P87, DOI 10.1016/S0022-1694(02)00121-X; Hrachowitz M, 2013, HYDROLOG SCI J, V58, P1198, DOI 10.1080/02626667.2013.803183; Hunter NM, 2007, GEOMORPHOLOGY, V90, P208, DOI 10.1016/j.geomorph.2006.10.021; Jafarzadegan K, 2020, ENVIRON MODELL SOFTW, V125, DOI 10.1016/j.envsoft.2019.104613; Jafarzadegan K, 2019, GEOMORPHOLOGY, V324, P48, DOI 10.1016/j.geomorph.2018.09.024; Jafarzadegan K, 2017, J HYDROL, V550, P650, DOI 10.1016/j.jhydrol.2017.04.053; Johnson JM, 2019, NAT HAZARD EARTH SYS, V19, P2405, DOI 10.5194/nhess-19-2405-2019; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Liu YY, 2018, J AM WATER RESOUR AS, V54, P770, DOI 10.1111/1752-1688.12660; Luke A, 2018, NAT HAZARD EARTH SYS, V18, P1097, DOI 10.5194/nhess-18-1097-2018; Maidment DR., 2016, NATL WATER CTR INNOV, P26; Mallakpour I, 2015, NAT CLIM CHANGE, V5, P250, DOI [10.1038/nclimate2516, 10.1038/NCLIMATE2516]; Manners R, 2013, J GEOPHYS RES-EARTH, V118, P65, DOI 10.1029/2011JF002188; Merwade V, 2008, J HYDROL ENG, V13, P608, DOI 10.1061/(ASCE)1084-0699(2008)13:7(608); Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; National Research Council, 2009, MAPP ZON IMPR FLOOD, DOI [10.17226/12573, DOI 10.17226/12573]; Nobre AD, 2016, HYDROL PROCESS, V30, P320, DOI 10.1002/hyp.10581; O'Hanley JR, 2011, J ENVIRON MANAGE, V92, P3112, DOI 10.1016/j.jenvman.2011.07.027; Opperman JJ, 2010, J AM WATER RESOUR AS, V46, P211, DOI 10.1111/j.1752-1688.2010.00426.x; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Papaioannou G., 2017, ADV GEOSCI, V44, P23; Pralle S, 2019, CLIMATIC CHANGE, V152, P227, DOI 10.1007/s10584-018-2287-y; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Rinaldi M, 2016, AQUAT SCI, V78, P17, DOI 10.1007/s00027-015-0438-z; Ruhi A, 2018, NAT SUSTAIN, V1, P198, DOI 10.1038/s41893-018-0047-7; Saksena S, 2015, J HYDROL, V530, P180, DOI 10.1016/j.jhydrol.2015.09.069; Sangwan N, 2015, J AM WATER RESOUR AS, V51, P1286, DOI 10.1111/1752-1688.12306; Savage JTS, 2016, HYDROL PROCESS, V30, P2014, DOI 10.1002/hyp.10749; Seavy N.E., 2009, ECOL RESTOR, V27, P330, DOI DOI 10.3368/ER.27.3.330; Serinaldi F, 2015, ADV WATER RESOUR, V77, P17, DOI 10.1016/j.advwatres.2014.12.013; Singh NK, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab1827; Smemoe CM, 2007, J AM WATER RESOUR AS, V43, P359, DOI 10.1111/j.1752-1688.2007.00028.x; Speckhann GA, 2018, HYDROLOG SCI J, V63, P87, DOI 10.1080/02626667.2017.1409896; Straatsma MW, 2008, INT J REMOTE SENS, V29, P1595, DOI 10.1080/01431160701736455; Straatsma MW, 2019, NAT HAZARD EARTH SYS, V19, P1167, DOI 10.5194/nhess-19-1167-2019; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Tarboton DG, 2005, TERRAIN ANAL USING D; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Trueheart ME, 2019, SIMULATING BRIDGE RI, DOI [10.1016/j.scitotenv.2019.134046, DOI 10.1016/J.SCITOTENV.2019.134046]; Watson KB, 2016, ECOL ECON, V130, P16, DOI 10.1016/j.ecolecon.2016.05.015; Werner MGF, 2005, J HYDROL, V314, P139, DOI 10.1016/j.jhydrol.2005.03.012; Wing OEJ, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaac65; Zhang JQ, 2018, J AM WATER RESOUR AS, V54, P820, DOI 10.1111/1752-1688.12623; Zheng X, 2018, WATER RESOUR RES, V54, P10013, DOI [10.1029/2018wr023457, 10.1029/2018WR023457]; Zheng X, 2018, J AM WATER RESOUR AS, V54, P785, DOI 10.1111/1752-1688.12661	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248683	10.1371/journal.pone.0248683	http://dx.doi.org/10.1371/journal.pone.0248683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780467	Green Published, gold			2022-12-26	WOS:000636336800012
J	Teshale, AB; Tesema, GA; Tessema, ZT				Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Tessema, Zemenu Tadesse			Spatial variations and associated factors of knowledge of ORS packet or pre-packaged liquids for the management of diarrhea among women of reproductive age in Ethiopia: A spatial and multilevel analysis	PLOS ONE			English	Article								Background Even though diarrhea is not lethal by itself, the lack of knowledge about its management results in devastating complications such as dehydration and lastly death. Using an oral rehydration solution (ORS) is an easy, inexpensive, and most reliable way of treating dehydration and reducing diarrhea-related mortalities. The literature revealed that Knowledge of ORS packet or pre-packaged liquids is a very important and critical factor for the utilization of ORS during the management of diarrhea. Methods We used the 2016 Ethiopian Demographic and Health Survey data, which is the fourth survey conducted by the Central Statistical Agency. A total weighted sample of 7590 reproductive-age women who gave birth within five years preceding the survey was used. Multilevel logistic regression analysis was done to assess factors associated with knowledge of ORS packet or pre-packaged liquids. Arc GIS version 10.3 and Kuldorff's SaTScan version 9.6 software were used for the spatial analysis. Results In the multilevel analysis maternal education, media exposure, residence, community illiteracy level, and region were significantly associated with knowledge of ORS packet or pre-packaged liquids. Besides, knowledge of ORS packet or pre-packaged liquids for the management of diarrhea was not random in Ethiopia (with Moran's Index = 0.46 and p-value <0.001), and the primary clusters spatial window was located in SNNPR, most parts of the Oromia region, and eastern parts of the Gambela region. Conclusion In this study knowledge of ORS packet or pre-packaged liquids was not random across the country. Lack of formal education, lack of media exposure, being from a rural area, and being from communities with a higher illiteracy level was associated with lower odds of knowledge of ORS packet or pre-packaged liquids. Therefore, special emphasis should be given to these high-risk groups and the hot spot regions (SNNPR, most parts of the Oromia region, and eastern parts of the Gambela region). Moreover, distributing information through different media regarding ORS packet or pre-packaged liquids is necessary.	[Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Tessema, Zemenu Tadesse] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	achambir08@gmail.com	Tadesse, Zemenu/ABG-1690-2021; Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Abdinia B, 2014, ARCH PEDIATR INFECT, V2, DOI 10.5812/pedinfect.17581; Agbolade M. O., 2015, African Journal of Biomedical Research, V18, P7; ANSELIN L, 1992, ANN REGIONAL SCI, V26, P19, DOI 10.1007/BF01581478; Bello DA., KNOWLEDGE USE ORAL R; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, DEM HLTH SURV 2016; Desta BK, 2017, NURS RES PRACT, V2017, DOI 10.1155/2017/8084548; Dodicho T., 2016, J HLTH MED NURS, V27, P71; Ghatam A., 2016, INT J COMMUNITY MED, V3, P1487, DOI [10.18203/2394-6040.ijcmph20161616, DOI 10.18203/2394-6040.IJCMPH20161616]; GIBBONS E, 1994, PUBLIC HEALTH REP, V109, P428; Hackett KM, 2015, MATERN CHILD NUTR, V11, P173, DOI 10.1111/mcn.12007; Kulldorff M, 2018, SATSCANTM USER GUIDE; Lamberti LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130845; Mengistie B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1029; Mitasova H, 1999, GEOGRAPHICAL INFORM, V1; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Ogunrinde OG, 2012, J TROP PEDIATRICS, V58, P143, DOI 10.1093/tropej/fmr048; Onwukwe S, 2016, S AFR FAM PRACT, V58, P42, DOI 10.1080/20786190.2015.1120933; Rao KV., KNOWLEDGE USE ORAL R; WHO, 2005, HDB IMCI INT MAN CHI; Wieczorek WF, 2009, WILEY INTERDISCIP RE, V1, P167, DOI 10.1002/wics.21; World Health Organization, 2017, STAT HLTH IN IND; Yasmin Mumtaz, 2014, Journal of the Dow University of Health Sciences, V8, P3	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247772	10.1371/journal.pone.0247772	http://dx.doi.org/10.1371/journal.pone.0247772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780468	Green Published, gold			2022-12-26	WOS:000636336800047
J	Park, Y; Park, YG; Lee, JH				Park, Yujeong; Park, Young-gyun; Lee, Joon-Ho			Comparison of life history parameters of two different genetic clusters of Bemisia tabaci MED (Hemiptera: Aleyrodidae) through single and cross mating	PLOS ONE			English	Article								Bemisia tabaci Mediterranean (Gennadius) (Hemiptera: Aleyrodidae) is an economically important insect pest worldwide. Previously, we have reported that most B. tabaci Mediterranean (MED) populations occurring in greenhouse tomatoes in Korea have been displaced from well-differentiated two genetic clusters (C1 and C2) to one (C2) during one-year period. To elucidate factors responsible for this phenomenon, we compared life history parameters of these two different genetic clusters through single and cross mating experiments on two different host plants, cucumber and tobacco, at 26 degrees C. Intrinsic rate of increase (r), finite rate of increase (lambda), and net reproductive rate (R-o) were significantly higher in the dominating cluster (C2) (0.247, 1.280, and 192.402, respectively on cucumber; 0.226, 1.253, and 133.792, respectively on tobacco) than in the other cluster (C1) (0.149, 1.161, and 50.539, respectively on cucumber; 0.145, 1.156, and 53.332, respectively on tobacco). Overall performances of cross mating groups, C2fC1m (C2 female x C1 male) and C1fC2m (C1 female x C2 male), were in-between those of C2 and C1, with C2fC1m performing better than C1fC2m. Thus, maternal inheritance appeared to be significantly associated with their life history parameters, with partial involvement of paternal inheritance. Our results demonstrated that the rapid displacement of genetic clusters of B. tabaci MED populations was clearly associated with differences in their life history parameters.	[Park, Yujeong; Park, Young-gyun; Lee, Joon-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul, South Korea; [Lee, Joon-Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul, South Korea.; Lee, JH (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	jh7lee@snu.ac.kr		Park, Young-gyun/0000-0002-6519-1069; Park, Yujeong/0000-0002-6422-3735	Rural Development Administration [PJ01194804]; Brain Korea 21 Plus	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Brain Korea 21 Plus	This research was funded by grants from the Rural Development Administration (project no. PJ01194804). Also, this study was partially supported by the Brain Korea 21 Plus.	Al-Zyoud F, 2005, J PEST SCI, V78, P25, DOI 10.1007/s10340-004-0063-4; Aregbesola OZ, 2020, J PEST SCI, V93, P1225, DOI 10.1007/s10340-020-01249-z; Aregbesola OZ, 2019, J PEST SCI, V92, P381, DOI 10.1007/s10340-018-1059-9; Bayhan E, 2006, PHYTOPARASITICA, V34, P235, DOI 10.1007/BF02980950; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bonato O, 2007, PHYSIOL ENTOMOL, V32, P50, DOI 10.1111/j.1365-3032.2006.00540.x; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; Chu D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04396; Czosnek H, 1997, ARCH VIROL, V142, P1391, DOI 10.1007/s007050050168; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, B ENTOMOL RES, V90, P103, DOI 10.1017/S0007485300000201; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Delatte H, 2005, B ENTOMOL RES, V95, P29, DOI 10.1079/BER2004337; Dinsdale A, 2012, B ENTOMOL RES, V102, P539, DOI 10.1017/S0007485312000077; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Fang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100423; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Guo JY, 2013, INSECT SCI, V20, P541, DOI 10.1111/j.1744-7917.2012.01546.x; Han EJ, 2013, J ASIA-PAC ENTOMOL, V16, P5, DOI 10.1016/j.aspen.2012.08.006; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Lee W, 2016, J ASIA-PAC ENTOMOL, V19, P23, DOI 10.1016/j.aspen.2015.11.006; Lee W, 2014, FLA ENTOMOL, V97, P155, DOI 10.1653/024.097.0121; Legg JP, 2002, MOL ECOL, V11, P1219, DOI 10.1046/j.1365-294X.2002.01514.x; LI TY, 1989, ENVIRON ENTOMOL, V18, P800, DOI 10.1093/ee/18.5.800; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Luan JB, 2008, ENTOMOL EXP APPL, V129, P316, DOI 10.1111/j.1570-7458.2008.00777.x; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; MITCHELL R, 1981, ANNU REV ENTOMOL, V26, P373, DOI 10.1146/annurev.en.26.010181.002105; Musa Peter D., 2005, Insect Science, V12, P25, DOI 10.1111/j.1672-9609.2005.00004.x; Nava-Camberos U, 2001, ENVIRON ENTOMOL, V30, P55, DOI 10.1603/0046-225X-30.1.55; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Maia ADN, 2014, J ECON ENTOMOL, V107, P432, DOI 10.1603/EC13222; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Park Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220327; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perring TM, 2006, ANN ENTOMOL SOC AM, V99, P598, DOI 10.1603/0013-8746(2006)99[598:CBOBAH]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Qiu Bao-li, 2003, Entomologia Sinica, V10, P43; Sas S, 2013, GUIDE SUS; Shah MMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077368; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Tsagkarakou A, 2003, MOL ECOL NOTES, V3, P196, DOI 10.1046/j.1471-8286.2003.00393.x; Xie M, 2011, J APPL ENTOMOL, V135, P252, DOI 10.1111/j.1439-0418.2010.01524.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Yang TC, 2006, J ECON ENTOMOL, V99, P691, DOI 10.1603/0022-0493-99.3.691; Zhang C, 2018, J INTEGR AGR, V17, P389, DOI [10.1016/S2095-3119(17)61773-8, 10.1016/s2095-3119(17)61773-8]; Zhao Q, 2014, ENTOMOL EXP APPL, V150, P19, DOI 10.1111/eea.12135	50	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248819	10.1371/journal.pone.0248819	http://dx.doi.org/10.1371/journal.pone.0248819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770138	gold, Green Published			2022-12-26	WOS:000634833500064
J	Rapp, J; Rath, P; Kilian, J; Brilisauer, K; Grond, S; Forchhammer, K				Rapp, Johanna; Rath, Pascal; Kilian, Joachim; Brilisauer, Klaus; Grond, Stephanie; Forchhammer, Karl			A bioactive molecule made by unusual salvage of radical SAM enzyme byproduct 5-deoxyadenosine blurs the boundary of primary and secondary metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; ESCHERICHIA-COLI; IDENTIFICATION; SUPERFAMILY; PHOSPHORYLASE; NUCLEOSIDASE; GENE; METHYLTHIOADENOSINE; 5'-DEOXYADENOSINE	5-Deoxyadenosine (5dAdo) is the byproduct of many radical S-adenosyl-L-methionine enzyme reactions in all domains of life. 5dAdo is also an inhibitor of the radical S-adenosyl-L-methionine enzymes themselves, making it necessary for cells to construct pathways to recycle or dispose of this toxic metabolite. However, the specific pathways involved have long remained unexplored. Recent research demonstrated a growth advantage in certain organisms by using 5dAdo or intermediates as a sole carbon source and elucidated the corresponding salvage pathway. We now provide evidence using supernatant analysis by GC-MS for another 5dAdo recycling route. Specifically, in the unicellular cyanobacterium Synechococcus elongatus PCC 7942 (S. elongatus), the activity of promiscuous enzymes leads to the synthesis and excretion first of 5-deoxyribose and subsequently of 7-deoxysedoheptulose. 7-Deoxysedoheptulose is an unusual deoxy-sugar, which acts as an antimetabolite of the shikimate pathway, thereby exhibiting antimicrobial and herbicidal activity. This strategy enables organisms with small genomes and lacking canonical gene clusters for the synthesis of secondary metabolites, like S. elongatus, to produce antimicrobial compounds from primary metabolism and enzymatic promiscuity. Our findings challenge the view of bioactive molecules as sole products of secondary metabolite gene clusters and expand the range of compounds that microorganisms can deploy to compete for their ecological niche.	[Rapp, Johanna; Brilisauer, Klaus; Forchhammer, Karl] Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbiol Organism Interact, Tubingen, Germany; [Rath, Pascal; Grond, Stephanie] Eberhard Karls Univ Tubingen, Inst Organ Chem, Tubingen, Germany; [Kilian, Joachim] Eberhard Karls Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbiol Organism Interact, Tubingen, Germany.	karl.forchhammer@uni-tuebinge.de			"Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg); Research Training Group "Molecular principles of bacterial survival strategies" [1708]; Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft) [ZUK 63]; DFG Cluster of Excellence [EXC 2124, 390838134]	"Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg); Research Training Group "Molecular principles of bacterial survival strategies"; Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft); DFG Cluster of Excellence(German Research Foundation (DFG))	The work is supported and funded by the "Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg), the Research Training Group 1708 "Molecular principles of bacterial survival strategies", and the Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft, ZUK 63). The work was further supported by infrastructural funding from the DFG Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections (project ID 390838134). We thank Dr Libera Lo Presti for critical reading of the article. We especially thank Tim Orthwein for fruitful discussions and Michaela Schuppe for the cultivation of Streptomyces setonensis.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Beaudoin GAW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05589-4; Blombach B, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00108; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Brilisauer K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08476-8; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Burnap Robert L., 2015, Life-Basel, V5, P348, DOI 10.3390/life5010348; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chattopadhyay MK, 2006, BIOCHEM BIOPH RES CO, V343, P203, DOI 10.1016/j.bbrc.2006.02.144; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Conradi FD, 2020, LIFE-BASEL, V10, DOI 10.3390/life10110252; Copeland A, 2014, COMPLETE SEQUENCE CH; Czerwik-Marcinkowska Joanna, 2011, Polish Botanical Journal, V56, P203; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Furtauer L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01912; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Golden SS, 2019, NEW ZEAL J BOT, V57, P70, DOI 10.1080/0028825X.2018.1551805; Herter T, 2006, APPL MICROBIOL BIOT, V70, P60, DOI 10.1007/s00253-005-0024-8; Holliday GL, 2018, METHOD ENZYMOL, V606, P1, DOI 10.1016/bs.mie.2018.06.004; Hughes JA, 2006, CAN J MICROBIOL, V52, P599, DOI 10.1139/W06-008; ITO T, 1971, CARBOHYD RES, V17, P375, DOI 10.1016/S0008-6215(00)82545-8; KAMATANI N, 1980, CANCER RES, V40, P4178; KOBORI Y, 1992, J ORG CHEM, V57, P5899, DOI 10.1021/jo00048a023; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lee JE, 2004, BIOCHEMISTRY-US, V43, P5159, DOI 10.1021/bi035492h; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Ma L, 2015, CHEM SCI, V6, P1414, DOI 10.1039/c4sc03540b; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Mattern H., 2018, BEITRAGE ALGEN BADEN, VI; Miller DV, 2018, MICROBIOL-SGM, V164, P969, DOI 10.1099/mic.0.000670; North JA, 2020, MOL MICROBIOL, V113, P923, DOI 10.1111/mmi.14459; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palmer LD, 2013, J BIOL CHEM, V288, P30693, DOI 10.1074/jbc.M113.500280; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; PLAGEMANN PGW, 1983, BIOCHEM PHARMACOL, V32, P1433, DOI 10.1016/0006-2952(83)90458-6; PRADEL E, 1988, J BACTERIOL, V170, P4916, DOI 10.1128/jb.170.10.4916-4923.1988; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rossi Federico, 2015, Life-Basel, V5, P1218, DOI 10.3390/life5021218; Sairam P, 2003, CARBOHYD RES, V338, P303, DOI 10.1016/S0008-6215(02)00464-0; SAVARESE TM, 1981, BIOCHEM PHARMACOL, V30, P189, DOI 10.1016/0006-2952(81)90077-0; SCHROEDER HR, 1972, BIOCHIM BIOPHYS ACTA, V273, P254, DOI 10.1016/0304-4165(72)90215-2; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2019, MICROB BIOTECHNOL, V12, P77, DOI 10.1111/1751-7915.13324; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Selim KA, 2018, P NATL ACAD SCI USA, V115, pE4861, DOI 10.1073/pnas.1803790115; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sugita C, 2007, PHOTOSYNTH RES, V93, P55, DOI 10.1007/s11120-006-9122-4; Suleimanova AD, 2015, APPL ENVIRON MICROB, V81, P6790, DOI 10.1128/AEM.01384-15; TURNER DH, 1960, BIOCHEM J, V74, P486, DOI 10.1042/bj0740486; Wang S. C., 2011, TRERDS BIOCH SCI, V32, P101; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; Yang YL, 2018, P NATL ACAD SCI USA, V115, pE12378, DOI 10.1073/pnas.1812871115; Zappia V, 1988, Adv Exp Med Biol, V250, P165; Zhang JT, 2013, ADV MATER RES-SWITZ, V781-784, P1184, DOI 10.4028/www.scientific.net/AMR.781-784.1184	61	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100621	10.1016/j.jbc.2021.100621	http://dx.doi.org/10.1016/j.jbc.2021.100621			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811856	Green Published, gold			2022-12-26	WOS:000672866400592
J	Ali, AAH; Abdel-Hafiz, L; Tundo-Lavalle, F; Hassan, SA; von Gall, C				Ali, Amira A. H.; Abdel-Hafiz, Laila; Tundo-Lavalle, Federica; Hassan, Soha A.; von Gall, Charlotte			P2Y(2) deficiency impacts adult neurogenesis and related forebrain functions	FASEB JOURNAL			English	Article						adult neurogenesis; olfaction; p-Akt; purinergic receptors; working memory	INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; GUT MICROBIOTA; RHEUMATOID-ARTHRITIS; OXIDATIVE-METABOLISM; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; TYROSYL RESIDUES; MYELOPEROXIDASE; NEUTROPHILS	Adult neurogenesis occurs particularly in the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ) of the lateral ventricle. This continuous addition of neurons to pre-existing neuronal networks is essential for intact cognitive and olfactory functions, respectively. Purinergic signaling modulates adult neurogenesis, however, the role of individual purinergic receptor subtypes in this dynamic process and related cognitive performance is poorly understood. In this study, we analyzed the role of P2Y(2) receptor in the neurogenic niches and in related forebrain functions such as spatial working memory and olfaction using mice with a targeted deletion of the P2Y(2) receptor (P2Y2(-/-)). Proliferation, migration, differentiation, and survival of neuronal precursor cells (NPCs) were analyzed by BrdU assay and immunohistochemistry; signal transduction pathway components were analyzed by immunoblot. In P2Y2(-/-) mice, proliferation of NPCs in the SGZ and the SVZ was reduced. However, migration, neuronal fate decision, and survival were not affected. Moreover, p-Akt expression was decreased in P2Y2(-/-) mice. P2Y2(-/-) mice showed an impaired performance in the Y-maze and a higher latency in the hidden food test. These data indicate that the P2Y(2) receptor plays an important role in NPC proliferation as well as in hippocampus-dependent working memory and olfactory function.	[Ali, Amira A. H.; Abdel-Hafiz, Laila; Tundo-Lavalle, Federica; Hassan, Soha A.; von Gall, Charlotte] Heinrich Heine Univ, Univ Hosp Dusseldorf, Inst Anat 2, Med Fac, Dusseldorf, Germany; [Hassan, Soha A.] Suez Univ, Zool Dept, Fac Sci, Suez, Egypt	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Egyptian Knowledge Bank (EKB); Suez University	von Gall, C (corresponding author), Heinrich Heine Univ, Med Fac, Inst Anat 2, Univ Str 1, D-40225 Dusseldorf, Germany.; von Gall, C (corresponding author), Heinrich Heine Univ, Univ Hosp Dusseldorf, Univ Str 1, D-40225 Dusseldorf, Germany.	charlotte.gall@uni-duesseldorf.de	Ali, Amira/AHB-8622-2022	Ali, Amira Amin Hassan/0000-0003-0058-0300; Hassan, Soha/0000-0001-8566-4727	Heinrich Heine University Duesseldorf	Heinrich Heine University Duesseldorf	The authors thank Hanna Bellert, Ralf Fassbender, Angelika Hallenberger, and Ursula Lammersen for excellent technical support. The authors also thank Prof. Joseph Huston for helpful discussions. The authors acknowledge support by the Heinrich Heine University Duesseldorf	Aherne CM, 2015, MUCOSAL IMMUNOL, V8, P1324, DOI 10.1038/mi.2015.22; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Arora AK, 2011, ADSORPT SCI TECHNOL, V29, P39, DOI 10.1260/0263-6174.29.1.39; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barry R, 2020, MUCOSAL IMMUNOL, V13, P322, DOI 10.1038/s41385-019-0235-4; BEAN RC, 1968, J GEN PHYSIOL, V52, P495, DOI 10.1085/jgp.52.3.495; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bendheim PE, 2002, J MOL NEUROSCI, V19, P213, DOI 10.1007/s12031-002-0036-0; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Cartwright IM, 2020, MUCOSAL IMMUNOL, V13, P230, DOI 10.1038/s41385-019-0237-2; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chami B, 2018, ARCH BIOCHEM BIOPHYS, V645, P61, DOI 10.1016/j.abb.2018.03.012; Chen MX, 2019, J FORMOS MED ASSOC, V118, pS10, DOI 10.1016/j.jfma.2018.09.007; Chen Y, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01339-3; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Churg A, 2012, AM J RESP CRIT CARE, V185, P34, DOI 10.1164/rccm.201103-0468OC; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Curtis VF, 2018, MOL BIOL CELL, V29, P2687, DOI 10.1091/mbc.E18-06-0377; Darkoh C, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00346-18; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; DECHATELET LR, 1976, BLOOD, V47, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeRoche TC, 2014, GASTROENTEROL REP, V2, P178, DOI 10.1093/gastro/gou031; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dowdell AS, 2020, MOL BIOL CELL, V31, P2249, DOI 10.1091/mbc.E20-05-0291; Ehrlich AM, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02023-y; Elliott SN, 1998, CAN J GASTROENTEROL, V12, P559, DOI 10.1155/1998/398384; FLIGIEL SEG, 1984, AM J PATHOL, V115, P418; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; Gao RY, 2021, MUCOSAL IMMUNOL, V14, P479, DOI 10.1038/s41385-020-00347-6; Grigorieva DV, 2016, B EXP BIOL MED+, V161, P495, DOI 10.1007/s10517-016-3446-7; Haselhorst Thomas, 2009, V534, P375, DOI 10.1007/978-1-59745-022-5_26; Heinecke JW, 2014, DIABETES, V63, P4001, DOI 10.2337/db14-1273; Hendrikx T, 2019, J INTERN MED, V286, P32, DOI 10.1111/joim.12892; Herraiz T, 2004, FREE RADICAL RES, V38, P323, DOI 10.1080/10611860310001648167; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Ilyasov IR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031131; Ji Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051579; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Kuenzig ME, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0054-z; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Lee JS, 2018, J BIOL CHEM, V293, P6039, DOI 10.1074/jbc.RA117.000269; Levy M, 2016, GENE DEV, V30, P1589, DOI 10.1101/gad.284091.116; LYMAR SV, 1995, CHEM RES TOXICOL, V8, P833, DOI 10.1021/tx00048a003; Manchanda K, 2018, ARTERIOSCL THROM VAS, V38, P1859, DOI 10.1161/ATVBAHA.118.311143; Matijasic M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082668; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meddows-Taylor S, 1999, CLIN DIAGN LAB IMMUN, V6, P345, DOI 10.1128/CDLI.6.3.345-351.1999; Mor M, 2003, ADV EXP MED BIOL, V527, P567; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Onyiah JC, 2018, J INNATE IMMUN, V10, P228, DOI 10.1159/000488914; Paoliello-Paschoalato AB, 2014, J IMMUNOL METHODS, V412, P70, DOI 10.1016/j.jim.2014.07.001; Phillipson M, 2019, TRENDS IMMUNOL, V40, P635, DOI 10.1016/j.it.2019.05.001; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosales C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1469780; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shurney D, 2019, AM J HEALTH PROMOT, V33, P821, DOI 10.1177/0890117119845711b; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; THOMAS EL, 1979, INFECT IMMUN, V25, P110, DOI 10.1128/IAI.25.1.110-116.1979; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Wang RX, 2020, P NATL ACAD SCI USA, V117, P11648, DOI 10.1073/pnas.1917597117; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wei ZL, 2003, J NEUROSCI RES, V73, P364, DOI 10.1002/jnr.10668; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Yisireyili M, 2017, NAGOYA J MED SCI, V79, P477, DOI 10.18999/nagjms.79.4.477; Zhang DC, 2019, BLOOD, V133, P2168, DOI 10.1182/blood-2018-11-844555; Zhang N, 2018, NUTRITION, V51-52, P80, DOI 10.1016/j.nut.2017.12.005; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	99	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21546	10.1096/fj.202002419RR	http://dx.doi.org/10.1096/fj.202002419RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817825	hybrid			2022-12-26	WOS:000645260100079
J	Gundorova, P; Kuznetcova, IA; Baydakova, GV; Stepanova, AA; Itkis, YS; Kakaulina, VS; Alferova, IP; Lyazina, LV; Andreeva, LP; Kanivets, I; Zakharova, EY; Kutsev, SI; Polyakov, AV				Gundorova, Polina; Kuznetcova, Irina A.; Baydakova, Galina, V; Stepanova, Anna A.; Itkis, Yulia S.; Kakaulina, Victoria S.; Alferova, Irina P.; Lyazina, Lidya, V; Andreeva, Lilya P.; Kanivets, Ilya; Zakharova, Ekaterina Y.; Kutsev, Sergey, I; Polyakov, Aleksander, V			BH4-deficient hyperphenylalaninemia in Russia	PLOS ONE			English	Article								A timely detection of patients with tetrahydrobiopterin (BH4) -deficient types of hyperphenylalaninemia (HPABH(4)) is important for assignment of correct therapy, allowing to avoid complications. Often HPABH(4) patients receive the same therapy as phenylalanine hydroxylase (PAH) -deficiency (phenylketonuria) patients-dietary treatment-and do not receive substitutive BH4 therapy until the diagnosis is confirmed by molecular genetic means. In this study, we present a cohort of 30 Russian patients with HPABH(4) with detected variants in genes causing different types of HPA. Family diagnostics and biochemical urinary pterin spectrum analyses were carried out. HPABH(4)A is shown to be the prevalent type, 83.3% of all HPABH(4) cases. The mutation spectrum for the PTS gene was defined, the most common variants in Russia were p.Thr106Met-32%, p.Asn72Lys-20%, p.Arg9His-8%, p.Ser32Gly-6%. We also detected 7 novel PTS variants and 3 novel QDPR variants. HPABH(4) prevalence was estimated to be 0.5-0.9% of all HPA cases in Russia, which is significantly lower than in European countries on average, China, and Saudi Arabia. The results of this research show the necessity of introducing differential diagnostics for HPABH(4) into neonatal screening practice.	[Gundorova, Polina; Kuznetcova, Irina A.; Baydakova, Galina, V; Stepanova, Anna A.; Itkis, Yulia S.; Zakharova, Ekaterina Y.; Kutsev, Sergey, I; Polyakov, Aleksander, V] Res Ctr Med Genet, Moscow, Russia; [Kakaulina, Victoria S.] Med Dept Moscow, Morozov Childrens City Clin Hosp, Fed State Budgetary Inst, Moscow, Russia; [Alferova, Irina P.] Clin Hosp 1, Municipal Autonomous Hlth Care Inst Order Red Ban, Chelyabinsk, Russia; [Lyazina, Lidya, V] St Petersburg State Publ Hlth Inst, Med Genet Diagnost Ctr, St Petersburg, Russia; [Andreeva, Lilya P.] Saratov Reg Childrens Clin Hosp, Saratov, Russia; [Kanivets, Ilya] Genomed, Moscow, Russia	Research Centre for Medical Genetics	Gundorova, P (corresponding author), Res Ctr Med Genet, Moscow, Russia.	p_gundorova@inbox.ru	Stepanova, Anna/AAU-5195-2021; Kutsev, Sergey I/L-3633-2018; Zakharova, Ekaterina/AAU-8702-2021	Stepanova, Anna/0000-0003-0416-8137; Kutsev, Sergey I/0000-0002-3133-8018; Baydakova, Galina/0000-0001-8806-5287; Kuznetsova, Irina/0000-0003-4973-8957; Gundorova, Polina/0000-0001-8703-7997; Kakaulina, Victoria/0000-0002-3764-2766				de Souza CAA, 2018, J PEDIAT-BRAZIL, V94, P170, DOI 10.1016/j.jped.2017.04.005; Anikster Y, 2017, AM J HUM GENET, V100, P257, DOI 10.1016/j.ajhg.2017.01.002; BLAU N, 1995, J PEDIATR-US, V126, P401, DOI 10.1016/S0022-3476(95)70458-2; Blau N, 2016, HUM MUTAT, V37, P508, DOI 10.1002/humu.22980; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Chiu YH, 2012, J HUM GENET, V57, P145, DOI 10.1038/jhg.2011.146; DHONDT JL, 1991, J INHERIT METAB DIS, V14, P117, DOI 10.1007/BF01800581; Dianzani I, 1998, HUM MUTAT, V12, P267, DOI 10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.3.CO;2-0; Dudesek A, 2001, EUR J PEDIATR, V160, P267, DOI 10.1007/s004310000722; Gallego D, 2020, HUM MUTAT, V41, P1329, DOI 10.1002/humu.24026; Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222; Jaggi L, 2008, MOL GENET METAB, V93, P295, DOI 10.1016/j.ymgme.2007.10.004; Khatami S, 2017, JIMD REP, V32, P7, DOI 10.1007/8904_2016_572; Kuznetcova I., 2019, METAB BRAIN DIS; Leuzzi V, 2010, CLIN GENET, V77, P249, DOI 10.1111/j.1399-0004.2009.01306.x; Liu TT, 2001, CLIN CHIM ACTA, V313, P157, DOI 10.1016/S0009-8981(01)00669-6; Liu TT, 1996, HUM GENET, V98, P313, DOI 10.1007/s004390050213; Moammar H, 2010, ANN SAUDI MED, V30, P271, DOI 10.4103/0256-4947.65254; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; NIEDERWIESER A, 1985, J INHERIT METAB DIS, V8, P34, DOI 10.1007/BF01800657; Opladen T, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01379-8; Opladen T, 2011, J INHERIT METAB DIS, V34, P819, DOI 10.1007/s10545-011-9300-1; Porta F, 2020, EUR J PAEDIATR NEURO, V28, P77, DOI 10.1016/j.ejpn.2020.07.011; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Straniero L, 2017, ANN NEUROL, V82, P640, DOI 10.1002/ana.25048; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Thomas J, 2018, MOL GENET METAB, V124, P27, DOI 10.1016/j.ymgme.2018.03.006; Thony B, 1997, HUM MUTAT, V10, P11; Trujillano D, 2014, EUR J HUM GENET, V22, P528, DOI 10.1038/ejhg.2013.175; van Spronsen FJ, 2018, J MED GENET, V55, P249, DOI 10.1136/jmedgenet-2017-104875; van Vliet D, 2018, J NUTR BIOCHEM, V53, P20, DOI 10.1016/j.jnutbio.2017.09.020; van Wegberg AMJ, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0685-2; Verbeekac MM, 2008, MOL GENET METAB, V94, P403, DOI 10.1016/j.ymgme.2008.04.003; Wang RF, 2018, CLIN CHIM ACTA, V481, P132, DOI 10.1016/j.cca.2018.02.035; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zekanowski C, 1998, MOL DIAGN, V3, P237, DOI 10.1016/S1084-8592(98)80047-7; Zurfluh MR, 2008, HUM MUTAT, V29, P167, DOI 10.1002/humu.20637	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249608	10.1371/journal.pone.0249608	http://dx.doi.org/10.1371/journal.pone.0249608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822819	Green Published, gold			2022-12-26	WOS:000637879100010
J	Sichone, J; Sinkala, M; Munsaka, S; Kikonko, M; Simuunza, M				Sichone, Joseph; Sinkala, Musalula; Munsaka, Sody; Kikonko, Mervis; Simuunza, Martin			Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study	PLOS ONE			English	Article							REPRODUCTIVE NUMBERS; COVID-19; CHOLERA	Introduction The novel Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in Africa is characterised by a more substantial proportion of asymptomatic (or mildly symptomatic) individuals thought to be playing a role in the spread of the infection. The exact proportion and degree of infectiousness of asymptomatic individuals remains unclear. Studies however indicate that their management is crucial for control of SARS-CoV-2 transmission. Methodology We developed a simplified deterministic susceptible-exposed-infectious-removed (SEIR) mathematical model to assess the effect of active isolation of SARS-CoV-2 infected but asymptomatic individuals through blanket testing for control of the outbreak in Lusaka Province of Zambia. Here we modelled two scenarios; (1) assuming asymptomatic individuals comprised 70% of all COVID-19 cases and (2) asymptomatic individuals comprised only 50% of the cases. For contrast, the model was assessed first under the assumption that asymptomatic individuals are equally as infectious as symptomatic individuals and then secondly, and more likely, assuming asymptomatic individuals are only half as infectious as symptomatic individuals. Results For the model assuming 70% asymptomatic cases, a minimum sustained daily blanket testing rate of >= 7911 tests/100000 population was sufficient to control the outbreak if asymptomatic individuals are only half as infectious while if equal infectiousness was assumed then a testing rate of >= 10028 tests/ 100000 population would be required. For 50% asymptomatic, minimum blanket testing rates of >= 4540 tests/ 100000 population was sufficient to control the outbreak at both assumed levels of infectiousness for asymptomatic individuals relative to symptomatic individuals. Discussion and conclusion Our model predicts that active isolation of COVID-19 cases, including asymptomatic individuals, through blanket testing can be used as a possible measure for the control of the SARS-Cov-2 transmission in Lusaka, Zambia, but it would come at a high cost.	[Sichone, Joseph; Sinkala, Musalula; Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Kikonko, Mervis] Univ Zambia, Sch Nat Sci, Dept Math & Stat, Lusaka, Zambia; [Simuunza, Martin] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Simuunza, Martin] Univ Zambia, Africa Ctr Excellence Infect Dis Humans & Anim, Lusaka, Zambia	University of Zambia; University of Zambia; University of Zambia; University of Zambia	Sichone, J (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	njeleza.sichone@gmail.com	Munsaka, Sody/AAD-9186-2022	Munsaka, Sody/0000-0002-6917-3888				Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Alshakhoury NS, 2017, MATH MODELING CONTRO; Anastassopoulou C., 2020, PLOS ONE, DOI [DOI 10.1371/JOURNAL.PONE.0230405, 10.1371/journal.pone.0230405 32231374]; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bastola A, 2020, LANCET INFECT DIS, V20, P279, DOI 10.1016/S1473-3099(20)30067-0; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Cabore JW, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002647; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020011; Choisy M., 2007, ENCY INFECT DIS MODE, V379; City population, 2020, POP STAT COUNTR ADM; Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fung ICH, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-1; Ganyani T., 2020, EUROSURVEILLANCE, DOI DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hellewell J., 2020, LANCET GLOB HEALTH, V8, pE488, DOI [10.1016/S2214-109X(20)30074-7, DOI 10.1101/2020.02.08.20021162, 10.1016/S2214-109X%2820%2930074-7, DOI 10.1016/S2214-109X(20)30074-7]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang Y., 2020, B WORLD HEALTH ORGAN, V10; Kretzschmar M, 2010, STAT BIOL HEALTH, P209, DOI 10.1007/978-0-387-93835-6_12; Lai CC., 2020, ARXIV PREPRINT ARXIV; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lavezzo E., 2020, SUPPRESSION COVID 1, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1, 10.1038/s41586-020-2488-1]; Li MY., 2018, INTRO MATH MODELING; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lu FS., 2020, ESTIMATING PREVALENC, DOI [10.1101/2020.04.18, DOI 10.1101/2020.04.18]; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; MOBS Laboratory Northeastern University Boston. Center for Inference and Dynamics of Infectious Diseases (CIDID). Fred Hutchinson Cancer Research Center, 2020, MOD LOC TRANSM BURD; MOH/ZNPH/WHO, 2020, SIT REP NEW COR DIS, P1; Mukandavire Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep00997; Mukandavire Z, 2011, P NATL ACAD SCI USA, V108, P8767, DOI 10.1073/pnas.1019712108; Munjita SM, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.23267, 10.11604/pamj.2020.35.2.23267]; Nightingale ES., 2020, MODELLING PROJECTION; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007; Pearson CA, 2020, PROJECTION EARLY SPE; Pearson CAB, 2020, EUROSURVEILLANCE, V25, P19, DOI 10.2807/1560-7917.ES.2020.25.18.2000543; Peng L., 2020, ARXIV PREPRINT ARXIV; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Ritchie H., 2020, WHAT DO WE KNOW RISK; Ritchie H, 2020, OUR WORLD DATA CORON; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Schraer R, 2020, BBC NEWS 0609; Sichone Joseph, 2020, PLoS Negl Trop Dis, V14, pe0008811, DOI 10.1371/journal.pntd.0008811; Singh R, 2020, AGE STRUCTURED IMPAC, DOI DOI 10.48550/ARXIV.2003.12055; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Sinkala M., 2020, COVID 19 PANDEMIC AF; Smith DRM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01866-6; Suxin W., 2020, J MED VIROL, V25783; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Xia W, 2020, TRANSMISSION CORONA, DOI 10.1101/2020.03.06.20031955; Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134; Zhang Y, 2020, CHEST, V157, pE99, DOI 10.1016/j.chest.2020.02.014; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N., 2019, PREPRINT ARXIV191111	75	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249479	10.1371/journal.pone.0249479	http://dx.doi.org/10.1371/journal.pone.0249479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822785	Green Submitted, gold, Green Published			2022-12-26	WOS:000637879100042
J	Sharma, K; Aggarwala, P; Gandhi, D; Mathias, A; Singh, P; Sharma, S; Negi, SS; Bhargava, A; Das, P; Gaikwad, U; Wankhede, A; Behra, A; Nagarkar, NM				Sharma, Kuldeep; Aggarwala, Pragya; Gandhi, Deepa; Mathias, Anuniti; Singh, Priyanka; Sharma, Somya; Negi, Sanjay Singh; Bhargava, Anudita; Das, Padma; Gaikwad, Ujjwala; Wankhede, Archana; Behra, Ajoy; Nagarkar, Nitin M.			Comparative analysis of various clinical specimens in detection of SARS-CoV-2 using rRT-PCR in new and follow up cases of COVID-19 infection: Quest for the best choice	PLOS ONE			English	Article								Background An appropriate specimen is of paramount importance in Real Time reverse transcription-polymerase chain reaction (rRT-PCR) based diagnosis of novel coronavirus (nCoV) disease (COVID-19). Thus, it's pertinent to evaluate various diversified clinical specimens' diagnostic utility in both diagnosis and follow-up of COVID-19. Methods A total of 924 initial specimens from 130 COVID-19 symptomatic cases before initiation of treatment and 665 follow up specimens from 15 randomly selected cases comprising of equal number of nasopharyngeal swab (NPS), oropharyngeal swab (OPS), combined NPS and OPS (Combined swab), sputum, plasma, serum and urine were evaluated by rRT-PCR. Results Demographic analysis showed males (86) twice more affected by COVID-19 than females (44) (p = 0.00001). Combined swabs showed a positivity rate of 100% followed by NPS (91.5%), OPS (72.3%), sputum (63%), while nCoV was found undetected in urine, plasma and serum specimens. The lowest cycle threshold (Ct) values of targeted genes E, ORF1b and RdRP are 10.56, 10.14 and 12.26 respectively and their lowest average Ct values were found in combined swab which indicates high viral load in combined swab among all other specimen types. Analysis of 665 follow-up multi-varied specimens also showed combined swab as the last specimen among all specimen types to become negative, after an average 6.6 (range 4-10) days post-treatment, having lowest (15.48) and average (29.96) Ct values of ORF1b respectively indicating posterior nasopharyngeal tract as primary nCoV afflicted site with high viral load. Conclusion The combined swab may be recommended as a more appropriate specimen for both diagnosis and monitoring of COVID-19 treatment by rRT-PCR for assessing virus clearance to help physicians in taking evidence-based decision before discharging patients. Implementing combined swabs globally will definitely help in management and control of the pandemic, as it is the need of the hour.	[Sharma, Kuldeep; Aggarwala, Pragya; Gandhi, Deepa; Mathias, Anuniti; Singh, Priyanka; Sharma, Somya; Negi, Sanjay Singh; Bhargava, Anudita; Das, Padma; Gaikwad, Ujjwala; Wankhede, Archana] AIIMS, Dept Microbiol, Raipur, Chhattisgarh, India; [Behra, Ajoy] AIIMS, Dept Pulm Med, Raipur, Chhattisgarh, India; [Nagarkar, Nitin M.] AIIMS, Raipur, Chhattisgarh, India	All India Institute of Medical Sciences (AIIMS) Raipur; All India Institute of Medical Sciences (AIIMS) Raipur; All India Institute of Medical Sciences (AIIMS) Raipur	Negi, SS (corresponding author), AIIMS, Dept Microbiol, Raipur, Chhattisgarh, India.	negidr@yahoo.co.in		Gaikwad, Ujjwala/0000-0002-9869-2839	AIIMS, Raipur, Chhattisgarh [AIIMS/Raipur/Admin/110]	AIIMS, Raipur, Chhattisgarh	This study was supported by AIIMS, Raipur, Chhattisgarh (AIIMS/Raipur/Admin/110).	Abduljalil JM, 2020, NEW MICROB NEW INFEC, V36, DOI 10.1016/j.nmni.2020.100713; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bhandari Sudhir, 2020, J Assoc Physicians India, V68, P13; Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w; Bwire GM, 2021, J MED VIROL, V93, P719, DOI 10.1002/jmv.26349; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen C, 2020, ANN INTERN MED, V172, P832, DOI 10.7326/M20-0991; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Czumbel LM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00465; Gao Z C, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE001, DOI 10.3760/cma.j.issn.1001-0939.2020.0001; Gorbalenya AE., 2020, BIORXIV, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]; Indian Council of Medcal Research (ICMR), 2020, REV ADV US HYDR HCQ; Kontou PI, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050319; Liu M, 2020, J VIROL METHODS, V286, DOI 10.1016/j.jviromet.2020.113974; Liu R, 2020, CLIN CHIM ACTA, V505, P172, DOI 10.1016/j.cca.2020.03.009; Lo IL, 2020, INT J BIOL SCI, V16, P1698, DOI 10.7150/ijbs.45357; Martinez Raquel M, 2020, Clin Microbiol Newsl, V42, P121, DOI 10.1016/j.clinmicnews.2020.07.001; Mohammadi A, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102903; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Poon L, 2020, BLOOMBERG; Rao M, 2021, J MED VIROL, V93, P2461, DOI 10.1002/jmv.26773; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Takayama K, 2020, TRENDS PHARMACOL SCI, V41, P513, DOI 10.1016/j.tips.2020.05.005; Tong YQ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02580-w; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wang X, 2020, INT J INFECT DIS, V94, P107, DOI 10.1016/j.ijid.2020.04.023; Wei X., 2020, J INFECT DIS, DOI DOI 10.1093/INFDIS/JIAA363; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie CB, 2020, INT J INFECT DIS, V93, P264, DOI 10.1016/j.ijid.2020.02.050; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Zhang HX, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa379; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	34	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249408	10.1371/journal.pone.0249408	http://dx.doi.org/10.1371/journal.pone.0249408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819290	gold, Green Published			2022-12-26	WOS:000637647200002
J	Taghvaei, M; Smith, B; Yazar, G; Bean, S; Tilley, M; Ioerger, B				Taghvaei, Mostafa; Smith, Brennan; Yazar, Gamze; Bean, Scott; Tilley, Michael; Ioerger, Brian			Identification of gluten-like proteins in selected pod bearing leguminous tree seeds	PLOS ONE			English	Article								The protein composition, molecular weight distribution, and rheological properties of honey locust, mesquite, Kentucky coffee tree, and carob seed germs were compared against wheat gluten. Polymeric and Osborne fractionation protocols were used to assess biochemical properties. Dynamic oscillatory shear tests were performed to evaluate protein functionality. All samples had similar ratios of protein fractions as well as high molecular weight disulfide linked proteins except for the Kentucky coffee tree germ proteins, which were found to have lower molecular weight proteins with little disulfide polymerization. Samples were rich in acidic and polar amino acids (glutamic acid and arginine,). Rheological analyses showed that vital wheat gluten had the most stable network, while Kentucky coffee seed proteins had the weakest. High molecular weight disulfide linked glutenous proteins are a common, but not universal feature of pod bearing leguminous trees.	[Taghvaei, Mostafa; Smith, Brennan; Yazar, Gamze] Univ Idaho, Anim Vet & Food Sci, Moscow, ID 83843 USA; [Smith, Brennan] ARS, USDA, Southern Reg Res Ctr, New Orleans, LA 70124 USA; [Bean, Scott; Tilley, Michael; Ioerger, Brian] ARS, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Smith, B (corresponding author), Univ Idaho, Anim Vet & Food Sci, Moscow, ID 83843 USA.; Smith, B (corresponding author), ARS, USDA, Southern Reg Res Ctr, New Orleans, LA 70124 USA.	brennan.smith@usda.gov	Bean, Scott R./AAE-9327-2019; Yazar, Gamze/GXM-7546-2022	Bean, Scott R./0000-0001-8678-8094; Tilley, Michael/0000-0003-1186-160X				AACC International, 1999, 463001 AACC INT; AACC International, 1999, 563701 AACC INT; Akin PA, 2019, J FOOD SCI, V84, P3522, DOI 10.1111/1750-3841.14832; Amonsou EO, 2012, FOOD CHEM, V134, P1519, DOI 10.1016/j.foodchem.2012.03.066; Batlle I., 1997, PROMOTING CONSERVATI, P23; Bean SR, 1998, CEREAL CHEM, V75, P374, DOI 10.1094/CCHEM.1998.75.3.374; Bernardi C, 2010, INT J FOOD SCI NUTR, V61, P245, DOI 10.3109/09637480903373336; Chaturvedi OH, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-598; Day L, 2006, TRENDS FOOD SCI TECH, V17, P82, DOI 10.1016/j.tifs.2005.10.003; Delcour J.A., 2010, PRINCIPLES CEREAL SC, V3rd ed.; Duvarci OC., 2019, HDB FOOD ENG, V3rd; Felker P, 2013, FOOD REV INT, V29, P49, DOI 10.1080/87559129.2012.692139; Hewlett Packard, 1990, AM QUANT OP HDB; Johnson JW, 2013, AGROFOREST SYST, V87, P849, DOI 10.1007/s10457-013-9601-5; Khuzwayo TA., 2020, LWT, V121, P89; Lafiandra D, 2004, GLUTEN PROTEINS; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; OrtegaNieblas M, 1996, J AGR FOOD CHEM, V44, P3130, DOI 10.1021/jf9506139; Phillips L, 2006, ARBOR AGE, V26, P12; Roman L, 2017, J FOOD SCI TECH MYS, V54, P2094, DOI 10.1007/s13197-017-2649-x; Smith BM, 2012, J FOOD SCI, V77, pC684, DOI 10.1111/j.1750-3841.2012.02739.x; Smith BM, 2017, J FOOD SCI, V82, P613, DOI 10.1111/1750-3841.13637; Smith BM, 2014, FOOD CHEM, V147, P230, DOI 10.1016/j.foodchem.2013.09.152; Smith BM, 2010, J AGR FOOD CHEM, V58, P7794, DOI 10.1021/jf101523p; Southan M, 1999, CEREAL CHEM, V76, P827, DOI 10.1094/CCHEM.1999.76.6.827; Steffe J. F, 1996, RHEOLOGICAL METHODS; Tabilo-Munizaga G, 2005, J FOOD ENG, V67, P147, DOI 10.1016/j.jfoodeng.2004.05.062; Weegels PL, 1996, J CEREAL SCI, V23, P1, DOI 10.1006/jcrs.1996.0001; Yufei L, 2017, ANAL AMINO ACIDS DER	30	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249427	10.1371/journal.pone.0249427	http://dx.doi.org/10.1371/journal.pone.0249427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819280	Green Published, gold			2022-12-26	WOS:000637647200006
J	Kinne, J; Lenz, D				Kinne, Jan; Lenz, David			Predicting innovative firms using web mining and deep learning	PLOS ONE			English	Article							PATENT STATISTICS; NEURAL-NETWORKS	Evidence-based STI (science, technology, and innovation) policy making requires accurate indicators of innovation in order to promote economic growth. However, traditional indicators from patents and questionnaire-based surveys often lack coverage, granularity as well as timeliness and may involve high data collection costs, especially when conducted at a large scale. Consequently, they struggle to provide policy makers and scientists with the full picture of the current state of the innovation system. In this paper, we propose a first approach on generating web-based innovation indicators which may have the potential to overcome some of the shortcomings of traditional indicators. Specifically, we develop a method to identify product innovator firms at a large scale and very low costs. We use traditional firm-level indicators from a questionnaire-based innovation survey (German Community Innovation Survey) to train an artificial neural network classification model on labelled (product innovator/no product innovator) web texts of surveyed firms. Subsequently, we apply this classification model to the web texts of hundreds of thousands of firms in Germany to predict whether they are product innovators or not. We then compare these predictions to firm-level patent statistics, survey extrapolation benchmark data, and regional innovation indicators. The results show that our approach produces reliable predictions and has the potential to be a valuable and highly cost-efficient addition to the existing set of innovation indicators, especially due to its coverage and regional granularity.	[Kinne, Jan] ZEW Ctr European Econ Res, Dept Econ Innovat & Ind Dynam, Mannheim, Germany; [Kinne, Jan] Univ Salzburg, Dept Geoinformat Z GIS, Salzburg, Austria; [Kinne, Jan; Lenz, David] Istari Ai, Mannheim, Germany; [Lenz, David] Justus Liebig Univ, Dept Econometr & Stat, Giessen, Germany	Zentrum fur Europaische Wirtschaftsforschung (ZEW); Salzburg University; Justus Liebig University Giessen	Kinne, J (corresponding author), ZEW Ctr European Econ Res, Dept Econ Innovat & Ind Dynam, Mannheim, Germany.; Kinne, J (corresponding author), Univ Salzburg, Dept Geoinformat Z GIS, Salzburg, Austria.; Kinne, J (corresponding author), Istari Ai, Mannheim, Germany.	jan.kinne@zew.de		Lenz, David/0000-0002-2418-6239	German Federal Ministry of Education and Research [16IFI001]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The German Federal Ministry of Education and Research provided funding for the research project (TOBI - Text Data BasedOutput Indicators as Base of a New Innovation Metric; funding ID: 16IFI001, Prof. Dr. Peter Winker) (https://www.bmbf.de/en/index.html).Additionally, DL and JK founded and are employed by istari.ai. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Acs ZJ, 2002, RES POLICY, V31, P1069, DOI 10.1016/S0048-7333(01)00184-6; Axenbeck J., WEB MINING FIRM WEBS; Blind K, 2019, KNOWLEDGE PROXIMITY; Danilak M., 2015, LANGDETECT; Dernis H, 2013, WORKING PAPERS; Devlin J., 2018, ARXIV181004805; European Commission, 2017, REGIONAL INNOVATION; Feser D, 2018, INNOVATIONSERHEBUNG; Gault F, 2013, ELGAR ORIG REF, P1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301; Kim Y., 2014, P 2014 C EMP METH NA, P1746; Kingma DP., 2014, ADAM METHOD STOCHAST; Kinne J., 2018, ARGUS AUTOMATED ROBO; Klambauer G, 2017, ADV NEUR IN, V30; Krieger B, 2019, INNOVATIONEN DTSCH W; Larsen VH, 2015, VALUE NEWS, P6; Levenberg Abby, 2014, International Journal of Computer and Communication Engineering, V3, P109, DOI 10.7763/IJCCE.2014.V3.302; Ludering J, 2016, JAHRB NATL STAT, V236, P483, DOI 10.1515/jbnst-2015-1026; Lundberg SM, 2017, ADV NEUR IN, V30; Manning CD, 2009, INTRO INFORM RETRIEV; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; Niefert M., 2014, MANNHEIM ENTERPRISE; OECD, 2009, MEAS CAP; OECD Eurostat, 2018, MEASUREMENT SCI TECH, V4th; Peters B, 2009, J TECHNOL TRANSFER, V34, P226, DOI 10.1007/s10961-007-9072-9; Ronnqvist S, 2017, NEUROCOMPUTING, V264, P57, DOI 10.1016/j.neucom.2016.12.110; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schmidt T, 2017, INNOVATIONSVERHALTEN; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Taddy M., 2017, TEXT DATA	32	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249071	10.1371/journal.pone.0249071	http://dx.doi.org/10.1371/journal.pone.0249071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793626	Green Submitted, gold, Green Published			2022-12-26	WOS:000636467000048
J	Dale, EE; Larcombe, MJ; Lee, WG				Dale, Esther E.; Larcombe, Matthew J.; Lee, William G.			The effect of single biome occupancy on the estimation of biome shifts and the detection of biome conservatism	PLOS ONE			English	Article								Biome conservatism is often regarded as common in diversifying lineages, based on the detection of low biome shift rates or high phylogenetic signal. However, many studies testing biome conservatism utilise a single-biome-per-species approach, which may influence the detection of biome conservatism. Meta-analyses show that biome shift rates are significantly lower (less than a tenth), when single biome occupancy approaches are adopted. Using New Zealand plant lineages, estimated biome shifts were also significantly lower (14-67% fewer biome shifts) when analysed under the assumption of a single biome per species. Although a single biome approach consistently resulted in lower biome shifts, it detected fewer instances of biome conservatism. A third of clades (3 out of 9) changed status in biome conservatism tests between single and multiple biome occupancy approaches, with more instances of significant biome conservatism when using a multiple biome occupancy approach. A single biome approach may change the likelihood of finding biome conservatism because it assumes biome specialisation within species, falsely recognises some biome shift types and fails to include other biome shift types. Our results indicate that the degree of biome fidelity assumed has a strong influence on analyses assessing biome shift rates, and biome conservatism testing. We advocate analyses that allow species to occupy multiple biomes.	[Dale, Esther E.; Lee, William G.] Manaaki Whenua Landcare Res, Dunedin, New Zealand; [Dale, Esther E.; Larcombe, Matthew J.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Lee, William G.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	Landcare Research - New Zealand; University of Otago; University of Auckland	Dale, EE (corresponding author), Manaaki Whenua Landcare Res, Dunedin, New Zealand.; Dale, EE (corresponding author), Univ Otago, Dept Bot, Dunedin, New Zealand.	dalee@landcareresearch.co.nz		Dale, Esther/0000-0001-8137-460X	University of Otago; Royal Society of New Zealand [LCR1702, UOO14411]	University of Otago; Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by a University of Otago for a Doctoral Scholarship and Doctoral Postgraduate Publishing Bursary to EED and The Royal Society of New Zealand (www.royalsociety.org.nz) Marsden Fund grants to WGL (LCR1702) and MJL (UOO14411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayly M. J., 2006, ILLUSTRATED GUIDE NZ; Brandt AJ, 2017, NEW PHYTOL, V215, P865, DOI 10.1111/nph.14544; Cantley JT, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw043; Cardillo M, 2017, EVOLUTION, V71, P1928, DOI 10.1111/evo.13276; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Cruz GAS, 2017, MOL PHYLOGENET EVOL, V107, P152, DOI 10.1016/j.ympev.2016.10.019; Dale EE., FIG SHARE2020, DOI [10.6084/m9.figshare.13373072, DOI 10.6084/M9.FIGSHARE.13373072]; Dale EE., 2019, ROLE BIOME SHIFTS LI; Dale EE, 2020, J BIOGEOGR, V47, P538, DOI 10.1111/jbi.13768; Donoghue MJ, 2014, ANNU REV ECOL EVOL S, V45, P547, DOI 10.1146/annurev-ecolsys-120213-091905; Edgar E., 2000, FLORA NZ, V5; Eiserhardt WL, 2017, NEW PHYTOL, V214, P1408, DOI 10.1111/nph.14516; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gagnon E, 2019, NEW PHYTOL, V222, P1994, DOI 10.1111/nph.15633; Gamisch A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0586-3; Garcia-Verdugo C, 2019, BOT J LINN SOC, V191, P155, DOI 10.1093/botlinnean/boz044; Heenan PB, 2004, NEW ZEAL J BOT, V42, P753, DOI 10.1080/0028825X.2004.9512929; Heenan PB, 1998, NEW ZEAL J BOT, V36, P381, DOI 10.1080/0028825X.1998.9512576; Heenan PB, 2013, NEW ZEAL J ECOL, V37, P105; Holstein N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-28; Isaac N., 2018, CAPER COMP ANAL PHYL; Jara-Arancio P, 2014, J BIOGEOGR, V41, P328, DOI 10.1111/jbi.12186; JOHNSON PN, 1989, WETLAND PLANTS NZ; Landis M, 2021, SYST BIOL, V70, P86, DOI 10.1093/sysbio/syaa045; Lee DE, 2016, NEW ZEAL J BOT, V54, P100, DOI 10.1080/0028825X.2016.1144623; Lee DE, 2001, AUST J BOT, V49, P341, DOI 10.1071/BT00031; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Mark AF., 2013, TREELINE NATURE GUID; MARK AF, 1995, NZ ALPINE PLANTS; Matzke N.J., 2013, BIOGEOBEARS BIOGEOGR; McGlone MS, 2010, TERRA AUSTRALIS, V32, P49; Meudt HM, 2015, BOT J LINN SOC, V178, P243, DOI 10.1111/boj.12276; Molloy BPJ, 1996, NEW ZEAL J BOT, V34, P431; MOLLOY BPJ, 1994, NEW ZEAL J BOT, V32, P113, DOI 10.1080/0028825X.1994.10410362; Moncrieff GR, 2016, J BIOGEOGR, V43, P863, DOI 10.1111/jbi.12701; Poole AL., 1964, TREES SHRUBS NZ; Ringelberg JJ, 2020, GLOBAL ECOL BIOGEOGR, V29, P1100, DOI 10.1111/geb.13089; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Spriggs EL, 2015, NEW PHYTOL, V207, P340, DOI 10.1111/nph.13305; Toon A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12398; WARDLE P, 1991, VEGETATION NZ; Weeks A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00409; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wilson HD, 1994, STEWART ISLAND PLANT; WILSON HD, 1996, WILD PLANTS MOUNT CO; WILSON HD, 1993, SMALL LEAVED SHRUBS; Zizka A, 2020, J BIOGEOGR, V47, P1310, DOI 10.1111/jbi.13815	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248839	10.1371/journal.pone.0248839	http://dx.doi.org/10.1371/journal.pone.0248839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784318	Green Published, gold			2022-12-26	WOS:000636359600004
J	Qin, WR; Xu, GC; Tai, PWL; Wang, CM; Luo, L; Li, CJ; Hu, X; Xue, JX; Lu, Y; Zhou, Q; Wei, Q; Wen, TF; Hu, JK; Xiao, YY; Yang, L; Li, WM; Flotte, TR; Wei, YQ; Gao, GP				Qin, Wanru; Xu, Guangchao; Tai, Phillip W. L.; Wang, Chunmei; Luo, Li; Li, Chengjian; Hu, Xun; Xue, Jianxin; Lu, You; Zhou, Qiao; Wei, Qiang; Wen, Tianfu; Hu, Jiankun; Xiao, Yuanyuan; Yang, Li; Li, Weimin; Flotte, Terence R.; Wei, Yuquan; Gao, Guangping			Large-scale molecular epidemiological analysis of AAV in a cancer patient population	ONCOGENE			English	Article								Recombinant adeno-associated viruses (rAAVs) are well-established vectors for delivering therapeutic genes. However, previous reports have suggested that wild-type AAV is linked to hepatocellular carcinoma, raising concern with the safety of rAAVs. In addition, a recent long-term follow-up study in canines, which received rAAVs for factor VIII gene therapy, demonstrated vector integration into the genome of liver cells, reviving the uncertainty between AAV and cancer. To further explore this relationship, we performed large-scale molecular epidemiology of AAV in resected tumor samples and non-lesion tissues collected from 413 patients, reflecting nine carcinoma types: breast carcinoma, rectal cancer, pancreas carcinoma, brain tumor, hepatoid adenocarcinoma, hepatocellular carcinoma, gastric carcinoma, lung squamous, and adenocarcinoma. We found that over 80% of patients were AAV-positive among all nine types of carcinoma examined. Importantly, the AAV sequences detected in patient-matched tumor and adjacent non-lesion tissues showed no significant difference in incidence, abundance, and variation. In addition, no specific AAV sequences predominated in tumor samples. Our data shows that AAV genomes are equally abundant in tumors and adjacent normal tissues, but lack clonality. The finding critically adds to the epidemiological profile of AAV in humans, and provides insights that may assist rAAV-based clinical studies and gene therapy strategies.	[Qin, Wanru; Xu, Guangchao; Wang, Chunmei; Luo, Li; Xiao, Yuanyuan; Yang, Li; Li, Weimin; Wei, Yuquan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Xu, Guangchao; Tai, Phillip W. L.; Luo, Li; Flotte, Terence R.; Gao, Guangping] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01605 USA; [Xu, Guangchao; Tai, Phillip W. L.; Gao, Guangping] Univ Massachusetts, Sch Med, Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Li, Chengjian] Fornax Biotech, Worcester, MA USA; [Hu, Xun] Sichuan Univ, West China Hosp, Biobank, Chengdu, Peoples R China; [Xue, Jianxin; Lu, You] Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Oncol, Chengdu, Peoples R China; [Xue, Jianxin; Lu, You] Sichuan Univ, West China Hosp, Canc Ctr, State Key Lab Biotherapy, Chengdu, Peoples R China; [Zhou, Qiao] Sichuan Univ, West China Hosp, West China Med Sch, Pathol Dept, Chengdu, Peoples R China; [Zhou, Qiao] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy, Chengdu, Peoples R China; [Wei, Qiang] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Peoples R China; [Wen, Tianfu] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China; [Hu, Jiankun] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu, Peoples R China; [Hu, Jiankun] Sichuan Univ, West China Hosp, Lab Gastr Canc, Chengdu, Peoples R China; [Flotte, Terence R.] Univ Massachusetts, Sch Med, Pediat, Worcester, MA 01605 USA	Sichuan University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of Massachusetts System; University of Massachusetts Worcester	Wei, YQ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.; Flotte, TR; Gao, GP (corresponding author), Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01605 USA.; Gao, GP (corresponding author), Univ Massachusetts, Sch Med, Microbiol & Physiol Syst, Worcester, MA 01605 USA.; Flotte, TR (corresponding author), Univ Massachusetts, Sch Med, Pediat, Worcester, MA 01605 USA.	Terry.Flotte@umassmed.edu; yqwei@scu.edu.cn; guangping.gao@umassmed.edu		Tai, Phillip/0000-0001-7409-8344; Xu, Guangchao/0000-0002-3806-2245	University of Massachusetts Medical School; NIH [R01NS076991-01, P01AI100263-01, P01HL131471-02, R01AI121135, UG3HL147367-01, R01HL097088, U19AI149646-01]	University of Massachusetts Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the University of Massachusetts Medical School (an internal grant) and by the NIH (R01NS076991-01, P01AI100263-01, P01HL131471-02, R01AI121135, UG3HL147367-01, R01HL097088, and U19AI149646-01).	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Berns KI, 2020, HUM GENE THER, V31, P518, DOI 10.1089/hum.2020.017; Berns KI, 2015, HUM GENE THER, V26, P779, DOI 10.1089/hum.2015.29014.kib; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Buning H, 2015, MOL THER, V23, P1673, DOI 10.1038/mt.2015.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chandler RJ, 2016, MOL THER, V24, P198, DOI 10.1038/mt.2016.17; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chen CL, 2005, J VIROL, V79, P14781, DOI 10.1128/JVI.79.23.14781-14792.2005; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gil-Farina I, 2016, CURR OPIN VIROL, V21, P35, DOI 10.1016/j.coviro.2016.07.004; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Hanlon KS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12449-2; Huser D, 2017, J VIROL, V91, DOI 10.1128/JVI.02137-16; KOTIN RM, 1991, GENOMICS, V10, P831, DOI 10.1016/0888-7543(91)90470-Y; Kramer CJH, 2019, BREAST CANCER RES TR, V173, P55, DOI 10.1007/s10549-018-4987-4; La Bella T, 2020, GUT, V69, P737, DOI 10.1136/gutjnl-2019-318281; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Ling C, 2015, J INTEGR MED-JIM, V13, P341, DOI 10.1016/S2095-4964(15)60200-X; Liu Q, 2014, GENE THER, V21, P732, DOI 10.1038/gt.2014.47; Liu Q, 2013, J MED VIROL, V85, P1550, DOI 10.1002/jmv.23647; Logan GJ, 2017, NAT GENET, V49, P1267, DOI 10.1038/ng.3893; Mesker WE, 2007, CELL ONCOL, V29, P387; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nault JC, 2016, MOL THER, V24, P659, DOI 10.1038/mt.2016.47; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Nguyen GN, 2021, NAT BIOTECHNOL, V39, P47, DOI 10.1038/s41587-020-0741-7; Ogden PJ, 2019, SCIENCE, V366, P1139, DOI 10.1126/science.aaw2900; Pachori AS, 2004, BIOCHEM BIOPH RES CO, V313, P528, DOI 10.1016/j.bbrc.2003.11.140; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109; Zhong L, 2013, HUM GENE THER, V24, P520, DOI 10.1089/hum.2012.112	38	5	5	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3060	3071		10.1038/s41388-021-01725-5	http://dx.doi.org/10.1038/s41388-021-01725-5		MAR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33782545	Green Accepted			2022-12-26	WOS:000634614900001
J	Khan, K; Arain, MI; Asghar, MA; Rehman, AA; Ghoto, MA; Dayo, A; Imtiaz, MS; Rana, MH; Asghar, MA				Khan, Kamran; Arain, Mudassar Iqbal; Asghar, Muhammad Arif; Rehman, Ahad Abdul; Ghoto, Muhammad Ali; Dayo, Abdullah; Imtiaz, Muhammad Suleman; Rana, Mohsin Hamied; Asghar, Muhammad Asif			Analysis of treatment cost and persistence among migraineurs: A two-year retrospective cohort study in Pakistan	PLOS ONE			English	Article								Objectives The persistence pattern of anti-migraine drugs' use among migraineurs is very low in the United States and different European countries. However, the cost and persistence of antimigraine drugs in Asian countries have not been well-studied. Hence, the present study aimed to evaluate the treatment cost and persistence among migraineurs in Pakistan. Methods Data from prescriptions collected from migraineurs who visited the Outpatient Department (OPD) of different public and private sector tertiary-care hospitals of Karachi, Pakistan were used to conduct this retrospective cohort study from 2017 to 2019. The minimum follow up period for each migraineur was about 12 months for persistence analysis while dropped-out patients data were also included in survival analysis as right censored data. Pairwise comparisons from Cox regression/hazards ratio were used to assess the predictors of persistence with the reference category of non-binary variables i.e. hazard ratio = 1 for low frequency migraineurs and NSAIDs users. Persistence with anti-migraine drugs was estimated using the Kaplan-Meier curve along with the Log Rank test. Results A total of 1597 patients were included in this study, 729 (45.6%) were male and 868 (54.3%) were female. Non-steroidal anti-inflammatory drugs (NSAIDs) were the most prescribed class of drug initially for all classes of migraineurs (26.1%). Of them, 57.3% of migraineurs discontinued their treatment, 28.5% continued while 14.8% were switched to other treatment approaches. Persistence with initial treatment was more profound in female (58.8%) patients compared to males while the median age of continuers was 31 years. The total cost of migraine treatment in the entire study cohort was 297532.5 Pakistani Rupees ($1901.1). By estimating the hazard ratios (HR) using the Cox regression analysis, it can be observed that patients with high frequency (HR, 1.628; 95%CI, 1.221-2.179; p<0.0001) migraine, depression (HR, 1.268; 95%CI, 1.084-1.458; p<0.0001), increasing age (HR, 1.293; 95%CI, 1.092-1.458; p<0.0001), combination analgesics (HR, 1.817; 95%CI, 0.841-2.725; p = 0.0004) and prophylaxis drugs (HR, 1.314; 95%CI, 0.958-1.424; p<0.0001) users were at a higher risk of treatment discontinuation. However, patients with chronic migraine (HR, 0.881; 95%CI, 0.762-0.912; p = 0.0002), epileptic seizure (HR, 0.922; 95%CI, 0.654-1.206; p = 0.0002), other comorbidities (HR, 0.671; 95%CI, 0.352-1.011; p = 0.0003) and users of triptan(s) (HR, 0.701; 95%CI, 0.182-1.414; p = 0.0005) and triptan(s) with NSAIDs (HR, 0.758; 95%CI, 0.501-1.289; p<0.0001) had more chances to continue their initial therapy. Conclusion Similar to western countries, the majority of migraineurs exhibited poor persistence to migraine treatments. Various factors of improved persistence were identified in this study.	[Khan, Kamran; Asghar, Muhammad Arif; Imtiaz, Muhammad Suleman] Jinnah Sindh Med Univ, Inst Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan; [Arain, Mudassar Iqbal; Ghoto, Muhammad Ali] Univ Sindh, Dept Pharm Practice, Fac Pharm, Jamshoro, Pakistan; [Rehman, Ahad Abdul] Jinnah Sindh Med Univ, Inst Pharmaceut Sci, Dept Pharmacol, Karachi, Pakistan; [Dayo, Abdullah] Univ Sindh, Dept Pharmaceut, Fac Pharm, Jamshoro, Pakistan; [Rana, Mohsin Hamied] Reckitt Benckiser, Dept Res & Dev, Karachi, Pakistan; [Asghar, Muhammad Asif] PCSIR Labs Complex, Food & Marine Resources Res Ctr, Food & Feed Safety Lab, Karachi, Sindh, Pakistan	Jinnah Sindh Medical University - Pakistan; University of Sindh; Jinnah Sindh Medical University - Pakistan; University of Sindh; PCSIR Laboratories Complex	Asghar, MA (corresponding author), Jinnah Sindh Med Univ, Inst Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan.	m.arifasgher@hotmail.com	Arain, Mudassar Iqbal/GQH-8642-2022					Baskin SM, 2009, NEUROL SCI, V30, pS61, DOI 10.1007/s10072-009-0071-5; Becker WJ, 2017, HEADACHE, V57, P1471, DOI 10.1111/head.13089; Bigal ME, 2006, NEUROLOGY, V67, P246, DOI 10.1212/01.wnl.0000225186.76323.69; Chen TB, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-48; Degli Esposti Luca, 2004, J Clin Hypertens (Greenwich), V6, P76, DOI 10.1111/j.1524-6175.2004.03044.x; Diener HC, 2004, LANCET NEUROL, V3, P475, DOI 10.1016/S1474-4422(04)00824-5; Etemad Lida R, 2005, J Manag Care Pharm, V11, P137; Forderreuther S, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0951-2; Ford JH, 2019, J MANAG CARE SPEC PH, V25, P46, DOI 10.18553/jmcp.2018.18058; Hagen M, 2020, PAIN MANAG, V10, P117, DOI 10.2217/pmt-2019-0057; Hepp Z, 2017, CEPHALALGIA, V37, P470, DOI 10.1177/0333102416678382; Hepp Z, 2015, CEPHALALGIA, V35, P478, DOI 10.1177/0333102414547138; Hepp Z, 2014, J MANAGE CARE PHARM, V20, P22, DOI 10.18553/jmcp.2014.20.1.22; Herekar AD, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-73; Hjalte F, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1015-y; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; Hughes CM, 2004, DRUG AGING, V21, P793, DOI 10.2165/00002512-200421120-00004; Juang KD, 2000, HEADACHE, V40, P818, DOI 10.1046/j.1526-4610.2000.00148.x; Khan K., 2019, ISRA MED J, V11, P275; Liu XC, 2011, CLINICOECONOMIC OUTC, V3, P63, DOI 10.2147/CEOR.S17846; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Loder E, 2010, NEW ENGL J MED, V363, P63, DOI 10.1056/NEJMct0910887; Messali AJ, 2014, HEADACHE, V54, P1120, DOI 10.1111/head.12404; Negro A, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1068-y; Ng-Mak DS, 2012, CEPHALALGIA, V32, P875, DOI 10.1177/0333102412449929; Raggi A, 2020, EUR J NEUROL, V27, P62, DOI 10.1111/ene.14034; Shau E, 2017, WORLD J EMERG MED, V8, P170, DOI 10.5847/wjem.j.1920-8642.2017.03.002; Silberstein SD, 2007, HEADACHE, V47, P500, DOI 10.1111/j.1526-4610.2007.00754.x; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI [10.1016/S1474-4422(18)30322-3, 10.1016/S1474-4422(18)30499-X]; Timmerman L, 2016, ACTA ANAESTH SCAND, V60, P416, DOI 10.1111/aas.12697; Tinsley A., 2019, CHRONIC HEADACHE SPR, P207; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Troy M, 2019, ADV PULMON HYPER, V53, P157; Woolley JM, 2017, HEADACHE, V57, P1399, DOI 10.1111/head.13157	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248761	10.1371/journal.pone.0248761	http://dx.doi.org/10.1371/journal.pone.0248761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770109	Green Published, gold			2022-12-26	WOS:000634833500020
J	Chacon, P; Vega-Rioja, A; Doukkali, B; Rodriguez, AD; Bellido, V; Puente, Y; Alcaniz, L; Rodriguez, D; Palacios, R; Cornejo-Garcia, JA; Monteseirin, J; Rivas-Perez, D				Chacon, Pedro; Vega-Rioja, Antonio; Doukkali, Bouchra; del Valle Rodriguez, Alberto; Bellido, Virginia; Puente, Yolanda; Alcaniz, Lorena; Rodriguez, David; Palacios, Ricardo; Antonio Cornejo-Garcia, Jose; Monteseirin, Javier; Rivas-Perez, David			Targeted inhibition of allergen-induced histamine production by neutrophils	FASEB JOURNAL			English	Article						allergen immunotherapy; asthma; diamine oxidase; histamine; histidine decarboxylase	ACTIVATED PROTEIN-KINASE; LUNG MAST-CELLS; DIAMINE OXIDASE; CYCLOSPORINE-A; THERAPEUTIC VACCINES; ASTHMATIC-PATIENTS; MEDIATOR RELEASE; HUMAN BASOPHILS; IN-VITRO; IMMUNOTHERAPY	Histamine is a critical inflammatory mediator in allergic diseases. We showed in a previous work that neutrophils from allergic patients produce histamine in response to allergens to which the patients were sensitized. Here, we investigate the molecular mechanisms involved in this process using peripheral blood neutrophils. We challenged these cells in vitro with allergens and analyzed histamine release in the culture supernatants. We also explored the effect of common therapeutic drugs that ameliorate allergic symptoms, as well as allergen-specific immunotherapy. Additionally, we examined the expression of histidine decarboxylase and diamine oxidase, critical enzymes in the metabolism of histamine, under allergen challenge. We show that allergen-induced histamine release is dependent on the activation of the phosphoinositide 3-kinase, mitogen-activated protein kinase p38, and extracellular signal-regulated kinase 1/2 signaling pathways. We also found a contribution of the phosphatase calcineurin to lesser extent. Anti-histamines, glucocorticoids, anti-M3-muscarinic receptor antagonists, and mainly beta(2)-receptor agonists abolished the allergen-dependent histamine release. Interestingly, allergen-specific immunotherapy canceled the histamine release through the downregulation of histidine decarboxylase expression. Our observations describe novel molecular mechanisms involved in the allergen-dependent histamine release by human neutrophils and provide new targets to inhibit histamine production.	[Chacon, Pedro; Vega-Rioja, Antonio; Doukkali, Bouchra; del Valle Rodriguez, Alberto; Bellido, Virginia; Puente, Yolanda; Monteseirin, Javier] Hosp Univ Virgen Macarena, UGC Alergol, Edificio Policlin 1a Planta,Ave Dr Fedriani 3, Seville 41009, Spain; [Alcaniz, Lorena] Hosp Univ Virgen Macarena, UGC Dermatol, Seville, Spain; [Rodriguez, David; Palacios, Ricardo] Labs Diater, Madrid, Spain; [Antonio Cornejo-Garcia, Jose] IBIMA Hosp Univ Reg Malaga UMA, Lab Invest, Malaga, Spain; [Monteseirin, Javier] Univ Seville, Fac Med, Dept Med, Seville, Spain; [Rivas-Perez, David] Univ Seville, Fac Odontol, Seville, Spain; [Monteseirin, Javier] Calle Asuncion 27,3 Izqda, Seville 41011, Spain; [Monteseirin, Javier] Hosp Quiron Infanta Luisa, Seville 41010, Spain	Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena; University of Sevilla; University of Sevilla	Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, UGC Alergol, Edificio Policlin 1a Planta,Ave Dr Fedriani 3, Seville 41009, Spain.	macrofago@us.es; fmonteseirin@us.es	RIBAS PEREZ, DAVID/GZA-6697-2022; Cornejo-Garcia, Jose Antonio/S-7726-2016	RIBAS PEREZ, DAVID/0000-0001-6123-9216; Vega Rioja, Antonio/0000-0003-4698-9697; Chacon Fernandez, Pedro Jose/0000-0003-0925-814X; Cornejo-Garcia, Jose Antonio/0000-0003-3465-8735	EC vertical bar European Regional Development Fund (ERDF); MINECO vertical bar Instituto de Salud Carlos III (ISCIII) [RD16/0006/0035]; MINECO vertical bar Agencia Estatal de Investigacion (AEI) [SAF2014-60649-JIN]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [PC--0217--2017]	EC vertical bar European Regional Development Fund (ERDF); MINECO vertical bar Instituto de Salud Carlos III (ISCIII); MINECO vertical bar Agencia Estatal de Investigacion (AEI); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia)	EC broken vertical bar European Regional Development Fund (ERDF); MINECO broken vertical bar Instituto de Salud Carlos III (ISCIII), Grant/Award Number: RD16/0006/0035; MINECO broken vertical bar Agencia Estatal de Investigacion (AEI), Grant/Award Number: SAF2014-60649-JIN; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: PC--0217--2017	Akabane Hirotomo, 2006, Allergol Int, V55, P387, DOI 10.2332/allergolint.55.387; Akdis CA, 2006, EUR J PHARMACOL, V533, P69; Alagha K, 2014, THER ADV CHRONIC DIS, V5, P85, DOI 10.1177/2040622313518227; Alcaniz L, 2013, FASEB J, V27, P2902; Aroca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094558; Barcik W, 2017, CURR OPIN IMMUNOL, V48, P108, DOI 10.1016/j.coi.2017.08.011; Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; BERGSTRAND H, 1984, ALLERGY, V39, P217, DOI 10.1111/j.1398-9995.1984.tb02627.x; Bergstrand H, 1986, ALLERGY, V41, P319; BERTHON B, 1994, BIOCHEM PHARMACOL, V47, P789, DOI 10.1016/0006-2952(94)90478-2; Billington CK, 2017, HANDB EXP PHARMACOL, V237, P23, DOI 10.1007/164_2016_64; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Carballo M, 1999, J BIOL CHEM, V274, P93; Chong LK, 1998, BRIT J PHARMACOL, V123, P1009, DOI 10.1038/sj.bjp.0701703; Ciepiela O, 2015, RESP PHYSIOL NEUROBI, V209, P13, DOI 10.1016/j.resp.2014.12.004; Ciz M, 2013, BRIT J PHARMACOL, V170, P17, DOI 10.1111/bph.12107; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DVORAK AM, 1993, J HISTOCHEM CYTOCHEM, V41, P787, DOI 10.1177/41.6.8315271; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; GALANT SP, 1980, J CLIN INVEST, V65, P577, DOI 10.1172/JCI109702; Gibbs BF, 2005, INT ARCH ALLERGY IMM, V136, P329, DOI 10.1159/000084226; HOLGATE ST, 1985, INT ARCH ALLER A IMM, V77, P47, DOI 10.1159/000233752; Hosoki K, 2016, CURR OPIN ALLERGY CL, V16, P45, DOI 10.1097/ACI.0000000000000231; Ibarrola I, 2004, ANN ALLERG ASTHMA IM, V93, P589, DOI 10.1016/S1081-1206(10)61268-9; Jutel A, 2006, CHEM IMMUNOL ALLERGY, V91, P174; Kips JC, 2001, AM J RESP CRIT CARE, V164, P923, DOI 10.1164/ajrccm.164.6.2010107; Koprak S, 2003, CELL IMMUNOL, V223, P1, DOI 10.1016/S0008-8749(03)00130-8; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Matera MG, 2017, HANDB EXP PHARMACOL, V237, P41, DOI 10.1007/164_2016_68; Milara J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210188; Miyamoto M, 2004, EUR RESPIR J, V24, P231, DOI 10.1183/09031936.04.00035204; Monteseirin J, 2005, CLIN EXP ALLERGY, V35, P1204, DOI 10.1111/j.1365-2222.2005.02320.x; Monteseirin J, 2002, J ASTHMA, V39, P619, DOI 10.1081/JAS-120014926; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Monteseirin J, 2001, J ALLERGY CLIN IMMUN, V107, P623, DOI 10.1067/mai.2001.113566; Monteseirin J, 2004, J LEUKOCYTE BIOL, V76, P692, DOI 10.1189/jlb.0903441; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; Profita M, 2005, ALLERGY, V60, P1361, DOI 10.1111/j.1398-9995.2005.00892.x; Ronchetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124090; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Schwelberger HG, 1998, INFLAMM RES, V47, pS60; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Sheikh A, 2013, CURR OPIN ALLERGY CL, V13, P263, DOI 10.1097/ACI.0b013e32836097f4; Shim JY, 2003, CLIN EXP ALLERGY, V33, P52, DOI 10.1046/j.1365-2222.2003.01567.x; Shiraishi M, 2000, BRIT J PHARMACOL, V129, P515, DOI 10.1038/sj.bjp.0703085; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Smolinska S, 2014, ALLERGY, V69, P273, DOI 10.1111/all.12330; Smuda C, 2011, IMMUNOL LETT, V141, P102, DOI 10.1016/j.imlet.2011.08.002; Sperr WR, 1997, INT ARCH ALLERGY IMM, V114, P68, DOI 10.1159/000237645; Sperr WR, 1996, J ALLERGY CLIN IMMUN, V98, P389, DOI 10.1016/S0091-6749(96)70163-X; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Tedeschi A, 2000, INT J IMMUNOPHARMACO, V22, P797, DOI 10.1016/S0192-0561(00)00041-2; Thangam EB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01873; Tsang F, 1998, BRIT J PHARMACOL, V125, P61, DOI 10.1038/sj.bjp.0702049; Vega A, 2007, J CELL SCI, V120, P2328, DOI 10.1242/jcs.000331; Vega A, 2006, J LEUKOCYTE BIOL, V80, P152, DOI 10.1189/jlb.0705411; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Ventura I, 2014, PEDIAT ALLERG IMM-UK, V25, P129, DOI 10.1111/pai.12145; Virchow JC, 2019, LANCET, V394, P1737, DOI 10.1016/S0140-6736(19)32215-9; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232	63	0	0	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21483	10.1096/fj.202001912R	http://dx.doi.org/10.1096/fj.202001912R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788304				2022-12-26	WOS:000645260100001
J	Figueiredo, AB; Castro, RADE; Nogueira-Paiva, NC; Moreira, F; Goncalves, FQ; Soares, RP; Castro-Borges, W; Silva, GG; Cunha, RA; Goncalves, T; Afonso, LCC				Figueiredo, Amanda Braga; de Oliveira e Castro, Renata Alves; Nogueira-Paiva, Nivia Carolina; Moreira, Filipa; Goncalves, Francisco Queiroz; Soares, Rodrigo Pedro; Castro-Borges, William; Silva, Gustavo Goncalves; Cunha, Rodrigo Antunes; Goncalves, Teresa; Crocco Afonso, Luis Carlos			Clustering of adenosine A(2B) receptors with ectonucleotidases in caveolin-rich lipid rafts underlies immunomodulation by Leishmania amazonensis	FASEB JOURNAL			English	Article						adenosine receptor; caveolin; cAMP; dendritic cell; Leishmania; lipid raft	IMMUNE-RESPONSE; PLASMA-MEMBRANE; EXPRESSION; INFLAMMATION; IL-10; COLOCALIZATION; ESTABLISHMENT; COMPARTMENTS; NUCLEOTIDES; MACROPHAGES	Extracellular adenosine plays important roles in modulating the immune responses. We have previously demonstrated that infection of dendritic cells (DC) by Leishmania amazonensis leads to increased expression of CD39 and CD73 and to the selective activation of the low affinity A(2B) receptors (A(2B)R), which contributes to DC inhibition, without involvement of the high affinity A(2A)R. To understand this apparent paradox, we now characterized the alterations of both adenosine receptors in infected cells. With this aim, bone marrow-derived DC from C57BL/6J mice were infected with metacyclic promastigotes of L. amazonensis. Fluorescence microscopy revealed that L. amazonensis infection stimulates the recruitment of A(2B)R, but not of A(2A)R, to the surface of infected DC, without altering the amount of mRNA or the total A(2B)R density, an effect dependent on lipophosphoglycan (LPG). Log-phase promastigotes or axenic amastigotes of L. amazonensis do not stimulate A(2B)R recruitment. A2BR clusters are localized in caveolin-rich lipid rafts and the disruption of these membrane domains impairs A(2B)R recruitment and activation. More importantly, our results show that A(2B)R co-localize with CD39 and CD73 forming a "purinergic cluster" that allows for the production of extracellular adenosine in close proximity with these receptors. We conclude that A(2B)R activation by locally produced adenosine constitutes an elegant and powerful evasion mechanism used by L. amazonensis to down-modulate the DC activation.	[Figueiredo, Amanda Braga; de Oliveira e Castro, Renata Alves; Crocco Afonso, Luis Carlos] Univ Fed Ouro Preto, Lab Imunoparasitol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Nogueira-Paiva, Nivia Carolina] Univ Fed Ouro Preto, Lab Multiusuario Microscopia, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Moreira, Filipa; Goncalves, Francisco Queiroz; Cunha, Rodrigo Antunes; Goncalves, Teresa] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Soares, Rodrigo Pedro] Fundacao Oswaldo Cruz, Inst Rene Rachou, Rio De Janeiro, Brazil; [Castro-Borges, William; Silva, Gustavo Goncalves] Univ Fed Ouro Preto, Lab Enzimol & Proteom, Nucleo Pesquisas Ciencias Biol, Ouro Preto, Brazil; [Cunha, Rodrigo Antunes; Goncalves, Teresa] Univ Coimbra, Fac Med, Coimbra, Portugal; [Figueiredo, Amanda Braga] Ctr Int Pesquisa & Ensino CIPE, AC Camargo Canc Ctr, Grp Imunooncol Translac, Sao Paulo, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade de Coimbra; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto; Universidade de Coimbra; A.C.Camargo Cancer Center	Afonso, LCC (corresponding author), Univ Fed Ouro Preto, ICEB NUPEB, Dept Ciencias Biol, Lab Imunoparasitol, Campus Morro Cruzeiro, BR-35400000 Ouro Preto, MG, Brazil.	afonso@ufop.edu.br	Gonçalves, Teresa/F-5146-2011; Cunha, Rodrigo A/E-7475-2015; Castro-Borges, William/GLR-8712-2022	Gonçalves, Teresa/0000-0001-9347-0535; Cunha, Rodrigo A/0000-0003-2550-6422; Goncalves Silva, Gustavo/0000-0002-6151-2320	FAPEMIG [CBB-APQ-00617-13, PRONEX-CBB-APQ-01419-14]; CNPq [444092/2014-5, 307695/2017-4]; CAPES [BEX-7462/14-0]; Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG [RED-00313-16]; FEDER (QREN), through Programa Mais Centro [CENTRO-01-0246-FEDER-000010, CENTRO-07-ST24-FEDER-002006]; Fundacao para a Ciencia e Tecnologia [POCI-01-0145-FEDER-03127, UIDB/04539/2020]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG; FEDER (QREN), through Programa Mais Centro; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FAPEMIG, Grant/Award Number: CBB-APQ-00617-13 and PRONEX-CBB-APQ-01419-14; CNPq, Grant/Award Number: 444092/2014-5 and 307695/2017-4; CAPES, Grant/Award Number: BEX-7462/14-0; Rede de Pesquisa em Doencas Infecciosas Humanas e Animais no Estado de Minas Gerais/FAPEMIG, Grant/Award Number: RED-00313-16; FEDER (QREN), through Programa Mais Centro, Grant/Award Number: CENTRO-01-0246-FEDER-000010 and CENTRO-07-ST24-FEDER-002006; Fundacao para a Ciencia e Tecnologia, Grant/Award Number: POCI-01-0145-FEDER-03127 and UIDB/04539/2020	Aaron JS, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211847; Allard B, 2016, CURR OPIN PHARMACOL, V29, P7, DOI 10.1016/j.coph.2016.04.001; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Savio LEB, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237560; Becher A, 2005, BIOCHEM SOC SYMP, V72, P151, DOI 10.1042/bss0720151; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P3093, DOI 10.1128/IAI.61.7.3093-3097.1993; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Cekic C, 2014, CANCER RES, V74, P7250, DOI 10.1158/0008-5472.CAN-13-3583; Chaves MM, 2014, J IMMUNOL, V192, P4765, DOI 10.4049/jimmunol.1301058; Cunha RA, 1998, J NEUROSCI, V18, P1987; D' Ambrosi N, 2013, CURR MED CHEM, V20, P56; de Assis RR, 2012, BBA-GEN SUBJECTS, V1820, P1354, DOI 10.1016/j.bbagen.2011.11.001; Figueiredo AB, 2012, EUR J IMMUNOL, V42, P1203, DOI 10.1002/eji.201141926; Figueiredo AB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00849; Fortin A, 2006, J LEUKOCYTE BIOL, V79, P574, DOI 10.1189/jlb.0505249; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Garcia-Marcos M, 2009, FEBS J, V276, P330, DOI 10.1111/j.1742-4658.2008.06794.x; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Goncalves R, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-39; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; He X, 2013, CELL SIGNAL, V25, P1913, DOI 10.1016/j.cellsig.2013.05.024; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Inoue Y, 2017, ONCOTARGET, V8, P8738, DOI 10.18632/oncotarget.14434; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Lasley RD, 2011, BBA-BIOMEMBRANES, V1808, P1284, DOI 10.1016/j.bbamem.2010.09.019; Lima MHF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00815; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marques-da-Silva ED, 2008, MICROBES INFECT, V10, P850, DOI 10.1016/j.micinf.2008.04.016; Mello PD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01526; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; Nogueira PM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2568-8; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; OSWALD IP, 1992, J IMMUNOL, V148, P3578; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Shamri R, 2002, J BIOL CHEM, V277, P40027, DOI 10.1074/jbc.M206806200; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; vanSteensel B, 1996, J CELL SCI, V109, P787; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Vijayan D, 2017, NAT REV CANCER, V17, P709, DOI 10.1038/nrc.2017.86; Wei Q, 2013, PURINERG SIGNAL, V9, P271, DOI 10.1007/s11302-012-9350-3; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Young A, 2017, CANCER RES, V77, P4684, DOI 10.1158/0008-5472.CAN-17-0393; Zhang W, 2018, PURINERG SIGNAL, V14, P443, DOI 10.1007/s11302-018-9628-1; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	57	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21509	10.1096/fj.202002396RR	http://dx.doi.org/10.1096/fj.202002396RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813781				2022-12-26	WOS:000645260100025
J	McGlade, EA; Herrera, GG; Stephens, KK; Olsen, SLW; Winuthayanon, S; Guner, J; Hewitt, SC; Korach, KS; DeMayo, FJ; Lydon, JP; Monsivais, D; Winuthayanon, W				McGlade, Emily A.; Herrera, Gerardo G.; Stephens, Kalli K.; Olsen, Sierra L. W.; Winuthayanon, Sarayut; Guner, Joie; Hewitt, Sylvia C.; Korach, Kenneth S.; DeMayo, Francesco J.; Lydon, John P.; Monsivais, Diana; Winuthayanon, Wipawee			Cell-type specific analysis of physiological action of estrogen in mouse oviducts	FASEB JOURNAL			English	Article						embryo development; embryo transport; estrogen; insulin-like growth factor 1; oviduct; scRNA-seq	ENDURANCE EXERCISE PERFORMANCE; RUNNING PERFORMANCE; SPLENIC CONTRACTION; GENDER-DIFFERENCES; SEX-DIFFERENCES; MUSCLE; WOMEN; MEN; MARATHON; ECONOMY	One of the endogenous estrogens, 17 beta-estradiol (E-2) is a female steroid hormone secreted from the ovary. It is well established that E-2 causes biochemical and histological changes in the uterus. However, it is not completely understood how E-2 regulates the oviductal environment in vivo. In this study, we assessed the effect of E-2 on each oviductal cell type, using an ovariectomized-hormone-replacement mouse model, single-cell RNA-sequencing (scRNA-seq), in situ hybridization, and cell-type-specific deletion in mice. We found that each cell type in the oviduct responded to E-2 distinctively, especially ciliated and secretory epithelial cells. The treatment of exogenous E-2 did not drastically alter the transcriptomic profile from that of endogenous E-2 produced during estrus. Moreover, we have identified and validated genes of interest in our datasets that may be used as cell-and region-specific markers in the oviduct. Insulin-like growth factor 1 (Igf1) was characterized as an E-2-target gene in the mouse oviduct and was also expressed in human fallopian tubes. Deletion of Igf1 in progesterone receptor (Pgr)-expressing cells resulted in female subfertility, partially due to an embryo developmental defect and embryo retention within the oviduct. In summary, we have shown that oviductal cell types, including epithelial, stromal, and muscle cells, are differentially regulated by E-2 and support gene expression changes, such as growth factors that are required for normal embryo development and transport in mouse models. Furthermore, we have identified cell-specific and region-specific gene markers for targeted studies and functional analysis in vivo.	[McGlade, Emily A.; Herrera, Gerardo G.; Stephens, Kalli K.; Olsen, Sierra L. W.; Winuthayanon, Sarayut; Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Biotechnol Life Sci Bldg,1770 Stadium Way, Pullman, WA 99164 USA; [Guner, Joie; Monsivais, Diana] Baylor Coll Med, Dept Pathol & Immunol, Ctr Reprod Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.; DeMayo, Francesco J.] Natl Inst Environm Hlth Sci, Dept Hlth & Human Serv, Reprod & Dev Biol Lab, Natl Inst Hlth NIH NIEHS, Res Triangle Pk, NC USA; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Washington State University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Winuthayanon, W (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Ctr Reprod Biol, Biotechnol Life Sci Bldg,1770 Stadium Way, Pullman, WA 99164 USA.	w.winuthayanon@wsu.edu		Korach, Kenneth/0000-0002-7765-418X; McGlade, Emily/0000-0003-4979-9979; Hewitt, Sylvia/0000-0001-7713-0805; /0000-0002-9323-3764; Winuthayanon, Sarayut/0000-0002-8439-0389	Burroughs Wellcome Fund (BWF); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [1ZIAES103311, 1ZIAES070065]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD042311, R01HD097087, R01HD097087-01S1, R01HD097087-02S1, R00HD096057]	Burroughs Wellcome Fund (BWF)(Burroughs Wellcome Fund); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Burroughs Wellcome Fund (BWF); Louis Stokes Alliance for Minority Participation (LSAMP) Research Award; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: 1ZIAES103311 and 1ZIAES070065; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD042311, R01HD097087, R01HD097087-01S1, R01HD097087-02S1 and R00HD096057	ARMSTRONG RB, 1992, J APPL PHYSIOL, V73, P2274, DOI 10.1152/jappl.1992.73.6.2274; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; Bakovic D, 2005, CLIN EXP PHARMACOL P, V32, P944, DOI 10.1111/j.1440-1681.2005.04289.x; Bower MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1644; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; Costa AM, 2012, SPORTS MED, V42, P449, DOI 10.2165/11650560-000000000-00000; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Entin P., 2007, Equine and Comparative Exercise Physiology, V4, P135; Fletcher JR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.178; Gagnon CM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0684; GUILHERME João Paulo Limongi França, 2014, Rev. bras. educ. fís. esporte, V28, P177, DOI 10.1590/S1807-55092014000100177; Guth LM, 2013, CURR OPIN PEDIATR, V25, P653, DOI 10.1097/MOP.0b013e3283659087; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Harper J., 2015, J SPORT CULT IDENTIT, V6, P1, DOI [DOI 10.18848/2381-6678/CGP/V06I01/54079, 10.18848/2381-6678/CGP/v06i01/54079]; Haugen T, 2018, INT J SPORT PHYSIOL, V13, P678, DOI 10.1123/ijspp.2017-0441; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; HELGERUD J, 1990, EUR J APPL PHYSIOL O, V61, P433, DOI 10.1007/BF00236064; Hilton EN, 2021, SPORTS MED, V51, P199, DOI 10.1007/s40279-020-01389-3; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Howden EJ, 2015, J APPL PHYSIOL, V119, P37, DOI 10.1152/japplphysiol.00092.2015; Hunter SK, 2015, J APPL PHYSIOL, V118, P1321, DOI 10.1152/japplphysiol.00852.2014; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; Jeon Y, 2019, J EXERC REHABIL, V15, P537, DOI 10.12965/jer.1938336.168; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2020, J APPL PHYSIOL, V128, P1065, DOI 10.1152/japplphysiol.00793.2019; Joyner MJ, 2019, SPORTS MED, V49, P199, DOI 10.1007/s40279-019-01164-z; Joyner MJ, 2017, J PHYSIOL-LONDON, V595, P2949, DOI 10.1113/JP272268; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Kim J, 2018, P NATL ACAD SCI USA, V115, pE7212, DOI 10.1073/pnas.1800455115; Kipp S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00079; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; Lauderdale M A, 1999, Equine Vet J Suppl, P586; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; LONGHURST JC, 1986, AM J PHYSIOL, V251, pH502, DOI 10.1152/ajpheart.1986.251.3.H502; Lund RJ, 1995, J S AFR VET ASSOC, V66, P239; McKeever K H, 2006, Equine Vet J Suppl, P233; Miller VM, 2015, J WOMENS HEALTH, V24, P969, DOI 10.1089/jwh.2015.5498; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Pate RR, 2007, SPORTS MED, V37, P294, DOI 10.2165/00007256-200737040-00006; Porter MM, 2002, J APPL PHYSIOL, V92, P1451, DOI 10.1152/japplphysiol.00744.2001; Roberts TA, 2020, BR J SPORTS MED; Rooney MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205664; Schagatay E, 2020, EUR J APPL PHYSIOL, V120, P2693, DOI 10.1007/s00421-020-04471-w; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld JW, 2020, JAMA-J AM MED ASSOC, V324, P99, DOI 10.1001/jama.2020.5655; Senefeld JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225724; Shave Rob, 2017, Vet Sci, V4, DOI 10.3390/vetsci4010009; Staaden R., 1984, THESIS MURDOCH U MUR; Thibault V, 2010, J SPORT SCI MED, V9, P214; Trachsel DS, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0846-x; VAHLQUIST B, 1950, BLOOD, V5, P874, DOI 10.1182/blood.V5.9.874.874; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Wiik A., 2020, J CLIN ENDOCR METAB, V105, P805; Yilmaz DC, 2013, INDIAN J MED RES, V137, P1111; Young LE, 2003, EXP PHYSIOL, V88, P659, DOI 10.1113/eph8802615; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x	65	6	6	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21563	10.1096/fj.202002747R	http://dx.doi.org/10.1096/fj.202002747R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33818810	Green Submitted, Green Accepted			2022-12-26	WOS:000645260100070
J	D'Ambrosio, R; Campi, I; Maggioni, M; Perbellini, R; Giammona, E; Stucchi, R; Borghi, M; Degasperi, E; De Silvestri, A; Persani, L; Fugazzola, L; Lampertico, P				D'Ambrosio, Roberta; Campi, Irene; Maggioni, Marco; Perbellini, Riccardo; Giammona, Enza; Stucchi, Roberta; Borghi, Marta; Degasperi, Elisabetta; De Silvestri, Annalisa; Persani, Luca; Fugazzola, Laura; Lampertico, Pietro			The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)	PLOS ONE			English	Article							HYPOTHYROIDISM; STEATOHEPATITIS; GLUCOSE	Background Data on the role of hypothyroidism in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are conflicting, although selective Thyroid Hormone Receptor (THR)-beta agonists have been identified as potential therapy in patients with non-alcoholic steatohepatitis (NASH). Therefore, we investigated the association between hypothyroidism and NAFLD histological features potentially associated with progressive liver disease. Methods Between 2014 and 2016, consecutive patients with histologically proven NAFLD and frozen serum available for thyroid function tests assessment were included. NAFLD was staged according to the NAFLD Activity Score (NAS), and fibrosis according to Kleiner. NASH was defined as NAS >= 4, significant fibrosis as F2-F4 and significant steatosis as S2-S3. Thyroid function tests (TFT; TSH, FT3, FT4, rT3), TPO-Ab and Tg-Ab were also assessed. Results Fifty-two patients were analyzed: median age 54 years, 58% females, LSM 7.8 kPa, 27% diabetics, 14% hypothyroid. At histology, NASH was present in 21 (40%), F2-F4 in 28 (54%) and S2-S3 in 30 (58%) patients. Rates of hypothyroidism were similar independently of the presence of NASH (p = 0.11), significant fibrosis (p = 0.21) or steatosis (p = 0.75). However, hypothyroid patients displayed a higher NAS (p = 0.02) and NASH (p = 0.06) prevalence. At multivariate analysis, TFT were not independently associated with histology. Conclusion Hypothyroidism was highly prevalent in NAFLD patients, and was associated with increased NAFLD activity, but not with fibrosis and steatosis severity. Thus, thyroid dysfunction might play a direct and/or indirect in the pathogenesis of NAFLD and NASH.	[D'Ambrosio, Roberta; Perbellini, Riccardo; Borghi, Marta; Degasperi, Elisabetta; Lampertico, Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy; [Campi, Irene; Persani, Luca; Fugazzola, Laura] IRCCS Ist Auxol Italiano, Dept Endocrine & Metab Dis, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, Milan, Italy; [Giammona, Enza; Stucchi, Roberta] IRCCS Ist Auxol Italiano, Div Lab Med, Milan, Italy; [De Silvestri, Annalisa] Fdn IRCCS Policlin San Matteo, Clin Epidemiol & Biometr Unit, Pavia, Italy; [Persani, Luca] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Fugazzola, Laura; Lampertico, Pietro] Univ Milan, CRCeA Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Auxologico Italiano; IRCCS Fondazione San Matteo; University of Milan; University of Milan	D'Ambrosio, R (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy.	roberta.dambrosio@policlinico.mi.it	De Silvestri, Annalisa/I-6024-2014; Maggioni, Marco/AAC-4617-2022; Persani, Luca/B-6543-2008	De Silvestri, Annalisa/0000-0003-3128-8441; Maggioni, Marco/0000-0001-8603-8998; Persani, Luca/0000-0003-2068-9581	University of Milan	University of Milan	The authors received no specific funding for this work. The University of Milan is acknowledged for support with publication fees.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bano A, 2016, J CLIN ENDOCR METAB, V101, P3204, DOI 10.1210/jc.2016-1300; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Carulli L, 2013, INTERN EMERG MED, V8, P297, DOI 10.1007/s11739-011-0609-4; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Mazo Daniel Ferraz de Campos, 2011, Arq. Gastroenterol., V48, P186, DOI 10.1590/S0004-28032011000300006; Dimitriadis G, 2006, J CLIN ENDOCR METAB, V91, P1112, DOI 10.1210/jc.2005-0960; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Eshraghian A, 2014, WORLD J GASTROENTERO, V20, P8102, DOI 10.3748/wjg.v20.i25.8102; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Guo ZQ, 2018, DIGEST LIVER DIS, V50, P1153, DOI 10.1016/j.dld.2018.08.012; Harrison SA, 2019, LANCET, V394, P2012, DOI 10.1016/S0140-6736(19)32517-6; He WW, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00335; Huang YY, 2013, WORLD J GASTROENTERO, V19, P8238, DOI 10.3748/wjg.v19.i45.8238; Jaruvongvanich V, 2017, EUR THYROID J, V6, P208, DOI 10.1159/000454920; Kim D, 2018, CLIN GASTROENTEROL H, V16, P123, DOI 10.1016/j.cgh.2017.08.014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee KW, 2015, CLIN MOL HEPATOL, V21, P372, DOI 10.3350/cmh.2015.21.4.372; Liu L, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5753039; Ludwig U, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0030-5; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Manka P, 2019, DIGEST DIS SCI, V64, P2351, DOI 10.1007/s10620-019-05687-3; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Escude AM, 2020, MED CLIN-BARCELONA, V154, P1, DOI 10.1016/j.medcli.2019.03.018; Michalaki MA, 2006, THYROID, V16, P73, DOI 10.1089/thy.2006.16.73; OBRIEN T, 1993, MAYO CLIN PROC, V68, P860, DOI 10.1016/S0025-6196(12)60694-6; Pagadala MR, 2012, DIGEST DIS SCI, V57, P528, DOI 10.1007/s10620-011-2006-2; Piantanida E, 2020, J ENDOCRINOL INVEST, V43, P885, DOI 10.1007/s40618-020-01208-6; Pucci E, 2000, INT J OBESITY, V24, pS109, DOI 10.1038/sj.ijo.0801292; Raftopoulos Y, 2004, OBES SURG, V14, P509, DOI 10.1381/096089204323013514; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Taub R, 2013, ATHEROSCLEROSIS, V230, P373, DOI 10.1016/j.atherosclerosis.2013.07.056; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Vallejo CG, 2005, AM J PHYSIOL-ENDOC M, V289, pE87, DOI 10.1152/ajpendo.00436.2004; Xu CF, 2011, CLIN ENDOCRINOL, V75, P240, DOI 10.1111/j.1365-2265.2011.04016.x	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249614	10.1371/journal.pone.0249614	http://dx.doi.org/10.1371/journal.pone.0249614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822817	gold, Green Published			2022-12-26	WOS:000637879100027
J	Feng, JT; Guo, YH; Yan, CR; Ye, YY; Yan, XJ; Li, JJ; Xu, KD; Guo, BY; Lu, ZM				Feng, Jiantong; Guo, Yahong; Yan, Chengrui; Ye, Yingying; Yan, Xiaojun; Li, Jiji; Xu, Kaida; Guo, Baoying; Lu, Zhenming			Novel gene rearrangement in the mitochondrial genome of Siliqua minima (Bivalvia, Adapedonta) and phylogenetic implications for Imparidentia	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE MTDNA; GIANT CLAM; DNA; MODEL; SEQUENCE; TREE; REPLICATION; EVOLUTION; PROGRAM	Siliqua minima (Gmelin, 1791) is an important economic shellfish species belonging to the family Pharidae. To date, the complete mitochondrial genome of only one species in this family (Sinonovacula constricta) has been sequenced. Research on the Pharidae family is very limited; to improve the evolution of this bivalve family, we sequenced the complete mitochondrial genome of S. minima by next-generation sequencing. The genome is 17,064 bp in length, consisting of 12 protein-coding genes (PCGs), 22 transfer RNA genes (tRNA), and two ribosomal RNA genes (rRNA). From the rearrangement analysis of bivalves, we found that the gene sequences of bivalves greatly variable among species, and with closer genetic relationship, the more consistent of the gene arrangement is higher among the species. Moreover, according to the gene arrangement of seven species from Adapedonta, we found that gene rearrangement among families is particularly obvious, while the gene order within families is relatively conservative. The phylogenetic analysis between species of the superorder Imparidentia using 12 conserved PCGs. The S. minima mitogenome was provided and will improve the phylogenetic resolution of Pharidae species.	[Feng, Jiantong; Guo, Yahong; Yan, Chengrui; Ye, Yingying; Yan, Xiaojun; Li, Jiji; Guo, Baoying; Lu, Zhenming] Zhejiang Ocean Univ, Natl Engn Res Ctr Marine Aquaculture, Zhoushan, Peoples R China; [Ye, Yingying; Guo, Baoying; Lu, Zhenming] Zhejiang Ocean Univ, Natl Engn Lab Marine Germplasm Resources Explorat, Zhoushan, Peoples R China; [Xu, Kaida] Marine Fisheries Res Inst Zhejiang, Key Lab Sustainable Utilizat Technol Res, Sci Observing & Expt Stn Fishery Resources Key Fi, MOA, Zhoushan, Peoples R China	Zhejiang Ocean University; Zhejiang Ocean University	Ye, YY; Yan, XJ (corresponding author), Zhejiang Ocean Univ, Natl Engn Res Ctr Marine Aquaculture, Zhoushan, Peoples R China.; Ye, YY (corresponding author), Zhejiang Ocean Univ, Natl Engn Lab Marine Germplasm Resources Explorat, Zhoushan, Peoples R China.	yeyy@zjou.edu.cn; yanxj@zjou.edu.cn	Li, Jiji/AAA-1042-2022	Yan, Xiaojun/0000-0003-0257-0157; Ye, Yingying/0000-0003-0056-030X	National Key R&D Program of China [2019YFD0901204]; Project of Bureau of Science and Technology of Zhoushan [2020C21026]; NSFC Projects of International Cooperation and Exchanges [42020104009]; National Natural Science Foundation of China [41976111, 42076119]	National Key R&D Program of China; Project of Bureau of Science and Technology of Zhoushan; NSFC Projects of International Cooperation and Exchanges; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Key R&D Program of China (2019YFD0901204), the Project of Bureau of Science and Technology of Zhoushan (2020C21026), NSFC Projects of International Cooperation and Exchanges (42020104009) and National Natural Science Foundation of China (41976111, 42076119).	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bieler R, 2014, INVERTEBR SYST, V28, P32, DOI 10.1071/IS13010; Bolotov IN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18873-y; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; Combosch DJ, 2017, MOL PHYLOGENET EVOL, V107, P191, DOI 10.1016/j.ympev.2016.11.003; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Fernandez-Perez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184464; Gan HM, 2016, MITOCHONDRIAL DNA A, V27, P3220, DOI 10.3109/19401736.2015.1007355; Ghosh E, 1920, REC INDIAN MUS, V19, P47; Gong L, 2019, GENE, V695, P75, DOI 10.1016/j.gene.2019.01.035; Gonzalez VL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2332; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hu P, 2019, GENE, V686, P76, DOI 10.1016/j.gene.2018.10.088; Huang Z., 2012, ILLUSTRATED GUIDE SP; Bisbal-Pardo CI, 2016, MITOCHONDRIAL DNA A, V27, P1957, DOI 10.3109/19401736.2014.971305; Bisbal-Pardo CI, 2016, MITOCHONDRIAL DNA A, V27, P1955, DOI 10.3109/19401736.2014.971304; JANKE A, 1993, NUCLEIC ACIDS RES, V21, P1523, DOI 10.1093/nar/21.7.1523; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumar V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57065-8; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lemer S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2684; Li Q, 2020, INT J BIOL MACROMOL, V145, P974, DOI 10.1016/j.ijbiomac.2019.09.188; Li R, 2020, GENOMICS, V112, P289, DOI 10.1016/j.ygeno.2019.02.008; Liu RY., 2008, CHECKLIST MARINE BIO; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu R.M., 2008, J MAR SCI, V26, P45; Lv CD, 2018, CONSERV GENET RESOUR, V10, P375, DOI 10.1007/s12686-017-0828-8; Lv CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196466; Ma HT, 2019, MITOCHONDRIAL DNA B, V4, P1051, DOI 10.1080/23802359.2019.1584061; Mukundan LP, 2020, BIOCHEM GENET, V58, P430, DOI 10.1007/s10528-020-09956-z; Ni XY, 2007, JIANGXI SCI, V25, P59, DOI [10.13990/j.issn1001, DOI 10.13990/J.ISSN1001]; Osca D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0197-9; Patra AK, 2016, MAR GENOM, V26, P63, DOI 10.1016/j.margen.2015.12.010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, FIGTREE VERSION 143; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shao Yan-qing, 2009, Marine Sciences (Beijing), V33, P26; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wang Y, 2021, ZOOL SCR, V50, P58, DOI 10.1111/zsc.12454; Wu AC, 2009, J WENZHOU U, V30, P19; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yang HR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113646; Yu MJ, 2016, MITOCHONDRIAL DNA B, V1, P883, DOI 10.1080/23802359.2016.1258338; Yuan XiPing, 2019, Agricultural Sciences, V10, P173, DOI 10.4236/as.2019.102015; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; Yuan Y, 2012, MITOCHONDR DNA, V23, P112, DOI 10.3109/19401736.2011.653802; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zhang M, 2019, INT J BIOL MACROMOL, V140, P794, DOI 10.1016/j.ijbiomac.2019.08.182; Zhang M, 2019, INT J BIOL MACROMOL, V129, P1069, DOI 10.1016/j.ijbiomac.2019.02.124; Zhang SP., 2008, ATLAS MARINE MOLLUSK; Zhang Yong-Pu, 2002, Chinese Journal of Zoology, V37, P63; Zheng RL, 2010, ACTA OCEANOL SIN, V29, P88, DOI 10.1007/s13131-010-0026-y; Zhu HC, 2012, MITOCHONDR DNA, V23, P115, DOI 10.3109/19401736.2011.653803; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	2	2	12	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249446	10.1371/journal.pone.0249446	http://dx.doi.org/10.1371/journal.pone.0249446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822813	Green Published, gold			2022-12-26	WOS:000637879100019
J	Lin, YX; Lin, CH; Lin, CH				Lin, You-Xuan; Lin, Chi-Hao; Lin, Chih-Hao			A challenge for healthcare system resilience after an earthquake: The crowdedness of a first-aid hospital by non-urgent patients	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; SEISMIC RESILIENCE; SIMULATION	After a violent earthquake, the supply of medical services may fall short of the rising demand, leading to overcrowding in hospitals, and, consequently, a collapse in the healthcare system. This paper takes the emergency care system in Taiwan as the research context, where first-aid hospitals are ranked to three levels, advanced, intermediate, and general, and, currently, emphasizes on a general emergency responsibility hospital. Having limited capacity and capability, a general emergency responsibility hospital treats minor and moderate injuries, from which the majority of earthquake-induced casualties suffer. The purpose of this study is to analyze the impact of this group of earthquake-induced non-urgent patients on the performance of a hospital. A patient flow model was built to represent patients' paths throughout emergency care. Based on the model, discrete event simulation was applied to simulate patients' trajectories and states of a hospital under four seismic scenarios, where patient visits are 1.4, 1.6, 1.9, and 2.3 times the normal number. A healthcare performance index, Crowdedness Index (CI), is proposed to measure crowdedness on a daily basis, which is defined as the ratio of the average waiting time for treatment to the recommended maximal waiting time. Results of simulations rendered the establishment of empirical equations, describing the relation between the maximum CIs and the patient growth ratios. In the most severe case in this study, the maximum CI exceeds 92 and it takes 10 days to recover from the quality drop. This highlights the problem a general emergency responsibility hospital may encounter if no emergency response measure is implemented. Findings are provided pertaining to the predication of a recovery curve and the alarming level of patient increase, which are supportive information for preparedness planning as well as response measure formulation to improve resilience.	[Lin, You-Xuan; Lin, Chi-Hao] Natl Ctr Res Earthquake Engn, Taipei, Taiwan; [Lin, Chih-Hao] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Lin, YX (corresponding author), Natl Ctr Res Earthquake Engn, Taipei, Taiwan.	yxlin@narlabs.org.tw						Abo-Hamad W, 2013, EUR J OPER RES, V224, P154, DOI 10.1016/j.ejor.2012.07.028; Ansah JP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244097; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Baril C, 2019, J OPER RES SOC, V70, P2019, DOI 10.1080/01605682.2018.1510805; Chen KC, 2019, 5 INT C SMART MON AS; Cimellaro GP, 2016, ADV STRUCT ENG, V19, P825, DOI 10.1177/1369433216630441; Cimellaro GP, 2010, STRUCT INFRASTRUCT E, V6, P127, DOI 10.1080/15732470802663847; Cote M., 1999, SOCIOECONOMIC PLANNI, V33, P231, DOI DOI 10.1016/S0038-0121(99)00007-5; Favier P, 2019, EARTHQ SPECTRA, V35, P489, DOI 10.1193/103017EQS224M; Federal Emergency Management Agency, 2020, HAZUS EARTHQUAKE MOD; Green LV, 2006, ACAD EMERG MED, V13, P61, DOI 10.1197/j.aem.2005.07.034; Gul M, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/2931219; Gul M, 2020, J OPER RES SOC, V71, P733, DOI 10.1080/01605682.2019.1582588; Gul M, 2015, COMPUT IND ENG, V83, P327, DOI 10.1016/j.cie.2015.02.018; Hassan EM, 2020, RELIAB ENG SYST SAFE, V201, DOI 10.1016/j.ress.2020.106953; Hatcher, 2020, NAT MED, V29, P1, DOI [10.1101/2020.03.18.20038018, DOI 10.1101/2020.03.18.20038018, 10.3389/fmolb.2020.604252, DOI 10.1038/S41591-020-0897-1]; Hoot NR, 2009, J AM MED INFORM ASSN, V16, P338, DOI 10.1197/jamia.M2772; Kao CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144227; Khanmohammadi S, 2018, INT J DISAST RISK RE, V31, P220, DOI 10.1016/j.ijdrr.2018.05.006; Kuo Y. H., 2014, HKIE T, V21, P253; Kuo YH, 2020, INT J MED INFORM, V139, DOI 10.1016/j.ijmedinf.2020.104143; Kuo YH, 2016, FLEX SERV MANUF J, V28, P120, DOI 10.1007/s10696-014-9198-7; Lin CH, 2016, LANCET, V388, P129, DOI 10.1016/S0140-6736(16)30978-3; Lin CH, 2015, J FORMOS MED ASSOC, V114, P64, DOI 10.1016/j.jfma.2012.09.007; Minister of the Interior, 2018, SUMM REP 0206 HUAL E; Muller K., 2003, SIMPY SIMULATING SYS; Ortiz-Barrios M, 2020, INT J DISAST RISK RE, V49, DOI 10.1016/j.ijdrr.2020.101748; Shiu MN., 2013, EMERGENCY DEP OVERCR; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; Vanbrabant L, 2019, COMPUT IND ENG, V131, P356, DOI 10.1016/j.cie.2019.03.025; Yeh CH, 2006, NAT HAZARDS, V37, P23, DOI 10.1007/s11069-005-4654-z; Yu P, 2019, ADV CIV ENG, V2019, DOI 10.1155/2019/7654683	32	0	0	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249522	10.1371/journal.pone.0249522	http://dx.doi.org/10.1371/journal.pone.0249522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798238	gold, Green Published			2022-12-26	WOS:000636737700015
J	Mercan, Y; Selcuk, KT				Mercan, Yeliz; Selcuk, Kevser Tari			Association between postpartum depression level, social support level and breastfeeding attitude and breastfeeding self-efficacy in early postpartum women	PLOS ONE			English	Article							POSTNATAL DEPRESSION; KNOWLEDGE; SCALE; PERIOD	Objective The study was aimed at investigating the association between postpartum women's breastfeeding self-efficacy levels and their depression levels, social support levels, and breastfeeding attitudes in early postpartum period. Methods The cross-sectional study was carried out in Kirklareli in Turkey. The population of the study consisted of 398 women aged 15-49 in the first 42 days of the postpartum period who presented to eight family health centers. The study data were collected face-to-face using the Personal Information Form, Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), Edinburgh Postnatal Depression Scale (EPDS), Multidimensional Scale of Perceived Social Support (MSPSS), and Breastfeeding Attitudes of the Evaluation Scale (BAES). Results The mean age of the participants was 28.61 +/- 5.72 (Min:18, Max: 44), and the mean score they obtained from the BSES-SF was 55.13 +/- 8.39. Statistically significant differences were detected between the participants' BSES-SF scores and age groups, employment status, perceived income level, and the number of living children (p < 0.05). No statistically significant differences were detected between marital status, educational status and BSES-SF scores (p > 0.05). In the multivariate regression analysis adjusted according to the sociodemographic characteristics, BAES, EPDS and MSPSS accounted for 48.3% of the BSES-SF. A negative association was found between BSES-SF scores and EPDS scores (beta = -0.178, 95% CI:-0.349, -0.006), and a positive relation between the BAES scores (beta = 0.194, 95% CI: 0.163, 0.226) and the MSPSS scores (beta = 0.114, 95% CI: 0.037, 0.191). Conclusion As the level of depression of women increases in the postpartum period, the level of breastfeeding self-efficacy decreases. The breastfeeding self-efficacy increases as the level of social support increases and as the attitudes that drive breastfeeding behavior change positively.	[Mercan, Yeliz] Kirklareli Univ, Sch Hlth, Dept Hlth Management, Kirklareli, Turkey; [Selcuk, Kevser Tari] Bandirma Onyedi Eylul Univ, Fac Hlth Sci, Dept Nurit & Dietet, Balikesir, Turkey	Kirklareli University; Bandirma Onyedi Eylul University	Mercan, Y (corresponding author), Kirklareli Univ, Sch Hlth, Dept Hlth Management, Kirklareli, Turkey.	mercan.yeliz@gmail.com		Mercan, Yeliz/0000-0002-7099-4536				Abbass-Dick J, 2015, PEDIATRICS, V135, P102, DOI 10.1542/peds.2014-1416; Alghamdi S, 2017, APPL NURS RES, V37, P24, DOI 10.1016/j.apnr.2017.07.009; Altamimi E, 2017, WORKPLACE HEALTH SAF, V65, P210, DOI 10.1177/2165079916665395; Arslan ozkan H, 2015, KADIN SAGLIGI HEMSIR, V2, P53; Aydin N, 2004, SOC PSYCH PSYCH EPID, V39, P483, DOI 10.1007/s00127-004-0770-4; Balogun OO, 2016, MATERN CHILD HLTH J, V20, P363, DOI 10.1007/s10995-015-1835-6; Bandura Albert, 1994, SELF EFFICACY; Brockway M, 2017, J HUM LACT, V33, P486, DOI 10.1177/0890334417707957; Casal CS, 2017, J HUM LACT, V33, P20, DOI 10.1177/0890334416677029; Chaput Kathleen H, 2016, CMAJ Open, V4, pE103, DOI 10.9778/cmajo.20150009; Cinar N, 2015, JCPSP-J COLL PHYSICI, V25, P271, DOI 04.2015/JCPSP.271275; Corby K, 2021, CAN J NURS RES, V53, P56, DOI 10.1177/0844562119888363; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; de Jager E, 2013, MIDWIFERY, V29, P506, DOI 10.1016/j.midw.2012.04.009; Dennis CL, 2003, JOGNN-J OBST GYN NEO, V32, P734, DOI 10.1177/0884217503258459; EKER D, 1995, SOC PSYCH PSYCH EPID, V30, P121, DOI 10.1007/BF00802040; Faridvand F, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12659; Figueiredo B, 2013, J PEDIAT-BRAZIL, V89, P332, DOI 10.1016/j.jped.2012.12.002; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; Gercek E, 2017, J CLIN NURS, V26, P994, DOI 10.1111/jocn.13423; Hacettepe University Institute of Population Studies, 2019, 2018 TURK DEM HLTH S, P139; Haga SM, 2012, ARCH WOMEN MENT HLTH, V15, P175, DOI 10.1007/s00737-012-0274-2; Hansen K, 2016, LANCET, V387, P416, DOI 10.1016/S0140-6736(16)00012-X; Hendrick V, 1998, PSYCHOSOMATICS, V39, P93, DOI 10.1016/S0033-3182(98)71355-6; Kilci H, 2016, BREASTFEED MED, V11, P188, DOI 10.1089/bfm.2015.0046; Kultur S., 1996, BAHAR SEMPOZYUMLARI, V1, P51; Ngo LTH, 2019, MIDWIFERY, V70, P84, DOI 10.1016/j.midw.2018.12.014; Maleki-Saghooni N, 2020, J MATERN-FETAL NEO M, V33, P3097, DOI 10.1080/14767058.2019.1568986; Pakseresht Sedighe, 2017, Electron Physician, V9, P3751, DOI 10.19082/3751; Robertson E., 2003, RISK FACTORS POSTPAR; Santos HP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191675; Tokat MA, 2010, MIDWIFERY, V26, P101, DOI 10.1016/j.midw.2008.04.002; Turkish Statistical Institute, ADDR BAS POP REG SYS; Tuthill EL, 2016, J HUM LACT, V32, P35, DOI 10.1177/0890334415599533; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; World Health Organization (WHO), INF YOUNG CHILD FEED; World Health Organization (WHO), WOM REPR AG 15 49 YE; Wu Yu-Hsuan, 2018, Hu Li Za Zhi, V65, P42, DOI 10.6224/JN.201802_65(1).07; Yang X, 2016, MIDWIFERY, V41, P1, DOI 10.1016/j.midw.2016.07.011; Zhang YJ, 2016, J HEALTH PSYCHOL, V21, P720, DOI 10.1177/1359105314536454; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zubaran C, 2013, SEX REPROD HEALTHC, V4, P9, DOI 10.1016/j.srhc.2012.12.001	42	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249538	10.1371/journal.pone.0249538	http://dx.doi.org/10.1371/journal.pone.0249538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798229	Green Published, gold			2022-12-26	WOS:000636737700020
J	Gros, C; Valenti, R; Schneider, L; Gutsche, B; Markovic, D				Gros, Claudius; Valenti, Roser; Schneider, Lukas; Gutsche, Benedikt; Markovic, Dimitrije			Predicting the cumulative medical load of COVID-19 outbreaks after the peak in daily fatalities	PLOS ONE			English	Article							HUMAN-BEHAVIOR; MODELS	The distinct ways the COVID-19 pandemic has been unfolding in different countries and regions suggest that local societal and governmental structures play an important role not only for the baseline infection rate, but also for short and long-term reactions to the outbreak. We propose to investigate the question of how societies as a whole, and governments in particular, modulate the dynamics of a novel epidemic using a generalization of the SIR model, the reactive SIR (short-term and long-term reaction) model. We posit that containment measures are equivalent to a feedback between the status of the outbreak and the reproduction factor. Short-term reaction to an outbreak corresponds in this framework to the reaction of governments and individuals to daily cases and fatalities. The reaction to the cumulative number of cases or deaths, and not to daily numbers, is captured in contrast by long-term reaction. We present the exact phase space solution of the controlled SIR model and use it to quantify containment policies for a large number of countries in terms of short and long-term control parameters. We find increased contributions of long-term control for countries and regions in which the outbreak was suppressed substantially together with a strong correlation between the strength of societal and governmental policies and the time needed to contain COVID-19 outbreaks. Furthermore, for numerous countries and regions we identified a predictive relation between the number of fatalities within a fixed period before and after the peak of daily fatality counts, which allows to gauge the cumulative medical load of COVID-19 outbreaks that should be expected after the peak. These results suggest that the proposed model is applicable not only for understanding the outbreak dynamics, but also for predicting future cases and fatalities once the effectiveness of outbreak suppression policies is established with sufficient certainty. Finally, we provide a web app () with tools for visualising the phase space representation of real-world COVID-19 data and for exporting the preprocessed data for further analysis.	[Gros, Claudius; Valenti, Roser; Schneider, Lukas; Gutsche, Benedikt] Goethe Univ Frankfurt, Frankfurt, Germany; [Markovic, Dimitrije] Tech Univ Dresden, Dresden, Germany	Goethe University Frankfurt; Technische Universitat Dresden	Gros, C (corresponding author), Goethe Univ Frankfurt, Frankfurt, Germany.	gros07@itp.uni-franfkurt.de		Markovic, Dimitrije/0000-0002-4185-696X; Gutsche, Benedikt/0000-0002-3886-6649	EU [101016233]	EU(European Commission)	C.G., R.V. and D.M. acknowledge financial support from the Horizon 2020 research and innovation program of the EU under grant agreement No. 101016233, H2020-SC1-PHE CORONAVIRUS-2020-2-RTD, PERISCOPE (Pan European Response to the Impacts of Covid-19 and future Pandemics and Epidemics).	Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; Alimadadi A, 2020, PHYSIOL GENOMICS, V52, P200, DOI 10.1152/physiolgenomics.00029.2020; Andersen M., 2020, EARLY EVIDENCE SOCIA, DOI [DOI 10.2139/SSRN.3569368, 10.2139/ssrn.3569368]; [Anonymous], 2020, OXFORD COVID 19 GOVT; [Anonymous], 2020, GOOGLE COVID 19 MOBI; Atkins KE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1115; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chitwood MH., 2020, BAYESIAN NOWCASTING; Ciminelli G, 2020, COVID 19 ITALY ANAL, P22; Cirillo P, 2020, NAT PHYS, V16, P606, DOI 10.1038/s41567-020-0921-x; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Dobrovolny HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236976; ECDS, 2020, EUROPEAN CTR DIS CON; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Funk MJ., 2020, QUANTIFYING SOCIAL D; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gaeta G., 2020, ARXIV PREPRINT ARXIV; Gros C., 2015, COMPLEX ADAPTIVE DYN; Gros D., ARXIV PREPRINT ARXIV; Hale T., 2020, VARIATION GOVT RESPO; Hennessy J, 2020, ARXIV PREPRINT ARXIV; JHU C, 2020, JOHNS HOPKINS CTR SY; Kauder E., 2015, HIST MARGINAL UTILIT, Vvol. 2238, DOI DOI 10.1515/9781400877744; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lalmuanawma S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110059; Landeros A, 2021, PLOS ONE, V16, DOI [10.1101/2020.08.05.20169086, 10.1371/journal.pone.0251242]; Leung KY, 2018, MATH BIOSCI, V301, P190, DOI 10.1016/j.mbs.2018.04.002; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Mogensen P. K., 2018, J OPEN SOURCE SOFTW, V3, P615, DOI [10.21105/joss.00615, DOI 10.21105/JOSS.00615]; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Rackauckas C, 2017, J OPEN RES STW, V5, DOI 10.1371/journal.pone.0002185; Reuters, 2020, SPAIN REVISES CORONA; RKI, 2020, ROBERT KOCH I COVID; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Siegenfeld AF, 2020, P NATL ACAD SCI USA, V117, P16092, DOI 10.1073/pnas.2011542117; Sims S., 2020, FLATTENING CURVE IT; WHO, 2012, WORLD MALARIA REPORT 2012, P1	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0247272	10.1371/journal.pone.0247272	http://dx.doi.org/10.1371/journal.pone.0247272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793551	Green Submitted, Green Published, gold			2022-12-26	WOS:000636467000080
J	Lee, JH; Lin, LG; Ye, XC; Wolfrum, C; Chen, YJ; Guo, SD; Sun, YX				Lee, Jong Han; Lin, Ligen; Ye, Xiangcang; Wolfrum, Christian; Chen, Yingjie; Guo, Shaodong; Sun, Yuxiang			GHS-R in brown fat potentiates differential thermogenic responses under metabolic and thermal stresses	PLOS ONE			English	Article							ADIPOSE-TISSUE; GHRELIN RECEPTOR; WHITE; BIOLOGY; OBESITY; BRITE; UCP1	In response to cold or diet, fatty acids are dissipated into heat through uncoupling protein 1 (UCP1) in brown adipose tissue (BAT). This process is termed non-shivering thermogenesis, which is important for body temperature maintenance and contributes to obesity pathogenesis. Thermogenic enhancement has been considered a promising anti-obesity strategy. Ghrelin and its receptor Growth Hormone Secretagogue Receptor (GHS-R) have critical roles in energy intake, nutrient sensing, and lipid metabolism. We previously reported that global Ghsr-knockout mice have increased energy expenditure due to enhanced thermogenesis. To determine the site of action for GHS-R mediated thermogenesis, we generated brown adipocyte-specific Ghsr knockout mice (UCP1-Cre(ER)/Ghsr(f/f)) and assessed thermogenic responses under regular diet (RD) fed homeostatic metabolic state or high-fat diet (HFD) fed metabolically-impaired obese state, under normal or cold housing environment. Under a RD-feeding, UCP1-Cre(ER)/Ghsr(f/f) mice showed increased body fat and a slightly elevated core body temperature under cold but not under normal temperature. Consistently, the expression of thermogenic genes in BAT of RD-fed UCP1-Cre(ER)/Ghsr(f/f) mice was increased in reposes to cold. Under HFD feeding, HFD-fed UCP1-Cre(ER)/Ghsr(f/f) mice showed no difference in body fat or body temperature under either normal or cold exposure. Interestingly, the expression of thermogenic genes in BAT of HFD-fed UCP1-Cre(ER)/Ghsr(f/f) mice was upregulated under normal temperature but downregulated under cold exposure. Overall, our data show that GHS-R has cell-autonomous effect in brown adipocytes, and GHS-R regulates BAT thermogenic activity in a temperature- and metabolic state-dependent manner. The thermogenic effect of GHS-R in BAT is more pronounced in cold environment and differentially variable based on metabolic state; under cold exposure, GHS-R inhibition in BAT activates thermogenesis under homeostatic state but suppresses thermogenesis under obese state. Our finding collectively suggests that GHS-R in BAT, acting as a "metabolic thermostat", differentially regulates thermogenesis in response to different metabolic and thermal stimuli.	[Lee, Jong Han; Lin, Ligen; Sun, Yuxiang] Baylor Coll Med, USDA ARS Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Ye, Xiangcang; Guo, Shaodong; Sun, Yuxiang] Texas A&M Univ, Dept Nutr, College Stn, TX USA; [Wolfrum, Christian] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Schwerzenbach, Switzerland; [Chen, Yingjie] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Lee, Jong Han] Hanseo Univ, Dept Marine Bio & Med Sci, Seosan, South Korea; [Lin, Ligen] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Mississippi; University of Mississippi Medical Center; Hanseo University; University of Macau	Sun, YX (corresponding author), Baylor Coll Med, USDA ARS Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.; Sun, YX (corresponding author), Texas A&M Univ, Dept Nutr, College Stn, TX USA.	yuxiangs@tamu.edu		Wolfrum, Christian/0000-0002-3862-6805; Chen, Yingjie/0000-0002-4059-7847	NIH [1R01DK118334, AG064869, P30 ES029067, 1R01DK120968]; USDA Hatch project [1010840]; USDA Multistate project [NE1939]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Hatch project; USDA Multistate project	This study was supported by NIH 1R01DK118334 and AG064869 (YS). This work was also supported in part by the USDA Hatch project 1010840 and Multistate project NE1939 (YS), NIH P30 ES029067(PI: David Threadgill), and NIH 1R01DK120968 (SG). Authors received a salary from: NIH 1R01DK118334 and AG064869: YS and SG NIH 1R01DK120968: SG and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basse AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1405-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chechi K, 2014, OBES REV, V15, P92, DOI 10.1111/obr.12116; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kirchner Henriette, 2012, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-642-24716-3_7; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lee JH, 2016, DIABETES, V65, P2169, DOI 10.2337/db15-1587; Lin LG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103002; Lin LG, 2016, AGING-US, V8, P178, DOI 10.18632/aging.100888; Lin LG, 2014, AGING-US, V6, P1019, DOI 10.18632/aging.100706; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Liu JX, 2019, DRUG DISCOV TODAY, V24, P300, DOI 10.1016/j.drudis.2018.09.013; Mao LF, 2017, DIABETES, V66, P407, DOI 10.2337/db16-0343; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; Mattsson CL, 2011, AM J PHYSIOL-ENDOC M, V301, pE1108, DOI 10.1152/ajpendo.00085.2011; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Razzoli M, 2018, FASEB J, V32, P5640, DOI 10.1096/fj.201800452R; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Saito M, 2013, OBES RES CLIN PRACT, V7, pE432, DOI 10.1016/j.orcp.2013.09.001; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Sun WF, 2020, NATURE, V587, P98, DOI 10.1038/s41586-020-2856-x; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Wu CS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040832; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249420	10.1371/journal.pone.0249420	http://dx.doi.org/10.1371/journal.pone.0249420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793646	Green Published, gold			2022-12-26	WOS:000636467000092
J	Mboya, IB; Mahande, MJ; Obure, J; Mwambi, HG				Mboya, Innocent B.; Mahande, Michael J.; Obure, Joseph; Mwambi, Henry G.			Predictors of singleton preterm birth using multinomial regression models accounting for missing data: A birth registry-based cohort study in northern Tanzania	PLOS ONE			English	Article								Background Preterm birth is a significant contributor of under-five and newborn deaths globally. Recent estimates indicated that, Tanzania ranks the tenth country with the highest preterm birth rates in the world, and shares 2.2% of the global proportion of all preterm births. Previous studies applied binary regression models to determine predictors of preterm birth by collapsing gestational age at birth to <37 weeks. For targeted interventions, this study aimed to determine predictors of preterm birth using multinomial regression models accounting for missing data. Methods We carried out a secondary analysis of cohort data from the KCMC zonal referral hospital Medical Birth Registry for 44,117 women who gave birth to singletons between 2000-2015. KCMC is located in the Moshi Municipality, Kilimanjaro region, northern Tanzania. Data analysis was performed using Stata version 15.1. Assuming a nonmonotone pattern of missingness, data were imputed using a fully conditional specification (FCS) technique under the missing at random (MAR) assumption. Multinomial regression models with robust standard errors were used to determine predictors of moderately to late ([32,37) weeks of gestation) and very/extreme (<32 weeks of gestation) preterm birth. Results The overall proportion of preterm births among singleton births was 11.7%. The trends of preterm birth were significantly rising between the years 2000-2015 by 22.2% (95%CI 12.2%, 32.1%, p<0.001) for moderately to late preterm and 4.6% (95%CI 2.2%, 7.0%, p = 0.001) for very/extremely preterm birth category. After imputation of missing values, higher odds of moderately to late preterm delivery were among adolescent mothers (OR = 1.23, 95%CI 1.09, 1.39), with primary education level (OR = 1.28, 95%CI 1.18, 1.39), referred for delivery (OR = 1.19, 95%CI 1.09, 1.29), with pre-eclampsia/eclampsia (OR = 1.77, 95%CI 1.54, 2.02), inadequate (<4) antenatal care (ANC) visits (OR = 2.55, 95%CI 2.37, 2.74), PROM (OR = 1.80, 95%CI 1.50, 2.17), abruption placenta (OR = 2.05, 95%CI 1.32, 3.18), placenta previa (OR = 4.35, 95%CI 2.58, 7.33), delivery through CS (OR = 1.16, 95%CI 1.08, 1.25), delivered LBW baby (OR = 8.08, 95%CI 7.46, 8.76), experienced perinatal death (OR = 2.09, 95%CI 1.83, 2.40), and delivered male children (OR = 1.11, 95%CI 1.04, 1.20). Maternal age, education level, abruption placenta, and CS delivery showed no statistically significant association with very/extremely preterm birth. The effect of (<4) ANC visits, placenta previa, LBW, and perinatal death were more pronounced on the very/extremely preterm compared to the moderately to late preterm birth. Notably, extremely higher odds of very/extreme preterm birth were among the LBW babies (OR = 38.34, 95%CI 31.87, 46.11). Conclusions The trends of preterm birth have increased over time in northern Tanzania. Policy decisions should intensify efforts to improve maternal and child care throughout the course of pregnancy and childbirth towards preterm birth prevention. For a positive pregnancy outcome, interventions to increase uptake and quality of ANC services should also be strengthened in Tanzania at all levels of care, where several interventions can easily be delivered to pregnant women, especially those at high-risk of experiencing adverse pregnancy outcomes.	[Mboya, Innocent B.; Mwambi, Henry G.] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa; [Mboya, Innocent B.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Mahande, Michael J.; Obure, Joseph] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Tanzania	University of Kwazulu Natal; Kilimanjaro Christian Medical Centre	Mboya, IB (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.; Mboya, IB (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.	ib.mboya@gmail.com	Mboya, Innocent/AAE-6488-2020	Mboya, Innocent/0000-0001-9861-5879	GSK Africa Non-Communicable Disease Open Lab through the DELTAS Africa Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB) [107754/Z/15/Z]	GSK Africa Non-Communicable Disease Open Lab through the DELTAS Africa Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB)	This work was funded by GSK Africa Non-Communicable Disease Open Lab through the DELTAS Africa Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB) Grant No. 107754/Z/15/Z-training programme. The views expressed in this publication are those of the author(s) and not necessarily those of GSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahankari A., 2001, F1000RESEARCH, V6, P1; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; [Anonymous], 2012, OPEN J OBS GYNECOL, DOI DOI 10.4236/OJOG.2012.23053; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bergsjo Per, 2007, East Afr J Public Health, V4, P1; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Chuwa FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182250; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Fuchs F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191002; Georgiou HM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/435014; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grantz KL, 2015, AM J EPIDEMIOL, V182, P157, DOI 10.1093/aje/kwv032; Gronvik T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204327; Hedeker D., 2008, HDB MULTILEVEL ANAL, P237, DOI [10.1007/978-0-387-73186-5_6, DOI 10.1007/978-0-387-73186-5_6]; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Kalengo NH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239037; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kim MK, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-017-0715-7; Kombo AY, 2017, J APPL STAT, V44, P270, DOI 10.1080/02664763.2016.1168370; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Laughon SK, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.014; Lisonkova S, 2012, BJOG-INT J OBSTET GY, V119, P1630, DOI 10.1111/j.1471-0528.2012.03403.x; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Lu LQ, 2015, TAIWAN J OBSTET GYNE, V54, P647, DOI 10.1016/j.tjog.2014.05.011; Mahande AM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1413-6; Mahande MJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0929-5; Mahande MJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-166; Mahande MJ, 2013, TROP MED INT HEALTH, V18, P962, DOI 10.1111/tmi.12111; Mahande MJ, 2015, RECURRENCE PERINATAL; Mahapula FA., 2016, TANZANIA J HLTH RES, V18; Malacova E, 2018, BJOG-INT J OBSTET GY, V125, P183, DOI 10.1111/1471-0528.14906; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Mboya IB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231636; Ministry of Health and Social Welfare [MoHSW], 2015, NATL ROAD MAP STRATE; Mitao M., 2016, Asian Pacific Journal of Reproduction, V5, P72; Mmbaga BT, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-116; MoHCDGEC, 2016, NATL ROAD MAP STRATE; MoHCDGEC [Tanzania Mainland] MoH [Zanzibar] NBS OCGS ICF, 2016, TANZANIA DEMOGRAPHIC; Mvunta MH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215768; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Phillips C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015402; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Requejo J, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S4; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Rugaimukam J.J., 2017, SOJ GYNECOL OBSTET W, V3, P1, DOI [10.15226/2381-2915/3/2/00124, DOI 10.15226/2381-2915/3/2/00124]; Ruiz M, 2015, J EPIDEMIOL COMMUN H, V69, P826, DOI 10.1136/jech-2014-205387; StataCorp L, 2017, STATA STAT SOFTWARE; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Su Dejun, 2018, Prev Med Rep, V11, P63, DOI 10.1016/j.pmedr.2018.05.011; Temu T.B., 2016, ASIAN PAC J REPROD, V5, P365, DOI [DOI 10.1016/j.apjr.2016.07.009, 10.1016/j.apjr.2016.07.009]; Teoh PJ, 2018, EUR J OBSTET GYN R B, V225, P155, DOI 10.1016/j.ejogrb.2018.04.025; UNICEF; WHO and World Bank Group, 2019, LEVELS TRENDS CHILD; Unterscheider J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-63; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; van den Broek NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090128; van Zijl MD, 2016, INT J WOMENS HEALTH, V8, P633, DOI 10.2147/IJWH.S89317; Vogel JP, 2018, BEST PRACT RES CL OB, V52, P3, DOI 10.1016/j.bpobgyn.2018.04.003; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Wado YD, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2204-z; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; WHO, 2016, WHO REC ANT CAR POST; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; World Health Organization, 2020, PRETERM BIRTH; World Health Organization, 2014, WHA GLOBAL NUTR TARG; World Health Organization, 2015, JAPAN TURNING CORNER; Yang J, 2016, OBSTET GYNECOL, V128, P364, DOI 10.1097/AOG.0000000000001506; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8; Zack RM, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/261689; Zhang G, 2018, BEST PRACT RES CL OB, V52, P33, DOI 10.1016/j.bpobgyn.2018.05.003; Zhong Y, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2787-4	76	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249411	10.1371/journal.pone.0249411	http://dx.doi.org/10.1371/journal.pone.0249411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793638	Green Published, gold			2022-12-26	WOS:000636467000014
J	Meiboom, MF; Hoffmann, W; Weitmann, K; von Boetticher, H				Meiboom, Merle Friederike; Hoffmann, Wolfgang; Weitmann, Kerstin; von Boetticher, Heiner			Tables for effective dose assessment from diagnostic radiology (period 1946-1995) in epidemiologic studies	PLOS ONE			English	Article							RADIATION-EXPOSURE; BREAST-CANCER	Diagnostic radiology is a leading cause of man-made radiation exposure to the population. It is an important factor in many epidemiological studies as variable of interest or as potential confounder. The effective dose as a risk related quantity is the most often stated patient dose. Nevertheless, there exists no comprehensive quantification model for retrospective analysis for this quantity. This paper gives a catalog of effective dose values for common and rare examinations and demonstrates how to modify the dose values to adapt them to different calendar years using a quantification concept already used for retrospective analysis of the red bone marrow dose. It covers the time period of 1946 to 1995 and allows considering technical development and different practical standards over time. For an individual dose assessment, if the dose area product is known, factors are given for most examinations to convert the dose area product into the effective dose. Additionally factors are stated for converting the effective dose into the red bone marrow dose or vice versa.	[Meiboom, Merle Friederike] Gesundheit Nord gGmbH Klinikverbund Bremen, Ctr Radiol & Nucl Med, Bremen, Germany; [Hoffmann, Wolfgang; Weitmann, Kerstin] Univ Med Greifswald, Sect Epidemiol Hlth Care & Community Hlth, Inst Community Med, Greifswald, Germany; [von Boetticher, Heiner] Carl Von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci 6, Div Med Radiat Phys, Oldenburg, Germany	Greifswald Medical School; Carl von Ossietzky Universitat Oldenburg	von Boetticher, H (corresponding author), Carl Von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci 6, Div Med Radiat Phys, Oldenburg, Germany.	heiner.vonboetticher@web.de						[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2019, RPB 184 REPORT NO 18; [Anonymous], 2005, HLTH RISKS EXPOSURE; Battiwalla M, 2014, HEMATOLOGY, V19, P275, DOI 10.1179/1607845413Y.0000000131; Bernhardt JH., 1995, STRAHLENEXPOSITION M, V30, P180; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bundesamt fur Strahlenschutz (BfS) Bundesministerium fur Umwelt Naturschutz und Reaktorsicherheit, 2014, URN NBNDE0221 201404; Conrad M, 2018, Z MED PHYS, V28, P276, DOI 10.1016/j.zemedi.2018.01.001; De Mauri A, 2012, NEPHROL DIAL TRANSPL, V27, P3645, DOI 10.1093/ndt/gfs145; Drexler G., 1993, DETERMINATION ORGAN, V2nd; EWEN K, 1984, DEUT ZAHNAERZTL Z, V39, P48; EWEN K, 1982, FORTSCHR RONTG NEUEN, V137, P704, DOI 10.1055/s-2008-1056282; Ewen K., 1988, PRACTICE INSTRUCTION, V2nd; Galanski M, 2001, ROFO-FORTSCHR RONTG, V173, pR1, DOI 10.1055/s-2001-19474; Goo HW, 2012, KOREAN J RADIOL, V13, P1, DOI 10.3348/kjr.2012.13.1.1; Gosch D, 1998, RADIAT PROT DOSIM, V80, P167, DOI 10.1093/oxfordjournals.rpd.a032497; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; Hoffmann W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078027; ICRP, 2021, ANN ICRP; ICRP 1977, 1977, DECRETO N 10755 22 N, V1, DOI 10.1177/ANIB_1_3; JACOBI W, 1975, RADIAT ENVIRON BIOPH, V12, P101, DOI 10.1007/BF01328971; Kalender WA., 1995, STRAHLENEXPOSITION M, V30, P121; Koehler V, 1968, ROENTGENDIAGNOSTISCH; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Martin E, 2013, J SPINAL CORD MED, V36, P112, DOI 10.1179/2045772312Y.0000000054; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; National Council on Radiation Protection and Measurements, 2009, REPORT NO 160; Pantos I, 2011, BRIT J RADIOL, V84, P293, DOI 10.1259/bjr/69070614; Reiners C., 1995, STRAHLENEXPOSITION M, V30, P279; Ron E, 1998, RADIAT RES, V150, pS30, DOI 10.2307/3579806; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Stender HS., 1990, TXB PHYSICIANSASSIST, DOI [10.1016/1011-1344%2890%2985151-l, DOI 10.1016/1011-1344%2890%2985151-L]; Strand P., 2009, Annals of the ICRP, V39, P9; THOMAS DB, 1994, CANCER CAUSE CONTROL, V5, P9, DOI 10.1007/BF01830721; Vogel H., 1989, RAD DOSE RADIATIONRI; Boetticher H, 2007, HEALTH PHYS, V92, P315, DOI 10.1097/01.HP.0000248478.18931.2d; Wachsmann F., 1976, GRAPHS TABLES USE RA, V2nd ed.; Wall B.F., 1994, NRPB R 262; Williams G., 1985, BESTIMMUNG ORGANDOSE	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248987	10.1371/journal.pone.0248987	http://dx.doi.org/10.1371/journal.pone.0248987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793615	Green Published, gold			2022-12-26	WOS:000636467000104
J	Sadowska-Krepa, E; Rozpara, M; Rzetecki, A; Bankowski, S; Zebrowska, A; Pilch, W				Sadowska-Krepa, Ewa; Rozpara, Michal; Rzetecki, Adam; Bankowski, Sebastian; Zebrowska, Aleksandra; Pilch, Wanda			Strenuous 12-h run elevates circulating biomarkers of oxidative stress, inflammation and intestinal permeability in middle-aged amateur runners: A preliminary study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TIGHT JUNCTIONS; CELIAC-DISEASE; I-FABP; EXERCISE; MARATHON; METAANALYSIS; ZONULIN; BARRIER; MARKERS	Given the solid evidence that prolonged strenuous exercise is a cause of metabolic stress, this study sought to determine whether a 12-h run would affect total oxidant status (TOS), total oxidant capacity (TOC), total antioxidant status (TAS), high-sensitivity C-reactive protein (hs-CRP) and the biomarkers of intestinal permeability (protein fatty acid-binding proteins (I-FABP) and zonulin) in middle-aged male subjects. Ten amateur long-distance runners (aged 52.0 +/- 6.2 years, body height 176.9 +/- 4.9 cm, body mass 73.9 +/- 6.0 kg) were enrolled in the study. The venous blood samples were collected 1 hour before and right after the run and were analyzed for the levels of TAS, TOS/TOC, hs-CRP, I-FABP and zonulin. The post-run concentrations of TOS/TOC were significantly elevated (p < 0.001), but TAS changes were not significant. Pearson's correlation coefficients calculated for the post run values of TAS and TOS/TOC were statistically significant and negative (r = -0.750, p < 0.05). Significant increases in the concentrations of hs-CRP (p < 0.001), I-FABP (p < 0.05) and zonulin (p < 0.01) were noted. The results indicate that a strenuous 12-h run disturbs the prooxidant-antioxidant balance in middle-aged men, as well as promoting inflammation and impairing intestinal permeability.	[Sadowska-Krepa, Ewa; Rozpara, Michal; Rzetecki, Adam; Bankowski, Sebastian; Zebrowska, Aleksandra] Jerzy Kukuczka Acad Phys Educ, Inst Sport Sci, Katowice, Poland; [Pilch, Wanda] Univ Phys Educ, Inst Basic Sci, Dept Chem & Biochem, Krakow, Poland	Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Sadowska-Krepa, E (corresponding author), Jerzy Kukuczka Acad Phys Educ, Inst Sport Sci, Katowice, Poland.	e.sadowska-krepa@awf.katowice.pl	Sadowska-Krepa, Ewa/X-1405-2018	Sadowska-Krepa, Ewa/0000-0002-9374-8071; Pilch, Wanda/0000-0001-6689-0155	Jerzy Kukuczka Academy of Physical Education, Katowice, Poland [BS5/PW/2018]	Jerzy Kukuczka Academy of Physical Education, Katowice, Poland	This study was supported by funding provided by Jerzy Kukuczka Academy of Physical Education, Katowice, Poland (Grant No. BS5/PW/2018) awarded to ESK.	Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; Ajamian M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210728; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blikslager AT, 2008, GASTROENTEROLOGY, V134, P346, DOI 10.1053/j.gastro.2007.11.049; Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0126-x; Costa KA, 2014, J NUTR, V144, P218, DOI 10.3945/jn.113.183186; Costa RJS, 2017, ALIMENT PHARM THER, V46, P246, DOI 10.1111/apt.14157; de Oliveira EP, 2014, SPORTS MED, V44, P79, DOI 10.1007/s40279-014-0153-2; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Ebele IJ., 2016, ASIAN J MED SCI, V7, P16; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fedewa MV, 2017, BRIT J SPORT MED, V51, P670, DOI 10.1136/bjsports-2016-095999; Funaoka Hiroyuki, 2010, Rinsho Byori, V58, P162; Halvorsen F A, 1990, Br J Sports Med, V24, P266; Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797; Karhu E, 2017, EUR J APPL PHYSIOL, V117, P2519, DOI 10.1007/s00421-017-3739-1; Klapcinska B, 2013, EUR J APPL PHYSIOL, V113, P2781, DOI 10.1007/s00421-013-2714-8; Knechtle B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00634; Kocabas R, 2018, J SPORT MED PHYS FIT, V58, P421, DOI 10.23736/S0022-4707.16.06720-7; KRAEMER RR, 1986, EUR J APPL PHYSIOL O, V55, P579, DOI 10.1007/BF00423200; Machefer G, 2004, J AM COLL NUTR, V23, P358, DOI 10.1080/07315724.2004.10719379; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mrakic-Sposta S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141780; Niemela M, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0045-0; Pals KL, 1997, J APPL PHYSIOL, V82, P571, DOI 10.1152/jappl.1997.82.2.571; Pilch W, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6468234; Powers SK, 2016, J PHYSIOL-LONDON, V594, P5081, DOI 10.1113/JP270646; Sanchez-Rodriguez MA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4128152; Sehovic E, 2013, J HUM SPORT EXERC, V8, P932, DOI 10.4100/jhse.2013.84.05; Sessions J, 2016, EUR J SPORT SCI, V16, P1064, DOI 10.1080/17461391.2016.1140231; Shin HE, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111077; Simons Stephen M, 2004, Curr Sports Med Rep, V3, P112; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208; Tota L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210651; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; van Wijck K, 2013, AM J PHYSIOL-REG I, V304, pR356, DOI 10.1152/ajpregu.00294.2012; Van Wijck K, 2012, MED SCI SPORT EXER, V44, P2257, DOI 10.1249/MSS.0b013e318265dd3d; van Wijck K, 2012, AM J PHYSIOL-GASTR L, V303, pG155, DOI 10.1152/ajpgi.00066.2012; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712, DOI 10.1152/jappl.1972.32.5.712; Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143; Vanuytsel T, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27321; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; WEIGHT LM, 1991, CLIN SCI, V81, P677, DOI 10.1042/cs0810677	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249183	10.1371/journal.pone.0249183	http://dx.doi.org/10.1371/journal.pone.0249183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793597	Green Published, gold			2022-12-26	WOS:000636467000038
J	Asai, Y; Nguyen, P; Hanna, TP				Asai, Yuka; Nguyen, Paul; Hanna, Timothy P.			Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study	PLOS ONE			English	Article								Background The COVID-19 pandemic has been unprecedented and has led to drastic reductions in non-urgent medical visits. Deferral of these visits may have critical health impact, including delayed diagnosis for melanoma and other skin cancers. We examined the influence of the pandemic on skin biopsy rates in a large population-based cohort. Methods Using a universal health care claims dataset from Ontario, we examined skin biopsies from January 6, 2020 to September 27, 2020, and compared these to the same period for 2019. Those diagnosed with anogenital cancers, younger than 20 years, residing out-of-province and with lapses in coverage were excluded. The sensitivity and specificity of claims diagnoses compared to a validated algorithm to identify keratinocyte carcinoma (KC), or to the cancer registry for melanoma was evaluated. Factors associated with biopsy during the early pandemic were investigated with modified Poisson regression. Results A precipitous drop in total skin biopsies (15% of expected), biopsies for KC (18%) and melanoma (27%) was seen with the onset of COVID-19 cases (p<0.01). Claims diagnoses were of high specificity for KC (99%), and for melanoma (98%), though sensitivity was less (61%, 28% respectively). In adjusted analysis, the elderly (80+ years), females and residents of certain regions were less likely to be biopsied during the pandemic. Subsequently, there were substantial improvements in biopsy rates over 10 weeks. However, compared to 2019, a large backlog of expected cases still remained 28 weeks after lockdown (45,710 all biopsy, 9,104 KC, 595 melanoma). Interpretation A drastic reduction in skin biopsies is noted early in the COVID-19 pandemic; this disproportionately affected the elderly, females and certain geographic regions. Though biopsies subsequently increased, a large backlog of cases remained after almost half a year. This will have implications for downstream care of skin cancer. Efforts should be made to limit diagnostic delay.	[Asai, Yuka] Queens Univ, Div Dermatol, Dept Med, Kingston, ON, Canada; [Nguyen, Paul] Queens Univ, ICES, Kingston, ON, Canada; [Hanna, Timothy P.] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada; [Hanna, Timothy P.] Queens Univ, Dept Oncol, Kingston, ON, Canada; [Hanna, Timothy P.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Hanna, TP (corresponding author), Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada.; Hanna, TP (corresponding author), Queens Univ, Dept Oncol, Kingston, ON, Canada.; Hanna, TP (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	tim.hanna@kingstonhsc.ca		Hanna, Timothy/0000-0003-3228-6042; Asai, Yuka/0000-0003-1674-3215	Government of Ontario [IA-035]; ICES from the Ontario Ministry of Health and Long-Term Care (MOHLTC)	Government of Ontario; ICES from the Ontario Ministry of Health and Long-Term Care (MOHLTC)	TPH holds a research chair provided by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario (#IA-035). This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan AW, 2016, JAMA DERMATOL, V152, P1122, DOI 10.1001/jamadermatol.2016.2609; Chow EY, 2010, J CUTAN MED SURG, V14, P71, DOI 10.2310/7750.2010.09025; Dinmohamed AG, 2020, LANCET ONCOL, V21, P750, DOI 10.1016/S1470-2045(20)30265-5; Eedy D, 2015, CLIN MED, V15, P509, DOI 10.7861/clinmedicine.15-6-509; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Heughan C, 2008, J CUTAN MED SURG, V12, P217, DOI 10.2310/7750.2008.07071; Kimball AB, 2008, J AM ACAD DERMATOL, V59, P741, DOI 10.1016/j.jaad.2008.06.037; Kralj B., 2009, MEASURING RURALITY R; Mavor Meaghan E, 2018, CMAJ Open, V6, pE502, DOI 10.9778/cmajo.20180089; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Renzi C, 2010, J AM ACAD DERMATOL, V63, P404, DOI 10.1016/j.jaad.2009.09.044; Ricci F, 2020, J EUR ACAD DERMATOL, V34, pE778, DOI 10.1111/jdv.16874; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Tran JM, 2016, CANCER CAUSE CONTROL, V27, P137, DOI 10.1007/s10552-015-0690-5; Wang DM, 2018, J AM ACAD DERMATOL, V78, P47, DOI 10.1016/j.jaad.2017.09.031; Yadav G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162767	17	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248492	10.1371/journal.pone.0248492	http://dx.doi.org/10.1371/journal.pone.0248492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788858	gold, Green Published			2022-12-26	WOS:000636354600036
J	Koop, Y; Dobbe, L; Maas, AHEM; van Spronsen, DJ; Atsma, F; El Messaoudi, S; Vermeulen, H				Koop, Yvonne; Dobbe, Laura; Maas, Angela H. E. M.; van Spronsen, Dick Johan; Atsma, Femke; El Messaoudi, Saloua; Vermeulen, Hester			Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study	PLOS ONE			English	Article							CARDIOVASCULAR COMPLICATIONS; HEART-FAILURE; MANAGEMENT; DIAGNOSIS; CONSENSUS; TOXICITY; THERAPY; CHEMOTHERAPY; PREVENTION; CARE	Breast cancer (BC) patients have an increased risk of developing cancer therapy-related cardiac dysfunction (CTRCD) and cardiovascular morbidity, which seems to have a substantial prognostic impact. Oncologists, in collaboration with dedicated cardiologists, have the opportunity to perform cardiovascular risk stratification. Despite guideline recommendations, strategies to detect cardiac damage at an early stage are not structurally implemented in clinical practice. The perspectives of oncology professionals regarding cardiac surveillance in BC patients have not been qualitatively evaluated. We aim to explore the perceptions of oncology professionals regarding cardiac surveillance in BC patients and, more specifically, the influencing factors of delivering cardiac surveillance. A qualitative study with semi-structured interviews was conducted and thematically analyzed. Twelve oncology professionals participated in this study. Four themes were selected to answer the study objectives: (1) sense of urgency, (2) multidisciplinary collaboration, (3) patient burden, and (4) practical tools for cardiac surveillance. Most professionals did not feel the need to deliver cardiac surveillance as they considered the incidence of CTRCD as rare. Multidisciplinary collaboration was also perceived as unnecessary, and cardiac surveillance was considered disproportionately burdensome with respect to its benefits. Nevertheless, professionals affirmed the need for practical tools to deliver cardiac surveillance. Most professionals are currently unaware of CTRCD incidence and cardiac surveillance benefits. Encouraging multidisciplinary collaboration and improving their knowledge of cardiotoxic effects of treatments and possibility of early detection can lead to structured cardiac surveillance for breast cancer patients.	[Koop, Yvonne; Maas, Angela H. E. M.; El Messaoudi, Saloua] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Dobbe, Laura] Radboud Univ Nijmegen Med Ctr, Dept Med Oncol, Nijmegen, Netherlands; [van Spronsen, Dick Johan] Radboud Univ Nijmegen Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Atsma, Femke; Vermeulen, Hester] Radboud Univ Nijmegen Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Vermeulen, Hester] HAN Univ Appl Sci, Fac Hlth & Social Studies, Res Dept Emergency & Crit Care, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Koop, Y (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands.	Yvonne.Koop@radboudumc.nl		Koop, Yvonne/0000-0001-6150-0859				Barros-Gomes Sergio, 2016, Cardiooncology, V2, P5, DOI 10.1186/s40959-016-0014-2; Beck CT, 2011, NURSING RES GENERATI, V9th, P768; Bodai Balazs I, 2015, Perm J, V19, P48, DOI 10.7812/TPP/14-241; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Chang HM, 2017, J AM COLL CARDIOL, V70, P2552, DOI 10.1016/j.jacc.2017.09.1095; Chang HM, 2017, J AM COLL CARDIOL, V70, P2536, DOI 10.1016/j.jacc.2017.09.1096; Chavez-MacGregor M, 2015, J CLIN ONCOL, V33, P2176, DOI 10.1200/JCO.2014.58.9465; Creswell J. W., 2007, QUALITATIVE INQUIRY; Curigliano G, 2020, ANN ONCOL, V31, P171, DOI 10.1016/j.annonc.2019.10.023; Curigliano G, 2012, ANN ONCOL, V23, P155, DOI 10.1093/annonc/mds293; Curigliano G, 2016, CA-CANCER J CLIN, V66, P310, DOI 10.3322/caac.21341; Galan-Arriola C, 2019, J AM COLL CARDIOL, V73, P779, DOI 10.1016/j.jacc.2018.11.046; Gujral DM, 2016, J AM COLL CARDIOL, V67, P1499, DOI 10.1016/j.jacc.2016.01.018; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haslbauer JD, 2019, INT J CARDIOL, V275, P179, DOI 10.1016/j.ijcard.2018.10.023; Holloway I., 2012, QUALITATIVE RES NURS, V3, P351; Integraal Kankercentrum Nederland (IKNL), 2012, MAMM LAND RICHTL; Koop Y, 2022, EUR J CARDIOVASC NUR, V21, P235, DOI 10.1093/eurjcn/zvab057; Lancellotti P, 2019, EUR HEART J, V40, P1756, DOI 10.1093/eurheartj/ehy453; Menke-van der Houven van Oordt CW., 2008, NED TIJDSCHR GENEES, V152; Nicol Martin, 2019, Card Fail Rev, V5, P31, DOI 10.15420/cfr.2018.25.1; Ohtani K, 2019, CLIN RES CARDIOL, V108, P600, DOI 10.1007/s00392-018-1386-0; Oikonomou EK, 2019, JAMA CARDIOL, V4, P1007, DOI 10.1001/jamacardio.2019.2952; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Peng J, 2019, CARDIO-ONCOLOGY, V5, DOI 10.1186/s40959-019-0049-2; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Signorelli C, 2017, CRIT REV ONCOL HEMAT, V114, P131, DOI 10.1016/j.critrevonc.2017.04.007; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249067	10.1371/journal.pone.0249067	http://dx.doi.org/10.1371/journal.pone.0249067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788897	Green Published, gold			2022-12-26	WOS:000636354600032
J	Bhaskar, S; Manu, B; Sreenivasa, MY				Bhaskar, S.; Manu, Basavaraju; Sreenivasa, M. Y.			Bioleaching of iron from laterite soil using an isolated Acidithiobacillus ferrooxidans strain and application of leached laterite iron as Fenton's catalyst in selective herbicide degradation	PLOS ONE			English	Article							COMPLEX SULFIDE ORE; THIOBACILLUS-FERROOXIDANS; OXIDATION; NICKEL; COPPER; CHALCOPYRITE; DISSOLUTION; PYRITE; MINERALIZATION; NANOPARTICLES	A novel isolated strain Acidithiobacillus ferrooxidans BMSNITK17 has been investigated for its bioleaching potential from lateritic soil and the results are presented. System conditions like pH, feed mineral particle size, pulp density, temperature, rotor speed influences bioleaching potential of Acidithiobcillus ferrooxidans BMSNITK17 in leaching out iron from laterite soil. Effect of sulfate addition on bioleaching efficiency is studied. The bioleached laterite iron (BLFe's) on evaluation for its catalytic role in Fenton's oxidation for the degradation of ametryn and dicamba exhibits 94.24% of ametryn degradation and 92.45% of dicamba degradation efficiency. Fenton's oxidation performed well with the acidic pH 3. The study confirms the role of Acidithiobacillus ferrooxidans in leaching iron from lateritic ore and the usage of bioleached lateritic iron as catalyst in the Fenton's Oxidation.	[Bhaskar, S.; Manu, Basavaraju] Natl Inst Technol Karnataka, Dept Civil Engn, Mangalore, India; [Sreenivasa, M. Y.] Univ Mysore, Dept Studies Microbiol, Mysuru, Karnataka, India; [Bhaskar, S.] St Joseph Engn Coll, Dept Civil Engn, Mangalore, India	National Institute of Technology (NIT System); National Institute of Technology Karnataka; University of Mysore; St Joseph Engineering College	Bhaskar, S (corresponding author), Natl Inst Technol Karnataka, Dept Civil Engn, Mangalore, India.; Bhaskar, S (corresponding author), St Joseph Engn Coll, Dept Civil Engn, Mangalore, India.	baskarmalwanitk@gmail.com	S, Bhaskar/HCH-0532-2022	S, Bhaskar/0000-0002-0203-3629				ACEVEDO F, 1989, BIOPROCESS ENG, V4, P223, DOI 10.1007/BF00369176; Amritha AS, 2018, APPL WATER SCI, V8, DOI 10.1007/s13201-018-0778-7; Amritha AS, 2016, WATER SCI TECHNOL, V74, P1919, DOI 10.2166/wst.2016.371; [Anonymous], 1992, 4500 AM ASS HLTH, P552; BATTAGLIA F, 1994, J BIOTECHNOL, V32, P11, DOI 10.1016/0168-1656(94)90115-5; Bhaskar S, 2019, J ENVIRON MANAGE, V232, P236, DOI 10.1016/j.jenvman.2018.11.048; BLANCARTEZURITA MA, 1986, BIOTECHNOL BIOENG, V28, P751, DOI 10.1002/bit.260280516; Bosecker K, 1997, FEMS MICROBIOL REV, V20, P591, DOI 10.1016/S0168-6445(97)00036-3; Brillas E, 2003, ELECTROCHIM ACTA, V48, P1697, DOI 10.1016/S0013-4686(03)00142-7; Buchs J, 2001, BIOCHEM ENG J, V7, P91, DOI 10.1016/S1369-703X(00)00106-6; Burbano AA, 2005, WATER RES, V39, P107, DOI 10.1016/j.watres.2004.09.008; Chamarro E, 2001, WATER RES, V35, P1047, DOI 10.1016/S0043-1354(00)00342-0; Chang YF, 2010, HYDROMETALLURGY, V101, P84, DOI 10.1016/j.hydromet.2009.11.014; Chen C, 2009, J HAZARD MATER, V172, P675, DOI 10.1016/j.jhazmat.2009.07.050; Chen FX, 2017, J HAZARD MATER, V322, P152, DOI 10.1016/j.jhazmat.2016.02.073; Coto O, 2008, HYDROMETALLURGY, V94, P18, DOI 10.1016/j.hydromet.2008.05.017; Daoud J, 2006, MINER ENG, V19, P960, DOI 10.1016/j.mineng.2005.10.024; de Oliveira DM, 2019, ENVIRON SCI POLLUT R, V26, P4348, DOI 10.1007/s11356-018-1342-6; Deng TL, 2000, MINER ENG, V13, P1543, DOI 10.1016/S0892-6875(00)00137-0; DEVASIA P, 1993, APPL ENVIRON MICROB, V59, P4051, DOI 10.1128/AEM.59.12.4051-4055.1993; Dew DW, 1999, PROCESS MET, V9, P229; Donati E, 1996, PROCESS BIOCHEM, V31, P129, DOI 10.1016/0032-9592(95)00037-2; Dong YBB, 2013, MINER ENG, V46-47, P177, DOI 10.1016/j.mineng.2013.04.014; du Plessis CA, 2011, HYDROMETALLURGY, V109, P221, DOI 10.1016/j.hydromet.2011.07.005; Ehrlich GG., 1979, GEOCHIM COSMOCHIM AC, DOI [10.1016/0016-7037%2879%2990234-5, DOI 10.1016/0016-7037%2879%2990234-5]; Eisenberg GM, 1943, IND ENG CHEM, V15, P327, DOI 10.1021/i560117a011; Fowler TA, 1999, APPL ENVIRON MICROB, V65, P2987; Gomez C, 1999, MINER ENG, V12, P93, DOI 10.1016/S0892-6875(98)00122-8; GRANT WF, 1979, MUTAT RES, V65, P83, DOI 10.1016/0165-1110(79)90001-0; Gupta PK., 2017, HERBICIDES FUNGICIDE, DOI [10.1016/B978-0-12-804239-7.00037%26%23x2013%3B8, DOI 10.1016/B978-0-12-804239-7.00037%26%23X2013%3B8]; Huang C. P., 1993, Waste Management, V13, P361, DOI 10.1016/0956-053X(93)90070-D; Jayaraj Ravindran, 2016, Interdiscip Toxicol, V9, P90, DOI 10.1515/intox-2016-0012; Johnson DB., 2009, CARBON IRON SULFUR M, DOI [10.1016/S0065-2911%2808%2900003-9, DOI 10.1016/S0065-2911%2808%2900003-9]; Junghans M, 2006, AQUAT TOXICOL, V76, P93, DOI 10.1016/j.aquatox.2005.10.001; Kang YW, 2000, WATER RES, V34, P2786, DOI 10.1016/S0043-1354(99)00388-7; Karale R, 2013, P INT C INN CIV ENG; Karimi GR, 2010, FOOD BIOPROD PROCESS, V88, P21, DOI 10.1016/j.fbp.2009.06.005; Khan E, 2009, J HAZARD MATER, V161, P1024, DOI 10.1016/j.jhazmat.2008.04.049; KONISHI Y, 1995, BIOTECHNOL BIOENG, V48, P592, DOI 10.1002/bit.260480606; LeBaron HM, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P1; LeBaron HM, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P1, DOI 10.1016/B978-044451167-6.50004-0; Marrero J, 2015, ENVIRON SCI TECHNOL, V49, P6674, DOI 10.1021/acs.est.5b00944; Marrero J, 2017, HYDROMETALLURGY, V168, P49, DOI 10.1016/j.hydromet.2016.08.012; Mohapatra S, 2007, HYDROMETALLURGY, V85, P1, DOI 10.1016/j.hydromet.2006.07.001; Mousavi SM, 2005, HYDROMETALLURGY, V80, P139, DOI 10.1016/j.hydromet.2005.08.001; Nasab MH, 2020, HYDROMETALLURGY, V195, DOI 10.1016/j.hydromet.2020.105387; Nemati M, 2000, J CHEM TECHNOL BIOT, V75, P526, DOI 10.1002/1097-4660(200007)75:7<526::AID-JCTB249>3.3.CO;2-W; Nestor D, 2001, INT J MINER PROCESS, V62, P187, DOI 10.1016/S0301-7516(00)00052-1; Palencia I, 1998, HYDROMETALLURGY, V48, P101, DOI 10.1016/S0304-386X(97)00071-6; Qin WQ, 2013, BIORESOURCE TECHNOL, V129, P200, DOI 10.1016/j.biortech.2012.11.050; Qiu MQ, 2006, J UNIV SCI TECHNOL B, V13, P108, DOI 10.1016/S1005-8850(06)60024-8; Sandstrom A, 1997, HYDROMETALLURGY, V46, P181; Sangami S, 2017, ENVIRON TECHNOL INNO, V8, P150, DOI 10.1016/j.eti.2017.06.003; Sangami S, 2019, ENVIRON TECHNOL, V40, P2671, DOI 10.1080/09593330.2018.1449899; Sangami S, 2017, WATER SCI TECHNOL, V75, P451, DOI 10.2166/wst.2016.538; SHRIHARI, 1990, APPL MICROBIOL BIOT, V33, P524; SHRIHARI, 1991, APPL MICROBIOL BIOT, V36, P278, DOI 10.1007/BF00164434; Simate GS, 2009, HYDROMETALLURGY, V98, P241, DOI 10.1016/j.hydromet.2009.05.007; Stott MB, 2000, MINER ENG, V13, P1117, DOI 10.1016/S0892-6875(00)00095-9; Tantak NP, 2006, J HAZARD MATER, V136, P698, DOI 10.1016/j.jhazmat.2005.12.049; TORMA AE, 1972, BIOTECHNOL BIOENG, V14, P777, DOI 10.1002/bit.260140507; TORO L, 1988, HYDROMETALLURGY, V20, P1, DOI 10.1016/0304-386X(88)90023-0; Valix M, 2001, MINER ENG, V14, P1629, DOI 10.1016/S0892-6875(01)00181-9; Veglio F, 1998, PROCESS BIOCHEM, V33, P367, DOI 10.1016/S0032-9592(98)00006-5; Williamson AJ, 2020, HYDROMETALLURGY, V195, DOI 10.1016/j.hydromet.2020.105409; Witne JY, 2001, MINER ENG, V14, P25, DOI 10.1016/S0892-6875(00)00158-8; Woods JT, 1941, IND ENG CHEM, V13, P0551, DOI 10.1021/i560096a013; Wu ZL, 2016, INT J MINER PROCESS, V149, P18, DOI 10.1016/j.minpro.2016.01.015; Yang BJ, 2020, SCI TOTAL ENVIRON, V698, DOI 10.1016/j.scitotenv.2019.134175; Zhang S, 2018, EXTREMOPHILES, V22, P563, DOI 10.1007/s00792-018-1024-9	70	5	5	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0243444	10.1371/journal.pone.0243444	http://dx.doi.org/10.1371/journal.pone.0243444			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784303	Green Published, gold			2022-12-26	WOS:000636359600040
J	Erster, O; Shkedi, O; Benedek, G; Zilber, E; Varkovitzky, I; Shirazi, R; Shorka, DO; Cohen, Y; Bar, T; Yechieli, R; Oikawa, MT; Venkert, D; Linial, M; Oiknine-Djian, E; Mandelboim, M; Livneh, Z; Shenhav-Saltzman, G; Mendelson, E; Wolf, D; Szwarcwort-Cohen, M; Mor, O; Lewis, Y; Zeevi, D				Erster, Oran; Shkedi, Omer; Benedek, Gil; Zilber, Eyal; Varkovitzky, Itay; Shirazi, Rachel; Oriya Shorka, Dorit; Cohen, Yuval; Bar, Tzahi; Yechieli, Rafi; Tepperberg Oikawa, Michal; Venkert, Dana; Linial, Michal; Oiknine-Djian, Esther; Mandelboim, Michal; Livneh, Zvi; Shenhav-Saltzman, Gilat; Mendelson, Ella; Wolf, Dana; Szwarcwort-Cohen, Moran; Mor, Orna; Lewis, Yair; Zeevi, Danny			Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis buffer	PLOS ONE			English	Article								Conducting numerous, rapid, and reliable PCR tests for SARS-CoV-2 is essential for our ability to monitor and control the current COVID-19 pandemic. Here, we tested the sensitivity and efficiency of SARS-CoV-2 detection in clinical samples collected directly into a mix of lysis buffer and RNA preservative, thus inactivating the virus immediately after sampling. We tested 79 COVID-19 patients and 20 healthy controls. We collected two samples (nasopharyngeal swabs) from each participant: one swab was inserted into a test tube with Viral Transport Medium (VTM), following the standard guideline used as the recommended method for sample collection; the other swab was inserted into a lysis buffer supplemented with nucleic acid stabilization mix (coined NSLB). We found that RT-qPCR tests of patients were significantly more sensitive with NSLB sampling, reaching detection threshold 2.1 +/- 0.6 (Mean +/- SE) PCR cycles earlier then VTM samples from the same patient. We show that this improvement is most likely since NSLB samples are not diluted in lysis buffer before RNA extraction. Re-extracting RNA from NSLB samples after 72 hours at room temperature did not affect the sensitivity of detection, demonstrating that NSLB allows for long periods of sample preservation without special cooling equipment. We also show that swirling the swab in NSLB and discarding it did not reduce sensitivity compared to retaining the swab in the tube, thus allowing improved automation of COVID-19 tests. Overall, we show that using NSLB instead of VTM can improve the sensitivity, safety, and rapidity of COVID-19 tests at a time most needed.	[Erster, Oran; Shirazi, Rachel; Tepperberg Oikawa, Michal; Mandelboim, Michal; Mendelson, Ella; Mor, Orna] Minist Hlth, Chaim Sheba Med Ctr, Cent Virol Lab, Ramat Gan, Israel; [Shkedi, Omer] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Benedek, Gil; Oriya Shorka, Dorit; Oiknine-Djian, Esther; Wolf, Dana] Hadassah Med Ctr, Jerusalem, Israel; [Zilber, Eyal; Shenhav-Saltzman, Gilat] Sheba Med Ctr, Dept Internal Med, Ramat Gan, Israel; [Varkovitzky, Itay; Cohen, Yuval] Israeli Minist Def, Directorate Def Res & Dev, Tel Aviv, Israel; [Venkert, Dana] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, Tel Aviv, Israel; [Linial, Michal] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, Jerusalem, Israel; [Erster, Oran; Mandelboim, Michal; Mendelson, Ella; Mor, Orna] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel; [Livneh, Zvi] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Shenhav-Saltzman, Gilat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Szwarcwort-Cohen, Moran] Rambam Hlth Care Campus, Virol Lab, Haifa, Israel; [Lewis, Yair] Maccabi Healthcare Serv, Tel Aviv, Israel; [Zeevi, Danny] Hadassah Acad Coll, Dept Biotechnol, Jerusalem, Israel	Chaim Sheba Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus	Zeevi, D (corresponding author), Hadassah Acad Coll, Dept Biotechnol, Jerusalem, Israel.	dzeevi@edu.hac.ac.il		Zeevi, Danny/0000-0002-6901-3737; Sadeh, Omer/0000-0001-9644-4236				CDC, 2020, CDC SOP DSR 052 05 P; Christoff AP, 2020, SWAB POOLING LARGE S, DOI [10.1101/2020.09.03.20187732, DOI 10.1101/2020.09.03.20187732]; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Malmstrom R., 2015, PROTOCOLSIO, DOI [10.17504/protocols.io.c56y9d, DOI 10.17504/PROTOCOLS.IO.C56Y9D]; Panpradist N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105786; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Wikramaratna PS, 2020, EUROSURVEILLANCE, V25, P28, DOI 10.2807/1560-7917.ES.2020.25.50.2000568; World Health Organization, 2020, LAB TEST 2019 NOV CO, P6; Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855	12	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249149	10.1371/journal.pone.0249149	http://dx.doi.org/10.1371/journal.pone.0249149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784369	Green Submitted, gold, Green Published			2022-12-26	WOS:000636359600047
J	Vander Hoorn, S; Murray, K; Nedkoff, L; Hankey, GJ; Flicker, L; Yeap, BB; Almeida, OP; Norman, P; Brunekreef, B; Nieuwenhuijsen, M; Heyworth, J				Vander Hoorn, Stephen; Murray, Kevin; Nedkoff, Lee; Hankey, Graeme J.; Flicker, Leon; Yeap, Bu B.; Almeida, Osvaldo P.; Norman, Paul; Brunekreef, Bert; Nieuwenhuijsen, Mark; Heyworth, Jane			Long-term exposure to outdoor air pollution and risk factors for cardiovascular disease within a cohort of older men in Perth	PLOS ONE			English	Article							USE REGRESSION-MODELS; PARTICULATE MATTER; RHEUMATOID-ARTHRITIS; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; INFLAMMATION; MORTALITY; MARKERS; ASSOCIATION; APOLIPOPROTEIN	While there is clear evidence that high levels of pollution are associated with increased all-cause mortality and cardiovascular mortality and morbidity, the biological mechanisms that would explain this association are less understood. We examined the association between long-term exposure to air pollutants and risk factors associated with cardiovascular disease. Air pollutant concentrations were estimated at place of residence for cohort members in the Western Australian Centre for Health and Ageing Health in Men Study. Blood samples and blood pressure measures were taken for a cohort of 4249 men aged 70 years and above between 2001 and 2004. We examined the association between 1-year average pollutant concentrations with blood pressure, cholesterol, triglycerides, C-reactive protein, and total homocysteine. Linear regression analyses were carried out, with adjustment for confounding, as well as an assessment of potential effect modification. The four pollutants examined were fine particulate matter, black carbon (BC), nitrogen dioxide, and nitrogen oxides. We found that a 2.25 mu g/m(3) higher exposure to fine particulate matter was associated with a 1.1 percent lower high-density cholesterol (95% confidence interval: -2.4 to 0.1) and 4.0 percent higher serum triglycerides (95% confidence interval: 1.5 to 6.6). Effect modification of these associations by diabetes history was apparent. We found no evidence of an association between any of the remaining risk factors or biomarkers with measures of outdoor air pollution. These findings indicate that long-term PM2.5 exposure is associated with elevated serum triglycerides and decreased HDL cholesterol. This requires further investigation to determine the reasons for this association.	[Vander Hoorn, Stephen; Murray, Kevin; Nedkoff, Lee; Heyworth, Jane] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Vander Hoorn, Stephen; Heyworth, Jane] Ctr Air Pollut Energy & Hlth Res, Glebe, NSW, Australia; [Hankey, Graeme J.; Flicker, Leon; Yeap, Bu B.; Almeida, Osvaldo P.; Norman, Paul] Univ Western Australia, Med Sch, Crawley, Australia; [Flicker, Leon; Almeida, Osvaldo P.] Univ Western Australia, WA Ctr Hlth & Ageing, Crawley, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Nieuwenhuijsen, Mark] Inst Global Hlth, Barcelona, Spain	University of Western Australia; University of Western Australia; University of Western Australia; Utrecht University; ISGlobal	Vander Hoorn, S (corresponding author), Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia.; Vander Hoorn, S (corresponding author), Ctr Air Pollut Energy & Hlth Res, Glebe, NSW, Australia.	stephen.vanderhoorn@research.uwa.edu.au	Flicker, Leon/AAE-1530-2022; Hankey, Graeme J/H-4968-2014; Heyworth, Jane/F-2795-2010; Murray, Kevin/H-5503-2014; Almeida, Osvaldo/A-4925-2008	Flicker, Leon/0000-0002-3650-0475; Hankey, Graeme J/0000-0002-6044-7328; Vander Hoorn, Stephen/0000-0002-0199-863X; Heyworth, Jane/0000-0003-1411-4554; Nedkoff, Lee/0000-0002-3970-625X; Murray, Kevin/0000-0002-8856-6046; Almeida, Osvaldo/0000-0002-8689-6199	National Health and Medical Research Council of Australia; NHMRC [634492, 1128083, 1045710 1003589]; Australian government Research Training Program Stipend; NHMRC Centre for Air pollution, energy and health Research (CAR PhD Top-Up Scholarship)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian government Research Training Program Stipend(Australian Government); NHMRC Centre for Air pollution, energy and health Research (CAR PhD Top-Up Scholarship)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/).NHMRC project Grant Numbers were 634492, 1128083, 1045710 1003589. JH, BBY, OA, PN, LF were all coinvestigators named on these grants. SV received an Australian government Research Training Program Stipend (https://www.une.edu.au/research/hdr/scholarships), and NHMRC Centre for Air pollution, energy and health Research (CAR PhD Top-Up Scholarship, https://www.car-cre.org.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, R LANGUAGE ENV STAT; Athyros VG, 2018, HORM-INT J ENDOCRINO, V17, P61, DOI 10.1007/s42000-018-0014-8; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bell G, 2017, ARTERIOSCL THROM VAS, V37, P976, DOI 10.1161/ATVBAHA.116.308193; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2014, ENVIRON HEALTH PERSP, V122, P624, DOI 10.1289/ehp.1306595; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cai YT, 2017, EUR HEART J, V38, P2290, DOI 10.1093/eurheartj/ehx263; Campbell B, 2003, CLIN CHEM, V49, P201, DOI 10.1373/49.1.201; Campbell B, 2002, ANN CLIN BIOCHEM, V39, P85, DOI 10.1258/0004563021901757; Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704; Chuang KJ, 2010, J OCCUP ENVIRON MED, V52, P258, DOI 10.1097/JOM.0b013e3181ceff7a; Chung CP, 2010, J RHEUMATOL, V37, P1633, DOI 10.3899/jrheum.090639; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; de Groot R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001017; Dirgawati M, 2019, EPIDEMIOLOGY, V30, pS82, DOI [10.1097/EDE.0000000000001034, 10.1097/ede.0000000000001034]; Dirgawati M, 2016, ATMOS ENVIRON, V144, P69, DOI 10.1016/j.atmosenv.2016.08.013; Dirgawati M, 2015, ENVIRON MODELL SOFTW, V74, P258, DOI 10.1016/j.envsoft.2015.07.008; Doucet J, 2012, DIABETES METAB, V38, P523, DOI 10.1016/j.diabet.2012.07.001; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Forbes LJL, 2009, EPIDEMIOLOGY, V20, P245, DOI 10.1097/EDE.0b013e318190ea3f; Friedewald VE, 2008, AM J CARDIOL, V102, P1631, DOI 10.1016/j.amjcard.2008.10.004; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Hinwood AL, 2006, INT J ENVIRON HEAL R, V16, P27, DOI 10.1080/09603120500397680; Hoffmann B, 2009, ENVIRON HEALTH PERSP, V117, P1302, DOI 10.1289/ehp.0800362; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Keywood M, 2017, AUSTR STATE ENV 2016, DOI 10.4226/94/58B65C70BC372; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Knowlton N, 2012, SCAND J RHEUMATOL, V41, P165, DOI 10.3109/03009742.2012.654815; Kushner Irving, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2005.06.057; Li Yanli, 2012, Reviews on Environmental Health, V27, P133, DOI 10.1515/reveh-2012-0012; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Miyata R, 2013, CHEST, V143, P452, DOI 10.1378/chest.12-1237; Mostafavi N, 2015, ENVIRON INT, V81, P1, DOI 10.1016/j.envint.2015.04.003; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Panasevich S, 2009, OCCUP ENVIRON MED, V66, P747, DOI 10.1136/oem.2008.043471; Pilz V, 2018, INT J HYG ENVIR HEAL, V221, P510, DOI 10.1016/j.ijheh.2018.01.016; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Prasad, 1999, Int J Angiol, V8, P76, DOI 10.1007/BF01616850; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Rudez G, 2009, ENVIRON HEALTH PERSP, V117, P995, DOI 10.1289/ehp.0800437; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sade MY, 2016, J CLIN ENDOCR METAB, V101, P2460, DOI 10.1210/jc.2016-1378; Seaton A, 1999, THORAX, V54, P1027, DOI 10.1136/thx.54.11.1027; Shanley RP, 2016, EPIDEMIOLOGY, V27, P291, DOI 10.1097/EDE.0000000000000426; Simpson R, 2005, AUST NZ J PUBL HEAL, V29, P205, DOI 10.1111/j.1467-842X.2005.tb00758.x; Spencer CA, 2005, PREV MED, V40, P712, DOI 10.1016/j.ypmed.2004.09.012; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; StataCorp, 2013, STAT REL 13; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Ulintz L., 2016, ENV DIS, V1, P109, DOI 10.4103/2468-5690.198616; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Young RP, 2013, CHEST, V144, P358, DOI 10.1378/chest.13-0496; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Zuurbier M, 2011, ENVIRON HEALTH PERSP, V119, P1384, DOI 10.1289/ehp.1003151	60	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248931	10.1371/journal.pone.0248931	http://dx.doi.org/10.1371/journal.pone.0248931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780497	gold, Green Published			2022-12-26	WOS:000636336800030
J	Wan, XG; Tan, XY				Wan, Xiaogeng; Tan, Xinying			A protein structural study based on the centrality analysis of protein sequence feature networks	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; AMINO-ACID-COMPOSITION; FOLD RECOGNITION; SELECTION; MAP	In this paper, we use network approaches to analyze the relations between protein sequence features for the top hierarchical classes of CATH and SCOP. We use fundamental connectivity measures such as correlation (CR), normalized mutual information rate (nMIR), and transfer entropy (TE) to analyze the pairwise-relationships between the protein sequence features, and use centrality measures to analyze weighted networks constructed from the relationship matrices. In the centrality analysis, we find both commonalities and differences between the different protein 3D structural classes. Results show that all top hierarchical classes of CATH and SCOP present strong non-deterministic interactions for the composition and arrangement features of Cystine (C), Methionine (M), Tryptophan (W), and also for the arrangement features of Histidine (H). The different protein 3D structural classes present different preferences in terms of their centrality distributions and significant features.	[Wan, Xiaogeng] Beijing Univ Chem Technol, Coll Math & Phys, Beijing, Peoples R China; [Tan, Xinying] Fourth Ctr PLA Gen Hosp, Beijing, Peoples R China	Beijing University of Chemical Technology	Wan, XG (corresponding author), Beijing Univ Chem Technol, Coll Math & Phys, Beijing, Peoples R China.	wxgbj88@sina.com			College of Mathematics and Physics at Beijing University of Chemical Technology	College of Mathematics and Physics at Beijing University of Chemical Technology	We acknowledge the College of Mathematics and Physics at Beijing University of Chemical Technology for providing the work space and facilities that support this study.	Box J. F., 1987, STAT SCI, V2, P45, DOI [10.1214/ss/1177013437, DOI 10.1214/SS/1177013437]; Bozhilova LV, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3036-6; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2005, J CHEM INF MODEL, V45, P407, DOI 10.1021/ci049686v; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU PY, 1977, TRENDS BIOCHEM SCI, V2, P128, DOI 10.1016/0968-0004(77)90440-6; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Edler L, 2001, MATH COMPUT MODEL, V33, P1401, DOI 10.1016/S0895-7177(01)80022-4; Fang J.G., 2019, STAT METHODS BIOMEDI; FASMAN GD, 1976, HDB BIOCH MOL BIOL; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Huang CD, 2003, IEEE T NANOBIOSCI, V2, P221, DOI 10.1109/TNB.2003.820284; ISOGAI Y, 1980, BIOPOLYMERS, V19, P1183, DOI 10.1002/bip.1980.360190607; Jeong JC, 2011, IEEE ACM T COMPUT BI, V8, P308, DOI 10.1109/TCBB.2010.93; Jo T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17573; JUKES TH, 1975, SCIENCE, V189, P50, DOI 10.1126/science.237322; Khan MA, 2016, INT J BIO-INSPIR COM, V8, P51, DOI 10.1504/IJBIC.2016.074631; KIDERA A, 1985, J PROTEIN CHEM, V4, P265, DOI 10.1007/BF01025494; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu C, 2020, PHYS REP, V846, P1, DOI 10.1016/j.physrep.2019.12.004; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; MAXFIELD FR, 1976, BIOCHEMISTRY-US, V15, P5138, DOI 10.1021/bi00668a030; Mitleton-Kelly E., 2018, HDB RES METHODS COMP; Newman M.E.J., 2010, NETWORKS INTRO; Papana A, 2013, ENTROPY-SWITZ, V15, P2635, DOI 10.3390/e15072635; PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5; Rackovsky S, 2009, P NATL ACAD SCI USA, V106, P14345, DOI 10.1073/pnas.0903433106; RACKOVSKY S, 1982, MACROMOLECULES, V15, P1340, DOI 10.1021/ma00233a025; Rost B, 1996, METHOD ENZYMOL, V266, P525; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALAMOV AA, 1995, J MOL BIOL, V247, P11, DOI 10.1006/jmbi.1994.0116; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; SHENG W, 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW306; Simossis VA, 2004, COMPUT BIOL CHEM, V28, P351, DOI 10.1016/j.compbiolchem.2004.09.005; Tian K, 2019, J BIOMOL STRUCT DYN, V37, P4151, DOI 10.1080/07391102.2018.1540359; Tian K, 2018, J THEOR BIOL, V456, P34, DOI 10.1016/j.jtbi.2018.07.035; Tian K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136577; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Wan X, 2015, THESIS IMPERIAL COLL; Wan XG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226768; Wan XG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208423; Wan XG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174386; Wang J., 2014, BIOINFORMATICS FUNDE; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wei LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122118; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei Y, 2012, P ROY SOC A-MATH PHY, V468, P831, DOI 10.1098/rspa.2011.0514; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu CL, 2013, GENE, V529, P250, DOI 10.1016/j.gene.2013.07.092; Yu CL, 2013, J THEOR BIOL, V318, P197, DOI 10.1016/j.jtbi.2012.11.005; Yu CL, 2011, GENE, V486, P110, DOI 10.1016/j.gene.2011.07.002; Zhao B, 2011, MOL PHYLOGENET EVOL, V59, P438, DOI 10.1016/j.ympev.2011.02.020; Zhao X, 2016, MOL PHYLOGENET EVOL, V98, P271, DOI 10.1016/j.ympev.2016.02.015	58	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248861	10.1371/journal.pone.0248861	http://dx.doi.org/10.1371/journal.pone.0248861			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780482	gold, Green Published			2022-12-26	WOS:000636336800045
J	Lamus, ERB; Carotti, V; de Vries, CRS; Witsel, F; Arntz, OJ; van de Loo, FAJ; Carvajal, CA; Bindels, RJM; Hoenderop, JGJ; Rigalli, JP				Lamus, Eric R. Barros; Carotti, Valentina; de Vries, Christine R. S.; Witsel, Femke; Arntz, Onno J.; van de Loo, Fons A. J.; Carvajal, Cristian A.; Bindels, Rene J. M.; Hoenderop, Joost G. J.; Rigalli, Juan P.			Extracellular vesicles regulate purinergic signaling and epithelial sodium channel expression in renal collecting duct cells	FASEB JOURNAL			English	Article						aldosterone; epithelial sodium channel; exosomes; extracellular vesicles; purinergic signaling	PROTEOMIC ANALYSIS; ADENYLYL-CYCLASE; NA+ CHANNELS; T-CELLS; EXOSOMES; RECEPTORS; CD39; IDENTIFICATION; SECRETION; PROTEINS	Purinergic signaling regulates several renal physiological and pathophysiological processes. Extracellular vesicles (EVs) are nanoparticles released by most cell types, which, in non-renal tissues, modulate purinergic signaling. The aim of this study was to investigate the effect of EVs from renal proximal tubule (HK2) and collecting duct cells (HCD) on intra-and intersegment modulation of extracellular ATP levels, the underlying molecular mechanisms, and the impact on the expression of the alpha subunit of the epithelial sodium channel (alpha ENaC). HK2 cells were exposed to HK2 EVs, while HCD cells were exposed to HK2 and HCD EVs. Extracellular ATP levels and alpha ENaC expression were measured by chemiluminescence and -qRT-PCR, respectively. ATPases in EV populations were identified by mass spectrometry. The effect of aldosterone was assessed using EVs from aldosterone-treated cells and urinary EVs (uEVs) from primary aldosteronism (PA) patients. HK2 EVs downregulated ectonucleoside-triphosphate-diphosphohydrolase-1 (ENTPD1) expression, increased extracellular ATP and downregulated alpha ENaC expression in HCD cells. ENTPD1 downregulation could be attributed to increased miR-205-3p and miR-505 levels. Conversely, HCD EVs decreased extracellular ATP levels and upregulated alpha ENaC expression in HCD cells, probably due to enrichment of 14-3-3 isoforms with ATPase activity. Pretreatment of donor cells with aldosterone or exposure to uEVs from PA patients enhanced the effects on extracellular ATP and alpha ENaC expression. We demonstrated inter-and intrasegment modulation of renal purinergic signaling by EVs. Our findings postulate EVs as carriers of information along the renal tubules, whereby processes affecting EV release and/or cargo may impact on purinergically regulated processes.	[Lamus, Eric R. Barros; Carotti, Valentina; de Vries, Christine R. S.; Witsel, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.; Rigalli, Juan P.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Lamus, Eric R. Barros; Carvajal, Cristian A.] Pontificia Univ Catolica Chile, Sch Med, Dept Endocrinol, Santiago, Chile; [Arntz, Onno J.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Rheumatol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Pontificia Universidad Catolica de Chile; Radboud University Nijmegen	Hoenderop, JGJ; Rigalli, JP (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl; juanpablo.rigalli@radboudumc.nl	Barros, Eric/P-5504-2018	Barros, Eric/0000-0001-6613-4181	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [VICI 016.130.668]; Radboud Universiteit (RU); MINEDUC \ Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [1150437, EQM-150023, 21171092]; MINEDUC \ CONICYT \ Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [1160695]; ICM-MINECON [IMII P09/16-F]; Pontificia Universidad Catolica de Chile (UC); SOCHED; DIDEMUC	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Radboud Universiteit (RU); MINEDUC \ Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MINEDUC \ CONICYT \ Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF); ICM-MINECON; Pontificia Universidad Catolica de Chile (UC); SOCHED; DIDEMUC	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: VICI 016.130.668; Radboud Universiteit (RU), Grant/Award Number: Radboud Excellence Initiative; MINEDUC vertical bar Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: 1150437, EQM-150023 and 21171092; MINEDUC vertical bar CONICYT vertical bar Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF), Grant/Award Number: 1160695; ICM--MINECON, Grant/Award Number: IMII P09/16-F; Pontificia Universidad Catolica de Chile (UC), Grant/Award Number: PhD grant; SOCHED, Grant/Award Number: PhD grant; DIDEMUC, Grant/Award Number: PhD grant	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arkhipov SN, 2019, BIOCHEM BIOPH RES CO, V513, P166, DOI 10.1016/j.bbrc.2019.03.177; Bai AP, 2014, J IMMUNOL, V193, P3366, DOI 10.4049/jimmunol.1400346; Berenguer J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1446660; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Burnstock G, 2014, PURINERG SIGNAL, V10, P71, DOI 10.1007/s11302-013-9400-5; Burrello J., 2019, HYPERTENSION, V74, p359; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czekalski S, 1996, KIDNEY INT, V50, P1125, DOI 10.1038/ki.1996.419; D'Souza-Schorey C, 2018, ESSAYS BIOCHEM, V62, P125, DOI 10.1042/EBC20170078; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Dang VD, 2017, FASEB J, V31, P5399, DOI 10.1096/fj.201700417R; DEMBINSKI TC, 1985, CANCER RES, V45, P3083; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; Drumm K, 2006, CELL PHYSIOL BIOCHEM, V17, P21, DOI 10.1159/000091456; Erozenci LA, 2019, FEBS LETT, V593, P1580, DOI 10.1002/1873-3468.13487; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Gerlach JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074801; Gildea JJ, 2014, CLIN BIOCHEM, V47, P89, DOI 10.1016/j.clinbiochem.2014.06.018; Gohar EY, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00329-0; Gonzalez DA, 2020, MOL CELL BIOCHEM, V463, P1, DOI 10.1007/s11010-019-03624-6; Gorelik J, 2005, P NATL ACAD SCI USA, V102, P15000, DOI 10.1073/pnas.0507008102; Gracia T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40601; Hanner F, 2012, AM J PHYSIOL-RENAL, V303, pF1454, DOI 10.1152/ajprenal.00206.2011; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jella KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165763; Jerez S, 2017, J CELL BIOCHEM, V118, P351, DOI 10.1002/jcb.25642; Kemp BA, 2013, KIDNEY INT, V84, P501, DOI 10.1038/ki.2013.187; Liu ZN, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Moriguchi-Mori K, 2016, BIOMED RES-TOKYO, V37, P37, DOI 10.2220/biomedres.37.37; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Muratsu-Ikeda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041462; Mustafa SB, 2008, J CELL PHYSIOL, V215, P101, DOI 10.1002/jcp.21291; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Orriss IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069057; Pathan M, 2019, NUCLEIC ACIDS RES, V47, pD516, DOI 10.1093/nar/gky1029; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Post SR, 1998, J BIOL CHEM, V273, P23093, DOI 10.1074/jbc.273.36.23093; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Ramteke MP, 2014, FEBS LETT, V588, P71, DOI 10.1016/j.febslet.2013.11.008; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigalli JP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00244; Robertson S, 2015, HYPERTENSION, V66, pAP002; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Salimu J, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1368823; Salomon C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00175; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; Sheller-Miller S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00432; Shirley DG, 2009, PURINERG SIGNAL, V5, P501, DOI 10.1007/s11302-009-9152-4; Simpson RJ., 2008, COLD SPRING HARB PRO, V3; Sinha Ankit, 2017, Curr Protoc Protein Sci, V87, DOI 10.1002/cpps.23; Street JM, 2017, ADV CLIN CHEM, V78, P103, DOI 10.1016/bs.acc.2016.07.003; Street JM, 2011, J PHYSIOL-LONDON, V589, P6119, DOI 10.1113/jphysiol.2011.220277; Svenningsen P, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13346; Svenningsen P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00292; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Torres B, 2002, J BIOL CHEM, V277, P7761, DOI 10.1074/jbc.M110352200; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Vekaria RM, 2006, AM J PHYSIOL-RENAL, V290, pF550, DOI 10.1152/ajprenal.00151.2005; Verschuren EHJ, 2020, FASEB J, V34, P6382, DOI 10.1096/fj.201902901R; Visovatti SH, 2016, AM J PHYSIOL-HEART C, V311, pH286, DOI 10.1152/ajpheart.00572.2015; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhong B, 2019, J CELL PHYSIOL, V234, P15025, DOI 10.1002/jcp.28142	80	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21506	10.1096/fj.202002559R	http://dx.doi.org/10.1096/fj.202002559R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811695	hybrid			2022-12-26	WOS:000645260100031
J	Wang, ZZ; Zheng, P; Xie, YY; Chen, X; Solowij, N; Green, K; Chew, YL; Huang, XF				Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng			Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of A beta pathology models	FASEB JOURNAL			English	Article						amyloid-beta; Alzheimer's disease; cannabidiol; cannabinoid receptor 1; Caenorhabditis elegans; neurite degeneration	ALZHEIMERS-DISEASE; RECEPTOR TRAFFICKING; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; INDUCED TOXICITY; HYDROLASE FAAH; NEURONAL LOSS; SYNAPTIC LOSS; CANNABINOIDS; PEPTIDE	Cannabidiol (CBD), a phytocannabinoid from the Cannabis sativa plant, exhibits a broad spectrum of potential therapeutic properties for neurodegenerative diseases. An accumulation of amyloid-beta (A beta) protein is one of the most important neuropathology in neurodegenerative diseases like Alzheimer's disease (AD). Data on the effect of CBD on the amelioration of A beta-induced neurite degeneration and its consequences of life and health spans is sparse. This study aimed to investigate the effects of CBD on neurite outgrowth in cells and lifespan and health span in Caenorhabditis elegans (C. elegans). In human SH-SY5Y neuronal cells, CBD prevented neurite lesion induced by A beta(1-42) and increased the expression of fatty acid amide hydrolase (FAAH) and cannabinoid receptor 1 (CB1R). Furthermore, CBD both protected the reduction of dendritic spine density and rescued the activity of synaptic Ca2+/calmodulin-dependent protein kinase II (CaMKII) from A beta(1-42) toxicity in primary hippocampal neurons. In C. elegans, we used the transgenic CL2355 strain of C. elegans, which expresses the human A beta peptide throughout the nervous system and found that CBD treatment extended lifespan and improved health span. The neuroprotective effect of CBD was further explored by observing the dopaminergic neurons using transgenic dat-1: GFP strains using the confocal microscope. This study shows that CBD prevents the neurite degeneration induced by A beta, by a mechanism involving CB1R activation, and extends lifespan and improves health span in A beta-overexpressing worms. Our findings support the potential therapeutic approach of CBD for the treatment of AD patients.	[Wang, Zhizhen; Solowij, Nadia; Green, Katrina; Huang, Xu-Feng] Australian Ctr Cannabinoid Clin & Res Excellence, New Lambton Hts, NSW, Australia; [Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia; [Wang, Zhizhen; Zheng, Peng; Xie, Yuanyi; Chen, Xi; Solowij, Nadia; Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Sch Med, Wollongong, NSW 2522, Australia; [Solowij, Nadia] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Green, Katrina; Chew, Yee Lian; Huang, Xu-Feng] Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong; University of Wollongong; University of Wollongong	Huang, XF (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia.; Huang, XF (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW 2522, Australia.; Chew, YL (corresponding author), Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons, Wollongong, NSW 2522, Australia.	ylchew@uow.edu.au; xhuang@uow.edu.au	Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Zheng, Peng/0000-0002-8248-1826	Australian Centre for Cannabinoid Clinical and Research Excellence [APP1176503]; Research Committee of the University of Wollongong, Australia	Australian Centre for Cannabinoid Clinical and Research Excellence; Research Committee of the University of Wollongong, Australia	This work was funded by Australian Centre for Cannabinoid Clinical and Research Excellence APP1176503 and Research Committee of the University of Wollongong, Australia	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alexander AG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00279; Androuin A, 2018, ACTA NEUROPATHOL, V135, P839, DOI 10.1007/s00401-018-1847-6; Aso E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00037; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beltramo M, 2000, J NEUROSCI, V20, P3401, DOI 10.1523/JNEUROSCI.20-09-03401.2000; Benito C, 2003, J NEUROSCI, V23, P11136; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Borlikova GG, 2013, NEUROBIOL AGING, V34, P1315, DOI 10.1016/j.neurobiolaging.2012.10.028; Branca JJV, 2019, INT J ENV RES PUB HE, V16; BRENNER S, 1974, GENETICS, V77, P71; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Burns JM, 2005, NEUROLOGY, V64, P1397, DOI 10.1212/01.WNL.0000158423.05224.7F; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Campos AC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00269; Campos AC, 2016, PHARMACOL RES, V112, P119, DOI 10.1016/j.phrs.2016.01.033; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Currais A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.12; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deutsch DG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.7016.00370; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Elmes MW, 2015, J BIOL CHEM, V290, P8711, DOI 10.1074/jbc.M114.618447; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; GIBB WRG, 1989, J NEUROL NEUROSUR PS, V52, P193, DOI 10.1136/jnnp.52.2.193; Glass M, 2001, PROG NEURO-PSYCHOPH, V25, P743, DOI 10.1016/S0278-5846(01)00162-2; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Santos NAG, 2015, TOXICOL IN VITRO, V30, P231, DOI 10.1016/j.tiv.2015.11.004; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Harvey BS, 2012, NEUROTOXICOLOGY, V33, P138, DOI 10.1016/j.neuro.2011.12.015; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Land MH, 2020, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0103; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Margie O, 2013, JOVE-J VIS EXP, DOI 10.3791/50069; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Maulik Malabika, 2017, Front Genet, V8, P77, DOI 10.3389/fgene.2017.00077; McCollum L, 2007, J PHARMACOL EXP THER, V321, P930, DOI 10.1124/jpet.106.117549; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Murakami H, 2008, NEUROBIOL AGING, V29, P1093, DOI 10.1016/j.neurobiolaging.2007.01.013; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Oakes MD, 2017, J NEUROSCI, V37, P2859, DOI 10.1523/JNEUROSCI.3151-16.2017; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pandelides Z, 2020, GEROSCIENCE, V42, P785, DOI 10.1007/s11357-020-00182-4; Popugaeva E, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0034-7; Prenderville JA, 2015, BRIT J PHARMACOL, V172, P3950, DOI 10.1111/bph.13186; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; STAMPANONI BM, 2017, CANNABIS CANNABINOID, V2, P21, DOI DOI 10.1089/CAN.2017.0002; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Takuma H, 2004, J NEUROPATH EXP NEUR, V63, P255, DOI 10.1093/jnen/63.3.255; Tejeda-Benitez L, 2016, REV ENVIRON CONTAM T, V237, P1, DOI 10.1007/978-3-319-23573-8_1; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Thomas A, 2004, EUR J PHARMACOL, V487, P213, DOI 10.1016/j.ejphar.2004.01.023; Wang CY, 2018, NEUROBIOL DIS, V109, P88, DOI 10.1016/j.nbd.2017.10.003; Watt G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00020; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang ZZ, 2018, FREE RADICAL BIO MED, V129, P310, DOI 10.1016/j.freeradbiomed.2018.09.035; Zheng MG, 2013, AMYLOID, V20, P13, DOI 10.3109/13506129.2012.755122	83	11	11	2	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21537	10.1096/fj.202002724R	http://dx.doi.org/10.1096/fj.202002724R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817834				2022-12-26	WOS:000645260100091
J	Zhang, JY; Liu, CC; Liang, Q; Zheng, F; Guan, YF; Yang, GR; Chen, LH				Zhang, Jiayang; Liu, Chengcheng; Liang, Qing; Zheng, Feng; Guan, Youfei; Yang, Guangrui; Chen, Lihong			Postnatal deletion of Bmal1 in mice protects against obstructive renal fibrosis via suppressing Gli2 transcription	FASEB JOURNAL			English	Article						Bmal1; circadian clock; Gli2; renal fibrosis	CIRCADIAN CLOCK; BLOOD-PRESSURE; INTERSTITIAL FIBROSIS; HYPERTENSION; MECHANISMS; DEFICIENT; COMPONENT; RHYTHMS; MODEL; NOTCH	Circadian clock is involved in regulating most renal physiological functions, including water and electrolyte balance and blood pressure homeostasis, however, the role of circadian clock in renal pathophysiology remains largely unknown. Here we aimed to investigate the role of Bmal1, a core clock component, in the development of renal fibrosis, the hallmark of pathological features in many renal diseases. The inducible Bmal1 knockout mice (iKO) whose gene deletion occurred in adulthood were used in the study. Analysis of the urinary water, sodium and potassium excretion showed that the iKO mice exhibit abolished diurnal variations. In the model of renal fibrosis induced by unilateral ureteral obstruction, the iKO mice displayed significantly decreased tubulointerstitial fibrosis reflected by attenuated collagen deposition and mitigated expression of fibrotic markers alpha-SMA and fibronectin. The hedgehog pathway transcriptional effectors Gli1 and Gli2, which have been reported to be involved in the pathogenesis of renal fibrosis, were significantly decreased in the iKO mice. Mechanistically, ChIP assay and luciferase reporter assay revealed that BMAL1 bound to the promoter of and activate the transcription of Gli2, but not Gli1, suggesting that the involvement of Bmal1 in renal fibrosis was possibly mediated via Gli2-dependent mechanisms. Furthermore, treatment with TGF-beta increased Bmal1 in cultured murine proximal tubular cells. Knockdown of Bmal1 abolished, while overexpression of Bmal1 increased, Gli2 and the expression of fibrosis-related genes. Collectively, these results revealed a prominent role of the core clock gene Bmal1 in tubulointerstitial fibrosis. Moreover, we identified Gli2 as a novel target of Bmal1, which may mediate the adverse effect of Bmal1 in obstructive nephropathy.	[Zhang, Jiayang; Liu, Chengcheng; Liang, Qing; Zheng, Feng; Guan, Youfei; Chen, Lihong] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Liaoning, Peoples R China; [Yang, Guangrui] Dalian Univ Technol, Sch Bioengn, Dalian, Peoples R China	Dalian Medical University; Dalian University of Technology	Chen, LH (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Liaoning, Peoples R China.	lihong@dmu.edu.cn			National Key R&D Program of China [2019YFA0802400]; National Natural Science Foundation of China [32071157, 81570643, 81670242]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: #2019YFA0802400; National Natural Science Foundation of China, Grant/Award Number: 32071157, 81570643 and 81670242	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1258, DOI 10.2215/CJN.10581110; Ansermet C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52682-9; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang L, 2018, CIRCULATION, V138, P67, DOI 10.1161/CIRCULATIONAHA.117.029972; Chen WD, 2015, AM J PATHOL, V185, P3152, DOI 10.1016/j.ajpath.2015.08.003; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ST., 2018, JCI INSIGHT, V3; Crislip GR, 2020, AM J PHYSIOL-RENAL, V318, pF1463, DOI 10.1152/ajprenal.00014.2020; Crislip GR, 2018, CURR OPIN PHYSIOL, V5, P38, DOI 10.1016/j.cophys.2018.06.002; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dan H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107661; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Hara M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07767-8; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Honma S, 2016, EUR J PHARMACOL, V780, P136, DOI 10.1016/j.ejphar.2016.03.041; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jiang SL, 2021, PHYTOMEDICINE, V80, DOI 10.1016/j.phymed.2020.153393; Johnston JG, 2020, HYPERTENSION, V75, P1624, DOI 10.1161/HYPERTENSIONAHA.119.13908; Johnston JG, 2018, FREE RADICAL BIO MED, V119, P93, DOI 10.1016/j.freeradbiomed.2018.01.018; Kim H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020305; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kramann R, 2016, NEPHROL DIAL TRANSPL, V31, P1989, DOI 10.1093/ndt/gfw102; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motohashi H, 2020, KIDNEY INT, V97, P728, DOI 10.1016/j.kint.2019.09.032; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Solocinski K, 2017, ACTA PHYSIOL, V220, P72, DOI 10.1111/apha.12804; Solocinski K, 2015, J BIOL RHYTHM, V30, P470, DOI 10.1177/0748730415610879; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881; Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318; Yang GR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125133; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006; Zha M, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2655-1; Zhang DG, 2020, AM J PHYSIOL-RENAL, V318, pF710, DOI 10.1152/ajprenal.00364.2019; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	49	7	7	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21530	10.1096/fj.202002452R	http://dx.doi.org/10.1096/fj.202002452R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813752				2022-12-26	WOS:000645260100102
J	Finkelstein, JL; Fothergill, A; Krisher, JT; Thomas, T; Kurpad, AV; Dwarkanath, P				Finkelstein, Julia L.; Fothergill, Amy; Krisher, Jesse T.; Thomas, Tinku; Kurpad, Anura, V; Dwarkanath, Pratibha			Maternal vitamin B-12 deficiency and perinatal outcomes in southern India	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID SUPPLEMENTATION; PLASMA TOTAL HOMOCYSTEINE; EARLY-PREGNANCY; FOLATE CONCENTRATIONS; METHYLMALONIC ACID; COBALAMIN STATUS; MICRONUTRIENT STATUS; INSULIN-RESISTANCE; SERUM VITAMIN-B12	Background Vitamin B-12 deficiency during pregnancy has been associated with adverse maternal and infant health outcomes. Few prospective studies have investigated vitamin B-12 status early in pregnancy, and its links to infant vitamin B-12 status, particularly in India where the burden of vitamin B-12 deficiency is estimated to be the highest globally. The objective of this study was to examine the associations of maternal vitamin B-12 biomarkers with neonatal vitamin B-12 status. Methods Pregnant women (similar to 12 weeks' gestation) were enrolled in a perinatal cohort study in Bangalore, India. Total vitamin B-12, methylmalonic acid (MMA), and homocysteine concentrations were evaluated in maternal samples at enrollment and in neonates at birth using cord blood. Linear and binomial regression models were used to evaluate the associations of maternal vitamin B-12 biomarkers with neonatal vitamin B-12 status and perinatal outcomes. Results A total of 63.2% of women had vitamin B-12 deficiency (<148 pmol/L), 87.2% had vitamin B-12 insufficiency (<221 pmol/L), and 47.3% had impaired vitamin B-12 status (vitamin B(12)0.26 mu mol/L) at enrollment; 40.8% of neonates had vitamin B-12 deficiency, 65.6% were insufficiency, and 38.1% had impaired vitamin B-12 status at birth. Higher maternal vitamin B-12 concentrations at enrollment were associated with increased neonatal vitamin B-12 concentrations (beta(SE): 0.40 (0.05); p<0.0001) and lower risk of neonatal vitamin B-12 deficiency (Risk Ratio [RR]: 0.53; 95% CI: [0.43, 0.65]; p<0.0001). Maternal vitamin B-12 deficiency (RR: 1.97 [1.43, 2.71]; p<0.001), insufficiency (RR: 2.18 [1.23, 3.85]; p = 0.007), and impaired vitamin B-12 status (RR: 1.49 [1.13, 1.97]; p = 0.005) predicted a two-fold increase in the risk of neonatal vitamin B-12 deficiency at birth. Conclusions The prevalence of vitamin B-12 deficiency was high early in pregnancy and predicted neonatal vitamin B-12 status. Future research is needed to determine the role of vitamin B-12 in the development of pregnancy and infant outcomes, and to inform screening and interventions to improve maternal and child health.	[Finkelstein, Julia L.; Fothergill, Amy; Krisher, Jesse T.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Finkelstein, Julia L.; Thomas, Tinku; Kurpad, Anura, V; Dwarkanath, Pratibha] St Johns Res Inst, Bangalore, Karnataka, India	Cornell University; St. John's National Academy of Health Sciences; St. John's Research Institute	Finkelstein, JL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.; Finkelstein, JL (corresponding author), St Johns Res Inst, Bangalore, Karnataka, India.	jfinkelstein@cornell.edu		Fothergill, Amy/0000-0001-7976-1096; Krisher, Jesse/0000-0002-3190-6126	Division of Nutrition, St. John's Research Institute; Division of Nutritional Sciences, Cornell University; ILSI North America Future Leader Award; National Institutes of Health [5 T32 HD087137]	Division of Nutrition, St. John's Research Institute; Division of Nutritional Sciences, Cornell University; ILSI North America Future Leader Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Division of Nutrition, St. John's Research Institute and the Division of Nutritional Sciences, Cornell University. J.L.F. was supported by the ILSI North America Future Leader Award. A.F. was supported by the National Institutes of Health under award 5 T32 HD087137. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2015, NUTRIENTS, V7, P2401, DOI 10.3390/nu7042401; ADAMS MJ, 1995, TERATOLOGY, V51, P311, DOI 10.1002/tera.1420510507; Allen LH, 2018, J NUTR, V148, p1995S, DOI 10.1093/jn/nxy201; Allen LH, 2010, FOOD NUTR BULL, V31, pS36, DOI 10.1177/15648265100311S104; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Baker PN, 2009, AM J CLIN NUTR, V89, P1114, DOI 10.3945/ajcn.2008.27097; Balci YI, 2014, PEDIATR HEMAT ONCOL, V31, P62, DOI 10.3109/08880018.2013.829894; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Bergen NE, 2016, PAEDIATR PERINAT EP, V30, P386, DOI 10.1111/ppe.12297; Bhardwaj A, 2013, ANEMIA, V2013, DOI 10.1155/2013/959605; Bhate VK, 2012, J DEV ORIG HLTH DIS, V3, P123, DOI 10.1017/S2040174411000778; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Chakraborty S, 2018, J HUM NUTR DIET, V31, P513, DOI 10.1111/jhn.12541; Chen LW, 2015, J NUTR, V145, P113, DOI 10.3945/jn.114.196352; Dayaldasani A, 2014, INT J VITAM NUTR RES, V84, P92, DOI 10.1024/0300-9831/a000196; Duggan C, 2014, J NUTR, V144, P758, DOI 10.3945/jn.113.187278; Dwarkanath P, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00116; Dwarkanath P, 2013, AM J CLIN NUTR, V98, P1450, DOI 10.3945/ajcn.112.056382; Fedosov SN, 2015, CLIN CHEM LAB MED, V53, P1215, DOI 10.1515/cclm-2014-0818; Finkelstein JL, 2017, EUR J CLIN NUTR, V71, P1046, DOI 10.1038/ejcn.2017.29; Finkelstein JL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020397; Finkelstein JL, 2015, ADV NUTR, V6, P552, DOI 10.3945/an.115.008201; Fofou-Caillierez MB., 2019, AM J CLIN NUTR, V109, P674, DOI DOI 10.1093/AJCN/NQY340; FRERY N, 1992, EUR J OBSTET GYN R B, V45, P155, DOI 10.1016/0028-2243(92)90076-B; Green R, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.40; Group WMGRS, 2009, WHO CHILD GROWTH STA; Gu Q, 2012, ACTA PAEDIATR, V101, pe486, DOI 10.1111/j.1651-2227.2012.02795.x; Guerra-Shinohara EM, 2002, BJOG-INT J OBSTET GY, V109, P784, DOI 10.1111/j.1471-0528.2002.01307.x; Halicioglu O, 2012, J MATERN-FETAL NEO M, V25, P1618, DOI 10.3109/14767058.2011.648244; Hay G, 2010, J NUTR, V140, P557, DOI 10.3945/jn.109.117424; Hogeveen M, 2012, AM J CLIN NUTR, V95, P130, DOI 10.3945/ajcn.111.016212; Hubner U, 2008, CLIN CHEM LAB MED, V46, P1265, DOI 10.1515/CCLM.2008.247; Schulze KJ, 2019, J NUTR, V149, P1260, DOI 10.1093/jn/nxz046; Jacquemyn Y, 2014, CLIN EXP OBSTET GYN, V41, P141; Jiang H L, 2016, Genet Mol Res, V15, DOI 10.4238/gmr15048890; Kalay Z, 2016, J MATERN-FETAL NEO M, V29, P60, DOI 10.3109/14767058.2014.986649; Katre P, 2010, ASIA PAC J CLIN NUTR, V19, P335; Kaymaz C, 2011, PRENATAL DIAG, V31, P1246, DOI 10.1002/pd.2874; Koc A, 2006, EUR J NUTR, V45, P291, DOI 10.1007/s00394-006-0598-7; Kouroglou E, 2019, ENDOCRINE, V66, P149, DOI 10.1007/s12020-019-02053-1; Krikke GG, 2016, BJOG-INT J OBSTET GY, V123, P384, DOI 10.1111/1471-0528.13574; Krishnaveni GV, 2014, DIABETOLOGIA, V57, P110, DOI 10.1007/s00125-013-3086-7; Lai JS, 2019, BRIT J NUTR, V121, P1303, DOI 10.1017/S0007114519000746; Lindblad B, 2005, ACTA OBSTET GYN SCAN, V84, P1055, DOI 10.1111/j.0001-6349.2005.00876.x; McCullough LE, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0174-9; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Mishra J, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23388; Mittal M, 2017, FOOD NUTR BULL, V38, P209, DOI 10.1177/0379572117697535; Molloy AM, 2018, ANN NY ACAD SCI, V1414, P109, DOI 10.1111/nyas.13574; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; Muthayya S, 2006, ASIA PAC J CLIN NUTR, V15, P538; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Naik S, 2018, BRIT J NUTR, V119, P629, DOI 10.1017/S0007114518000090; Nasri K, 2015, BIRTH DEFECTS RES A, V103, P1011, DOI 10.1002/bdra.23418; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Obeid R, 2006, CLIN CHEM, V52, P263, DOI 10.1373/clinchem.2005.057810; Organization WH., 2011, WHO ANTHR PERS COMP; Pathak P, 2007, FOOD NUTR BULL, V28, P435, DOI 10.1177/156482650702800409; Peker E, 2016, J MATERN-FETAL NEO M, V29, P2944, DOI 10.3109/14767058.2015.1109620; Pepper MR, 2011, SEMIN CELL DEV BIOL, V22, P619, DOI 10.1016/j.semcdb.2011.05.005; Pisal H, 2019, J HUM HYPERTENS, V33, P393, DOI 10.1038/s41371-019-0164-4; Radunovic N, 2015, J MATERN-FETAL NEO M, V28, P1244, DOI 10.3109/14767058.2014.951626; Ramirez-Velez R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0820-4; Ratan SK, 2008, PEDIATR SURG INT, V24, P803, DOI 10.1007/s00383-008-2167-z; Ray JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Reznikoff-Etievant MF, 2002, EUR J OBSTET GYN R B, V104, P156, DOI 10.1016/S0301-2115(02)00100-8; Riaz M, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/7382946; Rogne T, 2017, AM J EPIDEMIOL, V185, P212, DOI 10.1093/aje/kww212; ROWLAND AS, 1995, AM J EPIDEMIOL, V141, P531, DOI 10.1093/oxfordjournals.aje.a117468; Samuel TM, 2013, ANN NUTR METAB, V62, P113, DOI 10.1159/000345589; Schneede J., 2007, J NUTR; Senousy SM, 2018, J OBSTET GYNAECOL RE, V44, P1902, DOI 10.1111/jog.13751; Singla Rajiv, 2019, Indian J Endocrinol Metab, V23, P211, DOI 10.4103/ijem.IJEM_122_19; Sole-Navais P, 2018, AM J CLIN NUTR, V107, P173, DOI 10.1093/ajcn/nqx041; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stover PJ, 2010, CURR OPIN CLIN NUTR, V13, P24, DOI 10.1097/MCO.0b013e328333d157; Sukumar N, 2011, J DEV ORIG HLTH DIS, V2, pS128; Sukumar N, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1865; Sukumar N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120768; Sukumar N, 2016, AM J CLIN NUTR, V103, P1232, DOI 10.3945/ajcn.115.123083; Takimoto H, 2007, EUR J NUTR, V46, P300, DOI 10.1007/s00394-007-0667-6; TaneJa S, 2007, AM J CLIN NUTR, V86, P1302, DOI 10.1093/ajcn/86.5.1302; Thomas S, 2019, MATERN CHILD HLTH J, V23, P155, DOI 10.1007/s10995-018-2605-z; Thompson MD, 2009, AM J CLIN NUTR, V89, p697S, DOI 10.3945/ajcn.2008.26947B; Venkatramanan S, 2016, ADV NUTR, V7, P879, DOI 10.3945/an.115.012021; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Visentin CE, 2016, J NUTR, V146, P1035, DOI 10.3945/jn.115.226845; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; WHO, 2001, IRON DEFICIENCY ANAE; WHO, 2006, WHO CHILD GROWTH STA; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yang T, 2017, J CLIN BIOCHEM NUTR, V60, P136, DOI 10.3164/jcbn.16-45; Yetley EA, 2011, AM J CLIN NUTR, V94, p313S, DOI 10.3945/ajcn.111.013243; Youssry MA., 2017, OPEN J OBSTET GYNAEC, V07, P1102, DOI 10.4236/ojog.2017.711111; Zhu XJ, 2018, J OBSTET GYNAECOL RE, V44, P2037, DOI 10.1111/jog.13757; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	106	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248145	10.1371/journal.pone.0248145	http://dx.doi.org/10.1371/journal.pone.0248145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822790	gold, Green Published			2022-12-26	WOS:000637879100029
J	Li, XW; Xia, HT; Wang, JW; Chen, QX				Li, Xiaowen; Xia, Haitao; Wang, Jinwang; Chen, Qiuxia			Nutrient uptake and assimilation in fragrant rosewood (Dalbergia odorifera TC Chen) seedlings in growing media with un-composted spent mushroom residue	PLOS ONE			English	Article								The purpose of this study was to detect nutrient uptake and assimilation in woody plants subjected to growing media with some peat replaced by spent mushroom residue (SMR). Fragrant rosewood (Dalbergia odorifera T.C. Chen) seedlings were cultured in five types of growing media with SMR and peat in volumetric proportions of 0% (control), 25%, 50%, 75%, and 100%. With the increase of SMR proportion, ammonium- and nitrate-nitrogen (N) concentrations declined but available phosphorus (P) concentration and electrical conductance both increased. Seedlings in the full SMR substrates showed obvious mortality. Seedlings in substrates with SMR in proportions higher than 25% showed symptoms of excessive N and P toxicities. The utilization efficiency for P was highest in the 25% SMR growing-media. Mineral N in substrates had a positive relationship with growth and biomass but not with glutamine synthetase activity. Available P was negatively related with acid phosphatase activity in both leaves and roots. Un-composted SMR can replace 25% of peat in growing media for fragrant rosewood seedlings, benefitting P uptake and assimilation.	[Li, Xiaowen; Xia, Haitao; Wang, Jinwang; Chen, Qiuxia] Zhejiang Acad Agr Sci, Zhejiang Inst Subtrop Crops, Wenzhou, Peoples R China	Zhejiang Academy of Agricultural Sciences	Chen, QX (corresponding author), Zhejiang Acad Agr Sci, Zhejiang Inst Subtrop Crops, Wenzhou, Peoples R China.	yzscqx@163.com		Li, Xiao Wen/0000-0001-9776-5680	Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding [2016C02056-3]; Public Welfare Project for Agriculture in Zhejiang Province [2016C32041]	Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding; Public Welfare Project for Agriculture in Zhejiang Province	This research was funded by Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding (grant No.: 2016C02056-3) and the Public Welfare Project for Agriculture in Zhejiang Province (grant No.: 2016C32041).	Caballero R, 2009, SCI HORTIC-AMSTERDAM, V122, P244, DOI 10.1016/j.scienta.2009.05.010; de Oliveira LB, 2018, OECOLOGIA, V186, P633, DOI 10.1007/s00442-018-4059-9; Dickson A., 1960, Forestry Chronicle, V36, P10; Elsakhawy TA, 2020, EGYPT J SOIL SCI, V60, P31, DOI 10.21608/ejss.2019.18835.1320; Food and Agriculture Organization, 2016, FAOSTAT; Fortune Business Insights, 2018, FORTUNE BUSINESS INS; Fuertes-Mendizabal T, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9030322; Hawkins BJ, 2007, TREE PHYSIOL, V27, P911, DOI 10.1093/treephys/27.6.911; Kwack Y, 2012, COMPOST SCI UTIL, V20, P92; Li XW, 2018, FORESTS, V9, DOI 10.3390/f9010029; Li XW, 2017, SOIL SCI PLANT NUTR, V63, P153, DOI 10.1080/00380768.2017.1312518; Ma XL, 2016, PHYSIOL PLANTARUM, V158, P389, DOI 10.1111/ppl.12473; Medina E, 2009, BIORESOURCE TECHNOL, V100, P4227, DOI 10.1016/j.biortech.2009.03.055; Meng XY, 2018, J ENVIRON MANAGE, V216, P62, DOI 10.1016/j.jenvman.2017.09.056; Nakajima VM, 2018, BIOCATAL AGRIC BIOTE, V13, P58, DOI 10.1016/j.bcab.2017.11.011; Parida AK, 2004, J PLANT PHYSIOL, V161, P921, DOI 10.1016/j.jplph.2003.11.006; Paula FS, 2017, J ENVIRON MANAGE, V196, P476, DOI 10.1016/j.jenvman.2017.03.038; Research and Markets, 2020, GLOB MUSHR CULT IND; Ribas LCC, 2009, BIORESOURCE TECHNOL, V100, P4750, DOI 10.1016/j.biortech.2008.10.059; Salifu KF, 2003, CAN J FOREST RES, V33, P1287, DOI 10.1139/X03-057; Semple KT, 2001, ENVIRON POLLUT, V112, P269, DOI 10.1016/S0269-7491(00)00099-3; Serapiglia MJ, 2008, TREE PHYSIOL, V28, P1793, DOI 10.1093/treephys/28.12.1793; Soccol CR, 2003, BIOCHEM ENG J, V13, P205, DOI 10.1016/S1369-703X(02)00133-X; Unal M, 2015, EMIR J FOOD AGR, V27, P692, DOI 10.9755/ejfa.2015-05-206; Wang H, 2014, J ASIAN NAT PROD RES, V16, P1109, DOI 10.1080/10286020.2014.968559; Wang W, 2000, CHINESE CHEM LETT, V11, P993; Wei HX, 2020, FORESTS, V11, DOI 10.3390/f11010044; Wei HX, 2020, INT J AGRIC BIOL, V23, P644, DOI 10.17957/IJAB/15.1336; Wei HX, 2019, NOT BOT HORTI AGROBO, V47, P887, DOI 10.15835/nbha47311390; Wei HX, 2017, IFOREST, V10, P15, DOI 10.3832/ifor1988-009; Williams BC, 2001, BIORESOURCE TECHNOL, V79, P227, DOI 10.1016/S0960-8524(01)00073-6; Yao XY, 2019, FOREST ECOL MANAG, V449, DOI 10.1016/j.foreco.2019.117465; Yue XH., 2020, PLOS ONE, V15, P16; Zhao J, 2019, SOIL SCI PLANT NUTR, V65, P358, DOI 10.1080/00380768.2019.1631715; Zheng HG, 2020, FOOD SCI TECH-BRAZIL, V40, P235, DOI 10.1590/fst.08619; Zhu H, 2019, NOT BOT HORTI AGROBO, V47, P227, DOI 10.15835/nbha47111307	36	5	5	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249534	10.1371/journal.pone.0249534	http://dx.doi.org/10.1371/journal.pone.0249534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822784	Green Published, gold			2022-12-26	WOS:000637879100043
J	Ngaruiya, C; Wambua, M; Mutua, TK; Owambo, D; Muchemi, M; Rop, K; Maciejewski, KR; Leff, R; Mutua, M; Wachira, B				Ngaruiya, Christine; Wambua, Mbatha; Mutua, Thomas Kedera; Owambo, Daniel; Muchemi, Morgan; Rop, Kipkoech; Maciejewski, Kaitlin R.; Leff, Rebecca; Mutua, Mugane; Wachira, Benjamin			The last frontier for global non-communicable disease action: The emergency department-A cross-sectional study from East Africa	PLOS ONE			English	Article							PREVENTIVE-CARE; HYPERTENSION	Introduction Deaths due to non-communicable diseases (NCDs) have surpassed those due to communicable diseases globally and are projected to do so in Africa by 2030. Despite demonstrated effectiveness in high-income country (HIC) settings, the ED is a primary source of NCD care that has been under-prioritized in Africa. In this study, we assess the burden of leading NCDs and NCD risk factors in Kenyan Casualty Department patients to inform interventions targeting patients with NCDs in emergency care settings. Materials and methods Using the WHO STEPwise approach to surveillance (STEPS) tool and the Personal Health Questionnaire (PHQ-9), we conducted a survey of 923 adults aged 18 and over at Kenyatta National Hospital Emergency Department (KNH ED) between May-October 2018. Age, income, household size(t-test), sex, education, marital status, work status, and poverty status (chi-squared test or fisher's exact test) were assessed using descriptive statistics and analyzed using covariate-adjusted logistic analysis. Results Over a third of respondents had hypertension (35.8%, n = 225/628), 18.3% had raised blood sugar or diabetes (18.3%, n = 61/333), and 11.7% reported having cardiovascular disease (11.7%, n = 90/769). Having lower levels of education was associated with tobacco use (OR 6.0, 95% CI 2.808-12.618, p < 0.0001), while those with higher levels of education reported increased alcohol use (OR 0.620 (95% CI 0.386-0.994, p = 0. 0472). While a predominant proportion of respondents had had some form of screening for either hypertension (80.3%, n = 630/772), blood sugar (42.6%, n = 334/767) or cholesterol (13.9%, n = 109/766), the proportion of those on treatment was low, with the highest proportion being half of those diagnosed with hypertension reporting taking medication (51.6%, n = 116/225). Conclusions This study establishes the ED as a high-risk population with potential for high impact in East Africa, should targeted interventions be implemented. Comprehension of the unique epidemiology and characteristics of patients presenting to the ED is key to guide care in African populations.	[Ngaruiya, Christine; Leff, Rebecca] Yale Univ, Dept Emergency Med, New Haven, CT 06520 USA; [Wambua, Mbatha] Muhimbili Univ Hlth & Allied Sci, Dept Emergency Med, Dar Es Salaam, Tanzania; [Mutua, Thomas Kedera] Nairobi West Hosp, Nairobi, Kenya; [Owambo, Daniel] Aga Khan Univ Hosp, Nairobi, Kenya; [Muchemi, Morgan] Kenyatta Univ Teaching Referral & Res Hosp, Nairobi, Kenya; [Rop, Kipkoech] Univ Nairobi, Nairobi, Kenya; [Maciejewski, Kaitlin R.] Yale Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT USA; [Leff, Rebecca] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Med, Beer Sheva, Israel; [Wachira, Benjamin] Aga Khan Univ Hosp, Accid & Emergency Dept, Nairobi, Kenya	Yale University; Muhimbili University of Health & Allied Sciences; University of Nairobi; Yale University; Ben Gurion University	Ngaruiya, C (corresponding author), Yale Univ, Dept Emergency Med, New Haven, CT 06520 USA.	Christine.ngaruiya@yale.edu	Leff, Rebecca/AAK-4403-2021	Leff, Rebecca/0000-0001-9254-6884; Maciejewski, Kaitlin/0000-0002-6387-582X	Hecht-Albert Global Health Pilot Innovation Award for Junior Faculty, Global Health Leadership Institute, Yale University	Hecht-Albert Global Health Pilot Innovation Award for Junior Faculty, Global Health Leadership Institute, Yale University	The authors disclose receipt of the following financial support for the research, authorship, and publication of this article: This work was supported by the Hecht-Albert Global Health Pilot Innovation Award for Junior Faculty, Global Health Leadership Institute, Yale University awarded to CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder website: https://medicine.yale.edu/news-article/14993/	[Anonymous], 2017, STRENGTHENING HLTH S; Armitage LC, 2019, J CLIN HYPERTENS, V21, P1415, DOI 10.1111/jch.13643; Baker T.L., 1994, DOING SOCIAL RES; Brody A, 2015, ACAD EMERG MED, V22, P632, DOI 10.1111/acem.12660; Bukhman G, 2015, LANCET, V386, P1221, DOI 10.1016/S0140-6736(15)00278-0; Chiang WK, 1998, AM J EMERG MED, V16, P701, DOI 10.1016/S0735-6757(98)90181-4; Collins SE, 2016, ALCOHOL RES-CURR REV, V38, P83; D'Onofrio G, 2002, ACAD EMERG MED, V9, P627, DOI 10.1197/aemj.9.6.627; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Hales CM., 2017, HYPERTENSION PREVALE; Irvin CB, 2000, ACAD EMERG MED, V7, P1042; Lee K, 2009, GLOB INST, P1; Lemhoefer C, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160434; Ministry of Health Republic of Uganda, 2014, UG STEPS SURV 2014 F; Ministry of Health United Republic of Tanzania, 2012, TANZANIA STEPS SURVE; Mohamed SF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6052-y; Myers JG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014974; Ngaruiya C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220834; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Republic of Rwanda Ministry of Health, 2015, RWANDA NONC DIS RISK; The Lancet NCDI Poverty Commission, 2020, NCDI POV NEWS UPD CO; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2016, HEARTS TECHN PACK CA; *WHO, 2007, PROT EXP 2 HAND TOB; World Bank, 2020, UNDERSTANDING PEOPLE; World Health Organization, 2019, SAFER TECHN PACK 5 A; World Health Organization, 2018, WHO GUID HLTH POL SY, DOI DOI 1157598/RETRIEVE; World Health Organization, 2013, GLOB ACT PLAN PREV C	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248709	10.1371/journal.pone.0248709	http://dx.doi.org/10.1371/journal.pone.0248709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798234	gold, Green Published, Green Submitted			2022-12-26	WOS:000636737700018
J	Critchley, HD; Botan, V; Ward, J				Critchley, Hugo D.; Botan, Vanessa; Ward, Jamie			Absence of reliable physiological signature of illusory body ownership revealed by fine-grained autonomic measurement during the rubber hand illusion	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; BODILY SELF-CONSCIOUSNESS; HEART-RATE-VARIABILITY; RESPONSES; FEEL; IDENTIFICATION; REPRESENTATION; INTEROCEPTION; INTEGRATION; EMBODIMENT	The neural representation of a 'biological self' is linked theoretically to the control of bodily physiology. In an influential model, selfhood relates to internal agency and higher-order interoceptive representation, inferred from the predicted impact of efferent autonomic nervous activity on afferent viscerosensory feedback. Here we tested if an altered representation of physical self (illusory embodiment of an artificial hand) is accompanied by sustained shifts in autonomic activity. Participants (N = 37) underwent procedures for induction of the rubber hand illusion (synchronous stroking of own unseen hand and observed stroking of artificial hand) and a control condition (asychronous stroking). We recorded electrocardiography, electrodermal activity, and a non-invasive measure of multiunit skin sympathetic nerve activity (SKNA) from the chest. We compared these autonomic indices between task conditions, and between individuals who did and did not experience the illusion. Bayes factors quantified the strength of evidence for and against null hypotheses. Observed proprioceptive drift and subjective reports confirmed the efficacy of the synchronous (vs asynchronous) condition in inducing illusory hand ownership. Stringent discriminant analysis classified 24/37 individuals as experiencing the rubber hand illusion. Surprisingly, heart rate, heart rate variability, electrodermal activity, and SKNA measures revealed no autonomic differences between synchronous vs asynchronous conditions, nor between individuals who did or did not experience the rubber hand illusion. Bayes factors indicated substantial evidence for no physiological differences. In contrast to earlier reports, our autonomic data show the absence of a reliable change in physiological state during the rubber hand illusion. More encompassing perturbations of self-experience, for example in full body illusions, may nevertheless be coupled to, or facilitated by, changes in efferent autonomic activity and afferent viscerosensory feedback. Our findings suggest that such changes in bodily physiology are not sustained as an obligatory component of the rubber hand illusion.	[Critchley, Hugo D.; Botan, Vanessa; Ward, Jamie] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Critchley, Hugo D.; Botan, Vanessa; Ward, Jamie] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Critchley, Hugo D.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Critchley, Hugo D.] Univ Brighton, Brighton, E Sussex, England	University of Sussex; University of Sussex; University of Brighton; University of Sussex; University of Brighton	Critchley, HD (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.; Critchley, HD (corresponding author), Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England.; Critchley, HD (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England.; Critchley, HD (corresponding author), Univ Brighton, Brighton, E Sussex, England.	h.critchley@bsms.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284	Bial Foundation [128/14]	Bial Foundation(Bial Foundation)	This study was funded by a bursary from the Bial Foundation 128/14 to HC entitled: Microneurography and autonomic nerve recording as a tool for consciousness science.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Aspell JE, 2013, PSYCHOL SCI, V24, P2445, DOI 10.1177/0956797613498395; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Braithwaite J. J., 2013, PSYCHOPHYSIOLOGY, V49, P1017, DOI DOI 10.1111/J.1469-8986.2012.01384.X; Braithwaite JJ, 2014, J EXP PSYCHOL HUMAN, V40, P1131, DOI 10.1037/a0036077; Carruthers G, 2013, J CONSCIOUSNESS STUD, V20, P33; Chan YH, 2015, HEART RHYTHM, V12, P1619, DOI 10.1016/j.hrthm.2015.03.025; Corneille O, 2020, BIOL PSYCHOL, V152, DOI 10.1016/j.biopsycho.2020.107869; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2000, J NEUROSCI, V20, P3033; Crucianelli L, 2018, CORTEX, V104, P180, DOI 10.1016/j.cortex.2017.04.018; D'Alonzo M, 2020, J COGNITIVE NEUROSCI, V32, P1104, DOI 10.1162/jocn_a_01532; Damasio A.R., 2000, FEELING WHAT HAPPENS; de Haan AM, 2017, ACTA PSYCHOL, V179, P68, DOI 10.1016/j.actpsy.2017.07.003; Dienes Z., 2020, NATURE COMMS; Doytchinova A, 2017, HEART RHYTHM, V14, P25, DOI 10.1016/j.hrthm.2016.09.019; Drury RL, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00323; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Everett TH, 2017, TRENDS CARDIOVAS MED, V27, P463, DOI 10.1016/j.tcm.2017.05.003; Fedotov A. A., 2016, Biomedical Engineering, V50, P114, DOI 10.1007/s10527-016-9600-8; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Heydrich L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27698-2; Horvath A, 2020, CORTEX, V132, P361, DOI 10.1016/j.cortex.2020.08.026; Iodice P, 2019, P NATL ACAD SCI USA, V116, P13897, DOI 10.1073/pnas.1821032116; Jiang ZL, 2015, HEART RHYTHM, V12, P1324, DOI 10.1016/j.hrthm.2015.02.012; Johnson MI, 2016, SCAND J PAIN, V11, P1, DOI 10.1016/j.sjpain.2015.10.004; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Keysers C, 2020, NAT NEUROSCI, V23, P788, DOI 10.1038/s41593-020-0660-4; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Koreki A, 2020, EPILEPSIA, V61, P1156, DOI 10.1111/epi.16532; Kusayama T, 2020, NAT PROTOC, V15, P1853, DOI 10.1038/s41596-020-0316-6; Kusayama T, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125853; Lenggenhager B, 2011, EUR J NEUROSCI, V33, P1935, DOI 10.1111/j.1460-9568.2011.07647.x; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Ma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00604; Macefield VG, 2021, CLIN AUTON RES, V31, P59, DOI 10.1007/s10286-020-00700-6; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Mulcahy JS, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116072; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Riemer M, 2015, BIOL PSYCHOL, V109, P86, DOI 10.1016/j.biopsycho.2015.04.011; Ring C, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13084; Rohde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080688; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Romano D, 2014, BEHAV BRAIN RES, V261, P275, DOI 10.1016/j.bbr.2013.12.049; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Seth AK, 2018, TRENDS COGN SCI, V22, P969, DOI 10.1016/j.tics.2018.08.008; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Sierra M, 2002, ARCH GEN PSYCHIAT, V59, P833, DOI 10.1001/archpsyc.59.9.833; Suzuki K, 2013, NEUROPSYCHOLOGIA, V51, P2909, DOI 10.1016/j.neuropsychologia.2013.08.014; Sverrisdottir YB, 2012, CLIN AUTON RES, V22, P259, DOI 10.1007/s10286-012-0162-x; Thornton JM, 2001, J PHYSIOL-LONDON, V533, P823, DOI 10.1111/j.1469-7793.2001.00823.x; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Vallbo AB, 2018, J NEUROPHYSIOL, V120, P1415, DOI 10.1152/jn.00933.2017; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Wallin BG, 2003, ACTA PHYSIOL SCAND, V177, P291; WANG YD, 1992, BEHAV BRAIN RES, V52, P167, DOI 10.1016/S0166-4328(05)80227-X	64	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0237282	10.1371/journal.pone.0237282	http://dx.doi.org/10.1371/journal.pone.0237282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793569	gold, Green Published, Green Submitted			2022-12-26	WOS:000636467000085
J	Hariharan, VN; Yadav, R; Thakur, C; Singh, A; Gopinathan, R; Singh, DP; Sankhe, G; Malhotra, V; Chandra, N; Bhatt, A; Saini, DK				Hariharan, Vignesh Narayan; Yadav, Rahul; Thakur, Chandrani; Singh, Albel; Gopinathan, Renu; Singh, Devendra Pratap; Sankhe, Gaurav; Malhotra, Vandana; Chandra, Nagasuma; Bhatt, Apoorva; Saini, Deepak Kumar			Cyclic di-GMP sensing histidine kinase PdtaS controls mycobacterial adaptation to carbon sources	FASEB JOURNAL			English	Article						c&#8208; di&#8208; GMP; nutrient starvation; two&#8208; component system		Cell signaling relies on second messengers to transduce signals from the sensory apparatus to downstream signaling pathway components. In bacteria, one of the most important and ubiquitous second messenger is the small molecule cyclic diguanosine monophosphate (c-di-GMP). While the biosynthesis, degradation, and regulatory pathways controlled by c-di-GMP are well characterized, the mechanisms through which c-di-GMP controls these processes are not entirely understood. Herein we present the report of a c-di-GMP sensing sensor histidine kinase PdtaS (Rv3220c), which binds to c-di-GMP at submicromolar concentrations, subsequently perturbing signaling of the PdtaS-PdtaR (Rv1626) two-component system. Aided by biochemical analysis, genetics, molecular docking, FRET microscopy, and structural modelling, we have characterized the binding of c-di-GMP in the GAF domain of PdtaS. We show that a pdtaS knockout in Mycobacterium smegmatis is severely compromised in growth on amino acid deficient media and exhibits global transcriptional dysregulation. The perturbation of the c-di-GMP-PdtaS-PdtaR axis results in a cascade of cellular changes recorded by a multiparametric systems' approach of transcriptomics, unbiased metabolomics, and lipid analyses.	[Hariharan, Vignesh Narayan; Yadav, Rahul; Gopinathan, Renu; Singh, Devendra Pratap; Saini, Deepak Kumar] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Thakur, Chandrani; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Sankhe, Gaurav; Saini, Deepak Kumar] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore, Karnataka, India; [Malhotra, Vandana] Delhi Univ, Sri Venkateswara Coll, Dept Biochem, Delhi, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; University of Birmingham; University of Birmingham; Indian Institute of Science (IISC) - Bangalore; University of Delhi	Saini, DK (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	deepaksaini@iisc.ac.in		Yadav, Rahul/0000-0002-8537-6896; Hariharan, Vignesh Narayan/0000-0001-9624-1244	Council of Scientific & Industrial Research [37(1663)15/EMR-II)]; Department of Biotechnology, India [BT/PR17357/MED/29/1019/2016]; DBT partnership program [DBT/BF/PRIns/2011-12]; Infosys Foundation; DST [SR/FST/LSII-036/2016]; Newton-Bhabha fellowship; BIRAC-BMGF [BIRAC/PMU/2019/SENTINELS-001]	Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); DBT partnership program; Infosys Foundation; DST(Department of Science & Technology (India)); Newton-Bhabha fellowship; BIRAC-BMGF	This work was supported by the Council of Scientific & Industrial Research (Grant No. 37(1663)15/EMR-II) and Department of Biotechnology, India (Grant No. BT/PR17357/MED/29/1019/2016) to DKS. The study is also supported by the DBT partnership program to the Indian Institute of Science (DBT/BF/PRIns/2011-12) and Infosys Foundation; Equipment support by DST-Funds for Infrastructure in Science and Technology program (SR/FST/LSII-036/2016). Part of the work was also supported by the Newton-Bhabha fellowship to VNH and Sentinels grant from BIRAC-BMGF (BIRAC/PMU/2019/SENTINELS-001) to DKS	Agrawal R., 2013, DYNAMIC MODELS INFEC, P79, DOI [10.1007/978-1-4614-9224-5_4, DOI 10.1007/978-1-4614-9224-5_4]; Agrawal R, 2015, BIOCHEM J, V469, P121, DOI 10.1042/BJ20150268; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bharati BK, 2013, GENE, V528, P99, DOI 10.1016/j.gene.2013.07.043; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Dadura K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02145; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dubey BN, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600823; Gordhan BG, 2002, INFECT IMMUN, V70, P3080, DOI 10.1128/IAI.70.6.3080-3084.2002; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gupta KR, 2016, J BACTERIOL, V198, P1414, DOI 10.1128/JB.00126-16; Gupta KR, 2015, APPL ENVIRON MICROB, V81, P2571, DOI 10.1128/AEM.03999-14; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; Haydel SE, 2004, FEMS MICROBIOL LETT, V236, P341, DOI 10.1016/j.femsle.2004.06.010; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hong YZ, 2013, TUBERCULOSIS, V93, P625, DOI 10.1016/j.tube.2013.09.002; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; Morth JP, 2005, FEBS LETT, V579, P4145, DOI 10.1016/j.febslet.2005.06.043; Morth JP, 2004, STRUCTURE, V12, P1595, DOI 10.1016/j.str.2004.06.018; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Preu J, 2012, J STRUCT BIOL, V177, P498, DOI 10.1016/j.jsb.2011.11.012; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Sambarey A, 2017, EBIOMEDICINE, V15, P112, DOI 10.1016/j.ebiom.2016.12.009; Sharma IM, 2014, IUBMB LIFE, V66, P823, DOI 10.1002/iub.1339; Sousa EHS, 2017, J INORG BIOCHEM, V167, P12, DOI 10.1016/j.jinorgbio.2016.11.022; Singh A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164253; Singh N, 2015, ANTIOXID REDOX SIGN, V22, P603, DOI 10.1089/ars.2014.6020; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tiwari S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01878; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zhang HN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06289-7	41	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21475	10.1096/fj.202002537RR	http://dx.doi.org/10.1096/fj.202002537RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33772870				2022-12-26	WOS:000635216100004
J	Hosokawa, H; Kanno, S; Nishio, Y; Kawasaki, I; Hirayama, K; Sunaga, A; Shoji, N; Iwasaki, M; Nakasato, N; Tominaga, T; Suzuki, K				Hosokawa, Hiroaki; Kanno, Shigenori; Nishio, Yoshiyuki; Kawasaki, Iori; Hirayama, Kazumi; Sunaga, Atsuko; Shoji, Naotake; Iwasaki, Masaki; Nakasato, Nobukazu; Tominaga, Teiji; Suzuki, Kyoko			Facial memory ability and self-awareness in patients with temporal lobe epilepsy after anterior temporal lobectomy	PLOS ONE			English	Article							RECOGNITION MEMORY; NONVERBAL MEMORY; WORKING-MEMORY; FACES; SURGERY; OUTCOMES; DEFICITS; POPULATION; IMPAIRMENT; PREVALENCE	Anterior temporal lobectomy (ATL) is the most common surgical treatment for drug-resistant temporal lobe epilepsy (TLE). Right ATL has been reported to reduce facial memory ability in patients with TLE, as indicated by poor performance on the Warrington Recognition Memory Test for Faces (RMF), which is commonly used to evaluate visual memory in these patients. However, little is known about whether patients with TLE exhibit difficulties in identifying faces in daily life after ATL. The aim of this study was to investigate facial memory ability and self-awareness of face identification difficulties in patients with TLE after ATL. Sixteen patients with TLE after right ATL, 14 patients with TLE after left ATL, and 29 healthy controls were enrolled in this study. We developed the multiview face recognition test (MFRT), which comprises a learning phase (one or three frontal face images without external facial feature information) and a recognition phase (frontal, oblique, or noise-masked face images). Facial memory abilities were examined in all participants using the MFRT and RMF, and self-awareness of difficulties in face identification was evaluated using the 20-item prosopagnosia index (PI20), which has been widely used to assess developmental prosopagnosia. The MFRT performance in patients with TLE after ATL was significantly worse than that in healthy controls regardless of the resected side, whereas the RMF scores in patients with TLE were significantly worse than those in healthy controls only after right ATL. The MFRT performance in patients with TLE after both left and right ATL was more influenced by working memory load than that in healthy controls. The PI20 scores revealed that patients with TLE after left ATL were aware of their difficulties in identifying faces. These findings suggest that patients with TLE not only after right ATL but also after left ATL might have difficulties in face identification.	[Hosokawa, Hiroaki; Kanno, Shigenori; Suzuki, Kyoko] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi, Japan; [Hosokawa, Hiroaki; Kawasaki, Iori] Sendai Nishitaga Natl Hosp, Dept Rehabil, Sendai, Miyagi, Japan; [Nishio, Yoshiyuki] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat & Neurol, Tokyo, Japan; [Hirayama, Kazumi] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata, Japan; [Sunaga, Atsuko] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Psychiat, Kodaira, Tokyo, Japan; [Shoji, Naotake; Iwasaki, Masaki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Neurosurg, Kodaira, Tokyo, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan	Tohoku University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Tohoku University; Tohoku University	Kanno, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi, Japan.	s-kanno@med.tohoku.ac.jp	Iwasaki, Masaki/AAH-4985-2020; Kanno, Shigenori/AAA-9764-2019	Iwasaki, Masaki/0000-0002-4204-7144; Kanno, Shigenori/0000-0003-4140-0919; Suzuki, Kyoko/0000-0002-8380-1561	MEXT [19H04890]; Health Labor Sciences Research Grant [20GB1002, 20GC1008]; JSPS KAKENHI [JP20K11202]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labor Sciences Research Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas (No. 19H04890) from MEXT to KS, Health Labor Sciences Research Grant No. 20GB1002 and No. 20GC1008 to KS, and JSPS KAKENHI Grant Number JP20K11202 to SK. URL of MEXT: https://www.mext.go.jp/.	[Anonymous], 1994, ASSESSMENT CLIN MANU; Barense MD, 2010, HIPPOCAMPUS, V20, P389, DOI 10.1002/hipo.20641; Barr WB, 1997, BRAIN COGNITION, V35, P26, DOI 10.1006/brcg.1997.0925; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Bird CM, 2010, HIPPOCAMPUS, V20, P1154, DOI 10.1002/hipo.20715; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Chelune GJ, 1990, ADV PSYCHOL ASSESS, V7, P65; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Chiaravalloti ND, 2004, BRAIN COGNITION, V54, P35, DOI 10.1016/S0278-2626(03)00257-4; Chou CC, 2015, EPILEPTIC DISORD, V17, P177, DOI 10.1684/epd.2015.0744; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Drane DL, 2013, CORTEX, V49, P1648, DOI 10.1016/j.cortex.2012.08.009; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; Dulay MF, 2009, NEUROLOGY, V72, P1837, DOI 10.1212/WNL.0b013e3181a71132; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; Ende GR, 1997, RADIOLOGY, V202, P809, DOI 10.1148/radiology.202.3.9051038; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Gleissner U, 1998, EPILEPSY RES, V32, P401, DOI 10.1016/S0920-1211(98)00072-2; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; HART YM, 1995, EPILEPSY RES, V21, P43, DOI 10.1016/0920-1211(95)00007-W; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; Helmstaedter C, 2013, EPILEPTIC DISORD, V15, P221, DOI 10.1684/epd.2013.0587; HERMANN BP, 1995, J EPILEPSY, V8, P139, DOI 10.1016/0896-6974(95)00022-6; HERMANN BP, 1991, J EPILEPSY, V4, P139, DOI 10.1016/S0896-6974(05)80039-8; HERMANN BP, 1993, NEUROPSYCHOLOGY, V7, P343, DOI DOI 10.1037/0894-4105.7.3.343; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Jeyaraj MK, 2013, EPILEPSY BEHAV, V28, P460, DOI 10.1016/j.yebeh.2013.06.011; Karakis I, 2013, EPILEPSY RES, V107, P181, DOI 10.1016/j.eplepsyres.2013.08.006; Khalil AF, 2016, NEUROL MED-CHIR, V56, P716, DOI 10.2176/nmc.oa.2016-0004; Lee ACH, 2005, HIPPOCAMPUS, V15, P782, DOI 10.1002/hipo.20101; Liu JT, 2018, EPILEPSY BEHAV, V82, P179, DOI 10.1016/j.yebeh.2017.11.012; Martin R, 2006, EPILEPSY BEHAV, V8, P239, DOI 10.1016/j.yebeh.2005.10.004; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P175, DOI 10.1016/0028-3932(68)90017-1; MORRIS RG, 1995, BRIT J CLIN PSYCHOL, V34, P571, DOI 10.1111/j.2044-8260.1995.tb01490.x; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; Olson IR, 2006, J COGNITIVE NEUROSCI, V18, P1087, DOI 10.1162/jocn.2006.18.7.1087; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; Picot MC, 2008, EPILEPSIA, V49, P1230, DOI 10.1111/j.1528-1167.2008.01579.x; Rossion B, 2018, BEHAV RES METHODS, V50, P2442, DOI 10.3758/s13428-018-1023-x; Sawrie SM, 1999, NEUROLOGY, V53, P1511, DOI 10.1212/WNL.53.7.1511; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Shah P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140343; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; Testa SM, 2004, EPILEPSY BEHAV, V5, P236, DOI 10.1016/j.yebeh.2003.12.011; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Tippett LJ, 2000, COGNITIVE NEUROPSYCH, V17, P241, DOI 10.1080/026432900380599; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Vaz SAM, 2004, SEIZURE-EUR J EPILEP, V13, P446, DOI 10.1016/j.seizure.2003.12.004; Warrington E.K., 1984, RECOGNITION MEMORY T; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	54	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248785	10.1371/journal.pone.0248785	http://dx.doi.org/10.1371/journal.pone.0248785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793593	gold, Green Published			2022-12-26	WOS:000636467000047
J	McPadden, J; Warner, F; Young, HP; Hurley, NC; Pulk, RA; Singh, A; Durant, TJS; Gong, GN; Desai, N; Haimovich, A; Taylor, RA; Gunel, M; Dela Cruz, CS; Farhadian, SF; Siner, J; Villanueva, M; Churchwell, K; Hsiao, AL; Torre, CJ; Velazquez, EJ; Herbst, RS; Iwasaki, A; Ko, ALI; Mortazavi, BJ; Krumholz, HM; Schulz, WL				McPadden, Jacob; Warner, Frederick; Young, H. Patrick; Hurley, Nathan C.; Pulk, Rebecca A.; Singh, Avinainder; Durant, Thomas J. S.; Gong, Guannan; Desai, Nihar; Haimovich, Adrian; Taylor, Richard Andrew; Gunel, Murat; Dela Cruz, Charles S.; Farhadian, Shelli F.; Siner, Jonathan; Villanueva, Merceditas; Churchwell, Keith; Hsiao, Allen; Torre, Charles J., Jr.; Velazquez, Eric J.; Herbst, Roy S.; Iwasaki, Akiko; Ko, Albert I.; Mortazavi, Bobak J.; Krumholz, Harlan M.; Schulz, Wade L.			Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection	PLOS ONE			English	Article							COVID-19	Objective Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. Design This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. Setting Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas. Populations The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020. Main outcome and performance measures Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support. Results Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14-1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50-2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups. Conclusions This observational study identified, among people testing positive for SARS-CoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines.	[McPadden, Jacob; Hsiao, Allen] Yale Sch Med, Dept Pediat, New Haven, CT USA; [McPadden, Jacob; Warner, Frederick; Young, H. Patrick; Durant, Thomas J. S.; Gong, Guannan; Desai, Nihar; Mortazavi, Bobak J.; Krumholz, Harlan M.; Schulz, Wade L.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Warner, Frederick; Velazquez, Eric J.; Mortazavi, Bobak J.; Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA; [Young, H. Patrick; Singh, Avinainder; Villanueva, Merceditas] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hurley, Nathan C.; Mortazavi, Bobak J.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [Pulk, Rebecca A.] Yale New Haven Hlth, Corp Pharm Serv, New Haven, CT USA; [Durant, Thomas J. S.; Torre, Charles J., Jr.; Schulz, Wade L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Gong, Guannan] Yale Univ, Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT USA; [Haimovich, Adrian] Yale Sch Med, New Haven, CT USA; [Taylor, Richard Andrew] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gunel, Murat] Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Dela Cruz, Charles S.; Siner, Jonathan] Yale Sch Med, Dept Internal Med Pulm Crit Care & Sleep Med, New Haven, CT USA; [Farhadian, Shelli F.] Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT USA; [Villanueva, Merceditas] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Churchwell, Keith] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [Torre, Charles J., Jr.] Yale New Haven Hlth, Informat Technol Serv, New Haven, CT USA; [Herbst, Roy S.] Yale Sch Med, Yale Comprehens Canc Ctr, New Haven, CT USA; [Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Mortazavi, Bobak J.] Texas A&M Univ, Ctr Remote Hlth Technol & Syst, College Stn, TX USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; Texas A&M University System; Texas A&M University College Station; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Texas A&M University System; Texas A&M University College Station; Yale University	Schulz, WL (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.; Schulz, WL (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.	wade.schulz@yale.edu	Singh, Avinainder/AAJ-2920-2020; Ko, Albert/P-2343-2015	Singh, Avinainder/0000-0003-1717-005X; Ko, Albert/0000-0001-9023-2339; Durant, Thomas/0000-0003-1107-8148; Gong, Guannan/0000-0002-4972-6705; Young, Hobart/0000-0002-0879-8120; Hsiao, Allen/0000-0002-8080-0002; Desai, Nihar/0000-0003-2384-2545; Pulk, Rebecca/0000-0003-0949-9699	National Institutes of Health [5T15LM007056]; CTSA from National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR001863]; Beatrice Kleinberg Neuwirth Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH); Beatrice Kleinberg Neuwirth Fund	J.M. received funding from the National Institutes of Health 5T15LM007056. This publication was also made possible by CTSA Grant Number UL1 TR001863 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH) and the Beatrice Kleinberg Neuwirth Fund. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of any other organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Ah YM, 2019, BASIC CLIN PHARMACOL, V124, P741, DOI 10.1111/bcpt.13184; Anesi GL, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2082; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chen FY, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.40; Chen J, 2020, J IMMUNOL, V205, P313, DOI 10.4049/jimmunol.2000380; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gao C, 2020, EUR HEART J, V41, P2058, DOI 10.1093/eurheartj/ehaa433; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Kass DA, 2020, LANCET, V395, P1544, DOI 10.1016/S0140-6736(20)31024-2; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; McPadden J, 2019, J MED INTERNET RES, V21, DOI 10.2196/13043; Moore BJ, 2017, MED CARE, V55, P698, DOI 10.1097/MLR.0000000000000735; OMOP, COMMON DATA MODEL OH; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schulz WL, 2020, J MED INTERNET RES, V22, DOI 10.2196/18707; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; U.S. Census Bureau, QUICKFACTS CONNECTIC; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yale New Haven Health, FACTAND FIG; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0243291	10.1371/journal.pone.0243291	http://dx.doi.org/10.1371/journal.pone.0243291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788846	Green Published, Green Submitted, gold			2022-12-26	WOS:000636354600054
J	Olezene, CS; Hansen, E; Steere, HK; Giacino, JT; Polich, GR; Borg-Stein, J; Zafonte, RD; Schneider, JC				Olezene, Cameron Spencer; Hansen, Elizabeth; Steere, Hannah K.; Giacino, Joseph T.; Polich, Ginger R.; Borg-Stein, Joanne; Zafonte, Ross D.; Schneider, Jeffrey C.			Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection	PLOS ONE			English	Article							RESPONSIVENESS; BALANCE	Objective To characterize the functional impairments of a cohort of patients undergoing inpatient rehabilitation after surviving severe COVID-19 illness, in order to better understand the ongoing needs of this patient population. Methods This study consisted of a retrospective chart review of consecutive patients hospitalized for COVID-19 and admitted to a regional inpatient rehabilitation hospital from April 29(th) to May 22(nd), 2020. Patient demographics, clinical characteristics and complications from acute hospitalization were examined. Measures of fall risk (Berg Balance Scale), endurance (6 Minute Walk Test), gait speed (10 Meter Walk Test), mobility (transfer and ambulation independence), cognition, speech and swallowing (American Speech and Hearing Association National Outcomes Measurement System Functional Communication Measures) were assessed at rehabilitation admission and discharge. Results The study population included 29 patients and was 70% male, 58.6% white and with a mean age of 59.5. The mean length of acute hospitalization was 32.2 days with a mean of 18.7 days intubated. Patients spent a mean of 16.7 days in inpatient rehabilitation and 90% were discharged home. Patients demonstrated significant improvement from admission to discharge in measures of fall risk, endurance, gait speed, mobility, cognition, speech and swallowing, (p< 0.05). At discharge, a significant portion of the population continued to deficits in cognition (attention 37%; memory 28%; problem solving 28%), balance (55%) and gait speed (97%). Conclusion Patients admitted to inpatient rehabilitation after hospitalization with COVID-19 demonstrated deficits in mobility, cognition, speech and swallowing at admission and improved significantly in all of these domains by discharge. However, a significant number of patients exhibited residual deficits at discharge highlighting the post-acute care needs of this patient population.	[Olezene, Cameron Spencer; Hansen, Elizabeth; Steere, Hannah K.; Giacino, Joseph T.; Polich, Ginger R.; Borg-Stein, Joanne; Zafonte, Ross D.; Schneider, Jeffrey C.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02114 USA	Harvard University; Spaulding Rehabilitation Hospital	Olezene, CS (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02114 USA.	colezene@partners.org	Schneider, Jeffrey/AAO-2126-2020; Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Olezene, Cameron/0000-0001-5048-884X				American Speech-Language-Hearing Association, 2019, NATL OUTCOMES MEASUR; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bellet RN, 2012, PHYSIOTHERAPY, V98, P277, DOI 10.1016/j.physio.2011.11.003; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2678; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Chan WLS, 2019, EXP GERONTOL, V115, P9, DOI 10.1016/j.exger.2018.11.001; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019; Hess DC, 2020, TRANSL STROKE RES, V11, P322, DOI 10.1007/s12975-020-00818-9; Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479; Liu K, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101166; Mahmud E, 2020, J AM COLL CARDIOL, V76, P1375, DOI 10.1016/j.jacc.2020.04.039; Mcloughlin BC, 2020, EUR GERIATR MED, V11, P857, DOI 10.1007/s41999-020-00353-8; Myers EA, 2016, JAAPA-J AM ACAD PHYS, V29, P34, DOI 10.1097/01.JAA.0000481401.21841.32; Ntaios G, 2020, STROKE, V51, pE254, DOI 10.1161/STROKEAHA.120.031208; Ohtake PJ, 2018, PHYS THER, V98, P631, DOI 10.1093/ptj/pzy059; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Prescott HC, 2019, AM J RESP CRIT CARE, V200, P972, DOI 10.1164/rccm.201812-2383CP; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Sheehy Lisa Mary, 2020, JMIR Public Health Surveill, V6, pe19462, DOI 10.2196/19462; Simpson R, 2020, AM J PHYS MED REHAB, V99, P470, DOI 10.1097/PHM.0000000000001443; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Stam HJ, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2677; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435	28	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248824	10.1371/journal.pone.0248824	http://dx.doi.org/10.1371/journal.pone.0248824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788876	gold, Green Published			2022-12-26	WOS:000636354600038
J	Wunderlich, F; Weigelt, M; Rein, R; Memmert, D				Wunderlich, Fabian; Weigelt, Matthias; Rein, Robert; Memmert, Daniel			How does spectator presence affect football? Home advantage remains in European top-class football matches played without spectators during the COVID-19 pandemic	PLOS ONE			English	Article								The present paper investigates factors contributing to the home advantage, by using the exceptional opportunity to study professional football matches played in the absence of spectators due to the COVID-19 pandemic in 2020. More than 40,000 matches before and during the pandemic, including more than 1,000 professional matches without spectators across the main European football leagues, have been analyzed. Results support the notion of a crowd-induced referee bias as the increased sanctioning of away teams disappears in the absence of spectators with regard to fouls (p < .001), yellow cards (p < .001), and red cards (p < .05). Moreover, the match dominance of home teams decreases significantly as indicated by shots (p < .001) and shots on target (p < .01). In terms of the home advantage itself, surprisingly, only a non-significant decrease is found. While the present paper supports prior research with regard to a crowd-induced referee bias, spectators thus do not seem to be the main driving factor of the home advantage. Results from amateur football, being naturally played in absence of a crowd, provide further evidence that the home advantage is predominantly caused by factors not directly or indirectly attributable to a noteworthy number of spectators.	[Wunderlich, Fabian; Rein, Robert; Memmert, Daniel] German Sports Univ Cologne, Cologne, Germany; [Weigelt, Matthias] Univ Paderborn, Paderborn, Germany	German Sport University Cologne; University of Paderborn	Wunderlich, F (corresponding author), German Sports Univ Cologne, Cologne, Germany.	f.wunderlich@dshs-koeln.de						AGNEW GA, 1994, INT J SPORT PSYCHOL, V25, P53; Allen MS, 2014, INT J SPORT EXERC PS, V12, P10, DOI 10.1080/1612197X.2012.756230; Anders A, 2011, J QUANT ANAL SPORTS, V7, DOI 10.2202/1559-0410.1286; Angelini G, 2019, INT J FORECASTING, V35, P712, DOI 10.1016/j.ijforecast.2018.07.008; [Anonymous], 2002, FOOTBALL STUDIES; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V47, P85, DOI 10.1037/0022-3514.47.1.85; Bialkowski A., 2014, P 8 ANN MIT SLOAN SP, P1; Bray SR., 2000, J SPORT BEHAV, P23; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Clarke SR, 1995, STATISTICIAN, V44, P509, DOI 10.2307/2348899; Constantinou AC, 2013, J QUANT ANAL SPORTS, V9, P37, DOI 10.1515/jqas-2012-0036; COURNEYA KS, 1992, J SPORT EXERCISE PSY, V14, P13, DOI 10.1123/jsep.14.1.13; Dohmen TJ, 2008, J ECON BEHAV ORGAN, V65, P636, DOI 10.1016/j.jebo.2005.12.004; Forrest D, 2005, INT J FORECASTING, V21, P551, DOI 10.1016/j.ijforecast.2005.03.003; Garicano L, 2005, REV ECON STAT, V87, P208, DOI 10.1162/0034653053970267; Goddard J, 2004, J FORECASTING, V23, P51, DOI 10.1002/for.877; Goumas C, 2014, J SCI MED SPORT, V17, P119, DOI 10.1016/j.jsams.2013.02.014; Goumas C, 2014, EUR J SPORT SCI, V14, pS243, DOI 10.1080/17461391.2012.686062; Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hvattum LM, 2010, INT J FORECASTING, V26, P460, DOI 10.1016/j.ijforecast.2009.10.002; Jamieson JP, 2010, J APPL SOC PSYCHOL, V40, P1819, DOI 10.1111/j.1559-1816.2010.00641.x; Jones MB, 2013, PSYCHOL SPORT EXERC, V14, P397, DOI 10.1016/j.psychsport.2013.01.002; Lago-Penas C, 2011, J HUM KINET, V27, P137; Lago-Penas C, 2010, J SPORT SCI MED, V9, P288; MIZRUCHI MS, 1985, SOCIOL QUART, V26, P507, DOI 10.1111/j.1533-8525.1985.tb00241.x; Moore J. C., 1993, Journal of Sport Behavior, V16, P77; Neave N, 2003, PHYSIOL BEHAV, V78, P269, DOI 10.1016/S0031-9384(02)00969-1; Nevill AM, 1999, SPORTS MED, V28, P221, DOI 10.2165/00007256-199928040-00001; Nevill AM, 1996, J SPORT SCI, V14, P181, DOI 10.1080/02640419608727700; Pettersson-Lidbom P, 2010, ECON LETT, V108, P212, DOI 10.1016/j.econlet.2010.04.023; Pollard R, 2006, J SPORT SCI, V24, P231, DOI 10.1080/02640410500141836; Pollard R, 2005, J SPORT SCI, V23, P337, DOI 10.1080/02640410400021559; Pollard R, 2002, J SPORT SCI, V20, P969, DOI 10.1080/026404102321011724; Pollard R., 2008, OPEN SPORTS SCI J, V1, P12, DOI [10.2174/1875399X00801010012, DOI 10.2174/1875399X00801010012]; Pollard R, 2014, INT J SPORT EXERC PS, V12, P218, DOI 10.1080/1612197X.2014.888245; Pollard R, 2014, EUR J SPORT SCI, V14, pS77, DOI 10.1080/17461391.2011.651490; Pollard R, 1986, J SPORT SCI, V4, P237, DOI 10.1080/02640418608732122; Ponzo M, 2018, J SPORT ECON, V19, P562, DOI 10.1177/1527002516665794; RECHT LD, 1995, NATURE, V377, P583, DOI 10.1038/377583a0; Riedl D, 2015, J SPORT EXERCISE PSY, V37, P316, DOI 10.1123/jsep.2015-0018; Riedl D, 2015, J SPORT SCI, V33, P327, DOI 10.1080/02640414.2014.944558; Ruiz H., MEASURING SCORING EF, P149; RUSSELL GW, 1983, SOC BEHAV PERSONAL, V11, P9, DOI 10.2224/sbp.1983.11.1.9; SALMINEN S, 1993, PERCEPT MOTOR SKILL, V76, P1123, DOI 10.2466/pms.1993.76.3c.1123; Scoppa V, 2008, EMPIR ECON, V35, P123, DOI 10.1007/s00181-007-0146-1; Scoppa V, 2021, J ECON PSYCHOL, V82, DOI 10.1016/j.joep.2020.102344; Spann M, 2009, J FORECASTING, V28, P55, DOI 10.1002/for.1091; Spitz J, 2021, J SPORT SCI, V39, P147, DOI 10.1080/02640414.2020.1809163; Staufenbiel K, 2018, INT J SPORT EXERC PS, V16, P36, DOI 10.1080/1612197X.2016.1142463; Staufenbiel K, 2015, J SPORT SCI, V33, P1932, DOI 10.1080/02640414.2015.1018929; Strauss B, 2002, INT J SPORT PSYCHOL, V33, P372; Sutter M, 2004, J ECON PSYCHOL, V25, P461, DOI 10.1016/S0167-4870(03)00013-8; Tucker W., 2005, INT J PERF ANAL SPOR, V5, P23, DOI [10.1080/24748668.2005.11868325, DOI 10.1080/24748668.2005.11868325]; Unkelbach C, 2010, J SPORT EXERCISE PSY, V32, P483, DOI 10.1123/jsep.32.4.483; Wolfson S, 2005, J SPORT SCI, V23, P365, DOI 10.1080/02640410400021567; Wunderlich F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198668	57	37	37	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248590	10.1371/journal.pone.0248590	http://dx.doi.org/10.1371/journal.pone.0248590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788870	gold, Green Published			2022-12-26	WOS:000636354600018
J	Schulwitz, SE; Hill, GC; Fry, V; McClure, CJW				Schulwitz, Sarah E.; Hill, Greg C.; Fry, Vanessa; McClure, Christopher J. W.			Evaluating citizen science outreach: A case-study with The Peregrine Fund's American Kestrel Partnership	PLOS ONE			English	Article							MODEL SELECTION; MOTIVATIONS; NOISE	Citizen science programs can be powerful drivers of knowledge and scientific understanding and, in recent decades, they have become increasingly popular. Conducting successful research with the aid of citizen scientists often rests on the efficacy of a program's outreach strategies. Program evaluation is increasingly recognized as a critical practice for citizen science practitioners to ensure that all efforts, including outreach, contribute to the overall goals of the program. The Peregrine Fund's American Kestrel Partnership (AKP) is one such citizen science program that relies on outreach to engage participants in effective monitoring of a declining falcon species. Here, we examine whether various communication strategies were associated with desired outreach goals of the AKP. We demonstrate how social media, webcams, discussion boards, and newsletters were associated with perception of learning, agreement with our conservation messaging, and participation in our box monitoring program. Our results thus help us to improve our outreach methodology, suggest areas where other citizen science programs might improve their outreach efforts, and highlight future research priorities.	[Schulwitz, Sarah E.; McClure, Christopher J. W.] Peregrine Fund, Boise, ID 83709 USA; [Hill, Greg C.] Boise State Univ, Sch Publ Serv, Boise, ID 83725 USA; [Fry, Vanessa] Boise State Univ, Idaho Policy Inst, Boise, ID 83725 USA	Idaho; Boise State University; Idaho; Boise State University	Schulwitz, SE (corresponding author), Peregrine Fund, Boise, ID 83709 USA.	Schulwitz.Sarah@peregrinefund.org			McClure Family Foundation	McClure Family Foundation	SES received an award from the McClure Family Foundation (https://www.mcclurefamilyfoundation.org/) specific to funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexandrino ER., 2019, CITIZ SCI THEORY PRA, V4, P1, DOI [10.5334/cstp.247, DOI 10.5334/CSTP.247]; Anderson DL, 2019, ARCT SCI, V5, P148, DOI 10.1139/as-2018-0024; [Anonymous], 2018, MULTIMODEL INFERENCE; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bunkley JP, 2017, ECOL EVOL, V7, P2977, DOI 10.1002/ece3.2698; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Davis CM, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-01044-120205; de Vries M.J., 2019, CITIZ SCI THEORY PRA, V4, P2, DOI [10.5334/cstp.136, DOI 10.5334/CSTP.136]; Dickinson J.L., 2012, CITIZEN SCI PUBLIC P; Dillman D.A., 2014, TAILORED DESIGN METH; Dodson G, 2012, ZOO BIOL, V31, P414, DOI 10.1002/zoo.20405; Domroese MC, 2017, BIOL CONSERV, V208, P40, DOI 10.1016/j.biocon.2016.08.020; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Fowler JFJ., 2014, SURV RES METHODS-GER, V5th ed; Greenwood JJD, 2007, J ORNITHOL, V148, pS77, DOI 10.1007/s10336-007-0239-9; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Haklay M., 2013, CROWDSOURCING GEOGRA; Hayward MW, 2012, S AFR J WILDL RES, V42, P117, DOI 10.3957/056.042.0209; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson Michelle L., 2018, Arboriculture & Urban Forestry, V44, P59; Lewandowski E, 2015, CONSERV BIOL, V29, P713, DOI 10.1111/cobi.12481; Liberatore A., 2018, CITIZEN SCI THEORY P, V3, P3, DOI DOI 10.5334/CSTP.108; Masters K, 2016, JCOM-J SCI COMMUN, V15; McClure CJW, 2017, J RAPTOR RES, V51, P455, DOI 10.3356/JRR-16-73.1; McClure CJW, 2017, ECOL APPL, V27, P1155, DOI 10.1002/eap.1509; McClure CJW, 2015, J RAPTOR RES, V49, P231, DOI 10.3356/0892-1016-49.2.231; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; McLaren AA, 1999, J FIELD ORNITHOL, V70, P481; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Oberhauser Karen S., 2008, American Entomologist, V54; Peluso AI, 2013, AVIAN BIOL RES, V6, P215, DOI 10.3184/175815513X13740436033839; Phillips Tina, 2014, USERS GUIDE EVALUATI; Price CA, 2013, J RES SCI TEACH, V50, P773, DOI 10.1002/tea.21090; Ryan R.L., 2001, J ENVIRON PLANN MAN, V44, P629, DOI [10.1080/09640560120079948, DOI 10.1080/09640560120079948]; Schulwitz SE, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00434; Smallwood JA, 2009, J RAPTOR RES, V43, P274, DOI 10.3356/JRR-08-83.1; Sotos AEC., 2009, STAT ED RES J, V8, P33; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Vercayie D, 2015, NAT CONSERV-BULGARIA, P29, DOI 10.3897/natureconservation.11.4439; Ware HE, 2015, P NATL ACAD SCI USA, V112, P12105, DOI 10.1073/pnas.1504710112	45	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248948	10.1371/journal.pone.0248948	http://dx.doi.org/10.1371/journal.pone.0248948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784330	Green Published, gold			2022-12-26	WOS:000636359600056
J	Arias-Reyes, C; Carvajal-Rodriguez, F; Poma-Machicao, L; Aliaga-Raduan, F; Marques, DA; Zubieta-DeUrioste, N; Accinelli, RA; Schneider-Gasser, EM; Zubieta-Calleja, G; Dutschmann, M; Soliz, J				Arias-Reyes, Christian; Carvajal-Rodriguez, Favio; Poma-Machicao, Liliana; Aliaga-Raduan, Fernanda; Marques, Danuzia A.; Zubieta-DeUrioste, Natalia; Accinelli, Roberto Alfonso; Schneider-Gasser, Edith M.; Zubieta-Calleja, Gustavo; Dutschmann, Mathias; Soliz, Jorge			Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent	PLOS ONE			English	Article							EPO	The coronavirus disease 2019 (COVID-19) outbreak in North, Central, and South America has become the epicenter of the current pandemic. We have suggested previously that the infection rate of this virus might be lower in people living at high altitude (over 2,500 m) compared to that in the lowlands. Based on data from official sources, we performed a new epidemiological analysis of the development of the pandemic in 23 countries on the American continent as of May 23, 2020. Our results confirm our previous finding, further showing that the incidence of COVID-19 on the American continent decreases significantly starting at 1,000 m above sea level (masl). Moreover, epidemiological modeling indicates that the virus transmission rate is lower in the highlands (>1,000 masl) than in the lowlands (<1,000 masl). Finally, evaluating the differences in the recovery percentage of patients, the death-to-case ratio, and the theoretical fraction of undiagnosed cases, we found that the severity of COVID-19 is also decreased above 1,000 m. We conclude that the impact of the COVID-19 decreases significantly with altitude.	[Arias-Reyes, Christian; Carvajal-Rodriguez, Favio; Poma-Machicao, Liliana; Aliaga-Raduan, Fernanda; Marques, Danuzia A.; Soliz, Jorge] Univ Laval, Fac Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Zubieta-DeUrioste, Natalia; Zubieta-Calleja, Gustavo; Soliz, Jorge] High Altitude Pulm & Pathol Inst HAPPI IPPA, La Paz, Bolivia; [Accinelli, Roberto Alfonso] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru; [Schneider-Gasser, Edith M.] Univ Zurich, Vetsuisse Fac, Inst Vet Physiol, Zurich, Switzerland; [Dutschmann, Mathias] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Laval University; Universidad Peruana Cayetano Heredia; University of Zurich; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Soliz, J (corresponding author), Univ Laval, Fac Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.; Soliz, J (corresponding author), High Altitude Pulm & Pathol Inst HAPPI IPPA, La Paz, Bolivia.	jorge.soliz@crchuq.ulaval.ca	Soliz, Jorge/AAA-9752-2022; Zubieta-Calleja, Gustavo/ABB-8608-2021	Zubieta-Calleja, Gustavo/0000-0002-4283-6514; Arias Reyes, Christian/0000-0003-2802-8112; Soliz, Jorge/0000-0002-2335-5862; Marques, Danuzia/0000-0003-4144-2166				Aguirre M, DUDAS NUMERO PRUEBAS; Alcaldia de Bogota, CIFR COR COVID 19 BO; Americas Society Council of Administration A, ASCOA2020; Andrade M, 2020, RADIACION ULTRAVIOLE; Arias-Reyes C, 2020, RESP PHYSIOL NEUROBI, V277, DOI 10.1016/j.resp.2020.103443; Arnab BD, 2020, EPIDEMIC MODELING ES; Asyary A, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139016; Birbuet J. C., 2020, DINAMICA EXPANSION C; Cano-P&Atilde;&copy;rez E, 2020, AM J TROP MED HYG, V103, P2347, DOI 10.4269/ajtmh.20-1027; Center for International Earth Science Information Network-CIESIN-Columbia University, 2018, GRIDD POP WORLD VERS; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Comite Operativo de Emergencias UMSA, 2020, 3 U MAYOR SAN ANDR; Cowan G, 1998, STAT DATA ANAL; Dang ZC, 2020, J ETHNOPHARMACOL, V250, DOI 10.1016/j.jep.2019.112470; Engle S., 2020, STAYING HOME MOBILIT, DOI [10.2139/ssrn.3565703, DOI 10.2139/SSRN.3565703]; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; France 24, FRANC STICKS LOCKD E; Galindo J, 2020, FALTAN PRUEBAS MEDIR; GmbH O, OPENCAGE GEOC 2020; Gobierno de la Ciudad de Mexico, DAT AB SAL PUBL ACC; Hornbein T.F., 2001, HIGH ALTITUDE EXPLOR; Huamani C, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103448; Intimayta-Escalante C, 2020, HIGH ALT MED BIOL, V21, P426, DOI 10.1089/ham.2020.0133; JasonBarr TT., 2020, ARE CROWDED CITIES R; Jiang Bing-Hua, 1996, American Journal of Physiology, V271, pC1172; Jombart Thibaut, 2020, medRxiv, DOI [10.12688/wellcomeopenres.15786.1, 10.1101/2020.03.10.20033761]; Joshua Berlinger CNN, COR HAS NOW SPREAD E; Juul S, 2007, SEMIN FETAL NEONAT M, V12, P250, DOI 10.1016/j.siny.2007.01.015; Langton K, 2020, EXPRESS; Leon-Abarca JA, 2020, ARCH BRONCONEUMOLOGI; Li Y., 2020, SUNLIGHT VITAMIN D P; Martin D, 2008, POSTGRAD MED J, V84, P622, DOI 10.1136/pgmj.2008.068296; Ministerio de Saude de Brasil, COR BRAS 2020; Montreal S., CORONAVIRUS COVID 19; N. Y. C. Health Department, COVID 19 DAT SUMM NY; NPR, MILL RET WORK IT WEE; Pan-American Health Organization, 2020, COR DIS COVID 19 PAH; Pun M, 2020, HIGH ALT MED BIOL, V21, P217, DOI 10.1089/ham.2020.0114; Quevedo-Ramirez A, 2020, RESP PHYSIOL NEUROBI, V281, DOI 10.1016/j.resp.2020.103512; Rede Brasil Atual, 2020, CAS COVID 19 PER SAO; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa038; Rogers A, 2020, WIRED; SEDES La Paz, INF OF SEDES PAZ SIT; Segovia-Juarez J, 2020, RESP PHYSIOL NEUROBI, V281, DOI 10.1016/j.resp.2020.103494; Soliz J, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103476; Staub K, 2020, BLOOD, V135, P1066, DOI 10.1182/blood.2019004135; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; United-States-Environmental-Protection-Agency, 2017, CALC UV IND; Vasconez-Gonzalez E, 2020, EPIDEMIOLOGICAL SOCI, V15, DOI [10.1101/2020.05.08.20095943, DOI 10.1101/2020.05.08.20095943]; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang YX, 2020, EUR J ENVIRON CIV EN, V24, P2453, DOI 10.1080/19648189.2018.1509021; WHO, 2020, CLIN MAN COVID 19; World Health Organization (WHO), COR DIS COVID 19 EV; Worldometers.info, 2020, COR DEATH RAT COVID; Worldometers.info, 2020, COR UPD LIV 3804912; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang RF, 2009, AM J PHYSIOL-LUNG C, V297, pL631, DOI 10.1152/ajplung.90415.2008; Zubieta-Calleja G., 2020, COVID 19 PANDEMIA ES; Zubieta-Calleja G. R., 2017, BLDE U J HLTH SCI, V2, P80, DOI [DOI 10.4103/BJHS.BJHS_7_17, 10.4103/bjhs.bjhs_7_17]	60	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0237294	10.1371/journal.pone.0237294	http://dx.doi.org/10.1371/journal.pone.0237294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780470	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000636336800039
J	Yorzinski, JL; Harbourne, A; Thompson, W				Yorzinski, Jessica L.; Harbourne, Amy; Thompson, William			Sclera color in humans facilitates gaze perception during daytime and nighttime	PLOS ONE			English	Article							DIRECTION; EYES; EVOLUTION; ATTENTION; CHILDREN; ANIMALS; SIDE	Species vary widely in the conspicuousness of their eye morphology and this could influence gaze perception. Eyes with conspicuous morphology can enhance gaze perception while eyes with camouflaged morphology may hinder gaze perception. While evidence suggests that conspicuous eye morphology enhances gaze perception, little is known about how environmental conditions affect this interaction. Thus, we investigated whether environmental light conditions affect gaze perception. Human subjects (Homo sapiens) were instructed to find direct-gaze faces within arrays of averted-gaze faces or to find averted-gaze faces within arrays of directed-gaze faces. The faces were displayed under conditions simulating nighttime or daytime conditions. Furthermore, the faces had naturally-colored sclera (white) or modified sclera (same color as the iris). Participants were fastest and most accurate in detecting faces during the daytime and nighttime conditions when the sclera were naturally-colored. Participants were worst at detecting faces with modified sclera during the nighttime conditions. These results suggest that eyes with conspicuous morphology enhance gaze perception during both daytime and nighttime conditions.	[Yorzinski, Jessica L.] Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX USA; [Harbourne, Amy] Texas A&M Univ, Dept English, College Stn, TX USA; [Thompson, William] Univ Utah, Sch Comp, Salt Lake City, UT USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; University of Utah	Yorzinski, JL (corresponding author), Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX USA.	jyorzinski@tamu.edu			National Science Foundation [1926327]; College of Agriculture and Life Sciences at Texas AM University; Texas A&M AgriLife Research	National Science Foundation(National Science Foundation (NSF)); College of Agriculture and Life Sciences at Texas AM University; Texas A&M AgriLife Research	This study was funded by the National Science Foundation (BCS #1926327), the College of Agriculture and Life Sciences at Texas A&M University and Texas A&M AgriLife Research to J. L.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NC, 2016, PSYCHON B REV, V23, P817, DOI 10.3758/s13423-015-0971-8; Ando S, 2004, PERCEPTION, V33, P1173, DOI 10.1068/p5297; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Brunye TT, 2017, INT J PSYCHOPHYSIOL, V120, P60, DOI 10.1016/j.ijpsycho.2017.07.008; Chelnokova O, 2014, MOL PSYCHIATR, V19, P746, DOI 10.1038/mp.2014.1; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Ferwerda J. A., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P249, DOI 10.1145/237170.237262; Garcia JOP, 2016, J LANG EVOL, V1, P151, DOI 10.1093/jole/lzw004; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; HAMES RB, 1979, HUM ECOL, V7, P219, DOI 10.1007/BF00889493; HAWKES K, 1991, PHILOS T R SOC B, V334, P243, DOI 10.1098/rstb.1991.0113; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Jenkins R, 2007, PERCEPTION, V36, P1266, DOI 10.1068/p5745; Kaplan G, 2002, INT J PRIMATOL, V23, P501, DOI 10.1023/A:1014913532057; Kawai N, 2016, ANIM COGN, V19, P655, DOI 10.1007/s10071-015-0949-y; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Kyba C, 2017, ASTRON GEOPHYS, V58, DOI 10.1093/astrogeo/atx025; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Larson GW, 1997, IEEE T VIS COMPUT GR, V3, P291, DOI 10.1109/2945.646233; Lin RJ, 2015, OPTOMETRY VISION SCI, V92, P559, DOI 10.1097/OPX.0000000000000584; LoBue V, 2010, J EXP CHILD PSYCHOL, V107, P59, DOI 10.1016/j.jecp.2010.04.005; Mayhew JA, 2015, AM J PRIMATOL, V77, P869, DOI 10.1002/ajp.22411; Meyer WK, 2013, AM J PHYS ANTHROPOL, V151, P398, DOI 10.1002/ajpa.22280; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Olk B, 2008, PERCEPT PSYCHOPHYS, V70, P1298, DOI 10.3758/PP.70.7.1298; Paulun VC, 2015, VISION RES, V113, P155, DOI 10.1016/j.visres.2015.05.004; Pazda AD, 2016, PERCEPTION, V45, P739, DOI 10.1177/0301006616633386; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Penteriani V, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0064; Perea-Garcia JO, 2019, P NATL ACAD SCI USA, V116, P19248, DOI 10.1073/pnas.1911410116; Ricciardelli P, 2000, COGNITION, V77, pB1, DOI 10.1016/S0010-0277(00)00092-5; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shlaer S, 1937, J GEN PHYSIOL, V21, P165, DOI 10.1085/jgp.21.2.165; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Taglialatela JP, 2015, AM J PRIMATOL, V77, P1143, DOI 10.1002/ajp.22449; Tanaka JW, 2016, Q J EXP PSYCHOL, V69, P1876, DOI 10.1080/17470218.2016.1146780; Thompson W. B., 2002, Journal of Graphics Tools, V7, P1, DOI 10.1080/10867651.2002.10487550; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Ueda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098217; Worthman C. M., 2002, COMP DEV ECOLOGY HUM, P69; Worthman C. M., 2008, EVOLUTIONARY MED HLT, P291; Yokoyama T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03858; Yorzinski JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228275; Yorzinski JL, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150155; Yorzinski JL, 2014, EVOL PSYCHOL-US, V12, P534, DOI 10.1177/147470491401200304	48	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249137	10.1371/journal.pone.0249137	http://dx.doi.org/10.1371/journal.pone.0249137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780503	gold, Green Published			2022-12-26	WOS:000636336800015
J	Usuelli, M; Meyer, T; Mezzenga, R; Mitsi, M				Usuelli, Mattia; Meyer, Timmy; Mezzenga, Raffaele; Mitsi, Maria			VEGF and VEGFR2 bind to similar pH-sensitive sites on fibronectin, exposed by heparin-mediated conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ISOFORMS; ANGIOGENESIS; ACTIVATION; CELL; RECEPTORS; MECHANISM; TRANSPORT; RESPONSES	Physical interactions between vascular endothelial growth factor (VEGF), a central player in blood endothelial cell biology, and fibronectin, a major fibrillar protein of the extracellular matrix, are important determinants of angiogenic activity in health and disease. Conditions signaling the need for new blood vessel growth, such as hypoxia and low extracellular pH, increase VEGF-fibronectin interactions. These interactions can be further fine-tuned through changes in the availability of the VEGF-binding sites on fibronectin, regulated by conformational changes induced by heparin and heparan sulfate chains within the extracellular matrix. These interactions may alter VEGF bioavailability, generate gradients, or alter the way VEGF is recognized by and activates its cell-surface receptors. Here, using equilibrium and kinetic studies, we discovered that fibronectin can also interact with the extracellular domain of the VEGF receptor 2 (VEGFR2). The VEGFR2-binding sites on fibronectin show great similarity to the VEGF-binding sites, as they were also exposed upon heparin-induced conformational changes in fibronectin, and the interaction was enhanced at acidic pH. Kinetic parameters and affinities for VEGF and VEGFR2 binding to fibronectin were determined by surface plasmon resonance measurements, revealing two populations of fibronectin-binding sites for each molecule. Our data also suggest that a VEGF/VEGFR2/fibronectin triple complex may be formed by VEGF or VEGFR2 first binding to fibronectin and subsequently recruiting the third binding partner. The formation of such a complex may lead to the activation of distinct angiogenic signaling pathways, offering new possibilities for clinical applications that target angiogenesis.	[Usuelli, Mattia; Meyer, Timmy; Mezzenga, Raffaele; Mitsi, Maria] Swiss Fed Inst Technol, Lab Food & Soft Mat, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mezzenga, R; Mitsi, M (corresponding author), Swiss Fed Inst Technol, Lab Food & Soft Mat, Dept Hlth Sci & Technol, Zurich, Switzerland.	raffaele.mezzenga@hest.ethz.ch; maria.mitsi@alumni.ethz.ch	Mitsi, Maria/S-2519-2017	Mitsi, Maria/0000-0001-8983-1983; Usuelli, Mattia/0000-0003-1459-7250	SNF [200021_172767]	SNF	This study was funded by SNF grant (200021_172767) to R.M. in Switzerland.	Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Akerman S, 2013, INT J CANCER, V133, P2563, DOI 10.1002/ijc.28281; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Buczek-Thomas JA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205065; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Charafeddine RA, 2019, J BIOL CHEM, V294, P8779, DOI 10.1074/jbc.RA118.007004; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Childs S, 2002, DEVELOPMENT, V129, P973; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; Derricks KE, 2015, INTEGR BIOL-UK, V7, P1011, DOI 10.1039/c5ib00140d; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Finley SD, 2012, AAPS J, V14, P500, DOI 10.1208/s12248-012-9363-4; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Gopalakrishnan M, 2005, EUR BIOPHYS J BIOPHY, V34, P943, DOI 10.1007/s00249-005-0471-2; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Lagerholm BC, 1998, BIOPHYS J, V74, P1215, DOI 10.1016/S0006-3495(98)77836-1; Lupo G, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00519; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Maydeu-Olivares A., 2010, INT ENCY ED, V7, P190, DOI [10.1016/B978-0-08-044894-7.01333-6, DOI 10.1016/B978-0-08-044894-7.01333-6]; Mezzenga R, 2019, BIOMACROMOLECULES, V20, P55, DOI 10.1021/acs.biomac.8b01258; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Onell A, 2005, J MOL RECOGNIT, V18, P307, DOI 10.1002/jmr.745; Pahari S, 2019, BIOPHYS J, V116, p166A, DOI 10.1016/j.bpj.2018.11.924; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Peng YH, 2017, PROTEINS, V85, P282, DOI 10.1002/prot.25221; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sack KD, 2016, J CELL PHYSIOL, V231, P2026, DOI 10.1002/jcp.25312; Saint-Geniez M, 2009, INVEST OPHTH VIS SCI, V50, P311, DOI 10.1167/iovs.08-2461; SCHWARZBAUER JE, 1991, BIOESSAYS, V13, P527, DOI 10.1002/bies.950131006; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Small AR, 2008, J THEOR BIOL, V252, P593, DOI 10.1016/j.jtbi.2008.02.009; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Teleanu RI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010084; Wang L, 2016, BIOINFORMATICS, V32, P614, DOI 10.1093/bioinformatics/btv607; Watanabe H, 2019, ACS CHEM BIOL, V14, P2729, DOI 10.1021/acschembio.9b00652; Watanabe H, 2009, J BIOL CHEM, V284, P12373, DOI 10.1074/jbc.M809236200; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973	53	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100584	10.1016/j.jbc.2021.100584	http://dx.doi.org/10.1016/j.jbc.2021.100584			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771558	gold, Green Published			2022-12-26	WOS:000672866400556
J	McMillan, H; Lundy, FT; Dunne, OM; Al-Natour, B; Jeanneau, C; About, I; Curtis, TM; El Karim, I				McMillan, Hayley; Lundy, Fionnuala T.; Dunne, Orla M.; Al-Natour, Banan; Jeanneau, Charlotte; About, Imad; Curtis, Tim M.; El Karim, Ikhlas			Endogenous Mas-related G-protein-coupled receptor X1 activates and sensitizes TRPA1 in a human model of peripheral nerves	FASEB JOURNAL			English	Article						dental pulp; human; MrgprX1; nociception; peripheral neurons	GENE FAMILY; CHANNEL; CELLS; ANTAGONISTS; EXPRESSION; NEURONS; ITCH; PAIN; MRG	Mas-related G-protein-coupled receptor X1 (MrgprX1) is a human-specific Mrgpr and its expression is restricted to primary sensory neurons. However, its role in nociception and pain signaling pathways is largely unknown. This study aims to investigate a role for MrgprX1 in nociception via interaction with the pain receptor, Transient Receptor Potential Ankyrin 1 (TRPA1), using in-vitro and in-vivo human neuronal models. MrgprX1 protein expression in human trigeminal nociceptors was investigated by the immunolabeling of the dental pulp and cultured peripheral neuronal equivalent (PNE) cells. MrgprX1 receptor signaling was monitored by Fura-2-based Ca2+ imaging using PNEs and membrane potential responses were measured using FluoVolt (TM). Immunofluorescent staining revealed MrgprX1 expression in-vivo in dental afferents, which was more intense in inflamed compared to healthy dental pulps. Endogenous MrgprX1 protein expression was confirmed in the in-vitro human PNE model. MrgprX1 receptor signaling and the mechanisms through which it couples to TRPA1 were studied by Ca2+ imaging. Results showed that MrgprX1 activates TRPA1 and induces membrane depolarization in a TRPA1 dependent manner. In addition, MrgprX1 sensitizes TRPA1 to agonist stimulation via Protein Kinase C (PKC). The activation and sensitization of TRPA1 by MrgprX1 in a model of human nerves suggests an important role for this receptor in the modulation of nociception.	[McMillan, Hayley; Lundy, Fionnuala T.; Dunne, Orla M.; Al-Natour, Banan; Curtis, Tim M.; El Karim, Ikhlas] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Al-Natour, Banan] Jordan Univ Sci & Technol, Fac Dent, Dept Oral Med & Oral Surg, Irbid, Jordan; [Jeanneau, Charlotte; About, Imad] Aix Marseille Univ, Inst Movement Sci, ISM, CNRS, Marseille, France	Queens University Belfast; Jordan University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	El Karim, I (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	i.elkarim@qub.ac.uk	Curtis, Tim/AEU-9750-2022	Curtis, Tim/0000-0003-1543-2781; El karim, Ikhlas/0000-0002-5314-7378; Lundy, Fionnuala/0000-0003-3150-1150	Animal Free Research UK	Animal Free Research UK	This study was funded by Animal Free Research UK.	Albarran L, 2013, BBA-MOL CELL RES, V1833, P3025, DOI 10.1016/j.bbamcr.2013.08.014; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bayrakdarian M, 2011, BIOORG MED CHEM LETT, V21, P2102, DOI 10.1016/j.bmcl.2011.01.138; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Brackley AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01999-4; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Castro J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131712; [陈华鑫 Chen Huaxin], 2004, [长安大学学报. 自然科学版, Journal of Chang'An University Natural Science Edition], V24, P1; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Clarke R, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00995-2017; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; El Karim IA, 2016, J ENDODONT, V42, P589, DOI 10.1016/j.joen.2015.12.017; Fehrenbacher JC, 2009, PAIN, V144, P253, DOI 10.1016/j.pain.2009.03.027; Flegel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128951; Gervois P, 2015, STEM CELLS DEV, V24, P296, DOI 10.1089/scd.2014.0117; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Guan Y, 2010, P NATL ACAD SCI USA, V107, P15933, DOI 10.1073/pnas.1011221107; Guan Y, 2010, NEUROSCI LETT, V471, P43, DOI 10.1016/j.neulet.2010.01.006; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; He SQ, 2014, NEUROSCIENCE, V261, P43, DOI 10.1016/j.neuroscience.2013.12.041; He SQ, 2014, PAIN, V155, P534, DOI 10.1016/j.pain.2013.12.008; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; Kenakin T, 2006, EXPERT OPIN DRUG DIS, V1, P635, DOI 10.1517/17460441.1.7.635; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kunapuli P, 2006, ANAL BIOCHEM, V351, P50, DOI 10.1016/j.ab.2006.01.014; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li D, 2019, STEM CELL REV REP, V15, P67, DOI 10.1007/s12015-018-9854-5; Li Z, 2017, P NATL ACAD SCI USA, V114, pE1996, DOI 10.1073/pnas.1615255114; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; MATTHEWS B, 1994, ARCH ORAL BIOL, V39, pS87, DOI 10.1016/0003-9969(94)90193-7; Meents JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170097; Meixiong J, 2017, ANNU REV GENET, V51, P103, DOI 10.1146/annurev-genet-120116-024723; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Reddy VB, 2018, J INVEST DERMATOL, V138, P461, DOI 10.1016/j.jid.2017.05.042; Schmidt R, 2009, ADV EXP MED BIOL, V611, P111, DOI 10.1007/978-0-387-73657-0_49; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Solinski HJ, 2014, PHARMACOL REV, V66, P570, DOI 10.1124/pr.113.008425; Solinski HJ, 2012, J BIOL CHEM, V287, P40956, DOI 10.1074/jbc.M112.408617; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; SOWUNMI A, 1989, LANCET, V2, P213; Tecles O, 2005, ARCH ORAL BIOL, V50, P103, DOI 10.1016/j.archoralbio.2004.11.009; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yekkirala AS, 2013, LIFE SCI, V92, P438, DOI 10.1016/j.lfs.2012.06.021; Young FI, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1290561; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	57	2	2	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21492	10.1096/fj.202001667RR	http://dx.doi.org/10.1096/fj.202001667RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788969	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000645260100094
J	Kimani, E; Muhula, S; Kiptai, T; Orwa, J; Odero, T; Gachuno, O				Kimani, Evelyn; Muhula, Samuel; Kiptai, Titus; Orwa, James; Odero, Theresa; Gachuno, Onesmus			Factors influencing TB treatment interruption and treatment outcomes among patients in Kiambu County, 2016-2019	PLOS ONE			English	Article								Tuberculosis (TB) is the leading cause of mortality as a single infectious agent globally with increasing numbers of case notification in developing countries. This study seeks to investigate the clinical and socio-demographic factors of time to TB treatment interruption among Tuberculosis patients in Kiambu County, 2016-2019. We retrospectively analyzed data for all treatment outcomes patients obtained from TB tracing form linked with the Tuberculosis Information Basic Unit (TIBU) of patients in Kiambu County health facilities using time to treatment interruption as the main outcome. Categorical variables were presented using frequency and percentages. Kaplan-Meir curve was used to analyze probabilities of time to treatment interruptions between intensive and continuation phases. Log-rank test statistics was used to compare the equality of the curves. Cox proportion model was used to determine determinants of treatment interruption. A total of 292 participants were included in this study. Males were 68%, with majority (35%) of the participants were aged 24-35 years; 5.8% were aged 0-14 years and 5.1% aged above 55 years. The overall treatment success rate was 66.8% (cured, 34.6%; completed 32.2%), 60.3% were on intensive phase of treatment. Lack of knowledge and relocation were the major reasons of treatment interruptions. Patients on intensive phase were 1.58 times likely to interrupt treatment compared to those on continuation phase (aHR: 1.581; 95%CI: 1.232-2.031). There is need to develop TB interventions that target men and middle aged population in order to reduce treatment interruption and increase the treatment success rates in the County and Country.	[Kimani, Evelyn] TB Leprosy & Lung Dis Program Kiambu Cty, Dept Hlth, Kiambu, Kenya; [Muhula, Samuel; Kiptai, Titus] AMREF Hlth Africa Kenya, Nairobi, Kenya; [Orwa, James; Odero, Theresa; Gachuno, Onesmus] Univ Nairobi, Sch Med, Nairobi, Kenya	African Medical & Research Foundation (AMREF); University of Nairobi	Kimani, E (corresponding author), TB Leprosy & Lung Dis Program Kiambu Cty, Dept Hlth, Kiambu, Kenya.	drevelyne@gmail.com			Afya Bora Consortium	Afya Bora Consortium	We wish to acknowledge the support of Afya Bora Consortium for the scholarship they accorded me towards studying global health leadership. Also, we appreciate Dr Gachuno, Dr Theresa, Samuel Muhula, Titus Kiptai, and James Orwa for their guidance during the whole process of developing this manuscript. Finally, we are grateful for the Kiambu County, health department who allowed us to access the patients' files for data extraction.	A AOA, 2018, CLIN MED INVESTIG, V3, DOI [10.15761/cmi.1000152, DOI 10.15761/CMI.1000152]; County Government of Kiambu (CGoK), 2019, COUNT INT DEV PLAN; DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97; Kizito KW, 2011, T ROY SOC TROP MED H, V105, P52, DOI 10.1016/j.trstmh.2010.08.015; Kulkarni PY, 2013, ANN MED HEALTH SCI R, V3, P67, DOI 10.4103/2141-9248.109507; Marx FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045724; Mekonnen Habtamu Sewunet, 2018, BMC Res Notes, V11, P691, DOI 10.1186/s13104-018-3789-4; MOH, 2018, FIN NTLD ANN REP; MOH, 2017, GUID INT TUB LRPR LU; MOH, 2018, NAT STRAT PLAN TB LE; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; NLTP, 2014, KEN NAT STRAT PLAN T; NLTP, 2016, KEN TUB PREV SURV RE; Nuwaha F, 1997, E AFR MED J, V74, P690; Sarkar S., 2016, MYCOBACTERIAL DIS, V6, P2, DOI [10.4172/2161-1068.1000209, DOI 10.4172/2161-1068.1000209]; Sinha S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-168; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Vijay S., 2002, INDIAN J TUBERC; Waithaka S., 2019, INT J PROF PRACT; WHO, 2009, BRIEF HIST TUB CONTR; Woimo TT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4188-9; World Health Organization, 2019, GLOBAL TUBERCULOSIS, P297	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248820	10.1371/journal.pone.0248820	http://dx.doi.org/10.1371/journal.pone.0248820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822794	Green Published, gold			2022-12-26	WOS:000637879100036
J	Cimorelli, M; Nieuwland, R; Varga, Z; van der Pol, E				Cimorelli, Michael; Nieuwland, Rienk; Varga, Zoltan; van der Pol, Edwin			Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing	PLOS ONE			English	Article								The particle size distribution (PSD) of extracellular vesicles (EVs) and other submicron particles in biofluids is commonly measured by nanoparticle tracking analysis (NTA) and tunable resistive pulse sensing (TRPS). A new technique for measuring the PSD is microfluidic resistive pulse sensing (MRPS). Because specific guidelines for measuring EVs together with other particles in biofluids with MRPS are lacking, we developed an operating procedure to reproducibly measure the PSD. The PSDs of particles in human plasma, conditioned medium of PC3 prostate cancer cell line (PC3 CM), and human urine were measured with MRPS (nCS1, Spectradyne LLC) to investigate: (i) the optimal diluent that reduces the interfacial tension of the sample while keeping EVs intact, (ii) the lower limit of detection (LoD) of particle size, (iii) the reproducibility of the PSD, (iv) the optimal dilution for measuring the PSD, and (v) the agreement in measured concentration between microfluidic cartridges with overlapping detection ranges. We found that the optimal diluent is 0.1% bovine serum albumin (w/v) in Dulbecco's phosphate-buffered saline. Based on the shape of the PSD, which is expected to follow a power-law function within the full detection range, we obtained a lower LoD of 75 nm for plasma and PC3 CM and 65 nm for urine. Normalized PSDs are reproducible (R-2 > 0.950) at dilutions between 10-100x for plasma, 5-20x for PC3 CM, and 2-4x for urine. Furthermore, sample dilution does not impact the dilution-corrected concentration when the microfluidic cartridges are operated within their specified concentration ranges. PSDs from microfluidic cartridges with overlapping detection ranges agreed well (R-2 > 0.936) and when combined the overall PSD spanned 5 orders of magnitude of measured concentration. Based on these findings, we have developed operating guidelines to reproducibly measure the PSD of EVs together with other particles in biofluids with MRPS.	[Cimorelli, Michael] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA; [Cimorelli, Michael; Nieuwland, Rienk; van der Pol, Edwin] Univ Amsterdam, Locat AMC, Dept Clin Chem, Amsterdam, Netherlands; [Cimorelli, Michael; Nieuwland, Rienk; van der Pol, Edwin] Univ Amsterdam, Locat AMC, Vesicle Observat Ctr, Amsterdam, Netherlands; [van der Pol, Edwin] Univ Amsterdam, Locat AMC, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Varga, Zoltan] Res Ctr Nat Sci, Inst Mat & Environm Chem, Biol Nanochem Res Grp, Budapest, Hungary	Drexel University; University of Amsterdam; University of Amsterdam; University of Amsterdam; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Cimorelli, M (corresponding author), Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA.; Cimorelli, M (corresponding author), Univ Amsterdam, Locat AMC, Dept Clin Chem, Amsterdam, Netherlands.; Cimorelli, M (corresponding author), Univ Amsterdam, Locat AMC, Vesicle Observat Ctr, Amsterdam, Netherlands.	mjc428@drexel.edu	van der Pol, Edwin/H-2493-2013; Varga, Zoltan/C-5215-2008	van der Pol, Edwin/0000-0002-9497-8426; Cimorelli, Michael/0000-0003-0102-0006; Varga, Zoltan/0000-0002-5741-2669	National Science Foundation Graduate Research International Experience [1829436]; Fulbright Open Research Award - Netherlands-American Foundation; Janos Bolyai Research Fellowship; Netherlands Organisation for Scientific Research -Domain Applied and Engineering Sciences [VENI 15924]	National Science Foundation Graduate Research International Experience; Fulbright Open Research Award - Netherlands-American Foundation; Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); Netherlands Organisation for Scientific Research -Domain Applied and Engineering Sciences	This work was supported by the National Science Foundation Graduate Research International Experience (Award #1829436) (MC), the Fulbright Open Research Award sponsored through the Netherlands-American Foundation (MC), the Janos Bolyai Research Fellowship (ZV), and the Netherlands Organisation for Scientific Research -Domain Applied and Engineering Sciences, VENI 15924 (EvdP).	Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Coulter W. H., 1953, US Patent, Patent No. [US 2656508 A, 2656508]; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Coumans FAW, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25922; Crompot E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127209; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Rond L, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1643671; Fraikin JL, 2011, NAT NANOTECHNOL, V6, P308, DOI [10.1038/nnano.2011.24, 10.1038/NNANO.2011.24]; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Gyorgy B, 2014, BIOMATERIALS, V35, P7598, DOI 10.1016/j.biomaterials.2014.05.032; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Lichtenberg D, 2013, BIOPHYS J, V105, P289, DOI 10.1016/j.bpj.2013.06.007; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; O'Driscoll L, 2015, NEW ENGL J MED, V372, P2359, DOI 10.1056/NEJMcibr1503100; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rikkert LG, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00608; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; RUCKENSTEIN E, 1975, J PHYS CHEM-US, V79, P2622, DOI 10.1021/j100591a010; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Spectradyne LLC, 2017, SPECTRADYNE NCS1 OPE, V2, P1; Vaclavek T, 2019, J SEP SCI, V42, P445, DOI 10.1002/jssc.201800978; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Pol E, 2018, NANOMED-NANOTECHNOL, V14, P801, DOI 10.1016/j.nano.2017.12.012; van Eijndhoven MAJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89631; Varga Z, 2020, COLLOID SURFACE B, V192, DOI 10.1016/j.colsurfb.2020.111053; Vogel R, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31242; Welsh JA, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1713526; Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521; Yuana Y, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23262; Yuana Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21494; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	41	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249603	10.1371/journal.pone.0249603	http://dx.doi.org/10.1371/journal.pone.0249603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793681	Green Published, gold			2022-12-26	WOS:000636467000053
J	Kaps, L; Ahlbrand, CJ; Gadban, R; Nagel, M; Labenz, C; Klimpke, P; Holtz, S; Boedecker, S; Michel, M; Kremer, WM; Hilscher, M; Galle, PR; Kraus, D; Schattenberg, JM; Weinmann-Menke, J				Kaps, L.; Ahlbrand, C. J.; Gadban, R.; Nagel, M.; Labenz, C.; Klimpke, P.; Holtz, S.; Boedecker, S.; Michel, M.; Kremer, W. M.; Hilscher, M.; Galle, P. R.; Kraus, D.; Schattenberg, J. M.; Weinmann-Menke, J.			Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care	PLOS ONE			English	Article							MANAGEMENT	Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AKI were included. Majority of patients were male (65%) with alcoholic cirrhosis in 88% and infections as a trigger of ACLF in 96%. Liver function was severely compromised reflected by high median MELD and CLIF-C ACLF scores of 37 (IQR 32;40) and 56.5 (IQR 51;60), respectively. Patients were treated discontinuously with ADVOS over a median time of 12 days (IQR 8.25;17) and received 8 (IQR 4.25;9.75) treatment cycles on average. No treatment related adverse events were recorded, and safety laboratory parameters remained constant during the observation time. After 16 h cumulative dialysis therapy, ADVOS significantly reduced protein-bound bilirubin (14%), creatinine (11.8%) and blood urea nitrogen (BUN, 33%). Using a matched cohort with ACLF treated with hemodialysis, ADVOS achieved a stronger decrease in bilirubin (p = 0.01), while detoxification of water-soluble catabolites' including creatinine and BUN was comparable. The 28-days mortality in the ADVOS group was 56% (14/26) and was not inferior to predicted survival (predicted median 28-days mortality was 44%, IQR 30; 59). Conclusion Discontinuous ADVOS treatment was safe and effective in patients with ACLF outside intensive care and outperformed hemodialysis in reducing protein-bound metabolites.	[Kaps, L.; Ahlbrand, C. J.; Gadban, R.; Nagel, M.; Labenz, C.; Klimpke, P.; Holtz, S.; Boedecker, S.; Michel, M.; Kremer, W. M.; Hilscher, M.; Galle, P. R.; Kraus, D.; Schattenberg, J. M.; Weinmann-Menke, J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany; [Kaps, L.; Ahlbrand, C. J.; Nagel, M.; Labenz, C.; Michel, M.; Kremer, W. M.; Hilscher, M.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Cirrhosis Ctr Mainz CCM, Mainz, Germany; [Kaps, L.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Mainz, Germany; [Schattenberg, J. M.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMetabol Liver Res Program, Dept Med 1, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Weinmann-Menke, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany.	julia.weinmann-menke@unimedizin-mainz.de	Weinmann-Menke, Julia/ABC-3559-2021; Galle, Peter/ABE-2872-2021; Galle, Peter R/T-5292-2018; Schattenberg, Jörn M./C-1301-2013	Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992; Schattenberg, Jörn M./0000-0002-4224-4703; Ghadban, Ruba/0000-0003-4147-1020; Kaps, Leonard/0000-0002-4782-8003				Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Engelmann C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2156-0; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fuhrmann V, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00714-3; Henschel B., 2015, CRIT CARE, V19, pP383; Hernaez R, 2017, GUT, V66, P541, DOI 10.1136/gutjnl-2016-312670; Huber W, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0569-x; Kribben A, 2012, GASTROENTEROLOGY, V142, P782, DOI 10.1053/j.gastro.2011.12.056; Man NK., 1995, LONG TERM HEMODIALYS, P11; Martinez JJG, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0453-z; Moreau R, 2016, CLIN MOL HEPATOL, V22, P1, DOI 10.3350/cmh.2016.22.1.1; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Pawlotsky JM, 2020, J HEPATOL, V73, P1170, DOI 10.1016/j.jhep.2020.08.018; Score Calculators | EF Clif, EUR FDN STUD CHRON; Sponholz C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1159-3; Tsipotis E, 2015, ADV CHRONIC KIDNEY D, V22, P382, DOI 10.1053/j.ackd.2015.05.004; Wehler M, 2001, HEPATOLOGY, V34, P255, DOI 10.1053/jhep.2001.26522; Wong F, 2017, J HEPATOL, V66, P860, DOI 10.1016/j.jhep.2016.10.024	18	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249342	10.1371/journal.pone.0249342	http://dx.doi.org/10.1371/journal.pone.0249342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793644	Green Published, gold			2022-12-26	WOS:000636467000035
J	Kim, JD; Zhu, LP; Sun, Q; Fang, LH				Kim, Jun-dae; Zhu, Lingping; Sun, Quan; Fang, Longhou			Systemic metabolite profiling reveals sexual dimorphism of AIBP control of metabolism in mice	PLOS ONE			English	Article							APOLIPOPROTEIN A-1 BINDING; NAD(P)HX REPAIR SYSTEM; CHOLESTEROL EFFLUX; PROTEIN; ANGIOGENESIS; SEROTONIN; PATHWAYS; NAXE; HDL	Emerging studies indicate that APOA-I binding protein (AIBP) is a secreted protein and functions extracellularly to promote cellular cholesterol efflux, thereby disrupting lipid rafts on the plasma membrane. AIBP is also present in the mitochondria and acts as an epimerase, facilitating the repair of dysfunctional hydrated NAD(P)H, known as NAD(P)H(X). Importantly, AIBP deficiency contributes to lethal neurometabolic disorder, reminiscent of the Leigh syndrome in humans. Whereas cyclic NADPHX production is proposed to be the underlying cause, we hypothesize that an unbiased metabolic profiling may: 1) reveal new clues for the lethality, e.g., changes of mitochondrial metabolites., and 2) identify metabolites associated with new AIBP functions. To this end, we performed unbiased and profound metabolic studies of plasma obtained from adult AIBP knockout mice and control littermates of both genders. Our systemic metabolite profiling, encompassing 9 super pathways, identified a total of 640 compounds. Our studies demonstrate a surprising sexual dimorphism of metabolites affected by AIBP deletion, with more statistically significant changes in the AIBP knockout female vs male when compared with the corresponding controls. AIBP knockout trends to reduce cholesterol but increase the bile acid precursor 7-HOCA in female but not male. Complex lipids, phospholipids, sphingomyelin and plasmalogens were reduced, while monoacylglycerol, fatty acids and the lipid soluble vitamins E and carotene diol were elevated in AIBP knockout female but not male. NAD metabolites were not significantly different in AIBP knockout vs control mice but differed for male vs female mice. Metabolites associated with glycolysis and the Krebs cycle were unchanged by AIBP knockout. Importantly, polyamine spermidine, critical for many cellular functions including cerebral cortex synapses, was reduced in male but not female AIBP knockout. This is the first report of a systemic metabolite profile of plasma samples from AIBP knockout mice, and provides a metabolic basis for future studies of AIBP regulation of cellular metabolism and the pathophysiological presentation of AIBP deficiency in patients.	[Kim, Jun-dae; Zhu, Lingping; Sun, Quan; Fang, Longhou] Houston Methodist Res Inst, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA; [Zhu, Lingping; Sun, Quan] Cent South Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China; [Fang, Longhou] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Fang, Longhou] Weill Cornell Med Coll, New York, NY 10065 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Central South University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Fang, LH (corresponding author), Houston Methodist Res Inst, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA.; Fang, LH (corresponding author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.; Fang, LH (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	lhfang@houstonmethodist.org		Kim, Jun-dae/0000-0002-9747-6288; Fang, Longhou/0000-0003-1653-5221	NIH [HL132155]; AHA [18CDA34110132, 18TPA34250009]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	NIH HL132155 and AHA 18TPA34250009 to L.F and AHA 18CDA34110132 to JK	Becker-Kettern J, 2018, FEBS J, V285, P3376, DOI 10.1111/febs.14631; BEHRENS WA, 1982, AM J CLIN NUTR, V35, P691, DOI 10.1093/ajcn/35.4.691; Chen HN, 2018, J LIPID RES, V59, P1081, DOI 10.1194/jlr.C086512; Choi SH, 2021, ARTERIOSCL THROM VAS, V41, pE82, DOI 10.1161/ATVBAHA.120.315485; Choi SH, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101703; Choi SH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120519; Dubrovsky L, 2020, MBIO, V11, DOI 10.1128/mBio.02956-19; Fang LH, 2019, CURR OPIN LIPIDOL, V30, P218, DOI 10.1097/MOL.0000000000000596; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Goulinet S, 1997, ARTERIOSCL THROM VAS, V17, P786, DOI 10.1161/01.ATV.17.4.786; Gu QL, 2019, SCIENCE, V363, P1085, DOI 10.1126/science.aav1749; Incecik F, 2020, ACTA NEUROL BELG, V120, P733, DOI 10.1007/s13760-019-01242-z; Kremer LS, 2016, AM J HUM GENET, V99, P894, DOI 10.1016/j.ajhg.2016.07.018; Lee JS, 2020, CLIN GENET, V97, P586, DOI 10.1111/cge.13713; Low H, 2020, ARTERIOSCL THROM VAS, V40, P2346, DOI 10.1161/ATVBAHA.120.315037; Mao RF, 2017, CIRC RES, V120, P1727, DOI 10.1161/CIRCRESAHA.116.309754; Marbaix AY, 2014, BIOCHEM J, V460, P49, DOI 10.1042/BJ20131482; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Niehaus TD, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180223; Qiu XT, 2021, CURR ATHEROSCLER REP, V23, DOI 10.1007/s11883-020-00899-9; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Schneider DA, 2018, J LIPID RES, V59, P854, DOI 10.1194/jlr.M083618; Shajib MS, 2017, ACS CHEM NEUROSCI, V8, P920, DOI 10.1021/acschemneuro.6b00414; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; SIEMS W, 1982, EUR J BIOCHEM, V124, P567; Sorci-Thomas MG, 2017, CIRC RES, V120, P1690, DOI 10.1161/CIRCRESAHA.117.311023; Trinh J, 2020, J NEUROL, V267, P770, DOI 10.1007/s00415-019-09640-2; Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388; Westerterp M, 2018, ATHEROSCLEROSIS, V273, P117, DOI 10.1016/j.atherosclerosis.2018.04.018; Woller SA, 2018, CELL REP, V23, P2667, DOI 10.1016/j.celrep.2018.04.110; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhang M, 2018, CIRC J, V82, P1396, DOI 10.1253/circj.CJ-17-0877; Zhang M, 2018, ATHEROSCLEROSIS, V273, P122, DOI 10.1016/j.atherosclerosis.2018.03.010; Zhang M, 2016, ATHEROSCLEROSIS, V248, P149, DOI 10.1016/j.atherosclerosis.2016.03.008; Zhang T, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1910-7	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248964	10.1371/journal.pone.0248964	http://dx.doi.org/10.1371/journal.pone.0248964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793635	Green Published, gold			2022-12-26	WOS:000636467000019
J	Puhr, M; Eigentler, A; Handle, F; Hackl, H; Ploner, C; Heidegger, I; Schaefer, G; Brandt, MP; Hoefer, J; Van der Pluijm, G; Klocker, H				Puhr, Martin; Eigentler, Andrea; Handle, Florian; Hackl, Hubert; Ploner, Christian; Heidegger, Isabel; Schaefer, Georg; Brandt, Maximilian P.; Hoefer, Julia; Van der Pluijm, Gabri; Klocker, Helmut			Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer	ONCOGENE			English	Article								Despite increasing options for treatment of castration-resistant prostate cancer, development of drug resistance is inevitable. The glucocorticoid receptor (GR) is a prime suspect for acquired therapy resistance, as prostate cancer (PCa) cells are able to increase GR signaling during anti-androgen therapy and thereby circumvent androgen receptor (AR)-blockade and cell death. As standard AR-directed therapies fail to block the GR and GR inhibitors might result in intolerable side effects, the identification of GR signature genes, which are better suited for a targeted approach, is of clinical importance. Therefore, the specific epithelial and stromal GR signature was determined in cancer-associated fibroblasts as well as in abiraterone and enzalutamide-resistant cells after glucocorticoid (GC) treatment. Microarray and ChIP analysis identified MAO-A as a directly up-regulated mutual epithelial and stromal GR target, which is induced after GC treatment and during PCa progression. Elevated MAO-A levels were confirmed in in vitro cell models, in primary tissue cultures after GC treatment, and in patients after neoadjuvant chemotherapy with GCs. MAO-A expression correlates with GR/AR activity as well as with a reduced progression-free survival. Pharmacological MAO-A inhibition combined with 2(nd) generation AR signaling inhibitors or chemotherapeutics results in impaired growth of androgen-dependent, androgen-independent, and long-term anti-androgen-treated cells. In summary, these findings demonstrate that targeting MAO-A represents an innovative therapeutic strategy to synergistically block GR and AR dependent PCa cell growth and thereby overcome therapy resistance.	[Puhr, Martin; Eigentler, Andrea; Handle, Florian; Heidegger, Isabel; Hoefer, Julia; Klocker, Helmut] Med Univ Innsbruck, Dept Urol, Innsbruck, Austria; [Hackl, Hubert] Med Univ Innsbruck, Bioctr, Inst Bioinformat, Innsbruck, Austria; [Ploner, Christian] Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg Innsbruck, Innsbruck, Austria; [Schaefer, Georg] Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria; [Brandt, Maximilian P.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Urol, Mainz, Germany; [Van der Pluijm, Gabri] Leiden Univ, Med Ctr, Dept Urol, Leiden, Netherlands	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Puhr, M (corresponding author), Med Univ Innsbruck, Dept Urol, Innsbruck, Austria.	martin.puhr@i-med.ac.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; van der Pluijm, Gabri/0000-0002-1351-1884; Handle, Florian/0000-0002-7558-5635; Ploner, Christian/0000-0002-0313-2960	Anniversary Fund of the Oesterreichische Nationalbank (OeNB) [18280]	Anniversary Fund of the Oesterreichische Nationalbank (OeNB)	This study was supported by the Anniversary Fund of the Oesterreichische Nationalbank (OeNB), grant number 18280 to MP.	[Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Courcot E, 2012, DRUG METAB DISPOS, V40, P1953, DOI 10.1124/dmd.112.046896; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Finberg JPM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00340; Fizazi K, 2019, NEW ENGL J MED, V380, P1235, DOI 10.1056/NEJMoa1815671; Gaur S, 2019, PROSTATE, V79, P667, DOI 10.1002/pros.23774; Geney R, 2002, CLIN CHEM LAB MED, V40, P918, DOI 10.1515/CCLM.2002.161; Gordon RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104271; Grupp K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-145; Handle F, 2018, MOL CANCER THER, V17, P2722, DOI 10.1158/1535-7163.MCT-18-0508; Heidenreich A, 2014, EUR J CANCER, V50, P1090, DOI 10.1016/j.ejca.2014.01.006; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hunter P, 2010, EMBO REP, V11, P667, DOI 10.1038/embor.2010.122; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Kalsbeek AMF, 2016, AGING-US, V8, P2702, DOI 10.18632/aging.101044; Kluetz PG, 2013, CLIN CANCER RES, V19, P6650, DOI 10.1158/1078-0432.CCR-13-2134; Kroon J, 2016, ENDOCR-RELAT CANCER, V23, P35, DOI 10.1530/ERC-15-0343; Lempiainen JK, 2017, MOL CELL PROTEOMICS, V16, P1462, DOI 10.1074/mcp.M117.067488; Leon-Mateos L, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072066; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liao CP, 2018, ONCOGENE, V37, P5175, DOI 10.1038/s41388-018-0325-x; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Ndibe C, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-014-0320-6; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Puhr M, 2018, CLIN CANCER RES, V24, P927, DOI 10.1158/1078-0432.CCR-17-0989; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Schopf B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15237-5; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Small EJ, 2015, CLIN CANCER RES, V21, P3862, DOI 10.1158/1078-0432.CCR-15-0079; Smith MR, 2018, NEW ENGL J MED, V378, P1408, DOI 10.1056/NEJMoa1715546; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vanaja DK, 2003, CANCER RES, V63, P3877; Wang KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15396-5; Welsh JB, 2001, CANCER RES, V61, P5974; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Yin LJ, 2018, STEM CELLS, V36, P1249, DOI 10.1002/stem.2831	42	7	7	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3087	3100		10.1038/s41388-021-01754-0	http://dx.doi.org/10.1038/s41388-021-01754-0		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33795839	Green Published, hybrid			2022-12-26	WOS:000635873300001
J	Rong, H; Wang, LP; Gao, LY; Fang, YL; Chen, Q; Hu, JL; Ye, M; Liao, Q; Zhang, LN; Dong, CZ				Rong, Hao; Wang, Liping; Gao, Liuying; Fang, Yulu; Chen, Qin; Hu, Jianli; Ye, Meng; Liao, Qi; Zhang, Lina; Dong, Changzheng			Bioinformatics-based prediction of conformational epitopes for human parechovirus	PLOS ONE			English	Article							NEUTRALIZATION; REVEALS; PICORNAVIRUS; MODEL	Human parechoviruses (HPeVs) are human pathogens that usually cause diseases ranging from rash to neonatal sepsis in young children. HPeV1 and HPeV3 are the most frequently reported genotypes and their three-dimensional structures have been determined. However, there is a lack of systematic research on the antigenic epitopes of HPeVs, which are useful for understanding virus-receptor interactions, developing antiviral agents or molecular diagnostic tools, and monitoring antigenic evolution. Thus, we systematically predicted and compared the conformational epitopes of HPeV1 and HPeV3 using bioinformatics methods in the study. The results showed that both epitopes clustered into three sites (sites 1, 2 and 3). Site 1 was located on the "northern rim" near the fivefold vertex; site 2 was on the "puff"; and site 3 was divided into two parts, of which one was located on the "knob" and the other was close to the threefold vertex. The predicted epitopes highly overlapped with the reported antigenic epitopes, which indicated that the prediction results were accurate. Although the distribution positions of the epitopes of HPeV1 and HPeV3 were highly consistent, the residues varied largely and determined the genotypes. Three amino acid residues, VP3-91N, -92H and VP0-257S, were the key residues for monoclonal antibody (mAb) AM28 binding to HPeV1 and were also of great significance in distinguishing HPeV1 and HPeV3. We also found that two residues, VP1-85N and -87D, might affect the capability of mAb AT12-015 to bind to HPeV3.	[Rong, Hao; Wang, Liping; Gao, Liuying; Fang, Yulu; Hu, Jianli; Ye, Meng; Liao, Qi; Zhang, Lina; Dong, Changzheng] Ningbo Univ, Affiliated Hosp, Med Sch, Ningbo, Peoples R China; [Rong, Hao; Wang, Liping; Fang, Yulu; Ye, Meng; Liao, Qi; Zhang, Lina; Dong, Changzheng] Ningbo Univ, Dept Prevent Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Sch Med, Ningbo, Peoples R China; [Gao, Liuying] Ningbo Univ, Affiliated Peoples Hosp, Ningbo, Peoples R China; [Chen, Qin] Univ Chinese Acad Sci, HuaMei Hosp, Ningbo, Peoples R China	Ningbo University; Ningbo University; Ningbo University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, CZ (corresponding author), Ningbo Univ, Affiliated Hosp, Med Sch, Ningbo, Peoples R China.; Dong, CZ (corresponding author), Ningbo Univ, Dept Prevent Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Sch Med, Ningbo, Peoples R China.	dongchangzheng@nbu.edu.cn			Zhejiang Fundamental, Public-interest Research Project [LGF18C060001]; Ningbo Natural Science Foundation [2018A610240]; Medical and Health Program of Zhejiang Province [2019KY589]; K.C. Wong Magna Fund in Ningbo University	Zhejiang Fundamental, Public-interest Research Project; Ningbo Natural Science Foundation; Medical and Health Program of Zhejiang Province; K.C. Wong Magna Fund in Ningbo University	This work was supported by the Zhejiang Fundamental, Public-interest Research Project (LGF18C060001), the Ningbo Natural Science Foundation (2018A610240), Medical and Health Program of Zhejiang Province (2019KY589) and the K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2016, J INFECTION, V72, P223, DOI 10.1016/j.jinf.2015.10.010; Anderson CS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2042-4; [Anonymous], 2015, AUST J EMERG MANAG, V30, P9; [Anonymous], NUCLEOTIDE DATABASE; Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122; Brouwer L, 2019, ARCH VIROL, V164, P799, DOI 10.1007/s00705-018-04131-7; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Domanska A, 2019, J VIROL, V93, DOI 10.1128/JVI.01597-18; Du XJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1710; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Kalynych S, 2016, J VIROL, V90, P1377, DOI 10.1128/JVI.02346-15; Karelehto E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12458-5; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee H, 2013, J VIROL, V87, P11363, DOI 10.1128/JVI.01926-13; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Lu CY, 2020, BIOINFORMATICS, V36, P3251, DOI 10.1093/bioinformatics/btaa083; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Malasao R, 2019, ARCH VIROL, V164, P1743, DOI 10.1007/s00705-019-04249-2; MURDIN AD, 1989, J VIROL, V63, P5251, DOI 10.1128/JVI.63.12.5251-5257.1989; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rong Hao, 2019, Chinese Journal of Virology, V35, P762; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Schuffenecker I, 2012, J CLIN VIROL, V54, P337, DOI 10.1016/j.jcv.2012.04.016; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; Selvarangan R, 2011, PEDIATR INFECT DIS J, V30, P238, DOI 10.1097/INF.0b013e3181fbefc8; Shakeel S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11387; Shakeel S, 2015, J VIROL, V89, P9571, DOI 10.1128/JVI.01429-15; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240; Wildenbeest JG, 2010, EXPERT REV ANTI-INFE, V8, P1417, DOI [10.1586/eri.10.130, 10.1586/ERI.10.130]; Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013	36	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0247423	10.1371/journal.pone.0247423	http://dx.doi.org/10.1371/journal.pone.0247423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793559	Green Published, gold			2022-12-26	WOS:000636467000061
J	Borelli, E; Bigi, S; Potenza, L; Artioli, F; Eliardo, S; Mucciarini, C; Cagossi, K; Razzini, G; Pasqualini, A; Lui, FS; Ferlazzo, F; Cruciani, M; Bruera, E; Efficace, F; Luppi, M; Cacciari, C; Porro, CA; Bandieri, E				Borelli, Eleonora; Bigi, Sarah; Potenza, Leonardo; Artioli, Fabrizio; Eliardo, Sonia; Mucciarini, Claudia; Cagossi, Katia; Razzini, Giorgia; Pasqualini, Antonella; Lui, Fausta; Ferlazzo, Fabio; Cruciani, Massimiliano; Bruera, Eduardo; Efficace, Fabio; Luppi, Mario; Cacciari, Cristina; Porro, Carlo Adolfo; Bandieri, Elena			Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals	PLOS ONE			English	Article							EARLY PALLIATIVE CARE; QUALITY-OF-LIFE; PSYCHOLOGICAL PAIN; AMERICAN SOCIETY; LUNG; INTEGRATION; VALIDATION; ONCOLOGY; GOALS; QUESTIONNAIRE	Early palliative/supportive care (ePSC) is a medical intervention focused on patient's needs, that integrates standard oncological treatment, shortly after a diagnosis of advanced/metastatic cancer. ePSC improves the appropriate management of cancer pain. Understanding the semantic and emotional impact of the words used by patients to describe their pain may further improve its assessment in the ePSC setting. Psycholinguistics assumes that the semantic and affective properties of words affect the ease by which they are processed and comprehended. Therefore, in this cross-sectional survey study we collected normative data about the semantic and affective properties of words associated to physical and social pain, in order to investigate how patients with cancer pain on ePSC process them compared to healthy, pain-free individuals. One hundred ninety patients and 124 matched controls rated the Familiarity, Valence, Arousal, Pain-relatedness, Intensity, and Unpleasantness of 94 words expressing physical and social pain. Descriptive and inferential statistics were performed on ratings in order to unveil patients' semantic and affective representation of pain and compare it with those from controls. Possible effects of variables associated to the illness experience were also tested. Both groups perceived the words conveying social pain as more negative and pain-related than those expressing physical pain, confirming previous evidence of social pain described as worse than physical pain. Patients rated pain words as less negative, less pain-related, and conveying a lower intense and unpleasant pain than controls, suggesting either an adaptation to the pain experience or the role played by ePSC in improving patients' ability to cope with it. This exploratory study suggests that a chronic pain experience as the one experienced by cancer patients on ePSC affects the semantic and affective representation of pain words.	[Borelli, Eleonora; Lui, Fausta; Cacciari, Cristina; Porro, Carlo Adolfo] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Borelli, Eleonora; Lui, Fausta; Cacciari, Cristina; Porro, Carlo Adolfo] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy; [Bigi, Sarah] Univ Cattolica Sacro Cuore, Dept Linguist Sci & Foreign Literatures, Milan, Italy; [Potenza, Leonardo; Luppi, Mario] Azienda Osped Univ Modena, Hematol Unit & Chair, Modena, Italy; [Potenza, Leonardo; Luppi, Mario] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy; [Artioli, Fabrizio; Eliardo, Sonia; Mucciarini, Claudia; Cagossi, Katia; Razzini, Giorgia; Pasqualini, Antonella; Cruciani, Massimiliano; Bandieri, Elena] USL, Civil Hosp Carpi, Oncol & Palliat Care Units, Carpi, Italy; [Ferlazzo, Fabio] Sapienza Univ, Dept Psychol, Rome, Italy; [Bruera, Eduardo] UT MD Anderson Canc Ctr, Palliat Care & Rehabil Med, Houston, TX USA; [Efficace, Fabio] Italian Grp Adult Hematol Dis GIMEMA, Hlth Outcomes Res Unit, Rome, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Catholic University of the Sacred Heart; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Sapienza University Rome; University of Texas System; UTMD Anderson Cancer Center; Fondazione GIMEMA	Borelli, E (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.; Borelli, E (corresponding author), Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy.	eleonora.borelli@unimore.it	Lui, Fausta/P-3816-2015; Claudia, Mucciarini/AAY-8955-2021; Bruera, Eduardo/AAA-1550-2022; Borelli, Eleonora/AAU-9973-2021	Lui, Fausta/0000-0001-6577-059X; Claudia, Mucciarini/0000-0001-5439-6352; Efficace, Fabio/0000-0002-5065-5166; Borelli, Eleonora/0000-0002-3391-4437	FAR2016 grant from the University of Modena and Reggio Emilia	FAR2016 grant from the University of Modena and Reggio Emilia	This research was supported by the FAR2016 grant from the University of Modena and Reggio Emilia (https://www.unimore.it/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Back AL, 2014, J PALLIAT MED, V17, P1244, DOI 10.1089/jpm.2014.0146; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Bandieri E, 2012, ANN ONCOL, V23, P2016, DOI 10.1093/annonc/mds103; Bandieri E, 2020, BMJ SUPPORT PALLIAT, V10, DOI 10.1136/bmjspcare-2019-001794; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Borelli E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199658; Bruera E, 1991, J Palliat Care, V7, P6; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Chen ZS, 2008, PSYCHOL SCI, V19, P789, DOI 10.1111/j.1467-9280.2008.02158.x; Citron FMM, 2016, BEHAV RES METHODS, V48, P91, DOI 10.3758/s13428-015-0581-4; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Conejero I, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0893-z; Courtet P, 2019, ENCEPHALE, V45, pS7, DOI 10.1016/j.encep.2018.09.005; Cristofori I, 2013, CEREB CORTEX, V23, P2437, DOI 10.1093/cercor/bhs236; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Efficace F, 2006, ANN ONCOL, V17, P1698, DOI 10.1093/annonc/mdl183; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; El-Jawahri A, 2016, JAMA-J AM MED ASSOC, V316, P2094, DOI 10.1001/jama.2016.16786; Ferrell BR, 2017, J CLIN ONCOL, V35, P96, DOI 10.1200/JCO.2016.70.1474; Frumkin MR, 2021, J CLIN PSYCHOL, V77, P254, DOI 10.1002/jclp.23024; Galli G, 2019, J PAIN RES, V12, P1721, DOI 10.2147/JPR.S191548; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Hack TF, 2005, PSYCHO-ONCOLOGY, V14, P831, DOI 10.1002/pon.949; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Holland JC, 1998, PSYCHO-ONCOL, V7, P460, DOI 10.1002/(SICI)1099-1611(199811/12)7:6<460::AID-PON328>3.0.CO;2-R; Hui D, 2015, ANN ONCOL, V26, P1953, DOI 10.1093/annonc/mdv269; Jacobs AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00714; Jollant F, 2019, PROG NEURO-PSYCHOPH, V90, P55, DOI 10.1016/j.pnpbp.2018.10.018; Karayannis NV, 2019, ANN BEHAV MED, V53, P65, DOI 10.1093/abm/kay017; Karos K, 2018, J PAIN, V19, P787, DOI 10.1016/j.jpain.2018.02.011; Kelley AS, 2015, NEW ENGL J MED, V373, P747, DOI 10.1056/NEJMra1404684; KULIK JA, 1989, HEALTH PSYCHOL, V8, P221, DOI 10.1037/0278-6133.8.2.221; Levine EG., 2012, SPIRITUALITY BELIEF, P61; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Main CJ, 2016, PAIN, V157, P1387, DOI 10.1097/j.pain.0000000000000457; Maltoni M, 2016, EUR J CANCER, V65, P61, DOI 10.1016/j.ejca.2016.06.007; Manning-Walsh J, 2005, J HOLIST NURS, V23, P120, DOI 10.1177/0898010104272019; Masel EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158830; Masten CL, 2012, SOC COGN AFFECT NEUR, V7, P106, DOI 10.1093/scan/nsq098; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; Mee S, 2006, J PSYCHIATR RES, V40, P680, DOI 10.1016/j.jpsychires.2006.03.003; Mehta Anita., 2008, J HOSP PALLIAT NURS, V10, P26, DOI [10.1097/01.NJH.0000306714.50539.1a, DOI 10.1097/01.NJH.0000306714.50539.1A]; MELZACK R, 1968, P423; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Melzack R., 1983, OAIM MEAS; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; Moro C, 2006, SUPPORT CARE CANCER, V14, P30, DOI 10.1007/s00520-005-0834-3; Paice Judith A, 2004, J Natl Cancer Inst Monogr, P98; Panksepp J., 1998, SCI MATH; Papini MR, 2015, NEUROSCI BIOBEHAV R, V48, P53, DOI 10.1016/j.neubiorev.2014.11.012; Ponnampalam A., 2016, BMJ SUPPORT PALLIAT, V6, pA87; Ripamonti C, 2010, TUMORI, V96, P1016; Ripamonti CI, 2012, TUMORI, V98, P385, DOI 10.1700/1125.12409; Riva P, 2011, EUR J SOC PSYCHOL, V41, P681, DOI 10.1002/ejsp.837; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saunders C., 1964, NURS MIRROR, P7; Semino E., 2018, METAPHOR CANC END LI, DOI [10.4324/9781315629834, DOI 10.4324/9781315629834]; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Sontag S., 1979, ILLNESS METAPHOR; Tamburini M, 2000, ANN ONCOL, V11, P31, DOI 10.1023/A:1008396930832; Temel JS, 2017, J CLIN ONCOL, V35, P834, DOI 10.1200/JCO.2016.70.5046; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Thornhill R., 1989, SOCIOBIOLOGY SOCIAL; Vanbutsele G, 2018, LANCET ONCOL, V19, P394, DOI 10.1016/S1470-2045(18)30060-3; Wierzbicka A, 2012, EMOT REV, V4, P307, DOI 10.1177/1754073912439761; World Health Organization National Cancer Control Programmes, 2011, POLICIES MANAGERIAL; Yao ML, 2020, J PAIN, V21, P677, DOI 10.1016/j.jpain.2019.10.007; Yoong J, 2013, JAMA INTERN MED, V173, P283, DOI 10.1001/jamainternmed.2013.1874; Zhang M., 2019, BRAIN SCI ADV, V5, P265, DOI [DOI 10.26599/BSA.2019.9050023, 10.26599/BSA.2019.9050023]; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	77	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248755	10.1371/journal.pone.0248755	http://dx.doi.org/10.1371/journal.pone.0248755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788893	Green Published, gold			2022-12-26	WOS:000636354600009
J	Wang, WT; Ahmad, Z; Kharazmi, O; Ampadu, CB; Hafez, EH; El-Din, MMM				Wang, Wanting; Ahmad, Zubair; Kharazmi, Omid; Ampadu, Clement Boateng; Hafez, E. H.; Mohie El-Din, Marwa M.			New generalized-X family: Modeling the reliability engineering applications	PLOS ONE			English	Article								As is already known, statistical models are very important for modeling data in applied fields, particularly in engineering, medicine, and many other disciplines. In this paper, we propose a new family to introduce new distributions suitable for modeling reliability engineering data. We called our proposed family a new generalized-X family of distributions. For the practical illustration, we introduced a new special sub-model, called the new generalized-Weibull distribution, to describe the new family's significance. For the proposed family, we introduced some mathematical reliability properties. The maximum likelihood estimators for the parameters of the new generalized-X distributions are derived. For assessing the performance of these estimators, a comprehensive Monte Carlo simulation study is carried out. To assess the efficiency of the proposed model, the new generalized-Weibull model is applied to the coating machine failure time data. Finally, Bayesian analysis and performance of Gibbs sampling for the coating machine failure time data are also carried out. Furthermore, the measures such as Gelman-Rubin, Geweke and Raftery-Lewis are used to track algorithm convergence.	[Wang, Wanting] Capital Univ Econ & Business, Coll Finance, Beijing, Peoples R China; [Ahmad, Zubair] Yazd Univ, Dept Stat, Yazd, Iran; [Kharazmi, Omid] Vali e Asr Univ Rafsanjan, Dept Stat, Fac Sci, Rafsanjan, Iran; [Ampadu, Clement Boateng] 31 Carrolton Rd, Boston, MA USA; [Hafez, E. H.] Helwan Univ, Dept Math, Fac Sci, Cairo, Egypt; [Mohie El-Din, Marwa M.] Egyptian Russian Univ, Dept Math & Nat Sci, Fac Engn, Badr, Egypt	Capital University of Economics & Business; University of Yazd; Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Russian University	Ahmad, Z (corresponding author), Yazd Univ, Dept Stat, Yazd, Iran.	z.ferry21@gmail.com	hossam, eslam/AAF-4673-2019; Kharazmi, Omid/AAE-9058-2022	hossam, eslam/0000-0002-2527-5938; Kharazmi, Omid/0000-0003-4176-9708				Ahmad Z., 2019, J DATA SCI, V17, P726, DOI [10.6339/JDS.201910_17(4).0006, DOI 10.6339/JDS.201910_17(4).0006]; Ahmad Z, 2020, J TAIBAH UNIV SCI, V14, P359, DOI 10.1080/16583655.2020.1741942; Ahmad Z, 2019, PAK J STAT OPER RES, V15, P87, DOI 10.18187/pjsor.v15i1.2803; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Congdon P., 2001, BAYESIAN STAT MODELL; Cordeiro GM, 2010, J FRANKLIN I, V347, P1399, DOI 10.1016/j.jfranklin.2010.06.010; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gradshteyn I. S., 2007, TABLES INTEGRALS SER; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Kharazmi O., 2019, ODD HYPERBOLIC COSIN, V6, P765, DOI [10.1007/s40745-019-00200-z, DOI 10.1007/S40745-019-00200-Z]; Lee C, 2007, J MOD APPL STAT METH, V6, P173, DOI 10.22237/jmasm/1177992960; Lee CE, 2014, STOCH ENV RES RISK A, V28, P639, DOI 10.1007/s00477-013-0779-x; Lee E.T., 2003, STAT METHODS SURVIVA, P476; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nasiru S., 2017, J STAT ECONOMETRIC M, V6, P1; Stute W., 1993, METRIKA, V40, P243, DOI [DOI 10.1007/BF02613687, 10.1007/BF02613687]; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; Y AL-Jammal Z., 2008, IRAQI J STAT SCI, V8, P63, DOI [10.33899/iqjoss.2008.31434, DOI 10.33899/IQJOSS.2008.31434]; Yousof H. M., 2017, J DATA SCI, V15, P723, DOI [10.6339/JDS.201710_15(4).00008, DOI 10.6339/JDS.201710_15(4).00008]; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V100, P37, DOI 10.1016/j.aap.2016.12.023; Zhao W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237462	22	7	7	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248312	10.1371/journal.pone.0248312	http://dx.doi.org/10.1371/journal.pone.0248312			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788850	gold, Green Published			2022-12-26	WOS:000636354600011
J	Timmerman, LM; de Graaf, JF; Satravelas, N; Kesmir, C; Meyaard, L; van der Vlist, M				Timmerman, Laura M.; de Graaf, J. Frederique; Satravelas, Nikolaos; Kesmir, Can; Meyaard, Linde; van der Vlist, Michiel			Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory function	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; OX2 GLYCOPROTEIN; OVER-EXPRESSION; PTB DOMAIN; CELL; NPXY; INTERNALIZATION; FAMILY; MECHANISMS; SURVIVAL	The inhibitory signaling of CD200 receptor 1 (CD200R) has been attributed to its NPxY signaling motif. However, NPxY-motifs are present in multiple protein families and are mostly known to mediate protein trafficking between subcellular locations rather than signaling. Therefore, we investigated whether additional motifs specify the inhibitory function of CD200R. We performed phylogenetic analysis of the intracellular domain of CD200R in mammals, birds, bony fish, amphibians and reptiles. Indeed, the tyrosine of the NPxY-motif is fully conserved across species, in line with its central role in CD200R signaling. In contrast, P295 of the NPxY-motif is not conserved. Instead, a conserved stretch of negatively charged amino acids, EEDE279, and two conserved residues P285 and K292 in the flanking region prior to the NPxY-motif are required for CD200R mediated inhibition of p-Erk, p-Akt308, p-Akt473, p-rpS6 and LPS-induced IL-8 secretion. Altogether, we show that instead of the more common NPxY-motif, CD200R signaling can be assigned to a unique signaling motif in mammals defined by: EEDExxPYxxYxxKxNxxY.	[Timmerman, Laura M.; de Graaf, J. Frederique; Meyaard, Linde; van der Vlist, Michiel] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Dept Immunol, Utrecht, Netherlands; [Timmerman, Laura M.; Meyaard, Linde; van der Vlist, Michiel] Oncode Inst, Utrecht, Netherlands; [Satravelas, Nikolaos; Kesmir, Can] Univ Utrecht, Sci Fac, Theoret Biol & Bioinformat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	van der Vlist, M (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Dept Immunol, Utrecht, Netherlands.; van der Vlist, M (corresponding author), Oncode Inst, Utrecht, Netherlands.	mvlist2@umcutrecht.nl		Timmerman, Laura/0000-0002-2848-1681; van der Vlist, Michiel/0000-0003-0931-8982	Oncode Institute; Netherlands Organization for Scientific Research (NWO; ALW Grant ) [821.02.025, 863.14.016]; Netherlands Organization for Scientific Research (NWO) [NWO Vici 918.15.608]	Oncode Institute; Netherlands Organization for Scientific Research (NWO; ALW Grant )(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	JFG, NS and CK received no specific funding for this work. LM, LMT and MV received funding from Oncode Institute (https://www.oncode.nl/).LM received funding from the Netherlands Organization for Scientific Research (NWO; https://www.nwo.nl/; ALW Grant 821.02.025 and NWO Vici 918.15.608). MV received funding from the Netherlands Organization for Scientific Research (NWO; https://www.nwo.nl/; ALW Grant 863.14.016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aref S, 2018, HEMATOLOGY, V23, P263, DOI 10.1080/10245332.2017.1404276; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Barnes M, 2003, BIOINFORMATICS GENET; Bioinformatics G, TREEDYN; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Casulli J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10156-6; Chen JX, 2017, LEUKEMIA RES, V56, P1, DOI 10.1016/j.leukres.2017.01.021; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; El Din Fouad Neveen Bahaa, 2018, Asian Pac J Cancer Prev, V19, P3383; EMBL-EBI, MUSCLE; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Hatherley D, 2013, STRUCTURE, V21, P820, DOI 10.1016/j.str.2013.03.008; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; Hughan SC, 2007, J THROMB HAEMOST, V5, P387, DOI 10.1111/j.1538-7836.2007.02307.x; Hughan SC, 2014, J BIOL CHEM, V289, P5051, DOI 10.1074/jbc.M113.520148; JCVI, 2021, PROVEAN PROTEIN; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Kojima T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36457; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Kvedaraite E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018587118; Li L, 2016, MED SCI MONITOR, V22, P1079, DOI 10.12659/MSM.895245; Linhares AD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01909; Liu C, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0205-8; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; NCBI, 2020, PROT BLAST; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rijkers ESK, 2008, MOL IMMUNOL, V45, P1126, DOI 10.1016/j.molimm.2007.07.013; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Rumpret M, 2020, NAT REV IMMUNOL, V20, P771, DOI 10.1038/s41577-020-0352-z; Rygiel TP, 2012, ONCOGENE, V31, P2979, DOI 10.1038/onc.2011.477; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stephens TSaM, 2020, WEBLOGO; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; van der Vlist M., 2020, BIORXIV, DOI [10.1101/2020.02.06.933739, DOI 10.1101/2020.02.06.933739]; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Verbrugge A., 2005, CURR IMMUNOL REV, V1, P201, DOI DOI 10.2174/1573395054065160; Viertlboeck BC, 2013, DEV COMP IMMUNOL, V41, P403, DOI 10.1016/j.dci.2013.04.017; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Zhang SL, 2006, J LEUKOCYTE BIOL, V79, P363, DOI 10.1189/jlb.0705398; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	53	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0244770	10.1371/journal.pone.0244770	http://dx.doi.org/10.1371/journal.pone.0244770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780466	Green Submitted, Green Published, gold			2022-12-26	WOS:000636336800028
J	Drevinge, C; Scheffler, JM; Koro-Arvidsson, C; Sundh, D; Carlsten, H; Gjertsson, I; Lindholm, C; Lorentzon, M; Rudin, A; Ekwall, AKH; Islander, U				Drevinge, Christina; Scheffler, Julia M.; Koro-Arvidsson, Catalin; Sundh, Daniel; Carlsten, Hans; Gjertsson, Inger; Lindholm, Catharina; Lorentzon, Mattias; Rudin, Anna; Ekwall, Anna-Karin Hultgard; Islander, Ulrika			Intermediate monocytes correlate with CXCR3(+) Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis	PLOS ONE			English	Article								Background Rheumatoid arthritis (RA) is associated with development of generalized osteoporosis. Bone-degrading osteoclasts are derived from circulating precursor cells of monocytic lineage, and the intermediate monocyte population is important as osteoclast precursors in inflammatory conditions. T cells of various subsets are critical in the pathogenesis of both RA and associated osteoporosis, but so far, no studies have examined associations between circulating intermediate monocytes, T cell subsets and bone characteristics in patients with RA. The aim of this study was to investigate the frequency of intermediate monocytes in patients with untreated early rheumatoid arthritis (ueRA) compared to healthy controls (HC), and to explore the correlation between intermediate monocytes and a comprehensive panel of T helper cell subsets, bone density and bone microarchitecture in ueRA patients. Methods 78 patients with ueRA fulfilling the ACR/EULAR 2010 criteria were included and compared to 29 age- and sex-matched HC. Peripheral blood samples were obtained before start of treatment and proportions of monocyte subsets and CD4(+) helper and regulatory T cell subsets were analyzed by flow cytometry. Bone densitometry was performed on 46 of the ueRA patients at inclusion using DXA and HR-pQCT. Results Flow cytometric analyses showed that the majority of ueRA patients had frequencies of intermediate monocytes comparable to HC. The intermediate monocyte population correlated positively with CXCR3(+) Th17 cells in ueRA patients but not in HC. However, neither the proportions of intermediate monocytes nor CXCR3(+) Th17 cells were associated with bone density or bone microarchitecture measurements. Conclusions Our findings suggest that in early RA, the intermediate monocytes do not correlate with bone characteristics, despite positive correlation with circulating CXCR3(+) Th17 cells. Future longitudinal studies in patients with longer disease duration are required to fully explore the potential of intermediate monocytes to drive bone loss in RA.	[Drevinge, Christina; Scheffler, Julia M.; Sundh, Daniel; Lorentzon, Mattias; Islander, Ulrika] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Drevinge, Christina; Scheffler, Julia M.; Islander, Ulrika] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Krefting Res Ctr,Inst Med, Gothenburg, Sweden; [Koro-Arvidsson, Catalin; Carlsten, Hans; Lindholm, Catharina; Ekwall, Anna-Karin Hultgard] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Sundh, Daniel; Lorentzon, Mattias] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Geriatr Med,Inst Med, Gothenburg, Sweden; [Gjertsson, Inger; Rudin, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden; [Lorentzon, Mattias] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Australian Catholic University	Drevinge, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden.; Drevinge, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Krefting Res Ctr,Inst Med, Gothenburg, Sweden.	christina.drevinge@gu.se	Islander, Ulrika/S-4824-2019	Islander, Ulrika/0000-0002-8493-1739; Ekwall, Anna-Karin/0000-0001-8236-6089; Scheffler, Julia/0000-0002-4221-909X	Swedish Research Council [2016-01192]; Novo Nordisk Foundation [19928]; Swedish government [ALFGBG716421, ALFGBG-857161]; Swedish county councils, the ALF-agreement [ALFGBG716421, ALFGBG-857161]; Association against Rheumatism [R-749971]; King Gustav V's 80 years' foundation [FAI-2017-0358]; Nanna Svartz foundation; Emil and Wera Cornells foundation; IngaBritt and Arne Lundberg Foundation [LU-2018-0008, LU2020-0010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish government; Swedish county councils, the ALF-agreement; Association against Rheumatism; King Gustav V's 80 years' foundation; Nanna Svartz foundation; Emil and Wera Cornells foundation; IngaBritt and Arne Lundberg Foundation	This work was supported with grants from the Swedish Research Council (2016-01192 (UI) and (HC)), the Novo Nordisk Foundation (19928 (UI)), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG716421 (UI) and ALFGBG-857161 (HC)), the Association against Rheumatism (R-749971 (UI) and (HC)), King Gustav V's 80 years' foundation (FAI-2017-0358 (UI) and (HC)), the Nanna Svartz foundation (UI), the Emil and Wera Cornells foundation (UI), and the IngaBritt and Arne Lundberg Foundation (LU-2018-0008 and LU2020-0010 (UI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Aldridge J, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02349-y; Aldridge J, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1648-2; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bakheet SA, 2020, IMMUNOL LETT, V225, P74, DOI 10.1016/j.imlet.2020.06.014; Bakheet SA, 2019, CELL SIGNAL, V64, DOI 10.1016/j.cellsig.2019.109395; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chara L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0375-y; Chiu YG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2915; de Vries TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00505; Eriksson C, 2013, SCAND J RHEUMATOL, V42, P260, DOI 10.3109/03009742.2012.754937; Ferrer IR, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8704; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guler-Yuksel M, 2009, ANN RHEUM DIS, V68, P330, DOI 10.1136/ard.2007.086348; Heinlen L, 2017, OSTEOPOROSIS INT, V28, P2801, DOI 10.1007/s00198-017-4170-5; Herrera BS, 2014, J PERIODONTOL, V85, pE72, DOI 10.1902/jop.2013.130280; Hiyari S, 2018, J BONE MINER RES, V33, P1450, DOI 10.1002/jbmr.3440; Hwang J, 2017, OSTEOPOROSIS INT, V28, P231, DOI 10.1007/s00198-016-3703-7; Ikic M, 2014, INT ORTHOP, V38, P183, DOI 10.1007/s00264-013-2121-0; Johansson L, 2018, J BONE MINER RES, V33, P250, DOI 10.1002/jbmr.3297; Katrib A, 2001, RHEUMATOLOGY, V40, P988, DOI 10.1093/rheumatology/40.9.988; Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Lee JH, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1353-6; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; MacNeil JA, 2008, MED ENG PHYS, V30, P792, DOI 10.1016/j.medengphy.2007.11.003; Martini G, 2005, ARTHRITIS RES THER, V7, pR241, DOI 10.1186/ar1481; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; Motoki Yumi, 2003, Mod Rheumatol, V13, P114, DOI 10.3109/s10165-002-0209-2; Pandya JM, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1224-1; Pandya JM, 2016, J LEUKOCYTE BIOL, V100, P823, DOI 10.1189/jlb.5A0116-025R; Passos S, 2015, J INFECT DIS, V211, P274, DOI 10.1093/infdis/jiu439; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Phuan-udom R, 2018, CLIN RHEUMATOL, V37, P2603, DOI 10.1007/s10067-018-4218-8; Ponzetti M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00236; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Phan QT, 2020, P NATL ACAD SCI USA, V117, P19276, DOI 10.1073/pnas.2006093117; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Ruiz-Limon P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01111; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Sprangers S, 2016, J CELL PHYSIOL, V231, P1249, DOI 10.1002/jcp.25220; Srivastava RK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00657; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tsukamoto M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1216-6; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; van Hooij A, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00060-17; Yoon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109775; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	55	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249205	10.1371/journal.pone.0249205	http://dx.doi.org/10.1371/journal.pone.0249205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770137	gold, Green Published			2022-12-26	WOS:000634833500004
J	Barros, GC; Requiao, RD; Carneiro, RL; Masuda, CA; Moreira, MH; Rossetto, S; Domitrovic, T; Palhano, FL				Barros, Gessica C.; Requiao, Rodrigo D.; Carneiro, Rodolfo L.; Masuda, Claudio A.; Moreira, Mariana H.; Rossetto, Silvana; Domitrovic, Tatiana; Palhano, Fernando L.			Rqc1 and other yeast proteins containing highly positively charged sequences are not targets of the RQC complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA SURVEILLANCE; E3 UBIQUITIN LIGASE; QUALITY-CONTROL; RIBOSOME COLLISIONS; TRANSLATION ARREST; DEGRADATION; TERMINATION; CODON; INITIATION; LISTERIN	Previous work has suggested that highly positively charged protein segments coded by rare codons or poly (A) stretches induce ribosome stalling and translational arrest through electrostatic interactions with the negatively charged ribosome exit tunnel, leading to inefficient elongation. This arrest leads to the activation of the Ribosome Quality Control (RQC) pathway and results in low expression of these reporter proteins. However, the only endogenous yeast proteins known to activate the RQC are Rqc1, a protein essential for RQC function, and Sdd1, a protein with unknown function, both of which contain polybasic sequences. To explore the generality of this phenomenon, we investigated whether the RQC complex controls the expression of other proteins with polybasic sequences. We showed by ribosome profiling data analysis and western blot that proteins containing polybasic sequences similar to, or even more positively charged than those of Rqc1 and Sdd1, were not targeted by the RQC complex. We also observed that the previously reported Ltn1-dependent regulation of Rqc1 is posttranslational, independent of the RQC activity. Taken together, our results suggest that RQC should not be regarded as a general regulatory pathway for the expression of highly positively charged proteins in yeast.	[Barros, Gessica C.; Requiao, Rodrigo D.; Carneiro, Rodolfo L.; Moreira, Mariana H.; Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, RJ, Brazil; [Masuda, Claudio A.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil; [Rossetto, Silvana] Univ Fed Rio de Janeiro, Dept Ciencia Comp, Rio De Janeiro, RJ, Brazil; [Domitrovic, Tatiana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Palhano, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, RJ, Brazil.; Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, RJ, Brazil.	domitrovic@micro.ufrj.br; palhano@bioqmed.ufrj.br	Palhano, Fernando/C-2586-2008; Masuda, Claudio Akio/F-7214-2014	Palhano, Fernando/0000-0001-5336-632X; C Barros, Gessica/0000-0003-4611-8883; Hoyer Moreira, Mariana/0000-0002-7138-7279; Masuda, Claudio Akio/0000-0002-0310-7108; Carneiro, Rodolfo/0000-0002-1141-2735	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil.	Archer SK, 2016, NATURE, V535, P570, DOI 10.1038/nature18647; Arthur LL, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1486; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Carneiro RL, 2019, NUCLEIC ACIDS RES, V47, P2216, DOI 10.1093/nar/gkz033; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Chiabudini M, 2014, MOL CELL BIOL, V34, P4062, DOI 10.1128/MCB.00799-14; Chiabudini M, 2012, MOL CELL BIOL, V32, P4769, DOI 10.1128/MCB.00809-12; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Crowder JJ, 2015, J BIOL CHEM, V290, P18454, DOI 10.1074/jbc.M115.663559; Cuperus JT, 2017, GENOME RES, V27, P2015, DOI 10.1101/gr.224964.117; D'Orazio KN, 2019, ELIFE, V8, DOI 10.7554/eLife.49117; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Defenouillere Q, 2016, J BIOL CHEM, V291, P12245, DOI 10.1074/jbc.M116.722264; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doamekpor SK, 2016, P NATL ACAD SCI USA, V113, pE4151, DOI 10.1073/pnas.1605951113; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gamerdinger M, 2016, ESSAYS BIOCHEM, V60, P203, DOI 10.1042/EBC20160011; Ghoneim DH, 2019, NUCLEIC ACIDS RES, V47, P1164, DOI 10.1093/nar/gky1262; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldman DH, 2021, MOL CELL, V81, P1830, DOI 10.1016/j.molcel.2021.01.029; Habich M, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.45; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hickey KL, 2020, MOL CELL, V79, P950, DOI 10.1016/j.molcel.2020.07.007; Ikeuchi K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100276; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Inada T, 2020, NUCLEIC ACIDS RES, V48, P1084, DOI 10.1093/nar/gkz1201; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Juszkiewicz S, 2020, ELIFE, V9, DOI 10.7554/eLife.60038; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Karamyshev AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00431; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kiniry SJ, 2019, NUCLEIC ACIDS RES, V47, pD847, DOI 10.1093/nar/gky842; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2007, J MOL BIOL, V371, P1378, DOI 10.1016/j.jmb.2007.06.038; Matsuda R, 2014, GENES CELLS, V19, P1, DOI 10.1111/gtc.12106; Matsuo Y, 2020, NAT STRUCT MOL BIOL, V27, P323, DOI 10.1038/s41594-020-0393-9; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010; Nissley DA, 2020, J AM CHEM SOC, V142, P6103, DOI 10.1021/jacs.9b12264; Park H, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000396; Phillips B, 2020, J CELL SCI, V133, DOI 10.1242/jcs.251983; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Requiao RD, 2020, BIOCHEM J, V477, P2921, DOI 10.1042/BCJ20200303; Requiao RD, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005549; Requiao RD, 2016, RNA BIOL, V13, P561, DOI 10.1080/15476286.2016.1172755; Saito K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005197; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Simms CL, 2019, CELL REP, V28, P1679, DOI 10.1016/j.celrep.2019.07.046; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Sitron CS, 2019, NAT STRUCT MOL BIOL, V26, P450, DOI 10.1038/s41594-019-0230-1; Sitron CS, 2017, RNA, V23, P798, DOI 10.1261/rna.060897.117; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tesina P, 2020, EMBO J, V39, DOI 10.15252/embj.2019103365; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang JY, 2018, ELIFE, V7, DOI 10.7554/eLife.39637; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Wu CCC, 2019, MOL CELL, V73, P959, DOI 10.1016/j.molcel.2018.12.009; Xiao W., 2005, METHODS MOL BIOL, V313, P047; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794; Zhao T, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-020-02256-0; Zuzow N, 2018, MOL BIOL CELL, V29, P1258, DOI 10.1091/mbc.E17-12-0714	88	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100586	10.1016/j.jbc.2021.100586	http://dx.doi.org/10.1016/j.jbc.2021.100586			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774050	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400558
J	Chen, Y; Hu, WQ; Li, Q; Zhao, SW; Zhao, D; Zhang, S; Wei, Z; Yang, XX; Chen, YL; Li, XJ; Liao, CZ; Han, JH; Miao, QR; Duan, YJ				Chen, Yi; Hu, Wenquan; Li, Qi; Zhao, Shiwei; Zhao, Dan; Zhang, Shuang; Wei, Zhuo; Yang, Xiaoxiao; Chen, Yuanli; Li, Xiaoju; Liao, Chenzhong; Han, Jihong; Miao, Qing Robert; Duan, Yajun			NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOGO-B RECEPTOR; BETA-CELL MASS; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; FATTY-ACIDS; IN-VIVO; RESISTANCE; MECHANISMS; COMPLICATIONS; DYSFUNCTION	The reduction of insulin resistance or improvement of insulin sensitivity is the most effective treatment for type 2 diabetes (T2D). We previously reported that Nogo-B receptor (NGBR), encoded by the NUS1 gene, is required for attenuating hepatic lipogenesis by blocking nuclear translocation of liver X receptor alpha, suggesting its important role in regulating hepatic lipid metabolism. Herein, we demonstrate that NGBR expression was decreased in the liver of obesity-associated T2D patients and db/db mice. NGBR knockout in mouse hepatocytes resulted in increased blood glucose, insulin resistance, and beta-cell loss. High-fat diet (HFD)/streptozotocin (STZ)-treated mice presented the T2D phenotype by showing increased nonesterified fatty acid (NEFA) and triglyceride (TG) in the liver and plasma and increased insulin resistance and beta-cell loss. AAV-mediated NGBR overexpression in the liver reduced NEFA and TG in the liver and circulation and improved liver functions. Consequently, HFD/STZ-treated mice with hepatic NGBR overexpression had increased insulin sensitivity and reduced beta-cell loss. Mechanistically, NGBR overexpression restored insulin signaling of AMPK alpha 1-dependent phosphorylation of AKT and GSK3 beta. NGBR overexpression also reduced expression of endoplasmic reticulum stress-associated genes in the liver and skeletal muscle to improve insulin sensitivity. Together, our results reveal that NGBR is required to ameliorate T2D in mice, providing new insight into the role of hepatic NGBR in insulin sensitivity and T2D treatment.	[Chen, Yi; Li, Qi; Zhao, Shiwei; Zhao, Dan; Wei, Zhuo; Li, Xiaoju; Han, Jihong] Nankai Univ, Coll Life Sci, Minist Educ, State Key Lab Med Chem Biol,Key Lab Bioact Mat, Tianjin, Peoples R China; [Chen, Yi; Zhang, Shuang; Yang, Xiaoxiao; Chen, Yuanli; Liao, Chenzhong; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Food & Biol Engn, Anhui Dept Educ, Key Lab Major Metab Dis & Nutr Regulat, Hefei, Peoples R China; [Hu, Wenquan; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Hu, Wenquan; Miao, Qing Robert] NYU, Long Isl Sch Med, Diabet & Obes Res Ctr, Mineola, NY 11501 USA	Nankai University; Hefei University of Technology; Medical College of Wisconsin; New York University	Duan, YJ (corresponding author), Hefei Univ Technol, Coll Food & Biol Engn, Anhui Dept Educ, Key Lab Major Metab Dis & Nutr Regulat, Hefei, Peoples R China.; Miao, QR (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA.; Miao, QR (corresponding author), NYU, Long Isl Sch Med, Diabet & Obes Res Ctr, Mineola, NY 11501 USA.	Qing.Miao@nyulangone.org; yduan@hfut.edu.cn		Liao, Chenzhong/0000-0001-7080-1768; Chen, Yi/0000-0002-7474-6230	International Science & Technology Cooperation Programs of China [2017YFE0110100]; China NSFC [81722046, 81773727, 81973316, 31770863, 81803517]; Fundamental Research Funds for the Central Universities of China	International Science & Technology Cooperation Programs of China; China NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was funded by the International Science & Technology Cooperation Programs of China 2017YFE0110100 to J. H., Y. D., Y. C., and X. Y.; the China NSFC grants 81722046 to Y. D.; 81773727 and 81973316 to J. H., 31770863 to Y. C., and 81803517 to X. Y.; the Fundamental Research Funds for the Central Universities of China to Y. D., X. Y., and Y. C.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boteon YL, 2019, LIVER TRANSPLANT, V25, P1007, DOI 10.1002/lt.25439; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821; Dong CY, 2016, ONCOTARGET, V7, P8850, DOI 10.18632/oncotarget.7091; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Franko A, 2014, J HEPATOL, V60, P816, DOI 10.1016/j.jhep.2013.11.020; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Hu WQ, 2016, HEPATOLOGY, V64, P1559, DOI 10.1002/hep.28747; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lee JM, 2017, DIABETES METAB J, V41, P10, DOI 10.4093/dmj.2017.41.1.10; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05309-y; Ma CR, 2018, BRIT J PHARMACOL, V175, P1486, DOI 10.1111/bph.14156; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Marselli L, 2014, DIABETOLOGIA, V57, P362, DOI 10.1007/s00125-013-3098-3; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Moore JA, 2016, CELL SIGNAL, V28, P384, DOI 10.1016/j.cellsig.2016.01.017; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oh YS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00384; Petrie JR, 2011, BIOCHEM PHARMACOL, V81, P471, DOI 10.1016/j.bcp.2010.11.010; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sakai K, 2003, ENDOCRINOLOGY, V144, P2388, DOI 10.1210/en.2002-221133; Sun T, 2020, SEMIN CELL DEV BIOL, V103, P76, DOI 10.1016/j.semcdb.2019.12.002; Targher G, 2018, NAT REV ENDOCRINOL, V14, P99, DOI 10.1038/nrendo.2017.173; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Wallis MG, 2005, DIABETOLOGIA, V48, P2131, DOI 10.1007/s00125-005-1887-z; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yao XG, 2015, J ENDOCRINOL, V224, P327, DOI 10.1530/JOE-14-0721; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang S, 2020, J HEPATOL, V73, P1482, DOI 10.1016/j.jhep.2020.07.034; Zhang WW, 2018, BBA-MOL CELL BIOL L, V1863, P177, DOI 10.1016/j.bbalip.2017.12.002; Zhao B, 2017, ONCOGENE, V36, P3406, DOI 10.1038/onc.2016.484; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577; Zhou TT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.119	63	3	4	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100624	10.1016/j.jbc.2021.100624	http://dx.doi.org/10.1016/j.jbc.2021.100624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812996	gold, Green Published			2022-12-26	WOS:000672866400595
J	Fan, JJ; Xiao, Y; Quick, M; Yang, YW; Sun, ZY; Javitch, JA; Zhou, XM				Fan, Jianjun; Xiao, Yang; Quick, Matthias; Yang, Yuwei; Sun, Ziyi; Javitch, Jonathan A.; Zhou, Xiaoming			Crystal structures of LeuT reveal conformational dynamics in the outward-facing states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER-SODIUM SYMPORTER; BINDING-SITE; SUBSTRATE; MECHANISM; NA+; PROTEINS	The neurotransmitter:sodium symporter (NSS) homolog LeuT from Aquifex aeolicus has proven to be a valuable model for studying the transport mechanism of the NSS family. Crystal structures have captured LeuT in key conformations visited during the transport cycle, allowing for the construction of a nearly complete model of transport, with much of the conformational dynamics studied by computational simulations. Here, we report crystal structures of LeuT representing new intermediate conformations between the outward-facing open and occluded states. These structures, combined with binding and accessibility studies, reveal details of conformational dynamics that can follow substrate binding at the central substrate binding site (S1) of LeuT in outward-facing states, suggesting a potential competition for direction between the outward-open and outward-occluded states at this stage during substrate transport. Our structures further support an intimate interplay between the protonation state of Glu290 and binding of Na1 that may ultimately regulate the outward-open-to-occluded transition.	[Fan, Jianjun; Xiao, Yang; Yang, Yuwei; Sun, Ziyi; Zhou, Xiaoming] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Integrated Tradit Chinese & Western Med,Rare, Chengdu, Sichuan, Peoples R China; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, New York State Psychiat Inst, Div Mol Therapeut, New York, NY 10027 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA	Sichuan University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Sun, ZY; Zhou, XM (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Integrated Tradit Chinese & Western Med,Rare, Chengdu, Sichuan, Peoples R China.; Javitch, JA (corresponding author), Columbia Univ, New York State Psychiat Inst, Div Mol Therapeut, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.	ziyi.sun@scu.edu.cn; jonathan.javitch@nyspi.columbia.edu; x.zhou@scu.edu.cn		Javitch, Jonathan/0000-0001-7395-2967; Quick, Matthias/0000-0002-8620-827X; Xiao, Yang/0000-0001-6513-0533; Sun, Ziyi/0000-0002-3345-1065; Zhou, Xiaoming/0000-0001-8866-7245; Fan, Jianjun/0000-0002-2086-0839	National Natural Science Foundation of China [31770783]; National Institutes of Health [R01 DA041510, R01 GM119396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Natural Science Foundation of China grant No. 31770783 to X. Z., National Institutes of Health grant R01 DA041510 to JAJ, and R01 GM119396 to M. Q. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Conley BE, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01253-20; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gotfryd K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14735-w; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Kracke F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00575; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555	34	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100609	10.1016/j.jbc.2021.100609	http://dx.doi.org/10.1016/j.jbc.2021.100609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811858	gold, Green Published			2022-12-26	WOS:000672866400581
J	Porter, KJ; Cao, LY; Chen, YD; TerBush, AD; Chen, C; Erickson, HP; Osteryoung, KW				Porter, Katie J.; Cao, Lingyan; Chen, Yaodong; TerBush, Allan D.; Chen, Cheng; Erickson, Harold P.; Osteryoung, Katherine W.			The Arabidopsis thaliana chloroplast division protein FtsZ1 counterbalances FtsZ2 filament stability in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; PLASTID DIVISION; ESCHERICHIA-COLI; CHLOROPHYLL FLUORESCENCE; BACTERIAL CYTOKINESIS; GTPASE ACTIVITY; RING STRUCTURE; GENE FAMILIES; EXPRESSION; INSIGHTS	Bacterial cell and chloroplast division are driven by a contractile "Z ring" composed of the tubulin-like cytoskeletal GTPase FtsZ. Unlike bacterial Z rings, which consist of a single FtsZ, the chloroplast Z ring in plants is composed of two FtsZ proteins, FtsZ1 and FtsZ2. Both are required for chloroplast division in vivo, but their biochemical relationship is poorly understood. We used GTPase assays, light scattering, transmission electron microscopy, and sedimentation assays to investigate the assembly behavior of purified Arabidopsis thaliana (At) FtsZ1 and AtFtsZ2 both individually and together. Both proteins exhibited GTPase activity. AtFtsZ2 assembled relatively quickly, forming protofilament bundles that were exceptionally stable, as indicated by their sustained assembly and slow disassembly. AtFtsZ1 did not form detectable protofilaments on its own. When mixed with AtFtsZ2, AtFtsZ1 reduced the extent and rate of AtFtsZ2 assembly, consistent with its previously demonstrated ability to promote protofilament subunit turnover in living cells. Mixing the two FtsZ proteins did not increase the overall GTPase activity, indicating that the effect of AtFtsZ1 on AtFtsZ2 assembly was not due to a stimulation of GTPase activity. However, the GTPase activity of AtFtsZ1 was required to reduce AtFtsZ2 assembly. Truncated forms of AtFtsZ1 and AtFtsZ2 consisting of only their conserved core regions largely recapitulated the behaviors of the full-length proteins. Our in vitro findings provide evidence that FtsZ1 counterbalances the stability of FtsZ2 filaments in the regulation of chloroplast Z-ring dynamics and suggest that restraining FtsZ2 self-assembly is a critical function of FtsZ1 in chloroplasts.	[Porter, Katie J.; Cao, Lingyan; TerBush, Allan D.; Chen, Cheng; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Chen, Yaodong; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Chen, Yaodong] Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Chen, Cheng] Shanghai Jiao Tong Univ, Joint Ctr Single Cell Biol, Sch Agr & Biol, Dept Plant Sci, Shanghai 200240, Peoples R China	Michigan State University; Duke University; Northwest University Xi'an; Shanghai Jiao Tong University	Osteryoung, KW (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	osteryou@msu.edu		Porter, Katie/0000-0002-3995-0244; Erickson, Harold/0000-0002-9104-8987; Chen, Cheng/0000-0002-1423-118X; Chen, Yaodong/0000-0002-3751-0923	National Science Foundation [1121943, 1719376]; National Institute of General Medical Sciences [R01GM066014]	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant 1719376 (to K. W. O.), National Science Foundation grant 1121943 (to K. W. O. and H. P. E.), and National Institute of General Medical Sciences grant R01GM066014 (to H. P. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Chen C, 2018, PLANT PHYSIOL, V176, P138, DOI 10.1104/pp.17.01272; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Corbin LC, 2020, BIOPHYS J, V119, P792, DOI 10.1016/j.bpj.2020.05.041; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Du SS, 2019, TRENDS MICROBIOL, V27, P781, DOI 10.1016/j.tim.2019.04.011; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Dutta S, 2017, J EXP BOT, V68, P3541, DOI 10.1093/jxb/erx203; Dutta S, 2015, PLANT J, V84, P428, DOI 10.1111/tpj.13009; Ei-Kafafi E, 2005, BIOCHEM J, V387, p669 676; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Eun YJ, 2015, J BIOL CHEM, V290, P17181, DOI 10.1074/jbc.R115.637876; Fujiwara M, 2001, BIOCHEM BIOPH RES CO, V287, P462, DOI 10.1006/bbrc.2001.5588; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jeong KJ, 2003, APPL ENVIRON MICROB, V69, P1295, DOI 10.1128/AEM.69.2.1295-1298.2003; Johnson CB, 2015, MICROSC MICROANAL, V21, P313, DOI 10.1017/S1431927615000082; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; McQuillen R, 2020, ANNU REV BIOPHYS, V49, P309, DOI 10.1146/annurev-biophys-121219-081703; Miyagishima S, 2011, INT REV CEL MOL BIO, V291, P115, DOI 10.1016/B978-0-12-386035-4.00004-5; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; Ramirez-Diaz DA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004845; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rowlett VW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00478; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaik RS, 2018, BIOCHEM J, V475, P99, DOI 10.1042/BCJ20170697; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; TerBush AD, 2018, PLANT PHYSIOL, V176, P295, DOI 10.1104/pp.17.00558; TerBush AD, 2016, MICROSC MICROANAL, V22, P275, DOI 10.1017/S1431927616000143; TerBush AD, 2013, CURR OPIN CELL BIOL, V25, P461, DOI 10.1016/j.ceb.2013.04.006; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang N, 2019, J BIOL CHEM, V294, P16309, DOI 10.1074/jbc.RA119.009621; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995; Yoder DW, 2007, PLANT CELL PHYSIOL, V48, P775, DOI 10.1093/pcp/pcm049; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Zhang M, 2016, PLANT PHYSIOL, V170, P250, DOI 10.1104/pp.15.01460; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047	88	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100627	10.1016/j.jbc.2021.100627	http://dx.doi.org/10.1016/j.jbc.2021.100627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812992	gold, Green Published			2022-12-26	WOS:000672866400598
J	Chu, YY; Zhu, YR; Zhang, YJ; Liu, XJ; Guo, YL; Chang, L; Yun, XM; Wei, ZF; Xia, YF; Dai, Y				Chu, Yuyao; Zhu, Yanrong; Zhang, Yajing; Liu, Xiaojing; Guo, Yilei; Chang, Lan; Yun, Xinming; Wei, Zhifeng; Xia, Yufeng; Dai, Yue			Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway	FASEB JOURNAL			English	Article						aryl hydrocarbon receptor; colitis; intestinal epithelial barrier; Occludin; tetrandrine	TIGHT JUNCTIONS; MICE; PERMEABILITY; CELLS	The elevated intestinal permeability due to mucosal barrier defects is not only secondary to inflammatory bowel disease but also precedes enteritis. Tetrandrine, a bisbenzyl isoquinoline alkaloid isolated from the dried roots of Stephamis tetlandra S. Moor, was previously demonstrated to ameliorate colitis induced by dextran sulfate sodium (DSS) in mice. Here, we investigate whether and how tetrandrine protects against the disruption of the intestinal epithelial barrier under colitis condition. The data show that oral administration of tetrandrine significantly counteracted the increase of intestinal permeability in DSS-treated mice, enhanced the mRNA and protein expression of Occludin and Claudin1 in the colon, but hardly affected the expression of ZO-1 and Mucin2. In vitro, tetrandrine treatment rescued the decrease of monolayer transmembrane resistance and the increase of epithelial cell permeability induced by TNF-a, upregulated the expression of Occludin, and downregulated the expression of Claudin1 but did not affect the expression of ZO-1. The siRNA of Occludin largely weakened the protective effect of tetrandrine on the epithelial barrier function in Caco-2 cells. MiR-429 mimic obviously counteracted the upregulation of tetrandrine on the expression of Occludin and the amelioration on epithelial barrier defects, in contrast, miR-429 inhibitor showed the opposite effects. The antagonist (CH223191) and siAhR of aryl hydrocarbon receptor (AhR) nearly completely diminished the effects of tetrandrine, including inhibition of the miR429 expression, the upregulation of Occludin expression, and amelioration of intestinal epithelial barrier defects in Caco-2 cells. In colitis mice, CH223191 significantly weakened the protective effect of tetrandrine on colitis and intestinal mucosal barrier and diminished the downregulation on miR-429 expression and the promotion on Occludin expression in the colon. In summary, tetrandrine can attenuate the intestinal epithelial barrier defects in colitis through promoting Occludin expression via the AhR/miR-429 pathway, and it might be used to treat colitis as a barrier protector.	[Chu, Yuyao; Zhu, Yanrong; Zhang, Yajing; Liu, Xiaojing; Guo, Yilei; Chang, Lan; Yun, Xinming; Wei, Zhifeng; Xia, Yufeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing, Peoples R China	China Pharmaceutical University	Xia, YF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	yfxiacpu@126.com; yuedaicpu@cpu.edu.cn			"Double First-Class" University project [CPU2018GY10]; China National Natural Science Foundation [81673666]	"Double First-Class" University project; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	"Double First-Class" University project, Grant/Award Number: CPU2018GY10; China National Natural Science Foundation, Grant/Award Number: 81673666	Bauer H, 2016, CNS NEUROL DISORD-DR, V15, P1016, DOI 10.2174/1871527315666160915142244; Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427; Chen LY, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00035; Chinen I, 2015, INT IMMUNOL, V27, P405, DOI 10.1093/intimm/dxv015; Dong CY, 2020, J MOL NEUROSCI, V70, P56, DOI 10.1007/s12031-019-01400-1; Feng Y, 2019, BIOORG MED CHEM LETT, V29, P2051, DOI 10.1016/j.bmcl.2019.06.013; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Heinemann U, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236020; Hou QK, 2017, CELL PHYSIOL BIOCHEM, V44, P2256, DOI 10.1159/000486059; Jia YG, 2018, FASEB J, V32, P3398, DOI 10.1096/fj.201701148RR; Kumar V, 2018, J IMMUNOL, V200, P2677, DOI 10.4049/jimmunol.1701148; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Li GX, 2019, J CELL BIOCHEM, V120, P18995, DOI 10.1002/jcb.29222; Li J-X., 2015, EVID BASED COMPLEMEN, V2015, P1; Liu ZZ, 2018, INT J MOL MED, V41, P1560, DOI 10.3892/ijmm.2017.3341; Meng D., 1999, J 3 MIL MED U, V2, P78; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Miner-Williams WM, 2016, NUTR RES REV, V29, P40, DOI 10.1017/S0954422416000019; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rogers S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40539; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Sun L, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0146-0; Tan B, 2019, SCAND J GASTROENTERO, V54, P432, DOI 10.1080/00365521.2019.1595708; Tao Y, 2020, FASEB J, V34, P3069, DOI 10.1096/fj.201901638RR; Van Itallie CM, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1382671; Wang K, 2018, BIOCHEM PHARMACOL, V155, P494, DOI 10.1016/j.bcp.2018.07.039; Wu XX, 2019, INFLAMMATION, V42, P2215, DOI 10.1007/s10753-019-01085-z; Yang H, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28320; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu T, 2016, CELL TISSUE RES, V366, P341, DOI 10.1007/s00441-016-2435-5; Yuan XS, 2016, BIOCHEM PHARMACOL, V101, P87, DOI 10.1016/j.bcp.2015.11.025; Zhang D, 2009, INT J COLORECTAL DIS, V24, P5, DOI 10.1007/s00384-008-0544-7; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548; Zhang Y., 2017, MED INFORM, V30, P56	38	8	8	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21502	10.1096/fj.202002086RR	http://dx.doi.org/10.1096/fj.202002086RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811696				2022-12-26	WOS:000645260100027
J	Ohata, K; Kondo, M; Ozono, Y; Hanada, Y; Sato, T; Inohara, H; Shimada, S				Ohata, Kazuya; Kondo, Makoto; Ozono, Yoshiyuki; Hanada, Yukiko; Sato, Takashi; Inohara, Hidenori; Shimada, Shoichi			Cochlear protection against noise exposure requires serotonin type 3A receptor via the medial olivocochlear system	FASEB JOURNAL			English	Article						HT3A receptor; acoustic trauma; noise-induced hearing loss	ACETYLCHOLINE-RELEASE; 5-HT3 RECEPTOR; HEARING-LOSS; NEURONS; PROJECTIONS; MODULATION; PATHWAYS; DAMAGE; INNERVATION; STEREOCILIA	The cochlear efferent feedback system plays important roles in auditory processing, including regulation of the dynamic range of hearing, and provides protection against acoustic trauma. These functions are performed through medial olivocochlear (MOC) neurons. However, the underlying cellular and molecular mechanisms are not fully understood. The serotonin type 3A (5-HT3A) receptor is widely expressed throughout the nervous system, which suggests important roles in various neural functions. However, involvement of the 5-HT3A receptor in the MOC system remains unclear. We used mice in this study and found that the 5-HT3A receptor was expressed in MOC neurons that innervated outer hair cells in the cochlea and was involved in the activation of MOC neurons by noise exposure. 5-HT3A receptor knockout impaired MOC functions, potentiated noise-induced hearing loss, and increased loss of ribbon synapses following noise exposure. Furthermore, 5-HT3 receptor agonist treatment alleviated the noise-induced hearing loss and loss of ribbon synapses, which enhanced cochlear protection provided by the MOC system. Our findings demonstrate that the 5-HT3A receptor plays fundamental roles in the MOC system and critically contributes to protection from noise-induced hearing impairment.	[Ohata, Kazuya; Kondo, Makoto; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ohata, Kazuya; Ozono, Yoshiyuki; Hanada, Yukiko; Sato, Takashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan; [Kondo, Makoto; Shimada, Shoichi] Osaka Psychiat Med Ctr, Osaka Psychiat Res Ctr, Addict Res Unit, Osaka, Japan	Osaka University; Osaka University	Kondo, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkondo@anat1.med.osaka-u.ac.jp			MEXT vertical bar Japan Society for the Promotion of Science (JSPS) [17K16912, 19K18729, 19K11440]	MEXT vertical bar Japan Society for the Promotion of Science (JSPS)	MEXT broken vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17K16912, 19K18729 and 19K11440	Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Boero LE, 2018, J NEUROSCI, V38, P7440, DOI 10.1523/JNEUROSCI.0363-18.2018; Brown MC, 2008, NEUROSCIENCE, V154, P147, DOI 10.1016/j.neuroscience.2007.12.045; Brown MC, 2003, EXP BRAIN RES, V153, P491, DOI 10.1007/s00221-003-1679-y; BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; CONSOLO S, 1994, J NEUROCHEM, V62, P2254; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; Dean C, 2012, OTOL NEUROTOL, V33, P1085, DOI 10.1097/MAO.0b013e31825e7e12; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Franklin K., 2007, MOUSE BRAIN STEREOTA; Giovannini MG, 1998, J PHARMACOL EXP THER, V285, P1219; Grose JH, 2006, J ACOUST SOC AM, V119, P2305, DOI 10.1121/1.2172169; Guinan JJ, 1996, J ACOUST SOC AM, V100, P1680, DOI 10.1121/1.416066; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hanada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28618-0; HENRY KR, 1980, AUDIOLOGY, V19, P369; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Horvath M, 2003, EUR J NEUROSCI, V18, P1439, DOI 10.1046/j.1460-9568.2003.02870.x; KIANG NYS, 1982, SCIENCE, V217, P175, DOI 10.1126/science.7089553; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kondo M, 2018, MOL PSYCHIATR, V23, P833, DOI 10.1038/mp.2017.87; Kondo M, 2015, MOL PSYCHIATR, V20, P1428, DOI 10.1038/mp.2014.153; Kondo M, 2017, ANAT SCI INT, V92, P1, DOI 10.1007/s12565-016-0358-6; Kondo M, 2014, LEARN MEMORY, V21, P1, DOI 10.1101/lm.032193.113; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Koyama Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42884; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; LIBERMAN MC, 1987, HEARING RES, V26, P65, DOI 10.1016/0378-5955(87)90036-0; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; LIBERMAN MC, 1986, HEARING RES, V24, P17, DOI 10.1016/0378-5955(86)90003-1; Maison SF, 2013, J NEUROSCI, V33, P5542, DOI 10.1523/JNEUROSCI.5027-12.2013; Manzoor NF, 2013, BRAIN RES, V1523, P28, DOI 10.1016/j.brainres.2013.05.025; Morales M, 2002, J NEUROSCI, V22, P6732; Ofsie MS, 1997, HEARING RES, V113, P207, DOI 10.1016/S0378-5955(97)00150-0; Pilz PKD, 1997, HEARING RES, V105, P171, DOI 10.1016/S0378-5955(96)00206-7; Rajan R, 2000, J NEUROSCI, V20, P6684, DOI 10.1523/JNEUROSCI.20-17-06684.2000; Rothlin CV, 2003, MOL PHARMACOL, V63, P1067, DOI 10.1124/mol.63.5.1067; Smith DW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00012; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; Takimoto Y, 2014, BRAIN RES, V1557, P74, DOI 10.1016/j.brainres.2014.02.016; Taranda J, 2009, PLOS BIOL, V7, P71, DOI 10.1371/journal.pbio.1000018; Terreros G, 2016, J NEUROSCI, V36, P7198, DOI 10.1523/JNEUROSCI.4031-15.2016; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; THOMPSON AM, 1995, BRAIN RES, V695, P263, DOI 10.1016/0006-8993(95)00863-L; Ueda N, 2018, BIOCHEM BIOPH RES CO, V506, P498, DOI 10.1016/j.bbrc.2018.10.106; Wersinger E, 2011, HEARING RES, V279, P1, DOI 10.1016/j.heares.2010.12.018; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; WINSLOW RL, 1988, HEARING RES, V35, P165, DOI 10.1016/0378-5955(88)90116-5; Woods CI, 1999, BRAIN RES, V836, P9, DOI 10.1016/S0006-8993(99)01541-3; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zhu XX, 2007, J COMP NEUROL, V503, P593, DOI 10.1002/cne.21402	56	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21486	10.1096/fj.202002383R	http://dx.doi.org/10.1096/fj.202002383R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811700	hybrid			2022-12-26	WOS:000645260100006
J	Tang, F; Fu, MC; Wang, L; Song, WJ; Yu, JF; Wu, YB				Tang, Feng; Fu, Meichen; Wang, Li; Song, Wanjuan; Yu, Jiangfeng; Wu, Yanbin			Dynamic evolution and scenario simulation of habitat quality under the impact of land-use change in the Huaihe River Economic Belt, China	PLOS ONE			English	Article								Habitat quality is an important indicator for evaluating the biodiversity provided by ecosystem. Estimating and scenario-simulating the dynamic evolution and future development trends of habitat quality under the influence of land-use change is significant in regional biodiversity conservation, formulating land-use planning, and maintaining the ecological environmental sustainability. In this article, we included the Huaihe River Economic Belt as the area of study because of its vital location in China and applied the CA-Markov and InVEST models to analyze the spatio-temporal evolution of habitat quality and to simulate the future development trends of habitat quality under three different land-use scenarios: fast urban growth scenario, farmland conservation-oriented scenario, and ecological conservation-oriented scenario. The results showed that the land-use change in the Huaihe River Economic Belt was mostly represented by the continuous increase of the built-up area, whereas other land types all declined in area from 1995 to 2015. The land-use changes under these three abovementioned alternative future scenarios with different development orientations were considerably different. The built-up area has been shown to expand rapidly to occupy other land types on a large scale under the fast urban growth scenario. Urban land increased slightly and a large area of rural residential land would be converted into farmland under the farmland conservation-oriented scenario. The built-up area and farmland might decrease while woodland, grassland and water would increase in extent of areas under the ecological conservation-oriented scenario. Habitat quality has been shown to be generally poor, continuing to decline from 1995 to 2015, while its spatial distribution was higher in the southwest and northeast areas and lower in the central regions. The future habitat quality would display a downward trend under the fast urban growth and farmland conservation-oriented scenarios with a further deterioration of the ecological environment, while the ecological conservation-oriented scenario predicted the converse trend that the ecological environment would be improved productively. This study may be useful for understanding the impact of land-use dynamics on biodiversity. The research results can provide a scientific basis for the decision-makers to formulate biodiversity conservation and land management policies.	[Tang, Feng; Fu, Meichen] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Tang, Feng; Wang, Li; Song, Wanjuan] Chinese Acad Sci, Aerosp Informat Res Inst, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Tang, Feng; Wang, Li; Song, Wanjuan] Beijing Normal Univ, Beijing, Peoples R China; [Yu, Jiangfeng] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Wu, Yanbin] Hebei Univ Econ & Business, Sch Management Sci & Engn, Shijiazhuang, Hebei, Peoples R China; [Wu, Yanbin] Hebei Univ Econ & Business, GIS Big Data Platform Socioecon Hebei, Shijiazhuang, Hebei, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Beijing Normal University; Nanjing Agricultural University; Hebei University of Economics & Business; Hebei University of Economics & Business	Wang, L (corresponding author), Chinese Acad Sci, Aerosp Informat Res Inst, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Wang, L (corresponding author), Beijing Normal Univ, Beijing, Peoples R China.	wangli@radi.ac.cn	Wang, Li/P-9811-2018	Wang, Li/0000-0002-2929-4255	National Key Research and Development Project of China [2016YFC0502501]; National Natural Science Foundation of China [41871347]; Program of the Humanities and Social Sciences Research of the Ministry of Education of China [17YJCZH192]	National Key Research and Development Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the Humanities and Social Sciences Research of the Ministry of Education of China(Ministry of Education, China)	Li Wang received the National Key Research and Development Project of China (Grant No. 2016YFC0502501) and the National Natural Science Foundation of China (Grant No. 41871347), Yanbin Wu received the Program of the Humanities and Social Sciences Research of the Ministry of Education of China (Grant No. 17YJCZH192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2019, J ENVIRON MANAGE, V243, P299, DOI 10.1016/j.jenvman.2019.05.036; Aguilar R, 2019, ECOL LETT, V22, P1163, DOI 10.1111/ele.13272; Aneseyee AB, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071103; Bai LM, 2019, HABITAT INT, V93, DOI 10.1016/j.habitatint.2019.102042; Brown G, 2012, APPL GEOGR, V35, P84, DOI 10.1016/j.apgeog.2012.06.002; [曹玉华 Cao Yuhua], 2019, [经济地理, Economic Geography], V39, P213; Chu L, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10113854; Cotter M, 2017, ECOL INDIC, V75, P111, DOI 10.1016/j.ecolind.2016.11.038; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Di Febbraro M, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00513; Eastman J. R., 2012, IDRISI SELVA TUTORIA; Engel D.W., 1999, ENVIRON SCI POLICY, V2, P465, DOI [10.1016/S1462-9011(99)00043-X, DOI 10.1016/S1462-9011(99)00043-X]; Firozjaei MK, 2019, CITIES, V93, P120, DOI 10.1016/j.cities.2019.05.001; Gao JX, 2019, NATURE, V569, P457, DOI 10.1038/d41586-019-01563-2; Gashaw T, 2018, SCI TOTAL ENVIRON, V619, P1394, DOI 10.1016/j.scitotenv.2017.11.191; GOERTZ JW, 1964, ECOL MONOGR, V34, P359, DOI 10.2307/2937068; Han YW, 2019, URBAN FOR URBAN GREE, V41, P354, DOI 10.1016/j.ufug.2019.04.015; He JH, 2017, ECOL MODEL, V366, P58, DOI 10.1016/j.ecolmodel.2017.10.001; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; KEMPTON RA, 1979, BIOMETRICS, V35, P307, DOI 10.2307/2529952; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; Li FX, 2018, J ENVIRON MANAGE, V217, P486, DOI 10.1016/j.jenvman.2018.03.109; Liu D., 2018, CHIN RURAL EC, V12, P37; Liu Y, 2014, HABITAT INT, V44, P339, DOI 10.1016/j.habitatint.2014.07.009; Mansour S, 2020, LAND USE POLICY, V91, DOI 10.1016/j.landusepol.2019.104414; Moreira M, 2018, LAND USE POLICY, V78, P637, DOI 10.1016/j.landusepol.2018.07.015; National Development and Reform Commission, 2018, DEV PLAN HUAI RIV EC; Palmate SS, 2017, APPL GEOGR, V82, P11, DOI 10.1016/j.apgeog.2017.03.001; Petrosillo I, 2009, LANDSCAPE URBAN PLAN, V89, P49, DOI 10.1016/j.landurbplan.2008.10.003; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Ren J.L., 2018, J SHANDONG U PHILOS, V6, P27; Romero-Calcerrada R, 2006, ECOL MODEL, V196, P62, DOI 10.1016/j.ecolmodel.2006.02.017; Sallustio L, 2017, J ENVIRON MANAGE, V201, P129, DOI 10.1016/j.jenvman.2017.06.031; Sharp R., NATURAL CAPITAL PROJ; Song YF, 2020, ECOL ENG, V150, DOI 10.1016/j.ecoleng.2020.105834; Sun XY, 2019, ECOL INDIC, V102, P716, DOI 10.1016/j.ecolind.2019.03.041; Tang F, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106719; Vallecillo S, 2016, ECOL INDIC, V69, P488, DOI 10.1016/j.ecolind.2016.05.008; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Wang H, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9040243; Wang N, 2020, ISPRS J PHOTOGRAMM, V162, P137, DOI 10.1016/j.isprsjprs.2020.02.012; Xu LT, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133513; Xu X., 2017, GRID DATA SET SPATIA; Xu Xinliang, 2017, DATA REGISTRATION PU, DOI [10.12078/2017121102, DOI 10.12078/2017121102]; Yan SJ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124625; Zhou L, 2020, SUSTAIN CITIES SOC, V55, DOI 10.1016/j.scs.2020.102045	48	9	9	12	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249566	10.1371/journal.pone.0249566	http://dx.doi.org/10.1371/journal.pone.0249566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819303	Green Published, gold			2022-12-26	WOS:000637647200024
J	Xavier, IGG; Vieira, MC; Rodrigues, LF; da Silva, GMS; da Silva, PS; de Holanda, MT; Maciel, ER; Carneiro, FM; Mazzoli-Rocha, F; Sangenis, LHC; Mendes, FDNS; Hasslocher-Moreno, AM; de Sousa, AS; da Costa, AR; Saraiva, RM; do Brasil, PEAA; Mediano, MFF				Gomes Xavier, Isis Gabrielli; Vieira, Marcelo Carvalho; Rodrigues Junior, Luiz Fernando; Sperandio da Silva, Gilberto Marcelo; da Silva, Paula Simplicio; de Holanda, Marcelo Teixeira; Maciel, Erica Rodrigues; Carneiro, Fernanda Martins; Mazzoli-Rocha, Flavia; Conde Sangenis, Luiz Henrique; Nogueira Sardinha Mendes, Fernanda de Souza; Hasslocher-Moreno, Alejandro Marcel; de Sousa, Andrea Silvestre; da Costa, Andrea Rodrigues; Saraiva, Roberto Magalhaes; Alvarenga Americano do Brasil, Pedro Emmanuel; Felix Mediano, Mauro Felippe			Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease	PLOS ONE			English	Article								The increase in life expectancy and the migration of individuals with Chagas disease (ChD) from rural to urban centers exposes them to the development of chronic-degenerative abnormalities that may increase the prevalence of metabolic syndrome (MetS). The present study aimed to identify the prevalence of MetS and its components in individuals with chronic ChD. This is a cross-sectional study with 361 patients of both sexes, aging >18 years, followed at a national reference center (Rio de Janeiro, Brazil). MetS diagnosis followed the International Diabetes Federation 2005 criteria. The association between the variables was determined through logistic regression models. The mean age was and 60.7 +/- 10.8 years. About half (56.2%) were female and the majority self-reported their race as mulatto (59.8%). The percentage of individuals with MetS was 40.4%. The variables independently associated with MetS were age (OR 1.06; 95%CI 1.04-1.09), high education levels (OR 0.36; 95%CI 0.17-0.79) and cardiac form with heart failure (OR 0.34; 95%CI 0.17-0.68). Therefore, a high prevalence of MetS was found in this Brazilian chronic ChD cohort. The identification of the associated factors can facilitate the development of effective approaches for preventing and managing MetS in ChD patients.	[Gomes Xavier, Isis Gabrielli; Vieira, Marcelo Carvalho; Sperandio da Silva, Gilberto Marcelo; da Silva, Paula Simplicio; de Holanda, Marcelo Teixeira; Maciel, Erica Rodrigues; Carneiro, Fernanda Martins; Mazzoli-Rocha, Flavia; Conde Sangenis, Luiz Henrique; Nogueira Sardinha Mendes, Fernanda de Souza; Hasslocher-Moreno, Alejandro Marcel; de Sousa, Andrea Silvestre; da Costa, Andrea Rodrigues; Saraiva, Roberto Magalhaes; Alvarenga Americano do Brasil, Pedro Emmanuel; Felix Mediano, Mauro Felippe] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Vieira, Marcelo Carvalho] Aloysio de Castro State Inst Cardiol, Ctr Cardiol & Exercise, Rio De Janeiro, RJ, Brazil; [Rodrigues Junior, Luiz Fernando; Felix Mediano, Mauro Felippe] Natl Inst Cardiol, Dept Res & Educ, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	Mediano, MFF (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.; Mediano, MFF (corresponding author), Natl Inst Cardiol, Dept Res & Educ, Rio De Janeiro, RJ, Brazil.	mauro.mediano@ini.fiocruz.br	Xavier, Isis Gabrielli/GWZ-9097-2022; Rodrigues, Luiz Fernando/I-2718-2017; Hasslocher-Moreno, Alejandro Marcel/F-3414-2011; Costa, Andrea/A-6083-2018; Vieira, Marcelo Carvalho/Q-2450-2018	Xavier, Isis Gabrielli/0000-0002-6603-2895; Rodrigues, Luiz Fernando/0000-0001-7007-7431; Hasslocher-Moreno, Alejandro Marcel/0000-0002-5430-7222; Simplicio da Silva, Paula/0000-0002-7414-9698; Costa, Andrea/0000-0002-5033-4856; Vieira, Marcelo Carvalho/0000-0002-6137-0246	Fundacao de Amparo a Pesquisa Carlos Chagas [111.133/2014]; Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES) [001]	Fundacao de Amparo a Pesquisa Carlos Chagas; Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa Carlos Chagas (grant number 111.133/2014) and by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -CAPES) -Finance Code 001.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Agvall B, 2013, EUR J HEART FAIL, V15, P228, DOI 10.1093/eurjhf/hfs159; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Chagas Disease, 2020, MED SANS FRONTIERES; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Alves RMD, 2009, REV SOC BRAS MED TRO, V42, P622, DOI 10.1590/S0037-86822009000600002; de Castilhos MP, 2017, REV SOC BRAS MED TRO, V50, P795, DOI 10.1590/0037-8682-0237-2017; dos Santos JP, 2013, CAD SAUDE PUBLICA, V29, P1141, DOI [10.1590/S0102-311X2013000600011, 10.1590/S0102-311X2013001000011]; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Forman DE, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.003915; Lidani KCF, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00166; Hidron AI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000688; Honda T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3570-3; Ibrahim MS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027326; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQUISA ESPECIAL TA; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2011, CENS DEM 2010 CAR PO; Jackson Y, 2012, TROP MED INT HEALTH, V17, P595, DOI 10.1111/j.1365-3156.2012.02965.x; Kim I, 2018, METAB SYNDR RELAT D, V16, P416, DOI 10.1089/met.2017.0170; Kivimaki M, 2020, LANCET PUBLIC HEALTH, V5, pE140, DOI 10.1016/S2468-2667(19)30248-8; Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508; Monteiro CA, 2000, REV SAUDE PUBL, V34, P251, DOI 10.1590/S0034-89102000000300007; Saad MAN, 2014, ARQ BRAS CARDIOL, V102, P263, DOI 10.5935/abc.20140013; Ramires EKNM, 2018, ARQ BRAS CARDIOL, V110, P455, DOI 10.5935/abc.20180072; Pardini R., 2001, BRAZ J SCI MOV, V9, P45, DOI [10.18511/rbcm.v9i3.393, DOI 10.18511/RBCM.V9I3.393]; Pinazo MJ, 2015, ACTA TROP, V151, P16, DOI 10.1016/j.actatropica.2015.06.013; Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Salaroli LB, 2007, ARQ BRAS ENDOCRINOL, V51, P1143, DOI 10.1590/S0004-27302007000700018; Schulze MB, 2004, DIABETES CARE, V27, P613, DOI 10.2337/diacare.27.2.613; Shin D, 2018, INT J CARDIOL, V259, P216, DOI 10.1016/j.ijcard.2018.01.139; Sigit FS, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-019-0503-1; Steene-Johannessen J, 2016, MED SCI SPORT EXER, V48, P235, DOI 10.1249/MSS.0000000000000760; Toukhsati Samia R, 2015, Card Fail Rev, V1, P128, DOI 10.15420/cfr.2015.1.2.128; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vizzoni AG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2929-y; Winckers ANE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2656-7	42	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249116	10.1371/journal.pone.0249116	http://dx.doi.org/10.1371/journal.pone.0249116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798206	Green Published, gold			2022-12-26	WOS:000636737700051
J	Heo, YC; Han, DK; Kim, MT				Heo, Yeong-Cheol; Han, Dong-Kyoon; Kim, Min Tae			Therapeutic effect of local photothermal heating of gold nanoparticle-coated self-expandable metallic stents for suppressing granulation tissue formation in the mouse colon	PLOS ONE			English	Article								Purpose To investigate the therapeutic effect of local photothermal (PT) heating on suppression of stent-induced granulation tissue formation in mouse colon. Materials and methods A gold nanoparticle (GNP)-coated self-expandable metallic stent (SEMS) was prepared using a two-step synthesis process for local PT heating under near-infrared laser irradiation. Twenty-four mice were randomly divided into two groups of 12 and subjected to SEMS placement in the colon. Group A received a GNP-coated SEMS without local heating and Group B received a GNP-coated SEMS and underwent local heating at 55 degrees C after SEMS placement. The therapeutic effect of local heating was assessed by comparing the histopathological, immunohistochemical, and endoscopic results. Results Four mice were excluded because of stent migration (n = 3, group B) or death (n = 1, group A). Stent-induced granulation tissue-related variables were significantly lower in group B than in group A (p < 0.001). In vivo endoscopic images, 4 weeks after stent placement, showed granulation tissue formation over the wire mesh in group A and relatively good patency of the stented colon with no definite irregularities in group B. There was more vascular endothelial growth factor (VEGF) positivity in group A than in group B. Conclusion Local PT heating suppresses granulation tissue formation after stent placement in mouse colon.	[Heo, Yeong-Cheol; Han, Dong-Kyoon] Eulji Univ, Coll Hlth Sci, Dept Radiol Sci, Seongnam, South Korea; [Kim, Min Tae] Cheju Halla Univ, Dept Radiol Technol, Jeju Si, Jeju Do, South Korea; [Kim, Min Tae] Univ Ulsan, Biomed Engn Res Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea	Eulji University; University of Ulsan; Asan Medical Center	Kim, MT (corresponding author), Cheju Halla Univ, Dept Radiol Technol, Jeju Si, Jeju Do, South Korea.; Kim, MT (corresponding author), Univ Ulsan, Biomed Engn Res Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea.	soir09@naver.com		Kim, Min Tae/0000-0002-1294-2957	National Research Foundation of Korea - Korea government [NRF-2019R1F1A1040357]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea grant funded by the Korea government (NRF-2019R1F1A1040357).	Abbas MA, 2008, JSLS-J SOC LAPAROEND, V12, P88; Abbas MA, 2017, INT J COLORECTAL DIS, V32, P375, DOI 10.1007/s00384-016-2696-1; Abbas MA, 2009, JSLS-J SOC LAPAROEND, V13, P420; Baron TH, 2007, GASTROENTEROLOGY, V133, P1407, DOI 10.1053/j.gastro.2007.09.056; Brasselet C, 2008, EUR HEART J, V29, P402, DOI 10.1093/eurheartj/ehm596; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Diaz LP, 1999, CARDIOVASC INTER RAD, V22, P29, DOI 10.1007/s002709900325; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Farooq V, 2013, JACC-CARDIOVASC INTE, V6, P523, DOI 10.1016/j.jcin.2012.12.131; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Forshaw MJ, 2006, COLORECTAL DIS, V8, P102, DOI 10.1111/j.1463-1318.2005.00806.x; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Jeurnink SM, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-18; Jun EJ, 2017, GASTROINTEST ENDOSC, V86, P219, DOI 10.1016/j.gie.2017.01.013; Khot UP, 2002, BRIT J SURG, V89, P1096, DOI 10.1046/j.1365-2168.2002.02148.x; Kim JH, 2010, RADIOLOGY, V255, P75, DOI 10.1148/radiol.09090670; Kim KY, 2018, RADIOLOGY, V286, P140, DOI 10.1148/radiol.2017170414; Kim SY, 2014, BIOMED MICRODEVICES, V16, P897, DOI 10.1007/s10544-014-9894-9; Landsberg R, 2009, OTOLARYNG HEAD NECK, V140, P480, DOI 10.1016/j.otohns.2008.12.004; Lee S, 2018, ACS NANO, V12, P6756, DOI 10.1021/acsnano.8b01921; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lim TZ, 2019, J GASTROINTEST ONCOL, V10, P1171, DOI 10.21037/jgo.2019.02.15; Lopera JE, 2004, RADIOGRAPHICS, V24, P1561, DOI 10.1148/rg.246045033; Madsen SJ, 2015, LASER MED SCI, V30, P1357, DOI 10.1007/s10103-015-1742-5; Park HS, 2015, GASTROINTEST ENDOSC, V81, P1433, DOI 10.1016/j.gie.2014.09.040; Park JH, 2020, ACS BIOMATER SCI ENG, V6, P2450, DOI 10.1021/acsbiomaterials.0c00307; Park JH, 2018, ACS APPL MATER INTER, V10, P29357, DOI 10.1021/acsami.8b09819; Park W, 2017, SMALL, V13, DOI 10.1002/smll.201602722; Paul L, 2002, RADIOLOGY, V223, P715, DOI 10.1148/radiol.2233010866; Rayhanabad J, 2009, AM SURGEON, V75, P897; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Sebastian S, 2004, AM J GASTROENTEROL, V99, P2051, DOI 10.1111/j.1572-0241.2004.40017.x; Small AJ, 2008, SURG ENDOSC, V22, P454, DOI 10.1007/s00464-007-9453-z; Song JB, 2016, ACS APPL MATER INTER, V8, P27523, DOI 10.1021/acsami.6b09104; Suzuki N, 2004, DIS COLON RECTUM, V47, P1201, DOI 10.1007/s10350-004-0556-5; Tamim WZ, 2000, ARCH SURG-CHICAGO, V135, P434, DOI 10.1001/archsurg.135.4.434; Vemulapalli R, 2010, DIGEST DIS SCI, V55, P1732, DOI 10.1007/s10620-009-0945-7; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang D, 2017, ENDOSCOPY, V49, P327, DOI 10.1055/s-0042-122779; Zhang MC, 2014, PATHOL RES PRACT, V210, P1026, DOI 10.1016/j.prp.2014.04.004; Zhao K, 2017, J BIOMED MATER RES B, V105, P2352, DOI 10.1002/jbm.b.33773	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249530	10.1371/journal.pone.0249530	http://dx.doi.org/10.1371/journal.pone.0249530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798254	gold, Green Published			2022-12-26	WOS:000636737700024
J	Giddings, LA; Lountos, GT; Kim, KW; Brockley, M; Needle, D; Cherry, S; Tropea, JE; Waugh, DS				Giddings, Lesley-Ann; Lountos, George T.; Kim, Kang Woo; Brockley, Matthew; Needle, Danielle; Cherry, Scott; Tropea, Joseph E.; Waugh, David S.			Characterization of a broadly specific cadaverine N-hydroxylase involved in desferrioxamine B biosynthesis in Streptomyces sviceus	PLOS ONE			English	Article								N-hydroxylating flavin-dependent monooxygenases (FMOs) are involved in the biosynthesis of hydroxamate siderophores, playing a key role in microbial virulence. Herein, we report the first structural and kinetic characterization of a novel alkyl diamine N-hydroxylase DesB from Streptomyces sviceus (SsDesB). This enzyme catalyzes the first committed step in the biosynthesis of desferrioxamine B, a clinical drug used to treat iron overload disorders. X-ray crystal structures of the SsDesB holoenzyme with FAD and the ternary complex with bound NADP(+) were solved at 2.86 angstrom and 2.37 angstrom resolution, respectively, providing a structural view of the active site environment. SsDesB crystallized as a tetramer and the structure of the individual protomers closely resembles the structures of homologous N-hydroxylating FMOs from Erwinia amylovora (DfoA), Pseudomonas aeruginosa (PvdA), and Aspergillus fumigatus (SidA). Using NADPH oxidation, oxygen consumption, and product formation assays, kinetic parameters were determined for various substrates with SsDesB. SsDesB exhibited typical saturation kinetics with substrate inhibition at high concentrations of NAD(P)H as well as cadaverine. The apparent k(cat) values for NADPH in steady-state NADPH oxidation and oxygen consumption assays were 0.28 +/- 0.01 s(-1) and 0.24 +/- 0.01 s(-1), respectively. However, in product formation assays used to measure the rate of N-hydroxylation, the apparent k(cat) for NADPH (0.034 +/- 0.008 s(-1)) was almost 10-fold lower under saturating FAD and cadaverine concentrations, reflecting an uncoupled reaction, and the apparent NADPH K-M was 33 +/- 24 mu M. Under saturating FAD and NADPH concentrations, the apparent k(cat) and K-M for cadaverine in Csaky assays were 0.048 +/- 0.004 s(-1) and 19 +/- 9 mu M, respectively. SsDesB also N-hydroxylated putrescine, spermidine, and L-lysine substrates but not alkyl (di)amines that were branched or had fewer than four methylene units in an alkyl chain. These data demonstrate that SsDesB has wider substrate scope compared to other well-studied ornithine and lysine N-hydroxylases, making it an amenable biocatalyst for the production of desferrioxamine B, derivatives, and other N-substituted products.	[Giddings, Lesley-Ann] Smith Coll, Dept Chem, Northampton, MA 01063 USA; [Giddings, Lesley-Ann; Kim, Kang Woo; Brockley, Matthew] Middlebury Coll, Dept Chem & Biochem, Middlebury, VT 05753 USA; [Lountos, George T.] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD USA; [Needle, Danielle; Cherry, Scott; Tropea, Joseph E.; Waugh, David S.] NCI, Ctr Struct Biol, Ctr Canc Res, Frederick, MD 21701 USA	Smith College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giddings, LA (corresponding author), Smith Coll, Dept Chem, Northampton, MA 01063 USA.; Giddings, LA (corresponding author), Middlebury Coll, Dept Chem & Biochem, Middlebury, VT 05753 USA.	lgiddings@smith.edu		Lountos, George/0000-0003-3463-8881; Giddings, Lesley-Ann/0000-0003-1089-1276	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P20GM103449]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research [ZIA BC 010341, ZIC BC 011016]	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Institutional Development Award from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) (grant number P20GM103449 for L-A.G., K.K; https://www.nigms.nih.gov/Research/DRCB/IDeA/).Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract No. W-31-109-Eng-38. This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health under contract HHSN261200800001E (to G.T.L.) and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (ZIA BC 010341 to D.N and D.S.W; and ZIC BC 011016 to S.C and J.E.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Barona-Gomez F, 2006, MICROBIOL-SGM, V152, P3355, DOI 10.1099/mic.0.29161-0; Bertrand S, 2013, MINI-REV MED CHEM, V13, P1311; Binda C, 2015, J BIOL CHEM, V290, P12676, DOI 10.1074/jbc.M114.629485; Burrell M, 2012, MOL MICROBIOL, V86, P485, DOI 10.1111/j.1365-2958.2012.08208.x; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Codd R, 2018, ACS CHEM BIOL, V13, P11, DOI 10.1021/acschembio.7b00851; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esuola CO, 2016, J MOL CATAL B-ENZYM, V134, P378, DOI 10.1016/j.molcatb.2016.08.003; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Ge L, 2006, J BACTERIOL, V188, P7205, DOI 10.1128/JB.00949-06; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kang HY, 1996, J BACTERIOL, V178, P4877, DOI 10.1128/jb.178.16.4877-4884.1996; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Li B, 2016, ACS CHEM BIOL, V11, P2782, DOI 10.1021/acschembio.6b00629; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Minandri F, 2016, INFECT IMMUN, V84, P2324, DOI 10.1128/IAI.00098-16; Mindt M, 2020, BIOTECHNOL J, V15, DOI 10.1002/biot.201900451; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mobarra Naser, 2016, Int J Hematol Oncol Stem Cell Res, V10, P239; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mugge C, 2020, APPL MICROBIOL BIOT, V104, P6481, DOI 10.1007/s00253-020-10705-w; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Neumann CS, 2012, CHEMBIOCHEM, V13, P972, DOI 10.1002/cbic.201200054; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Patel P, 2010, BIOCHEMISTRY-US, V49, P8033, DOI 10.1021/bi100451k; Petrik M, 2017, CLIN TRANSL IMAGING, V5, P15, DOI 10.1007/s40336-016-0211-x; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Raran-Kurussi S, 2017, METHODS MOL BIOL, V1586, P221, DOI 10.1007/978-1-4939-6887-9_14; Robinson R, 2015, ARCH BIOCHEM BIOPHYS, V585, P25, DOI 10.1016/j.abb.2015.09.008; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Ronan JL, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0068; Salomone-Stagni M, 2018, J STRUCT BIOL, V202, P236, DOI 10.1016/j.jsb.2018.02.002; SCHUPP T, 1988, GENE, V64, P179, DOI 10.1016/0378-1119(88)90333-2; SCHUPP T, 1987, FEMS MICROBIOL LETT, V42, P135; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Soe CZ, 2012, CHEM BIODIVERS, V9, P1880, DOI 10.1002/cbdv.201200014; Telfer TJ, 2016, ACS CHEM BIOL, V11, P1452, DOI 10.1021/acschembio.6b00056; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Weichenberger CX, 2014, ACTA CRYSTALLOGR D, V70, P1579, DOI 10.1107/S1399004714005550; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248385	10.1371/journal.pone.0248385	http://dx.doi.org/10.1371/journal.pone.0248385			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784308	Green Published, gold			2022-12-26	WOS:000636359600058
J	Slot, LM; Vergroesen, RD; Kerkman, PF; Staudinger, E; Reijm, S; van Dooren, HJ; van der Voort, EIH; Huizinga, TWJ; Toes, REM; Scherer, HU				Slot, Linda M.; Vergroesen, Rochelle D.; Kerkman, Priscilla F.; Staudinger, Ellen; Reijm, Sanne; van Dooren, Hugo J.; van der Voort, Ellen I. H.; Huizinga, Tom W. J.; Toes, Rene E. M.; Scherer, Hans U.			Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis	PLOS ONE			English	Article								Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presumably survived tolerance checkpoints. So far, it is unclear how and when such autoreactive B cells emerge. Light chain (LC) rearrangement and mutation rates can be informative with regard to selection steps during B-cell development. Therefore, we studied LC characteristics of ACPA-expressing B cells and secreted ACPA with the aim to better understand the development of this disease-specific, autoreactive B-cell response. Paired ACPA-IgG and ACPA-depleted IgG were isolated from serum (n = 87) and synovial fluid (SF, n = 21) of patients with established RA. We determined the LC composition for each fraction by ELISA using kappa(Ig kappa)- and lambda(Ig lambda) LC-specific antibodies. Cellular LC expression was determined using flow cytometry. In addition, we used a B-cell receptor (BCR)-specific PCR to obtain LC variable region sequences of citrullinated antigen- and tetanus toxoid (TT)-binding B cells. In serum, we observed an increased frequency of lambda LC in ACPA-IgG (1.64:1) compared to control IgG (2.03:1) and to the kappa/lambda ratio reported for healthy individuals (2:1). A similar trend towards higher frequencies of lambda LCs was observed for ACPA-IgG in SF (1.84:1). Additionally, the percentage of Ig lambda-expressing B cells was higher for citrullinated antigen-binding B cells (51%) compared to TT-specific (43%) and total CD19(+)CD20(+) B cells (36%). Moreover, an increased Ig lambda percentage was observed in BCR-sequences derived from ACPA-expressing (49%) compared to TT-specific B cells (34%). Taken together, we report an enhanced frequency of lambda LCs in the secreted ACPA-IgG repertoire and, on the cellular level, in BCR sequences of ACPA-expressing B cells compared to control. This skewing in the autoreactive B-cell repertoire could reflect a process of active selection.	[Slot, Linda M.; Vergroesen, Rochelle D.; Kerkman, Priscilla F.; Staudinger, Ellen; Reijm, Sanne; van Dooren, Hugo J.; van der Voort, Ellen I. H.; Huizinga, Tom W. J.; Toes, Rene E. M.; Scherer, Hans U.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Kerkman, Priscilla F.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Scherer, HU (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands.	h.u.scherer@lumc.nl		Slot, Linda/0000-0002-7993-5831; Kerkman, Priscilla/0000-0002-6212-002X; Scherer, Hans Ulrich/0000-0002-5700-5617	Dutch Arthritis Foundation [12-2403, 15-2-402, 18-1-205]; Netherlands Organization for Scientific Research (NWO) [91214031]; ZonMW clinical fellowship [90714509]; ZonMW VENI grant [91617107]; ZonMW OffRoad grant [451001012]; IMI [115142-2]; RTCure [777357]; Target-to-B! consortium by 'Samenwerkende Gezondheidsfondsen' (SGF); Business Life [LSHM18055-SGF]; European Research Council (ERC) [AdG2019-884796]	Dutch Arthritis Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMW clinical fellowship; ZonMW VENI grant; ZonMW OffRoad grant; IMI; RTCure; Target-to-B! consortium by 'Samenwerkende Gezondheidsfondsen' (SGF); Business Life; European Research Council (ERC)(European Research Council (ERC)European Commission)	This study was supported by grants from the Dutch Arthritis Foundation (project no. 12-2403, REM Toes; no. 15-2-402, HU Scherer and no. 18-1-205, HU Scherer), the Netherlands Organization for Scientific Research (NWO; project no. 91214031, REM Toes), a ZonMW clinical fellowship (project no. 90714509, HU Scherer), ZonMW VENI grant (no. 91617107, HU Scherer), ZonMW OffRoad grant (no. 451001012, HU Scherer), the IMI-funded consortium projects BeTheCure (contract no. 115142-2, REM Toes) and RTCure (contract no. 777357, REM Toes) and has been funded as part of the Target-to-B! consortium by 'Samenwerkende Gezondheidsfondsen' (SGF) consisting of 20 health funds including KWF Kankerbestrijding, ReumaNederland, Topsector Life Sciences & Health (Health*Holland) and the Business Life (LSHM18055-SGF). R.E.M.T. is the recipient of an European Research Council (ERC) Advanced grant (AdG2019-884796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDERSON EE, 1993, J CLIN INVEST, V91, P2734, DOI 10.1172/JCI116514; ADDERSON EE, 1992, J CLIN INVEST, V89, P729, DOI 10.1172/JCI115649; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 2018, Q REV BIOL, V93, P59; Chen HI, 2006, AM J CLIN PATHOL, V125, P42, DOI 10.1309/1G5F902YE7DDUNMA; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Diaw L, 2000, MOL IMMUNOL, V37, P775, DOI 10.1016/S0161-5890(00)00100-0; Foster SJ, 1997, J CLIN INVEST, V99, P1614, DOI 10.1172/JCI119324; Fournier EM, 2012, J EXP MED, V209, P1797, DOI 10.1084/jem.20120332; Fraser LD, 2015, EUR J IMMUNOL, V45, P2409, DOI 10.1002/eji.201545599; GIACHINO C, 1995, J EXP MED, V181, P1245, DOI 10.1084/jem.181.3.1245; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Habets KLL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0665-7; Hafkenscheid L, 2017, MOL CELL PROTEOMICS, V16, P278, DOI 10.1074/mcp.M116.062919; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARALDSSON A, 1995, CLIN RHEUMATOL, V14, P51, DOI 10.1007/BF02208084; IJspeert H, 2017, J IMMUNOL, V198, P4156, DOI 10.4049/jimmunol.1601921; Kawajiri-Manako C, 2018, AM J HEMATOL, V93, P1161, DOI 10.1002/ajh.25213; Kerkman PF, 2016, ANN RHEUM DIS, V75, P1170, DOI 10.1136/annrheumdis-2014-207182; Kim HJ, 1999, J IMMUNOL, V162, P3053; Kissel T, 2020, ANN RHEUM DIS, V79, P472, DOI 10.1136/annrheumdis-2019-216499; KNIGHT J, 1986, J CLIN ENDOCR METAB, V62, P342, DOI 10.1210/jcem-62-2-342; Koning MT, 2017, BRIT J HAEMATOL, V178, P983, DOI 10.1111/bjh.14180; Kristyanto H, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5327; LAM CWK, 1991, CLIN BIOCHEM, V24, P283, DOI 10.1016/0009-9120(91)80021-T; Li YC, 1996, J MOL BIOL, V256, P577, DOI 10.1006/jmbi.1996.0110; Lighaam LC, 2014, J ALLERGY CLIN IMMUN, V133, P267, DOI 10.1016/j.jaci.2013.07.044; Low JM, 2007, SCAND J IMMUNOL, V65, P76, DOI 10.1111/j.1365-3083.2006.01859.x; Maes J, 2000, J IMMUNOL, V165, P703, DOI 10.4049/jimmunol.165.2.703; Mehr R, 1999, J IMMUNOL, V163, P1793; Mockridge CI, 1998, CLIN EXP IMMUNOL, V114, P129; Nagafuchi H, 2004, CLIN EXP IMMUNOL, V136, P76, DOI 10.1111/j.1365-2249.2004.02423.x; Nei T, 2013, CLIN IMMUNOL, V149, P357, DOI 10.1016/j.clim.2013.10.002; PASCUAL V, 1992, ARTHRITIS RHEUM-US, V35, P11, DOI 10.1002/art.1780350103; Pelanda R, 2014, CURR OPIN IMMUNOL, V27, P53, DOI 10.1016/j.coi.2014.01.012; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Raats JMH, 2003, J RHEUMATOL, V30, P1696; REEVES WH, 1989, J IMMUNOL, V143, P3614; Rezanka LJ, 2005, IMMUNOBIOLOGY, V210, P769, DOI 10.1016/j.imbio.2005.10.008; Rochas C, 2007, AUTOIMMUN REV, V7, P155, DOI 10.1016/j.autrev.2007.02.011; Rombouts Y, 2016, ANN RHEUM DIS, V75, P578, DOI 10.1136/annrheumdis-2014-206598; SANZ I, 1987, P NATL ACAD SCI USA, V84, P1085, DOI 10.1073/pnas.84.4.1085; Scherer HU, 2018, NAT REV RHEUMATOL, V14, P157, DOI 10.1038/nrrheum.2018.10; SHASTRI KA, 1991, AM J HEMATOL, V37, P167, DOI 10.1002/ajh.2830370307; Silberstein LE, 1996, BLOOD CELL MOL DIS, V22, P126, DOI 10.1006/bcmd.1996.0020; Snir O, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93961; Sozzi E, 2011, HEMATOL ONCOL, V29, P31, DOI 10.1002/hon.952; Stamatopoulos K, 2005, BLOOD, V106, P3575, DOI 10.1182/blood-2005-04-1511; Steen J, 2019, ARTHRITIS RHEUMATOL, V71, P196, DOI 10.1002/art.40699; Suwannalai P, 2011, ANN RHEUM DIS, V70, P373, DOI 10.1136/ard.2010.135509; Suwannalai P, 2012, MOD RHEUMATOL, V22, P15, DOI 10.1007/s10165-011-0486-8; Titcombe PJ, 2018, ARTHRITIS RHEUMATOL, V70, P1933, DOI 10.1002/art.40590; Trouw LA, 2013, ANN RHEUM DIS, V72, P132, DOI 10.1136/annrheumdis-2012-202349; van de Stadt LA, 2013, RHEUMATOLOGY, V52, P631, DOI 10.1093/rheumatology/kes371; van der Burg M, 2001, BLOOD, V97, P1001, DOI 10.1182/blood.V97.4.1001; van Vollenhoven RF, 1999, J RHEUMATOL, V26, P1727; Vergroesen RD, 2018, ANN RHEUM DIS, V77, P955, DOI 10.1136/annrheumdis-2017-212052; Vincent C, 2005, AUTOIMMUNITY, V38, P17, DOI 10.1080/08916930400022582; Wang J, 2007, INT J DERMATOL, V46, P1146, DOI 10.1111/j.1365-4632.2007.03267.x; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204; WYSOCKI LJ, 1987, J EXP MED, V166, P1, DOI 10.1084/jem.166.1.1; Zhang ZX, 2001, ARTHRITIS RHEUM, V44, P2275, DOI 10.1002/1529-0131(200110)44:10<2275::AID-ART390>3.0.CO;2-K	64	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0247847	10.1371/journal.pone.0247847	http://dx.doi.org/10.1371/journal.pone.0247847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784344	gold, Green Published			2022-12-26	WOS:000636359600042
J	Lee, T; Kwon, HD; Lee, J				Lee, Taeyong; Kwon, Hee-Dae; Lee, Jeehyun			The effect of control measures on COVID-19 transmission in South Korea	PLOS ONE			English	Article								Countries around the world have taken control measures to mitigate the spread of COVID-19, including Korea. Social distancing is considered an essential strategy to reduce transmission in the absence of vaccination or treatment. While interventions have been successful in controlling COVID-19 in Korea, maintaining the current restrictions incurs great social costs. Thus, it is important to analyze the impact of different polices on the spread of the epidemic. To model the COVID-19 outbreak, we use an extended age-structured SEIR model with quarantine and isolation compartments. The model is calibrated to age-specific cumulative confirmed cases provided by the Korea Disease Control and Prevention Agency (KDCA). Four control measures-school closure, social distancing, quarantine, and isolation-are investigated. Because the infectiousness of the exposed has been controversial, we study two major scenarios, considering contributions to infection of the exposed, the quarantined, and the isolated. Assuming the transmission rate would increase more than 1.7 times after the end of social distancing, a second outbreak is expected in the first scenario. The epidemic threshold for increase of contacts between teenagers after school reopening is 3.3 times, which brings the net reproduction number to 1. The threshold values are higher in the second scenario. If the average time taken until isolation and quarantine reduces from three days to two, cumulative cases are reduced by 60% and 47% in the first scenario, respectively. Meanwhile, the reduction is 33% and 41%, respectively, for rapid isolation and quarantine in the second scenario. Without social distancing, a second wave is possible, irrespective of whether we assume risk of infection by the exposed. In the non-infectivity of the exposed scenario, early detection and isolation are significantly more effective than quarantine. Furthermore, quarantining the exposed is as important as isolating the infectious when we assume that the exposed also contribute to infection.	[Lee, Taeyong; Lee, Jeehyun] Yonsei Univ, Sch Math & Comp Math, Seoul, South Korea; [Kwon, Hee-Dae] Inha Univ, Dept Math, Incheon, South Korea; [Lee, Jeehyun] Yonsei Univ, Sch Math & Comp, Seoul, South Korea	Yonsei University; Inha University; Yonsei University	Lee, J (corresponding author), Yonsei Univ, Sch Math & Comp Math, Seoul, South Korea.; Lee, J (corresponding author), Yonsei Univ, Sch Math & Comp, Seoul, South Korea.	ezhyun@yonsei.ac.kr		Lee, Taeyong/0000-0002-1940-0210	National Research Foundation of Korea [2020R1A2C1A0101077511]; Korea Health Industry Development Institute [HG20C0003030020]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	The work of Jeehyun Lee was supported by National Research Foundation of Korea [grant number: 2020R1A2C1A0101077511] and Korea Health Industry Development Institute [grant number: HG20C0003030020]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Brauer F, 2006, MATH BIOSCI ENG, V3, P1; Chen YM, 2020, RHEUMATOLOGY, V59, P3201, DOI 10.1093/rheumatology/keaa067; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Jia JW, 2020, ELECTRON J DIFFER EQ; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kim S, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e143; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Korean Statistical Information Service (KOSIS), 2020, STAT KOREA POPULATIO; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; WHO, 2019, COVID 19 SITUATION R	25	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249262	10.1371/journal.pone.0249262	http://dx.doi.org/10.1371/journal.pone.0249262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780504	Green Published, gold			2022-12-26	WOS:000636336800035
J	Masenya, TI; Mlambo, V; Mnisi, CM				Masenya, Thabiso Isaac; Mlambo, Victor; Mnisi, Caven Mguvane			Complete replacement of maize grain with sorghum and pearl millet grains in Jumbo quail diets: Feed intake, physiological parameters, and meat quality traits	PLOS ONE			English	Article							PERFORMANCE	In sub-Saharan Africa, the use of maize (Zea mays L.) grain as an energy source in poultry feeds has become unsustainable due to competing demands and suboptimal growing conditions for the maize crop. Sorghum (Sorghum bicolor Moench L.) and pearl millet (Pennisetum glaucum) grains are potential sustainable alternatives, given their tolerance to local growing conditions. Therefore, this study evaluated the effect of total replacement of maize grain with whole or crushed sorghum and pearl millet grains on feed intake, and physiological and meat quality parameters of Jumbo quail. Five experimental diets were formulated by completely replacing crushed maize grain in a commercial grower diet (CON) with whole sorghum (WSG), crushed sorghum (CSG), whole millet (WMG), or crushed millet (CMG). Three hundred and fifty, two-week-old Jumbo quail chicks (74.7 +/- 8.81 g live-weight) were evenly distributed into 35 replicate pens to which the experimental diets were allotted. Statistically similar (P > 0.05) weight gain and FCE values were observed between birds reared on the control and pearl millet-based diets. However, birds fed with sorghum-based diets had the lowest FCE and weight gain. Blood parameters fell within the normal ranges reported for healthy quail. Birds fed the whole sorghum grain diet had the least (P < 0.05) serum calcium and higher monocytes, cholesterol, and alkaline phosphatase (ALP) concentrations compared to those reared on the control diet. Compared to the control, the whole sorghum-containing diet reduced (P < 0.05) carcass, breast, wing, thigh, drumstick, liver, gizzard, and large intestine weights of the birds. Complete replacement of maize grain with pearl millet grain (whole or crushed) did not compromise feed intake, growth performance, and meat quality traits of the Jumbo quail birds. However, whole sorghum grain reduced growth performance of the birds.	[Masenya, Thabiso Isaac; Mnisi, Caven Mguvane] North West Univ, Sch Agr Sci, Dept Anim Sci, Mafikeng, South Africa; [Mlambo, Victor] Univ Mpumalanga, Sch Agr Sci, Fac Agr & Nat Sci, Nelspruit, South Africa; [Mnisi, Caven Mguvane] North West Univ, Food Secur & Safety Niche Area, Fac Nat & Agr Sci, Mafikeng, South Africa	North West University - South Africa; North West University - South Africa	Mnisi, CM (corresponding author), North West Univ, Sch Agr Sci, Dept Anim Sci, Mafikeng, South Africa.; Mnisi, CM (corresponding author), North West Univ, Food Secur & Safety Niche Area, Fac Nat & Agr Sci, Mafikeng, South Africa.	mnisiecm@gmail.com	Mnisi, Caven Mguvane/L-7199-2019	Mnisi, Caven Mguvane/0000-0003-1385-1093; Mlambo, Victor/0000-0002-0799-3899	National Research Foundation [117339]	National Research Foundation	The funding received by the first author from the National Research Foundation (ZA), grant number: 117339 is hereby acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MA., 2013, J WORLDS POULTRY RES, V3, P13; AOAC, 2005, AOAC OFFICIAL METHOD, V18th ed.; BARBUT S, 1993, FOOD RES INT, V26, P39, DOI 10.1016/0963-9969(93)90103-P; Behnke KC, 1996, ANIM FEED SCI TECH, V62, P49, DOI 10.1016/S0377-8401(96)01005-X; Beta T, 2004, CEREAL CHEM, V81, P418, DOI 10.1094/CCHEM.2004.81.3.418; CIE, 1976, DEFINITION DUN SPACE; Cisse RS, 2017, J APPL POULTRY RES, V26, P9, DOI 10.3382/japr/pfw042; Grau R., 1957, Z FUR LEBENSM UND FO, V105, P446, DOI [DOI 10.1007/BF01126901, 10.1007/BF01126901]; GUALTIERI M, 1990, WORLD POULTRY SCI J, V46, P246, DOI 10.1079/WPS19900024; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Issa S., 2007, POULTRY SCI, V86, P59, DOI [10.1093/ps/86.1.59, DOI 10.1093/PS/86.1.59]; Kwari I. D., 2011, International Journal of Poultry Science, V10, P608; Kwari ID., 2011, IJSN, V2, P22; Leandro NSM., 2001, BRAZILIAN J ANIMAL S, V30, P1266; Liu SY, 2015, AGRICULTURE-BASEL, V5, P1224, DOI 10.3390/agriculture5041224; Liu SY, 2013, ANIM FEED SCI TECH, V181, P1, DOI 10.1016/j.anifeedsci.2013.01.008; LIVESEY G, 1989, J SCI FOOD AGR, V48, P475, DOI 10.1002/jsfa.2740480410; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Manyelo TG, 2019, J APPL POULTRY RES, V28, P647, DOI 10.3382/japr/pfz015; Marareni M, 2020, VET ANIM SCI, V10, DOI 10.1016/j.vas.2020.100141; Mbhele FGT, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236592; Mnisi CM, 2018, ANIM NUTR, V4, P37, DOI 10.1016/j.aninu.2017.08.011; Morne P., 2017, FACTS TRENDS SA AGR, P1; Muchenje V, 2009, MEAT SCI, V81, P653, DOI 10.1016/j.meatsci.2008.11.004; National Research Council, 1994, NUTR REQ POULTR; NORTHCUTT JK, 1994, POULTRY SCI, V73, P308, DOI 10.3382/ps.0730308; Oatway L, 2001, FOOD REV INT, V17, P419, DOI 10.1081/FRI-100108531; Qaisrani SN, 2019, J APPL POULTRY RES, V28, P242, DOI 10.3382/japr/pfy073; Raju M. V. L. N., 2004, Animal Nutrition and Feed Technology, V4, P53; Rao S. V. Rama, 2003, Indian Journal of Poultry Science, V38, P236; Saleh ASM, 2013, COMPR REV FOOD SCI F, V12, P281, DOI 10.1111/1541-4337.12012; Selle PH, 2019, BRIT POULTRY SCI, V60, P209, DOI 10.1080/00071668.2016.1257777; Selle PH, 2003, AUST J EXP AGR, V43, P475, DOI 10.1071/EA02155; Statistical Analysis System [SAS], 2010, US GUID STAT VERS 9; Tandiang D. M., 2014, International Journal of Poultry Science, V13, P568; Taylor JRN, 2010, CEREAL CHEM, V87, P263, DOI 10.1094/CCHEM-87-4-0263; Tenenbaum DJ, 2008, ENVIRON HEALTH PERSP, V116, pA254, DOI 10.1289/ehp.116-a254; Truong HH, 2016, ANIM PROD SCI, V56, P797, DOI 10.1071/AN15056; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Weglarz A, 2010, CZECH J ANIM SCI, V55, P548, DOI 10.17221/2520-CJAS; Xu Y, 2015, POULTRY SCI, V94, P1549, DOI 10.3382/ps/pev074; Zhang X, 2017, INT J FOOD SCI TECH, V52, P2097, DOI 10.1111/ijfs.13488	42	0	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249371	10.1371/journal.pone.0249371	http://dx.doi.org/10.1371/journal.pone.0249371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780513	Green Published, gold			2022-12-26	WOS:000636336800018
J	So, H; Oh, CH; Song, TJ; Ko, SW; Hwang, JS; Oh, D; Park, D; Lee, SS; Seo, DW; Dong, SH; Lee, SK; Kim, MH				So, Hoonsub; Oh, Chi Hyuk; Song, Tae Jun; Ko, Sung Woo; Hwang, Jun Seong; Oh, Dongwook; Park, Do Hyun; Lee, Sang Soo; Seo, Dong-Wan; Dong, Seok Ho; Lee, Sung Koo; Kim, Myung-Hwan			Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction	PLOS ONE			English	Article							PLACEMENT; CELL	Introduction For unresectable hilar obstruction, restoring and maintaining biliary ductal patency are crucial for improved survival and quality of life. The endoscopic placement of stents is now a mainstay of its treatment, and bilateral stenting is effective for biliary decompression. This study aimed to determine the clinical outcomes of bilateral metal stent placement using large cell-type stents and the clinical predictors of stent dysfunction in patients with malignant hilar obstruction. Methods We performed a retrospective analysis of patients who underwent bilateral metal stent placement using two large cell-type stents at two academic teaching hospitals between September 2017 and February 2019. The primary outcome was stent dysfunction. Secondary outcomes included predictors related to stent dysfunction and overall survival. Results The study included 87 patients who underwent bilateral metal stent placement for malignant hilar obstruction. Technical success and clinical success were achieved in 80 patients (92.0%) and 83 patients (95.4%), respectively. During the follow-up period (median: 201, range: 18-671 days), stent dysfunction occurred in 42 patients (48.3%), and the median stent patency was 199 days (95% confidence interval [CI]: 181-262). In univariate analysis, age, cholangitis before stent insertion, and subsequent chemotherapy were found to be associated with the cumulative risk of stent dysfunction. In multivariate analysis, cholangitis before stent insertion (hazards ratio [HR]: 2.26, 95% CI: 1.216-4.209, P = 0.010) and subsequent chemotherapy (HR: 0.250, 95% CI: 0.130-0.482, P<0.001) remained as statically significant factors associated with the cumulative risk of stent dysfunction. The median overall survival was 288 days (95% CI: 230-327). Conclusion The bilateral placement of large cell-type stents for malignant hilar obstruction was effective with high technical and clinical success rates and acceptable patency. Cholangitis before stent insertion was associated with shorter patency, and subsequent chemotherapy was associated with longer stent patency.	[So, Hoonsub] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea; [Oh, Chi Hyuk; Dong, Seok Ho; Lee, Sung Koo] Kyung Hee Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea; [Song, Tae Jun; Ko, Sung Woo; Oh, Dongwook; Park, Do Hyun; Lee, Sang Soo; Seo, Dong-Wan; Lee, Sung Koo; Kim, Myung-Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Div Gastroenterol,Dept Internal Med, Seoul, South Korea; [Hwang, Jun Seong] Inje Univ, Coll Med, Dept Internal Med, Haeundae Paik Hosp,Div Gastroenterol, Busan, South Korea	University of Ulsan; Ulsan University Hospital; Kyung Hee University; Kyung Hee University Hospital; University of Ulsan; Asan Medical Center; Inje University	Song, TJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Gastroenterol,Dept Internal Med, Seoul, South Korea.	drsong@amc.seoul.kr		Oh, Chi Hyuk/0000-0002-4382-5876				Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; Blechacz B, 2017, GUT LIVER, V11, P13, DOI 10.5009/gnl15568; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Dumonceau JM, 2011, ENDOSCOPY, V43, P617, DOI 10.1055/s-0030-1256315; Dumonceau JM, 2018, ENDOSCOPY, V50, P910, DOI 10.1055/a-0659-9864; Heo JY, 2018, YONSEI MED J, V59, P827, DOI 10.3349/ymj.2018.59.7.827; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kogure H, 2014, DIGEST ENDOSC, V26, P93, DOI 10.1111/den.12055; Kogure H, 2011, J HEPATO-BIL-PAN SCI, V18, P653, DOI 10.1007/s00534-011-0407-4; Kwon CI, 2016, CLIN ENDOSC, V49, P139, DOI 10.5946/ce.2016.024; Lee JM, 2015, DIGEST ENDOSC, V27, P692, DOI 10.1111/den.12466; Lee TH, 2017, GASTROINTEST ENDOSC, V86, P817, DOI 10.1016/j.gie.2017.04.037; Martin RCG, 2002, SURG ENDOSC, V16, P667, DOI 10.1007/s004640080006; Miura S, 2016, ENDOSCOPY, V48, P536, DOI 10.1055/s-0042-102651; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Nam HS, 2016, CLIN ENDOSC, V49, P124, DOI 10.5946/ce.2016.023; Paik WH, 2018, AM J GASTROENTEROL, V113, P987, DOI 10.1038/s41395-018-0122-8; Park JM, 2016, HEPATOB PANCREAT DIS, V15, P633, DOI 10.1016/S1499-3872(16)60107-8; Puli SR, 2013, INDIAN J GASTROENTER, V32, P355, DOI 10.1007/s12664-013-0413-3; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Yang JF, 2018, ENDOSCOPY, V50, P751, DOI 10.1055/s-0043-124870; Yang MJ, 2018, GUT LIVER, V12, P722, DOI 10.5009/gnl17468	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249096	10.1371/journal.pone.0249096	http://dx.doi.org/10.1371/journal.pone.0249096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780489	gold, Green Published			2022-12-26	WOS:000636336800019
J	Wang, L; Huang, Z; Gao, HD; Ni, C				Wang, Li; Huang, Zhuo; Gao, Handong; Ni, Chao			A method for continuously monitoring the quality of Masson pine seedlings	PLOS ONE			English	Article								Root growth potential (RGP) is a popular physiological indicator used to evaluate seedling vigor. However, the time scale used in the RGP test is the order of days, which leads to poor performance of the RGP method. We propose an optical interference method, called statistical interferometry, to measure minute root elongation at a sub-nanometer scale, which can decrease the time used in measuring RGP. The time scale of this method is also 10(4) times less than that of the RGP method. Because we can measure the length of root elongation continuously, we can compute the root elongation rate (RER), which is the variety of the length of root elongation per second. Continuous monitoring can help determine the quality of Masson pine seedling as soon as possible. To show the effectiveness of our proposed method, we designed an experiment, in which we applied different water stresses to our collected Masson pine seedlings and acquired two groups of pines, representing two different qualities: one stressed by water and one not. After measuring the RER of the groups in our experiments, we found that RER is interrelated with the quality of seedlings.	[Wang, Li; Huang, Zhuo; Gao, Handong; Ni, Chao] Nanjing Forest Univ, Nanjing, Jiangshu, Peoples R China	Nanjing Forestry University	Ni, C (corresponding author), Nanjing Forest Univ, Nanjing, Jiangshu, Peoples R China.	chaoni@njfu.edu.cn			National Natural Science Foundation of China [NSFC: 31570714]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents Program	National Natural Science Foundation of China (NSFC: 31570714) and Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents Program.	Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; BRIERS JD, 1977, J EXP BOT, V28, P493, DOI 10.1093/jxb/28.2.493; BRIERS JD, 1978, J EXP BOT, V29, P395, DOI 10.1093/jxb/29.2.395; BURDETT AN, 1983, FOREST CHRON, V59, P132, DOI 10.5558/tfc59132-3; BURDETT AN, 1987, CAN J FOREST RES, V17, P768, DOI 10.1139/x87-123; Ciuonzo D, 2017, IEEE T SIGNAL PROCES, V65, P5078, DOI 10.1109/TSP.2017.2712124; Desobry F, 2005, IEEE T SIGNAL PROCES, V53, P2961, DOI 10.1109/TSP.2005.851098; Dyrseth AA, 1996, APPL OPTICS, V35, P3695, DOI 10.1364/AO.35.003695; FOX MD, 1977, PLANT PHYSIOL, V60, P30, DOI 10.1104/pp.60.1.30; GLADSTONE WT, 1990, FOREST ECOL MANAG, V35, P69, DOI 10.1016/0378-1127(90)90232-Z; Grossnickle S.C., 2000, ECOPHYSIOLOGY NO SPR; Grossnickle SC, 2016, NEW FOREST, V47, P1, DOI 10.1007/s11056-015-9476-6; Haase D.L., 2008, TREE PLANTERS NOTES, V52, P24; JIANG Z, 1989, J EXP BOT, V40, P1169, DOI 10.1093/jxb/40.10.1169; Johnson JD, 1991, FOREST REGENERATION, P143, DOI DOI 10.1007/978-94-011-3800-0_8; Kadono H, 2003, P SOC PHOTO-OPT INS, V4829, P988, DOI 10.1117/12.527504; KADONO H, 1991, OPT LETT, V16, P883, DOI 10.1364/OL.16.000883; Landis Thomas D., 2010, CONTAINER TREE NURSE; Lazar T., 2003, ANN BOT-LONDON, V91, P750, DOI DOI 10.1093/AOB/MCG079; Madjarova V, 2003, OPT REV, V10, P370, DOI 10.1007/s10043-003-0370-7; Mohammed GH, 1997, NEW FOREST, V13, P491, DOI 10.1023/A:1006571718255; Pescape A, 2019, CHARACTERIZING CLOUD; Rathnayake AP, 2008, ENVIRON EXP BOT, V64, P314, DOI 10.1016/j.envexpbot.2008.02.007; RITCHIE GA, 1990, USDA ROCKY, V200, P37; Ritchie GA, 1984, FOREST NURSERY MANUA, P243, DOI [10.1007/978-94-009-6110-4_23, DOI 10.1007/978-94-009-6110-4_23]; RUDOLF PAUL 0., 1939, JOUR FOREST, V37, P377; Schmundt D, 1998, PLANT J, V16, P505, DOI 10.1046/j.1365-313x.1998.00314.x; Simpson DG, 1997, NEW FOREST, V13, P253, DOI 10.1023/A:1006542526433; South DB, 2005, FOREST ECOL MANAG, V204, P385, DOI 10.1016/j.foreco.2004.09.016; STONE EDWARD C., 1955, FOREST SCI, V1, P90; Thompson B.E., 1985, SEEDLING MORPHOLOGIC; Toumey J.W., 1942, SEEDING PLANTING PRA; van der Weele CM, 2003, PLANT PHYSIOL, V132, P1138, DOI 10.1104/pp.103.021345; Walter A, 2002, J EXP BOT, V53, P689, DOI 10.1093/jexbot/53.369.689	34	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0234592	10.1371/journal.pone.0234592	http://dx.doi.org/10.1371/journal.pone.0234592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780451	gold, Green Published			2022-12-26	WOS:000636336800008
J	Granqvist, V; Holmgren, C; Larsson, C				Granqvist, Victoria; Holmgren, Christian; Larsson, Christer			Induction of interferon-beta and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; APOPTOSIS; RECEPTOR; ANTAGONISTS; INHIBITORS; FAMILY; IAP	Breast cancer prognosis is frequently good but a substantial number of patients suffer from relapse. The death receptor ligand TRAIL can in combination with Smac mimetics induce apoptosis in some luminal-like ER-positive breast cancer cell lines, such as CAMA-1, but not in MCF-7 cells. Here we show that TRAIL and the Smac mimetic LCL161 induce non-canonical NF-kappa B and IFN signaling in ER-positive MCF-7 cells and in CAMA-1 breast cancer cells when apoptosis is blocked by caspase inhibition. Levels of p52 are increased and STAT1 gets phosphorylated. STAT1 phosphorylation is induced by TRAIL alone in MCF-7 cells and is independent of non-canonical NF-kappa B since downregulation of NIK has no effect. The phosphorylation of STAT1 is a rather late event, appearing after 24 hours of TRAIL stimulation. It is preceded by an increase in IFNB1 mRNA levels and can be blocked by siRNA targeting the type I IFN receptor IFNAR1 and by inhibition of Janus kinases by Ruxolitinib. Moreover, downregulation of caspase-8, but not inhibition of caspase activity, blocks TRAIL-mediated STAT1 phosphorylation and induction of IFN-related genes. The data suggest that TRAIL-induced IFNB1 expression in MCF-7 cells is dependent on a non-apoptotic role of caspase-8 and leads to autocrine interferon-beta signaling.	[Granqvist, Victoria; Holmgren, Christian; Larsson, Christer] Lund Univ, Translat Canc Res, Lund, Sweden	Lund University	Larsson, C (corresponding author), Lund Univ, Translat Canc Res, Lund, Sweden.	Christer.Larsson@med.lu.se			Swedish Cancer Society; Royal Physiographic Society of Lund	Swedish Cancer Society(Swedish Cancer Society); Royal Physiographic Society of Lund	CL: The Swedish Cancer Society, https://www.cancerfonden.se/CH: The Royal Physiographic Society of Lund, https://www.fysiografen.se/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anurag M, 2020, JNCI-J NATL CANCER I, V112, P737, DOI 10.1093/jnci/djz213; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bai LC, 2014, PHARMACOL THERAPEUT, V144, P82, DOI 10.1016/j.pharmthera.2014.05.007; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Brueffer C, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00135; Choi HJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0506-7; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; COHEN B, 1995, MOL CELL BIOL, V15, P4208; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dine JL, 2016, BREAST CANCER RES TR, V155, P235, DOI 10.1007/s10549-015-3673-z; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Greer YE, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1116-1; Harada H, 1996, GENES CELLS, V1, P995, DOI 10.1046/j.1365-2443.1996.870287.x; Hartwig T, 2017, MOL CELL, V65, P730, DOI 10.1016/j.molcel.2017.01.021; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Horn S, 2017, CELL REP, V19, P785, DOI 10.1016/j.celrep.2017.04.010; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Ji MJ, 2011, DIAGN PATHOL, V6, DOI [10.1186/1746-1596-6-48, 10.1186/1746-1596-6-49]; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; Lafont E, 2018, NAT CELL BIOL, V20, P1389, DOI 10.1038/s41556-018-0229-6; Lan Q, 2019, ONCOGENE, V38, P2814, DOI 10.1038/s41388-018-0624-2; Legrier ME, 2016, BRIT J CANCER, V114, P177, DOI 10.1038/bjc.2015.398; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Mariani SM, 1997, J CELL BIOL, V137, P221, DOI 10.1083/jcb.137.1.221; Morrish E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020406; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peteranderl C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00313; Post AEM, 2018, CLIN CANCER RES, V24, P3397, DOI 10.1158/1078-0432.CCR-17-2551; Qadir AS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58211-3; REIS LFL, 1989, J BIOL CHEM, V264, P16351; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saleh D, 2017, J IMMUNOL, V198, P4435, DOI 10.4049/jimmunol.1601717; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Silginer M, 2017, NEURO-ONCOLOGY, V19, P1338, DOI 10.1093/neuonc/nox051; Song JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136629; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stickeler E, 2011, BREAST CARE, V6, P193, DOI 10.1159/000329471; Tang WH, 2009, CELL RES, V19, P758, DOI 10.1038/cr.2009.57; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9	60	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248175	10.1371/journal.pone.0248175	http://dx.doi.org/10.1371/journal.pone.0248175			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770100	gold, Green Published			2022-12-26	WOS:000634833500050
J	Taylor, A; Grapentine, S; Ichhpuniani, J; Bakovic, M				Taylor, Adrian; Grapentine, Sophie; Ichhpuniani, Jasmine; Bakovic, Marica			Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE GENE; FUNCTIONAL-CHARACTERIZATION; CTP; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; DEFICIENCY; TARGET; CANCER; CELLS	The membrane phospholipids phosphatidylcholine and phosphatidylethanolamine (PE) are synthesized de novo by the CDP-choline and CDP-ethanolamine (Kennedy) pathway, in which the extracellular substrates choline and ethanolamine are transported into the cell, phosphorylated, and coupled with diacylglycerol to form the final phospholipid product. Although multiple transport systems have been established for choline, ethanolamine transport is poorly characterized and there is no single protein assigned a transport function for ethanolamine. The solute carriers 44A (SLC44A) known as choline transporter-like proteins-1 and -2 (CTL1 and CTL2) are choline transporter at the plasma membrane and mitochondria. We report a novel function of CTL1 and CTL2 in ethanolamine transport. Using the lack or the gain of gene function in combination with specific antibodies and transport inhibitors we established two distinct ethanolamine transport systems of a high affinity, mediated by CTL1, and of a low affinity, mediated by CTL2. Both transporters are Na+-independent ethanolamine/H+ antiporters. Primary human fibroblasts with separate frameshift mutations in the CTL1 gene (M1 = SLC44A1(Delta Asp517) and M2 = SLC44A1(Delta Ser126)) are devoid of CTL1 ethanolamine transport but maintain unaffected CTL2 transport. The lack of CTL1 in M2 cells reduced the ethanolamine transport, the flux through the CDP-ethanolamine Kennedy pathway, and PE synthesis. In contrast, overexpression of CTL1 in M2 cells improved ethanolamine transport and PE synthesis. These data firmly establish that CTL1 and CTL2 are the first identified ethanolamine transporters in whole cells and mitochondria, with intrinsic roles in de novo PE synthesis by the Kennedy pathway and intracellular redistribution of ethanolamine.	[Taylor, Adrian; Grapentine, Sophie; Ichhpuniani, Jasmine; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada	University of Guelph	Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada.	mbakovic@uoguelph.ca		Bakovic, Marica/0000-0001-9081-3539	University of Guelph Scholarship; Canadian Institutes of Health Research Grant [CIHR-450137]; National Sciences and Engineering Research Council of Canada [NSERC-400482]	University of Guelph Scholarship; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the University of Guelph Scholarship (to A. T. and S. G.), the Canadian Institutes of Health Research Grant #CIHR-450137, and the National Sciences and Engineering Research Council of Canada Discovery Grant #NSERC-400482 (to M. B.).	Ball WB, 2018, J BIOL CHEM, V293, P10870, DOI 10.1074/jbc.RA118.004014; Bennett JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17254-w; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang WG, 2019, J CELL MOL MED, V23, P702, DOI 10.1111/jcmm.13984; Constantinescu-Bercu A, 2020, J THROMB HAEMOST, V18, P1556, DOI 10.1111/jth.14834; Constantinescu-Bercu A, 2020, ELIFE, V9, DOI 10.7554/eLife.53353; Fagerberg CR, 2020, BRAIN, V143, P94, DOI 10.1093/brain/awz376; Flesch BK, 2018, TRANSFUS MED HEMOTH, V45, P300, DOI 10.1159/000491031; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Girardi JP, 2011, MED HYPOTHESES, V77, P1083, DOI 10.1016/j.mehy.2011.09.008; Heden TD, 2016, TRENDS ENDOCRIN MET, V27, P553, DOI 10.1016/j.tem.2016.05.007; Hedtke V, 2019, EXP BIOL MED, V244, P655, DOI 10.1177/1535370219830997; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Iwao B, 2016, NEUROCHEM INT, V93, P40, DOI 10.1016/j.neuint.2015.12.011; Jennings W, 2020, CHEM PHYS LIPIDS, V230, DOI 10.1016/j.chemphyslip.2020.104914; Kouji H, 2009, ARCH BIOCHEM BIOPHYS, V483, P90, DOI 10.1016/j.abb.2008.12.008; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; LIPTON BA, 1988, J CELL PHYSIOL, V137, P571, DOI 10.1002/jcp.1041370325; Martensson CU, 2017, BBA-MOL CELL BIOL L, V1862, P102, DOI 10.1016/j.bbalip.2016.06.015; MASSARELLI AC, 1986, NEUROCHEM RES, V11, P29, DOI 10.1007/BF00965162; Michel V, 2006, EXP BIOL MED, V231, P490; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Nagashima F, 2018, BIOMOL THER, V26, P399, DOI 10.4062/biomolther.2017.113; Nair T. S., GENOMICS, V108, P201; Nishiyama R, 2016, J PHARMACOL SCI, V131, P101, DOI 10.1016/j.jphs.2016.04.022; Patel D, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/4829180; Pavlovic Z, 2014, J BIOL CHEM, V289, P9053, DOI 10.1074/jbc.M113.544932; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Schenkel LC, 2015, J NUTR BIOCHEM, V26, P1221, DOI 10.1016/j.jnutbio.2015.05.014; Schenkel LC, 2015, FASEB J, V29, P1663, DOI 10.1096/fj.14-258566; Schenkel LC, 2014, LIPIDS, V49, P731, DOI 10.1007/s11745-014-3925-4; Selathurai A, 2015, CELL METAB, V21, P718, DOI 10.1016/j.cmet.2015.04.001; Sivanesan S, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00061; Taguchi C, 2014, BIOCHEM PHARMACOL, V88, P303, DOI 10.1016/j.bcp.2014.01.033; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Tilburg J, 2020, J THROMB HAEMOST, V18, P1714, DOI 10.1111/jth.14835; Tilburg J, 2018, THROMB RES, V171, P155, DOI 10.1016/j.thromres.2018.09.057; Trotta F, 2020, MOL CANCER THER, V19, P1909, DOI 10.1158/1535-7163.MCT-19-1063; Yang HS, 2016, IN VITRO CELL DEV-AN, V52, P562, DOI 10.1007/s11626-016-0002-8; YOREK MA, 1986, J LIPID RES, V27, P1205; ZELINSKI TA, 1984, BIOCHIM BIOPHYS ACTA, V794, P326, DOI 10.1016/0005-2760(84)90163-2; ZHA XL, 1992, BIOCHEM CELL BIOL, V70, P1319, DOI 10.1139/o92-179; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	45	8	8	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100604	10.1016/j.jbc.2021.100604	http://dx.doi.org/10.1016/j.jbc.2021.100604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789160	Green Published, gold			2022-12-26	WOS:000672866400576
J	Li, J; Song, J; Yan, BX; Weiss, HL; Weiss, LT; Gao, TY; Evers, BM				Li, Jing; Song, Jun; Yan, Baoxiang; Weiss, Heidi L.; Weiss, L. Todd; Gao, Tianyan; Evers, B. Mark			Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance	FASEB JOURNAL			English	Article						cancer; gut hormones; high-fat diet; metabolism; obesity	RECEPTOR; FAT; RELEASE; MICE; CELL	Studies demonstrate a role for neurotensin (NT) in obesity and related comorbidities. Bile acid (BA) homeostasis alterations are associated with obesity. We determined the effect of NT on BA metabolism in obese and non-obese conditions. Plasma and fecal BA profiles were analyzed by LC-MS/MS in male and female NT+/+ and NT-/- mice fed low-fat (LFD) or high-fat diet (HFD) for 6 weeks (early stage of obesity) or greater than 20 weeks (late stage of obesity). The nuclear farnesoid X receptor (FXR) and BA transporter mRNA expression were assessed in ileum, mouse enteroids, and human cell lines. HFD decreased plasma primary and secondary BAs in NT+/+ mice; HFD-induced decrease of plasma BAs was improved in NT-deficient mice. In NT+/+ mice, HFD inhibited ileal FXR and BA transporter expression; HFD-decreased expression of FXR and BA transporters was prevented in NT-/- mice. Compared with LFD-fed NT+/+ mice, LFD-fed NT-/- mice had relatively lower levels of ileal FXR and BA transporter expression. Moreover, NT stimulates the expression of FXR and BA transporters in Caco-2 cells; however, stimulated expression of BA transporters was attenuated in NT-/- enteroids. Therefore, we demonstrate that HFD disrupts the BA metabolism and ileal FXR and BA transporter axis which are improved in the absence of NT, suggesting that NT contributes to HFD-induced disruption of BA metabolism and plays an inhibitory role in the regulation of ileal FXR and BA transporter signaling under obese conditions. Conversely, NT positively regulates the expression of ileal FXR and BA transporters under non-obese conditions. Therefore, NT plays a dual role in obese and non-obese conditions, suggesting possible therapeutic strategies for obesity control.	[Li, Jing; Song, Jun; Evers, B. Mark] Univ Kentucky, Med Ctr, Lexington, KY 40536 USA; [Li, Jing; Song, Jun; Yan, Baoxiang; Weiss, Heidi L.; Weiss, L. Todd; Gao, Tianyan; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Weiss, Heidi L.] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, H181 UK Chandler Hosp, 800 Rose St, Lexington, KY 40536 USA.	mark.evers@uky.edu			HHS vertical bar National Institutes of Health (NIH) [R01 DK112034, R01 DK48489]	HHS vertical bar National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: R01 DK112034 and R01 DK48489	ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1983, GASTROENTEROLOGY, V84, P556; BARBER DL, 1991, AM J PHYSIOL, V261, pG497, DOI 10.1152/ajpgi.1991.261.3.G497; Besserer-Offroy E, 2017, EUR J PHARMACOL, V805, P1, DOI 10.1016/j.ejphar.2017.03.046; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bird JL, 2017, EUR J PHARM BIOPHARM, V119, P300, DOI 10.1016/j.ejpb.2017.06.027; BLACKBURN AM, 1981, J PHYSIOL-LONDON, V314, P11, DOI 10.1113/jphysiol.1981.sp013686; Browning MG, 2019, CURR OBES REP, V8, P175, DOI 10.1007/s13679-019-00334-4; Cariou B, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-48; Chen LM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108212; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; EVERS BM, 1992, ANN SURG, V216, P423, DOI 10.1097/00000658-199210000-00005; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gonzalez FJ, 2017, DIGEST DIS, V35, P178, DOI 10.1159/000450908; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gui XY, 2004, AM J PHYSIOL-GASTR L, V287, pG408, DOI 10.1152/ajpgi.00178.2003; Haeusler RA, 2016, J CLIN ENDOCR METAB, V101, P1935, DOI 10.1210/jc.2015-2583; Hofmann AF, 2009, HEPATOLOGY, V49, P1403, DOI 10.1002/hep.22789; Ippagunta SM, 2018, J NUTR, V148, P510, DOI 10.1093/jn/nxy022; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; La Merrill M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103337; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li J, 2020, FASEB J, V34, P8596, DOI 10.1096/fj.201902374RR; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; Prinz P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00199; ROSELL S, 1979, ACTA PHYSIOL SCAND, V107, P263, DOI 10.1111/j.1748-1716.1979.tb06472.x; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sundaram S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101197; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Xiao YT, 2018, EBIOMEDICINE, V35, P133, DOI 10.1016/j.ebiom.2018.08.006	43	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21371	10.1096/fj.202001692R	http://dx.doi.org/10.1096/fj.202001692R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811694	Green Accepted			2022-12-26	WOS:000645260100093
J	Wang, X; Guan, RJ; Zhao, XM; Chen, J; Zhu, DN; Shen, LL; Song, NN				Wang, Xia; Guan, Ruijuan; Zhao, Xiaomei; Chen, Jun; Zhu, Danian; Shen, Linlin; Song, Nana			TASK1 and TASK3 in orexin neuron of lateral hypothalamus contribute to respiratory chemoreflex by projecting to nucleus tractus solitarius	FASEB JOURNAL			English	Article						chemoreflex; lateral hypothalamus; nucleus tractus solitarius; orexin; TASK1; TASK3	LYMPHATIC ENDOTHELIAL-CELLS; VESSEL FORMATION; HYALURONAN; HYDROGELS; RECEPTOR; LYMPHANGIOGENESIS; ANGIOGENESIS; INDUCTION; MT1-MMP; BINDING	TWIK-related acid-sensitive potassium channels (TASKs)-like current was recorded in orexin neurons in the lateral hypothalamus (LH), which are essential in respiratory chemoreflex. However, the specific mechanism responsible for the pH-sensitivity remains elusive. Thus, we hypothesized that TASKs contribute to respiratory chemoreflex. In the present study, we found that TASK1 and TASK3 were expressed in orexin neurons. Blocking TASKs or microinjecting acid artificial cerebrospinal fluid (ACSF) in the LH stimulated breathing. In contrast, alkaline ACSF inhibited breathing, which was attenuated by blocking TASK1. Damage of orexin neurons attenuated the stimulatory effect on respiration caused by microinjection of acid ACSF (at a pH of 6.5) or TASKs antagonists. The orexinA-positive fiber and orexin type 1 receptor (OX1R) neurons were located in the nucleus tractus solitarius (NTS). The exciting effect of acidosis in the LH on respiration was inhibited by blocking OX1R of the NTS. Taken together, we conclude that orexin neurons sense the extracellular pH change through TASKs and regulate respiration by projecting to the NTS.	[Wang, Xia; Guan, Ruijuan; Zhao, Xiaomei; Zhu, Danian; Shen, Linlin] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Wang, Xia] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China; [Chen, Jun] Naval Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China; [Shen, Linlin] Fudan Univ, Shanghai Key Lab Med Imaging Comp & Comp Assisted, Shanghai 200032, Peoples R China; [Song, Nana] Fudan Univ, Zhongshan Hosp, Div Nephrol, Shanghai 200032, Peoples R China	Fudan University; Shanghai Jiao Tong University; Naval Medical University; Fudan University; Fudan University	Shen, LL (corresponding author), Fudan Univ, Shanghai Key Lab Med Imaging Comp & Comp Assisted, Shanghai 200032, Peoples R China.; Song, NN (corresponding author), Fudan Univ, Zhongshan Hosp, Div Nephrol, Shanghai 200032, Peoples R China.	shenll@shmu.edu.cn; song.nana@zs-hospital.sh.cn			NSFC vertical bar Major Research Plan [81470203]; NSFC vertical bar Young Scientists Fund [81500048]	NSFC vertical bar Major Research Plan; NSFC vertical bar Young Scientists Fund	NSFC broken vertical bar Major Research Plan, Grant/Award Number: 81470203; NSFC broken vertical bar Young Scientists Fund, Grant/Award Number: 81500048	BANERJEE SD, 1992, J CELL BIOL, V119, P643, DOI 10.1083/jcb.119.3.643; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Campbell KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181484; Cho H, 2019, CIRC RES, V124, P225, DOI 10.1161/CIRCRESAHA.118.313707; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Detry B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-29; Dixon JB, 2009, BIOTECHNOL BIOENG, V103, P1224, DOI 10.1002/bit.22337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faust HJ, 2018, BIOMATERIALS, V183, P93, DOI 10.1016/j.biomaterials.2018.08.045; Frye M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03959-6; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Gramolelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27739-w; Grimm L, 2019, ELIFE, V8, DOI 10.7554/eLife.42881; Guc E, 2017, BIOMATERIALS, V131, P160, DOI 10.1016/j.biomaterials.2017.03.033; Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hanjaya-Putra D, 2009, BIOTECHNOL PROGR, V25, P2, DOI 10.1002/btpr.129; Helm CLE, 2007, BIOTECHNOL BIOENG, V96, P167, DOI 10.1002/bit.21185; Hillel AT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002331; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kazenwadel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040497; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Knezevic Lea, 2017, Front Bioeng Biotechnol, V5, P25, DOI 10.3389/fbioe.2017.00025; Kono T, 2006, ARTERIOSCL THROM VAS, V26, P2070, DOI 10.1161/01.ATV.0000225770.57219.b0; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Liao S, 2013, LYMPHAT RES BIOL, V11, P136, DOI 10.1089/lrb.2013.0012; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894; Mason DE, 2019, J CELL BIOL, V218, P1369, DOI 10.1083/jcb.201806065; Muylaert DEP, 2014, HEART, V100, P1825, DOI 10.1136/heartjnl-2014-306092; Nguyen EH, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0096; Oliver G, 2020, CELL, V182, P270, DOI 10.1016/j.cell.2020.06.039; Park KM, 2014, DEVELOPMENT, V141, P2760, DOI 10.1242/dev.102194; Petrova TV, 2020, SCIENCE, V369, P157, DOI 10.1126/science.aax4063; Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Schaupper M, 2016, TISSUE ENG PART B-RE, V22, P395, DOI 10.1089/ten.teb.2016.0034; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Sweat RS, 2014, MICROCIRCULATION, V21, P532, DOI 10.1111/micc.12132; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141; Varberg KM, 2018, JOVE-J VIS EXP, DOI 10.3791/57044; Varberg KM, 2017, AM J PHYSIOL-CELL PH, V312, pC446, DOI 10.1152/ajpcell.00367.2016; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wolf KJ, 2019, ACS BIOMATER SCI ENG, V5, P3753, DOI 10.1021/acsbiomaterials.8b01268; Wong HLX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10824; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d; Yao GY, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-98; Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.TEA.2010.0481, 10.1089/ten.tea.2010.0481]; Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809	60	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21532	10.1096/fj.202002189R	http://dx.doi.org/10.1096/fj.202002189R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817828	hybrid			2022-12-26	WOS:000645260100100
J	Liu, Y; Tang, TC; Yang, XS; Qin, P; Wang, PS; Zhang, HP; Bai, M; Wu, R; Li, F				Liu, Yang; Tang, Tianchi; Yang, Xiaosheng; Qin, Peng; Wang, Pusen; Zhang, Huiping; Bai, Min; Wu, Rong; Li, Fan			Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition through the Wnt/beta-catenin pathway by silencing AXIN2	ONCOGENE			English	Article								Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies and rapidly progressive diseases. Exosomes and long noncoding RNAs (lncRNAs) are emerging as vital mediators in tumor cells and their microenvironment. However, the detailed roles and mechanisms of exosomal lncRNAs in PDAC progression remain unknown. Here, we aimed to clarify the clinical significance and mechanisms of exosomal lncRNA 01133 (LINC01133) in PDAC. We analyzed the expression of LINC01133 in PDAC and found that exosomal LINC01133 expression was high and positively correlated with higher TNM stage and poor overall survival rate of PDAC patients. Further research demonstrated that Periostin could increase exosome secretion and then enhance LINC01133 expression. In addition, Periostin increased p-EGFR, p-Erk, and c-myc expression, and c-myc could bind to the LINC01133 promoter region. These findings suggested that LINC01133 can be regulated by Periostin via EGFR pathway activity. We also observed that LINC01133 promoted the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of pancreatic cancer cells. We subsequently evaluated the effect of LINC01133 on the Wnt/beta-catenin pathway and confirmed that LINC01133 can interact with Enhancer Of Zeste Homolog 2 (EZH2) and then promote H3K27 trimethylation. This can further silence AXIN2 and suppress GSK3 activity, ultimately activating beta-catenin. Collectively, these data indicate that exosomal LINC01133 plays an important role in pancreatic tumor progression, and targeting LINC01133 may provide a potential treatment strategy for PDAC.	[Liu, Yang; Bai, Min; Wu, Rong; Li, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ultrasound, Shanghai, Peoples R China; [Tang, Tianchi] Shanghai Jiao Tong Univ, Sch Med, Affiliated Xinhua Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Yang, Xiaosheng] Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China; [Qin, Peng] Shanghai Jiao Tong Univ, Dept Instrument Sci & Engn, Shanghai, Peoples R China; [Wang, Pusen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Zhang, Huiping] East China Normal Univ, Shanghai Changning Matern & Infant Hlth Hosp, Matern & Infant Hlth Hosp, Dept Ultrasound, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University	Wu, R; Li, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ultrasound, Shanghai, Peoples R China.	wurong7111@163.com; medicineli@163.com		Fan, Li/0000-0003-3550-0243	Shanghai Municipal Commission of Health and Family Planning [20184Y0363]; Medical and Engineering Cross-Foundation of Shanghai Jiaotong University [ZH2018QNA21]; Songjiang District Science and Technology Research Projects of Shanghai [19SJKJGG29]; National Natural Science Foundation of China [81571679, 81771838]; Shanghai Natural Science Foundation [19ZR1441500]	Shanghai Municipal Commission of Health and Family Planning; Medical and Engineering Cross-Foundation of Shanghai Jiaotong University; Songjiang District Science and Technology Research Projects of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	Funding were provided by Shanghai Municipal Commission of Health and Family Planning (20184Y0363), the Medical and Engineering Cross-Foundation of Shanghai Jiaotong University (ZH2018QNA21), Songjiang District Science and Technology Research Projects of Shanghai (19SJKJGG29), the National Natural Science Foundation of China (Nos. 81571679 and 81771838) and the Shanghai Natural Science Foundation (19ZR1441500).	Bolha L, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/7243968; Danieau G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153751; Ding J, 2018, ONCOGENE, V37, P5037, DOI 10.1038/s41388-018-0175-6; Dong D, 2018, CANCER SCI, V109, P2841, DOI 10.1111/cas.13712; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feng Y, 2019, CANCER BIOL THER, V20, P1453, DOI 10.1080/15384047.2019.1647058; Foroughi K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123881; Fu YJ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0815-z; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Gruszka AM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111403; Han ML, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1145-5; He P, 2018, GASTROENTEROLOGY, V154, P1494, DOI 10.1053/j.gastro.2017.12.005; Huang YK, 2020, AM J CANCER RES, V10, P131; Jin H, 2017, CLIN TRANSL ONCOL, V19, P921, DOI 10.1007/s12094-017-1625-2; Kong JL, 2016, CANCER LETT, V380, P476, DOI 10.1016/j.canlet.2016.07.015; Kumar MM, 2017, CURR TOP MED CHEM, V17, P1750, DOI 10.2174/1568026617666161116144744; Lan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184332; Liu Y, 2017, ONCOTARGET, V8, P89552, DOI 10.18632/oncotarget.11533; Lu HZ, 2017, CANCER MED-US, V6, P1181, DOI 10.1002/cam4.1064; Makena MR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174242; Murillo-Garzon V, 2017, NAT REV UROL, V14, P683, DOI 10.1038/nrurol.2017.144; Pirogov SA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070668; Ren B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0858-1; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Saini F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050424; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sun QY, 2018, NUCLEIC ACIDS RES, V46, P10405, DOI 10.1093/nar/gky696; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tandon M, 2019, CANCER RES, V79, P5316, DOI 10.1158/0008-5472.CAN-18-3064; Tang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1128-6; Thomas D, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0927-5; Viotti M, 2018, J CELL BIOL, V217, P763, DOI 10.1083/jcb.201705031; Wang J, 2020, INT J CANCER, V146, P906, DOI 10.1002/ijc.32277; Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841; Ware MJ, 2016, BIOMATERIALS, V108, P129, DOI 10.1016/j.biomaterials.2016.08.041; Wen ZZ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0590-2; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Zeng FR, 2020, ONCOGENE, V39, P293, DOI 10.1038/s41388-019-0984-2; Zeng HF, 2018, ONCOL RES, V26, P335, DOI 10.3727/096504017X14907375885605; Zhang J, 2015, TUMOR BIOL, V36, P7465, DOI 10.1007/s13277-015-3460-9; Zhang YF, 2018, CANCER LETT, V431, P190, DOI 10.1016/j.canlet.2018.05.027; Zheng YF, 2019, J CELL BIOCHEM, V120, P4172, DOI 10.1002/jcb.27704; Zhuang XQ, 2017, NAT CELL BIOL, V19, P1274, DOI 10.1038/ncb3613	44	21	21	4	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3164	3179		10.1038/s41388-021-01762-0	http://dx.doi.org/10.1038/s41388-021-01762-0		APR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33824474	Green Published, hybrid			2022-12-26	WOS:000637478800003
J	Lakew, BT; Nicholas, AH; Walkden-Brown, SW				Lakew, Biniam T.; Nicholas, Adrian H.; Walkden-Brown, Stephen W.			Spatial and temporal distribution of Culicoides species in the New England region of New South Wales, Australia between 1990 and 2018	PLOS ONE			English	Article							BREVITARSIS KIEFFER DIPTERA; BITING-MIDGES; ARBOVIRUS VECTOR; SPP. DIPTERA; CERATOPOGONIDAE; DISPERSAL; BLUETONGUE; DISTANCE; ABUNDANCE	Culicoides are one of the smallest hematophagous flies measuring 1-5 mm in size with only females seeking blood for egg development. The present study investigated spatio-temporal distribution of Culicoides species trapped between 1990 and 2018 at 13 sites in the New England region of NSW, Australia using automated light traps. Trapping locations were divided into three subregions (tablelands, slopes and plains). Nineteen Culicoides species were identified. Culicoides marksi and C. austropalpalis were the most abundant and widespread species. Culicoides brevitarsis, the principal vector of livestock diseases in New South Wales comprised 2.9% of the total catch and was detected in 12 of the 13 locations in the study. Abundance as determined by Log(10) Culicoides count per trapping event for the eight most abundant species did not vary significantly with season but trended towards higher counts in summer for C. marksi (P = 0.09) and C. austropalpalis (P = 0.05). Significant geographic variation in abundance was observed for C. marksi, C. austropalpalis and C. dycei with counts decreasing with increasing altitude from the plains to the slopes and tablelands. Culicoides victoriae exhibited the reverse trend in abundance (P = 0.08). Greater abundance during the warmer seasons and at lower altitudes for C. marksi and C. austropalpalis was indicative of temperature and rainfall dependence in this region with moderate summer dominance in rainfall. The Shannon-Wiener diversity index of species was higher on the tablelands (H = 1.59) than the slopes (H = 1.33) and plains (H = 1.08) with evenness indices of 0.62, 0.46 and 0.39 respectively. Culicoides species on the tablelands were more diverse than on the slopes and plains where C. marksi and C. austropalpalis dominated. The temporal and spatial variation in abundance, diversity and evenness of species reported in this diverse region of Australia provides additional insight into Culicoides as pests and disease vectors and may contribute to future modelling studies.	[Lakew, Biniam T.; Walkden-Brown, Stephen W.] Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia; [Lakew, Biniam T.] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia; [Nicholas, Adrian H.] Cent Coast Primary Ind Ctr, Dept Reg New South Wales, Ourimbah, NSW, Australia	University of New England; Haramaya University	Lakew, BT (corresponding author), Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia.; Lakew, BT (corresponding author), Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia.	blakew@myune.edu.au		Walkden-Brown, Stephen/0000-0002-0638-5533; TSEGAYE, BINIAM/0000-0002-7379-8733	School of Environmental and Rural Science, University of New England, Australia under BTL PhD project	School of Environmental and Rural Science, University of New England, Australia under BTL PhD project	This study was supported by a postgraduate operating grant from the School of Environmental and Rural Science, University of New England, Australia under BTL PhD project and the author(s) received no specific funding for this work.	ABARES, 2019, CATCHM SCAL LAND US, DOI [10.25814/5c7728700fd2a, DOI 10.25814/5C7728700FD2A]; Australian Bureau of Statistics, 2016, 2016 CENS; Bellis Glenn A., 2005, Arbovirus Research in Australia, V9, P33; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 1996, AUST J ENTOMOL, V35, P361, DOI 10.1111/j.1440-6055.1996.tb01419.x; Bishop AL, 1996, AUST VET J, V73, P174, DOI 10.1111/j.1751-0813.1996.tb10021.x; BISHOP AL, 1994, J AUST ENTOMOL SOC, V33, P159; Bishop AL, 2004, VETER ITAL SER, V40, P266; Bishop AL, 2004, PREV VET MED, V65, P135, DOI 10.1016/j.prevetmed.2004.06.011; Bishop AL, 2004, AUST J ENTOMOL, V43, P184, DOI 10.1111/j.1440-6055.2003.00391.x; BISHOP AL, 1995, J AUST ENTOMOL SOC, V34, P289; Bishop AL, 2006, AUST J ENTOMOL, V45, P202, DOI 10.1111/j.1440-6055.2006.00538.x; Borkent A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)449<0001:AWALAL>2.0.CO;2; Borkent A, 2004, ZOOTAXA, P1; Borkent A, 2020, ZOOTAXA, V4787, P1, DOI 10.11646/zootaxa.4787.1.1; BRAVERMAN Y, 1981, Journal of the Entomological Society of Southern Africa, V44, P315; Cannon L. R. G., 1966, Journal of the Entomological Society of Queensland, V5, P7; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; DYCE A L, 1972, Journal of the Australian Entomological Society, V11, P91; Dyce A. L., 1966, Journal of the Entomological Society of Queensland, V5, P37; Dyce AL, 2007, PICTORIAL ATLAS AUST; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Eagles D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-135; Gale P, 2009, J APPL MICROBIOL, V106, P1409, DOI 10.1111/j.1365-2672.2008.04036.x; GEORGE TS, 1989, AUST VET J, V66, P393, DOI 10.1111/j.1751-0813.1989.tb13555.x; Johansen CA, 2003, MED VET ENTOMOL, V17, P102, DOI 10.1046/j.1365-2915.2003.00413.x; Kirkland PD, 1995, ACIAR PROC, P95; Kirkland PD, 2004, VETER ITAL SER, V40, P47; Lea D, 1977, ATLAS NEW ENGLAND, P1; Leta S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50765-1; Leta S, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0197-0; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mukhopadhyay E, 2017, ACTA TROP, V176, P402, DOI 10.1016/j.actatropica.2017.09.008; Mullen GR, 2019, MEDICAL AND VETERINARY ENTOMOLOGY, 3RD EDITION, P213, DOI 10.1016/B978-0-12-814043-7.00013-3; MULLER MJ, 1977, AUST J ZOOL, V25, P75, DOI 10.1071/ZO9770075; Muller MJ, 1982, SELECTED CLIMATIC DA; MURRAY MD, 1987, AUST VET J, V64, P305, DOI 10.1111/j.1751-0813.1987.tb07332.x; MURRAY MD, 1975, AUST VET J, V51, P216, DOI 10.1111/j.1751-0813.1975.tb00060.x; MURRAY MD, 1987, AUST J ZOOL, V35, P559, DOI 10.1071/ZO9870559; MURRAY MD, 1991, AUST J ZOOL, V39, P333, DOI 10.1071/ZO9910333; SELLERS RF, 1977, J HYG-CAMBRIDGE, V79, P279, DOI 10.1017/S0022172400053109; Standfast H.A., 1985, Progress in Clinical and Biological Research, V178, P177; STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351; STANDFAST HA, 1972, AUST VET J, V48, P224, DOI 10.1111/j.1751-0813.1972.tb05139.x; STANDFAST HA, 1989, AUST VET J, V66, P396, DOI 10.1111/j.1751-0813.1989.tb13556.x; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Tay WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146699; Taylor MA., 2016, VET PARASITOL, VFourth; Walker G., 1977, ATLAS NEW ENGLAND, V2, P11; Yu Y., 2005, INSECTA DIPTERA, V1, P2	52	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249468	10.1371/journal.pone.0249468	http://dx.doi.org/10.1371/journal.pone.0249468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819313	gold, Green Published			2022-12-26	WOS:000637647200023
J	Seligman, H; Zaman, S; Pitcher, DS; Shun-Shin, MJ; Lloyd, FH; Androschuk, V; Sen, S; Al-Lamee, R; Miller, DM; Barnett, HW; Haji, GS; Howard, LS; Nijjer, S; Mayet, J; Francis, DP; Ces, O; Linton, NWF; Peters, NS; Petraco, R				Seligman, Henry; Zaman, Sameer; Pitcher, David S.; Shun-Shin, Matthew J.; Hepworth Lloyd, Freya; Androschuk, Vitaliy; Sen, Sayan; Al-Lamee, Rasha; Miller, David M.; Barnett, Harry W.; Haji, Gulam S.; Howard, Luke S.; Nijjer, Sukhjinder; Mayet, Jamil; Francis, Darrel P.; Ces, Oscar; Linton, Nicholas W. F.; Peters, Nicholas S.; Petraco, Ricardo			Reusable snorkel masks adapted as particulate respirators	PLOS ONE			English	Article							FACE MASKS	Introduction During viral pandemics, filtering facepiece (FFP) masks together with eye protection form the essential components of personal protective equipment (PPE) for healthcare workers. There remain concerns regarding insufficient global supply and imperfect protection offered by currently available PPE strategies. A range of full-face snorkel masks were adapted to accept high grade medical respiratory filters using bespoke-designed 3D-printed connectors. We compared the protection offered by the snorkel to that of standard PPE using a placebo-con-trolled respirator filtering test as well as a fluorescent droplet deposition experiment. Out of the 56 subjects tested, 42 (75%) passed filtering testing with the snorkel mask compared to 31 (55%) with a FFP3 respirator mask (p = 0.003). Amongst the 43 subjects who were not excluded following a placebo control, 85% passed filtering testing with the snorkel versus to 68% with a FFP3 mask (p = 0.008). Following front and lateral spray of fluorescence liquid particles, the snorkel mask also provided superior protection against droplet deposition within the subject's face, when compared to a standard PPE combination of FFP3 masks and eye protection (3.19x10(8) versus 6.81x10(8) fluorescence units, p<0.001). The 3D printable adap-tors are available for free download online at https://www.ImperialHackspace.com/COVID-19-Snorkel-Respirator-Project/. Conclusion Full-face snorkel masks adapted as particulate respirators performed better than a standard PPE combination of FFP3 mask and eye protection against aerosol inhalation and droplet deposition. This adaptation is therefore a promising PPE solution for healthcare workers during highly contagious viral outbreaks.	[Seligman, Henry; Zaman, Sameer; Shun-Shin, Matthew J.; Hepworth Lloyd, Freya; Androschuk, Vitaliy; Sen, Sayan; Al-Lamee, Rasha; Haji, Gulam S.; Howard, Luke S.; Nijjer, Sukhjinder; Mayet, Jamil; Francis, Darrel P.; Linton, Nicholas W. F.; Peters, Nicholas S.; Petraco, Ricardo] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Seligman, Henry; Zaman, Sameer; Shun-Shin, Matthew J.; Sen, Sayan; Al-Lamee, Rasha; Haji, Gulam S.; Howard, Luke S.; Nijjer, Sukhjinder; Mayet, Jamil; Francis, Darrel P.; Linton, Nicholas W. F.; Peters, Nicholas S.; Petraco, Ricardo] Imperial Coll Healthcare NHS Trust, Dept Cardiol, London, England; [Seligman, Henry; Zaman, Sameer; Pitcher, David S.; Shun-Shin, Matthew J.; Hepworth Lloyd, Freya; Androschuk, Vitaliy; Sen, Sayan; Al-Lamee, Rasha; Miller, David M.; Barnett, Harry W.; Haji, Gulam S.; Howard, Luke S.; Nijjer, Sukhjinder; Mayet, Jamil; Francis, Darrel P.; Linton, Nicholas W. F.; Peters, Nicholas S.; Petraco, Ricardo] Imperial Coll London, Imperial Ctr Cardiac Engn, London, England; [Pitcher, David S.; Miller, David M.; Barnett, Harry W.; Ces, Oscar] Imperial Coll London, Adv Hackspace, London, England; [Ces, Oscar] Imperial Coll London, Dept Chem, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Petraco, R (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Petraco, R (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Cardiol, London, England.; Petraco, R (corresponding author), Imperial Coll London, Imperial Ctr Cardiac Engn, London, England.	r.petraco@imperial.ac.uk		Shun-Shin, Matthew/0000-0002-1179-0867; Zaman, Sameer/0000-0002-1467-8176; Nijjer, Sukhjinder/0000-0001-9146-1037	Imperial College COVID Research Fund [WHCP G26284]	Imperial College COVID Research Fund	Funding for this study was provided by a grant from the Imperial College COVID Research Fund (grant WHCP G26284) to RP https://www.imperial.ac.uk/. We are grateful for the infrastructural support from the National Institute of Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. Funders played no role in the design of the study, data collection, analysis, decision to publish or preparation of the manuscript.	3M, 2009, 3M TECHNOLOGICAL B; Centers for Disease Control and Prevention, 2020, INTERIM INFECT PREVE; Chen YJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16924; Ciotti C, 2012, MED MALADIES INFECT, V42, P264, DOI 10.1016/j.medmal.2012.05.001; Dallas MP, 2021, WORLD DEV, V139, DOI 10.1016/j.worlddev.2020.105324; Dyatkin B, 2020, MRS BULL, V45, P794, DOI 10.1557/mrs.2020.258; FOD Central Specialist Division, 2012, HLTH SAFETY EXECUTIV, P44; Germonpre P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124347; Greig PR, 2020, ANAESTHESIA, V75, P970, DOI 10.1111/anae.15085; Hammond L, 2014, MEASURING CELL FLUOR; Intersurgical, 2020, FILTA THERM PRODUCT; Isinnova, 2020, EMERGENCY MASK HOSP; Judson SD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100940; Kroo L, 2020, MEDRXIV; Mitchell Brett G, 2012, Healthc Infect, V17, P111, DOI 10.1071/HI12019; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Ong SC, 2020, OPHTHALMOLOGY, V127, P1427, DOI 10.1016/j.ophtha.2020.06.031; Public Health England, 2020, NEW PERSONAL PROTECT; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tang JW, 2021, J HOSP INFECT; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wilson N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3206; Winter S, 2010, CRIT CARE RESUSC, V12, P24; World Health Organzation, 2020, RATIONAL USE PERSONA	24	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249201	10.1371/journal.pone.0249201	http://dx.doi.org/10.1371/journal.pone.0249201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819279	Green Published, gold			2022-12-26	WOS:000637647200014
J	Arora, P; Gudelsky, G; Desai, PB				Arora, Priyanka; Gudelsky, Gary; Desai, Pankaj B.			Gender-based differences in brain and plasma pharmacokinetics of letrozole in sprague-dawley rats: Application of physiologically-based pharmacokinetic modeling to gain quantitative insights	PLOS ONE			English	Article							GROWTH-HORMONE PROFILES; TISSUE DISTRIBUTION; GLIOBLASTOMA; BARRIER; CYTOCHROME-P450; MICRODIALYSIS; DISCOVERY; AROMATASE	Based on the discovery that the estrogen synthase aromatase (CYP19A1) is abundantly expressed in high- grade gliomas, the aromatase inhibitor, letrozole is being investigated in pre-clinical models as a novel agent against this malignancy. Here, we investigated the systemic and brain pharmacokinetics of letrozole following single and steady state dosing in both male and female Sprague-Dawley rats. Furthermore, we employed physiologically-based pharmacokinetic (PBPK) modeling to gain quantitative insights into the blood-brain barrier penetration of this drug. Letrozole (4 mg/kg) was administered intraperitoneally daily for 5 days (for males) and 11 days (for females) and intracerebral microdialysis was performed for brain extracellular fluid (ECF) collection simultaneously with venous blood sampling. Drug levels were measured using HPLC and non-compartmental analysis was conducted employing WinNonlin (R). Simcyp animal simulator was used for conducting bottom-up PBPK approach incorporating the specified multi-compartment brain model. Overall, marked gender-specific differences in the systemic and brain pharmacokinetics of letrozole were observed. Letrozole clearance was much slower in female rats resulting in markedly higher plasma and brain drug concentrations. At steady state, the plasma AUC 0-24 was 103.0 and 24.8 mu g*h/ml and brain ECF AUC 0-12 was 24.0 and 4.8 mu g*h/ml in female and male rats, respectively. The PBPK model simulated brain concentration profiles were in close agreement with the observed profiles. While gender-specific differences in letrozole PK are not observed in the clinical setting, these findings will guide the dose optimization during pre-clinical investigations of this compound. The PBPK model will serve as an important clinical translational tool.	[Arora, Priyanka; Gudelsky, Gary; Desai, Pankaj B.] Univ Cincinnati, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Desai, PB (corresponding author), Univ Cincinnati, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA.	desaipb@ucmail.uc.edu	Arora, Priyanka/HDO-4785-2022		University of Cincinnati Brain Tumor Center Molecular Therapeutics Program; Gardner Neuroscience Institute; Technology Validation Support Fund by the State of Ohio [TECG20160468]	University of Cincinnati Brain Tumor Center Molecular Therapeutics Program; Gardner Neuroscience Institute; Technology Validation Support Fund by the State of Ohio	The study was supported by grants from the University of Cincinnati Brain Tumor Center Molecular Therapeutics Program and Gardner Neuroscience Institute and the Technology Validation Support Fund by the State of Ohio (Grant number: TECG20160468) awarded to PBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2001, MOL CELL ENDOCRINOL, V173, P167, DOI 10.1016/S0303-7207(00)00401-9; Aklillu E, 2014, OMICS, V18, P446, DOI 10.1089/omi.2013.0140; Arora P, 2019, CANCER CHEMOTH PHARM, V83, P81, DOI 10.1007/s00280-018-3705-6; Avdeef A, 2011, PHARM RES-DORDR, V28, P517, DOI 10.1007/s11095-010-0298-0; Badhan Raj K Singh, 2014, Pharmaceutics, V6, P97, DOI 10.3390/pharmaceutics6010097; Ball K, 2012, J PHARM SCI-US, V101, P4277, DOI 10.1002/jps.23266; Bhatnagar AS, 2007, BREAST CANCER RES TR, V105, P7, DOI 10.1007/s10549-007-9696-3; Dave N., 2015, NEUROONCOL, V17, pV20; Dave N, 2015, MOL CANCER THER, V14, P857, DOI 10.1158/1535-7163.MCT-14-0743; Dave N, 2013, CANCER CHEMOTH PHARM, V72, P349, DOI 10.1007/s00280-013-2205-y; Donovan MD, 2018, BIOPHARM DRUG DISPOS, V39, P125, DOI 10.1002/bdd.2119; Jimenez JMD, 2014, J NEURO-ONCOL, V119, P275, DOI 10.1007/s11060-014-1509-z; Gallego O, 2015, CURR ONCOL, V22, pE273, DOI 10.3747/co.22.2436; Gaohua Lu, 2016, Drug Metab Pharmacokinet, V31, P224, DOI 10.1016/j.dmpk.2016.03.005; Habets EJJ, 2014, J NEURO-ONCOL, V116, P161, DOI 10.1007/s11060-013-1278-0; Jones HM, 2015, CLIN PHARMACOL THER, V97, P247, DOI 10.1002/cpt.37; Julka PK, 2013, J CANCER RES THER, V9, P381, DOI 10.4103/0973-1482.119310; Ke A, 2016, CPT-PHARMACOMET SYST, V5, P367, DOI 10.1002/psp4.12088; Lee KJ, 2003, PHARMACEUT RES, V20, P1015, DOI 10.1023/A:1024406221962; Li J, 2017, CLIN CANCER RES, V23, P7454, DOI 10.1158/1078-0432.CCR-17-0983; Liu XD, 2000, ACTA PHARMACOL SIN, V21, P680; Liu XR, 2009, DRUG METAB DISPOS, V37, P787, DOI 10.1124/dmd.108.024125; Minniti G, 2009, ANTICANCER RES, V29, P5171; Miyajima M, 2013, J PHARM SCI-US, V102, P3309, DOI 10.1002/jps.23600; Murai K, 2009, XENOBIOTICA, V39, P795, DOI 10.3109/00498250903171395; Paez X, 1996, LIFE SCI, V58, P1209, DOI 10.1016/0024-3205(96)00082-3; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pardridge William M, 2005, NeuroRx, V2, P3; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Pfister C., 1993, EUR J DRUG METAB PH, V18, P117; Pfister CU, 2001, BIOPHARM DRUG DISPOS, V22, P191, DOI 10.1002/bdd.273; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; Roy S, 2015, SOUTH ASIAN J CANCER, V4, P163, DOI 10.4103/2278-330X.175953; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Simpson D, 2004, DRUGS, V64, P1213, DOI 10.2165/00003495-200464110-00005; Tao X, 2007, J PHARMACEUT BIOMED, V43, P1078, DOI 10.1016/j.jpba.2006.09.016; Thangavel C, 2006, DRUG METAB DISPOS, V34, P410, DOI 10.1124/dmd.105.007716; Tivnan A, 2017, ONCOTARGET, V8, P16605, DOI 10.18632/oncotarget.15073; Wagner C, 2016, CLIN PHARMACOKINET, V55, P475, DOI 10.1007/s40262-015-0330-y; Waldon Daniel, 2011, Drug Metab Lett, V5, P290; Yusof SR, 2017, EUR J PHARM SCI, V106, P274, DOI 10.1016/j.ejps.2017.06.016; Zhou QY, 2005, AAPS J, V7, pE659, DOI 10.1208/aapsj070366; Zhuang XM, 2016, ACTA PHARM SIN B, V6, P430, DOI 10.1016/j.apsb.2016.04.004	44	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248579	10.1371/journal.pone.0248579	http://dx.doi.org/10.1371/journal.pone.0248579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798227	gold, Green Published			2022-12-26	WOS:000636737700039
J	Freitas, AD; Santana, ML; Schenkel, FS; Mercadante, MEZ; Cyrillo, JNDG; de Paz, CCP				Freitas, Anielly de Paula; Santana Junior, Mario Luiz; Schenkel, Flavio Schramm; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Paro de Paz, Claudia Cristina			Different selection practices affect the environmental sensitivity of beef cattle	PLOS ONE			English	Article							REACTION NORMS; PHENOTYPIC PLASTICITY; YEARLING WEIGHT; ANGUS CATTLE; GENOTYPE; TRAITS; MODELS; PERFORMANCE; GROWTH; AGE	The objective of the present study was to evaluate the effects of different selection practices on the environmental sensitivity of reproductive and growth traits in males and females of three Nellore selection lines [control (NeC), selection (NeS), and traditional (NeT) lines]. Moreover, genetic trends for the intercept and slope were estimated for each line, and the possible reranking of sires was examined. A total of 8,757 records of selection weight (SW), 3,331 records of scrotal circumference (SC), and 2,311 records of days to first calving (DFC) from Nellore cattle born between 1981 and 2017 were analyzed. (Co)variance components and genetic parameters of all traits were estimated using a reaction norm model with Gibbs sampler. In all cattle lines, the mean heritability of the studied traits ranged from 0.39 to 0.75 for SW in both males and females, from 0.46 to 0.68 for SC, and from 0.06 to 0.57 for DFC along with the environmental descriptor. In all cattle lines, the genetic correlation coefficients between the intercept and slope ranged from 0.03 to 0.81 for SW, from -0.14 to 0.39 for SC, and from -0.87 to -0.42 for DFC. Genetic trends for the slope and proportion of plastic genotypes indicated that the NeS line was more responsive to environmental changes, whereas the NeC and NeT lines tended to respond more modestly. Reranking of sires was observed for all traits, specifically in the NeC and NeT lines, because of the weak correlation between the opposite extreme environments. In the NeS line, reranking of sires was observed for DFC alone. Our results indicate that the effects of genotype-environment interaction are important and should be considered in genetic evaluations of Nellore cattle. Moreover, different selection practices affected the environmental sensitivity of the Nellore selection lines tested in this study.	[Freitas, Anielly de Paula; Paro de Paz, Claudia Cristina] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil; [Santana Junior, Mario Luiz; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Paro de Paz, Claudia Cristina] Anim Sci Inst APTA SAA, Adv Beef Cattle Res Ctr, Sertaozinho, SP, Brazil; [Schenkel, Flavio Schramm] Univ Guelph, Ctr Genet Improvement Livestock, Dept Anim Biosci, Guelph, ON, Canada	Universidade de Sao Paulo; University of Guelph	Freitas, AD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil.	aniellypf@hotmail.com	Santana, Mário/W-3129-2019; Schenkel, Flavio/ABG-1842-2021; Paz, Claudia Cristina Paro/E-8791-2012; Mercadante, Maria Eugenia/C-9536-2012	Santana, Mário/0000-0001-8392-1304; Paz, Claudia Cristina Paro/0000-0002-7267-4552; de Paula Freitas, Anielly/0000-0002-6291-5930; Schenkel, Flavio/0000-0001-8700-0633; Mercadante, Maria Eugenia/0000-0002-1218-5378	Sao Paulo Research Foundation (FAPESP, Brazil) [2016/17517-4, 2019/01814-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES Brazil) [001]; National Counsel of Technological and Scientific Development (CNPq) [303972-2018-1, 301918/2017-1]	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES Brazil); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP, Brazil, grant number #2016/17517-4 and #2019/01814-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES Brazil, Finance Code 001) for the fellowship awarded to AdPF. This work was also supported in the form of grants by productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq) awarded to CCPdP (#303972-2018-1), MLSJ (#301918/2017-1), and MEZM (#301918/2017-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P1754, DOI 10.3168/jds.2009-2756; Ambrosini DP, 2016, PESQUI AGROPECU BRAS, V51, P177, DOI 10.1590/S0100-204X2016000200010; Benfica LF, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa350; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Correa MBB, 2009, REV BRAS ZOOTECN, V38, P1468, DOI 10.1590/S1516-35982009000800010; Carabano MJ, 2019, ANIM FRONT, V9, P62, DOI 10.1093/af/vfy033; Cardoso DF, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0381-2; Cardoso FF, 2012, J ANIM SCI, V90, P2130, DOI 10.2527/jas.2011-4333; Cardoso LL, 2011, REV BRAS ZOOTECN, V40, P294, DOI 10.1590/S1516-35982011000200009; Chiaia HLJ, 2015, J ANIM SCI, V93, P1503, DOI 10.2527/jas.2014-8217; de Araujo Neto FR, 2018, ANIM SCI J, V89, P939, DOI 10.1111/asj.12994; de Jong G, 2002, LIVEST PROD SCI, V78, P195, DOI 10.1016/S0301-6226(02)00096-9; de Souza JC, 2018, SEMIN-CIENC AGRAR, V39, P349, DOI 10.5433/1679-0359.2018v39n1p349; DEJONG G, 1995, AM NAT, V145, P493, DOI 10.1086/285752; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Geweke J., 1992, BAYESIAN STAT, V4; Johnston DJ, 1996, LIVEST PROD SCI, V45, P13, DOI 10.1016/0301-6226(95)00088-7; Kolmodin R, 2004, GENET SEL EVOL, V36, P435, DOI 10.1051/gse:2004010; Lemos MVA, 2015, GENET MOL RES, V14, P7151, DOI 10.4238/2015.June.29.9; Mattar M, 2011, J ANIM SCI, V89, P2349, DOI 10.2527/jas.2010-3770; Mercadante MEZ, 2003, J ANIM SCI, V81, P376; MISZTAL I, 2002, BLUPF90 RELATED PROG, V28, P743; Mota LFM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63516-4; Mota RR, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-015-0178-5; Pires BC, 2017, ANIM PROD SCI, V57, P415, DOI 10.1071/AN15458; Ribeiro S, 2018, ANIM PROD SCI, V58, P1996, DOI 10.1071/AN17048; Ribeiro S, 2009, ARQ BRAS MED VET ZOO, V61, P668, DOI 10.1590/S0102-09352009000300021; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; Santana ML, 2013, ANIMAL, V7, P202, DOI 10.1017/S1751731112001711; Santana ML, 2015, J APPL GENET, V56, P219, DOI 10.1007/s13353-014-0242-9; Santos GG, 2008, ARQ BRAS MED VET ZOO, V60, P1188, DOI 10.1590/S0102-09352008000500022; Schmidt PI, 2018, THERIOGENOLOGY, V108, P81, DOI 10.1016/j.theriogenology.2017.11.035; Silva T de L., 2019, LIVEST SCI INTERNET, V230; Souza LD, 2016, REV CAATINGA, V29, P206, DOI 10.1590/1983-21252016v29n124rc; Strandberg E., 2000, INTERBULL B, P41; Tonsor SJ, 2013, EVOLUTION, V67, P2923, DOI 10.1111/evo.12175; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110, DOI DOI 10.1007/BF01876686	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248186	10.1371/journal.pone.0248186	http://dx.doi.org/10.1371/journal.pone.0248186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798231	gold, Green Published			2022-12-26	WOS:000636737700054
J	Berrios, L; Ely, B				Berrios, Louis; Ely, Bert			Genes related to redox and cell curvature facilitate interactions between Caulobacter strains and Arabidopsis	PLOS ONE			English	Article							BACTERIAL COMMUNITY; SEED-GERMINATION; PLANT; GROWTH; HOMEOSTASIS; EXPRESSION; PH; GENERATION; MICROBIOTA; SURVIVAL	Bacteria play an integral role in shaping plant growth and development. However, the genetic factors that facilitate plant-bacteria interactions remain largely unknown. Here, we demonstrated the importance of two bacterial genetic factors that facilitate the interactions between plant-growth-promoting (PGP) bacteria in the genus Caulobacter and the host plant Arabidopsis. Using homologous recombination, we disrupted the cytochrome ubiquinol oxidase (cyo) operon in both C. vibrioides CB13 and C. segnis TK0059 by knocking out the expression of cyoB (critical subunit of the cyo operon) and showed that the mutant strains were unable to enhance the growth of Arabidopsis. In addition, disruption of the cyo operon, metabolomic reconstructions, and pH measurements suggested that both elevated cyoB expression and acid production by strain CB13 contribute to the previously observed inhibition of Arabidopsis seed germination. We also showed that the crescent shape of the PGP bacterial strain C. crescentus CB15 contributes to its ability to enhance plant growth. Thus, we have identified specific genetic factors that explain how select Caulobacter strains interact with Arabidopsis plants.	[Berrios, Louis; Ely, Bert] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Berrios, L (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	Lberrios@email.sc.edu	Berrios, Louis/GQA-5956-2022	Berrios, Louis/0000-0003-3888-9928	University of South Carolina SPARC	University of South Carolina SPARC	This work was funded in part by a University of South Carolina SPARC grant (https://sc.edu/about/offices_and_divisions/research/internal_funding_awards/students/sparc/index.php) awarded to LB. The funders did not contribute to the design of the experiments, data collection, analyses, decision to publish, or the preparation of the manuscript.	Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baek D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00963; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Berrios L, 2020, PLANT SOIL, V449, P81, DOI 10.1007/s11104-020-04472-w; Berrios L, 2019, CURR MICROBIOL, V76, P558, DOI 10.1007/s00284-019-01656-1; Bi C, 2017, PLANT MOL BIOL, V94, P197, DOI 10.1007/s11103-017-0603-y; Blaser MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00714-16; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Cai YZ, 2003, J AGR FOOD CHEM, V51, P2288, DOI 10.1021/jf030045u; Chahtane H, 2018, ELIFE, V7, DOI 10.7554/eLife.37082; Cole BJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002860; Dominguez JJA, 2019, CHEMOSPHERE, V234, P789, DOI 10.1016/j.chemosphere.2019.05.290; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; Escobar MA, 2006, PLANT J, V45, P775, DOI 10.1111/j.1365-313X.2005.02640.x; Finkel OM, 2020, NATURE, V587, P103, DOI 10.1038/s41586-020-2778-7; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Garcia-Lemos AM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01937; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hu WM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02671; Huang HL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00800; JOHNSON RC, 1977, GENETICS, V86, P25; Koger CH, 2004, WEED SCI, V52, P989, DOI 10.1614/WS-03-139R2; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Levy A, 2018, CELL HOST MICROBE, V24, P475, DOI 10.1016/j.chom.2018.09.005; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Lin PC, 2007, PLANT PHYSIOL, V143, P745, DOI 10.1104/pp.106.084103; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Luo DX, 2019, MOL PLANT MICROBE IN, V32, P1162, DOI 10.1094/MPMI-12-18-0347-R; Lutzoni F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07849-9; Mashiane RA, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2249-y; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naveed M, 2014, BIOL FERT SOILS, V50, P249, DOI 10.1007/s00374-013-0854-y; Pereira SIA, 2016, ECOL ENG, V87, P91, DOI 10.1016/j.ecoleng.2015.11.033; Persat A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4824; Phyo P, 2019, CELLULOSE, V26, P291, DOI 10.1007/s10570-018-2094-7; Ramirez-Vega H, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101503; Ramirez-Villacis DX, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00484-20; Schippers JHM, 2016, CURR OPIN PLANT BIOL, V29, P121, DOI 10.1016/j.pbi.2015.11.009; Singer E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02181; Singh R, 2016, FRONT PLANT SCI, V7, P1, DOI 10.3389/fpls.2016.01299; Su C, 2016, J PLANT BIOL, V59, P260, DOI 10.1007/s12374-016-0052-1; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taurian T, 2010, PLANT SOIL, V329, P421, DOI 10.1007/s11104-009-0168-x; Tiepo AN, 2020, PLANTA, V251, DOI 10.1007/s00425-020-03373-7; Voges MJEEE, 2019, P NATL ACAD SCI USA, V116, P12558, DOI 10.1073/pnas.1820691116; Willing CE, 2020, MOL ECOL, V29, P4721, DOI 10.1111/mec.15666; Wyszkowska J, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11120246; Yan XM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01848; Yang DC, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00724-18; Yang ED, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1569-z; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zeng J, 2017, EMBO J, V36, P2844, DOI 10.15252/embj.201695955; Zhao T, 2007, PLANT CELL ENVIRON, V30, P518, DOI 10.1111/j.1365-3040.2007.01638.x	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249227	10.1371/journal.pone.0249227	http://dx.doi.org/10.1371/journal.pone.0249227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793620	gold, Green Published			2022-12-26	WOS:000636467000036
J	Nazif-Munoz, JI; Pena, S; Oulhote, Y				Nazif-Munoz, Jose Ignacio; Pena, Sebastian; Oulhote, Youssef			The global viralization of policies to contain the spreading of the COVID-19 pandemic: Analyses of school closures and first reported cases	PLOS ONE			English	Article							HUMAN-RIGHTS; DIFFUSION	Background On January 30(th) 2020, the World Health Organization (WHO) declared a international health emergency due to the unprecedented phenomenon of COVID-19. After this declaration countries swiftly implemented a variety of health policies. In this work we examine how rapid countries responded to this pandemic using two events: the day in which the first case of COVID-19 was reported, and first day in which countries used school closure as one of the measures to avoid outbreaks. We also assessed how countries' health systems, globalization, economic development, political systems, and economic integration to China, Republic of Korea and Italy increased the speed of adoption. Methods We compiled information from multiple sources, from December 31(st) 2019 to June 1(st) 2020, to trace when 172 countries reported their first COVID-19 case and implemented school closure to contain outbreaks. We applied cross-national Weibull survival analysis to evaluate the global speed of detection of first COVID-19 reported cases and school closure. Results Ten days after WHO declared COVID-19 to be an international emergency, relative to seven days from this declaration, countries were 28 (95% CI: 12-77) times more likely to report first COVID-19 cases and 42 (95% CI: 22-90) times more likely to close schools. One standard deviation increase in the epidemic security index rises the rate of report first cases by 37% (Hazard Ratio (HR) 1.37 (95% CI: 1.09-1.72) and delays the adoption for school closures by 36% (HR 0.64 (95% CI:0.50-0.82). One standard deviation increase in the globalization index augments the adoption for school closures by 74% (HR 1.74 (95% CI:1.34-2.24). Conclusion After the WHO declared a global emergency, countries were unprecedently acting very rapidly. While countries more globally integrated were swifter in closing schools, countries with better designed health systems to tackle epidemics were slower in adopting it. More studies are needed to assess how the speed of school closures and other policies will affect the development of the pandemic.	[Nazif-Munoz, Jose Ignacio] Univ Sherbrooke, Fac Med & Hlth Sci, Longueuil, PQ, Canada; [Nazif-Munoz, Jose Ignacio; Oulhote, Youssef] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Pena, Sebastian] Finnish Inst Hlth & Welf THL, Dept Publ Hlth Solut, Helsinki, Finland; [Pena, Sebastian] Univ Diego Portales, Fac Med, Santiago, Chile; [Oulhote, Youssef] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Biostat & Epidemiol, Amherst, MA 01003 USA	University of Sherbrooke; Harvard University; Harvard T.H. Chan School of Public Health; University Diego Portales; University of Massachusetts System; University of Massachusetts Amherst	Nazif-Munoz, JI (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Longueuil, PQ, Canada.; Nazif-Munoz, JI (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	jjose.ignacio.nazif-munoz@usherbrooke.ca		Nazif-Munoz, Jose Ignacio/0000-0002-8944-5182; Pena, Sebastian/0000-0002-2555-4179	Fonds de recherche du Quebec - Sante	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	JINM received funds from the Fonds de recherche du Quebec - Sante. Junior 1 http://www.frqs.gouv.qc.ca/.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Cleves M., 2010, INTRO SURVIVAL ANAL; Cole WM, 2012, AM J SOCIOL, V117, P1131, DOI 10.1086/662706; Dobbin F, 2007, ANNU REV SOCIOL, V33, P449, DOI 10.1146/annurev.soc.33.090106.142507; Economist, 2020, EC; Frank DJ, 2010, AM SOCIOL REV, V75, P867, DOI 10.1177/0003122410388493; Global Health Security Index, 2019, IND; Gonsalves GS, 2020, ACHIEVING FAIR EFFEC; Gygli S, 2019, REV INT ORGAN, V14, P543, DOI 10.1007/s11558-019-09344-2; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Kogut B, 2007, GLOBAL DIFFUSION OF MARKETS AND DEMOCRACY, P104; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Marsh D, 2009, POLICY STUD-UK, V30, P269, DOI 10.1080/01442870902863851; Meyer JW, 1997, AM J SOCIOL, V103, P144, DOI 10.1086/231174; Nazif-Munoz JI, 2015, TRAFFIC INJ PREV, V16, pS32, DOI 10.1080/15389588.2015.1061661; Shor E, 2014, INT J COMP SOCIOL, V55, P294, DOI 10.1177/0020715214552460; StataCorp, 2015, STAT STAT SOFTW REL; Strang D., 1994, COMP POLITICAL EC WE, P278, DOI [DOI 10.1017/CBO9781139174053.012, DOI 10.1017/CBO9781139174053]; UNESCO, 2020, COVID 19 ED DISRUPTI; United Nations, 2019, COMM TRAD STAT DAT; United Nations, 2015, ESAPWP241 UN; Wejnert B, 2005, AM SOCIOL REV, V70, P53, DOI 10.1177/000312240507000104; WHO, 2020, PUBL HLTH EM INT DEC; WHO, 2020, COVID 19 PREP RESP; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; World Bank, 2015, WORLD DEV INDICATORS; World Health Organization, 2020, PNEUM UNKN CAUS CHIN; Worldometers, COR WORLD COUNTR; Zapp M, 2019, COMP EDUC, V55, P473, DOI 10.1080/03050068.2019.1638103; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248828	10.1371/journal.pone.0248828	http://dx.doi.org/10.1371/journal.pone.0248828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793570	Green Published, gold, Green Submitted			2022-12-26	WOS:000636467000044
J	Marca, NR; Lopez, RP; Naoki, K				Roque Marca, Natalio; Lopez, Ramiro Pablo; Naoki, Kazuya			Effect of shade and precipitation on germination and seedling establishment of dominant plant species in an Andean arid region, the Bolivian Prepuna	PLOS ONE			English	Article							NURSE-PLANTS; POSITIVE INTERACTIONS; TEHUACAN VALLEY; ATACAMA DESERT; EL-NINO; WOODY-PLANTS; DRY FOREST; FACILITATION; SURVIVAL; DROUGHT	Germination and seedling establishment are two critical processes in the life cycle of plants. Seeds and seedlings must pass through a series of abiotic and biotic filters in order to recruit as members of their communities. These processes are part of the regeneration niche of the species. In arid regions, the regeneration niche is frequently associated to facilitation by shade. Facilitation is a positive interaction between plants, in which one of them acts as a benefactor (the nurse) of the other (the beneficiary). The result of this interaction can be reflected in the increased growth, survival, and/or reproduction of the beneficiary plant. In this study, we determined experimentally the effect of shade and irrigation on the germination and early survival of dominant species of a semi-arid Andean region, the Bolivian Prepuna. An experiment with Acacia feddeana, Prosopis ferox, Cercidium andicola (woody species), Parodia maassii, and Oreocereus celsianus (cactus species) was carried out at an experimental garden in La Paz, Bolivia, with a bifactorial design, considering shaded and unshaded pots, subjected to two irrigation treatments (approximate to 50 and 80 mm of rainfall during the whole study period). Microenvironmental conditions did not affect the seed germination of the woody species. However, they showed differences in seedling survival: A. feddeana survived better under shade, whereas P. ferox and C. andicola survived better without shade. Cercidium andicola, compared to P. ferox, was more affected by shade and low irrigation. Although germination success of cacti was low, both species germinated better under shade and with high irrigation. These results showed differences in the regeneration niche of dominant species of the Prepuna which may favor their coexistence and which may be characteristic of other dry Andean regions.	[Roque Marca, Natalio; Lopez, Ramiro Pablo] Univ Mayor San Andres, Carrera Biol, La Paz, Bolivia; [Roque Marca, Natalio] Univ Mayor, Real & Pontificia San Francisco Xavier Chuquisaca, Inst Expt Biol Dr Luis Adam Briancon, Sucre, Bolivia; [Lopez, Ramiro Pablo; Naoki, Kazuya] Univ Mayor San Andres, Carrera Biol, Inst Ecol, La Paz, Bolivia; [Lopez, Ramiro Pablo] Herbario Nacl Bolivia, La Paz, Bolivia; [Roque Marca, Natalio] Asociaci Boliviana Invest & Conservac Ecosistemas, Programa Ciencia & Tecnol, Cobija, Bolivia	Universidad Mayor de San Andres; Universidad Mayor de San Andres	Marca, NR (corresponding author), Univ Mayor San Andres, Carrera Biol, La Paz, Bolivia.; Marca, NR (corresponding author), Univ Mayor, Real & Pontificia San Francisco Xavier Chuquisaca, Inst Expt Biol Dr Luis Adam Briancon, Sucre, Bolivia.; Marca, NR (corresponding author), Asociaci Boliviana Invest & Conservac Ecosistemas, Programa Ciencia & Tecnol, Cobija, Bolivia.	roque.natalio@usfx.bo	Lopez, Ramiro Pablo/O-3491-2019	Naoki, Kazuya/0000-0002-6656-6950	Instituto de Ecologia, Universidad Mayor de San Andres [15/2011]	Instituto de Ecologia, Universidad Mayor de San Andres	This study was funded by Instituto de Ecologia, Universidad Mayor de San Andres to NRM (No. 15/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2009, J ARID ENVIRON, V73, P144, DOI 10.1016/j.jaridenv.2008.09.028; Baes PO, 2002, J ARID ENVIRON, V50, P185, DOI 10.1006/jare.2001.0859; Barchuk AH, 1998, FOREST ECOL MANAG, V103, P203, DOI 10.1016/S0378-1127(97)00214-4; Barton K., 2019, **DATA OBJECT**; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bewley J. Derek, 1994; Bowers J. E., 1994, Madrono, V41, P73; Breshears DD, 1998, INT J PLANT SCI, V159, P1010, DOI 10.1086/314083; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bustamante-Sanchez MA, 2011, J ECOL, V99, P288, DOI 10.1111/j.1365-2745.2010.01737.x; Cabrera A.L., 1973, BIOGEOGRAF A AM RICA; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Carrillo-Garcia A, 2000, PLANT SOIL, V218, P207, DOI 10.1023/A:1014953028163; Castro-Marin G, 2011, TROP ECOL, V52, P1; Chirara C., 2001, TREE INVASION SEMIAR, V63; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COX DR, 1972, J R STAT SOC B, V34, P187; Daws MI, 2002, FUNCT ECOL, V16, P258, DOI 10.1046/j.1365-2435.2002.00615.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Duncan C, 2019, AOB PLANTS, V11, DOI 10.1093/aobpla/plz066; Egawa C, 2015, ACTA OECOL, V62, P45, DOI 10.1016/j.actao.2014.12.001; Esparza-Olguin L, 2002, BIOL CONSERV, V103, P349, DOI 10.1016/S0006-3207(01)00146-X; Flores-Martinez A, 2008, NAT AREA J, V28, P51, DOI 10.3375/0885-8608(2008)28[51:SAGRAS]2.0.CO;2; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Galera FM., 2000, ESPECIES G NERO PROS; Garcia E., 1994, LE OSAS TILES POTOS; Gomez-Aparicio L, 2005, J VEG SCI, V16, P191, DOI 10.1111/j.1654-1103.2005.tb02355.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guo QF, 1998, PLANT ECOL, V139, P71, DOI 10.1023/A:1009737025870; Hastwell GT, 2003, J ECOL, V91, P941, DOI 10.1046/j.1365-2745.2003.00832.x; Hernandez V., 2000, REV GEOGR NORTE GD, V27, P37; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Holmgren M, 2000, OIKOS, V90, P67, DOI 10.1034/j.1600-0706.2000.900107.x; Houston J, 2006, INT J CLIMATOL, V26, P2181, DOI 10.1002/joc.1359; Julia C., 2008, LIBRO ROJO FLORA NAT, P25; Lancelot R., 2012, **DATA OBJECT**; Larrea Alcazar DM., 2009, ECOL BOLIV, V44, P99; Loayza AP, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx056; López Ramiro Pablo, 2009, Ecología en Bolivia, V44, P5; Lopez R. P., 2000, Ecologia en Bolivia, P45; López Ramiro P, 2008, Ecol. austral, V18, P119; Lopez RP, 2007, OECOLOGIA, V152, P779, DOI 10.1007/s00442-007-0698-y; Lopez RP, 2007, J VEG SCI, V18, P263, DOI 10.1111/j.1654-1103.2007.tb02537.x; Lopez RP, 2003, PLANT ECOL, V168, P85, DOI 10.1023/A:1024490312759; Lopez RP, 1999, ECOLOGIA BOLIVIA, V33, P63; Lopez RP, 2002, ECOLOGIA BOLIVIA, V37, P15; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; McKay CP, 2003, ASTROBIOLOGY, V3, P393, DOI 10.1089/153110703769016460; McLaren KP, 2003, FOREST ECOL MANAG, V183, P61, DOI 10.1016/S0378-1127(03)00100-2; Miquelajauregui Y, 2010, J ARID ENVIRON, V74, P1624, DOI 10.1016/j.jaridenv.2010.07.006; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Montesinos DB, 2012, PHYTOCOENOLOGIA, V42, P29, DOI 10.1127/0340-269X/2012/0042-0516; Munguia-Rosas MA, 2008, ANN BOT-LONDON, V101, P175, DOI 10.1093/aob/mcm302; Neuschulz EL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29839; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Lopez RP, 2020, J VEG SCI, V31, P180, DOI 10.1111/jvs.12821; Lopez RP, 2016, ECOLOGY, V97, P1593, DOI 10.1890/15-1152.1; Peters EM, 2008, J ARID ENVIRON, V72, P593, DOI 10.1016/j.jaridenv.2007.10.004; Prider JN, 2004, FUNCT ECOL, V18, P67, DOI 10.1046/j.0269-8463.2004.00810.x; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Quero JL, 2008, BASIC APPL ECOL, V9, P635, DOI 10.1016/j.baae.2007.06.012; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Tobias HM, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-11; Reid JS, 2005, ATMOS CHEM PHYS, V5, P799, DOI 10.5194/acp-5-799-2005; Reid W.V., 2005, ECOSYSTEMS HUMAN WEL; Reynolds JF, 2007, TERRESTRIAL ECOSYSTE, P247, DOI DOI 10.1007/978-3-540-32730-1_20; Rojas-Arechiga M, 1998, PLANT ECOL, V135, P207, DOI 10.1023/A:1009757227493; Rojas-Arechiga M, 2000, J ARID ENVIRON, V44, P85, DOI 10.1006/jare.1999.0582; Romero H, 2013, REV GEOGR NORTE GD, P19, DOI 10.4067/S0718-34022013000200003; Ryser P, 2000, AM J BOT, V87, P402, DOI 10.2307/2656636; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Schob C, 2012, PLANT ECOL DIVERS, V5, P27, DOI 10.1080/17550874.2012.674067; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; SKOGLUND J, 1992, J VEG SCI, V3, P357, DOI 10.2307/3235760; Skolmen RG., 2000, BIOECOLOG A ARBOLES, V428; Teran A., 2008, ROL PROSOPIS FLEXUOS; Tewksbury JJ, 2001, OECOLOGIA, V127, P425, DOI 10.1007/s004420000614; TURNER RM, 1966, BOT GAZ, V127, P95, DOI 10.1086/336348; Tyree MT, 2002, J EXP BOT, V53, P2239, DOI 10.1093/jxb/erf078; Valdez Cepeda R., 2001, 5AS JORN INVESTIG U, V8; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P15, DOI 10.2307/3235893; VALIENTEBANUET A, 1991, J ECOL, V79, P961, DOI 10.2307/2261091; Valladares F, 2005, J EXP BOT, V56, P483, DOI 10.1093/jxb/eri037; Valladares F, 2002, PLANT CELL ENVIRON, V25, P749, DOI 10.1046/j.1365-3040.2002.00856.x; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Verdu M, 2010, J ECOL, V98, P1454, DOI 10.1111/j.1365-2745.2010.01731.x; Villalba R., 2018, PUNA ARGENT, V75; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Whitford W., 2002, ECOLOGY DESERT SYSTE; Yuto T de la E., 2006, 2 JORN SANTIAGO ESTE; Zou CB, 2010, J ARID ENVIRON, V74, P156, DOI 10.1016/j.jaridenv.2009.07.001	98	0	0	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248619	10.1371/journal.pone.0248619	http://dx.doi.org/10.1371/journal.pone.0248619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788871	gold, Green Published			2022-12-26	WOS:000636354600029
J	Abir, T; Ekwudu, O; Kalimullah, NA; Yazdani, DMNA; Al Mamun, A; Basak, P; Osuagwu, UL; Permarupan, PY; Milton, AH; Talukder, SH; Agho, KE				Abir, Tanvir; Ekwudu, O'mezie; Kalimullah, Nazmul Ahsan; Nur-A Yazdani, Dewan Muhammad; Al Mamun, Abdullah; Basak, Palash; Osuagwu, Uchechukwu Levi; Permarupan, P. Yukthamarani; Milton, Abdul Hasnat; Talukder, Shamim Hyder; Agho, Kingsley E.			Dengue in Dhaka, Bangladesh: Hospital-based cross-sectional KAP assessment at Dhaka North and Dhaka South City Corporation area	PLOS ONE			English	Article							KNOWLEDGE; FEVER; ATTITUDES; TRANSMISSION; INFECTION; EPIDEMIC	Dengue, the most important mosquito-borne viral disease of humans is a recurring global health problem. In Bangladesh, dengue outbreaks are on the increase despite the efforts of government and it is not clear what the understanding of the general Dhaka population towards dengue fever is. Knowledge, attitude and practice (KAP) studies are essential guides in public health interventions. Hence, using KAP, this study aims to assess patient-perspectives with regards to factors associated with dengue, as well as investigate the associated factors between the two corporations in Dhaka. A Hospital-based cross-sectional study of 242 fever patients from two city-corporations in Dhaka (Dhaka North City Corporations, DNCC (n = 91, 37.6%) and Dhaka South City Corporation, DSCC (n = 151, 62.4%) was conducted using pre-tested KAP items. Wilcoxon's Rank Sum was used to determine the KAP by DNCC, DSCC and both corporations and multivariate Poisson regression analyses. The two corporations were analysed separately due to the differences in income distribution, concentration of slums, hospitals and clinics. The study found that more than half of the study population were knowledgeable about dengue (mean percentage scores was 52%), possess an appropriate and acceptable attitude towards the disease (69.2%), and about two thirds of the respondents (71.4%) engaged in practices towards its prevention. After adjusting for the potential cofounders, the factors associated with KAP about dengue fever varied between DNCC and DSCC; with duration of residency and use of mosquito nets were associated with knowledge in the north while income class and age were associated with knowledge and attitude in the south. In the pooled analysis (combining both corporations), knowledge of dengue was associated with good practice towards dengue fever among the respondents. The duration of residence in Dhaka (10+ years), not using mosquito nets and length of time spent in the hospital (7+ days) due to dengue, and decreased knowledge (Adjusted coefficient (beta) = -0.01, 95%CI: -0.02, -0.01) were associated with attitude towards dengue in DNCC. On the other hand, middle-high income class, age (40+ years) and increased knowledge were associated with practice towards dengue in DSCC (beta = 0.02, 95%CI: 0.01, 0.03). Efforts to increase knowledge about dengue fever through education by the administrations of both corporations would benefit from targeting these high-risk groups for a more sustainable outcome.	[Abir, Tanvir; Nur-A Yazdani, Dewan Muhammad] Int Univ Business, Coll Business Adm, Agr & Technol, Dhaka, Bangladesh; [Ekwudu, O'mezie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Kalimullah, Nazmul Ahsan] Begum Rokeya Univ, Rangpur, Bangladesh; [Al Mamun, Abdullah] UCSI Univ, Fac Business & Management, Kuala Lumpur, Malaysia; [Basak, Palash] Univ Newcastle, Sch Environm & Life Sci, Environm Sci & Management, Callaghan, NSW, Australia; [Osuagwu, Uchechukwu Levi] Western Sydney Univ, Sch Med, Diabet Obes & Translat Res Unit DOMTRU, Sydney, NSW, Australia; [Permarupan, P. Yukthamarani] Univ Malaysia Kelantan, Fac Entrepreneurship & Business, Kota Baharu, Kelantan, Malaysia; [Milton, Abdul Hasnat] Epidemiol Resource Ctr, Newcastle, NSW, Australia; [Talukder, Shamim Hyder] Eminence Associates Social Dev, Dhaka, Bangladesh; [Agho, Kingsley E.] Western Sydney Univ, Sch Hlth Sci, Sydney, NSW, Australia	Queensland University of Technology (QUT); UCSI University; University of Newcastle; Western Sydney University; Universiti Malaysia Kelantan; Western Sydney University	Ekwudu, O (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.	omezie@gmail.com	Agho, Kingsley/AAW-5622-2021; Mamun, Abdullah/HHM-9898-2022; osuagwu, Uchechukwu Levi/K-5236-2015; Nur -A Yazdani, Dewan Muhammad/ADM-7514-2022; Al Mamun, Abdullah/B-6226-2013	Agho, Kingsley/0000-0003-4111-3207; osuagwu, Uchechukwu Levi/0000-0002-1727-6914; Nur -A Yazdani, Dewan Muhammad/0000-0001-8219-8417; Al Mamun, Abdullah/0000-0002-9713-742X; /0000-0002-9689-4808				Alyousefi TAA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1895-2; Amin N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221193; [Anonymous], 2013, GLOB STRAT DENG PREV; AZIZ MOHAMMED A., 1967, PAKISTAN J MED RES, V6, P83; Banu S, 2012, TROP MED INT HEALTH, V17, P1086, DOI 10.1111/j.1365-3156.2012.03038.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Chandren JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003954; de la Cruz A M, 1999, Rev Cubana Med Trop, V51, P135; Dhar-Chowdhury P, 2014, INT HEALTH, V6, P306, DOI 10.1093/inthealth/ihu032; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; Directorate DC,, 2019, DENGUE REGISTER; Ghani NA, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010037; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z; Herbuela VDM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234705; Hossain MA, 2003, EMERG INFECT DIS, V9, P1411, DOI 10.3201/eid0911.030117; Hsan K, 2019, LANCET INFECT DIS, V19, P1287, DOI 10.1016/S1473-3099(19)30616-4; Islam S, 2020, INT HEALTH, V12, P444, DOI 10.1093/inthealth/ihz079; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Klett-Tammen CJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2784-8; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; Kumaran E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006268; Launiala A., 2009, ANTHR MATTERS, V11, P1, DOI [https://doi.org/10.22582/am.v11i1.31, DOI 10.22582/AM.V11I1.31]; Lugova H, 2017, J COMMUN HEALTH, V42, P413, DOI 10.1007/s10900-016-0270-y; Mahyiddin NS., 2016, MALAYS J NURS, V8, P39; Mamun MA, 2019, LANCET, V394, P2149, DOI 10.1016/S0140-6736(19)32524-3; Mayxay M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-434; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1; Ramirez G., 2017, OPEN PUBLIC HLTH J, V10, P80, DOI [10.2174/1874944501710010080, DOI 10.2174/1874944501710010080]; Higuera-Mendieta DR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005016; Roy S, 2019, ENVIRON URBAN ASIA, V10, P216, DOI 10.1177/0975425319859126; Salje H, 2019, ELIFE, V8, DOI 10.7554/eLife.42869; Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9; Selvarajoo S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66212-5; Sharmin S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006947; Sharmin S, 2015, T ROY SOC TROP MED H, V109, P619, DOI 10.1093/trstmh/trv067; Statistics BBo , 2011, POPULATION HOUSING C; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; ul Haq N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-448; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; WHO, DENG SEV DENG; WHO, 2017, DENG SEV DENG; WHO, 2018, NEGLECTED TROPICAL D; WHO, 2018, REVIS SAGE REC US DE, DOI [10.1016/j.vaccine.2018.09.063, DOI 10.1016/J.VACCINE.2018.09.063]; WHO Department of Control of Neglected Tropical D World Health Organization E Pandemic A, 2009, DENG GUID DIAGN TREA; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890; Wong LP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002789; World Health Organization, 2012, GLOB STRAT DENG PREV; Zaki R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212497; Zamri SNZBM, 2020, BANGLADESH J MED SCI, V19, P245, DOI 10.3329/bjms.v19i2.45003	54	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249135	10.1371/journal.pone.0249135	http://dx.doi.org/10.1371/journal.pone.0249135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784366	gold, Green Published			2022-12-26	WOS:000636359600029
J	DeLeeuw, LW; Monsen, RC; Petrauskas, V; Gray, RD; Baranauskiene, L; Matulis, D; Trent, JO; Chaires, JB				DeLeeuw, Lynn W.; Monsen, Robert C.; Petrauskas, Vytautas; Gray, Robert D.; Baranauskiene, Lina; Matulis, Daumantas; Trent, John O.; Chaires, Jonathan B.			POT1 stability and binding measured by fluorescence thermal shift assays	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; PROTEIN-PROTEIN INTERACTIONS; G-QUADRUPLEX DNA; NUCLEIC-ACID; BISINTERCALATING ANTHRACYCLINE; COIL TRANSITION; TELOMERASE; MODEL; INHIBITION; DISCOVERY	The protein POT1 (Protection of Telomeres 1) is an integral part of the shelterin complex that protects the ends of human chromosomes from degradation or end fusions. It is the only component of shelterin that binds single-stranded DNA. We describe here the application of two separate fluorescent thermal shift assays (FTSA) that provide quantitative biophysical characterization of POT1 stability and its interactions. The first assay uses Sypro Orange (TM) and monitors the thermal stability of POT1 and its binding under a variety of conditions. This assay is useful for the quality control of POT1 preparations, for biophysical characterization of its DNA binding and, potentially, as an efficient screening tool for binding of small molecule drug candidates. The second assay uses a FRET-labeled human telomeric G-quadruplex structure that reveals the effects of POT1 binding on thermal stability from the DNA frame of reference. These complementary assays provide efficient biophysical approaches for the quantitative characterization of multiple aspects of POT1 structure and function. The results from these assays provide thermodynamics details of POT1 folding, the sequence selectivity of its DNA binding and the thermodynamic profile for its binding to its preferred DNA binding sequence. Most significantly, results from these assays elucidate two mechanisms for the inhibition of POT1 -DNA interactions. The first is by competitive inhibition at the POT1 DNA binding site. The second is indirect and is by stabilization of G-quadruplex formation within the normal POT1 single-stranded DNA sequence to prevent POT1 binding.	[DeLeeuw, Lynn W.; Monsen, Robert C.; Gray, Robert D.; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Petrauskas, Vytautas; Baranauskiene, Lina; Matulis, Daumantas] Vilnius Univ, Life Sci Ctr, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania	University of Louisville; Vilnius University	Trent, JO; Chaires, JB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.; Matulis, D (corresponding author), Vilnius Univ, Life Sci Ctr, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	j.chaires@louisville.edu; john.trent@louisville.edu; daumantas.matulis@bti.vu.lt	Monsen, Robert/AAQ-6128-2021; Baranauskiene, Lina/P-5088-2016; Petrauskas, Vytautas/A-2659-2013	Baranauskiene, Lina/0000-0002-9924-9177; Chaires, Jonathan/0000-0001-5477-945X; Monsen, Robert/0000-0002-6283-3249; Petrauskas, Vytautas/0000-0001-7983-4128; trent, John/0000-0002-7346-4231	National Institutes of Health [GM077422]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by grant GM077422 from the National Institutes of Health (JBC, JOT). https://www.nih.gov/grants-funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SE, 2012, BIOCHEMISTRY-US, V51, P7833, DOI 10.1021/bi300365k; [Anonymous], 2018, SCHRODINGER MAESTRO; Aramburu T, 2020, COMPUT STRUCT BIOTEC, V18, P1939, DOI 10.1016/j.csbj.2020.06.040; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; BRTS J, 1990, BIOCHEMISTRY-US, V29, P6927, DOI DOI 10.1021/BI00481A024; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Chaires J. B., 2018, DNA TARGETING MOL TH, V7, P74; Chaires JB, 2020, NUCLEIC ACIDS RES, V48, P4976, DOI 10.1093/nar/gkaa202; Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14929; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; CROTHERS DM, 1971, BIOPOLYMERS, V10, P2147, DOI 10.1002/bip.360101110; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Dailey MM, 2009, EXP MOL PATHOL, V86, P141, DOI 10.1016/j.yexmp.2009.01.011; Darby RAJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e39; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; Estrada J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-104; Frank AO, 2013, J MED CHEM, V56, P9242, DOI 10.1021/jm401333u; Gong Y, 2020, CURR OPIN GENET DEV, V60, P48, DOI 10.1016/j.gde.2020.02.002; Gray Robert D, 2011, Curr Protoc Nucleic Acid Chem, VChapter 17, DOI 10.1002/0471142700.nc1704s45; Gupta M, 2020, J THERM ANAL CALORIM, V142, P1545, DOI 10.1007/s10973-020-09453-w; Huang CY, 2018, BIOCHEM BIOPH RES CO, V504, P704, DOI 10.1016/j.bbrc.2018.08.188; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Hwang H, 2012, STRUCTURE, V20, P1872, DOI 10.1016/j.str.2012.08.018; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jansson LI, 2019, P NATL ACAD SCI USA, V116, P9350, DOI 10.1073/pnas.1814777116; Jaumot J, 2012, CURR PHARM DESIGN, V18, P1900, DOI 10.2174/138161212799958486; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Leng FF, 1998, BIOCHEMISTRY-US, V37, P1743, DOI 10.1021/bi9720742; LERMAN LS, 1964, J CELL COMPAR PHYSL, V64, P1, DOI 10.1002/jcp.1030640403; Li QI, 2018, METHOD ENZYMOL, V601, P243, DOI 10.1016/bs.mie.2017.11.036; LiCata VJ, 2011, METHOD ENZYMOL, P219, DOI 10.1016/B978-0-12-381268-1.00009-4; Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w; Liu CC, 2008, BIOPHYS J, V94, P3258, DOI 10.1529/biophysj.107.117697; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; MCGHEE JD, 1976, BIOPOLYMERS, V15, P1345, DOI 10.1002/bip.1976.360150710; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Mergny JL, 2001, P NATL ACAD SCI USA, V98, P3062, DOI 10.1073/pnas.051620698; Monchaud D, 2008, BIOCHIMIE, V90, P1207, DOI 10.1016/j.biochi.2008.02.019; Mullins MR, 2016, J MOL BIOL, V428, P2695, DOI 10.1016/j.jmb.2016.04.031; Murat P, 2011, CHEM SOC REV, V40, P5293, DOI 10.1039/c1cs15117g; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PELLER L, 1959, J PHYS CHEM-US, V63, P1199, DOI 10.1021/j150577a045; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Portugal J, 2005, J MED CHEM, V48, P8209, DOI 10.1021/jm050902g; Ray S, 2014, P NATL ACAD SCI USA, V111, P2990, DOI 10.1073/pnas.1321436111; Redhead M, 2017, BIOCHEMISTRY-US, V56, P6187, DOI 10.1021/acs.biochem.7b00860; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Sanfelice D, 2016, BIOPHYS CHEM, V208, P4, DOI 10.1016/j.bpc.2015.05.007; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; SCHELLMAN JA, 1959, J PHYS CHEM-US, V62, P1485; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Shi XC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj012; Shuck SC, 2010, CANCER RES, V70, P3189, DOI 10.1158/0008-5472.CAN-09-3422; Simeonov A, 2013, EXPERT OPIN DRUG DIS, V8, P1071, DOI 10.1517/17460441.2013.806479; Spitzer R, 2012, J COMPUT AID MOL DES, V26, P687, DOI 10.1007/s10822-011-9533-y; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wu YX, 2020, CANCERS, V12, DOI 10.3390/cancers12102739; Xu MY, 2019, P NATL ACAD SCI USA, V116, P23527, DOI 10.1073/pnas.1905381116; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	76	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0245675	10.1371/journal.pone.0245675	http://dx.doi.org/10.1371/journal.pone.0245675			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784306	Green Published, Green Submitted, gold			2022-12-26	WOS:000636359600061
J	Geibel, J; Reimer, C; Weigend, S; Weigend, A; Pook, T; Simianer, H				Geibel, Johannes; Reimer, Christian; Weigend, Steffen; Weigend, Annett; Pook, Torsten; Simianer, Henner			How array design creates SNP ascertainment bias	PLOS ONE			English	Article							NEXT-GENERATION; GENETIC DIVERSITY; GENOME ANALYSIS; CHIP; PREDICTION; FRAMEWORK; EVOLUTION; SELECTION; ANCESTRY; MARKERS	Single nucleotide polymorphisms (SNPs), genotyped with arrays, have become a widely used marker type in population genetic analyses over the last 10 years. However, compared to whole genome re-sequencing data, arrays are known to lack a substantial proportion of globally rare variants and tend to be biased towards variants present in populations involved in the development process of the respective array. This affects population genetic estimators and is known as SNP ascertainment bias. We investigated factors contributing to ascertainment bias in array development by redesigning the Axiom((TM)) Genome-Wide Chicken Array in silico and evaluating changes in allele frequency spectra and heterozygosity estimates in a stepwise manner. A sequential reduction of rare alleles during the development process was shown. This was mainly caused by the identification of SNPs in a limited set of populations and a within-population selection of common SNPs when aiming for equidistant spacing. These effects were shown to be less severe with a larger discovery panel. Additionally, a generally massive overestimation of expected heterozygosity for the ascertained SNP sets was shown. This overestimation was 24% higher for populations involved in the discovery process than not involved populations in case of the original array. The same was observed after the SNP discovery step in the redesign. However, an unequal contribution of populations during the SNP selection can mask this effect but also adds uncertainty. Finally, we make suggestions for the design of specialized arrays for large scale projects where whole genome re-sequencing techniques are still too expensive.	[Geibel, Johannes; Reimer, Christian; Pook, Torsten; Simianer, Henner] Univ Goettingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany; [Geibel, Johannes; Reimer, Christian; Weigend, Steffen; Pook, Torsten; Simianer, Henner] Univ Goettingen, Ctr Integrated Breeding Res, Gottingen, Germany; [Weigend, Steffen; Weigend, Annett] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany	University of Gottingen; University of Gottingen; Friedrich Loeffler Institute	Geibel, J (corresponding author), Univ Goettingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany.; Geibel, J (corresponding author), Univ Goettingen, Ctr Integrated Breeding Res, Gottingen, Germany.	johannes.geibel@uni-goettingen.de	Geibel, Johannes/ABH-3270-2021	Geibel, Johannes/0000-0001-7172-3263; Weigend, Steffen/0000-0002-5670-2808; Pook, Torsten/0000-0001-7874-8500	EC project AVIANDIV (EC) [BIO4-CT98_0342]; German Federal Ministry of Education and Research (BMBF) via the SYNBREED project [FKZ 0315528E]; University of Goettingen	EC project AVIANDIV (EC); German Federal Ministry of Education and Research (BMBF) via the SYNBREED project(Federal Ministry of Education & Research (BMBF)); University of Goettingen	The sampling and sequencing of the chicken populations was funded by the EC project AVIANDIV (EC Contract No. BIO4-CT98_0342; 1998 -2000; https://aviandiv.fli.de/) and the German Federal Ministry of Education and Research (BMBF) via the SYNBREED project (FKZ 0315528E; 2009 - 2014; www.synbreed.tum.de).The authors further acknowledge support by the Open Access Publication Funds of the University of Goettingen.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; [Anonymous], 2015, PICARD TOOLS 2 0 1; [Anonymous], 2021, LANG ENV STAT COMP; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Bradbury IR, 2011, MOL ECOL RESOUR, V11, P218, DOI 10.1111/j.1755-0998.2010.02949.x; Broad Institute, 2018, GATK US GUID; Chen XW, 2012, GENET EPIDEMIOL, V36, P549, DOI 10.1002/gepi.21648; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Crawford RD., 1993, POULTRY BREEDING GEN, V2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Eller E, 2001, HUM BIOL, V73, P411, DOI 10.1353/hub.2001.0034; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; ENSEMBL, 2016, CHICK GERML SNP INDE; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Guillot G, 2009, BIOINFORMATICS, V25, P552, DOI 10.1093/bioinformatics/btn665; Heslot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074612; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; KIMURA M, 1991, JPN J GENET, V66, P367, DOI 10.1266/jjg.66.367; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Lawal RA, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0738-1; Lenth RV., 2021, EMMEANS ESTIMATED MA; Li H., ALIGNING SEQUENCE RE; Malomane DK, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5727-9; Malomane DK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4416-9; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mayer M, 2017, THEOR APPL GENET, V130, P2283, DOI 10.1007/s00122-017-2959-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Meuwissen THE, 2001, GENETICS, V157, P1819; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perez-Enciso M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0117-5; Peripolli E, 2017, ANIM GENET, V48, P255, DOI 10.1111/age.12526; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007989; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Quinto-Cortes CD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28539-y; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rocha D, 2014, J ANIM BREED GENET, V131, P483, DOI 10.1111/jbg.12095; Sandenbergh L, 2016, S AFR J ANIM SCI, V46, P89, DOI 10.4314/sajas.v46i1.11; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tixier-Boichard M, 2011, CR BIOL, V334, P197, DOI 10.1016/j.crvi.2010.12.012; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; Travis AJ, 2015, RICE, V8, DOI 10.1186/s12284-015-0068-z; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Wainschtein P., 2019, RECOVERY TRAIT HERIT, DOI 10.1101/588020; Wang JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33256; Warren WC, 2017, G3-GENES GENOM GENET, V7, P109, DOI 10.1534/g3.116.035923; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; WRIGHT S, 1951, ANN EUGENIC, V15, P323	77	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0245178	10.1371/journal.pone.0245178	http://dx.doi.org/10.1371/journal.pone.0245178			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784304	Green Published			2022-12-26	WOS:000636359600032
J	Brazil, A; Needham, L; Palmer, JL; Bezodis, IN				Brazil, Adam; Needham, Laurie; Palmer, Jac L.; Bezodis, Ian N.			A comprehensive biomechanical analysis of the barbell hip thrust	PLOS ONE			English	Article							SPRINT PERFORMANCE; MUSCULAR STRENGTH; GLUTEUS MAXIMUS; BICEPS FEMORIS; LOWER-LIMB; SQUAT; ELECTROMYOGRAPHY; KNEE	Barbell hip thrust exercises have risen in popularity within the biomechanics and strength and conditioning literature over recent years, as a method of developing the hip extensor musculature. Biomechanical analysis of the hip thrust beyond electromyography is yet to be conducted. The aim of this study was therefore to perform the first comprehensive biomechanical analysis the barbell hip thrust. Nineteen resistance trained males performed three repetitions of the barbell hip thrust at 70% one-repetition maximum. Kinematic (250 Hz) and kinetic (1000 Hz) data were used to calculate angle, angular velocity, moment and power data at the ankle, knee, hip and pelvic-trunk joint during the lifting phase. Results highlighted that the hip thrust elicits significantly (p < 0.05) greater bilateral extensor demand at the hip joint in comparison with the knee and pelvic-trunk joints, whilst ankle joint kinetics were found to be negligible. Against contemporary belief, hip extensor moments were not found to be consistent throughout the repetition and instead diminished throughout the lifting phase. The current study provides unique insight to joint kinematics and kinetics of the barbell hip thrust, based on a novel approach, that offers a robust evidence base for practitioners to guide exercise selection.	[Brazil, Adam; Needham, Laurie] Univ Bath, Dept Hlth, Bath, Avon, England; [Palmer, Jac L.; Bezodis, Ian N.] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff, Wales	University of Bath; Cardiff Metropolitan University	Brazil, A (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	A.brazil@bath.ac.uk		Needham, Laurie/0000-0002-8675-4684; Brazil, Adam/0000-0003-1850-9852				Andersen V, 2018, J STRENGTH COND RES, V32, P587, DOI 10.1519/JSC.0000000000001826; Brazil A, 2020, J SPORT SCI, V38, P1140, DOI 10.1080/02640414.2020.1743065; Garcia CLC, 2020, J STRENGTH COND RES, V34, P2449, DOI 10.1519/JSC.0000000000002859; Contreras B, 2017, J STRENGTH COND RES, V31, P999, DOI 10.1519/JSC.0000000000001510; Contreras B, 2016, J APPL BIOMECH, V32, P254, DOI 10.1123/jab.2015-0091; Contreras B, 2015, J APPL BIOMECH, V31, P452, DOI 10.1123/jab.2014-0301; Contreras B, 2011, STRENGTH COND J, V33, P58, DOI 10.1519/SSC.0b013e31822fa09d; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Dello Iacono A, 2018, J SPORT SCI, V36, P1269, DOI 10.1080/02640414.2017.1374657; Dempster W, 1955, SPACE REQUIREMENTS S; Farris DJ, 2016, SCAND J MED SCI SPOR, V26, P774, DOI 10.1111/sms.12508; Fitzpatrick DA, 2019, SPORTS, V7, DOI 10.3390/sports7020030; Fry AC, 2003, J STRENGTH COND RES, V17, P629; Hanavan E, 1964, MATH MODEL HUMAN BOD; Hanley B, 2013, J SPORT SCI, V31, P1222, DOI 10.1080/02640414.2013.777763; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; JACOBS R, 1992, J BIOMECH, V25, P953, DOI 10.1016/0021-9290(92)90031-U; Jandacka D, 2014, SPORT BIOMECH, V13, P75, DOI 10.1080/14763141.2013.872287; Jarvis P, 2019, J STRENGTH COND RES, V33, pS78, DOI 10.1519/JSC.0000000000002146; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Loturco I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201475; Neto WK, 2019, J SPORT SCI MED, V18, P198; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Selbie W.S., 2014, RES METHODS BIOMECHA, P151, DOI 10.1016/S0140-6736%2814%2962033-X; Southwell DJ, 2016, J ELECTROMYOGR KINES, V31, P111, DOI 10.1016/j.jelekin.2016.10.005; Suchomel TJ, 2018, SPORTS MED, V48, P765, DOI 10.1007/s40279-018-0862-z; Suchomel TJ, 2016, SPORTS MED, V46, P1419, DOI 10.1007/s40279-016-0486-0; Swinton PA, 2012, J STRENGTH COND RES, V26, P1805, DOI 10.1519/JSC.0b013e3182577067; Swinton PA, 2011, J STRENGTH COND RES, V25, P2000, DOI 10.1519/JSC.0b013e3181e73f87; Williams MJ, 2021, J STRENGTH COND RES, V35, P16, DOI 10.1519/JSC.0000000000002651; Winter D. A, 2009, BIOMECHANICS MOTOR C	32	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249307	10.1371/journal.pone.0249307	http://dx.doi.org/10.1371/journal.pone.0249307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780488	Green Published, gold			2022-12-26	WOS:000636336800021
J	Kopnick, AL; Jansen, A; Geistlinger, K; Epalle, NH; Beitz, E				Koepnick, Anna-Lena; Jansen, Annika; Geistlinger, Katharina; Epalle, Nathan Hugo; Beitz, Eric			Basigin drives intracellular accumulation of l-lactate by harvesting protons and substrate anions	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER; PLASMA-MEMBRANE; PROTEIN; CD147; EXPRESSION; CELLS; YEAST; MCT1; ELECTROSTATICS; GLYCOPROTEIN	Transmembrane transport of l-lactate by members of the monocarboxylate transporter family, MCT, is vital in human physiology and a malignancy factor in cancer. Interaction with an accessory protein, typically basigin, is required to deliver the MCT to the plasma membrane. It is unknown whether basigin additionally exerts direct effects on the transmembrane l-lactate transport of MCT1. Here, we show that the presence of basigin leads to an intracellular accumulation of l-lactate 4.5-fold above the substrate/proton concentrations provided by the external buffer. Using basigin truncations we localized the effect to arise from the extracellular Ig-I domain. Identification of surface patches of condensed opposite electrostatic potential, and experimental analysis of charge-affecting Ig-I mutants indicated a bivalent harvesting antenna functionality for both, protons and substrate anions. From these data, and determinations of the cytosolic pH with a fluorescent probe, we conclude that the basigin Ig-I domain drives lactate uptake by locally increasing the proton and substrate concentration at the extracellular MCT entry site. The biophysical properties are physiologically relevant as cell growth on lactate media was strongly promoted in the presence of the Ig-I domain. Lack of the domain due to shedding, or misfolding due to breakage of a stabilizing disulfide bridge reversed the effect. Tumor progression according to classical or reverse Warburg effects depends on the transmembrane l-lactate distribution, and this study shows that the basigin Ig-I domain is a pivotal determinant.	[Koepnick, Anna-Lena; Jansen, Annika; Geistlinger, Katharina; Epalle, Nathan Hugo; Beitz, Eric] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany	University of Kiel	Beitz, E (corresponding author), Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [860592]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 860592.	Bader A, 2020, MEMBRANES-BASEL, V10, DOI 10.3390/membranes10090236; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bosshart PD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10566-6; Bracey D, 1998, J MICROBIOL METH, V31, P113, DOI 10.1016/S0167-7012(97)00095-X; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Forero-Quintero LS, 2019, J BIOL CHEM, V294, P593, DOI 10.1074/jbc.RA118.005536; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Golldack A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006172; Gong DS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06075-7; Grollman EF, 2000, BIOCHEMISTRY-US, V39, P9351, DOI 10.1021/bi000464+; GUIARD B, 1985, EMBO J, V4, P3265, DOI 10.1002/j.1460-2075.1985.tb04076.x; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Klier M, 2014, J BIOL CHEM, V289, P2765, DOI 10.1074/jbc.M113.537043; KRUPKA RM, 1981, J BIOL CHEM, V256, P5410; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Makuc J, 2004, FEMS YEAST RES, V4, P795, DOI 10.1016/j.femsyr.2004.06.003; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Martinez Cristian, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00027; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Noble RA, 2017, HAEMATOLOGICA, V102, P1247, DOI 10.3324/haematol.2016.163030; Noor SI, 2018, ELIFE, V7, DOI 10.7554/eLife.35176; Payen VL, 2020, MOL METAB, V33, P48, DOI 10.1016/j.molmet.2019.07.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poole RC, 1997, J BIOL CHEM, V272, P14624, DOI 10.1074/jbc.272.23.14624; Pucino V, 2018, EXPERT OPIN THER TAR, V22, P735, DOI 10.1080/14728222.2018.1511706; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Redzic JS, 2011, J MOL BIOL, V411, P68, DOI 10.1016/j.jmb.2011.04.060; Rothert M, 2017, J BIOL CHEM, V292, P9358, DOI 10.1074/jbc.M117.782516; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; Sandforth L, 2020, CANCERS, V12, DOI 10.3390/cancers12030581; Schmidt N, 2017, NEURON, V96, P827, DOI 10.1016/j.neuron.2017.09.038; Soares-Silva I, 2007, MOL MEMBR BIOL, V24, P464, DOI 10.1080/09687680701342669; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Updegraff BL, 2018, CELL REP, V25, P2223, DOI 10.1016/j.celrep.2018.10.100; Volkov V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00425; Wang N, 2021, CELL, V184, P370, DOI 10.1016/j.cell.2020.11.043; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wu BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7284; Yamaguchi A, 2020, BIOCHEM BIOPH RES CO, V529, P1061, DOI 10.1016/j.bbrc.2020.06.068; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zhang B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16334-1	58	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249110	10.1371/journal.pone.0249110	http://dx.doi.org/10.1371/journal.pone.0249110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770122	Green Published, gold			2022-12-26	WOS:000634833500062
J	Lee, HN; Choi, YS; Kim, SH; Zhong, X; Kim, W; Park, JS; Saeidi, S; Han, BW; Kim, N; Lee, HS; Choi, YJ; Baek, JH; Na, HK; Surh, YJ				Lee, Ha-Na; Choi, Yeon-Seo; Kim, Seong Hoon; Zhong, Xiancai; Kim, Wonki; Park, Joon Sung; Saeidi, Soma; Han, Byung Woo; Kim, Nayoung; Lee, Hye Seung; Choi, Yoon Jin; Baek, Jeong-Heum; Na, Hye-Kyung; Surh, Young-Joon			Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality	FASEB JOURNAL			English	Article						cyclin D1; IL-6; IL-6R antagonist; inflammation-associated colorectal cancer; mitotic spindle abnormality; RvD1; STAT3	SMALL-MOLECULE INHIBITOR; SODIUM-INDUCED COLITIS; CRYO-EM STRUCTURE; NLRP3 INFLAMMASOME; BOWEL-DISEASE; PYRIN INFLAMMASOME; INTESTINAL INFLAMMATION; CROHNS-DISEASE; GUT MICROBIOTA; GASDERMIN D	While failure in resolution of inflammation is considered to increase the risk of tumorigenesis, there is paucity of experimental as well as clinical evidence supporting this association. Resolvin D1 (RvD1) is a representative pro-resolving lipid mediator that is endogenously generated from docosahexaenoic acid for the resolution of inflammation. Here, we report a decreased level of RvD1 in the blood from colorectal cancer patients and mice having inflammation-induced colon cancer, suggesting plasma RvD1 as a potential biomarker for monitoring colorectal cancer. Administration of RvD1 attenuated dextran sodium sulfate (DSS)-induced colitis and azoxymethane (AOM) plus DSS-induced colorectal carcinogenesis by suppressing the production of interleukin-6 (IL-6) and IL-6-mediated chromosomal instability. The protective effect of RvD1 against chromosomal instability is associated with downregulation of IL-6-induced Cyclin D1 expression, which appears to be mediated by blocking the Janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) axis. RvD1 inhibited the STAT3 signaling pathway by interfering with the binding of IL-6 to its receptor (IL-6R), suggesting the novel function of RvD1 as a putative IL-6R antagonist. Together, our findings suggest that RvD1-mediated blockade of IL-6 signal transmission may contribute to inhibition of chromosomal instability and tumorigenesis.	[Lee, Ha-Na; Choi, Yeon-Seo; Kim, Seong Hoon; Zhong, Xiancai; Kim, Wonki; Park, Joon Sung; Saeidi, Soma; Han, Byung Woo; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 08826, South Korea; [Choi, Yeon-Seo; Saeidi, Soma; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Nayoung; Choi, Yoon Jin] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Baek, Jeong-Heum] Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg,Div Colon & Rectal Surg, Incheon, South Korea; [Na, Hye-Kyung] Sungshin Womens Univ, Coll Human Ecol, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gachon University; Sungshin Women's University; Seoul National University (SNU)	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAM-3069-2020; Zhong, Xiancai/AAV-2761-2020; Lee, Hye Seung/G-6419-2011	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Lee, Hye Seung/0000-0002-1667-7986; Park, Joon Sung/0000-0002-1575-1849	National Research Foundation of Korea (NRF) [2011-0030001]; BK21 FOUR Program [5120200513755]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); BK21 FOUR Program	National Research Foundation of Korea (NRF), Grant/Award Number: GCRC Grant (no. 2011-0030001) and BK21 FOUR Program (5120200513755)	Alatab S, 2020, LANCET GASTROENTEROL, V5, P17, DOI 10.1016/S2468-1253(19)30333-4; Alimov I, 2019, J BIOL CHEM, V294, P3359, DOI 10.1074/jbc.RA118.005103; Allam O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194185; Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P1089, DOI 10.1097/MIB.0000000000000338; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Balakrishnan A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0068-z; Bank S, 2019, ALIMENT PHARM THER, V49, P890, DOI 10.1111/apt.15187; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauer R, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100863; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Bulek K, 2020, J CLIN INVEST, V130, P4218, DOI 10.1172/JCI138103; Cao F, 2019, AUTOIMMUN REV, V18, P767, DOI 10.1016/j.autrev.2019.06.009; Cao J, 2019, EUR J PHARM BIOPHARM, V137, P112, DOI 10.1016/j.ejpb.2019.02.011; Caseley EA, 2020, GENES IMMUN, V21, P211, DOI 10.1038/s41435-020-0104-x; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chen L, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01910; Chen XL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2157-1; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Dai GL, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00721; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Silva EFD, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021686; De Vroey B, 2011, NAT REV GASTRO HEPAT, V8, P74, DOI 10.1038/nrgastro.2010.218; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1480, DOI 10.1038/mi.2014.36; Deng ZB, 2017, MOL THER, V25, P1641, DOI 10.1016/j.ymthe.2017.01.025; Dhimolea E, 2010, MABS-AUSTIN, V2, P3, DOI 10.4161/mabs.2.1.10328; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duncan JA, 2018, IMMUNOL REV, V281, P115, DOI 10.1111/imr.12607; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eren E, 2020, EMBO REP, V21, DOI 10.15252/embr.202050829; Fan TJ, 2018, INFLAMM BOWEL DIS, V24, P2394, DOI 10.1093/ibd/izy244; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Feuerstein JD, 2019, MAYO CLIN PROC, V94, P1357, DOI 10.1016/j.mayocp.2019.01.018; Finethy R, 2020, EMBO REP, V21, DOI 10.15252/embr.202050830; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Flood B, 2019, ONCOGENE, V38, P2658, DOI 10.1038/s41388-018-0613-5; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Gai K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1817-5; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Giacomelli R., 2020, CLIN EXP RHEUMATOL, P1; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Gomes MTR, 2019, J LEUKOCYTE BIOL, V106, P553, DOI 10.1002/JLB.4MR0119-013R; Gong ZZ, 2018, MOL IMMUNOL, V104, P11, DOI 10.1016/j.molimm.2018.09.004; Gram AM, 2021, J IMMUNOL, V206, P631, DOI 10.4049/jimmunol.2000382; Grammatikopoulou MG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111737; Hara H, 2018, CELL, V175, P1651, DOI 10.1016/j.cell.2018.09.047; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Heilig R, 2018, EUR J IMMUNOL, V48, P230, DOI 10.1002/eji.201746947; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Huang Y, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708689; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Iqbal U, 2018, AM J MED SCI, V356, P350, DOI 10.1016/j.amjms.2018.06.023; Itani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39075; Jamilloux Y, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty020; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jin TC, 2013, PROTEINS, V81, P1266, DOI 10.1002/prot.24287; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jing WD, 2021, CELL MICROBIOL, V23, DOI 10.1111/cmi.13309; Martinez-Garcia JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10626-x; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Khatri V, 2015, J DIGEST DIS, V16, P585, DOI 10.1111/1751-2980.12290; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kirsner JB, 2001, WORLD J GASTROENTERO, V7, P175; Lazaridis LD, 2017, DIGEST DIS SCI, V62, P2348, DOI 10.1007/s10620-017-4609-8; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Lemire P, 2017, CELL REP, V21, P3653, DOI 10.1016/j.celrep.2017.12.026; Leng FW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57043-0; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Levy M, 2017, TRENDS IMMUNOL, V38, P248, DOI 10.1016/j.it.2017.01.001; Li MS, 2020, BIOL RES, V53, DOI 10.1186/s40659-020-00279-2; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040354; Li YY, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111847; Liu L, 2017, J CROHNS COLITIS, V11, P737, DOI 10.1093/ecco-jcc/jjw219; Liu QQ, 2016, J DIGEST DIS, V17, P104, DOI 10.1111/1751-2980.12314; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Liu ZH, 2020, IMMUNITY, V53, P106, DOI 10.1016/j.immuni.2020.06.007; Loeven NA, 2020, CURR OPIN MICROBIOL, V54, P77, DOI 10.1016/j.mib.2020.01.005; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Ludwiczek O, 2005, EUR CYTOKINE NETW, V16, P27; Ma CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6717; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mak WY, 2020, J GASTROEN HEPATOL, V35, P380, DOI 10.1111/jgh.14872; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Man SM, 2018, NAT REV GASTRO HEPAT, V15, P721, DOI 10.1038/s41575-018-0054-1; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Mao LM, 2018, J CLIN INVEST, V128, P1793, DOI 10.1172/JCI98642; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Maruzuru Y, 2021, J VIROL, V95, DOI 10.1128/JVI.02172-20; Mazarakis N, 2020, CLIN NUTR, V39, P664, DOI 10.1016/j.clnu.2019.03.022; Mazgaeen L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020379; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; Melmed GY, 2006, AM J GASTROENTEROL, V101, P1834, DOI 10.1111/j.1572-0241.2006.00646.x; Mezzasoma L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010024; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mishra R, 2020, WORLD J STEM CELLS, V12, P1050, DOI 10.4252/wjsc.v12.i10.1050; Morrison G, 2009, AUST FAM PHYSICIAN, V38, P956; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Mu J, 2019, J MED GENET, V56, P471, DOI 10.1136/jmedgenet-2018-105936; Mukherjee S, 2020, NAT IMMUNOL, V21, P626, DOI 10.1038/s41590-020-0681-x; Mullins B., 2020, IMMUNOLOGY, V162, P1; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Nie H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6182464; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Oficjalska K, 2015, J IMMUNOL, V194, P1252, DOI 10.4049/jimmunol.1400501; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Onoufriadis A, 2018, J CROHNS COLITIS, V12, P321, DOI 10.1093/ecco-jcc/jjx157; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Perera AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26775-w; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Prochnicki Tomasz, 2016, F1000Res, V5, DOI 10.12688/f1000research.8614.1; Ranson N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010057; Ranson N, 2018, CELL MOL GASTROENTER, V6, P110, DOI 10.1016/j.jcmgh.2018.03.001; Ranson N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112379; Rapa SF, 2020, FASEB J, V34, P1576, DOI 10.1096/fj.201902040R; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruiz VMR, 2017, P NATL ACAD SCI USA, V114, P13242, DOI 10.1073/pnas.1710433114; Saber S., 2020, INFLAMMOPHARMACOLOGY, V28, P1; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Schnappauf O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01745; Seregin SS, 2017, MUCOSAL IMMUNOL, V10, P434, DOI 10.1038/mi.2016.55; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Shen C, 2019, P NATL ACAD SCI USA, V116, P2052, DOI 10.1073/pnas.1817221116; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Song-Zhao GX, 2014, MUCOSAL IMMUNOL, V7, P763, DOI 10.1038/mi.2013.94; Standing ASI, 2017, J EXP MED, V214, P59, DOI 10.1084/jem.20161228; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Taabazuing CY, 2020, IMMUNOL REV, V297, P13, DOI 10.1111/imr.12884; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tatiya-aphiradee Nitima, 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P1, DOI 10.1515/jbcpp-2018-0036; Thomas MG, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023765; Tian XQ, 2020, INT J RADIAT BIOL, V96, P740, DOI 10.1080/09553002.2020.1694188; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Toubai T, 2019, NAT MICROBIOL, V4, P800, DOI 10.1038/s41564-019-0373-1; Umiker B, 2019, INNATE IMMUN-LONDON, V25, P132, DOI 10.1177/1753425919826367; Valmiki S, 2017, WORLD J GASTROENTERO, V23, P5324, DOI 10.3748/wjg.v23.i29.5324; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Vande Walle L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000354; Verma D., 2020, J INVEST DERMATOL, P1; Verstockt B, 2018, J GASTROENTEROL, V53, P585, DOI 10.1007/s00535-018-1449-z; Volk JK, 2019, J EXP MED, V216, P2602, DOI 10.1084/jem.20190679; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang B, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100869; Wang HL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0901-8; Wang LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01487; Wang SB, 2015, J GASTROEN HEPATOL, V30, P504, DOI 10.1111/jgh.12710; Wang YQ, 2018, IMMUNOPHARM IMMUNOT, V40, P476, DOI 10.1080/08923973.2018.1469145; Wani S, 2020, AM J PHYSIOL-GASTR L, V319, pG646, DOI 10.1152/ajpgi.00295.2020; Wasan SK, 2011, INFLAMM BOWEL DIS, V17, P2536, DOI 10.1002/ibd.21667; Wera O, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120118; Wilks S., 1859, LONDON MED GAZETT, V2, P264; Williams MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01091; Williams TM, 2015, AM J PHYSIOL-GASTR L, V308, pG139, DOI 10.1152/ajpgi.00234.2014; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu DC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3048532; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang XR, 2018, CELL RES, V28, P35, DOI 10.1038/cr.2017.148; Yao XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01917-2; Yin JH, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12555; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang HB, 2017, J IMMUNOL, V198, P4383, DOI 10.4049/jimmunol.1600714; Zhang J, 2014, MUCOSAL IMMUNOL, V7, P1139, DOI 10.1038/mi.2014.1; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2019, MUCOSAL IMMUNOL, V12, P1150, DOI 10.1038/s41385-019-0177-x; Zheng DP, 2021, IMMUNOLOGY, V162, P281, DOI 10.1111/imm.13293; Zheng DP, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0167-x; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhou HB, 2015, CELL REP, V13, P1149, DOI 10.1016/j.celrep.2015.09.073	214	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21432	10.1096/fj.202002392R	http://dx.doi.org/10.1096/fj.202002392R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33794029				2022-12-26	WOS:000645260100077
J	Howarth, T; Ben Saad, H; Perez, AJ; Atos, CB; White, E; Heraganahally, SS				Howarth, Timothy; Ben Saad, Helmi; Perez, Ara J.; Atos, Charmain B.; White, Elisha; Heraganahally, Subash S.			Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults	PLOS ONE			English	Article							FORCED VITAL CAPACITY; REFERENCE VALUES; NORTHERN-TERRITORY; PULMONARY-FUNCTION; STANDARDIZATION; SPIROMETRY; SYMPTOMS; DISEASE; POPULATION	Background and objective Currently there is paucity of evidence in the literature in relation to normative values for diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) among Indigenous Australians. Hence, in this study we assessed the DLCO and TLC parameters among Indigenous Australians in comparison to Australian Caucasian counterparts. Methods DLCO and TLC values were assessed and compared between Indigenous Australians and Australian Caucasians matched for age, sex and body mass index, with normal chest radiology. Results Of the 1350 and 5634 pulmonary function tests assessed in Indigenous Australian and Australian Caucasian adults respectively, a total of 129 Indigenous Australians and 197 Australian Caucasians met the inclusion criteria. Absolute DLCO and TLC values for Indigenous Australians were a mean 4.3 ml/min/mmHg (95% CI 2.86, 5.74) and 1.03 L (95% CI 0.78, 1.27) lower than Australian Caucasians (p<0.01). Percentage predicted values were 15.38 (95% CI 11.59, 19.17) and 16.63 (95% CI 13.59, 19.68) points lower for DLCO and TLC, respectively. Lower limit of normal (LLN) values did not significantly differ between groups, however a significantly greater proportion of Indigenous Australians recorded values below the LLN in comparison to Australian Caucasians for DLCO (64 vs. 25%, p<0.01) and TLC (66 vs. 21%, p<0.01). Significant differences for the interaction of sex on DLCO and TLC were noted in Australian Caucasians, with reduced or absent sex differentiation among Indigenous Australians. Conclusions There are significant differences in DLCO and TLC parameters between Indigenous Australian compared to Australian Caucasians. Appropriate DLCO and TLC norms need to be established for Indigenous Australians.	[Howarth, Timothy] Charles Darwin Univ, Coll Hlth & Human Sci, Darwin, NT, Australia; [Howarth, Timothy; Perez, Ara J.; Atos, Charmain B.; Heraganahally, Subash S.] Darwin Private Hosp, Darwin Resp & Sleep Hlth, Darwin, NT, Australia; [Ben Saad, Helmi] Univ Sousse, Fac Med Sousse, Lab Physiol, Sousse, Tunisia; [Ben Saad, Helmi] Farhat HACHED Hosp, Dept Physiol & Funct Explorat, Sousse, Tunisia; [Ben Saad, Helmi] Farhat HACHED Hosp, Heart Failure Res Lab LR12SP09, Sousse, Tunisia; [White, Elisha; Heraganahally, Subash S.] Royal Darwin Hosp, Dept Resp & Sleep Med, Darwin, NT, Australia; [Heraganahally, Subash S.] Flinders Univ S Australia, Coll Med, Adelaide, SA, Australia; [Heraganahally, Subash S.] Flinders Univ S Australia, Publ Hlth & Northern Terr Med Programme, Adelaide, SA, Australia	Charles Darwin University; Universite de Sousse; Universite de Sousse; Hopital Farhat Hached; Universite de Sousse; Hopital Farhat Hached; Flinders University South Australia; Flinders University South Australia	Howarth, T (corresponding author), Charles Darwin Univ, Coll Hlth & Human Sci, Darwin, NT, Australia.; Howarth, T (corresponding author), Darwin Private Hosp, Darwin Resp & Sleep Hlth, Darwin, NT, Australia.	timothypaul.howarth@cdu.edu.au	Ben Saad, Helmi/C-8263-2018	Ben Saad, Helmi/0000-0002-7477-2965; Howarth, Timothy/0000-0003-3028-0376	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	We thank Mr Xinlin Jing, from the Health Information Services, Royal Darwin Hospital, Darwin, Northern Territory, Australia and Mrs Joy J Mingi, Department of Public Health, Charles Darwin University, Darwin, Northern Territory, Australia for helping with lung function data collection for this study. We also sincerely thank Boehringer Ingelheim, pharmaceutical company for their generosity in voluntarily donating funding towards this study to address Indigenous Australian respiratory issues in the NT population.	AIHW,, 2020, AB TORR STRAIT ISL H; [Anonymous], 2020, POP AUSTR BUR STAT; Australian Bureau of Statistics, AB TORR STRAIT ISL P; Australian Bureau of Statistics Canberra, 2016, ABORIGINAL TORRES ST; Australian Institute of Health Welfare, 2019, AUSTR MOTH BAB 2017; Blake TL, 2020, RESPIROLOGY, V25, P281, DOI 10.1111/resp.13649; Blake TL, 2016, MED J AUSTRALIA, V205, P35, DOI 10.5694/mja16.00226; Bolliger CT, 1998, EUR RESPIR J, V11, P198, DOI 10.1183/09031936.98.11010198; Bremner PR, 1998, AM J RESP CRIT CARE, V158, P1724, DOI 10.1164/ajrccm.158.6.9702068; Carroll SJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032173; Cooksley NAJB, 2015, RESPIROLOGY, V20, P766, DOI 10.1111/resp.12482; Ford EJ, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1946-3; Gibson GJ, 1996, EUR RESPIR J, V9, P2640, DOI 10.1183/09031936.96.09122640; Gochicoa-Rangel L, 2017, RESP CARE, V62, P231, DOI 10.4187/respcare.04983; Hall G, 2019, AUSTR INDIGENOUS HLT, V19; Hall GL, 2015, RESPIROLOGY, V20, P693, DOI 10.1111/resp.12552; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hassel E, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0317-0; Heraganahally SS, 2021, EXPERT REV RESP MED, V15, P833, DOI 10.1080/17476348.2021.1847649; Heraganahally SS, 2020, INTERN MED J, V50, P1505, DOI 10.1111/imj.14718; Heraganahally SS, 2019, INT J CHRONIC OBSTR, V14, P2205, DOI 10.2147/COPD.S213947; Heris CL, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp29121906; Howarth T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231798; Interpretation of single-breath TLC, NDD MED AG 03 2013 C; Isaac BTJ, 2015, LUNG INDIA, V32, P584, DOI 10.4103/0970-2113.168131; Kirby M, 2013, THORAX, V68, P752, DOI 10.1136/thoraxjnl-2012-203108; Kruavit A, 2017, AUST J RURAL HEALTH, V25, P275, DOI 10.1111/ajr.12349; Le Gouellec N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181692; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Musk AW, 2008, RESPIROLOGY, V13, P257, DOI 10.1111/j.1440-1843.2007.01221.x; NDD Medical Technologies, 2017, EASYONE PRO; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PRIGNOT J, 1987, EUR J RESPIR DIS, V70, P1; Punjabi NM, 1998, CHEST, V114, P907, DOI 10.1378/chest.114.3.907; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Schubert J, 2019, INTERN MED J, V49, P217, DOI 10.1111/imj.14112; Stanojevic S, 2020, RESPIROLOGY, V25, P236, DOI 10.1111/resp.13684; Stanojevic S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00010-2017; Thompson BR, 2008, THORAX, V63, P889, DOI 10.1136/thx.2007.091959; Thompson BR, 2011, RESPIROLOGY, V16, P912, DOI 10.1111/j.1440-1843.2011.01970.x; THOMPSON JE, 1992, MED J AUSTRALIA, V156, P566, DOI 10.5694/j.1326-5377.1992.tb121420.x; Veale AJ, 1997, AUST NZ J MED, V27, P543, DOI 10.1111/j.1445-5994.1997.tb00962.x; Verheijden MW, 2002, RESPIROLOGY, V7, P247, DOI 10.1046/j.1440-1843.2002.00396.x; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Waschki B, 2015, AM J RESP CRIT CARE, V192, P295, DOI 10.1164/rccm.201501-0081OC; Weiner DJ, 2020, ANN AM THORAC SOC, V17, P128, DOI 10.1513/AnnalsATS.201910-732LE; Westrupp EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212130	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248900	10.1371/journal.pone.0248900	http://dx.doi.org/10.1371/journal.pone.0248900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798242	Green Published, gold			2022-12-26	WOS:000636737700046
J	Yoo, R; So, H; Seo, E; Kim, M; Lee, J				Yoo, Reenar; So, Hyejin; Seo, Euri; Kim, Mina; Lee, Jina			Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children	PLOS ONE			English	Article							INFECTIONS; PHARMACODYNAMICS; NEPHROTOXICITY	Optimal vancomycin exposure is important to minimize treatment failure of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. We aimed to analyze the impact of initial vancomycin pharmacokinetic/pharmacodynamic (PK/PD) parameters, including the initial vancomycin C (trough) and the area under the curve (AUC)/minimal inhibitory concentration (MIC) on the outcomes of pediatric MRSA bacteremia. The study population consisted of hospitalized children aged between 2 months and 18 years with MRSA bacteremia, in whom C (trough) was measured at least one time within the time period of January 2010 to March 2018. Demographic profiles, underlying diseases, and clinical/microbiological outcomes were abstracted retrospectively. During the study period, 73 cases of MRSA bacteremia occurred in children with a median age of 12.4 months. Severe clinical outcomes leading to intensive care unit stay and/or use of mechanical ventilation occurred in 47.5% (35/73); all-cause 30-day mortality was 9.7% (7/72). The median dosage of vancomycin was 40.0 mg/kg/day. There was a weak linear relationship between C (trough) and the corresponding AUC/MIC (r = 0.235). ROC curves for achieving an AUC/MIC of 300 suggested that the initial C (trough) at 10 mu g/mL could be used as a cut-off value with a sensitivity of 90.5% and a specificity of 44%. Although persistent bacteremia at 48-72 hours after vancomycin administration was observed more frequently when the initial C (trough) was < 10 mu g/mL and initial AUC/MIC was < 300, initial AUC/MIC < 300 was the only risk factor associated with persistent bacteremia at 48-72 hours (adjusted OR 3.05; 95% CI, 1.07-8.68). Initial C (trough) and AUC/MIC were not associated with 30-day mortality. Although there was a weak relationship between C (trough) and AUC/MIC, initial AUC/MIC < 300 could be used as a predictor of persistent MRSA bacteremia at 48-72 hours. Further prospective data on optimal vancomycin dosing are necessary to improve clinical and microbiological outcomes in pediatric MRSA bacteremia.	[Yoo, Reenar; So, Hyejin; Lee, Jina] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, Seoul, South Korea; [Seo, Euri] Dongguk Univ, Coll Med, Ilsan Hosp, Dept Pediat, Goyang, South Korea; [Kim, Mina] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; Dongguk University; NHIS Ilsan Hospital; University of Ulsan; Asan Medical Center	Lee, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, Seoul, South Korea.	entier@amc.seoul.kr	So, Hyejin/ABE-1517-2021	So, Hyejin/0000-0003-4322-0452				Adani S, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.02512-17, 10.1128/AAC.02512-17]; Alsultan A, 2018, PEDIATR INFECT DIS J, V37, P880, DOI 10.1097/INF.0000000000001943; Chang ChiaNing, 2018, Journal of Medical Sciences, V38, P275, DOI 10.4103/jmedsci.jmedsci_103_18; CHANG D, 1995, PEDIATR INFECT DIS J, V14, P667, DOI 10.1097/00006454-199508000-00004; Chhim RF, 2013, J PEDIAT INF DIS SOC, V2, P292, DOI [10.1093/jpids/pit032, 10.1093/jpids/pis083]; Frymoyer A, 2013, PEDIATR INFECT DIS J, V32, P1077, DOI 10.1097/INF.0b013e318299f75c; Frymoyer A, 2010, CLIN THER, V32, P534, DOI 10.1016/j.clinthera.2010.03.005; Hsu AJ, 2018, J PEDIAT INF DIS SOC, V7, P338, DOI 10.1093/jpids/pix068; Hsu DI, 2008, INT J ANTIMICROB AG, V32, P378, DOI 10.1016/j.ijantimicag.2008.05.007; Kishk Omayma A, 2017, J Pediatr Pharmacol Ther, V22, P41, DOI 10.5863/1551-6776-22.1.41; Kruzel MC, 2011, J CLIN MICROBIOL, V49, P2272, DOI 10.1128/JCM.02215-10; Le J, 2013, PEDIATR INFECT DIS J, V32, pE155, DOI 10.1097/INF.0b013e318286378e; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Lodise TP, 2009, CLIN INFECT DIS, V49, P507, DOI 10.1086/600884; McNeil JC, 2016, PEDIATR INFECT DIS J, V35, P263, DOI 10.1097/INF.0000000000000991; Mogle BT, 2018, INT J ANTIMICROB AG, V52, P805, DOI 10.1016/j.ijantimicag.2018.08.024; Moise-Broder PA, 2004, CLIN PHARMACOKINET, V43, P925, DOI 10.2165/00003088-200443130-00005; Neely MN, 2014, ANTIMICROB AGENTS CH, V58, P309, DOI 10.1128/AAC.01653-13; Pai MP, 2014, ADV DRUG DELIVER REV, V77, P50, DOI 10.1016/j.addr.2014.05.016; Ragab AR, 2013, INFECT DIS THER, V2, P37, DOI 10.1007/s40121-013-0004-8; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2020, AM J HEALTH-SYST PH, V77, P835, DOI 10.1093/ajhp/zxaa036; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Sader HS, 2009, ANTIMICROB AGENTS CH, V53, P4127, DOI 10.1128/AAC.00616-09; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Yoo RN, 2017, J KOREAN MED SCI, V32, P22, DOI 10.3346/jkms.2017.32.1.22	28	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0247714	10.1371/journal.pone.0247714	http://dx.doi.org/10.1371/journal.pone.0247714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793589	Green Published, gold			2022-12-26	WOS:000636467000069
J	Liu, SF; Fu, YQ; He, YM; Zeng, XC				Liu, Suifei; Fu, Yongqi; He, Yongming; Zeng, Xiaochun			Transcriptome analysis of the impact of exogenous methyl jasmonate on the opening of sorghum florets	PLOS ONE			English	Article								Background Methyl Jasmonate (MeJA) could promote the opening of sorghum florets, but the molecular mechanism remains unclear. Objective We aimed to investigate the molecular mechanism of exogenous MeJA in promoting the opening of sorghum florets. Methods Hybrid sorghum Aikang-8 was selected as the test material in this study. Sorghum plants of uniform growth with approximately 20%-25% florets open were selected and treated with 0, 0.5 and 2.0 mmol/L of MeJA. Totally there were 27 samples with lodicules removed were obtained at different time points and used for the transcriptome analysis using the BGISEQ_500RS platform. Results The results showed the sorghum florets opened earlier than the control after the treatment with exogenous MeJA, and the promotive effect increased along with the increase of exogenous MeJA concentration. The number of differentially expressed genes (DEGs) in plasma cells increased with the increase of MeJA concentration, whether up- or down-regulated, after the exogenous MeJA treatment. Besides, the number of metabolic pathways was also positively correlated with the concentration of MeJA. GO and KEGG analysis suggested the DEGs were mainly enriched in starch and sucrose metabolism-related pathways (i.e., LOC8063704, LOC8083539 and LOC8056206), plant hormone signal transduction pathways (i.e., LOC8084842, LOC8072010, and LOC8057408), energy metabolic pathway (i.e., LOC8076139) and the alpha-linolenic acid metabolic pathway (i.e., LOC8055636, LOC8057399, LOC8063048 and LOC110430730). Functional analysis of target genes showed that two genes named LOC-1 (LOC8063704) and LOC-2 (LOC8076139) could induce the earlier flowering of Arabidopsis thaliana. Conclusion The results of this study suggest that exogenous MeJA treatments could induce the up- or down- regulation of genes related to starch and sucrose metabolism, -linolenic acid metabolism and plant hormone signal transduction pathways in the plasma cells of sorghum florets, thereby promoting the opening of sorghum florets.	[Liu, Suifei; Fu, Yongqi; He, Yongming] Jiangxi Agr Univ, Nanchang, Jiangxi, Peoples R China; [Liu, Suifei] Jiangxi Agr Engn Coll, Zhangshu, Jiangxi, Peoples R China; [Zeng, Xiaochun] Yichun Univ, Yichun, Jiangxi, Peoples R China	Jiangxi Agricultural University; Yichun University	Zeng, XC (corresponding author), Yichun Univ, Yichun, Jiangxi, Peoples R China.	xchzeng2013@163.com	Fu, Yongqi/B-5058-2008		National Natural Science Foundation of China [31360297]; Jiangxi-Poyang Lake Talent 555 Project, Science/Technology Support Program [20111BBF60009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi-Poyang Lake Talent 555 Project, Science/Technology Support Program	This study was supported by National Natural Science Foundation of China (grant #31360297) and Jiangxi-Poyang Lake Talent 555 Project, Science/Technology Support Program (grant #20111BBF60009).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Chen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59183-0; Chen YX, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix120; Cheng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38215; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Craufurd PQ, 1999, THEOR APPL GENET, V99, P900, DOI 10.1007/s001220051311; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gao XQ, 2004, PLANT GROWTH REGUL, V43, P269, DOI 10.1023/B:GROW.0000046004.77424.1d; Han MG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061479; He B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144518; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaplan F, 2006, PHYSIOL PLANTARUM, V126, P120, DOI [10.1111/j.1399-3054.2006.00604.x, 10.1111/j.1399-3054.2005.00604.x]; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kong WL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134615; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mukherjee R, 2012, CROP SCI, V52, P1743, DOI 10.2135/cropsci2011.07.0352; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Niu H, 2020, MOL BREEDING, V40, DOI 10.1007/s11032-020-01151-7; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Okada M, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1498-8; Okechukwu MF, 2006, ABSTRACTS PAPERS AM, V231; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Rooney WL, 1999, CROP SCI, V39, P397, DOI 10.2135/cropsci1999.0011183X0039000200016x; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Song P, 2001, ACTA BOT SIN, V43, P480; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tang W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226599; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P405, DOI 10.1016/j.tplants.2006.06.003; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Wang YH, 2011, PLANT SIGNAL BEHAV, V6, P494, DOI 10.4161/psb.6.4.14558; Wang YG, 2016, SCI HORTIC-AMSTERDAM, V211, P19, DOI 10.1016/j.scienta.2016.08.004; Yang B, 2019, MITOCHONDRIAL DNA B, V4, P1421, DOI 10.1080/23802359.2019.1598797; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Zeng XC, 1999, J PLANT GROWTH REGUL, V18, P153, DOI 10.1007/PL00007063; Zhu GZ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4449-8	39	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248962	10.1371/journal.pone.0248962	http://dx.doi.org/10.1371/journal.pone.0248962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788892	Green Published, gold			2022-12-26	WOS:000636354600027
J	de Souza, AA; Mingoti, SA; Paes-Sousa, RM; Heller, L				de Souza, Anelise Andrade; Mingoti, Sueli Aparecida; Paes-Sousa, Romulo; Heller, Leo			Combined effects of conditional cash transfer program and environmental health interventions on diarrhea and malnutrition morbidity in children less than five years of age in Brazil, 2006-2016	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; NUTRITIONAL-STATUS; INFANT-MORTALITY; SPATIAL-ANALYSIS; GLOBAL BURDEN; RISK-FACTORS; SANITATION; DISEASE; MUNICIPALITIES; EPIDEMIOLOGY	Introduction Governmental measures aiming at social protection, with components of disease control, have potential positive impacts in the nutritional and health outcomes of the beneficiaries. The concomitant presence of these measures with environmental sanitation interventions may increase their positive effect. The context of simultaneous improvement of social protection and environmental sanitation is found in Brazil since 2007 and an assessment of the combined effects of both programs has not been performed so far. Objective To evaluate whether interaction effects between improvement of access to water, sanitation and solid waste collection with the Bolsa Familia Program [PBF] were related to better responses in the reduction of morbidity due to diarrhea and malnutrition in children less than five years of age, acknowledging the positive results of these improved conditions and the PBF separately in coping with these diseases. Methods Descriptive and inferential analyses were performed through Generalized Linear Models of the Negative Binomial type of fixed effects, with and without addition of zeros. Interaction models were inserted in order to evaluate the outcomes when the two public policies of interest in the current study were present simultaneously in the municipalities. Results Interaction with negative effect when a concomitantly high municipal coverage of the Bolsa Familia Program and adequate access to sanitation and solid waste collection were present. In contrast, regardless of municipal coverage by the PBF, the simultaneous presence of water and sanitation (0.028% / 0.019%); water and solid waste collection (0.033% / 0.014%); sanitation and solid waste collection (0.018% / 0.021%), all resulted in a positive effect, with a decrease in the average morbidity rates for both diseases. Conclusion Investments aimed at universalizing water, sanitation and solid waste collection services should be priorities, aiming at reducing the incidence of morbidity due to malnutrition and diarrhea and preventing deaths from these poverty-related diseases.	[de Souza, Anelise Andrade; Paes-Sousa, Romulo; Heller, Leo] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Mingoti, Sueli Aparecida] Univ Fed Minas Gerais, Dept Stat, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	de Souza, AA (corresponding author), Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.	anelise.souza@fiocruz.br	Paes de Sousa, Romulo/ABE-3987-2021	Paes de Sousa, Romulo/0000-0002-3384-6657	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) [001]; Instituto Rene Rachou -Fiocruz Minas	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Rene Rachou -Fiocruz Minas	This study was conducted with the support of the Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) Financing Code 001 and the Instituto Rene Rachou -Fiocruz Minas.	Agencia Nacional de Aguas, 2019, OD6 NO BRAS VIS ANA; [Anonymous], PESQUISA NACL AMOSTR, V2; [Anonymous], 2007, EST DIR NAC SAN BAS; [Anonymous], 2004, LEI NO 10 836 09 JAN; Araújo Thiago Santos de, 2016, Rev. bras. epidemiol., V19, P554, DOI 10.1590/1980-5497201600030007; Araujo-Jorge T., 2014, DOENCAS NEGLIGENCIAD, V1; Arruda NM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00213816, 10.1590/0102-311x00213816]; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Barros R. P., 2010, DETERMINANTES QUEDA; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Ben-Shlomo Y, 2005, INT J EPIDEMIOL, V34, P1181, DOI 10.1093/ije/dyi242; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Berhanu G, 2017, CURR PEDIAT RES, V21, P291; Berriel CM., 2017, ECON APL, V21, P185, DOI [10.11606/1413-8050/ea139199, DOI 10.11606/1413-8050/EA139199]; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga AC, 2017, REV LINE POLIT GEST, V21, P24, DOI 10.22633/rpge.v21.n.1.2017.9986; Brevidelli MM, 2012, CIENC SAUDE COLETIVA, V17, P2471, DOI 10.1590/S1413-81232012000900027; Brito F., 2018, OPEN SCI FRAMEWORK P; Buhler HF, 2014, CAD SAUDE PUBLICA, V30, P1921, DOI 10.1590/0102-311X00078013; Camelo RS., 2009, ECONOMIA; Torres RMC, 2013, CIENC SAUDE COLETIVA, V18, P1441, DOI 10.1590/S1413-81232013000500029; Oliveira FDC, 2011, EPIDEMIOL SERV SAUDE, V20, P7, DOI 10.5123/S1679-49742011000100002; Castro JA.Modesto, 2010, BOLSA FAMILIA 2003 2; CEDEPLAR, 2007, AV IMP PROGR BOLS FA; Chagas Deysianne Costa das, 2013, Rev. bras. epidemiol., V16, P146, DOI 10.1590/S1415-790X2013000100014; Chediek J., 2012, REPUBLICA FEDERATIVA; Chielle EO, 2019, 101 NCIA SA DE, V12, P2, DOI [10.15448/1983-652X.2019.2.30022, DOI 10.15448/1983-652X.2019.2.30022]; CNS-Conselho Nacional de Saude, RES NO 510 07 ABR 20; CNS-Conselho Nacional de Saude, RES NO 466 12 DEZ 20; Cotta RMM, 2016, REV PANAM SALUD PUBL, V83, P85; Coutinho JG, 2008, CAD SAUDE PUBLICA, V24, pS332, DOI 10.1590/S0102-311X2008001400018; Cowman G, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.101.12806; Benicio MHD, 2013, REV SAUDE PUBL, V47, P560, DOI 10.1590/S0034-8910.2013047004379; da Silva ESA, 2019, CIENC SAUDE COLETIVA, V24, P623, DOI 10.1590/1413-81232018242.04782017; Deribew A, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0112-2; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; do Carmo AS, 2016, J PEDIAT-BRAZIL, V92, P381, DOI 10.1016/j.jped.2015.10.008; Ezeh OK, 2014, INT J ENV RES PUB HE, V11, P9256, DOI 10.3390/ijerph110909256; Ferraro AR, HIST INACABADA ANALF; Gomes UAF, 2016, AM LAT HOY, V72, P129, DOI 10.14201/alh201672129144; Fonseca SC, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051007013, 10.11606/s1518-8787.2017051007013]; Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441; Gadelha SRB, 2013, 353CMICRO27; Galvao Junior AC., 2009, REV PANAM SALUD PUBL, V25; Glantz S.A., 2002, PRIMER BIOSTATISTICS; Gouveia N., 1999, SAUDE SOC-SAO PAULO, V8, P49, DOI [10.1590/S0104-12901999000100005, DOI 10.1590/S0104-12901999000100005]; Greene LE, 2012, AM J TROP MED HYG, V87, P385, DOI 10.4269/ajtmh.2012.11-0633; Guanais FC, 2014, REV PANAM SALUD PUBL, V36, P65; Haddad S., 2015, REV BRASILEIRA ANALF, V1, P88; Hair JF, 2005, ANALISE MULTIVARIADA, Vfifth; Hilbe J., 2008, NEGATIVE BINOMIAL RE; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Humphrey JH, 2019, LANCET GLOB HEALTH, V7, pE132, DOI 10.1016/S2214-109X(18)30374-7; Imada KS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006505, 10.1590/S1518-8787.2016050006505]; Instituto Brasileiro de Analises Sociais e Economicas & Instituto Brasileiro de Analises Sociais e Economicas, 2008, REP PROGR BOLS FAM S; Jackman S, 2020, PACKAGE PSCL CLASSES; Khalil I, 2016, AM J TROP MED HYG, V95, P1319, DOI 10.4269/ajtmh.16-0339; Kumar S, 2013, HEALTH ECON, V22, P410, DOI 10.1002/hec.2809; Lahoz RAL., 2015, REV ESTUDOS CONSTITU, V7, P62; Malta DC, 2016, CIENC SAUDE COLETIVA, V21, P327, DOI 10.1590/1413-81232015212.23602015; MDS-Ministerio do Desenvolvimento Social, PROGR BOLS FAM; Mendonca CS, 2009, CIENC SAUDE COLETIVA, V14, P1493, DOI 10.1590/S1413-81232009000800022; Meneguessi GM, 2015, EPIDEMIOL SERV SAUDE, V24, P721, DOI 10.5123/S1679-49742015000400014; Mukabutera A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3435-9; Neri Marcelo, 2002, Cad Saude Publica, V18 Suppl, P77, DOI 10.1590/S0102-311X2002000700009; Njuguna C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1814-6; Oliveira Evangelina X. G. de, 2004, Cad. Saúde Pública, V20, pS298, DOI 10.1590/S0102-311X2004000800023; Osorio RG., 2007, AVALIANDO IMPACTO PR; Paes-Sousa R, 2013, 113 INT POL CTR INCL; Paes-Sousa R, 2011, B WORLD HEALTH ORGAN, V89, P496, DOI 10.2471/BLT.10.084202; Paula DV., 2012, EPIDEMIOL SERV SAUDE, V21, P385, DOI 10.5123/S1679-49742012000300004; Nahas MIP, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00100818, 10.1590/0102-311X00100818]; Pesquisa de Orcamentos Familiares-POF, 2008, IBGE; Pesquisa de Orcamentos Familiares-POF, 2002, IBGE; Rasella D, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1316-7; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; de Oliveira TCR, 2010, REV SAUDE PUBL, V44, P102, DOI 10.1590/S0034-89102010000100011; Saldanha LF., 2014, REV MED MINAS GERAIS, V24, P478, DOI [10.5935/2238-3182.20140139, DOI 10.5935/2238-3182.20140139]; Segall-Correa AM, 2008, REV NUTR, V21, P39; Sharifa Begum, 2011, Bangladesh Development Studies, V34, P1; Silva ESA, 2018, HOLOS, V34, P201, DOI 10.15628/holos.2018.4836; Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019; Sistema Nacional de Informacoes sobre Saneamento-SNIS, SISTEMA NACL INFORM; Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668; de Andrade CLT, 2007, CAD SAUDE PUBLICA, V23, P1207, DOI 10.1590/S0102-311X2007000500022; Teixeira JU, 2007, CAD SAUDE PUBLICA, V23, P1489, DOI 10.1590/S0102-311X2007000600024; Teixeira JC, 2011, ENG SANIT AMBIENT, V16, P197, DOI 10.1590/S1413-41522011000200014; Pereira TST, 2015, ENG SANIT AMBIENT, V20, P395, DOI 10.1590/S1413-41522015020000098824; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; UNICEF, SIT MUND INF 2008; United Nations International Children's Emergency Fund (UNICEF), STATE WORLDS CHILDRE; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; Vasconcelos Maria Josemere de Oliveira Borba, 2008, Rev. bras. epidemiol., V11, P128, DOI 10.1590/S1415-790X2008000100012; Vaz Fernanda Pires Cecchetti, 2017, Rev. Bras. Saude Mater. Infant., V17, P475, DOI 10.1590/1806-93042017000300004; Venables WN, 2020, PACKAGE MASS R PACKA	95	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248676	10.1371/journal.pone.0248676	http://dx.doi.org/10.1371/journal.pone.0248676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784331	Green Published, gold			2022-12-26	WOS:000636359600016
J	Hu, YH; Sun, S; Dai, YX				Hu, Yuanhong; Sun, Sheng; Dai, Yixin			Environmental regulation, green innovation, and international competitiveness of manufacturing enterprises in China: From the perspective of heterogeneous regulatory tools	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOPHISTICATION; EXPORTS; MEDIATION; SECTOR; IMPACT	Based on combined data from the China Patent Database, China Industrial Enterprise Database, and China Customs Import and Export Database for the period 2004-2010, this study investigates the impact of heterogeneous environmental regulations on the export technological sophistication of manufacturing enterprises. Given deepening international market segmentation of production and the increasing proportion of intermediate trade, and compared with the traditional method based on exports, the export technological sophistication calculated here, based on value-added, is closer to the true level. Since there has been no in-depth comparative study on the relationship between heterogeneous environmental regulation and export technological sophistication, this study fills the gap. The results show that all three regulation types bear a U-shaped impact on export technological sophistication. Command-control regulation exhibits a restraining effect on mixed trade, eastern, and foreign-funded enterprises. Market-incentive regulation promotes processing and mixed trade enterprises as well as domestic and foreign-funded enterprises. Voluntary-participation regulation promotes all enterprises with different trade patterns and ownership. The mechanism analysis shows that command-control and market-participation environmental regulations affect export technological sophistication through the green invention and green utility innovation channels, while, additionally, market-incentive environmental regulation affects export technological sophistication through the green design innovation channel. Considering the environmental governance issues, the policy implications for enhancing the entire industrial chain and enterprises' export competitiveness are clear. Due to the unclear functions and powers of competent departments and a rigid threshold, command-control regulation is not conducive to cleaner production technology and the promotion of enterprises' export competitiveness; it should thus be discouraged. Although both market-incentive and voluntary-participation regulations have promoted cleaner production technology and enterprises' competitiveness significantly, the environmental tax system requires continuous improvement. The government should continue to raise public involvement in environmental protection to enrich the channels and forms of environmental management.	[Hu, Yuanhong] Shanghai Univ Finance & Econ, Coll Business, Shanghai, Peoples R China; [Sun, Sheng; Dai, Yixin] Nanjing Univ, Coll Econ, Nanjing, Jiangsu, Peoples R China	Shanghai University of Finance & Economics; Nanjing University	Dai, YX (corresponding author), Nanjing Univ, Coll Econ, Nanjing, Jiangsu, Peoples R China.	dg1602018@smail.nju.edu.cn		Hu, Yuanhong/0000-0001-8719-663X	School of Business, Shanghai University of Finance and Economics [CXJJ-2017-347]; National Natural Science Foundation of China [71773047]; Social Science Foundation Project of Jiangsu Province "Analysis of the Influence Mechanism of FDI on Advanced Manufacturing Industry of Jiangsu Province under the Path of High-level Opening" [18EYA004]; Shanghai University of Finance and Economics; National Natural Science Foundation of China; Social Science Foundation Project of Jiangsu Province	School of Business, Shanghai University of Finance and Economics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science Foundation Project of Jiangsu Province "Analysis of the Influence Mechanism of FDI on Advanced Manufacturing Industry of Jiangsu Province under the Path of High-level Opening"; Shanghai University of Finance and Economics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science Foundation Project of Jiangsu Province	This research was funded by School of Business, Shanghai University of Finance and Economics, grant number CXJJ-2017-347. National Natural Science Foundation of China: "Human capital heterogeneity, innovation and productivity of producer services: impact and path" (No. 71773047). The Social Science Foundation Project of Jiangsu Province "Analysis of the Influence Mechanism of FDI on Advanced Manufacturing Industry of Jiangsu Province under the Path of High-level Opening" (No. 18EYA004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The recipients and funders Yuanhong Hu: Shanghai University of Finance and Economics. Yixin Dai: National Natural Science Foundation of China, the Social Science Foundation Project of Jiangsu Province.	Ahn J, 2011, J INT ECON, V84, P73, DOI 10.1016/j.jinteco.2010.12.003; Baliamoune-Lutz M, 2019, J POLICY MODEL, V41, P39, DOI 10.1016/j.jpolmod.2018.09.003; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bernard AB, 2010, AM ECON REV, V100, P70, DOI 10.1257/aer.100.1.70; Blackman A, 2008, POLICY STUD J, V36, P119, DOI 10.1111/j.1541-0072.2007.00256.x; Bowen F, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.135571; Brandt L, 2012, J DEV ECON, V97, P339, DOI 10.1016/j.jdeveco.2011.02.002; Broner F, 2012, NAT BUREAU EC RES; Bu ML, 2020, ECON MODEL, V89, P10, DOI 10.1016/j.econmod.2019.12.020; Corsatea TD, 2018, ENERGY, V164, P1286, DOI 10.1016/j.energy.2018.08.145; Darnall N., 2007, RES CORPORATE SUSTAI, P123; De Santis R., 2021, INT EC, V165, P264, DOI DOI 10.1016/J.INTECO.2021.01.002; Domazlicky BR, 2004, ENVIRON RESOUR ECON, V28, P301, DOI 10.1023/B:EARE.0000031056.93333.3a; Dugan MT, 2017, RES ACCOUNTING REGUL, V29, P152, DOI [10.1016/j.racreg.2017.09.007, DOI 10.1016/J.RACREG.2017.09.007]; Elrod AA, 2017, J ENVIRON ECON MANAG, V83, P164, DOI 10.1016/j.jeem.2017.03.002; Farzin YH., 2000, J PUBLIC ECON THEORY, V2, P183, DOI [10.1111/1097-3923.00036, DOI 10.1111/1097-3923.00036]; Friedman M., 2007, CORPORATE ETHICS COR, P173, DOI DOI 10.1007/978-3-540-70818-6_14; Gowin KD, 2021, FINANC RES LETT, V40, DOI 10.1016/j.frl.2020.101675; Hall BH, 2002, OXFORD REV ECON POL, V18, P35, DOI 10.1093/oxrep/18.1.35; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hering L, 2014, J ENVIRON ECON MANAG, V68, P296, DOI 10.1016/j.jeem.2014.06.005; Holland SP, 2012, J ENVIRON ECON MANAG, V63, P375, DOI 10.1016/j.jeem.2011.12.002; Jaffe AB, 1997, REV ECON STAT, V79, P610, DOI 10.1162/003465397557196; Jiang FX., 2013, CHINA IND EC, P44; Jiang ZY, 2020, BUS STRATEG ENVIRON, V29, P390, DOI 10.1002/bse.2372; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kee HL, 2016, AM ECON REV, V106, P1402, DOI 10.1257/aer.20131687; Kleibergen F, 2006, J ECONOMETRICS, V133, P97, DOI 10.1016/j.jeconom.2005.02.011; Kolcava D, 2021, ENVIRON SCI POLICY, V115, P61, DOI 10.1016/j.envsci.2020.09.013; Koopman R, 2012, J DEV ECON, V99, P178, DOI 10.1016/j.jdeveco.2011.12.004; Lahteenmaki-Uutela A, 2017, J CLEAN PROD, V154, P553, DOI 10.1016/j.jclepro.2017.03.224; Lectard P, 2018, WORLD DEV, V102, P90, DOI 10.1016/j.worlddev.2017.09.012; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Lind JT, 2010, OXFORD B ECON STAT, V72, P109, DOI 10.1111/j.1468-0084.2009.00569.x; Lyon TP, 2003, J PUBLIC ECON, V87, P1453, DOI 10.1016/S0047-2727(01)00221-3; Ma YD, 2020, ASIA-PAC J CHEM ENG, V15, DOI 10.1002/apj.2493; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Montero JP, 2002, J ENVIRON ECON MANAG, V44, P23, DOI 10.1006/jeem.2001.1194; Mu MF, 2020, ENVIRON MODELL SOFTW, V123, DOI 10.1016/j.envsoft.2019.104514; Nie H., 2012, J WORLD EC, P142; Riikonen A, 2016, TECHNOL FORECAST SOC, V103, P313, DOI 10.1016/j.techfore.2015.11.017; Salas-Velasco M, 2018, ECON ANAL POLICY, V57, P60, DOI 10.1016/j.eap.2017.11.003; Sandu S, 2014, PROC ECON FINANC, V15, P80, DOI 10.1016/S2212-5671(14)00450-X; Schantl SF, 2021, J ACCOUNT PUBLIC POL, V40, DOI 10.1016/j.jaccpubpol.2020.106803; Sen S, 2015, EUR ECON REV, V80, P36, DOI 10.1016/j.euroecorev.2015.08.004; Shen J, 2017, J CLEAN PROD, V148, P785, DOI 10.1016/j.jclepro.2017.02.050; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Tian W., 2013, MANAGE WORLD, P28; Tong J., 2016, EC RES J, V07, P43; Wang J., 2014, CHINA IND EC, V3, P44, DOI [10.19581/j.cnki.ciejournal.2014.03.004, DOI 10.19581/J.CNKI.CIEJOURNAL.2014.03.004]; Wang K, 2019, J IND ECOL, V23, P389, DOI 10.1111/jiec.12740; Wang XL., 2013, J NATL SCH ADM, P24; Wang YF., 2016, SOC SCI GUANGDONG, P17, DOI DOI 10.3390/SOCSCI5020017; Wang YJ., 2010, EC RES, V45, P103; Wu LC, 2021, RES POLICY, V50, DOI 10.1016/j.respol.2020.104093; Xiao XJ., 2019, COLLECTED ESSAYS FIN, P104; Xu B, 2010, CHINA ECON REV, V21, P482, DOI 10.1016/j.chieco.2010.04.005; Xu MY., 2013, CHINA IND EC, P72; Yang J, 2018, J CLEAN PROD, V202, P993, DOI 10.1016/j.jclepro.2018.08.144; Yu LH., 2014, EC Q, V13, P127; Yu MG., 2016, CHINA IND EC, P5; [余伟 Yu Wei], 2017, [科研管理, Science Research Management], V38, P18; Yu Y., 2015, MILITARY MED RES, V1, P180; Zhang J., 2015, CHINA IND EC, P68; Zhang J., 2013, EC RES, V48, P124; Zheng HH, 2019, RENEW SUST ENERG REV, V108, P140, DOI 10.1016/j.rser.2019.03.038	68	8	8	26	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249169	10.1371/journal.pone.0249169	http://dx.doi.org/10.1371/journal.pone.0249169			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784363	Green Published, gold			2022-12-26	WOS:000636359600009
J	Ochoa, JM; Bair, K; Holton, T; Bobik, TA; Yeates, TO				Ochoa, Jessica M.; Bair, Kaylie; Holton, Thomas; Bobik, Thomas A.; Yeates, Todd O.			MCPdb: The bacterial microcompartment database	PLOS ONE			English	Article							SHELL PROTEIN; ORGANELLES; CONSTRUCTION; BINDING; ENZYME; EUTL; PDU; NANOCOMPARTMENT; ENCAPSULATION; CARBOXYSOMES	Bacterial microcompartments are organelle-like structures composed entirely of proteins. They have evolved to carry out several distinct and specialized metabolic functions in a wide variety of bacteria. Their outer shell is constructed from thousands of tessellating protein subunits, encapsulating enzymes that carry out the internal metabolic reactions. The shell proteins are varied, with single, tandem and permuted versions of the PF00936 protein family domain comprising the primary structural component of their polyhedral architecture, which is reminiscent of a viral capsid. While considerable amounts of structural and biophysical data have been generated in the last 15 years, the existing functionalities of current resources have limited our ability to rapidly understand the functional and structural properties of microcompartments (MCPs) and their diversity. In order to make the remarkable structural features of bacterial microcompartments accessible to a broad community of scientists and non-specialists, we developed MCPdb: The Bacterial Microcompartment Database (https://mcpdb.mbi. ucla.edu/). MCPdb is a comprehensive resource that categorizes and organizes known microcompartment protein structures and their larger assemblies. To emphasize the critical roles symmetric assembly and architecture play in microcompartment function, each structure in the MCPdb is validated and annotated with respect to: (1) its predicted natural assembly state (2) tertiary structure and topology and (3) the metabolic compartment type from which it derives. The current database includes 163 structures and is available to the public with the anticipation that it will serve as a growing resource for scientists interested in understanding protein-based metabolic organelles in bacteria.	[Ochoa, Jessica M.; Yeates, Todd O.] Univ Calif Los Angeles, UCLA Mol Biol Inst, Los Angeles, CA USA; [Bair, Kaylie; Yeates, Todd O.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA; [Holton, Thomas; Yeates, Todd O.] Univ Calif Los Angeles, UCLA Dept Chem & Biochem, Los Angeles, CA USA; [Bobik, Thomas A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Iowa State University	Yeates, TO (corresponding author), Univ Calif Los Angeles, UCLA Mol Biol Inst, Los Angeles, CA USA.; Yeates, TO (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA.; Yeates, TO (corresponding author), Univ Calif Los Angeles, UCLA Dept Chem & Biochem, Los Angeles, CA USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	NIH/NIAID from the National Institutes of Health [R01AI081146-08]; Gilliam Fellowship from the Howard Hughes Medical Institute	NIH/NIAID from the National Institutes of Health; Gilliam Fellowship from the Howard Hughes Medical Institute	T.O.Y and T.A.B were supported by NIH/NIAID Grant R01AI081146-08, from the National Institutes of Health (https://www.nih.gov/) J.M.O. was supported by a Gilliam Fellowship from the Howard Hughes Medical Institute (https://www.hhmi.org/science-education/programs/gilliamfellowships-advanced-study) These funders did not play any role in the study.	Abdul-Rahman F, 2013, J PHYLOGENET EVOL BI, V1, P4, DOI DOI 10.4172/2329-9002.1000118; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Beeby M, 2009, PROTEIN SCI, V18, P69, DOI 10.1002/pro.1; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bobik TA, 2015, MOL MICROBIOL, V98, P193, DOI 10.1111/mmi.13117; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Contreras H, 2014, J BIOL CHEM, V289, P18279, DOI 10.1074/jbc.M114.570119; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Fang Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00739; Gabashvili AN, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060966; Giessen TW, 2019, ELIFE, V8, DOI 10.7554/eLife.46070; Giessen TW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.29; Hagen A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05162-z; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Huang JC, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00432; Huber I, 2017, ACS SYNTH BIOL, V6, P2145, DOI 10.1021/acssynbio.7b00167; Jakobson CM, 2016, J MOL BIOL, V428, P2989, DOI 10.1016/j.jmb.2016.07.006; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kanev GK, 2021, NUCLEIC ACIDS RES, V49, pD562, DOI 10.1093/nar/gkaa895; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence AD, 2014, ACS SYNTH BIOL, V3, P454, DOI 10.1021/sb4001118; Lee MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05922-x; Lee MJ, 2018, NAT CHEM BIOL, V14, P142, DOI 10.1038/nchembio.2535; Lundin AP, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00017-20; LURZ R, 1979, ARCH MICROBIOL, V120, P255, DOI 10.1007/BF00423073; Mallette E, 2018, J BIOL CHEM, V293, P19909, DOI 10.1074/jbc.RA118.005485; Mallette E, 2018, BIOCHEMISTRY-US, V57, P3780, DOI 10.1021/acs.biochem.8b00464; McHugh CA, 2014, EMBO J, V33, P1896, DOI 10.15252/embj.201488566; Nichols RJ, 2017, CRIT REV BIOCHEM MOL, V52, P583, DOI 10.1080/10409238.2017.1337709; Niknafs N, 2013, HUM GENET, V132, P1235, DOI 10.1007/s00439-013-1325-0; Ochoa JM, 2020, PROTEIN SCI, V29, P2201, DOI 10.1002/pro.3941; Pang A, 2011, ACTA CRYSTALLOGR D, V67, P91, DOI 10.1107/S0907444910050201; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Petit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054337; Quin MB, 2016, APPL MICROBIOL BIOT, V100, P9187, DOI 10.1007/s00253-016-7737-8; Ravcheev DA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00636; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Takenoya M, 2010, J BACTERIOL, V192, P6056, DOI 10.1128/JB.00652-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Thompson MC, 2015, PROTEIN SCI, V24, P956, DOI 10.1002/pro.2672; Thompson MC, 2014, J MOL BIOL, V426, P3287, DOI 10.1016/j.jmb.2014.07.018; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Wagner HJ, 2017, ENG LIFE SCI, V17, P36, DOI 10.1002/elsc.201600107; Wheatley NM, 2013, PROTEIN SCI, V22, P660, DOI 10.1002/pro.2246; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; Zarzycki J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42757; Zhang GQ, 2019, ACS SYNTH BIOL, V8, P1867, DOI 10.1021/acssynbio.9b00187	63	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248269	10.1371/journal.pone.0248269	http://dx.doi.org/10.1371/journal.pone.0248269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780471	Green Published, gold, Green Submitted			2022-12-26	WOS:000636336800054
J	Pulsipher, A; Savage, JR; Kennedy, TP; Gupta, K; Cuiffo, BG; Sonis, ST; Lee, WY				Pulsipher, Abigail; Savage, Justin R.; Kennedy, Thomas P.; Gupta, Kavita; Cuiffo, Benjamin G.; Sonis, Stephen T.; Lee, Won Yong			GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling	PLOS ONE			English	Article								Purpose Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune system upon irradiation has been identified as a key precipitating event of OM. To better understand OM's pathogenesis, we studied pattern recognition receptors (PRRs) and their downstream pro-inflammatory cytokines in a mouse model of radiation-induced OM. We also tested therapeutic efficacy of GM-1111 that targets innate immune system to reduce radiation-induced OM. Methods and materials The pathogenesis of OM was studied in a single X-ray induced mouse model. The severity of OM was measured by visual and microscopical examinations. The irradiation-induced changes of PRRs and their downstream effector cytokine gene expression levels were determined. The efficacy of GM-1111 to reduce OM was tested in single and fractionated irradiation mouse models. The impact of the drug on tumor response to radiation therapy was also tested in a mouse model of human HNC. Results Radiation-induced tissue ulcerations were radiation-dosage and -time dependent. The lesions showed selective increases in PRR and pro-inflammatory cytokine gene expression levels. Once daily administration of GM-1111 (>= 30 mg/kg, s.c.) significantly reduced the severity and the incidence of OM. The drug had little effect on PRRs but significantly inhibited downstream pro-inflammatory cytokine genes. GM-1111 did not interfere radiation therapy to induce HNC SCC-25 tumor regression. Instead, we observed significant drug-induced tumor regression. Conclusions Radiation induces tissue damages. The increased expression levels of PRRs and their downstream pro-inflammatory cytokine genes in the damaged tissues suggest their important contribution to the pathogenesis of OM. Drug GM-1111 that targets these innate immune molecules may be a potential drug candidate as an intervention for OM.	[Pulsipher, Abigail; Savage, Justin R.; Kennedy, Thomas P.; Gupta, Kavita; Lee, Won Yong] GlycoMira Therapeut, Salt Lake City, UT 84108 USA; [Cuiffo, Benjamin G.; Sonis, Stephen T.] Biomodels, Waltham, MA USA		Lee, WY (corresponding author), GlycoMira Therapeut, Salt Lake City, UT 84108 USA.	lee.wonyong@glycomira.com		Lee, Won Yong/0000-0001-7915-1829	National Institute of Dental and Craniofacial Research [R44DE024024]; National Institute of Allergy and Infectious Diseases [R44AI126987]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WYL: R44DE024024 (National Institute of Dental and Craniofacial Research) https://www.nidcr.nih.gov/AP: R44AI126987 (National Institute of Allergy and Infectious Diseases) https://www.niaid.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [AP, JRS, TPK, KG, BGC, STS, and WYL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alt JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204709; Anderson CM, 2019, J CLIN ONCOL, V37, P3256, DOI 10.1200/JCO.19.01507; Basile D, 2019, CANCERS, V11, DOI 10.3390/cancers11060857; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Brake R, 2008, MOL CANCER RES, V6, P1337, DOI 10.1158/1541-7786.MCR-07-2131; Chatterjee S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010176; Chen PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152995; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Fernandez B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174474; Frith C. H., 1997, Digestive system,, P223; Fuentes-Antras J, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/847827; Gao X, 2008, J STAT PLAN INFER, V138, P2574, DOI 10.1016/j.jspi.2007.10.015; Gruber S, 2017, STRAHLENTHER ONKOL, V193, P499, DOI 10.1007/s00066-017-1119-8; ISHIHARA H, 1993, RADIAT RES, V133, P321, DOI 10.2307/3578216; ISHIHARA H, 1995, J RADIAT RES, V36, P112, DOI 10.1269/jrr.36.112; Kondo M, 2014, J BIOMED MATER RES A, V102, P1829, DOI 10.1002/jbm.a.34849; Kudrimoti M, 2016, J BIOTECHNOL, V239, P115, DOI 10.1016/j.jbiotec.2016.10.010; Kumar PSS, 2009, INDIAN J PALLIAT CAR, V15, P95, DOI 10.4103/0973-1075.58452; Liu YG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.460; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; Morla S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081963; Muanza TM, 2005, CLIN CANCER RES, V11, P5121, DOI 10.1158/1078-0432.CCR-05-0403; Mukanyangezi MF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215250; Nicolatou-Galitis O, 2013, SUPPORT CARE CANCER, V21, P357, DOI 10.1007/s00520-012-1613-6; Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714; Paderi J, 2018, ADV THER-GERMANY, V1, DOI 10.1002/adtp.201800082; Perrone MS, 2017, INT J RADIAT ONCOL, V99, pE613, DOI 10.1016/j.ijrobp.2017.06.2078; Prestwich G, Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof., Patent No. [WO2009124266, 2009124266]; Ratikan JA, 2015, CANCER LETT, V368, P238, DOI 10.1016/j.canlet.2015.03.031; Ryu SH, 2010, J RADIAT RES, V51, P595, DOI 10.1269/jrr.10069; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Thirion-Delalande C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183398; Wu DM, 2018, INT J RADIAT ONCOL, V101, P107, DOI 10.1016/j.ijrobp.2018.01.035; Yoshino H, 2014, J RADIAT RES, V55, P876, DOI 10.1093/jrr/rru040; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zheng CY, 2009, CLIN CANCER RES, V15, P4641, DOI 10.1158/1078-0432.CCR-09-0819	42	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249343	10.1371/journal.pone.0249343	http://dx.doi.org/10.1371/journal.pone.0249343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770116	Green Published, gold			2022-12-26	WOS:000634833500044
J	Omata, Y; Yamauchi, T; Tsuruta, A; Matsunaga, N; Koyanagi, S; Ohdo, S				Omata, Yuji; Yamauchi, Tomoaki; Tsuruta, Akito; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro			RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; MULTIDRUG-RESISTANCE; INTESTINAL EXPRESSION; MEMBRANE TRANSPORTERS; 24-HOUR RHYTHM; CANCER; TIME; PHARMACOKINETICS; MRP2	The expression and function of some xenobiotic transporters vary according to the time of the day, causing the dosing time-dependent changes in drug disposition and toxicity. P-glycoprotein (P-gp), encoded by the ABCB1 gene, is highly expressed in the kidneys and functions in the renal elimination of various drugs. The elimination of several P-gp substrates was demonstrated to vary depending on administration time, but the underlying mechanism remains unclear. We found that adenosine deaminase acting on RNA (ADAR1) was involved in the circadian regulation of P-gp expression in human renal proximal tubular epithelial cells (RPTECs). After synchronization of the cellular circadian clock by dexamethasone treatment, the expression of P-gp exhibited a significant 24-h oscillation in RPTECs, but this oscillation was disrupted by the downregulation of ADAR1. Although ADAR1 catalyzes adenosine-to-inosine (A-to-I) RNA editing in double-stranded RNA substrates, no significant ADAR1-regulated editing sites were detected in the human ABCB1 transcripts in RPTECs. On the other hand, downregulation of ADAR1 induced alternative splicing in intron 27 of the human ABCB1 gene, resulting in the production of retained intron transcripts. The aberrant spliced transcript was sensitive to nonsense-mediated mRNA decay, leading to the decreased stability of ABCB1 mRNA and prevention of the 24-h oscillation of P-gp expression. These findings support the notion that ADAR1-mediated regulation of alternative splicing of the ABCB1 gene is a key mechanism of circadian expression of P-gp in RPTECs, and the regulatory mechanism may underlie the dosing time-dependent variations in the renal elimination of P-gp substrates.	[Omata, Yuji; Yamauchi, Tomoaki; Tsuruta, Akito; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka, Japan; [Matsunaga, Naoya; Koyanagi, Satoru] Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Fukuoka, Japan	Kyushu University; Kyushu University	Koyanagi, S; Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka, Japan.; Koyanagi, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Fukuoka, Japan.	koyanagi@phar.kyushu-u.ac.jp; ohdo@phar.kyushu-u.ac.jp		Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Naito Foundation; Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED [JP20am0101091];  [18H04019]	Naito Foundation(Naito Memorial Foundation); Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED; 	This study was supported in part by a Grant-in-Aid for Scientific Research A (18H04019 to S. K.), the Naito Foundation (S. K.), and the Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED (Grant Number JP20am0101091).	Agranat L, 2010, RNA BIOL, V7, P253, DOI 10.4161/rna.7.2.11568; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Choi JS, 1999, RES COMMUN MOL PATH, V103, P109; Dallmann R, 2016, TRENDS MOL MED, V22, P430, DOI 10.1016/j.molmed.2016.03.004; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; FERRAZZINI G, 1991, EUR J CLIN PHARMACOL, V41, P425, DOI 10.1007/BF00626363; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hsiao YHE, 2018, GENOME RES, V28, P812, DOI 10.1101/gr.231209.117; Iwasaki M, 2015, MOL PHARMACOL, V88, P29, DOI 10.1124/mol.114.096735; Jones BR, 2005, MOL PHARMACOL, V68, P701, DOI 10.1124/mol.105.013144; Kato M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70321-6; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakano M, 2018, PHARMACOL THERAPEUT, V181, P13, DOI 10.1016/j.pharmthera.2017.07.003; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohdo S, 2019, PHARMACOL THERAPEUT, V202, P72, DOI 10.1016/j.pharmthera.2019.05.018; Ohdo S, 2011, J PHARM SCI-US, V100, P3560, DOI 10.1002/jps.22656; Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Picardi E, 2017, NUCLEIC ACIDS RES, V45, pD750, DOI 10.1093/nar/gkw767; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Shang Y, 2014, ONCOGENE, V33, P3267, DOI 10.1038/onc.2013.297; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Sissung TM, 2014, METHODS MOL BIOL, V1175, P91, DOI 10.1007/978-1-4939-0956-8_6; Tang SJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14621-5; Terajima H, 2017, NAT GENET, V49, P146, DOI 10.1038/ng.3731; Tsurudome Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27280-w; Ushijima K, 2012, MOL PHARMACOL, V82, P264, DOI 10.1124/mol.112.079079; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wong JJL, 2016, BIOESSAYS, V38, P41, DOI 10.1002/bies.201500117; Yu FJ, 2019, THERANOSTICS, V9, P2754, DOI 10.7150/thno.33395	49	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100601	10.1016/j.jbc.2021.100601	http://dx.doi.org/10.1016/j.jbc.2021.100601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781748	gold, Green Published			2022-12-26	WOS:000672866400573
J	Sutton, EC; DeRose, VJ				Sutton, Emily C.; DeRose, Victoria J.			Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE I; DNA-DAMAGE; TRANSCRIPTION; ACTIVATION; REDISTRIBUTION; COMPONENTS; ADDUCTS; CX-5461; CYCLE; P53	Recent reports provide evidence that the platinum chemotherapeutic oxaliplatin causes cell death via ribosome biogenesis stress, while cisplatin causes cell death via the DNA damage response (DDR). Underlying differences in mechanisms that might initiate disparate routes to cell death by these two broadly used platinum compounds have not yet been carefully explored. Additionally, prior studies had demonstrated that cisplatin can also inhibit ribosome biogenesis. Therefore, we sought to directly compare the initial influences of oxaliplatin and cisplatin on nucleolar processes and on the DDR. Using pulse-chase experiments, we found that at equivalent doses, oxaliplatin but not cisplatin significantly inhibited ribosomal RNA (rRNA) synthesis by Pol I, but neither compound affected rRNA processing. Inhibition of rRNA synthesis occurred as early as 90 min after oxaliplatin treatment in A549 cells, concurrent with the initial redistribution of the nucleolar protein nucleophosmin (NPM1). We observed that the nucleolar protein fibrillarin began to redistribute by 6 h after oxaliplatin treatment and formed canonical nucleolar caps by 24 h. In cisplatin-treated cells, DNA damage, as measured by gamma H2AX immunofluorescence, was more extensive, whereas nucleolar organization was unaffected. Taken together, our results demonstrate that oxaliplatin causes early nucleolar disruption via inhibition of rRNA synthesis accompanied by NPM1 relocalization and subsequently causes extensive nucleolar reorganization, while cisplatin causes early DNA damage without significant nucleolar disruption. These data support a model in which, at clinically relevant doses, cisplatin kills cells via the canonical DDR, and oxaliplatin kills cells via ribosome biogenesis stress, specifically via rapid inhibition of rRNA synthesis.	[Sutton, Emily C.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Sutton, Emily C.; DeRose, Victoria J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [DeRose, Victoria J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Oregon	DeRose, VJ (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.; DeRose, VJ (corresponding author), Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.	derose@uoregon.edu		Sutton, Emily/0000-0002-9607-3890	National Science Foundation [CHE1710721, CHE1531189]; National Institutes of Health [T32 GM007759-29]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation [CHE1710721 to V. J. D. and CHE1531189 for microscopy] and the National Institutes of Health [T32 GM007759-29 to E. C. S.].	Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brodska B, 2016, J CELL BIOCHEM, V117, P1319, DOI 10.1002/jcb.25420; Bruno PM, 2020, P NATL ACAD SCI USA, V117, P4053, DOI 10.1073/pnas.1921649117; Bruno PM, 2017, NAT MED, V23, P461, DOI 10.1038/nm.4291; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hamdane N, 2015, ONCOTARGET, V6, P27519, DOI 10.18632/oncotarget.4823; Horky M, 2001, J CELL SCI, V114, P663; Jordan P, 1998, NUCLEIC ACIDS RES, V26, P2831, DOI 10.1093/nar/26.12.2831; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Korsholm LM, 2020, NUCLEIC ACIDS RES, V48, P9449, DOI 10.1093/nar/gkaa713; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Larsen DH, 2014, NAT CELL BIOL, V16, P792, DOI 10.1038/ncb3007; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; McDevitt CE, 2019, J BIOL INORG CHEM, V24, P899, DOI 10.1007/s00775-019-01707-9; McKeage MJ, 2001, BRIT J CANCER, V85, P1219, DOI 10.1054/bjoc.2001.2024; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Ozdian T, 2017, J PROTEOMICS, V162, P73, DOI 10.1016/j.jprot.2017.05.005; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Pickard AJ, 2013, CHEMMEDCHEM, V8, P1441, DOI 10.1002/cmdc.201300262; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Scott DD, 2016, BIOCHEM CELL BIOL, V94, P419, DOI 10.1139/bcb-2016-0068; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sutton EC, 2019, J AM CHEM SOC, V141, P18411, DOI 10.1021/jacs.9b10319; Terenzi A, 2016, J INORG BIOCHEM, V165, P71, DOI 10.1016/j.jinorgbio.2016.06.021; TREIBER DK, 1994, P NATL ACAD SCI USA, V91, P5672, DOI 10.1073/pnas.91.12.5672; Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van Sluis M, 2017, CURR OPIN CELL BIOL, V46, P81, DOI 10.1016/j.ceb.2017.03.004; van Sluis M, 2015, GENE DEV, V29, P1151, DOI 10.1101/gad.260703.115; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei M, 2001, J BIOL CHEM, V276, P38774, DOI 10.1074/jbc.M106374200; Wei T, 2018, CELL REP, V23, P404, DOI 10.1016/j.celrep.2018.03.066; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Woynarowski JM, 1998, MOL PHARMACOL, V54, P770, DOI 10.1124/mol.54.5.770; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Zhai XQ, 1998, BIOCHEMISTRY-US, V37, P16307, DOI 10.1021/bi981708h	50	7	7	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100633	10.1016/j.jbc.2021.100633	http://dx.doi.org/10.1016/j.jbc.2021.100633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33819479	Green Published, gold			2022-12-26	WOS:000672866400604
J	Chen, Y; Zhao, H				Chen, Ying; Zhao, Hui			Spatial distribution of the summer subsurface chlorophyll maximum in the North South China Sea	PLOS ONE			English	Article								Based on the biological, nutrients and hydrological data in August 2018, the vertical chlorophyll a (Chl-a) concentration profiles and the relationship among surface Chl-a (Chl-a((0))) concentration, maximum Chl-a (Chl-a((m))) concentration and depth-integrated Chl-a (Chl-a((int))) concentration were studied in the Northern South China Sea (NSCS). The results indicate that there are 4 different patterns in the vertical Chl-a profiles in the NSCS: (i) Chl-a increases with depth from the surface (e.g. station 1); (ii) there exists subsurface chlorophyll maximum (SCM), with low Chl-a on the surface and at the bottom layers respectively (e.g. station 5); (iii) there is no SCM, only with high Chl-a on the surface and in the bottom (e.g. station 14); (iv) the 4(th) pattern is similar to (ii), with the higher Chl-a((0)) (e.g. station 28). The SCM is observed at 95% stations in the NSCS and is not detected only at a few stations near the Pearl River (PR) estuary. These patterns are mainly regulated by alternative limitation of nutrients and light from the surface to the bottom of euphotic layer. For the pattern 1 (e.g. station 1), light is not a limited factor, and Chl-a and nutrients increase with depth. The pattern 2 (e.g. station 5) exists with the limitation of surface nutrients in offshore region. The nutrients increases with depth and the nutrients limitation turns to light limitation gradually from surface to bottom. And the SCM appears in the layer which need of the light and nutrients is roughly equivalent. Compared with that the offshore SCM, the nutrients for the pattern 3 (e.g. station 14) are rich on the surface with nutrients concentration and light irradiance. Therefore, it is seawater intrusion from the bottom that brings the higher nutrients concentration. The reason for the high Chl-a((0)) on the pattern 4 (e.g. station 28) is terrestrial matter from the nearshore. High correlation (R-2 = 0.5206, p<0.01) between the depth of SCM (Depth((m))) and Chl-a((0)) indicates that the SCM depth is regulated by light masking effect of surface phytoplankton, generally with shallow nutriclines and fast light attenuation for high Chl-a((0)) and vice versa low Chl-a((0)) brings deeper nutriclines and light attenuate slowly with less shading effect. Further research results shows that Chl-a((int)) and Chl-a((m)) have a good correlation(R-2 = 0.6397, p<0.01). However, the correlation between Chl-a((int)) and Chl-a((0)) is relative weak (R-2 = 0.3202, p<0.01). That could be attributed to the availability of nutrients playing an important role in growth of phytoplankton, with high nutrients at upper euphotic layers for the stations with high Chl-a((0)).	[Chen, Ying; Zhao, Hui] Guangdong Ocean Univ, Zhanjiang, Peoples R China; [Zhao, Hui] Southern Marine Sci & Engn Guangdong Lab, Zhuhai, Peoples R China	Guangdong Ocean University; Southern Marine Science & Engineering Guangdong Laboratory	Zhao, H (corresponding author), Guangdong Ocean Univ, Zhanjiang, Peoples R China.; Zhao, H (corresponding author), Southern Marine Sci & Engn Guangdong Lab, Zhuhai, Peoples R China.	huizhao1978@163.com			National Natural Science Foundation of China [42076162]; (Innovation Group Project of Southern Marine Science and Engineering Guangdong Laboratory Zhuhai) [311020004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); (Innovation Group Project of Southern Marine Science and Engineering Guangdong Laboratory Zhuhai)	This study received support from the following sources: National Natural Science Foundation of China (No. 42076162, awarded to HZ); and Innovation Group Project of Southern Marine Science and Engineering Guangdong Laboratory Zhuhai) (No. 311020004, awarded to HZ)	Ardyna M, 2013, BIOGEOSCIENCES, V10, P4383, DOI 10.5194/bg-10-4383-2013; Chai XY., 2009, THESIS CHONGING U; Chen BZ, 2011, CONT SHELF RES, V31, P1527, DOI 10.1016/j.csr.2011.06.018; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Cullen JJ, 2015, ANNU REV MAR SCI, V7, P207, DOI 10.1146/annurev-marine-010213-135111; DICKSON ML, 1995, LIMNOL OCEANOGR, V40, P533, DOI 10.4319/lo.1995.40.3.0533; Fu MZ, 2018, CONT SHELF RES, V165, P93, DOI 10.1016/j.csr.2018.07.007; [宫响 Gong Xiang], 2012, [地球科学进展, Advance in Earth Sciences], V27, P539; Hanson CE, 2007, DEEP-SEA RES PT II, V54, P902, DOI 10.1016/j.dsr2.2006.10.002; He QY, 2018, J GEOPHYS RES-OCEANS, V123, P4906, DOI 10.1029/2018JC014054; Hickman AE, 2012, MAR ECOL PROG SER, V463, P39, DOI 10.3354/meps09836; Hodges BA, 2004, DEEP-SEA RES PT I, V51, P999, DOI 10.1016/j.dsr.2004.02.009; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; JUSTIC D, 1995, ESTUAR COAST SHELF S, V40, P339, DOI 10.1016/S0272-7714(05)80014-9; Kuang Q., 1992, Yingyong Shengtai Xuebao, V3, P165; Lalli C.M., 2004, BIOL OCEANOGRAPHY IN; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Liao Xiuli, 2018, Journal of Tropical Oceanography, V37, P45, DOI 10.11978/2017020; Lin XY, 2015, DEEP-SEA RES PT I, V99, P46, DOI 10.1016/j.dsr.2015.01.007; [刘恒彪 Liu Hengbiao], 2011, [光学学报, Acta Optica Sinica], V31, P133; Martin J, 2012, BIOGEOSCIENCES, V9, P5353, DOI 10.5194/bg-9-5353-2012; Morton B, 2001, MAR POLLUT BULL, V42, P1236, DOI 10.1016/S0025-326X(01)00240-5; National Marine Environmental Monitoring Center, 2007, GB173782007 NAT MAR; An NT, 2007, ASIAN J WATER ENVIRO, V4, P37; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; Ning XR, 2005, MAR ECOL PROG SER, V293, P17, DOI 10.3354/meps293017; Phlips EJ, 1997, J PLANKTON RES, V19, P319; Picado A, 2016, INT J CLIMATOL, V36, P3280, DOI 10.1002/joc.4555; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Richardson K, 2000, J PLANKTON RES, V22, P1663, DOI 10.1093/plankt/22.9.1663; SATHYENDRANATH S, 1991, NATURE, V349, P54, DOI 10.1038/349054a0; Siswanto E, 2005, J OCEANOGR, V61, P575, DOI 10.1007/s10872-005-0066-7; Song XY, 2012, CONT SHELF RES, V48, P110, DOI 10.1016/j.csr.2012.07.016; Sun WJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10050795; TAKAHASHI M, 1984, MAR BIOL, V79, P177, DOI 10.1007/BF00951826; Tang DL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002045; Tang DL, 2003, REMOTE SENS ENVIRON, V85, P475, DOI 10.1016/S0034-4257(03)00049-X; Tang DL, 1998, CONT SHELF RES, V18, P1493, DOI 10.1016/S0278-4343(98)00039-9; Tang DL, 1999, MAR ECOL PROG SER, V191, P43, DOI 10.3354/meps191043; Tang SL, 2014, AQUAT ECOSYST HEALTH, V17, P242, DOI 10.1080/14634988.2014.942590; Wang JJ, 2014, DEEP-SEA RES PT II, V101, P120, DOI 10.1016/j.dsr2.2013.09.020; Wu ML, 2009, OCEANOLOGIA, V51, P217, DOI 10.5697/oc.51-2.217; Xu N., 2001, MAR ENVIRON SCI, V2, P2; Yang, 2019, J GUANGDONG OCEAN U, V39, P56, DOI [10.3969/j.issn.1673-9159.2019.01.009, DOI 10.3969/J.ISSN.1673-9159.2019.01.009]; Zhai WD, 2005, MAR CHEM, V96, P87, DOI 10.1016/j.marchem.2004.12.002; Zhai WD, 2005, MAR CHEM, V93, P21, DOI 10.1016/j.marchem.2004.07.003; Zhao H., 2005, ACTA OCEANOGR, V27, P45, DOI [10.3321/j.issn:0253, DOI 10.3321/J.ISSN:0253, 10.3321/j.issn:0253-4193.2005.04.006, DOI 10.3321/J.ISSN:0253-4193.2005.04.006]; Zhao H., 2014, J GUANGDONG OCEAN U, V34, P98, DOI [10.3969/j.issn.1673-159.01.016, DOI 10.3969/J.ISSN.1673-159.01.016]; Zhao H, 2018, J GEOPHYS RES-OCEANS, V123, P2903, DOI 10.1002/2017JC013549; [赵辉 ZHAO Hui], 2005, [热带海洋学报, Journal of tropical oceanography], V24, P31	50	3	3	11	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0248715	10.1371/journal.pone.0248715	http://dx.doi.org/10.1371/journal.pone.0248715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826626	Green Published, gold			2022-12-26	WOS:000638119900002
J	Clark, CG; Kearney, AK; Tschetter, L; Robertson, J; Pollari, F; Parker, S; Arya, G; Ziebell, K; Johnson, R; Nash, J; Nadon, C				Clark, Clifford G.; Kearney, Ashley K.; Tschetter, Lorelee; Robertson, James; Pollari, Frank; Parker, Stephen; Arya, Gitanjali; Ziebell, Kim; Johnson, Roger; Nash, John; Nadon, Celine			Population structure, case clusters, and genetic lesions associated with Canadian Salmonella 4,[5],12:i:- isolates	PLOS ONE			English	Article								Monophasic Salmonella 4,[5]:12:i:- are a major public health problem because they are one of the top five Salmonella serotypes isolated from clinical cases globally and because they can carry resistance to multiple antibiotics. A total of 811 Salmonella 4,[5]:12:i:- and S. Typhimurium whole genome sequences (WGS) were generated. The various genetic lesions causing the Salmonella 4,[5]:12:i:- genotype were identified and assessed with regards to their distribution in the population of 811 Salmonella 4,[5]:12:i:- and S. Typhimurium isolates, their geographical and temporal distribution, and their association with non-human sources. Several clades were identified in the population structure, and the largest two were associated almost exclusively with a short prophage insertion and insertion of a mobile element carrying loci encoding antibiotic and mercury resistance. IS26-mediated deletions and fljB point mutants appeared to spread clonally. 'Inconsistent' Salmonella 4,[5]:12:i:- isolates associated with specific, single amino acid changes in fljA and hin were found in a single clade composed of water, shellfish, and avian isolates. Inclusion of isolates from different case clusters identified previously by PFGE validated some of the clusters and invalidated others. Some wgMLST clusters of clinical isolates composed of very closely related isolates contained an isolate(s) with a different genetic lesion, suggesting continuing mobility of the implicated element responsible. Such cases may need to be left out of epidemiological investigations until sufficient numbers of isolates are included that statistical significance of association with sources is not impaired. Non-human sources were frequently found in or near clinical case clusters. Prospective surveillance and WGS of non-human sources and retrospective analysis by WGS of isolates from existing culture collections provides data critical for epidemiological investigations of food- and waterborne outbreaks.	[Clark, Clifford G.; Kearney, Ashley K.; Tschetter, Lorelee; Nadon, Celine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada; [Robertson, James; Arya, Gitanjali; Ziebell, Kim; Johnson, Roger; Nash, John] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Guelph, ON, Canada; [Pollari, Frank; Parker, Stephen] Publ Hlth Agcy Canada, FoodNet Canada, Guelph, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada	Clark, CG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada.	clifford.clark@canada.ca	; Nash, John/P-2384-2017	Clark, Clifford/0000-0003-0566-1468; Nash, John/0000-0003-2925-8710	Government of Canada Genomics Research and Development (GRDI); Government of Canada	Government of Canada Genomics Research and Development (GRDI); Government of Canada(CGIAR)	Government of Canada Genomics Research and Development (GRDI) - Phase VI-CGC, RJ; Government of Canada A-base program funding -CGC, RJ, CN, JN, FP, SP.	Arruda BL, 2019, EMERG INFECT DIS, V25, P1377, DOI 10.3201/eid2507.181453; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barco L, 2014, FOODBORNE PATHOG DIS, V11, P497, DOI 10.1089/fpd.2013.1714; Besser JM, 2019, FOODBORNE PATHOG DIS, V16, P504, DOI 10.1089/fpd.2019.2650; Campos J, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010019; Cartwright EJ, 2016, ZOONOSES PUBLIC HLTH, V63, P62, DOI 10.1111/zph.12205; Chattaway MA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00317; Clark CG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236436; Cui QJ, 2019, ENVIRON POLLUT, V249, P24, DOI 10.1016/j.envpol.2019.02.094; Elnekave E, 2018, CLIN INFECT DIS, V66, P877, DOI 10.1093/cid/cix909; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Gerner-Smidt P, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00172; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hopkins KL, 2010, EUROSURVEILLANCE, V15, P2; Hynds PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093301; Ido N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104380; Keefer AB, 2019, MICROBIOL-SGM, V165, P270, DOI 10.1099/mic.0.000768; Kozyreva Varvara K, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1bb3e36e74bd5779bc43ac3a8dae52e6; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Mastrorilli E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00715; Mather AE, 2018, MBIO, V9, DOI [10.1128/mbio.01056-18, 10.1128/mBio.01056-18]; Matthews TC., 2018, 381830 BIORXIV, P381830, DOI [10.1101/381830, DOI 10.1101/381830]; Medardus JJ, 2014, APPL ENVIRON MICROB, V80, P2317, DOI 10.1128/AEM.04283-13; Morganti M., 2018, EURO SURVEILL, P17, DOI [10.2807/1560-7917.ES2018.23.13.17-00375, DOI 10.2807/1560-7917.ES2018.23.13.17-00375]; Mourao J, 2015, INT J ANTIMICROB AG, V45, P610, DOI 10.1016/j.ijantimicag.2015.01.013; Mulvey MR, 2013, J ANTIMICROB CHEMOTH, V68, P1982, DOI 10.1093/jac/dkt149; Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544; O'Brien SJ, 2013, CLIN INFECT DIS, V56, P705, DOI 10.1093/cid/cis967; Palma F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33266-5; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Petrovska L, 2016, EMERG INFECT DIS, V22, P617, DOI 10.3201/eid2204.150531; Powell MR, 2018, EPIDEMIOL INFECT, V146, P437, DOI 10.1017/S0950268818000195; Schonfeld J, 2021, MICROBIOL RESOUR ANN, V10, DOI 10.1128/MRA.00734-20; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Silva C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0020-2013; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Sun HH, 2020, FOODBORNE PATHOG DIS, V17, P87, DOI 10.1089/fpd.2019.2676; Sweat D., 2012, Morbidity and Mortality Weekly Report, V61, P277; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Walker M, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00074-20; White PL, 2019, FOODBORNE PATHOG DIS, V16, P679, DOI 10.1089/fpd.2018.2573; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249079	10.1371/journal.pone.0249079	http://dx.doi.org/10.1371/journal.pone.0249079			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822792	Green Published, gold			2022-12-26	WOS:000637879100034
J	Fungtammasan, S; Phupong, V				Fungtammasan, Siraphat; Phupong, Vorapong			The effect of Moringa oleifera capsule in increasing breastmilk volume in early postpartum patients: A double-blind, randomized controlled trial	PLOS ONE			English	Article								Moringa oleifera is an herbal galactagogue that has been used to increase the volume of breastmilk. Few studies have evaluated the effect of Moringa oleifera in breastfeeding. There are conflicting data whether it can increase the volume of breastmilk or not. Thus, the objective of this study is to evaluate the efficacy of Moringa oleifera leaves in increasing the volume of breastmilk in early postpartum mothers. A randomized, double-blind, placebo-controlled trial will be conducted. The outcomes of this study will provide the data of Moringa oleifera as an herbal medication to increase the volume of breastmilk. This information will be used to increase the rate of exclusive breastfeeding for the first 6 months as recommended by the World Health Organization.	[Fungtammasan, Siraphat; Phupong, Vorapong] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Placental Related Dis Res Unit, Bangkok, Thailand	Chulalongkorn University	Phupong, V (corresponding author), Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Placental Related Dis Res Unit, Bangkok, Thailand.	vorapong.p@chula.ac.th		Fungtammasan, Siraphat/0000-0003-0379-7150; Phupong, Vorapong/0000-0003-0151-9595	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University)	We plan to apply for Internal research grant: Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University.	Boss Melinda, 2018, F1000Res, V7, DOI 10.12688/f1000research.14452.1; BUTTE NF, 1988, AM J CLIN NUTR, V47, P815, DOI 10.1093/ajcn/47.5.815; Espinosa-Kuo C, 2005, FIL FAM PHYS, V43, P26; Estrella M.C.P., 2000, PHILIPP J PEDIAT, V49, P3; Foong SC, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011505.pub2; Kamalifard M, 2018, INT J WOMEN HEAL REP, V6, P84, DOI 10.15296/ijwhr.2018.15; Kent JC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091144; King J., 2013, PHILIPP J PEDIAT, V61, P34; Othman N, 2014, PROCD SOC BEHV, V153, P199, DOI 10.1016/j.sbspro.2014.10.054; Paritakul P, 2016, BREASTFEED MED, V11, P361, DOI 10.1089/bfm.2016.0073; Stohs SJ, 2015, PHYTOTHER RES, V29, P796, DOI 10.1002/ptr.5325; Sumarni, 2020, ENFERM CLIN, V30, P99, DOI 10.1016/j.enfcli.2019.10.050; World Health Organization, 2017, PROTECTING PROMOTING	13	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248950	10.1371/journal.pone.0248950	http://dx.doi.org/10.1371/journal.pone.0248950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822798	Green Published, gold			2022-12-26	WOS:000637879100017
J	Giuriato, M; Kawczynski, A; Mroczek, D; Lovecchio, N; Nevill, A				Giuriato, Matteo; Kawczynski, Adam; Mroczek, Dariusz; Lovecchio, Nicola; Nevill, Alan			Allometric association between physical fitness test results, body size/shape, biological maturity, and time spent playing sports in adolescents	PLOS ONE			English	Article								Regular participation in strength and conditioning activities positively correlates with health-related benefits in sports (team and individual). Maturity offset (MO) is a recognized parameter in fitness outcome assessment. The aims of the present study are to analyze cross-sectional allometric development of motor performances in a sample of adolescents and relate scaled motor performance to the estimated amount and type of physical activity and biological maturity status in 771 subjects aged 14-19 years. Three physical fitness components were evaluated using field tests (standing broad jump, sit-ups, shuttle run). Extra hours of sport after school (EHS) and MO were the covariates. The model to predict the physical performance variables was: Y = a Greek ano teleia M-k1 Greek ano teleia H-k2 Greek ano teleia WCk3 Greek ano teleia exp(b Greek ano teleia EHS + c Greek ano teleia MO) Greek ano teleia epsilon. Results suggest that having controlled for body size and body shape, performing EHS and being an early developer (identified by a positive MO slope parameter) benefits children in physical fitness and motor performance tasks.	[Giuriato, Matteo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Giuriato, Matteo] Gdansk Univ Phys Educ & Sport, Fac Phys Culture, Dept Hlth & Nat Sci, Unit Mol Biol, Gdansk, Poland; [Kawczynski, Adam; Mroczek, Dariusz] Univ Sch Phys Educ, Dept Paralymp Sports, Wroclaw, Poland; [Lovecchio, Nicola] Univ Pavia, Dept Publ Hlth Expt Med & Forens Sci, Lab Adapted Motor Act LAMA, Pavia, Italy; [Lovecchio, Nicola] Univ Bergamo, Dept Human & Social Sci, Bergamo, Italy; [Nevill, Alan] Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Wolverhampton, England	University of Verona; Gdansk University of Physical Education & Sport; University of Pavia; University of Bergamo; University of Wolverhampton	Lovecchio, N (corresponding author), Univ Pavia, Dept Publ Hlth Expt Med & Forens Sci, Lab Adapted Motor Act LAMA, Pavia, Italy.; Lovecchio, N (corresponding author), Univ Bergamo, Dept Human & Social Sci, Bergamo, Italy.	nicola.lovecchio@unipv.it	Mroczek, Dariusz/K-2074-2019; Kawczynski, Adam/AAK-3031-2021; Giuriato, Matteo/AAA-2917-2021	Mroczek, Dariusz/0000-0002-4783-3152; Kawczynski, Adam/0000-0001-7840-3799; Giuriato, Matteo/0000-0002-4829-1447; Nevill, Alan/0000-0003-0506-3652				Altmann S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220982; Armstrong N, 2019, B WORLD HEALTH ORGAN, V97, P777, DOI 10.2471/BLT.18.227546; Artero EG, 2011, INT J SPORTS MED, V32, P159, DOI 10.1055/s-0030-1268488; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; Berkson SS, 2013, J SCHOOL HEALTH, V83, P21, DOI 10.1111/j.1746-1561.2012.00743.x; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Pellino VC, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10186430; Clarys J. P., 2006, Morphologie, V90, P189, DOI 10.1016/S1286-0115(06)74505-2; Committee for the Development of Sport, 1988, EUROFIT HDB EUROFIT, P1; Espana-Romero V, 2010, INT J SPORTS MED, V31, P490, DOI 10.1055/s-0030-1251990; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; Giuriato M, 2020, J SPORT MED PHYS FIT, V60, P417, DOI 10.23736/S0022-4707.19.10282-4; Kemper HCG, 1996, PEDIATR EXERC SCI, V8, P201, DOI 10.1123/pes.8.3.201; Lovecchio N, 2019, J SPORT MED PHYS FIT, V59, P1389, DOI 10.23736/S0022-4707.18.08926-0; Lovecchio N, 2019, J SPORT SCI, V37, P1434, DOI 10.1080/02640414.2018.1562615; Lovecchio N, 2019, J SPORT MED PHYS FIT, V59, P298, DOI 10.23736/S0022-4707.18.08271-3; Lovecchio N, 2015, PERCEPT MOTOR SKILL, V120, P367, DOI 10.2466/06.PMS.120v11x8; MALINA RM, 1990, SCHR HAMB M, V4, P1; MALINA RM, 1990, EXERCISE, FITNESS, AND HEALTH, P637; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; Marin-Puyalto J, 2018, OSTEOPOROSIS INT, V29, P2693, DOI 10.1007/s00198-018-4731-2; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moore SA, 2015, MED SCI SPORT EXER, V47, P1755, DOI 10.1249/MSS.0000000000000588; Mujika I, 2018, INT J SPORT PHYSIOL, V13, P538, DOI 10.1123/ijspp.2018-0093; Murtagh CF, 2018, J STRENGTH COND RES, V32, P297, DOI 10.1519/JSC.0000000000002367; Nevill A, 2009, PEDIATR EXERC SCI, V21, P220, DOI 10.1123/pes.21.2.220; Nevill A, 2009, J SPORT SCI, V27, P419, DOI 10.1080/02640410802668676; Nevill AM, 2019, INT J SPORTS SCI COA, V14, P329, DOI 10.1177/1747954119837710; NEVILL AM, 1992, EUR J APPL PHYSIOL O, V64, P419, DOI 10.1007/BF00625060; Nevill AM, 1998, J APPL PHYSIOL, V84, P963, DOI 10.1152/jappl.1998.84.3.963; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Silva S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149493; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Winter EM, 2009, KINANTHROPOMETRY EXE, P300	35	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249626	10.1371/journal.pone.0249626	http://dx.doi.org/10.1371/journal.pone.0249626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822815	gold, Green Published			2022-12-26	WOS:000637879100003
J	Young, TP; Kimuyu, DM; Odadi, WO; Wells, HBM; Wolf, AA				Young, Truman P.; Kimuyu, Duncan M.; Odadi, Wilfred O.; Wells, Harry B. M.; Wolf, Amelia A.			Naive plant communities and individuals may initially suffer in the face of reintroduced megafauna: An experimental exploration of rewilding from an African savanna rangeland	PLOS ONE			English	Article							INTRODUCED HERBIVORES; RESTORATION; DEFENSE; CATTLE; FIRE	Excluding large native mammals is an inverse test of rewilding. A 25-year exclosure experiment in an African savanna rangeland offers insight into the potentials and pitfalls of the rewilding endeavor as they relate to the native plant community. A broad theme that has emerged from this research is that entire plant communities, as well as individual plants, adjust to the absence of herbivores in ways that can ill-prepare them for the return of these herbivores. Three lines of evidence suggest that these "naive" individuals, populations, and communities are likely to initially suffer from herbivore rewilding. First, plots protected from wild herbivores for the past 25 years have developed rich diversity of woody plants that are absent from unfenced plots, and presumably would disappear upon rewilding. Second, individuals of the dominant tree in this system, Acacia drepanolobium, greatly reduce their defences in the absence of browsers, and the sudden arrival of these herbivores (in this case, through a temporary fence break), resulted in far greater elephant damage than for their conspecifics in adjacent plots that had been continually exposed to herbivory. Third, the removal of herbivores favoured the most palatable grass species, and a large number of rarer species, which presumably would be at risk from herbivore re-introduction. In summary, the native communities that we observe in defaunated landscapes may be very different from their pre-defaunation states, and we are likely to see some large changes to these plant communities upon rewilding with large herbivores, including potential reductions in plant diversity. Lastly, our experimental manipulation of cattle represents an additional test of the role of livestock in rewilding. Cattle are in many ways ecologically dissimilar to wildlife (in particular their greater densities), but in other ways they may serve as ecological surrogates for wildlife, which could buffer ecosystems from some of the ecological costs of rewilding. More fundamentally, African savannah ecosystems represent a challenge to traditional Western definitions of "wilderness" as ecosystems free of human impacts. We support the suggestion that as we "rewild" our biodiversity landscapes, we redefine "wildness" in the 21(st) Century to be inclusive of (low impact, and sometimes traditional) human practices that are compatible with the sustainability of native (and re-introduced) biodiversity.	[Young, Truman P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Young, Truman P.] Univ Calif Davis, Ecol Grad Grp, Davis, CA 95616 USA; [Young, Truman P.; Kimuyu, Duncan M.; Odadi, Wilfred O.] Mpala Res Ctr, Nanyuki, Kenya; [Kimuyu, Duncan M.] Karatina Univ, Dept Nat Resources, Karatina, Kenya; [Odadi, Wilfred O.] Egerton Univ, Dept Nat Resources, Egerton, Kenya; [Wells, Harry B. M.] Univ Leeds, Sch Earth & Environm, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Wells, Harry B. M.] Lolldaiga Hills Res Programme, Nanyuki, Kenya; [Wolf, Amelia A.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of California System; University of California Davis; University of California System; University of California Davis; Egerton University; University of Leeds; University of Texas System; University of Texas Austin	Young, TP (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Young, TP (corresponding author), Univ Calif Davis, Ecol Grad Grp, Davis, CA 95616 USA.; Young, TP (corresponding author), Mpala Res Ctr, Nanyuki, Kenya.	tpyoung@ucdavis.edu		Kimuyu, Duncan/0000-0001-6077-4970; Wells, Harry/0000-0001-5463-9297	James Smithson Fund of the Smithsonian Institution; National Geographic Society [4691-91, 9106-12, 9986-16]; National Science Foundation [LTREB DEB 97-07477, 03-16402, 0816453, 12-56004, 12-56034, 19-31224]; African Elephant Program of the U.S. Fish and Wildlife Service [98210-0-G563]	James Smithson Fund of the Smithsonian Institution(Smithsonian Institution); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); African Elephant Program of the U.S. Fish and Wildlife Service	The KLEE exclosure plots were built and maintained by grants from the James Smithson Fund of the Smithsonian Institution (to A.P. Smith), The National Geographic Society (Grants 4691-91, 9106-12, and 9986-16), The National Science Foundation (LTREB DEB 97-07477, 03-16402, 0816453, 12-56004, 12-56034, and 19-31224) and the African Elephant Program of the U.S. Fish and Wildlife Service (98210-0-G563) (to T.P. Young, C. Riginos, and K.E. Veblen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni KJ, 2021, J ARID ENVIRON, V184, DOI 10.1016/j.jaridenv.2020.104302; Asa C., 2013, USING SCI IMPROVE BL; Augustine David J., 2011, Smithsonian Contributions to Zoology, P55; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barsh RL., 1990, STRUGGLE LAND, P103; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bowen L, 1997, CONSERV BIOL, V11, P1249, DOI 10.1046/j.1523-1739.1997.96368.x; Callicott JB., 1998, GREAT NEW WILDERNESS; Capozzelli JF, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.2993; Cubas J, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0136; Davies KW, 2019, BIOSCIENCE, V69, P558, DOI 10.1093/biosci/biz060; Toit JT, 2019, J APPL ECOL, V56, P2467, DOI 10.1111/1365-2664.13487; du Toit JT, 2014, CONSERV SCI PRACT, V14, P289; Edkins MT, 2008, AFR J ECOL, V46, P119, DOI 10.1111/j.1365-2028.2007.00798.x; Eldridge DJ, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108367; Gadd ME, 2001, OIKOS, V92, P515, DOI 10.1034/j.1600-0706.2001.920312.x; Hayward MW, 2019, ECOL REV, P325; Huntzinger M, 2004, ECOLOGY, V85, P609, DOI 10.1890/03-3056; Karban R., 1997, INDUCED RESPONSES HE; Kimuyu DM, 2021, BIOTROPICA, V53, P86, DOI 10.1111/btp.12848; Kimuyu DM, 2014, ECOL APPL, V24, P741, DOI 10.1890/13-1135.1; Lane Paul, 2011, Smithsonian Contributions to Zoology, P11; Lorimer J, 2014, T I BRIT GEOGR, V39, P169, DOI 10.1111/tran.12030; Lundgren EJ, 2020, P NATL ACAD SCI USA, V117, P7871, DOI 10.1073/pnas.1915769117; Maclean JE, 2011, ECOLOGY, V92, P1626, DOI 10.1890/10-2097.1; Marchant R, 2018, EARTH-SCI REV, V178, P322, DOI 10.1016/j.earscirev.2017.12.010; Marchant R, 2014, J ARCHAEOL SCI, V51, P12, DOI 10.1016/j.jas.2013.07.005; Marshall F, 2002, J WORLD PREHIST, V16, P99, DOI 10.1023/A:1019954903395; Marshall F, 2018, NATURE, V561, P387, DOI 10.1038/s41586-018-0456-9; Odadi WO, 2013, ECOL APPL, V23, P455, DOI 10.1890/12-0878.1; Olofsson J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0437; Palmer TM., 2017, ANT PLANT INTERACTIO, P200; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Pettorelli N., 2019, REWILDING; Porensky LM, 2013, OECOLOGIA, V173, P591, DOI 10.1007/s00442-013-2637-4; Pringle RM, 2015, J ANIM ECOL, V84, P1637, DOI 10.1111/1365-2656.12404; Reid RS., 2012, OPERATIONS MANAGEMEN; Riginos C, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-10; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Semprebon GM, 2016, PALAEOGEOGR PALAEOCL, V442, P110, DOI 10.1016/j.palaeo.2015.11.004; Shier DM, 2006, BIOL CONSERV, V132, P126, DOI 10.1016/j.biocon.2006.03.020; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; Svenning JC, 2019, ECOL REV, P73; Tetzlaff SJ, 2019, BIOL CONSERV, V236, P324, DOI 10.1016/j.biocon.2019.05.054; Thouless C., 2016, OCCASIONAL PAPER SER, V60; van der Kaars S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14142; Veblen KE, 2016, ECOL APPL, V26, P1610, DOI 10.1890/15-1367.1; Ward D, 2002, J CHEM ECOL, V28, P921, DOI 10.1023/A:1015249431942; Ward K, 2019, ECOL REV, P34; Werner CM, 2021, ECOLOGY; Young TP, 1998, OECOLOGIA, V115, P508, DOI 10.1007/s004420050548; Young TP, 2003, OIKOS, V101, P171, DOI 10.1034/j.1600-0706.2003.12067.x; Young TP, 2000, BIOL CONSERV, V92, P73, DOI 10.1016/S0006-3207(99)00057-9; Young TP., 1997, AFR J RANGE FOR SCI, V14, P94; Young TP, 2019, Q REV BIOL, V94, P320; Young TP, 2018, RANGELAND ECOL MANAG, V71, P281, DOI 10.1016/j.rama.2018.01.005	58	3	3	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248855	10.1371/journal.pone.0248855	http://dx.doi.org/10.1371/journal.pone.0248855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822786	Green Published, Green Submitted, gold			2022-12-26	WOS:000637879100004
J	Cho, JC				Cho, Jae-Chang			Human microbiome privacy risks associated with summary statistics	PLOS ONE			English	Article								Recognizing that microbial community composition within the human microbiome is associated with the physiological state of the host has sparked a large number of human microbiome association studies (HMAS). With the increasing size of publicly available HMAS data, the privacy risk is also increasing because HMAS metadata could contain sensitive private information. I demonstrate that a simple test statistic based on the taxonomic profiles of an individual's microbiome along with summary statistics of HMAS data can reveal the membership of the individual's microbiome in an HMAS sample. In particular, species-level taxonomic data obtained from small-scale HMAS can be highly vulnerable to privacy risk. Minimal guidelines for HMAS data privacy are suggested, and an assessment of HMAS privacy risk using the simulation method proposed is recommended at the time of study design.	[Cho, Jae-Chang] Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea; [Cho, Jae-Chang] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea	Hankuk University Foreign Studies; Hankuk University Foreign Studies	Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea.; Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea.	chojc@hufs.ac.uk			2021 HUFS internal research grant	2021 HUFS internal research grant	This work was supported in part by a 2021 HUFS internal research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Braun R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000668; Callaway E, 2015, NATURE, V521, P136, DOI 10.1038/521136a; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Gilbert JA, 2019, NAT MED, V25, P884, DOI 10.1038/s41591-019-0464-9; Greenbaum D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002278; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Kort R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-41; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wagner J, 2016, BIOINFORMATICS, V32, P1873, DOI 10.1093/bioinformatics/btw073; Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83	18	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249528	10.1371/journal.pone.0249528	http://dx.doi.org/10.1371/journal.pone.0249528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798253	gold, Green Published			2022-12-26	WOS:000636737700001
J	Wilson-Barnes, SL; Hunt, JEA; Mendis, J; Williams, EL; King, D; Roberts, H; Lanham-New, SA; Manders, RJF				Wilson-Barnes, Saskia L.; Hunt, Julie E. A.; Mendis, Jeewaka; Williams, Emma L.; King, David; Roberts, Harry; Lanham-New, Susan A.; Manders, Ralph J. F.			The relationship between vitamin D status, intake and exercise performance in UK University-level athletes and healthy inactive controls	PLOS ONE			English	Article							BODY-COMPOSITION; MUSCLE STRENGTH; D DEFICIENCY; SUPPLEMENTATION; PREVALENCE; 25(OH)D; IMPACT	The potential ergogenic effects of vitamin D (vitD) in high performing athletes has received considerable attention in the literature and media. However, little is known about non-supplemented university athletes and students residing at a higher latitude. This study aimed to investigate the effects of vitD (biochemical status and dietary intake) on exercise performance in UK university athletes and sedentary students. A total of 34 athletes and 16 sedentary controls were studied during the spring and summer months. Serum vitD status and sunlight exposure were assessed using LC-MS/MS and dosimetry, respectively. Muscular strength of the upper and lower body was assessed using handgrip and knee extensor dynamometry (KE). Countermovement jump (CMJ) and aerobic fitness were measured using an Optojump and VO2max test, respectively. Statistical analysis was performed using paired/ independent t-tests, ANCOVA and Pearson/ Spearman correlations, depending on normality. VitD status increased significantly over the seasons, with athletes measuring higher status both in spring (51.7 +/- 20.5 vs. 37.2 +/- 18.9 nmol/L, p = 0.03) and summer (66.7 +/- 15.8 vs 55.6 +/- 18.8 nmol/L, p = 0.04) when compared to controls, respectively. Notably, 22% of the subjects recruited were vitD deficient during the spring term only (<25nmol/L, n 9). Subjects with 'insufficient' vitD status (<50nmol/L) elicited significantly lower CMJ when contrasted to the vitD 'sufficient' (>50nmol/l) group (p = 0.055) and a lower VO2 max (p = 0.05) in the spring and summer term (p = 0.05 and p = 0.01, respectively). However, an ANCOVA test showed no significant difference detected for either CMJ or VO2max following adjustments for co-variates. In conclusion, we provide novel information on the vitD status, dietary intake, physical fitness and sunlight exposure of UK young adults across two separate seasons, for which there is limited data at present.	[Wilson-Barnes, Saskia L.; Hunt, Julie E. A.; King, David; Roberts, Harry; Lanham-New, Susan A.; Manders, Ralph J. F.] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Dept Nutr Sci, Guildford, Surrey, England; [Mendis, Jeewaka] NIHR Res Design Serv SE, Surrey Clin Res Ctr, Surrey Clin Trials Unit, Guildford, Surrey, England; [Williams, Emma L.] Imperial Coll Healthcare NHS Trust, Div Womens Childrens & Clin Support, London, England	University of Surrey; University of Surrey; Imperial College London	Wilson-Barnes, SL (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Dept Nutr Sci, Guildford, Surrey, England.	s.wilson-barnes@surrey.ac.uk		Wilson-Barnes, Saskia Louise/0000-0001-9945-4800; Williams, Emma Louise/0000-0002-0309-129X				[Anonymous], 2016, VIT D HLTH; Beaudart C, 2014, J CLIN ENDOCR METAB, V99, P4336, DOI 10.1210/jc.2014-1742; Carswell AT, 2018, MED SCI SPORT EXER, V50, P2555, DOI [10.1249/MSS.0000000000001721, 10.1249/mss.0000000000001721]; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Ceglia L, 2013, J CLIN ENDOCR METAB, V98, pE1927, DOI 10.1210/jc.2013-2820; Close GL, 2013, BRIT J SPORT MED, V47, P692, DOI 10.1136/bjsports-2012-091735; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Darling AL, 2013, OSTEOPOROSIS INT, V24, P477, DOI 10.1007/s00198-012-1973-2; Farrokhyar F, 2015, SPORTS MED, V45, P365, DOI 10.1007/s40279-014-0267-6; Fitzgerald JS, 2014, J STRENGTH COND RES, V28, P3200, DOI 10.1519/JSC.0000000000000523; Forney LA, 2014, J STRENGTH COND RES, V28, P814, DOI 10.1519/JSC.0b013e3182a35ed0; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Grober U, 2012, DERM-ENDOCRINOL, V4, P158, DOI 10.4161/derm.20731; Halliday TM, 2011, MED SCI SPORT EXER, V43, P335, DOI 10.1249/MSS.0b013e3181eb9d4d; Hamilton B, 2014, J SCI MED SPORT, V17, P139, DOI 10.1016/j.jsams.2013.03.006; Heaney RP, 2013, J STEROID BIOCHEM, V136, P224, DOI 10.1016/j.jsbmb.2012.09.032; Heller JE, 2015, INT J SPORT NUTR EXE, V25, P128, DOI 10.1123/ijsnem.2013-0250; Hengist A, 2019, NUTR BULL, V44, P25, DOI 10.1111/nbu.12369; Jaaskelainen T, 2017, AM J CLIN NUTR, V105, P1512, DOI 10.3945/ajcn.116.151415; Jerome SP, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1314414; Jung HC, 2018, INT J SPORT NUTR EXE, V28, P635, DOI 10.1123/ijsnem.2017-0412; Ksiazek A, 2016, J HUM KINET, V50, P71, DOI 10.1515/hukin-2015-0144; Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027; Neal S, 2015, PHYSICIAN SPORTSMED, V43, P161, DOI 10.1080/00913847.2015.1020248; Orysiak J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195284; Owens DJ, 2018, SPORTS MED, V48, pS3, DOI 10.1007/s40279-017-0841-9; Owens DJ, 2014, EUR J APPL PHYSIOL, V114, P1309, DOI 10.1007/s00421-014-2865-2; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Smith W., 2006, WHO SOLAR ULTRAVIOLE; Todd JJ, 2017, EUR J NUTR, V56, P1577, DOI 10.1007/s00394-016-1202-4; Tomlinson PB, 2015, J SCI MED SPORT, V18, P575, DOI 10.1016/j.jsams.2014.07.022; Villacis D, 2014, SPORTS HEALTH, V6, P340, DOI 10.1177/1941738114524517; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; WEISHAAR RE, 1987, J CLIN INVEST, V79, P1706, DOI 10.1172/JCI113010	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249671	10.1371/journal.pone.0249671	http://dx.doi.org/10.1371/journal.pone.0249671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798240	Green Published, gold			2022-12-26	WOS:000636737700053
J	Hawari, FI; Obeidat, NA; Dodin, YI; Albtoosh, AS; Manasrah, RM; Alaqeel, IO; Mansour, AH				Hawari, Feras I.; Obeidat, Nour A.; Dodin, Yasmeen I.; Albtoosh, Asma S.; Manasrah, Rasha M.; Alaqeel, Ibrahim O.; Mansour, Asem H.			The inevitability of Covid-19 related distress among healthcare workers: Findings from a low caseload country under lockdown	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; SARS; EPIDEMIC; LINKING; STAFF	Objectives To characterize psychological distress and factors associated with distress in healthcare practitioners working during a stringent lockdown in a country (Jordan) that had exhibited one of the lowest incidence rates of Covid-19 globally at the time of the survey. Methods A cross-sectional online survey sent to healthcare practitioners working in various hospitals and community pharmacies. Demographic, professional and psychological characteristics (distress using Kessler-6 questionnaire, anxiety, depression, burnout, sleep issues, exhaustion) were measured as were sources of fear. Descriptive and multivariable statistics were performed using level of distress as the outcome. Results We surveyed 937 practitioners (56.1% females). Approximately 68%, 14%, and 18% were nurses/technicians, physicians, and pharmacists (respectively). 32% suffered from high distress while 20% suffered from severe distress. Exhaustion, anxiety, depression, and sleep disturbances were reported (in past seven days) by approximately 34%, 34%, 19%, and 29% of subjects (respectively). Being older or male, a positive perception of communications with peers, and being satisfied at work, were significantly associated with lower distress. Conversely, suffering burnout; reporting sleep-related functional problems; exhaustion; being a pharmacist (relative to a physician); working in a cancer center; harboring fear about virus spreading; fear that the virus threatened life; fear of alienation from family/friends; and fear of workload increases, were significantly associated with higher distress. Conclusion Despite low caseloads, Jordanian practitioners still experienced high levels of distress. Identified demographic, professional and psychological factors influencing distress should inform interventions to improve medical professionals' resilience and distress likelihood, regardless of the variable Covid-19 situation.	[Hawari, Feras I.] King Hussein Canc Ctr, Dept Internal Med, Sect Pulm & Crit Care, Amman, Jordan; [Hawari, Feras I.] Univ Jordan, Amman, Jordan; [Hawari, Feras I.; Obeidat, Nour A.; Dodin, Yasmeen I.; Manasrah, Rasha M.] King Hussein Canc Ctr, Canc Control Off, Amman, Jordan; [Albtoosh, Asma S.] Univ Jordan, Resp Div, Internal Med Dept, Amman, Jordan; [Alaqeel, Ibrahim O.] Ibn Alhaytham Hosp, Amman, Jordan; [Mansour, Asem H.] King Hussein Canc Ctr, Gen Off, Amman, Jordan	King Hussein Cancer Center; University of Jordan; King Hussein Cancer Center; University of Jordan; King Hussein Cancer Center	Hawari, FI (corresponding author), King Hussein Canc Ctr, Dept Internal Med, Sect Pulm & Crit Care, Amman, Jordan.; Hawari, FI (corresponding author), Univ Jordan, Amman, Jordan.; Hawari, FI (corresponding author), King Hussein Canc Ctr, Canc Control Off, Amman, Jordan.	fhawari@khcc.jo		Mansour, Asem/0000-0003-3443-5873				Alqutob R, 2020, JMIR PUBLIC HLTH SUR, V6, P6, DOI 10.2196/19332; Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020; Benfante A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.569935; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cabarkapa Sonja, 2020, Brain Behav Immun Health, V8, P100144, DOI 10.1016/j.bbih.2020.100144; Carmassi C, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113312; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Chew QH, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.20r13450; Chew QH, 2020, SINGAP MED J, V61, P350, DOI 10.11622/smedj.2020046; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Dolan ED, 2015, J GEN INTERN MED, V30, P582, DOI 10.1007/s11606-014-3112-6; Forman-Hoffman VL., 2014, PSYCHOL DISTRESS MOR; Friedberg M.W., 2013, FACTORS AFFECTING PH; Galli F, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.568664; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Hlubocky Fay J, 2016, Am Soc Clin Oncol Educ Book, V35, P271, DOI 10.14694/EDBK_156120; Ho SMY, 2005, J CONSULT CLIN PSYCH, V73, P344, DOI 10.1037/0022-006X.73.2.344; Imai T, 2005, EMERG INFECT DIS, V11, P404; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lancee WJ, 2008, PSYCHIAT SERV, V59, P91, DOI 10.1176/ps.2008.59.1.91; Man MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134899; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Naser AY, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1730; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Preti E, 2020, CURR PSYCHIAT REP, V22, DOI 10.1007/s11920-020-01166-z; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Sanghera J, 2020, J OCCUP HEALTH, V62, DOI 10.1002/1348-9585.12175; Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006; Shah A, 2018, STAT SOFTWARE COMPON; Shah DP., 2020, CLIN IMPACT COVID 19, DOI [10.1016/S0140-6736%2820%2931187-9, DOI 10.1016/S0140-6736%2820%2931187-9]; Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119; Suleiman A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093181; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Thombs BD, 2020, J PSYCHOSOM RES, V133, DOI 10.1016/j.jpsychores.2020.110113; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; Zhang SX, 2020, BRAIN BEHAV IMMUN, V87, P144, DOI 10.1016/j.bbi.2020.05.010	41	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248741	10.1371/journal.pone.0248741	http://dx.doi.org/10.1371/journal.pone.0248741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793579	Green Submitted, Green Published, gold			2022-12-26	WOS:000636467000114
J	Parkinson, L; Stawicki, TM				Parkinson, Lauren; Stawicki, Tamara M.			alms1 mutant zebrafish do not show hair cell phenotypes seen in other cilia mutants	PLOS ONE			English	Article								Multiple cilia-associated genes have been shown to affect hair cells in zebrafish (Danio rerio), including the human deafness gene dcdc2, the radial spoke gene rsph9, and multiple intraflagellar transport (IFT) and transition zone genes. Recently a zebrafish alms1 mutant was generated. The ALMS1 gene is the gene mutated in the ciliopathy Alstrom Syndrome a disease that causes hearing loss among other symptoms. The hearing loss seen in Alstrom Syndrome may be due in part to hair cell defects as Alms1 mutant mice show stereocilia polarity defects and a loss of hair cells. Hair cell loss is also seen in postmortem analysis of Alstrom patients. The zebrafish alms1 mutant has metabolic defects similar to those seen in Alstrom syndrome and Alms1 mutant mice. We wished to investigate if it also had hair cell defects. We, however, failed to find any hair cell related phenotypes in alms1 mutant zebrafish. They had normal lateral line hair cell numbers as both larvae and adults and normal kinocilia formation. They also showed grossly normal swimming behavior, response to vibrational stimuli, and FM1-43 loading. Mutants also showed a normal degree of sensitivity to both short-term neomycin and long-term gentamicin treatment. These results indicate that cilia-associated genes differentially affect different hair cell types.	[Parkinson, Lauren; Stawicki, Tamara M.] Lafayette Coll, Neurosci Program, Easton, PA 18042 USA	Lafayette College	Stawicki, TM (corresponding author), Lafayette Coll, Neurosci Program, Easton, PA 18042 USA.	stawickt@lafayette.edu		Stawicki, Tamara/0000-0003-2191-8550				Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; ALSTROM C H, 1959, Acta Psychiatr Neurol Scand Suppl, V129, P1; Arsov T, 2006, MOL ENDOCRINOL, V20, P1610, DOI 10.1210/me.2005-0494; Bahmad F, 2014, BRAZ J OTORHINOLAR, V80, P99, DOI 10.5935/1808-8694.20140023; Barta CL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.5; Blanco-Sanchez B, 2017, METHOD CELL BIOL, V138, P415, DOI 10.1016/bs.mcb.2016.10.006; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Chen JH, 2017, MOL GENET GENOM MED, V5, P390, DOI 10.1002/mgg3.296; Chou SW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01604-2; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Delmaghani S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072309; Delmaghani S, 2016, AM J HUM GENET, V98, P1266, DOI 10.1016/j.ajhg.2016.04.015; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eppsteiner RW, 2011, CURR OPIN OTOLARYNGO, V19, P397, DOI 10.1097/MOO.0b013e32834a9852; Erickson T, 2020, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00320; Erickson T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2072-5; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Esposito G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0372-0; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Galego-Martinez A, 2018, J NEUROL, V265, P29, DOI 10.1007/s00415-018-8842-7; Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210; Goman AM, 2016, AM J PUBLIC HEALTH, V106, P1820, DOI 10.2105/AJPH.2016.303299; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Grati M, 2015, HUM MOL GENET, V24, P2482, DOI 10.1093/hmg/ddv009; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hearn T, 2019, J MOL MED, V97, P1, DOI 10.1007/s00109-018-1714-x; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Imtiaz A, 2018, HUM MOL GENET, V27, P780, DOI 10.1093/hmg/ddx440; Jagger D, 2011, HUM MOL GENET, V20, P466, DOI 10.1093/hmg/ddq493; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Khateb S, 2014, J MED GENET, V51, P460, DOI 10.1136/jmedgenet-2014-102287; Kindt KS, 2012, DEV CELL, V23, P329, DOI 10.1016/j.devcel.2012.05.022; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Koleilat A, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.043885; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li P, 2019, J HUM GENET, V64, P39, DOI 10.1038/s10038-018-0514-z; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lindsey S, 2017, AM J MED GENET A, V173, P2210, DOI 10.1002/ajmg.a.38316; Lush ME, 2019, ELIFE, V8, DOI 10.7554/eLife.44431; Lv CX, 2016, CELL REP, V15, P2784, DOI 10.1016/j.celrep.2016.05.045; Malicki J, 1996, DEVELOPMENT, V123, P275; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Marshall JD, 1997, AM J MED GENET, V73, P150, DOI 10.1002/(SICI)1096-8628(19971212)73:2<150::AID-AJMG9>3.0.CO;2-Y; May-Simera HL, 2009, J COMP NEUROL, V514, P174, DOI 10.1002/cne.22001; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michaud JL, 1996, J PEDIATR-US, V128, P225, DOI 10.1016/S0022-3476(96)70394-3; Nadol JB, 2015, AUDIOL NEURO-OTOL, V20, P267, DOI 10.1159/000381935; Namburi P, 2016, AM J HUM GENET, V99, P777, DOI 10.1016/j.ajhg.2016.07.010; Nesmith JE, 2019, HUM MOL GENET, V28, P2212, DOI 10.1093/hmg/ddz053; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Nicolson T, 2015, HEARING RES, V330, P170, DOI 10.1016/j.heares.2015.04.003; Nicolson T, 2017, J NEUROGENET, V31, P102, DOI 10.1080/01677063.2017.1342246; Nikopoulos K, 2016, AM J HUM GENET, V99, P770, DOI 10.1016/j.ajhg.2016.07.009; Ogun O, 2014, J CELL BIOL, V207, P375, DOI 10.1083/jcb.201404016; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Sedykh I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34437; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Singh PP, 2020, NUCLEIC ACIDS RES, V48, pD724, DOI 10.1093/nar/gkz909; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stawicki TM, 2019, BIOL OPEN, V8, DOI 10.1242/bio.038745; Stawicki TM, 2016, G3-GENES GENOM GENET, V6, P2225, DOI 10.1534/g3.116.030080; Stawicki TM, 2014, DIS MODEL MECH, V7, P847, DOI 10.1242/dmm.016576; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Van Camp G., 2020, HEREDITARY HEARING L; Vona B, 2020, HEARING RES, V397, DOI 10.1016/j.heares.2020.107906; Whitfield TT, 1996, DEVELOPMENT, V123, P241	81	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0246844	10.1371/journal.pone.0246844	http://dx.doi.org/10.1371/journal.pone.0246844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793549	gold, Green Published, Green Submitted			2022-12-26	WOS:000636467000105
J	Wu, WY; Chou, PL; Yang, JC; Chien, CT				Wu, Wei-Yi; Chou, Pei-Li; Yang, Jyh-Chin; Chien, Chiang-Ting			Silicon-containing water intake confers antioxidant effect, gastrointestinal protection, and gut microbiota modulation in the rodents	PLOS ONE			English	Article								We explored the effects of silicon-containing water (BT) intake on gastrointestinal function and gut microbiota. BT was obtained by pressuring tap water through silicon minerals (mullite, Al6Si2O13) column. BT decreased H2O2 chemiluminescence counts, indicating its antioxidant activity. Four weeks of BT drinking increased H2O2 scavenging activity and glutathione peroxidase activity of plasma. BT drinking did not affect the body weight but significantly reduced the weight of feces and gastrointestinal motility. BT drinking significantly suppressed pylorus ligation enhanced gastric juice secretion, gastric reactive oxygen species amount, erythrocyte extravasation, IL-1 beta production by infiltrating leukocyte, and lipid peroxidation within gastric mucosa. Data from 16S rRNA sequencing revealed BT drinking significantly increased beneficial flora including Ruminococcaceae UCG-005, Prevotellaceae NK3B31, Weissella paramesenteroides, Lactobacillus reuteri, and Lactobacillus murinus and decreased harmful flora including Mucispirillum, Rodentibacter, and Staphylococcus aureus. This study pioneerly provided scientific evidences for the potential effects of water-soluble forms of silicon intake on antioxidant activity, gastrointestinal function, and gut microbiota modulation.	[Wu, Wei-Yi; Chou, Pei-Li; Chien, Chiang-Ting] Natl Taiwan Normal Univ, Sch Life Sci, Dept Life Sci, Taipei, Taiwan; [Yang, Jyh-Chin] Natl Taiwan Univ, Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan Normal University; National Taiwan University	Chien, CT (corresponding author), Natl Taiwan Normal Univ, Sch Life Sci, Dept Life Sci, Taipei, Taiwan.; Yang, JC (corresponding author), Natl Taiwan Univ, Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan.	ctchien@ntnu.edu.tw; jcyang47@ntu.edu.tw			Ministry of Science and Technology in Taiwan [MOST-107-2218-E-003-001]; Bestec Biotechnology Co., Ltd. in Taiwan; Ministry of Science and Technology; Bestec Biotechnology Co., Ltd.	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Bestec Biotechnology Co., Ltd. in Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Bestec Biotechnology Co., Ltd.	This work was supported by grant from Ministry of Science and Technology in Taiwan (MOST-107-2218-E-003-001) and Bestec Biotechnology Co., Ltd. in Taiwan. Ministry of Science and Technology provided financial support in the form of salaries for CTC and WYW and research material. Bestec Biotechnology Co., Ltd. provided financial support in research material. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01197; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Arthur-Ataam J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112574; Benga L, 2018, VET MICROBIOL, V217, P121, DOI 10.1016/j.vetmic.2018.03.011; Berry D, 2013, BEST PRACT RES CL GA, V27, P47, DOI 10.1016/j.bpg.2013.03.005; Bian X, 2016, CURR MICROBIOL, V73, P65, DOI 10.1007/s00284-016-1010-3; Bucker R, 2014, GUT, V63, P1893, DOI 10.1136/gutjnl-2013-306099; Chen DL, 2011, TRANSL RES, V157, P306, DOI 10.1016/j.trsl.2010.12.012; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Garcimartin A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-384; Gotz W, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11030117; Gray CA, 2006, J OCCUP ENVIRON MED, V48, P1279, DOI 10.1097/01.jom.0000251477.40643.2a; Huang KY, 2019, J AGR FOOD CHEM, V67, P11408, DOI 10.1021/acs.jafc.9b04411; Jing YP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1781036; Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99; Jugdaohsingh R, 2002, AM J CLIN NUTR, V75, P887, DOI 10.1093/ajcn/75.5.887; Jugdaohsingh R, 2013, BRIT J NUTR, V110, P1024, DOI 10.1017/S0007114513000184; Jurkic LM, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-2; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luckey SW, 2002, J PHARMACOL EXP THER, V302, P296, DOI 10.1124/jpet.102.033522; Macdonald HM, 2012, BONE, V50, P681, DOI 10.1016/j.bone.2011.11.020; Martin Keith R, 2013, Met Ions Life Sci, V13, P451, DOI 10.1007/978-94-007-7500-8_14; Mittelstadt S. W., 2005, Journal of Pharmacological and Toxicological Methods, V52, P154, DOI 10.1016/j.vascn.2005.04.017; Miyauchi E, 2009, J DAIRY SCI, V92, P2400, DOI 10.3168/jds.2008-1698; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Price CT, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/316783; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Ruan JW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.220; Santos-Lopez JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147469; Shu LM, 2014, KIDNEY INT, V86, P58, DOI 10.1038/ki.2013.520; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Tieroshyn V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62386-0; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; VENABLES CW, 1986, GUT, V27, P233, DOI 10.1136/gut.27.3.233; Vesterlund S, 2006, MICROBIOL-SGM, V152, P1819, DOI 10.1099/mic.0.28522-0; Wang XY, 2018, CARBOHYD POLYM, V186, P100, DOI 10.1016/j.carbpol.2018.01.004; Wu ZX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180717; Xu P, 2016, INT J BIOL MACROMOL, V86, P10, DOI 10.1016/j.ijbiomac.2016.01.036; Yang PJ, 2016, OBES SURG, V26, P1576, DOI 10.1007/s11695-015-1968-0	41	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248508	10.1371/journal.pone.0248508	http://dx.doi.org/10.1371/journal.pone.0248508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788857	gold, Green Published			2022-12-26	WOS:000636354600040
J	Matsuo, S; Nishinaka-Arai, Y; Kazuki, Y; Oshimura, M; Nakahata, T; Niwa, A; Saito, MK				Matsuo, Shiori; Nishinaka-Arai, Yoko; Kazuki, Yasuhiro; Oshimura, Mitsuo; Nakahata, Tatsutoshi; Niwa, Akira; Saito, Megumu K.			Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification	PLOS ONE			English	Article								Children with Down syndrome (DS) are susceptible to two blood disorders, transient abnormal myelopoiesis (TAM) and Down syndrome-associated acute megakaryocytic leukemia (DS-AMKL). Mutations in GATA binding protein 1 (GATA1) have been identified as the cause of these diseases, and the expression levels of the resulting protein, short-form GATA1 (GATA1s), are known to correlate with the severity of TAM. On the other hand, despite the presence of GATA1 mutations in almost all cases of DS-AMKL, the incidence of DS-AMKL in TAM patients is inversely correlated with the expression of GATA1s. This discovery has required the need to clarify the role of GATA1s in generating the cells of origin linked to the risk of both diseases. Focusing on this point, we examined the characteristics of GATA1 mutant trisomy-21 pluripotent stem cells transfected with a doxycycline (Dox)-inducible GATA1s expression cassette in a stepwise hematopoietic differentiation protocol. We found that higher GATA1s expression significantly reduced commitment into the megakaryocytic lineage at the early hematopoietic progenitor cell (HPC) stage, but once committed, the effect was reversed in progenitor cells and acted to maintain the progenitors. These differentiation stage-dependent reversal effects were in contrast to the results of myeloid lineage, where GATA1s simply sustained and increased the number of immature myeloid cells. These results suggest that although GATA1 mutant cells cause the increase in myeloid and megakaryocytic progenitors regardless of the intensity of GATA1s expression, the pathways vary with the expression level. This study provides experimental support for the paradoxical clinical features of GATA1 mutations in the two diseases.	[Matsuo, Shiori; Nishinaka-Arai, Yoko; Niwa, Akira; Saito, Megumu K.] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Nishinaka-Arai, Yoko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Tottori, Japan; [Kazuki, Yasuhiro] Tottori Univ, Sch Life Sci, Div Genome & Cellular Funct, Dept Mol & Cellular Biol,Fac Med, Tottori, Japan; [Nakahata, Tatsutoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat, Drug Discovery Technol Dev Off, Kyoto, Japan	Kyoto University; Kyoto University; Tottori University; Tottori University; Kyoto University	Nishinaka-Arai, Y; Niwa, A; Saito, MK (corresponding author), Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.; Nishinaka-Arai, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan.	yoko@cira.kyoto-u.ac.jp; akiranw@cira.kyoto-u.ac.jp; msaito@cira.kyoto-u.ac.jp			KAKENHI of Ministry of Education, Culture, Sports, Science and Technology of Japan [19K17358, 16K10026]; Japan Agency for Medical Research and Development (AMED) [17935423]; JST CREST of AMED [JPMJCR18S4]; Practical Research for Innovative Cancer Control of AMED [19188198]; Program for Intractable Diseases Research utilizing Disease-specific iPS cells of AMED [17935423]; Program for Intractable Diseases Research utilizing Diseasespecific iPS cells of AMED [17935423]	KAKENHI of Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JST CREST of AMED; Practical Research for Innovative Cancer Control of AMED; Program for Intractable Diseases Research utilizing Disease-specific iPS cells of AMED; Program for Intractable Diseases Research utilizing Diseasespecific iPS cells of AMED	Y.N.A. #KAKENHI(19K17358) of Ministry of Education, Culture, Sports, Science and Technology of Japan #Program for Intractable Diseases Research utilizing Disease-specific iPS cells(17935423) of the Japan Agency for Medical Research and Development (AMED) #JST CREST (JPMJCR18S4) of AMED A.N. #KAKENHI (16K10026) of Ministry of Education, Culture, Sports, Science and Technology of Japan #Practical Research for Innovative Cancer Control (19188198) of AMED T.N. #Program for Intractable Diseases Research utilizing Disease-specific iPS cells(17935423) of AMED M.K.S. #Program for Intractable Diseases Research utilizing Diseasespecific iPS cells(17935423) of AMED.	Ahmed M, 2004, BLOOD, V103, P2480, DOI 10.1182/blood-2003-10-3383; Banno K, 2016, CELL REP, V15, P1228, DOI 10.1016/j.celrep.2016.04.031; Bhatnagar N, 2016, CURR HEMATOL MALIG R, V11, P333, DOI 10.1007/s11899-016-0338-x; Byrska-Bishop M, 2015, J CLIN INVEST, V125, P993, DOI 10.1172/JCI75714; Doulatov S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5645; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gamis AS, 2011, BLOOD, V118, P6752, DOI 10.1182/blood-2011-04-350017; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Honda-Ozaki F, 2018, STEM CELL REP, V10, P1835, DOI 10.1016/j.stemcr.2018.04.004; Kanezaki R, 2010, BLOOD, V116, P4631, DOI 10.1182/blood-2010-05-282426; Karagiannis P, 2019, EXP HEMATOL, V71, P43, DOI 10.1016/j.exphem.2019.01.005; Kazuki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06136; Klusmann JH, 2008, BLOOD, V111, P2991, DOI 10.1182/blood-2007-10-118810; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maroz A, 2014, LEUKEMIA, V28, P1259, DOI 10.1038/leu.2013.373; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Massey GV, 2006, BLOOD, V107, P4606, DOI 10.1182/blood-2005-06-2448; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; Muramatsu H, 2008, BRIT J HAEMATOL, V142, P610, DOI 10.1111/j.1365-2141.2008.07231.x; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishinaka-Arai Y, 2021, HAEMATOLOGICA, V106, P635, DOI 10.3324/haematol.2019.242693; Ohta R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35680; ORKIN SH, 1992, BLOOD, V80, P575; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pine SR, 2007, BLOOD, V110, P2128, DOI 10.1182/blood-2007-01-069542; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Roberts I, 2013, BLOOD, V122, P3908, DOI 10.1182/blood-2013-07-515148; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; Roy A, 2009, BRIT J HAEMATOL, V147, P3, DOI 10.1111/j.1365-2141.2009.07789.x; Shimada A, 2004, BLOOD, V103, P366, DOI 10.1182/blood-2003-09-3219; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Stark B, 2002, BRIT J HAEMATOL, V118, P1082, DOI 10.1046/j.1365-2141.2002.03756.x; Suzuki NM, 2015, STEM CELL TRANSL MED, V4, P333, DOI 10.5966/sctm.2013-0172; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Vyas P, 1999, BLOOD, V93, P2867; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247595	10.1371/journal.pone.0247595	http://dx.doi.org/10.1371/journal.pone.0247595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780474	Green Submitted, Green Published, gold			2022-12-26	WOS:000636336800009
J	Nijman, G; Wientjes, M; Ramjith, J; Janssen, N; Hoogerwerf, J; Abbink, E; Blaauw, M; Dofferhoff, T; van Apeldoorn, M; Veerman, K; de Mast, Q; ten Oever, J; Hoefsloot, W; Reijers, MH; van Crevel, R; van de Maat, JS				Nijman, Gerine; Wientjes, Maike; Ramjith, Jordache; Janssen, Nico; Hoogerwerf, Jacobien; Abbink, Evertine; Blaauw, Marc; Dofferhoff, Ton; van Apeldoorn, Marjan; Veerman, Karin; de Mast, Quirijn; ten Oever, Jaap; Hoefsloot, Wouter; Reijers, Monique H.; van Crevel, Reinout; van de Maat, Josephine S.			Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; CUMULATIVE INCIDENCE; CYTOKINE STORM; ANTICOAGULATION; SARS; MERS	Background To date, survival data on risk factors for COVID-19 mortality in western Europe is limited, and none of the published survival studies have used a competing risk approach. This study aims to identify risk factors for in-hospital mortality in COVID-19 patients in the Netherlands, considering recovery as a competing risk. Methods In this observational multicenter cohort study we included adults with PCR-confirmed SARS-CoV-2 infection that were admitted to one of five hospitals in the Netherlands (March to May 2020). We performed a competing risk survival analysis, presenting cause-specific hazard ratios (HRCS) for the effect of preselected factors on the absolute risk of death and recovery. Results 1,006 patients were included (63.9% male; median age 69 years, IQR: 58-77). Patients were hospitalized for a median duration of 6 days (IQR: 3-13); 243 (24.6%) of them died, 689 (69.9%) recovered, and 74 (7.4%) were censored. Patients with higher age (HRCS 1.10, 95% CI 1.08-1.12), immunocompromised state (HRCS 1.46, 95% CI 1.08-1.98), who used anticoagulants or antiplatelet medication (HRCS 1.38, 95% CI 1.01-1.88), with higher modified early warning score (MEWS) (HRCS 1.09, 95% CI 1.01-1.18), and higher blood LDH at time of admission (HRCS 6.68, 95% CI 1.95-22.8) had increased risk of death, whereas fever (HRCS 0.70, 95% CI 0.52-0.95) decreased risk of death. We found no increased mortality risk in male patients, high BMI or diabetes. Conclusion Our competing risk survival analysis confirms specific risk factors for COVID-19 mortality in a the Netherlands, which can be used for prediction research, more intense in-hospital monitoring or prioritizing particular patients for new treatments or vaccination.	[Nijman, Gerine; Hoogerwerf, Jacobien; Abbink, Evertine; de Mast, Quirijn; ten Oever, Jaap; van Crevel, Reinout; van de Maat, Josephine S.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Nijman, Gerine; Janssen, Nico; Hoogerwerf, Jacobien; de Mast, Quirijn; ten Oever, Jaap; Hoefsloot, Wouter; Reijers, Monique H.; van Crevel, Reinout; van de Maat, Josephine S.] Radboud Univ Nijmegen, Radboud Ctr Infect Dis RCI, Med Ctr, Nijmegen, Netherlands; [Wientjes, Maike] Sint Maartensklin, Dept Res, Nijmegen, Netherlands; [Ramjith, Jordache] Radboud Univ Nijmegen, Sect Biostat, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands; [Janssen, Nico] Radboud Univ Nijmegen, Canisius Wilhelmina Hosp, Ctr Expertise Mycol, Med Ctr, Nijmegen, Netherlands; [Blaauw, Marc] Bernhoven Hosp, Dept Internal Med, Uden, Netherlands; [Dofferhoff, Ton] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [van Apeldoorn, Marjan] Jeroen Bosch Hosp, Dept Internal Med, Den Bosch, Netherlands; [Veerman, Karin] Sint Maartensklin, Dept Internal Med, Nijmegen, Netherlands; [Hoefsloot, Wouter; Reijers, Monique H.] Radboud Univ Nijmegen, Dept Pulm Dis, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Jeroen Bosch Ziekenhuis; Sint Maartens Clinic; Radboud University Nijmegen	van de Maat, JS (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.; van de Maat, JS (corresponding author), Radboud Univ Nijmegen, Radboud Ctr Infect Dis RCI, Med Ctr, Nijmegen, Netherlands.	Josephine.vandemaat@radboudumc.nl	Oever, Jaap ten/P-6617-2015; Ramjith, Jordache/N-7307-2018; Nijman, Gerine/ABC-2301-2021; Ramjith, Jordache/AAB-7339-2019; Veerman, Karin/AHD-3097-2022; Janssen, Nico/R-5973-2017	Oever, Jaap ten/0000-0003-2397-0125; Ramjith, Jordache/0000-0003-4431-7395; Ramjith, Jordache/0000-0003-4431-7395; Veerman, Karin/0000-0002-3175-6316; de Mast, Quirijn/0000-0001-6056-157X; Janssen, Nico/0000-0002-9629-8627				Abdulamir AS, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7850; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364; Bavaro DF, 2020, INT J INFECT DIS, V98, P225, DOI 10.1016/j.ijid.2020.06.066; Chen FY, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.40; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Demler Olga V, 2018, Diagn Progn Res, V2, DOI 10.1186/s41512-018-0034-5; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Erez A, 2014, ISR MED ASSOC J, V16, P439; Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863; Gao Y, 2020, J INFECTION, V81, pE93, DOI 10.1016/j.jinf.2020.05.017; Giacomelli A, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104931; Goel S, 2020, CARDIOL THER, V9, P553, DOI 10.1007/s40119-020-00189-0; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Henry BM, 2020, AM J EMERG MED, V38, P1722, DOI 10.1016/j.ajem.2020.05.073; Hu H, 2020, ACAD EMERG MED, V27, P461, DOI 10.1111/acem.13992; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Lee K, 2009, GLOB INST, P1; Lu L, 2020, J INFECTION, V81, pE18, DOI 10.1016/j.jinf.2020.07.002; Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Minotti C, 2020, J INFECTION, V81, pE61, DOI 10.1016/j.jinf.2020.04.026; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Parohan M, 2020, AGING MALE, V23, P1416, DOI 10.1080/13685538.2020.1774748; Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772; Qin J, 2010, BIOMETRICS, V66, P382, DOI 10.1111/j.1541-0420.2009.01287.x; Salah HM, 2020, AM J CARDIOL, V134, P155, DOI 10.1016/j.amjcard.2020.08.005; Schuster NA, 2020, J CLIN EPIDEMIOL, V122, P42, DOI 10.1016/j.jclinepi.2020.03.004; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Steyerberg EW., 2019, CLIN PREDICTION MODE; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; The Dutch National Institute for Public Health and the Environment (RIVM), 2020, COR MON SEW RES; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wijaya I, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620960797; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Zhu XY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009204	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249231	10.1371/journal.pone.0249231	http://dx.doi.org/10.1371/journal.pone.0249231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770140	Green Published, gold			2022-12-26	WOS:000634833500063
J	Tanigawa, K; Hayashi, Y; Hama, K; Yamashita, A; Yokoyama, K; Luo, YQ; Kawashima, A; Maeda, Y; Nakamura, Y; Harada, A; Kiriya, M; Karasawa, K; Suzuki, K				Tanigawa, Kazunari; Hayashi, Yasuhiro; Hama, Kotaro; Yamashita, Atsushi; Yokoyama, Kazuaki; Luo, Yuqian; Kawashima, Akira; Maeda, Yumi; Nakamura, Yasuhiro; Harada, Ayako; Kiriya, Mitsuo; Karasawa, Ken; Suzuki, Koichi			Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells	PLOS ONE			English	Article								Mycobacterium leprae (M. leprae) is the etiological agent of leprosy, and the skin lesions of lepromatous leprosy are filled with numerous foamy or xanthomatous histiocytes that are parasitized by M. leprae. Lipids are an important nutrient for the intracellular survival of M. leprae. In this study, we attempted to determine the intracellular lipid composition and underlying mechanisms for changes in host cell lipid metabolism induced by M. leprae infection. Using high-performance thin-layer chromatography (HPTLC), we demonstrated specific induction of triacylglycerol (TAG) production in human macrophage THP-1 cells following M. leprae infection. We then used [C-14] stearic acid tracing to show incorporation of this newly synthesized host cell TAG into M. leprae. In parallel with TAG accumulation, expression of host glycerol-3-phosphate acyltransferase 3 (GPAT3), a key enzyme in de novo TAG synthesis, was significantly increased in M. leprae-infected cells. CRISPR/Cas9 genome editing of GPAT3 in THP-1 cells (GPAT3 KO) dramatically reduced accumulation of TAG following M. leprae infection, intracellular mycobacterial load, and bacteria viability. These results together suggest that M. leprae induces host GPAT3 expression to facilitate TAG accumulation within macrophages to maintain a suitable environment that is crucial for intracellular survival of these bacilli.	[Tanigawa, Kazunari; Nakamura, Yasuhiro; Harada, Ayako; Karasawa, Ken] Teikyo Univ, Fac Pharma Sci, Dept Mol Pharmaceut, Itabashi Ku, Tokyo, Japan; [Hayashi, Yasuhiro; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Dept Biol Chem, Itabashi Ku, Tokyo, Japan; [Hama, Kotaro; Yokoyama, Kazuaki] Teikyo Univ, Fac Pharma Sci, Dept Phys Pharmaceut, Itabashi Ku, Tokyo, Japan; [Luo, Yuqian; Kawashima, Akira; Kiriya, Mitsuo; Suzuki, Koichi] Teikyo Univ, Fac Med Technol, Dept Clin Lab Sci, Itabashi Ku, Tokyo, Japan; [Maeda, Yumi; Suzuki, Koichi] Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Higashimurayama, Tokyo, Japan	Teikyo University; Teikyo University; Teikyo University; Teikyo University; National Institute of Infectious Diseases (NIID)	Suzuki, K (corresponding author), Teikyo Univ, Fac Med Technol, Dept Clin Lab Sci, Itabashi Ku, Tokyo, Japan.; Suzuki, K (corresponding author), Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Higashimurayama, Tokyo, Japan.	koichis0923@med.teikyo-u.ac.jp		Yamashita, Atsushi/0000-0002-2544-2134; Nakamura, Yasuhiro/0000-0003-2167-9182	AMED [JP17fk0108303, JP20fk0108064]; MEXT KAKENHI [15K190097, 18K15150]; Sasakawa Scientific Research Grant [26-428]	AMED; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant	This work was supported by AMED under Grant Numbers JP17fk0108303 (to K.S.) and JP20fk0108064 (to K.S.), MEXT KAKENHI Grant Numbers 15K190097 (to K.T.) and 18K15150 (to K.T.), and Sasakawa Scientific Research Grant Number 26-428 (to K.T.).	Medeiros RCA, 2016, J BIOL CHEM, V291, P21375, DOI 10.1074/jbc.M116.725283; Akama T, 2010, MICROB PATHOGENESIS, V49, P181, DOI 10.1016/j.micpath.2010.05.010; Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; [Anonymous], 2019, Weekly Epidemiological Record, V94, P389; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Birsoy K, 2013, J CELL SCI, V126, P1541, DOI 10.1242/jcs.104992; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; CHATTERJEE KR, 1959, EXP CELL RES, V18, P521, DOI 10.1016/0014-4827(59)90317-9; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Degang Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001936; Acosta CCD, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007151; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Gorga A, 2017, CELL TISSUE RES, V369, P611, DOI 10.1007/s00441-017-2615-y; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Lee MJ, 2019, J LIPID RES, V60, P856, DOI [10.1194/jlr.M091173, 10.1194/jlr.m091173]; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Luo YQ, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008850; Luo YQ, 2016, THYROID, V26, P1630, DOI 10.1089/thy.2016.0187; Marques MAM, 2015, J BACTERIOL, V197, P3698, DOI 10.1128/JB.00625-15; Matsuoka M, 2010, LEPROSY REV, V81, P137; Mattos KA, 2014, CELL MICROBIOL, V16, P797, DOI 10.1111/cmi.12279; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nakamura K, 2009, MICROB PATHOGENESIS, V47, P183, DOI 10.1016/j.micpath.2009.06.006; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Quiroga IY, 2019, BIOCHEM J, V476, P85, DOI 10.1042/BCJ20180381; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Sugita Y, 1996, ARCH DERMATOL, V132, P1397, DOI 10.1001/archderm.132.11.1397; Suzuki K, 1998, MOL CELL BIOL, V18, P7410, DOI 10.1128/MCB.18.12.7410; Suzuki K, 2002, CLIN EXP IMMUNOL, V127, P234, DOI 10.1046/j.1365-2249.2002.01767.x; Suzuki K, 2006, ACTA HISTOCHEM CYTOC, V39, P107, DOI 10.1267/ahc.06010; Suzuki K, 2006, FEMS MICROBIOL LETT, V259, P208, DOI 10.1111/j.1574-6968.2006.00276.x; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; Tanigawa K, 2008, FEMS MICROBIOL LETT, V289, P72, DOI 10.1111/j.1574-6968.2008.01369.x; Tanigawa K, 2012, MICROB PATHOGENESIS, V52, P285, DOI 10.1016/j.micpath.2012.02.003; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wang H, 2017, BBA-MOL CELL BIOL L, V1862, P1131, DOI 10.1016/j.bbalip.2017.06.010; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; WEISS SB, 1956, NATURE, V178, P594, DOI 10.1038/178594a0; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071	45	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249184	10.1371/journal.pone.0249184	http://dx.doi.org/10.1371/journal.pone.0249184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770127	gold, Green Published			2022-12-26	WOS:000634833500051
J	Basu, R; Nahar, K; Kulkarni, P; Kerekes, O; Sattler, M; Hall, Z; Neggers, S; Holub, JM; Kopchick, JJ				Basu, Reetobrata; Nahar, Khairun; Kulkarni, Prateek; Kerekes, Olivia; Sattler, Maya; Hall, Zachary; Neggers, Sebastian; Holub, Justin M.; Kopchick, John J.			A novel peptide antagonist of the human growth hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DOMAIN; HGH RECEPTOR; ALPHA-HELIX; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; 22-KDA HGH; IN-VITRO; GENE; BINDING; MOUSE	Excess circulating human growth hormone (hGH) in vivo is linked to metabolic and growth disorders such as cancer, diabetes, and acromegaly. Consequently, there is considerable interest in developing antagonists of hGH action. Here, we present the design, synthesis, and characterization of a 16-residue peptide (site 1-binding helix [S1H]) that inhibits hGH-mediated STAT5 phosphorylation in cultured cells. S1H was designed as a direct sequence mimetic of the site 1 minihelix (residues 36-51) of wild-type hGH and acts by inhibiting the interaction of hGH with the human growth hormone receptor (hGHR). In vitro studies indicated that S1H is stable in human serum and can adopt an alpha-helix in solution. Our results also show that S1H mitigates phosphorylation of STAT5 in cells co-treated with hGH, reducing intracellular STAT5 phosphorylation levels to those observed in untreated controls. Furthermore, S1H was found to attenuate the activity of the hGHR and the human prolactin receptor, suggesting that this peptide acts as an antagonist of both lactogenic and somatotrophic hGH actions. Finally, we used alanine scanning to determine how discrete amino acids within the S1H sequence contribute to its structural organization and biological activity. We observed a strong correlation between helical propensity and inhibitory effect, indicating that S1H-mediated antagonism of the hGHR is largely dependent on the ability for S1H to adopt an a-helix. Taken together, these results show that S1H not only acts as a novel peptide-based antagonist of the hGHR but can also be applied as a chemical tool to study the molecular nature of hGH-hGHR interactions.	[Basu, Reetobrata; Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Basu, Reetobrata; Kulkarni, Prateek; Holub, Justin M.; Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [Nahar, Khairun; Kerekes, Olivia; Sattler, Maya; Hall, Zachary; Holub, Justin M.] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Kulkarni, Prateek; Holub, Justin M.; Kopchick, John J.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Sattler, Maya] Ohio Univ, Honors Tutorial Coll, Athens, OH 45701 USA; [Neggers, Sebastian] Erasmus MC, Dept Med, Endocrinol Sect, Rotterdam, Netherlands	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Erasmus University Rotterdam; Erasmus MC	Kopchick, JJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Holub, JM; Kopchick, JJ (corresponding author), Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.; Holub, JM (corresponding author), Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA.; Holub, JM; Kopchick, JJ (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.	holub@ohio.edu; kopchick@ohio.edu	Holub, Justin M/G-6537-2015; Basu, Reetobrata/I-8828-2019	Basu, Reetobrata/0000-0001-8415-1356; Hall, Zachary/0000-0001-6463-8570	State of Ohio's Eminent Scholar Program; Edison Biotechnology Institute at Ohio University, Athens, OH; Department of Chemistry and Biochemistry	State of Ohio's Eminent Scholar Program; Edison Biotechnology Institute at Ohio University, Athens, OH; Department of Chemistry and Biochemistry	This work was supported in part by the State of Ohio's Eminent Scholar Program to J. J. K. that includes a gift from Milton and Lawrence Goll and by the Edison Biotechnology Institute at Ohio University, Athens, OH. J. M. H. was supported by the Department of Chemistry and Biochemistry and the Edison Biotechnology Institute at Ohio University, Athens, OH.	ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; ALBERT JS, 1995, BIOCHEMISTRY-US, V34, P984, DOI 10.1021/bi00003a033; Arachchige D, 2017, J PEPT SCI, V23, P367, DOI 10.1002/psc.2999; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Basu R, 2018, EUR J ENDOCRINOL, V178, pR155, DOI 10.1530/EJE-18-0018; Basu R, 2017, ONCOTARGET, V8, P21579, DOI 10.18632/oncotarget.15375; Berryman DE, 2006, ENDOCRINOLOGY, V147, P2801, DOI 10.1210/en.2006-0086; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Boatman PD, 1999, J MED CHEM, V42, P1367, DOI 10.1021/jm980354p; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; BREMS DN, 1988, P NATL ACAD SCI USA, V85, P3367, DOI 10.1073/pnas.85.10.3367; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carter-Su Christin, 1996, Endocrine Journal, V43, pS65, DOI 10.1507/endocrj.43.Suppl_S65; Carter-Su C, 2016, GROWTH HORM IGF RES, V28, P11, DOI 10.1016/j.ghir.2015.09.002; CHEN WY, 1994, J BIOL CHEM, V269, P15892; CHEN WY, 1991, J BIOL CHEM, V266, P2252; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; CHEN WY, 1990, P NATL ACAD SCI USA, V87, P5061, DOI 10.1073/pnas.87.13.5061; CHEN WY, 1991, ENDOCRINOLOGY, V129, P1402, DOI 10.1210/endo-129-3-1402; Chesnokova V, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125762; Chien CH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2898-5; Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6; COOKE NE, 1988, J CLIN INVEST, V82, P270, DOI 10.1172/JCI113582; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579; Feldt-Rasmussen U., 2000, ADULT GROWTH HORMONE; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Frank SJ, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110999; Freda PU, 2015, ENDOCR PRACT, V21, P264, DOI 10.4158/EP14330.OR; Gadelha MR, 2019, ENDOCR REV, V40, P268, DOI 10.1210/er.2018-00115; Garner J, 2007, ORG BIOMOL CHEM, V5, P3577, DOI 10.1039/b710425a; Gesing A, 2017, J GERONTOL A-BIOL, V72, P1054, DOI 10.1093/gerona/glw193; Gross A, 2016, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00211; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Harvey S, 2000, CAN J PHYSIOL PHARM, V78, P1013, DOI 10.1139/cjpp-78-12-1013; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Healy ML, 2003, J CLIN ENDOCR METAB, V88, P5221, DOI 10.1210/jc.2002-021872; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holub JM, 2017, DRUG DEVELOP RES, V78, P268, DOI 10.1002/ddr.21408; HOUSSAY BA, 1953, ENDOCRINOLOGY, V53, P114, DOI 10.1210/endo-53-1-114; HSIEH KUANG-MEI, 1952, ENDOCRINOLOGY, V51, P298; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Jochim AL, 2009, MOL BIOSYST, V5, P924, DOI 10.1039/b903202a; Johnstone SA, 2001, BBA-BIOMEMBRANES, V1513, P25, DOI 10.1016/S0005-2736(01)00292-9; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kooijman R, 1997, ENDOCRINOLOGY, V138, P3949, DOI 10.1210/en.138.9.3949; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Kopchick JJ, 2014, MOL CELL ENDOCRINOL, V386, P34, DOI 10.1016/j.mce.2013.09.004; Kossiakoff AA, 2004, ADV PROTEIN CHEM, V68, P147; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Laron Z, 2011, LARON SYNDROME - FROM MAN TO MOUSE: LESSONS FROM CLINICAL AND EXPERIEMENTAL EXPERIENCE, P1, DOI 10.1007/978-3-642-11183-9; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Laron Z, 2015, ENDOCR PRACT, V21, P1395, DOI 10.4158/EP15939.RA; List EO, 2020, MOL CELL ENDOCRINOL, V515, DOI 10.1016/j.mce.2020.110919; List EO, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa097; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003; Lu M, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0036-y; Mabonga Lloyd, 2019, Biophys Rev, V11, P559, DOI 10.1007/s12551-019-00570-x; Madsen M, 2014, CLIN ENDOCRINOL, V80, P92, DOI 10.1111/cen.12239; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Miles JA, 2016, CHEM SCI, V7, P3694, DOI 10.1039/c5sc04048e; MILLER WL, 1980, J BIOL CHEM, V255, P7521; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Moon H, 2015, CURR OPIN CHEM BIOL, V24, P38, DOI 10.1016/j.cbpa.2014.10.023; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; Palasek SA, 2007, J PEPT SCI, V13, P143, DOI 10.1002/psc.804; Parkinson C, 2003, ADV DRUG DELIVER REV, V55, P1303, DOI 10.1016/S0169-409X(03)00111-X; Peterson FC, 2004, PROTEIN ENG DES SEL, V17, P417, DOI 10.1093/protein/gzh051; Pradhananga S, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290011; Puche JE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-224; RABINOWI.D, 1965, J CLIN INVEST, V44, P51, DOI 10.1172/JCI105126; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Ranke MB, 2018, NAT REV ENDOCRINOL, V14, P285, DOI 10.1038/nrendo.2018.22; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Roy S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040118; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; Tsunekawa B, 1999, ENDOCRINOLOGY, V140, P3909, DOI 10.1210/en.140.9.3909; Uchida H, 1999, J MOL ENDOCRINOL, V23, P347, DOI 10.1677/jme.0.0230347; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Verhoef JJF, 2013, DRUG DELIV TRANSL RE, V3, P499, DOI 10.1007/s13346-013-0176-5; Wada M, 1997, MOL CELL ENDOCRINOL, V133, P99, DOI 10.1016/S0303-7207(97)00151-2; Wada M, 1998, MOL ENDOCRINOL, V12, P146, DOI 10.1210/mend.12.1.0054; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Wang XZ, 1996, MOL ENDOCRINOL, V10, P1249, DOI 10.1210/me.10.10.1249; Waters MJ, 2011, HORM RES PAEDIAT, V76, P12, DOI 10.1159/000329138; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Wingfield Paul T, 2015, Curr Protoc Protein Sci, V80, DOI 10.1002/0471140864.ps0601s80; Yi JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134427; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	111	2	2	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100588	10.1016/j.jbc.2021.100588	http://dx.doi.org/10.1016/j.jbc.2021.100588			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774052	gold, Green Published			2022-12-26	WOS:000672866400560
J	Pridham, G; Hossain, S; Rawji, KS; Zhang, YY				Pridham, Glen; Hossain, Shahnewaz; Rawji, Khalil S.; Zhang, Yunyan			A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; MOUSE MODEL; CLASSIFICATION; REMYELINATION; SEGMENTATION; DENSITY; IMAGES	Myelin plays a critical role in the pathogenesis of neurological disorders but is difficult to characterize in vivo using standard analysis methods. Our goal was to develop a novel analytical framework for estimating myelin content using T2-weighted magnetic resonance imaging (MRI) based on a de- and re-myelination model of multiple sclerosis. We examined 18 mice with lysolecithin induced demyelination and spontaneous remyelination in the ventral white matter of thoracic spinal cord. Cohorts of 6 mice underwent 9.4T MRI at days 7 (peak demyelination), 14 (ongoing recovery), and 28 (near complete recovery), as well as histological analysis of myelin and the associated cellularity at corresponding timepoints. Our MRI framework took an unsupervised learning approach, including tissue segmentation using a Gaussian Markov random field (GMRF), and myelin and cellularity feature estimation based on the Mahalanobis distance. For comparison, we also investigated 2 regression-based supervised learning approaches, one using our GMRF results, and another using a freely available generalized additive model (GAM). Results showed that GMRF segmentation was 73.2% accurate, and our unsupervised learning method achieved a correlation coefficient of 0.67 (top quartile: 0.78) with histological myelin, similar to 0.70 (top quartile: 0.78) obtained using supervised analyses. Further, the area under the receiver operator characteristic curve of our unsupervised myelin feature (0.883, 95% CI: 0.874-0.891) was significantly better than any of the supervised models in detecting white matter myelin as compared to histology. Collectively, metric learning using standard MRI may prove to be a new alternative method for estimating myelin content, which ultimately can improve our disease monitoring ability in a clinical setting.	[Pridham, Glen; Rawji, Khalil S.; Zhang, Yunyan] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Pridham, Glen; Zhang, Yunyan] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Hossain, Shahnewaz] Univ Calgary, Dept Med Sci, Calgary, AB, Canada; [Zhang, Yunyan] Univ Calgary, Dept Radiol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Zhang, YY (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.; Zhang, YY (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Zhang, YY (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.	yunyzhan@ucalgary.ca			Multiple Sclerosis Society of Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Hotchkiss Brain Institute Multiple Sclerosis Brain and Mental Health Team of the University of Calgary	Multiple Sclerosis Society of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hotchkiss Brain Institute Multiple Sclerosis Brain and Mental Health Team of the University of Calgary	YZ received the funding support from the Multiple Sclerosis Society of Canada, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, and the Hotchkiss Brain Institute Multiple Sclerosis Brain and Mental Health Team of the University of Calgary; KSR received Fellowship Award from the Multiple Sclerosis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold D, 2009, MS LESION SEGMENTATI; Aung Wint Yan, 2013, Imaging Med, V5, P427; Avants BB, 2019, ANTSR ANTS R QUANTIF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Begin S, 2013, BIOMED OPT EXPRESS, V4, P2003, DOI 10.1364/BOE.4.002003; Bellet A., 2013, ARXIV; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BESAG J, 1986, J R STAT SOC B, V48, P259; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; CHELLAPPA R, 1985, IEEE T ACOUST SPEECH, V33, P959, DOI 10.1109/TASSP.1985.1164641; Clayden J, 2017, RNIFTYREG IMAGE REGI; Fasiolo M, 2017, FAST CALIBRATED ADDI; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Friedman J., 2021, LASSO ELASTIC NET RE; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2nd ed; Hagiwara A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28852-6; Hauberg S, 2012, P C WORKSH NEUR INF, P2024; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; James G., 2013, INTRO STAT LEARNING, DOI [10.1007/978-1-4614-7138-7, DOI 10.1007/978-1-4614-7138-7]; JEFFERY ND, 1995, J NEUROCYTOL, V24, P775, DOI 10.1007/BF01191213; Kamalpour-Ansari M., 2014, THESIS U CALGARY CAL; Kardar M., 2007, STAT PHYS FIELDS; Keough MB, 2015, JOVE-J VIS EXP, DOI 10.3791/52679; Kiernan J., 2008, HISTOLOGICAL HISTOCH, V4th ed; Klawiter Eric C, 2013, Continuum (Minneap Minn), V19, P1058, DOI 10.1212/01.CON.0000433283.00221.37; Koenker R., 2019, R PACKAGE VERSION 55; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Levitt M., 2008, SPIN DYNAMICS BASICS, V2nd ed; Llado X, 2012, INFORM SCIENCES, V186, P164, DOI 10.1016/j.ins.2011.10.011; Luo T, 2019, J MAGN RESON IMAGING, V49, P1750, DOI 10.1002/jmri.26328; MacKay AL, 2009, NEUROIMAG CLIN N AM, V19, P1, DOI 10.1016/j.nic.2008.09.007; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Paget R, 1998, IEEE T IMAGE PROCESS, V7, P925, DOI 10.1109/83.679446; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; RCore Team, 2020, R LANG ENV STAT COMP; Robert C, 1999, MONTE CARLO STAT MET; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruan S, 2000, IEEE T MED IMAGING, V19, P1179, DOI 10.1109/42.897810; RUE H., 2005, GAUSSIAN MARKOV RAND; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scrucca L, 2016, R J, V8, P289; Stankiewicz JM, 2014, NEUROBIOL AGING, V35, pS51, DOI 10.1016/j.neurobiolaging.2014.03.039; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yu O, 2004, MAGN RESON IMAGING, V22, P1139, DOI 10.1016/j.mri.2004.08.017; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	51	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249460	10.1371/journal.pone.0249460	http://dx.doi.org/10.1371/journal.pone.0249460			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819278	Green Published, gold			2022-12-26	WOS:000637647200029
J	Yang, JL; Zhou, L; Liu, HW				Yang, Jianglong; Zhou, Li; Liu, Huwei			Hybrid genetic algorithm-based optimisation of the batch order picking in a dense mobile rack warehouse	PLOS ONE			English	Article								The utilization of a storage space can be considerably improved by using dense mobile racks. However, it is necessary to perform an optimisation study on the order picking to reduce the time cost as much as possible. According to the channel location information that needs to be sorted, the multiple orders are divided into different batches by using hierarchical clustering. On this basis, a mathematical model for the virtual order clusters formed in the batches is established to optimize the order cluster picking and rack position movement, with the minimum picking time as the objective. For this model, a hybrid genetic algorithm is designed, and the characteristics of the different examples and solution algorithms are further analysed to provide a reference for the solution of the order picking optimisation problem in a dense mobile rack warehouse.	[Yang, Jianglong; Liu, Huwei] Capital Univ Econ & Business, Sch Management Engn, Beijing, Peoples R China; [Zhou, Li] Beijing Wuzi Univ, Sch Informat, Beijing, Peoples R China	Capital University of Economics & Business; Beijing Wuzi University	Liu, HW (corresponding author), Capital Univ Econ & Business, Sch Management Engn, Beijing, Peoples R China.	darion8@163.com		Liu, Huwei/0000-0003-1647-6233	key project of Beijing Social Science Foundation "Strategic research on improving the service quality of capital logistics based on big data technology" [18GLA009]; National Nature Science Foundation of China "Research on the warehouse picking system blocking influence factors and combined control strategy" [71501015]; Beijing the Great Wall scholars' program [CIT TCD20170317]; Beijing Tongzhou canal plan "leading talent plan", Beijing Intelligent Logistics System Collaborative Innovation Center open topic [BILSCIC-2019KF-03]; Graduate Science and Technology Innovation Project of Capital University of Economics and Business	key project of Beijing Social Science Foundation "Strategic research on improving the service quality of capital logistics based on big data technology"; National Nature Science Foundation of China "Research on the warehouse picking system blocking influence factors and combined control strategy"; Beijing the Great Wall scholars' program; Beijing Tongzhou canal plan "leading talent plan", Beijing Intelligent Logistics System Collaborative Innovation Center open topic; Graduate Science and Technology Innovation Project of Capital University of Economics and Business	The study is supported by the key project of Beijing Social Science Foundation "Strategic research on improving the service quality of capital logistics based on big data technology" (18GLA009), the National Nature Science Foundation of China "Research on the warehouse picking system blocking influence factors and combined control strategy" (No. 71501015), Beijing the Great Wall scholars' program (No. CIT & TCD20170317), Beijing Tongzhou canal plan "leading talent plan", Beijing Intelligent Logistics System Collaborative Innovation Center open topic (No. BILSCIC-2019KF-03), and funded by the Graduate Science and Technology Innovation Project of Capital University of Economics and Business.	Bo Q, 2012, OPTIMIZATION PICKING; Boysen N, 2017, EUR J OPER RES, V259, P293, DOI 10.1016/j.ejor.2016.09.046; Eng M., 2017, U.S. Patent Application, Patent No. [15/787,597, 15787597]; Imahori S, 2016, J ADV MECH DES SYST, V10, DOI 10.1299/jamdsm.2016jamdsm0039; Kota VR, 2015, J MANUF TECHNOL MANA, V26, P582, DOI 10.1108/JMTM-08-2013-0109; Li L, 2017, U.S. Patent Application, Patent No. [15/499,107, 15499107]; Liu Q, 2013, RES INTEGRATION CARG; Meng C, 2014, ACTIVE DENSE AUTOMAT; Mirzaei M, 2017, INT J PROD RES, V55, P6423, DOI 10.1080/00207543.2017.1304660; Nastasi G, 2018, J INTELL MANUF, V29, P1545, DOI 10.1007/s10845-016-1198-x; Reilly PJ, 2017, INT J PROD RES, V55, P5435, DOI 10.1080/00207543.2017.1319582; Tang JJ, 2018, PHYSICA A, V512, P745, DOI 10.1016/j.physa.2018.08.017; Tang Junqing, 2020, IEEE T INTELL TRANSP, P1; Wang Y, 2020, TRANSPORT RES E-LOG, V143, DOI 10.1016/j.tre.2020.102118; Wang Y, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120590; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Yu YG, 2009, IIE TRANS, V41, P194, DOI 10.1080/07408170802375778; Zaerpour N, 2017, IISE TRANS, V49, P653, DOI 10.1080/24725854.2016.1273564; Zaerpour N, 2017, IISE TRANS, V49, P461, DOI 10.1080/24725854.2016.1273563; Zhao N, 2018, COMPUT IND ENG, V124, P48, DOI 10.1016/j.cie.2018.07.007; Zhou M., 1999, GENETIC ALGORITHMS T	21	0	0	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249543	10.1371/journal.pone.0249543	http://dx.doi.org/10.1371/journal.pone.0249543			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819281	Green Published, gold			2022-12-26	WOS:000637647200013
J	Hur, J; Schulze, KJ; Thorne-Lyman, AL; Wu, LSF; Shaikh, S; Ali, H; Labrique, AB; West, KP				Hur, Jinhee; Schulze, Kerry J.; Thorne-Lyman, Andrew L.; Wu, Lee S-F; Shaikh, Saijuddin; Ali, Hasmot; Labrique, Alain B.; West, Keith P., Jr.			Characterization of pubertal development of girls in rural Bangladesh	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; AGE-OF-ONSET; NUTRITIONAL-STATUS; INFANT-MORTALITY; VITAMIN-A; MENARCHE; PREGNANCY; GROWTH; MARRIAGE; CHILDREN	This study aimed to describe the timing and patterns of pubertal maturation of girls living in rural Bangladesh. Starting in September 2015, a total of 15,320 girls from a birth cohort, aged 9 to 15 years at initial encounter, were visited twice at about a one year interval, typically in their birth month. Participants were asked to self-report extent of pubertal maturation, including breast development, pubic hair growth and age at menarche, if applicable. Pubertal stage (abbreviated as B2 and B3-4 for breast development and PH2 and PH3-4 for pubic hair growth) was assigned. Data from both visits were pooled, yielding a total of 29,377 age-related observations per pubertal characteristic. Probit regression models were used to estimate distributions of age at which each stage of pubertal development was attained. Before age 8, <3% of the study population initiated pubertal maturation as indicated by onset of breast development (B2). The median (95% confidence interval) age of B2 and B3-4 was 11.02 (11.00-11.04) and 12.82 (12.80-12.83) years, respectively; and 12.93 (12.91-12.94) and 14.29 (14.27-14.31) years for the onset (PH2) and advanced stage (PH3-4) of pubic hair growth, respectively. Median age at menarche was 13.17 (13.15-13.19) years, with 2.15 years of timespan from B2 to menarche. Girls in rural Bangladesh progressed through puberty following a well-documented sequence of sexual maturation stages. The age at which each pubertal milestone took place was somewhat later, but the tempo from breast development to menarche was comparable to that observed elsewhere. Our findings present a current norm of pubertal maturation in a typical, rural adolescent population in South Asia, which could help inform future studies and interventions to preserve or improve early adolescent health and development.	[Hur, Jinhee; Schulze, Kerry J.; Thorne-Lyman, Andrew L.; Wu, Lee S-F; Labrique, Alain B.; West, Keith P., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; [Shaikh, Saijuddin; Ali, Hasmot] JiVitA Project, Gaibandha, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	West, KP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	kwest1@jhu.edu		Hur, Jinhee/0000-0003-0968-208X; West, Jr., Keith/0000-0001-9458-362X; Labrique, Alain/0000-0003-2502-7819; Ali, Hasmot/0000-0003-0044-1992	Bill & Melinda Gates Foundation, Seattle, WA [OPP614, OPP1141435]; Sight and Life Global Nutrition Research Institute, Baltimore, MD	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); Sight and Life Global Nutrition Research Institute, Baltimore, MD	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA (grant numbers OPP614 and OPP1141435 to KPW; www.gatesfoundation.org) and the Sight and Life Global Nutrition Research Institute, Baltimore, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D K, 1992, Indian Pediatr, V29, P1203; Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; Biro FM, 2013, PEDIATRICS, V132, P1019, DOI 10.1542/peds.2012-3773; Bishwajit Ghose, 2015, F1000Res, V4, P8, DOI 10.12688/f1000research.5732.2; Campisi SC, 2020, J PEDIATR ENDOCR MET, V33, P1191, DOI 10.1515/jpem-2020-0246; Campisi SC, 2020, ACTA PAEDIATR, V109, P1019, DOI 10.1111/apa.15053; Chan NPT, 2010, MATERN CHILD HLTH J, V14, P466, DOI 10.1007/s10995-009-0481-2; CHOWDHURY AKMA, 1977, SOC BIOL, V24, P316, DOI 10.1080/19485565.1977.9988302; Chowdhury S, 2000, ANN HUM BIOL, V27, P249, DOI 10.1080/030144600282136; Christian P, 2015, INT J EPIDEMIOL, V44, P1862, DOI 10.1093/ije/dyv155; Dasgupta P, 2015, PHYS GROWTH BODY COM; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Eckert-Lind C, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2019.5881; Field E, 2008, J POLIT ECON, V116, P881, DOI 10.1086/593333; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gunnsteinsson S, 2010, J HEALTH POPUL NUTR, V28, P509; Gupta Neeru, 2007, J Indian Med Assoc, V105, P119; Hastuti J., 2017, PAK J NUTR, V16, P351; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Huen KF, 1997, ACTA PAEDIATR, V86, P1121, DOI 10.1111/j.1651-2227.1997.tb14820.x; Ibitoye M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178884; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kashani HH, 2009, WORLD J PEDIATR, V5, P132, DOI 10.1007/s12519-009-0026-1; Khadgawat R, 2016, INDIAN PEDIATR, V53, P383, DOI 10.1007/s13312-016-0857-5; Klemm RDW, 2015, MATERN CHILD NUTR, V11, P583, DOI 10.1111/mcn.12041; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Koopman-Verhoeff ME, 2020, J ADOLESCENT HEALTH, V66, P597, DOI 10.1016/j.jadohealth.2019.11.308; Labrique AB, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-102; Llop-Vinolas D, 2004, ACTA PAEDIATR, V93, P874, DOI 10.1111/j.1651-2227.2004.tb02683.x; Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638; Mahachoklertwattana Pat, 2002, Journal of the Medical Association of Thailand, V85, pS1127; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MartiHenneberg C, 1997, J PEDIATR-US, V131, P618, DOI 10.1016/S0022-3476(97)70073-8; Miller EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112216; Moodie JL, 2020, ADV NUTR, V11, P951, DOI 10.1093/advances/nmaa007; Na MZ, 2020, BRIT J NUTR, V123, P1415, DOI 10.1017/S0007114520000707; Na MZ, 2016, J NUTR, V146, P2109, DOI 10.3945/jn.116.234229; Opare-Addo PM, 2012, J OBSTET GYNAECOL, V32, P159, DOI 10.3109/01443615.2011.638092; Parent AS, 2015, FRONT NEUROENDOCRIN, V38, P12, DOI 10.1016/j.yfrne.2014.12.004; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pompeia S, 2019, REV SAUDE PUBL, V53, DOI 10.11606/s1518-8787.2019053000915; QAMRA S R, 1991, Indian Pediatrics, V28, P147; Rabbani A, 2008, J PEDIATR ENDOCR MET, V21, P681; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rah JH, 2009, J HEALTH POPUL NUTR, V27, P802; Rao S, 1998, Indian Pediatr, V35, P619; Sayem AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-16; Shahabuddin ASM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157664; Svefors P, 2020, ACTA PAEDIATR, V109, P122, DOI 10.1111/apa.14929; TANNER J. M., 1962, Growth at adolescence. With a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity.; Thorne-Lyman AL, 2020, ANN NY ACAD SCI, V1468, P3, DOI 10.1111/nyas.14207; United Nations Fund for Population Activities, 2012, MARR TOO YOUNG END; West KP, 2014, JAMA-J AM MED ASSOC, V312, P2649, DOI 10.1001/jama.2014.16819; West KP, 2011, JAMA-J AM MED ASSOC, V305, P1986, DOI 10.1001/jama.2011.656; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0247762	10.1371/journal.pone.0247762	http://dx.doi.org/10.1371/journal.pone.0247762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798230	gold, Green Published			2022-12-26	WOS:000636737700040
J	Jenkins, M; Hoek, J; Jenkin, G; Gendall, P; Stanley, J; Beaglehole, B; Bell, C; Rapsey, C; Every-Palmer, S				Jenkins, Matthew; Hoek, Janet; Jenkin, Gabrielle; Gendall, Philip; Stanley, James; Beaglehole, Ben; Bell, Caroline; Rapsey, Charlene; Every-Palmer, Susanna			Silver linings of the COVID-19 lockdown in New Zealand	PLOS ONE			English	Article							POSTTRAUMATIC GROWTH; SOCIAL COHESION; DISASTER; RESILIENCE; MOTIVATION; EARTHQUAKE; OLDER	The COVID-19 pandemic has caused significant disruption, distress, and loss of life around the world. While negative health, economic, and social consequences are being extensively studied, there has been less research on the resilience and post-traumatic growth that people show in the face of adversity. We investigated New Zealanders' experiences of benefit-finding during the COVID-19 pandemic and analysed qualitative responses to a survey examining mental well-being during the New Zealand lockdown. A total of 1175 of 2010 eligible participants responded to an open-ended question probing 'silver linings' (i.e., positive aspects) they may have experienced during this period. We analysed these qualitative responses using a thematic analysis approach. Two thirds of participants identified silver linings from the lockdown and we developed two overarching themes: Surviving (coping well, meeting basic needs, and maintaining health) and thriving (self-development, reflection, and growth). Assessing positive as well as negative consequences of the pandemic provides more nuanced insights into the impact that New Zealand's response had on mental well-being.	[Jenkins, Matthew; Jenkin, Gabrielle; Every-Palmer, Susanna] Univ Otago, Dept Psychol Med, Wellington, New Zealand; [Hoek, Janet; Gendall, Philip; Stanley, James] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Beaglehole, Ben; Bell, Caroline] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Rapsey, Charlene] Univ Otago, Dept Psychol Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Jenkins, M (corresponding author), Univ Otago, Dept Psychol Med, Wellington, New Zealand.	matthew.jenkins@otago.ac.nz		Every-Palmer, Susanna/0000-0001-6455-9741; Jenkins, Matthew/0000-0002-3958-3739	Dynata	Dynata	We would like to acknowledge and thank Dynata for their support of this research. Thank you to the NZ Ministry of Health, Ministry of Justice, Department of Statistics, and to Anaru Waa, Emma Sutich, Marcellus Paki, Fiona Mathieson, Giles Newton-Howes, and Elliot Bell for expert advice on survey content and design.	[Anonymous], LEVEL 2 ANNOUNCEMENT; [Anonymous], COVID TIM TRUST LEAD; [Anonymous], NZ OV; [Anonymous], 2020, SURVIVING; Arslan G., 2020, J POS SCHOOL PSY, V5, P1; August R., 2020, TRANSPORT EXPERT HAI; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cherry KE, 2015, AGING MENT HEALTH, V19, P430, DOI 10.1080/13607863.2014.941325; Cloninger C Robert, 2012, Int J Pers Cent Med, V2, P179; Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Delhey J, 2016, INT J PSYCHOL, V51, P163, DOI 10.1002/ijop.12149; Every-Palmer S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241658; Felix E, 2015, AM J ORTHOPSYCHIAT, V85, P191, DOI 10.1037/ort0000054; Folkman S, 2007, SCOPE OF SOCIAL PSYCHOLOGY: THEORY AND APPLICATIONS, P193; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Fouda A, 2020, HEALTH POLICY TECHN, V9, P510, DOI 10.1016/j.hlpt.2020.08.015; Gallagher S, 2020, APPL PSYCHOL-HLTH WE, V12, P513, DOI 10.1111/aphw.12195; Hagerty Sarah L, 2020, Brain Behav Immun Health, V5, P100078, DOI 10.1016/j.bbih.2020.100078; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Joseph S., 2004, RIC PSICOL; Kalaitzaki AE, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102172; Kaniasty K, 2012, PSYCHOL TRAUMA-US, V4, P22, DOI 10.1037/a0021412; Kraemer B, 2009, AUST NZ J PSYCHIAT, V43, P420, DOI 10.1080/00048670902817653; Lau JTF, 2006, J INFECTION, V53, P114, DOI 10.1016/j.jinf.2005.10.019; Lock Sarah, 2012, PLoS Curr, V4, DOI 10.1371/currents.dis.a9b76fed1b2dd5c5bfcfc13c87a2f24f; Manca, 2014, ENCY QUALITY LIFE WE, P6026, DOI [10.1007/978-94-007-0753-5_2739, DOI 10.1007/978-94-007-0753-5_2739]; McGuire D, 2020, HUM RESOUR DEV INT, V23, P361, DOI 10.1080/13678868.2020.1779543; McKibbin W., 2020, EC TIME COVID 19, P45, DOI DOI 10.2139/SSRN.3547729; Moore JW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01272; Morphett K, 2019, DRUG ALCOHOL REV, V38, P234, DOI 10.1111/dar.12907; New Zealand Government, COVID 19 AL SYST; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Qian M., 2020, PSYCHOL RESPONSES BE, DOI DOI 10.1101/2020.02.18.20024448; Rowney C, 2014, NEW ZEAL J PSYCHOL, V43, P4; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Sattler DN, 2000, J APPL SOC PSYCHOL, V30, P1396, DOI 10.1111/j.1559-1816.2000.tb02527.x; Sheldon KM, 2004, J CROSS CULT PSYCHOL, V35, P209, DOI 10.1177/0022022103262245; Smith R., 2017, AUSTRALASIAN J DISAS, V21, P31; Stanko KE, 2015, CURR PSYCHOL, V34, P564, DOI 10.1007/s12144-015-9366-2; Tamiolaki A, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113044; Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Teixeira PJ, 2020, MOTIV SCI, V6, P438, DOI 10.1037/mot0000172; Townshend I, 2015, NAT HAZARDS, V76, P913, DOI 10.1007/s11069-014-1526-4; Troy AS, 2010, EMOTION, V10, P783, DOI 10.1037/a0020262; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; WHO, 2020, ARCHIVED WHO TIMELIN; Wilson S, 2020, LEADERSHIP-LONDON, V16, P279, DOI 10.1177/1742715020929151; Zacher H, 2021, AM PSYCHOL, V76, P50, DOI 10.1037/amp0000702	52	18	18	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249678	10.1371/journal.pone.0249678	http://dx.doi.org/10.1371/journal.pone.0249678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793672	gold, Green Published			2022-12-26	WOS:000636467000111
J	Nopsopon, T; Pongpirul, K; Chotirosniramit, K; Jakaew, W; Kaewwijit, C; Kanchana, S; Hiransuthikul, N				Nopsopon, Tanawin; Pongpirul, Krit; Chotirosniramit, Korn; Jakaew, Wutichai; Kaewwijit, Chuenkhwan; Kanchana, Sawan; Hiransuthikul, Narin			Seroprevalence of hospital staff in a province with zero COVID-19 cases	PLOS ONE			English	Article							ANTIBODIES; IGM	Background COVID-19 seroprevalence data, particularly in less developed countries with a relatively low incidence, has been scant. We aimed to explore the seroprevalence of hospital staff in the area with zero confirmed COVID-19 case to shed light on the situation of COVID-19 infection in zero or low infection rate countries where mass screening was not readily available. Methods A locally developed rapid immunoglobulin M (IgM)/immunoglobulin G (IgG) test kit was used for hospital staff screening of Ranong hospital which is located in a province with zero COVID-19 prevalence in Thailand from 17(th) April to 17(th) May 2020. All staff was tested, 100 of which were randomly invited to have a repeating antibody test in one month. (Thai Clinical Trials Registry: TCTR20200426002) Results Of 844 hospital staff, 82 were tested twice one month apart (response rate for repeating antibody test 82%). Overall, 0.8% of the participants (7 of 844) had positive IgM, none had positive IgG. Female staff had 1.0% positive IgM (95% CI: 0.5-2.1%) while male had 0.5% positive IgM (95% CI: 0.1-2.6%). No participants with a history of travel to the high-risk area or close contact with PCR-confirmed COVID-19 case developed SARS-CoV-2 antibodies. Among 844 staff, 811 had no symptoms and six of them developed IgM seropositive (0.7%) while 33 had minor symptoms and only one of them developed IgM seropositive (3.0%). No association between SARS-CoV-2 IgM status and gender, history of travel to a high-risk area, close contact with PCR-confirmed or suspected COVID-19 case, presence of symptoms within 14 days, or previous PCR status was found. None of the hospital staff developed SARS-CoV-2 IgG. Conclusions COVID-19 antibody test could detect a considerable number of hospital staff who could be potential silent spreaders in a province with zero COVID-19 cases. Accurate antibody testing is a valuable screening tool, particularly in asymptomatic healthcare workers.	[Nopsopon, Tanawin; Pongpirul, Krit; Chotirosniramit, Korn; Hiransuthikul, Narin] Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand; [Pongpirul, Krit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Pongpirul, Krit] Bumrungrad Int Hosp, Bangkok, Thailand; [Jakaew, Wutichai; Kaewwijit, Chuenkhwan; Kanchana, Sawan] Ranong Hosp, Ranong, Thailand; [Kanchana, Sawan] Chumphon Khet Udomsakdi Hosp, Chumphon, Thailand	Chulalongkorn University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pongpirul, K (corresponding author), Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand.; Pongpirul, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Pongpirul, K (corresponding author), Bumrungrad Int Hosp, Bangkok, Thailand.	doctorkrit@gmail.com	Nopsopon, Tanawin/GPC-4514-2022; Nopsopon, Tanawin/GOJ-7774-2022; Pongpirul, Krit/H-4064-2019	Nopsopon, Tanawin/0000-0003-0428-973X; Nopsopon, Tanawin/0000-0003-0428-973X; Pongpirul, Krit/0000-0003-3818-9761				Basoulis D., 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0243025, DOI 10.1371/journal.pone.0243025]; Beeching NJ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1403; Chen C, 2021, INT J INFECT DIS, V104, P458, DOI 10.1016/j.ijid.2021.01.017; Chen YX, 2020, J INFECTION, V81, P420, DOI 10.1016/j.jinf.2020.05.067; Costa SF, 2021, CLIN INFECT DIS, V73, pE1214, DOI 10.1093/cid/ciaa1845; Galanis P, 2021, J HOSP INFECT, V108, P120, DOI 10.1016/j.jhin.2020.11.008; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; Hains DS, 2020, JAMA-J AM MED ASSOC, V323, P2424, DOI 10.1001/jama.2020.8438; Houlihan C., 2020, SARS COV 2 VIRUS ANT, DOI [10.1101/2020.06.08.20120584, DOI 10.1101/2020.06.08.20120584V1]; Insua C, 2020, ARCH ARGENT PEDIATR, V118, P381, DOI 10.5546/aap.2020.eng.381; Kammon AM., 2020, PREPRINT, P1, DOI [10.1101/2020.05.25.20109470, DOI 10.1101/2020.05.25.20109470]; Lee YL, 2020, J INFECTION, V81, pE55, DOI 10.1016/j.jinf.2020.04.019; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Ma H, 2020, CELL MOL IMMUNOL, V17, P773, DOI 10.1038/s41423-020-0474-z; Mughal MS, 2021, INFECT CONT HOSP EP, V42, P638, DOI 10.1017/ice.2020.298; Chau NVV, 2021, J INFECTION, V82, pE36, DOI 10.1016/j.jinf.2020.11.018; Nopsopon T., 2020, COVID 19 ANTIBODY TH, DOI [10.1101/2020.06.24.20139188, DOI 10.1101/2020.06.24.20139188]; Olayanju O, 2021, AM J TROP MED HYG, V104, P91, DOI 10.4269/ajtmh.20-1235; Post N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244126; Qin XZ, 2021, BMC IMMUNOL, V22, DOI 10.1186/s12865-021-00404-0; Sato R, 2020, SEROPREVALENCE ANTIB, DOI [10.1101/2020.06.15.20132316, DOI 10.1101/2020.06.15.20132316]; Schmidt SB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235417; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; Takita M, 2020, PRELIMINARY RESULTS, DOI 10.1101/2020.04.29.20085449; Wang B, 2020, J MED VIROL, V92, P1684, DOI 10.1002/jmv.25946; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6; Yanes-Lane M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241536; Yong SEF, 2020, LANCET INFECT DIS, V20, P809, DOI 10.1016/S1473-3099(20)30273-5; Younes N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060582	31	20	20	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0238088	10.1371/journal.pone.0238088	http://dx.doi.org/10.1371/journal.pone.0238088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793556	Green Submitted, gold, Green Published			2022-12-26	WOS:000636467000013
J	Sailaja, BS; Aita, R; Maledatu, S; Ribnicky, D; Verzi, MP; Raskin, I				Sailaja, Badi Sri; Aita, Rohit; Maledatu, Shane; Ribnicky, David; Verzi, Michael P.; Raskin, Ilya			Moringa isothiocyanate-1 regulates Nrf2 and NF-kappa B pathway in response to LPS-driven sepsis and inflammation	PLOS ONE			English	Article							SULFORAPHANE; OLEIFERA; EXTRACT; STRESS; CELLS; ROS; KB	This study aims to document the dual mode of pharmacological action of moringa isothiocyanate-1 (MIC-1) derived from seeds of Moringa oleifera Lam. Oral administration of chemically stable MIC-1 (80 mg/kg) significantly reduced the expression of inflammatory markers (Tnf-alpha, Ifn-alpha, IL-1 beta, IL-6) in the liver, kidney, spleen, and colon and decreased spleen weight in the lipopolysaccharide (LPS)-induced sepsis / acute inflammation model in mice. Transcriptomic analysis of the effect of MIC-1 on the liver and in the LPS-induced RAW264.7 murine macrophage showed that MIC-1 decreases inflammation via inflammation, immunity, and oxidative stress pathways. These results are supported by the immunocytochemical observations that MIC-1 increased the nuclear accumulation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor and decreased the nuclear accumulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in the LPS-induced macrophages. Transcriptional activation of antioxidant genes by MIC-1 translated into a reduction of reactive oxygen species (ROS) in the cytoplasm, decrease of mitochondrial superoxide content, and restoration of the mitochondrial membrane potential in the LPS-induced macrophages. Our data indicate that MIC-1 affects inflammation and oxidative stress, two key processes involved in the etiology of many chronic diseases. These effects involve upstream regulation of two key transcriptional factors regulating responses to these processes at a gene expression level.	[Sailaja, Badi Sri; Maledatu, Shane; Ribnicky, David; Raskin, Ilya] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Aita, Rohit; Verzi, Michael P.] Rutgers State Univ, Dept Genet, New Brunswick, NJ USA; [Aita, Rohit; Verzi, Michael P.] Rutgers State Univ, Human Genet Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sailaja, BS; Raskin, I (corresponding author), Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol, New Brunswick, NJ 08901 USA.	raskin@rutgers.edu; sb1747@sebs.rutgers.edu		Aita, Rohit/0000-0001-5524-9717; Meledathu, Shane/0000-0002-7506-9657	National Institutes of Health, National Center for Complementary and Alternative Medicine [1R01AT008618-01, 1R01AT008618-05]	National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine)	This work was funded by the National Institutes of Health, National Center for Complementary and Alternative Medicine (IR, 1R01AT008618-01 and IR, 1R01AT008618-05). SSB is a T32 postdoctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Batra S, 2010, MOL CANCER THER, V9, P1596, DOI 10.1158/1535-7163.MCT-09-1146; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Dey M, 2006, J PHARMACOL EXP THER, V317, P326, DOI 10.1124/jpet.105.096511; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Houghton CA, 2013, NUTR REV, V71, P709, DOI 10.1111/nure.12060; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Jaja-Chimedza A, 2018, J FUNCT FOODS, V47, P376, DOI 10.1016/j.jff.2018.05.056; Jaja-Chimedza A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182658; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kim SH, 2017, ONCOL LETT, V13, P4427, DOI 10.3892/ol.2017.5950; Kim Y, 2018, TOXICOL REP, V5, P418, DOI 10.1016/j.toxrep.2018.02.012; Kim Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184709; Kubo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14520-8; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mokhtari RB, 2018, J CELL COMMUN SIGNAL, V12, P91, DOI 10.1007/s12079-017-0401-y; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Prakash Dhan, 2012, J Complement Integr Med, V9, P13, DOI 10.1515/1553-3840.1611; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raskin I, 2004, CURR PHARM DESIGN, V10, P3419, DOI 10.2174/1381612043383070; Russo M, 2018, CRIT REV FOOD SCI, V58, P1391, DOI 10.1080/10408398.2016.1259983; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sailaja BS, 2012, METHODS MOL BIOL, V809, P353, DOI 10.1007/978-1-61779-376-9_24; Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Tumer TB, 2015, J AGR FOOD CHEM, V63, P1505, DOI 10.1021/jf505014n; Virag L, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101261; Vomund S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122772; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Wells G, 2015, BIOCHEM SOC T, V43, P674, DOI 10.1042/BST20150051; Woznica EA, 2018, ADV CLIN EXP MED, V27, P547, DOI 10.17219/acem/68363; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yan J, 2014, INT REV IMMUNOL, V33, P498, DOI 10.3109/08830185.2014.889129; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248691	10.1371/journal.pone.0248691	http://dx.doi.org/10.1371/journal.pone.0248691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793581	gold, Green Published			2022-12-26	WOS:000636467000099
J	El Agy, F; el Bardai, S; El Otmani, I; Benbrahim, Z; Karim, IH; Mazaz, K; Benjelloun, E; Ousadden, A; El Abkari, M; Ibrahimi, SA; Chbani, L				El Agy, Fatima; el Bardai, Sanae; El Otmani, Ihsane; Benbrahim, Zineb; Karim, Ibn Majdoub Hassani; Mazaz, Khalid; Benjelloun, El Bachir; Ousadden, Abdelmalek; El Abkari, Mohammed; Ibrahimi, Sidi Adil; Chbani, Laila			Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report	PLOS ONE			English	Article								This study aimed to estimate the incidence of KRAS, NRAS, and BRAF mutations in the Moroccan population, and investigate the associations of KRAS and NRAS gene mutations with clinicopathological characteristics and their prognosis value. To achieve these objectives, we reviewed medical and pathology reports for 210 patients. RAS testing was investigated by Sanger sequencing and Pyrosequencing technology. BRAF (exon 15) status was analyzed by the Sanger method. The expression of MMR proteins was evaluated by Immunohistochemistry. KRAS and NRAS mutations were found in 36.7% and 2.9% of 210 patients, respectively. KRAS exon 2 mutations were identified in 76.5% of the cases. RAS-mutated colon cancers were significantly associated with female gender, presence of vascular invasion, classical adenocarcinoma, moderately differentiated tumors, advanced TNM stage III-IV, left colon site, higher incidence of distant metastases at the time of diagnostic, microsatellite stable phenotype, lower number of total lymph nodes, and higher means of positive lymph nodes and lymph node ratio. KRAS exon 2-mutated colon cancers, compared with KRAS wild-type colon cancers were associated with the same clinicopathological features of RAS-mutated colon cancers. NRAS-mutated patients were associated with lower total lymph node rate and the presence of positive lymph node. Rare RAS-mutated tumors, compared with wild-type tumors were more frequently moderately differentiated and associated with lower lymph node rate. We found that KRAS codon 13-mutated, tumors compared to codon 12-mutated tumors were significantly correlated with a higher death cases number, a lower rate of positive lymph, lower follow-up time, and poor overall survival. Our findings show that KRAS and NRAS mutations have distinct clinicopathological features. KRAS codon 13-mutated status was the worst predictor of prognosis at all stages in our population.	[El Agy, Fatima; El Otmani, Ihsane; Chbani, Laila] Sidi Mohamed Ben Abdellah Univ, Fac Med & Pharm, Lab Biomed & Translat Res, Fes, Morocco; [El Agy, Fatima; el Bardai, Sanae; El Otmani, Ihsane; Chbani, Laila] Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Lab Anat Pathol & Mol Pathol, Fes, Morocco; [El Otmani, Ihsane] Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Unit Med Genet & Oncogenet, Fes, Morocco; [Benbrahim, Zineb] Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Dept Oncol, Fes, Morocco; [Karim, Ibn Majdoub Hassani; Mazaz, Khalid; Benjelloun, El Bachir; Ousadden, Abdelmalek; Ibrahimi, Sidi Adil] Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Dept Gen Surg, Fes, Morocco; [El Abkari, Mohammed] Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Dept Gastroenterol, Fes, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez	El Agy, F (corresponding author), Sidi Mohamed Ben Abdellah Univ, Fac Med & Pharm, Lab Biomed & Translat Res, Fes, Morocco.; El Agy, F (corresponding author), Sidi Mohamed Ben Abdellah Univ, Univ Hosp Hassan II, Lab Anat Pathol & Mol Pathol, Fes, Morocco.	Fatima.elagy@usmba.ac.ma	agy, Fatima El/E-7773-2019; agy, Fatima El/AAA-1361-2021	agy, Fatima El/0000-0002-4467-4555				Andersen SN, 1997, SCAND J GASTROENTERO, V32, P62, DOI 10.3109/00365529709025065; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Baltruskeviien E., 2016, SIGNIFICANCE KRAS NR, V23, P24, DOI [10.6001/actamedica.v23i1.3267, DOI 10.6001/ACTAMEDICA.V23I1.3267]; Barbie DA., 2010, PROCESSING A PROGRAM, V462, P108; Barras D., 2016, BRAF V600E MUTANT CO, DOI [10.1158/1078-0432.CCR-16-0140, DOI 10.1158/1078-0432.CCR-16-0140]; Blons H, 2014, ANN ONCOL, V25, P2378, DOI 10.1093/annonc/mdu464; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Conlin A, 2005, GUT, V54, P1283, DOI 10.1136/gut.2005.066514; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; El Agy F, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/3210710; Ferreira CG, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-73; Noguera JG, 2017, MOL CLIN ONCOL, V6, P403, DOI 10.3892/mco.2017.1149; Gonsalves WI, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju106; Guo F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24306-1; Hsieh LL, 2012, CLIN CHIM ACTA, V413, P1605, DOI 10.1016/j.cca.2012.04.029; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Jeantet M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122015; Kawazoe A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1276-z; Koochak Aghigh, 2016, Asian Pac J Cancer Prev, V17, P603; Kwak MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007882; Li WQ, 2019, J BIOL CHEM, V294, P8310, DOI 10.1074/jbc.W119.009032; Li WQ, 2018, CELL PHYSIOL BIOCHEM, V50, P1496, DOI 10.1159/000494649; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Mannan A, 2012, APMIS, V120, P459, DOI 10.1111/j.1600-0463.2011.02852.x; Modest DP, 2016, ANN ONCOL, V27, P1746, DOI 10.1093/annonc/mdw261; Modest DP, 2011, ANTI-CANCER DRUG, V22, P913, DOI 10.1097/CAD.0b013e3283493160; Neumann J, 2013, VIRCHOWS ARCH, V463, P509, DOI 10.1007/s00428-013-1450-0; Niu WB, 2019, ONCOL LETT, V17, P332, DOI 10.3892/ol.2018.9611; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Omidifar N, 2015, IRAN J MED SCI, V40, P454; Palomba G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1053-z; Pentheroudakis G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-49; Petrelli F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0650-4; Reinacher-Schick A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-349; Ren JJ, 2012, DIS COLON RECTUM, V55, P913, DOI 10.1097/DCR.0b013e318251d8d9; Rimbert J., 2017, ASS CLINICOPATHOLOGI, P1, DOI [10.1038/modpathol.2017.119, DOI 10.1038/MODPATHOL.2017.119]; Rodriguez-Salas N, 2017, CRIT REV ONCOL HEMAT, V109, P9, DOI 10.1016/j.critrevonc.2016.11.007; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Schirripa M, 2015, INT J CANCER, V136, P83, DOI 10.1002/ijc.28955; Serebriiskii IG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11530-0; Sinicrope FA, 2015, CLIN CANCER RES, V21, P5294, DOI 10.1158/1078-0432.CCR-15-0527; Taieb J, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw272; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Wang YF, 2013, CANCER DISCOV, V3, P294, DOI 10.1158/2159-8290.CD-12-0198; Yaeger R, 2015, CANCER-AM CANCER SOC, V121, P1195, DOI 10.1002/cncr.29196; Ye JX, 2015, WORLD J GASTROENTERO, V21, P1595, DOI 10.3748/wjg.v21.i5.1595; Yoon HH, 2014, CLIN CANCER RES, V20, P3033, DOI 10.1158/1078-0432.CCR-13-3140; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18678	51	4	4	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248522	10.1371/journal.pone.0248522	http://dx.doi.org/10.1371/journal.pone.0248522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784337	gold, Green Published			2022-12-26	WOS:000636359600035
J	Bernhardson, BM; Tishelman, C; Rasmussen, BH; Hajdarevic, S; Malmstrom, M; Hasle, TLO; Locock, L; Eriksson, LE				Bernhardson, Britt-Marie; Tishelman, Carol; Rasmussen, Birgit H.; Hajdarevic, Senada; Malmstrom, Marlene; Overgaard Hasle, Trine Laura; Locock, Louise; Eriksson, Lars E.			Sensations, symptoms, and then what? Early bodily experiences prior to diagnosis of lung cancer	PLOS ONE			English	Article							BENCHMARKING PARTNERSHIP; CLINICAL-FEATURES; GENERAL-PRACTICE; AUSTRALIA; PEOPLE; TIME; DENMARK; NORWAY; SWEDEN; CANADA	Lung cancer (LC) generally lacks unique core symptoms or signs. However, there are a multitude of bodily sensations that are often non-specific, not easily understood, and many times initially not recognized as indicative of LC by the affected person, which often leads to late diagnosis. In this international qualitative study, we inductively analyzed retrospective accounts of 61 people diagnosed with LC in Denmark, England and Sweden. Using the bodily sensations they most commonly spoke about (tiredness, breathlessness, pain, and cough), we constructed four sensation-based cases to understand the pre-diagnostic processes of reasoning and practice triggered by these key indicators of LC. We thereafter critically applied Hay's model of sensations to symptoms transformation, examining its central concepts of duration, disability and vulnerability, to support understanding of these processes. We found that while duration and disability are clearly relevant, vulnerability is more implicitly expressed in relation to perceived threat. Tiredness, even when of long duration and causing disability, was often related to normal aging, rather than a health threat. Regardless of duration, breathlessness was disturbing and threatening enough to lead to care-seeking. Pain varied by location, duration and degree of disability, and thus also varied in degree of threat perceived. Preconceived, but unmet expectations of what LC-related cough and pain would entail could cause delays by misleading participants; if cough lasted long enough, it could trigger health care contact. Duration, disability, and sense of threat, rather than vulnerability, were found to be relevant concepts for understanding the trajectory to diagnosis for LC among these participants. The process by which an individual, their family and health care providers legitimize sensations, allowing them to be seen as potential symptoms of disease, is also an essential, but varying part of the diagnostic processes described here.	[Bernhardson, Britt-Marie; Tishelman, Carol; Eriksson, Lars E.] Karolinska Inst, Div Innovat Care Res, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Tishelman, Carol] Stockholms Cty Council SLL, Stockholm Hlth Care Serv SLSO, Stockholm, Sweden; [Rasmussen, Birgit H.; Malmstrom, Marlene] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Rasmussen, Birgit H.; Malmstrom, Marlene] Lund Univ & Region, Inst Palliat Care, Skane, Sweden; [Hajdarevic, Senada] Umea Univ, Dept Nursing, Umea, Sweden; [Overgaard Hasle, Trine Laura] Aarhus Univ, Res Unit Gen Practice, Res Ctr Canc Diag Primary Care, Dept Publ Hlth, Aarhus, Denmark; [Locock, Louise] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Locock, Louise] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Hlth Experiences Res Grp, Oxford, England; [Eriksson, Lars E.] Univ London, Sch Hlth Sci, London, England; [Eriksson, Lars E.] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden	Karolinska Institutet; Lund University; Umea University; Aarhus University; University of Aberdeen; University of Oxford; University of London; Karolinska Institutet; Karolinska University Hospital	Bernhardson, BM (corresponding author), Karolinska Inst, Div Innovat Care Res, Dept Learning Informat Management & Eth, Stockholm, Sweden.	britt-marie.bernhardson@ki.se		Bernhardson, Britt-Marie/0000-0001-6907-3134; Malmstrom, Marlene/0000-0001-9575-0311; Tishelman, Carol/0000-0003-4161-0342; Locock, Louise/0000-0002-8109-1930	National Awareness and Early Diagnosis Initiative (NAEDI); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR Collaboration for Leadership in Applied Health Research and Care Oxford (CLAHRC) at Oxford Health NHS Foundation Trust; Research Centre for Cancer Diagnosis in Primary Care - Danish Cancer Society; Novo Nordic Foundation; Vardal Foundation; Strategic Research Program in Care Sciences (SFO-V), Umea University; Cancer Research Foundation in Northern Sweden; Swedish Research Council; National Health Service in Sweden	National Awareness and Early Diagnosis Initiative (NAEDI); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care Oxford (CLAHRC) at Oxford Health NHS Foundation Trust; Research Centre for Cancer Diagnosis in Primary Care - Danish Cancer Society; Novo Nordic Foundation(Novo Nordisk Foundation); Vardal Foundation; Strategic Research Program in Care Sciences (SFO-V), Umea University; Cancer Research Foundation in Northern Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Health Service in Sweden	This paper presents independent research funded by organisations from 3 European countries as follows: In the UK, the study was supported by the National Awareness and Early Diagnosis Initiative (NAEDI), http://www.naedi.org.uk.The contributing partners include: Cancer Research UK; Department of Health, England; Economic and Social Research Council; Health and Social Care Research and Development Division, Pubic Health Agency, Northern Ireland; National Institute for Social Care and Health Research, Wales; and the Scottish Government. This funding also covered the costs associated with the comparative analysis meetings in Denmark and Sweden and funded translation of the Danish and Swedish material for publication. During the study, LL was Director of Applied Research at the Health Experiences Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, and was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford (CLAHRC) at Oxford Health NHS Foundation Trust. In Denmark, the study was supported by the Research Centre for Cancer Diagnosis in Primary Care funded by The Danish Cancer Society and the Novo Nordic Foundation. In Sweden, the study was supported by the Vardal Foundation; the Strategic Research Program in Care Sciences (SFO-V), Umea University; the Cancer Research Foundation in Northern Sweden; the Swedish Research Council and government funding of clinical research within the National Health Service in Sweden. The views expressed in this paper are those of the authors, and not necessarily those of the NAEDI, Danish and Swedish funding partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2014, INT J EPIDEMIOL, V43, P1865, DOI 10.1093/ije/dyu174; Ahlin CH, 2019, J CLIN NURS, V28, P1223, DOI 10.1111/jocn.14730; American Anthropological Association, 1998, ANTHR NEWS INTERNET, V39, P19, DOI [10.1177/1355819618790985, DOI 10.1177/1355819618790985]; Andersen RS, 2020, CRIT PUBLIC HEALTH, V30, P567, DOI 10.1080/09581596.2019.1623381; Botey AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239374; Chapple A, 2018, QUAL HEALTH RES, V28, P789, DOI 10.1177/1049732317736284; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Corner J., 2005, THORAX, V60, P314, DOI [10.1136/thx.2004.029264, DOI 10.1136/THX.2004.029264]; Crane M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3051-8; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Evans J., 2007, FAM PRACT, V24, P48, DOI [10.1093/fampra/cml063, DOI 10.1093/FAMPRA/CML063]; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Friedemann Smith C., 2016, THORAX, V71, P659, DOI [10.1136/thoraxjnl-2015-208063, DOI 10.1136/THORAXJNL-2015-208063]; Globocan, 2018, FACT SHEETS CANC; Hajdarevic S., 2010, J NURS HEALTHC CHRON, V2, P164, DOI [10.1111/j.1752-9824.2010.01057.x, DOI 10.1111/J.1752-9824.2010.01057.X]; Hajdarevic S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023934; Hall N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008448; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hannaford PC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228033; Hay AC, 2008, TRANSCULT PSYCHIATRY, V45, P198, DOI 10.1177/1363461508089765; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Huggenberger IK., 2015, DAN MED J, V62, P1; Iyen-Omofoman B, 2013, THORAX, V68, P451, DOI 10.1136/thoraxjnl-2012-202348; Levitsky A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52915-x; Lovgren M., 2008, ACTA ONCOL, V47, P397, DOI [10.1080/02841860701592392, DOI 10.1080/02841860701592392]; MacArtney J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018210; MacLean A., 2017, SOC SCI MED, V191, P134, DOI [10.1016/j.socscimed.2017.09.015, DOI 10.1016/J.SOCSCIMED.2017.09.015]; Malmstrom M, 2018, EUR J ONCOL NURS, V34, P82, DOI 10.1016/j.ejon.2018.04.002; McCutchan G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025902; McLachlan S, 2015, FAM PRACT, V32, P568, DOI 10.1093/fampra/cmv048; Meinert L, 2017, ANTHROPOL ACTION, V24, P20, DOI 10.3167/aia.2017.240104; Mitchell ED., 2015, BMJ OPEN, V5; Molassiotis A, 2011, SUPPORT CARE CANCER, V19, P1997, DOI 10.1007/s00520-010-1050-3; Murray SR, 2017, FAM PRACT, V34, P740, DOI 10.1093/fampra/cmx057; Nichter M., 2017, EUR J INT MANAG, V1, P1, DOI DOI 10.1504/EJIM.2008.016967; Nichter M, 2008, TRANSCULT PSYCHIATRY, V45, P163, DOI 10.1177/1363461508089764; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Offersen SMH., 2017, ANTHROPOL ACTION, V24, P6; Ohlen J, 2007, PSYCHOONCOLOGY; Okoli GN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207686; Pedersen AF, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4287-8; Rose S, 2018, ONCOL NURS FORUM, V45, P737, DOI 10.1188/18.ONF.737-747; Sandelowski M, 2011, RES NURS HEALTH, V34, P153, DOI 10.1002/nur.20421; Skowronski M., 2017, QUAL RES MED HEALTHC, V1, P138; Thorne S., 2016, DEV QUAL INQ, Vsecond, P317; Tishelman C, 2005, CANCER, V104, P2013, DOI 10.1002/cncr.21398; TISHELMAN C, 1993, CANCER NURS, V16, P270; Tishelman C, 1998, QUAL HEALTH RES, V8, P48, DOI 10.1177/104973239800800104; Tishelman C., 1994, SCAND J CARING SCI, V8, P213, DOI [10.1111/j.1471-6712.1994.tb00247.x, DOI 10.1111/J.1471-6712.1994.TB00247.X]; Walabyeki J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183647; Walter FM, 2015, BRIT J CANCER, V112, pS6, DOI 10.1038/bjc.2015.30; Ziebland S, 2019, J HEALTH SERV RES PO, V24, P52, DOI 10.1177/1355819618790985	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249114	10.1371/journal.pone.0249114	http://dx.doi.org/10.1371/journal.pone.0249114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780498	Green Published, gold, Green Accepted			2022-12-26	WOS:000636336800043
J	Gentile, A; Della Latta, MP; Bloch, M; Martorelli, L; Wisner, B; Pereira, CS; Regueira, M; Juarez, MD; Umido, V; Efron, A				Gentile, Angela; Della Latta, Maria Paula; Bloch, Mercedes; Martorelli, Luisina; Wisner, Barbara; Sorhouet Pereira, Cecilia; Regueira, Mabel; Juarez, Maria del Valle; Umido, Veronica; Efron, Adriana			Oropharyngeal meningococcal carriage in children and adolescents, a single center study in Buenos Aires, Argentina	PLOS ONE			English	Article								Background Neisseria meningitidis (Nm) pharyngeal carriage is a necessary condition for invasive disease. We present the first carriage study in children in Buenos Aires, Argentina, considering 2017 as a transition year. Aims: to assess the rate of Nm carriage, to determine genogroup, clonal complex and outer membrane protein distribution, to determine carriage risk factors by age. Methods Cross-sectional study including children 1-17 yrs, at Ricardo Gutierrez Children's Hospital in Buenos Aires 2017. Oro-pharyngeal swabs were taken and cultured within a short time after collection. Genogroup was determined by PCR and clonal complex by MLST. Categorical variables were analyzed. Results A total of 1,751 children were included. Group 1: 943 children 1-9 yrs, 38 Nm were isolated; overall carriage 4.0%. Genogroup distribution: B 26.3%, W 5.3%, Y 2.6%, Z 5.3%, other groups 7.9% and capsule null (cnl) 52.6%. Participating in extracurricular activities was the only independent predictor of Nm carriage. Group 2: 808 children 10-17 yrs, 76 Nm were isolated; overall carriage 9.4%. Genogroup distribution: B 19.7%, C 5.3%, W 7.9%, Y 9.2%, Z 5.3%, other groups 7.9% and cnl 44.7%. Independent predictors of carriage: attending pubs/night clubs and passive smoking (adjusted OR: 0.55, 95%CI = 0.32-0.93; p = 0.025). Conclusions Overall carriage was higher in 10-17 yrs. The isolates presenting the cnl locus were prevalent in both age groups and genogroup B was the second most frequent.	[Gentile, Angela; Della Latta, Maria Paula; Bloch, Mercedes; Juarez, Maria del Valle; Umido, Veronica] Dr Ricardo Gutierrez Childrens Hosp, Epidemiol Div, Buenos Aires, DF, Argentina; [Martorelli, Luisina; Wisner, Barbara; Sorhouet Pereira, Cecilia; Regueira, Mabel; Efron, Adriana] INEI ANLIS Dr Carlos G Malbran, Clin Microbiol Serv, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez	Gentile, A (corresponding author), Dr Ricardo Gutierrez Childrens Hosp, Epidemiol Div, Buenos Aires, DF, Argentina.	angelagentile21@gmail.com		Gentile, Angela/0000-0002-1072-7700	GSK (Galxosmithkine) [V72-85OBTP]	GSK (Galxosmithkine)	Grant awarded by GSK (Galxosmithkine) to support the investigation. Study number V72-85OBTP. The sponsors did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Argentina Ministerio de Salud de la Nacion., 2016, FUNDAMENTOS INTRODUC; Argentina Ministerio de Salud de la Nacion., 2017, FUNDAMENTOS INTRODUC; Bennett DE, 2004, J CLIN MICROBIOL, V42, P1764, DOI 10.1128/JCM.42.4.1764-1765.2004; BLACKWELL CC, 1990, EPIDEMIOL INFECT, V104, P203, DOI 10.1017/S0950268800059367; Bogaert D, 2005, CLIN INFECT DIS, V40, P899, DOI 10.1086/428351; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Diaz J, 2016, J INFECT PUBLIC HEAL, V9, P506, DOI 10.1016/j.jiph.2015.12.011; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Efron A., 2016, VIGILANCIA LABORATOR; Efron A, 2014, 19 INT PATH NEISS C; de los Monteros LEED, 2009, SALUD PUBLICA MEXICO, V51, P114, DOI 10.1590/S0036-36342009000200006; Gagetti P, 2018, VIGILANCIA NACL RESI; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Huttunen R, 2011, J INTERN MED, V269, P258, DOI 10.1111/j.1365-2796.2010.02332.x; Ibarz Pavon A, 2014, 14 INT PATH NEISS C; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006; Kremastinou J, 1999, FEMS IMMUNOL MED MIC, V24, P73, DOI 10.1111/j.1574-695X.1999.tb01267.x; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; MAIDEN MCJ, 1992, J CLIN MICROBIOL, V30, P2835, DOI 10.1128/JCM.30.11.2835-2841.1992; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martínez Isabel, 2003, Rev Cubana Med Trop, V55, P162; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; OLCEN P, 1981, SCAND J INFECT DIS, V13, P105, DOI 10.3109/inf.1981.13.issue-2.05; OLSEN SF, 1991, EPIDEMIOL INFECT, V106, P445, DOI 10.1017/S0950268800067492; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; Rashid H, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-160; SAUNDERS NB, 1993, GENE, V137, P153, DOI 10.1016/0378-1119(93)90001-J; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Weckx LY, 2017, BRAZ J INFECT DIS, V21, P587, DOI 10.1016/j.bjid.2017.06.005; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247991	10.1371/journal.pone.0247991	http://dx.doi.org/10.1371/journal.pone.0247991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780457	gold, Green Published			2022-12-26	WOS:000636336800010
J	Sabusap, CM; Joshi, D; Simhaev, L; Oliver, KE; Senderowitz, H; van Willigen, M; Braakman, I; Rab, A; Sorscher, EJ; Hong, JS				Sabusap, Carleen Mae; Joshi, Disha; Simhaev, Luba; Oliver, Kathryn E.; Senderowitz, Hanoch; van Willigen, Marcel; Braakman, Ineke; Rab, Andras; Sorscher, Eric J.; Hong, Jeong S.			The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; CONFORMATIONAL MATURATION; CORRECTOR VX-809; R-DOMAIN; PROTEIN; MODEL; MECHANISM	Patients with cystic fibrosis (CF) harboring the P67L variant in the cystic fibrosis transmembrane conductance regulator (CFTR) often exhibit a typical CF phenotype, including severe respiratory compromise. This rare mutation (reported in <300 patients worldwide) responds robustly to CFTR correctors, such as lumacaftor and tezacaftor, with rescue in model systems that far exceed what can be achieved for the archetypical CFTR mutant F508del. However, the specific molecular consequences of the P67L mutation are poorly characterized. In this study, we conducted biochemical measurements following low-temperature growth and/or intragenic suppression, which suggest a mechanism underlying P67L that (1) shares key pathogenic features with F508del, including off-pathway (non-native) folding intermediates, (2) is linked to folding stability of nucleotide-binding domains 1 and 2, and (3) demonstrates pharmacologic rescue that requires domains in the carboxyl half of the protein. We also investigated the "lasso" helices 1 and 2, which occur immediately upstream of P67. Based on limited proteolysis, pulse chase, and molecular dynamics analysis of full-length CFTR and a series of deletion constructs, we argue that P67L and other maturational processing (class 2) defects impair the integrity of the lasso motif and confer misfolding of downstream domains. Thus, amino-terminal missense variants elicit a conformational change throughout CFTR that abrogates maturation while providing a robust substrate for pharmacologic repair.	[Sabusap, Carleen Mae] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Joshi, Disha; Oliver, Kathryn E.; Rab, Andras; Sorscher, Eric J.; Hong, Jeong S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Simhaev, Luba; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [van Willigen, Marcel; Braakman, Ineke] Univ Utrecht, Dept Cellular Prot Chem, Utrecht, Netherlands; [Sabusap, Carleen Mae] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, 1161 21st Avenuke South,T-1218 MCN, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; Emory University; Bar Ilan University; Utrecht University; Vanderbilt University	Sorscher, EJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	esorscher@emory.edu		Oliver, Kathryn/0000-0002-7781-7006; Braakman, Ineke/0000-0003-1592-4364	Cystic Fibrosis Foundation Therapeutics [SORSCH13XX0, BRAAKM14XX0, SENDERO9XX0]; National Institutes of Health [P30 DK072482, R01HL136414, RO1HL139876]; National Center for Advancing Translational Sciences of National Institutes of Health [UL1TR000454]; Netherlands Organization for Health Research and Development (ZonMw TOP) [40-00812-98-14103]; Netherlands Cystic Fibrosis Foundation (HIT-CF grant)	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of National Institutes of Health; Netherlands Organization for Health Research and Development (ZonMw TOP)(Netherlands Organization for Health Research and Development); Netherlands Cystic Fibrosis Foundation (HIT-CF grant)	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics (SORSCH13XX0, BRAAKM14XX0, and SENDERO9XX0), National Institutes of Health (P30 DK072482, R01HL136414, and RO1HL139876), the National Center for Advancing Translational Sciences of National Institutes of Health (under UL1TR000454), the Netherlands Organization for Health Research and Development (ZonMw TOP grant 40-00812-98-14103), and the Netherlands Cystic Fibrosis Foundation (HIT-CF grant). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Corradi V, 2018, BIOPHYS J, V114, P1751, DOI 10.1016/j.bpj.2018.03.003; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DULHANTY AM, 1994, FEBS LETT, V343, P109, DOI 10.1016/0014-5793(94)80300-5; Durmowicz AG, 2018, ANN AM THORAC SOC, V15, P1, DOI 10.1513/AnnalsATS.201708-668PS; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; Han ST, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121159; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hoffmann B, 2018, CELL MOL LIFE SCI, V75, P3829, DOI 10.1007/s00018-018-2835-7; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hudson R, 2016, PEDIATR PULM, V51, P213; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; King SA, 2000, BIOCHEMISTRY-US, V39, P9868, DOI 10.1021/bi992807d; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Laselva O, 2018, MOL PHARMACOL, V93, P612, DOI 10.1124/mol.118.111799; Law EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157553; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Manfredi C, 2019, SCIENCE, V365, P220, DOI 10.1126/science.aaw0553; McCague AF, 2019, AM J RESP CRIT CARE, V199, P1116, DOI 10.1164/rccm.201901-0145OC; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molinski SV, 2018, PROTEINS, V86, P833, DOI 10.1002/prot.25496; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Niemyska W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36895; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Oliver KE, 2019, J CLIN INVEST, V129, P5236, DOI 10.1172/JCI124282; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintani E., 2020, J CYST FIBROS, V19, pS34; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Raraigh KS, 2018, AM J HUM GENET, V102, P1062, DOI 10.1016/j.ajhg.2018.04.003; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sabusap CM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86581; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schuck RN, 2018, CLIN PHARMACOL THER, V104, P282, DOI 10.1002/cpt.1041; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Shelar A, 2016, BBA-BIOMEMBRANES, V1858, P2804, DOI 10.1016/j.bbamem.2016.08.003; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Tordai H, 2017, BIOCHEM BIOPH RES CO, V491, P986, DOI 10.1016/j.bbrc.2017.07.165; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; van Meegen MA, 2013, J CYST FIBROS, V12, P487, DOI 10.1016/j.jcf.2012.12.005; van Willigen M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800172; Vergani P, 2005, BIOCHEM SOC T, V33, P1003, DOI 10.1042/BST0331003; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Yousef S, 2015, CHEST, V147, pE79, DOI 10.1378/chest.14-1198; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhenin M, 2015, J CHEM INF MODEL, V55, P2349, DOI 10.1021/acs.jcim.5b00312	81	8	8	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100598	10.1016/j.jbc.2021.100598	http://dx.doi.org/10.1016/j.jbc.2021.100598			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781744	Green Published, gold			2022-12-26	WOS:000672866400570
J	Amgarth-Duff, I; Hosie, A; Caplan, GA; Agar, M				Amgarth-Duff, Ingrid; Hosie, Annmarie; Caplan, Gideon A.; Agar, Meera			Delirium researchers' perspectives of the challenges in delirium biomarker research: A qualitative study	PLOS ONE			English	Article							INFORMED-CONSENT; CHECKLIST; DEMENTIA; ETHICS; TRIALS; CANCER; IMPACT	Background Despite the prevalence and impact of delirium, its pathophysiology remains unclear. In order to advance this field of research, robust scientific methodology is required, yet quality of reporting in this field of research has been highly inconsistent. Delirium biomarker research poses several challenges, none of which have been documented in the literature before. The aim of this study was to explore the perspectives of delirium researchers about key methodological issues in delirium biomarker research. Methods Following a Delphi study with delirium experts resulting in 60 recommendations for reporting delirium biomarker studies, semi-structured interviews with international delirium researchers were conducted. Interviews were audio-taped and transcribed verbatim, followed by thematic analysis of the qualitative data. Results Fifteen participants were interviewed between August and November 2019. Most were male (n = 12; 75%), clinician researchers (n = 13; 86%), and had more than ten years' experience in conducting delirium research (n = 9; 60%). Analysis revealed two major themes and ten sub-themes, outlining key considerations to advance the field of delirium biomarker research. The major themes were: 1) Practical and scientific challenges of delirium biomarker research: stagnation versus driving improved methods and reporting; and 2) Valuing delirium research through investment and collaboration. Conclusion Findings identified a range of factors that contribute to the practical and ethical challenges of conducting delirium biomarker research, which have not previously been explicitly acknowledged or reported. A clear vision for collaborative efforts to enhance research quality for improved impact was also presented by the delirium researchers. This work complements the preceding Delphi and together these studies provide an in-depth understanding of what is needed in the field to inform and improve methods and reporting of delirium biomarker research.	[Amgarth-Duff, Ingrid; Agar, Meera] Univ Technol Sydney, IMPACCT Improving Palliat Aged & Chron Care Clin, Sydney, NSW, Australia; [Hosie, Annmarie] Univ Notre Dame Australia, Sch Nursing Sydney, Sydney, NSW, Australia; [Hosie, Annmarie] St Vincents Hlth Network Sydney, Cunningham Ctr Palliat Care Res, Sydney, NSW, Australia; [Caplan, Gideon A.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Caplan, Gideon A.] Prince Wales Hosp, Dept Geriatr Med, Sydney, NSW, Australia; [Agar, Meera] Univ New South Wales, South West Sydney Clin Sch, Sydney, NSW, Australia; [Agar, Meera] Ingham Inst Appl Med Res, Sydney, NSW, Australia	University of Technology Sydney; University of Notre Dame Australia; University of New South Wales Sydney; University of New South Wales Sydney; Ingham Institute for Applied Medical Research	Amgarth-Duff, I (corresponding author), Univ Technol Sydney, IMPACCT Improving Palliat Aged & Chron Care Clin, Sydney, NSW, Australia.	Ingrid.Amgarth-Duff@uts.edu.au		Caplan, Gideon/0000-0002-9991-3146; Hosie, Annmarie/0000-0003-1674-2124; Agar, Meera/0000-0002-6756-6119; Amgarth-Duff, Ingrid/0000-0002-5038-890X				Adamis D, 2015, AGE AGEING, V44, P318, DOI 10.1093/ageing/afu152; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Amgarth-Duff I, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02584-2; Amgarth-Duff I, 2020, INT J GERIATR PSYCH, V35, P737, DOI 10.1002/gps.5292; Bracken-Roche D, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-016-0164-6; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Bruera E, 2009, CANCER, V115, P2004, DOI 10.1002/cncr.24215; de la Cruz M, 2015, SUPPORT CARE CANCER, V23, P2427, DOI 10.1007/s00520-015-2610-3; Fick DM, 2002, J AM GERIATR SOC, V50, P1723, DOI 10.1046/j.1532-5415.2002.50468.x; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Haggstrom LR, 2017, J CEREBR BLOOD F MET, V37, P3556, DOI 10.1177/0271678X17701764; Holt R, 2008, J PSYCHOSOM RES, V65, P283, DOI 10.1016/j.jpsychores.2008.05.023; Inouye SK, 2006, J GERONTOL A-BIOL, V61, P1277, DOI 10.1093/gerona/61.12.1277; Khachaturian AS, 2020, ALZHEIMERS DEMENT, V16, P711, DOI 10.1002/alz.12075; Kim EJ, 2015, CLIN TRIALS, V12, P232, DOI 10.1177/1740774515571139; Lange PW, 2019, J CLIN NURS, V28, P2537, DOI 10.1111/jocn.14833; Levine D., 2016, RADIOLOGY, P280, DOI [10.1148/radiol.2016152641, DOI 10.1148/RADIOL.2016152641]; Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Mayoral R., 2018, SALUD MENT, V41; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Narchi Hassib, 2012, Hosp Pediatr, V2, P93, DOI 10.1542/hpeds.2011-0034; National Institute for Health and Clinical Excellence National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Oh ES, 2020, ALZHEIMERS DEMENT, V16, P726, DOI 10.1002/alz.12076; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pezzullo L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027514; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Prusaczyk B, 2017, CLIN GERONTOLOGIST, V40, P63, DOI 10.1080/07317115.2016.1201714; Salluh J, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h3129, 10.1136/bmj.h2538]; Schmitt EM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.08.004; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Sinclair C., 2020, GERONTOLOGIST, DOI [10.1093/geront/gnaa118, DOI 10.1016/S0140-6736(17)32366-8]; Slooter AJC, 2020, INTENS CARE MED, V46, P1020, DOI 10.1007/s00134-019-05907-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0243254	10.1371/journal.pone.0243254	http://dx.doi.org/10.1371/journal.pone.0243254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RK2GO	33826629	Green Published, gold			2022-12-26	WOS:000638119900050
J	Acevedo-Villanueva, K; Renu, S; Gourapura, R; Selvaraj, R				Acevedo-Villanueva, Keila; Renu, Sankar; Gourapura, Renukaradhya; Selvaraj, Ramesh			Efficacy of a nanoparticle vaccine administered in-ovo against Salmonella in broilers	PLOS ONE			English	Article							CHITOSAN	Salmonella is a zoonotic pathogen that persists in poultry. Salmonella vaccines that can be delivered in-ovo can be cost-effective and can decrease Salmonella load in poultry. This study evaluates the efficacy of a Salmonella chitosan-nanoparticle (CNP) vaccine, administered in-ovo, in broilers. CNP vaccine was synthesized with Salmonella Enteritidis (SE) outer-membrane-proteins (OMPs) and flagellin proteins. At embryonic-d18, one-hundred-thirty-six eggs were injected with 200 mu l PBS or 1000 mu g CNP into the amniotic cavity. At d1-of-age, 132 chicks were allocated in 6 pens/treatment with 11 chicks/pen. At d7, birds were orally challenged with 1x10(9) CFU/bird SE. At d1, 8h-post-challenge, d14, and d21, serum anti-SE-OMPs IgY were analyzed. At d14 and d21, cloacal swabs and bile anti-SE-OMPs IgA, CD4(+)/CD8(+)-T-cell ratios, and ceca SE loads were analyzed. At d21, cecal tonsil IL-1 beta, IL-10, and iNOS mRNA were analyzed. Body-weight-gain (BWG) and feed-conversion-ratio (FCR) were recorded weekly. Data were analyzed by Student's t-test at P<0.05. There were no significant differences in BWG or FCR between vaccinated birds compared to control. At d1, CNP-vaccinated birds had 5.62% greater levels (P<0.05) of anti-SE-OMPs IgY, compared to control. At 8h-post-challenge, CNP-vaccinated birds had 6.39% greater levels (P<0.05) of anti-SE-OMPs IgY, compared to control. At 2wk-post-challenge, CNP-vaccinated birds had 7.34% lower levels (P<0.05) of anti-SE-OMPs IgY, compared to control. At 1wk-post-challenge, CNP-vaccinated birds had 15.30% greater levels (P<0.05) of bile anti-SE-OMPs IgA, compared to control. At d14 and d21, CNP-vaccinated birds had 0.62 and 0.85 Log10 CFU/g, decreased SE ceca load (P<0.05), respectively, compared to control. There were no significant differences in CD4(+)/CD8(+)-T-cell ratios between vaccinated birds compared to control. There were no significant differences in IL-1 beta, IL-10, iNOS mRNA between vaccinated birds compared to control. Findings demonstrate that the in-ovo administration of CNP vaccine can induce an antigen-specific immune response against SE and can decrease SE cecal load in broilers.	[Acevedo-Villanueva, Keila; Selvaraj, Ramesh] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Renu, Sankar; Gourapura, Renukaradhya] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA	University System of Georgia; University of Georgia; University System of Ohio; Ohio State University	Selvaraj, R (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	selvaraj@uga.edu	Sankar, Renu/F-6912-2012	Sankar, Renu/0000-0003-4197-9684; Acevedo-Villanueva, Keila Yanis/0000-0002-4164-7658	Hatch grant; USDA-NIFA [2017-05035, 58-6040-8-034]	Hatch grant; USDA-NIFA(United States Department of Agriculture (USDA))	This research was partially supported by Hatch grant and USDA-NIFA grant 2017-05035 and 58-6040-8-034, awarded to RKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of authors in this manuscript is mentioned in authors contribution section.	Abbas Abul K., 2015, CELL MOL IMMUNOL, V8; Acevedo-Villanueva KY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231998; Akerele G, 2020, VET IMMUNOL IMMUNOP, V224, DOI 10.1016/j.vetimm.2020.110059; Andino A, 2015, ScientificWorldJournal, V2015, P520179, DOI 10.1155/2015/520179; Centers for Disease Control and Prevention, 2020, SALMONELLA; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; Cogan TA, 2003, J APPL MICROBIOL, V94, p114S, DOI 10.1046/j.1365-2672.94.s1.13.x; Fernandes JIM, 2016, BRAZ J POULTRY SCI, V18, P55, DOI 10.1590/1806-9061-2015-0216; Godlewska R, 2016, APPL MICROBIOL BIOT, V100, P8855, DOI 10.1007/s00253-016-7699-x; Gonzalez Carlos., 2016, OVO VACCINATION INTR; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Guo RX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00547; Hansen KR, 2006, J APPL MICROBIOL, V100, P144, DOI 10.1111/j.1365-2672.2005.02758.x; Kang SH, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10090948; Markazi A, 2018, POULTRY SCI, V97, P3510, DOI 10.3382/ps/pey234; McNeill E, 2015, FREE RADICAL BIO MED, V79, P206, DOI 10.1016/j.freeradbiomed.2014.10.575; Mohammed MA, 2017, PHARMACEUTICS, V9, DOI 10.3390/pharmaceutics9040053; Morris A, 2014, POULTRY SCI, V93, P1951, DOI 10.3382/ps.2014-03939; Peebles ED, 2018, POULTRY SCI, V97, P2322, DOI 10.3382/ps/pey081; Penaloza HF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02047; Renu S, 2020, INT J NANOMED, V15, P761, DOI 10.2147/IJN.S238445; Renu S, 2018, INT J NANOMED, V13, P8195, DOI 10.2147/IJN.S185588; Revolledo L, 2012, J APPL POULTRY RES, V21, P418, DOI 10.3382/japr.2011-00409; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Sahdev P, 2014, PHARM RES-DORDR, V31, P2563, DOI 10.1007/s11095-014-1419-y; Sankar Renu, 2018, J IMMUNOL, V200; Selvaraj Ramesh., 2017, Nanoparticle Patent No, Patent No. [10336-342WO1, 10336342]; Shanmugasundaram R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223577; Shanmugasundaram R, 2015, POULTRY SCI, V94, P1828, DOI 10.3382/ps/pev161; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; SHARMA JM, 1985, AVIAN DIS, V29, P1155, DOI 10.2307/1590469; Stern NJ, 2001, POULTRY SCI, V80, P156, DOI 10.1093/ps/80.2.156; Tiwari G, 2012, INT J PHARM INVESTIG, V2, P2, DOI 10.4103/2230-973X.96920; Woodward MJ, 1996, VET REC, V138, P411, DOI 10.1136/vr.138.17.411; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	36	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0247938	10.1371/journal.pone.0247938	http://dx.doi.org/10.1371/journal.pone.0247938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822791	gold, Green Published			2022-12-26	WOS:000637879100028
J	Chen, K; Hou, YF; Liao, R; Li, YZ; Yang, HJ; Gong, J				Chen, Kai; Hou, Yifu; Liao, Rui; Li, Youzan; Yang, Hongji; Gong, Jun			LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1	ONCOGENE			English	Article							LONG NONCODING RNA; CELL-PROLIFERATION; UP-REGULATION; CANCER; PROGRESSION; APOPTOSIS; GROWTH; CERNA; METHYLATION; METASTASIS	Emerging evidence suggests that long noncoding RNAs (lncRNAs) function as competitive endogenous RNA (ceRNA) targeting proteins and genes; however, the role of lncRNAs in hepatocellular carcinoma (HCC) is not well understood. We investigated the mechanism by which lncRNA SNHG6 promotes the development of HCC. RT-qPCR revealed upregulated lncRNA SNHG6 in the HCC setting. Elevated SNHG6 expression was indicative of poor prognosis in patients with HCC. SNHG6 overexpression resulted in increased cyclin D1, cyclin E1, and E2F1 expression both in vitro and in vivo. SNHG6 also promoted HCC cell proliferation by enhancing G1-S phase transition in vitro. Dual luciferase reporter assays, RIP, and RNA pull-down assays demonstrated SNHG6 competitively bound to miR-204-5p and inhibited its expression preventing miR-204-5p from targeting E2F1. Overexpression of miR-204-5p abolished the effect of SNHG6. Our data suggest that SNHG6 functions as a ceRNA that targets miR-204-5p resulting in an increased E2F1 expression and enhanced G1-S phase transition, thereby promoting the tumorigenesis of HCC.	[Chen, Kai; Hou, Yifu; Yang, Hongji] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Organ Transplant Ctr, Chengdu, Peoples R China; [Chen, Kai; Hou, Yifu; Yang, Hongji; Gong, Jun] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Peoples R China; [Chen, Kai; Hou, Yifu; Yang, Hongji] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Ward Hepatobiliary Pancreat Surg 3, Chengdu, Peoples R China; [Liao, Rui; Li, Youzan] Southwest Med Univ, Sch Clin Med, Dept Hepatobiliary, Luzhou, Peoples R China; [Gong, Jun] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Ward Hepatobiliary Pancreat Surg 2, Chengdu, Peoples R China	Sichuan Provincial People's Hospital; Chinese Academy of Sciences; Sichuan Provincial People's Hospital; Southwest Medical University; Sichuan Provincial People's Hospital	Yang, HJ (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Organ Transplant Ctr, Chengdu, Peoples R China.; Yang, HJ; Gong, J (corresponding author), Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Peoples R China.; Yang, HJ (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Ward Hepatobiliary Pancreat Surg 3, Chengdu, Peoples R China.; Gong, J (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Ward Hepatobiliary Pancreat Surg 2, Chengdu, Peoples R China.	yanghongji99@163.com; 756772096@qq.com	Hou, Yifu/GYQ-7105-2022					Ali Syeda Z, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051723; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Birgani MT, 2018, PATHOL ONCOL RES, V24, P329, DOI 10.1007/s12253-017-0241-3; Boon RA, 2016, J AM COLL CARDIOL, V67, P1214, DOI 10.1016/j.jacc.2015.12.051; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao C, 2017, ONCOGENE, V36, P1112, DOI 10.1038/onc.2016.278; Chang L, 2016, CANCER LETT, V383, P183, DOI 10.1016/j.canlet.2016.09.034; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Chen QC, 2018, J CELL PHYSIOL, V233, P1213, DOI 10.1002/jcp.25988; Chu Y, 2018, FEBS OPEN BIO, V8, P189, DOI 10.1002/2211-5463.12363; Duan SH, 2018, ONCOL RES, V26, P713, DOI 10.3727/096504017X15016337254641; Duan YJ, 2016, ONCOTARGET, V7, P45863, DOI 10.18632/oncotarget.10244; Duan YX, 2020, ONCOTARGETS THER, V13, P2701, DOI 10.2147/OTT.S237069; Farra R, 2015, BIOCHIMIE, V112, P85, DOI 10.1016/j.biochi.2015.02.015; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Greten TF, 2019, GASTROENTEROLOGY, V156, P510, DOI 10.1053/j.gastro.2018.09.051; Grieco FA, 2019, J MOL ENDOCRINOL, V63, P139, DOI 10.1530/JME-19-0066; Gu Y, 2018, ONCOL REP, V40, P1863, DOI 10.3892/or.2018.6621; He Y, 2020, LIFE SCI, V252, DOI 10.1016/j.lfs.2020.117656; HU F, 2018, CLIN INFECT DIS, V17; Huang JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20384; Huang Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01188-4; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Ingham M, 2017, J CLIN ONCOL, V35, P2949, DOI 10.1200/JCO.2016.69.0032; Jiang GB, 2017, BIOMED PHARMACOTHER, V90, P806, DOI 10.1016/j.biopha.2017.03.081; Jin Y, 2019, HEPATOL INT, V13, P180, DOI 10.1007/s12072-018-9920-8; Kent LN, 2019, NAT REV CANCER, V19, P326, DOI 10.1038/s41568-019-0143-7; Kumari A, 2015, CELL DEATH DIFFER, V22, P311, DOI 10.1038/cdd.2014.146; Li HM, 2020, ONCOTARGETS THER, V13, P757, DOI 10.2147/OTT.S224550; Li Y, 2018, LIFE SCI, V208, P295, DOI 10.1016/j.lfs.2018.07.032; Liu JY, 2019, PEERJ, V7, DOI 10.7717/peerj.7310; Long JY, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0817-y; Lu M, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110566; Ma L, 2017, ONCOL REP, V38, P2951, DOI 10.3892/or.2017.5971; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Pecoraro A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51723-7; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tsang FHC, 2015, LIVER INT, V35, P1597, DOI 10.1111/liv.12746; Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169; Wu G, 2019, CELL CYCLE, V18, P1849, DOI 10.1080/15384101.2019.1629772; Wu XJ, 2015, FEBS LETT, V589, P645, DOI 10.1016/j.febslet.2015.01.030; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yuan SX, 2016, CANCER LETT, V379, P239, DOI 10.1016/j.canlet.2015.08.008; Zhang J, 2020, J CANCER, V11, P3199, DOI 10.7150/jca.33273; Zhang P, 2020, CANCER BIOMARK, V28, P381, DOI 10.3233/CBM-191064; Zhang Y, 2020, MOL NEUROBIOL, V57, P2377, DOI 10.1007/s12035-020-01887-5; Zhao HW, 2016, ONCOL RES, V23, P237, DOI 10.3727/096504016X14562725373671; Zhao LJ, 2019, AGING-US, V11, P7098, DOI 10.18632/aging.102240; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039	57	9	9	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3217	3230		10.1038/s41388-021-01671-2	http://dx.doi.org/10.1038/s41388-021-01671-2		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33824472				2022-12-26	WOS:000637478800001
J	Moshi, FV				Moshi, Fabiola, V			Prevalence and factors which influence early antenatal booking among women of reproductive age in Tanzania: An analysis of data from the 2015-16 Tanzania Demographic Health Survey and Malaria Indicators Survey	PLOS ONE			English	Article								Background Early initiation of the antenatal clinic is vital as it allows early detection, management, and prevention of problems that may occur during pregnancy time. The analysis aimed to determine the prevalence and factors which influence early antenatal booking among women of reproductive age in Tanzania. Method The study used data from the 2015-16 Tanzania Demographic and Health Survey and Malaria Indicators Survey (2015-16 TDHS-MIS). A total of 6924 women of active reproductive age from 15 to 49 were included in the analysis. Both univariate and multiple regression analyses were used to determine predictors of early antenatal booking. Results Only 1586 (22.9%) of pregnant women had early antenatal booking. After adjusted for the confounders, factors which influenced early antenatal booking were age of a woman [20 to 34 years, Adjusted Odds Ratio (AOR) = 1.554 at 95% Confidence Interval (CI) = 1.213-1.993, and more than 34 years, AOR = 1.758 at 95% CI = 1.306-2.368]; wealth status [rich, AOR = 1.520 at 95% CI = 1.282-1.802]; education level [higher education, AOR = 2.355 at 95% CI = 1.36-4.079]; parity [Para 2 to 3, AOR = 0.85 at 95% CI = 0.727-0.994 and Para 5+, AOR = 0.577 at 95%CI = 0.465-0.715]; zones [Unguja, AOR = 0.433 at 95% CI = 0.284-0.658 and Pemba, AOR = 0.392 at 95% CI = 0.236-0.649]. Conclusion Early antenatal booking in Tanzania is extremely low. Women who were more likely to initiate antenatal visits within the first 12 weeks are those from well-off families, those with higher education, primiparity women, and those from Tanzania mainland urban. The innovative interventional study is highly recommended to come up with an effective strategy to improve timing for antenatal booking.	[Moshi, Fabiola, V] Univ Dodoma, Sch Nursing & Publ Hlth, Dept Nursing Management & Educ, Dodoma, Tanzania		Moshi, FV (corresponding author), Univ Dodoma, Sch Nursing & Publ Hlth, Dept Nursing Management & Educ, Dodoma, Tanzania.	fabiola.moshi@gmail.com	Moshi, Fabiola/ABG-4603-2021	Moshi, Fabiola/0000-0001-8829-2746				Annie Kearns., 2014, FOCUSED ANTENATAL CA, P1; [Anonymous], 2016, WHO REC ANT CAR POS, V368; Arunda M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328796; Belayneh T, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/132494; Enje PMIU, 2012, MED REVIJA MED REV O, V4, P259; Feijen-de Jong EI, 2012, EUR J PUBLIC HEALTH, V22, P904, DOI 10.1093/eurpub/ckr164; Fisseha G., 2015, NO ETHIOPIA J GYNECO, V3, P55, DOI [10.11648/j.jgo.20150303.13, DOI 10.11648/J.JGO.20150303.13]; Geller SE, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0527-2; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Lincetto O., 2013, INT J SCI TECHNOLOGY, V2, P51; Moshi F, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0397-z; National Bureau of Statistics, 2016, TANZ DEM HLTH SURV M, P172; Njiku F, 2017, TANZAN J HLTH RES, V19, P1; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Papadopoulos T., 2011, ORIGINAL ARTICLE ERH, P119; Pearson L., 2007, OPPOR AFRICAS NEWBOR, P63; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; WHO, 2019, DUKE LAW J, V1, P1; Woldeamanuel GG, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119827096; Woldeyes WS., 2018, BMC PREGNANCY CHILDB, V18, P1; World Health Organization, 2019, MAT MORT 2000 2017 I, P1	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249337	10.1371/journal.pone.0249337	http://dx.doi.org/10.1371/journal.pone.0249337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ8VV	33822797	gold, Green Published			2022-12-26	WOS:000637879100037
J	Sheneman, L; Stephanopoulos, G; Vasdekis, AE				Sheneman, Luke; Stephanopoulos, Gregory; Vasdekis, Andreas E.			Deep learning classification of lipid droplets in quantitative phase images	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; OPERATING CHARACTERISTIC CURVES; RANDOM FOREST; DIFFRACTION TOMOGRAPHY; DISCRIMINANT-ANALYSIS; MULTIPLE-SCATTERING; JACCARD INDEX; SEGMENTATION; CELLS; ALGORITHM	We report the application of supervised machine learning to the automated classification of lipid droplets in label-free, quantitative-phase images. By comparing various machine learning methods commonly used in biomedical imaging and remote sensing, we found convolutional neural networks to outperform others, both quantitatively and qualitatively. We describe our imaging approach, all implemented machine learning methods, and their performance with respect to computational efficiency, required training resources, and relative method performance measured across multiple metrics. Overall, our results indicate that quantitative-phase imaging coupled to machine learning enables accurate lipid droplet classification in single living cells. As such, the present paradigm presents an excellent alternative of the more common fluorescent and Raman imaging modalities by enabling label-free, ultra-low phototoxicity, and deeper insight into the thermodynamics of metabolism of single cells.	[Sheneman, Luke] Univ Idaho, Northwest Knowledge Network, Moscow, ID 83843 USA; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Vasdekis, Andreas E.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA	Idaho; University of Idaho; Massachusetts Institute of Technology (MIT); Idaho; University of Idaho	Sheneman, L (corresponding author), Univ Idaho, Northwest Knowledge Network, Moscow, ID 83843 USA.; Vasdekis, AE (corresponding author), Univ Idaho, Dept Phys, Moscow, ID 83844 USA.	sheneman@uidaho.edu; andreasv@uidaho.edu		Sheneman, Lucas/0000-0001-8781-2041	U.S. Department of Energy (DoE) [DE-SC0019249]	U.S. Department of Energy (DoE)(United States Department of Energy (DOE))	The work described in this manuscript was funded by a U.S. Department of Energy (DoE) grant (DE-SC0019249) entitled, "Multi-Modal Imager of Metabolome and Enzyme Dynamics for Co-Optimizing Yields and Titers in Biofuel Producing Microorganisms". Two manuscript authors: AEV (Project PI) and LJS (Project Senior Personnel) received funding under this DoE award. URL of funder: www.doe.gov The funder (DoE, Grant #DE-SC0019249) provided funding for the study design, data collection/analysis, and preparation of the manuscript. However, the funder was not an active hands-on participant in any of these activities.	Abdiansah A., 2015, TIME COMPLEXITY ANAL; Alanazi H, 2017, CYTOM PART A, V91A, P443, DOI 10.1002/cyto.a.23099; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Audebert N, 2017, LECT NOTES COMPUT SC, V10111, P180, DOI 10.1007/978-3-319-54181-5_12; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bakas S., 2016, GLISTRBOOST COMBININ; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Belgiu M, 2016, ISPRS J PHOTOGRAMM, V114, P24, DOI 10.1016/j.isprsjprs.2016.01.011; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bertels J., 2019, OPTIMIZING DICE SCOR; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Breiman L., 2001, MACH LEARN, V45, P5; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chakraborty S, 2017, 2017 IEEE SMARTWORLD, UBIQUITOUS INTELLIGENCE & COMPUTING, ADVANCED & TRUSTED COMPUTED, SCALABLE COMPUTING & COMMUNICATIONS, CLOUD & BIG DATA COMPUTING, INTERNET OF PEOPLE AND SMART CITY INNOVATION (SMARTWORLD/SCALCOM/UIC/ATC/CBDCOM/IOP/SCI); Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Coradetti ST, 2018, ELIFE, V7, DOI 10.7554/eLife.32110; Cruz ALS, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2297-3; Daemen S, 2016, MOL METAB, V5, P153, DOI 10.1016/j.molmet.2015.12.005; Deng M, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-0267-2; Desir C., 2012, RANDOM FOREST BASED; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Feng QL, 2015, REMOTE SENS-BASEL, V7, P1074, DOI 10.3390/rs70101074; Fidon L, 2018, LECT NOTES COMPUT SC, V10670, P64, DOI 10.1007/978-3-319-75238-9_6; Fontana JM, 2013, IEEE ENG MED BIO, P6756, DOI 10.1109/EMBC.2013.6611107; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Fukuda H, 2001, J BIOSCI BIOENG, V92, P405, DOI 10.1016/S1389-1723(01)80288-7; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Garcia EJ, 2018, FRONT BIOSCI-LANDMRK, V23, P1552, DOI 10.2741/46601; Georganos S, 2018, IEEE GEOSCI REMOTE S, V15, P607, DOI 10.1109/LGRS.2018.2803259; Gibert X, 2015, IEEE IMAGE PROC, P621, DOI 10.1109/ICIP.2015.7350873; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Gjorloff-Wingren A, 2017, CYTOM PART A, V91A, P752, DOI 10.1002/cyto.a.23104; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Gopalakrishnan K, 2017, CONSTR BUILD MATER, V157, P322, DOI 10.1016/j.conbuildmat.2017.09.110; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gu L., 2017, SEMISUPERVISED LEARN; Guo YM, 2018, INT J MULTIMED INF R, V7, P87, DOI 10.1007/s13735-017-0141-z; HAMERS L, 1989, INFORM PROCESS MANAG, V25, P315, DOI 10.1016/0306-4573(89)90048-4; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Herms A, 2013, CURR BIOL, V23, P1489, DOI 10.1016/j.cub.2013.06.032; Hu FH, 2019, NAT METHODS, V16, P830, DOI 10.1038/s41592-019-0538-0; Izenman AJ, 2008, SPRINGER TEXTS STAT, P237, DOI 10.1007/978-0-387-78189-1_8; Jia WJ, 2019, MATH FDN COMPUT, V2, P73, DOI 10.3934/mfc.2019006; Jin D, 2017, J OPT SOC AM B, V34, pB64, DOI 10.1364/JOSAB.34.000B64; Jo Y, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2018.2859234; Jog A, 2017, MED IMAGE ANAL, V35, P475, DOI 10.1016/j.media.2016.08.009; Jung J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24393-0; Kamilov US, 2015, OPTICA, V2, P517, DOI 10.1364/OPTICA.2.000517; Kang L, 2014, INT C PATT RECOG, P3168, DOI 10.1109/ICPR.2014.546; KANOPOULOS N, 1988, IEEE J SOLID-ST CIRC, V23, P358, DOI 10.1109/4.996; Kensert A, 2019, SLAS DISCOV, V24, P466, DOI 10.1177/2472555218818756; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Khan A, 2020, ARTIF INTELL REV, V53, P5455, DOI 10.1007/s10462-020-09825-6; Khotanzad A, 1998, NEURAL COMPUT APPL, V7, P249, DOI 10.1007/BF01414886; Kim G, 2019, BIOSENS BIOELECTRON, V123, P69, DOI 10.1016/j.bios.2018.09.068; Kim T, 2014, NAT PHOTONICS, V8, P256, DOI [10.1038/NPHOTON.2013.350, 10.1038/nphoton.2013.350]; Knuth D.E., 1997, ART COMPUTER PROGRAM, V3; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee D, 2019, TRANSPORT RES REC, V2673, P865, DOI 10.1177/0361198119857953; Lee J, 2019, IEEE ACCESS, V7, P83449, DOI 10.1109/ACCESS.2019.2924255; Lee KCM, 2019, CYTOM PART A, V95A, P510, DOI 10.1002/cyto.a.23765; Lemaitre G., 2015, INT C QUAL CONTR ART, V9534; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; Lim J, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0195-1; Little MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix020; Lobo A, 1997, IEEE T GEOSCI REMOTE, V35, P1136, DOI 10.1109/36.628781; Majeed H, 2017, J BIOPHOTONICS, V10, P177, DOI 10.1002/jbio.201600113; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moeskops P., 2016, DEEP LEARNING MULTIT; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Mursalin M, 2017, NEUROCOMPUTING, V241, P204, DOI 10.1016/j.neucom.2017.02.053; Murtagh F., 1991, NEUROCOMPUTING, V2, P183, DOI [10.1016/0925-2312(91)90023-5, DOI 10.1016/0925-2312(91)90023-5]; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Nanni L., 2018, APPL COMPUT INFORM, DOI [DOI 10.1016/J.ACI.2018.06.002, 10.1016/j.aci.2018.06.002]; Nedjar I, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415400254; Nguyen TH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44034; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Pan F., 2009, P 18 ACM C INFORM KN; Pang B, 2020, J EDUC BEHAV STAT, V45, P227, DOI 10.3102/1076998619872761; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Park Y, 2018, NAT PHOTONICS, V12, P578, DOI 10.1038/s41566-018-0253-x; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rao H, 2019, APPL SOFT COMPUT, V74, P634, DOI 10.1016/j.asoc.2018.10.036; Rawat W, 2017, NEURAL COMPUT, V29, P2352, DOI [10.1162/NECO_a_00990, 10.1162/neco_a_00990]; Rivenson Y, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0196-0; Rivenson Y, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0129-y; Roingeard P, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12688; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Sharifi M, 2002, INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: CODING AND COMPUTING, PROCEEDINGS, P117, DOI 10.1109/ITCC.2002.1000371; Shmilovici A, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P257, DOI 10.1007/0-387-25465-X_12; Singh V, 2020, OPT LASER TECHNOL, V124, DOI 10.1016/j.optlastec.2019.105980; Slavkovikj V, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1159, DOI 10.1145/2733373.2806306; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Soukup D, 2014, LECT NOTES COMPUT SC, V8887, P668, DOI 10.1007/978-3-319-14249-4_64; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sun Y, 2018, OPT EXPRESS, V26, P14678, DOI 10.1364/OE.26.014678; Suthaharan S, 2016, INTEGR SER INFORM SY, V36, P1, DOI 10.1007/978-1-4899-7641-3; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Ueno M, 2013, J LIPID RES, V54, P734, DOI 10.1194/jlr.M033365; Vasdekis AE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08717-w; Vasdekis AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep17689; Venkata HNN, 2012, CHEM BIOL, V19, P1373, DOI 10.1016/j.chembiol.2012.08.020; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vorontsov IE, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-23; Wang CW, 2016, BBA-MOL CELL BIOL L, V1861, P793, DOI 10.1016/j.bbalip.2015.12.010; Wang XY, 2011, PATTERN RECOGN, V44, P777, DOI 10.1016/j.patcog.2010.08.008; Wang YY, 2019, APPL SOFT COMPUT, V77, P188, DOI 10.1016/j.asoc.2019.01.015; Wang ZB, 2020, ARTIF INTELL REV, V53, P5637, DOI 10.1007/s10462-020-09830-9; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolf E., 1969, Optics Communications, V1, P153, DOI 10.1016/0030-4018(69)90052-2; Xanthopoulos P., 2013, ROBUST DATA MINING, P27, DOI DOI 10.1007/978-1-4419-9878-1_4; Yang T, 2016, BIOMED SIGNAL PROCES, V28, P50, DOI 10.1016/j.bspc.2016.04.004; Yoo J., 2019, IEEE T MED IMAGING; Zangle TA, 2014, NAT METHODS, V11, P1221, DOI 10.1038/nmeth.3175; Zelinsky A., 2008, IEEE ROBOT AUTOM MAG, V16, P100; Zhang JFK, 2020, APL PHOTONICS, V5, DOI 10.1063/5.0004723	137	5	5	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249196	10.1371/journal.pone.0249196	http://dx.doi.org/10.1371/journal.pone.0249196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819277	Green Published, gold, Green Submitted			2022-12-26	WOS:000637647200044
J	Nguyen, QH; Ly, HB; Nguyen, TA; Phan, VH; Nguyen, LK; Tran, VQ				Quang Hung Nguyen; Hai-Bang Ly; Thuy-Anh Nguyen; Viet-Hung Phan; Long Khanh Nguyen; Van Quan Tran			Investigation of ANN architecture for predicting shear strength of fiber reinforcement bars concrete beams	PLOS ONE			English	Article							CRITICAL BUCKLING LOAD; LANDSLIDE SUSCEPTIBILITY; DESIGN EQUATIONS; NEURAL-NETWORK; MEMBERS; MODELS; ALGORITHMS; FRAMEWORK; CAPACITY; BEHAVIOR	In this paper, an extensive simulation program is conducted to find out the optimal ANN model to predict the shear strength of fiber-reinforced polymer (FRP) concrete beams containing both flexural and shear reinforcements. For acquiring this purpose, an experimental database containing 125 samples is collected from the literature and used to find the best architecture of ANN. In this database, the input variables consist of 9 inputs, such as the ratio of the beam width, the effective depth, the shear span to the effective depth, the compressive strength of concrete, the longitudinal FRP reinforcement ratio, the modulus of elasticity of longitudinal FRP reinforcement, the FRP shear reinforcement ratio, the tensile strength of FRP shear reinforcement, the modulus of elasticity of FRP shear reinforcement. Thereafter, the selection of the appropriate architecture of ANN model is performed and evaluated by common statistical measurements. The results show that the optimal ANN model is a highly efficient predictor of the shear strength of FRP concrete beams with a maximum R-2 value of 0.9634 on the training part and an R-2 of 0.9577 on the testing part, using the best architecture. In addition, a sensitivity analysis using the optimal ANN model over 500 Monte Carlo simulations is performed to interpret the influence of reinforcement type on the stability and accuracy of ANN model in predicting shear strength. The results of this investigation could facilitate and enhance the use of ANN model in different real-world problems in the field of civil engineering.	[Quang Hung Nguyen] Thuyloi Univ, Hanoi, Vietnam; [Hai-Bang Ly; Thuy-Anh Nguyen; Long Khanh Nguyen; Van Quan Tran] Univ Transport Technol, Hanoi, Vietnam; [Viet-Hung Phan] Univ Transport & Commun, Hanoi, Vietnam	Thuyloi University; University of Transport & Communications (UTC)	Nguyen, QH (corresponding author), Thuyloi Univ, Hanoi, Vietnam.; Nguyen, TA (corresponding author), Univ Transport Technol, Hanoi, Vietnam.	hungwuhan@tlu.edu.vn; anhnt@utt.edu.vn		Tran, Van Quan/0000-0002-4157-7717; Nguyen, Thuy-Anh/0000-0003-4266-1707				Abbasloo AA, 2019, MAG CONCRETE RES, V71, P271, DOI 10.1680/jmacr.17.00425; Ahmed EA, 2010, J BRIDGE ENG, V15, P44, DOI 10.1061/(ASCE)BE.1943-5592.0000035; Al-Gasham TS, 2020, CASE STUD CONSTR MAT, V13, DOI 10.1016/j.cscm.2020.e00363; Alam MS, 2012, J COMPOS CONSTR, V16, P119, DOI 10.1061/(ASCE)CC.1943-5614.0000248; Alkhrdaji T, 2001, COMPOSITES IN CONSTRUCTION, P409; Alsayed SH, 1997, NONMETALLIC FRP REIN, V2, P285; [Anonymous], 2003, 440 ACI COMM; [Anonymous], GUIDE DESIGN CONSTRU; Argatov II, 2019, TRIBOL INT, V138, P211, DOI 10.1016/j.triboint.2019.05.040; Association C. C. S, 2014, CAN HIGHW BRIDG DES; Barris C, 2012, J CIV ENG MANAG, V18, P843, DOI 10.3846/13923730.2012.720934; Bentz EC, 2010, J COMPOS CONSTR, V14, P637, DOI 10.1061/(ASCE)CC.1943-5614.0000108; Pham BT, 2020, WATER-SUI, V12, DOI 10.3390/w12010239; Pham BT, 2019, SCI TOTAL ENVIRON, V679, P172, DOI 10.1016/j.scitotenv.2019.05.061; Pham B, 2017, J INDIAN SOC REMOTE, V45, P673, DOI 10.1007/s12524-016-0620-3; Budvytis M., 2018, ENG STRUCTURES TECHN, V10, P46; Burden Frank, 2008, V458, P25; Bywalski C, 2016, ARCH CIV MECH ENG, V16, P901, DOI 10.1016/j.acme.2016.06.006; Chahrour A, 2005, J COMPOS CONSTR, V9, P170, DOI 10.1061/(ASCE)1090-0268(2005)9:2(170); Cosenza E., 2001, COMPOSITES CONSTRUCT; Dao DV, 2020, CATENA, V188, DOI 10.1016/j.catena.2019.104451; Dao DV, 2020, MATERIALS, V13, DOI 10.3390/ma13051072; Dao DV, 2019, MATERIALS, V12, DOI 10.3390/ma12060983; Dou J, 2019, NAT HAZARDS, V97, P579, DOI 10.1007/s11069-019-03659-4; Duranovic N, 1997, NONMET REINF CONCR S, V2, P479; FAZA A. N. S., 2002, DESIGNING CONSTRUCTI, P49; Fico R, 2008, COMPOS PART B-ENG, V39, P792, DOI 10.1016/j.compositesb.2007.10.007; Foresee FD, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1930, DOI 10.1109/ICNN.1997.614194; Gallant S.I., 1993, NEURAL NETWORK LEARN; Goh ATC, 1995, GEOTECHNIQUE, V45, P709, DOI 10.1680/geot.1995.45.4.709; Guilleminot J, 2013, ACTA MECH SINICA-PRC, V29, P773, DOI 10.1007/s10409-013-0101-7; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245458; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183841; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112258; Ly HB, 2019, MATERIALS, V12, DOI 10.3390/ma12111828; Harris H.G., 1998, J COMPOS CONSTR, V2, P28, DOI 10.1061/%28ASCE%291090-0268%281998%292%3A1%2828%29; Hola J, 2015, B POL ACAD SCI-TECH, V63, P87, DOI 10.1515/bpasts-2015-0010; Nguyen HQ, 2020, MATERIALS, V13, DOI 10.3390/ma13051205; Kanellopoulos I, 1997, INT J REMOTE SENS, V18, P711, DOI 10.1080/014311697218719; Kayri Murat, 2016, Mathematical & Computational Applications, V21, DOI 10.3390/mca21020020; Chang KT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48773-2; Li GH, 2018, MATERIALS, V11, DOI 10.3390/ma11061028; Le LM, 2019, MATERIALS, V12, DOI 10.3390/ma12101670; Ly HB, 2019, MATERIALS, V12, DOI 10.3390/ma12091544; Machida A., 1997, RECOMMENDATION DESIG; MACKAY DJC, 1992, NEURAL COMPUT, V4, P448, DOI 10.1162/neco.1992.4.3.448; Maruyama K., 1994, FLEXURAL SHEAR BEHAV; Maruyama K., 1996, SIZE EFFECT SHEAR BE, P227; Mohamed HM, 2014, J COMPOS CONSTR, V18, DOI 10.1061/(ASCE)CC.1943-5614.0000429; Mordechai S., 2011, APPL MONTE CARLO MET; Nagasaka T, 1993, SPEC PUBL J L B SMIT, V138, P789, DOI 10.14359/4138; Nagendra S., 1998, PRACTICAL ASPECTS US; Nakamura H, 1995, DOBOKU GAKKAI RONBUN, V1995, P89; Nanni A, 1993, PROPERTIES APPL DEV; Neale K.W, 1992, 1 INT C SHERBR QUEB; Nehdi M, 2008, MATER STRUCT, V41, P1713, DOI 10.1617/s11527-008-9359-9; Nehdi M, 2007, J MATER CIVIL ENG, V19, P1033, DOI 10.1061/(ASCE)0899-1561(2007)19:12(1033); Neville A.M., 2013, PROPERTIES CONCRETE; Niewels J, ZUM TRAGVERHALTEN BE, P299; Okamoto T, 1994, J STRUCT CONSTR ENG, V59, P127; Orneman Z, 2008, CAN J CIVIL ENG, V35, P1, DOI 10.1139/L07-080; Pham BT, 2019, GEOCARTO INT, V34, P1385, DOI 10.1080/10106049.2018.1489422; Pham BT, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062339; Qi CC, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125450; Nguyen QH, 2020, MOLECULES, V25, DOI 10.3390/molecules25153486; Razaqpur AG, 2015, J COMPOS CONSTR, V19, DOI 10.1061/(ASCE)CC.1943-5614.0000483; Razaqpur AG, 2006, ACI STRUCT J, V103, P93; Shehata E, 2000, CAN J CIVIL ENG, V27, P859, DOI 10.1139/cjce-27-5-859; Shehata EF, 1999, FIBRE REINFORCED POL; Staber B, 2019, COMPUT METHOD APPL M, V347, P425, DOI 10.1016/j.cma.2018.12.036; Standard C. S. A, 2002, DESIGN CONSTRUCTION; Taerwe L, 1997, P INT CONFERENCENEW, P15; Tighiouart B, 1998, CONSTR BUILD MATER, V12, P453, DOI 10.1016/S0950-0618(98)00027-0; Tottori S, 1993, PROC ACI SP DETROIT, V138, P615, DOI DOI 10.14359/3944; Pham TA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051871; Nguyen VT, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247118; Vijay P.V., 1996, SHEAR DUCTILITY BEHA; Yong WX, 2021, ENG COMPUT-GERMANY, V37, P2111, DOI 10.1007/s00366-019-00932-9; Yost JR, 2001, J COMPOS CONSTR, V5, P268, DOI 10.1061/(ASCE)1090-0268(2001)5:4(268); Zhao W., 1995, 2 INT S NONM FRP REI, V23, P352; Zhou RY, 2018, FORESTS, V9, DOI 10.3390/f9120757	81	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0247391	10.1371/journal.pone.0247391	http://dx.doi.org/10.1371/journal.pone.0247391			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798200	Green Published, gold			2022-12-26	WOS:000636737700031
J	Amrenova, A; Suzuki, K; Saenko, V; Yamashita, S; Mitsutake, N				Amrenova, Aidana; Suzuki, Keiji; Saenko, Vladimir; Yamashita, Shunichi; Mitsutake, Norisato			Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue	PLOS ONE			English	Article								The microenvironment of an early-stage tumor, in which a small number of cancer cells is surrounded by a normal counterpart milieu, plays a crucial role in determining the fate of initiated cells. Here, we examined cell competition between anaplastic thyroid cancer cells and normal thyroid follicular cells using co-culture method. Cancer cells were grown until they formed small clusters, to which normal cells were added to create high-density co-culture condition. We found that co-culture with normal cells significantly suppressed the growth of cancer cell clusters through the activation of Akt-Skp2 pathway. In turn, cancer cells triggered apoptosis in the neighboring normal cells through local activation of ERK1/2. A bi-directional cell competition provides a suppressive mechanism of anaplastic thyroid cancer progression. Since the competitive effect was negated by terminal growth arrest caused by radiation exposure to normal cells, modulation of reciprocal stress response in vivo could be an intrinsic mechanism associated with tumor initiation, propagation, and metastasis.	[Amrenova, Aidana; Suzuki, Keiji; Mitsutake, Norisato] Nagasaki Univ, Grad Sch Biomed Sci, Life Sci & Radiat Res, Nagasaki, Japan; [Amrenova, Aidana; Suzuki, Keiji; Saenko, Vladimir; Yamashita, Shunichi; Mitsutake, Norisato] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki, Japan; [Yamashita, Shunichi] Fukushima Med Univ, Fukushima, Japan; [Yamashita, Shunichi] Natl Inst Quantum & Radiol Sci & Technol, Ctr Adv Radiat Emergency Med, Chiba, Japan	Nagasaki University; Nagasaki University; Fukushima Medical University; National Institutes for Quantum Science & Technology	Suzuki, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Life Sci & Radiat Res, Nagasaki, Japan.; Suzuki, K (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki, Japan.	kzsuzuki@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	, Keiji/0000-0002-6635-9185				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Archetti M, 2019, NAT REV CANCER, V19, P110, DOI 10.1038/s41568-018-0083-7; Baker NE, 2020, NAT REV GENET, V21, P683, DOI 10.1038/s41576-020-0262-8; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bowling S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167486; Bras-Pereira C, 2018, CURR OPIN CELL BIOL, V51, P15, DOI 10.1016/j.ceb.2017.10.003; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chung SH, 2002, JPN J CANCER RES, V93, P1358, DOI 10.1111/j.1349-7006.2002.tb01245.x; Claveria C, 2016, ANNU REV CELL DEV BI, V32, P411, DOI 10.1146/annurev-cellbio-111315-125142; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Corominas-Murtra B, 2020, P NATL ACAD SCI USA, V117, P16969, DOI 10.1073/pnas.1921205117; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Di Giacomo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13002-1; Di Gregorio A, 2016, DEV CELL, V38, P621, DOI 10.1016/j.devcel.2016.08.012; Ecker K, 2009, NAT CELL BIOL, V11, P377, DOI [10.1038/ncb1859, 10.1038/ncb0409-377]; Ellis SJ, 2019, NATURE, V569, P497, DOI 10.1038/s41586-019-1199-y; Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9; Gogna R, 2020, SEMIN CANCER BIOL, V63, pIII, DOI 10.1016/j.semcancer.2020.04.005; Gogna R, 2015, ANNU REV GENET, V49, P697, DOI 10.1146/annurev-genet-112414-055214; Gutierrez-Martinez A, 2020, SEMIN CANCER BIOL, V63, P27, DOI 10.1016/j.semcancer.2019.05.015; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Ibrahimpasic T, 2019, THYROID, V29, P311, DOI 10.1089/thy.2018.0509; Iyer PC, 2018, THYROID, V28, P79, DOI 10.1089/thy.2017.0285; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kasaian K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1955-9; Kim W, 2020, TRENDS GENET, V36, P490, DOI 10.1016/j.tig.2020.04.003; Kitahara CM, 2020, NAT REV ENDOCRINOL, V16, P617, DOI 10.1038/s41574-020-00414-9; Kolahgar G, 2015, DEV CELL, V34, P297, DOI 10.1016/j.devcel.2015.06.010; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kunstman JW, 2015, HUM MOL GENET, V24, P2318, DOI 10.1093/hmg/ddu749; Lee SE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.12; Levayer R, 2020, SEMIN CANCER BIOL, V63, P69, DOI 10.1016/j.semcancer.2019.05.004; Levine AJ, 2020, NAT REV CANCER, V20, P471, DOI 10.1038/s41568-020-0262-1; Lin B, 2019, AM J TRANSL RES, V11, P5888; Liu N, 2019, NATURE, V568, P344, DOI 10.1038/s41586-019-1085-7; Liu ZM, 2019, APPL IMMUNOHISTO M M, V27, P59, DOI 10.1097/PAI.0000000000000544; Madan E, 2019, NATURE, V572, P260, DOI 10.1038/s41586-019-1429-3; Madan E, 2018, CURR OPIN CELL BIOL, V55, P150, DOI 10.1016/j.ceb.2018.08.002; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Menendez J, 2010, P NATL ACAD SCI USA, V107, P14651, DOI 10.1073/pnas.1009376107; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Moreno E, 2019, CURR BIOL, V29, P23, DOI 10.1016/j.cub.2018.11.007; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Moya IM, 2019, SCIENCE, V366, P1029, DOI 10.1126/science.aaw9886; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Murai K, 2018, CELL STEM CELL, V23, P687, DOI 10.1016/j.stem.2018.08.017; Nagata R, 2018, DEV GROWTH DIFFER, V60, P522, DOI 10.1111/dgd.12575; Nikiforov YE, 2016, NAT REV ENDOCRINOL, V12, P67, DOI 10.1038/nrendo.2015.217; Paglia S, 2020, SEMIN CANCER BIOL, V63, P49, DOI 10.1016/j.semcancer.2019.05.009; Parker T, 2020, TRENDS CANCER, V6, P732, DOI [10.1016/j.trecan.2020.03008, 10.1016/j.trecan.2020.03.008]; Parker TM, 2020, SEMIN CANCER BIOL, V63, P1, DOI 10.1016/j.semcancer.2019.09.003; Pelham CJ, 2020, SEMIN CANCER BIOL, V63, P11, DOI 10.1016/j.semcancer.2019.07.008; Pereira M, 2020, THYROID, V30, P1132, DOI 10.1089/thy.2019.0415; Pozdeyev N, 2020, SEMIN CANCER BIOL, V61, P23, DOI 10.1016/j.semcancer.2020.01.005; Rasband W.S., 1997, IMAGEJ; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019354; Tamori Y, 2013, DEV CELL, V25, P350, DOI 10.1016/j.devcel.2013.04.013; Tanimura N, 2020, SEMIN CANCER BIOL, V63, P44, DOI 10.1016/j.semcancer.2019.05.011; Tiedje V, 2020, NAT REV ENDOCRINOL, V16, P77, DOI 10.1038/s41574-019-0307-2; Tsuboi A, 2018, CURR BIOL, V28, P2115, DOI 10.1016/j.cub.2018.05.029; del Campo CV, 2014, CELL REP, V8, P1741, DOI 10.1016/j.celrep.2014.08.005; Vishwakarma M, 2020, NAT REV CANCER, V20, P187, DOI 10.1038/s41568-019-0231-8; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Watanabe H, 2018, CELL REP, V23, P3721, DOI 10.1016/j.celrep.2018.05.081; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Yoo SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10680-5; Zanconato F, 2019, NAT REV CANCER, V19, P454, DOI 10.1038/s41568-019-0168-y	76	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249059	10.1371/journal.pone.0249059	http://dx.doi.org/10.1371/journal.pone.0249059			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793628	Green Published, gold			2022-12-26	WOS:000636467000070
J	Nagasawa, Y; Takei, M; Iwata, M; Nagatsuka, Y; Tsuzuki, H; Imai, K; Imadome, KI; Fujiwara, S; Kitamura, N				Nagasawa, Yosuke; Takei, Masami; Iwata, Mitsuhiro; Nagatsuka, Yasuko; Tsuzuki, Hiroshi; Imai, Kenichi; Imadome, Ken-Ichi; Fujiwara, Shigeyoshi; Kitamura, Noboru			Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2R gamma(null) mice	PLOS ONE			English	Article								Many human viruses, including Epstein-Barr virus (EBV), do not infect mice, which is challenging for biomedical research. We have previously reported that EBV infection induces erosive arthritis, which histologically resembles rheumatoid arthritis, in humanized NOD/Shi-scid/IL-2R gamma(null) (hu-NOG) mice; however, the underlying mechanisms are not known. Osteoclast-like multinucleated cells were observed during bone erosion in this mouse model, and therefore, we aimed to determine whether the human or mouse immune system activated bone erosion and analyzed the characteristics and origin of the multinucleated cells in hu-NOG mice. Sections of the mice knee joint tissues were immunostained with anti-human antibodies against certain osteoclast markers, including cathepsin K and matrix metalloproteinase-9 (MMP-9). Multinucleated cells observed during bone erosion stained positively for human cathepsin K and MMP-9. These results indicate that human osteoclasts primarily induce erosive arthritis during EBV infections. Human osteoclast development from hematopoietic stem cells transplanted in hu-NOG mice remains unclear. To confirm their differentiation potential into human osteoclasts, we cultured bone marrow cells of EBV-infected hu-NOG mice and analyzed their characteristics. Multinucleated cells cultured from the bone marrow cells stained positive for human cathepsin K and human MMP-9, indicating that bone marrow cells of hu-NOG mice could differentiate from human osteoclast progenitor cells into human osteoclasts. These results indicate that the human immune response to EBV infection may induce human osteoclast activation and cause erosive arthritis in this mouse model. Moreover, this study is the first, to our knowledge, to demonstrate human osteoclastogenesis in humanized mice. We consider that this model is useful for studying associations of EBV infections with rheumatoid arthritis and human bone metabolism.	[Nagasawa, Yosuke; Takei, Masami; Iwata, Mitsuhiro; Nagatsuka, Yasuko; Tsuzuki, Hiroshi; Fujiwara, Shigeyoshi; Kitamura, Noboru] Nihon Univ, Sch Med, Div Hematol & Rheumatol, Dept Med, Tokyo, Japan; [Imai, Kenichi] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo, Japan; [Imadome, Ken-Ichi] Natl Ctr Child Hlth & Dev, Dept Adv Med Infect, Tokyo, Japan; [Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan	Nihon University; Nihon University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Takei, M; Kitamura, N (corresponding author), Nihon Univ, Sch Med, Div Hematol & Rheumatol, Dept Med, Tokyo, Japan.	takei.masami@nihon-u.ac.jp; kitamura.noboru@nihon-u.ac.jp			MEXT; Nihon University	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University	This work was supported by the MEXTSupported Program for the Strategic Research Foundation at Private Universities and Nihon University Multidisciplinary Research Grant for 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018; Blaschke S, 2000, J RHEUMATOL, V27, P866; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Croia C, 2014, ARTHRITIS RHEUMATOL, V66, P2545, DOI 10.1002/art.38726; Croia C, 2013, ANN RHEUM DIS, V72, P1559, DOI 10.1136/annrheumdis-2012-202352; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Ding Y, 2015, INT J CLIN EXP MED, V8, P6073; Dittfeld A, 2016, CENT EUR J IMMUNOL, V41, P297, DOI 10.5114/ceji.2016.63130; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Edinger JW, 1999, J IMMUNOL, V162, P3694; Fernandez-Menendez S, 2016, J NEUROL SCI, V361, P213, DOI 10.1016/j.jns.2016.01.013; FOX RI, 1992, J RHEUMATOL, V19, P18; Fujiwara S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.88; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Hanlon P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4429; IBBOTSON KJ, 1984, J CELL BIOL, V99, P471, DOI 10.1083/jcb.99.2.471; Inoue H, 2001, J IMMUNOL, V166, P5801, DOI 10.4049/jimmunol.166.9.5801; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Knipe Condit R. C., 2001, FIELDS VIROLOGY, V1, P19; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kuwana Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026630; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; McClain MT, 2006, ARTHRITIS RHEUM-US, V54, P360, DOI 10.1002/art.21682; Mehraein Y, 2004, MODERN PATHOL, V17, P781, DOI 10.1038/modpathol.3800119; Nagata K, 2015, AUTOIMMUNITY, V48, P328, DOI 10.3109/08916934.2015.1022163; Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109; Niedobitek G, 2000, ARTHRITIS RHEUM, V43, P151, DOI 10.1002/1529-0131(200001)43:1<151::AID-ANR19>3.0.CO;2-I; OKADA Y, 1995, LAB INVEST, V72, P311; Pasoto SG, 2013, RHEUMATOL INT, V33, P1149, DOI 10.1007/s00296-012-2504-3; Pathi SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008849; Saal JG, 1999, ARTHRITIS RHEUM-US, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takeda T, 2000, ARTHRITIS RHEUM, V43, P1218, DOI 10.1002/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2; Takei M, 1997, INT IMMUNOL, V9, P739, DOI 10.1093/intimm/9.5.739; Toussirot E, 2007, JOINT BONE SPINE, V74, P418, DOI 10.1016/j.jbspin.2007.05.001; WUCHERPFENNIG AL, 1994, J BONE MINER RES, V9, P549; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249340	10.1371/journal.pone.0249340	http://dx.doi.org/10.1371/journal.pone.0249340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793647	Green Published, gold			2022-12-26	WOS:000636467000040
J	Alshogran, OY; Al-Eitan, LN; Altawalbeh, SM; Aman, HA				Alshogran, Osama Y.; Al-Eitan, Laith N.; Altawalbeh, Shoroq M.; Aman, Hatem A.			Association of DRD4 exon III and 5-HTTLPR VNTR genetic polymorphisms with psychiatric symptoms in hemodialysis patients	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; ANXIETY-RELATED TRAITS; DEPRESSION; DISORDERS; CHILDREN; ALLELE; ADHD; TPH	Mental illness is prevalent among hemodialysis (HD) patients. Given that the dopaminergic and serotonergic pathways are involved in the etiology of psychiatric disease, this study evaluated the genetic association of dopamine D4 receptor (DRD4) and serotonin transporter (SLC6A4) genes with psychiatric symptom susceptibility among HD patients. Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depressive symptoms among patients (n = 265). Genetic polymorphisms of DRD4 (48 bp VNTR) and SLC6A4 (5-HTTLPR VNTR and rs25531) were examined using a conventional polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique, as appropriate. Significant differences were observed in the distribution of 5-HTTLPR genotypes, SLC6A4 tri-allelic-phased genotype, and DRD4-Exon III VNTR genotypes/alleles between patients with anxiety symptoms versus those with normal/borderline conditions (p<0.05). Binary logistic regression analyses showed that the heterozygous 4,5 VNTR genotype of DRD4 was associated with a higher risk of anxiety symptoms after adjusting for other covariates (odds ratio = 4.25, p = 0.028). None of the studied polymorphisms was linked to depression in HD patients. Collectively, the current findings provide genetic clues to psychopathology in HD patients and suggest that the DRD4 exon III VNTR polymorphism is involved in the etiology of anxiety in this patient population.	[Alshogran, Osama Y.; Altawalbeh, Shoroq M.] Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan; [Al-Eitan, Laith N.; Aman, Hatem A.] Jordan Univ Sci & Technol, Dept Appl Biol Sci, Irbid, Jordan; [Al-Eitan, Laith N.] Jordan Univ Sci & Technol, Dept Biotechnol & Genet Engn, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Alshogran, OY (corresponding author), Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan.	oyalshogran@just.edu.jo		Alshogran, Osama/0000-0002-2466-4763; Al-Eitan, Laith/0000-0003-0064-0190	Deanship of Scientific Research at Jordan University of Science and Technology [16/2017]	Deanship of Scientific Research at Jordan University of Science and Technology	Osama Y. Alshogran has received funding from the Deanship of Scientific Research at Jordan University of Science and Technology (grant number 16/2017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DE, 2012, DEV PSYCHOPATHOL, V24, P267, DOI 10.1017/S0954579411000824; Al-Eitan LN, 2020, GENE, V733, DOI 10.1016/j.gene.2019.144267; Al-Eitan LN, 2014, TOXICOL IND HEALTH, V30, P598, DOI 10.1177/0748233712462446; Alshogran OY, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109657; Alshogran OY, 2018, GEN HOSP PSYCHIAT, V53, P25, DOI 10.1016/j.genhosppsych.2018.04.003; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bonvicini C, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0755-4; Border R, 2019, AM J PSYCHIAT, V176, P376, DOI 10.1176/appi.ajp.2018.18070881; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cheng PF, 2021, ACTA NEUROL BELG, V121, P933, DOI 10.1007/s13760-020-01342-1; Cheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244; Chilcot J, 2018, ANN BEHAV MED, V52, P1, DOI 10.1007/s12160-017-9918-9; Cukor D, 2007, CLIN J AM SOC NEPHRO, V2, P484, DOI 10.2215/CJN.00040107; Culverhouse RC, 2018, MOL PSYCHIATR, V23, P133, DOI 10.1038/mp.2017.44; Dell'Osso L, 2016, CURR PHARM DESIGN, V22, P949, DOI 10.2174/1381612822666151214104826; Gervasini G, 2018, GENE, V654, P43, DOI 10.1016/j.gene.2018.02.035; Guenzani D, 2019, J PSYCHOSOM RES, V124, DOI 10.1016/j.jpsychores.2019.109783; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Hu JJ, 2019, PSYCHIAT GENET, V29, P97, DOI 10.1097/YPG.0000000000000222; Januar V, 2015, INT J EPIDEMIOL, V44, P1364, DOI 10.1093/ije/dyu273; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Koks G, 2020, EXP BIOL MED, V245, P733, DOI 10.1177/1535370220916888; Koks G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01398; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Leung PWL, 2005, AM J MED GENET B, V133B, P54, DOI 10.1002/ajmg.b.30129; Lopez LS, 2005, BIOL PSYCHIAT, V57, P999, DOI 10.1016/j.biopsych.2005.01.030; Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50; Osher Y, 2000, MOL PSYCHIATR, V5, P216, DOI 10.1038/sj.mp.4000660; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Ryan J, 2019, J GERIATR PSYCH NEUR, V32, P175, DOI 10.1177/0891988719841725; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Schouten RW, 2020, J PSYCHOSOM RES, V133, DOI 10.1016/j.jpsychores.2020.109995; Serretti A, 2002, AM J MED GENET, V114, P361, DOI 10.1002/ajmg.10356; Tamminga CA, 2002, BIOL PSYCHIAT, V52, P589, DOI 10.1016/S0006-3223(02)01470-1; Tochigi M, 2006, NEUROSCI LETT, V398, P333, DOI 10.1016/j.neulet.2006.01.020; Vandenbergh DJ, 2000, AM J MED GENET, V96, P678, DOI 10.1002/1096-8628(20001009)96:5<678::AID-AJMG15>3.0.CO;2-8; Wang LJ, 2014, NEUROPSYCH DIS TREAT, V10, P1235, DOI 10.2147/NDT.S54277; Xiang LB, 2008, BRAIN RES, V1207, P214, DOI 10.1016/j.brainres.2008.02.009; Yin L, 2015, PHARMACOPSYCHIATRY, V48, P95, DOI 10.1055/s-0034-1398508; Zhang LJ, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01424-1	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249284	10.1371/journal.pone.0249284	http://dx.doi.org/10.1371/journal.pone.0249284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784353	gold, Green Published			2022-12-26	WOS:000636359600020
J	Pavlu, K; Kassahun, T; Pavlu, VV; Pavlu, L; Blazek, P; Homolka, P				Pavlu, Klara; Kassahun, Teowdroes; Pavlu, Vilem V.; Pavlu, Lenka; Blazek, Petr; Homolka, Petr			The effects of first defoliation and previous management intensity on forage quality of a semi-natural species-rich grassland	PLOS ONE			English	Article							NUTRITIVE-VALUE; MINERAL-COMPOSITION; GRAZING MANAGEMENT; HERBAGE QUALITY; DIGESTIBILITY; VEGETATION; NITROGEN; CATTLE; PERFORMANCE; YIELD	Semi-natural grasslands occupy large parts of the European landscape but little information exists about seasonal variations in their nutritive value during the growing season. This paper presents results of novel data showing the effect of 13 years of previous contrasting management intensities on herbage nutritional value in relation to different dates of first defoliation (by grazing or haymaking). The treatments were: extensive management and intensive management from previous years (1998-2011). Both treatments were cut in June followed by intensive/extensive grazing for the rest of the grazing season (July-October). To evaluate forage quality in the first defoliation date, biomass sampling was performed in the year 2012 for 23 weeks from May to mid-October, and in 2013 for seven weeks from May to mid-June. Sampling was performed from plots that were not under management during the sampling year. Previous extensive management was associated with significantly reduced forage quality for in vitro organic matter digestibility (IVOMD), crude protein, neutral detergent fibre, acid detergent fibre and reduced divalent cations (Ca, Mg) and Na during the first seven weeks of the grazing season and the forage was suitable only for beef cattle. Due to low forage IVOMD, the forage is suitable only for cattle maintenance or for low quality hay when the start of grazing was postponed from seven weeks of vegetative growth to 13 weeks, regardless of the previous intensity. Herbage harvested after 13 weeks of the grazing season was of very low quality and was unsuitable as a forage for cattle when it was the only source of feed. Agri-environmental payments are necessary to help agricultural utilisation to maintain semi-natural grasslands by compensating for deterioration of forage quality, not only for the postponement of the first defoliation (either as cutting or grazing) after mid-June, but also when extensive management is required.	[Pavlu, Klara; Kassahun, Teowdroes; Pavlu, Vilem V.] Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Pavlu, Klara; Homolka, Petr] Inst Anim Sci, Dept Nutr & Feeding Farm Anim, Prague, Czech Republic; [Pavlu, Vilem V.; Pavlu, Lenka] Crop Res Inst, Dept Weeds & Vegetat Agroecosyst, Grassland Res Stn Liberec, Prague, Czech Republic; [Blazek, Petr] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Blazek, Petr] Acad Sci Czech Republic, Inst Entomol, Ceske Budejovice, Czech Republic; [Homolka, Petr] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Deparment Microbiol Nutr & Dietet, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Czech Crop Research Institute (CRI); University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Pavlu, VV (corresponding author), Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.; Pavlu, VV (corresponding author), Crop Res Inst, Dept Weeds & Vegetat Agroecosyst, Grassland Res Stn Liberec, Prague, Czech Republic.	pavlu@vurv.cz	Homolka, Petr/AAY-5289-2021; Blažek, Petr/AAW-8682-2020	Blažek, Petr/0000-0002-0901-4578; Teka, Teowdroes Kassahun/0000-0001-8881-0224; Homolka, Petr/0000-0002-2228-9859	Ministry of Agriculture of the Czech Republic [MZe RO0418, MZe RO0718]; Internal Grant Agency Faculty of Environmental Sciences, Czech University of Life Sciences Prague [20194211]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Internal Grant Agency Faculty of Environmental Sciences, Czech University of Life Sciences Prague	The experiment was maintained under support of the Ministry of Agriculture of the Czech Republic Project No. MZe RO0418 (VP, LP). The laboratory analyses were financed by the Ministry of Agriculture of the Czech Republic, Project No. MZe RO0718 (KP, PH). This paper was finalized under support by the Internal Grant Agency Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Project No. 20194211 (KP, TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Research Council, 1980, NUTR REQ RUM LIV; Andueza D, 2016, GRASS FORAGE SCI, V71, P366, DOI 10.1111/gfs.12189; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Ata S, 2011, J MED PLANTS RES, V5, P6164, DOI 10.5897/JMPR11.866; AUFRERE J, 1988, ANIM FEED SCI TECH, V20, P203, DOI 10.1016/0377-8401(88)90044-2; Biel W, 2017, CAN J PLANT SCI, V97, P1165, DOI 10.1139/cjps-2016-0409; BOKDAM J, 1992, CONSERV BIOL, V6, P399, DOI 10.1046/j.1523-1739.1992.06030399.x; Boob M, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9090198; Bruinenberg MH, 2002, GRASS FORAGE SCI, V57, P292, DOI 10.1046/j.1365-2494.2002.00327.x; Chytr M, 2007, TRAVINNA KERICKOVA V; Dell Inc, 2016, DELL STAT DAT AN SOF; Dudek T, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020273; Duru M, 1997, NUTR CYCL AGROECOSYS, V47, P59; Elgersma A, 2016, EUR J AGRON, V78, P73, DOI 10.1016/j.eja.2016.04.011; Fiems LO, 2004, ARCH ANIM NUTR, V58, P233, DOI 10.1080/00039420410001701369; Frame J., 1992, IMPROVED GRASSLAND M; Goering KH, 1970, AGR HDB ARS; Grunes D. L., 1970, Advances in Agronomy, V22, P331, DOI 10.1016/S0065-2113(08)60272-2; Grzegorczyk S, 2013, J ELEMENTOL, V18, P69, DOI 10.5601/jelem.2013.18.1.05; Harrington K. C., 2006, New Zealand Plant Protection, V59, P261; Henkin Z, 2011, GRASS FORAGE SCI, V66, P516, DOI 10.1111/j.1365-2494.2011.00808.x; Isselstein J., 2005, Agronomy Research, V3, P139; Jancovic J, 1999, ROST VYROBA, V45, P79; Kassahun T, 2016, BIOBASED EC SUSTAINA, P39; Koidou M, 2019, ARCH ANIM BREED, V62, P215, DOI 10.5194/aab-62-215-2019; Kudrna V, 1998, PRODUKCE KRMIV VIVA; Lakner S, 2020, LAND USE POLICY, V97, DOI 10.1016/j.landusepol.2020.104642; Ma L, 2014, LIVEST SCI, V161, P185, DOI 10.1016/j.livsci.2013.12.025; McDowell LR, 2000, FORAGE EVALUATION IN RUMINANT NUTRITION, P373, DOI 10.1079/9780851993447.0373; Mika V., 1997, KVALITA PICE, P97; Mladek J, 2011, FOLIA GEOBOT, V46, P17, DOI 10.1007/s12224-010-9083-4; MOTAZEDIAN I, 1990, J RANGE MANAGE, V43, P198, DOI 10.2307/3898671; National Research Council, 2000, NUTR REQ BEEF CATTL; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Pavlu V, 2006, AGR ECOSYST ENVIRON, V113, P349, DOI 10.1016/j.agee.2005.10.010; Pavlu V, 2007, APPL VEG SCI, V10, P375, DOI 10.1111/j.1654-109X.2007.tb00436.x; Pelletier S, 2006, AGRON J, V98, P774, DOI 10.2134/agronj2005.0229; Pelve ME, 2012, LIVEST SCI, V144, P48, DOI 10.1016/j.livsci.2011.10.012; Pirhofer-Walzl K, 2011, GRASS FORAGE SCI, V66, P415, DOI 10.1111/j.1365-2494.2011.00799.x; Rychnovska M., 1985, EKOLOGIE LUCNICH POR, P11; Rymer C, 2000, FORAGE EVALUATION IN RUMINANT NUTRITION, P113, DOI 10.1079/9780851993447.0113; Schaffers AP, 2002, PLANT ECOL, V158, P229, DOI 10.1023/A:1015576520936; Schaub S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14541-4; Schlegel P, 2016, ANIM FEED SCI TECH, V219, P226, DOI 10.1016/j.anifeedsci.2016.06.022; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Solen L, 2019, J ENVIRON MANAGE, V251, DOI 10.1016/j.jenvman.2019.109372; Stejskalova M, 2013, ANIM SCI J, V84, P622, DOI 10.1111/asj.12048; Suttle N.F., 2010, MINERAL NUTR LIVESTO, V4th ed., P54; Tallowin JRB, 1999, GRASS FORAGE SCI, V54, P99, DOI 10.1046/j.1365-2494.1999.00171.x; Thumm U, 2009, ARTENREICHES GRONLAN, P305; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Voisin A., 1963, GRASS TETANY; Whitehead D. C., 2000, Nutrient elements in grassland: soil-plant-animal relationships, DOI 10.1079/9780851994376.0000; WILMAN D, 1994, J AGR SCI, V122, P217, DOI 10.1017/S0021859600087396	55	1	1	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248804	10.1371/journal.pone.0248804	http://dx.doi.org/10.1371/journal.pone.0248804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784309	Green Published			2022-12-26	WOS:000636359600025
J	Gowayed, SMH; Abd El-Moneim, D				Gowayed, Salah M. H.; Abd El-Moneim, Diaa			Detection of genetic divergence among some wheat (Triticum aestivum L.) genotypes using molecular and biochemical indicators under salinity stress	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; SALT TOLERANCE; GAMMA-IRRADIATION; MARKERS; PLANTS; POLYMORPHISM; DIVERSITY; PROLINE; BARLEY; RAPD	Wheat has remarkable importance among cereals in Egypt. Salt stress affects plant growth, development, and crop productivity. Therefore, salinity tolerance is an essential trait that must be incorporated in crops. This research aimed to investigate molecular and biochemical indicators and defence responses in seedlings of 14 Egyptian wheat genotypes to distinguish the most contrasting salt-responsive genotypes. Analysis of ISSR and SCoT markers revealed high polymorphism and reproducible fingerprinting profiles for evaluating genetic variability within the studied genotypes. The HB-10 and SCoT 1 primers had the highest values for all the studied parameters. All the tested primers generated a set of 66 polymorphic bands among tolerant and sensitive genotypes. The transcript profiles of eight TaWRKY genes showed significant induction under the salinity treatments. Moreover, the expression of TaWRKY6 for genotypes Sids 14 and Sakha 93 sharply increased and recorded the highest expression, while the expression of TaWRKY20 for Misr 1 recorded the lowest expression. Under salt stress, the total sugar, proline, and phenolic contents increased significantly, while the chlorophyll content decreased significantly. Additionally, five peroxidase and polyphenol oxidase isoforms were observed in treated leaves and clustered into five different patterns. Some isoforms increased significantly as salinity levels increased. This increase was clearer in salt-tolerant than in salt-sensitive genotypes. Eighteen protein bands appeared, most of which were not affected by salinity compared with the control, and specific bands were rare. Generally, the Sids 14, Sakha 93, Sohag 4, and Gemmeiza 12 genotypes are considered salt tolerant in comparison to the other genotypes.	[Gowayed, Salah M. H.] Univ Jeddah, Dept Biol, Coll Sci, Jeddah, Saudi Arabia; [Gowayed, Salah M. H.] Suez Canal Univ, Fac Agr, Dept Bot, Ismailia, Egypt; [Abd El-Moneim, Diaa] Arish Univ, Fac Environm & Agr Sci, Genet Branch, Dept Plant Prod, Al Arish, Egypt	University of Jeddah; Egyptian Knowledge Bank (EKB); Suez Canal University	Abd El-Moneim, D (corresponding author), Arish Univ, Fac Environm & Agr Sci, Genet Branch, Dept Plant Prod, Al Arish, Egypt.	dabdelmoniem@Aru.edu.eg	Abd El Moneim, Diaa/AAY-7021-2021	Abd El Moneim, Diaa/0000-0003-3285-0563	University of Jeddah, Saudi Arabia [UJ-02016-DR]	University of Jeddah, Saudi Arabia	This work was funded by the University of Jeddah, Saudi Arabia, under grant no. (UJ-02016-DR). The authors, therefore, acknowledge with thanks the University technical and financial support.	Abd El-Moneim D., 2020, Journal of Plant Biotechnology, V47, P1, DOI 10.5010/JPB.2020.47.1.001; Abdein M.A., 2018, EGYPT J GENET CYTOL, V47, P139; Aly AAH, 2019, BANGL J BOT, V48, P177; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Atarodi B, 2018, TOXICOL ENVIRON CHEM, V100, P440, DOI 10.1080/02772248.2018.1529235; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN AHD, 1978, THEOR APPL GENET, V52, P145, DOI 10.1007/BF00282571; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Cruz JL, 2017, ACTA SCI-AGRON, V39, P545, DOI 10.4025/actasciagron.v39i4.32952; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Davis J.C., 1986, STAT DATA ANAL GEOLO; Dere Sukran, 1998, Turkish Journal of Botany, V22, P13; El-Beltagi HS, 2013, NOT BOT HORTI AGROBO, V41, P104; El-Moneim A, 2019, J PLANT PRODUCTION S, V8, P31; El-Moneim D. A. A., 2008, Annals of Agricultural Science (Cairo), V53, P171; El-Nasharty AB, 2017, BIOSCI RES, V14, P193; Elhamid E. M. A., 2014, Agricultural Sciences, V5, P1269, DOI 10.4236/as.2014.513135; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Finatto T, 2018, GENET MOL BIOL, V41, P533, DOI [10.1590/1678-4685-GMB-2017-0232, 10.1590/1678-4685-gmb-2017-0232]; Gadallah MA., 2017, ALEXANDRIA SCI EXCHA, V38, P2; Gholamian F, 2019, BIOTECHNOL BIOTEC EQ, V33, P1653, DOI 10.1080/13102818.2019.1691466; Gonzalez A, 2005, CROP SCI, V45, P606, DOI 10.2135/cropsci2005.0606; Gupta S, 2008, AFR J BIOTECHNOL, V7, P4230; Hamilton, 2009, POPULATION GENETICS, P234; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hussain S., 2009, CLIMATE CHANGE AGR, P1; Hussein E.H.A., 2006, ARAB J BIOTECHNOL, V9, P313; Kandil EE, 2016, EGYPT ACAD J BIOLOG, V7, P9; Karaca M, 2008, J FOOD AGRIC ENVIRON, V6, P219; Kaushik A, 2003, EUPHYTICA, V134, P231, DOI 10.1023/B:EUPH.0000003986.29822.42; Khalipe S., 2018, ADV BIORESEARCH, V9, P181, DOI DOI 10.15515/abr.0976-4585.9.1.181186; Konate I, 2007, THESIS U MOHAMMED V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Legendre P., 1998, NUMERICAL ECOLOGY; Liu C, 2014, RUSS J PLANT PHYSL+, V61, P374, DOI 10.1134/S1021443714020083; Lutts S, 1999, PHYSIOL PLANTARUM, V105, P450, DOI 10.1034/j.1399-3054.1999.105309.x; Manisha Jain, 2013, Journal of Pharmacy Research, V7, P506, DOI 10.1016/j.jopr.2013.05.002; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Meratan A. A., 2008, JUST, V33, P1; Metwali EMR., 2013, ARCH SCI, V66, P19; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Moghaieb REA, 2011, AFR J BIOTECHNOL, V10, P18092, DOI 10.5897/AJB11.2576; Monfared Mohammad Asadi, 2018, Journal of Genetic Engineering and Biotechnology, V16, P661, DOI 10.1016/j.jgeb.2018.04.005; Munir Ahmad, 2013, Australian Journal of Crop Science, V7, P66; Nabila M. Z., 2007, Journal of Applied Sciences Research, P1121; Nguyen Thi Lang, 2001, Omonrice, P9; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petersen, 2011, MOL ECOL, P165, DOI [10.1002/9780470979365, DOI 10.1002/9780470979365]; Pourian Mohammad Aref, 2019, Journal of Horticultural Research, V27, P37, DOI 10.2478/johr-2019-0005; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Qin YX, 2015, BIOCHEM BIOPH RES CO, V464, P428, DOI 10.1016/j.bbrc.2015.06.128; Radi A. A., 2013, Journal of Biology and Earth Sciences, V3, pB72; Ragab K.E., 2016, J PLANT PROD MANSOUR, V7, P147, DOI [10.21608/jpp.2016.45248, DOI 10.21608/JPP.2016.45248]; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; RIAZI A, 1985, J EXP BOT, V36, P1716, DOI 10.1093/jxb/36.11.1716; Sairam RK, 2001, J AGRON CROP SCI, V186, P63, DOI 10.1046/j.1439-037x.2001.00461.x; Stagemann H, 1985, MANUAL GEL ELECTROPH; Tajbakhsh M, 2006, AUST J EXP AGR, V46, P555, DOI 10.1071/EA05026; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang Y, 2000, J HORTIC SCI BIOTECH, V75, P623, DOI 10.1080/14620316.2000.11511297; Waterhouse A. L., 2002, CURRENT PROTOCOLS FO, P1, DOI DOI 10.1002/0471142913.FAA0101S06; Yue QC, 2019, CIENC RURAL, V49, DOI 10.1590/0103-8478cr20190247; Zheng YH, 2008, J PLANT PHYSIOL, V165, P1455, DOI 10.1016/j.jplph.2008.01.001; Zhou S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225712; Zhu XL, 2013, PLANT MOL BIOL REP, V31, P1053, DOI 10.1007/s11105-013-0565-4; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151; Zvingila D, 2012, ZEMDIRBYSTE, V99, P139	73	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248890	10.1371/journal.pone.0248890	http://dx.doi.org/10.1371/journal.pone.0248890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780480	Green Published, gold			2022-12-26	WOS:000636336800034
J	Greenwood, A; Keating, J; Kenwright, D; Shekouh, A; Dalzell, A; Dennett, E; Danielson, K				Greenwood, Annabelle; Keating, John; Kenwright, Diane; Shekouh, Ali; Dalzell, Alex; Dennett, Elizabeth; Danielson, Kirsty			Brief report: Lymph node morphology in stage II colorectal cancer	PLOS ONE			English	Article								Background Colorectal cancer is one of the leading causes of cancer-associated morbidity and mortality worldwide. The local anti-tumour immune response is particularly important for patients with stage II where the tumour-draining lymph nodes have not yet succumbed to tumour spread. The lymph nodes allow for the expansion and release of B cell compartments such as primary follicles and germinal centres. A variation in this anti-tumour immune response may influence the observed clinical heterogeneity in stage II patients. Aim The aim of this study was to explore tumour-draining lymph node histomorphological changes and tumour pathological risk factors including the immunomodulatory microRNA-21 (miR-21) in a small cohort of stage II CRC. Methods A total of 23 stage II colorectal cancer patients were included. Tumour and normal mucosa samples were analysed for miR-21 expression levels and B-cell compartments were quantified from Haematoxylin and Eosin slides of lymph nodes. These measures were compared to clinicopathological risk factors such as perforation, bowel obstruction, T4 stage and high-grade. Results We observed greater Follicle density in patients with a lower tumour T stage and higher germinal centre density in patients with higher pre-operative carcinoembryonic antigen levels. Trends were also detected between tumours with deficiency in mismatch repair proteins, lymphatic invasion and both the density and size of B-cell compartments. Lastly, elevated tumour miR-21 was associated with decreased Follicle and germinal centre size. Conclusion Variation in B-cell compartments of tumour-draining lymph nodes is associated with clinicopathological risk factors in stage II CRC patients.	[Greenwood, Annabelle; Dennett, Elizabeth; Danielson, Kirsty] Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand; [Keating, John; Shekouh, Ali; Dalzell, Alex; Dennett, Elizabeth] Wellington Reg Hosp, Dept Gen Surg, Wellington, New Zealand; [Kenwright, Diane] Univ Otago, Dept Pathol & Mol Med, Wellington, New Zealand	University of Otago; University of Otago	Greenwood, A (corresponding author), Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand.	grean360@student.otago.ac.nz		Greenwood, Annabelle/0000-0002-4348-2199; Danielson, Kirsty/0000-0002-1667-2528	University of Otago, Wellington Dean's Research Grant	University of Otago, Wellington Dean's Research Grant	This study was funded by the University of Otago, Wellington Dean's Research Grant (2017).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Benson AB, 2011, J CLIN ONCOL, V29, P4599, DOI 10.1200/JCO.2011.37.8646; Cancer I.A. f.R.o, 2018, LATEST GLOBAL CANC D; Casadaban L, 2016, CANCER-AM CANCER SOC, V122, P3277, DOI 10.1002/cncr.30181; Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Ferris RL, 2012, CLIN EXP METASTAS, V29, P729, DOI 10.1007/s10585-012-9520-2; Linnebacher M, 2012, ONCOIMMUNOLOGY, V1, P1186, DOI 10.4161/onci.20641; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2014, MOL CANCER RES, V12, P890, DOI 10.1158/1541-7786.MCR-13-0419; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Mima K, 2016, CANCER IMMUNOL RES, V4, P33, DOI 10.1158/2326-6066.CIR-15-0084; National Comprehensive Cancer Network (NCCN), CLIN PRACTICE GUIDEL; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Seidl M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23629-3; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsukamoto M, 2017, ONCOLOGY-BASEL, V92, P360, DOI 10.1159/000463387; Vered M, 2014, CLIN EXP METASTAS, V31, P327, DOI 10.1007/s10585-013-9631-4; Weiser MR, 2018, ANN SURG ONCOL, V25, P1454, DOI 10.1245/s10434-018-6462-1	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249197	10.1371/journal.pone.0249197	http://dx.doi.org/10.1371/journal.pone.0249197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780511	gold, Green Published			2022-12-26	WOS:000636336800056
J	Weng, CL; Wang, XC; Huang, L; Lin, XS; Liu, QH				Weng, Cuilian; Wang, Xincai; Huang, Long; Lin, Xingsheng; Liu, Qinghua			Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study	PLOS ONE			English	Article							ANTICOAGULATION; THROMBOSIS	Introduction Patients at intermediate-high risk of developing a pulmonary embolism (PE) are very likely to experience adverse outcomes, such as cardiovascular instability and death. The role of thrombolytic therapy in intermediate-high-risk PE remains controversial. Objectives This study aimed to determine the efficacy and safety of low-dose urokinase (UK) thrombolytic therapy for intermediate-high-risk PE. Patients and methods This retrospective study included 81 consecutive patients with intermediate-high-risk PE from two centers. Patients received low-dose UK or low-molecular-weight heparin (anticoagulant therapy group). The efficacy outcomes were mortality, computed tomography pulmonary angiography (CTPA)-confirmed absorption, and dyspnea. Safety was assessed as the incidence of bleedings. Results The in-hospital mortality, 9-month mortality, and long-term mortality at the last follow-up were comparable for the low-dose UK group and the anticoagulant therapy group (6.45% vs. 0%, p = 0.144, 9.68% vs. 8.16%, p = 0.815, and 12.90% vs. 12.24%, p = 0.931, respectively). CTPA-confirmed absorption at one month after admission was higher in the low-dose UK group than in the anticoagulant therapy group (p = 0.016). The incidences of short-term dyspnea at discharge and long-term dyspnea at the last follow-up were lower in the low-dose UK group than in the anticoagulant therapy group (27.59% vs. 52%, p = 0.035, 33.33% vs. 58.14%, p = 0.043, respectively). No major bleeding occurred. The incidence of minor bleeding was not significantly different between the two groups (3.23% vs. 6%, p = 0.974). Conclusion In intermediate-high-risk PE, a low-dose UK might increase CTPA-confirmed absorption and improve short-term and long-term dyspnea without affecting mortality or increasing the bleeding risk.	[Weng, Cuilian; Wang, Xincai; Huang, Long; Lin, Xingsheng] Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Intens Care Unit,South Branch, Fuzhou, Fujian, Peoples R China; [Liu, Qinghua] Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Otorhinolaryngol, Fuzhou, Fujian, Peoples R China; [Weng, Cuilian; Wang, Xincai; Huang, Long; Lin, Xingsheng] Fujian Prov Hosp, South Branch, Dept Intens Care Unit, Fuzhou, Fujian, Peoples R China; [Liu, Qinghua] Fujian Prov Hosp, Dept Otorhinolaryngol, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Medical University; Fujian Provincial Hospital; Fujian Provincial Hospital; Fujian Provincial Hospital	Liu, QH (corresponding author), Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Otorhinolaryngol, Fuzhou, Fujian, Peoples R China.; Liu, QH (corresponding author), Fujian Prov Hosp, Dept Otorhinolaryngol, Fuzhou, Fujian, Peoples R China.	15280096007@163.com		Wang, Xincai/0000-0001-7098-770X	National Science Foundation of China [81301995]; Fujian Provincial Department of Science and Technology [2020J011095, 2018ZQN-6]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science and Technology	This study was supported by: the National Science Foundation of China (grant 81301995); the Fujian Provincial Department of Science and Technology (2020J011095 and 2018ZQN-6). The funding institutions were not involved in the design of the study; in the collection, management, analysis, or interpretation of data; in the preparation, review, or approval of the manuscript; or in the decision to submit for publication.	Barco S, 2019, CLIN RES CARDIOL, V108, P772, DOI 10.1007/s00392-018-1405-1; Becattini C, 2016, EUR RESPIR J, V48, P780, DOI 10.1183/13993003.00024-2016; Bhamani Amyn, 2019, F1000Res, V8, DOI 10.12688/f1000research.17861.1; Bulpa P, 2009, CHEST, V136, P1141, DOI 10.1378/chest.08-2583; Eberle H, 2018, AM J HEALTH-SYST PH, V75, P1275, DOI 10.2146/ajhp170357; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kahn SR, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.03.033; Kline JA, 2014, J THROMB HAEMOST, V12, P459, DOI 10.1111/jth.12521; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; Konstantinides SV, 2017, J AM COLL CARDIOL, V69, P1536, DOI 10.1016/j.jacc.2016.12.039; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kuo WT, 2015, CHEST, V148, P667, DOI 10.1378/chest.15-0119; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Mirambeaux Rosa, 2019, TH Open, V3, pe356, DOI 10.1055/s-0039-3401003; Schissler AJ, 2018, PULM CIRC, V8, DOI 10.1177/2045894018800265; Sharifi M, 2013, AM J CARDIOL, V111, P273, DOI 10.1016/j.amjcard.2012.09.027; Sista AK, 2017, VASC MED, V22, P37, DOI 10.1177/1358863X16670250; Stevinson BG, 2007, EUR HEART J, V28, P2517, DOI 10.1093/eurheartj/ehm295; Tapson VF, 2018, JACC-CARDIOVASC INTE, V11, P1401, DOI 10.1016/j.jcin.2018.04.008; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; Xu QX, 2015, J THORAC DIS, V7, P810, DOI 10.3978/j.issn.2072-1439.2015.04.51; Zhao TM, 2018, CLIN APPL THROMB-HEM, V24, P1067, DOI 10.1177/1076029618758953	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248603	10.1371/journal.pone.0248603	http://dx.doi.org/10.1371/journal.pone.0248603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770113	Green Published, gold			2022-12-26	WOS:000634833500016
J	Choi, M; Park, S; Yi, JK; Kwon, W; Jang, S; Kim, SY; Yu, W; Kim, MO; Ryoo, ZY; Choi, SK				Choi, Minjee; Park, Song; Yi, Jun Koo; Kwon, Wookbong; Jang, Soyoung; Kim, Si-Yong; Yu, Wookyung; Kim, Myoung Ok; Ryoo, Zae Young; Choi, Seong-Kyoon			Overexpression of hepatic serum amyloid A1 in mice increases IL-17-producing innate immune cells and decreases bone density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR; NEUTROPHILIA; DISEASE; WNT	Serum amyloid A (SAA) is an acute-phase protein produced primarily in the liver that plays a key role in both the initiation and maintenance of inflammation. Rapidly secreted SAA induces neutrophilia at inflammatory sites, initiating inflammation and inducing the secretion of various cytokines, including TNF-a, IL-6, and IL-17. IL-17 is expressed in several inflammatory cells, including innate immune cells such as.dT cells, ILC3 cells, and neutrophils. Increased IL-17 levels exacerbate various inflammatory diseases. Among other roles, IL-17 induces bone loss by increasing receptor activator of nuclear factor-.B ligand (RANKL) secretion, which stimulates osteoclast differentiation. Several studies have demonstrated that chronic inflammation induces bone loss, suggesting a role for SAA in bone health. To test this possibility, we observed an increase in IL-17-producing innate immune cells, neutrophils, and.dT cells in these mice. In 6-month-old animals, we detected increased osteoclast-related gene expression and IL17 expression in bone lysates. We also observed an increase in neutrophils that secreted RANKL in the bone marrow of TG mice. Finally, we demonstrated decreased bone mineral density in these transgenic (TG) mice. Our results revealed that the TG mice have increased populations of IL-17-producing innate immune cells,.dT cells, and neutrophils in TG mice. We additionally detected increased RANKL and IL-17 expression in the bone marrow of 6-month-old TG mice. Furthermore, we confirmed significant increases in RANKL-expressing neutrophils in TG mice and decreased bone mineral density. Our results provide evidence that chronic inflammation induced by SAA1 causes bone loss via IL-17-secreting innate immune cells.	[Choi, Minjee; Park, Song; Choi, Seong-Kyoon] DGIST, Core Prot Resources Ctr, Daegu, South Korea; [Park, Song; Yu, Wookyung] DGIST, Dept Brain & Cognit Sci, Daegu, South Korea; [Yi, Jun Koo] Gyeongsangbukdo Livestock Res Inst, Yeongju Si, South Korea; [Kwon, Wookbong; Choi, Seong-Kyoon] DGIST, Div Biotechnol, Daegu, South Korea; [Jang, Soyoung; Kim, Si-Yong; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, BK21 KNU Creat Biores Grp 4, Daegu, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Sch Anim Sci Biotechnol, Sangju Si, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Kyungpook National University; Kyungpook National University	Choi, SK (corresponding author), DGIST, Core Prot Resources Ctr, Daegu, South Korea.; Choi, SK (corresponding author), DGIST, Div Biotechnol, Daegu, South Korea.; Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci, BK21 KNU Creat Biores Grp 4, Daegu, South Korea.	jaewoong64@hanmail.net; cskbest@dgist.ac.kr		Jang, Soyoung/0000-0003-2673-4259; Kim, Si-Yong/0000-0002-9583-8193; Kwon, Wookbong/0000-0002-0655-6531; Yi, JunKoo/0000-0003-2593-6529	DGIST R&D Program of the Ministry of Science and ICT [2020010096]; pCoE program of DGIST [DGIST 20-CoE-BT-01]; National Research Foundation of Korea (NRF) - Ministry of Education [2020R1I1A2075315]	DGIST R&D Program of the Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); pCoE program of DGIST; National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea)	This work was supported by the DGIST R&D Program of the Ministry of Science and ICT (2020010096), the pCoE program of DGIST (DGIST 20-CoE-BT-01), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1I1A2075315).	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Choi M, 2019, SCAND J IMMUNOL, V89, DOI 10.1111/sji.12764; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Edwards SW, 1997, IMMUNOL TODAY, V18, P320, DOI 10.1016/S0167-5699(97)01087-6; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gravallese EM, 2018, NAT REV RHEUMATOL, V14, P631, DOI 10.1038/s41584-018-0091-8; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Jang WY, 2016, APPL PHYSIOL NUTR ME, V41, P640, DOI 10.1139/apnm-2015-0369; Ji YR, 2015, J BIOL CHEM, V290, P12804, DOI 10.1074/jbc.M114.635763; Kim AR, 2020, J PERIODONTAL RES, V55, P868, DOI 10.1111/jre.12779; Kim J, 2016, J LEUKOCYTE BIOL, V99, P595, DOI 10.1189/jlb.3A0415-173R; Kirkham G, 2007, TOP TISSUE ENG, P1; Li JY, 2019, J BONE MINER RES, V34, P349, DOI 10.1002/jbmr.3600; Milanova V, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/643406; Morizane S, 2017, J INVEST DERMATOL, V137, P757, DOI 10.1016/j.jid.2016.10.016; Oh E, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.83; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Srivastava RK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00657; Uluckan O, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8996; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	31	4	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100595	10.1016/j.jbc.2021.100595	http://dx.doi.org/10.1016/j.jbc.2021.100595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781747	Green Published, gold			2022-12-26	WOS:000672866400567
J	Liu, XY; Wang, YW; Chen, DS; Ji, SY; Yang, LT; Huang, QM; Guan, X; Chang, KX; Li, D; Yuan, RY; Ouyang, CY; Hu, TY; Liu, ZQ; Sun, BQ; Xu, GR; Liu, ZG; Yang, PC				Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Yang, Li-Teng; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Hu, Tian-Yong; Liu, Zhi-Qiang; Sun, Baoqing; Xu, Guorong; Liu, Zhi-Gang; Yang, Ping-Chang			Dust-mite-derived protein disulfide isomerase suppresses airway allergy by inducing tolerogenic dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS	House dust mites (HDMs) are a potent allergen source that are commonly found in human living environments. While HDMs are known to induce allergic diseases in humans, such as asthma, its other biological activities related to human health are less understood. Our laboratory recently purified the HDM protein PDI (protein disulfide isomerase). In this study, we assess the role of PDI in contributing to immune regulation. Using mass spectrometry, we analyzed the complexes of DEC205 and HDM extracts, and the role of PDI in the induction of tolerogenic dendritic cells (DCs) was assessed in human cell culture experiments and verified in a murine model. We found that more than 20 HDM-derived proteins, including PDI, bound to DCs by forming complexes with DEC205. Additionally, DEC205-mediated the endocytosis of PDI. HDM-derived PDI (HDM-PDI) promoted Foxp3 expression in DCs. HDM-PDI-primed DCs also showed tolerogenic properties that induced regulatory T cell development, indicating that the primed DCs were tolerogenic DCs. Our results suggested that the PDI/DEC205/TIEG1/Foxp3 signal pathway activation was involved in the HDM-PDI-induced Foxp3 expression in DCs. Finally, we found that HDM-PDI competitively counteracted the Th2 cytokines to restore DC's tolerogenicity, and administration of HDM-PDI could suppress experimental asthma. In conclusion, our data suggest that HDM-PDI contributes to immune regulation by inducing tolerogenic DC development. Administration of HDM-PDI can alleviate experimental asthma. These findings demonstrate that HDM-PDI has translational potential to be used in the treatment of immune disorders such as asthma.	[Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen, Peoples R China; [Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China; [Yang, Li-Teng] Shenzhen Univ, Affiliated Hosp 3, Dept Respirol, Shenzhen, Peoples R China; [Hu, Tian-Yong; Liu, Zhi-Qiang] Longgnag ENT Hosp, Dept Allergy, Shenzhen, Peoples R China; [Sun, Baoqing] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Peoples R China; [Xu, Guorong] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Yang, Ping-Chang] Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China	Shenzhen University; State Key Laboratory of Respiratory Disease; Shenzhen University; Shenzhen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese University of Hong Kong	Liu, ZG; Yang, PC (corresponding author), Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen, Peoples R China.; Liu, ZG; Yang, PC (corresponding author), Shenzhen Univ, Sch Med, Shenzhen, Peoples R China.; Sun, BQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Peoples R China.; Yang, PC (corresponding author), Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China.	lzg@szu.edu.cn; pc2356@163.com	Yang, Liteng/AAK-1611-2021	Hu, TianYong/0000-0002-4416-6948; Wang, Yuwei/0000-0003-4996-6458	National Nature and Science Foundation of China [32090052, 31570932, U1801286, 82071807, 82004046]; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases [2019B030301009]; Medical and Health Technology Project of Guangzhou [20171A010042]; Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund [LHTD20180007]; Shenzhen science, technology and innovation committee [KQTD20170331145453160, GJHZ20180418190535757, KQJSCX20180328095619081]; Shenzhen Key Medical Discipline Construction Fund [SZXK039]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Regional Immunity and Diseases; Medical and Health Technology Project of Guangzhou; Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund; Shenzhen science, technology and innovation committee; Shenzhen Key Medical Discipline Construction Fund	This study was supported by grants of the National Nature and Science Foundation of China (32090052, 31570932, U1801286, 82071807, 82004046), Guangdong Provincial Key Laboratory of Regional Immunity and Diseases (2019B030301009), The Funding of Medical and Health Technology Project of Guangzhou (20171A010042), Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund (LHTD20180007), and Shenzhen science, technology and innovation committee (KQTD20170331145453160, GJHZ20180418190535757, KQJSCX20180328095619081) and Shenzhen Key Medical Discipline Construction Fund (No.SZXK039).	Abediankenari S, 2009, IRAN J ALLERGY ASTHM, V8, P25, DOI 08.01/ijaai.2530; Alroqi FJ, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0606-9; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Cho J, 2013, J THROMB HAEMOST, V11, P2084, DOI 10.1111/jth.12413; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cui YB, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0200-4; Esebanmen GE, 2017, IMMUNOL RES, V65, P987, DOI 10.1007/s12026-017-8944-9; Hoffman SM, 2016, J ALLERGY CLIN IMMUN, V137, P822, DOI 10.1016/j.jaci.2015.08.018; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Koch S, 2017, SEMIN IMMUNOPATHOL, V39, P55, DOI 10.1007/s00281-016-0601-1; Lee E, 2017, BMB REP, V50, P401, DOI 10.5483/BMBRep.2017.50.8.107; Lin JL, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02375-2019; Peng DJ, 2011, J IMMUNOL, V186, P5638, DOI 10.4049/jimmunol.1003801; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Spiering R, 2015, J IMMUNOL, V194, P4804, DOI 10.4049/jimmunol.1400986; Stopa JD, 2018, THROMB RES, V164, pS130, DOI 10.1016/j.thromres.2018.01.005; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Wang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep43322; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson JM, 2018, J ALLER CL IMM-PRACT, V6, P1, DOI 10.1016/j.jaip.2017.10.003; Zhang HP, 2020, ALLERGY, V75, P1205, DOI 10.1111/all.14157	22	0	0	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100585	10.1016/j.jbc.2021.100585	http://dx.doi.org/10.1016/j.jbc.2021.100585			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771560	Green Published, gold			2022-12-26	WOS:000672866400557
J	Kolosenko, I; Goroshchuk, O; Vidarsdottir, L; Bjorklund, AC; Dowdy, SF; Palm-Apergi, C				Kolosenko, Iryna; Goroshchuk, Oksana; Vidarsdottir, Linda; Bjorklund, Ann-Charlotte; Dowdy, Steven F.; Palm-Apergi, Caroline			RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients	FASEB JOURNAL			English	Article						cytarabine; pediatric acute myeloid leukemia; Polo-like kinase; Prodrugs; RNA interference	TARGETING PLK1; VOLASERTIB; DELIVERY; NANOPARTICLES; CYTARABINE; INHIBITOR; TRIAL; SIRNA	Polo-like kinase 1 (Plk1) is an important regulator of the cell cycle and it is frequently overexpressed in cancer cells. Several small molecule inhibitors have been developed to target Plk1 and some of them have reached clinical trials in adults with acute myeloid leukemia (AML). Pediatric AML patients have a poor prognosis and survivors suffer from long-term side effects. As adult AML cells have an elevated expression of Plk1, AML is a disease candidate for Plk1 inhibition. However, the relative success of clinical trials have been hampered by adverse reactions. Herein, PLK1-targeting RNA interference (RNAi) prodrugs that enter cells without a trans-fection reagent are used to target PLK1 selectively in primary cells from pediatric AML patients. We show that PLK1 and PLK4 mRNA expression are significantly higher in pediatric AML patients when compared to healthy donors and that PLK1 is downregulated by on average 50% using RNAi prodrugs without a significant effect on other PLK family members. In addition, the RNAi prodrug-induced decrease in PLK1 can be used to potentiate the effect of cytarabine. In summary, PLK1-targeting RNAi prodrugs can decrease the elevated levels of PLK1 in primary cells from pediatric AML patients and sensitize pediatric AML cells to chemotherapeutics.	[Kolosenko, Iryna; Goroshchuk, Oksana; Vidarsdottir, Linda; Bjorklund, Ann-Charlotte; Palm-Apergi, Caroline] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med Biomol & Cellular Med, 5th Floor,Halsovagen 7, S-14157 Stockholm, Sweden; [Dowdy, Steven F.] UCSD Sch Med, Dept Cellular & Mol Med, La Jolla, CA USA	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego	Palm-Apergi, C (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med Biomol & Cellular Med, 5th Floor,Halsovagen 7, S-14157 Stockholm, Sweden.	caroline.palm.apergi@ki.se		Vidarsdottir, Linda/0000-0003-3082-1320; Goroshchuk, Oksana/0000-0002-1585-1962; Palm Apergi, Caroline/0000-0003-2236-2099	Swedish Childhood Cancer Foundation; Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Swedish Childhood Cancer Foundation(European Commission); Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Swedish Childhood Cancer Foundation; Gunvor and Josef Aner Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Karolinska Institutets Forskningsstiftelser; Stiftelsen Clas Groschinskys Minnesfond	Alexander S, 2015, LANCET ONCOL, V16, pE604, DOI 10.1016/S1470-2045(15)00197-7; [Anonymous], 2018, TECHNIQUES; Blum WG, 2020, CANCER-AM CANCER SOC, V126, P4668, DOI 10.1002/cncr.32904; Brandwein JM, 2015, THER ADV HEMATOL, V6, P80, DOI 10.1177/2040620715571077; Chevallier P, 2011, LEUKEMIA, V25, P939, DOI 10.1038/leu.2011.25; De Braud FG, 2013, J CLIN ONCOL, V31; Debacker AJ, 2020, MOL THER, V28, P1759, DOI 10.1016/j.ymthe.2020.06.015; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Driscoll DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111060; Megias-Vericat JE, 2018, ANN HEMATOL, V97, P1115, DOI 10.1007/s00277-018-3304-y; Ellis PM., 2013, J THORAC ONCOL, V8, pS2; Goroshchuk O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59653-5; Goroshchuk O, 2019, ONCOGENE, V38, P1, DOI 10.1038/s41388-018-0443-5; Guo JF, 2017, MOL PHARMACEUT, V14, P940, DOI 10.1021/acs.molpharmaceut.6b01150; Hao ZL, 2015, ONCOTARGETS THER, V8, P1761, DOI 10.2147/OTT.S60762; Hou HA, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00674-7; Ikezoe T, 2009, LEUKEMIA, V23, P1564, DOI 10.1038/leu.2009.94; Jarfelt M, 2016, BRIT J HAEMATOL, V175, P577, DOI 10.1111/bjh.14374; Kassim Adetola A, 2017, Hematol Oncol Stem Cell Ther, V10, P245, DOI 10.1016/j.hemonc.2017.05.021; Kolosenko I, 2017, J CONTROL RELEASE, V261, P199, DOI 10.1016/j.jconrel.2017.07.002; Kristen AV, 2019, NEURODEGENER DIS MAN, V9, P5, DOI 10.2217/nmt-2018-0033; Landry B, 2016, J CONTROL RELEASE, V224, P8, DOI 10.1016/j.jconrel.2015.12.052; Lee KS, 2015, TRENDS PHARMACOL SCI, V36, P858, DOI 10.1016/j.tips.2015.08.013; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; McCarroll JA, 2015, ONCOTARGET, V6, P12020, DOI 10.18632/oncotarget.2664; Meade BR, 2014, NAT BIOTECHNOL, V32, P1256, DOI 10.1038/nbt.3078; Medinger Michael, 2016, Leuk Res Rep, V6, P39; Molgaard-Hansen L, 2011, PEDIATR BLOOD CANCER, V57, P1222, DOI 10.1002/pbc.22931; Molgaard-Hansen L, 2010, BRIT J HAEMATOL, V151, P447, DOI 10.1111/j.1365-2141.2010.08389.x; Ottmann OG, 2019, BRIT J HAEMATOL, V184, P1017, DOI 10.1111/bjh.15204; Peeters M, 2013, J CLIN ONCOL, V31; Pujade-Lauraine E, 2013, J CLIN ONCOL, V31; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Renner AG, 2009, BLOOD, V114, P659, DOI 10.1182/blood-2008-12-195867; Richardson DR, 2019, SEMIN ONCOL NURS, V35, DOI 10.1016/j.soncn.2019.150957; Rudolph D, 2015, J PHARMACOL EXP THER, V352, P579, DOI 10.1124/jpet.114.221150; Setten RL, 2019, NAT REV DRUG DISCOV, V18, P421, DOI 10.1038/s41573-019-0017-4; Solans BP, 2018, CLIN PHARMACOKINET, V57, P379, DOI 10.1007/s40262-017-0566-9; Talati C, 2016, CRIT REV ONCOL HEMAT, V98, P200, DOI 10.1016/j.critrevonc.2015.10.013; Tsvetkov L, 2005, J BIOL CHEM, V280, P11943, DOI 10.1074/jbc.M413514200; Turcotte LM, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123477; van Ens D, 2020, BONE MARROW TRANSPL, V55, P2308, DOI 10.1038/s41409-020-0966-6; Wang NN, 2015, INT J MOL SCI, V16, P1266, DOI 10.3390/ijms16011266; Wang YQ, 2020, CANCER GENE THER, V27, P45, DOI 10.1038/s41417-019-0095-9; Wilhelmsson M, 2019, BONE MARROW TRANSPL, V54, P726, DOI 10.1038/s41409-018-0337-8; Yang ZG, 2014, NANOSCALE, V6, P9742, DOI 10.1039/c4nr01510j; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Zeidan AM, 2020, CLIN CANCER RES, V26, P6132, DOI 10.1158/1078-0432.CCR-20-2586	48	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21476	10.1096/fj.202002454RR	http://dx.doi.org/10.1096/fj.202002454RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788972	hybrid			2022-12-26	WOS:000645260100019
J	Smith, E; Miller, E; Aguayo, JM; Figueroa, CF; Nezworski, J; Studniski, M; Wileman, B; Johnson, T				Smith, Emily; Miller, Elizabeth; Aguayo, Jeannette Munoz; Figueroa, Cristian Flores; Nezworski, Jill; Studniski, Marissa; Wileman, Ben; Johnson, Timothy			Genomic diversity and molecular epidemiology of Pasteurella multocida	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; VIRULENCE-ASSOCIATED GENES; ANTIMICROBIAL RESISTANCE; HEMORRHAGIC SEPTICEMIA; PROTECTIVE IMMUNITY; SEQUENCE-ANALYSIS; SUBSP SEPTICA; REP-PCR; IDENTIFICATION; PATHOGENESIS	Pasteurella multocida is a bacterial pathogen with the ability to infect a multitude of hosts including humans, companion animals, livestock, and wildlife. This study used bioinformatic approaches to explore the genomic diversity of 656 P. multocida isolates and epidemiological associations between host factors and specific genotypes. Isolates included in this study originated from a variety of hosts, including poultry, cattle, swine, rabbits, rodents, and humans, from five different continents. Multi-locus sequence typing identified 69 different sequence types. In-silico methodology for determining capsular serogroup was developed, validated, and applied to all genome sequences, whereby capsular serogroups A, B, D, and F were found. Whole genome phylogeny was constructed from 237,670 core single nucleotide variants (SNVs) and demonstrated an overall lack of host or capsular serogroup specificity, with the exception of isolates from bovine sources. Specific SNVs within the srlB gene were identified in P. multocida subsp. septica genomes, representing specific mutations that may be useful for differentiating one of the three known subspecies. Significant associations were identified between capsular serogroup and virulence factors, including capsular serogroup A and OmpH1, OmpH3, PlpE, and PfhB1; capsular serogroup B and HgbA and PtfA; and capsular serogroup F and PtfA and PlpP. Various mobile genetic elements were identified including those similar to ICEPmu1, ICEhin1056, and IncQ1 plasmids, all of which harbored multiple antimicrobial resistance-encoding genes. Additional analyses were performed on a subset of 99 isolates obtained from turkeys during fowl cholera outbreaks from a single company which revealed that multiple strains of P. multocida were circulating during the outbreak, instead of a single, highly virulent clone. This study further demonstrates the extensive genomic diversity of P. multocida, provides epidemiological context to the various genotyping schemes that have traditionally been used for differentiating isolates, and introduces additional tools for P. multocida molecular typing.	[Smith, Emily; Miller, Elizabeth; Johnson, Timothy] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Aguayo, Jeannette Munoz; Figueroa, Cristian Flores; Johnson, Timothy] Univ Minnesota, Midcent Res & Outreach Ctr, Willmar, MN USA; [Nezworski, Jill] Blue House Vet LLC, Buffalo Lake, MN USA; [Studniski, Marissa; Wileman, Ben] Select Genet, Willmar, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System	Smith, E (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	smit8380@umn.edu		Smith, Emily/0000-0002-0501-4693	USDA National Institute of Food and Agriculture [2018-68003-27464]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by Grant no. 2018-68003-27464 from the USDA National Institute of Food and Agriculture. This work was supported by Grant no. 2018-68003-27464 from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov), awarded to TJ.	Abdulrahman RF., 2016, MOL EVOLUTION OUTER; Adler Adam C, 2011, Conn Med, V75, P603; Amonsin A, 2002, J CLIN MICROBIOL, V40, P3025, DOI 10.1128/JCM.40.8.3025-3031.2002; Aski HS, 2016, MICROB PATHOGENESIS, V96, P52, DOI 10.1016/j.micpath.2016.04.008; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bertelsen MF, 2012, J ZOO WILDLIFE MED, V43, P726, DOI 10.1638/2011-0051R.1; BIBERSTEIN EL, 1991, J VET DIAGN INVEST, V3, P319, DOI 10.1177/104063879100300408; Bisgaard M, 2013, MICROBIOL-SGM, V159, P580, DOI 10.1099/mic.0.063461-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bosch M, 2002, INFECT IMMUN, V70, P5955, DOI 10.1128/IAI.70.11.5955-5964.2002; Botros S., 2015, J EXP MICROBIOL IMMU, V19; Boyce JD, 2000, INFECT IMMUN, V68, P3463, DOI 10.1128/IAI.68.6.3463-3468.2000; Boyce JD, 2000, J BIOTECHNOL, V83, P153, DOI 10.1016/S0168-1656(00)00309-6; Brynildsrud O, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1108-8; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CARPENTER TE, 1991, AM J VET RES, V52, P1345; Carter G., 1961, VET REC, V73; CARTER GR, 1955, AM J VET RES, V16, P481; Chung JY, 2001, INFECT IMMUN, V69, P2487, DOI 10.1128/IAI.69.4.2487-2492.2001; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Dahl C, 2002, VET MICROBIOL, V86, P313, DOI 10.1016/S0378-1135(02)00015-9; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Furian TQ, 2016, BRAZ J MICROBIOL, V47, P210, DOI 10.1016/j.bjm.2015.11.014; Garcia-Alvarez A, 2017, VET MICROBIOL, V204, P180, DOI 10.1016/j.vetmic.2017.04.015; Gerardo SH, 2001, J CLIN MICROBIOL, V39, P2558, DOI 10.1128/JCM.39.7.2558-2564.2001; Gong Q, 2013, VET IMMUNOL IMMUNOP, V152, P317, DOI 10.1016/j.vetimm.2013.01.001; Gunawardana GA, 2000, VET MICROBIOL, V72, P97, DOI 10.1016/S0378-1135(99)00191-1; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Harper M, 2015, J CLIN MICROBIOL, V53, P477, DOI 10.1128/JCM.02824-14; HEDDLESTON KL, 1972, AVIAN DIS, V16, P925, DOI 10.2307/1588773; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Heydemann J, 2010, INT J INFECT DIS, V14, pE242, DOI 10.1016/j.ijid.2009.09.007; HOLST E, 1992, J CLIN MICROBIOL, V30, P2984, DOI 10.1128/JCM.30.11.2984-2987.1992; Hooton SPT, 2014, PLASMID, V76, P32, DOI 10.1016/j.plasmid.2014.08.002; Hotchkiss EJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-115; JACQUES M, 1993, INFECT IMMUN, V61, P4785, DOI 10.1128/IAI.61.11.4785-4792.1993; JARVIS WR, 1981, AM J DIS CHILD, V135, P625, DOI 10.1001/archpedi.1981.02130310031011; Johnson TJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-106; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kai B., NCBI GENOME DOWNLOAD; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kehrenberg C, 2005, J ANTIMICROB CHEMOTH, V55, P773, DOI 10.1093/jac/dki102; Keseler IM, 2017, NUCLEIC ACIDS RES, V45, pD543, DOI 10.1093/nar/gkw1003; Kondgen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024236; Kubatzky KF, 2012, CURR TOP MICROBIOL, V361, P53, DOI 10.1007/82_2012_204; Kuhnert P, 2000, INT J MED MICROBIOL, V290, P599, DOI 10.1016/S1438-4221(00)80008-9; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee J, 2007, J MICROBIOL, V45, P179; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liu M, 2019, NUCLEIC ACIDS RES, V47, pD660, DOI 10.1093/nar/gky1123; LU YS, 1983, J CLIN MICROBIOL, V18, P292, DOI 10.1128/JCM.18.2.292-295.1983; Luo YG, 1999, VACCINE, V17, P821, DOI 10.1016/S0264-410X(98)00266-7; Marruchella G, 2019, LARGE ANIM REV, V25, P111; Massacci FR, 2018, VET MICROBIOL, V213, P66, DOI 10.1016/j.vetmic.2017.11.023; Mbuthia PG, 2008, AVIAN PATHOL, V37, P51, DOI 10.1080/03079450701784891; MCENTEE K, 1977, J BACTERIOL, V132, P904, DOI 10.1128/JB.132.3.904-911.1977; McFadden AMJ, 2011, NEW ZEAL VET J, V59, P40, DOI 10.1080/00480169.2011.547168; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P84, DOI 10.1093/jac/dkr406; Mir R., 2011, INDIAN J COMP MICROB, V32, P30; Moustafa AM, 2013, RES VET SCI, V95, P986, DOI 10.1016/j.rvsc.2013.07.003; Oh YH, 2019, VET MICROBIOL, V233, P159, DOI 10.1016/j.vetmic.2019.05.001; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pastorello I, 2013, MBIO, V4, DOI 10.1128/mBio.00206-13; Peng Z, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00014-19; Peng Z, 2018, ARCH MICROBIOL, V200, P107, DOI 10.1007/s00203-017-1421-y; PERELMAN B, 1990, AVIAN PATHOL, V19, P131, DOI 10.1080/03079459008418662; Petersen A, 2014, VET MICROBIOL, V170, P335, DOI 10.1016/j.vetmic.2014.02.022; Porter L., ESTIMATES ON FARM AN, P2013; RIMLER RB, 1984, AM J VET RES, V45, P759; ROSENAU A, 1991, ANTIMICROB AGENTS CH, V35, P2419, DOI 10.1128/AAC.35.11.2419; Ross Richard F., 2006, Animal Health Research Reviews, V7, P13, DOI 10.1017/S1466252307001211; Millan AS, 2009, ANTIMICROB AGENTS CH, V53, P3399, DOI 10.1128/AAC.01522-08; Sarangi LN, 2015, COMP IMMUNOL MICROB, V38, P33, DOI 10.1016/j.cimid.2014.11.003; Saxena MK, 2006, VET RES COMMUN, V30, P851, DOI 10.1007/s11259-006-3321-5; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Seemann T., SNIPPY; Seemann T., MLST; Seemann T, ABRICATE; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Subaaharan S, 2010, VET MICROBIOL, V141, P354, DOI 10.1016/j.vetmic.2010.01.017; Sudaryatma PE, 2018, VET MICROBIOL, V220, P33, DOI 10.1016/j.vetmic.2018.04.031; Tabatabai LB, 2004, INFECT IMMUN, V72, P1195, DOI 10.1128/IAI.72.2.1195-1198.2004; Tang XBA, 2009, J CLIN MICROBIOL, V47, P951, DOI 10.1128/JCM.02029-08; Team R.S., 2015, R STUDIO INTEGRATED, V42, P14; Team STD, SRA TOOLS; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Turni C, 2018, AUST VET J, V96, P390, DOI 10.1111/avj.12748; Turni C, 2016, VET MICROBIOL, V195, P17, DOI 10.1016/j.vetmic.2016.08.022; Verma S, 2013, VET RES COMMUN, V37, P83, DOI 10.1007/s11259-012-9539-5; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001; Wilkie IW, 2012, CURR TOP MICROBIOL, V361, P1, DOI 10.1007/82_2012_216; Wilson BA, 2013, CLIN MICROBIOL REV, V26, P631, DOI 10.1128/CMR.00024-13; Wu JR, 2007, VACCINE, V25, P4140, DOI 10.1016/j.vaccine.2007.03.005; Zhu WF, 2020, VET MICROBIOL, V244, DOI 10.1016/j.vetmic.2020.108649	104	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249138	10.1371/journal.pone.0249138	http://dx.doi.org/10.1371/journal.pone.0249138			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822782	Green Published, gold			2022-12-26	WOS:000637879100041
J	Garcia-Gordillo, JA; Camiro-Zuniga, A; Aguilar-Soto, M; Cuenca, D; Cadena-Fernandez, A; Khouri, LS; Rayek, JN; Mercado, M				Garcia-Gordillo, Jose Antonio; Camiro-Zuniga, Antonio; Aguilar-Soto, Mercedes; Cuenca, Dalia; Cadena-Fernandez, Arturo; Khouri, Latife Salame; Rayek, Jesica Naanous; Mercado, Moises		ARMII Study Grp	COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19	PLOS ONE			English	Article								Background Coronavirus disease 2019 (COVID-19) is a systemic disease that can rapidly progress into acute respiratory failure and death. Timely identification of these patients is crucial for a proper administration of health-care resources. Objective To develop a predictive score that estimates the risk of invasive mechanical ventilation (IMV) among patients with COVID-19. Study design Retrospective cohort study of 401 COVID-19 patients diagnosed from March 12, to August 10, 2020. The score development cohort comprised 211 patients (52.62% of total sample) whereas the validation cohort included 190 patients (47.38% of total sample). We divided participants according to the need of invasive mechanical ventilation (IMV) and looked for potential predictive variables. Results We developed two predictive scores, one based on Interleukin-6 (IL-6) and the other one on the Neutrophil/Lymphocyte ratio (NLR), using the following variables: respiratory rate, SpO2/FiO2 ratio and lactic dehydrogenase (LDH). The area under the curve (AUC) in the development cohort was 0.877 (0.823-0.931) using the NLR based score and 0.891 (0.843-0.939) using the IL-6 based score. When compared with other similar scores developed for the prediction of adverse outcomes in COVID-19, the COVID-IRS scores proved to be superior in the prediction of IMV. Conclusion The COVID-IRS scores accurately predict the need for mechanical ventilation in COVID-19 patients using readily available variables taken upon admission. More studies testing the applicability of COVID-IRS in other centers and populations, as well as its performance as a triage tool for COVID-19 patients are needed.	[Garcia-Gordillo, Jose Antonio; Camiro-Zuniga, Antonio; Aguilar-Soto, Mercedes; Cuenca, Dalia; Cadena-Fernandez, Arturo; Khouri, Latife Salame; Rayek, Jesica Naanous] Amer British Cowdray Med Ctr, Internal Med Dept, Mexico City, DF, Mexico; [Mercado, Moises] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Especialidades, Res Unit Endocrine Dis, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Camiro-Zuniga, A (corresponding author), Amer British Cowdray Med Ctr, Internal Med Dept, Mexico City, DF, Mexico.	antoniocamiro@hotmail.com	camiro, antonio/AGW-3423-2022	camiro, antonio/0000-0003-0957-9509; Garcia Gordillo, Jose Antonio/0000-0002-0118-2390; Aguilar Soto, Mercedes/0000-0002-3522-8406; Mercado, Moises/0000-0002-4748-9734; Cadena, Arturo/0000-0001-6125-6286	Internal Medicine group practice of the American British Cowdray Medical Center	Internal Medicine group practice of the American British Cowdray Medical Center	We would also like to deeply thank the support of Eduardo Fernandez Campuzano and the Internal Medicine group practice of the American British Cowdray Medical Center, whose guidance and support made this possible. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of interests: none.	Akilli NB, 2014, AM J EMERG MED, V32, P1476, DOI 10.1016/j.ajem.2014.09.001; Andrade RD, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3032; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bartoletti M., 2020, CLIN MICROBIOLO INFE, V26, P1545, DOI [10.1016/j.cmj.2020.08.003, DOI 10.1016/J.CMJ.2020.08.003]; Cash R, 2020, LANCET, V395, P1687, DOI 10.1016/S0140-6736(20)31089-8; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Duca Andrea, 2020, Emerg Med Pract, V22, pCD1; Farhana A., 2020, STATPEARLS; Gobierno de Mexico Secretaria de Salud, 2020, COR COVID 19 COM TEC; Goh KJ, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00458-z; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Johns Hopkins University (JHU), 2020, COVID 19 DASHB CTR S; Kermali M, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117788; Kolber Witold, 2018, Folia Med Cracov, V58, P57; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; Mejia-Vilet JM, 2021, SALUD PUBLICA MEXICO, V63, P1, DOI 10.21149/11684; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; National Center for Health Statistics, NATL VITAL STAT SYST; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Roca O, 2016, J CRIT CARE, V35, P200, DOI 10.1016/j.jcrc.2016.05.022; Saied A, 2014, CANCER GENE THER, V21, P457, DOI 10.1038/cgt.2014.50; Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang Y, 2019, THER CLIN RISK MANAG, V15, P911, DOI 10.2147/TCRM.S206930; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0248357	10.1371/journal.pone.0248357	http://dx.doi.org/10.1371/journal.pone.0248357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819261	gold, Green Published			2022-12-26	WOS:000637647200025
J	Wei, GZ; Ohri, SS; Khattar, NK; Listerman, AW; Doyle, CH; Andres, KR; Karuppagounder, SS; Ratan, RR; Whittemore, SR; Hetman, M				Wei, George Z.; Saraswat Ohri, Sujata; Khattar, Nicolas K.; Listerman, Adam W.; Doyle, Catherine H.; Andres, Kariena R.; Karuppagounder, Saravanan S.; Ratan, Rajiv R.; Whittemore, Scott R.; Hetman, Michal			Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery	PLOS ONE			English	Article								Traumatic spinal cord injury (SCI) is a devastating neurological condition that involves both primary and secondary tissue loss. Various cytotoxic events including hypoxia, hemorrhage and blood lysis, bioenergetic failure, oxidative stress, endoplasmic reticulum (ER) stress, and neuroinflammation contribute to secondary injury. The HIF prolyl hydroxylase domain (PHD/EGLN) family of proteins are iron-dependent, oxygen-sensing enzymes that regulate the stability of hypoxia inducible factor-1 alpha (HIF-1 alpha) and also mediate oxidative stress caused by free iron liberated from the lysis of blood. PHD inhibition improves outcome after experimental intracerebral hemorrhage (ICH) by reducing activating transcription factor 4 (ATF4)-driven neuronal death. As the ATF4-CHOP (CCAAT-enhancer-binding protein homologous protein) pathway plays a role in the pathogenesis of contusive SCI, we examined the effects of PHD inhibition in a mouse model of moderate T9 contusive SCI in which white matter damage is the primary driver of locomotor dysfunction. Pharmacological inhibition of PHDs using adaptaquin (AQ) moderately lowers acute induction of Atf4 and Chop mRNAs and prevents the acute decline of oligodendrocyte (OL) lineage mRNAs, but does not improve long-term recovery of hindlimb locomotion or increase chronic white matter sparing. Conditional genetic ablation of all three PHD isoenzymes in OLs did not affect Atf4, Chop or OL mRNAs expression levels, locomotor recovery, and white matter sparing after SCI. Hence, PHDs may not be suitable targets to improve outcomes in traumatic CNS pathologies that involve acute white matter injury.	[Wei, George Z.; Hetman, Michal] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Wei, George Z.; Khattar, Nicolas K.; Whittemore, Scott R.; Hetman, Michal] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Wei, George Z.; Saraswat Ohri, Sujata; Khattar, Nicolas K.; Listerman, Adam W.; Doyle, Catherine H.; Andres, Kariena R.; Whittemore, Scott R.; Hetman, Michal] Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Saraswat Ohri, Sujata; Khattar, Nicolas K.; Doyle, Catherine H.; Whittemore, Scott R.; Hetman, Michal] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA; [Karuppagounder, Saravanan S.; Ratan, Rajiv R.] Burke Neurol Inst, Sperling Ctr Hemorrhag Stroke Recovery, White Plains, NY USA; [Karuppagounder, Saravanan S.; Ratan, Rajiv R.] Cornell Univ, Feil Family Brain & Mind Res Inst, Weill Med Coll, New York, NY 10021 USA; [Whittemore, Scott R.; Hetman, Michal] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; Cornell University; University of Louisville	Hetman, M (corresponding author), Univ Louisville, Sch Med, Louisville, KY 40292 USA.; Whittemore, SR; Hetman, M (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.; Whittemore, SR; Hetman, M (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.; Whittemore, SR; Hetman, M (corresponding author), Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA.; Whittemore, SR; Hetman, M (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	swhittemore@louisville.edu; michal.hetman@louisville.edu		Whittemore, Scott/0000-0001-6437-7200	NIH [NS108529, GM10350]; Norton Healthcare; Commonwealth of Kentucky Research Challenge for Excellence Trust Fund; Leona M. and Harry B. Helmsley Charitable Trust; Integrated Programs in Biomedical Sciences	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norton Healthcare; Commonwealth of Kentucky Research Challenge for Excellence Trust Fund; Leona M. and Harry B. Helmsley Charitable Trust; Integrated Programs in Biomedical Sciences	This work was supported by The NIH: NS108529 (NINDS), GM10350 (NIGMS), Norton Healthcare, the Commonwealth of Kentucky Research Challenge for Excellence Trust Fund (SRW, MH) and the Leona M. and Harry B. Helmsley Charitable Trust (SRW, SSO, MH) and the Integrated Programs in Biomedical Sciences (GZW).	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Aime P, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104725; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; D'Antonio M, 2009, J NEUROSCI RES, V87, P3241, DOI 10.1002/jnr.22066; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fukutoku T, 2020, J NEUROTRAUM, V37, P2235, DOI 10.1089/neu.2019.6929; Fuss B, 2001, MOL CELL NEUROSCI, V18, P221, DOI 10.1006/mcne.2001.1011; Hadi B, 2000, J NEUROSURG, V93, P266, DOI 10.3171/spi.2000.93.2.0266; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Karuppagounder SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac6008; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li KN, 2019, J NEUROCHEM, V150, P759, DOI 10.1111/jnc.14790; Li LX, 2016, NEUROBIOL DIS, V91, P221, DOI 10.1016/j.nbd.2016.03.018; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Luchetti S, 2010, J NEUROTRAUM, V27, P411, DOI 10.1089/neu.2009.0930; Magnuson DSK, 2005, J NEUROTRAUM, V22, P529, DOI 10.1089/neu.2005.22.529; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Myers SA, 2019, NEUROBIOL DIS, V124, P353, DOI 10.1016/j.nbd.2018.12.008; Neitemeier S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.107; Niatsetskaya Z, 2010, ANTIOXID REDOX SIGN, V12, P435, DOI 10.1089/ars.2009.2800; Nishida F, 2015, NEUROTOXICOLOGY, V49, P68, DOI 10.1016/j.neuro.2015.05.006; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Ohri SS, 2018, J NEUROSCI, V38, P5900, DOI 10.1523/JNEUROSCI.0679-17.2018; Ohri SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109703; Ohri SS, 2013, NEUROBIOL DIS, V58, P29, DOI 10.1016/j.nbd.2013.04.021; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Ramakrishnan S, 2014, J NEUROIMMUNE PHARM, V9, P142, DOI 10.1007/s11481-014-9531-7; Ratan RR, 2020, CELL CHEM BIOL, V27, P479, DOI 10.1016/j.chembiol.2020.03.007; Ohri SS, 2021, J NEUROTRAUM, V38, P365, DOI 10.1089/neu.2020.7258; Ohri SS, 2021, GLIA, V69, P424, DOI 10.1002/glia.23907; Sathyamurthy A, 2018, CELL REP, V22, P2216, DOI 10.1016/j.celrep.2018.02.003; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Smirnova NA, 2010, CHEM BIOL, V17, P380, DOI 10.1016/j.chembiol.2010.03.008; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Stefanovic D, 2015, BIOTECH HISTOCHEM, V90, P461, DOI 10.3109/10520295.2015.1057765; Stewart AN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00802; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thinnes CC, 2015, CHEM COMMUN, V51, P15458, DOI 10.1039/c5cc06095h; Tojo Y, 2015, MOL CELL BIOL, V35, P2658, DOI 10.1128/MCB.00161-15; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Valerio-Gomes B, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00090; Walker CL, 2019, J NEUROTRAUM, V36, P1974, DOI 10.1089/neu.2018.6233; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249591	10.1371/journal.pone.0249591	http://dx.doi.org/10.1371/journal.pone.0249591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819286	Green Published, gold			2022-12-26	WOS:000637647200046
J	Trujillo, N; Gomez, D; Trujillo, S; Lopez, JD; Ibanez, A; Parra, MA				Trujillo, Natalia; Gomez, Diana; Trujillo, Sandra; David Lopez, Jose; Ibanez, Agustin; Parra, Mario A.			Attentional bias during emotional processing: Behavioral and electrophysiological evidence from an Emotional Flanker Task	PLOS ONE			English	Article								Threatening stimuli seem to capture attention more swiftly than neutral stimuli. This attention bias has been observed under different experimental conditions and with different types of stimuli. It remains unclear whether this adaptive behaviour reflects the function of automatic or controlled attention mechanisms. Additionally, the spatiotemporal dynamics of its neural correlates are largely unknown. The present study investigates these issues using an Emotional Flanker Task synchronized with EEG recordings. A group of 32 healthy participants saw response-relevant images (emotional scenes from IAPS or line drawings of objects) flanked by response-irrelevant distracters (i.e., emotional scenes flanked by line drawings or vice versa). We assessed behavioural and ERP responses drawn from four task conditions (Threat-Central, Neutral-Central, Threat-Peripheral, and Neutral-Peripheral) and subjected these responses to repeated-measures ANOVA models. When presented as response-relevant targets, threatening images attracted faster and more accurate responses. They did not affect response accuracy to targets when presented as response-irrelevant flankers. However, response times were significantly slower when threatening images flanked objects than when neutral images were shown as flankers. This result replicated the well-known Emotional Flanker Effect. Behavioural responses to response-relevant threatening targets were accompanied by significant modulations of ERP activity across all time-windows and regions of interest and displayed some meaningful correlations. The Emotional Flanker Effect was accompanied by a modulation over parietal and central-parietal regions within a time-window between 550-690ms. Such a modulation suggests that the attentional disruption to targets caused by response-irrelevant threatening flankers appears to reflect less neural resources available, which are seemingly drawn away by distracting threatening flankers. The observed spatiotemporal dynamics seem to concur with understanding of the important adaptive role attributed to threat-related attention bias.	[Trujillo, Natalia; Trujillo, Sandra; Parra, Mario A.] Univ Antioquia UdeA, Neurosci Grp, Medellin, Colombia; [Trujillo, Natalia; Gomez, Diana; Trujillo, Sandra] Univ Antioquia UdeA Medellin, Fac Nacl Salud Publ, GISAME, Medellin, Colombia; [Gomez, Diana; David Lopez, Jose] Univ Antioquia UdeA, Fac Ingn, SISTEMIC, Medellin, Colombia; [Ibanez, Agustin] Univ Calif San Francisco UCSF, Global Brain Hlth Inst GBHI, San Francisco, CA USA; [Ibanez, Agustin] Trinity Coll Dublin TCD, Dublin, Ireland; [Ibanez, Agustin] Univ San Andres, Cognit Neurosci Ctr CNC, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Univ Adolfo Ibanez, Latin Amer Inst Brain Hlth BrainLat, Santiago, Chile; [Parra, Mario A.] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Parra, Mario A.] Univ Autonoma Caribe, Barranquilla, Colombia	Universidad de Antioquia; Universidad de Antioquia; University of California System; University of California San Francisco; Trinity College Dublin; Universidad de San Andres Argentina; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Adolfo Ibanez; University of Strathclyde	Trujillo, N; Parra, MA (corresponding author), Univ Antioquia UdeA, Neurosci Grp, Medellin, Colombia.; Trujillo, N (corresponding author), Univ Antioquia UdeA Medellin, Fac Nacl Salud Publ, GISAME, Medellin, Colombia.; Parra, MA (corresponding author), Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland.; Parra, MA (corresponding author), Univ Autonoma Caribe, Barranquilla, Colombia.	natalia.trujillo@udea.edu.co; mario.parra-rodriguez@strath.ac.uk	Ibanez, Agustin/H-7976-2015; Lopez, Jose David/N-3738-2015	Ibanez, Agustin/0000-0001-6758-5101; Lopez, Jose David/0000-0003-2213-1186	MinCiencias (Colombia) [111577757638, 111584467273]; Alzheimer's Association [GBHI ALZ UK-20-639295]; Takeda [CW2680521]; CONICET [ANID/FONDAP/15150012]; Sistema General de Regalias [BPIN2018000100059];  [613-2013]	MinCiencias (Colombia); Alzheimer's Association(Alzheimer's Association); Takeda(Takeda Pharmaceutical Company Ltd); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sistema General de Regalias; 	This work was supported by MinCiencias (Colombia) in the form of grants awarded to NT (111577757638, 111584467273) and a grant awarded to NT and MAP (613-2013). AI is partially supported by grants from Alzheimer's Association (GBHI ALZ UK-20-639295), Takeda (CW2680521), CONICET (ANID/FONDAP/15150012), Sistema General de Regalias (BPIN2018000100059),	Asgeirsson AG, 2017, COGNITION, V168, P191, DOI 10.1016/j.cognition.2017.07.001; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Barratt D, 2012, COGNITION EMOTION, V26, P1223, DOI 10.1080/02699931.2011.645279; Bekhtereva V, 2017, COGN AFFECT BEHAV NE, V17, P1028, DOI 10.3758/s13415-017-0530-z; Bekhtereva V, 2015, NEUROIMAGE, V112, P254, DOI 10.1016/j.neuroimage.2015.03.052; Bertsch K, 2011, HORM BEHAV, V59, P428, DOI 10.1016/j.yhbeh.2010.12.010; Blanchette I, 2006, Q J EXP PSYCHOL, V59, P1484, DOI 10.1080/02724980543000204; Boylan MR, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13332; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Brown C, 2010, BRAIN COGNITION, V74, P281, DOI 10.1016/j.bandc.2010.08.008; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Carboni A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07249-x; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cullen KR, 2016, BRAIN IMAGING BEHAV, V10, P319, DOI 10.1007/s11682-015-9406-4; Cunningham WA, 2005, NEUROIMAGE, V28, P827, DOI 10.1016/j.neuroimage.2005.04.044; de Oca BM, 2013, AM J PSYCHOL, V126, P287; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deweese MM, 2014, PSYCHIAT RES, V219, P329, DOI 10.1016/j.psychres.2014.05.042; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Fox E, 2007, EMOTION, V7, P691, DOI 10.1037/1528-3542.7.4.691; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Gable PA, 2010, EMOTION, V10, P441, DOI 10.1037/a0018425; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Hahn S, 2006, ACTA PSYCHOL, V123, P312, DOI 10.1016/j.actpsy.2006.01.008; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; He MY, 2018, NEUROSCIENCE, V379, P93, DOI 10.1016/j.neuroscience.2018.02.043; Heim S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00439; Hesse E, 2016, BRAIN, V139, P54, DOI 10.1093/brain/awv336; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Horstmann G, 2006, EMOTION, V6, P28, DOI 10.1037/1528-3542.6.1.28; Huang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075386; Hurtado E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-69; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Kappenman Emily S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P110; Kappenman ES, 2015, SOC COGN AFFECT NEUR, V10, P577, DOI 10.1093/scan/nsu098; Koenig T, 2014, BRAIN TOPOGR, V27, P72, DOI 10.1007/s10548-013-0310-1; Koster EHW, 2004, EMOTION, V4, P312, DOI 10.1037/1528-3542.4.3.312; Lakens D, 2013, COGNITION EMOTION, V27, P1225, DOI 10.1080/02699931.2013.781501; Lang P.J., 2008, A8 U FLOR; Lang P.J., 1988, INT AFFECTIVE PICTUR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LeDoux J., 1996, EMOTIONAL BRAIN, V384; Li WH, 2014, MOTIV EMOTION, V38, P451, DOI 10.1007/s11031-013-9387-9; Li YD, 2013, BRAIN RES, V1538, P61, DOI 10.1016/j.brainres.2013.09.021; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Lv JY, 2011, BRAIN RES BULL, V86, P106, DOI 10.1016/j.brainresbull.2011.06.010; Ma JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31278; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Mermillod M, 2009, COGNITION, V110, P346, DOI 10.1016/j.cognition.2008.11.009; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Moradi A, 2017, BASIC CLIN NEUROSCI, V8, P27, DOI 10.15412/J.BCN.03080104; Mueller CJ, 2016, PSYCHOL RES-PSYCH FO, V80, P963, DOI 10.1007/s00426-015-0696-3; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Novitskiy N, 2011, NEUROIMAGE, V54, P824, DOI 10.1016/j.neuroimage.2010.09.041; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; OHMAN A, 1978, J PERS SOC PSYCHOL, V36, P1251; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Parra MA, 2018, COGNITION EMOTION, V32, P275, DOI 10.1080/02699931.2017.1298994; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Posner M.I., 2004, ATTENTION COGNITIVE, V205; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Riels KM, 2020, NEUROPSYCHOLOGIA, V136, DOI 10.1016/j.neuropsychologia.2019.107283; Rigoulot S, 2008, BRAIN TOPOGR, V20, P216, DOI 10.1007/s10548-008-0050-9; Schmuser L, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00175; Schneider IK, 2016, EMOTION, V16, P426, DOI 10.1037/emo0000164; Schonwald LI, 2014, HUM BRAIN MAPP, V35, P1477, DOI 10.1002/hbm.22267; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Vida MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13203-8; Voges MM, 2019, BIOL PSYCHOL, V143, P74, DOI 10.1016/j.biopsycho.2019.02.010; Weymar M, 2011, NEUROIMAGE, V58, P946, DOI 10.1016/j.neuroimage.2011.06.061; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Yao SX, 2013, NEUROSCI LETT, V548, P275, DOI 10.1016/j.neulet.2013.06.006; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698; Zhou PY, 2016, COGNITION EMOTION, V30, P621, DOI 10.1080/02699931.2015.1020051; Zhou PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060548; Zhu M., 2015, HEALTH, V07, P183, DOI [10.1016/j.neulet.2010.04.036, DOI 10.1016/J.NEULET.2010.04.036]; Zhuravleva TY, 2014, J CLIN NEUROPHYSIOL, V31, P261, DOI 10.1097/WNP.0000000000000056	88	3	3	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249407	10.1371/journal.pone.0249407	http://dx.doi.org/10.1371/journal.pone.0249407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798215	gold, Green Accepted, Green Published			2022-12-26	WOS:000636737700002
J	Kimura, Y; Sasaki, Y; Suzuki, J; Suzuki, J; Igei, H; Suzukawa, M; Matsui, H				Kimura, Yuya; Sasaki, Yuka; Suzuki, Junko; Suzuki, Jun; Igei, Hiroshi; Suzukawa, Maho; Matsui, Hirotoshi			Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan	PLOS ONE			English	Article								Background Chronic pulmonary aspergillosis (CPA) develops in various underlying pulmonary conditions. There is scarce data evaluating interstitial lung disease (ILD)/abnormalities (ILA) as such conditions, and it has not been explored much whether non-tuberculous mycobacterial pulmonary disease (NTM-PD) is a prognostic factor for mortality in CPA patients. Few reports had investigated prognostic factors of CPA including underlying pulmonary conditions. Objectives To explore prognostic factors of CPA including pulmonary conditions. Methods We conducted a retrospective cohort study of 264 CPA patients from a center for pulmonary aspergillosis in Japan. Results Survival rates were 78.7%, 61.0%, and 47.4% at 1, 3, and 5 years, respectively. Of 264 patients, 53 (20.1%) and 87 (33.1%) were complicated with ILA and NTM-PD. Several independent prognostic factors were identified by multivariate Cox proportional analysis: ILA (HR 1.76, 95%CI 1.06-2.92, p = 0.029), age (1.05, 1.02-1.08, p<0.001), male sex (2.48, 1.34-4.59, p = 0.004), body mass index of <18.5 kg/m(2) (1,87, 1.20-2.90, p = 0.005), presence of aspergilloma (1.59, 1.04-2.45, p = 0.033), and lower serum albumin (0.56, 0.38-0.83, p = 0.004). NTM-PD was not associated with higher mortality (0.85, 0.52-1.38, p = 0.51). Conclusions The poor prognosis of CPA and several prognostic factors were revealed. Early diagnosis and intervention is required with reference to such factors.	[Kimura, Yuya; Sasaki, Yuka; Suzuki, Junko; Suzuki, Jun; Igei, Hiroshi; Suzukawa, Maho; Matsui, Hirotoshi] Natl Hosp Org Tokyo Natl Hosp, Ctr Pulm Dis, Dept Resp Med, Tokyo, Japan		Kimura, Y (corresponding author), Natl Hosp Org Tokyo Natl Hosp, Ctr Pulm Dis, Dept Resp Med, Tokyo, Japan.	yuk.close.to.wrd.34@gmail.com		Suzukawa, Maho/0000-0002-2265-1950; Kimura, Yuya/0000-0003-1649-0596				Aguilar-Company J, 2019, MYCOSES, V62, P765, DOI 10.1111/myc.12950; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Bongomin F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193732; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Camara B, 2015, CLIN RESPIR J, V9, P65, DOI 10.1111/crj.12105; CAMPBELL MJ, 1964, AM REV RESPIR DIS, V89, P186; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.31; COLEMAN RM, 1972, APPL MICROBIOL, V23, P301, DOI 10.1128/AEM.23.2.301-308.1972; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Farid S, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-180; Furuuchi K, 2018, J INFECT CHEMOTHER, V24, P654, DOI 10.1016/j.jiac.2018.04.002; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Jhun BW, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00798-2019; Jhun BW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188716; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kurosaki F, 2014, INTERNAL MED, V53, P1299, DOI 10.2169/internalmedicine.53.1578; Lowes D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01062-2016; Marras TK, 2017, EMERG INFECT DIS, V23, P468, DOI 10.3201/eid2303.161927; Nakamoto K, 2013, INTERNAL MED, V52, P727, DOI 10.2169/internalmedicine.52.9142; Nam HS, 2010, INT J INFECT DIS, V14, pE479, DOI 10.1016/j.ijid.2009.07.011; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Sehgal IS, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.01.007; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; Takeda K, 2016, MED MYCOL, V54, P120, DOI 10.1093/mmy/myv093; TOMLINSON JR, 1987, CHEST, V92, P505, DOI 10.1378/chest.92.3.505; Tuberculosis Surveillance Center, 2018, TUB JAP ANN REP 2018	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249455	10.1371/journal.pone.0249455	http://dx.doi.org/10.1371/journal.pone.0249455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793645	gold, Green Published			2022-12-26	WOS:000636467000071
J	Scott, SM; Gross, LJ				Scott, Shelby M.; Gross, Louis J.			COVID-19 and crime: Analysis of crime dynamics amidst social distancing protocols	PLOS ONE			English	Article								In response to the pandemic in early 2020, cities implemented states of emergency and stay at home orders to reduce virus spread. Changes in social dynamics due to local restrictions impacted human behavior and led to a shift in crime dynamics. We analyze shifts in crime types by comparing crimes before the implementation of stay at home orders and the time period shortly after these orders were put in place across three cities. We find consistent changes across Chicago, Baltimore, and Baton Rouge with significant declines in total crimes during the time period immediately following stay at home orders. The starkest differences occurred in Chicago, but in all three cities the crime types contributing to these declines were related to property crime and statutory crime rather than interpersonal crimes.	[Scott, Shelby M.; Gross, Louis J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Gross, Louis J.] Natl Inst Math & Biol Synth, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Scott, SM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	sscott41@vols.utk.edu		Scott, Shelby/0000-0003-2104-4398	National Institute for Mathematical and Biological Synthesis (NIMBioS) through NSF [DBI-1300426]; University of Tennessee, Knoxville; National Defense Science and Engineering Graduate (NDSEG) Fellowship	National Institute for Mathematical and Biological Synthesis (NIMBioS) through NSF; University of Tennessee, Knoxville; National Defense Science and Engineering Graduate (NDSEG) Fellowship	LJG is supported by the National Institute for Mathematical and Biological Synthesis (NIMBioS), which is funded through NSF Award #DBI-1300426, with additional support from The University of Tennessee, Knoxville (http://www.nimbios.org/).SMS is funded through the National Defense Science and Engineering Graduate (NDSEG) Fellowship (https://ndseg.sysplus.com/).	Ashby MPJ, 2020, CRIME SCI, V9, DOI 10.1186/s40163-020-00117-6; Boman JH, 2020, AM J CRIM JUSTICE, V45, P537, DOI 10.1007/s12103-020-09551-3; Center for Disease Control and Prevention, 2017, WEB BAS INJ STAT QUE; Chicago Police Department Citizen Law Enforcement Analysis & Reporting (CLEAR) System,, 2020, CRIMES 2001 PRESENT; Fenton J., BALTIMORE SUN; Hansun Seng., 2013, 2013 C NEW MEDIA STU, P1; Hunter M, 2020, NOLA; Justia, 2018, TYPES CRIMINAL OFFEN; Kim TK, 2015, KOREAN J ANESTHESIOL, V68, P540, DOI 10.4097/kjae.2015.68.6.540; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Lopez, 2020, COVID 19 HOMICIDE FI; MacFarquhar N., NEW YORK TIMES; Open Baltimore,, 2020, BPD 1; Open Data B.R, 2020, BATON ROUGE CRIME IN; Riley C, 2017, J URBAN HEALTH, V94, P619, DOI 10.1007/s11524-016-0121-2; Smith P, 2020, WBEZ CHICAGO; Stickle B, 2020, AM J CRIM JUSTICE, V45, P525, DOI 10.1007/s12103-020-09546-0; Sweeney A., 2020, TELEGRAPH HERALD; U.S. Census, 2019, QUICKFACTS; unacast, SOCIAL DISTANCING SC; Van Den Bos J., 2017, COST COMMUNITY VIOLE; VanderWeele TJ, 2019, AM J EPIDEMIOL, V188, P617, DOI 10.1093/aje/kwy250; Yin A, 2020, THE CHICAGO TRIBUNE	23	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249414	10.1371/journal.pone.0249414	http://dx.doi.org/10.1371/journal.pone.0249414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793642	Green Published, Green Submitted, gold			2022-12-26	WOS:000636467000020
J	Hanfi, MYM; Masoud, MS; Sayyed, MI; Khandaker, MU; Faruque, MRI; Bradley, DA; Mostafa, MYA				Hanfi, Mohamed Youssef Mohamed; Masoud, Masoud Salah; Sayyed, M. I.; Khandaker, Mayeen Uddin; Faruque, Mohammed Rashed Iqbal; Bradley, D. A.; Mostafa, Mostafa Yuness Abdelfatah			The presence of radioactive heavy minerals in prospecting trenches and concomitant occupational exposure	PLOS ONE			English	Article							ACTIVITY SIZE DISTRIBUTION; NATURAL RADIOACTIVITY; SPATIAL-DISTRIBUTION; EASTERN DESERT; RADIONUCLIDES; SEDIMENTS; BEACH; SAND; AREA; SOIL	Uranium, perhaps the most strategically important component of heavy minerals, finds particular significance in the nuclear industry. In prospecting trenches, the radioactivity of U-238 and Th-232 provides a good signature of the presence of heavy minerals. In the work herein, the activity concentrations of several key primordial radionuclides (U-238, Th-232, and K-40) were measured in prospecting trenches (each of the latter being of approximately the same geometry and physical situation). All of these are located in the Seila area of the South Eastern desert of Egypt. A recently introduced industry standard, the portable hand-held RS-230 BGO gamma-ray spectrometer (1024 channels) was employed in the study. Based on the measured data, the trenches were classified as either non-regulated (U activity less than 1000 Bq kg(-1)) or regulated (with U-238 activity more than 1000 Bq kg(-1)). Several radiological hazard parameters were calculated, statistical analysis also being performed to examine correlations between the origins of the radionuclides and their influence on the calculated values. While the radioactivity and hazard parameters exceed United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) guided limits, the mean annual effective doses of 0.49 and 1.4 mSv y(-1) in non-regulated and regulated trenches respectively remain well below the International Commission on Radiological Protection (ICRP) recommended 20 mSv/y maximum occupational limit. This investigation reveals that the studied area contains high uranium content, suitable for extraction of U-minerals for use in the nuclear fuel cycle.	[Hanfi, Mohamed Youssef Mohamed; Mostafa, Mostafa Yuness Abdelfatah] Ural Fed Univ, Ekaterinburg, Russia; [Hanfi, Mohamed Youssef Mohamed; Masoud, Masoud Salah] Nucl Mat Author, Cairo, Egypt; [Sayyed, M. I.] Isra Univ, Dept Phys, Fac Sci, Amman, Jordan; [Sayyed, M. I.] Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat, Dept Nucl Med Res, Dammam, Saudi Arabia; [Khandaker, Mayeen Uddin] Sunway University, Ctr Appl Phys & Radiat Technol, Sch Engn & Technol, Subang Jaya, Selangor, Malaysia; [Faruque, Mohammed Rashed Iqbal; Bradley, D. A.] Univ Kebangsaan Malaysia, Space Sci Ctr ANGKASA, Bangi, Selangor, Malaysia; [Bradley, D. A.] Univ Surrey, Dept Phys, Guildford, Surrey, England; [Mostafa, Mostafa Yuness Abdelfatah] Minia Univ, Dept Phys, Fac Sci, Al Minya, Egypt	Ural Federal University; Egyptian Knowledge Bank (EKB); Nuclear Materials Authority (NMA); Isra University; Imam Abdulrahman Bin Faisal University; Universiti Kebangsaan Malaysia; University of Surrey; Egyptian Knowledge Bank (EKB); Minia University	Hanfi, MYM; Mostafa, MYA (corresponding author), Ural Fed Univ, Ekaterinburg, Russia.; Hanfi, MYM (corresponding author), Nucl Mat Author, Cairo, Egypt.; Khandaker, MU (corresponding author), Sunway University, Ctr Appl Phys & Radiat Technol, Sch Engn & Technol, Subang Jaya, Selangor, Malaysia.; Mostafa, MYA (corresponding author), Minia Univ, Dept Phys, Fac Sci, Al Minya, Egypt.	mayeenk@sunway.edu.my; Mokhamed.Khanfi@urfu.ru; Mostafa.youness@mu.edu.eg	, Hanfi/O-9400-2019; Khandaker, Mayeen Uddin/F-5376-2011; , M.I.Sayyed/AAB-7789-2022; Mostafa, Mostafa Yunees Abdelfatah/A-8003-2018	, Hanfi/0000-0001-6619-642X; Khandaker, Mayeen Uddin/0000-0003-3772-294X; Mostafa, Mostafa Yunees Abdelfatah/0000-0002-5445-0248	Universiti Kebangsaan Malaysia, Dana Impak Perdana (DIP) [2020-018]	Universiti Kebangsaan Malaysia, Dana Impak Perdana (DIP)	This work was supported by Research Universiti Grant, Universiti Kebangsaan Malaysia, Dana Impak Perdana (DIP), code: 2020-018.	Abbady A., 2008, UPP EG INT C RAD ENV, P15; Abbady AGE, 2005, J ENVIRON RADIOACTIV, V84, P65, DOI 10.1016/j.jenvrad.2005.04.003; Abdel-Razek YA, 2017, ARAB J NUCL SCI APPL, V50, P22; Abdel-Razek YA, 2016, J TAIBAH UNIV SCI, V10, P271, DOI 10.1016/j.jtusci.2015.06.010; Abedin MJ, 2019, ARAB J GEOSCI, V12, DOI 10.1007/s12517-019-4355-7; Akozcan S, 2014, TOXICOL ENVIRON CHEM, V96, P379, DOI 10.1080/02772248.2014.939177; [Anonymous], 2000, SOURCES EFFECTS IONI, P84, DOI [10.1097/00004032-199907000-00007, DOI 10.1097/00004032-199907000-00007]; [Anonymous], TERRAPLUS RS 230 BGO; Baba-Ahmed L, 2018, RADIOCHIM ACTA, V106, P939, DOI 10.1515/ract-2018-2926; Bisher A.H., 2012, 11 AR C PEAC US AT E; El-Taher A, 2018, APPL RADIAT ISOTOPES, V131, P13, DOI 10.1016/j.apradiso.2017.09.024; Gunay O, 2019, ARAB J GEOSCI, V12, DOI 10.1007/s12517-019-4830-1; Hanfi MY, 2020, ENVIRON SCI POLLUT R, V27, P40309, DOI 10.1007/s11356-020-10084-9; Hanfi MY, 2020, J RADIOANAL NUCL CH, V323, P1047, DOI 10.1007/s10967-020-07020-z; Hanfi MY, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-019-7947-5; Hanfi MY, 2019, J RADIOANAL NUCL CH, V321, P831, DOI 10.1007/s10967-019-06657-9; Hanfi MYM, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8089-3; HEAMAN LM, 1990, GEOCHIM COSMOCHIM AC, V54, P1597, DOI 10.1016/0016-7037(90)90394-Z; HUSSEIN HA, 1992, ORE GEOL REV, V7, P125, DOI 10.1016/0169-1368(92)90008-9; Ibrahim M., 2005, P 9 INT MINING PETRO, P41; International Atomic Energy Agency (IAEA) Vienna, 2018, P INT S ORG I RAD PR; Islam AMS, 2019, J RADIOANAL NUCL CH, V322, P157, DOI 10.1007/s10967-019-06582-x; Khalaf HN, 2019, APPL RADIAT ISOTOPES, V145, P95, DOI 10.1016/j.apradiso.2018.12.022; Khalaf HNB, 2019, RADIAT PHYS CHEM, V165, DOI 10.1016/j.radphyschem.2019.108402; Khandaker MU, 2019, RADIOPROTECTION, V54, P211, DOI 10.1051/radiopro/2019024; Khandaker MU, 2018, MAR POLLUT BULL, V127, P654, DOI 10.1016/j.marpolbul.2017.12.055; Kolo MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158100; Kolo MT, 2015, ENVIRON SCI POLLUT R, V22, P13127, DOI 10.1007/s11356-015-4577-5; Maurice, 1980, URANIUM IN GRANITES, V120, DOI [10.1017/S0016756800025577, DOI 10.1017/S0016756800025577]; Mostafa MYA, 2020, APPL RADIAT ISOTOPES, V156, DOI 10.1016/j.apradiso.2019.108981; Ozturk BC, 2013, J ENVIRON SCI HEAL A, V48, P1522, DOI 10.1080/10934529.2013.797242; Paul D, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000497; Qureshi AA, 2014, J RADIAT RES APPL SC, V7, P438, DOI 10.1016/j.jrras.2014.07.008; Shahin HAA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-573; Shuaibu HK, 2017, MAR POLLUT BULL, V119, P423, DOI 10.1016/j.marpolbul.2017.03.026; Uosif MAM, 2015, J RADIAT RES APPL SC, V8, P393, DOI 10.1016/j.jrras.2015.02.005; VENNART J, 1991, Journal of Radiological Protection, V11, P199, DOI 10.1088/0952-4746/11/3/006; Verdoya M, 2001, ECLOGAE GEOL HELV, V94, P213; Yasmin S, 2018, RESULTS PHYS, V8, P1268, DOI 10.1016/j.rinp.2018.02.013; Yuness M, 2016, STOCH ENV RES RISK A, V30, P167, DOI 10.1007/s00477-015-1057-x; Yuness M, 2015, APPL RADIAT ISOTOPES, V97, P34, DOI 10.1016/j.apradiso.2014.12.002	42	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249329	10.1371/journal.pone.0249329	http://dx.doi.org/10.1371/journal.pone.0249329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788889	Green Published, gold			2022-12-26	WOS:000636354600002
J	Verberk, JDM; Anthierens, SA; Tonkin-Crine, S; Goossens, H; Kinsman, J; de Hoog, MLA; Bielicki, JA; Bruijning-Verhagen, PCJL; Gobat, NH				Verberk, Janneke D. M.; Anthierens, Sibyl A.; Tonkin-Crine, Sarah; Goossens, Herman; Kinsman, John; de Hoog, Marieke L. A.; Bielicki, Julia A.; Bruijning-Verhagen, Patricia C. J. L.; Gobat, Nina H.			Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study	PLOS ONE			English	Article								Background Households are important sites for transmission of SARS-CoV-2 and preventive measures are recommended. This study aimed to 1) investigate the impact of living with a person infected with SARS-CoV-2; 2) understand how household members implemented infection control recommendations in their home; and 3) identify the information and support needs of household members. Methods For this observational mixed-methods study, households with a person with confirmed SARS-CoV-2 infection were recruited via drive-through testing sites of Municipal Health Services, healthcare worker screening or hospital emergency visits in the University Medical Centre Utrecht, the Netherlands and via primary care physicians, hospital emergency visits or preoperative screening in the University Hospital of Antwerp, Belgium. We recorded household characteristics, including characteristics of all household members, together with their views on prevention measures. In a subset of households one adult household member was asked to participate in an interview investigating their views on preventive measures. Survey data were analysed using descriptive statistics and interview data by rapid framework analysis. A triangulation protocol was used to integrate findings. Results Thirty-four households (120 household members) were included in the quantitative survey. Twenty-two households were invited to be interviewed, of which 18 completed an interview (response 81.8%). Survey data showed that almost all households implemented some preventive measures, the use of face masks being least frequently reported. Measures taken depended on what was physically possible, the perceived severity of illness of the index patient and to what extent household members were willing to limit social interaction. Respondents did not believe in the effectiveness of wearing face masks within the house, and from the interviews this was explained by media coverage of face masks, impracticality and the stigma associated with wearing masks. Interviewees reported that quarantine had a high emotional burden and wished to have more information about the exact duration of quarantine, their own COVID-19 status, symptoms and when to seek medical help. Conclusion People were willing to implement prevention measures, however actual adherence depended on perceived severity of illness and the perceived risk of becoming infected. Homes are social environments and recommendations for infection prevention should account for this context. Incorporating our findings into policy making could provide households with more relevant and actionable advice.	[Verberk, Janneke D. M.] Univ Med Ctr Utrecht, Dept Med Microbiol & Infect Prevent, Utrecht, Netherlands; [Verberk, Janneke D. M.; de Hoog, Marieke L. A.; Bruijning-Verhagen, Patricia C. J. L.] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Anthierens, Sibyl A.] Univ Antwerp, Family Med & Populat Hlth FAMPOP, Antwerp, Belgium; [Tonkin-Crine, Sarah; Gobat, Nina H.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Tonkin-Crine, Sarah] Univ Oxford, Hlth Protect Res Unit Antimicrobial Resistance &, Oxford, England; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Antwerp, Belgium; [Kinsman, John] European Ctr Dis Prevent & Control, Solna, Sweden; [Bielicki, Julia A.] Univ Basel, Infect Prevent & Control, Childrens Hosp, Basel, Switzerland; [Bielicki, Julia A.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Antwerp; University of Oxford; University of Oxford; University of Antwerp; European Centre for Disease Prevention & Control; University of Basel; St Georges University London	Gobat, NH (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	nina.gobat@phc.ox.ac.uk	Bruijning-Verhagen, Patricia C.J.L./E-4134-2015; Gobat, Nina/AAW-8402-2021; Tonkin-Crine, Sarah/Q-1198-2016	Bruijning-Verhagen, Patricia C.J.L./0000-0003-4105-9669; Anthierens, Sibyl/0000-0003-4762-1907; Kinsman, John/0000-0003-1332-4138; Gobat, Nina/0000-0002-1558-557X; Tonkin-Crine, Sarah/0000-0003-4470-1151; Verberk, Janneke/0000-0003-2148-5935	EU Horizon 2020 research and innovation programme [101003589]; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England	EU Horizon 2020 research and innovation programme; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England	This work forms part of RECOVER (Rapid European COVID-19 Emergency Response research). RECOVER is funded by the EU Horizon 2020 research and innovation programme under grant agreement number 101003589. ST-C is funded by the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England.	[Anonymous], 2002, Bull World Health Organ, V80, P983; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; Chan EYY, 2020, LANCET, V395, P1957, DOI 10.1016/S0140-6736(20)31254-X; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020; European Centre for Disease Prevention and Control, 2020, INFECT PREVENTION CO; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Gao XS, 2020, EUR J CLIN MICROBIOL, V39, P1611, DOI 10.1007/s10096-020-03880-1; Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z; Greenhalgh T., MANAGING UNCERTAINTY; Huang R, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30147-X; Jiang XL, 2020, J INFECT DIS, V221, P1948, DOI 10.1093/infdis/jiaa206; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Johnson GA, 2017, SOC SCI MED, V189, P63, DOI 10.1016/j.socscimed.2017.07.029; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Nasir LC, 2010, LONDON J PRIM CARE, V3, P124, DOI 10.1080/17571472.2010.11493317; O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587; Peto J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200915; Rosenberg ES, 2020, CLIN INFECT DIS, V71, P1953, DOI 10.1093/cid/ciaa549; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Taylor B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019993; Tonkin-Crine S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0436-0; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; Wang ZL, 2020, J INFECTION, V81, P179, DOI 10.1016/j.jinf.2020.03.040; World Health Organization, 1998, WELLBEING MEASURES P; World Health Organization, 2020, HOME CARE PATIENTS S	30	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249391	10.1371/journal.pone.0249391	http://dx.doi.org/10.1371/journal.pone.0249391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788890	gold, Green Accepted, Green Published			2022-12-26	WOS:000636354600048
J	Alboksmaty, A; Kumar, S; Parekh, R; Aylin, P				Alboksmaty, Ahmed; Kumar, Sonia; Parekh, Ravi; Aylin, Paul			Management and patient safety of complex elderly patients in primary care during the COVID-19 pandemic in the UK-Qualitative assessment	PLOS ONE			English	Article							HEALTH-CARE; MULTIMORBIDITY; RESILIENT	Objectives The study aims to investigate GPs' experiences of how UK COVID-19 policies have affected the management and safety of complex elderly patients, who suffer from multimorbidity, at the primary care level in North West London (NWL). Design This is a service evaluation adopting a qualitative approach. Setting Individual semi-structured interviews were conducted between 6 and 22 May 2020, 2 months after the introduction of the UK COVID-19 Action Plan, allowing GPs to adapt to the new changes and reflect on their impact. Participants Fourteen GPs working in NWL were interviewed, until data saturation was reached. Outcome measures The impact of COVID-19 policies on the management and safety of complex elderly patients in primary care from the GPs' perspective. Results Participants' average experience was fourteen years working in primary care for the NHS. They stated that COVID-19 policies have affected primary care at three levels, patients' behaviour, work conditions, and clinical practice. GPs reflected on the impact through five major themes; four of which have been adapted from the Safety Attitudes Questionnaire (SAQ) framework, changes in primary care (at the three levels mentioned above), involvement of GPs in policy making, communication and coordination (with patients and in between medical teams), stressors and worries; in addition to a fifth theme to conclude the GPs' suggestions for improvement (either proposed mitigation strategies, or existing actions that showed relative success). A participant used an expression of "infodemic" to describe the GPs' everyday pressure of receiving new policy updates with their subsequent changes in practice. Conclusion The COVID-19 pandemic has affected all levels of the health system in the UK, particularly primary care. Based on the GPs' perspective in NWL, changes to practice have offered opportunities to maintain safe healthcare as well as possible drawbacks that should be of concern.	[Alboksmaty, Ahmed] Imperial Coll London, NIHR Patient Safety Translat Res Ctr PSTRC, London, England; [Kumar, Sonia] Imperial Coll London, Undergrad Primary Care Educ & Med Educ Innovat &, London, England; [Parekh, Ravi] Imperial Coll London, Med Educ Innovat & Res Ctr MEdIC, London, England; [Aylin, Paul] Imperial Coll London, Sch Publ Hlth, Epidemiol & Publ Hlth Director Dr Foster Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Alboksmaty, A (corresponding author), Imperial Coll London, NIHR Patient Safety Translat Res Ctr PSTRC, London, England.	ama1716@ic.ac.uk		Parekh, Ravi/0000-0003-0219-4956; Kumar, Sonia/0000-0003-3630-3006; Alboksmaty, Ahmed/0000-0001-5570-3609; Aylin, Paul/0000-0003-4589-1743	National Institute for Health Research (NIHR) [PSTRC2016-004]; National Institute for Health Research (NIHR) under the Applied Health Research (ARC) programme for North West London; Imperial NIHR Biomedical Research Centre	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) under the Applied Health Research (ARC) programme for North West London; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research (NIHR), program grants for applied research, grant number: PSTRC2016-004. We are grateful for support from the National Institute for Health Research (NIHR) under the Applied Health Research (ARC) programme for North West London and the Imperial NIHR Biomedical Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Braithwaite J, 2015, INT J QUAL HEALTH C, V27, P418, DOI 10.1093/intqhc/mzv063; Briggs AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205533; de Vasconcelos PF, 2019, PUBLIC HEALTH, V171, P31, DOI 10.1016/j.puhe.2019.03.021; Department of Health & Social Care-the UK Government, 2020, COR; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Evison C., A E ATTENDANCES EMER; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ford JA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010652; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Guerra SG, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1173-4; Hine D., 2010, 2009 INFLUENZA PANDE; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Islam MM, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00011; Kelly Christopher J, 2017, Future Healthc J, V4, P121, DOI 10.7861/futurehosp.4-2-121; King Ann, 2013, J Grad Med Educ, V5, P385, DOI 10.4300/JGME-D-13-00072.1; Kozlowska Olga, 2018, Future Healthc J, V5, P64, DOI 10.7861/futurehosp.5-1-64; Landi F, 2020, J NUTR HEALTH AGING, V24, P466, DOI 10.1007/s12603-020-1356-x; Lay M., 2007, EVALUATION-US, V13, P495; LINCOLN YS, 1992, CAN J PUBLIC HEALTH, V83, pS6; Malcolm M, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0968-x; National Health Service (NHS), 2020, NEXT STEPS GEN PRACT; National Research Council (US) Panel on a Research Agenda and New Data for an Aging World, 2001, HLTH AG POP PREP AG; NHS England, 2020, RAP NHS RESP TEAMS H; NHS Research Ethics Committee, 2020, NHS REC GUID INT RES; Nieuwboer MS, 2019, EUR J GEN PRACT, V25, P7, DOI 10.1080/13814788.2018.1515907; Nuzzo JB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7707-z; Office for National Statistics, 2019, OV UK POP AUG 2019 O; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Public Health England, 2014, PAND INFL RESP PLAN; Sandelowski M., 2008, SAGE ENCY QUALITATIV, V2, P875; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Shehata M, 2020, FAM MED COMMUNITY HE, V8, DOI 10.1136/fmch-2020-000343; The Health Foundation, 2011, EV SCAN MEAS SAF CUL, V2011; The Health Foundation, 2020, MIGHT COVID 19 HAV A; Thornton J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1279; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; WHO European Regional Office for Primary Care, 2020, AD PRIM HLTTH CAR SE	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248387	10.1371/journal.pone.0248387	http://dx.doi.org/10.1371/journal.pone.0248387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780464	gold, Green Published			2022-12-26	WOS:000636336800042
J	Eszterbauer, E; Szego, D; Ursu, K; Sipos, D; Gellert, A				Eszterbauer, Edit; Szego, Dora; Ursu, Krisztina; Sipos, Dora; Gellert, Akos			Serine protease inhibitors of the whirling disease parasite Myxobolus cerebralis (Cnidaria, Myxozoa): Expression profiling and functional predictions	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; SUSCEPTIBILITY; IDENTIFICATION; RECOGNITION; PHYLOGENY; INVASION; SEQUENCE; GENES; LIGHT	Here, we studied the expression pattern and putative function of four, previously identified serine protease inhibitors (serpins) of Myxobolus cerebralis, a pathogenic myxozoan species (Cnidaria: Myxozoa) causing whirling disease of salmonid fishes. The relative expression profiles of serpins were determined at different developmental stages both in fish and in annelid hosts using serpin-specific qPCR assays. The expression of serpin Mc-S1 was similar throughout the life cycle, whereas a significant decrease was detected in the relative expression of Mc-S3 and Mc-S5 during the development in fish, and then in the sporogonic stage in the worm host. A decreasing tendency could also be observed in the expression of Mc-S4 in fish, which was, however, upregulated in the worm host. For the first time, we predicted the function of M. cerebralis serpins by the use of several bioinformatics-based applications. Mc-S1 is putatively a chymotrypsin-like inhibitor that locates extracellularly and is capable of heparin binding. The other three serpins are caspase-like inhibitors, and they are probably involved in protease and cell degradation processes during the early stage of fish invasion.	[Eszterbauer, Edit; Szego, Dora; Sipos, Dora; Gellert, Akos] Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Ursu, Krisztina] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Eszterbauer, E (corresponding author), Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.	eszterbauer.edit@atk.hu		Eszterbauer, Edit/0000-0002-4612-0898; Gellert, Akos/0000-0002-1455-8879	National Research, Development and Innovation Office, Hungary [NN124220]	National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary)	The study was funded by the National Research, Development and Innovation Office, Hungary (Grant No. NN124220). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2013, MOL BIOCHEM PARASIT, V191, P58, DOI 10.1016/j.molbiopara.2013.09.006; Alama-Bermejo G, 2020, GENOME BIOL EVOL, V12, P1258, DOI 10.1093/gbe/evaa109; Americus B, 2020, INT J PARASITOL, V50, P763, DOI 10.1016/j.ijpara.2020.04.012; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartholomew JL, 2002, AM FISH S S, V29, P3; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Di Maggio LS, 2020, INT J PARASITOL, V50, P931, DOI 10.1016/j.ijpara.2020.05.010; Doyle PS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002139; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; El-Matbouli M, 1998, INT J PARASITOL, V28, P195, DOI 10.1016/S0020-7519(97)00176-8; ELMATBOULI M, 1995, J FISH BIOL, V46, P919, DOI 10.1111/j.1095-8649.1995.tb01397.x; Eszterbauer E, 2009, PARASITOLOGY, V136, P367, DOI 10.1017/S0031182008005398; Eszterbauer E., 2015, MYXOZOAN EVOLUTION E, P175, DOI [10.1007/978-3-319-14753-6_10, DOI 10.1007/978-3-319-14753-6_10]; Eszterbauer E, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101502; Eszterbauer E, 2019, ACTA VET HUNG, V67, P212, DOI 10.1556/004.2019.023; Eszterbauer E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0744-2; Faber M., 2020, BIORXIV, DOI [10.1101/2020.09.28.312801, DOI 10.1101/2020.09.28.312801]; Fetherman ER, 2012, DIS AQUAT ORGAN, V102, P97, DOI 10.3354/dao02543; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; Fiala I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-228; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garg Aarti, 2008, In Silico Biology, V8, P129; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gorgoglione B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-55; Hartigan A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6705-y; Hedrick RP, 1999, DIS AQUAT ORGAN, V37, P173, DOI 10.3354/dao037173; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herczeg D, 2017, ACTA VET HUNG, V65, P517, DOI 10.1556/004.2017.050; Holzer AS, 2018, MOL ECOL, V27, P1651, DOI 10.1111/mec.14558; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kallert D.M., 2015, MYXOZOAN EVOLUTION E, P235, DOI DOI 10.1007/978-3-319-14753-6_13; Kelley GO, 2004, DIS AQUAT ORGAN, V59, P235, DOI 10.3354/dao059235; Kelley GO, 2003, EXP PARASITOL, V105, P201, DOI 10.1016/j.exppara.2003.12.004; Khan Mohammad Sazzad, 2011, J Amino Acids, V2011, P606797, DOI 10.4061/2011/606797; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kosakyan A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51479-0; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeBlanc AC, 2003, PROG NEURO-PSYCHOPH, V27, P215, DOI 10.1016/S0278-5846(03)00017-4; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Lu H, 2016, HYPERTENS RES, V39, P492, DOI 10.1038/hr.2016.17; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Marton S, 2012, J FISH DIS, V35, P303, DOI 10.1111/j.1365-2761.2012.01347.x; Morris DJ, 2010, INT J PARASITOL, V40, P357, DOI 10.1016/j.ijpara.2009.08.014; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Okamura B., 2015, MYXOZOAN EVOLUTION E, P441, DOI DOI 10.1007/978-3-319-14753-6; Quezada LAL, 2011, AN ACAD BRAS CIENC, V83, P663, DOI 10.1590/S0001-37652011000200025; R Core Team, 2021, R LANGUAGE ENV STAT; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saleh M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234479; Sarker S, 2015, DIS AQUAT ORGAN, V114, P155, DOI 10.3354/dao02856; Schrodinger L., 2019, SCHR DINGER SUITE; Sipos D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204437; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Valdivieso E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1006-z; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yahalomi D, 2020, P NATL ACAD SCI USA, V117, P5358, DOI 10.1073/pnas.1909907117; Yang YL, 2014, GENOME BIOL EVOL, V6, P3182, DOI 10.1093/gbe/evu247; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366; Zhang FL, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01052-0; Zhao LL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55351-z	70	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249266	10.1371/journal.pone.0249266	http://dx.doi.org/10.1371/journal.pone.0249266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780500	Green Published, gold, Green Accepted			2022-12-26	WOS:000636336800024
J	Hassan, SH; Teo, SZ; Ramayah, T; Al-Kumaim, NH				Hassan, Siti Hasnah; Teo, Shao Zhen; Ramayah, T.; Al-Kumaim, Nabil Hasan			The credibility of social media beauty gurus in young millennials' cosmetic product choice	PLOS ONE			English	Article							ONLINE CONSUMER REVIEWS; PURCHASE INTENTION; CELEBRITY; TRUST; COMMERCE; PERCEPTIONS; TRUSTWORTHINESS; COMMUNICATION; ENDORSEMENTS; HELPFULNESS	Social media influencers play a role in the beauty industry by making it more accessible and diverse, engaging in cultural acceptance and diversity, and making their lives public through social media. Known as 'beauty gurus', these influencers use their makeup skills to work with cosmetics brands, in which they earn substantial remuneration by raising brand awareness among social media audiences. While work was conducted on social media influencers, there was no clear focus on how influencers engage with young millennials regarding the choice of cosmetics products and its use. Hence, this study analysed the beauty 'gurus' credibility in influencing young female millennials' cosmetics brands of choice. A survey method was used to collect data using a judgemental sampling from young females who have subscribed and observed makeup tutorials on social media platforms, such as YouTube, Instagram, and Facebook, among many others. Additionally, a total of 271 usable questionnaires were gathered and analysed using AMOS. Credibility traits, such as knowledge, attractiveness, and relatability, were the core elements of an influencer's capability to influence young millennials. Social media influencers were seen as a new and effective marketing tool in targeting a broad demographic and increasing brand awareness.	[Hassan, Siti Hasnah; Teo, Shao Zhen; Ramayah, T.] Univ Sains Malaysia, Sch Management, George Town, Malaysia; [Ramayah, T.] Minjiang Univ, Newhuadu Business Sch, Internet Innovat Res Ctr, Fuzhou, Fujian, Peoples R China; [Ramayah, T.] Sunway Univ Business Sch SUBS, Dept Management, Petaling Jaya, Selangor, Malaysia; [Ramayah, T.] Univ Malaysia Sarawak, Fac Econ & Business, Sarawak, Malaysia; [Al-Kumaim, Nabil Hasan] Univ Tekn Malaysia Melaka UTeM Melaka, Durian Tunggal, Malaysia	Universiti Sains Malaysia; Minjiang University; University of Malaysia Sarawak; University Teknikal Malaysia Melaka	Hassan, SH (corresponding author), Univ Sains Malaysia, Sch Management, George Town, Malaysia.	siti.hassan@usm.my	Al-kumaim, *Nabil Hasan/AFH-5472-2022; T., Ramayah/E-4629-2010; Hassan, Siti Hasnah/E-3199-2012	Al-kumaim, *Nabil Hasan/0000-0002-3249-3714; T., Ramayah/0000-0002-7580-7058; Hassan, Siti Hasnah/0000-0003-4954-3674	Ministry of Malaysian Education [203.PMGT.671184]; Universiti Sains Malaysia [203.PMGT.671184]	Ministry of Malaysian Education; Universiti Sains Malaysia(Universiti Sains Malaysia)	Ministry of Malaysian Education and Universiti Sains Malaysia for funding this research under the Fundamental Research Grant Scheme (203.PMGT.671184). No. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu R., 2019, SOCIAL MEDIA MICROIN; Arai A, 2014, SPORT MANAG REV, V17, P97, DOI 10.1016/j.smr.2013.04.003; Bandura Albert, 1989, B BRIT PSYCHOL SOC, V2, P411, DOI DOI 10.1080/10413209008406426; Bruns I, 2018, THESIS DUBLIN BUSINE; Buhlmann H., 2006, COURSE CREDIBILITY T; Byrne B.M., 2001, INT J TESTING, V1, P55, DOI [10.1207/S15327574IJT0101_4, DOI 10.1207/S15327574IJT0101_4]; Chapple C., 2017, J PROMOTIONAL COMMUN, V5, P73523262; Chen J, 2019, ELECTRON COMMER R A, V35, DOI 10.1016/j.elerap.2019.100846; Chen S. C., 2003, Information Technology & Management, V4, P303, DOI 10.1023/A:1022962631249; Chou SY, 2016, J BUS RES, V69, P2226, DOI 10.1016/j.jbusres.2015.12.034; Chu S.C., 2008, J INTERACTIVE ADVERT, V8, P26, DOI DOI 10.1080/15252019.2008.10722140; Chuah SHW, 2016, COMPUT HUM BEHAV, V65, P276, DOI 10.1016/j.chb.2016.07.047; Creswell W. C., 2011, DESIGNING CONDUCTING; CrowdMedia, 2019, 10 TOP BEAUT BRANDS; Djafarova E, 2017, COMPUT HUM BEHAV, V68, P1, DOI 10.1016/j.chb.2016.11.009; Dutt H., 2011, INT J KNOWLEDGE MANA, V4, P389; Eisend M, 2004, ADV CONSUM RES, V31, P352; Erdogan, 1999, J MARK MANAG, V15, P291, DOI [DOI 10.1362/026725799784870379, 10.1362/026725799784870379]; Ewers N., 2017, SPONSORED INFLUENCER; Fastenau J, 2018, INFLUENCE POWER SOCI; Filieri R, 2018, INFORM MANAGE-AMSTER, V55, P956, DOI 10.1016/j.im.2018.04.010; Flavian C, 2006, INFORM MANAGE-AMSTER, V43, P1, DOI 10.1016/j.im.2005.01.002; Forbes K., 2016, ELON J UNDERGRADUATE, V7, P78, DOI [10.1016/j.mib.2008.10.001, DOI 10.1016/J.MIB.2008.10.001]; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gashi L, 2017, SOCIAL MEDIA INFLUEN; Gecti F., 2013, INT J MARKETING STUD, V5, P111, DOI [10.5539/ijms.v5n2p111, DOI 10.5539/IJMS.V5N2P111]; Glucksman M, 2017, ELON J UNDERGRADUATE, V8, P77; Greenacre L., 2014, ACAD MARKETING STUDI, V18, P169; Halim R.E., SSRN, V5169, P2006; Halzack S., 2016, WASH POST; Hassali MA., 2015, PHARM REGULATORY AFF, V4, P1, DOI DOI 10.4172/2167-7689.1000155; Hellmueller L., 2012, P WAPOR 65 ANN C; Hollensen S, 2013, MARK INTELL PLAN; Hsu CL, 2013, INTERNET RES, V23, P69, DOI 10.1108/10662241311295782; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ismagilova E, 2020, J RETAIL CONSUM SERV, V53, DOI 10.1016/j.jretconser.2019.01.005; Kelley H.H., 1953, COMMUNICATION PERSUA; Khamis S, 2017, CELEBR STUD, V8, P191, DOI 10.1080/19392397.2016.1218292; Ki CW, 2019, PSYCHOL MARKET, V36, P905, DOI 10.1002/mar.21244; Ki CW, 2018, DRIVERS IMPACTS SOCI; Kim K., 2010, J MED MARKETING, V10, P165; Kline R.B., 2011, PRINCIPLES PRACTICE; Langner S, 2013, J CONSUM MARK, V30, P31; Lee CH, 2014, J HOSP TOUR RES, V38, P330, DOI 10.1177/1096348012451455; 최재원, 2010, Management Science & Financial Engineering, V16, P81; Lee JE, 2016, J BUS RES, V69, P5753, DOI 10.1016/j.jbusres.2016.04.171; Lee Y, 2011, J MANAGE INFORM SYST, V28, P269, DOI 10.2753/MIS0742-1222280308; Levin D.Z, 2002, IBM I KNOWLEDGE BASE, V19, P1; Lin HC, 2018, BUS HORIZONS, V61, P431, DOI 10.1016/j.bushor.2018.01.010; Lin YC, 2012, J STAT MANAG SYST, V15, P581, DOI 10.1080/09720510.2012.10701643; Lincoln C., 2016, INFLUENCER MARKETING; Lu BZ, 2016, COMPUT HUM BEHAV, V56, P225, DOI 10.1016/j.chb.2015.11.057; Marwick A.E, 2013, 7 INT AIII C WEBL SO; Marwick AE, 2011, NEW MEDIA SOC, V13, P114, DOI 10.1177/1461444810365313; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; McCormick K, 2016, J RETAIL CONSUM SERV, V32, P39, DOI 10.1016/j.jretconser.2016.05.012; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; McKnight DH, 2002, INFORM SYST RES, V13, P334, DOI 10.1287/isre.13.3.334.81; McMillan SJ, 2002, J ADVERTISING, V31, P29, DOI 10.1080/00913367.2002.10673674; Moore A., 2018, INT TEXTILE APPAREL; OHANIAN R, 1991, J ADVERTISING RES, V31, P46; OHANIAN R, 1990, J ADVERTISING, V19, P39, DOI 10.1080/00913367.1990.10673191; Oliveira T, 2017, COMPUT HUM BEHAV, V71, P153, DOI 10.1016/j.chb.2017.01.050; Onorato RS, 2004, EUR J SOC PSYCHOL, V34, P257, DOI 10.1002/ejsp.195; Pan LY, 2011, J INTERACT MARK, V25, P67, DOI 10.1016/j.intmar.2011.01.002; Pitkanen A, 2019, SIGNIFICANCE CONSUME; Pophal L, 2016, ECONTENT, V39, P18; Qiutong M., 2019, ACAD MARKETING STUDI, V23, P1; Saaksjarvi M, 2016, EUR J MARKETING, V50, P421, DOI 10.1108/EJM-06-2014-0346; Schouten AP, 2020, INT J ADVERT, V39, P258, DOI 10.1080/02650487.2019.1634898; Senft Theresa M., 2008, CAMGIRLS CELEBRITY C, V4; Smith T. J., 2015, J BUSINESS DIVERSITY, V15, P39; Srivastava V, 2019, J INTERACT MARK, V48, P33, DOI 10.1016/j.intmar.2018.12.003; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Turner J.C., 2010, REDISCOVERING SOCIAL; Wathen CN, 2002, J AM SOC INF SCI TEC, V53, P134, DOI 10.1002/asi.10016; Weiss R, 2014, MARK HEALTH SERV, V34, P16; Wilson E.J., 1993, J ACAD MARKET SCI, V21, P101, DOI [10.1007/BF02894421, DOI 10.1007/BF02894421, https://doi.org/10.1007/BF02894421]; Wolf Jed, 2017, GEN Z MILLENNIALS AR; Wymer W, 2015, VOLUNTAS, V26, P2694, DOI 10.1007/s11266-014-9546-y; Xiao L, 2016, BUILDING LOYALTY E C; Yadav MS, 2013, J INTERACT MARK, V27, P311, DOI 10.1016/j.intmar.2013.09.001; Zasuwa G, 2019, SOC RESPONSIB J, V15, P977, DOI 10.1108/SRJ-08-2017-0140; Zhang KZK, 2016, DECIS SUPPORT SYST, V86, P95, DOI 10.1016/j.dss.2016.04.001	84	2	2	21	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249286	10.1371/journal.pone.0249286	http://dx.doi.org/10.1371/journal.pone.0249286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780487	Green Published, gold			2022-12-26	WOS:000636336800006
J	Kim, K; Choi, H				Kim, Kyeongjin; Choi, Hojong			High-efficiency high-voltage class F amplifier for high-frequency wireless ultrasound systems	PLOS ONE			English	Article								This paper presents a novel amplifier that satisfies both low distortion and high efficiency for high-frequency wireless ultrasound systems with limited battery life and size. While increasing the amplifier efficiency helps to address the problems for wireless ultrasound systems, it can cause signal distortion owing to harmonic components. Therefore, a new type of class F amplifier is designed to achieve high efficiency and low distortion. In the amplifier, the resonant circuit at each stage controls the harmonic components to reduce distortion and improve efficiency. Transformers with a large shunt resistor are also helpful to reduce the remaining noise in the input signal. The proposed class F amplifier is tested using simulations, and the voltage and current waveforms are analyzed to achieve correct operation with adequate efficiency and distortion. The measured performance of the class F amplifier has a gain of 23.2 dB and a power added efficiency (PAE) of 88.9% at 25 MHz. The measured DC current is 121 mA with a variance of less than 1% when the PA is operating. We measured the received echo signal through the pulse-echo response using a 25-MHz transducer owing to the compatibility of the designed class F amplifier with high- frequency transducers. The measured total harmonic distortion (THD) of the echo signal was obtained as 4.5% with a slightly low ring-down. The results show that the low THD and high PAE of the new high-efficiency and high-voltage amplifier may increase battery life and reduce the cooling fan size, thus providing a suitable environment for high-frequency wireless ultrasound systems.	[Kim, Kyeongjin; Choi, Hojong] Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gumi, South Korea	Kumoh National University Technology	Choi, H (corresponding author), Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gumi, South Korea.	hojongch@kumoh.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A2C4001606]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1A2C4001606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushberg J.T., 2011, ESSENTIAL PHYS MED I; Cai W., 2016, P 2 WORLD C NEW TECH; Camacho J, 2008, IEEE T ULTRASON FERR, V55, P1160, DOI 10.1109/TUFFC.2008.769; Capineri L, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4897155; Choi H, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10100697; Choi H, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19020287; Choi HJ, 2014, ULTRASONICS, V54, P121, DOI 10.1016/j.ultras.2013.04.018; Choi H, 2011, IEEE T ULTRASON FERR, V58, P2646, DOI 10.1109/TUFFC.2011.2127; Cicek I, 2005, IEEE T ULTRASON FERR, V52, P2235, DOI 10.1109/TUFFC.2005.1563266; CRIPPS S, 2002, ADV TECHNIQUES RF PO; Cripps S., 2006, RF POWER AMPLIFIERS; Daniels J.M., 2016, PRACTICAL POINT OF C; Goldberg BB, 2003, J ULTRAS MED, V22, P549, DOI 10.7863/jum.2003.22.6.549; Grebennikov A., 2005, RF MICROWAVE POWER A, DOI [10.1017/S1431927605050622, DOI 10.1017/S1431927605050622]; Grebennikov A., 2011, SWITCHMODE RF POWER; He ZY, 2015, J ACOUST SOC AM, V137, P2785, DOI 10.1121/1.4919318; Hella M.M., 2006, RF CMOS POWER AMPLIF, VVolume 659; Hoskins P.R., 2010, DIAGNOSTIC ULTRASOUN; Huang HY, 2011, IEEE T ULTRASON FERR, V58, P2699, DOI 10.1109/TUFFC.2011.2132; Kazimierczuk MK, 2015, RF POWER AMPLIFIERS, 2ND EDITION, P1; Kim GD, 2012, IEEE T ULTRASON FERR, V59, P1386, DOI 10.1109/TUFFC.2012.2339; Kim J, 2009, MICROW OPT TECHN LET, V51, P2323, DOI 10.1002/mop.24631; KLAUS DT., 2018, GUIDE MEDICAL IMAGE; Kremkau F. W., 2015, SONOGRAPHY PRINCIPLE; Kubowicz R., 2000, THESIS U TORONTO; Lam KH, 2013, ULTRASONICS, V53, P1033, DOI 10.1016/j.ultras.2013.01.012; Li JP, 2019, CARBON, V145, P112, DOI 10.1016/j.carbon.2019.01.025; Mader TB, 1998, IEEE T MICROW THEORY, V46, P1391, DOI 10.1109/22.721140; Michailovich OV, 2006, IEEE T ULTRASON FERR, V53, P64, DOI 10.1109/TUFFC.2006.1588392; ODONNELL M, 1992, IEEE T ULTRASON FERR, V39, P341, DOI 10.1109/58.143168; Oelze ML, 2007, IEEE T ULTRASON FERR, V54, P768, DOI 10.1109/TUFFC.2007.310; Poland M., 2010, LIGHT WEIGHT WIRELES; Qiu WB, 2017, IEEE T BIO-MED ENG, V64, P1935, DOI 10.1109/TBME.2016.2631224; Raab FH, 2001, IEEE T MICROW THEORY, V49, P1162, DOI 10.1109/22.925511; Rathod VT, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8020169; Reynaert P., 2006, RF POWER AMPLIFIERS; Schwebert B, 2018, RF POWER AMPLIFIER 2; Shung K.K., 2015, DIAGNOSTIC ULTRASOUN; Shung K. K., 2012, PRINCIPLES MED IMAGI; Smith NB., 2010, INTRO MED IMAGING PH; Soni NJ., 2014, POINT CARE ULTRASOUN, V1; Su M, 2019, IEEE T ULTRASON FERR, V66, P849, DOI 10.1109/TUFFC.2019.2898256; Vogt M, 2005, FREQUENZ, V59, P150, DOI 10.1515/FREQ.2005.59.5-6.150; Vuolevi J., 2003, ARTECH MICR; Wagner MS, 2014, AVIAT SPACE ENVIR MD, V85, P730, DOI 10.3357/ASEM.3754.2014; Walker JL, 2011, HDB RF MICROWAVE POW; Wojda RP., 2011, P IEEE INT S CIRC SY; Zagzebski JA, 1996, ESSENTIALS ULTRASOUN; Zhou QF, 2014, PROG MATER SCI, V66, P87, DOI 10.1016/j.pmatsci.2014.06.001; Zhu BP, 2013, IEEE T ULTRASON FERR, V60, P854, DOI 10.1109/TUFFC.2013.2635	51	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249034	10.1371/journal.pone.0249034	http://dx.doi.org/10.1371/journal.pone.0249034			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780492	Green Published, gold			2022-12-26	WOS:000636336800048
J	Ahouidi, A; Oliveira, R; Lobo, L; Diedhiou, C; Mboup, S; Nogueira, F				Ahouidi, Ambroise; Oliveira, Rafael; Lobo, Lis; Diedhiou, Cyrille; Mboup, Souleymane; Nogueira, Fatima			Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; DRUG-RESISTANCE; ARTEMISININ DERIVATIVES; MOLECULAR EPIDEMIOLOGY; MALARIA; SELECTION; GENE; CHLOROQUINE; ALLELES	Background Delayed Plasmodium falciparum parasite clearance has been associated with Single Nucleotide Polymorphisms (SNPs) in the kelch protein propeller domain (coded by pfk13 gene). SNPs in the Plasmodium falciparum multidrug resistance gene 1 (pfmdr1) are associated with multi-drug resistance including the combination artemether-lumefantrine. To our knowledge, this is the first work providing information on the prevalence of k13-propeller and pfmdr1 mutations from Sedhiou, a region in the south of Senegal. Methods 147 dried blood spots on filter papers were collected from symptomatic patients attending a hospital located in Bounkiling City, Sedhiou Region, Southern Senegal. All samples were collected between 2015-2017 during the malaria transmission season. Specific regions of the gene pfk13 and pfmdr1 were analyzed using PCR amplification and Sanger sequencing. Results The majority of parasites (92.9%) harboured the pfk13 wild type sequence and 6 samples harboured synonymous changes. Regarding pfmdr1, wild-type alleles represented the majority except at codon 184. Overall, prevalence of 86Y was 11.9%, 184F was 56.3% and 1246Y was 1.5%. The mutant allele 184F decreased from 73.7% in 2015 to 40.7% in 2017. The prevalence of haplotype NFD decreased from 71.4% in 2015 to 20.8% in 2017. Conclusions This study provides the first description of pfk13 and pfmdr1 genes variations in Bounkiling, a city in the Sedhiou Region of Senegal, contributing to closing the gap of information on anti-malaria drug resistance molecular markers in southern Senegal.	[Ahouidi, Ambroise] Hosp Aristide Dantec, Lab Bacteriol & Virol, Dakar, Senegal; [Ahouidi, Ambroise; Diedhiou, Cyrille; Mboup, Souleymane] Inst Hlth Res Epidemiol Surveillance & Training I, Dakar, Senegal; [Oliveira, Rafael; Lobo, Lis; Nogueira, Fatima] Univ Nova Lisboa, Inst Higiene Med & Trop, Global Hlth & Trop Med, GHTM,IHMT,UNL, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Ahouidi, A (corresponding author), Hosp Aristide Dantec, Lab Bacteriol & Virol, Dakar, Senegal.; Ahouidi, A (corresponding author), Inst Hlth Res Epidemiol Surveillance & Training I, Dakar, Senegal.	ambroise.ahouidi@iressef.org	nogueira, fatima/I-2148-2012	nogueira, fatima/0000-0003-0313-0778; Ahouidi, Ambroise/0000-0002-7009-8408; Tavares Coelho Lobo, Lis/0000-0001-7251-5538	EDCTP/Wanetam RegNet [2015-1049]; European Research Council [AdG-2011-294428]; Portuguese FCT RD center [GHTM-UID/04413/2020]	EDCTP/Wanetam RegNet; European Research Council(European Research Council (ERC)European Commission); Portuguese FCT RD center	A.A: was support by EDCTP/Wanetam RegNet2015-1049 and European Research Council (AdG-2011-294428). F.N: was funded by Portuguese FCT R&D center GHTM-UID/04413/2020.	Abdulla S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0445-x; Amambua-Ngwa A, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00759-17; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Asua V, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01818-18; Baliraine FN, 2011, J INFECT DIS, V204, P1120, DOI 10.1093/infdis/jir486; Baraka V, 2015, ANTIMICROB AGENTS CH, V59, P734, DOI 10.1128/AAC.03647-14; Bereczky S, 2005, AM J TROP MED HYG, V72, P249, DOI 10.4269/ajtmh.2005.72.249; Boussaroque A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1379-2; Boussaroque A, 2016, ANTIMICROB AGENTS CH, V60, P624, DOI 10.1128/AAC.01346-15; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Dama S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1700-8; Diallo MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65553-5; Diawara S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1773-4; Dieye B, 2016, AM J TROP MED HYG, V95, P1054, DOI 10.4269/ajtmh.16-0053; Dieye Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1965; Djaman JA, 2017, AM J TROP MED HYG, V97, P222, DOI 10.4269/ajtmh.16-0889; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorkenoo AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1381-8; Ebohon O, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0163-2019; Escobar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119215; Fall B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0589-3; Faye S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2305-6; Gendrot M, 2019, ACTA TROP, V196, P126, DOI 10.1016/j.actatropica.2019.05.020; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kavishe RA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-264; Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7; Madamet M, 2017, INT J ANTIMICROB AG, V49, P754, DOI 10.1016/j.ijantimicag.2017.01.032; Malmberg M, 2013, J INFECT DIS, V207, P842, DOI 10.1093/infdis/jis747; Matrevi SA, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00802-19; Mbaye A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1490-4; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Muiruri P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2534-8; Nag S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2894-8; Nag S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02724-x; Ndiaye D, 2013, INT J PARASITOL-DRUG, V3, P135, DOI 10.1016/j.ijpddr.2013.07.001; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Hong NV, 2014, EMERG INFECT DIS, V20, P1199, DOI 10.3201/eid2007.140155; Nwakanma DC, 2014, J INFECT DIS, V209, P1126, DOI 10.1093/infdis/jit618; Ocan M, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2701-6; Okell LC, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000999; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Pillai DR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-131; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Programme National de Lutte Contre le Paludisme, 2010, PROGR IMP SER FOC SE, P1; Programme National de Lutte Contre le Paludisme, 2018, B EP ANN 2017 PAL SE, P1; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Talundzic E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02116-16, 10.1128/aac.02116-16]; Taylor AR, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw229; Torrentino-Madamet M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-472; Van Tyne D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-441; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2018, ART RES ART BAS COMB; Wurtz N, 2014, ANTIMICROB AGENTS CH, V58, P7032, DOI 10.1128/AAC.03494-14; WWARN, 2020, PLASMODIUM FALCIPARU; Xu C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31207-w	61	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249357	10.1371/journal.pone.0249357	http://dx.doi.org/10.1371/journal.pone.0249357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770151	gold, Green Published			2022-12-26	WOS:000634833500060
J	Huddart, S; Singh, M; Jha, N; Benedetti, A; Pai, M				Huddart, Sophie; Singh, Mugdha; Jha, Nita; Benedetti, Andrea; Pai, Madhukar			Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India	PLOS ONE			English	Article							MORTALITY; RELAPSE; SPLINES; DOTS	Background A key component of the WHO End TB Strategy is quality of care, for which case fatality is a critical marker. Half of India's nearly 3 million TB patients are treated in the highly unregulated private sector, yet little is known about the outcomes of these patients. Using a retrospective cohort design, we estimated the case fatality ratio (CFR) and rate of recurrent TB among patients managed in the private healthcare sector in Patna, India. Methods World Health Partners' Private Provider Interface Agencies (PPIA) pilot project in Patna has treated 89,906 private sector TB patients since 2013. A random sample of 4,000 patients treated from 2014 to 2016 were surveyed in 2018 for case fatality and recurrent TB. CFR is defined as the proportion of patients who die during the period of interest. Treatment CFRs, post-treatment CFRs and rates of recurrent TB were estimated. Predictors for fatality and recurrence were identified using Cox proportional hazards modelling. Survey non-response was adjusted for using inverse probability selection weighting. Results The survey response rate was 56.0%. The weighted average follow-up times were 8.7 months in the treatment phase and 26.4 months in the post-treatment phase. Unobserved patients were more likely to have less than one month of treatment adherence (32.0% vs. 13.5%) and were more likely to live in rural Patna (21.9% vs. 15.0%). The adjusted treatment phase CFR was 7.27% (5.97%, 8.49%) and at 24 months post-treatment was 3.32% (2.36%, 4.42%). The adjusted 24 month post-treatment phase recurrent TB rate was 3.56% (2.54%, 4.79%). Conclusions Our cohort study provides critical estimates of TB patient outcomes in the Indian private sector, and accounts for selection bias. Patients in the private sector in Patna experienced a moderate treatment CFR but rates of recurrent TB and post-treatment fatality were low.	[Huddart, Sophie; Benedetti, Andrea; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Huddart, Sophie; Pai, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada; [Huddart, Sophie] Univ Calif San Francisco, Fac Med, San Francisco, CA 94143 USA; [Singh, Mugdha; Jha, Nita] World Hlth Partners, Patna, Bihar, India; [Pai, Madhukar] Manipal Acad Higher Educ, Manipal McGill Ctr Infect Dis, Manipal, India	McGill University; University of California System; University of California San Francisco; Manipal Academy of Higher Education (MAHE)	Huddart, S (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Huddart, S (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.; Huddart, S (corresponding author), Univ Calif San Francisco, Fac Med, San Francisco, CA 94143 USA.	sophie.huddart@ucsf.edu	Pai, Madhukar/AAX-9901-2021; Huddart, Sophie/AAF-8844-2020	Pai, Madhukar/0000-0003-3667-4536; Huddart, Sophie/0000-0001-6425-3371	Bill & Melinda Gates Foundation [BMGF OPP1091843P]; Fonds de recherche du Quebec -Sante Doctoral Fellowship	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Fonds de recherche du Quebec -Sante Doctoral Fellowship	The fieldwork in Patna was supported by a grant from the Bill & Melinda Gates Foundation (BMGF OPP1091843P) (https://www.gatesfoundation.org/). SH was supported by a Fonds de recherche du Que ' bec -Sante Doctoral Fellowship (http://www.frqs.gouv.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-21; Arinaminpathy N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39799-7; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Azhar GS, 2012, LUNG INDIA, V29, P147, DOI 10.4103/0970-2113.95320; Central TB Division, 2020, IND TB REP, V292; COX DR, 1972, J R STAT SOC B, V34, P187; DiCiccio TJ, 1996, STAT SCI, V11, P189; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Feleke BE, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0953-0; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gomes M, 2017, HEALTH AFFAIR, V36, P1887, DOI 10.1377/hlthaff.2017.0635; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Huddart S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002080; Khan AN, 2015, INDIAN J PHARM SCI, V77, P2, DOI 10.4103/0250-474X.151550; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kwan A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002653; Mahishale Vinay, 2015, Chonnam Med J, V51, P86, DOI 10.4068/cmj.2015.51.2.86; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Revised National Tuberculosis Control Programme, 2017, TB IND 2017; Romanowski K., 2019, CLIN INFECT DIS, DOI [10.1016/S1473-3099%2819%2930309-3, DOI 10.1016/S1473-3099%2819%2930309-3]; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Shah Sanchi, 2020, Gates Open Res, V4, P32, DOI 10.12688/gatesopenres.13113.1; SLEEPER LA, 1990, J AM STAT ASSOC, V85, P941, DOI 10.2307/2289591; Soyam VC., 2015, ASIAN J MED SCI, V7, P53, DOI [10.3126/ajms.v7i1.12744, DOI 10.3126/AJMS.V7I1.12744]; Subbaraman R, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002754; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vasantha M, 2008, Indian J Tuberc, V55, P64; Velayutham B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200150; Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842; WHO, 2015, END TB STRAT GLOB ST; World Health Organisation, 2014, WHOHTMTB20132; World Health Organization, 2021, 10 THREATS GLOB HLTH; Xue YS, 2017, COMMUN STAT APPL MET, V24, P583, DOI 10.29220/CSAM.2017.24.6.583	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249225	10.1371/journal.pone.0249225	http://dx.doi.org/10.1371/journal.pone.0249225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770134	gold, Green Published			2022-12-26	WOS:000634833500048
J	Larsen, MN; Krustrup, P; Povoas, SCA; Castagna, C				Larsen, Malte Nejst; Krustrup, Peter; Povoas, Susana Cristina Araujo; Castagna, Carlo			Accuracy and reliability of the InBody 270 multi-frequency body composition analyser in 10-12-year-old children	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; X-RAY ABSORPTIOMETRY; CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; MUSCLE MASS; METABOLIC SYNDROME; ADOLESCENTS; VALIDITY; FAT; OBESITY	The aim of this study was at examining the validity and reliability of a marketed bioimpedance (BIA) scale for body composition assessment, in children engaged in an educational football project (FIFA 11 for Health). One-hundred and twenty-seven children (70 boys and 57 girls; age 10.7 +/- 0.5 years, body mass 41.2 +/- 9.0 kg, Body mass index 18.5 +/- 3.3 kg.m(-2) and stature 149 +/- 7 cm) were evaluated for total body mass, lean body mass, muscle mass, using BIA (InBody 270, Biospace, California, USA) and dual-energy X-ray absorptiometry (DEXA, Lunar Prodigy, GE Medical Systems, Madison, Wisconsin, USA), at baseline conditions. Data analyses were carried out separately for girls and boys. Nearly perfect associations (r = 0.97-0.99) and excellent absolute (TEM = 0.04-1.9%) and relative (ICC = 0.98-1.00) inter-device reliability were found between DEXA and BIA variables. Fat and lean body mass bias (p < .0001) were practically relevant both for the boys (2.56 and 11.22 kg, respectively) and the girls (2.33 and 10.49 kg, respectively). Muscle mass and body fat were underestimated and overestimated, respectively, for the boys and girls. InBody 270 is a valid BIA system for estimating body composition with an excellent inter-device relative and absolute reliability. However, the remarkable measurements bias of BIA fat and muscle mass values discourage its use for clinical prescription. The BIA body composition biases were sex dependent.	[Larsen, Malte Nejst; Krustrup, Peter; Povoas, Susana Cristina Araujo] Univ Southern Denmark, Fac Hlth Sci, SDU Sport & Hlth Sci Cluster SHSC, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Dept Sport & Hlth Sci, Exeter, Devon, England; [Krustrup, Peter] Shanghai Univ Sport, Shanghai SUS, Dept Phys Educ & Sports Training, Shanghai, Peoples R China; [Povoas, Susana Cristina Araujo] Univ Inst Maia, ISMAI, CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Maia, Portugal; [Castagna, Carlo] Italian Football Federat, Fitness Training & Biomech Lab, Tech Dept, Florence, Italy; [Castagna, Carlo] Univ Roma Tor Vergata, Sch Sport & Exercise Sci, Rome, Italy	University of Southern Denmark; University of Exeter; Shanghai University of Sport; Instituto Universitario da Maia (ISMAI); University of Rome Tor Vergata	Larsen, MN (corresponding author), Univ Southern Denmark, Fac Hlth Sci, SDU Sport & Hlth Sci Cluster SHSC, Dept Sports Sci & Clin Biomech, Odense, Denmark.	mnlarsen@health.sdu.dk	Krustrup, Peter/D-2659-2019	Krustrup, Peter/0000-0002-1461-9838; Larsen, Malte Nejst/0000-0002-2600-7126	Nordea-foundation (Nordea-fonden); Aase and Ejnar Danielsens Foundation; Danish Football Association (Dansk Boldspil-Union, DBU)	Nordea-foundation (Nordea-fonden); Aase and Ejnar Danielsens Foundation; Danish Football Association (Dansk Boldspil-Union, DBU)	The authors would also like to acknowledge the financial support of the Nordea-foundation (Nordea-fonden), Aase and Ejnar Danielsens Foundation and the Danish Football Association (Dansk Boldspil-Union, DBU).	Aandstad A, 2014, MIL MED, V179, P208, DOI 10.7205/MILMED-D-12-00545; Andersen TB, 2011, CLIN NUTR, V30, P326, DOI 10.1016/j.clnu.2010.10.005; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buckinx F, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0510-9; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Dixon PM, 2018, MED SCI SPORT EXER, V50, P837, DOI 10.1249/MSS.0000000000001481; Fosbol MO, 2015, CLIN PHYSIOL FUNCT I, V35, P81, DOI 10.1111/cpf.12152; Fowke JH, 2010, PROSTATE, V70, P120, DOI 10.1002/pros.21039; GUTIN B, 1994, J PEDIATR-US, V125, P847, DOI 10.1016/S0022-3476(05)81997-3; Hangartner TN, 2013, J CLIN DENSITOM, V16, P520, DOI 10.1016/j.jocd.2013.08.007; Hens W, 2017, OBES REV, V18, P1310, DOI 10.1111/obr.12577; Hosking J, 2006, BRIT J NUTR, V96, P1163, DOI 10.1017/BJN20061960; JACKSON AS, 1988, J APPL PHYSIOL, V64, P529, DOI 10.1152/jappl.1988.64.2.529; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Kabiri LS, 2015, CHILD OBES, V11, P650, DOI 10.1089/chi.2014.0156; Kim JH, 2016, NUTR RES, V36, P1423, DOI 10.1016/j.nutres.2016.09.013; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; Leahy S, 2012, EUR J APPL PHYSIOL, V112, P589, DOI 10.1007/s00421-011-2010-4; Lee LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171568; Lind RR, 2018, EUR J SPORT SCI, V18, P130, DOI 10.1080/17461391.2017.1394369; Madden AM, 2016, J HUM NUTR DIET, V29, P7, DOI 10.1111/jhn.12278; McLester CN, 2020, J CLIN DENSITOM, V23, P443, DOI 10.1016/j.jocd.2018.10.008; Orsso CE, 2019, CLIN NUTR, V38, P2002, DOI 10.1016/j.clnu.2019.04.012; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reed KE, 2008, PREV MED, V46, P525, DOI 10.1016/j.ypmed.2008.02.020; Salamat MR, 2014, ARCH IRAN MED, V17, P674, DOI 0141710/AIM.007; Siebert M., 2019, TRANSPORTATION; Skoradal MB, 2018, SCAND J MED SCI SPOR, V28, P8, DOI 10.1111/sms.13209; Srikanthan P, 2016, AM J CARDIOL, V117, P1355, DOI 10.1016/j.amjcard.2016.01.033; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Talma H, 2013, OBES REV, V14, P895, DOI 10.1111/obr.12061; Thibault R, 2012, ANN NUTR METAB, V60, P6, DOI 10.1159/000334879; Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249; Volgyi E, 2008, OBESITY, V16, P700, DOI 10.1038/oby.2007.94; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358; Zeng Q, 2012, BRAZ J MED BIOL RES, V45, P591, DOI 10.1590/S0100-879X2012007500059; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	39	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0247362	10.1371/journal.pone.0247362	http://dx.doi.org/10.1371/journal.pone.0247362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770106	Green Published, gold			2022-12-26	WOS:000634833500042
J	Pasi, H; Lintunen, T; Leskinen, E; Hagger, MS				Pasi, Heidi; Lintunen, Taru; Leskinen, Esko; Hagger, Martin S.			Predicting school students' physical activity intentions in leisure-time and school recess contexts: Testing an integrated model based on self-determination theory and theory of planned behavior	PLOS ONE			English	Article							PERCEIVED AUTONOMY SUPPORT; HEALTH BEHAVIOR; CAUSALITY ORIENTATIONS; ACTIVITY MOTIVATION; REASONED ACTION; PAST BEHAVIOR; EDUCATION; EFFICACY; VALIDITY; COVARIANCE	Background Identifying psychological correlates of children's physical activity intentions may signpost potentially modifiable targets for interventions aimed at promoting physical activity participation. School recess and leisure-time outside of school are appropriate contexts in which such interventions may be delivered. However, few studies have identified correlates of physical activity intentions in these environments. Examining correlates in these contexts may provide formative evidence on which to base interventions to promote physical activity. Purpose The current study adopted an integrated theoretical model to test relations between motivational constructs from self-determination theory, social cognition constructs from the theory of planned behavior, and physical activity intentions in leisure-time and school recess contexts. Methods Finnish school children (N = 845, M age = 13.93, SD = 0.99) from three lower-secondary schools completed self-report measures of perceived autonomy support by peers, autonomous and controlled motivation, attitudes, subjective norms, perceived behavioral control, and physical activity intentions for both contexts. Results Well-fitting structural equation models controlling for past behavior indicated that autonomous motivation in the school recess context and attitude in both contexts were the most pervasive predictors of physical activity intentions, and mediated the relationship between perceived autonomy support and intentions. Multi-group analyses supported invariance of the models in both contexts across gender, grades, and school, with few variations. Conclusions The current study supports relations between motivational and social cognition correlates of children's physical activity intentions in school recess and leisure-time contexts. Future research should extend these findings to the prediction of follow-up participation in physical activity.	[Pasi, Heidi; Lintunen, Taru] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Leskinen, Esko] Univ Jyvaskyla, Dept Math & Stat, Jyvaskyla, Finland; [Hagger, Martin S.] Univ Calif Merced, Psychol Sci, Merced, CA USA	University of Jyvaskyla; University of Jyvaskyla; University of California System; University of California Merced	Pasi, H (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	heidi.pasi@jyu.fi	Hagger, Martin S./G-5211-2012; Lintunen, Taru/G-2838-2011	Hagger, Martin S./0000-0002-2685-1546; Lintunen, Taru/0000-0001-5191-2251	Finnish Ministry of Education and Culture [76/627/2008]	Finnish Ministry of Education and Culture	HP: grant number: 76/627/2008. Finnish Ministry of Education and Culture (https://minedu.fi/en/frontpage).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Atkin AJ, 2016, PREV MED, V87, P167, DOI 10.1016/j.ypmed.2016.02.040; Beresin A., 2016, INT J PLAY, V5, P159, DOI 10.1080/21594937.2016.1203920; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Chan DKC, 2020, PSYCHOL SPORT EXERC, V48, DOI 10.1016/j.psychsport.2020.101660; Chatzisarantis NLD, 2008, PSYCHOL HEALTH, V23, P347, DOI 10.1080/14768320601185866; Chatzisarantis NLD, 2008, PSYCHOL SPORT EXERC, V9, P27, DOI 10.1016/j.psychsport.2006.12.003; Chatzisarantis NLD, 2009, PSYCHOL HEALTH, V24, P29, DOI 10.1080/08870440701809533; Chatzisarantis NLD, 2004, BRIT J SOC PSYCHOL, V43, P551, DOI 10.1348/0144666042565399; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Courneya KS, 2000, AM J HEALTH BEHAV, V24, P300, DOI 10.5993/AJHB.24.4.6; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Finland government publications, 2015, FINL LAND SOL STRAT; Finnish National Agency for Education, 2016, NAT COR CURR BAS ED; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Gillis L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-112; Haapala HL, 2014, HEALTH EDUC RES, V29, P840, DOI 10.1093/her/cyu030; Hagger M, 2009, PSYCHOL HEALTH, V24, P689, DOI 10.1080/08870440801956192; Hagger MS, 2007, PSYCHOL SPORT EXERC, V8, P632, DOI 10.1016/j.psychsport.2006.09.001; Hagger MS, 2021, EUR J PERSONALITY, V35, P710, DOI 10.1177/0890207020962330; Hagger MS, 2019, PSYCHOL SPORT EXERC, V42, P118, DOI 10.1016/j.psychsport.2018.12.007; Hagger MS, 2018, SOC SCI MED, V213, P85, DOI 10.1016/j.socscimed.2018.07.038; Hagger MS, 2016, PREV MED, V89, P154, DOI 10.1016/j.ypmed.2016.05.020; Hagger MS, 2016, REV EDUC RES, V86, P360, DOI 10.3102/0034654315585005; Hagger MS, 2015, PERS INDIV DIFFER, V72, P107, DOI 10.1016/j.paid.2014.08.012; Hagger MS, 2012, EUR J PSYCHOL EDUC, V27, P195, DOI 10.1007/s10212-011-0082-5; Hagger MS, 2009, BRIT J HEALTH PSYCH, V14, P275, DOI 10.1348/135910708X373959; Hagger MS, 2001, J SPORT SCI, V19, P711, DOI 10.1080/02640410152475847; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hagger MS, 2003, J EDUC PSYCHOL, V95, P784, DOI 10.1037/0022-0663.95.4.784; Hagger MS., 2020, HDB BEHAV CHANGE, DOI [10.1017/97811086773180, DOI 10.1017/97811086773180.002]; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hamilton K, 2017, HEALTH EDUC BEHAV, V44, P175, DOI 10.1177/1090198116648266; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Jacobs N, 2011, BRIT J HEALTH PSYCH, V16, P113, DOI 10.1348/135910710X519305; Kannas L., 2004, KOULULAISTEN TERVEYS; Keatley D, 2012, PSYCHOL HEALTH, V27, P550, DOI 10.1080/08870446.2011.605451; Lau EY, 2017, J SCHOOL HEALTH, V87, P531, DOI 10.1111/josh.12523; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lonsdale C, 2009, PREV MED, V48, P69, DOI 10.1016/j.ypmed.2008.09.013; Martin R, 2017, RES Q EXERCISE SPORT, V88, P149, DOI 10.1080/02701367.2017.1294244; McDavid L, 2012, PSYCHOL SPORT EXERC, V13, P99, DOI 10.1016/j.psychsport.2011.10.003; MILLER KA, 1988, CONTEMP SOCIOL, V17, P253, DOI 10.2307/2070638; Mullan E, 1997, PERS INDIV DIFFER, V23, P745, DOI 10.1016/S0191-8869(97)00107-4; Muthen LK., 2017, MUTH N B0 MPLUS USER, V8th ed; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Reeve J., 2020, HDB BEHAV CHANGE, P510, DOI DOI 10.1017/97811086773180.035; Rhodes RE, 2013, BRIT J HEALTH PSYCH, V18, P296, DOI 10.1111/bjhp.12032; Rich A, 2015, J BEHAV MED, V38, P673, DOI 10.1007/s10865-015-9644-3; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ridgers ND, 2012, BRIT J SPORT MED, V46, P741, DOI 10.1136/bjsm.2011.084921; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; Sheeran P, 1999, J APPL SOC PSYCHOL, V29, P2107, DOI 10.1111/j.1559-1816.1999.tb02298.x; Standage M, 2003, J EDUC PSYCHOL, V95, P97, DOI 10.1037/0022-0663.95.1.97; Stellino MB, 2013, RES Q EXERCISE SPORT, V84, P167, DOI 10.1080/02701367.2013.786159; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Su YL, 2011, EDUC PSYCHOL REV, V23, P159, DOI 10.1007/s10648-010-9142-7; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; TERRY DJ, 1995, BRIT J SOC PSYCHOL, V34, P199, DOI 10.1111/j.2044-8309.1995.tb01058.x; Tilga H, 2019, EDUC PSYCHOL-UK, V39, P862, DOI 10.1080/01443410.2018.1546830; Wellhead TL, 2010, RES Q EXERCISE SPORT, V81, P442; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH; Zhang Z, 2018, PRACTICAL STAT POWER	72	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249019	10.1371/journal.pone.0249019	http://dx.doi.org/10.1371/journal.pone.0249019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770119	Green Published, gold			2022-12-26	WOS:000634833500026
J	Canalis, E; Zanotti, S; Schilling, L; Eller, T; Yu, J				Canalis, Ernesto; Zanotti, Stefano; Schilling, Lauren; Eller, Tabitha; Yu, Jungeun			Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; PROTEOLYTIC ACTIVATION; PROGENITOR CELLS; TRABECULAR BONE; GROWTH-FACTOR; BETA-CATENIN; EXPRESSION; OSTEOCLASTOGENESIS; OSTEOCYTE; MICE	Notch receptors maintain skeletal homeostasis. NOTCH1 and 2 have been studied for their effects on bone remodeling. Although NOTCH3 plays a significant role in vascular physiology, knowledge about its function in other cellular environments, including bone, is limited. The present study was conducted to establish the function of NOTCH3 in skeletal cells using models of Notch3 misexpression. Microcomputed tomography demonstrated that Notch3 null mice did not have appreciable bone phenotypes. To study the effects of the NOTCH3 activation in the osteoblast lineage, BGLAP-Cre or Dmp1-Cre transgenics were crossed with Rosa(Notch3) mice, where the NOTCH3 intracellular domain is expressed following the removal of a loxP-flanked STOP cassette. Microcomputed tomography demonstrated that BGLAP-Cre;Rosa(Notch3) and Dmp1-Cre;Rosa(Notch3) mice of both sexes exhibited an increase in trabecular bone and in connectivity, with a decrease in cortical bone and increased cortical porosity. Histological analysis revealed a decrease in osteoclast number and bone resorption in trabecular bone and an increase in osteoclast number and void or pore area in cortical bone of Rosa(Notch3) mice. Bone formation was either decreased or could not be determined in Cre;Rosa(Notch3) mice. NOTCH3 activation in osteoblasts inhibited Alpl (alkaline phosphatase) and Bglap (osteocalcin) and induced Tnfsf11 (RANKL) and Tnfrsf11b (osteoprotegerin) mRNA, possibly explaining the trabecular bone phenotype. However, NOTCH3 induced Tnfsf11 and suppressed Tnfrsf11b in osteocytes, possibly explaining the cortical porosity. In conclusion, basal NOTCH3 is dispensable for skeletal homeostasis, whereas activation of NOTCH3 in osteoblasts/osteocytes inhibits osteoclastogenesis and bone resorption in cancellous bone but increases intracortical remodeling and causes cortical porosity.	[Canalis, Ernesto; Zanotti, Stefano; Yu, Jungeun] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Canalis, Ernesto; Zanotti, Stefano; Schilling, Lauren; Eller, Tabitha; Yu, Jungeun] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Zanotti, Stefano] Dyne Therapeut, Waltham, MA 02451 USA		Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR072987, AR076747]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases AR072987 (E. C.) and AR076747 (E. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cadet ER, 2003, J BONE JOINT SURG AM, V85A, P1739, DOI 10.2106/00004623-200309000-00013; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.620334; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2017, J CELL PHYSIOL, V232, P363, DOI 10.1002/jcp.25433; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cho DC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00920-x; Choy L, 2017, CANCER RES, V77, P1439, DOI 10.1158/0008-5472.CAN-16-1022; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Gripp KW, 2015, AM J MED GENET A, V167, P271, DOI 10.1002/ajmg.a.36863; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; McCright B, 2001, DEVELOPMENT, V128, P491; Moon YJ, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0119-9; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; NYE JS, 1994, DEVELOPMENT, V120, P2421; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Ryeom SW, 2011, J CLIN INVEST, V121, P508, DOI 10.1172/JCI45976; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Walker EC, 2020, ELIFE, V9, DOI 10.7554/eLife.56666; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Yorgan T, 2016, BONE, V87, P136, DOI 10.1016/j.bone.2016.04.012; Yu J, 2019, J BIOL CHEM, V294, P14203, DOI 10.1074/jbc.RA119.009824; Yu JG, 2020, J CELL PHYSIOL, V235, P210, DOI 10.1002/jcp.28960; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2017, J BIOL CHEM, V292, P12232, DOI 10.1074/jbc.M117.786129; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2014, BONE, V62, P22, DOI 10.1016/j.bone.2014.01.023; Zanotti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086757; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	81	4	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100583	10.1016/j.jbc.2021.100583	http://dx.doi.org/10.1016/j.jbc.2021.100583			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774049	Green Published, gold			2022-12-26	WOS:000672866400555
J	Huang, YZ; Yang, YT; Wang, JL; Yao, SS; Yao, T; Xu, YN; Chen, ZZ; Yuan, PT; Gao, J; Shen, SY; Ma, JJ				Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Xu, Yining; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun			miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANKL-INDUCED OSTEOCLAST; DIFFERENTIATION; ESTROGEN	Osteoporosis results from an imbalance between bone formation and bone resorption. Traditional drugs for treating osteoporosis are associated with serious side effects, and thus, new treatment methods are required. This study investigated the role of differentially expressed microRNAs during osteoclast differentiation and osteoclast activity during osteoarthritis as well as the associated underlying mechanisms. We used a microarray to screen microRNAs that decreased in the process of osteoclast differentiation and verified miR-21-5p to decrease significantly using RT-qPCR. In follow-up experiments, we found that miR-21-5p targets SKP2 to regulate osteoclast differentiation. In vivo, ovariectomized mice were used to simulate perimenopausal osteoporosis induced by estrogen deficiency, and miR-21-5p treatment inhibited bone resorption and maintained bone cortex and trabecular structure. These results suggest that miR-21-5p is a new therapeutic target for osteoporosis.	[Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Sch Med, Hangzhou, Peoples R China; [Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun] Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Peoples R China; [Xu, Yining] Shaoxing Univ, Sch Med, Shaoxing, Peoples R China	Zhejiang University; Shaoxing University	Shen, SY; Ma, JJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Sch Med, Hangzhou, Peoples R China.; Shen, SY; Ma, JJ (corresponding author), Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Peoples R China.	11207057@zju.edu.cn; sealteam@zju.edu.cn			Medical Healthy Scientific Technology Project of Zhejiang Province [2020388803, 2020RC070, WKJ-ZJ-1906]; National Natural Science Foundation of China [81972504, 81802680, 81972089, 81871797, 81874015, 81871796, 81802147]; Zhejiang Provincial Natural Science Foundation of China [LY19H160058, Z20H060003, Q20H160293, Q20H160237]; National Key R&D Program of China [2018YFC1105202, 2019YFC110055]; Key research and development plan in Zhejiang province [2018C03060, 2020C03041]	Medical Healthy Scientific Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Key research and development plan in Zhejiang province	This work was supported by Medical Healthy Scientific Technology Project of Zhejiang Province (2020388803, 2020RC070, WKJ-ZJ-1906), National Natural Science Foundation of China (81972504, 81802680, 81972089, 81972504, 81871797, 81874015, 81871796, 81802147), Zhejiang Provincial Natural Science Foundation of China (LY19H160058, Z20H060003, Q20H160293, Q20H160237), National Key R&D Program of China (No. 2018YFC1105202, 2019YFC110055), the Key research and development plan in Zhejiang province (No. 2018C03060, 2020C03041).	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Cai Z, 2020, SEMIN CANCER BIOL, V67, P16, DOI 10.1016/j.semcancer.2020.01.013; Chen X, 2019, RNA BIOL, V16, P1249, DOI 10.1080/15476286.2019.1624470; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Kabekkodu SP, 2018, BIOL REV, V93, P1955, DOI 10.1111/brv.12428; Li C, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1069-3; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li JY, 2019, EUR REV MED PHARMACO, V23, P6394, DOI 10.26355/eurrev_201908_18519; Li J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2159-z; Li LY, 2018, ADV EXP MED BIOL, V1086, P199, DOI 10.1007/978-981-13-1117-8_13; Lian WS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1942-1; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Munoz-Torres Manuel, 2004, Treat Endocrinol, V3, P117; Song CC, 2019, J CELL PHYSIOL, V234, P11969, DOI 10.1002/jcp.27852; Sun L, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0146-0; Thacker G, 2016, BBA-MOL CELL RES, V1863, P510, DOI 10.1016/j.bbamcr.2016.01.010; Vaananen HK, 1996, MATURITAS, V23, pS65; Wang L, 2021, CELL BIOL INT, V45, P612, DOI 10.1002/cbin.11544; Wang SS, 2021, DNA CELL BIOL, V40, P147, DOI 10.1089/dna.2020.6151; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5; Xiao Y, 2018, MOL MED REP, V17, P7789, DOI 10.3892/mmr.2018.8845; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Yan S, 2019, CELL BIOCHEM FUNCT, V37, P598, DOI 10.1002/cbf.3436; Yin ZQ, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172550; Yuan F, 2019, INT J SURG, V66, P1, DOI 10.1016/j.ijsu.2019.03.004; Zhang YD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32428-9; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhao HY, 2017, MOL CELLS, V40, P211, DOI 10.14348/molcells.2017.2303	29	10	10	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100617	10.1016/j.jbc.2021.100617	http://dx.doi.org/10.1016/j.jbc.2021.100617			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811860	Green Published, gold			2022-12-26	WOS:000672866400588
J	Wang, J; Yan, X; Feng, W; Wang, QT; Shi, WH; Chai, LM; Zhang, QQ; Chen, YQ; Liu, J; Qu, Z; Xie, XM; Li, MX				Wang, Jian; Yan, Xin; Feng, Wei; Wang, Qingting; Shi, Wenhua; Chai, Limin; Zhang, Qianqian; Chen, Yuqian; Liu, Jin; Qu, Zhan; Xie, Xinming; Li, Manxiang			S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT STAT3 ACTIVATION; SPHINGOSINE-1-PHOSPHATE; PATHWAY; CANCER; METABOLISM; MIGRATION; LIGASES	Sphingosine-1-phosphate (S1P), a natural multifunctional phospholipid, is highly increased in plasma from patients with pulmonary arterial hypertension and mediates proliferation of pulmonary artery smooth muscle cells (PASMCs) by activating the Notch3 signaling pathway. However, the mechanisms underpinning S1P-mediated induction of PASMCs proliferation remain unclear. In this study, using biochemical and molecular biology approaches, RNA interference and gene expression analyses, 5'-ethynyl-2'-deoxyuridine incorporation assay, and 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay, we demonstrated that S1P promoted the activation of signal transducers and activators of transcription 3 (STAT3) through sphingosine-1-phosphate receptor 2 (S1PR2), and subsequently upregulated the expression of the microRNA miR-135b, which further reduced the expression of E3 ubiquitin ligase beta-transduction repeat-containing protein and led to a reduction in yes-associated protein (YAP) ubiquitinated degradation in PASMCs. YAP is the core effector of the Hippo pathway and mediates the expression of particular genes. The accumulation of YAP further increased the expression and activation of Notch3 and ultimately promoted the proliferation of PASMCs. In addition, we showed that preblocking S1PR2, prior silencing of STAT3, miR-135b, or YAP, and prior inhibition of Notch3 all attenuated S1P-induced PASMCs proliferation. Taken together, our study indicates that S1P stimulates PASMCs proliferation by activation of the S1PR2/STAT3/miR-135b/beta-transduction repeat-containing protein/YAP/Notch3 pathway, and our data suggest that targeting this cascade might have potential value in ameliorating PASMCs hyperproliferation and benefit pulmonary arterial hypertension.	[Wang, Jian; Yan, Xin; Feng, Wei; Wang, Qingting; Shi, Wenhua; Chai, Limin; Zhang, Qianqian; Chen, Yuqian; Liu, Jin; Qu, Zhan; Xie, Xinming; Li, Manxiang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Li, MX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian, Shaanxi, Peoples R China.	manxiangli@hotmail.com	SHI, wen/GPW-9531-2022	Wang, Jian/0000-0001-5066-1526	National Natural Science Foundation of China [81670051, 81970050, 81800052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81670051 and No. 81970050 to M. L. and No. 81800052 to X. X.).	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Bao YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102109; Chen JW, 2014, AM J RESP CRIT CARE, V190, P1032, DOI 10.1164/rccm.201401-0121OC; de Lima JE, 2016, ELIFE, V5, DOI 10.7554/eLife.15593; Dieffenbach PB, 2017, AM J PHYSIOL-LUNG C, V313, pL628, DOI 10.1152/ajplung.00173.2017; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gairhe S, 2016, PULM CIRC, V6, P369, DOI 10.1086/687766; Galoczova M, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0078-0; Hemnes AR, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0093-2017; Hirata N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5806; Huang XW, 2019, LIFE SCI, V220, P76, DOI 10.1016/j.lfs.2019.01.041; Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7; Ji C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2510-4; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Kim Y, 2018, BMB REP, V51, P143, DOI 10.5483/BMBRep.2018.51.3.017; Kudryashova TV, 2016, AM J RESP CRIT CARE, V194, P866, DOI 10.1164/rccm.201510-2003OC; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Leong WI, 2010, BIOCHIMIE, V92, P716, DOI 10.1016/j.biochi.2010.02.014; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2020, ADV EXP MED BIOL, V1217, P123, DOI 10.1007/978-981-15-1025-0_9; Liu L, 2018, AM J PHYSIOL-LUNG C, V315, pL609, DOI 10.1152/ajplung.00554.2017; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Manderfield LJ, 2015, DEVELOPMENT, V142, P2962, DOI 10.1242/dev.125807; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Misra JR, 2018, ANNU REV GENET, V52, P65, DOI 10.1146/annurev-genet-120417-031621; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Qian ZJ, 2018, AM J PHYSIOL-LUNG C, V315, pL965, DOI 10.1152/ajplung.00224.2018; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Shi WW, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00694; Song Y, 2015, FEBS OPEN BIO, V5, P656, DOI 10.1016/j.fob.2015.08.007; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Wang J, 2018, PULM CIRC, V9, DOI 10.1177/2045894018816977; Wang SS, 2018, MED SCI MONITOR, V24, P1912, DOI 10.12659/MSM.905833; Wang YB, 2018, CIRCULATION, V138, P48, DOI 10.1161/CIRCULATIONAHA.117.032398; Wu YY, 2014, EXP LUNG RES, V40, P251, DOI 10.3109/01902148.2014.913092; Yan X, 2019, BIOCHEM BIOPH RES CO, V516, P921, DOI 10.1016/j.bbrc.2019.06.160; Yin J, 2018, J CELL MOL MED, V22, P1507, DOI 10.1111/jcmm.13416; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang Yanbing, 2015, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V31, P1316; Zhang YH, 2015, EXP LUNG RES, V41, P435, DOI 10.3109/01902148.2015.1060545; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhu YT, 2018, EXP CELL RES, V371, P379, DOI 10.1016/j.yexcr.2018.08.032	51	6	6	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100599	10.1016/j.jbc.2021.100599	http://dx.doi.org/10.1016/j.jbc.2021.100599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781742	Green Published, gold			2022-12-26	WOS:000672866400571
J	Aboushousha, R; Elko, E; Chia, SB; Manuel, AM; van de Wetering, C; van der Velden, J; MacPherson, M; Erickson, C; Reisz, JA; D'Alessandro, A; Wouters, EFM; Reynaert, NL; Lam, YW; Anathy, V; van der Vliet, A; Seward, DJ; Janssen-Heininger, YMW				Aboushousha, Reem; Elko, Evan; Chia, Shi B.; Manuel, Allison M.; van de Wetering, Cheryl; van der Velden, Jos; MacPherson, Maximilian; Erickson, Cuixia; Reisz, Julie A.; D'Alessandro, Angelo; Wouters, Emiel F. M.; Reynaert, Niki L.; Lam, Ying-Wai; Anathy, Vikas; van der Vliet, Albert; Seward, David J.; Janssen-Heininger, Yvonne M. W.			Glutathionylation chemistry promotes interleukin-1 beta-mediated glycolytic reprogramming and pro-inflammatory signaling in lung epithelial cells	FASEB JOURNAL			English	Article						asthma; glutathionylation; glycolysis; inflammation	SKELETAL-MUSCLE; PHENOTYPIC FLEXIBILITY; SEASONAL-VARIATION; OXIDATIVE STRESS; BODY-TEMPERATURE; THERMOGENESIS; MITOCHONDRIA; BIRDS; LIVER; MECHANISMS	Glycolysis is a well-known process by which metabolically active cells, such as tumor or immune cells meet their high metabolic demands. Previously, our laboratory has demonstrated that in airway epithelial cells, the pleiotropic cytokine, interleukin-1 beta (IL1B) induces glycolysis and that this contributes to allergic airway inflammation and remodeling. Activation of glycolysis is known to increase NADPH reducing equivalents generated from the pentose phosphate pathway, linking metabolic reprogramming with redox homeostasis. In addition, numerous glycolytic enzymes are known to be redox regulated. However, whether and how redox chemistry regulates metabolic reprogramming more generally remains unclear. In this study, we employed a multi-omics approach in primary mouse airway basal cells to evaluate the role of protein redox biochemistry, specifically protein glutathionylation, in mediating metabolic reprogramming. Our findings demonstrate that IL1B induces glutathionylation of multiple proteins involved in metabolic regulation, notably in the glycolysis pathway. Cells lacking Glutaredoxin-1 (Glrx), the enzyme responsible for reversing glutathionylation, show modulation of multiple metabolic pathways including an enhanced IL1B-induced glycolytic response. This was accompanied by increased secretion of thymic stromal lymphopoietin (TSLP), a cytokine important in asthma pathogenesis. Targeted inhibition of glycolysis prevented TSLP release, confirming the functional relevance of enhanced glycolysis in cells stimulated with IL1B. Collectively, data herein point to an intriguing link between glutathionylation chemistry and glycolytic reprogramming in epithelial cells and suggest that glutathionylation chemistry may represent a therapeutic target in pulmonary pathologies with perturbations in the glycolysis pathway.	[Aboushousha, Reem; Elko, Evan; Chia, Shi B.; Manuel, Allison M.; van de Wetering, Cheryl; van der Velden, Jos; MacPherson, Maximilian; Erickson, Cuixia; Anathy, Vikas; van der Vliet, Albert; Seward, David J.; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT USA; [Lam, Ying-Wai] Univ Vermont, Coll Med, Dept Biol, Burlington, VT USA; [Reisz, Julie A.; D'Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA; [Wouters, Emiel F. M.; Reynaert, Niki L.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab Toxicol & Me, Dept Resp Med, Med Ctr, Maastricht, Netherlands; [Wouters, Emiel F. M.] Ludwig Boltzmann Inst Lung Res, Vienna, Austria	University of Vermont; University of Vermont; University of Colorado System; University of Colorado Anschutz Medical Campus; Maastricht University	Seward, DJ (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Hlth Sci Res Facil, Room 206, Burlington, VT 05405 USA.; Janssen-Heininger, YMW (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Hlth Sci Res Facil, Room 216A, Burlington, VT 05405 USA.	david.seward@uvmhealth.org; Yvonne.janssen@uvm.edu	D'Alessandro, Angelo/AAA-4695-2019; Wouters, Emiel/ABD-6200-2021	D'Alessandro, Angelo/0000-0002-2258-6490; Aboushousha, Reem/0000-0003-2284-2180; van der Velden, Jos/0000-0002-2451-3180	National Institutes of Health [R35HL135828, R01HL137268, R01HL085646, R01HL138708, R21AG055325, T32HL076122, R01HL122383]; National Institute of General Medical Sciences (NIGMS) [P20GM103449]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, Grant/Award Number: R35HL135828, R01HL137268, R01HL085646, R01HL138708, R21AG055325, T32HL076122 and R01HL122383; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM103449	Andersson MN, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00093; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Blix A.S., 1989, P117; Blix AS, 2016, J EXP BIOL, V219, P1093, DOI 10.1242/jeb.120477; Blondin DP, 2017, J PHYSIOL-LONDON, V595, P2099, DOI 10.1113/JP273395; Bourguignon A, 2017, J EXP BIOL, V220, P2445, DOI 10.1242/jeb.159087; Brodin A, 2017, OECOLOGIA, V185, P43, DOI 10.1007/s00442-017-3923-3; Casagrande S, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.222513; Davis LM, 2008, EPILEPSIA, V49, P117, DOI 10.1111/j.1528-1167.2008.01854.x; Dawson NJ, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110883; Dawson NJ, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13030; Dawson NJ, 2016, J EXP BIOL, V219, P3719, DOI 10.1242/jeb.142711; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; HAFTORN S, 1992, ORNIS SCAND, V23, P435, DOI 10.2307/3676674; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Laursen WJ, 2015, P NATL ACAD SCI USA, V112, P1607, DOI 10.1073/pnas.1421419112; Lenth RV., 2019, **DATA OBJECT**; Liknes ET, 2011, J THERM BIOL, V36, P430, DOI 10.1016/j.jtherbio.2011.07.011; Mahalingam S, 2020, J PHYSIOL-LONDON, V598, P5411, DOI 10.1113/JP280298; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Monternier PA, 2017, COMP BIOCHEM PHYS A, V212, P1, DOI 10.1016/j.cbpa.2017.06.018; Monternier PA, 2014, J EXP BIOL, V217, P2691, DOI 10.1242/jeb.104505; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; NICHOLLS DG, 2013, BIOENERGETICS; Perrins C.M., 1979, BRIT TITS; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; R Core Team, 2020, R LANG ENV STAT COMP; Rey B, 2017, COMP BIOCHEM PHYS A, V211, P56, DOI 10.1016/j.cbpa.2017.06.009; Roussel D, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.233684; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Salin K, 2018, FUNCT ECOL, V32, P2149, DOI 10.1111/1365-2435.13125; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Sjovall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001; Stager M, 2015, J EXP BIOL, V218, P767, DOI 10.1242/jeb.113472; Stier A, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0536; Stier A, 2017, METHODS ECOL EVOL, V8, P1172, DOI 10.1111/2041-210X.12724; Stier A, 2014, J EXP BIOL, V217, P624, DOI 10.1242/jeb.092700; Stier A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-33; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264; Swanson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101577; Swanson DL, 2015, J ORNITHOL, V156, pS377, DOI 10.1007/s10336-015-1192-7; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Toyomizu M, 2002, FEBS LETT, V529, P313, DOI 10.1016/S0014-5793(02)03395-1; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; Wang Y, 2019, ZOOL STUD, V58, DOI 10.6620/ZS.2019.58-06; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Zhang L, 2011, ANIM BIOL, V61, P385, DOI 10.1163/157075511X596873; Zheng WH, 2014, PHYSIOL BIOCHEM ZOOL, V87, P704, DOI 10.1086/676832; Zheng Wei-Hong, 2010, Zoological Research, V31, P319, DOI 10.3724/SP.J.1141.2010.03319	55	3	3	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21525	10.1096/fj.202002687RR	http://dx.doi.org/10.1096/fj.202002687RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817836	Green Accepted			2022-12-26	WOS:000645260100105
J	Chang, KT; Wang, LH; Lin, YM; Cheng, CF; Wang, GS				Chang, Kuei-Ting; Wang, Lee-Hsin; Lin, Yu-Mei; Cheng, Ching-Feng; Wang, Guey-Shin			CELF1 promotes vascular endothelial growth factor degradation resulting in impaired microvasculature in heart failure	FASEB JOURNAL			English	Article						cardiomyopathy; CELF1; mRNA degradation; VEGF	CUGBP1; HYPERTROPHY; STABILITY	Vascular rarefaction due to impaired angiogenesis is associated with contractile dysfunction and the transition from compensation to decompensation and heart failure. The regulatory mechanism controlling vascular rarefaction during the transition remains elusive. Increased expression of a nuclear RNA-binding protein CUGBP Elav-like family member 1 (CELF1) in the adult heart is associated with the transition from compensated hypertrophy to decompensated heart failure. Elevated CELF1 level resulted in degradation of the major cardiac gap junction protein, connexin 43, in dilated cardiomyopathy (DCM), the most common cause of heart failure. In the present study, we investigated the role of increased CELF1 expression in causing vascular rarefaction in DCM. CELF1 overexpression (CELF1-OE) in cardiomyocytes resulted in reduced capillary density. CELF1-OE mice administered hypoxyprobe showed immunoreactivity and increased mRNA levels of HIF1 alpha, Glut-1, and Pdk-1, which suggested the association of a reduced capillary density-induced hypoxic condition with CELF1 overexpression. Vegfa mRNA level was downregulated in mouse hearts exhibiting DCM, including CELF1-OE and infarcted hearts. Vegfa mRNA level was also downregulated to a similar extent in cardiomyocytes isolated from infarcted hearts by Langendorff preparation, which suggested cardiomyocyte-derived Vegfa expression mediated by CELF1. Cardiomyocyte-specific depletion of CELF1 preserved the capillary density and Vegfa mRNA level in infarcted mouse hearts. Also, CELF1 bound to Vegfa mRNA and regulated Vegfa mRNA stability via the 3' untranslated region. These results suggest that elevated CELF1 level has dual effects on impairing the functions of cardiomyocytes and microvasculature in DCM.	[Chang, Kuei-Ting; Lin, Yu-Mei; Cheng, Ching-Feng; Wang, Guey-Shin] Acad Sinica, Inst Biomed Sci, 128,Sect 2 Acad Rd, Taipei 11529, Taiwan; [Wang, Lee-Hsin; Wang, Guey-Shin] Natl Yang Ming Univ, Taiwan Int Grad Program Interdisciplinary Neurosc, Taipei, Taiwan; [Wang, Lee-Hsin; Wang, Guey-Shin] Acad Sinica, Taipei, Taiwan; [Cheng, Ching-Feng] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Cheng, Ching-Feng] Tzu Chi Univ, Dept Pediat, Hualien, Taiwan; [Wang, Guey-Shin] Natl Yang Ming Univ, Mol Med Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University	Wang, GS (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2 Acad Rd, Taipei 11529, Taiwan.	gswang@ibms.sinica.edu.tw	Wang, Guey-Shin/Q-3968-2018; CHENG, Ching-Feng/AAB-8861-2019; Cheng, Ching-Feng/AAB-8523-2019	Wang, Guey-Shin/0000-0003-4485-1811; CHENG, Ching-Feng/0000-0003-0104-0146; Wang, Lee-Hsin/0000-0002-3824-8840	National Health Research Institute, Taiwan [NHRI-EX105-10342SI]; Institute of Biomedical Science, Academia Sinica, Taiwan [IBMS400503]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Institute of Biomedical Science, Academia Sinica, Taiwan	This work was supported by the National Health Research Institute, Taiwan [NHRI-EX105--10342SI to GSW] and Institute of Biomedical Science, Academia Sinica, Taiwan [IBMS400503 to GSW].	Abraham D, 2000, CIRC RES, V87, P644, DOI 10.1161/01.RES.87.8.644; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Chang KT, 2017, CIRC RES, V121, P1140, DOI 10.1161/CIRCRESAHA.117.311281; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Giamouzis G, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003259; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Nako H, 2012, HYPERTENS RES, V35, P194, DOI 10.1038/hr.2011.175; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Patel KV, 2018, EUR J HEART FAIL, V20, P1557, DOI 10.1002/ejhf.1253; Poltorak Z, 2000, HERZ, V25, P126, DOI 10.1007/PL00001950; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976	24	5	5	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21512	10.1096/fj.202002553R	http://dx.doi.org/10.1096/fj.202002553R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811692				2022-12-26	WOS:000645260100011
J	Tovissode, CF; Diop, A; Kakai, RG				Tovissode, Chenangnon Frederic; Diop, Aliou; Kakai, Romain Glele			Inference in skew generalized t-link models for clustered binary outcome via a parameter-expanded EM algorithm	PLOS ONE			English	Article							MIXED-EFFECTS MODELS; MAXIMUM-LIKELIHOOD; SCALE MIXTURE; REGRESSION; MISSPECIFICATION	Binary Generalized Linear Mixed Model (GLMM) is the most common method used by researchers to analyze clustered binary data in biological and social sciences. The traditional approach to GLMMs causes substantial bias in estimates due to steady shape of logistic and normal distribution assumptions thereby resulting into wrong and misleading decisions. This study brings forward an approach governed by skew generalized t distributions that belong to a class of potentially skewed and heavy tailed distributions. Interestingly, both the traditional logistic and probit mixed models, as well as other available methods can be utilized within the skew generalized t-link model (SGTLM) frame. We have taken advantage of the Expectation-Maximization algorithm accelerated via parameter-expansion for model fitting. We evaluated the performance of this approach to GLMMs through a simulation experiment by varying sample size and data distribution. Our findings indicated that the proposed methodology outperforms competing approaches in estimating population parameters and predicting random effects, when the traditional link and normality assumptions are violated. In addition, empirical standard errors and information criteria proved useful for detecting spurious skewness and avoiding complex models for probit data. An application with respiratory infection data points out to the superiority of the SGTLM which turns to be the most adequate model. In future, studies should focus on integrating the demonstrated flexibility in other generalized linear mixed models to enhance robust modeling.	[Tovissode, Chenangnon Frederic; Kakai, Romain Glele] Univ Abomey Calavi, Fac Sci Agronom, Lab Biomath & Estimat Forestieres, Abomey Calavi, Benin; [Diop, Aliou] Univ Gaston Berger St Louis, Lab Etud & Rech Stat & Dev, St Louis, Senegal	University of Abomey Calavi	Tovissode, CF (corresponding author), Univ Abomey Calavi, Fac Sci Agronom, Lab Biomath & Estimat Forestieres, Abomey Calavi, Benin.	chenangnon@gmail.com		Tovissode, Chenangnon Frederic/0000-0002-3685-3043	Centre d'Excellence Africain en Sciences Mathematiques et Applications (CEA-SMA); African German Network of Excellence in Science (AGNES), through the "AGNES mobility grant for young scientists from sub Saharan Africa"	Centre d'Excellence Africain en Sciences Mathematiques et Applications (CEA-SMA); African German Network of Excellence in Science (AGNES), through the "AGNES mobility grant for young scientists from sub Saharan Africa"	CFT is grateful to the Centre d'Excellence Africain en Sciences Mathematiques et Applications (CEA-SMA, https://ceasma-benin.org/) for funding his work. CFT was also financially supported by the African German Network of Excellence in Science (AGNES), through the "AGNES mobility grant for young scientists from sub Saharan Africa" (https://agnes-h.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanto-Valle CA, 2014, COMPUT STAT DATA AN, V71, P274, DOI 10.1016/j.csda.2013.01.009; Agresti A, 2004, COMPUT STAT DATA AN, V47, P639, DOI 10.1016/j.csda.2003.12.009; Ahmed A., 2013, IOSR J MATH, V5, P55, DOI [10.9790/5728-0525561, DOI 10.9790/5728-0525561]; Pereira MAA, 2019, J APPL STAT, V46, P1602, DOI 10.1080/02664763.2018.1557122; Arellano-Valle RB, 2007, J APPL STAT, V34, P663, DOI 10.1080/02664760701236905; Arellano-Valle RB, 2005, J MULTIVARIATE ANAL, V96, P93, DOI 10.1016/j.jmva.2004.10.002; Arellano-Valle RB, 2005, J DATA SCI, V3, P415, DOI DOI 10.6339/JDS.2005.03(4).238; Asgharzadeh A, 2013, REVSTAT-STAT J, V11, P317; Azzalini A, 2003, J R STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; Azzalini A., 2018, R PACKAGE SN SKEW NO; Basu S, 2000, BIOSTAT-A SER REF T, V5, P231; Branco MD, 2001, J MULTIVARIATE ANAL, V79, P99, DOI 10.1006/jmva.2000.1960; Brostrom G, 2011, COMPUT STAT DATA AN, V55, P3123, DOI 10.1016/j.csda.2011.06.011; Capitanio A., 2012, CANONICAL FORM SCALE; Carlin J B, 2001, Biostatistics, V2, P397, DOI 10.1093/biostatistics/2.4.397; Chen MH, 2004, SKEW-ELLIPTICAL DISTRIBUTIONS AND THEIR APPLICATIONS: A JOURNEY BEYOND NORMALITY, P131; Chen MH, 1999, J AM STAT ASSOC, V94, P1172, DOI 10.2307/2669933; Cox C, 2005, ENCY BIOSTATISTICS, P1540, DOI [DOI 10.1002/0470011815.B2A15029, 10.1002/0470011815.b2a15029]; CZADO C, 1992, J STAT PLAN INFER, V33, P213, DOI 10.1016/0378-3758(92)90069-5; da Silva Braga A, 2017, J AGR BIOL ENVIR ST, V22, P615, DOI 10.1007/s13253-017-0301-x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; El Kholy, 2012, INT J PROBAB STAT, V1, P41, DOI [10.5923/j.ijps.20120103.03, DOI 10.5923/J.IJPS.20120103.03]; El-Saeiti IN, 2015, AIP CONF PROC, V1643, P80, DOI 10.1063/1.4907428; Fernandez C, 1999, BIOMETRIKA, V86, P153, DOI 10.1093/biomet/86.1.153; Fox J., 2018, R COMPANION APPL REG, VThird; Galarza CE, 2020, ARXIV PREPRINT ARXIV; Galarza CE, 2021, METRIKA, V84, P825, DOI 10.1007/s00184-020-00802-1; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Ho HJ, 2012, J STAT PLAN INFER, V142, P25, DOI 10.1016/j.jspi.2011.06.006; Hosseini F, 2011, COMPUT STAT DATA AN, V55, P1791, DOI 10.1016/j.csda.2010.11.011; Hugo LDV., 2018, FINITE MIXTURE SKEWE, P15; Keri G, 2001, APPL OPTIMIZAT, V59, P119; Kim S, 2008, BIOMETRIKA, V95, P93, DOI 10.1093/biomet/asm079; Komori O, 2016, METHODS ECOL EVOL, V7, P249, DOI 10.1111/2041-210X.12473; Lachos VH., 2014, PROMATHEMATICA, V28, P11; Lachos VH, 2010, STAT SINICA, V20, P303; Lachos VH, 2009, J STAT PLAN INFER, V139, P4098, DOI 10.1016/j.jspi.2009.05.040; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Lee D, 2019, J STAT COMPUT SIM, V89, P1621, DOI 10.1080/00949655.2019.1590579; Lemonte AJ, 2018, TEST-SPAIN, V27, P597, DOI 10.1007/s11749-017-0563-1; Lin TI, 2008, STAT MED, V27, P1490, DOI 10.1002/sim.3026; Liu C., 2004, APPL BAYESIAN MODELI, P227; LIU CH, 1994, BIOMETRIKA, V81, P633; Liu CH, 1998, BIOMETRIKA, V85, P755, DOI 10.1093/biomet/85.4.755; MCCULLOCH CE, 1994, J AM STAT ASSOC, V89, P330, DOI 10.2307/2291229; McCulloch CE, 2011, STAT SCI, V26, P388, DOI 10.1214/11-STS361; MEILIJSON I, 1989, J ROY STAT SOC B MET, V51, P127; Meza C, 2012, STAT COMPUT, V22, P121, DOI 10.1007/s11222-010-9212-1; Meza C, 2009, COMPUT STAT DATA AN, V53, P1350, DOI 10.1016/j.csda.2008.11.024; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson KP, 2006, J COMPUT GRAPH STAT, V15, P39, DOI 10.1198/106186006X96854; Pinheiro JC, 2001, J COMPUT GRAPH STAT, V10, P249, DOI 10.1198/10618600152628059; Prates MO, 2014, STAT COMPUT, V24, P1111, DOI 10.1007/s11222-013-9423-3; R Core Team, 2021, R LANGUAGE ENV STAT; Santos CC, 2017, J STAT COMPUT SIM, V87, P2940, DOI 10.1080/00949655.2017.1350678; Stewart MB, 2004, STATA J, V4, P27, DOI 10.1177/1536867X0100400102; Yan J., 2002, R NEWS, V2, P12	58	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249604	10.1371/journal.pone.0249604	http://dx.doi.org/10.1371/journal.pone.0249604			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822818	gold, Green Published			2022-12-26	WOS:000637879100005
J	Frazure, ML; Brown, AD; Greene, CL; Iceman, KE; Pitts, T				Frazure, Michael L.; Brown, Alyssa D.; Greene, Clinton L.; Iceman, Kimberly E.; Pitts, Teresa			Rapid activation of esophageal mechanoreceptors alters the pharyngeal phase of swallow: Evidence for inspiratory activity during swallow	PLOS ONE			English	Article								Swallow is a complex behavior that consists of three coordinated phases: oral, pharyngeal, and esophageal. Esophageal distension (EDist) has been shown to elicit pharyngeal swallow, but the physiologic characteristics of EDist-induced pharyngeal swallow have not been specifically described. We examined the effect of rapid EDist on oropharyngeal swallow, with and without an oral water stimulus, in spontaneously breathing, sodium pentobarbital anesthetized cats (n = 5). Electromyograms (EMGs) of activity of 8 muscles were used to evaluate swallow: mylohyoid (MyHy), geniohyoid (GeHy), thyrohyoid (ThHy), thyropharyngeus (ThPh), thyroarytenoid (ThAr), cricopharyngeus (upper esophageal sphincter: UES), parasternal (PS), and costal diaphragm (Dia). Swallow was defined as quiescence of the UES with overlapping upper airway activity, and it was analyzed across three stimulus conditions: 1) oropharyngeal water infusion only, 2) rapid esophageal distension (EDist) only, and 3) combined stimuli. Results show a significant effect of stimulus condition on swallow EMG amplitude of the mylohyoid, geniohyoid, thyroarytenoid, diaphragm, and UES muscles. Collectively, we found that, compared to rapid cervical esophageal distension alone, the stimulus condition of rapid distension combined with water infusion is correlated with increased laryngeal adductor and diaphragm swallow-related EMG activity (schluckatmung), and post-swallow UES recruitment. We hypothesize that these effects of upper esophageal distension activate the brainstem swallow network, and function to protect the airway through initiation and/or modulation of a pharyngeal swallow response.	[Frazure, Michael L.; Greene, Clinton L.; Iceman, Kimberly E.; Pitts, Teresa] Univ Louisville, Dept Neurol Surg, Coll Med, Louisville, KY 40292 USA; [Frazure, Michael L.; Greene, Clinton L.; Iceman, Kimberly E.; Pitts, Teresa] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Coll Med, Louisville, KY 40292 USA; [Frazure, Michael L.] Univ Louisville, Dept Physiol, Louisville, KY USA; [Brown, Alyssa D.] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Brown, Alyssa D.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; Mayo Clinic	Iceman, KE (corresponding author), Univ Louisville, Dept Neurol Surg, Coll Med, Louisville, KY 40292 USA.; Iceman, KE (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Coll Med, Louisville, KY 40292 USA.	kimberly.iceman@louisville.edu		Iceman, Kimberly/0000-0002-9004-3893; Brown, Alyssa/0000-0003-4422-3356	National Institutes of Health [HL111215, NS110169, T32 HL105355]; Kentucky Spinal Cord and Head Injury Research Trust; University of Louisville Summer Research Scholar Program; Commonwealth of Kentucky Challenge for Excellence; Craig F. Neilsen Foundation [CNF546714]; American Physiological Society; Giles F. Filley Family	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; University of Louisville Summer Research Scholar Program; Commonwealth of Kentucky Challenge for Excellence; Craig F. Neilsen Foundation; American Physiological Society; Giles F. Filley Family	This study was funded by the National Institutes of Health to TP (HL111215 and NS110169) and AB (T32 HL105355), the Kentucky Spinal Cord and Head Injury Research Trust to TP, the University of Louisville Summer Research Scholar Program to TP, The Commonwealth of Kentucky Challenge for Excellence to TP, and the Craig F. Neilsen Foundation to TP (CNF546714), The American Physiological Society to TP, and the Giles F. Filley Family to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GN, 1996, DYSPHAGIA, V11, P2, DOI 10.1007/BF00385791; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; ATKINSON M, 1957, J CLIN INVEST, V36, P581, DOI 10.1172/JCI103457; Babaei A, 2012, GASTROENTEROLOGY, V142, P734, DOI 10.1053/j.gastro.2012.01.006; BAO XM, 1995, BRAIN RES, V696, P246, DOI 10.1016/0006-8993(95)00817-A; BARRETT RT, 1994, GASTROENTEROLOGY, V107, P728, DOI 10.1016/0016-5085(94)90120-1; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; CLERC N, 1983, J PHYSIOL-LONDON, V336, P487, DOI 10.1113/jphysiol.1983.sp014593; CLERC N, 1984, J AUTONOM NERV SYST, V10, P213, DOI 10.1016/0165-1838(84)90015-8; COLLMAN PI, 1993, GASTROENTEROLOGY, V104, P1430, DOI 10.1016/0016-5085(93)90352-D; COLLMAN PI, 1992, GASTROENTEROLOGY, V103, P817, DOI 10.1016/0016-5085(92)90012-N; COOK IJ, 1989, AM J PHYSIOL, V257, pG748, DOI 10.1152/ajpgi.1989.257.5.G748; DICK TE, 1993, J PHYSIOL-LONDON, V465, P715, DOI 10.1113/jphysiol.1993.sp019702; DOTY RW, 1956, J NEUROPHYSIOL, V19, P44, DOI 10.1152/jn.1956.19.1.44; ENZMANN DR, 1977, GASTROENTEROLOGY, V72, P1292; Ertekin C, 2000, Suppl Clin Neurophysiol, V53, P148; EZURE K, 1993, BRAIN RES, V632, P216, DOI 10.1016/0006-8993(93)91156-M; FALEMPIN M, 1978, PFLUG ARCH EUR J PHY, V373, P25, DOI 10.1007/BF00581145; German RZ, 2009, J NEUROPHYSIOL, V102, P1017, DOI 10.1152/jn.00100.2009; GIDDA JS, 1984, J NEUROPHYSIOL, V52, P1169, DOI 10.1152/jn.1984.52.6.1169; Goyal Raj K., 1993, Dysphagia, V8, P252, DOI 10.1007/BF01354547; Goyal RK., 1981, PHYSL GASTROINTESTIN, V1, P359; Goyal RK, 1989, HDB PHYSL GASTROINTE, P865; HARDING R, 1975, J PHYSIOL-LONDON, V247, pP52; HELLEMANS J, 1968, AM J DIG DIS, V13, P320, DOI 10.1007/BF02233007; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hiss SG, 2001, DYSPHAGIA, V16, P128, DOI 10.1007/s004550011001; HOLSTEGE G, 1983, BRAIN BEHAV EVOLUT, V23, P47, DOI 10.1159/000121488; Huff A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234193; Huff A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234194; Huff A, 2018, LUNG, V196, P601, DOI 10.1007/s00408-018-0133-7; HWANG K, 1954, J APPL PHYSIOL, V6, P781, DOI 10.1152/jappl.1954.6.12.781; JEAN A, 1984, J AUTONOM NERV SYST, V10, P225, DOI 10.1016/0165-1838(84)90017-1; JEAN A, 1972, J PHYSIOL-PARIS, V64, P227; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; KALIA M, 1980, J COMP NEUROL, V193, P435, DOI 10.1002/cne.901930210; KALIA M, 1980, J COMP NEUROL, V193, P467, DOI 10.1002/cne.901930211; KESSLER JP, 1985, EXP BRAIN RES, V57, P256; King SN, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00112; Lang IM, 2012, AM J PHYSIOL-GASTR L, V302, pG1445, DOI 10.1152/ajpgi.00007.2012; Lang IM, 2001, AM J PHYSIOL-GASTR L, V281, pG1246, DOI 10.1152/ajpgi.2001.281.5.G1246; Lang IM, 2018, PEDIATR RES, V83, P731, DOI 10.1038/pr.2017.302; Lang IM, 2016, AM J PHYSIOL-GASTR L, V311, pG827, DOI 10.1152/ajpgi.00291.2016; Lang IM, 2016, J APPL PHYSIOL, V120, P774, DOI 10.1152/japplphysiol.00758.2015; Lang IM, 2014, AM J PHYSIOL-GASTR L, V306, pG728, DOI 10.1152/ajpgi.00411.2013; Lang IM, 2011, BRAIN RES, V1368, P119, DOI 10.1016/j.brainres.2010.10.061; Lang IM, 2010, BRAIN RES, V1352, P94, DOI 10.1016/j.brainres.2010.07.048; Lennerz JKM, 2007, J PHYSIOL-LONDON, V582, P229, DOI 10.1113/jphysiol.2007.130823; Logan AM, 2020, J SPEECH LANG HEAR R, V63, P3594, DOI 10.1044/2020_JSLHR-19-00401; Logemann JA, 1998, HEAD NECK-J SCI SPEC, V20, P52; MADSEN T, 1983, SCAND J GASTROENTERO, V18, P513, DOI 10.3109/00365528309181631; Mantilla CB, 2010, RESP PHYSIOL NEUROBI, V173, P101, DOI 10.1016/j.resp.2010.07.001; MARTIN BJW, 1994, J APPL PHYSIOL, V76, P714, DOI 10.1152/jappl.1994.76.2.714; MCCONNEL FMS, 1992, OTOLARYNG HEAD NECK, V106, P169, DOI 10.1177/019459989210600219; MCCONNEL FMS, 1991, LARYNGOSCOPE, V101, P510; MEI N, 1970, EXP BRAIN RES, V11, P502; MILLER HC, 1952, YALE J BIOL MED, V24, P284; Negus V, 1948, ACTA OTOLARYNGOL S, V49, P79; OOTANI S, 1995, BRAIN RES BULL, V37, P397, DOI 10.1016/0361-9230(95)00018-6; Page AJ, 1998, J PHYSIOL-LONDON, V512, P907, DOI 10.1111/j.1469-7793.1998.907bd.x; PASARO R, 1983, EXP NEUROL, V82, P623, DOI 10.1016/0014-4886(83)90085-7; Pitts T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199903; Pitts T, 2015, LUNG, V193, P129, DOI 10.1007/s00408-014-9662-x; Pitts T, 2013, RESP PHYSIOL NEUROBI, V189, P543, DOI 10.1016/j.resp.2013.08.009; Pommerenke WT, 1928, AM J PHYSIOL, V84, P36, DOI 10.1152/ajplegacy.1928.84.1.36; Rademaker AW, 1998, J SPEECH LANG HEAR R, V41, P275, DOI 10.1044/jslhr.4102.275; Richter JE, 2001, LANCET, V358, P823, DOI 10.1016/S0140-6736(01)05973-6; SANDERS I, 1987, LARYNGOSCOPE, V97, P663; SCHULTZ JL, 1994, ARCH PHYS MED REHAB, V75, P183; Seven YB, 2014, J APPL PHYSIOL, V117, P1308, DOI 10.1152/japplphysiol.01395.2013; Seven YB, 2013, RESP PHYSIOL NEUROBI, V185, P400, DOI 10.1016/j.resp.2012.08.020; SIECK GC, 1989, J APPL PHYSIOL, V66, P2539, DOI 10.1152/jappl.1989.66.6.2539; SIFRIM D, 1994, GASTROENTEROLOGY, V106, P875, DOI 10.1016/0016-5085(94)90745-5; SIFRIM D, 1992, GASTROENTEROLOGY, V103, P876, DOI 10.1016/0016-5085(92)90020-Y; Spearman DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106121; STOREY AT, 1968, EXP NEUROL, V20, P359, DOI 10.1016/0014-4886(68)90079-4; Szczesniak MM, 2008, AM J PHYSIOL-GASTR L, V294, pG982, DOI 10.1152/ajpgi.00496.2007; Taniguchi H, 2020, DYSPHAGIA, V35, P657, DOI 10.1007/s00455-019-10068-z; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006; Thexton AJ, 2009, J NEUROPHYSIOL, V101, P1386, DOI 10.1152/jn.90847.2008; Troche MS, 2008, DYSPHAGIA, V23, P26, DOI 10.1007/s00455-007-9090-7; Tsujimura T, 2017, AM J PHYSIOL-GASTR L, V312, pG498, DOI 10.1152/ajpgi.00299.2016; VANEK AW, 1987, GASTROENTEROLOGY, V92, P643, DOI 10.1016/0016-5085(87)90012-6; VANLOVEREN H, 1985, NEUROSCI LETT, V58, P251, DOI 10.1016/0304-3940(85)90173-9; Wang AY, 2005, GASTROINTEST ENDOSC, V61, P148, DOI 10.1016/S0016-5107(04)02447-2; WANG YT, 1991, AM J PHYSIOL, V261, pR639, DOI 10.1152/ajpregu.1991.261.3.R639; Wank M, 2001, J COMP NEUROL, V435, P41, DOI 10.1002/cne.1192; WEERASURIYA A, 1980, AM J PHYSIOL, V239, pR407, DOI 10.1152/ajpregu.1980.239.5.R407; Yamamura K, 2010, BIOL PHARM BULL, V33, P1786, DOI 10.1248/bpb.33.1786; YOSHIDA Y, 1981, NEUROSCI LETT, V22, P91, DOI 10.1016/0304-3940(81)90069-0; ZEHR EP, 1994, CAN J APPL PHYSIOL, V19, P363, DOI 10.1139/h94-030	91	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248994	10.1371/journal.pone.0248994	http://dx.doi.org/10.1371/journal.pone.0248994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798212	gold, Green Published			2022-12-26	WOS:000636737700014
J	Finlayson, C; Lopez, JMG; del Rio, MCR; Romero, AMS; Guzman, FG; Finlayson, G; Pacheco, FG; Abulafia, D; Finlayson, S; Jennings, RP; Vidal, JR				Finlayson, Clive; Gutierrez Lopez, Jose Maria; Reinoso del Rio, M. Cristina; Saez Romero, Antonio M.; Giles Guzman, Francisco; Finlayson, Geraldine; Giles Pacheco, Francisco; Abulafia, David; Finlayson, Stewart; Jennings, Richard P.; Rodriguez Vidal, Joaquin			Where myth and archaeology meet: Discovering the Gorgon Medusa's Lair	PLOS ONE			English	Article							SCHLIEMANN,HEINRICH	Here we report the discovery of ceramic fragments that form part of a Gorgoneion, a ceramic image representation of the Gorgon Medusa. The fragments were found in a deep part of Gorham's Cave, well known to ancient mariners as a natural shrine, between the 8(th) and 2(nd) century BCE. We discuss the context of this discovery, both within the inner topography of the cave itself, and also the broader geographical context. The discovery is situated at the extreme western end of the Mediterranean Sea, where it meets the Atlantic Ocean. The location was known to ancient mariners as the northern Pillar of Herakles, which marked the end of the known world. We relate the discovery, and its geographical and chronological context, to Greek legends that situated the lair of the Gorgon sisters at a location which coincides with the physical attributes and geographical position of Gorham's Cave. We thus provide, uniquely, a geographical and archaeological context to the myth of Perseus and the slaying of the Gorgon Medusa.	[Finlayson, Clive; Giles Guzman, Francisco; Finlayson, Geraldine; Giles Pacheco, Francisco; Finlayson, Stewart] Gibraltar Natl Museum, Gibraltar, Spain; [Finlayson, Clive; Finlayson, Geraldine; Finlayson, Stewart] Univ Gibraltar, Gibraltar, Gibraltar; [Finlayson, Clive] Univ Toronto, Dept Anthropol, Toronto, ON, Canada; [Finlayson, Clive; Finlayson, Geraldine; Jennings, Richard P.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England; [Gutierrez Lopez, Jose Maria; Reinoso del Rio, M. Cristina] Museo Hist Municipal Villamartin, Cadiz, Spain; [Saez Romero, Antonio M.] Univ Seville, Dept Prehist & Archaeol, Seville, Spain; [Abulafia, David] Univ Cambridge, Gonville & Caius Coll, Cambridge, England; [Finlayson, Stewart] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England; [Rodriguez Vidal, Joaquin] Univ Huelva, Dept Earth Sci, Huelva, Spain; [Rodriguez Vidal, Joaquin] Univ Huelva, CIPHCN Heritage Ctr, Huelva, Spain	University of Toronto; Liverpool John Moores University; University of Sevilla; University of Cambridge; Anglia Ruskin University; Universidad de Huelva; Universidad de Huelva	Finlayson, G (corresponding author), Gibraltar Natl Museum, Gibraltar, Spain.; Finlayson, G (corresponding author), Univ Gibraltar, Gibraltar, Gibraltar.; Finlayson, G (corresponding author), Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England.	geraldine.finlayson@gibmuseum.gi	Saez Romero, Antonio Manuel/HGE-3519-2022; Gutierrez-Lopez, Jose Maria/AAM-8329-2020	Saez Romero, Antonio Manuel/0000-0001-7071-9748; Gutierrez-Lopez, Jose Maria/0000-0001-5257-0556; Finlayson, Geraldine/0000-0002-1751-5655; Giles Guzman, Francisco Jose/0000-0002-8092-7302				AZZOPARDI G, 2017, RAS IL WARDIJA SANCT; Bernard G., 2012, CONFINES EXTREMO MUN, P303; CHRISTIAN M.A., 2014, CAHIERS I PROCHE ORI, V2, P373; Christian MA, 2013, WELT ORIENTS, V43, P179; Collina-Girard J, 2001, CR ACAD SCI II A, V333, P233, DOI 10.1016/S1251-8050(01)01629-9; Dworkin R., 1977, LOEB CLASSICAL LIB; Easton DF, 1998, CLASSICAL WORLD, V91, P335, DOI 10.2307/4352102; Evans A., 1921, PALACE MINOS KNOSSOS, V1; Finlayson G., 2013, COMPLUTUM, V214, P113; Gantz T., 1993, EARLY GREEK MYTH GUI; GOMEZ BELLARD C., 2000, SANTUARIOS FENICIO P, P103; Gomez Espelosin Javier, 2009, COLONIAL ENCOUNTERS, P281; Graves R., 1960, GREEK MYTHS; Gutierrez Lopez JM., 2012, AFRICA ROMANA 19, P3017; Gutierrez Lopez JM., 2014, PHENICIENS ORIENT OC, P619; Harrington SPM, 1999, ARCHAEOLOGY, V52, P51; Herodotus, 1988, HIST; Hesiod, 2006, LOEB CLASSICAL LIB; Krauskopf I., 1988, LEXICON ICONOGRAPHIC; Mangas J., 1998, PENINSULA IBERICA AU; Martin SR., 2017, ART CONTACT COMP APP; Mora G., 2013, ORIENTE GRIEGO PENIN; Ogden D, 2008, GODS HEROES ANC WORL, P1; Quinn J., 2018, MIR S BALM LECT ANC; Schliemann H., 1881, ILIOS CITY COUNTRY T; Silius Italicus, 1961, LOEB CLASSICAL LIB	26	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249606	10.1371/journal.pone.0249606	http://dx.doi.org/10.1371/journal.pone.0249606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793665	Green Published, Green Accepted, gold			2022-12-26	WOS:000636467000051
J	Khan, R				Khan, Rabnawaz			Beta decoupling relationship between CO2 emissions by GDP, energy consumption, electricity production, value-added industries, and population in China	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; ECONOMIC-GROWTH; EMPIRICAL-EVIDENCE; FRAMEWORK; IMPACT; POLICY; SECTORS; SCIENCE; GAS	The credible sources of fossil energy efficiently are a vital cause of economic growth and considerable influence on adequate security. Whereas radiant energy positively enhances or ostensibly promotes socio-economic stability and the controlled environment. The fossil energy sources supply has become progressively stern in China and reconnoitering the beta decoupling relationships between CO2 emissions, GDP, energy consumption, electricity consumption, value-added industries, and population. The results will be favorable for illustrative the security of the valuable resources. This study adopts the extended stochastic model (STIRPAT) with Beta Decoupling Techniques (BDT). This modern technique merely employs the decoupling situation by the alpha and beta effects from 1989 to 2018 and calculates the % change in CO2 emissions by GDP growth and energy consumption. The estimated results represent negative and economic growth depends on coal and natural gas. First, CO2 emissions annually increasing cause of rapid growth, energy consumption, and electricity production, and the structural contradiction of energy remained static. Second, the Value-added industries estimated that CO2 emissions reduce by primary industries. Third, the decoupling states of CO2 emissions and population show an inverse relationship. This paper tentatively suggests China is sustainable, naturally strengthens energy output, transmutes the energy consumption structure, and advances development policies under environmental circumstances.	[Khan, Rabnawaz] Fujian Univ Technol, Sch Internet Econ & Business, Fuzhou, Fujian, Peoples R China	Fujian University of Technology	Khan, R (corresponding author), Fujian Univ Technol, Sch Internet Econ & Business, Fuzhou, Fujian, Peoples R China.	khan.rab@fjut.edu.cn		Khan, Rabnawaz/0000-0003-2356-1882	Fujian University of Technology (CN).	Fujian University of Technology (CN).	The sources of funding as for the publication is supported by the "Fujian University of Technology (CN). The funder had only a role decision to publish the accepted manuscript. The author has not received any salary from any funder. The authors received no specific funding for this work.	Abbas J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11123434; Abbas J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113006; Abbasi KR, 2021, ENERG POLICY, V149, DOI 10.1016/j.enpol.2020.112087; Abbasi KR, 2021, AIMS ENERGY, V9, P29, DOI 10.3934/energy.2021003; Acheampong AO, 2018, ENERG ECON, V74, P677, DOI 10.1016/j.eneco.2018.07.022; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; [Anonymous], 2009, FONDLY WE HOPE FERVE; Anwar A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072531; ASTM International, 2016, STANDARD TEST METHOD, DOI DOI 10.1520/D5298-16; Aydin M, 2019, RENEW ENERG, V138, P620, DOI 10.1016/j.renene.2019.02.001; Baz K, 2019, ENERGY, V189, DOI 10.1016/j.energy.2019.116254; Berk I, 2020, ENERG ECON, V87, DOI 10.1016/j.eneco.2018.02.013; Chen JD, 2020, REG ENVIRON CHANGE, V20, DOI 10.1007/s10113-020-01605-w; Chen JD, 2019, J CLEAN PROD, V213, P1087, DOI 10.1016/j.jclepro.2018.12.203; Cheng C, 2019, SCI TOTAL ENVIRON, V668, P1328, DOI 10.1016/j.scitotenv.2019.02.063; China-Manufacturing,, 2021, VAL ADD GDP US TRAD; Danish, 2019, SCI TOTAL ENVIRON, V670, P1075, DOI 10.1016/j.scitotenv.2019.03.268; Danish, 2017, J CLEAN PROD, V156, P855, DOI 10.1016/j.jclepro.2017.03.203; Diaconu L, 2018, TRANSFORM BUS ECON, V17, P760; Dietz T., 1994, HUM ECOL REV, V1, P277, DOI [10.2307/24706840, DOI 10.2307/24706840]; Dong F, 2019, J CLEAN PROD, V223, P759, DOI 10.1016/j.jclepro.2019.03.152; Dong KY, 2017, J CLEAN PROD, V162, P400, DOI 10.1016/j.jclepro.2017.06.100; Dubey R, 2017, J CLEAN PROD, V142, P1119, DOI 10.1016/j.jclepro.2016.03.117; EIA UEiA, 2020, MONTHL EN REV; Fang CL, 2015, APPL ENERG, V158, P519, DOI 10.1016/j.apenergy.2015.08.095; Feng KS, 2016, ENERGY ECOL ENVIRON, V1, P39, DOI 10.1007/s40974-016-0015-x; Gao YQ, 2018, SCI TOTAL ENVIRON, V631-632, P1192, DOI 10.1016/j.scitotenv.2018.03.126; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Goh T, 2018, ENERG EFFIC, V12, P829, DOI 10.1007/s12053-018-9683-z; Hao Y, 2019, ENERGY, V180, P615, DOI 10.1016/j.energy.2019.05.014; Hu MJ, 2020, J CLEAN PROD, V277, DOI 10.1016/j.jclepro.2020.123272; Huo TF, 2020, SUSTAIN CITIES SOC, V56, DOI 10.1016/j.scs.2020.102068; Hussain T, 2021, J URBAN PLAN DEV, V147, DOI 10.1061/(ASCE)UP.1943-5444.0000645; IEA, 2020, WORLD EN OUTL, DOI DOI 10.1787/CO2_FUEL-2016-EN; International Energy Agency, 2021, NET ZER 2050 ROADM G, DOI DOI 10.1787/D394399E-EN; Jenner S, 2013, ENERG POLICY, V53, P442, DOI 10.1016/j.enpol.2012.11.010; Jia FR, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120347; Jiang TY, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121507; Jie T, 2020, RESOUR CONSERV RECY, V153, DOI 10.1016/j.resconrec.2019.104510; Khan R, 2020, EKONOMIKA, V99, P26, DOI [10.15388/Ekon.2020.1.2, DOI 10.15388/EKON.2020.1.2]; Kong YS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209532; Le Quere C, 2018, EARTH SYST SCI DATA, V10, P2141, DOI 10.5194/essd-10-2141-2018; Li JS, 2019, EARTHS FUTURE, V7, P1407, DOI 10.1029/2019EF001269; Lin BQ, 2021, SUSTAIN PROD CONSUMP, V27, P217, DOI 10.1016/j.spc.2020.10.029; Lin BQ, 2019, ENERGY, V185, P951, DOI 10.1016/j.energy.2019.07.090; Liu P, 2020, APPL ENERG, V277, DOI 10.1016/j.apenergy.2020.115546; Lv Q, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134394; Ministry RsH., 2020, SPUTNIK 5 VACCINES P; Mirasgedis S, 2004, ENERG CONVERS MANAGE, V45, P537, DOI 10.1016/S0196-8904(03)00160-2; Mubeen R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083480; Muhammad B, 2019, ENERGY REP, V5, P1305, DOI 10.1016/j.egyr.2019.09.004; Muhammad B, 2019, ENERGY, V179, P232, DOI 10.1016/j.energy.2019.03.126; (NCCC) NCCoCC, 2012, 2 NAT COMM VLIM CHAN; Ofosu-Adarkwa J, 2020, RENEW SUST ENERG REV, V130, DOI 10.1016/j.rser.2020.109945; Okamoto N, 2017, 2017 INTERNATIONAL CONFERENCE ON CULTURE AND COMPUTING (CULTURE AND COMPUTING), P7, DOI 10.1109/Culture.and.Computing.2017.18; Plecher H., 2020, SRI LANKA URBANIZATI; Ren SG, 2012, ENERG POLICY, V43, P407, DOI 10.1016/j.enpol.2012.01.021; Schmidt TS, 2012, ENERG POLICY, V43, P466, DOI 10.1016/j.enpol.2012.01.041; Shan YL, 2019, SCI DATA, V6, DOI 10.1038/sdata.2019.27; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Shimizu N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1747108; Smart A, 1999, AM ETHNOL, V26, P481, DOI 10.1525/ae.1999.26.2.481; Sonnichsen N., 2020, AVERAGE ANN W TEXAS; SOPER T, 2020, GEEKWIRE; Tasdoven H, 2012, ENERG POLICY, V43, P226, DOI 10.1016/j.enpol.2011.12.059; Waggoner PE, 2002, P NATL ACAD SCI USA, V99, P7860, DOI 10.1073/pnas.122235999; Wang HM, 2018, J CLEAN PROD, V174, P1096, DOI 10.1016/j.jclepro.2017.11.070; Wang J, 2019, RENEW SUST ENERG REV, V116, DOI 10.1016/j.rser.2019.109433; Wang M., 2006, ANLESD066; Wang Q, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123838; Wang SH, 2020, J ENVIRON MANAGE, V276, DOI 10.1016/j.jenvman.2020.111371; Wang Z, 2010, ENERG POLICY, V38, P5242, DOI 10.1016/j.enpol.2010.05.012; Wei WD, 2020, RESOUR POLICY, V68, DOI 10.1016/j.resourpol.2020.101693; Wong S., TOTAL ELECT GENERATI; Xia FQ, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134587; Xie PJ, 2020, ENERGY, V209, DOI 10.1016/j.energy.2020.118341; Xie PJ, 2019, J CLEAN PROD, V211, P598, DOI 10.1016/j.jclepro.2018.11.212; Xie QC, 2019, J CLEAN PROD, V220, P873, DOI 10.1016/j.jclepro.2019.02.166; Xu GY, 2020, RENEW SUST ENERG REV, V122, DOI 10.1016/j.rser.2020.109737; Yang J, 2020, SCI TOTAL ENVIRON, V711, DOI 10.1016/j.scitotenv.2019.134569; Yang LX, 2018, J CLEAN PROD, V180, P595, DOI 10.1016/j.jclepro.2018.01.116; Yang WY, 2020, J CLEAN PROD, V277, DOI 10.1016/j.jclepro.2020.124071; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068; Yuan R, 2019, J CLEAN PROD, V233, P932, DOI 10.1016/j.jclepro.2019.06.110; Zhang J., 1999, CHEMOS GLOB CHANGE S, V1, P353, DOI [10.1016/S1465-9972(99)00004-5, DOI 10.1016/S1465-9972(99)00004-5]; Zhang M, 2015, NAT HAZARDS, V78, P653, DOI 10.1007/s11069-015-1738-2; Zhang M, 2013, ENERG POLICY, V52, P159, DOI 10.1016/j.enpol.2012.10.013; Zhang WS, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.123188; Zhang ZX, 2000, WORLD DEV, V28, P739, DOI 10.1016/S0305-750X(99)00154-0; Zhou SL, 2019, ENVIRON SCI TECHNOL, V53, P14063, DOI 10.1021/acs.est.9b04683; Zizhuo C., 2021, CHINA INCREASE EFFOR	92	9	10	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249444	10.1371/journal.pone.0249444	http://dx.doi.org/10.1371/journal.pone.0249444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793639	gold, Green Published			2022-12-26	WOS:000636467000054
J	Lehnert, T; Prausse, MTE; Hunniger, K; Praetorius, JP; Kurzai, O; Figge, MT				Lehnert, Teresa; Prausse, Maria T. E.; Huenniger, Kerstin; Praetorius, Jan-Philipp; Kurzai, Oliver; Figge, Marc Thilo			Comparative assessment of immune evasion mechanisms in human whole-blood infection assays by a systems biology approach	PLOS ONE			English	Article								Computer simulations of mathematical models open up the possibility of assessing hypotheses generated by experiments on pathogen immune evasion in human whole-blood infection assays. We apply an interdisciplinary systems biology approach in which virtual infection models implemented for the dissection of specific immune mechanisms are combined with experimental studies to validate or falsify the respective hypotheses. Focusing on the assessment of mechanisms that enable pathogens to evade the immune response in the early time course of a whole-blood infection, the least-square error (LSE) as a measure for the quantitative agreement between the theoretical and experimental kinetics is combined with the Akaike information criterion (AIC) as a measure for the model quality depending on its complexity. In particular, we compare mathematical models with three different types of pathogen immune evasion as well as all their combinations: (i) spontaneous immune evasion, (ii) evasion mediated by immune cells, and (iii) pre-existence of an immune-evasive pathogen subpopulation. For example, by testing theoretical predictions in subsequent imaging experiments, we demonstrate that the simple hypothesis of having a subpopulation of pre-existing immune-evasive pathogens can be ruled out. Furthermore, in this study we extend our previous whole-blood infection assays for the two fungal pathogens Candida albicans and C. glabrata by the bacterial pathogen Staphylococcus aureus and calibrated the model predictions to the time-resolved experimental data for each pathogen. Our quantitative assessment generally reveals that models with a lower number of parameters are not only scored with better AIC values, but also exhibit lower values for the LSE. Furthermore, we describe in detail model-specific and pathogen-specific patterns in the kinetics of cell populations that may be measured in future experiments to distinguish and pinpoint the underlying immune mechanisms.	[Lehnert, Teresa; Prausse, Maria T. E.; Praetorius, Jan-Philipp; Figge, Marc Thilo] Hans Knoll Inst HKI, Leibniz Inst Nat Prod Res Infect Biol, Appl Syst Biol, Jena, Germany; [Lehnert, Teresa; Kurzai, Oliver; Figge, Marc Thilo] Jena Univ Hosp, Ctr Sepsis Control & Care CSCC, Jena, Germany; [Prausse, Maria T. E.; Praetorius, Jan-Philipp; Figge, Marc Thilo] Friedrich Schiller Univ Jena, Inst Microbiol, Fac Biol Sci, Jena, Germany; [Huenniger, Kerstin; Kurzai, Oliver] Hans Knoll Inst HKI, Leibniz Inst Nat Prod Res Infect Biol, Fungal Sept, Jena, Germany; [Huenniger, Kerstin; Kurzai, Oliver] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Wurzburg	Figge, MT (corresponding author), Hans Knoll Inst HKI, Leibniz Inst Nat Prod Res Infect Biol, Appl Syst Biol, Jena, Germany.; Figge, MT (corresponding author), Jena Univ Hosp, Ctr Sepsis Control & Care CSCC, Jena, Germany.; Figge, MT (corresponding author), Friedrich Schiller Univ Jena, Inst Microbiol, Fac Biol Sci, Jena, Germany.	thilo.figge@leibniz-hki.de		Praetorius, Jan-Philipp/0000-0002-1828-8351	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS); Deutsche Forschungsgemeinschaft (DFG) [210879364]	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) and by the Deutsche Forschungsgemeinschaft (DFG) through the CRC/TR124 FungiNet under DFG project number 210879364 (project B4 to MTF and project C3 to OK).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Zaben N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39725-x; Brandes S, 2017, MED IMAGE ANAL, V36, P172, DOI 10.1016/j.media.2016.11.007; Brandes S, 2015, MED IMAGE ANAL, V20, P34, DOI 10.1016/j.media.2014.10.002; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELCTION MULTI, V2nd; Calderone RA, 2011, CANDIDA CANDIDIASIS; Cornell SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12172-y; Duggan S, 2015, CELL MICROBIOL, V17, P1259, DOI 10.1111/cmi.12443; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Essig F, 2015, FUNGAL GENET BIOL, V84, P37, DOI 10.1016/j.fgb.2015.09.008; Farhan M, 2013, PATTERN RECOGN, V46, P741, DOI 10.1016/j.patcog.2012.09.008; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guan DB, 2019, BIOMECH MODEL MECHAN, V18, P1213, DOI 10.1007/s10237-019-01140-6; Hunniger K, 2015, J IMMUNOL, V194, P1199, DOI 10.4049/jimmunol.1401845; Hunniger K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003479; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lehnert T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00608; Li CZ, 2016, INT J FATIGUE, V82, P474, DOI 10.1016/j.ijfatigue.2015.09.002; Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mech F, 2014, CYTOM PART A, V85, P126, DOI 10.1002/cyto.a.22418; Medyukhina A, 2015, CYTOM PART A, V87A, P462, DOI 10.1002/cyto.a.22638; Portet S, 2020, INFECT DIS MODEL, V5, P111, DOI 10.1016/j.idm.2019.12.010; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prausse MTE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00560; Sagar A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187373; Schonfisch B, 1999, BIOSYSTEMS, V51, P123, DOI 10.1016/S0303-2647(99)00025-8; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Sreekantapuram S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00500; Stoica P, 2004, IEEE SIGNAL PROC MAG, V21, P36, DOI 10.1109/MSP.2004.1311138; Thomer L, 2016, ANNU REV PATHOL-MECH, V11, P343, DOI 10.1146/annurev-pathol-012615-044351; Timme S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00667; Tuchscherr L, 2019, TOXINS, V11, DOI 10.3390/toxins11030135; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; Warne DJ, 2019, B MATH BIOL, V81, P1760, DOI 10.1007/s11538-019-00589-x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; Yang H, 2015, BIOMETRICAL J, V57, P422, DOI 10.1002/bimj.201400106; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249372	10.1371/journal.pone.0249372	http://dx.doi.org/10.1371/journal.pone.0249372			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793643	Green Published, gold			2022-12-26	WOS:000636467000028
J	Mehraj, H; Shea, DJ; Takahashi, S; Miyaji, N; Akter, A; Seki, M; Dennis, ES; Fujimoto, R; Osabe, K				Mehraj, Hasan; Shea, Daniel J.; Takahashi, Satoshi; Miyaji, Naomi; Akter, Ayasha; Seki, Motoaki; Dennis, Elizabeth S.; Fujimoto, Ryo; Osabe, Kenji			Genome-wide analysis of long noncoding RNAs, 24-nt siRNAs, DNA methylation and H3K27me3 marks in Brassica rapa	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; GENE-EXPRESSION; HISTONE MODIFICATION; REGULATORY ROLES; CHINESE-CABBAGE; ARABIDOPSIS; REVEALS; IDENTIFICATION; LNCRNAS; EVOLUTION	Long noncoding RNAs (lncRNAs) are RNA fragments that generally do not code for a protein but are involved in epigenetic gene regulation. In this study, lncRNAs of Brassica rapa were classified into long intergenic noncoding RNAs, natural antisense RNAs, and intronic noncoding RNAs and their expression analyzed in relation to genome-wide 24-nt small interfering RNAs (siRNAs), DNA methylation, and histone H3 lysine 27 trimethylation marks (H3K27me3). More than 65% of the lncRNAs analyzed consisted of one exon, and more than 55% overlapped with inverted repeat regions (IRRs). Overlap of lncRNAs with IRRs or genomic regions encoding for 24-nt siRNAs resulted in increased DNA methylation levels when both were present. LncRNA did not overlap greatly with H3K27me3 marks, but the expression level of intronic noncoding RNAs that did coincide with H3K27me3 marks was higher than without H3K27me3 marks. The Brassica genus comprises important vegetables and oil seed crops grown across the world. B. rapa is a diploid (AA genome) thought to be one of the ancestral species of both B. juncea (AABB genome) and B. napus (AACC) through genome merging (allotetrapolyploidization). Complex genome restructuring and epigenetic alterations are thought to be involved in these allotetrapolyploidization events. Comparison of lncRNAs between B. rapa and B. nigra, B. oleracea, B. juncea, and B. napus showed the highest conservation with B. oleracea. This study presents a comprehensive analysis of the epigenome structure of B. rapa at multi-epigenetic levels (siRNAs, DNA methylation, H3K27me3, and lncRNAs) and identified a suite of candidate lncRNAs that may be epigenetically regulated in the Brassica genus.	[Mehraj, Hasan; Miyaji, Naomi; Akter, Ayasha; Fujimoto, Ryo] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Shea, Daniel J.] Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan; [Takahashi, Satoshi; Seki, Motoaki] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Akter, Ayasha] Bangladesh Agr Univ, Fac Agr, Dept Hort, Mymensingh, Bangladesh; [Seki, Motoaki] RIKEN, Cluster Pioneering Res, Wako, Saitama, Japan; [Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa, Japan; [Dennis, Elizabeth S.] CSIRO Agr & Food, Canberra, ACT, Australia; [Dennis, Elizabeth S.] Univ Technol, Sydney, NSW, Australia; [Osabe, Kenji] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan	Kobe University; Niigata University; RIKEN; Bangladesh Agricultural University (BAU); RIKEN; Yokohama City University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney; Osaka University	Osabe, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan.	o3b@sanken.osaka-u.ac.jp	Mehraj, Hasan/A-5928-2018; Akter, Ayasha/AAG-8088-2021; Seki, Motoaki/I-2854-2012	Mehraj, Hasan/0000-0003-0600-9973; Akter, Ayasha/0000-0003-1968-8207; Seki, Motoaki/0000-0001-8288-0467	Open Partnership Joint Projects of JSPS Bilateral Joint Research Projects; Fund for the Promotion of Joint International Research [16KK0171];  [20K21313]	Open Partnership Joint Projects of JSPS Bilateral Joint Research Projects; Fund for the Promotion of Joint International Research; 	This work was supported by an Open Partnership Joint Projects of JSPS Bilateral Joint Research Projects, Fund for the Promotion of Joint International Research (16KK0171) (JSPS), and Grant-in-Aid for Exploratory Research (20K21313) to R. Fujimoto.	Akter A, 2019, DNA RES, V26, P433, DOI 10.1093/dnares/dsz021; Au PCK, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080198; Bewick AJ, 2017, CURR OPIN PLANT BIOL, V36, P103, DOI 10.1016/j.pbi.2016.12.007; Blevins T, 2015, ELIFE, V4, DOI 10.7554/eLife.09591; Bohmdorfer G, 2016, ELIFE, V5, DOI 10.7554/eLife.19092; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chekanova JA, 2015, CURR OPIN PLANT BIOL, V27, P207, DOI 10.1016/j.pbi.2015.08.003; Chen L, 2020, PLANTA, V252, DOI 10.1007/s00425-020-03480-5; Chen R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6101-7; Cho J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00600; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fedak H, 2016, P NATL ACAD SCI USA, V113, pE7846, DOI 10.1073/pnas.1608827113; Fujimoto R, 2012, INT J MOL SCI, V13, P9900, DOI 10.3390/ijms13089900; Fukushima S, 2016, PLANT CELL PHYSIOL, V57, P2541, DOI 10.1093/pcp/pcw185; Gaiti F, 2018, RNA BIOL, V15, P696, DOI 10.1080/15476286.2018.1460166; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Huang L, 2018, PLANT J, V96, P203, DOI 10.1111/tpj.14016; Itabashi E, 2018, PLANT CELL REP, V37, P87, DOI 10.1007/s00299-017-2223-z; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Johnson C, 2018, PLANT PHYSIOL, V177, P1198, DOI 10.1104/pp.17.01269; Joshi RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158784; Karlik E, 2019, BIOTECHNOL BIOTEC EQ, V33, P429, DOI 10.1080/13102818.2019.1581085; Kawamura K, 2016, PLANT GENE, V5, P1, DOI DOI 10.1016/J.PLGENE.2015.10.003; Kim DH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006939; Kim DH, 2017, DEV CELL, V40, P302, DOI 10.1016/j.devcel.2016.12.021; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li SF, 2015, GENOME RES, V25, P235, DOI 10.1101/gr.182238.114; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Liu ZW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59697-7; Lu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09134-9; Lv H., 2020, GENOMIC DESIGNING CL, P161, DOI [10.1007/978-3-319-97415-6_3, DOI 10.1007/978-3-319-97415-6_3]; Makarevitch I, 2013, PLANT CELL, V25, P780, DOI 10.1105/tpc.112.106427; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Miyaji N, 2017, PLANT CELL REP, V36, P1841, DOI 10.1007/s00299-017-2198-9; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaharu U., 1935, J JPN BOT, V7, P389; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Rai MI, 2019, GENOMICS, V111, P997, DOI 10.1016/j.ygeno.2018.04.014; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Sampath P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094499; Seo JS, 2017, PLANT CELL, V29, P1024, DOI 10.1105/tpc.16.00886; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Shea DJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45650-w; Shea DJ, 2018, BREEDING SCI, V68, P375, DOI 10.1270/jsbbs.17124; Shen EH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5117-8; Shimizu M, 2014, PLANT MOL BIOL, V85, P247, DOI 10.1007/s11103-014-0182-0; Song XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2625-2; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Takahashi S, 2018, DNA RES, V25, P511, DOI 10.1093/dnares/dsy021; Tian YK, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7246; Tu SQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41669; Vandivier LE, 2016, ANNU REV PLANT BIOL, V67, P463, DOI 10.1146/annurev-arplant-043015-111754; Wang AH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41428-2; Wang CG, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122659; Wang D, 2017, PLANT J, V90, P133, DOI 10.1111/tpj.13481; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang RH, 2018, ECOL EVOL, V8, P6034, DOI 10.1002/ece3.4152; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wang YQ, 2014, P NATL ACAD SCI USA, V111, P10359, DOI 10.1073/pnas.1409457111; Wu CT, 2001, SCIENCE, V293, P1103, DOI 10.1126/science.293.5532.1103; Yan HD, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1202-0; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Yu JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-664; Yu TT, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020053; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhai JX, 2015, CELL, V163, P445, DOI 10.1016/j.cell.2015.09.032; Zhang JF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23334-1; Zhao XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07500-7	80	2	2	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0242530	10.1371/journal.pone.0242530	http://dx.doi.org/10.1371/journal.pone.0242530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788851	gold, Green Published			2022-12-26	WOS:000636354600013
J	Estravis-Barcala, M; Heer, K; Marchelli, P; Ziegenhagen, B; Arana, MV; Bellora, N				Estravis-Barcala, Maximiliano; Heer, Katrin; Marchelli, Paula; Ziegenhagen, Birgit; Arana, Maria Veronica; Bellora, Nicolas			Deciphering the transcriptomic regulation of heat stress responses in Nothofagus pumilio	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; BRASSICA-NAPUS REVEALS; DROUGHT TOLERANCE; SALT STRESS; GENE FAMILY; COMPREHENSIVE ANALYSIS; ABIOTIC STRESSES; CIRCADIAN CLOCK; ABSCISIC-ACID; COLD STRESS	Global warming is predicted to exert negative impacts on plant growth due to the damaging effect of high temperatures on plant physiology. Revealing the genetic architecture underlying the heat stress response is therefore crucial for the development of conservation strategies, and for breeding heat-resistant plant genotypes. Here we investigated the transcriptional changes induced by heat in Nothofagus pumilio, an emblematic tree species of the sub-Antarctic forests of South America. Through the performance of RNA-seq of leaves of plants exposed to 20 degrees C (control) or 34 degrees C (heat shock), we generated the first transcriptomic resource for the species. We also studied the changes in protein-coding transcripts expression in response to heat. We found 5,214 contigs differentially expressed between temperatures. The heat treatment resulted in a down-regulation of genes related to photosynthesis and carbon metabolism, whereas secondary metabolism, protein re-folding and response to stress were up-regulated. Moreover, several transcription factor families like WRKY or ERF were promoted by heat, alongside spliceosome machinery and hormone signaling pathways. Through a comparative analysis of gene regulation in response to heat in Arabidopsis thaliana, Populus tomentosa and N. pumilio we provide evidence of the existence of shared molecular features of heat stress responses across angiosperms, and identify genes of potential biotechnological application.	[Estravis-Barcala, Maximiliano; Bellora, Nicolas] Consejo Nacl Invest Cient & Tecn, Natl Sci & Res Council, INTECNUS, Inst Nucl Technol Hlth, San Carlos De Bariloche, Argentina; [Heer, Katrin; Ziegenhagen, Birgit] Philipps Univ Marburg, Marburg, Germany; [Marchelli, Paula; Arana, Maria Veronica] Consejo Nacl Invest Cient & Tecn, EEA Bariloche, INTA, IFAB, San Carlos De Bariloche, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Philipps University Marburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Bellora, N (corresponding author), Consejo Nacl Invest Cient & Tecn, Natl Sci & Res Council, INTECNUS, Inst Nucl Technol Hlth, San Carlos De Bariloche, Argentina.; Arana, MV (corresponding author), Consejo Nacl Invest Cient & Tecn, EEA Bariloche, INTA, IFAB, San Carlos De Bariloche, Argentina.	arana@agro.uba.ar; nbellora@gmail.com	Estravis Barcala, Maximiliano/ABA-6391-2021; Bellora, Nicolas/E-6356-2014; Heer, Katrin/C-6725-2018	Estravis Barcala, Maximiliano/0000-0002-0337-023X; Marchelli, Paula/0000-0002-6949-0656; Bellora, Nicolas/0000-0001-6637-3465; Heer, Katrin/0000-0002-1036-599X	Ministerio de Ciencia y Tecnologia (MINCyT), Argentina [MINCyT-DAAD DA/13/06]; Deutscher Akademischer Austauschdienst (DAAD), Germany; Trees4Future, European Union Seventh Framework Programme [P113]; Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion [PICT2016-1116, PICT2017-2656]; Instituto Nacional de Tecnologia Agropecuaria (INTA) [M.V.A. 2019-PD-E6-I116-001]	Ministerio de Ciencia y Tecnologia (MINCyT), Argentina; Deutscher Akademischer Austauschdienst (DAAD), Germany(Deutscher Akademischer Austausch Dienst (DAAD)); Trees4Future, European Union Seventh Framework Programme; Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion; Instituto Nacional de Tecnologia Agropecuaria (INTA)	P.M. and B.Z. MINCyT-DAAD DA/13/06 Ministerio de Ciencia y Tecnologia (MINCyT), Argentina; Deutscher Akademischer Austauschdienst (DAAD), Germany https://www.argentina.gob.ar/ciencia; https://www.daad.de/en/, NO. B.Z. Trees4Future P113, European Union Seventh Framework Programme http://trees4future.eu/, YES, they chose the sequencing technology: IonTorrent, IonProton. P.M and M.V.A PICT2016-1116, Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion, https://www.argentina.gob.ar/ciencia/agencia, NO. M.V.A PICT2017-2656 Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion, https://www.argentina.gob.ar/ciencia/agencia, NO. M.V.A. 2019-PD-E6-I116-001 Instituto Nacional de Tecnologia Agropecuaria (INTA), https://www.argentina.gob.ar/inta, NO.	Andrews S., 2010, FASTQC QUALITY CONTR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baillo EH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100771; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bellora N, 2018, LENGA; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryant D, 1998, ISSUES SCI TECHNOL, V14, P85; Cagnacci J, 2020, FOREST ECOL MANAG, V464, DOI 10.1016/j.foreco.2020.118034; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen F, 2017, CRIT REV PLANT SCI, V36, P311, DOI 10.1080/07352689.2018.1441103; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dimitri MJ, 1972, REGI N BOSQUES ANDIN; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estravis-Barcala M, 2020, J EXP BOT, V71, P3765, DOI 10.1093/jxb/erz532; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feng J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2541; Filichkin SA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00005; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fu M, 2014, PLANT CELL PHYSIOL, V55, P1892, DOI 10.1093/pcp/pcu118; Gordon A, 2010, FASTX TOOLKIT FASTQ; Grinevich DO, 2019, PLANT MOL BIOL, V101, P1, DOI 10.1007/s11103-019-00873-3; Gugger PF, 2017, TREE PHYSIOL, V37, P632, DOI 10.1093/treephys/tpw122; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hess M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3022-6; Higashi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10533; Huang YC, 2016, PLANT PHYSIOL, V172, P1182, DOI 10.1104/pp.16.00860; Hwang JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28552-1; Isah T, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0246-3; Jagadhesan B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66338-6; Jia JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43215; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Ksouri N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01715; Laloum T, 2018, TRENDS PLANT SCI, V23, P140, DOI 10.1016/j.tplants.2017.09.019; Lane T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3052-0; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Lee S, 2014, PLANT SCI, V227, P76, DOI 10.1016/j.plantsci.2014.07.003; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li BJ, 2018, J INTEGR PLANT BIOL, V60, P757, DOI 10.1111/jipb.12701; Li KQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149352; Li MD, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5684-3; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Life Technologies, 2014, ION PROTON SYSTEM SP; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez-Pastur GJ, 2010, REV CHIL HIST NAT, V83, P159; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Mohanta TK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231425; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peng XJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0489-2; Peri P. L., 2009, Journal of Forest Science (Prague), V55, P101, DOI 10.17221/66/2008-JFS; Punzo P, 2020, BIOCHEM SOC T, V48, P2117, DOI 10.1042/BST20200281; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Rambaut A., 2014, FIGTREE V1 4 3 SOFTW; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Ren SX, 2019, FORESTS, V10, DOI 10.3390/f10050383; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song L, 2016, SCIENCE, V354, DOI 10.1126/science.aag1550; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stark R, 2019, NAT REV GENET, V20, P631, DOI 10.1038/s41576-019-0150-2; Sun YD, 2015, PLANT CELL REP, V34, P1295, DOI 10.1007/s00299-015-1787-8; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tian F, 2020, NUCLEIC ACIDS RES, V48, pD1104, DOI 10.1093/nar/gkz1020; Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veblen Thomas T., 1996, P293; Wang L, 2014, GENE, V545, P141, DOI 10.1016/j.gene.2014.04.058; Wang MM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113470; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu FQ, 2019, PLANT CELL ENVIRON, V42, P2931, DOI 10.1111/pce.13633; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Zhang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1398-3; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang M, 2016, PLANT MOL BIOL, V91, P651, DOI 10.1007/s11103-016-0488-1; Zhang Q, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1161-9; Zhang XH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42165; Zhao K, 2019, PLANT SCI, V289, DOI 10.1016/j.plantsci.2019.110259	105	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0246615	10.1371/journal.pone.0246615	http://dx.doi.org/10.1371/journal.pone.0246615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784314	Green Published, Green Submitted, gold			2022-12-26	WOS:000636359600006
J	McLean, S; Nichols, DS; Davies, NW				McLean, Stuart; Nichols, David S.; Davies, Noel W.			Volatile scent chemicals in the urine of the red fox, Vulpes vulpes	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CHROMATOGRAPHY-MASS SPECTROMETRY; XENOBIOTIC ORGANIC-COMPOUNDS; ANAL-SAC SECRETIONS; WOLF CANIS-LUPUS; BIOGEOGRAPHICAL PATTERNS; DEFENSIVE SECRETION; SEX-DIFFERENCES; MARKING FLUID; AMINO-ACIDS	The red fox is a highly adaptable mammal that has established itself world-wide in many different environments. Contributing to its success is a social structure based on chemical signalling between individuals. Urine scent marking behaviour has long been known in foxes, but there has not been a recent study of the chemical composition of fox urine. We have used solid-phase microextraction and gas chromatography-mass spectrometry to analyze the urinary volatiles in 15 free-ranging wild foxes (2 female) living in farmlands and bush in Victoria, Australia. Foxes here are routinely culled as feral pests, and the urine was collected by bladder puncture soon after death. Compounds were identified from their mass spectra and Kovats retention indices. There were 53 possible endogenous scent compounds, 10 plant-derived compounds and 5 anthropogenic xenobiotics. Among the plant chemicals were several aromatic apocarotenoids previously found in greater abundance in the fox tail gland. They reflect the dietary consumption of carotenoids, essential for optimal health. One third of all the endogenous volatiles were sulfur compounds, a highly odiferous group which included thiols, methylsulfides and polysulfides. Five of the sulfur compounds (3-isopentenyl thiol, 1- and 2-phenylethyl methyl sulfide, octanethiol and benzyl methyl sulfide) have only been found in foxes, and four others (isopentyl methyl sulfide, 3-isopentenyl methyl sulfide, and 1- and 2-phenylethane thiol) only in some canid, mink and skunk species. This indicates that they are not normal mammalian metabolites and have evolved to serve a specific role. This role is for defence in musteloids and most likely for chemical communication in canids. The total production of sulfur compounds varied greatly between foxes (median 1.2, range 0.4-32.3 mu g 'acetophenone equivalents'/mg creatinine) as did the relative abundance of different chemical types. The urinary scent chemistry may represent a highly evolved system of semiochemicals for communication between foxes.	[McLean, Stuart] Univ Tasmania, Sch Pharm & Pharmacol, Hobart, Tas, Australia; [Nichols, David S.; Davies, Noel W.] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	McLean, S (corresponding author), Univ Tasmania, Sch Pharm & Pharmacol, Hobart, Tas, Australia.	stuart.mclean@utas.edu.au		Nichols, David/0000-0002-8066-3132				Alberta Forestry AAa, 2016, BIOL CONTROL SKUNKS; ALBONE ES, 1975, NATURE, V256, P575, DOI 10.1038/256575a0; Amat JA, 2011, BEHAV ECOL SOCIOBIOL, V65, P665, DOI 10.1007/s00265-010-1068-z; Andersen KF, 1999, CHEM SENSES, V24, P179, DOI 10.1093/chemse/24.2.179; ANDERSEN KK, 1982, TETRAHEDRON, V38, P1965, DOI 10.1016/0040-4020(82)80046-X; [Anonymous], 2014, PHEROMONES ANIMAL BE; Apps PJ, 2015, NAT PROD REP, V32, P1131, DOI 10.1039/c5np00029g; Apps PJ, 2013, NATURWISSENSCHAFTEN, V100, P487, DOI 10.1007/s00114-013-1054-1; Arnaiz E, 2014, ANAL LETT, V47, P721, DOI 10.1080/00032719.2013.853182; ASA CS, 1993, AM ZOOL, V33, P167; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Beynon J.H., 1968, MASS SPECTRA ORGANIC; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Boyle RR, 2002, J CHROMATOGR B, V780, P397, DOI 10.1016/S1570-0232(02)00625-6; Braun JP, 2003, VET CLIN PATH, V32, P162, DOI 10.1111/j.1939-165X.2003.tb00332.x; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brunetti AE, 2019, P NATL ACAD SCI USA, V116, P2124, DOI 10.1073/pnas.1806834116; Burger BV, 2008, J CHEM ECOL, V34, P659, DOI 10.1007/s10886-008-9462-y; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Cancio I, 2017, J ARID ENVIRON, V145, P24, DOI 10.1016/j.jaridenv.2017.05.004; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Corrales J, 2015, DOSE-RESPONSE, V13, DOI 10.1177/1559325815598308; Davis NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120975; Dawson SJ, 2016, WILDLIFE RES, V43, P615, DOI 10.1071/WR16066; DETTNER K, 1991, BIOCHEM SYST ECOL, V19, P291, DOI 10.1016/0305-1978(91)90017-T; Devenish-Nelson ES, 2013, OIKOS, V122, P705, DOI 10.1111/j.1600-0706.2012.20706.x; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dong F, 2012, J PLANT PHYSIOL, V169, P217, DOI 10.1016/j.jplph.2011.12.003; Dorning J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56713-3; Dorning J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220792; Doving KB, 1998, J EXP BIOL, V201, P2913; Dzieciol M, 2018, ANIM REPROD SCI, V197, P87, DOI 10.1016/j.anireprosci.2018.08.016; Eriksson E, 2003, WATER SA, V29, P135; Esteban R, 2015, ENVIRON EXP BOT, V119, P63, DOI 10.1016/j.envexpbot.2015.04.009; Estevez M, 2020, MEAT SCI, V163, DOI 10.1016/j.meatsci.2020.108087; Fairfax RJ, 2019, BIOL INVASIONS, V21, P1259, DOI 10.1007/s10530-018-1897-7; Fauguel CM, 2017, PLANT PATHOL, V66, P1128, DOI 10.1111/ppa.12663; Fawcett JK, 2013, J ETHOL, V31, P41, DOI 10.1007/s10164-012-0348-7; Felemban A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01168; Fineschi S, 2012, IFOREST, V5, P13, DOI 10.3832/ifor0607-009; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Forbes-Harper JL, 2017, J ZOOL, V303, P54, DOI 10.1111/jzo.12463; Galili G, 2005, BIOL CHEM, V386, P817, DOI 10.1515/BC.2005.097; Gordon AR, 2018, CHEM SENSES, V43, P711, DOI 10.1093/chemse/bjy059; Grimm CC, 2000, J CHROMATOGR SCI, V38, P289, DOI 10.1093/chromsci/38.7.289; Handler AM, 2020, CAN J ZOOL, V98, P79, DOI 10.1139/cjz-2019-0004; Henneken J, 2017, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00145; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Hradsky BA, 2019, J APPL ECOL, V56, P1460, DOI 10.1111/1365-2664.13374; HUBNER B, 1992, FRESEN J ANAL CHEM, V342, P746, DOI 10.1007/BF00321870; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Ingenbleek Y, 2013, NUTR REV, V71, P413, DOI 10.1111/nure.12050; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; JORGENSON JW, 1978, SCIENCE, V199, P796, DOI 10.1126/science.199.4330.796; KASEDA H, 1973, J BIOCHEM-TOKYO, V74, P127, DOI 10.1093/oxfordjournals.jbchem.a130215; Kropp KG, 1998, CAN J MICROBIOL, V44, P605, DOI 10.1139/w98-045; Lanszki J, 2019, MAMM STUDY, V44, P33, DOI 10.3106/ms2018-0048; Liu RZ, 2019, ENVIRON POLLUT, V252, P1423, DOI 10.1016/j.envpol.2019.06.077; Maffei ME, 2011, NAT PROD REP, V28, P1359, DOI 10.1039/c1np00021g; Martin J, 2010, BIOCHEM SYST ECOL, V38, P1096, DOI 10.1016/j.bse.2010.10.014; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; McLean S, 2019, CHEM SENSES, V44, P215, DOI 10.1093/chemse/bjz009; McLean S, 2017, LIPIDS, V52, P599, DOI 10.1007/s11745-017-4270-1; McLean S, 2015, LIPIDS, V50, P591, DOI 10.1007/s11745-015-4025-9; McPherson RA, 2011, CURR OPIN CLIN NUTR, V14, P562, DOI 10.1097/MCO.0b013e32834c1780; Medill SA, 2011, ETHOL ECOL EVOL, V23, P41, DOI 10.1080/03949370.2010.529826; Michalowicz J, 2014, ENVIRON TOXICOL PHAR, V37, P738, DOI 10.1016/j.etap.2014.02.003; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Nielsen LT, 2006, J CAVE KARST STUD, V68, P27; NIST, 2014, NIST MASS SPECTR LIB; O'Connor JM, 2019, AUST J ZOOL, V67, P82, DOI 10.1071/ZO19059; Ortiz-Leal I, 2020, J ANAT, V237, P890, DOI 10.1111/joa.13254; Osada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061753; Otranto D, 2019, INT J PARASITOL-PAR, V9, P370, DOI 10.1016/j.ijppaw.2018.12.011; Parsons MH, 2018, BIOL REV, V93, P98, DOI 10.1111/brv.12334; Pedersen JA, 2003, J AGR FOOD CHEM, V51, P1360, DOI 10.1021/jf025953q; Pisano SRR, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3762-7; Pouech C, 2014, ANAL BIOANAL CHEM, V406, P1493, DOI 10.1007/s00216-013-7551-4; RAYMER J, 1984, EXPERIENTIA, V40, P707, DOI 10.1007/BF01949734; RAYMER J, 1986, J CHEM ECOL, V12, P297, DOI 10.1007/BF01045612; Reidel RVB, 2017, BIOCHEM SYST ECOL, V75, P10, DOI 10.1016/j.bse.2017.10.001; Roberts SA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0512-9; Saini RK, 2015, FOOD RES INT, V76, P735, DOI 10.1016/j.foodres.2015.07.047; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Sheehan MJ, 2019, MOL ECOL, V28, P3587, DOI 10.1111/mec.15155; Silva L, 2017, ANNU REV ANIM BIOSCI, V5, P353, DOI 10.1146/annurev-animal-022516-022801; Soe E, 2017, MAMMAL REV, V47, P198, DOI 10.1111/mam.12092; SOKOLOV VE, 1980, J CHEM ECOL, V6, P805, DOI 10.1007/BF00990405; Soso SB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04973-2; Stepkovitch B, 2019, J ZOOL, DOI 10.1111/jzo.12723; Stutz H, 2015, FREE RADICAL RES, V49, P650, DOI 10.3109/10715762.2015.1022539; Suarez R, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00050; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tian HH, 2020, J CHROMATOGR A, V1614, DOI 10.1016/j.chroma.2019.460717; TOMALSKI MD, 1987, J CHEM ECOL, V13, P253, DOI 10.1007/BF01025886; VANZOEST R, 1991, SCI TOTAL ENVIRON, V103, P57, DOI 10.1016/0048-9697(91)90353-G; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Walton Z, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1223-9; Wang L, 2010, PROCESS BIOCHEM, V45, P919, DOI 10.1016/j.procbio.2010.02.012; Wanlong Z, 2017, EUR ZOOL J, V84, P512, DOI 10.1080/24750263.2017.1391340; White JG, 2006, WILDLIFE RES, V33, P175, DOI 10.1071/WR05037; WHITE PJ, 1989, J MAMMAL, V70, P814, DOI 10.2307/1381717; WHITTEN WK, 1980, J CHEM ECOL, V6, P49, DOI 10.1007/BF00987526; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wood WF, 2002, J CHEM ECOL, V28, P1865, DOI 10.1023/A:1020573404341; Woszczylo M, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112112; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Yang ZQ, 2008, CHEMOSPHERE, V72, P1751, DOI 10.1016/j.chemosphere.2008.04.090; Zhang JX, 2005, CHEM SENSES, V30, P727, DOI 10.1093/chemse/bji065	115	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248961	10.1371/journal.pone.0248961	http://dx.doi.org/10.1371/journal.pone.0248961			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784329	Green Published, Green Accepted, gold			2022-12-26	WOS:000636359600034
J	Posel, D; Oyenubi, A; Kollamparambil, U				Posel, Dorrit; Oyenubi, Adeola; Kollamparambil, Umakrishnan			Job loss and mental health during the COVID-19 lockdown: Evidence from South Africa	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; UNEMPLOYMENT; EMPLOYMENT; POVERTY; PANEL	Objectives Existing literature on how employment loss affects depression has struggled to address potential endogeneity bias caused by reverse causality. The COVID-19 pandemic offers a unique natural experiment because the source of unemployment is very likely to be exogenous to the individual. This study assessed the effect of job loss and job furlough on the mental health of individuals in South Africa during the COVID-19 pandemic. Data and methods The data for the study came from the first and second waves of the national survey, the National Income Dynamics-Coronavirus Rapid Mobile Survey (NIDS-CRAM), conducted during May-June and July-August 2020, respectively. The sample for NIDS-CRAM was drawn from an earlier national survey, conducted in 2017, which had collected data on mental health. Questions on depressive symptoms during the lockdown were asked in Wave 2 of NIDS-CRAM, using a 2-question version of the Patient Health Questionnaire (PHQ-2). The PHQ-2 responses (0-6 on the discrete scale) were regrouped into four categories making the ordered logit regression model the most suited for assessing the impact of employment status on depressive symptoms. Results The study revealed that adults who retained paid employment during the COVID-19 lockdown had significantly lower depression scores than adults who lost employment. The benefits of employment also accumulated over time, underscoring the effect of unemployment duration on mental health. The analysis revealed no mental health benefits to being furloughed (on unpaid leave), but paid leave had a strong and significant positive effect on the mental health of adults. Conclusions The economic fallout of the COVID-19 pandemic resulted in unprecedented job losses, which impaired mental wellbeing significantly. Health policy responses to the crisis therefore need to focus on both physical and mental health interventions.	[Posel, Dorrit; Oyenubi, Adeola; Kollamparambil, Umakrishnan] Univ Witwatersrand, Sch Econ & Finance, Johannesburg, South Africa	University of Witwatersrand	Posel, D (corresponding author), Univ Witwatersrand, Sch Econ & Finance, Johannesburg, South Africa.	dorrit.posel@wits.ac.za	Kollamparambil, Umakrishnan/ABB-1918-2021; Oyenubi, Adeola/AAH-6843-2021	Kollamparambil, Umakrishnan/0000-0002-6201-1923; Oyenubi, Adeola/0000-0001-6068-1723; Posel, Dorrit/0000-0002-3343-875X				ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Ardington C, 2010, Tydskr Stud Ekon Ekon, V34, P69; Banerjee A, 2008, ECON TRANSIT, V16, P715, DOI 10.1111/j.1468-0351.2008.00340.x; Banks J, 2020, FISC STUD, V41, P685, DOI 10.1111/1475-5890.12239; Baron EC, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1178-x; Bornman E, 2016, INFORM COMMUN SOC, V19, P264, DOI 10.1080/1369118X.2015.1065285; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P438; Burgard SA, 2007, J HEALTH SOC BEHAV, V48, P369, DOI 10.1177/002214650704800403; Burger R, 2017, J AFFECT DISORDERS, V218, P170, DOI 10.1016/j.jad.2017.04.031; Casale D, 2021, RES SOC STRAT MOBIL, V71, DOI 10.1016/j.rssm.2020.100569; Culyer AJ., 2014, ENCY HLTH EC AMSTERD, P343; Daniels R. C., 2020, DETERMINANTS ATTRITI; Das J, 2007, SOC SCI MED, V65, P467, DOI 10.1016/j.socscimed.2007.02.037; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; GRAETZ B, 1993, SOC SCI MED, V36, P715, DOI 10.1016/0277-9536(93)90032-Y; Hamad R, 2008, J EPIDEMIOL COMMUN H, V62, P538, DOI 10.1136/jech.2007.066191; Holtge J, 2018, EUR J HEALTH PSYCHOL, V25, P53, DOI 10.1027/2512-8442/a000011; JAHODA M, 1981, AM PSYCHOL, V36, P184, DOI 10.1037/0003-066X.36.2.184; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; Jain Ronak, 2020, LABOR MARKET POVERTY; Kerr A., 2020, NATL INCOME DYNAMICS; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Mein SA, 2020, J GEN INTERN MED, V35, P2439, DOI 10.1007/s11606-020-05880-5; Murphy GC, 1999, J OCCUP ORGAN PSYCH, V72, P83, DOI 10.1348/096317999166518; Nwosu CO, 2018, DEV SO AFR, V35, P145, DOI [10.1080/0376835x.2017.1392847, 10.1080/0376835X.2017.1392847]; Oyedemi T, 2018, AFR EDUC RE, V15, P175, DOI 10.1080/18146627.2016.1264866; Oyenubi A., 2020, REPORT NO 10; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Petersen I, 2011, SAMJ S AFR MED J, V101, P751; Posel D, 2021, FAMILIES HOUSEHOLD F; Posel D, 2014, S AFR J ECON, V82, P66, DOI 10.1111/saje.12035; Posel D, 2012, DEV SO AFR, V29, P97, DOI 10.1080/0376835X.2012.645645; Proto E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244419; Seedat S, 2004, MOL PSYCHIATR, V9, P891, DOI 10.1038/sj.mp.4001572; Sorsdahl K, 2012, AFR J PSYCHIATRY, V15, P168, DOI [10.4314/ajpsy.v15i3.21, http://dx.doi.org/10.4314/ajpsy.v15i3.21]; Spaull N., 2020, WORKING PAPER SERIES, V17; Statistics South Africa, 2020, Q LABOUR FORCE SURVE; Steffick D.E., 2000, DOCUMENTATION AFFECT; Ting L, 2015, DEV SO AFR, V32, P675, DOI 10.1080/0376835X.2015.1063987; Tomita A, 2013, J AFFECT DISORDERS, V144, P101, DOI 10.1016/j.jad.2012.05.066; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Warr P., 1987, WORK UNEMPLOYMENT ME; Williams R., 2013, GERM STAT US GROUP; Wills G., 2020, WORKING PAPER SERIES; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001	52	80	80	9	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249352	10.1371/journal.pone.0249352	http://dx.doi.org/10.1371/journal.pone.0249352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784339	Green Published, gold			2022-12-26	WOS:000636359600064
J	Tekliye, E; Alemayehu, T; Bacha, T				Tekliye, Endashaw; Alemayehu, Tinsae; Bacha, Tigist			Clinical, immunologic and virologic outcomes of children and adolescents receiving second line anti-retroviral therapy in two referral hospitals in Addis Ababa, Ethiopia	PLOS ONE			English	Article								Background Ethiopia launched free access for antiretroviral therapy in 2005. The number of patients on second line antiretroviral treatment has increased with each passing year. The objectives of this study were to describe the clinical, immunological and virologic outcomes of children and adolescents receiving second line anti-retroviral therapy in two referral hospitals, Yekatit 12 and Zewditu Memorial Hospitals, in Addis Ababa, Ethiopia. Methods This was a hospital based retrospective cohort study conducted among children and adolescents aged 18 years and less and receiving a second line antiretroviral drugs. Data was collected using structured questionnaires. Means and percentages were used for nominal variables. Statistical analysis was made using statistical software-SPSS 23.0. Kaplan Meier analysis, long rank test and multivariate Cox proportion model were used to identify factors affecting survival. Results A total of 75 children and adolescents were studied with a mean age of 13.28 years (SD: 4) with a mean treatment period on second line regimens of 35.2 months (SD: 21.8 months). Forty-eight participants were experiencing successful measures (in all three parameters) for their second line anti-retroviral treatment. Ten had virologic treatment failure while seven had died. Both treatment failure and death rates were higher within the first two years of treatment. Poor treatment adherence (Adjusted hazard ratio: 5.1 (95% CI: 1.1-23.2; p-value = 0.02)) and advanced World Health Organization clinical stage at start of the second line antiretrovirals (Adjusted hazard ratio: 7.51 (95% CI: 1.35-18.02; p-value = 0.002)) correlated significantly with survival of children and adolescents receiving treatment. Conclusions The study describes clinical, immunological and virologic outcomes of second line antiretroviral treatment in a pediatric cohort under care in two hospitals in Addis Ababa, Ethiopia. Poor adherence and pre-treatment advanced clinical stages were predictors of survival.	[Tekliye, Endashaw] Sabiyan Gen Hosp, Dire Dawa, Ethiopia; [Alemayehu, Tinsae] Amer Med Ctr, Specialty Clin Infect Dis & Travel Med, Addis Ababa, Ethiopia; [Alemayehu, Tinsae] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Bacha, Tigist] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Alemayehu, T (corresponding author), Amer Med Ctr, Specialty Clin Infect Dis & Travel Med, Addis Ababa, Ethiopia.; Alemayehu, T (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.	tigisttinsae@gmail.com		Bacha, Tigist/0000-0002-8322-1612; Alemayehu, Tinsae/0000-0003-0699-8433				Alemayehu T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65714-6; Alene M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4243-5; Boerma RS, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21930; Boerma RS, 2017, J TROP PEDIATRICS, V63, P135, DOI 10.1093/tropej/fmw062; Collins IJ, 2019, LANCET HIV, V6, pE105, DOI 10.1016/S2352-3018(18)30319-9; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9; Edessa D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220159; Forsythe SS, 2019, HEALTH AFFAIR, V38, P1163, DOI 10.1377/hlthaff.2018.05391; Haftu AZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239191; Haile GS, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1402-1; Hailu GG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196259; Khan S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24861; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Martelli G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214014; Mehta K, 2016, AIDS BEHAV, V20, P1076, DOI 10.1007/s10461-015-1207-7; Mofenson LM, 1997, J INFECT DIS, V175, P1029, DOI 10.1086/516441; Okechukwu AA., 2015, J HIV CLIN SCI RES, V2, P049, DOI [10.17352/2455-3786.000014, DOI 10.17352/2455-3786.000014]; Patel K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25477; Prasitsuebsai W, 2016, JAIDS-J ACQ IMM DEF, V72, P380, DOI 10.1097/QAI.0000000000000971; Rohr JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161469; Suaysod R, 2015, CLIN INFECT DIS, V61, P95, DOI 10.1093/cid/civ271; The Federal Ministry of Health of Ethiopia, 2018, NATL GUIDELINES COMP; Tsegaye AT, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012537; Zanoni BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049591	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249085	10.1371/journal.pone.0249085	http://dx.doi.org/10.1371/journal.pone.0249085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784335	gold, Green Published			2022-12-26	WOS:000636359600021
J	Sturm, MB; Smith, S; Ganbaatar, O; Buuveibaatar, B; Balint, B; Payne, JC; Voigt, CC; Kaczensky, P				Sturm, Martina Burnik; Smith, Steve; Ganbaatar, Oyunsaikhan; Buuveibaatar, Bayarbaatar; Balint, Boglarka; Payne, John C.; Voigt, Christian C.; Kaczensky, Petra			Isotope analysis combined with DNA barcoding provide new insights into the dietary niche of khulan in the Mongolian Gobi	PLOS ONE			English	Article							STABLE-ISOTOPES; COMPETITION; HERBIVORE; DENSITY; WORLDS	With increasing livestock numbers, competition and avoidance are increasingly shaping resource availability for wild ungulates. Shifts in the dietary niche of wild ungulates are likely and can be expected to negatively affect their fitness. The Mongolian Gobi constitutes the largest remaining refuge for several threatened ungulates, but unprecedentedly high livestock numbers are sparking growing concerns over rangeland health and impacts on threatened ungulates like the Asiatic wild ass (khulan). Previous stable isotope analysis of khulan tail hair from the Dzungarian Gobi suggested that they graze in summer but switch to a poorer mixed C3 grass / C4 shrub diet in winter, most likely in reaction to local herders and their livestock. Here we attempt to validate these findings with a different methodology, DNA metabarcoding. Further, we extend the scope of the original study to the South Gobi Region, where we expect higher proportions of low-quality browse in the khulan winter diet due to a higher human and livestock presence. Barcoding confirmed the assumptions behind the seasonal diet change observed in the Dzungarian Gobi isotope data, and new isotope analysis revealed a strong seasonal pattern and higher C4 plant intake in the South Gobi Region, in line with our expectations. However, DNA barcoding revealed C4 domination of winter diet was due to C4 grasses (rather than shrubs) for the South Gobi Region. Slight climatic differences result in regional shifts in the occurrence of C3 and C4 grasses and shrubs, which do not allow for an isotopic separation along the grazer-browser continuum over the entire Gobi. Our findings do not allow us to confirm human impacts upon dietary preferences in khulan as we lack seasonal samples from the South Gobi Region. However, these data provide novel insight into khulan diet, raise new questions about plant availability versus preference, and provide a cautionary tale about indirect analysis methods if used in isolation or extrapolated to the landscape level. Good concordance between relative read abundance of C4 genera from barcoding and proportion of C4 plants from isotope analysis adds to a growing body of evidence that barcoding is a promising quantitative tool to understand resource partitioning in ungulates.	[Sturm, Martina Burnik; Payne, John C.; Kaczensky, Petra] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Smith, Steve] Univ Vet Med, Konrad Lorenz Inst Ethol, Vienna, Austria; [Ganbaatar, Oyunsaikhan; Balint, Boglarka] Great Gobi B Strictly Protected Area Adm, Takhin Tal, Gobi Altai Prov, Mongolia; [Ganbaatar, Oyunsaikhan] Natl Univ Mongolia, Sch Biol & Biotechnol, Dept Zool, Ulaanbaatar, Mongolia; [Buuveibaatar, Bayarbaatar] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongolia; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Kaczensky, Petra] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Sturm, Martina Burnik] Univ Nat Resources & Life Sci BOKU, Inst Analyt Chem, Vienna, Austria; [Kaczensky, Petra] Inland Norway Univ Appl Sci INN, Dept Forestry & Wildlife Management, Evenstad, Norway	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; National University of Mongolia; Leibniz Institut fur Zoo und Wildtierforschung; Norwegian Institute Nature Research; University of Natural Resources & Life Sciences, Vienna	Kaczensky, P (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.; Kaczensky, P (corresponding author), Norwegian Inst Nat Res NINA, Trondheim, Norway.; Kaczensky, P (corresponding author), Inland Norway Univ Appl Sci INN, Dept Forestry & Wildlife Management, Evenstad, Norway.	petra.kaczensky@inn.no		Bayarbaatar, Buuveibaatar/0000-0003-1803-0745; Kaczensky, Petra/0000-0001-5428-1176; Burnik Sturm, Martina/0000-0002-3198-1687; Smith, Steve/0000-0002-1318-0018	Austrian Science Fund (FWF) [P24231]; Research Institute of Wildlife Ecology at the University of Veterinary Medicine Vienna; Research Council of Norway [251112]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Research Institute of Wildlife Ecology at the University of Veterinary Medicine Vienna; Research Council of Norway(Research Council of Norway)	Funding for the isotope analysis came from the Austrian Science Fund (FWF) to PK and MBS. (grant P24231) and the Research Institute of Wildlife Ecology at the University of Veterinary Medicine Vienna. During data analysis and writing PK was supported by the Research Council of Norway (Grant 251112). Sampling of khulan tail hair in the SGR happened within the framework of the Oyu Tolgoi's Core Biodiversity Monitoring Program, implemented by the WCS through a cooperative agreement with Sustainability East Asia LLC. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Batsaikhan N, 2014, CONSERV BIOL, V28, P1736, DOI 10.1111/cobi.12297; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Berger J, 2013, CONSERV BIOL, V27, P679, DOI 10.1111/cobi.12100; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Bouadjenek MR, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax021; Burnik Sturm M, 2015, RAPID COMMUN MASS SP, V29, P1047, DOI 10.1002/rcm.7196; Buuveibaatar B, 2017, ORYX, V51, P639, DOI 10.1017/S0030605316000417; Buuveibaatar B, 2016, BIOL CONSERV, V203, P168, DOI 10.1016/j.biocon.2016.09.013; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Codron D, 2007, EUR J WILDLIFE RES, V53, P161, DOI 10.1007/s10344-006-0075-x; Deagle BE, 2019, MOL ECOL, V28, P391, DOI 10.1111/mec.14734; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Erickson DL, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx015; Fernandez-Gimenez ME, 2017, ANTHROPOCENE, V17, P46, DOI 10.1016/j.ancene.2017.01.003; Fernandez-Gimenez ME, 1999, HUM ECOL, V27, P1, DOI 10.1023/A:1018757632589; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Ichinkhorloo O., 2013, NAT CONSERV; Kaczensky P., 2015, IUCN RED LIST THREAT; Kaczensky P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05329-6; Kaczensky P, 2014, BIOL CONSERV, V169, P311, DOI 10.1016/j.biocon.2013.11.033; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; King SRB, 2019, RANGELAND ECOL MANAG, V72, P661, DOI 10.1016/j.rama.2019.02.005; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mishra C, 2002, ANIM CONSERV, V5, P251, DOI 10.1017/S1367943002002305; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Proutkina M, 1981, ASIAN WILD ASS LESNA; Pyankov VI, 2000, OECOLOGIA, V123, P15, DOI 10.1007/s004420050985; Ransom JI, 2012, BIOL CONSERV, V153, P219, DOI 10.1016/j.biocon.2012.05.006; Schoenecker K.A., 2016, WILD EQUIDS ECOLOGY, P41; Shipley LA., 1999, GRAZERS BROWSERS DIG, P20; Shipley LA, 2009, INTEGR COMP BIOL, V49, P274, DOI 10.1093/icb/icp051; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sturm MB, 2017, J APPL ECOL, V54, P1110, DOI 10.1111/1365-2664.12825; Sugimoto T, 2018, J MAMMAL, V99, P450, DOI 10.1093/jmammal/gyx182; Thomas AC, 2016, MOL ECOL RESOUR, V16, P714, DOI 10.1111/1755-0998.12490; Toderich K., 2007, CLIMATE CHANGE TERRE, P33; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; von Wehrden Henrik, 2006, Mongolian Journal of Biological Sciences, V4, P3; von Wehrden H, 2009, PHYTOCOENOLOGIA, V39, P331, DOI 10.1127/0340-269X/2009/0039-0331; Xu WX, 2012, ITAL J ZOOL, V79, P92, DOI 10.1080/11250003.2011.620635	51	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248294	10.1371/journal.pone.0248294	http://dx.doi.org/10.1371/journal.pone.0248294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780458	Green Published, gold			2022-12-26	WOS:000636336800037
J	Wang, FX; Tan, ZQ; Yu, ZH; Yao, SQ; Guo, CF				Wang, Fangxiong; Tan, Ziqian; Yu, Zaihui; Yao, Siqi; Guo, Changfeng			Transmission and control pressure analysis of the COVID-19 epidemic situation using multisource spatio-temporal big data	PLOS ONE			English	Article							INFECTIOUS-DISEASE SURVEILLANCE	Taking the Guangdong-Hong Kong-Macao Greater Bay Area as the research area, this paper used OD cluster analysis based on Baidu migration data from January 11 to January 25 (before the sealing-off of Wuhan) and concluded that there is a significant correlation 1the migration level from Wuhan to the GBA and the epidemic severity index. This paper also analyzed the migration levels and diffusivity of the outer and inner cities of the GBA. Lastly, four evaluation indexes were selected to research the possibility of work resumption and the rating of epidemic prevention and control through kernel density estimation. According to the study, the amount of migration depends on the geographical proximity, relationship and economic development of the source region, and the severity of the epidemic depends mainly on the migration volume and the severity of the epidemic in the source region. The epidemic risk is related not only to the severity of the epidemic in the source region but also to the degree of urban traffic development and the degree of urban openness. After the resumption of work, the pressure of epidemic prevention and control has been concentrated mainly in Shenzhen and Canton; the further away a region is from the core cities, the lower the pressure in that region. The mass migration of the population makes it difficult to control the epidemic effectively. The study of the relationship between migration volume, epidemic severity and epidemic risk is helpful to further analyze transmission types and predict the trends of the epidemic.	[Wang, Fangxiong; Tan, Ziqian; Yu, Zaihui; Yao, Siqi; Guo, Changfeng] Liaoning Normal Univ, Sch Geog, Dalian, Peoples R China	Liaoning Normal University	Tan, ZQ (corresponding author), Liaoning Normal Univ, Sch Geog, Dalian, Peoples R China.	2061717897@qq.com		Tan, Ziqian/0000-0003-3636-6816				[Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen S, 1 CASE NOVEL CORONAV; Cheng Y., 2020, J J SHAANXI NORMAL U, P38; Dou Z., 2010, SPATIAL CLUSTERING A; Guangdong Provincial Bureau of Statistics, 2019, STAT YB GUANGD PROV; Guo DS, 2012, T GIS, V16, P411, DOI 10.1111/j.1467-9671.2012.01344.x; Hong Kong Bureau of Statistics, 2019, HONG KONG STAT YB; Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309; Huang R, 2020, J INFECT DEV COUNTR, V14, P246, DOI 10.3855/jidc.12585; Kang D, 2020, INT J INFECT DIS, V94, P96, DOI 10.1016/j.ijid.2020.03.076; Lee EC, 2016, J INFECT DIS, V214, pS409, DOI 10.1093/infdis/jiw344; Li YK, HONG KONG MAY HAVE I; Liu T, 2020, TIME VARYING TRANSMI, DOI 10.1101/2020.01.25.919787; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993; [梅文娟 Mei Wenjuan], 2020, [电子科技大学学报, Journal of University of Electronic Science and Technology of China], V49, P362; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peng ZH, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9060402; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Ren L.J, 1 CONFIRMED CASE NOV; Sarkodie SA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03747; Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090; Song Gao, 2020, SIGSPATIAL Special, V12, P16, DOI 10.1145/3404820.3404824; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; [邬群勇 Wu Qunyong], 2018, [地球信息科学学报, Journal of Geo-Information Science], V20, P647; [信睿 Xin Rui], 2015, [地球信息科学学报, Journal of Geo-Information Science], V17, P1187; [许小可 Xu Xiaoke], 2020, [电子科技大学学报, Journal of University of Electronic Science and Technology of China], V49, P324; Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434; Yao X, 2018, IEEE ACCESS, V6, P44666, DOI 10.1109/ACCESS.2018.2864662; Yu Wenhao, 2016, Geomatics and Information Science of Wuhan University, V41, P221, DOI 10.13203/j.whugis20140092; [禹文豪 Yu Wenhao], 2015, [测绘学报, Acta Geodetica et Cartographica Sinica], V44, P82; [张玲 Zhang Ling], 2012, [测绘通报, Bulletin of Surveying and Mapping], P82; [赵卫锋 ZHAO Weifeng], 2011, [遥感学报, Journal of Remote Sensing], V15, P973; Zhou ZG, 2019, IEEE T VIS COMPUT GR, V25, P43, DOI 10.1109/TVCG.2018.2864503	36	3	3	12	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249145	10.1371/journal.pone.0249145	http://dx.doi.org/10.1371/journal.pone.0249145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780496	Green Published, gold, Green Submitted			2022-12-26	WOS:000636336800022
J	Allie, T; Jackson, A; Ambler, J; Johnston, K; Du Bruyn, E; Schultz, C; Boloko, L; Wasserman, S; Davis, A; Meintjes, G; Wilkinson, RJ; Tiffin, N				Allie, Taryn; Jackson, Amanda; Ambler, Jon; Johnston, Katherine; Du Bruyn, Elsa; Schultz, Charlotte; Boloko, Linda; Wasserman, Sean; Davis, Angharad; Meintjes, Graeme; Wilkinson, Robert J.; Tiffin, Nicki			TBDBT: A TB DataBase Template for collection of harmonized TB clinical research data in REDCap, facilitating data standardisation for inter-study comparison and meta-analyses	PLOS ONE			English	Article								Clinical tuberculosis research, both within research groups and across research ecosystems, is often undertaken in isolation using bespoke data collection platforms and applying differing data conventions. This failure to harmonise clinical phenotype data or apply standardised data collection and storage standards in turn limits the opportunity to undertake meta-analyses using data generated across multiple research projects for the same research domain. We have developed the Tuberculosis DataBase Template (TBDBT), a template for the well-supported, free and commonly deployed clinical databasing platform, REDCap. This template can be used to set up a new tuberculosis research database with a built-in set of standardised data conventions, to ensure standardised data capture across research projects and programs. A modular design enables researchers to implement only the modules of the database template that are appropriate for their particular study. The template includes core modules for informed consent data, participant demographics, clinical symptoms and presentation, diagnostic imaging and laboratory tests. Optional modules have been designed for visit scheduling and calendar functionality, clinical trial randomisation, study logistics and operations, and pharmacokinetic data. Additional fields can be added as needed. This REDCap template can facilitate collection of high-quality data for tuberculosis research, providing a tool to ensure better data harmonisation, analysis and meta-analysis.	[Allie, Taryn; Jackson, Amanda; Ambler, Jon; Du Bruyn, Elsa; Schultz, Charlotte; Boloko, Linda; Wasserman, Sean; Davis, Angharad; Meintjes, Graeme; Wilkinson, Robert J.; Tiffin, Nicki] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Ambler, Jon; Johnston, Katherine; Tiffin, Nicki] Univ Cape Town, Computat Biol Div, Integrat Biomed Sci, Cape Town, South Africa; [Du Bruyn, Elsa; Schultz, Charlotte; Boloko, Linda; Wasserman, Sean; Meintjes, Graeme; Wilkinson, Robert J.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Wilkinson, Robert J.] Imperial Coll London, Dept Infect Dis, London, England; [Wilkinson, Robert J.] Francis Crick Inst, London, England; [Tiffin, Nicki] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol Res, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; Imperial College London; Francis Crick Institute; University of Cape Town	Tiffin, N (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.; Tiffin, N (corresponding author), Univ Cape Town, Computat Biol Div, Integrat Biomed Sci, Cape Town, South Africa.; Tiffin, N (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol Res, Cape Town, South Africa.	nicki.tiffin@uct.ac.za	Wasserman, Sean/AAR-1752-2021; Schutz, Charlotte/G-6864-2016	Wasserman, Sean/0000-0002-3508-6719; Meintjes, Graeme/0000-0003-1196-4414; Wilkinson, Robert/0000-0002-2753-1800; Ambler, Jon/0000-0001-7583-0963; Schutz, Charlotte/0000-0001-8329-6158	Wellcome [104803, 203135, FC0010215]; NIH H3ABioNET award [U24HG006941]; NIH B-Positive Grant [R01HD080465]; IKRI [FC0010218]; CRUK [FC0010218]; EDCTP [SRIA1065-2015, RIA2017T-2005]; NIH [AI115940]	Wellcome; NIH H3ABioNET award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH B-Positive Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IKRI; CRUK(Cancer Research UK); EDCTP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by Wellcome (104803, 203135). NT additionally receives funding from the NIH H3ABioNET award (U24HG006941), and is supported by the NIH B-Positive Grant (R01HD080465). RJW receives additional support from Francis Crick Institute which is funded by IKRI (FC0010218), Wellcome (FC0010215) and CRUK (FC0010218). He also receives support from EDCTP (SRIA1065-2015 and RIA2017T-2005) and NIH (AI115940).	Abhishek K., 2016, INT J ENG TECHNOL, V8, P2860, DOI [10.21817/ijet/2016/v8i6/160806247, DOI 10.21817/IJET/2016/V8I6/160806247]; Gaddale Jagadeeswara Rao, 2015, Perspect Clin Res, V6, P179, DOI 10.4103/2229-3485.167101; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Levine DM, 2015, TUBERCULOSIS, V95, P570, DOI 10.1016/j.tube.2015.05.012; Lew JM, 2013, TUBERCULOSIS, V93, P12, DOI 10.1016/j.tube.2012.11.003; Nembaware V, 2019, NAT GENET, V51, P1566, DOI 10.1038/s41588-019-0520-x; Obeid JS, 2013, J BIOMED INFORM, V46, P259, DOI 10.1016/j.jbi.2012.10.006; Yamamoto K, 2017, J BIOMED INFORM, V70, P65, DOI 10.1016/j.jbi.2017.05.003; Yerlikaya S, 2017, INT J INFECT DIS, V56, P253, DOI 10.1016/j.ijid.2017.01.025	10	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249165	10.1371/journal.pone.0249165	http://dx.doi.org/10.1371/journal.pone.0249165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770143	gold, Green Published			2022-12-26	WOS:000634833500010
J	Goto, H; Miyamoto, M; Kihara, A				Goto, Hirotaka; Miyamoto, Masatoshi; Kihara, Akio			Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; TRANSPORTER SPNS2; IDENTIFICATION; DEGRADATION; RECEPTOR; PLASMA; PHOSPHOHYDROLASE; SPHINGOLIPIDS	Sphingosine-1-phosphate (S1P) is a lipid mediator that is relatively abundant in plasma and plays an important role in the vascular and immune systems. To date, the only known mechanism for removing S1P from plasma has been dephosphorylation by phospholipid phosphatases (PLPPs) on the surface of cells in contact with the plasma. However, there remains a possibility that PLPP-independent dephosphorylation or direct S1P uptake into cells could occur. To examine these possibilities, here we generated triple KO (TKO) HAP1 cells that lacked all PLPPs (PLPP1-3) present in mammals. In the TKO cells, the intracellular metabolism of externally added deuterium-labeled S1P to ceramide was reduced to 17% compared with the WT cells, indicating that most extracellular S1P is dephosphorylated by PLPPs and then taken up into cells. However, this result also reveals the existence of a PLPP-independent S1P uptake pathway. Tracer experiments using [P-32]S1P showed the existence of a direct S1P uptake pathway that functions without prior dephosphorylation. Overexpression of sphingolipid transporter 2 (SPNS2) or of major facilitator superfamily domain containing 2B (MFSD2B), both known S1P efflux transporters, in TKO cells increased the direct uptake of S1P, whereas KO of MFSD2B in TKO cells reduced this uptake. These results suggest that these are channel-type transporters and capable of not only exporting but also importing S1P. Furthermore, we observed that erythroid cells expressing MFSD2B, exhibited high S1P uptake activity. Our findings describing direct S1P uptake may contribute to the elucidation of the molecular mechanisms that regulate plasma S1P concentration.	[Goto, Hirotaka; Miyamoto, Masatoshi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.	kihara@pharm.hokudai.ac.jp	; KIHARA, AKIO/A-3802-2012	Miyamoto, Masatoshi/0000-0002-7785-7438; KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science KAKENHI [JP18H03976]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grant number JP18H03976 (to A. K.).	Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Caligan TB, 2000, ANAL BIOCHEM, V281, P36, DOI 10.1006/abio.2000.4555; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hla T, 2005, SCIENCE, V309, P1682, DOI 10.1126/science.1118340; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jojima K, 2020, FASEB J, V34, P3318, DOI 10.1096/fj.201902645R; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kobayashi N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23300-x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25469; Obinata H, 2019, J LIPID RES, V60, P1912, DOI 10.1194/jlr.RA119000277; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rees SE, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.011; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P1345, DOI 10.1515/bchm2.1967.348.1.1345; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tukijan F, 2018, BRIT J PHARMACOL, V175, P3741, DOI 10.1111/bph.14451; Vance DE, 2008, N COMP BIOC, P1; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vu TM, 2017, NATURE, V550, P524, DOI 10.1038/nature24053; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Yamanaka M, 2008, BIOCHEM BIOPH RES CO, V375, P675, DOI 10.1016/j.bbrc.2008.07.165; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	52	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100605	10.1016/j.jbc.2021.100605	http://dx.doi.org/10.1016/j.jbc.2021.100605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785361	Green Published, gold			2022-12-26	WOS:000672866400577
J	Brier, S; Rasetti-Escargueil, C; Wijkhuisen, A; Simon, S; Marechal, M; Lemichez, E; Popoff, MR				Brier, Sebastien; Rasetti-Escargueil, Christine; Wijkhuisen, Anne; Simon, Stephanie; Marechal, Maud; Lemichez, Emmanuel; Popoff, Michel R.			Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A	FASEB JOURNAL			English	Article						botulinum neurotoxin; botulism; epitope mapping; GT1b; mass spectrometry; Hydrogen-Deuterium eXchange; monoclonal antibody; synaptic vesicle protein 2	CD8(+) T-CELLS; TRANSCRIPTION FACTOR; CUTTING EDGE; REVEALS TOX; FACTOR-I; MEMORY; TCF-1; EXPRESSION; CHECKPOINT; DIFFERENTIATION	Compared to conventional antisera strategies, monoclonal antibodies (mAbs) represent an alternative and safer way to treat botulism, a fatal flaccid paralysis due to botulinum neurotoxins (BoNTs). In addition, mAbs offer the advantage to be produced in a reproducible manner. We previously identified a unique and potent mouse mAb (TA12) targeting BoNT/A1 with high affinity and neutralizing activity. In this study, we characterized the molecular basis of TA12 neutralization by combining Hydrogen/Deuterium eXchange Mass Spectrometry (HDX-MS) with site-directed mutagenesis and functional studies. We found that TA12 recognizes a conformational epitope located at the interface between the H-CN and H-CC subdomains of the BoNT/A1 receptor-binding domain (H-C). The TA12-binding interface shares common structural features with the ciA-C2 VHH epitope and lies on the face opposite recognized by ciA-C2-and the CR1/CR2-neutralizing mAbs. The single substitution of N1006 was sufficient to affect TA12 binding to H-C confirming the position of the epitope. We further uncovered that the TA12 epitope overlaps with the BoNT/A1-binding site for both the neuronal cell surface receptor synaptic vesicle glycoprotein 2 isoform C (SV2C) and the GT1b ganglioside. Hence, TA12 potently blocks the entry of BoNT/A1 into neurons by interfering simultaneously with the binding of SV2C and to a lower extent GT1b. Our study reveals the unique neutralization mechanism of TA12 and emphasizes on the potential of using single mAbs for the treatment of botulism type A.	[Brier, Sebastien] Inst Pasteur, CNRS, UMR3528, Biol NMR Technol Platform, Paris, France; [Rasetti-Escargueil, Christine; Marechal, Maud; Lemichez, Emmanuel; Popoff, Michel R.] Inst Pasteur, UMR CNRS 2001, Unite Toxines Bacteriennes, Paris, France; [Wijkhuisen, Anne; Simon, Stephanie] Univ Paris Saclay, CEA, INRAE, Dept Medicaments & Technol Sante, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Popoff, MR (corresponding author), Inst Pasteur, Toxines Bacteriennes, UMR CNRS 2001, F-75015 Paris, France.	popoff2m@gmail.com	Simon, Stephanie/E-4289-2012; lemichez, emmanuel/G-3559-2013; Popoff, Michel/O-7719-2016	Simon, Stephanie/0000-0002-6071-8255; lemichez, emmanuel/0000-0001-9080-7761; Brier, Sebastien/0000-0003-1758-8237; Popoff, Michel/0000-0001-9305-8989	CACSICE Equipex [ANR-11-EQPX-0008]; French joint ministerial program against CBRNE	CACSICE Equipex; French joint ministerial program against CBRNE	CACSICE Equipex, Grant/Award Number: ANR--11--EQPX--0008; French joint ministerial program against CBRNE	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Batra SA, 2020, CANCER IMMUNOL RES, V8, P309, DOI 10.1158/2326-6066.CIR-19-0293; Beavis PA, 2017, J CLIN INVEST, V127, P929, DOI 10.1172/JCI89455; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Cai HM, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091051; Chang YM, 2020, J VIROL, V94, DOI 10.1128/JVI.00935-20; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Chu T, 2020, IMMUNITY, V52, P724, DOI 10.1016/j.immuni.2020.04.019; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Delpoux A, 2018, J EXP MED, V215, P575, DOI 10.1084/jem.20170697; Delpoux A, 2017, P NATL ACAD SCI USA, V114, pE8865, DOI 10.1073/pnas.1618916114; Donnarumma T, 2016, CELL REP, V17, P1571, DOI 10.1016/j.celrep.2016.10.013; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Garcia-Perez L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw7313; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Gentzler R, 2016, IMMUNOTHERAPY-UK, V8, P583, DOI 10.2217/imt-2015-0029; Giuffrida L, 2020, MOL THER, V28, P2379, DOI 10.1016/j.ymthe.2020.07.018; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guan Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00586; Harly C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00470; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim K, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00722-9; Kratchmarov R, 2018, BLOOD ADV, V2, P1685, DOI 10.1182/bloodadvances.2018016279; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liu ZY, 2019, J IMMUNOL, V203, P323, DOI 10.4049/jimmunol.1900014; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Maier E, 2011, J BIOL CHEM, V286, P919, DOI 10.1074/jbc.M110.144949; Marcel N, 2020, CURR OPIN IMMUNOL, V63, P51, DOI 10.1016/j.coi.2020.02.001; Martinez M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00128; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miron M, 2018, J IMMUNOL, V201, P2132, DOI 10.4049/jimmunol.1800716; Newick K, 2017, ANNU REV MED, V68, P139, DOI 10.1146/annurev-med-062315-120245; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Ouyang KF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5814; Paley MA, 2013, J LEUKOCYTE BIOL, V93, P307, DOI 10.1189/jlb.0812400; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pilipow K, 2020, METHOD ENZYMOL, V631, P137, DOI 10.1016/bs.mie.2019.08.016; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sekine T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba7918; Shan Q, 2021, CELL MOL IMMUNOL, V18, P1262, DOI 10.1038/s41423-020-0436-5; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simsek M, 2019, EURASIAN J MED, V51, P90, DOI 10.5152/eurasianjmed.2018.18194; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2018, CELL REP, V22, P3454, DOI 10.1016/j.celrep.2018.03.020; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang F, 2021, CELL MOL IMMUNOL, V18, P644, DOI 10.1038/s41423-020-00527-1; Wang YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00169; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welten SPM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16219-3; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yang J, 2020, J CELL PHYSIOL, V235, P3894, DOI 10.1002/jcp.29283; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang J, 2018, J IMMUNOL, V200, P3397, DOI 10.4049/jimmunol.1800193; Zhang LP, 2019, EBIOMEDICINE, V44, P275, DOI 10.1016/j.ebiom.2019.03.076; Zhang XP, 2013, J CLIN ENDOCR METAB, V98, pE1305, DOI 10.1210/jc.2012-3602; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhao MZ, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008555; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	111	3	3	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21540	10.1096/fj.202002492R	http://dx.doi.org/10.1096/fj.202002492R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817838	Green Submitted			2022-12-26	WOS:000645260100084
J	Kaneva, MK; Muley, MM; Krustev, E; Reid, AR; Souza, PR; Dell'Accio, F; McDougall, JJ; Perretti, M				Kaneva, Magdalena K.; Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; Souza, Patricia R.; Dell'Accio, Francesco; McDougall, Jason J.; Perretti, Mauro			Alpha-1-antitrypsin reduces inflammation and exerts chondroprotection in arthritis	FASEB JOURNAL			English	Article						alpha-1-antitrypsin; arthritis; cartilage; chondrocyte; SERPINA1; tissue protection	WNT SIGNALING PATHWAY; NEUTROPHIL ELASTASE; ARTICULAR-CARTILAGE; PROTEINASE-INHIBITORS; GENE-EXPRESSION; ACTIVATION; PAIN; OSTEOARTHRITIS; COMPLEXES; LEUKOCYTE	While new treatments have been developed to control joint disease in rheumatoid arthritis, they are partially effective and do not promote structural repair of cartilage. Following an initial identification of alpha-1-Antitrypsin (AAT) during the resolution phase of acute inflammation, we report here the properties of this protein in the context of cartilage protection, joint inflammation, and associated pain behavior. Intra-articular and systemic administration of AAT reversed joint inflammation, nociception, and cartilage degradation in the KBxN serum and neutrophil elastase models of arthritis. Ex vivo analyses of arthritic joints revealed that AAT promoted transcription of col2a1, acan, and sox9 and downregulated mmp13 and adamts5 gene expression. In vitro studies using human chondrocytes revealed that SERPINA1 transfection and rAAT protein promoted chondrogenic differentiation through activation of PKA-dependent CREB signaling and inhibition of Wnt/beta-catenin pathways. Thus, AAT is endowed with anti-inflammatory, analgesic, and chondroprotective properties that are partially inter-related. We propose that AAT could be developed for new therapeutic strategies to reduce arthritic pain and repair damaged cartilage.	[Kaneva, Magdalena K.; Souza, Patricia R.; Dell'Accio, Francesco; Perretti, Mauro] Queen Mary Univ London, London Sch Med, William Harvey Res Inst, London, England; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Pain Management, Halifax, NS, Canada; [Muley, Milind M.; Krustev, Eugene; Reid, Allison R.; McDougall, Jason J.] Dalhousie Univ, Dept Perioperat Med, Halifax, NS, Canada; [Dell'Accio, Francesco; Perretti, Mauro] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Muley, Milind M.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning PGCRL, Neurosci & Mental Hlth, Toronto, ON, Canada	University of London; Queen Mary University London; Dalhousie University; Dalhousie University; Dalhousie University; University of London; Queen Mary University London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kaneva, MK (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	kaneva.magdalena@gmail.com	Souza, Patricia/GLQ-8979-2022	Souza, Patricia/0000-0003-3826-6261; Kaneva, Magdalena K/0000-0003-3822-749X; Muley, Milind/0000-0002-8138-9964; Perretti, Mauro/0000-0003-2068-3331	William Harvey Research Foundation; Canadian Institute for Health Research; MRC [MR/R000956/1]; CIHR team grant [PJT-153303]	William Harvey Research Foundation; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CIHR team grant(Canadian Institutes of Health Research (CIHR))	This work was largely supported by the William Harvey Research Foundation through an unrestricted grant (MKK and MP), with additional support by operating grants from the Canadian Institute for Health Research and a CIHR team grant (PJT--153303; REACH; JJMcD) and the MRC (MR/R000956/1, FDA).	Aldonyte R, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-11; Andruski B, 2008, AM J PHYSIOL-REG I, V295, pR814, DOI 10.1152/ajpregu.90524.2008; Bergin DA, 2012, ARCH IMMUNOL THER EX, V60, P81, DOI 10.1007/s00005-012-0162-5; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Carroll TP, 2010, J IMMUNOL, V184, P4538, DOI 10.4049/jimmunol.0802864; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cichy J, 1997, J BIOL CHEM, V272, P8250, DOI 10.1074/jbc.272.13.8250; Potilinski MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228895; Deshmukh V, 2019, OSTEOARTHR CARTILAGE, V27, P1347, DOI 10.1016/j.joca.2019.05.006; Deshmukh V, 2018, OSTEOARTHR CARTILAGE, V26, P18, DOI 10.1016/j.joca.2017.08.015; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DUBOIS RM, 1991, BLOOD, V77, P2724; Eldridge SE, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax9086; Gao WX, 2014, J HEART LUNG TRANSPL, V33, P309, DOI 10.1016/j.healun.2013.10.031; Gold M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0165-8; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Greco KV, 2014, BIOCHEM PHARMACOL, V91, P348, DOI 10.1016/j.bcp.2014.07.034; Grimstein C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-21; Grimstein C, 2010, J GENE MED, V12, P35, DOI 10.1002/jgm.1409; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; JAMES HL, 1978, J CLIN INVEST, V62, P1344, DOI 10.1172/JCI109255; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Janciauskiene SM, 2007, NEW TRICKS J BIOL CH, V282, P8573; Joosten LAB, 2016, ANN RHEUM DIS, V75, P1219, DOI 10.1136/annrheumdis-2014-206966; Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kaneva MK, 2017, J IMMUNOL, V198, P2876, DOI 10.4049/jimmunol.1601111; Kaneva MK, 2012, BRIT J PHARMACOL, V167, P67, DOI 10.1111/j.1476-5381.2012.01968.x; Kim KH, 2009, ANIM CELLS SYST, V13, P289, DOI 10.1080/19768354.2009.9647221; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Krustev E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0437-9; Landman EBM., 2013, ARTHRITIS RES THER, V15, P1; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McBride JD, 2014, J INVEST DERMATOL, V134, P1725, DOI 10.1038/jid.2014.40; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Momohara S, 1997, CLIN RHEUMATOL, V16, P133, DOI 10.1007/BF02247841; Monteagudo S, 2017, NAT REV RHEUMATOL, V13, P670, DOI 10.1038/nrrheum.2017.171; Moore AR, 1999, ANN RHEUM DIS, V58, P109, DOI 10.1136/ard.58.2.109; Muley MM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0944-0; Muley MM, 2016, BRIT J PHARMACOL, V173, P766, DOI 10.1111/bph.13237; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Philpott HT, 2017, PAIN, V158, P2442, DOI 10.1097/j.pain.0000000000001052; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Rabelo FD, 2010, AUTOIMMUN REV, V9, P207, DOI 10.1016/j.autrev.2009.08.003; Salgado E, 2014, MED CLIN-BARCELONA, V143, P461, DOI 10.1016/j.medcli.2013.11.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; TRAVIS J, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P313; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; WATANABE H, 1990, J BIOCHEM-TOKYO, V108, P753, DOI 10.1093/oxfordjournals.jbchem.a123277; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yazici Y, 2017, OSTEOARTHR CARTILAGE, V25, P1598, DOI 10.1016/j.joca.2017.07.006; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107	69	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21472	10.1096/fj.202001801R	http://dx.doi.org/10.1096/fj.202001801R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788977				2022-12-26	WOS:000645260100014
J	Sopariwala, DH; Likhite, N; Pei, GS; Haroon, F; Lin, LS; Yadav, V; Zhao, ZM; Narkar, VA				Sopariwala, Danesh H.; Likhite, Neah; Pei, Gungsheng; Haroon, Fnu; Lin, Lisa; Yadav, Vikas; Zhao, Zhongming; Narkar, Vihang A.			Estrogen-related receptor a is involved in angiogenesis and skeletal muscle revascularization in hindlimb ischemia	FASEB JOURNAL			English	Article						angiogenesis; gene expression; ischemia; nuclear receptors; skeletal muscle	ENDOTHELIAL GROWTH-FACTOR; PROLIFERATOR-ACTIVATED RECEPTOR; ERR-ALPHA; PROMOTES ANGIOGENESIS; LIPID-ACCUMULATION; KEY REGULATOR; FIBER-TYPE; EXPRESSION; EXERCISE; METABOLISM	Skeletal muscle ischemia is a major consequence of peripheral arterial disease (PAD) or critical limb ischemia (CLI). Although therapeutic options for resolving muscle ischemia in PAD/CLI are limited, the issue is compounded by poor understanding of the mechanisms driving muscle vascularization. We found that nuclear receptor estrogen-related receptor alpha (ERR alpha) expression is induced in murine skeletal muscle by hindlimb ischemia (HLI), and in cultured myotubes by hypoxia, suggesting a potential role for ERR alpha in ischemic response. To test this, we generated skeletal muscle-specific ERR alpha transgenic (TG) mice. In these mice, ERR alpha drives myofiber type switch from glycolytic type IIB to oxidative type IIA/IIX myofibers, which are typically associated with more vascular supply in muscle. Indeed, RNA sequencing and functional enrichment analysis of TG muscle revealed that "paracrine angiogenesis" is the top-ranked transcriptional program activated by ERR alpha in the skeletal muscle. Immunohistochemistry and angiography showed that ERR alpha overexpression increases baseline capillarity, arterioles and non-leaky blood vessel formation in the skeletal muscles. Moreover, ERR alpha overexpression facilitates ischemic neo-angiogenesis and perfusion recovery in hindlimb musculature of mice subjected to HLI. Therefore, ERR alpha is a hypoxia inducible nuclear receptor that is involved in skeletal muscle angiogenesis and could be potentially targeted for treating PAD/CLI.	[Sopariwala, Danesh H.; Likhite, Neah; Haroon, Fnu; Lin, Lisa; Yadav, Vikas; Narkar, Vihang A.] UTHlth, McGovern Med Sch, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Pei, Gungsheng; Zhao, Zhongming] UTHlth, Sch Biomed Informat, Ctr Precis Med, Houston, TX 77030 USA; [Lin, Lisa] Rice Univ, Biochem & Cell Biol, Houston, TX USA; [Zhao, Zhongming] UTHlth, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Narkar, Vihang A.] UTHlth, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Yadav, Vikas] Jawaharlal Nehru Univ, Life Sci, New Delhi, India	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Rice University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Jawaharlal Nehru University, New Delhi	Narkar, VA (corresponding author), UTHlth, McGovern Med Sch, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	vihang.a.narkar@uth.tmc.edu		Pei, Guangsheng/0000-0003-1804-7598; yadav, vikas/0000-0001-5445-3775	NIH [1R01HL129191, R01LM012806]; Bayer Pharmaceuticals [0014079]; American Heart Association [20TPA35410038, 19POST34380771]; Hamman Foundation Endowment in Cardiovascular Research; Ramalingaswami Department of Biotechnology, Government of India Fellowship [BT/RLF/Re-entry/29/2014]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180734]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Pharmaceuticals(Bayer AG); American Heart Association(American Heart Association); Hamman Foundation Endowment in Cardiovascular Research; Ramalingaswami Department of Biotechnology, Government of India Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT)	This research was supported by funding to V.A.N from NIH (#1R01HL129191), Bayer Pharmaceuticals (#0014079), American Heart Association (20TPA35410038) and Hamman Foundation Endowment in Cardiovascular Research. D.H.S. was supported by a post--doctoral fellowship from American Heart Association (#19POST34380771). V.Y. was supported by Ramalingaswami Department of Biotechnology, Government of India Fellowship (#BT/RLF/Re--entry/29/2014). Z.Z. is supported by NIH grant #R01LM012806. RNA sequencing and data analysis work was performed through the UTHealth Cancer Genomics Core funded by Cancer Prevention and Research Institute of Texas (CPRIT) core grant (#RP180734). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amoasii L, 2019, P NATL ACAD SCI USA, V116, P11299, DOI 10.1073/pnas.1902490116; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Ashoff A, 2012, J VASC RES, V49, P260, DOI 10.1159/000335214; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bonaca MP, 2015, CIRC RES, V116, P1579, DOI 10.1161/CIRCRESAHA.114.303505; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cooke JP, 2015, CIRC RES, V116, P1561, DOI 10.1161/CIRCRESAHA.115.303565; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hiatt WR, 2015, CIRC RES, V116, P1527, DOI 10.1161/CIRCRESAHA.116.303566; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Jude EB, 2010, DIABETIC MED, V27, P4, DOI 10.1111/j.1464-5491.2009.02866.x; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Khazaei M, 2012, J DIABETES COMPLICAT, V26, P137, DOI 10.1016/j.jdiacomp.2012.02.005; Kim SY, 2018, AUTOPHAGY, V14, P152, DOI 10.1080/15548627.2017.1339001; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kupr B, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029835; LaBarge S, 2014, FASEB J, V28, P1082, DOI 10.1096/fj.13-229211; Li P, 2010, AM J PHYSIOL-ENDOC M, V299, pE560, DOI 10.1152/ajpendo.00284.2010; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Likhite N, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00411-18; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; Matsakas A, 2010, CURR SPORT MED REP, V9, P227, DOI 10.1249/JSR.0b013e3181e93938; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Nagahama R, 2012, ARTERIOSCL THROM VAS, V32, P2427, DOI 10.1161/ATVBAHA.112.253823; Nagai H, 1987, Josanpu Zasshi, V41, P602; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12; Perry MC, 2014, MOL ENDOCRINOL, V28, P2060, DOI 10.1210/me.2014-1281; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salehi E, 2012, GEN PHYSIOL BIOPHYS, V31, P255, DOI 10.4149/gpb_2012_033; Sass FA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030835; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yadav V, 2014, CELL REP, V8, P783, DOI 10.1016/j.celrep.2014.06.040; Yang QB, 2018, ANGIOGENESIS, V21, P313, DOI 10.1007/s10456-018-9597-6; Yoshida S, 2013, CIRCULATION, V128, P60, DOI 10.1161/CIRCULATIONAHA.113.001533; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003	75	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21480	10.1096/fj.202001794RR	http://dx.doi.org/10.1096/fj.202001794RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788962				2022-12-26	WOS:000645260100007
J	Spiroski, AM; Niu, YG; Nicholas, LM; Austin-Williams, S; Camm, EJ; Sutherland, MR; Ashmore, TJ; Skeffington, KL; Logan, A; Ozanne, SE; Murphy, MP; Giussani, DA				Spiroski, Ana-Mishel; Niu, Youguo; Nicholas, Lisa M.; Austin-Williams, Shani; Camm, Emily J.; Sutherland, Megan R.; Ashmore, Thomas J.; Skeffington, Katie. L.; Logan, Angela; Ozanne, Susan E.; Murphy, Michael P.; Giussani, Dino A.			Mitochondria antioxidant protection against cardiovascular dysfunction programmed by early-onset gestational hypoxia	FASEB JOURNAL			English	Article						cardiovascular; fetus; hypoxia; IUGR; mitochondria; oxidative stress; programming	INTRAUTERINE GROWTH RESTRICTION; PRENATAL HYPOXIA; OXIDATIVE STRESS; MATERNAL HYPOXIA; ACUTE HYPOXEMIA; NITRIC-OXIDE; BLOOD-FLOW; FETAL; RAT; DEFENSE	Mitochondria-derived oxidative stress during fetal development increases cardiovascular risk in adult offspring of pregnancies complicated by chronic fetal hypoxia. We investigated the efficacy of the mitochondria-targeted antioxidant MitoQ in preventing cardiovascular dysfunction in adult rat offspring exposed to gestational hypoxia, integrating functional experiments in vivo, with those at the isolated organ and molecular levels. Rats were randomized to normoxic or hypoxic (13%-14% O2) pregnancy +/- MitoQ (500 mu M day(-1)) in the maternal drinking water. At 4 months of age, one cohort of male offspring was chronically instrumented with vascular catheters and flow probes to test in vivo cardiovascular function. In a second cohort, the heart was isolated and mounted onto a Langendorff preparation. To establish mechanisms linking gestational hypoxia with cardiovascular dysfunction and protection by MitoQ, we quantified the expression of antioxidant system, beta-adrenergic signaling, and calcium handling genes in the fetus and adult, in frozen tissues from a third cohort. Maternal MitoQ in hypoxic pregnancy protected offspring against increased alpha(1)-adrenergic reactivity of the cardiovascular system, enhanced reactive hyperemia in peripheral vascular beds, and sympathetic dominance, hypercontractility and diastolic dysfunction in the heart. Inhibition of Nfe2l2-mediated oxidative stress in the fetal heart and preservation of calcium regulatory responses in the hearts of fetal and adult offspring link molecular mechanisms to the protective actions of MitoQ treatment of hypoxic pregnancy. Therefore, these data show the efficacy of MitoQ in buffering mitochondrial stress through NADPH-induced oxidative damage and the prevention of programmed cardiovascular disease in adult offspring of hypoxic pregnancy.	[Spiroski, Ana-Mishel; Niu, Youguo; Austin-Williams, Shani; Camm, Emily J.; Sutherland, Megan R.; Ashmore, Thomas J.; Skeffington, Katie. L.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Spiroski, Ana-Mishel; Niu, Youguo; Ozanne, Susan E.; Giussani, Dino A.] Cambridge Cardiovasc Strateg Res Initiat, Cambridge, England; [Nicholas, Lisa M.; Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge, England; [Logan, Angela; Murphy, Michael P.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England; [Ozanne, Susan E.; Giussani, Dino A.] Strateg Res Initiat Reprod, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Dept Med, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	dag26@cam.ac.uk		Spiroski, Ana-Mishel/0000-0002-8584-8048; Austin-Williams, Shani/0000-0002-8255-583X	British Heart Foundation [PG/14/5/30547, RG/17/12/33167]; Medical Research Council UK [MC_U105663142, MC_UU_00014/4]; Wellcome Trust [110159/A/15/Z]	British Heart Foundation(British Heart Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to the staff of the University of Cambridge Combined Animal Facility. This work was supported by the British Heart Foundation (Giussani lab: PG/14/5/30547). Work in the Murphy lab is supported by the Medical Research Council UK (MC_U105663142) and by a Wellcome Trust Investigator award (110159/A/15/Z). MPM consults for MitoQ Inc Work in the Ozanne lab is supported by the Medical Research Council UK (MC_UU_00014/4) and the British Heart Foundation (RG/17/12/33167).	Aljunaidy MM, 2018, PHARMACOL RES, V134, P332, DOI 10.1016/j.phrs.2018.05.006; Allison BJ, 2016, J PHYSIOL-LONDON, V594, P1247, DOI 10.1113/JP271091; Bansal A, 2020, J DEV ORIG HLTH DIS, P1; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Beeson JH, 2018, MOL METAB, V16, P35, DOI 10.1016/j.molmet.2018.06.009; Bertagnolli M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0637-6; Botting KJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1929; Brain KL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006552; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Coney AM, 2010, J PHYSIOL-LONDON, V588, P5115, DOI 10.1113/jphysiol.2010.198275; Danielson L, 2005, J PHYSIOL-LONDON, V563, P611, DOI 10.1113/jphysiol.2004.080523; Darby JRT, 2021, J PHYSIOL-LONDON, V599, P1307, DOI 10.1113/JP280693; Darby JRT, 2020, THERIOGENOLOGY, V150, P84, DOI 10.1016/j.theriogenology.2020.01.080; Donovan EL, 2017, REPROD SCI, V24, P865, DOI 10.1177/1933719116670516; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; Fortner KA, 2020, LUPUS SCI MED, V7; Fowden AL, 2021, CURR VASC PHARMACOL, V19, P113, DOI 10.2174/1570161118666200513115316; FUJII J, 1991, J BIOL CHEM, V266, P11669; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Ganguly E, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104836; Ganguly E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00562; Gardner DS, 2002, J PHYSIOL-LONDON, V540, P351, DOI 10.1113/jphysiol.2001.013434; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 1999, J PHYSIOL-LONDON, V515, P233, DOI 10.1111/j.1469-7793.1999.233ad.x; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez-Candia A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101128; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heimlich JB, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12052; Herrera EA, 2017, J PHYSIOL-LONDON, V595, P1077, DOI 10.1113/JP273396; Hovnanian A., 2007, V45, P337; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Kane AD, 2013, CIRC J, V77, P2604, DOI 10.1253/circj.CJ-13-0311; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kumar P, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14327; Leo F, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113893; Lindgren I, 2013, AM J PHYSIOL-REG I, V305, pR1093, DOI 10.1152/ajpregu.00320.2013; Mortensen SP, 2012, J PHYSIOL-LONDON, V590, P4391, DOI 10.1113/jphysiol.2012.235952; Niu YG, 2018, HYPERTENSION, V72, P971, DOI 10.1161/HYPERTENSIONAHA.118.11363; Niu YG, 2013, J PHYSIOL-LONDON, V591, P5083, DOI 10.1113/jphysiol.2013.258210; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; OTSU K, 1990, J BIOL CHEM, V265, P13472; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Pinho BR, 2020, FREE RADICAL BIO MED, V146, P372, DOI 10.1016/j.freeradbiomed.2019.11.021; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Rook W, 2014, HYPERTENSION, V64, P1321, DOI 10.1161/HYPERTENSIONAHA.114.04374; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Ruijtenbeek K, 2003, PFLUG ARCH EUR J PHY, V447, P158, DOI 10.1007/s00424-003-1170-4; Ruijtenbeek K, 2000, CIRCULATION, V102, P2892; Ryoo IG, 2018, TOXICOL APPL PHARM, V359, P24, DOI 10.1016/j.taap.2018.09.014; Shah A, 2016, J PHYSIOL-LONDON, V594, P1465, DOI 10.1113/JP271133; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Skeffington KL, 2020, HYPERTENSION, V76, P533, DOI 10.1161/HYPERTENSIONAHA.120.15045; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Spiroski AM, 2018, J PHYSIOL-LONDON, V596, P5925, DOI 10.1113/JP274999; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; Tymko MM, 2020, CIRC RES, V127, pE1, DOI 10.1161/CIRCRESAHA.119.316053; Van Buren T, 1998, CARDIOVASC RES, V38, P763, DOI 10.1016/S0008-6363(98)00038-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh MP, 2006, J PHYSIOL-LONDON, V575, P263, DOI 10.1113/jphysiol.2006.108753; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004	76	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21446	10.1096/fj.202002705R	http://dx.doi.org/10.1096/fj.202002705R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788974	Green Published, Green Accepted			2022-12-26	WOS:000645260100062
J	Saeki, C; Saito, M; Kanai, T; Nakano, M; Oikawa, T; Torisu, Y; Saruta, M; Tsubota, A				Saeki, Chisato; Saito, Mitsuru; Kanai, Tomoya; Nakano, Masanori; Oikawa, Tsunekazu; Torisu, Yuichi; Saruta, Masayuki; Tsubota, Akihito			Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; SERUM PENTOSIDINE; OSTEOPOROSIS; RISK; HEALTH	Aim Osteoporotic fractures negatively impact health-related quality of life and prognosis. Advanced glycation end products (AGEs) impair bone quality and reduce bone strength. The aim of this study was to determine the relationship between plasma levels of pentosidine, a surrogate marker for AGEs, and prevalent fractures in patients with chronic liver disease (CLD). Methods This cross-sectional study included 324 patients with CLD. Vertebral fractures were evaluated using lateral thoracolumbar spine radiographs. Information on prevalent fractures was obtained through a medical interview, medical records, and/or radiography. The patients were classified into low (L), intermediate (I), and high (H) pentosidine (Pen) groups based on baseline plasma pentosidine levels. Results Of the 324 patients, 105 (32.4%) had prevalent fractures. The prevalence of liver cirrhosis (LC) and prevalent fractures significantly increased stepwise with elevated pentosidine levels. The H-Pen group had the highest prevalence of LC (88.6%, p < 0.001) and prevalent fractures (44.3%, p = 0.007), whereas the L-Pen group had the lowest prevalence of LC (32.1%, p < 0.001) and prevalent fractures (21.0%, p = 0.007). Multiple logistic regression analysis identified pentosidine as a significant independent factor related to prevalent fractures (odds ratio = 1.069, p < 0.001). Pentosidine levels increased stepwise and correlated with liver disease severity. They were markedly high in patients with decompensated LC. In multiple regression analysis, liver functional reserve factors (total bilirubin, albumin, and prothrombin time-international normalized ratio) significantly and independently correlated with pentosidine levels. Conclusions Plasma pentosidine was significantly associated with prevalent fractures and liver functional reserve in patients with CLD. Pentosidine may be useful in predicting fracture risk and should be closely followed in CLD patients with advanced disease.	[Saeki, Chisato; Kanai, Tomoya; Nakano, Masanori; Oikawa, Tsunekazu; Torisu, Yuichi; Saruta, Masayuki] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan; [Saeki, Chisato; Kanai, Tomoya; Nakano, Masanori; Torisu, Yuichi] Fuji City Gen Hosp, Dept Internal Med, Div Gastroenterol, Fuji, Shizuoka, Japan; [Saito, Mitsuru] Jikei Univ, Dept Orthopaed Surg, Sch Med, Tokyo, Japan; [Tsubota, Akihito] Jikei Univ, Res Ctr Med Sci, Core Res Facil, Sch Med, Tokyo, Japan	Jikei University; Jikei University; Jikei University	Saeki, C (corresponding author), Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan.; Saeki, C (corresponding author), Fuji City Gen Hosp, Dept Internal Med, Div Gastroenterol, Fuji, Shizuoka, Japan.; Tsubota, A (corresponding author), Jikei Univ, Res Ctr Med Sci, Core Res Facil, Sch Med, Tokyo, Japan.	chisato@jikei.ac.jp; atsubo@jikei.ac.jp	Saruta, Masayuki/ABL-4991-2022	Saruta, Masayuki/0000-0001-8172-3240; Saeki, Chisato/0000-0002-7407-6142; TORISU, YUICHI/0000-0002-2349-8855				ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Child C G, 1964, Major Probl Clin Surg, V1, P1; European Assoc Study Liver, 2019, J HEPATOL, V70, P172, DOI 10.1016/j.jhep.2018.06.024; Guanabens N, 2018, LIVER INT, V38, P776, DOI 10.1111/liv.13730; Hein GE, 2005, RHEUMATOL INT, V26, P137, DOI 10.1007/s00296-004-0518-1; Hidalgo DF., 2020, META ANAL, V12, P10483, DOI [10.7759/cureus.10483, DOI 10.7759/CUREUS.10483]; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jeong HM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174270; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; Kitada T, 2001, J HEPATOL, V35, P613, DOI 10.1016/S0168-8278(01)00171-4; Liang J, 2018, CLIN ENDOCRINOL, V89, P408, DOI 10.1111/cen.13762; Lupoli R, 2016, CLIN ENDOCRINOL, V84, P30, DOI 10.1111/cen.12780; Mitome J, 2011, CALCIFIED TISSUE INT, V88, P521, DOI 10.1007/s00223-011-9488-y; Nakchbandi IA, 2014, WORLD J GASTROENTERO, V20, P9427, DOI 10.3748/wjg.v20.i28.9427; Neumann T, 2014, OSTEOPOROSIS INT, V25, P1527, DOI 10.1007/s00198-014-2631-7; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Oleksik AM, 2005, OSTEOPOROSIS INT, V16, P861, DOI 10.1007/s00198-004-1774-3; Patel A, 2019, J CLIN GASTROENTEROL, V53, P543, DOI 10.1097/MCG.0000000000001105; Piano S, 2017, LIVER INT, V37, P116, DOI 10.1111/liv.13305; Saeki C, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i33.4960; Saeki C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082381; Saeki C, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2983-4; Saito M, 2011, OSTEOPOROSIS INT, V22, P2373, DOI 10.1007/s00198-010-1454-4; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saito M, 2015, CALCIFIED TISSUE INT, V97, P242, DOI 10.1007/s00223-015-9985-5; Sanaka T, 2002, NEPHRON, V91, P64, DOI 10.1159/000057606; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Shiraki M, 2019, J BONE MINER METAB, V37, P1067, DOI 10.1007/s00774-019-01017-9; Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469; Svedbom A, 2018, OSTEOPOROSIS INT, V29, P557, DOI 10.1007/s00198-017-4317-4; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; WU CY, 1995, OSTEOPOROSIS INT, V5, P354, DOI 10.1007/BF01622258; Yamamoto M, 2008, J CLIN ENDOCR METAB, V93, P1013, DOI 10.1210/jc.2007-1270; Yamamoto M, 2016, CURR OSTEOPOROS REP, V14, P320, DOI 10.1007/s11914-016-0332-1; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249728	10.1371/journal.pone.0249728	http://dx.doi.org/10.1371/journal.pone.0249728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798236	Green Published, gold			2022-12-26	WOS:000636737700005
J	Levy, H; Levy, M				Levy, Haim; Levy, Moshe			Prospect theory, constant relative risk aversion, and the investment horizon	PLOS ONE			English	Article							MYOPIC LOSS AVERSION; EXPERIMENTAL TESTS; PORTFOLIO CHOICE; EQUITY PREMIUM; UTILITY; MODEL; RATIONALITY; ELICITATION; DECISIONS; LOSSES	Prospect Theory (PT) and Constant-Relative-Risk-Aversion (CRRA) preferences have clear-cut and very different implications for the optimal asset allocation between a riskless asset and a risky stock as a function of the investment horizon. While CRRA implies that the optimal allocation is independent of the horizon, we show that PT implies a dramatic and discontinuous "jump" in the optimal allocation as the horizon increases. We experimentally test these predictions at the individual level. We find rather strong support for CRRA, but very little support for PT.	[Levy, Haim; Levy, Moshe] Hebrew Univ Jerusalem, Jerusalem, Israel	Hebrew University of Jerusalem	Levy, M (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	mslm@huji.ac.il		Levy, Moshe/0000-0002-2570-6128				Abdellaoui M, 2000, MANAGE SCI, V46, P1497, DOI 10.1287/mnsc.46.11.1497.12080; Abdellaoui M, 2005, MANAGE SCI, V51, P1384, DOI 10.1287/mnsc.1050.0388; Arrow K.J., 1971, ESSAYS THEORY RISK B; Bali TG, 2009, J MONETARY ECON, V56, P817, DOI 10.1016/j.jmoneco.2009.06.015; Barron G, 2003, J BEHAV DECIS MAKING, V16, P215, DOI 10.1002/bdm.443; Benartzi S, 1999, MANAGE SCI, V45, P364, DOI 10.1287/mnsc.45.3.364; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Berkelaar AB, 2004, REV ECON STAT, V86, P973, DOI 10.1162/0034653043125167; Bilgin B, 2012, ORGAN BEHAV HUM DEC, V118, P203, DOI 10.1016/j.obhdp.2012.03.008; Blackburn DW, 2013, MANAGE SCI, V59, P470, DOI 10.1287/mnsc.1120.1608; Brown A.L., 2021, CESIFO WORKING PAPER, DOI [10.2139/ssrn.3772089, DOI 10.2139/SSRN.3772089]; Bruhin A, 2010, ECONOMETRICA, V78, P1375, DOI 10.3982/ECTA7139; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Diecidue E, 2015, J RISK UNCERTAINTY, V51, P245, DOI 10.1007/s11166-015-9229-0; Eisenbach TM, 2016, J FINANC ECON, V121, P414, DOI 10.1016/j.jfineco.2015.10.002; Fellner G, 2009, ECON J, V119, P900, DOI 10.1111/j.1468-0297.2009.02251.x; Fraser-Mackenzie P, 2015, ORGAN BEHAV HUM DEC, V131, P67, DOI 10.1016/j.obhdp.2015.08.004; FRIEND I, 1975, AM ECON REV, V65, P900; Gneezy U, 2003, J FINANC, V58, P821, DOI 10.1111/1540-6261.00547; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Gomes FJ, 2005, J BUS, V78, P675, DOI 10.1086/427643; GORDON MJ, 1972, AM ECON REV, V62, P107; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kirman A.P., 2012, INTERACTION MARKET S, V484; KIRMAN AP, 1992, J ECON PERSPECT, V6, P117, DOI 10.1257/jep.6.2.117; Klos A, 2005, MANAGE SCI, V51, P1777, DOI 10.1287/mnsc.1050.0429; Koszegi B, 2006, Q J ECON, V121, P1133, DOI 10.1093/qje/121.4.1133; KROLL Y, 1988, ORGAN BEHAV HUM DEC, V42, P388, DOI 10.1016/0749-5978(88)90007-6; Langer T, 2008, J ECON BEHAV ORGAN, V67, P810, DOI 10.1016/j.jebo.2006.05.019; Levy H, 2004, REV FINANC STUD, V17, P1015, DOI 10.1093/rfs/hhg062; Levy H, 2006, STUD RISK UNCERTAIN, V12, P1, DOI 10.1007/0-387-29311-6; LEVY H, 1994, J RISK UNCERTAINTY, V8, P289, DOI 10.1007/BF01064046; Levy H, 2012, EUR FINANC MANAG, V18, P163, DOI 10.1111/j.1468-036X.2011.00617.x; LEVY M, 1994, ECON LETT, V45, P103, DOI 10.1016/0165-1765(94)90065-5; Levy M, 2010, QUANT FINANC, V10, P1009, DOI 10.1080/14697680903059416; Levy M, 2002, MANAGE SCI, V48, P1334, DOI 10.1287/mnsc.48.10.1334.276; LUCAS RE, 1976, CARN ROCH CONF SERIE, V1, P19, DOI 10.1016/S0167-2231(76)80003-6; MEHRA R, 1985, J MONETARY ECON, V15, P145, DOI 10.1016/0304-3932(85)90061-3; Mehra R., 2003, HDB EC FINANCE, V1B; Merton R. C., 1974, J FINANC ECON, V1, P67, DOI DOI 10.1016/0304-405X(74)90009-9; Merton R.C., 1992, CONTINUOUS TIME FINA; MOSSIN J, 1968, J BUS, V41, P215, DOI 10.1086/295078; Pennings JME, 2003, MANAGE SCI, V49, P1251, DOI 10.1287/mnsc.49.9.1251.16566; Polman E, 2012, ORGAN BEHAV HUM DEC, V119, P141, DOI 10.1016/j.obhdp.2012.06.005; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; SAMUELSON PA, 1969, REV ECON STAT, V51, P239, DOI 10.2307/1926559; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van Binsbergen J, 2012, AM ECON REV, V102, P1596, DOI 10.1257/aer.102.4.1596; Viceira L.M., 2002, CLARENDON LECT EC; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676	54	2	2	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248904	10.1371/journal.pone.0248904	http://dx.doi.org/10.1371/journal.pone.0248904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793619	gold, Green Published			2022-12-26	WOS:000636467000107
J	Mirzazadeh, A; Kahn, JG; Haddad, MB; Hill, AN; Marks, SM; Readhead, A; Barry, PM; Flood, J; Mermin, JH; Shete, PB				Mirzazadeh, Ali; Kahn, James G.; Haddad, Maryam B.; Hill, Andrew N.; Marks, Suzanne M.; Readhead, Adam; Barry, Pennan M.; Flood, Jennifer; Mermin, Jonathan H.; Shete, Priya B.			State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity	PLOS ONE			English	Article							BORN	Introduction Preventing tuberculosis (TB) disease requires treatment of latent TB infection (LTBI) as well as prevention of person-to-person transmission. We estimated the LTBI prevalence for the entire United States and for each state by medical risk factors, age, and race/ethnicity, both in the total population and stratified by nativity. Methods We created a mathematical model using all incident TB disease cases during 2013-2017 reported to the National Tuberculosis Surveillance System that were classified using genotype-based methods or imputation as not attributed to recent TB transmission. Using the annual average number of TB cases among US-born and non-US-born persons by medical risk factor, age group, and race/ethnicity, we applied population-specific reactivation rates (and corresponding 95% confidence intervals [CI]) to back-calculate the estimated prevalence of untreated LTBI in each population for the United States and for each of the 50 states and the District of Columbia in 2015. Results We estimated that 2.7% (CI: 2.6%-2.8%) of the U.S. population, or 8.6 (CI: 8.3-8.8) million people, were living with LTBI in 2015. Estimated LTBI prevalence among US-born persons was 1.0% (CI: 1.0%-1.1%) and among non-US-born persons was 13.9% (CI: 13.5%-14.3%). Among US-born persons, the highest LTBI prevalence was in persons aged >= 65 years (2.1%) and in persons of non-Hispanic Black race/ethnicity (3.1%). Among non-US-born persons, the highest LTBI prevalence was estimated in persons aged 45-64 years (16.3%) and persons of Asian and other racial/ethnic groups (19.1%). Conclusions Our estimations of the prevalence of LTBI by medical risk factors and demographic characteristics for each state could facilitate planning for testing and treatment interventions to eliminate TB in the United States. Our back-calculation method feasibly estimates untreated LTBI prevalence and can be updated using future TB disease case counts at the state or national level.	[Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Mirzazadeh, Ali; Kahn, James G.; Shete, Priya B.] Univ Calif San Francisco, Consortium Assess Prevent Econ, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Haddad, Maryam B.; Hill, Andrew N.; Marks, Suzanne M.] US Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Readhead, Adam; Barry, Pennan M.; Flood, Jennifer] Ctr Infect Dis, Div Communicable Dis Control, Calif Dept Publ Hlth, TB Control Branch, Richmond, CA USA; [Mermin, Jonathan H.] US Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Shete, Priya B.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Shete, Priya B.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; California Department of Public Health; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Global Hlth Sci, San Francisco, CA 94143 USA.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Consortium Assess Prevent Econ, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	ali.mirzazadeh@ucsf.edu		Marks, Suzanne/0000-0003-3024-1940; Haddad, Maryam/0000-0001-6327-068X; Mirzazadeh, Ali/0000-0002-0478-3220	U.S. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Epidemiologic and Economic Modeling Agreement (NEEMA) [U38PS004649]	U.S. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Epidemiologic and Economic Modeling Agreement (NEEMA)	This project is supported by U.S. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Epidemiologic and Economic Modeling Agreement (NEEMA) #U38PS004649. The findings and conclusions in this report are those of the authors and do not represent the official position of the CDC. Based on the CDC mandate to collect national infectious disease surveillance data, the funder was involved in targeted data collection for this study; however, authors had final say on which data to include in the analysis.	[Anonymous], 2020, BMC PUBLIC HEALTH, V20, P1; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Branch TC, 2017, CALIFORNIA TUBERCULO; CDC, DIVISION TUBERCULOSI; CDC, REPORTED TUBERCULOSI; CDC, 2020, NATL DIABETES STAT R; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Division of Tuberculosis Elimination, DIVISION TUBERCULOSI; France AM, 2015, AM J EPIDEMIOL, V182, P799, DOI 10.1093/aje/kwv121; Haddad MB, 2018, EMERG INFECT DIS, V24, P1930, DOI 10.3201/eid2410.180716; Jo Y, 2021, CLIN INFECT DIS, V73, pE3476, DOI 10.1093/cid/ciaa857; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; R Core Team, 2020, R LANG ENV STAT COMP; Schmit KM, 2017, MMWR-MORBID MORTAL W, V66, P289, DOI 10.15585/mmwr.mm6611a2; Schwartz NG, 2020, MMWR-MORBID MORTAL W, V69, P286, DOI 10.15585/mmwr.mm6911a3; Sharnprapai S, 2002, EMERG INFECT DIS, V8, P1239; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Tasillo A, 2017, JAMA INTERN MED, V177, P1755, DOI 10.1001/jamainternmed.2017.3941; van Buuren S, 2011, J STAT SOFTW, V45, P1; World Health Organization, 2018, LATENT TUBERCULOSIS; Yeats J., 2015, 3 ESSAYS; Yuen CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153728	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249012	10.1371/journal.pone.0249012	http://dx.doi.org/10.1371/journal.pone.0249012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793612	gold, Green Published			2022-12-26	WOS:000636467000015
J	Scalsky, RJ; Chen, YJ; Desai, K; O'Connell, JR; Perry, JA; Hong, CC				Scalsky, Ryan J.; Chen, Yi-Ju; Desai, Karan; O'Connell, Jeffery R.; Perry, James A.; Hong, Charles C.			Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank	PLOS ONE			English	Article								Background SARS-CoV-2 is a rapidly spreading coronavirus responsible for the Covid-19 pandemic, which is characterized by severe respiratory infection. Many factors have been identified as risk factors for SARS-CoV-2, with much early attention being paid to body mass index (BMI), which is a well-known cardiometabolic risk factor. Objective This study seeks to examine the impact of additional baseline cardiometabolic risk factors including high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), Apolipoprotein A-I (ApoA-I), Apolipoprotein B (ApoB), triglycerides, hemoglobin A1c (HbA1c) and diabetes on the odds of testing positive for SARS-CoV-2 in UK Biobank (UKB) study participants. Methods We examined the effect of BMI, lipid profiles, diabetes and alcohol intake on the odds of testing positive for SARS-Cov-2 among 9,005 UKB participants tested for SARS-CoV-2 from March 16 through July 14, 2020. Odds ratios and 95% confidence intervals were computed using logistic regression adjusted for age, sex and ancestry. Results Higher BMI, Type II diabetes and HbA1c were associated with increased SARS-CoV-2 odds (p < 0.05) while HDL-C and ApoA-I were associated with decreased odds (p < 0.001). Though the effect of BMI, Type II diabetes and HbA1c were eliminated when HDL-C was controlled, the effect of HDL-C remained significant when BMI was controlled for. LDL-C, ApoB and triglyceride levels were not found to be significantly associated with increased odds. Conclusion Elevated HDL-C and ApoA-I levels were associated with reduced odds of testing positive for SARS-CoV-2, while higher BMI, type II diabetes and HbA1c were associated with increased odds. The effects of BMI, type II diabetes and HbA1c levels were no longer significant after controlling for HDL-C, suggesting that these effects may be mediated in part through regulation of HDL-C levels. In summary, our study suggests that baseline HDL-C level may be useful for stratifying SARS-CoV-2 infection risk and corroborates the emerging picture that HDL-C may confer protection against sepsis in general and SARS-CoV-2 in particular.	[Scalsky, Ryan J.] Univ Maryland, Sch Med, Med Scientist Training Program, Baltimore, MD 21201 USA; [Chen, Yi-Ju; Desai, Karan; O'Connell, Jeffery R.; Perry, James A.; Hong, Charles C.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Perry, JA; Hong, CC (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	JPerry@som.umaryland.edu; Charles.hong@som.umaryland.edu		Scalsky, Ryan/0000-0003-4321-1740; Hong, Charles/0000-0002-0424-8252	National Institute of General Medical Sciences (NIGMS) [5T32GM092237-10]; NIGMS [R01GM118557]; National Heart, Lung, and Blood Institute (NHLBI) [R01HL135129]; NHLBI [1U01HL137181]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was conducted using the UK Biobank Resource under Application Number 49852. This work was supported by National Institute of General Medical Sciences (NIGMS) 5T32GM092237-10 to RS, NIGMS R01GM118557, National Heart, Lung, and Blood Institute (NHLBI) R01HL135129 to CCH, and NHLBI 1U01HL137181 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauw LL, 2020, TRENDS ENDOCRIN MET, V31, P334, DOI 10.1016/j.tem.2020.01.003; Brownstein J., 2020, COVID 19; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Ding WQ, 2016, J EPIDEMIOL, V26, P637, DOI 10.2188/jea.JE20140252; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Hu XZ, 2020, CLIN CHIM ACTA, V510, P105, DOI 10.1016/j.cca.2020.07.015; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Kassir R, 2020, OBES REV, V21, DOI 10.1111/obr.13034; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Lu YN, 2008, BIOCHEM BIOPH RES CO, V369, P344, DOI 10.1016/j.bbrc.2008.02.023; Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; Tanaka S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02860-3; Tian J, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/818075; Trinder M, 2021, CIRCULATION, V143, P921, DOI 10.1161/CIRCULATIONAHA.120.048568; Wei XQ, 2020, J CLIN LIPIDOL, V14, P297, DOI 10.1016/j.jacl.2020.04.008; White R., 2017, ADV LIPOPROTEIN RES, DOI [10.5772/67141, DOI 10.5772/67141]; Wu P, 2019, JMIR MED INF, V7, P360, DOI 10.2196/14325; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	23	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248602	10.1371/journal.pone.0248602	http://dx.doi.org/10.1371/journal.pone.0248602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793566	Green Published, gold			2022-12-26	WOS:000636467000012
J	Rodriguez-Monguio, R; Naveed, M; Seoane-Vazquez, E				Rodriguez-Monguio, Rosa; Naveed, Mahim; Seoane-Vazquez, Enrique			Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?	PLOS ONE			English	Article								Background Shortages of opioid analgesics are increasingly common, interfere with patient care and increase healthcare cost. This study characterized the incidence of shortages of opioid analgesics in the period 2015-2019 and evaluated potential predictors to forecast the risk of shortages. Methods This was an observational retrospective study using the US Food and Drug Administration (FDA) drug shortages data. All FDA approved opioids were included in the study. Opioid analgesics were identified using the FDA National Drug Codes (NDC) and classified according to the Drug Enforcement Administration (DEA) schedule. We conducted Least Absolute Shrinkage and Selection Operator logistic regression analysis to assess direction of the association between risk of shortage and potential predictors. We used multivariable penalized logistic regression analysis to model predictors of shortages. We split the dataset into training and validation sets to evaluate the performance of the model. Findings The FDA approved 8,207 unique NDCs for opioid analgesics; 3,017 (36.8%) were in the market as of April 30, 2019 and 91(3.0%) of them were listed as in shortage by the FDA. All NDCs in shortage were schedule II opioids; 86 (94.5%) were injectable and 84 (92.3%) generics. There were 418 companies with at least one opioid NDC listed by the FDA. Three companies accounted for more than 4 in 5 of the schedule II active injectable opioids. For each unit increase in the number of prior instances of shortages of a company, the likelihood of an NDC shortage for that company increased by 3.4%. For each unit increase in number of NDCs marketed by a company, the odds of an NDC shortage for that company decreased by 1%. Conclusions In the period 2015-2019, shortages of opioid analgesics disproportionally impacted schedule II and injectable opioids. The risk of shortage of opioid analgesics significantly increased with the incidence of previous instances of shortages of a manufacturing company and decreased with the number of NDCs marketed by a company. The characteristics of the manufacturing company, rather than the number of companies, might be the missing piece to the complex puzzle of drug shortages in the US.	[Rodriguez-Monguio, Rosa] Univ Calif San Francisco UCSF, Dept Clin Pharm, San Francisco, CA 94143 USA; [Rodriguez-Monguio, Rosa; Naveed, Mahim] Univ Calif San Francisco UCSF, Medicat Outcomes Ctr, San Francisco, CA 94143 USA; [Rodriguez-Monguio, Rosa] Univ Calif San Francisco UCSF, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Seoane-Vazquez, Enrique] Chapman Univ Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA USA; [Seoane-Vazquez, Enrique] Chapman Univ, Econ Sci Inst, Argyros Sch Business & Econ, Irvine, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chapman University System; Chapman University	Rodriguez-Monguio, R (corresponding author), Univ Calif San Francisco UCSF, Dept Clin Pharm, San Francisco, CA 94143 USA.; Rodriguez-Monguio, R (corresponding author), Univ Calif San Francisco UCSF, Medicat Outcomes Ctr, San Francisco, CA 94143 USA.; Rodriguez-Monguio, R (corresponding author), Univ Calif San Francisco UCSF, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	Rosa.Rodriguez-Monguio@ucsf.edu		Naveed, Mahim/0000-0001-7434-7654; Rodriguez-Monguio, Rosa/0000-0002-5526-9395	National Center for Advancing Translational Sciences, National Institutes of Health (NIH) through UCSF-CTSI [UL1 TR001872]	National Center for Advancing Translational Sciences, National Institutes of Health (NIH) through UCSF-CTSI	This study was funded in part by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) through UCSF-CTSI (#UL1 TR001872). The content of this publication is solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The NIH/CTSI did not participate in any aspects of the study or manuscript.	American Hospital Association (AHA), 2011, SURV DRUG SHORT; ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Balkhi B, 2013, J PHARM HEALTH SERV, V4, P13, DOI 10.1111/jphs.12006; Bruera E, 2018, NEW ENGL J MED, V379, P601, DOI 10.1056/NEJMp1807117; De Oliveira GS, 2011, ANESTH ANALG, V113, P1429, DOI 10.1213/ANE.0b013e31821f23ef; FDA, 2019, DRUG SHORT ROOT CAUS; Furlow B, 2015, LANCET RESP MED, V3, P182, DOI 10.1016/S2213-2600(15)00053-3; General Accounting Office (GAO),, 2014, GAO14194; General Accounting Office (GAO), 2011, GAO12116; Hollingsworth Hanna, 2018, J Opioid Manag, V14, P81, DOI 10.5055/jom.2018.0434; Institute for Safe Medication Practices (ISMP), 2012, ACUTE CARE, V17, P1; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; McLaughlin M, 2013, J MANAGE CARE PHARM, V19, P783, DOI 10.18553/jmcp.2013.19.9.783; Phuong JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215837; Traynor K, 2010, AM J HEALTH-SYST PH, V67, P1492, DOI 10.2146/news100064; Tucker EL, 2020, CLIN PHARMACOL THER, V108, P1150, DOI 10.1002/cpt.1934; U.S. Food and Drug Administration, 2011, REV FDAS APPR MED PR; U.S. Food and Drug Administration (FDA, 2020, NAT DRUG COD NDC DIR; U.S. Food and Drug Administration (FDA, STRAT PLAN PREV MIT; U.S. Food and Drug Administration (FDA), AG DRUG SHORT TASK F; U.S. Food and Drug Administration (FDA). Center for Drug Evaluation and Research (CDER), DRUG SHORT MAN MAN P; U.S. Food Drug Administration, CURR RES DRUG SHORT	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249274	10.1371/journal.pone.0249274	http://dx.doi.org/10.1371/journal.pone.0249274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788898	Green Published, gold			2022-12-26	WOS:000636354600052
J	Buetti-Dinh, A; Ruinelli, M; Czerski, D; Scapozza, C; Martignier, A; Roman, S; Caminada, A; Tonolla, M				Buetti-Dinh, Antoine; Ruinelli, Michela; Czerski, Dorota; Scapozza, Cristian; Martignier, Agathe; Roman, Samuele; Caminada, Annapaola; Tonolla, Mauro			Geochemical and metagenomics study of a metal-rich, green-turquoise-coloured stream in the southern Swiss Alps	PLOS ONE			English	Article								The Swiss Alpine environments are poorly described from a microbiological perspective. Near the Greina plateau in the Camadra valley in Ticino (southern Swiss Alps), a green-turquoise-coloured water spring streams off the mountain cliffs. Geochemical profiling revealed naturally elevated concentrations of heavy metals such as copper, lithium, zinc and cadmium, which are highly unusual for the geomorphology of the region. Of particular interest, was the presence of a thick biofilm, that was revealed by microscopic analysis to be mainly composed of Cyanobacteria. A metagenome was further assembled to detail the genes found in this environment. A multitude of genes for resistance/tolerance to high heavy metal concentrations were indeed found, such as, various transport systems, and genes involved in the synthesis of extracellular polymeric substances (EPS). EPS have been evoked as a central component in photosynthetic environments rich in heavy metals, for their ability to drive the sequestration of toxic, positively-charged metal ions under high regimes of cyanobacteria-driven photosynthesis. The results of this study provide a geochemical and microbiological description of this unusual environment in the southern Swiss Alps, the role of cyanobacterial photosynthesis in metal resistance, and the potential role of such microbial community in bioremediation of metal-contaminated environments.	[Buetti-Dinh, Antoine; Ruinelli, Michela; Roman, Samuele; Caminada, Annapaola; Tonolla, Mauro] Univ Appl Sci Southern Switzerland SUPSI, Lab Appl Microbiol LMA, Dept Environm Construct & Design DACD, Bellinzona, Switzerland; [Buetti-Dinh, Antoine] Swiss Inst Bioinformat, Lausanne, Switzerland; [Czerski, Dorota; Scapozza, Cristian] Univ Appl Sci Southern Switzerland SUPSI, Inst Earth Sci, Trevano, Canobbio, Switzerland; [Martignier, Agathe] Univ Geneva, Dept Earth Sci, Geneva, Switzerland; [Roman, Samuele; Tonolla, Mauro] Alpine Biol Ctr Fdn, Bellinzona, Switzerland; [Tonolla, Mauro] Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland	Swiss Institute of Bioinformatics; University of Geneva; University of Geneva	Buetti-Dinh, A; Tonolla, M (corresponding author), Univ Appl Sci Southern Switzerland SUPSI, Lab Appl Microbiol LMA, Dept Environm Construct & Design DACD, Bellinzona, Switzerland.; Buetti-Dinh, A (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.; Tonolla, M (corresponding author), Alpine Biol Ctr Fdn, Bellinzona, Switzerland.; Tonolla, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland.	antoine.buetti@supsi.ch; mauro.tonolla@supsi.ch		Buetti-Dinh, Antoine/0000-0002-6469-0296; Scapozza, Cristian/0000-0002-9003-7864; Tonolla, Mauro/0000-0002-8861-7763				Aboulmagd E, 2000, ARCH MICROBIOL, V174, P297, DOI 10.1007/s002030000206; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Angerer A, 1998, ARCH MICROBIOL, V169, P483, DOI 10.1007/s002030050600; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Ardin AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107569; Baker-Austin C, 2005, MICROBIOL-SGM, V151, P2637, DOI 10.1099/mic.0.28076-0; Banci L, 2010, J BIOL INORG CHEM, V15, P87, DOI 10.1007/s00775-009-0568-7; Baptista MS, 2006, CRIT REV MICROBIOL, V32, P127, DOI 10.1080/10408410600822934; Bartsevich VV, 1999, J BACTERIOL, V181, P3591, DOI 10.1128/JB.181.11.3591-3593.1999; Bellenberg S, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01835-18; Ben Fekih I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02473; Ben Hania W, 2017, ENVIRON MICROBIOL, V19, P1134, DOI 10.1111/1462-2920.13639; BENNETT LT, 1988, MOL MICROBIOL, V2, P315, DOI 10.1111/j.1365-2958.1988.tb00034.x; BERKELMAN T, 1994, J BACTERIOL, V176, P4430, DOI 10.1128/jb.176.14.4430-4436.1994; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Bolhuis H, 2014, FEMS MICROBIOL ECOL, V90, P335, DOI 10.1111/1574-6941.12408; Bundesamt fur Gesundheit, 2003, SCHWEIZERISCHES LEBE; Burganskaya EI, 2019, ARCH MICROBIOL, V201, P795, DOI 10.1007/s00203-019-01648-6; Burnat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006204; Carreira C, 2015, LIMNOL OCEANOGR-METH, V13, P169, DOI 10.1002/lom3.10016; Chakravarty S, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00268-17; Choi SH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15812; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P2726, DOI 10.1128/AEM.68.6.2726-2730.2002; De Philippis R, 2003, REC RES DEV MICROBIO, V7, P13; De Philippis R, 1998, APPL ENVIRON MICROB, V64, P1130; De Philippis R, 2001, J APPL PHYCOL, V13, P293, DOI 10.1023/A:1017590425924; De Philippis R, 2011, APPL MICROBIOL BIOT, V92, P697, DOI 10.1007/s00253-011-3601-z; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Dilthey AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10934-2; Dudeja Suman, 2012, CELLULAR ORIGIN LIFE; Falcon LI, 2007, MICROB ECOL, V54, P363, DOI 10.1007/s00248-007-9240-3; Frias JE, 1997, J BACTERIOL, V179, P477, DOI 10.1128/jb.179.2.477-486.1997; FRISE E, 1994, J BACTERIOL, V176, P6545, DOI 10.1128/JB.176.21.6545-6549.1994; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Gassel M, 1998, BBA-BIOMEMBRANES, V1415, P77, DOI 10.1016/S0005-2736(98)00179-5; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2000, J BACTERIOL, V182, P1390, DOI 10.1128/JB.182.5.1390-1398.2000; Grosse C, 1999, J BACTERIOL, V181, P2385; Guine V, 2006, ENVIRON SCI TECHNOL, V40, P1806, DOI 10.1021/es050981l; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Gupta Pratima, 2017, Biotechnol Rep (Amst), V13, P58, DOI 10.1016/j.btre.2016.12.006; Hall CW, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02762-17; Hall JA, 2005, J BACTERIOL, V187, P5189, DOI 10.1128/JB.187.15.5189-5194.2005; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; HUANG JZ, 1989, J BACTERIOL, V171, P3767, DOI 10.1128/jb.171.7.3767-3774.1989; Hubel H, 1990, J BASIC MICROB, V30, P560; Hudek L, 2016, APPL ENVIRON MICROB, V82, P6344, DOI 10.1128/AEM.01336-16; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Inskeep WP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00067; Iwashita K, 1999, APPL ENVIRON MICROB, V65, P5546; Johann Dietrich Frey, 1967, THESIS; Joseph Seckbach, 2010, MICROBIAL MATS MODER; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Kosugi A, 2006, BIOCHEM BIOPH RES CO, V349, P20, DOI 10.1016/j.bbrc.2006.07.038; Kozubal MA, 2013, ISME J, V7, P622, DOI 10.1038/ismej.2012.132; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Li P, 2001, Biotechnol Genet Eng Rev, V18, P375; Liu PL, 2015, INT J MOL SCI, V16, P17005, DOI 10.3390/ijms160817005; Liu YX, 2015, GEOCHIM COSMOCHIM AC, V169, P30, DOI 10.1016/j.gca.2015.07.033; Lopez-Lopez Olalla, 2013, Life-Basel, V3, P308, DOI 10.3390/life3020308; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Malwade CR, 2016, COMPUT-AIDED CHEM EN, V38A, P61, DOI 10.1016/B978-0-444-63428-3.50015-1; Marc-Henri Derron, 2004, G OCHIMIE EAUX SOURC; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; Mattes TE, 2008, APPL ENVIRON MICROB, V74, P6405, DOI 10.1128/AEM.00197-08; Mota R, 2015, J PROTEOMICS, V120, P75, DOI 10.1016/j.jprot.2015.03.004; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Nawapan S, 2009, J BACTERIOL, V191, P5159, DOI 10.1128/JB.00384-09; Nienaber A, 2000, J BACTERIOL, V182, P1472, DOI 10.1128/JB.182.6.1472-1480.2000; NIES DH, 1992, J BACTERIOL, V174, P8102, DOI 10.1128/JB.174.24.8102-8110.1992; Oger C, 2003, FEMS MICROBIOL ECOL, V43, P173, DOI 10.1111/j.1574-6941.2003.tb01056.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Paerl HW, 1996, MICROB ECOL, V31, P225; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peeters K, 2012, POLAR BIOL, V35, P543, DOI 10.1007/s00300-011-1100-4; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Pi HL, 2017, METALLOMICS, V9, P840, DOI 10.1039/c7mt00112f; Prabha R, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120608; Prieto-Barajas CM, 2018, ELECTRON J BIOTECHN, V31, P48, DOI 10.1016/j.ejbt.2017.11.001; PUGSLEY AP, 1988, MOL MICROBIOL, V2, P473, DOI 10.1111/j.1365-2958.1988.tb00053.x; Raeymaekers L, 2002, CELL CALCIUM, V32, P93, DOI 10.1016/S0143-4160(02)00125-2; Reeve WG, 2002, MOL MICROBIOL, V43, P981, DOI 10.1046/j.1365-2958.2002.02791.x; Resch CT, 2010, BIOCHEMISTRY-US, V49, P2520, DOI 10.1021/bi902173y; Ruvindy R, 2016, ISME J, V10, P183, DOI 10.1038/ismej.2015.87; Sandro Oldrati, 2017, ARMANDO DAD EDITORE; Schmidt S.Th., 1983, MINERAL DEPOSITS ALP, P117, DOI DOI 10.1016/S0140-6736(17)32366-8; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Shigematsu T, 1997, BIOSCI BIOTECH BIOCH, V61, P768, DOI 10.1271/bbb.61.768; SIRKO A, 1995, J BACTERIOL, V177, P4134, DOI 10.1128/jb.177.14.4134-4136.1995; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Sutterlin S, 2017, J HOSP INFECT, V96, P256, DOI 10.1016/j.jhin.2017.04.017; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Thiel Teresa, 2014, Life-Basel, V4, P944, DOI 10.3390/life4040944; Tiwari B, 2015, MICROBIOLOGY+, V84, P291, DOI 10.1134/S0026261715030200; Toner B, 2005, ENVIRON SCI TECHNOL, V39, P8288, DOI 10.1021/es050528+; TSAI KJ, 1992, J BACTERIOL, V174, P116, DOI 10.1128/jb.174.1.116-121.1992; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Villanueva L, 2007, ARCH MICROBIOL, V188, P137, DOI 10.1007/s00203-007-0229-6; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Woebken D, 2015, ISME J, V9, P485, DOI 10.1038/ismej.2014.144; Woodley P, 1996, FEMS MICROBIOL LETT, V135, P213; YAMADA M, 1989, J BACTERIOL, V171, P5601, DOI 10.1128/jb.171.10.5601-5606.1989; Yernool DA, 2000, J BACTERIOL, V182, P5172, DOI 10.1128/JB.182.18.5172-5179.2000; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78	112	0	0	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248877	10.1371/journal.pone.0248877	http://dx.doi.org/10.1371/journal.pone.0248877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784327	Green Published, gold			2022-12-26	WOS:000636359600001
J	Johnathan, M; Muhamad, SA; Gan, SH; Stanslas, J; Fuad, WEM; Hussain, FA; Ahmad, WANW; Nurul, AA				Johnathan, Malagobadan; Muhamad, Siti Aminah; Gan, Siew Hua; Stanslas, Johnson; Mohd Fuad, Wan Ezumi; Hussain, Faezahtul Arbaeyah; Wan Ahmad, Wan Amir Nizam; Nurul, Asma Abdullah			Lignosus rhinocerotis Cooke Ryvarden ameliorates airway inflammation, mucus hypersecretion and airway hyperresponsiveness in a murine model of asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; BASOPHILS; TARGETS	Lignosus rhinocerotis Cooke. (L. rhinocerotis) is a medicinal mushroom traditionally used in the treatment of asthma and several other diseases by the indigenous communities in Malaysia. In this study, the effects of L. rhinocerotis on allergic airway inflammation and hyperresponsiveness were investigated. L. rhinocerotis extract (LRE) was prepared by hot water extraction using soxhlet. Airway hyperresponsiveness (AHR) study was performed in house dust mite (HDM)-induced asthma in Balb/c mice while airway inflammation study was performed in ovalbumin (OVA)-induced asthma in Sprague-Dawley rats. Treatment with different doses of LRE (125, 250 and 500 mg/kg) significantly inhibited AHR in HDM-induced mice. Treatment with LRE also significantly decreased the elevated IgE in serum, Th2 cytokines in bronchoalveolar lavage fluid and ameliorated OVA-induced histological changes in rats by attenuating leukocyte infiltration, mucus hypersecretion and goblet cell hyperplasia in the lungs. LRE also significantly reduced the number of eosinophils and neutrophils in BALF. Interestingly, a significant reduction of the FOXP3(+) regulatory T lymphocytes was observed following OVA induction, but the cells were significantly elevated with LRE treatment. Subsequent analyses on gene expression revealed regulation of several important genes i.e. IL17A, ADAM33, CCL5, IL4, CCR3, CCR8, PMCH, CCL22, IFNG, CCL17, CCR4, PRG2, FCER1A, CLCA1, CHIA and Cma1 which were up-regulated following OVA induction but down-regulated following treatment with LRE. In conclusion, LRE alleviates allergy airway inflammation and hyperresponsiveness, thus suggesting its therapeutic potential as a new armamentarium against allergic asthma.	[Johnathan, Malagobadan; Muhamad, Siti Aminah; Mohd Fuad, Wan Ezumi; Wan Ahmad, Wan Amir Nizam; Nurul, Asma Abdullah] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia; [Gan, Siew Hua] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Stanslas, Johnson] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Pharmacotherapeut Unit, Serdang, Selangor, Malaysia; [Hussain, Faezahtul Arbaeyah] Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Monash University; Monash University Sunway; Universiti Putra Malaysia; Universiti Sains Malaysia	Nurul, AA (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia.	nurulasma@usm.my	Ahmad, Wan Amir Nizam Wan/P-4104-2019; nurul, asma abdullah/AAK-7939-2021	Ahmad, Wan Amir Nizam Wan/0000-0002-0771-2559; nurul, asma abdullah/0000-0003-1180-8809; Malagobadan, Johnathan/0000-0002-8446-1917	Universiti Sains Malaysia [1001/PPSG/813065, 1001/PPSK/812180]	Universiti Sains Malaysia(Universiti Sains Malaysia)	This work was supported by the Universiti Sains Malaysia Research University Grants (www.usm.my) (Grant no: 1001/PPSG/813065 and 1001/PPSK/812180). The grants were awarded to Nurul AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; An TJ, 2018, TUBERC RESPIR DIS, V81, P80, DOI 10.4046/trd.2017.0108; Bai J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/410232; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Davies ER, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87632; Fallon PG, 2020, J ALLERGY CLIN IMMUN, V145, P496, DOI 10.1016/j.jaci.2019.11.031; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; Garcia G, 2005, CURR ALLERGY ASTHM R, V5, P155, DOI 10.1007/s11882-005-0090-0; Gill MA, 2012, J ALLERGY CLIN IMMUN, V129, P889, DOI 10.1016/j.jaci.2012.02.028; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hasegawa T, 2017, EUR CYTOKINE NETW, V28, P8, DOI 10.1684/ecn.2017.0390; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Huo Y, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050237; Johnathan M, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1141-x; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Kim SB, 2019, J ETHNOPHARMACOL, V232, P165, DOI 10.1016/j.jep.2018.12.016; Lee MY, 2011, INHAL TOXICOL, V23, P938, DOI 10.3109/08958378.2011.627392; Lee SS, 2009, FOREST ECOL MANAG, V257, P2062, DOI 10.1016/j.foreco.2008.09.044; Lee SS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-359; Li HF, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1006-1; Liu KJ, 2010, IMMUNOLOGY, V129, P351, DOI 10.1111/j.1365-2567.2009.03175.x; Manson SC, 2009, RESP MED, V103, P975, DOI 10.1016/j.rmed.2009.01.003; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Morianos I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217930; Muhamad SA, 2019, EXP THER MED, V17, P3867, DOI 10.3892/etm.2019.7416; Nallathamby N, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00998; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Noble PB., 2012, J ALLERGY, V2012; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Porsbjerg CM, 2013, RESPIROLOGY, V18, P1128, DOI 10.1111/resp.12142; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Silverpil E, 2011, INFLAMMATION, V34, P1, DOI 10.1007/s10753-010-9201-8; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tanaka H, 2001, INFLAMM RES, V50, P616, DOI 10.1007/PL00000243; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Xu WH, 2018, J ETHNOPHARMACOL, V221, P1, DOI 10.1016/j.jep.2018.04.012	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249091	10.1371/journal.pone.0249091	http://dx.doi.org/10.1371/journal.pone.0249091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784348	Green Published, gold			2022-12-26	WOS:000636359600038
J	Sebate, B; Cuttler, K; Cloete, R; Britz, M; Christoffels, A; Williams, M; Carr, J; Bardien, S				Sebate, Boiketlo; Cuttler, Katelyn; Cloete, Ruben; Britz, Marcell; Christoffels, Alan; Williams, Monique; Carr, Jonathan; Bardien, Soraya			Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools	PLOS ONE			English	Article							COPY-NUMBER VARIATION; PROTEIN STABILITY; MUTATIONS; EXOME; PREDICTION; PHENOTYPES; DISCOVERY; DATABASE; COMPLEX; IMPACT	Parkinson's disease (PD) is a neurodegenerative disorder exhibiting Mendelian inheritance in some families. Next-generation sequencing approaches, including whole exome sequencing (WES), have revolutionized the field of Mendelian disorders and have identified a number of PD genes. We recruited a South African family with autosomal dominant PD and used WES to identify a possible pathogenic mutation. After filtration and prioritization, we found five potential causative variants in CFAP65, RTF1, NRXN2, TEP1 and CCNF. The variant in NRXN2 was selected for further analysis based on consistent prediction of deleteriousness across computational tools, not being present in unaffected family members, ethnic-matched controls or public databases, and its expression in the substantia nigra. A protein model for NRNX2 was created which provided a three-dimensional (3D) structure that satisfied qualitative mean and global model quality assessment scores. Trajectory analysis showed destabilizing effects of the variant on protein structure, indicated by high flexibility of the LNS-6 domain adopting an extended conformation. We also found that the known substrate N-acetyl-D-glucosamine (NAG) contributed to restoration of the structural stability of mutant NRXN2. If NRXN2 is indeed found to be the causal gene, this could reveal a new mechanism for the pathobiology of PD.	[Sebate, Boiketlo; Cuttler, Katelyn; Bardien, Soraya] Stellenbosch Univ, Div Mol Biol & Human Genet, Dept Biomed Sci, Fac Med & Hlth Sci, Cape Town, South Africa; [Cloete, Ruben; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Cape Town, South Africa; [Britz, Marcell] Greenacres Med Ctr, Port Elizabeth, South Africa; [Williams, Monique] Stellenbosch Univ, South African Med Res Council, Div Mol Biol & Human Genet,Ctr TB Res,Fac Med & H, Dept Biomed Sci,NRF DST Ctr Excellence Biomed TB, Cape Town, South Africa; [Carr, Jonathan] Stellenbosch Univ, Div Neurol, Dept Med, Cape Town, South Africa	Stellenbosch University; South African Medical Research Council; University of the Western Cape; South African Medical Research Council; Stellenbosch University; Stellenbosch University	Bardien, S (corresponding author), Stellenbosch Univ, Div Mol Biol & Human Genet, Dept Biomed Sci, Fac Med & Hlth Sci, Cape Town, South Africa.; Cloete, R (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Cape Town, South Africa.	ruben@sanbi.ac.za; sbardien@sun.ac.za	Bardien, Soraya/ABB-3313-2020	Bardien, Soraya/0000-0002-3508-3438; Cuttler, Katelyn/0000-0003-1833-5426; Williams, Monique/0000-0002-6701-8403	National Research Foundation of South Africa [106052]; South African Medical Research Council; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF) of South Africa [64751]	National Research Foundation of South Africa(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	SB and JC received support from the National Research Foundation of South Africa (Grant Number: 106052) and the South African Medical Research Council (Self-Initiated Research Grant). RC and AC were supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa (award number UID 64751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Christensen KD, 2015, J PERS MED, V5, P470, DOI 10.3390/jpm5040470; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Deng HX, 2016, NAT GENET, V48, P733, DOI 10.1038/ng.3589; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Greeff JM, 2007, ANN HUM GENET, V71, P674, DOI 10.1111/j.1469-1809.2007.00363.x; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klein C, 2011, MOVEMENT DISORD, V26, P1793, DOI 10.1002/mds.23853; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Li H., 2013, ARXIV13033997 Q BIO; Lill CM, 2016, MOL CELL PROBE, V30, P386, DOI 10.1016/j.mcp.2016.11.001; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Naito Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42548; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Puschmann A, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0780-8; Quadri M, 2018, LANCET NEUROL, V17, P597, DOI 10.1016/S1474-4422(18)30179-0; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3514; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Tanabe Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00333-w; Tang HM, 2016, GENETICS, V203, P635, DOI 10.1534/genetics.116.190033; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Williams T., 2011, GNUPLOT 44 INTERACTI; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249324	10.1371/journal.pone.0249324	http://dx.doi.org/10.1371/journal.pone.0249324			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770142	Green Published, gold			2022-12-26	WOS:000634833500007
J	Stager, JC; Wiltse, B; Cumming, BF; Messner, TC; Robtoy, J; Cushing, S				Stager, J. Curt; Wiltse, Brendan; Cumming, Brian F.; Messner, Timothy C.; Robtoy, Joshua; Cushing, Sidney			Hydroclimatic and cultural instability in northeastern North America during the last millennium	PLOS ONE			English	Article							DEPTH MODELS; GREAT-PLAINS; NEW-YORK; ICE-AGE; DROUGHT; LAKE; PRECIPITATION; VARIABILITY; EUTROPHICATION; RECONSTRUCTION	Long-term, large-scale perspectives are necessary for understanding climate variability and its effects on ecosystems and cultures. Tree ring records of the Medieval Climate Anomaly (MCA) and Little Ice Age (LIA) have documented major hydroclimatic variability during the last millennium in the American West, but fewer continuous, high-resolution hydroclimate records of the MCA-LIA period are available for eastern North America, particularly during the transition from the MCA to the LIA (ca. A.D. 1250-1400). Diatoms (micro-algae with silica cell walls) in sediment cores from three Adirondack (NY, USA) lakes and a hiatus in a wetland peat deposit in the Adirondack uplands provide novel insights into the late Holocene hydroclimate history of the Northeast. These records demonstrate that two of the region's most extreme decadal-scale droughts of the last millennium occurred ca. A.D. 1260-1330 and ca. A.D. 1360-1390 during a dry-wet-dry (DWD) oscillation in the Adirondacks that contributed to forest fires and desiccation of wetlands in New York and Maine. The bimodal drying was probably related to more extreme droughts farther west and coincided with major events in Iroquoian and Abenaki cultural history. Although the causes of the DWD oscillation in the Adirondacks remain uncertain, changing sea-surface temperatures and solar variability are likely to have played a role.	[Stager, J. Curt; Wiltse, Brendan; Robtoy, Joshua; Cushing, Sidney] Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA; [Cumming, Brian F.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Messner, Timothy C.] SUNY Coll Potsdam, Dept Anthropol, Potsdam, NY USA	Queens University - Canada; State University of New York (SUNY) System	Stager, JC (corresponding author), Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu			Draper-Lussi Endowment; U.S. National Science Foundation (P2C2) [1358362]	Draper-Lussi Endowment; U.S. National Science Foundation (P2C2)	We thank the Draper-Lussi Endowment (no URL) and U.S. National Science Foundation (P2C2 grant #1358362, https://www.nsf.gov) for funding provided to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel TJ, 2019, AM ANTIQUITY, V84, P748, DOI 10.1017/aaq.2019.50; [Anonymous], 1991, BACILLARIOPHYCEAE 3; Benson LV, 2007, QUATERNARY SCI REV, V26, P336, DOI 10.1016/j.quascirev.2006.08.001; Birch J, 2018, AM ANTIQUITY, V83, P13, DOI 10.1017/aaq.2017.59; Birch J, 2015, J ARCHAEOL RES, V23, P263, DOI 10.1007/s10814-015-9082-3; Bird BW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41628; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Bradbury JA, 2002, J AM WATER RESOUR AS, V38, P1287, DOI 10.1111/j.1752-1688.2002.tb04348.x; Buckley BM, 2004, CAN J FOREST RES, V34, P2541, DOI [10.1139/x04-129, 10.1139/X04-129]; Clifford MJ, 2013, CLIMATIC CHANGE, V119, P693, DOI 10.1007/s10584-013-0771-y; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Cook BI, 2016, WIRES CLIM CHANGE, V7, P411, DOI 10.1002/wcc.394; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; Dee SG, 2020, SCIENCE, V367, P1477, DOI 10.1126/science.aax2000; Denniston RF, 2015, P NATL ACAD SCI USA, V112, P4576, DOI 10.1073/pnas.1422270112; Ekdahl EJ, 2004, GEOLOGY, V32, P745, DOI 10.1130/G20496.1; GAJEWSKI K, 1988, QUATERNARY RES, V29, P255, DOI 10.1016/0033-5894(88)90034-8; Grochocki KK, 2019, J PALEOLIMNOL, V62, P301, DOI 10.1007/s10933-019-00093-1; Gushulak CAC, 2017, J PALEOLIMNOL, V58, P231, DOI 10.1007/s10933-017-9974-y; Hart JP, CURRENT RES NEW YORK, DOI [1121227/Current_Research_in_New_York_State_Archaeology_A.D._700_1300, DOI 11/44679/INDEX.HTM]; Haviland WA., 1994, ORIGINAL VERMONTERS; Herweijer C, 2007, J CLIMATE, V20, P1353, DOI 10.1175/JCLI4042.1; Hubeny JB, 2011, P NATL ACAD SCI USA, V108, P17895, DOI 10.1073/pnas.1019301108; Lafontaine-Boyer K, 2014, HOLOCENE, V24, P1515, DOI 10.1177/0959683614544054; Laird KR, 2008, QUATERNARY RES, V69, P292, DOI 10.1016/j.yqres.2007.11.003; Laird KR, 2011, QUATERNARY SCI REV, V30, P1201, DOI 10.1016/j.quascirev.2011.02.009; Laird KR, 1996, NATURE, V384, P552, DOI 10.1038/384552a0; LeBoeuf KA., THESIS LEHIGH U, P2014; Lewis T.K., 2018, IMPACTS RISKS, VII, DOI [10.7930/ NCA4.2018, DOI 10.7930/NCA4.2018]; Ljungqvist FC, 2020, QUATERNARY SCI REV, V230, DOI 10.1016/j.quascirev.2019.106074; MacDonald GM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022478; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marsicek JP, 2013, QUATERNARY SCI REV, V80, P129, DOI 10.1016/j.quascirev.2013.09.001; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Menne MJ, 2009, B AM METEOROL SOC, V90, P993, DOI 10.1175/2008BAMS2613.1; Miller DR, 2018, CLIM PAST, V14, P1653, DOI 10.5194/cp-14-1653-2018; Newby PE, 2014, GEOPHYS RES LETT, V41, P4300, DOI 10.1002/2014GL060183; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Patrick R, 1975, MONOGR ACAD NAT SCI, V13; Patrick R, 1966, MONOGR ACAD NAT SCI, V13; Pederson DC, 2005, QUATERNARY RES, V63, P238, DOI 10.1016/j.yqres.2005.01.001; Routson CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149573; Schindler DW, 1997, BIOGEOCHEMISTRY, V36, P9, DOI 10.1023/A:1005792014547; Shapley MD, 2005, HOLOCENE, V15, P29, DOI 10.1191/0959683605hl781rp; Shuman BN, 2018, CLIM PAST, V14, P665, DOI 10.5194/cp-14-665-2018; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Snow DR., 2007, ARCHAEOLOGY IROQUOIS; Stager JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191755; Stager JC, 2003, ADIRONDACK J ENV STU, V10, P6; Stager JC., 2016, HOLOCENE, DOI [10.1177/0959683616650268, DOI 10.1177/0959683616650268]; Stahle DW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046472; Stahle DW., 2007, CLIMATIC CHANGE, DOI [10.1007/s10584-006-9233-0, DOI 10.1007/S10584-006-9233-0]; Stone JR, 2004, LIMNOL OCEANOGR, V49, P1540; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sun C, 2015, CLIM DYNAM, V45, P2083, DOI 10.1007/s00382-014-2459-z; Tierney JE, 2020, SCIENCE, V370, P680, DOI 10.1126/science.aay3701; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Usoskin IG, 2007, ASTRON ASTROPHYS, V471, P301, DOI 10.1051/0004-6361:20077704; Warrick G., 2007, ARCHAEOLOGY IROQUOIS; Wigdahl-Perry CR, 2016, J PALEOLIMNOL, V55, P339, DOI 10.1007/s10933-016-9883-5; Williams AP, 2020, SCIENCE, V368, P314, DOI 10.1126/science.aaz9600	62	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248060	10.1371/journal.pone.0248060	http://dx.doi.org/10.1371/journal.pone.0248060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770105	gold, Green Published			2022-12-26	WOS:000634833500061
J	Landor, SKJ; Santio, NM; Eccleshall, WB; Paramonov, VM; Gagliani, EK; Hall, D; Jin, SB; Dahlstrom, KM; Salminen, TA; Rivero-Muller, A; Lendahl, U; Kovall, RA; Koskinen, PJ; Sahlgren, C				Landor, Sebastian K. J.; Santio, Niina M.; Eccleshall, William B.; Paramonov, Valeriy M.; Gagliani, Ellen K.; Hall, Daniel; Jin, Shao-Bo; Dahlstrom, Kathe M.; Salminen, Tiina A.; Rivero-Muller, Adolfo; Lendahl, Urban; Kovall, Rhett A.; Koskinen, Paivi J.; Sahlgren, Cecilia			PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOONCOGENE PIM-1; RECEPTOR; KINASES; REFINEMENT; SWITCH	Dysregulation of the developmentally important Notch signaling pathway is implicated in several types of cancer, including breast cancer. However, the specific roles and regulation of the four different Notch receptors have remained elusive. We have previously reported that the oncogenic PIM kinases phosphorylate Notch1 and Notch3. Phosphorylation of Notch1 within the second nuclear localization sequence of its intracellular domain (ICD) enhances its transcriptional activity and tumorigenicity. In this study, we analyzed Notch3 phosphorylation and its functional impact. Unexpectedly, we observed that the PIM target sites are not conserved between Notch1 and Notch3. Notch3 ICD (N3ICD) is phosphorylated within a domain, which is essential for formation of a transcriptionally active complex with the DNA-binding protein CSL. Through molecular modeling, X-ray crystallography, and isothermal titration calorimetry, we demonstrate that phosphorylation of N3ICD sterically hinders its interaction with CSL and thereby inhibits its CSL-dependent transcriptional activity. Surprisingly however, phosphorylated N3ICD still maintains tumorigenic potential in breast cancer cells under estrogenic conditions, which support PIM expression. Taken together, our data indicate that PIM kinases modulate the signaling output of different Notch paralogs by targeting distinct protein domains and thereby promote breast cancer tumorigenesis via both CSL-dependent and CSL-independent mechanisms.	[Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Rivero-Muller, Adolfo; Sahlgren, Cecilia] Abo Akad Univ, Fac Sci & Engn Cell Biol, Turku, Finland; [Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Sahlgren, Cecilia] Univ Turku, Turku Biosci, Turku, Finland; [Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Sahlgren, Cecilia] Abo Akad Univ, Turku, Finland; [Santio, Niina M.; Eccleshall, William B.; Rivero-Muller, Adolfo; Koskinen, Paivi J.] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Dept Biol, Turku, Finland; [Paramonov, Valeriy M.] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Gagliani, Ellen K.; Hall, Daniel; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA; [Jin, Shao-Bo; Lendahl, Urban] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Dahlstrom, Kathe M.; Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland; [Sahlgren, Cecilia] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands; [Rivero-Muller, Adolfo] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland	Abo Akademi University; University of Turku; Abo Akademi University; University of Turku; University of Turku; University System of Ohio; University of Cincinnati; Karolinska Institutet; Abo Akademi University; Eindhoven University of Technology; Medical University of Lublin	Sahlgren, C (corresponding author), Abo Akad Univ, Fac Sci & Engn Cell Biol, Turku, Finland.; Sahlgren, C (corresponding author), Univ Turku, Turku Biosci, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Turku, Finland.; Koskinen, PJ (corresponding author), Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Dept Biol, Turku, Finland.; Sahlgren, C (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands.	paivi.koskinen@utu.fi; csahlgre@abo.fi	Salminen, Tiina A/G-7492-2019; Rivero-Muller, Adolfo/A-5120-2008; Salminen, Tiina A./AAM-5443-2021	Salminen, Tiina A/0000-0002-4135-8020; Rivero-Muller, Adolfo/0000-0002-9794-802X; Salminen, Tiina A./0000-0002-4135-8020; Eccleshall, William/0000-0003-1841-8897; Kolb Gagliani, Ellen/0000-0001-7270-6254; Sahlgren, Cecilia/0000-0003-3350-4937; Dahlstrom, Kathe M./0000-0002-4880-8135	Academy of Finland [309373, 287040]; Jane and Aatos Erkko Foundation; Drug Research Doctoral Programme; Turku Doctoral Programme of Molecular Medicine; Swedish Cultural Foundation of Finland; Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; K. Albin Johansson Foundation; European Community Mobility Programme EMA2; Turku University Foundation; Instrumentarium Science Foundation; Sigrid Juselius Foundation; Tor, Joe, and Pentti Borg's Foundation; Swedish Cancer Society; National Institutes of Health [CA178974]; Finnish-Norwegian Medical Foundation; Ida Montin Foundation	Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Drug Research Doctoral Programme; Turku Doctoral Programme of Molecular Medicine; Swedish Cultural Foundation of Finland; Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; K. Albin Johansson Foundation; European Community Mobility Programme EMA2; Turku University Foundation; Instrumentarium Science Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe, and Pentti Borg's Foundation; Swedish Cancer Society(Swedish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish-Norwegian Medical Foundation; Ida Montin Foundation	99 This study was financially supported by Academy of Finland (grants 309373 to C. S. and 287040 to P. J. K.), Jane and Aatos Erkko Foundation (to C. S.), Drug Research Doctoral Programme (to N. M. S. and W. B. E.), Turku Doctoral Programme of Molecular Medicine (to V. M. P.), Swedish Cultural Foundation of Finland and Finnish-Norwegian Medical Foundation (to S. K. J. L.), Emil Aaltonen Foundation (to N. M. S.), Maud Kuistila Memorial Foundation (W. B. E.), K. Albin Johansson Foundation (to S. K. J. L. and V. M. P.), European Community Mobility Programme EMA2, Ida Montin Foundation, Turku University Foundation and Instrumentarium Science Foundation (to V. M. P.), Sigrid Juselius Foundation (K. M. D. and T. A. S.) and Tor, Joe, and Pentti Borg's Foundation (T. A. S.), the Swedish Cancer Society (to U. L.), and the National Institutes of Health (CA178974 to R. K.). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Antfolk D, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.07.002; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhat V, 2016, STEM CELLS DEV, V25, P522, DOI 10.1089/scd.2015.0315; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diluvio G, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0051-9; Dou XW, 2017, THERANOSTICS, V7, P4041, DOI 10.7150/thno.19989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Inder S, 2017, CANCER TREAT REV, V60, P69, DOI 10.1016/j.ctrv.2017.08.011; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kato H, 1997, DEVELOPMENT, V124, P4133; Kiriazis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055409; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Lee HJ, 2015, BMB REP, V48, P431, DOI 10.5483/BMBRep.2015.48.8.107; Leontovich AA, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1020-0; Lin HY, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0069-z; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; R Core Team, 2020, R LANG ENV STAT COMP; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Santio NM, 2017, INT J BIOCHEM CELL B, V93, P74, DOI 10.1016/j.biocel.2017.10.016; Santio NM, 2016, ONCOTARGET, V7, P43220, DOI 10.18632/oncotarget.9215; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Steinbuck MP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01230	48	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100593	10.1016/j.jbc.2021.100593	http://dx.doi.org/10.1016/j.jbc.2021.100593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775697	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400565
J	Busquets-Cortes, C; Bennasar-Veny, M; Lopez-Gonzalez, AA; Fresneda, S; Abbate, M; Yanez, AM				Busquets-Cortes, Carla; Bennasar-Veny, Miquel; Arturo Lopez-Gonzalez, Angel; Fresneda, Sergio; Abbate, Manuela; Yanez, Aina M.			Utility of Fatty Liver Index to predict reversion to normoglycemia in people with prediabetes	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; BETA-CELL FUNCTION; PHYSICAL-ACTIVITY; DISEASE; ASSOCIATION; RISK; OBESITY; NAFLD	Background Fatty Liver Index (FLI) is strongly associated with changes in glycemic status and incident Type 2 Diabetes (T2D). The probability of reverting to normoglycemia from a state prediabetes could be determined by FLI, however such relationship remains poorly understood. Aim To determine the clinical interest of using FLI to estimate prediabetes reversion at 5 years in patients with impaired fasting plasma glucose at baseline, and identify those factors associated with changes in FLI, that could contribute to the reversion of prediabetes. Methods This 5-year cohort study included 16,648 Spanish working adults with prediabetes. Prediabetes was defined as fasting plasma glucose (FPG) between 100 and 125 mg/dl according to the ADA criteria, while prediabetes reversion was defined as a FPG <100 mg/dL. The population was classified as: FLI <30 (no hepatic steatosis), FLI 30-59 (intermediate status), and FLI >= 60 (hepatic steatosis). Results At 5 years follow-up, 33.7% of subjects reverted to normoglycemia (annual rate of 6.7%). The adjusted binomial logistic regression model showed that scoring FLI <30 (OR 1.544; 95% CI 1.355-1.759), performing at least 150 min/week of physical activity (OR 4.600; 95% CI 4.088-5.177) and consuming fruits and vegetables daily (OR 1.682; 95% CI 1.526-1.855) were associated with the probability of reverting form prediabetes to normoglycemia. The ROC curve for prediction of reversion showed that FLI (AUC 0.774;95% CI 0.767-0.781) was a better predictor than FPG (AUC 0.656; 95% CI 0.648-0.664). Conclusions Regular physical activity, healthy dietary habits and absence of hepatic steatosis are independently associated with the probability of reversion to normoglycemia in adult workers with prediabetes at baseline. Low FLI values (especially FLI< 30) may be useful to predict the probability of prediabetes reversion, especially in active subjects with healthy eating habits, and thus identify those who might benefit from early lifestyle intervention.	[Busquets-Cortes, Carla; Bennasar-Veny, Miquel; Fresneda, Sergio] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca, Spain; [Busquets-Cortes, Carla; Arturo Lopez-Gonzalez, Angel] Escuela Univ ADEMA, Palma De Mallorca, Illes Balears, Spain; [Busquets-Cortes, Carla; Abbate, Manuela; Yanez, Aina M.] Univ Balearic Isl, Global Hlth & Human Dev Res Grp, Palma De Mallorca, Spain; [Bennasar-Veny, Miquel; Fresneda, Sergio; Yanez, Aina M.] Inst Invest Sanitaria Illes Balears IdISBa, Palma De Mallorca, Illes Balears, Spain; [Bennasar-Veny, Miquel; Fresneda, Sergio; Yanez, Aina M.] Balearic Isl Univ, Dept Nursing & Physiotherapy, Palma De Mallorca, Illes Balears, Spain; [Arturo Lopez-Gonzalez, Angel] Balearic Isl Hlth Serv, Prevent Occupat Risks Hlth Serv, Palma De Mallorca, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears	Bennasar-Veny, M (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca, Spain.; Bennasar-Veny, M (corresponding author), Inst Invest Sanitaria Illes Balears IdISBa, Palma De Mallorca, Illes Balears, Spain.; Bennasar-Veny, M (corresponding author), Balearic Isl Univ, Dept Nursing & Physiotherapy, Palma De Mallorca, Illes Balears, Spain.	miquel.bennasar@uib.es	Abbate, Manuela/HCI-8844-2022; Yañez, Aina M/AAF-7087-2021; Bennasar-Veny, Miquel/C-5881-2008	Yañez, Aina M/0000-0001-8527-3937; Bennasar-Veny, Miquel/0000-0003-1668-2141; Fresneda, Sergio/0000-0002-1208-8981; Abbate, Manuela/0000-0001-9905-2414				Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bennasar-Veny M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051538; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Dharmalingam Mala, 2018, Indian J Endocrinol Metab, V22, P421, DOI 10.4103/ijem.IJEM_585_17; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ferrannini E, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.suppl_3.S26; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Franch-Nadal J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198327; Heianza Y, 2012, DIABETIC MED, V29, pE279, DOI 10.1111/j.1464-5491.2012.03686.x; Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953; Jager S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124749; Jimenez-Cruz A, 2014, NUTR HOSP, V29, P771, DOI 10.3305/nh.2014.29.4.7216; Khetan AK, 2018, CAN J CARDIOL, V34, P615, DOI 10.1016/j.cjca.2017.12.030; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Koolhaas CM, 2017, EUR J PREV CARDIOL, V24, P934, DOI 10.1177/2047487317693952; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Movahedian M, 2020, PRIM CARE DIABETES, V14, P577, DOI 10.1016/j.pcd.2020.02.011; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Petta S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122082; Richter B, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012661.pub2; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Saponaro C, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0607-4; Schmidt AM, 2018, ARTERIOSCL THROM VAS, V38, pE1, DOI 10.1161/ATVBAHA.117.310221; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tana C, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173104; Taylor R, 2018, CELL METAB, V28, P547, DOI 10.1016/j.cmet.2018.07.003; Vistisen D, 2019, DIABETOLOGIA, V62, P1385, DOI 10.1007/s00125-019-4895-0; Wargny M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221524; Wieckowska A, 2008, SEMIN LIVER DIS, V28, P386, DOI 10.1055/s-0028-1091983; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhou KN, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0858-6	38	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249221	10.1371/journal.pone.0249221	http://dx.doi.org/10.1371/journal.pone.0249221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822783	gold, Green Published			2022-12-26	WOS:000637879100013
J	Mendez-Toribio, M; Martinez-Garza, C; Ceccon, E				Mendez-Toribio, Moises; Martinez-Garza, Cristina; Ceccon, Eliane			Challenges during the execution, results, and monitoring phases of ecological restoration: Learning from a country-wide assessment	PLOS ONE			English	Article							ECOSYSTEM SERVICES; NATURAL REGENERATION; FOREST RESTORATION; GLOBAL METAANALYSIS; BIODIVERSITY; KNOWLEDGE; LANDSCAPES; STRATEGIES; MANAGEMENT; PROGRESS	Outcomes from restoration projects are often difficult for policymakers and stakeholders to assess, but this information is fundamental for scaling up ecological restoration actions. We evaluated technical aspects of the interventions, results (ecological and socio-economic) and monitoring practices in 75 restoration projects in Mexico using a digital survey composed of 137 questions. We found that restoration projects in terrestrial ecosystems generally relied on actions included in minimal (97%) and maximal (86%) intervention, while in wetlands, the preferred restoration strategies were intermediate (75%) and minimal intervention (63%). Only a third of the projects (38%) relied on collective learning as a source of knowledge to generate techniques (traditional management). In most of the projects (73%), multiple criteria (>2) were considered when selecting plant species for plantings; the most frequently used criterion was that plant species were found within the restoration area, native or naturalized (i.e., a circa situm criterion; 88%). In 48% of the projects, the biological material required for restoration (e.g., seeds and seedlings) were gathered or propagated by project implementers rather than purchased commercially. Only a few projects (between 33 and 34%) reached a high level of biodiversity recovery (>75%). Most of the projects (between 69 to71%) recovered less than 50% of the ecological services. Most of the projects (82%) led to improved individual relationships. The analysis revealed a need to implement strategies that are cost-effective, the application of traditional ecological knowledge and the inclusion of indigenous people and local communities in restoration programs at all stages-from planning to implementation, through monitoring. We also identified the need to expand research to develop effective tools to assess ecosystems' regeneration potential and develop theoretical frameworks to move beyond short-term markers to set and achieve medium- and long-term goals. Cautious and comprehensive planning of national strategies must consider the abovementioned identified gaps.	[Mendez-Toribio, Moises] Inst Ecol, Ctr Reg Bajio, Red Diversidad Biol Occidente Mexicano, Patzcuaro, Michoacan, Mexico; [Mendez-Toribio, Moises; Martinez-Garza, Cristina] Univ Autonoma Estado Morelos UAEM, Ctr Invest Biodiversidad & Conservac CIByC, Cuernavaca, Morelos, Mexico; [Ceccon, Eliane] Univ Nacl Autonoma Mexico, Ctr Reg Invest Multidisciplinarias, Cuernavaca, Morelos, Mexico	Instituto de Ecologia - Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Mendez-Toribio, M (corresponding author), Inst Ecol, Ctr Reg Bajio, Red Diversidad Biol Occidente Mexicano, Patzcuaro, Michoacan, Mexico.; Mendez-Toribio, M (corresponding author), Univ Autonoma Estado Morelos UAEM, Ctr Invest Biodiversidad & Conservac CIByC, Cuernavaca, Morelos, Mexico.	moises.mendez@inecol.mx			CIFOR; CIByC; Department of International Development of the United Kingdom (DFID) through the KNOWFOR project; DGAPA-PAPIIT [IN300119]	CIFOR(CGIAR); CIByC; Department of International Development of the United Kingdom (DFID) through the KNOWFOR project; DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	MMT acknowledges CIFOR and CIByC for the financial support granted during postdoctoral research at UAEM. This study was financed by the Department of International Development of the United Kingdom (DFID) through the KNOWFOR project and under the activity "La restauracion de ecosistemas terrestres en Mexico: Situacion actual, tendencias, necesidades y oportunidades". EC is thankfull to the DGAPA-PAPIIT IN300119 project.	Anderson M. K., 2003, Ecological Restoration, V21, P269, DOI 10.3368/er.21.4.269; [Anonymous], 2016, EXPERIENCIAS MEXICAN; [Anonymous], 2014, INITIATIVE 20X20; Aronson J, 2020, RESTOR ECOL, V28, P730, DOI 10.1111/rec.13170; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Arroyo-Rodriguez V, 2017, BIOL REV, V92, P326, DOI 10.1111/brv.12231; Booth TH, 2016, ECOL MANAG RESTOR, V17, P228, DOI 10.1111/emr.12219; Bourdieu P., 2011, CULTURAL THEORY ANTH, P81; Brockmeyer R.E. Jr, 1997, Wetlands Ecology and Management, V4, P93, DOI 10.1007/BF01876231; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; CBD (Convention on Biological Diveristy), 2016, AICH BIOD TARG; Ceccon E, 2014, FRONTIERS ECOLOGY EV, P50, DOI DOI 10.1039/C39900001550; Ceccon E., 2013, RESTAURACION BOSQUES, DOI 10.1016/j.rbr.2013.06.002; Ceccon E, 2020, HUM ECOL, V48, P609, DOI 10.1007/s10745-020-00178-w; Cerron J., 2017, LECCIONES APRENDIDAS; Chazdon R. L., 2018, CIFOR Occasional Paper; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab79e6; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; Clewell A., 2000, GUIDELINES DEVELOPIN; Coppus R, 2019, ENVIRON RES COMMUN, V1, DOI 10.1088/2515-7620/ab2102; Cortina Jordi, 2006, Journal for Nature Conservation (Jena), V14, P152, DOI 10.1016/j.jnc.2006.04.004; Coughlan MR, 2014, FOREST ECOL MANAG, V312, P55, DOI 10.1016/j.foreco.2013.10.021; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Cuaron Alfonso, 2018, ROMA; Cuerrier A, 2015, J ETHNOBIOL, V35, P427, DOI 10.2993/0278-0771-35.3.427; de Rezende CL, 2015, BIODIVERS CONSERV, V24, P2255, DOI 10.1007/s10531-015-0980-y; Dellasala D. A., 2003, Ecological Restoration, V21, P14, DOI 10.3368/er.21.1.14; Dey DC, 2014, J SUSTAIN FOREST, V33, pS43, DOI 10.1080/10549811.2014.883999; Didham RK, 2005, OIKOS, V110, P409, DOI 10.1111/j.0030-1299.2005.13883.x; Diemont SAW, 2009, ECOL APPL, V19, P254, DOI 10.1890/08-0176.1; Douterlungne D, 2010, RESTOR ECOL, V18, P322, DOI 10.1111/j.1526-100X.2008.00459.x; Edwards SR, 2017, ROUTL HANDBK, P49; Ellison AM, 2000, RESTOR ECOL, V8, P219, DOI 10.1046/j.1526-100x.2000.80033.x; Estrada-Carmona N, 2014, LANDSCAPE URBAN PLAN, V129, P1, DOI 10.1016/j.landurbplan.2014.05.001; Evans K, 2018, CONSERV BIOL, V32, P525, DOI 10.1111/cobi.13110; Fremout T, 2021, RESTOR ECOL, V29, DOI 10.1111/rec.13347; Gann GD, 2019, RESTOR ECOL, V27, pS3, DOI 10.1111/rec.13035; Ganz D. J., 2003, ADV ASSISTED NATURAL, P1; Garibaldi A, 2004, ECOL SOC, V9; Grime J.P., 2002, PLANT STRATEGIES VEG; Guariguata MR, 2020, RESTOR ECOL, V28, P742, DOI 10.1111/rec.13076; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Gutierrez MMT, 2013, DIRECTORIO MEXICANO; Guzman-Luna A, 2016, BOT SCI, V94, P757, DOI 10.17129/botsci.659; Harrison PA, 2017, RESTOR ECOL, V25, P524, DOI 10.1111/rec.12488; Hartoyo APP, 2016, PROCEDIA ENVIRON SCI, V33, P376, DOI 10.1016/j.proenv.2016.03.088; Holl KD, 2017, SCIENCE, V355, P455, DOI 10.1126/science.aam5432; Holl KD, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P411; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper E, 2002, ECOL APPL, V12, P1626, DOI 10.1890/1051-0761(2002)012[1626:RONTST]2.0.CO;2; Jansen A, 2001, J APPL ECOL, V38, P63, DOI 10.1046/j.1365-2664.2001.00557.x; Lam DPM, 2020, ECOL SOC, V25, DOI 10.5751/ES-11305-250103; Latawiec AE, 2016, BIOTROPICA, V48, P844, DOI 10.1111/btp.12386; Laughlin DC, 2014, ECOL LETT, V17, P771, DOI 10.1111/ele.12288; Le HD, 2012, J RURAL STUD, V28, P5, DOI 10.1016/j.jrurstud.2011.07.006; M'Gonigle LK, 2017, CONSERV LETT, V10, P105, DOI 10.1111/conl.12261; Mansourian S, 2017, ECOL RESTOR, V35, P281, DOI 10.3368/er.35.4.281; Mansourian S, 2014, ENVIRON MANAGE, V53, P241, DOI 10.1007/s00267-013-0213-7; Martinez-Garza C., 2016, EXPERIENCIAS MEXICAN, P385; Martinez-Garza C, 2021, BOT SCI, V99, P242, DOI 10.17129/botsci.2695; Martorell C, 2005, BIOL CONSERV, V124, P199, DOI 10.1016/j.biocon.2005.01.025; McCall MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146038; McDonald T., 2016, INT STANDARDS PRACTI, DOI DOI 10.1177/; Meli P, 2019, RESTOR ECOL, V27, P477, DOI 10.1111/rec.12933; Meli P, 2017, RESTOR ECOL, V25, P156, DOI 10.1111/rec.12473; Mendez-Toribio M., 2018, RESTAURACI N ECOSIST; Mendez-Toribio M, 2019, ECOL RESTOR, V37, P113, DOI 10.3368/er.37.2.113; Mijangos JL, 2015, MOL ECOL, V24, P22, DOI 10.1111/mec.12995; Mills M, 2003, WATER SCI TECHNOL, V48, P129, DOI 10.2166/wst.2003.0433; Moreno-Calles AI., 2016, ETNOAGROFORESTER A M; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; Murcia C., 2015, MONITOREO PROCESOS R, P250; Murcia C, 2014, DOCUMENTOS OCASIONAL; Murcia C., 2017, RESTAURACI N BOSQUES; Murcia C, 2016, CONSERV LETT, V9, P213, DOI 10.1111/conl.12199; Murcia C, 2014, RESTOR ECOL, V22, P279, DOI 10.1111/rec.12100; NYDF . New York Declaration on Forests, 2014, PROGR ASSESSMENT GER; Ostertag R, 2015, J APPL ECOL, V52, P805, DOI 10.1111/1365-2664.12413; Ostertag R, 2009, ECOSYSTEMS, V12, P503, DOI 10.1007/s10021-009-9239-3; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Paquette A, 2009, ECOL SOC, V14; Pela-Restauracao-da-Mata-Atlantica-[PACTO] , 2013, MONITORING PROTOCOL; Perez-Ceballos R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227665; Pierce S, 2017, FUNCT ECOL, V31, P444, DOI 10.1111/1365-2435.12722; Pirard R, 2014, FORESTS, V5, P404, DOI 10.3390/f5030404; Pistorius T, 2017, FORESTS, V8, DOI 10.3390/f8030061; PROCER, 2019, T RMINOS REFERENCIA; R Core Team, 2021, R LANGUAGE ENV STAT; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyes-Garcia V, 2019, RESTOR ECOL, V27, P3, DOI 10.1111/rec.12894; Robertson M, 2000, ECOSYST HEALTH, V6, P119, DOI 10.1046/j.1526-0992.2000.00013.x; Rubens de Miranda B., 2017, EC RESTAURA O FLORES; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; de Mendonca MFS, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006912, 10.1590/s1518-8787.2017051006912]; Schnitzer SA, 2015, ECOLOGY OF LIANAS, P1, DOI 10.1002/9781118392409; SER, 2004, PRIMER SOC ECOLOGICA; Shabman Leonard A., 1995, P35; Shono K, 2007, RESTOR ECOL, V15, P620, DOI 10.1111/j.1526-100X.2007.00274.x; Sinclair ARE, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12390; Stanturf J., 2017, PRACTITIONERS GUIDE; Stanturf JA, 2014, FOREST ECOL MANAG, V331, P292, DOI 10.1016/j.foreco.2014.07.029; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Turner R.E., 1997, Wetlands Ecology and Management, V4, P65, DOI 10.1007/BF01876229; United Nations Convention to Combat Desertification (UNCCD), 2012, SUSTAINABLE DEV GOAL; United Nations (UN), 2020, DECADE ECOSYSTEM RES; United Nations (UN), 2015, SOCIAL DEV GOALS GOA; Uprety Y, 2012, ECOSCIENCE, V19, P225, DOI 10.2980/19-3-3530; Vidal CY, 2020, RESTOR ECOL, V28, P427, DOI 10.1111/rec.13096; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wangpakapattanawong P, 2010, FOREST ECOL MANAG, V260, P1399, DOI 10.1016/j.foreco.2010.07.042; Wehi PM, 2017, CONSERV BIOL, V31, P1109, DOI 10.1111/cobi.12915; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Zahawi RA, 2014, RESTOR ECOL, V22, P284, DOI 10.1111/rec.12098; Zaldivar-Jimenez M. A., 2010, Ecological Restoration, V28, P333; Zermeno-Hernandez I, 2015, APPL VEG SCI, V18, P443, DOI 10.1111/avsc.12161	118	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249573	10.1371/journal.pone.0249573	http://dx.doi.org/10.1371/journal.pone.0249573			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ8VV	33822816	gold, Green Published			2022-12-26	WOS:000637879100035
J	Bradfield, J; Kitchener, AC; Buckley, M				Bradfield, Justin; Kitchener, Andrew C.; Buckley, Michael			Selection preferences for animal species used in bone-tool-manufacturing strategies in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							SAN ROCK ART; IDENTIFICATION; NORTH; SETTLEMENT; BEHAVIOR; BELIEFS; MATRIX; POINT	Animal symbolism is a prominent feature of many human societies globally. In some cases, these symbolic attributes manifest in the technological domain, influencing the decision to use the bones of certain animals and not others for tool manufacture. In southern Africa, animals feature prominently in the cosmogenic narratives of both hunter-gatherer and Bantu-speaking farmer groups. Whenever these two culturally distinct groups came into contact with each other there would be an assimilation of cosmogenic concepts of power and the adoption of certain symbolically important animals. In this paper, we report on which animals were selected to make bone tools during the first millennium AD contact period in KwaZulu-Natal Province, South Africa, and explore the extent to which this selection may have been influenced by the symbolic associations of specific animals. Our results show selective targeting of specific animals for tool manufacture at some sites, with a narrowing of the range of selected species during the first millennium AD contact period. Certain antelope tribes, such as Aepycerotini, Cephalophini and Antilopini, appear to have been deliberately avoided, thus arguing against opportunistic selection. Nor does the range of selected animals appear to show any obvious mechanical considerations, as has been noted in similar studies. We highlight the potential of ZooMS for understanding the dynamics of animal symbolism in the past.	[Bradfield, Justin] Univ Johannesburg, Palaeo Res Inst, Johannesburg, South Africa; [Kitchener, Andrew C.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Kitchener, Andrew C.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Buckley, Michael] Univ Manchester, Sch Nat Sci, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Johannesburg; University of Edinburgh; University of Manchester	Bradfield, J (corresponding author), Univ Johannesburg, Palaeo Res Inst, Johannesburg, South Africa.	justinb@uj.ac.za		Bradfield, Justin/0000-0002-6139-6227	National Research Foundation of South Africa [116324]; Royal Society [UF120473]	National Research Foundation of South Africa(National Research Foundation - South Africa); Royal Society(Royal Society of London)	JB received funding from the National Research Foundation of South Africa (https://www.nrf.ac.za), grant 116324. MB received funding from The Royal Society (https://royalsociety.org), grant UF120473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonites AR, 2016, AFR ARCHAEOL REV, V33, P345, DOI 10.1007/s10437-016-9237-8; Antonites AR, 2016, AFR ARCHAEOL REV, V33, P437, DOI 10.1007/s10437-016-9233-z; Bleek DF, 1936, BANTU STUD, V10, P131, DOI 10.1080/02561751.1936.9676027; Bleek D.F., 1924, MANTIS HIS FRIENDS; Bleek W.H.I., 1911, SPECIMENS BUSHMEN FO; Boeyens JCA, 2014, SOUTH AFR HUMANIT, V26, P21; Bouchard GP, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.05.027; Bradfield J., 2018, PLOS ONE, V13, P1; Bradfield J, 2014, POINTED BONE TOOL TE; Bradfield J, 2019, ARCHAEOL ANTHROP SCI, V11, P2419, DOI 10.1007/s12520-018-0688-5; Bradfield J, 2016, VERTEBR PALEOBIOL PA, P31, DOI 10.1007/978-94-024-0899-7_3; Bradfield J, 2015, SOUTH AFR HUMANIT, V27, P1; Bravo G, 2019, INT J OSTEOARCHAEOL, V29, P314, DOI 10.1002/oa.2742; Brunton S, 2013, AZANIA, V48, P111, DOI 10.1080/0067270X.2012.759691; Bruton M., 2016, TRADITIONAL FISHING; Buckley M., 2018, ZOOARCHAEOLOGY PRACT, P227, DOI DOI 10.1007/978-3-319-64763-0_12; Buckley M., 2011, ANTIQUA, V1, pe1, DOI [10.4081/antiqua.2011.e1.-e1, DOI 10.4081/ANTIQUA.2011.E1.-E1, DOI 10.4081/ANTIQUA.2011.E1]; Buckley M, 2008, ANAL BIOCHEM, V374, P325, DOI 10.1016/j.ab.2007.12.002; Buckley M, 2019, QUATERNARY SCI REV, V224, DOI 10.1016/j.quascirev.2019.105882; Buckley M, 2017, BOREAS, V46, P402, DOI 10.1111/bor.12225; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Cable J. H. C., 1980, ANN NAT MUS, V24, P1; Callaway H., 1868, NURSERY TALES TRADIT, V1; Canonici N, 1995, THESIS U NATAL; Challis W., 2005, S AFRICAN ARCHAEOLOG, V9, P11; Chowdhury MP, 2019, ARCHAEOMETRY, V61, P1382, DOI 10.1111/arcm.12492; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Coutu AN, 2016, AFR ARCHAEOL REV, V33, P411, DOI 10.1007/s10437-016-9232-0; Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002; Currey JD, 2012, J MATER SCI, V47, P41, DOI 10.1007/s10853-011-5914-9; Deacon J, 1992, ARROWS AGENTS BELIEF; Derricourt R. M., 1977, PREHISTORIC MAN CISK; Desmond A, 2018, J ARCHAEOL SCI, V98, P149, DOI 10.1016/j.jas.2018.08.012; Dewar G, 2006, J ARCHAEOL SCI, V33, P1266, DOI 10.1016/j.jas.2006.01.003; Dornan S. S, 1925, VULNERABILITY; Eastwood E., 2006, CAPTURING SPOOR EXPL; Eastwood EB, 1999, S AFR ARCHAEOL BULL, V54, P107, DOI 10.2307/3889289; Fowler Kent D., 2008, BAR International Series, V1849, P169; Fowler KD, 2009, SOUTH AFR HUMANIT, V21, P345; Francillon-Vieillot H., 1990, P471; Gardiner A.F., 1836, NARRATIVE JOURNEY ZO; Groves C, 2011, UNGULATE TAXONOMY; Gussler J., 1973, RELIGION, P88; Hall S., 1986, S AFRICAN ARCHAEOLOG, V5, P42; Hall SL., 1994, CONTESTED IMAGES DIV, P61; Hammond-Tooke WD, 1999, S AFR ARCHAEOL BULL, V54, P128, DOI 10.2307/3889291; Hammond-Tooke WD, 2002, AFRICA, V72, P277; Hirst M., 1996, CURARE, V19, P255; Hirst M., 1990, THESIS RHODES U; Hogarth C., 2004, SHAMANISM ENCY WORLD, P3; Hoke N, 2019, ARCHAEOL ANTHROP SCI, V11, P3357, DOI 10.1007/s12520-018-0765-9; Ingold T., 1988, WHAT IS ANIMAL; Irvine L, 2004, SYMB INTERACT, V27, P3, DOI 10.1525/si.2004.27.1.3; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jenkins T, 1982, Prog Clin Biol Res, V103 Pt A, P227; Jolly P, 1996, CURR ANTHROPOL, V37, P277, DOI 10.1086/204492; Jolly P., 2000, SOUTH AFR HUMANIT, V12, P79; Jolly P., 1995, S AFR ARCHAEOL BULL, V50, P68, DOI DOI 10.2307/3889275; Kopytoff I, 1989, AFRICAN FRONTIER REP; Krige E. J., 1936, SOCIAL SYSTEM ZULUS; Krige EJ., 1980, STUDY PATTERN LOVEDU; KUPER H, 1973, MAN, V8, P613, DOI 10.2307/2800744; Levi-Strauss C., 1963, TOTEMISM; Lewis-Williams D, 1981, BELIEVING SEEING SYM; Lewis-Williams JD, 2012, ANTIQUITY, V86, P696, DOI 10.1017/S0003598X00047852; Li SM, 2013, J MECH BEHAV BIOMED, V21, P109, DOI 10.1016/j.jmbbm.2013.02.021; Loubser H. N., 1993, NATAL MUSEUM J HUMAN, V5, P109; MAGGS T, 1984, Annals of the Natal Museum, V26, P71; MAGGS T, 1980, Annals of the Natal Museum, V24, P35; MAGGS T M O, 1975, Annals of the Natal Museum, V22, P449; Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x; Martisius NL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64358-w; Mazd AD, 2013, TIME MIND, V6, P49, DOI 10.2752/175169713X13500468476565; Mazel A, 1989, SOUTH AFR HUMANIT, V1, P1; Mazel A.D., 1988, Annals of the Natal Museum, V29, P321; MAZEL A D, 1986, Annals of the Natal Museum, V27, P357; Mazel A.D., 2003, SO AFRICAN HUMANITIE, V15, P59; Mazel A.D., 1990, NATAL MUSEUM J HUMAN, V2, P95; Mazel A.D., 1996, NATAL MUSEUM J HUMAN, V8, P1; Mazel A.D., 1992, NATAL MUSEUM J HUMAN, V4, P1; Mazel AD., 1989, S AFRICAN ARCHAEOLOG, V6, P33; McGhee R, 1977, CANADIAN J ARCHAEOLO, V1, P141; McGranaghan M, 2014, CRIT ARTS, V28, P670, DOI 10.1080/02560046.2014.929223; McGrath K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47299-x; Mitchell P., 2003, RES AFRICAS NEW CONT, V57, P35; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Olupona J, 2008, ANTHR HUMANISM, V18, P3; Ouzman Sven, 1995, South African Archaeological Bulletin, V50, P55, DOI 10.2307/3889274; Overton NJ, 2013, ARCHAEOL DIALOG, V20, P111, DOI 10.1017/S1380203813000159; PARKINGTON J, 1987, J AFR HIST, V28, P1, DOI 10.1017/S002185370002939X; Pestle WJ, 2012, J ARCHAEOL SCI, V39, P2079, DOI 10.1016/j.jas.2012.03.008; PLUG I, 1996, NATAL MUSEUM J HUMAN, V8, P41; Plug I., 1992, NATAL MUSEUM J HUMAN, V4, P53; Plug I, 2012, MCDONALD I MONOGRAPH, P87; Plug I, 1987, RES NATL CULTURAL HI, V1, P50; PLUG I, 2002, SOUTH AFR HUMANIT, V14, P51; Plug Ina, 1999, Archaeozoologia, V10, P189; Prins F., 1990, S AFRICAN J ETHNOLOG, V13, P110; PRINS FE, 1992, ETHNOLOGY, V31, P133, DOI 10.2307/3773617; Russell N., 2012, SOCIAL ZOOARCHAEOLOG; Russell T, 2000, S AFR ARCHAEOL BULL, V55, P60, DOI 10.2307/3888893; Ryan K., 1995, MASCA RES PAPERS SCI; Schapera Isaac, 1971, RAINMAKING RITES TSW; St-Pierre CG, 2018, J ARCHAEOL SCI-REP, V20, P853, DOI 10.1016/j.jasrep.2018.02.026; Stow G.W., 1930, ROCK PAINTINGS S AFR; Tapper Richard, 1988, WHAT IS ANIMAL, P47; Taylor WA, 2006, S AFR J WILDL RES, V36, P183; Thackeray F., 1994, CONTESTED IMAGES DIV, P223; Thackeray F, 1996, PICTOGRAM, V8, P22; Thackeray J., 2019, AFRIQUE ARCH OLOGIE, V15, P17; Thackeray JF, 2005, ANTIQUITY, V79, P5, DOI 10.1017/S0003598X00113663; Tomasso A, 2018, J ARCHAEOL SCI, V100, P158, DOI 10.1016/j.jas.2018.05.003; Van der Ryst MM., 2003, ANTHR SO AFRICA, V16, P42; van der Sluis LG, 2014, PALAEOGEOGR PALAEOCL, V416, P80, DOI 10.1016/j.palaeo.2014.06.003; van Doornum B. L., 2005, THESIS U WITWATERSRA; van Schalkwyk L., 1994, NATAL MUSEUM J HUMAN, V6, P65; Van Warmelo NJ., 1932, RELIG TRIBAL RITUAL; Vinnicombe P, 1976, PEOPLE OF THE ELAND; Voigt, 1983, MAPUNGUBWE ARCHAEOZO; VOIGT E A, 1984, Annals of the Natal Museum, V26, P95; Voigt E. A., 1994, NATAL MUSEUM J HUMAN, V6, P105; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P122; Walton J., 1957, P 3 PAN AFR C PREH L, P277; Whitelaw G., 1994, NATAL MUSEUM J HUMAN, V6, P1; WIESSNER P, 1983, AM ANTIQUITY, V48, P253, DOI 10.2307/280450; Willerslev R, 2007, SOUL HUNTERS: HUNTING, ANIMISM, AND PERSONHOOD AMONG THE SIBERIAN YUKAGHIRS, P1, DOI 10.1525/california/9780520252165.001.0001; Wright J, 1971, BUSHMAN RAIDERS DRAK; Zutovski K, 2016, QUATERN INT, V406, P227, DOI 10.1016/j.quaint.2015.01.033	128	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249296	10.1371/journal.pone.0249296	http://dx.doi.org/10.1371/journal.pone.0249296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793614	gold, Green Published			2022-12-26	WOS:000636467000082
J	Nath, T; Ahima, RS; Santhanam, P				Nath, Tanmay; Ahima, Rexford S.; Santhanam, Prasanna			Body fat predicts exercise capacity in persons with Type 2 Diabetes Mellitus: A machine learning approach	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; CARDIOVASCULAR-DISEASE; GLUCOSE-TOLERANCE; MORTALITY; INDIVIDUALS; MEN; INSULIN; MASS	Diabetes mellitus is associated with increased cardiovascular disease (CVD) related morbidity, mortality and death. Exercise capacity in persons with type 2 diabetes has been shown to be predictive of cardiovascular events. In this study, we used the data from the prospective randomized LOOK AHEAD study and used machine learning algorithms to help predict exercise capacity (measured in Mets) from the baseline data that included cardiovascular history, medications, blood pressure, demographic information, anthropometric and Dual-energy X-Ray Absorptiometry (DXA) measured body composition metrics. We excluded variables with high collinearity and included DXA obtained Subtotal (total minus head) fat percentage and Subtotal lean mass (gms). Thereafter, we used different machine learning methods to predict maximum exercise capacity. The different machine learning models showed a strong predictive performance for both females and males. Our study shows that using baseline data from a large prospective cohort, we can predict maximum exercise capacity in persons with diabetes mellitus. We show that subtotal fat percentage is the most important feature for predicting the exercise capacity for males and females after accounting for other important variables. Until now, BMI and waist circumference were commonly used surrogates for adiposity and there was a relative under-appreciation of body composition metrics for understanding the pathophysiology of CVD. The recognition of body fat percentage as an important marker in determining CVD risk has prognostic implications with respect to cardiovascular morbidity and mortality.	[Nath, Tanmay] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Ahima, Rexford S.; Santhanam, Prasanna] Johns Hopkins Univ, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Santhanam, P (corresponding author), Johns Hopkins Univ, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA.	psantha1@jhmi.edu		Nath, Tanmay/0000-0002-2092-7159	Bloomberg Distinguished Professorship in Diabetes; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing Research (NINR); National Institute of Minority Health and Health Disparities (NIMHD); Office of Research on Women's Health (ORWH); Centers for Disease Control and Prevention (CDC)	Bloomberg Distinguished Professorship in Diabetes; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute of Minority Health and Health Disparities (NIMHD); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The authors received no specific funding for this work. The publication expenses were supported by Bloomberg Distinguished Professorship in Diabetes.; Look AHEAD was conducted by the Look AHEAD Research Group and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Heart, Lung, and Blood Institute (NHLBI); the National Institute of Nursing Research (NINR); the National Institute of Minority Health and Health Disparities (NIMHD); the Office of Research on Women's Health (ORWH); and the Centers for Disease Control and Prevention (CDC). The data [and samples] from Look AHEAD were supplied by the NIDDK Central Repositories. This manuscript was not prepared under the auspices of the Look AHEAD and does not represent analyses or conclusions of the Look AHEAD Research Group, the NIDDK Central Repositories, or the NIH.	Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; Baum A, 2017, LANCET DIABETES ENDO, V5, P808, DOI 10.1016/S2213-8587(17)30176-6; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Bray G., 2006, DIABETES VASC DIS RE, V3, P202; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L., 2001, MACH LEARN, V45, P5; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; COON PJ, 1989, METABOLISM, V38, P1201, DOI 10.1016/0026-0495(89)90160-1; Fang ZY, 2005, DIABETES CARE, V28, P1643, DOI 10.2337/diacare.28.7.1643; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Howell CR, 2018, OBESITY, V26, P1372, DOI 10.1002/oby.22251; Kimyagarov S, 2010, ARCH GERONTOL GERIAT, V51, P227, DOI 10.1016/j.archger.2009.10.013; King DB, 2015, ACS SYM SER, V1214, P1; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Koliaki C, 2019, METABOLISM, V92, P98, DOI 10.1016/j.metabol.2018.10.011; Korpelainen R, 2016, ANN MED, V48, P359, DOI 10.1080/07853890.2016.1178856; Krittanawong C, 2017, J AM COLL CARDIOL, V69, P2657, DOI 10.1016/j.jacc.2017.03.571; Kwon JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219302; Lavie CJ, 2011, MAYO CLIN PROC, V86, P857, DOI 10.4065/mcp.2011.0092; Lundberg SM, 2017, ADV NEUR IN, V30; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; MONTOYE HJ, 1985, MED SCI SPORT EXER, V17, P640, DOI 10.1249/00005768-198512000-00003; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nadeau KJ, 2009, J CLIN ENDOCR METAB, V94, P3687, DOI 10.1210/jc.2008-2844; Nath T, 2020, J CLIN HYPERTENS, V22, P1098, DOI 10.1111/jch.13914; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pownall HJ, 2015, OBESITY, V23, P565, DOI 10.1002/oby.21005; Regensteiner JG, 1998, J APPL PHYSIOL, V85, P310, DOI 10.1152/jappl.1998.85.1.310; REGENSTEINER JG, 1995, DIABETES CARE, V18, P490, DOI 10.2337/diacare.18.4.490; Ribisl PM, 2007, DIABETES CARE, V30, P2679, DOI 10.2337/dc06-2487; Salokari E, 2019, EUR J PREV CARDIOL, V26, P199, DOI 10.1177/2047487318804618; Santhanam P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233336; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Srikanthan P, 2016, AM J CARDIOL, V117, P1355, DOI 10.1016/j.amjcard.2016.01.033; Vapnik V, 2013, NATURE STAT LEARNING, V2013; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2013, NEW ENGL J MED, V369, P2358, DOI 10.1056/NEJMc1312802	44	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248039	10.1371/journal.pone.0248039	http://dx.doi.org/10.1371/journal.pone.0248039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788855	gold, Green Published			2022-12-26	WOS:000636354600007
J	Vang, P; Baumann, CW; Barok, R; Larson, AA; Dougherty, BJ; Lowe, DA				Vang, Pangdra; Baumann, Cory W.; Barok, Rebecca; Larson, Alexie A.; Dougherty, Brendan J.; Lowe, Dawn A.			Impact of estrogen deficiency on diaphragm and leg muscle contractile function in female mdx mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; X-CHROMOSOME INACTIVATION; SKELETAL-MUSCLE; MANIFESTING CARRIERS; MOUSE MODEL; GENETIC-CHARACTERIZATION; OVARIAN HORMONES; STRENGTH LOSS; EXPRESSION; WOMEN	Female carriers of Duchenne muscular dystrophy (DMD) presenting with DMD symptomology similar to males with DMD, such as skeletal muscle weakness and cardiomyopathy, are termed manifesting carriers. There is phenotypic variability among manifesting carriers including the age of onset, which can range from the first to fourth decade of life. In females, estrogen levels typically begin to decline during the fourth decade of life and estrogen deficiency contributes to loss of muscle strength and recovery of strength following injury. Thus, we questioned whether the decline of estrogen impacts the development of DMD symptoms in females. To address this question, we studied 6-8 month-old homozygous mdx female mice randomly assigned to a sham or ovariectomy (OVX) surgical group. In vivo whole-body plethysmography assessed ventilatory function and diaphragm muscle strength was measured in vitro before and after fatigue. Anterior crural muscles were analyzed in vivo for contractile function, fatigue, and in response to eccentric contraction (ECC)-induced injury. For the latter, 50 maximal ECCs were performed by the anterior crural muscles to induce injury. Body mass, uterine mass, hypoxia-hypercapnia ventilatory response, and fatigue index were analyzed by a pooled unpaired t-test. A two-way ANOVA was used to analyze ventilatory measurements. Fatigue and ECC-injury recovery experiments were analyzed by a two-way repeated-measures ANOVA. Results show no differences between sham and OVX mdx mice in ventilatory function, strength, or recovery of strength after fatigue in the diaphragm muscle or anterior crural muscles (p >= 0.078). However, OVX mice had significantly greater eccentric torque loss and blunted recovery of strength after ECC-induced injury compared to sham mice (p <= 0.019). Although the results show that loss of estrogen has minimal impact on skeletal muscle contractile function in female mdx mice, a key finding suggests that estrogen is important in muscle recovery in female mdx mice after injury.	[Vang, Pangdra; Baumann, Cory W.; Barok, Rebecca; Dougherty, Brendan J.; Lowe, Dawn A.] Univ Minnesota, Dept Rehabil Med, Div Rehabil Sci, Minneapolis, MN 55455 USA; [Larson, Alexie A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Dougherty, Brendan J.; Lowe, Dawn A.] Univ Minnesota, Div Phys Therapy, Dept Rehabil Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lowe, DA (corresponding author), Univ Minnesota, Dept Rehabil Med, Div Rehabil Sci, Minneapolis, MN 55455 USA.; Lowe, DA (corresponding author), Univ Minnesota, Div Phys Therapy, Dept Rehabil Med, Minneapolis, MN 55455 USA.	lowex017@umn.edu		Dougherty, Brendan/0000-0002-5995-8948	Greg Marzolf Jr. Foundation; NIH Training Program in Muscle Research [T32AR007612]; NIH Training Program in Functional Proteomics in Aging Training Grant [T32AG29796]	Greg Marzolf Jr. Foundation; NIH Training Program in Muscle Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program in Functional Proteomics in Aging Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from The Greg Marzolf Jr. Foundation to DAL. PV was supported by the NIH Training Program in Muscle Research (T32AR007612). CWB and AAL were supported by the NIH Training Program in Functional Proteomics in Aging Training Grant (T32AG29796).	Baumann CW, 2020, MED SCI SPORT EXER, V52, P354, DOI 10.1249/MSS.0000000000002126; Baumann CW, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12081; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bedoschi G, 2016, FUTURE ONCOL, V12, P2333, DOI 10.2217/fon-2016-0176; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Brioschi S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-73; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burns DP, 2019, J PHYSIOL-LONDON, V597, P831, DOI 10.1113/JP277443; Burns DP, 2018, J PHYSIOL-LONDON, V596, P5175, DOI 10.1113/JP276954; Burns DP, 2017, J PHYSIOL-LONDON, V595, P6653, DOI 10.1113/JP274792; Burns DP, 2015, ADV EXP MED BIOL, V860, P239, DOI 10.1007/978-3-319-18440-1_27; BUSHBY KMD, 1993, NEUROMUSCULAR DISORD, V3, P57, DOI 10.1016/0960-8966(93)90042-I; Carberry S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691641; Carberry S, 2012, INT J MOL MED, V30, P229, DOI 10.3892/ijmm.2012.1006; Cho Yu Na, 2013, [Journal of Genetic Medicine, 대한의학유전학회지], V10, P94; Collins BC, 2019, CELL REP, V28, P368, DOI 10.1016/j.celrep.2019.06.025; Collins BC, 2019, BONE, V123, P137, DOI 10.1016/j.bone.2019.03.033; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Cotta A, 2017, CAN J NEUROL SCI, V44, P304, DOI 10.1017/cjn.2016.448; Drivsholm P, 2016, NEUROMUSCULAR DISORD, V26, pS123, DOI 10.1016/j.nmd.2016.06.138; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Grain L, 2001, NEUROMUSCULAR DISORD, V11, P186, DOI 10.1016/S0960-8966(00)00185-1; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Greising SM, 2016, METHODS MOL BIOL, V1460, P309, DOI 10.1007/978-1-4939-3810-0_21; Greising SM, 2015, AM J PHYSIOL-LUNG C, V309, pL46, DOI 10.1152/ajplung.00064.2015; Greising SM, 2013, EXP GERONTOL, V48, P881, DOI 10.1016/j.exger.2013.06.001; Greising SM, 2009, J GERONTOL A-BIOL, V64, P1071, DOI 10.1093/gerona/glp082; Hakim CH, 2012, MUSCLE NERVE, V45, P250, DOI 10.1002/mus.22275; Heide S, 2015, EUR J MED GENET, V58, P341, DOI 10.1016/j.ejmg.2015.04.003; Henry CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183853; Hermes TD, 2018, CELL BIOL INT, V42, P1611, DOI 10.1002/cbin.11057; Hoogerwaard EM, 1999, LANCET, V353, P2116, DOI 10.1016/S0140-6736(98)10028-4; Hourde C, 2013, MUSCLE NERVE, V48, P68, DOI 10.1002/mus.23700; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Ishizaki M, 2018, NEUROMUSCULAR DISORD, V28, P572, DOI 10.1016/j.nmd.2018.04.005; Kitajima Y, 2016, J ENDOCRINOL, V229, P267, DOI 10.1530/JOE-15-0476; Kosir AM, 2015, MED SCI SPORT EXER, V47, P1177, DOI 10.1249/MSS.0000000000000531; Larson AA, 2020, EXP PHYSIOL, V105, P1700, DOI 10.1113/EP088827; Le G, 2018, J PHYSIOL-LONDON, V596, P4665, DOI 10.1113/JP276432; Lindsay A, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-0221-2; LOWE DA, 1995, J APPL PHYSIOL, V79, P1260, DOI 10.1152/jappl.1995.79.4.1260; MATTHEWS PM, 1995, NEUROMUSCULAR DISORD, V5, P209, DOI 10.1016/0960-8966(94)00057-G; Mckeehen JN, 2013, MED SCI SPORT EXER, V45, P1051, DOI 10.1249/MSS.0b013e3182811947; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Meyers TA, 2020, HUM MOL GENET, V29, P944, DOI 10.1093/hmg/ddaa015; Meyers TA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174098; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Molina JR, 2005, DRUG SAFETY, V28, P401, DOI 10.2165/00002018-200528050-00004; Moran AL, 2006, J APPL PHYSIOL, V100, P548, DOI 10.1152/japplphysiol.01029.2005; MOSER H, 1974, CLIN GENET, V5, P271; Mosqueira M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069567; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Pollanen E, 2015, AGING CELL, V14, P236, DOI 10.1111/acel.12309; Rall Susanne, 2012, Acta Myol, V31, P117; Salimena M, 2004, HISTOCHEM CELL BIOL, V122, P435, DOI 10.1007/s00418-004-0707-8; Shufelt CL, 2017, SEMIN REPROD MED, V35, P256, DOI 10.1055/s-0037-1603581; SIDDLE N, 1987, FERTIL STERIL, V47, P94; Sipila S, 2015, CALCIFIED TISSUE INT, V96, P222, DOI 10.1007/s00223-014-9924-x; Sipila S, 2013, BIOGERONTOLOGY, V14, P231, DOI 10.1007/s10522-013-9425-8; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Vang P, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14305; Viggiano E, 2013, CLIN GENET, V84, P265, DOI 10.1111/cge.12048; Viggiano E, 2016, HUM GENET, V135, P685, DOI 10.1007/s00439-016-1666-6; Zelikovich AS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42203-z	69	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249472	10.1371/journal.pone.0249472	http://dx.doi.org/10.1371/journal.pone.0249472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788896	Green Published, gold			2022-12-26	WOS:000636354600051
J	West, JA; Tsakmaki, A; Ghosh, SS; Parkes, DG; Gronlund, RV; Pedersen, PJ; Maggs, D; Rajagopalan, H; Bewick, GA				West, Jason A.; Tsakmaki, Anastasia; Ghosh, Soumitra S.; Parkes, David G.; Gronlund, Rikke V.; Pedersen, Philip J.; Maggs, David; Rajagopalan, Harith; Bewick, Gavin A.			Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; GASTRIC BYPASS-SURGERY; BETA-CELL FUNCTION; COMPETITIVE ANTAGONIST; 7-36 AMIDE; OBESITY; GIP(3-30)NH2; RESISTANCE	Combinatorial gut hormone therapy is one of the more promising strategies for identifying improved treatments for metabolic disease. Many approaches combine the established benefits of glucagon-like peptide-1 (GLP-1) agonism with one or more additional molecules with the aim of improving metabolic outcomes. Recent attention has been drawn to the glucose-dependent insulinotropic polypeptide (GIP) system due to compelling pre-clinical evidence describing the metabolic benefits of antagonising the GIP receptor (GIPR). We rationalised that benefit might be accrued from combining GIPR antagonism with GLP-1 agonism. Two GIPR peptide antagonists, GIPA-1 (mouse GIP(3-30)NH2) and GIPA-2 (N alpha Ac-K10[gamma E gamma E-C16]-Arg18-hGIP(5-42)), were pharmacologically characterised and both exhibited potent antagonist properties. Acute in vivo administration of GIPA-1 during an oral glucose tolerance test (OGTT) had negligible effects on glucose tolerance and insulin in lean mice. In contrast, GIPA-2 impaired glucose tolerance and attenuated circulating insulin levels. A mouse model of diet-induced obesity (DIO) was used to investigate the potential metabolic benefits of chronic dosing of each antagonist, alone or in combination with liraglutide. Chronic administration studies showed expected effects of liraglutide, lowering food intake, body weight, fasting blood glucose and plasma insulin concentrations while improving glucose sensitivity, whereas delivery of either GIPR antagonist alone had negligible effects on these parameters. Interestingly, chronic dual therapy augmented insulin sensitizing effects and lowered plasma triglycerides and free-fatty acids, with more notable effects observed with GIPA-1 compared to GIPA-2. Thus, the co-administration of both a GIPR antagonist with a GLP1 agonist uncovers interesting beneficial effects on measures of insulin sensitivity, circulating lipids and certain adipose stores that seem influenced by the degree or nature of GIP receptor antagonism.	[West, Jason A.; Maggs, David; Rajagopalan, Harith] Fractyl Labs Inc, Lexington, MA USA; [Tsakmaki, Anastasia; Bewick, Gavin A.] Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, Diabet Res Grp, London, England; [Ghosh, Soumitra S.] Doon Associates LLC, San Diego, CA USA; [Parkes, David G.] DGP Sci Inc, San Diego, CA USA; [Gronlund, Rikke V.; Pedersen, Philip J.] Gubra ApS, Horsholm, Denmark	University of London; King's College London	Bewick, GA (corresponding author), Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, Diabet Res Grp, London, England.	gavin.bewick@kcl.ac.uk	West, Jason/I-4445-2014	West, Jason/0000-0002-7252-8651; Bewick, Gavin/0000-0002-4335-8403; Ghosh, Soumitra/0000-0002-7405-0436	Fractyl Laboratories Inc., Lexington, MA	Fractyl Laboratories Inc., Lexington, MA	This study was supported by Fractyl Laboratories Inc., Lexington, MA. Employees and shareholders of Fractyl Laboratories Inc played a prominent role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. All authors reviewed and critiqued the manuscript throughout the editorial process, approved the final manuscript draft submitted for publication, and agreed to be accountable for all aspects of the work, ensuring the accuracy and integrity of the publication.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Asmar M, 2010, DIABETES, V59, P2160, DOI 10.2337/db10-0098; BAILEY CJ, 1986, NAT GENET, V112, P224, DOI [DOI 10.1530/acta.0.1120224, DOI 10.1530/ACTA.0.1120224]; BAILEY CJ, 2020, AM J PHYSIOL-ENDOC M, V125, P70202, DOI [DOI 10.1016/J.PEPTIDES.2019.170202, DOI 10.1016/j.peptides.2019.170202]; BALDASSANO S, 2019, DIABETOLOGIA, V10, P492, DOI DOI 10.3389/fendo.2019.00492; BOYLAN MO, 2015, BIOL CHEM, V309, pE1008, DOI [DOI 10.1152/ajpendo.00345.2015, DOI 10.1152/AJPENDO.00345.2015]; Brandt SJ, 2018, PEPTIDES, V100, P190, DOI 10.1016/j.peptides.2017.12.021; Burcelin R, 2017, OBES REV, V18, P86, DOI 10.1111/obr.12465; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; CAMPBELL JE, 2016, MOL METAB, V22, P84, DOI [DOI 10.1038/NM.3997, DOI 10.1038/nm.3997]; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; Drucker DJ, 2017, J CLIN INVEST, V127, P4217, DOI 10.1172/JCI97233; Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Gabe MBN, 2018, BIOCHEM PHARMACOL, V150, P97, DOI 10.1016/j.bcp.2018.01.040; Gasbjerg LS, 2019, DIABETES, V68, P906, DOI 10.2337/db18-1123; Gasbjerg LS, 2018, DIABETOLOGIA, V61, P413, DOI 10.1007/s00125-017-4447-4; Gasbjerg LS, 2018, PEPTIDES, V100, P173, DOI 10.1016/j.peptides.2017.11.021; Gimeno RE, 2020, CELL METAB, V31, P679, DOI 10.1016/j.cmet.2020.02.014; Gogebakan O., 2012, DIABETES, V61, P292, DOI DOI 10.2337/DB10-0902; Hansen LS, 2016, BRIT J PHARMACOL, V173, P826, DOI 10.1111/bph.13384; Hare KJ, 2010, DIABETES, V59, P1765, DOI 10.2337/db09-1414; Hoist JJ, 2019, METABOLISM, V96, P46, DOI 10.1016/j.metabol.2019.04.014; Holst JJ, 2020, J CLIN ENDOCR METAB, V105, pE2710, DOI 10.1210/clinem/dgaa327; Irwin N, 2009, BIOL CHEM, V390, P75, DOI 10.1515/BC.2009.002; JORGENSEN NB, 2012, GASTROENT RES PRACT, V303, pE122, DOI [DOI 10.1152/AJPENDO.00073.2012, DOI 10.1152/ajpendo.00073.2012]; KANEKO K, 2019, BIOCHEM BIOPH RES CO, V129, P3786, DOI DOI 10.1172/JCI126107; KERR BD, 2011, CLIN MED INSIGHTS-EN, V404, P870, DOI [DOI 10.1016/j.bbrc.2010.12.077, DOI 10.1016/J.BBRC.2010.12.077]; KILLION EA, 2020, BRIT J PHARMACOL, V11, P4981, DOI [DOI 10.1038/s41467-020-18751-8, DOI 10.1038/S41467-020-18751-8]; KILLION EA, 2020, J CLIN ENDOCR METAB, V41, DOI DOI 10.1210/ENDREV/BNZ002; Killion EA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat3392; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Larraufie P, 2019, CELL REP, V26, P1399, DOI 10.1016/j.celrep.2019.01.047; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; MROZ PA, 2019, FRONT ENDOCRINOL, V20, P51, DOI [DOI 10.1016/j.molmet.2018.12.001, DOI 10.1016/J.MOLMET.2018.12.001]; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nauck MA, 2018, DIABETES OBES METAB, V20, P5, DOI 10.1111/dom.13129; PAMIR N, 2003, NAT MED, V284, pE931, DOI [DOI 10.1152/ajpendo.00270.2002, DOI 10.1152/AJPENDO.00270.2002]; Paratore Sabrina, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P210; Pathak V, 2015, MOL CELL ENDOCRINOL, V401, P120, DOI 10.1016/j.mce.2014.10.025; PERRY RA, 2019, BRIT J PHARMACOL, V12, P75453, DOI DOI 10.1177/1179551419875453; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Reimann F, 2016, J DIABETES INVEST, V7, P13, DOI 10.1111/jdi.12478; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Salehi M, 2011, DIABETES, V60, P2308, DOI 10.2337/db11-0203; Seeley RJ, 2015, CELL METAB, V21, P369, DOI 10.1016/j.cmet.2015.01.001; Sparre-Ulrich AH, 2017, BIOCHEM PHARMACOL, V131, P78, DOI 10.1016/j.bcp.2017.02.012; Sparre-Ulrich AH, 2016, BRIT J PHARMACOL, V173, P27, DOI 10.1111/bph.13323; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Svendsen B, 2020, MOL METAB, V32, P44, DOI 10.1016/j.molmet.2019.11.018; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x; XIONG SW, 2015, ANN SURG, V2015, P25196, DOI DOI 10.1155/2015/625196; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zervos EE, 2010, J AM COLL SURGEONS, V210, P564, DOI 10.1016/j.jamcollsurg.2009.12.025	61	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249239	10.1371/journal.pone.0249239	http://dx.doi.org/10.1371/journal.pone.0249239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788878	Green Published, gold			2022-12-26	WOS:000636354600044
J	Sakyi, SA; Laing, EF; Mantey, R; Kwarteng, A; Owiredu, EW; Dadzie, RE; Amoani, B; Opoku, S; Afranie, BO; Boakye, D				Sakyi, Samuel Asamoah; Laing, Edwin Ferguson; Mantey, Richard; Kwarteng, Alexander; Owiredu, Eddie-Williams; Dadzie, Richard Ephraim; Amoani, Benjamin; Opoku, Stephen; Afranie, Bright Oppong; Boakye, Daniel			Profiling immuno-metabolic mediators of vitamin B-12 deficiency among metformin-treated type 2 diabetic patients in Ghana	PLOS ONE			English	Article							HOMOCYSTEINE METABOLISM; BIOCHEMICAL MARKERS; RISK-FACTORS; ASSOCIATION; FOLATE; RECOMMENDATIONS; PREVALENCE; PREVENTION; DIAGNOSIS; GERMAN	Background The association between prolong metformin usage and B12 deficiency has been documented. However, the prevalence estimates of metformin-induced vitamin B12 deficiency showed substantial disparity among studies due to varied study definitions of vitamin B12 deficiency. Metformin blocks the calcium dependent absorption of the vitamin B12-Intrinsic Factor complex at the terminal ileum. Lack of intrinsic factor due to the presence of auto-antibodies to parietal cells (IFA) could lead to vitamin B12 deficiency and subsequently cause peripheral neuropathy. We investigated the prevalence of vitamin B12 deficiency using more sensitive, combined markers of vitamin B12 status (4cB12) and the immuno-biochemical mediators of vitamin B12 deficiency. Methods In this observational study, 200 consecutive consenting metformin-treated T2DM patients, aged 35 and above, attending the diabetic clinic at KATH were recruited. Vitamin B-12 deficiency was classified based on the Fedosov age-normalized wellness quotient. Anthropometric measurement was taken as well as blood samples for immunological and biochemical mediators. Peripheral neuropathy was assessed using the Michigan Neuropathy Screening Instrument (MNSI). Statistical analysis was performed using the R Language for Statistical Computing. Results Using the combined indicator (4cB(12)), the prevalence of metformin induced vitamin B12 deficiency was 40.5% whilst the prevalence of MNSI-Q and MNSI-PE diabetic neuropathy was 32.5% and 6.5% respectively. Participants with vitamin B-12 deficiency had significantly higher levels of IFA, GPA, TNF-alpha, TC, LDL and albumin compared to those with normal vitamin B-12 levels (p < 0.05). Correlation analysis revealed a statistically significant negative association between 4cB(12) and the immunological markers [IFA (rs = -0.301, p<0.0001), GPA (rs = -0.244, p = 0.001), TNF-alpha (rs = -0.242, p = 0.001) and IL-6 (rs = -0.145, p = 0.041)]. Likewise, 4cB(12) was negatively associated with TC (rs = -0.203, p = 0.004) and LDL (rs = -0.222, p = 0.002) but positively correlated with HDL (rs = 0.196, p = 0.005). Conclusion Vitamin B12 deficiency and diabetic neuropathy are very high among metformin-treated T2DM patients and it is associated with increased GPA, IFA, TNF-alpha and cardiometabolic risk factors (higher LDL and TC and lower HDL). Upon verification of these findings in a prospective case-control study, it may be beneficial to include periodic measurement of Vitamin B12 using the more sensitive combined indicators (4cB 12) in the management of patients with T2DM treated with metformin in Ghana.	[Sakyi, Samuel Asamoah; Laing, Edwin Ferguson; Mantey, Richard; Owiredu, Eddie-Williams; Afranie, Bright Oppong] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana; [Kwarteng, Alexander] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Dadzie, Richard Ephraim] Univ Cape Coast, Fac Allied Hlth Sci, Dept Med Lab Technol, Cape Coast, Ghana; [Amoani, Benjamin] Univ Cape Coast, Sch Allied Hlth Sci, Dept Biomed Sci, Cape Coast, Ghana; [Opoku, Stephen] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Med Diagnost, Coll Hlth Sci, Kumasi, Ghana; [Boakye, Daniel] Leibniz Inst Prevent Res & Epidemiol BIP S, Dept Epidemiol Methods & Etiol Res, Bremen, Germany	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Cape Coast; University of Cape Coast; Kwame Nkrumah University Science & Technology	Sakyi, SA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana.	samasamoahsakyi@yahoo.co.uk	Sakyi, Samuel Asamoah/AAQ-3998-2021	Boakye, Daniel/0000-0003-4684-0841; Oppong Afranie, Bright/0000-0001-7179-4977; Opoku, Stephen/0000-0002-1949-2338; Owiredu, Eddie-Williams/0000-0003-4499-0678; sakyi, samuel/0000-0001-5168-4762	 [KNUST/Kref/2018]		KNUST/Kref/2018	Ahmed MA, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0088-3; Al Washali A. Y., 2014, INT J PUBLIC HLTH CL, V1, P141; Al-Daghri NM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090460; Al-Maskari Masoud Y, 2012, Nutrition, V28, pe23, DOI 10.1016/j.nut.2012.01.005; Alvarez M, 2019, ENDOCR CONNECT, V8, P1324, DOI 10.1530/EC-19-0382; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Aroda VR, 2016, J CLIN ENDOCR METAB, V101, P1754, DOI 10.1210/jc.2015-3754; Baraz S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-19; Bulugahapitiya U, 2009, DIABETES VASC DIS RE, V6, P21, DOI 10.3132/dvdr.2009.004; Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229; CHEESBROUGH M, 1981, TROP DOCT, V11, P188, DOI 10.1177/004947558101100416; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Danquah I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-210; Fedosov SN, 2015, CLIN CHEM LAB MED, V53, P1215, DOI 10.1515/cclm-2014-0818; Fedosov SN, 2013, CLIN CHIM ACTA, V422, P47, DOI 10.1016/j.cca.2013.04.002; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Fondjo LA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9369282; Green R, 2017, BLOOD, V129, P2603, DOI 10.1182/blood-2016-10-569186; Gupta K, 2018, DIABETES METAB SYND, V12, P51, DOI 10.1016/j.dsx.2017.08.014; Hermann LS, 2004, BRIT J DIABETES VASC, V4, P401; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Mazokopakis EE, 2012, DIABETES RES CLIN PR, V97, P359, DOI 10.1016/j.diabres.2012.06.001; Mbanya JC, 2006, LANCET, V368, P1628, DOI 10.1016/S0140-6736(06)69673-6; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Miller JW, 2002, NUTR REV, V60, P142; Mishra AK, 2019, LEUKEMIA, V33, P2695, DOI 10.1038/s41375-019-0470-4; Ng KC, 2002, ANN ACAD MED SINGAP, V31, P636; Perera M., 2017, SRI LANKA J DIABETES, V7; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Qureshi SA, 2011, PRACT DIABETES, V28, P302, DOI 10.1002/pdi.1619; R Core Team, 2020, R LANG ENV STAT COMP; Risch M, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0060-x; Rosenberg IH, 2008, DIABETOLOGIA, V51, P6, DOI 10.1007/s00125-007-0869-8; Roy Rudra Prasad, 2016, Indian J Endocrinol Metab, V20, P631; Saravanan P., 2018, INCREASED PROINFLAMM; Strain JJ, 2004, P NUTR SOC, V63, P597, DOI 10.1079/PNS2004390; Sun A, 2013, ORAL DIS, V19, P381, DOI 10.1111/odi.12014; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; Weikert C, 2005, J NUTR, V135, P1981, DOI 10.1093/jn/135.8.1981; Weikert C, 2007, STROKE, V38, P2912, DOI 10.1161/STROKEAHA.107.486068; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33; World Health Organization, 2016, GUIDE IMPLEMENTATION; Yakubu M, 2019, ALEX J MED, V55, P58, DOI 10.1080/20905068.2019.1662647; Yeboah K, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/2320737	47	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249325	10.1371/journal.pone.0249325	http://dx.doi.org/10.1371/journal.pone.0249325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784336	gold, Green Published			2022-12-26	WOS:000636359600015
J	Wu, CC; Cao, QQ; Fei, F; Yang, DH; Xu, BG; Zhang, GL; Zeng, H; Song, AG				Wu, Changcheng; Cao, Qingqing; Fei, Fei; Yang, Dehua; Xu, Baoguo; Zhang, Guanglie; Zeng, Hong; Song, Aiguo			Optimal strategy of sEMG feature and measurement position for grasp force estimation	PLOS ONE			English	Article							SURFACE EMG; POSTURE	Grasp force estimation based on surface electromyography (sEMG) is essential for the dexterous control of a prosthetic hand. Nowadays, although increasing the number of sEMG measurement positions and extracting more features are common methods to increase the accuracy of grasp force estimation, it will increase the computational burden. In this paper, an approach based on analysis of variance (ANOVA) and generalized regression neural network (GRNN) for optimal measurement positions and features is proposed, with the purpose of using fewer measurement positions or features to achieve higher estimation accuracy. Firstly, we captured six channels of sEMG from subjects' forearm and grasp force synchronously. Then, four kinds of features in time domain are extracted from each channel of sEMG. By combining different measurement position sets (MPSs) and feature set (FSs), we construct 945 data sets. These data sets are fed to GRNN to realize grasp force estimation. Normalized root mean square error (NRMS), normalized mean of absolute error (NMAE), and correlation coefficient (CC) between estimated grasp force and actual force are introduced to evaluate the performance of grasp force estimation. Finally, ANOVA and Tukey HSD testing are introduced to analyze grasp force estimation results so as to obtain the optimal measurement positions and features. We obtain the optimal MPSs for grasp force estimation when different FSs are employed, and the optimal FSs when different MPSs are utilized.	[Wu, Changcheng; Fei, Fei; Yang, Dehua] Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China; [Cao, Qingqing] Nanjing Vocat Univ Ind Technol, Sch Aviat Engn, Nanjing, Jiangsu, Peoples R China; [Wu, Changcheng; Xu, Baoguo; Zeng, Hong; Song, Aiguo] Southeast Univ, Sch Instrument Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Guanglie] City Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Vocational University of Industry Technology; Southeast University - China; City University of Hong Kong	Wu, CC (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China.; Wu, CC (corresponding author), Southeast Univ, Sch Instrument Sci & Engn, Nanjing, Jiangsu, Peoples R China.	changchengwu@nuaa.edu.cn			National Natural Science Foundation of China [61803201, 61773205, 61673278]; Jiangsu Natural Science Foundation [BK20170803]; China Postdoctoral Science Foundation [2019M661686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This paper is supported by the National Natural Science Foundation of China under Grant Nos. 61803201 (CW), 61773205 (CW) and 61673278 (GZ). Jiangsu Natural Science Foundation under Grant No.BK20170803 (CW), and China Postdoctoral Science Foundation under Grant No. 2019M661686 (CW).	Baldacchino T, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00013; Ban Y, 2018, LECT NOTES COMPUT SC, V10894, P226, DOI 10.1007/978-3-319-93399-3_21; Cao HX, 2017, SOFT COMPUT, V21, P491, DOI 10.1007/s00500-015-1800-8; Chen YP, 2020, IEEE ACCESS, V8, P13195, DOI 10.1109/ACCESS.2020.2966303; Hu RC, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab2e18; Huang CJ, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa63ba; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kamavuako EN, 2012, IEEE T BIO-MED ENG, V59, P1804, DOI 10.1109/TBME.2012.2197210; Khezri M, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-45; Kim S, 2019, J BIONIC ENG, V16, P455, DOI [10.1007/s42235-019-0037-0, 10.14400/JDC.2018.16.11.455]; Ma RY, 2020, ALEX ENG J, V59, P1135, DOI 10.1016/j.aej.2020.01.007; Martinez IJR, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab673f; Parajuli N, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19204596; Rehman SU, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030240; Wu CC, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00343; Wu CC, 2015, J SENSORS, V2015, DOI 10.1155/2015/869175; [吴常铖 Wu Changcheng], 2013, [仪器仪表学报, Chinese Journal of Scientific Instrument], V34, P1339; Xiaoming Zhang, 2017, 2017 IEEE International Ultrasonics Symposium (IUS), DOI 10.1109/ULTSYM.2017.8091739; Xu LF, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103226; Yamanoi Y, 2017, BIOMED SIGNAL PROCES, V38, P312, DOI 10.1016/j.bspc.2017.06.019; Yang DP, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P516, DOI 10.1109/IROS.2009.5354544; Yang DP, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-7, CONFERENCE PROCEEDINGS, P1795, DOI 10.1109/ICMA.2009.5246102; Yang ZL, 2016, NEUROCOMPUTING, V207, P568, DOI 10.1016/j.neucom.2016.05.038; Yokoyama M, 2017, J SENSORS, V2017, DOI 10.1155/2017/3980906; Zardoshti-Kermani M., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P324, DOI 10.1109/86.481972; Zhang C, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aad38e	26	1	1	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0247883	10.1371/journal.pone.0247883	http://dx.doi.org/10.1371/journal.pone.0247883			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784334	gold, Green Published			2022-12-26	WOS:000636359600048
J	Gadisa, TB; Michael, MWG; Reda, MM; Aboma, BD				Gadisa, Tariku Bekela; G Michael, Mengistu Welday; Reda, Mihretab Mehari; Aboma, Beyene Dorsisa			Early resumption of postpartum sexual intercourse and its associated risk factors among married postpartum women who visited public hospitals of Jimma zone, Southwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							DETERMINANTS; HEALTH	Introduction Postpartum sexual resumption without the use of contraception is a risk for unintended and closely spaced pregnancies. Although counseling related to the resumption of postpartum sexual intercourse is a key component of postpartum sexual health, it is not widely addressed during the postnatal period. Thus, this study aimed to assess the early resumption of postpartum sexual intercourse and its associated risk factors among married postpartum women who visited public hospitals of Jimma zone, Southwest Ethiopia, for child immunization services. Methods The facility-based cross-sectional study design was undertaken, and a systematic random sampling technique was carried out to select 330 participants. Data were collected using a pretested interviewer-administered questionnaire from August to September 2019. Obtained data were analyzed using descriptive statistics. A bivariate analysis was used to determine the significance of the association. Variables that showed association in the bivariate analysis at p-value <0.2 were fitted into a multivariable logistic regression model to control for confounders, and the significance of association was determined at p-value <0.05 with a 95% confidence interval (CI). Results Approximately 53.9% of the respondents practiced early resumption of postpartum sexual intercourse. Factors such as low income (AOR = 0.19 (95% CI = 0.10-.37)), monogamous marriage 3.78(1.32-10.79), practicing sexual intercourse during pregnancy (AOR = 4.55 (95% CI = 1.29-15.97)), a cesarean delivery (AOR = 0.06 95%CI = (0.03-0.15)) and use of contraceptives (AOR = 3.7(95%CI = 1.92-7.14)) were significantly associated with early resumption of postpartum sexual intercourse. Conclusion and recommendation The findings of this study suggested that, most postpartum mothers resumed sexual intercourse during the early postpartum period and its associated risk factors include low income, monogamous marriage, practicing sexual intercourse during pregnancy, cesarean delivery, and use of contraceptives. Discussion with couples about postpartum sexual health during the antenatal and postnatal period is crucial to prevent unwanted pregnancies and adverse health outcomes.	[Gadisa, Tariku Bekela] Jimma Univ, Fac Hlth Sci, Inst Hlth, Sch Midwifery, Jimma, Ethiopia; [G Michael, Mengistu Welday; Reda, Mihretab Mehari] Mekelle Univ, Coll Hlth Sci, Dept Midwifery, Mekelle, Ethiopia; [Aboma, Beyene Dorsisa] Jimma Univ, Inst Hlth, Sch Nursing, Fac Hlth Sci, Jimma, Ethiopia	Jimma University; Mekelle University; Jimma University	Gadisa, TB (corresponding author), Jimma Univ, Fac Hlth Sci, Inst Hlth, Sch Midwifery, Jimma, Ethiopia.	gadaa2007@gmail.com	Bekela, Tariku/AAX-6821-2021	Bekela, Tariku/0000-0002-8132-8678				Adanikin AI, 2015, EUR J CONTRACEP REPR, V20, P241, DOI 10.3109/13625187.2014.971742; Adeniji AO., 2014, INT J REPROD CONTRAC, V3, P1061, DOI DOI 10.5455/2320-1770.IJRCOG20141236; Alum AC, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0089-5; [Anonymous], 2015, **NON-TRADITIONAL**; Anzaku AS, 2014, ANN MED HEALTH SCI R, V4, P210, DOI 10.4103/2141-9248.129044; DAVIDSON E, 1963, J CLIN PATHOL, V16, P112, DOI 10.1136/jcp.16.2.112; Holanda JBD, 2014, ACTA PAUL ENFERM, V27, P573, DOI 10.1590/1982-0194201400093; Enderle CD, 2013, REV LAT-AM ENFERM, V21, P719, DOI 10.1590/S0104-11692013000300010; Iliyasu Z, 2018, AFR J REPROD HEALTH, V22, P103, DOI 10.29063/ajrh2018/v22i1.10; Imo CK, 2018, AFR J REPROD HEALTH, V22, P102, DOI 10.29063/ajrh2018/v22i4.11; Kinuthia J, 2017, JAIDS-J ACQ IMM DEF, V74, P142, DOI 10.1097/QAI.0000000000001225; Kunwar S, 2010, BIOSCI TRENDS, V4, P186; Makanani B, 2010, INT J GYNECOL OBSTET, V108, P26, DOI 10.1016/j.ijgo.2009.08.014; McDonald E., 2019, JOG, V46, P173, DOI [10.1111/birt.12363, DOI 10.1111/BIRT.12363]; O'Malley D, 2015, J ADV NURS, V71, P2247, DOI 10.1111/jan.12692; Palmer AR, 2003, J MIDWIFERY WOM HEAL, V48, P282, DOI 10.1016/S1526-9523(03)00143-0; Radziah M., 2013, INT J REPROD CONTRAC, V2, P124, DOI DOI 10.5455/2320-1770.IJRCOG20130603; Rezaei N., 2017, STUDY RELATIONSHIP S, P10; Tesfaye F., 2018, ETHIOPIAN J REPROD H, V10, P22; World Health Organization, 2017, SEX HLTH ITS LINK RE; Yohannes S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-38; Zhuang CX, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026132	22	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247769	10.1371/journal.pone.0247769	http://dx.doi.org/10.1371/journal.pone.0247769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780453	gold, Green Published			2022-12-26	WOS:000636336800020
J	Kraus, D; Kleiber, A; Ehrhardt, E; Leifheit, M; Horbert, P; Urban, M; Gleichmann, N; Mayer, G; Popp, J; Henkel, T				Kraus, Daniel; Kleiber, Andreas; Ehrhardt, Enrico; Leifheit, Matthias; Horbert, Peter; Urban, Matthias; Gleichmann, Nils; Mayer, Guenter; Popp, Juergen; Henkel, Thomas			Three step flow focusing enables image-based discrimination and sorting of late stage 1 Haematococcus pluvialis cells	PLOS ONE			English	Article								Label-free and gentle separation of cell stages with desired target properties from mixed stage populations are a major research task in modern biotechnological cultivation process and optimization of micro algae. The reported microfluidic sorter system (MSS) allows the subsequent investigation of separated subpopulations. The implementation of a viability preserving MSS is shown for separation of late stage 1 Haematococcus pluvialis (HP) cells form a mixed stage population. The MSS combines a three-step flow focusing unit for aligning the cells in single file transportation mode at the center of the microfluidic channel with a pure hydrodynamic sorter structure for cell sorting. Lateral displacement of the cells into one of the two outlet channels is generated by piezo-actuated pump chambers. In-line decision making for sorting is based on a user-definable set of image features and properties. The reported MSS significantly increased the purity of target cells in the sorted population (94%) in comparison to the initial mixed stage population (19%).	[Kraus, Daniel; Kleiber, Andreas; Horbert, Peter; Urban, Matthias; Gleichmann, Nils; Mayer, Guenter; Popp, Juergen; Henkel, Thomas] Leibniz Inst Photon Technol, Jena, Germany; [Ehrhardt, Enrico; Leifheit, Matthias] Bio & Umwelttechnologien eV GMBU, Gesell Forderung Med, Halle, Salle, Germany; [Popp, Juergen] Friedrich Schiller Univ, Inst Phys Chem, Jena, Germany; [Popp, Juergen] Friedrich Schiller Univ, Abbe Ctr Photon, Jena, Germany	Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kraus, D (corresponding author), Leibniz Inst Photon Technol, Jena, Germany.	daniel.kraus@leibniz-ipht.de	Henkel, Thomas/GWD-1172-2022	Henkel, Thomas/0000-0003-2896-500X; Kraus, Daniel/0000-0001-7539-5260	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Wirtschaft und Technologie [Pollen3D-ZF4006816CR8]; Thuringer Aufbaubank [2018 SD 0066]; Open Access Fund of the Leibniz Association	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); Thuringer Aufbaubank; Open Access Fund of the Leibniz Association	This study is part of the collaborative research center AquaDiva (CRC 1076 AquaDiva) funded by the Deutsche Forschungsgemeinschaft (DFG). The funding from Bundesministerium fur Wirtschaft und Technologie to AK (Pollen3D-ZF4006816CR8) and Thuringer Aufbaubank to DK (2018 SD 0066) is gratefully acknowledged. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Anagnostidis V, 2020, LAB CHIP, V20, P889, DOI 10.1039/d0lc00055h; Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Bauer M, 2015, PROCEEDINGS OF SC15: THE INTERNATIONAL CONFERENCE FOR HIGH PERFORMANCE COMPUTING, NETWORKING, STORAGE AND ANALYSIS, DOI 10.1145/2807591.2807662; Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Caen O, 2018, MICROSYST NANOENG, V4, DOI 10.1038/s41378-018-0033-2; Chabert M, 2008, P NATL ACAD SCI USA, V105, P3191, DOI 10.1073/pnas.0708321105; Cheng IF, 2007, BIOMICROFLUIDICS, V1, DOI 10.1063/1.2723669; Fabregas J, 2000, APPL MICROBIOL BIOT, V53, P530, DOI 10.1007/s002530051652; Girault M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40072; Gorthi SS, 2012, OPT LETT, V37, P707, DOI 10.1364/OL.37.000707; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Jezek J, 2012, PROC SPIE, V8697, DOI 10.1117/12.2008649; Karimi A, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4799787; Kleiber A, 2020, LAB CHIP, V20, P1676, DOI 10.1039/d0lc00244e; Lee W., 2017, MICROTECHNOLOGY CELL; Li J, 2011, BIOTECHNOL ADV, V29, P568, DOI 10.1016/j.biotechadv.2011.04.001; Li YL, 2007, LAB CHIP, V7, P239, DOI 10.1039/b613344d; Liu N, 2019, BIOANALYSIS-ADV MAT, V7, P99, DOI 10.1007/978-981-13-6229-3_5; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Nivedita N, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4819275; Olofsson K, 2020, LAB CHIP, V20, P1981, DOI 10.1039/d0lc00175a; Ota S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23854-w; Rajkumar JS, 2020, INVEST OPHTH VIS SCI, V61; Saha SK, 2013, BIORESOURCE TECHNOL, V128, P118, DOI 10.1016/j.biortech.2012.10.049; Schaap A, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-016-1787-1; Schmid L, 2014, LAB CHIP, V14, P3710, DOI 10.1039/c4lc00588k; Sciambi A, 2015, LAB CHIP, V15, P47, DOI 10.1039/c4lc01194e; Sesen M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65483-2; Shah MMR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00531; Su YX, 2014, BIORESOURCE TECHNOL, V170, P522, DOI 10.1016/j.biortech.2014.08.018; Sun JS, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774311; Syed MS, 2018, BIORESOURCE TECHNOL, V252, P91, DOI 10.1016/j.biortech.2017.12.065; Vidhyavathi R, 2008, J EXP BOT, V59, P1409, DOI 10.1093/jxb/ern048; Villone MM, 2018, LAB CHIP, V18, P126, DOI 10.1039/c7lc00943g; Wan Y, 2012, LAB CHIP, V12, P4693, DOI 10.1039/c2lc21251j; Wang XL, 2011, LAB CHIP, V11, P3656, DOI 10.1039/c1lc20653b; Wayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053618; Wu L, 2013, BIOMED MICRODEVICES, V15, P553, DOI 10.1007/s10544-013-9754-z; Wu MX, 2019, MICROSYST NANOENG, V5, DOI 10.1038/s41378-019-0064-3; Wuest W., 1954, ING ARCH, V22, P357, DOI [10.1007/BF00536569, DOI 10.1007/BF00536569]; Yang AHJ, 2012, ANAL CHEM, V84, P10756, DOI 10.1021/ac3026674	43	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249192	10.1371/journal.pone.0249192	http://dx.doi.org/10.1371/journal.pone.0249192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780476	gold, Green Published			2022-12-26	WOS:000636336800055
J	Duster, R; Kaltheuner, IH; Schmitz, M; Geyer, M				Duester, Robert; Kaltheuner, Ines H.; Schmitz, Maximilian; Geyer, Matthias			1,6-Hexanediol, commonly used to dissolve liquid-liquid phase separated condensates, directly impairs kinase and phosphatase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DOMAIN; INHIBITION; PERMEABILITY; METHYLATION; TRANSITION; COMPLEXES; DYNAMICS; BINDING	The concept of liquid-liquid phase separation (LLPS) has emerged as an intriguing mechanism for the organization of membraneless compartments in cells. The alcohol 1,6-hexanediol is widely used as a control to dissolve LLPS assemblies in phase separation studies in diverse fields. However, little is known about potential side effects of 1,6-hexanediol, which could compromise data interpretation and mislead the scientific debate. To examine this issue, we analyzed the effect of 1,6-hexanediol on the activities of various enzymes in vitro. Already at 1% volume concentration, 1,6-hexanediol strongly impaired kinases and phosphatases and partly blocked DNA polymerases, while it had no effect on DNase activity. At concentrations that are usually used to dissolve LLPS droplets (5-10%), both kinases and phosphatases were virtually inactive. Given the widespread function of protein phosphorylation in cells, our data argue for a careful review of 1,6-hexanediol in phase separation studies.	[Duester, Robert; Kaltheuner, Ines H.; Schmitz, Maximilian; Geyer, Matthias] Univ Bonn, Inst Struct Biol, Bonn, Germany	University of Bonn	Geyer, M (corresponding author), Univ Bonn, Inst Struct Biol, Bonn, Germany.	matthias.geyer@uni-bonn.de	Kaltheuner, Ines H/AEP-0385-2022	Kaltheuner, Ines H/0000-0001-8450-4959; Geyer, Matthias/0000-0002-7718-5002; Duster, Robert/0000-0003-4954-6883	Deutsche Forschungsgemeinschaft (DFG) [GE 976/9-2]; DFG under Germany's Excellence Strategy [EXC2151-390873048]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) to M. G. (GE 976/9-2). M. G. is funded by the DFG under Germany's Excellence Strategy-EXC2151-390873048.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Davis D, 2019, J VIROL, V93, DOI 10.1128/JVI.01014-19; Dechene M, 2009, PROTEINS, V76, P861, DOI 10.1002/prot.22393; Ding DQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13609-0; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fuller GG, 2020, ELIFE, V9, DOI 10.7554/eLife.48480; Guo YE, 2019, NATURE, V572, P543, DOI 10.1038/s41586-019-1464-0; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hofweber M, 2019, J BIOL CHEM, V294, P7137, DOI 10.1074/jbc.TM118.001189; Klein IA, 2020, SCIENCE, V368, P1386, DOI 10.1126/science.aaz4427; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Maharana S., 2017, MATTERS, DOI [10.19185/matters.201702000010, DOI 10.19185/MATTERS.201702000010]; Martin EW, 2018, BIOCHEMISTRY-US, V57, P2478, DOI 10.1021/acs.biochem.8b00008; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Olson CM, 2019, CELL CHEM BIOL, V26, P792, DOI 10.1016/j.chembiol.2019.02.012; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peng Q, 2020, J VIROL, V94, DOI 10.1128/JVI.01771-19; Pessina F, 2019, NAT CELL BIOL, V21, P1286, DOI 10.1038/s41556-019-0392-4; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; SHAMBERGER RJ, 1987, CLIN CHEM, V33, P589; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; TANISHIMA K, 1987, J CLIN CHEM CLIN BIO, V25, P729; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033	57	22	22	5	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100260	10.1016/j.jbc.2021.100260	http://dx.doi.org/10.1016/j.jbc.2021.100260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33814344	Green Published, gold			2022-12-26	WOS:000672866400236
J	Granados, JC; Nigam, AK; Bush, KT; Jamshidi, N; Nigam, SK				Granados, Jeffry C.; Nigam, Anisha K.; Bush, Kevin T.; Jamshidi, Neema; Nigam, Sanjay K.			A key role for the transporter OAT1 in systemic lipid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; POTENTIAL ENDOGENOUS BIOMARKERS; GENOME-WIDE ASSOCIATION; DRUG TRANSPORTERS; ACID TRANSPORTERS; RENAL TRANSPORT; FATTY-ACIDS; FAMILY; RECEPTORS; PATHWAYS	Organic anion transporter 1 (OAT1/SLC22A6) is a drug transporter with numerous xenobiotic and endogenous substrates. The Remote Sensing and Signaling Theory suggests that drug transporters with compatible ligand preferences can play a role in "organ crosstalk," mediating overall organismal communication. Other drug transporters are well known to transport lipids, but surprisingly little is known about the role of OAT1 in lipid metabolism. To explore this subject, we constructed a genome-scale metabolic model using omics data from the Oat1 knockout mouse. The model implicated OAT1 in the regulation of many classes of lipids, including fatty acids, bile acids, and prostaglandins. Accordingly, serum metabolomics of Oat1 knockout mice revealed increased polyunsaturated fatty acids, diacylglycerols, and long-chain fatty acids and decreased ceramides and bile acids when compared with wildtype controls. Some aged knockout mice also displayed increased lipid droplets in the liver when compared with wildtype mice. Chemoinformatics and machine learning analyses of these altered lipids defined molecular properties that form the structural basis for lipid-transporter interactions, including the number of rings, positive charge/volume, and complexity of the lipids. Finally, we obtained targeted serum metabolomics data after short-term treatment of rodents with the OAT-inhibiting drug probenecid to identify potential drug-metabolite interactions. The treatment resulted in alterations in eicosanoids and fatty acids, further supporting our metabolic reconstruction predictions. Consistent with the Remote Sensing and Signaling Theory, the data support a role of OAT1 in systemic lipid metabolism.	[Granados, Jeffry C.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Nigam, Anisha K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jamshidi, Neema] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@health.ucsd.edu		Granados, Jeffry/0000-0003-0393-7141; Bush, Kevin/0000-0001-5889-2847	National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS) [R01GM132938]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB009380]	National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS) R01GM132938 (to S. K. N.), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) T32EB009380 (to J. C. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Basit A, 2019, DRUG METAB DISPOS, V47, P802, DOI 10.1124/dmd.119.086579; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Cattan N, 2000, EUR CYTOKINE NETW, V11, P293; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chiappini F, 2016, SCI REP-UK, V6, DOI 10.1038/srep31587; Demsar J, 2007, J BIOMED INFORM, V40, P661, DOI 10.1016/j.jbi.2007.03.010; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; DUNN M, 1987, DRUGS, V33, P56, DOI 10.2165/00003495-198700331-00009; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Gu CD, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1730-3; Hagos Y, 2010, TOXINS, V2, P2055, DOI 10.3390/toxins2082055; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Herink M., 2000, MED INDUCED CHANGES; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Jung KY, 2001, LIFE SCI, V69, P2123, DOI 10.1016/S0024-3205(01)01296-6; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Miyamoto J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040450; Nigam AK, 2020, J BIOL CHEM, V295, P1829, DOI 10.1074/jbc.RA119.010729; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Otani N, 2017, ANAT SCI INT, V92, P200, DOI 10.1007/s12565-016-0369-3; Papackova Z, 2015, INT J MOL SCI, V16, P3831, DOI 10.3390/ijms16023831; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sauvant C, 2006, J AM SOC NEPHROL, V17, P46, DOI 10.1681/ASN.2005070727; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Ulven T, 2015, ANNU REV NUTR, V35, P239, DOI 10.1146/annurev-nutr-071714-034410; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wofford Marion R, 2006, J Clin Hypertens (Greenwich), V8, P114, DOI 10.1111/j.1524-6175.2006.04751.x; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Yee S, 2017, CLIN PHARMACOL THER, V101, pS96; Yee SW, 2016, CLIN PHARMACOL THER, V100, P524, DOI 10.1002/cpt.434; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	61	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100603	10.1016/j.jbc.2021.100603	http://dx.doi.org/10.1016/j.jbc.2021.100603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785360	gold, Green Published			2022-12-26	WOS:000672866400575
J	Malcova, I; Bumba, L; Uljanic, F; Kuzmenko, D; Nedomova, J; Kamanova, J				Malcova, Ivana; Bumba, Ladislav; Uljanic, Filip; Kuzmenko, Darya; Nedomova, Jana; Kamanova, Jana			Lipid binding by the N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; SACCHAROMYCES-CEREVISIAE; YEAST; PIP2; BRONCHISEPTICA; DOMAIN; PHOSPHOINOSITIDES; ORGANIZATION; MUTANTS	The respiratory pathogens Bordetella pertussis and Bordetella bronchiseptica employ a type III secretion system (T3SS) to inject a 69-kDa BteA effector protein into host cells. This effector is known to contain two functional domains, including an N-terminal lipid raft targeting (LRT) domain and a cytotoxic C-terminal domain that induces nonapoptotic and caspase-1-independent host cell death. However, the exact molecular mechanisms underlying the interaction of BteA with plasma membrane (PM) as well as its cytotoxic activity in the course of Bordetella infections remain poorly understood. Using a protein-lipid overlay assay and surface plasmon resonance, we show here that the recombinant LRT domain binds negatively charged membrane phospholipids. Specifically, we determined that the dissociation constants of the LRT domain-binding liposomes containing phosphatidylinositol 4,5-bisphosphate, phosphatidic acid, and phosphatidylserine were similar to 450 nM, similar to 490 nM, and similar to 1.2 mu M, respectively. Both phosphatidylserine and phosphatidylinositol 4,5-bisphosphate were required to target the LRT domain and/or full-length BteA to the PM of yeast cells. The membrane association further involved electrostatic and hydrophobic interactions of LRT and depended on a leucine residue in the L1 loop between the first two helices of the four-helix bundle. Importantly, charge-reversal substitutions within the L1 region disrupted PM localization of the BteA effector without hampering its cytotoxic activity during B. bronchiseptica infection of HeLa cells. The LRT-mediated targeting of BteA to the cytosolic leaflet of the PM of host cells is, therefore, dispensable for effector cytotoxicity.	[Malcova, Ivana; Uljanic, Filip; Kuzmenko, Darya; Nedomova, Jana; Kamanova, Jana] Czech Acad Sci, Inst Microbiol, Lab Infect Biol, Prague, Czech Republic; [Bumba, Ladislav] Czech Acad Sci, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kamanova, J (corresponding author), Czech Acad Sci, Inst Microbiol, Lab Infect Biol, Prague, Czech Republic.	kamanova@biomed.cas.cz	Malcova, Ivana/ABB-6413-2021; Kamanova, Jana/Q-4477-2017; Bumba, Ladislav/ABC-9943-2020	Malcova, Ivana/0000-0002-4385-3842; Kamanova, Jana/0000-0001-6574-4404; Bumba, Ladislav/0000-0001-6659-5447; Uljanic, Filip/0000-0002-9601-7266	Czech Science Foundation [18-16772Y]; Czech Academy of Sciences [LQ200202001]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]; Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences [RVO 61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences	This work was supported by grant 18-16772Y of the Czech Science Foundation (www.gacr.cz) and Lumina Queruntur Fellowship LQ200202001 of the Czech Academy of Sciences to J. K., project LM2018133 (EATRIS-CZ, Czech National Node to the European Infrastructure for Translational Medicine) of the Ministry of Education, Youth and Sports of the Czech Republic (https://www.msmt.cz) to L. B., and by the Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences RVO 61388971.	Aronov S, 2004, J BIOL CHEM, V279, P36962, DOI 10.1074/jbc.M402068200; Bart MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01301-14; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bayer-Santos E, 2016, CELL HOST MICROBE, V20, P584, DOI 10.1016/j.chom.2016.10.007; Bayram J, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008512; Brachmann CB, 1998, YEAST, V14, P115; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chavez CV, 2016, TOXINS, V8, DOI 10.3390/toxins8040090; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chierico L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06056; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Craven R, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-15; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Grycova L, 2015, ACS CHEM NEUROSCI, V6, P386, DOI 10.1021/cn500250r; Guttman C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081557; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Ji C, 2015, J BIOL CHEM, V290, P26978, DOI 10.1074/jbc.M115.663013; Kamanova J, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00466; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kuwae A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148387; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nicholson TL, 2014, INFECT IMMUN, V82, P1092, DOI 10.1128/IAI.01115-13; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skopova K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00937-16; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stockbauer KE, 2003, CELL MICROBIOL, V5, P123, DOI 10.1046/j.1462-5822.2003.00260.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Tyson GH, 2015, J BIOL CHEM, V290, P2919, DOI 10.1074/jbc.M114.611251; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Varela-Chavez C, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13213; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Yahalom A, 2019, BBA-BIOMEMBRANES, V1861, DOI 10.1016/j.bbamem.2019.183054; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zegarlinska J, 2018, ACTA BIOCHIM POL, V65, P163, DOI 10.18388/abp.2018_2592	57	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100607	10.1016/j.jbc.2021.100607	http://dx.doi.org/10.1016/j.jbc.2021.100607			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789161	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400579
J	Impheng, H; Lemmers, C; Bouasse, M; Legros, C; Pakaprot, N; Guerineau, NC; Lory, P; Monteil, A				Impheng, Hathaichanok; Lemmers, Celine; Bouasse, Malik; Legros, Christian; Pakaprot, Narawut; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud			The sodium leak channel NALCN regulates cell excitability of pituitary endocrine cells	FASEB JOURNAL			English	Article						background conductance; extracellular Ca2+; ion channels; resting membrane potential	NONSELECTIVE CATION CHANNELS; MEMBRANE-POTENTIAL CHANGES; ELECTRICAL-ACTIVITY; NEURONAL EXCITABILITY; GROWTH-HORMONE; CLONAL STRAINS; TUMOR CELLS; CALCIUM; PROLACTIN; LINE	Anterior pituitary endocrine cells that release hormones such as growth hormone and prolactin are excitable and fire action potentials. In these cells, several studies previously showed that extracellular sodium (Na+) removal resulted in a negative shift of the resting membrane potential (RMP) and a subsequent inhibition of the spontaneous firing of action potentials, suggesting the contribution of a Na+ background conductance. Here, we show that the Na+ leak channel NALCN conducts a Ca2+-Gd3+-sensitive and TTX-resistant Na+ background conductance in the GH(3) cell line, a cell model of pituitary endocrine cells. NALCN knockdown hyperpolarized the RMP, altered GH(3) cell electrical properties and inhibited prolactin secretion. Conversely, the overexpression of NALCN depolarized the RMP, also reshaping the electrical properties of GH(3) cells. Overall, our results indicate that NALCN is functional in GH(3) cells and involved in endocrine cell excitability as well as in hormone secretion. Indeed, the GH(3) cell line suitably models native pituitary cells that display a similar Na+ background conductance and appears as a proper cellular model to study the role of NALCN in cellular excitability.	[Impheng, Hathaichanok; Lemmers, Celine; Bouasse, Malik; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud] Univ Montpellier, CNRS, IGF, INSERM, Montpellier, France; [Impheng, Hathaichanok; Bouasse, Malik; Guerineau, Nathalie C.; Lory, Philippe; Monteil, Arnaud] LabEx Ion Channel Sci & Therapeut, Montpellier, France; [Lemmers, Celine; Monteil, Arnaud] Univ Montpellier, INSERM, CNRS, BCM,PVM, Montpellier, France; [Legros, Christian] Univ Angers, MITOVASC Inst, UMR CNRS 6015, UMR INSERM U1083, Angers, France; [Pakaprot, Narawut] Mahidol Univ, Fac Med, Dept Physiol, Siriraj Hosp, Bangkok, Thailand; [Impheng, Hathaichanok] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers; Mahidol University; Naresuan University	Monteil, A (corresponding author), Univ Montpellier, CNRS, IGF, INSERM, Montpellier, France.	arnaud.monteil@igf.cnrs.fr		LEGROS, Christian/0000-0002-3346-7059; Monteil, Arnaud/0000-0003-1632-7318; Impheng, Hathaichanok/0000-0001-8350-1692; LORY, philippe/0000-0002-1638-7604; Guerineau, Nathalie/0000-0003-2517-4210	Fondation pour la Recherche Medicale (FRM) [DEQ20170336728]; Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM) [20151]; Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEQ20170336728; Laboratory of Excellence 'Ion Channel Science and Therapeutics'; Association Francaise contre les Myopathies (AFM), Grant/Award Number: 20151; Fondation Maladies Rares; Naresuan University (NU); French Ministry for Foreign Affairs	Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; BIALES B, 1977, NATURE, V267, P172, DOI 10.1038/267172a0; Bouasse M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48071-x; CHILDS GV, 1987, ENDOCRINOLOGY, V120, P2059, DOI 10.1210/endo-120-5-2059; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Chua HC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3154; Cochet-Bissuel M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00132; COLLU R, 1984, ENDOCRINOLOGY, V114, P1302, DOI 10.1210/endo-114-4-1302; Fletcher PA, 2018, MOL CELL ENDOCRINOL, V463, P23, DOI 10.1016/j.mce.2017.06.022; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Ford NC, 2018, PAIN, V159, P1719, DOI 10.1097/j.pain.0000000000001258; Fujisawa S, 2006, CEREB CORTEX, V16, P639, DOI 10.1093/cercor/bhj010; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Gao SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7323; Kayano T, 2019, CELL CALCIUM, V79, P11, DOI 10.1016/j.ceca.2019.02.001; KIDOKORO Y, 1975, NATURE, V258, P741, DOI 10.1038/258741a0; Kschonsak M, 2020, NATURE, V587, P313, DOI 10.1038/s41586-020-2570-8; Kucka M, 2012, PHYSIOL RES, V61, P267, DOI 10.33549/physiolres.932301; Kucka M, 2010, MOL PHARMACOL, V77, P270, DOI 10.1124/mol.109.059386; Kwiecien R, 1998, J PHYSIOL-LONDON, V508, P883, DOI 10.1111/j.1469-7793.1998.883bp.x; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lee SY, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0325-0; Liang Z, 2011, J PHYSIOL-LONDON, V589, P5965, DOI 10.1113/jphysiol.2011.219378; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; Lutas A, 2016, ELIFE, V5, DOI 10.7554/eLife.15271; OSTLUND RE, 1978, ENDOCRINOLOGY, V103, P1245, DOI 10.1210/endo-103-4-1245; OZAWA S, 1979, P NATL ACAD SCI USA, V76, P6017, DOI 10.1073/pnas.76.11.6017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippart F, 2018, ELIFE, V7, DOI 10.7554/eLife.40984; Reinl EL, 2015, MOL HUM REPROD, V21, P816, DOI 10.1093/molehr/gav038; Sankaranarayanan S, 1996, AM J PHYSIOL-CELL PH, V271, pC1927, DOI 10.1152/ajpcell.1996.271.6.C1927; Shi YT, 2016, J NEUROSCI, V36, P8174, DOI 10.1523/JNEUROSCI.1096-16.2016; SIMASKO SM, 1994, AM J PHYSIOL, V266, pC709, DOI 10.1152/ajpcell.1994.266.3.C709; Snutch TP, 2007, NEURON, V54, P505, DOI 10.1016/j.neuron.2007.05.005; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; TARASKEVICH PS, 1980, NEUROSCIENCE, V5, P421, DOI 10.1016/0306-4522(80)90117-7; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Tomic M, 2011, AM J PHYSIOL-ENDOC M, V301, pE370, DOI 10.1152/ajpendo.00130.2011; Tsaneva-Atanasova K, 2007, J NEUROPHYSIOL, V98, P131, DOI 10.1152/jn.00872.2006; TSE A, 1993, ENDOCRINOLOGY, V132, P1475, DOI 10.1210/en.132.4.1475; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Goor F, 2001, MOL ENDOCRINOL, V15, P1222, DOI 10.1210/me.15.7.1222; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Yang SK, 2008, ENDOCRINOLOGY, V149, P4726, DOI 10.1210/en.2008-0405; Yeh SY, 2017, NEURON, V94, P294, DOI 10.1016/j.neuron.2017.03.024; Zemkova H, 2016, ENDOCRINOLOGY, V157, P1576, DOI 10.1210/en.2015-1899	50	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21400	10.1096/fj.202000841RR	http://dx.doi.org/10.1096/fj.202000841RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33793981	hybrid, Green Published			2022-12-26	WOS:000645260100004
J	Ives, A; Le Roy, D; Theroude, C; Bernhagen, J; Roger, T; Calandra, T				Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Bernhagen, Juergen; Roger, Thierry; Calandra, Thierry			Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway	FASEB JOURNAL			English	Article						chemokine; cytokine; dendritic cell; innate immunity; MIF; motility	ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; FAT-CELL; OBESITY; WHITE; BROWN; ADIPOGENESIS; EXPANSION; GIP	Constitutively expressed by innate immune cells, the cytokine macrophage migration inhibitory factor (MIF) initiates host immune responses and drives pathogenic responses in infectious, inflammatory, and autoimmune diseases. Dendritic cells (DCs) express high levels of MIF, but the role of MIF in DC function remains poorly characterized. As migration is critical for DC immune surveillance, we investigated whether MIF promoted the migration of DCs. In classical transwell experiments, MIF-/- bone marrow-derived DCs (BMDCs) or MIF+/+ BMDCs treated with ISO-1, an inhibitor of MIF, showed markedly reduced spontaneous migration and chemotaxis. CD74(-/-) BMDCs that are deficient in the ligand-binding component of the cognate MIF receptor exhibited a migration defect similar to that of MIF-/- BMDCs. Adoptive transfer experiments of LPS-matured MIF+/+ and MIF-/- and of CD74(+/+) and CD74(-/-) BMDCs injected into the hind footpads of homologous or heterologous mice showed that the autocrine and paracrine MIF activity acting via CD74 contributed to the recruitment of DCs to the draining lymph nodes. Mechanistically, MIF activated the Src/PI3K signaling pathway and myosin II complexes, which were required for the migration of BMDCs. Altogether, these data show that the cytokine MIF exerts chemokine-like activity for DC motility and trafficking.	[Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Roger, Thierry; Calandra, Thierry] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Ives, Annette; Le Roy, Didier; Theroude, Charlotte; Roger, Thierry; Calandra, Thierry] Univ Lausanne, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Bernhagen, Juergen] Ludwig Maximilians Univ LMU, Klinikum Univ Munchen KUM, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Munich; University of Munich	Calandra, T (corresponding author), Lausanne Univ Hosp, Dept Med, Infect Dis Serv, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.; Calandra, T (corresponding author), Univ Lausanne, BH-10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Thierry.Calandra@chuv.ch	Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Ives, Annette/0000-0002-7407-960X; Calandra, Thierry/0000-0003-3051-1285; Theroude, Charlotte/0000-0002-9864-1644	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [310030_138488, CRSII3_147662S, 316030_145014, 310030_173123]; Wilhelm Sander-Stiftung (Wilhelm Sander Foundation) [2017.009.1]; Deutsche Forschungsgemeinschaft (DFG) [SFB1123/A3]; Societe Academique Vaudoise, Lausanne, Switzerland; EC \ Horizon 2020 Framework Programme (H2020) [676129]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF); Wilhelm Sander-Stiftung (Wilhelm Sander Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Societe Academique Vaudoise, Lausanne, Switzerland; EC \ Horizon 2020 Framework Programme (H2020)	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 310030_138488, CRSII3_147662S, 316030_145014 and 310030_173123; Wilhelm Sander-Stiftung (Wilhelm Sander Foundation), Grant/Award Number: 2017.009.1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1123/A3; EC | Horizon 2020 Framework Programme (H2020), Grant/Award Number: 676129; Societe Academique Vaudoise, Lausanne, Switzerland	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Beaudry JL, 2019, MOL METAB, V28, P14, DOI 10.1016/j.molmet.2019.08.006; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Goedecke JH, 2011, J CLIN ENDOCR METAB, V96, pE2029, DOI 10.1210/jc.2011-1576; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; He XY, 2018, INT J OBESITY, V42, P1051, DOI 10.1038/s41366-018-0024-2; Inoue N, 2008, J BIOL CHEM, V283, P21220, DOI 10.1074/jbc.M801824200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Liang WW, 2015, ONCOTARGET, V6, P31780, DOI 10.18632/oncotarget.5566; Lopez-Mejia IC, 2018, CELL MOL LIFE SCI, V75, P975, DOI 10.1007/s00018-017-2668-9; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McIntosh CHS, 2012, J DIABETES INVEST, V3, P96, DOI 10.1111/j.2040-1124.2012.00196.x; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Montanari T, 2017, OBES REV, V18, P495, DOI 10.1111/obr.12520; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Ng SYA, 2014, EXPERT OPIN BIOL TH, V14, P1215, DOI 10.1517/14712598.2014.925870; Panina YA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01656; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Preston KJ, 2019, FASEB J, V33, P11993, DOI 10.1096/fj.201802637RR; Quang MDX, 2013, CYTOM PART A, V83, P933, DOI 10.1002/cyto.a.22333; Rose F, 2019, EXPERT OPIN DRUG DIS, V14, P1151, DOI 10.1080/17460441.2019.1646243; Rui LY, 2017, COMPR PHYSIOL, V7, P1281, DOI 10.1002/cphy.c170001; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schrover IM, 2018, EUR J PREV CARDIOL, V25, P1548, DOI 10.1177/2047487318790722; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Wilkins HM, 2016, J NEUROCHEM, V137, P76, DOI 10.1111/jnc.13545; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang Y, 2018, J CLIN INVEST, V128, P4898, DOI 10.1172/JCI98353; Zhang Z, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110970	53	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21418	10.1096/fj.202001605R	http://dx.doi.org/10.1096/fj.202001605R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774873	Green Published, hybrid			2022-12-26	WOS:000645260100090
J	Carter, B; Fisher-Smith, D; Porter, D; Lane, S; Peak, M; Taylor-Robinson, D; Bracken, L; Carrol, ED				Carter, Bernie; Fisher-Smith, Debra; Porter, David; Lane, Steven; Peak, Matthew; Taylor-Robinson, David; Bracken, Louise; Carrol, Enitan D.			Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians	PLOS ONE			English	Article							ANTIBIOTIC-THERAPY; INFECTIONS	Background Little evidence exists about parental satisfaction and their influence on referral to paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT). Aim This study aimed to examine the experiences of parents, children and clinicians of OPAT at a large tertiary children's hospital. Method A prospective e-survey, using closed and open questions, of parents (n = 33) of 33 children who had received OPAT (3 children completed a survey), and clinicians (n = 31) involved in OPAT at a tertiary hospital. Data were collected September 2016 to July 2018. Results Data were analysed using simple descriptive statistics. The results show that OPAT offered benefits (less stress, re-establishment of family life) compared to hospital-based treatment for parents and children, although some were anxious. Clinicians' referral judgements were based on child, home, and clinical factors. Some clinicians found the process of referral complex. Conclusion Most parents and children were satisfied with the OPAT service and preferred the option of home-based treatment as it promoted the child's comfort and recovery and supported family routines.	[Carter, Bernie] Edge Hill Univ, Fac Hlth Social Care & Med, Ormskirk, England; [Carter, Bernie] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Fisher-Smith, Debra] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Porter, David; Carrol, Enitan D.] Alder Hey Childrens NHS Fdn Trust, Dept Infect Dis & Immunol, Liverpool, Merseyside, England; [Lane, Steven] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Peak, Matthew; Bracken, Louise] Alder Hey Childrens NHS Fdn Trust, Paediat Med Res Unit, Inst Pk, Liverpool, Merseyside, England; [Taylor-Robinson, David] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Carrol, Enitan D.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Carrol, Enitan D.] Liverpool Sci Pk, Liverpool Hlth Partners, Liverpool, Merseyside, England	Edge Hill University; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool	Carter, B (corresponding author), Edge Hill Univ, Fac Hlth Social Care & Med, Ormskirk, England.; Carter, B (corresponding author), Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England.	bernie.carter@edgehill.ac.uk	Carter, Bernie/AER-9898-2022; Carter, Bernie/AAG-7946-2022	Carter, Bernie/0000-0001-5226-9878; Carter, Bernie/0000-0001-5226-9878; Bracken, Louise/0000-0002-9632-2252	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC) [CLAHRC-NWC-034]	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC)	This work was supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC): study reference CLAHRC-NWC-034. Authors initials of those who received the award: EDC, BC, DT-R,DP, SL. MP. The views expressed are those of the authors and not necessarily those of the NHS, NIHR or Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Motlaq MA, 2019, J CHILD HEALTH CARE, V23, P458, DOI 10.1177/1367493518795341; Berrevoets MAH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024564; Bolsover Sally, 2018, Nurs Child Young People, V30, P24, DOI 10.7748/ncyp.2018.e974; Carter B, 2020, ARCH DIS CHILD, V105, P276, DOI 10.1136/archdischild-2019-317629; Carter B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021603; Chary A, 2006, CLIN INFECT DIS, V43, P1290, DOI 10.1086/508456; Crouch C., 2018, ARCH DIS CHILDHOOD, V103, pE2; Dore-Bergeron MJ, 2009, PEDIATRICS, V124, P16, DOI 10.1542/peds.2008-2583; Ford K., 2014, CHILD CENTRED NURSIN; Glackin L, 2014, Ir Med J, V107, P110; Gupta A, 2009, J PEDIAT HEMATOL ONC, V31, P635, DOI 10.1097/MPH.0b013e3181acd8cd; Ibrahim L., 2018, OPEN FORUM INFECT DI, V5, pS557, DOI [10.1093/ofid/ofy210.1922, DOI 10.1093/OFID/OFY210.1922]; Jones CW, 2018, J PEDIATR NURS, V41, P110, DOI 10.1016/j.pedn.2018.03.011; Keller SC, 2019, AM J INFECT CONTROL, V47, P425, DOI 10.1016/j.ajic.2018.09.020; Krah NM, 2018, J PEDIAT INF DIS SOC, V7, pE40, DOI 10.1093/jpids/piy002; Lippert M, 2017, CURR ONCOL, V24, P23, DOI 10.3747/co.24.3326; Mace AO, 2018, ARCH DIS CHILD, V103, P165, DOI 10.1136/archdischild-2017-313071; Madigan T, 2013, PEDIATR INFECT DIS J, V32, P346, DOI 10.1097/INF.0b013e31827ee1c2; Mitchell ED, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013560; Muldoon EG, 2013, CLIN INFECT DIS, V57, P419, DOI 10.1093/cid/cit211; O'Connor S, 2019, J CLIN NURS, V28, P3353, DOI 10.1111/jocn.14913; Patel S, 2015, J ANTIMICROB CHEMOTH, V70, P360, DOI 10.1093/jac/dku401; Cantero MJP, 2014, AN PEDIATR, V81, P86, DOI 10.1016/j.anpedi.2013.05.009; Psaltikidis EM, 2017, EXPERT REV PHARM OUT, V17, P355, DOI 10.1080/14737167.2017.1360767; RUCKER RW, 1974, PEDIATRICS, V54, P358; Sriskandarajah S, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13216; Twiddy M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019099; Van Winkle P, 2008, PEDIATR INFECT DIS J, V27, P1069, DOI 10.1097/INF.0b013e31817d32f2; VANDERLAAG J, 1995, INT J ANTIMICROB AG, V5, P63, DOI 10.1016/0924-8579(94)00060-8; Vaz LE, 2018, J PEDIAT INF DIS SOC, V7, P136, DOI 10.1093/jpids/pix023	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249514	10.1371/journal.pone.0249514	http://dx.doi.org/10.1371/journal.pone.0249514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798226	Green Submitted, Green Published, gold			2022-12-26	WOS:000636737700050
J	Hubler, M; Pothen, F				Huebler, Michael; Pothen, Frank			Can smart policies solve the sand mining problem?	PLOS ONE			English	Article								While sand has become a scarce essential resource for construction and land reclamation worldwide, its extraction causes severe ecological damage and high social costs. To derive policy solutions to this paramount global challenge with broad applicability, this model-based analysis exemplarily studies sand trade from Southeast Asia to Singapore. Accordingly, a coordinated transboundary sand output tax reduces sand mining to a large extent, while the economic costs are small for the sand importer and slightly positive for the exporters. As a novel policy implementation approach, a "Sand Extraction Allowances Trading Scheme" is proposed, which helps sustainably balance the importer's economic growth with the exporters' economic development.	[Huebler, Michael; Pothen, Frank] Leibniz Univ Hannover, Inst Environm Econ & World Trade, Hannover, Germany; [Huebler, Michael] Justus Liebig Univ Giessen, Ctr Int Dev & Environm Res ZEU, Giessen, Germany; [Huebler, Michael] Justus Liebig Univ Giessen, Inst Agr Policy & Market Res, Agr Food & Environm Policy, Giessen, Germany; [Pothen, Frank] Ctr Econ Mat CEM, Fraunhofer Ctr Int Management & Knowledge Econ IM, Halle, Saale, Germany	Leibniz University Hannover; Justus Liebig University Giessen; Justus Liebig University Giessen	Hubler, M (corresponding author), Leibniz Univ Hannover, Inst Environm Econ & World Trade, Hannover, Germany.; Hubler, M (corresponding author), Justus Liebig Univ Giessen, Ctr Int Dev & Environm Res ZEU, Giessen, Germany.; Hubler, M (corresponding author), Justus Liebig Univ Giessen, Inst Agr Policy & Market Res, Agr Food & Environm Policy, Giessen, Germany.	michael.huebler@agrar.uni-giessen.de		Pothen, Frank/0000-0003-4078-7074	German Federal Ministry of Education and Research (BMBF) [01LA1828C]; Federal State of Saxony-Anhalt [ZS/2018/12/96265]; European Regional Development Fund (ERDF) [ZS/2018/12/96265]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal State of Saxony-Anhalt; European Regional Development Fund (ERDF)(European Commission)	This study was supported by the German Federal Ministry of Education and Research in the form of a grant (BMBF, project ROCHADE, Grant No. 01LA1828C) awarded to M. H. and by the Federal State of Saxony-Anhalt and European Regional Development Fund (ERDF) in the form of a grant (Grant No. ZS/2018/12/96265 (Economic Structural Dynamics)) awarded to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako T.A., 2014, UNIVERSAL J GEOSCIEN, V2, P42, DOI [10.12691/jgg-2-2-1, DOI 10.12691/jgg-2-2-1]; Anthony EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14745; Bohringer C, 2012, ENERG ECON, V34, pS97, DOI 10.1016/j.eneco.2012.10.003; Bravard J.-P., 2013, ECHOGEO, V26, DOI [10.4000/echogeo.13659, DOI 10.4000/ECHOGEO.13659]; Brunier G, 2014, GEOMORPHOLOGY, V224, P177, DOI 10.1016/j.geomorph.2014.07.009; Caliendo L, 2015, REV ECON STUD, V82, P1, DOI 10.1093/restud/rdu035; Chan G, 2012, NATL TAX J, V65, P419, DOI 10.17310/ntj.2012.2.06; Darby SE, 2016, NATURE, V539, P276, DOI 10.1038/nature19809; Dekle R, 2008, IMF STAFF PAPERS, V55, P511, DOI 10.1057/imfsp.2008.17; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Ellis LD, 2020, P NATL ACAD SCI USA, V117, P12584, DOI 10.1073/pnas.1821673116; Franke M., 2014, 362014 BERL SCH EC L; Gallagher L., 2019, SAND SUSTAINABILITY; Gassmann M., 2019, DIESE DTSCH IDEE SOL; Global Witness, 2010, SHIFT SAND HOW SING; Hazelton Pamela, 2009, Sustainability, V1, P319, DOI 10.3390/su1020319; Hoogmartens R., 2014, FUTURE PERSPECTIVES; Kim TG, 2008, ECOL ECON, V65, P498, DOI 10.1016/j.ecolecon.2007.07.016; MONTGOMERY WD, 1972, J ECON THEORY, V5, P395, DOI 10.1016/0022-0531(72)90049-X; Nakweya G., 2019, SATELLITE IMAGERY HE; National Geographic, 2018, DRAM PHOT SHOW SAND; Manh NV, 2015, GLOBAL PLANET CHANGE, V127, P22, DOI 10.1016/j.gloplacha.2015.01.001; Padmalal D, 2014, ENVIRON SCI ENG, P1, DOI 10.1007/978-94-017-9144-1; Pothen F, 2018, EUR ECON REV, V107, P1, DOI 10.1016/j.euroecorev.2018.04.004; Statista, 2018, AV US PRIC SAND GRAV; UN Comtrade, 2016, UN TRAD STAT; UNEP, 2014, SAND RAR ON THINKS	27	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248882	10.1371/journal.pone.0248882	http://dx.doi.org/10.1371/journal.pone.0248882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798223	Green Published, gold			2022-12-26	WOS:000636737700022
J	Nguyen, AM; Malig, BJ; Basu, R				Nguyen, Angela-Maithy; Malig, Brian J.; Basu, Rupa			The association between ozone and fine particles and mental health-related emergency department visits in California, 2005-2013	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; OLDER-ADULTS; TIME-SERIES; SEASONAL-VARIATION; SCHIZOPHRENIA; DEPRESSION; ADMISSIONS; DISORDERS; SUICIDE; TEMPERATURE	Recent studies suggest that air pollutant exposure may increase the incidence of mental health conditions, however research is limited. We examined the association between ozone (O-3) and fine particles (PM2.5) and emergency department (ED) visits related to mental health outcomes, including psychosis, neurosis, neurotic/stress, substance use, mood/affective, depression, bipolar, schizotypal/delusional, schizophrenia, self-harm/suicide, and homicide/inflicted injury, from 2005 through 2013 in California. Air monitoring data were provided by the U.S. EPA's Air Quality System Data Mart and ED data were provided by the California Office of Statewide Health Planning and Development. We used the time-series method with a quasi-Poisson regression, controlling for apparent temperature, day of the week, holidays, and seasonal/long-term trends. Per 10 parts per billion increase, we observed significant cumulative 7-day associations between O-3 and all mental health [0.64%, 95% confidence interval (CI): 0.21, 1.07], depression [1.87%, 95% CI: 0.62, 3.15], self-harm/suicide [1.43%, 95% CI: 0.35, 2.51], and bipolar [2.83%, 95% CI: 1.53, 4.15]. We observed 30-day lag associations between O-3 and neurotic disorder [1.22%, 95% CI: 0.48, 1.97] and homicide/inflicted injury [2.01%, 95% CI: 1.00, 3.02]. Same-day mean PM2.5 was associated with a 0.42% [95% CI: 0.14, 0.70] increase in all mental health, 1.15% [95% CI: 0.62, 1.69] increase in homicide/inflicted injury, and a 0.57% [95% CI: 0.22, 0.92] increase in neurotic disorders per 10 mu g/m(3) increase. Other outcomes not listed here were not statistically significant for O-3 or PM2.5. Risk varied by age group and was generally greater for females, Asians, and Hispanics. We also observed seasonal variation for outcomes including but not limited to depression, bipolar, schizophrenia, self-harm/suicide, and homicide/inflicted injury. Ambient O-3 or PM2.5 may increase the risk of mental health illness, though underlying biological mechanisms remain poorly understood. Findings warrant further investigation to better understand the impacts of air pollutant exposure among vulnerable groups.	[Nguyen, Angela-Maithy; Malig, Brian J.; Basu, Rupa] Calif Off Environm Hlth Hazard Assessment, Air & Climate Epidemiol Sect, Oakland, CA 94612 USA; [Nguyen, Angela-Maithy] Univ Calif Berkeley, Sch Publ Hlth, Interdisciplinary Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Basu, R (corresponding author), Calif Off Environm Hlth Hazard Assessment, Air & Climate Epidemiol Sect, Oakland, CA 94612 USA.	rupa.basu@oehha.ca.gov		Nguyen, Angela-Maithy/0000-0002-6572-9877				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7; Basu R, 2018, AM J EPIDEMIOL, V187, P726, DOI 10.1093/aje/kwx295; Bell ML, 2014, AM J EPIDEMIOL, V180, P15, DOI 10.1093/aje/kwu115; Bernardini F, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000623; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Brokamp C, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4815; Buoli M, 2018, ENVIRON INT, V118, P154, DOI 10.1016/j.envint.2018.05.044; Burkhardt J, 2019, J ENVIRON ECON MANAG, V98, DOI 10.1016/j.jeem.2019.102267; Calderon-Garciduenas L, 2015, PRIM HEALTH CARE RES, V16, P329, DOI 10.1017/S146342361400036X; Casas L, 2017, EUR J EPIDEMIOL, V32, P973, DOI 10.1007/s10654-017-0273-8; Cassidy F, 2002, J AFFECT DISORDERS, V68, P25, DOI 10.1016/S0165-0327(00)00325-6; Centers for Medicare & Medicaid Services, 2014, ICD 9 900 DIAGNOSIS; Chen YS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8409-2; Cooper N, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab486a; Diwan S, 2007, AM J GERIAT PSYCHIAT, V15, P991, DOI 10.1097/JGP.0b013e31815ae34b; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Duan J, 2018, SCI TOTAL ENVIRON, V644, P14, DOI 10.1016/j.scitotenv.2018.06.218; Felmet Kandi, 2011, Clin Schizophr Relat Psychoses, V4, P239, DOI 10.3371/CSRP.4.4.4; Gamble JL, 2012, WEST J EMERG MED, V13, P239, DOI 10.5811/westjem.2012.3.11746; Gao Q, 2017, EUR PSYCHIAT, V44, P68, DOI 10.1016/j.eurpsy.2017.02.492; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Hajat Anjum, 2015, Curr Environ Health Rep, V2, P440, DOI 10.1007/s40572-015-0069-5; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; HARE EH, 1978, J EPIDEMIOL COMMUN H, V32, P47, DOI 10.1136/jech.32.1.47; Health Resources and Services Administration, 2017, UDS MAPPER; Heinz A, 2013, WORLD PSYCHIATRY, V12, P187, DOI 10.1002/wps.20056; Junger WL, 2015, ATMOS ENVIRON, V102, P96, DOI 10.1016/j.atmosenv.2014.11.049; Kelleher I, 2012, ARCH GEN PSYCHIAT, V69, P1277, DOI 10.1001/archgenpsychiatry.2012.164; Khan A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000353; Kim HB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112608; Kim H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.575330; Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117929; Kioumourtzoglou MA, 2017, AM J EPIDEMIOL, V185, P801, DOI 10.1093/aje/kww163; Lee H, 2018, SCI TOTAL ENVIRON, V639, P944, DOI 10.1016/j.scitotenv.2018.05.210; Liang Z, 2019, ENVIRON POLLUT, V244, P102, DOI 10.1016/j.envpol.2018.09.142; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Lin G-Z., 2016, Environ Health, P15, DOI 10.1186/s12940-016-0110-7; Lu JG, 2018, PSYCHOL SCI, V29, P340, DOI 10.1177/0956797617735807; Newbury JB, 2019, JAMA PSYCHIAT, V76, P614, DOI 10.1001/jamapsychiatry.2019.0056; Office of Water Use Efficiency CD of WR, 2014, CIMIS CALIFORNIA IRR; Oudin A, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-017-0348-8; Padhy SK, 2014, ASIAN J PSYCHIATR, V12, P17, DOI 10.1016/j.ajp.2014.09.006; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; Quello Susan B, 2005, Sci Pract Perspect, V3, P13; Rajji TK, 2009, BRIT J PSYCHIAT, V195, P286, DOI 10.1192/bjp.bp.108.060723; Rajkumar Ravi Philip, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.15m01780; Romain AJ, 2018, J AFFECT DISORDERS, V225, P381, DOI 10.1016/j.jad.2017.08.065; RStudio Team, 2018, RSTUDIO INT DEV R; Salim S, 2014, CURR NEUROPHARMACOL, V12, P140, DOI 10.2174/1570159X11666131120230309; Segalowitz SJ, 2008, BRAIN COGNITION, V68, P115, DOI 10.1016/j.bandc.2008.08.011; SMITH JA, 1991, SEMIN HEMATOL, V28, P209; Spalt EW, 2016, J EXPO SCI ENV EPID, V26, P349, DOI 10.1038/jes.2015.29; Szyszkowicz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199826; Szyszkowicz M, 2016, ENVIRON HEALTH INSIG, V10, P155, DOI [10.4137/EHI.S40493, 10.4137/ehi.s40493]; Szyszkowicz M, 2010, ENVIRON HEALTH INSIG, V4, P79, DOI 10.4137/EHI.S5662; Szyszkowicz Mieczyslaw, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P241, DOI 10.2478/v10001-007-0024-2; Thilakaratne RA, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.140915; Tillman R, 2008, BIPOLAR DISORD, V10, P45, DOI 10.1111/j.1399-5618.2008.00480.x; U.S. Census Bureau, 2011, AM FACTFINDER; U.S. Environmental Protection Agency, 2014, AIR QUALITY SYSTEM A; Wang Y, 2014, ENVIRON HEALTH PERSP, V122, P553, DOI 10.1289/ehp.1205909; Woo B, 2019, RACE SOC PROBL, V11, P60, DOI 10.1007/s12552-018-9254-0; Xu XH, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00157; Yang CY, 2019, J TOXICOL ENV HEAL A, V82, P638, DOI 10.1080/15287394.2019.1640980; Zahran H. S., 2004, Morbidity and Mortality Weekly Report, V53, P963	72	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249675	10.1371/journal.pone.0249675	http://dx.doi.org/10.1371/journal.pone.0249675			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798241	gold, Green Published			2022-12-26	WOS:000636737700048
J	Ferry, AV; Keanie, C; Denvir, MA; Mills, NL; Strachan, FE				Ferry, Amy V.; Keanie, Collette; Denvir, Martin A.; Mills, Nicholas L.; Strachan, Fiona E.			Chest pain presentations to hospital during the COVID-19 lockdown: Lessons for public health media campaigns	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PEOPLE	Objective Emergency Department (ED) attendances with chest pain reduced during the COVID-19 lockdown. We performed a service evaluation project in NHS Lothian to explore how and why the COVID-19 pandemic and public health advice had affected chest pain presentations and help-seeking behaviour at an individual patient level using a qualitative interview approach. Methods We carried out 28 semi-structured telephone interviews with a convenience sample of patients who presented with chest pain during lockdown and in patients with known coronary heart disease under the outpatient care of a cardiologist in April and May 2020. Interviews were audio recorded and voice files listened to while making detailed notes. Salient themes and issues were documented as verbatim extracts. Interviews were analysed thematically. Results Patient interviews revealed three main themes. 1) pandemic help-seeking behaviour; describing how participants made the decision to seek professional healthcare assessment. 2) COVID-19 exposure concerns; describing how the subthemes of perceived vulnerability, wishing to protect others and adding pressure to the health service shaped their decision making for an episode of acute chest pain. 3) hospital experience; describing the difference between the imagined and actual experience in hospital. Conclusions Qualitative interviews revealed how the pandemic shaped help-seeking practices, how patients interpreted their personal vulnerability to the virus, and described patient experience of attending hospital for assessment during this time. As patient numbers presenting to hospital appeared to mirror public health messaging, dynamic monitoring of this messaging should evaluate public response to healthcare campaigns to ensure the net impact on health, pandemic and non-pandemic related, is optimised.	[Ferry, Amy V.; Denvir, Martin A.; Mills, Nicholas L.; Strachan, Fiona E.] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Keanie, Collette] Royal Infirm Edinburgh NHS Trust, Dept Cardiol, Edinburgh, Midlothian, Scotland; [Mills, Nicholas L.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Ferry, AV (corresponding author), Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	amy.ferry@ed.ac.uk	Denvir, Martin A/ABA-3141-2021	Mills, Nicholas/0000-0003-0533-7991				Abdelaziz HK, 2020, AM HEART J, V226, P45, DOI 10.1016/j.ahj.2020.04.022; [Anonymous], 2020, ANGIOPLASTYORG; Balog-Way DHP, 2020, J RISK RES, V23, P838, DOI 10.1080/13669877.2020.1758192; Barbour, 2014, INTRO QUALITATIVE RE; BBC, 2020, CORONAVIRUS 1 CASE C; Byrne S., 2009, COMMUNICATION YB, V33, P3, DOI DOI 10.1080/23808985.2009.11679083; Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423; Cornally N, 2011, INT J NURS PRACT, V17, P280, DOI 10.1111/j.1440-172X.2011.01936.x; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Durdella N., 2019, QUALITATIVE DISSERTA, DOI 10.4135/9781506345147; Ferry AV, 2020, ANN EMERG MED, V75, P502, DOI 10.1016/j.annemergmed.2019.11.012; Lyall MJ, 2021, EMERG MED J, V38, P366, DOI 10.1136/emermed-2020-210030; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; MCKINLAY JB, 1973, SOC FORCES, V51, P275, DOI 10.1093/sf/51.3.275; Office National Statistics, ANAL DEATH REGISTRAT; Pattenden J, 2002, BMJ-BRIT MED J, V324, P1006, DOI 10.1136/bmj.324.7344.1006; Philip KEJ, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01363-9; Richards H, 2003, FAM PRACT, V20, P711, DOI 10.1093/fampra/cmg615; Scottish Government, 2020, URGENT MEDICAL HELP; Shah ASV, 2018, LANCET, V392, P919, DOI 10.1016/S0140-6736(18)31923-8; Sheard L, 2017, SOC SCI MED, V178, P19, DOI 10.1016/j.socscimed.2017.02.005; Stepinska J, 2020, EUR HEART J-ACUTE CA, V9, P76, DOI 10.1177/2048872619885346; Stretcher V. J., 1997, HLTH BEHAV HLTH ED T, P113, DOI DOI 10.1111/J.1365-2648.2010.05450.X; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Upshur R., 2001, NATURE QUALITATIVE E	26	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249389	10.1371/journal.pone.0249389	http://dx.doi.org/10.1371/journal.pone.0249389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793662	Green Published, Green Submitted, gold			2022-12-26	WOS:000636467000087
J	Hoitz, F; von Tscharner, V; Baltich, J; Nigg, BM				Hoitz, Fabian; von Tscharner, Vinzenz; Baltich, Jennifer; Nigg, Benno M.			Individuality decoded by running patterns: Movement characteristics that determine the uniqueness of human running	PLOS ONE			English	Article							GAIT PATTERNS; RECOGNITION; TIME; CLASSIFICATION; KINEMATICS; WALKING	Human gait is as unique to an individual as is their fingerprint. It remains unknown, however, what gait characteristics differentiate well between individuals that could define the uniqueness of human gait. The purpose of this work was to determine the gait characteristics that were most relevant for a neural network to identify individuals based on their running patterns. An artificial neural network was trained to recognize kinetic and kinematic movement trajectories of overground running from 50 healthy novice runners (males and females). Using layer-wise relevance propagation, the contribution of each variable to the classification result of the neural network was determined. It was found that gait characteristics of the coronal and transverse plane as well as medio-lateral ground reaction forces provided more information for subject identification than gait characteristics of the sagittal plane and ground reaction forces in vertical or anterior-posterior direction. Additionally, gait characteristics during the early stance were more relevant for gait recognition than those of the mid and late stance phase. It was concluded that the uniqueness of human gait is predominantly encoded in movements of the coronal and transverse plane during early stance.	[Hoitz, Fabian; Nigg, Benno M.] Univ Calgary, Schulich Sch Engn, Biomed Engn, Calgary, AB, Canada; [Hoitz, Fabian; von Tscharner, Vinzenz; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Baltich, Jennifer] Brooks Sports Inc, Seattle, WA USA	University of Calgary; University of Calgary	Hoitz, F (corresponding author), Univ Calgary, Schulich Sch Engn, Biomed Engn, Calgary, AB, Canada.; Hoitz, F (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	fabian.hoitz@ucalgary.ca		Hoitz, Fabian/0000-0002-8512-1543	Brooks Sports Inc.; Alberta Innovates; Alberta Advanced Education; Biomedical Engineering Graduate Program of the University of Calgary	Brooks Sports Inc.; Alberta Innovates; Alberta Advanced Education; Biomedical Engineering Graduate Program of the University of Calgary	The funder (Brooks Sports Inc.) provided support in the form of salaries for Jennifer Baltich but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Alberta Innovates and Alberta Advanced Education for their support of Fabian Hoitz's doctoral research by means of the Alberta Innovates Graduate Student Scholarship for Data-enabled Innovation. Additional support for Fabian Hoitz's research has been granted the Biomedical Engineering Graduate Program of the University of Calgary and the research group around Dr. Benno Nigg.	Almeida MO, 2015, J ORTHOP SPORT PHYS, V45, P738, DOI 10.2519/jospt.2015.6019; Arras L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181142; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baltich J, 2017, SCAND J MED SCI SPOR, V27, P1372, DOI 10.1111/sms.12743; Baltich J., 2016, EFFECTS RESISTANCE S, DOI [10.11575/prism/28115, DOI 10.11575/PRISM/28115]; Baltich J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-407; Chau T, 2001, GAIT POSTURE, V13, P102, DOI 10.1016/S0966-6362(00)00095-3; Dehzangi O, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122735; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Giakas G, 1997, GAIT POSTURE, V5, P189, DOI 10.1016/S0966-6362(96)01083-1; Halilaj E, 2018, J BIOMECH, V81, P1, DOI 10.1016/j.jbiomech.2018.09.009; Hoerzer S, 2015, J BIOMECH, V48, P2072, DOI 10.1016/j.jbiomech.2015.03.017; Horst F, 2017, GAIT POSTURE, V58, P476, DOI 10.1016/j.gaitpost.2017.09.003; Horst F, 2016, GAIT POSTURE, V49, P309, DOI 10.1016/j.gaitpost.2016.07.073; Horst F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38748-8; Janssen D, 2008, J NONVERBAL BEHAV, V32, P79, DOI 10.1007/s10919-007-0045-3; Lapuschkin S, 2016, J MACH LEARN RES, V17; Lin YC, 2011, J MED BIOL ENG, V31, P255, DOI 10.5405/jmbe.806; Liu SX, 2017, VIS INFORM, V1, P48, DOI 10.1016/j.visinf.2017.01.006; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Nigg, 2017, CISS, V2, P1; Nigg BM, 2017, MED SCI SPORT EXER, V49, P1641, DOI 10.1249/MSS.0000000000001260; Nixon MS., 2006, HUMAN IDENTIFICATION, DOI [10.1007/978-0-387-29488-9, DOI 10.1007/978-0-387-29488-9]; Pataky TC, 2012, J R SOC INTERFACE, V9, P790, DOI 10.1098/rsif.2011.0430; Phinyomark A, 2018, J MED BIOL ENG, V38, P244, DOI 10.1007/s40846-017-0297-2; Schollhorn WI, 2002, GAIT POSTURE, V15, P180, DOI 10.1016/S0966-6362(01)00193-X; Shiraga K, 2016, INT CONF BIOMETR; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Stefanyshyn D., 2015, FOOTWEAR SCI, V7, pS99, DOI [10.1080/19424280.2015.1038630, DOI 10.1080/19424280.2015.1038630]; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Weich C, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20143810; Xue ZJ, 2010, PATTERN RECOGN, V43, P2904, DOI 10.1016/j.patcog.2010.03.011; Yoo JH, 2008, 2008 FIRST INTERNATIONAL WORKSHOPS ON IMAGE PROCESSING THEORY, TOOLS AND APPLICATIONS (IPTA), P372; Yoo JH, 2005, LECT NOTES COMPUT SC, V3708, P138	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249657	10.1371/journal.pone.0249657	http://dx.doi.org/10.1371/journal.pone.0249657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793671	Green Published, gold			2022-12-26	WOS:000636467000017
J	Kassahun, T; Pavlu, K; Pavlu, V; Pavlu, L; Novak, J; Blazek, P				Kassahun, Teowdroes; Pavlu, Klara; Pavlu, Vilem; Pavlu, Lenka; Novak, Jan; Blazek, Petr			Restoration management of cattle resting place in mountain grassland	PLOS ONE			English	Article							SOIL	This study investigated the effect of restoration management of a weed-infested area, previously used as cattle resting place, on herbage production and nutrient concentrations in the soil and herbage. The experiment was undertaken from 2004 to 2011 at the National Park of Nizke Tatry, Slovakia. Three treatments were applied: (i) cutting twice per year, (ii) herbicide application, followed after three weeks by reseeding with a mixture of vascular plant species and then cut twice per year, and (iii) unmanaged. Treatments had significant effect on biomass production and concentration of nutrients in the soil and in herbage. Nutrient concentrations in herbage and in soil declined progressively under the cutting treatments and reached optimum ranges for dairy cattle at the end of the experiment when herbage N was less than 15 g kg(-1) and herbage P was 3.4 g kg(-1). There was also a strong positive relationship under the cutting treatments between soil nutrient concentrations and herbage nutrient concentrations for N, P, K, Mg and Ca. Although the cutting management as well as the combination of herbicide application with cutting management reduced nutrient concentrations in the soil and in herbage, the nutrient concentrations remained relatively high. We can conclude that restoration of grassland covered with weedy species like Urtica dioica and Rumex obtusifolius, with excessive levels of soil nutrients, cannot be achieved just by cutting and herbicide application.	[Kassahun, Teowdroes; Pavlu, Klara; Pavlu, Vilem] Czech Univ Life Sci Prague, Dept Ecol, Prague, Czech Republic; [Pavlu, Vilem; Pavlu, Lenka] Crop Res Inst, Dept Weeds & Vegetat Agroecosyst, Prague, Czech Republic; [Novak, Jan] Slovak Univ Agr, Fac Agrobiol & Food Resources, Nitra, Slovakia; [Blazek, Petr] Univ South Bohemia, Dept Bot, Fac Sci, Ceske Budejovice, Czech Republic; [Blazek, Petr] Acad Sci Czech Republ, Inst Entomol, Ceske Budejovice, Czech Republic	Czech University of Life Sciences Prague; Czech Crop Research Institute (CRI); Slovak University of Agriculture Nitra; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Pavlu, V (corresponding author), Czech Univ Life Sci Prague, Dept Ecol, Prague, Czech Republic.; Pavlu, V (corresponding author), Crop Res Inst, Dept Weeds & Vegetat Agroecosyst, Prague, Czech Republic.	pavlu@vurv.cz	Blažek, Petr/AAW-8682-2020	Blažek, Petr/0000-0002-0901-4578; Teka, Teowdroes Kassahun/0000-0001-8881-0224	Slovak Research and Development Agency [1/3453/06]; Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences Prague, "Vertical and Horizontal sward structure of species rich upland grassland under long-term grazing management" [20194211]; Ministry of Agriculture of the Czech Republic [RO0418]	Slovak Research and Development Agency(Slovak Research and Development Agency); Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences Prague, "Vertical and Horizontal sward structure of species rich upland grassland under long-term grazing management"; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This research was conducted under support from the Slovak Research and Development Agency (1/3453/06, https://www.apvv.sk/?lang=en); J.N. This paper was written under support from the Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences Prague, "Vertical and Horizontal sward structure of species rich upland grassland under long-term grazing management", No. 20194211(https://www.fzp.czu.cz/cs/r-6897veda-a-vyzkum/r-7266-interni-granty); T.K., K.P., V.P. and the Ministry of Agriculture of the Czech Republic (RO0418, http://eagri.cz/public/web/mze/); V.P., L.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.O.A.C, 1990, OFFICIAL METHODS ANA, V15th; Aarons SR, 2004, AUST J SOIL RES, V42, P107, DOI 10.1071/SR03008; Alexander M., 1977, Introduction to soil microbiology.; Baeten L, 2011, PLANT ECOL, V212, P901, DOI 10.1007/s11258-010-9876-9; Bakker, 1989, NATURE MANAGEMENT GR, P400; Benbrook CM, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0070-0; Decau ML, 2003, J ENVIRON QUAL, V32, P1405, DOI 10.2134/jeq2003.1405; Dell I., 2019, DELL STAT VERS 13 1; Flory SL, 2009, J APPL ECOL, V46, P434, DOI 10.1111/j.1365-2664.2009.01610.x; Galvanek D, 2009, APPL VEG SCI, V12, P273, DOI 10.1111/j.1654-109X.2009.01022.x; Gaupp-Berghausen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12886; GEORGE MR, 1992, J RANGE MANAGE, V45, P436, DOI 10.2307/4002898; Gibbons S, 1996, B ECOL SOC AM; Golodets C, 2010, PLANT SOIL, V329, P365, DOI 10.1007/s11104-009-0164-1; Haney RL, 2002, BIOL FERT SOILS, V35, P35, DOI 10.1007/s00374-001-0437-1; Hanke I, 2010, CHEMOSPHERE, V81, P422, DOI 10.1016/j.chemosphere.2010.06.067; Hansson M, 2000, J VEG SCI, V11, P31, DOI 10.2307/3236772; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hejcman M, 2012, GRASS FORAGE SCI, V67, P488, DOI 10.1111/j.1365-2494.2012.00864.x; Hejcman M, 2010, APPL VEG SCI, V13, P257, DOI 10.1111/j.1654-109X.2010.01077.x; Hrevusova Z, 2009, AGR ECOSYST ENVIRON, V130, P123, DOI 10.1016/j.agee.2008.12.008; Huyghe C., 2014, EGF at 50: The future of European grasslands. Proceedings of the 25th General Meeting of the European Grassland Federation, Aberystwyth, Wales, 7-11 September 2014, P29; Kanissery R, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8110499; Kimball S, 2014, RESTOR ECOL, V22, P81, DOI 10.1111/rec.12022; Kleinebecker T, 2011, PLANT ECOL, V212, P1563, DOI 10.1007/s11258-011-9931-1; Liebisch F, 2013, EUR J AGRON, V44, P67, DOI 10.1016/j.eja.2012.08.004; Marsden KA, 2016, ANIM PROD SCI, V56, P265, DOI 10.1071/AN15613; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Mpokos JP, 2014, J MT SCI-ENGL, V11, P1579, DOI 10.1007/s11629-013-2905-0; Mullerova V, 2014, ACTA OECOL, V59, P1, DOI 10.1016/j.actao.2014.05.004; Norton JB, 2004, J ARID ENVIRON, V57, P445, DOI 10.1016/S0140-1963(03)00104-6; NUZZO V A, 1991, Natural Areas Journal, V11, P158; Orloff L. N., 2015, Ecological Restoration, V33, P147, DOI 10.3368/er.33.2.147; Pavl V., 2006, BODENKULTUR, P501; Pavlu K, 2019, PLANT SOIL ENVIRON, V65, P343, DOI 10.17221/177/2019-PSE; Pavlu L, 2016, AGR ECOSYST ENVIRON, V217, P13, DOI 10.1016/j.agee.2015.10.026; Pavlu L, 2013, FLORA, V208, P599, DOI 10.1016/j.flora.2013.09.003; Perring MP, 2009, ECOSYSTEMS, V12, P1130, DOI 10.1007/s10021-009-9279-8; Pirhofer-Walzl K, 2011, GRASS FORAGE SCI, V66, P415, DOI 10.1111/j.1365-2494.2011.00799.x; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Schaffers AP, 2002, PLANT ECOL, V158, P229, DOI 10.1023/A:1015576520936; Schnitzler A, 1998, J VEG SCI, V9, P317, DOI 10.2307/3237096; Shepherd MJ, 2000, RAPID COMMUN MASS SP, V14, P1361, DOI 10.1002/1097-0231(20000815)14:15<1361::AID-RCM35>3.0.CO;2-#; Simmons MT, 2007, RESTOR ECOL, V15, P662, DOI 10.1111/j.1526-100X.2007.00278.x; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Smith P, 2008, ADV AGRON, V97, P1, DOI 10.1016/S0065-2113(07)00001-6; Smits NAC, 2008, APPL VEG SCI, V11, P279, DOI 10.3170/2008-7-18417; Balbuena MS, 2015, J EXP BIOL, V218, P2799, DOI 10.1242/jeb.117291; Stover HJ, 2017, APPL VEG SCI, V20, P608, DOI 10.1111/avsc.12316; Stromberg MR., 1996, RESTORATION MANAGEME, V14, P102; Tallowin JRB, 1999, GRASS FORAGE SCI, V54, P99, DOI 10.1046/j.1365-2494.1999.00171.x; Taylor K, 2009, J ECOL, V97, P1436, DOI 10.1111/j.1365-2745.2009.01575.x; ter Braak C.J.F., 2012, CANOCO VERSION 5 SOF; Thompson K, 1997, NEW PHYTOL, V136, P679, DOI 10.1046/j.1469-8137.1997.00787.x; Tsui MTK, 2003, CHEMOSPHERE, V52, P1189, DOI 10.1016/S0045-6535(03)00306-0; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Whitehead D. C., 2000, Nutrient elements in grassland: soil-plant-animal relationships, DOI 10.1079/9780851994376.0000; Wilson MV, 2001, APPL VEG SCI, V4, P129, DOI 10.1111/j.1654-109X.2001.tb00243.x; Wilson SD, 1995, RESTOR ECOL, V3, P290, DOI 10.1111/j.1526-100X.1995.tb00096.x	59	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249445	10.1371/journal.pone.0249445	http://dx.doi.org/10.1371/journal.pone.0249445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793653	Green Published, gold			2022-12-26	WOS:000636467000063
J	Khan, S; Tufail, M; Khan, MT; Khan, ZA; Iqbal, J; Wasim, A				Khan, Shahbaz; Tufail, Muhammad; Khan, Muhammad Tahir; Khan, Zubair Ahmad; Iqbal, Javaid; Wasim, Arsalan			Real-time recognition of spraying area for UAV sprayers using a deep learning approach	PLOS ONE			English	Article							NETWORKS; SYSTEM	Agricultural production is vital for the stability of the country's economy. Controlling weed infestation through agrochemicals is necessary for increasing crop productivity. However, its excessive use has severe repercussions on the environment (damaging the ecosystem) and the human operators exposed to it. The use of Unmanned Aerial Vehicles (UAVs) has been proposed by several authors in the literature for performing the desired spraying and is considered safer and more precise than the conventional methods. Therefore, the study's objective was to develop an accurate real-time recognition system of spraying areas for UAVs, which is of utmost importance for UAV-based sprayers. A two-step target recognition system was developed by using deep learning for the images collected from a UAV. Agriculture cropland of coriander was considered for building a classifier for recognizing spraying areas. The developed deep learning system achieved an average F1 score of 0.955, while the classifier recognition average computation time was 3.68 ms. The developed deep learning system can be deployed in real-time to UAV-based sprayers for accurate spraying.	[Khan, Shahbaz; Tufail, Muhammad; Khan, Muhammad Tahir; Khan, Zubair Ahmad] Univ Engn & Technol, Dept Mechatron Engn, Peshawar, Pakistan; [Khan, Shahbaz; Tufail, Muhammad; Khan, Muhammad Tahir] Natl Ctr Robot & Automat NCRA, Adv Robot & Automat Lab, Rawalpindi, Pakistan; [Iqbal, Javaid] Natl Univ Sci & Technol NUST, Coll Elect & Mech Engn CEME, Islamabad, Pakistan; [Wasim, Arsalan] Hitec Univ, Dept Elect Engn, Taxila, Pakistan	University of Engineering & Technology Peshawar; National University of Sciences & Technology - Pakistan; NITEC University	Khan, S (corresponding author), Univ Engn & Technol, Dept Mechatron Engn, Peshawar, Pakistan.; Khan, S (corresponding author), Natl Ctr Robot & Automat NCRA, Adv Robot & Automat Lab, Rawalpindi, Pakistan.	Shahbazkhan@uetpeshawar.edu.pk	Khan, Shahbaz/AAZ-3348-2021	Khan, Shahbaz/0000-0001-7715-0603				Abdulridha J, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11111373; Albetis J, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11010023; Alexandridis TK, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17092007; Alom M.Z., 2017, HANDWRITTEN BANGLA C, P1; Dai B., 2018, 2017 IEEE INT C ROB, V2018, P1; Devanand Maski, 2015, IEEE GLOB HUM TECHN; Faical BS, 2017, COMPUT ELECTRON AGR, V138, P210, DOI 10.1016/j.compag.2017.04.011; Faical BS, 2016, INT J ARTIF INTELL T, V25, DOI 10.1142/S0218213016600034; Faical BS, 2014, J SYST ARCHITECT, V60, P393, DOI 10.1016/j.sysarc.2014.01.004; Gao PB, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19020313; Giles DK, 2015, CHEM ENGINEER TRANS, V44, P307, DOI 10.3303/CET1544052; Hinas A, 2018, INT CONF UNMAN AIRCR, P1320; Huang HS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196302; Huang Y, 2009, APPL ENG AGRIC, V25, P803; Huang Y., 2014, J AGR SCI-CAMBRIDGE, V7, P148, DOI [10.5539/jas.v7n1p148, DOI 10.5539/JAS.V7N1P148]; Huang YB, 2013, INT J AGR BIOL ENG, V6, P1, DOI 10.3965/j.ijabe.20130603.001; Islam S. M. Riazul, 2019, arXiv; Khan S, 2021, TURK J ELECTR ENG CO, V29, P241, DOI 10.3906/elk-2004-4; Lv ZH, 2021, IEEE INTERNET THINGS, V8, P9531, DOI 10.1109/JIOT.2020.3007130; Lv ZH, 2021, IEEE T IND INFORM, V17, P1496, DOI 10.1109/TII.2020.2994747; Lv ZH, 2021, IEEE T INTELL TRANSP, V22, P2048, DOI 10.1109/TITS.2020.3019756; Lv ZH, 2019, COMPUT COMMUN, V148, P208, DOI 10.1016/j.comcom.2019.09.018; Manasa V.K, 2017, IEEE 2 INT C COMP CO, V3, P252; Ministry of Finance, AGRICULTURE; Mogili UMR, 2018, PROCEDIA COMPUT SCI, V133, P502, DOI 10.1016/j.procs.2018.07.063; Pakistan Bureau of Statistics, 2019, AGR STAT; Perez-Ortiz M, 2015, APPL SOFT COMPUT, V37, P533, DOI 10.1016/j.asoc.2015.08.027; Pimentel D., 2012, ENVIRON DEV SUSTAIN, V14, P1, DOI [10.1007/s10668-011-9325-5, DOI 10.1007/s10668-011-9325-5]; Puri V, 2017, J STAT MANAG SYST, V20, P507, DOI 10.1080/09720510.2017.1395171; Rahman MM, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1682-y; Sampedro C, 2019, J INTELL ROBOT SYST, V95, P601, DOI 10.1007/s10846-018-0898-1; Su JY, 2018, COMPUT ELECTRON AGR, V155, P157, DOI 10.1016/j.compag.2018.10.017; Valente J., 2019, ISPRS ANN PHOTOGRAMM, Vvol. 4, P179, DOI [10.5194/isprs-annals-IV-2-W5-179-2019, DOI 10.5194/ISPRS-ANNALS-IV-2-W5-179-2019]; Wei GF, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010217; Wen S., 2019, SENSORS SWITZERLAND, Vvol. 19, DOI [10.3390/s19051112, DOI 10.3390/S19051112]; Xue XY, 2016, COMPUT ELECTRON AGR, V128, P58, DOI 10.1016/j.compag.2016.07.022; Zhu H, 2010, J BIONIC ENG, V7, P276, DOI 10.1016/S1672-6529(10)60251-X	37	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249436	10.1371/journal.pone.0249436	http://dx.doi.org/10.1371/journal.pone.0249436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793634	gold, Green Published			2022-12-26	WOS:000636467000112
J	Woldesemayat, EM; Azeze, Z				Woldesemayat, Endrias Markos; Azeze, Zewtir			Treatment outcome of tuberculosis at Dilla Referral Hospital, Gedeo Zone, southern Ethiopia: A retrospective study	PLOS ONE			English	Article							NIGERIA	Background Tuberculosis (TB) is one of the major public health problems in Ethiopia. Determining treatment outcome of TB cases could help to understand the effectiveness of TB control efforts. The objective of this study was to assess TB treatment outcome and associated factors and determine the risk factors of death among TB cases who were on Directly Observed Treatment Short course (DOTS). Methodology We analyzed a retrospective data for TB cases who were on DOTS at Dilla Referral Hospital from July 2011- June 2016. The study population was TB cases with known HIV status and whose treatment outcome was evaluated at the Hospital. Data were entered, cleaned and analyzed using statistical package SPSS for windows, version 20. Result Out of 899 registered TB cases, 731 included in this analysis. Of these cases, 424 (58.0%) were male and 334 (45.7%) were in the age group of below 25 years. Treatment success rate of TB was 675 (92.3%) and death rate was 18 (2.5%). Treatment outcome showed statistically significant variation by HIV status (P < 0.001). HIV status of the TB cases and pretreatment weight were associated with TB treatment outcome. HIV status of the TB cases was associated with death of the TB cases (Adjusted Odds Ratio (AOR) 5.0; CI 95%: 1.8-13.5). Conclusion TB treatment success rate found in this study was high. Patient's weight and HIV status were associated with treatment outcome. Moreover, HIV status predicted death of TB cases. Cautious treatment follow-up and defaulter tracing mechanisms for TB cases with these risk factors were suggested.	[Woldesemayat, Endrias Markos] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia; [Azeze, Zewtir] John Snow Inc, Digital Hlth Act, Addis Ababa, Ethiopia	Hawassa University	Woldesemayat, EM (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.	endromark@yahoo.com		Woldesemayat, Endrias/0000-0003-4275-3695				Adamu AL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2249-4; Ali SA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1967-3; [Anonymous], 2013, U CALIFORNIA SAN FRA; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Ejeta E., 2015, GEN MED, V3; Endris M., 2014, TUBERCULOSIS RES TRE; Federal Ministry of Health Ethiopia, 2016, GUID CLIN PROGR MAN, V6th; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; FMOH, 2016, COMPREHENSIVE MANUAL; FMOH, TBHIV LEPROSY ETHIOP; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Melese Addisu, 2016, Tuberc Res Treat, V2016, P1354356, DOI 10.1155/2016/1354356; MOH, 2008, IMPLEMENTATION GUIDE; Mohammed T, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0184-x; Ofoegbu OS, 2015, S AFR FAM PRACT, V57, P50, DOI 10.1080/20786190.2014.995913; Opoku S., TUBERCULOSIS TREATME; Osei E, 2019, GLOB HEALTH RES POL, V4, DOI 10.1186/s41256-019-0128-9; Takarinda Kudakwashe C, 2017, Tuberc Res Treat, V2017, P6232071, DOI 10.1155/2017/6232071; Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-124; Tesema T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232468; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; Tola Assefa, 2019, Tuberc Res Treat, V2019, P1503219, DOI 10.1155/2019/1503219; WHO, 2020, GLOB TUB REP; WHO, 2016, GLOB TUB REP; Wondale Biniam, 2017, BMC Res Notes, V10, P680, DOI 10.1186/s13104-017-3020-z; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2021, 10 THREATS GLOB HLTH	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249369	10.1371/journal.pone.0249369	http://dx.doi.org/10.1371/journal.pone.0249369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793648	gold, Green Published			2022-12-26	WOS:000636467000005
J	Aspachs, O; Durante, R; Graziano, A; Mestres, J; Reynal-Querol, M; Montalvo, JG				Aspachs, Oriol; Durante, Ruben; Graziano, Alberto; Mestres, Josep; Reynal-Querol, Marta; Montalvo, Jose G.			Tracking the impact of COVID-19 on economic inequality at high frequency	PLOS ONE			English	Article								Pandemics have historically had a significant impact on economic inequality. However, official inequality statistics are only available at low frequency and with considerable delay, which challenges policymakers in their objective to mitigate inequality and fine-tune public policies. We show that using data from bank records it is possible to measure economic inequality at high frequency. The approach proposed in this paper allows measuring, timely and accurately, the impact on inequality of fast-unfolding crises, like the COVID-19 pandemic. Applying this approach to data from a representative sample of over three million residents of Spain we find that, absent government intervention, inequality would have increased by almost 30% in just one month. The granularity of the data allows analyzing with great detail the sources of the increases in inequality. In the Spanish case we find that it is primarily driven by job losses and wage cuts experienced by low-wage earners. Government support, in particular extended unemployment insurance and benefits for furloughed workers, were generally effective at mitigating the increase in inequality, though less so among young people and foreign-born workers. Therefore, our approach provides knowledge on the evolution of inequality at high frequency, the effectiveness of public policies in mitigating the increase of inequality and the subgroups of the population most affected by the changes in inequality. This information is fundamental to fine-tune public policies on the wake of a fast-moving pandemic like the COVID-19.	[Aspachs, Oriol; Graziano, Alberto; Mestres, Josep] Caixabank, Caixabank Res, Barcelona, Catalonia, Spain; [Durante, Ruben; Reynal-Querol, Marta; Montalvo, Jose G.] Univ Pompeu Fabra UPF, Dept Econ & Business, Barcelona, Catalonia, Spain; [Durante, Ruben; Reynal-Querol, Marta] ICREA, Barcelona, Catalonia, Spain; [Durante, Ruben; Reynal-Querol, Marta; Montalvo, Jose G.] Inst Polit Econ & Governance IPEG, Barcelona, Catalonia, Spain; [Durante, Ruben; Reynal-Querol, Marta; Montalvo, Jose G.] Barcelona Grad Sch Econ BGSE, Barcelona, Catalonia, Spain	Pompeu Fabra University; ICREA	Montalvo, JG (corresponding author), Univ Pompeu Fabra UPF, Dept Econ & Business, Barcelona, Catalonia, Spain.; Montalvo, JG (corresponding author), Inst Polit Econ & Governance IPEG, Barcelona, Catalonia, Spain.; Montalvo, JG (corresponding author), Barcelona Grad Sch Econ BGSE, Barcelona, Catalonia, Spain.	jose.garcia-montalvo@upf.edu	Montalvo, Jose G./D-6731-2013	Montalvo, Jose G./0000-0003-4161-5055	Spanish Ministry of Science and Innovation [ECO2017-82696P]; Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica SARS-CoV-2 y COVID-19; Research Department of CaixaBank; Severo Ochoa Program for Centers of Excellence [CEX 2019-000915S]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica SARS-CoV-2 y COVID-19; Research Department of CaixaBank; Severo Ochoa Program for Centers of Excellence	JGM & MRQ: ECO2017-82696P, Spanish Ministry of Science and Innovation (http://www.ciencia.gob.es/); CEX 2019-000915S Severo Ochoa Program for Centers of Excellence (http://www.ciencia.gob.es/).The Research Department of CaixaBank provided support in the form of salaries for authors OA, AG and, JM. The specific roles of these authors are articulated in the 'author contributions' section. JGM, MRQ and RD acknowledge the financial support of the "Ayudas Fundacion BBVA a Equipos de Investigacion Cientifica SARS-CoV-2 y COVID-19." The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspachs Oriol., 2020, REAL TIME INEQUALITY; Autor D., 2020, TECHNICAL REPORT; Bachas N., 2020, NBER WORKING PAPER 2; Baker SR, 2020, REV ASSET PRICING ST, V10, P834, DOI 10.1093/rapstu/raaa009; Baker SR, 2018, J POLIT ECON, V126, P1504, DOI 10.1086/698106; Bick Alexander., 2020, TECHNICAL REPORT; Cajner Tomaz., 2020, TECHNICAL REPORT; Carvalho VascoM., 2020, TECHNICAL REPORT CEP; Chen Sophia., 2020, TECHNICAL REPORT IMF; Chetty Raj., 2020, TECHNICAL REPORT NBE; Cicala Steve, 2020, TECHNICAL REPORT; Gelman M, 2014, SCIENCE, V345, P212, DOI 10.1126/science.1247727; Giles DEA, 2004, OXFORD B ECON STAT, V66, P425, DOI 10.1111/j.1468-0084.2004.00086.x; Gourinchas PO., 2020, MITIGATING COVID EC, V2, P31; Hacioglu S., 2020, CEPR DISCUSSION PAPE; IMF, 2020, SPAIN 2020 ARTICLE 4; Olafsson A, 2018, REV FINANC STUD, V31, P4398, DOI 10.1093/rfs/hhy055; Scheidel W., 2018, DYNAMICS POLICIES PR; Sheridan A, 2020, P NATL ACAD SCI USA, V117, P20468, DOI 10.1073/pnas.2010068117; Wade L, 2020, SCIENCE, V368, P700, DOI 10.1126/science.368.6492.700; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249121	10.1371/journal.pone.0249121	http://dx.doi.org/10.1371/journal.pone.0249121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788886	Green Published, gold			2022-12-26	WOS:000636354600017
J	Al-Mugotir, M; Lovelace, JJ; George, J; Bessho, M; Pal, D; Struble, L; Kolar, C; Rana, S; Natarajan, A; Bessho, T; Borgstahl, GEO				Al-Mugotir, Mona; Lovelace, Jeffrey J.; George, Joseph; Bessho, Mika; Pal, Dhananjaya; Struble, Lucas; Kolar, Carol; Rana, Sandeep; Natarajan, Amarnath; Bessho, Tadayoshi; Borgstahl, Gloria E. O.			Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN RAD52; DNA-REPAIR; BRCA2-DEFICIENT CELLS; SYNTHETICALLY LETHAL; MITOXANTRONE; COMPLEX; PATHWAYS; KINASE; BRCA2	Synthetic lethality is a successful strategy employed to develop selective chemotherapeutics against cancer cells. Inactivation of RAD52 is synthetically lethal to homologous recombination (HR) deficient cancer cell lines. Replication protein A (RPA) recruits RAD52 to repair sites, and the formation of this protein-protein complex is critical for RAD52 activity. To discover small molecules that inhibit the RPA:RAD52 protein-protein interaction (PPI), we screened chemical libraries with our newly developed Fluorescence-based protein-protein Interaction Assay (FluorIA). Eleven compounds were identified, including FDA-approved drugs (quinacrine, mitoxantrone, and doxorubicin). The FluorIA was used to rank the compounds by their ability to inhibit the RPA:RAD52 PPI and showed mitoxantrone and doxorubicin to be the most effective. Initial studies using the three FDA-approved drugs showed selective killing of BRCA1-mutated breast cancer cells (HCC1937), BRCA2-mutated ovarian cancer cells (PE01), and BRCA1-mutated ovarian cancer cells (UWB1.289). It was noteworthy that selective killing was seen in cells known to be resistant to PARP inhibitors (HCC1937 and UWB1 SYr13). A cell-based double-strand break (DSB) repair assay indicated that mitoxantrone significantly suppressed RAD52-dependent single-strand annealing (SSA) and mitoxantrone treatment disrupted the RPA:RAD52 PPI in cells. Furthermore, mitoxantrone reduced radiation-induced foci-formation of RAD52 with no significant activity against RAD51 foci formation. The results indicate that the RPA:RAD52 PPI could be a therapeutic target for HR-deficient cancers. These data also suggest that RAD52 is one of the targets of mitoxantrone and related compounds.	[Al-Mugotir, Mona; Lovelace, Jeffrey J.; George, Joseph; Bessho, Mika; Pal, Dhananjaya; Struble, Lucas; Kolar, Carol; Rana, Sandeep; Natarajan, Amarnath; Bessho, Tadayoshi; Borgstahl, Gloria E. O.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Bessho, T; Borgstahl, GEO (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	gborgstahl@unmc.edu; tbessho@unmc.edu		Natarajan, Amarnath/0000-0001-5067-0203	Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]; Nebraska Research Initiative; Nebraska Department of Health and Human Services [2017-08, 2018-11]; U.S. Department of Education GAANN [P200A120231]; Nebraska NASA EPSCoR Space Grant	Fred & Pamela Buffett Cancer Center Support Grant; Nebraska Research Initiative; Nebraska Department of Health and Human Services; U.S. Department of Education GAANN(US Department of Education); Nebraska NASA EPSCoR Space Grant	The research was supported by the Fred & Pamela Buffett Cancer Center Support Grant (P30CA036727) pilot project funding (GB & TB), the Nebraska Research Initiative (GB), the Nebraska Department of Health and Human Services (2015, 2017-08, 2018-11; GB); and the U.S. Department of Education GAANN (P200A120231) (GB) and Nebraska NASA EPSCoR Space Grant (MAM) for student fellowships.	Al-Mugotir M, 2019, ANAL BIOCHEM, V569, P46, DOI 10.1016/j.ab.2019.01.010; Aparicio T, 2016, J CELL BIOL, V212, P399, DOI 10.1083/jcb.201504005; Ashworth A, 2018, NAT REV CLIN ONCOL, V15, P564, DOI 10.1038/s41571-018-0055-6; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Brana MF, 2001, CURR PHARM DESIGN, V7, P1745, DOI 10.2174/1381612013397113; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cadena I, 2018, ECANCERMEDICALSCIENC, V12, DOI 10.3332/ecancer.2018.837; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Chandramouly G, 2015, CHEM BIOL, V22, P1491, DOI 10.1016/j.chembiol.2015.10.003; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Das S, 2017, ONCOTARGET, V8, P248, DOI 10.18632/oncotarget.11335; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Deng XY, 2009, BIOCHEMISTRY-US, V48, P6633, DOI 10.1021/bi900564k; Dev H, 2018, NAT CELL BIOL, V20, P954, DOI 10.1038/s41556-018-0140-1; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; Domagala P, 2017, INT J CANCER, V140, P1545, DOI 10.1002/ijc.30570; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; Eriksson A, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.31; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; FRY AM, 1991, CANCER RES, V51, P6592; George SHL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00005; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Guestini F, 2016, EXPERT OPIN THER TAR, V20, P705, DOI 10.1517/14728222.2016.1125469; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Halpern Anna B, 2018, Oncotarget, V9, P36543, DOI 10.18632/oncotarget.26383; Hanamshet K, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090063; Hengel SR, 2017, CELL CHEM BIOL, V24, P1101, DOI 10.1016/j.chembiol.2017.08.027; Hengel SR, 2016, ELIFE, V5, DOI 10.7554/eLife.14740; Huang F, 2016, NUCLEIC ACIDS RES, V44, P4189, DOI 10.1093/nar/gkw087; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; Jung D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20531-w; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li SQ, 2019, J CELL MOL MED, V23, P1987, DOI 10.1111/jcmm.14100; Liang ZX, 2013, PHARM RES-DORDR, V30, P1008, DOI 10.1007/s11095-012-0936-9; Liao HW, 2018, EMBO REP, V19, DOI 10.15252/embr.201846263; Liu LL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113516; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; LOWN JW, 1984, MOL PHARMACOL, V25, P178; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; Minond D, 2009, BIOORGAN MED CHEM, V17, P5027, DOI 10.1016/j.bmc.2009.05.070; Mirman Z, 2018, NATURE, V560, P112, DOI 10.1038/s41586-018-0324-7; Mohapatra P, 2012, ONCOL RES, V20, P81, DOI 10.3727/096504012X13473664562628; Morales JC, 2014, CRIT REV EUKAR GENE, V24, P15, DOI 10.1615/CritRevEukaryotGeneExpr.2013006875; Nakamura K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000828; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Park SH, 2018, ONCOL LETT, V15, P9687, DOI 10.3892/ol.2018.8547; Parsons CA, 2000, EMBO J, V19, P4175, DOI 10.1093/emboj/19.15.4175; Pettitt SJ, 2019, CURR OPIN GENET DEV, V54, P55, DOI 10.1016/j.gde.2019.03.001; Pierce A, 2013, CANCER BIOL THER, V14, P537, DOI 10.4161/cbt.24349; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Ranatunga W, 2001, BIOCHEMISTRY-US, V40, P8557, DOI 10.1021/bi0155089; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Saotome M, 2018, ISCIENCE, V3, P50, DOI 10.1016/j.isci.2018.04.005; Sasanuma H, 2018, P NATL ACAD SCI USA, V115, pE10642, DOI 10.1073/pnas.1803177115; Shaheen M, 2011, BLOOD, V117, P6074, DOI 10.1182/blood-2011-01-313734; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sotiriou SK, 2016, MOL CELL, V64, P1127, DOI 10.1016/j.molcel.2016.10.038; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; TAKEUCHI N, 1992, J BIOCHEM-TOKYO, V112, P762, DOI 10.1093/oxfordjournals.jbchem.a123972; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Wan XB, 2013, J MED CHEM, V56, P2619, DOI 10.1021/jm400045y; Wehenkel A, 2006, FEBS LETT, V580, P3018, DOI 10.1016/j.febslet.2006.04.046; Wiseman LR, 1997, DRUG AGING, V10, P473, DOI 10.2165/00002512-199710060-00007; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Yasuhara T, 2018, CELL, V175, P558, DOI 10.1016/j.cell.2018.08.056; Yazinski SA, 2017, GENE DEV, V31, P318, DOI 10.1101/gad.290957.116; Ylilauri M, 2013, BBA-PROTEINS PROTEOM, V1834, P1988, DOI 10.1016/j.bbapap.2013.07.001; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	80	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248941	10.1371/journal.pone.0248941	http://dx.doi.org/10.1371/journal.pone.0248941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784323	Green Published			2022-12-26	WOS:000636359600060
J	Perez-Cruz, M; Kone, B; Porte, R; Carnoy, C; Tabareau, J; Gosset, P; Trottein, F; Sirard, JC; Pichavant, M; Gosset, P				Perez-Cruz, Magdiel; Kone, Bachirou; Porte, Remi; Carnoy, Christophe; Tabareau, Julien; Gosset, Pierre; Trottein, Francois; Sirard, Jean-Claude; Pichavant, Muriel; Gosset, Philippe			The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice	PLOS ONE			English	Article								Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. The major bacterial cause of COPD exacerbations is non-typeable Haemophilus influenzae (NTHi). 25 to over 80% of cases are associated with NTHi. This susceptibility to infection involves a defective production of interleukin (IL)-22 which plays an important role in mucosal defense. Prophylactic administration of flagellin, a Toll-like receptor 5 (TLR5) agonist, protects healthy mice against respiratory pathogenic bacteria. We hypothesized that TLR5-mediated stimulation of lung immunity might prevent COPD exacerbations. Mice chronically exposed to cigarette smoke (CS), which presented COPD symptoms, were infected with NTHi and intraperitoneally treated with recombinant flagellin following a prophylactic or therapeutic protocol. Compared with control, cigarette smoke-exposed mice treated with flagellin showed a lower bacterial load in the airways, the lungs and the blood. This protection was associated with an early neutrophilia, a lower production of pro-inflammatory cytokines and an increased IL-22 production. Flagellin treatment decreased the recruitment of inflammatory cells and the lung damages related to exacerbation. Morover, the protective effect of flagellin against NTHi was altered by treatment with anti-IL-22 blocking antibodies in cigarette smoke-exposed mice and in Il22(-/-) mice. The effect of flagellin treatment did not implicated the anti-bacterial peptides calgranulins and defensin-beta 2. This study shows that stimulation of innate immunity by a TLR5 ligand is a potent antibacterial treatment in CS-exposed mice, suggesting innovative therapeutic strategies against acute exacerbation in COPD.	[Perez-Cruz, Magdiel; Kone, Bachirou; Porte, Remi; Carnoy, Christophe; Tabareau, Julien; Trottein, Francois; Sirard, Jean-Claude; Pichavant, Muriel; Gosset, Philippe] Univ Lille, Inst Pasteur Lille, CIIL Ctr Infect & Immun Lille, CNRS,Inserm,CHRU Lille,UMR9017,U1019, Lille, France; [Gosset, Pierre] Hop St Vincent de Paul, Serv Anatomopathol, Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Gosset, P (corresponding author), Univ Lille, Inst Pasteur Lille, CIIL Ctr Infect & Immun Lille, CNRS,Inserm,CHRU Lille,UMR9017,U1019, Lille, France.	philippe.gosset@pasteur-lille.fr	Sirard, Jean-Claude/B-5932-2011; Pérez-Cruz, Magdiel/AAC-6164-2020; Gosset, Philippe/C-6174-2018; Pichavant, Muriel/B-9036-2018	Sirard, Jean-Claude/0000-0001-9854-4652; Pérez-Cruz, Magdiel/0000-0003-1215-2100; Gosset, Philippe/0000-0002-4043-6429; Pichavant, Muriel/0000-0002-1315-4397	Conseil Regional du Nord-Pas de Calais [StreptoCOPD project] [13005300]; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University of Lille	Conseil Regional du Nord-Pas de Calais [StreptoCOPD project]; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Lille	This work was granted by the Conseil Regional du Nord-Pas de Calais [StreptoCOPD project; grant number #13005300]. This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the Centre National de la Recherche Scientifique (CNRS) and the University of Lille. Funders had no role in study design, data collection, data analysis, interpretation, and writing of the report.	Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Boixeda Ramon, 2015, Int J Chron Obstruct Pulmon Dis, V10, P2581, DOI 10.2147/COPD.S88702; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Filippo K, 2014, FASEB J, V28, P3600, DOI 10.1096/fj.13-247460; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Kone B, 2020, CLIN EXP IMMUNOL, V201, P171, DOI 10.1111/cei.13445; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; Liaudet L, 2002, DRUG NEWS PERSPECT, V15, P397, DOI 10.1358/dnp.2002.15.7.840075; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Mulcahy ME, 2016, MUCOSAL IMMUNOL, V9, P1429, DOI 10.1038/mi.2016.24; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pichavant M, 2014, MUCOSAL IMMUNOL, V7, P568, DOI 10.1038/mi.2013.75; Pichavant M, 2015, EBIOMEDICINE, V2, P1686, DOI 10.1016/j.ebiom.2015.09.040; Porte R, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00806-16; Porte R, 2015, ANTIMICROB AGENTS CH, V59, P6064, DOI 10.1128/AAC.01210-15; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Romagne F, 2007, DRUG DISCOV TODAY, V12, P80, DOI 10.1016/j.drudis.2006.11.007; Roos AB, 2015, AM J RESP CRIT CARE, V192, P428, DOI 10.1164/rccm.201409-1689OC; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sharan R, 2017, MUCOSAL IMMUNOL, V10, P139, DOI 10.1038/mi.2016.40; Simpson JL, 2016, RESPIROLOGY, V21, P697, DOI 10.1111/resp.12734; Starkey MR, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00174-2018; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Van Pottelberge GR, 2009, COPD, V6, P284, DOI 10.1080/15412550903049124; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Woo JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090933	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0236216	10.1371/journal.pone.0236216	http://dx.doi.org/10.1371/journal.pone.0236216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784296	Green Published, gold			2022-12-26	WOS:000636359600018
J	Washburn, E; Nesbitt, J; Ibarra, B; Fehren-Schmitz, L; Oelze, VM				Washburn, Eden; Nesbitt, Jason; Ibarra, Bebel; Fehren-Schmitz, Lars; Oelze, Vicky M.			A strontium isoscape for the Conchucos region of highland Peru and its application to Andean archaeology	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; RESIDENTIAL-MOBILITY; HUMAN REMAINS; TOOTH ENAMEL; AYACUCHO VALLEY; MACHU-PICCHU; NILE VALLEY; SR ISOTOPES; NEW-KINGDOM; SAN PEDRO	Strontium isotope (Sr-87/Sr-86) analysis of human skeletal remains is an important method in archaeology to examine past human mobility and landscape use. Sr-87/Sr-86 signatures of a given location are largely determined by the underlying bedrock, and these geology specific isotope signatures are incorporated into skeletal tissue through food and water, often permitting the differentiation of local and non-local individuals in past human populations. This study presents the results of a systematic survey of modern flora and fauna (n = 100) from 14 locations to map the bioavailable Sr-87/Sr-86 signatures of the Conchucos region, an area where the extent of geologic variability was previously unknown. We illustrate the necessity to examine the variation in Sr-87/Sr-86 values of the different geological formations available to human land use to document the range of possible local Sr-87/Sr-86 values. Within the Conchucos region we found significant variation in environmental Sr-87/Sr-86 values (0.7078-0.7214). The resulting isoscape represents the largest regionally specific bioavailable Sr-87/Sr-86 map (3,840 km(2)) to date for the Andes, and will serve as a baseline for future archaeological studies of human mobility in this part of the Peruvian highlands.	[Washburn, Eden; Fehren-Schmitz, Lars; Oelze, Vicky M.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Nesbitt, Jason; Ibarra, Bebel] Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA	University of California System; University of California Santa Cruz; Tulane University	Washburn, E (corresponding author), Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA.	ewashbur@ucsc.edu		Ibarra, Bebel/0000-0002-5708-815X; , Eden/0000-0002-5393-3619	National Science Foundation [NSF -1842447]	National Science Foundation(National Science Foundation (NSF))	EW - This research was funded by the National Science Foundation (NSF -1842447) https://www.nsf.gov/publications/pub_summ.jsp? ods_key=nsf08564 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, GEOARCHAEOLOGY, V34, P231, DOI 10.1002/gea.21728; Altschul JH, 2020, P NATL ACAD SCI USA, V117, P20342, DOI 10.1073/pnas.2015146117; Andrushko VA, 2009, LAT AM ANTIQ, V20, P57, DOI 10.1017/S1045663500002510; Barberena R, 2017, AM J PHYS ANTHROPOL, V164, P305, DOI 10.1002/ajpa.23270; Bataille CP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197386; Bataille CP, 2012, CHEM GEOL, V304, P39, DOI 10.1016/j.chemgeo.2012.01.028; Bentley, 2006, EUR J ARCHAEOL, V2-3, P259; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Bentley RA, 2003, ARCHAEOMETRY, V45, P471, DOI 10.1111/1475-4754.00122; Bentley RA, 2002, CURR ANTHROPOL, V43, P799, DOI 10.1086/344373; Bethard JD., 2008, ARCHAEOBIOS, P3; Blank M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204649; Bowen GJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P425, DOI 10.1007/978-90-481-3354-3_20; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; BRUSH SB, 1976, HUM ECOL, V4, P147, DOI 10.1007/BF01531218; Burger R. L., 1992, CHAVIN ORIGINS ANDEA; Burger RL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P681, DOI 10.1007/978-0-387-74907-5_35; Buzon MR, 2007, J ARCHAEOL SCI, V34, P1391, DOI 10.1016/j.jas.2006.10.029; Buzon MR, 2013, AM J PHYS ANTHROPOL, V151, P1, DOI 10.1002/ajpa.22235; Buzon MR, 2012, J ARCHAEOL SCI, V39, P2627, DOI 10.1016/j.jas.2012.04.003; Caus E, 2016, CRETACEOUS RES, V57, P402, DOI 10.1016/j.cretres.2015.05.012; Chala-Aldana D, 2018, J ARCHAEOL SCI-REP, V19, P811, DOI 10.1016/j.jasrep.2017.10.023; Cobbing E.J., 1981, GEOLOGY W CORDILLERA; Cobbing J, 1996, EPISODES, V19, P103, DOI 10.18814/epiiugs/1996/v19i4/002; Conlee CA, 2009, J ARCHAEOL SCI, V36, P2755, DOI 10.1016/j.jas.2009.08.016; Copeland SR, 2016, QUATERNARY SCI REV, V141, P65, DOI 10.1016/j.quascirev.2016.04.002; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; Duran VA, 2018, J ARCHAEOL SCI-REP, V18, P668, DOI 10.1016/j.jasrep.2017.05.047; Eckardt H, 2009, J ARCHAEOL SCI, V36, P2816, DOI 10.1016/j.jas.2009.09.010; Eerkens JW, 2016, AM J PHYS ANTHROPOL, V159, P116, DOI 10.1002/ajpa.22843; Ehleringer JR, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P357, DOI 10.1007/978-90-481-3354-3_17; ELIAS RW, 1982, GEOCHIM COSMOCHIM AC, V46, P2561, DOI 10.1016/0016-7037(82)90378-7; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evans J, 2019, ARCHAEOL ANTHROP SCI, V11, P5181, DOI 10.1007/s12520-019-00849-w; Fan TL, 2020, GEOL SOC AM BULL, V132, P803, DOI 10.1130/B35088.1; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Faure G., 1972, STRONTIUM ISOTOPE GE; Fenner JN, 2014, J ARCHAEOL SCI, V44, P99, DOI 10.1016/j.jas.2014.01.020; Finucane B, 2006, J ARCHAEOL SCI, V33, P1766, DOI 10.1016/j.jas.2006.03.012; Finucane BC, 2007, J ARCHAEOL SCI, V34, P2115, DOI 10.1016/j.jas.2007.02.006; Finucane BC, 2009, CURR ANTHROPOL, V50, P534, DOI 10.1086/599860; Forman SH, 1976, FUTURE VALUE THE VER; FRANCIS PW, 1977, EARTH PLANET SC LETT, V37, P197, DOI 10.1016/0012-821X(77)90164-9; Frei KM, 2012, ARCHAEOL ANTHROP SCI, V4, P103, DOI 10.1007/s12520-011-0087-7; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Fux P., 2013, ARCHITECTURE RITUAL; Giblin JI, 2009, J ARCHAEOL SCI, V36, P491, DOI 10.1016/j.jas.2008.09.034; Graustein W.C., 1989, STABLE ISOTOPES ECOL, P491; Gregoricka LA, 2013, J ARCHAEOL SCI, V40, P452, DOI 10.1016/j.jas.2012.07.017; Grimstead DN, 2017, ADV ARCHAEOL PRACT, V5, P184, DOI 10.1017/aap.2017.6; Grupe G, 1997, APPL GEOCHEM, V12, P517, DOI 10.1016/S0883-2927(97)00030-9; Hewitt BR., 2013, FOREIGNERS DEAD T CU; Hirsch E, 2018, J LAT AM CARIBB ANTH, V23, P189, DOI 10.1111/jlca.12260; Ibarra Ascencios B, 2020, DIACHRONIC STUDY MOR; Ibarra B, 2003, ARQUEOLOG A SIERRA A, P251; Ibarra B, 2006, INFORME TEMPORADA; Ibarra B., 2009, HIST PREHISP NICA HU; Jaillard E, 1996, J S AM EARTH SCI, V9, P131, DOI 10.1016/0895-9811(96)00033-8; JORDAN TE, 1983, GEOL SOC AM BULL, V94, P341, DOI 10.1130/0016-7606(1983)94<341:ATRTGO>2.0.CO;2; Juengst SL, 2017, INT J OSTEOARCHAEOL, V27, P67, DOI 10.1002/oa.2469; Juengst SL, 2017, ARCHAEOLOGICAL PAPER, V28, P24; Kamenov GD, 2009, GEOCHIM COSMOCHIM AC, V73, P3549, DOI 10.1016/j.gca.2009.03.017; Kinaston RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064580; Knudson KJ, 2007, INT J OSTEOARCHAEOL, V17, P563, DOI 10.1002/oa.916; Knudson KJ, 2008, LAT AM ANTIQ, V19, P3, DOI 10.2307/25478206; Knudson KJ, 2007, AM J PHYS ANTHROPOL, V132, P25, DOI 10.1002/ajpa.20480; Knudson KJ, 2017, J ARCHAEOL SCI-REP, V13, P249, DOI 10.1016/j.jasrep.2017.03.047; Knudson KJ, 2016, J ARCHAEOL SCI-REP, V5, P590, DOI 10.1016/j.jasrep.2016.01.016; Knudson KJ, 2014, LAT AM ANTIQ, V25, P170, DOI 10.7183/1045-6635.25.2.170; Knudson KJ, 2014, AM J PHYS ANTHROPOL, V155, P405, DOI 10.1002/ajpa.22584; Knudson KJ, 2014, ARCHAEOL ANTHROP SCI, V6, P205, DOI 10.1007/s12520-013-0148-1; Knudson KJ, 2012, J ARCHAEOL SCI, V39, P479, DOI 10.1016/j.jas.2011.10.003; Knudson KJ, 2011, AM J PHYS ANTHROPOL, V145, P299, DOI 10.1002/ajpa.21494; Knudson KJ, 2010, J ARCHAEOL SCI, V37, P2352, DOI 10.1016/j.jas.2010.04.009; Knudson KJ, 2009, J ANTHROPOL ARCHAEOL, V28, P244, DOI 10.1016/j.jaa.2008.10.006; Knudson KJ, 2009, AM J PHYS ANTHROPOL, V138, P473, DOI 10.1002/ajpa.20965; Knudson KJ, 2005, J ARCHAEOL SCI, V32, P903, DOI 10.1016/j.jas.2005.01.007; Knudson KJ, 2004, ARCHAEOMETRY, V46, P5, DOI 10.1111/j.1475-4754.2004.00140.x; Knudson KJ., 2007, USING ARCHAEOLOGICAL; Kurin DS, 2016, INT J OSTEOARCHAEOL, V26, P93, DOI 10.1002/oa.2398; Kuznetsov AB, 2018, STRATIGR GEO CORREL+, V26, P367, DOI 10.1134/S0869593818040056; Ladegaard-Pedersen P, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134714; Laffoon JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172562; Lau G, 2016, ARCHAEOLOGY ANCASH S; Lugli F, 2019, NAT ECOL EVOL, V3, P905, DOI 10.1038/s41559-019-0900-8; Lumbreras LG., 1993, CHAV N HU NTAR EXCAV; Marsteller SJ, 2017, J ARCHAEOL SCI-REP, V13, P535, DOI 10.1016/j.jasrep.2017.04.016; Maxwell K, 2011, HUM ECOL, V39, P465, DOI 10.1007/s10745-011-9393-z; Meiggs DC., 2017, ISOTOPIC INVESTIGATI, P77; Meijer J, 2019, INT J OSTEOARCHAEOL, V29, P574, DOI 10.1002/oa.2753; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Montgomery J, 2005, AM J PHYS ANTHROPOL, V126, P123, DOI 10.1002/ajpa.20111; Moseley M.E., 2001, INCAS THEIR ANCESTOR; Moseley ME, 1985, EARLY CEREMONIAL ARC, P29; Murra JV, 1972, EL CONTROL VERTICAL; Murra JV, 1985, ANDEAN ECOLOGY CIVIL, V91, P15; NELSON BK, 1986, GEOCHIM COSMOCHIM AC, V50, P1941, DOI 10.1016/0016-7037(86)90250-4; Nesbitt J., 2020, AWPA PACHA, P1; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; PAERREGAARD K, 1992, ETHNOLOGY, V31, P15, DOI 10.2307/3773439; Panagiotopoulou E, 2018, EUR J ARCHAEOL, V21, P590, DOI 10.1017/eaa.2017.88; Pellegrini M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34986; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Price TD, 2006, AM J PHYS ANTHROPOL, V130, P485, DOI 10.1002/ajpa.20390; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; PRICE TD, 1994, J ARCHAEOL SCI, V21, P315, DOI 10.1006/jasc.1994.1031; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Rick John W., 2008, CHAVIN ART ARCHITECT, P3; Rick JW., 2004, ARCHEOL PAP AM ANTHR, V14, P71; Robinson Edward, 2017, Caribbean Journal of Earth Science, V49, P11; ROGERS G, 1989, EARTH PLANET SC LETT, V91, P271, DOI 10.1016/0012-821X(89)90003-4; ROSENTHAL GM, 1965, NATURE, V207, P51, DOI 10.1038/207051b0; Sanchez R, 1977, B SOC LATIN AM STUDI, P24; Scaffidi BK, 2020, J ARCHAEOL SCI, V117, DOI 10.1016/j.jas.2020.105121; SCHOENINGER MJ, 1992, J WORLD PREHIST, V6, P247, DOI 10.1007/BF00975551; Shand P, 2009, APPL GEOCHEM, V24, P574, DOI 10.1016/j.apgeochem.2008.12.011; Shaw H, 2016, J ARCHAEOL SCI, V66, P57, DOI 10.1016/j.jas.2015.12.001; SILLEN A, 1982, Yearbook of Physical Anthropology, V25, P67; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Slovak NM, 2011, ADV ISOTOP GEOCHEM, P743, DOI 10.1007/978-3-642-10637-8_35; Slovak NM, 2009, J ARCHAEOL SCI, V36, P157, DOI 10.1016/j.jas.2008.08.004; Slovak NM, 2018, J ARCHAEOL SCI-REP, V19, P411, DOI 10.1016/j.jasrep.2018.03.014; Snoeck C, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.136248; Standen VG, 2018, GEOARCHAEOLOGY, V33, P162, DOI 10.1002/gea.21594; STANISH C, 1992, ANCIENT ANDEAN POLIT; Stanish C, 2018, P NATL ACAD SCI USA, V115, pE6716, DOI 10.1073/pnas.1806632115; Sutter RC, 2000, LAT AM ANTIQ, V11, P43, DOI 10.2307/1571670; Takihata M, 2019, EXPERT OPIN PHARMACO, V20, P2185, DOI 10.1080/14656566.2019.1656717; Tello JC., 1960, CHAV N CULTURA MATRI; Tello JC, 1943, AM ANTIQUITY, V9, P135, DOI 10.2307/275457; Thornton EK, 2011, INT J OSTEOARCHAEOL, V21, P544, DOI 10.1002/oa.1157; Tomczak PD, 2003, J ANTHROPOL ARCHAEOL, V22, P262, DOI 10.1016/S0278-4165(03)00039-4; Tomczyk W, 2019, ARCHAEOL ANTHROP SCI, V11, P1307, DOI 10.1007/s12520-017-0590-6; Tritos NA, 2014, J CLIN ENDOCR METAB, V99, P2018, DOI 10.1210/jc.2014-1013; Tung TA, 2008, CURR ANTHROPOL, V49, P915, DOI 10.1086/591318; Tung TA, 2011, J ANTHROPOL ARCHAEOL, V30, P247, DOI 10.1016/j.jaa.2011.06.005; TUREKIAN KK, 1956, GEOCHIM COSMOCHIM AC, V10, P245, DOI 10.1016/0016-7037(56)90015-1; Turner BL, 2012, AM J PHYS ANTHROPOL, V149, P71, DOI 10.1002/ajpa.22096; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Valentine B, 2008, J ARCHAEOL SCI, V35, P1463, DOI 10.1016/j.jas.2007.10.016; van Aswegen t, 2017, EGU GEN ASS C; VanBuren M, 1996, AM ANTHROPOL, V98, P338; Vesteinsson O., 2014, J N ATL, V2014, P137; West JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002447; White CD, 2009, J ARCHAEOL SCI, V36, P1527, DOI 10.1016/j.jas.2009.03.008; Willmes M, 2018, APPL GEOCHEM, V90, P75, DOI 10.1016/j.apgeochem.2017.12.025	149	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248209	10.1371/journal.pone.0248209	http://dx.doi.org/10.1371/journal.pone.0248209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784347	Green Published			2022-12-26	WOS:000636359600022
J	Artetxe-Arrate, I; Fraile, I; Farley, J; Darnaude, AM; Clear, N; Rodriguez-Ezpeleta, N; Dettman, DL; Pecheyran, C; Krug, I; Medieu, A; Ahusan, M; Proctor, C; Priatna, A; Lestari, P; Davies, C; Marsac, F; Murua, H				Artetxe-Arrate, Iraide; Fraile, Igaratza; Farley, Jessica; Darnaude, Audrey M.; Clear, Naomi; Rodriguez-Ezpeleta, Naiara; Dettman, David L.; Pecheyran, Christophe; Krug, Inigo; Medieu, Anais; Ahusan, Mohamed; Proctor, Craig; Priatna, Asep; Lestari, Pratiwi; Davies, Campbell; Marsac, Francis; Murua, Hilario			Otolith chemical fingerprints of skipjack tuna (Katsuwonus pelamis) in the Indian Ocean: First insights into stock structure delineation	PLOS ONE			English	Article							YELLOWFIN TUNA; THUNNUS-ALBACARES; POPULATION-STRUCTURE; WESTERN PACIFIC; FISH; CHEMISTRY; MICROCHEMISTRY; CONNECTIVITY; VARIABILITY; CIRCULATION	The chemical composition of otoliths (earbones) can provide valuable information about stock structure and connectivity patterns among marine fish. For that, chemical signatures must be sufficiently distinct to allow accurate classification of an unknown fish to their area of origin. Here we have examined the suitability of otolith microchemistry as a tool to better understand the spatial dynamics of skipjack tuna (Katsuwonus pelamis), a highly valuable commercial species for which uncertainties remain regarding its stock structure in the Indian Ocean. For this aim, we have compared the early life otolith chemical composition of young-of-the-year (<6 months) skipjack tuna captured from the three main nursery areas of the equatorial Indian Ocean (West, Central and East). Elemental (Li:Ca, Sr:Ca, Ba:Ca, Mg:Ca and Mn:Ca) and stable isotopic (delta C-13, delta O-18) signatures were used, from individuals captured in 2018 and 2019. Otolith Sr:Ca, Ba:Ca, Mg:Ca and delta O-18 significantly differed among fish from different nurseries, but, in general, the chemical signatures of the three nursery areas largely overlapped. Multivariate analyses of otolith chemical signatures revealed low geographic separation among Central and Eastern nurseries, achieving a maximum overall random forest cross validated classification success of 51%. Cohort effect on otolith trace element signatures was also detected, indicating that variations in chemical signatures associated with seasonal changes in oceanographic conditions must be well understood, particularly for species with several reproductive peaks throughout the year. Otolith microchemistry in conjunction with other techniques (e.g., genetics, particle tracking) should be further investigated to resolve skipjack stock structure, which will ultimately contribute to the sustainable management of this stock in the Indian Ocean.	[Artetxe-Arrate, Iraide; Fraile, Igaratza; Rodriguez-Ezpeleta, Naiara; Krug, Inigo] Basque Res & Technol Alliance BRTA, Marine Res, AZTI, Pasaia, Gipuzkoa, Spain; [Farley, Jessica; Clear, Naomi; Proctor, Craig; Davies, Campbell] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Darnaude, Audrey M.] Univ Montpellier, CNRS, IFREMER, Marbec,IRD, Montpellier, France; [Dettman, David L.] Univ Arizona, Dept Geosci, Environm Isotope Lab, Tucson, AZ 85721 USA; [Pecheyran, Christophe] Univ Pau & Pays Adour, CNRS, IPREM, E2S UPPA, Pau, France; [Medieu, Anais] Univ Montpellier, CNRS, IFREMER, Marbec,IRD, Victoria, Seychelles; [Ahusan, Mohamed] Minist Fisheries Marine Resources & Agr, Mald Marine Res Inst, Male, Maldives; [Priatna, Asep; Lestari, Pratiwi] Res Inst Marine Fisheries, Jakarta, Indonesia; [Marsac, Francis] Univ Montpellierm, CNRS, IFREMER, Marbec,IRD, Sete, France; [Murua, Hilario] Int Seafood Sustainabil Fdn, Washington, DC USA	AZTI; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Arizona; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour; Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD)	Artetxe-Arrate, I (corresponding author), Basque Res & Technol Alliance BRTA, Marine Res, AZTI, Pasaia, Gipuzkoa, Spain.	iraide.artetxe@azti.es	Farley, Jessica/E-4957-2014; Marsac, Francis S/L-7707-2017; Artetxe-Arrate, Iraide/AGU-6216-2022; Davies, Campbell R/N-8086-2013; Rodriguez-Ezpeleta, Naiara/B-7138-2014	Farley, Jessica/0000-0002-5047-746X; Artetxe-Arrate, Iraide/0000-0001-9314-6479; Davies, Campbell R/0000-0002-2028-1060; Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Medieu, Anais/0000-0003-2928-1419; Priatna, Asep/0000-0002-5112-7314	European Union [S12.697993]; FAO/IOTC [GCP/INT/233/EC]; AZTI; Institut de Recherche pour le Developpement (IRD); Indonesia's Center for Fisheries Research (CFR); Department of Agriculture, Fisheries and Food Policy from the Basque Government (Convocatoria ayudas de formacion a jovenes investigadores y tecnologos 2017)	European Union(European Commission); FAO/IOTC; AZTI; Institut de Recherche pour le Developpement (IRD); Indonesia's Center for Fisheries Research (CFR); Department of Agriculture, Fisheries and Food Policy from the Basque Government (Convocatoria ayudas de formacion a jovenes investigadores y tecnologos 2017)	This research was funded by the European Union (Grant number S12.697993) and the FAO/IOTC, within the framework of a collaborative project (GCP/INT/233/EC - Population structure of IOTC species in the Indian Ocean) between FAO/IOTC and CSIRO Oceans and Atmosphere, AZTI, Institut de Recherche pour le Developpement (IRD), and Indonesia's Center for Fisheries Research (CFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein can in no way be taken to reflect the official opinion of the European Union. The first author was funded by a Ph.D. research grant from the Department of Agriculture, Fisheries and Food Policy from the Basque Government (Convocatoria ayudas de formacion a jovenes investigadores y tecnologos 2017).	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arai T, 2005, J MAR BIOL ASSOC UK, V85, P1211, DOI 10.1017/S0025315405012336; Artetxe-Arrate I, 2019, MAR FRESHWATER RES, V70, P1708, DOI 10.1071/MF19067; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Bao SL, 2020, J OCEANOGR, V76, P389, DOI 10.1007/s10872-020-00552-8; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bosley KM, 2019, FISH RES, V220, DOI 10.1016/j.fishres.2019.105344; Breiman L., 2001, MACH LEARN, V45, P5; Brophy D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71355-6; Cadrin S. X., 2014, STOCK IDENTIFICATION; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Chung MT, 2019, MAR FRESHWATER RES, V70, P1747, DOI 10.1071/MF18317; Claverie F, 2009, J ANAL ATOM SPECTROM, V24, P891, DOI 10.1039/b904134f; Collette B. B., 1983, SCOMBRIDS WORLD ANNO; Dammannagoda ST, 2011, CAN J FISH AQUAT SCI, V68, P210, DOI 10.1139/F10-136; Dettman D, 2020, IOTC2020WPTT22AS06RE; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Eveson JP, 2015, FISH RES, V163, P58, DOI 10.1016/j.fishres.2014.05.016; Fonteneau A, 1995, FAO FISH TECH PAP; Fonteneau A, 2003, IOTC P, P8; Fonteneau A, 2015, FISH RES, V163, P7, DOI 10.1016/j.fishres.2014.03.022; Grande M, 2016, J FISH BIOL, V89, P2434, DOI 10.1111/jfb.13125; Grande M, 2014, FISH RES, V156, P14, DOI 10.1016/j.fishres.2014.04.011; Grande M, 2012, J SEA RES, V73, P117, DOI 10.1016/j.seares.2012.06.008; Hegg JC, 2019, CAN J FISH AQUAT SCI, V76, P81, DOI 10.1139/cjfas-2017-0341; HILBORN R, 1988, MAR POLICY, V12, P31, DOI 10.1016/0308-597X(88)90005-X; Hoey JA, 2020, MOL ECOL, V29, P1421, DOI 10.1111/mec.15414; Hoyle SD, 2020, FISH RES, V228, DOI 10.1016/j.fishres.2020.105586; Hussy K, 2021, REV FISH SCI AQUAC, V29, P445, DOI 10.1080/23308249.2020.1760204; IOTC, 2017, STAT SUMM SPEC TUN T; ISSF (International Seafood Sustainability Foundation), 2020, 202016 ISSF; Izzo C, 2016, MAR FRESHWATER RES, V67, P1072, DOI 10.1071/MF15064; Kerr L.A., 2014, STOCK IDENTIFICATION, P205, DOI DOI 10.1016/B978-0-12-397003-9.00011-4; Kerr LA, 2017, ICES J MAR SCI, V74, P1708, DOI 10.1093/icesjms/fsw188; Keshtgar B, 2020, CLIM DYNAM, V54, P3627, DOI 10.1007/s00382-020-05195-5; Kitagawa T, 2013, MAR ECOL PROG SER, V481, P199, DOI 10.3354/meps10202; Kitchens L., 2017, THESIS TEXAS A M U; Kitchens LL, 2018, MAR ECOL PROG SER, V603, P201, DOI 10.3354/meps12676; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Leis JM, 2011, OCEANOGR MAR BIOL, V49, P193; Limburg KE, 2018, REV FISH SCI AQUAC, V26, P479, DOI 10.1080/23308249.2018.1458817; Macdonald JI, 2020, REV FISH BIOL FISHER, V30, P173, DOI 10.1007/s11160-019-09591-x; Magozzi S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1763; Marsac F, 1989, FAO FISH TECH PAP, P238; Martino JC, 2019, ECOL INDIC, V97, P10, DOI 10.1016/j.ecolind.2018.10.010; Menezes MR, 2012, J FISH BIOL, V80, P2198, DOI 10.1111/j.1095-8649.2012.03270.x; Murua H, 2020, STUDY POPULATION STR; Murua H, 2017, REV FISH BIOL FISHER, V27, P733, DOI 10.1007/s11160-017-9474-1; Nikolic N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72369-w; Pita A, 2016, FISH RES, V173, P185, DOI 10.1016/j.fishres.2015.10.029; RCore Team, 2020, R LANG ENV STAT COMP; Reglero P, 2014, MAR ECOL PROG SER, V501, P207, DOI 10.3354/meps10666; Reis-Santos P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28701-6; Rogers A., 2016, NETTING BILLIONS GLO; Rogers TA, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00711; Rooker JR, 2016, FISH OCEANOGR, V25, P277, DOI 10.1111/fog.12154; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Shankar D, 2002, PROG OCEANOGR, V52, P63, DOI 10.1016/S0079-6611(02)00024-1; Stequert B, 2001, AQUAT LIVING RESOUR, V14, P313, DOI 10.1016/S0990-7440(01)01126-3; Sturgeon RE, 2005, J ANAL ATOM SPECTROM, V20, P1067, DOI 10.1039/b503655k; Taillebois L, 2017, EVOL APPL, V10, P978, DOI 10.1111/eva.12499; Tanner SE, 2016, FISH RES, V173, P206, DOI 10.1016/j.fishres.2015.07.019; Thomas ORB, 2020, MAR ECOL PROG SER, V636, P169, DOI 10.3354/meps13229; Thomas ORB, 2017, METALLOMICS, V9, P239, DOI 10.1039/c6mt00189k; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Tomczak M., 2003, REGIONAL OCEANOGRAPH, V2; Trueman CN, 2012, J FISH BIOL, V81, P826, DOI 10.1111/j.1095-8649.2012.03361.x; Wells RJD, 2012, MAR ECOL PROG SER, V461, P187, DOI 10.3354/meps09833; Wiggert JD, 2006, DEEP-SEA RES PT II, V53, P644, DOI 10.1016/j.dsr2.2006.01.027	73	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249327	10.1371/journal.pone.0249327	http://dx.doi.org/10.1371/journal.pone.0249327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780495	gold, Green Published			2022-12-26	WOS:000636336800004
J	Bianchi, F; Sommariva, M; Le Noci, V; Camelliti, S; Gagliano, N; Giussani, M; Balsari, A; Tagliabue, E; Sfondrini, L				Bianchi, Francesca; Sommariva, Michele; Le Noci, Valentino; Camelliti, Simone; Gagliano, Nicoletta; Giussani, Marta; Balsari, Andrea; Tagliabue, Elda; Sfondrini, Lucia			Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; NATURAL-KILLER-CELLS; ALVEOLAR MACROPHAGES; 25-HYDROXYVITAMIN D; LUNG-CANCER; RISK; CYTOTOXICITY; ACTIVATION; EXPRESSION; PROTEIN	Background 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] plays a role in calcium homeostasis but can also exert immunomodulatory effects. In lungs, characterized by a particular immunosuppressive environment primarily due to the presence of alveolar macrophages (AM), 1,25(OH)2D3 has been shown to favor the immune response against pathogens. Here, we explored the ability of aerosolized 1,25(OH)2D3 to locally promote an anti-tumor phenotype in alveolar macrophages (AM) in the treatment of lung metastases. Methods Cytotoxicity assay has been used to assess the capability of AM, in vitro treated of not with 1,25(OH)2D3, to stimulate NK cells. Sulforhodamine B (SRB) assay has been used to assess the effect of 1,25(OH)2D3 on MC-38 and B16 tumor cells in vitro growth. 1,25(OH)2D3 was aerosolized in immunocompetent mouse models to evaluate the effect of local administration of 1,25(OH)2D3 on in vivo growth of MC-38 and B16 tumor cells within lungs and on infiltrating immune cells. Results In vitro incubation of naive AM with 1,25(OH)2D3 improved their ability to stimulate NK cell cytotoxicity. In vivo aerosolized 1,25(OH)2D3 significantly reduced the metastatic growth of MC-38 colon carcinoma, a tumor histotype that frequently metastasizes to lung in human. Immune infiltrate obtained from digested lungs of 1,25(OH)2D3-treated mice bearing MC-38 metastases revealed an increased expression of MHCII and CD80 on AM and an up-modulation of CD69 expression on effector cells that paralleled a strong increased ability of these cells to kill MC-38 tumor in vitro. Conclusions Together, these data show that aerosol delivery can represent a feasible and novel approach to supplement 1,25(OH)2D3 directly to the lungs promoting the activation of local immunity against cancer.	[Bianchi, Francesca; Sommariva, Michele; Le Noci, Valentino; Camelliti, Simone; Gagliano, Nicoletta; Balsari, Andrea; Sfondrini, Lucia] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy; [Bianchi, Francesca; Balsari, Andrea; Tagliabue, Elda] Fdn IRCCS Ist Nazl Tumori, Dept Res, Mol Targeting Unit, Milan, Italy; [Giussani, Marta] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Pathol & Lab, Lab Med Unit, Milan, Italy	University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Sfondrini, L (corresponding author), Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy.	lucia.sfondrini@unimi.it	Bianchi, Francesca/ABD-5518-2020; LE NOCI, VALENTINO MARIO/C-9504-2017	Bianchi, Francesca/0000-0001-5197-5279; LE NOCI, VALENTINO MARIO/0000-0002-7470-6909; Camelliti, Simone/0000-0001-5072-2798	AIRC (Associazione Italiana per la Ricerca sul Cancro) [12162, 24718]; Fondazione Umberto Veronesi; Piano di Sostegno alla Ricerca 2017 Universita degli Studi di Milano	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Piano di Sostegno alla Ricerca 2017 Universita degli Studi di Milano	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro; No 12162 to E. T. and No 24718 to L. S.), by Fondazione Umberto Veronesi (Fellowship 2018 and 2019 to F.B.) and Piano di Sostegno alla Ricerca 2017 Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu el Maaty MA, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0183-6; Abu el Maaty MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102184; ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Balogh G, 1999, EXP MOL PATHOL, V67, P63, DOI 10.1006/exmp.1999.2264; BERGER U, 1988, J CLIN ENDOCR METAB, V67, P607, DOI 10.1210/jcem-67-3-607; Bianchi F, 2015, J CELL PHYSIOL, V230, P2661, DOI 10.1002/jcp.24968; Bittenbring JT, 2014, J CLIN ONCOL, V32, P3242, DOI 10.1200/JCO.2013.53.4537; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007469.pub2; Bochen F, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1476817; Bozzetto S, 2012, ALLERGY, V67, P10, DOI 10.1111/j.1398-9995.2011.02711.x; Bruns H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3230; Chen GC, 2015, CANCER CAUSE CONTROL, V26, P1719, DOI 10.1007/s10552-015-0665-6; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; COHEN MS, 1986, J IMMUNOL, V136, P1049; Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005; El-Shazly AE, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/373589; Feng QQ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008613; Gerke AK, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-18; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Greiller CL, 2015, NUTRIENTS, V7, P4240, DOI 10.3390/nu7064240; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hernandez Jose L., 2021, Journal of Clinical Endocrinology & Metabolism, V106, pE1343, DOI 10.1210/clinem/dgaa733; Hidaka M, 2013, EUR J PHARMACOL, V721, P305, DOI 10.1016/j.ejphar.2013.09.014; Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8; Jeon SM, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0038-9; Jiang X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80655-w; Kaneno R, 2002, IMMUNOL LETT, V81, P183, DOI 10.1016/S0165-2478(02)00037-8; Kelly JL, 2015, J CLIN ONCOL, V33, P1482, DOI 10.1200/JCO.2014.57.5092; Le Noci V, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/2015892; Le Noci V, 2018, CELL REP, V24, P3528, DOI 10.1016/j.celrep.2018.08.090; Le Noci V, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1040214; Lee GY, 2018, J NUTR BIOCHEM, V55, P178, DOI 10.1016/j.jnutbio.2018.01.004; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092736; Mann EH, 2014, ANN NY ACAD SCI, V1317, P57, DOI 10.1111/nyas.12410; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Martens PJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051248; Mattiola I, 2015, J IMMUNOL, V195, P2818, DOI 10.4049/jimmunol.1500325; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; MERINO F, 1989, CELL IMMUNOL, V118, P328, DOI 10.1016/0008-8749(89)90381-X; Mitchell F, 2020, LANCET DIABETES ENDO, V8, P570, DOI 10.1016/S2213-8587(20)30183-2; Mohan M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008874; Mondul AM, 2017, EPIDEMIOL REV, V39, P28, DOI 10.1093/epirev/mxx005; Mortara L, 2018, TARGET ONCOL, V13, P657, DOI 10.1007/s11523-018-0586-x; Najafi M, 2019, J CELL BIOCHEM, V120, P2756, DOI 10.1002/jcb.27646; Nica-Badea D, 2021, ANTI-CANCER AGENT ME, V21, P1942, DOI 10.2174/1871520621666210112115846; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Ota K, 2015, EUR J IMMUNOL, V45, P3188, DOI 10.1002/eji.201545541; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; QUESADA JM, 1995, CALCIFIED TISSUE INT, V56, P113, DOI 10.1007/BF00296341; Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446; Sommariva M, 2017, CELL IMMUNOL, V313, P52, DOI 10.1016/j.cellimm.2017.01.004; Taylor SK, 2016, LUNG, V194, P931, DOI 10.1007/s00408-016-9939-3; Turdo F, 2016, ONCOTARGET, V7, P69649, DOI 10.18632/oncotarget.11935; Vogiatzi MG, 2014, J CLIN ENDOCR METAB, V99, P1132, DOI 10.1210/jc.2013-3655; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Welsh J, 2007, ACTA PHARMACOL SIN, V28, P1373, DOI 10.1111/j.1745-7254.2007.00700.x; Wierzbicka JM, 2015, INT J ONCOL, V47, P1084, DOI 10.3892/ijo.2015.3088; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Wu X, 2019, ACTA PHARM SIN B, V9, P203, DOI 10.1016/j.apsb.2018.09.002; XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x; Yakoob MY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008824.pub2; Zhang LQ, 2015, CELL PHYSIOL BIOCHEM, V36, P299, DOI 10.1159/000374072; Zittermann A, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0208-y	70	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248789	10.1371/journal.pone.0248789	http://dx.doi.org/10.1371/journal.pone.0248789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780475	Green Published, gold			2022-12-26	WOS:000636336800040
J	van Egmond, S; de Vries, E; Hollestein, L; Bastiaens, M; de Roos, KP; Kuijpers, D; Steyerberg, E; Wakkee, M; Mosterd, K; Nijsten, T; de Bekker-Grob, EW				van Egmond, Sven; de Vries, Esther; Hollestein, Loes; Bastiaens, Maarten; de Roos, Kees-Peter; Kuijpers, Danielle; Steyerberg, Ewout; Wakkee, Marlies; Mosterd, Klara; Nijsten, Tamar; de Bekker-Grob, Esther W.			What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment	PLOS ONE			English	Article								Background Follow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this 'low-value' care, it is important to obtain insights into the preferences of patients and dermatologists. Objective To determine the preferences and needs of patients and dermatologists to reduce low-risk BCC follow-up care, and the trade-offs they are willing to make. Methods A questionnaire including a discrete choice experiment was created, containing attributes regarding amount of follow-up, continuity of care, method of providing addition information, type of healthcare provider, duration of follow-up visits and skin examination. In total, 371 BCC patients and all Dutch dermatologists and dermatology residents (n = 620) were invited to complete the questionnaire. A panel latent class model was used for analysis. Results Eighty-four dermatologists and 266 BCC patients (21% and 72% response rates respectively) completed the discrete choice experiment. If the post-treatment visit was performed by the same person as treatment provider and a hand-out was provided to patients containing personalised information, the acceptance of having no additional follow-up visits (i.e. following the guidelines) would increase from 55% to 77% by patients. Female patients and older dermatologists, however, are less willing to accept the guidelines and prefer additional follow-up visits. Limitations The low response rate of dermatologists. Conclusion This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.	[van Egmond, Sven; Hollestein, Loes; Wakkee, Marlies; Nijsten, Tamar] Erasmus MC Canc Inst, Dept Dermatol, Rotterdam, Netherlands; [de Vries, Esther] Pontificia Univ Javeriana, Hosp San Ignacio, Dept Clin Epidemiol & Biostat, Bogota, Colombia; [de Vries, Esther; Steyerberg, Ewout] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Bastiaens, Maarten] TweeSteden Ziekenhuis, Dept Dermatol, Tilburg, Netherlands; [de Roos, Kees-Peter] DermaPark, Dept Dermatol, Uden, Netherlands; [Kuijpers, Danielle] Amphia Ziekenhuis, Dept Dermatol, Breda, Netherlands; [Steyerberg, Ewout] Leiden Univ Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Mosterd, Klara] Maastricht Univ Med Ctr, Dept Dermatol, Maastricht, Netherlands; [de Bekker-Grob, Esther W.] Erasmus Univ, Sect Hlth Technol Assessment, Rotterdam, Netherlands; [de Bekker-Grob, Esther W.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Erasmus Choice Modelling Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Hospital Universitario San Ignacio; Pontificia Universidad Javeriana; Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Leiden University; Leiden University Medical Center (LUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus University Rotterdam	van Egmond, S (corresponding author), Erasmus MC Canc Inst, Dept Dermatol, Rotterdam, Netherlands.	s.vanegmond@erasmusmc.nl	Hollestein, Loes/AFL-0006-2022; de Vries, Esther/A-6603-2009; de Roos, Kees-Peter/B-4364-2014; Steyerberg, Ewout/C-1509-2018	Hollestein, Loes/0000-0001-8922-6791; de Vries, Esther/0000-0002-5560-2258; de Roos, Kees-Peter/0000-0002-2970-8649; van Egmond, Sven/0000-0002-1323-4928; Steyerberg, Ewout/0000-0002-7787-0122	Citrienfonds (Dutch Ministry of Health, Welfare and Sport); health insurance company VGZ	Citrienfonds (Dutch Ministry of Health, Welfare and Sport); health insurance company VGZ	This study was sponsored by Citrienfonds (Dutch Ministry of Health, Welfare and Sport) and the health insurance company VGZ (https://www.vgz.nl/). The funders had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the report nor in the decision to submit the article for publication.	[Anonymous], 1999, MEDISCHE PROFIELEN B; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Clark MD, 2014, PHARMACOECONOMICS, V32, P883, DOI 10.1007/s40273-014-0170-x; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; Cummings SM, 2001, HEALTH SERV RES, V35, P1347; Cunningham CT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0016-z; Damery S, 2014, EJSO-EUR J SURG ONC, V40, P1655, DOI 10.1016/j.ejso.2014.04.020; de Bekker-Grob EW, 2015, PATIENT, V8, P373, DOI 10.1007/s40271-015-0118-z; de Bock GH, 2004, BRIT J CANCER, V90, P1144, DOI 10.1038/sj.bjc.6601655; Essers BAB, 2010, PHARMACOECONOMICS, V28, P507, DOI 10.2165/11532240-000000000-00000; Feiten S, 2014, DTSCH ARZTEBL INT, V111, P537, DOI 10.3238/arztebl.2014.0537; Flohil SC, 2011, BRIT J DERMATOL, V165, P874, DOI 10.1111/j.1365-2133.2011.10488.x; Gordon LG, 2015, EUR J CANCER PREV, V24, P141, DOI 10.1097/CEJ.0000000000000056; Greene W.H, 2016, NLOGIT VERSION 5 REF; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Jones R, 1999, BRIT MED J, V319, P1241, DOI 10.1136/bmj.319.7219.1241; Kimman ML, 2010, ACTA ONCOL, V49, P328, DOI 10.3109/02841860903536002; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Leavitt M, 2001, MedGenMed, V3, P2; Marzuka Alexander G., 2015, Yale Journal of Biology and Medicine, V88, P167; Montgomery DA, 2008, BREAST, V17, P347, DOI 10.1016/j.breast.2008.02.004; Murchie P, 2010, BRIT J CANCER, V102, P1447, DOI 10.1038/sj.bjc.6605638; Murchie P, 2010, SUPPORT CARE CANCER, V18, P225, DOI 10.1007/s00520-009-0648-9; Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV), 2014, EV BAS RICHTL BAS; Saunders CL, 2016, MED CARE, V54, P45, DOI 10.1097/MLR.0000000000000457; Soekhai V, 2019, PHARMACOECONOMICS, V37, P201, DOI 10.1007/s40273-018-0734-2; Street DJ, 2005, INT J RES MARK, V22, P459, DOI 10.1016/j.ijresmar.2005.09.003; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; Trakatelli M, 2014, EUR J DERMATOL, V24, P312, DOI 10.1684/ejd.2014.2271; van Egmond S, 2019, BRIT J DERMATOL, V180, P122, DOI 10.1111/bjd.16900; van Egmond S., 2018, BRIT J DERMATOL; Verkouteren JAC, 2017, BRIT J DERMATOL, V177, P359, DOI 10.1111/bjd.15321; Wakkee M, 2019, EUR J CANCER, V117, P32, DOI 10.1016/j.ejca.2019.05.010; Watson V, 2017, HEALTH ECON, V26, P810, DOI 10.1002/hec.3354	35	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249298	10.1371/journal.pone.0249298	http://dx.doi.org/10.1371/journal.pone.0249298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780499	gold, Green Published			2022-12-26	WOS:000636336800011
J	Kaelen, S; van den Boogaard, W; Pellecchia, U; Spiers, S; De Cramer, C; Demaegd, G; Fouqueray, E; Van den Bergh, R; Goublomme, S; Decroo, T; Quinet, M; Van Hoof, E; Draguez, B				Kaelen, Sanne; van den Boogaard, Wilma; Pellecchia, Umberto; Spiers, Sofie; De Cramer, Caroline; Demaegd, Gwennin; Fouqueray, Edouard; Van den Bergh, Rafael; Goublomme, Stephanie; Decroo, Tom; Quinet, Muriel; Van Hoof, Elke; Draguez, Bertrand			How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes-A qualitative study	PLOS ONE			English	Article							LONG-TERM-CARE; SOCIAL-ISOLATION; MORAL DISTRESS; HEALTH; LONELINESS; TORONTO; IMPACT; SARS	Background Nursing homes (NH) for the elderly have been particularly affected by the Covid-19 pandemic mainly due to their hosted vulnerable populations and poor outbreak preparedness. In Belgium, the medical humanitarian organization Medecins Sans Frontieres (MSF) implemented a support project for NH including training on infection prevention and control (IPC), (re)-organization of care, and psychosocial support for NH staff. As psychosocial and mental health needs of NH residents in times of Covid-19 are poorly understood and addressed, this study aimed to better understand these needs and how staff could respond accordingly. Methods A qualitative study adopting thematic content analysis. Eight focus group discussions with direct caring staff and 56 in-depth interviews with residents were conducted in eight purposively and conveniently selected NHs in Brussels, Belgium, June 2020. Results NH residents experienced losses of freedom, social life, autonomy, and recreational activities that deprived them of their basic psychological needs. This had a massive impact on their mental well-being expressed in feeling depressed, anxious, and frustrated as well as decreased meaning and quality of life. Staff felt unprepared for the challenges posed by the pandemic; lacking guidelines, personal protective equipment and clarity around organization of care. They were confronted with professional and ethical dilemmas, feeling 'trapped' between IPC and the residents' wellbeing. They witnessed the detrimental effects of the measures imposed on their residents. Conclusion This study revealed the insights of residents' and NH staff at the height of the early Covid-19 pandemic. Clearer outbreak plans, including psychosocial support, could have prevented the aggravated mental health conditions of both residents and staff. A holistic approach is needed in NHs in which tailor-made essential restrictive IPC measures are combined with psychosocial support measures to reduce the impact on residents' mental health impact and to enhance their quality of life.	[Kaelen, Sanne; Spiers, Sofie; De Cramer, Caroline; Demaegd, Gwennin; Fouqueray, Edouard; Van den Bergh, Rafael; Goublomme, Stephanie; Draguez, Bertrand] Med Sans Frontieres, Operat Ctr Brussels, Belgium Covid 19 Project, Brussels, Belgium; [van den Boogaard, Wilma; Pellecchia, Umberto] Med Sans Frontieres, Operat Ctr Brussels, Operat Res Unit LuxOR, Luxembourg, Luxembourg; [van den Boogaard, Wilma; Pellecchia, Umberto] Med Sans Frontieres, Operat Ctr Brussels, Operat Res Unit LuxOR, Brussels, Belgium; [Decroo, Tom] Inst Trop Med, Antwerp, Belgium; [Quinet, Muriel] Iriscare, Publ Hlth Inst, Brussels, Belgium; [Van Hoof, Elke] Super Hlth Council, Working Grp Psychosocial Impact COVID 19 Pandem, Brussels, Belgium; [Van Hoof, Elke] GEES, Mental Hlth Subworking Grp, Brussels, Belgium; [Van Hoof, Elke] Vrije Univ Brussel, Brussels, Belgium	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel	Kaelen, S (corresponding author), Med Sans Frontieres, Operat Ctr Brussels, Belgium Covid 19 Project, Brussels, Belgium.	sanne.kaelen@hotmail.com	Decroo, Tom/AAV-7208-2020	Decroo, Tom/0000-0002-1205-1484; Van den Bergh, Rafael/0000-0001-6277-8713				Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cacchione PZ, 2020, CLIN NURS RES, V29, P215, DOI 10.1177/1054773820920385; Cantarero K, 2021, SOC PSYCHOL PERS SCI, V12, P821, DOI 10.1177/1948550620942708; Melo MCA, 2020, INT J SOC PSYCHIATR, V66, P625, DOI 10.1177/0020764020927047; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Dichter MN, 2020, INT PSYCHOGERIATR, V32, P1157, DOI 10.1017/S1041610220000897; Gordon AL, 2020, AGE AGEING, V49, P701, DOI 10.1093/ageing/afaa113; Green J., 2018, QUALITATIVE METHODS, VFourth; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Iden KR, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0019-y; Inzitari M, 2020, J NUTR HEALTH AGING, V24, P1042, DOI 10.1007/s12603-020-1447-8; Kalvemark S, 2004, SOC SCI MED, V58, P1075, DOI 10.1016/S0277-9536(03)00279-X; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Morley Georgina, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc047; Mudecins Sans Frontiu┐res, 2020, LEFT TIME COVID 19 B; Mukhtar S, 2020, INT J SOC PSYCHIATR, V66, P512, DOI 10.1177/0020764020925835; Quested E, 2011, J SPORT EXERCISE PSY, V33, P828, DOI 10.1123/jsep.33.6.828; Reis HT, 2000, PERS SOC PSYCHOL B, V26, P419, DOI 10.1177/0146167200266002; Rios P, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01486-4; Robert R, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00702-7; Robertson E, 2004, CAN J PSYCHIAT, V49, P403; Roy J, 2020, INT J GERIATR PSYCH, V35, P1437, DOI 10.1002/gps.5389; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Santiago-Bravo G, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e971; Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0; Schlaudecker JD, 2020, J AM MED DIR ASSOC, V21, P983, DOI 10.1016/j.jamda.2020.05.027; Sciensano, 2020, EPIDEMIOLOGICAL B 30; Senczyszyn A, 2020, J AM MED DIR ASSOC, V21, P1576, DOI 10.1016/j.jamda.2020.09.020; Simning A, 2017, INT PSYCHOGERIATR, V29, P209, DOI 10.1017/S1041610216001733; Snowdon J, 2010, INT PSYCHOGERIATR, V22, P1063, DOI 10.1017/S1041610210000773; Szczerbinska K, 2020, EUR GERIATR MED, V11, P639, DOI 10.1007/s41999-020-00362-7; Trabucchi M, 2020, LANCET PSYCHIAT, V7, P387, DOI 10.1016/S2215-0366(20)30149-8; Vansteenkiste M, 2020, MOTIV EMOTION, V44, P1, DOI 10.1007/s11031-019-09818-1; Verbeek H, 2020, J AM MED DIR ASSOC, V21, P900, DOI 10.1016/j.jamda.2020.06.020; Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1	38	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249098	10.1371/journal.pone.0249098	http://dx.doi.org/10.1371/journal.pone.0249098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770110	Green Published, gold			2022-12-26	WOS:000634833500034
J	Larson, JL; Larson, DL; Venette, RC				Larson, Jennifer L.; Larson, Diane L.; Venette, Robert C.			Balancing the need for seed against invasive species risks in prairie habitat restorations	PLOS ONE			English	Article							ECOREGIONS	Adequate diversity and abundance of native seed for large-scale grassland restorations often require commercially produced seed from distant sources. However, as sourcing distance increases, the likelihood of inadvertent introduction of multiple novel, non-native weed species as seed contaminants also increases. We created a model to determine an "optimal maximum distance" that would maximize availability of native prairie seed from commercial sources while minimizing the risk of novel invasive weeds via contamination. The model focused on the central portion of the Level II temperate prairie ecoregion in the Midwest US. The median optimal maximum distance from which to source seed was 272 km (169 miles). In addition, we weighted the model to address potential concerns from restoration practitioners: 1. sourcing seed via a facilitated migration strategy (i.e., direct movement of species from areas south of a given restoration site to assist species' range expansion) to account for warming due to climate change; and 2. emphasizing non-native, exotic species with a federal mandate to control. Weighting the model for climate change increased the median optimal maximum distance to 398 km (247 miles), but this was not statistically different from the distance calculated without taking sourcing for climate adaptation into account. Weighting the model for federally mandated exotic species increased the median optimal maximum distance only slightly to 293 km (182 miles), so practitioners may not need to adjust their sourcing strategy, compared to the original model. This decision framework highlights some potential inadvertent consequences from species translocations and provides insight on how to balance needs for prairie seed against those risks.	[Larson, Jennifer L.; Larson, Diane L.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Minnesota Field Stn, St Paul, MN 55114 USA; [Venette, Robert C.] US Forest Serv, USDA, Northern Res Stn, St Paul, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service	Larson, JL (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Minnesota Field Stn, St Paul, MN 55114 USA.	jllarson@usgs.gov		Larson, Jennifer/0000-0002-6259-0101	Northeast Climate Adaptation Science Center (NE CASC) United States Geological Survey (USGS)	Northeast Climate Adaptation Science Center (NE CASC) United States Geological Survey (USGS)	DL and RV received the award. Northeast Climate Adaptation Science Center (NE CASC) United States Geological Survey (USGS) There are no grant numbers associated with funding. https://www.usgs.gov/https://necsc.umass.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borders BD, 2011, NAT AREA J, V31, P190, DOI 10.3375/043.031.0213; Breed MF, 2018, BIOSCIENCE, V68, P510, DOI 10.1093/biosci/biy050; Bucharova A, 2017, RESTOR ECOL, V25, P14, DOI 10.1111/rec.12457; EDDMaps, 2019, EARL DET DISTR MAPP; Gerla PJ, 2012, SUSTAINABILITY-BASEL, V4, P3066, DOI 10.3390/su4113066; Guo QF, 2007, BASIC APPL ECOL, V8, P199, DOI 10.1016/j.baae.2006.02.005; Guo QF, 2018, INVAS PLANT SCI MANA, V11, P163, DOI 10.1017/inp.2018.29; Havens K, 2015, NAT AREA J, V35, P122, DOI 10.3375/043.035.0116; Helzer C, 2011, GUIDE SELLING NATIVE; Helzer C, 2010, ECOLOGY MANAGEMENT P, P232; Helzer C., 2011, GUIDE PRAIRIE WETLAN; Kartesz J.T., 2015, N AM PLANT ATLAS; Kilkenny FF, 2015, NAT AREA J, V35, P152, DOI 10.3375/043.035.0110; Ladouceur E, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12381; Larson JL, 2021, **DATA OBJECT**, DOI [10.5066/P9HS0ZKB, DOI 10.5066/P9HS0ZKB]; Meissen JC, 2015, RESTOR ECOL, V23, P882, DOI 10.1111/rec.12295; MN BWSR, 2017, NATIVE VEGETATION ES; MN Department of Agriculture, 2015, MINN SEED LAW MINN S, P46; MN DNR, 2019, PRAIR EST MAINT TECH; Nevill PG, 2016, ECOL EVOL, V6, P7490, DOI 10.1002/ece3.2455; Omernik JM, 2014, ENVIRON MANAGE, V54, P1249, DOI 10.1007/s00267-014-0364-1; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Perring MP, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00121.1; R Core Team, 2020, R LANG ENV STAT COMP; Ramalho CE, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00095; Runquist RDB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38054-9; Sedivec DK., 2017, PRAIRIE RECONSTRUCTI, V32; Singh S, 2019, PEST MANAG SCI, V75, P1131, DOI 10.1002/ps.5232; Solomon S., 2007, PHYS SCI BASIS WORKI; Thornburg A, 1982, PLANT MAT USE SURFAC; USDA, 2019, FED SEED ACT; USDA, 2018, PALM AM; USDA, 1998, FED SEED ACT 7 USC 1, P16; *USDA, 2019, PLANTS DAT; USDA-NRCS-Iowa, NO TITLE; White A, 2018, RESTOR ECOL, V26, P605, DOI 10.1111/rec.12705	36	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0248583	10.1371/journal.pone.0248583	http://dx.doi.org/10.1371/journal.pone.0248583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826620	gold, Green Published			2022-12-26	WOS:000638119900044
J	Zheng, XY; Jia, R; Gong, LL; Aisikaer; Ma, XP; Dang, J; Lv, ZH				Zheng, Xiangyu; Jia, Rong; Gong, Linling; Aisikaer; Ma, Xiping; Dang, Jian; Lv, Zhihan			Relay protection system of transmission line based on AI	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK	With the development of modern power systems, higher requirements are imposed on relay protection technology. Traditional relay protection and fault diagnosis technologies have been unable to meet the requirements of the continuous development of power systems, and relay protection systems based on artificial intelligence(AI) technology have received increasing attention. Therefore, this document first analyses the weaknesses of traditional broadcast line protection and uses the adaptability and self-learning of artificial intelligence(AI); to propose the concept of protection of a relay line based on AI. In combination with the artificial nervous network, the AI-based relay protection system shall be studied and the experimental model shall be developed. This paper validates it with simulation experiments. The research results show that for the analysis of the ANN test results of the subnetwork, the actual output of the subnetwork is very close to the ideal output, and the error does not exceed 0.2%. The system has good performance and high reliability.	[Zheng, Xiangyu; Jia, Rong; Dang, Jian] Xian Univ Technol, Sch Elect Engn, Xian, Shaanxi, Peoples R China; [Zheng, Xiangyu; Ma, Xiping] State Grid GanSu Elect Power Res Inst, Lanzhou, Gansu, Peoples R China; [Jia, Rong] Xian Univ Technol, Energy Intelligence Lab, Xian, Shaanxi, Peoples R China; [Gong, Linling] Lanzhou Petrochem Coll Vocat Technol, Lanzhou, Gansu, Peoples R China; [Aisikaer] Xinjiang Goldwind Sci & Technol Co Ltd, Urumqi, Xinjiang, Peoples R China	Xi'an University of Technology; Xi'an University of Technology; Lanzhou Petrochemical University of Vocational Technology	Zheng, XY (corresponding author), Xian Univ Technol, Sch Elect Engn, Xian, Shaanxi, Peoples R China.; Zheng, XY (corresponding author), State Grid GanSu Elect Power Res Inst, Lanzhou, Gansu, Peoples R China.	1102zxy@163.com	Lv, Zhihan/I-3187-2014; Lv, Zhihan/GLR-6000-2022; Dang, Jian/HDM-6049-2022; Jia, Rong/HDM-6106-2022	Lv, Zhihan/0000-0003-2525-3074; Lv, Zhihan/0000-0003-2525-3074; 	Key project of Natural Science Basic Research plan in Shaanxi Province of China [2019ZDLGY18-03]; State Grid Gansu Electric Power Research Institute	Key project of Natural Science Basic Research plan in Shaanxi Province of China; State Grid Gansu Electric Power Research Institute	This study was supported in the form of funding by Key project of Natural Science Basic Research plan in Shaanxi Province of China (Grant No. 2018ZDXM-GY-169) and Key project of Natural Science Basic Research plan in Shaanxi Province of China (Grant No. 2019ZDLGY18-03) for authors XZ, RJ, and JD. Xinjiang Goldwind Technology Co., Ltd. provided funding via salary for SA; and State Grid Gansu Electric Power Research Institute provided funding via salary for XM. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen D, 2017, DIANGONG JISHU XUEBA, V32, P115; Cheng CT, 2015, WATER-SUI, V7, P4232, DOI 10.3390/w7084232; Djemili R, 2016, BIOCYBERN BIOMED ENG, V36, P285, DOI 10.1016/j.bbe.2015.10.006; Dubey R, 2016, IET GENER TRANSM DIS, V10, P247, DOI 10.1049/iet-gtd.2015.0775; Feng XY, 2015, IEEE T POWER SYST, V30, P1327, DOI 10.1109/TPWRS.2014.2340393; Ghaedi M, 2015, J DISPER SCI TECHNOL, V36, P1339, DOI 10.1080/01932691.2014.964359; Ghosh I., 2015, INT J COMPUTER APPL, V120, P7, DOI [10.5120/21245-4034, DOI 10.5120/21245-4034]; Hans Hoidalen., 2016, IEEE T POWER DELIVER, V32, P1, DOI [10.1109/TPWRS.2016.2587938, DOI 10.1109/TPWRS.2016.2587938]; Ibragimov R.N., 2017, MATH MODELING NATURA, P1, DOI [10.1007/s40096-017-0224-2, DOI 10.1007/S40096-017-0224-2]; Jeavons A., 2017, RES WORLD, V2017, P75, DOI [10.1371/journal.pone.0155133, DOI 10.1002/RWM3.20554, 10.1002/rwm3.20554]; Jedrzejczak J, 2017, IEEE T POWER DELIVER, V32, P556, DOI 10.1109/TPWRD.2016.2544801; Khademi F, 2017, FRONT STRUCT CIV ENG, V11, P90, DOI 10.1007/s11709-016-0363-9; Li Xiaojie, 2015, Geomatics and Information Science of Wuhan University, V40, P1253, DOI 10.13203/j.whugis20130603; M Honarm S, 2015, J ENVIRON SCI ENG, V56, P1, DOI [10.1016/0550-3213%2893%2990636-4, DOI 10.1016/0550-3213%2893%2990636-4]; Misak S, 2016, ELECTR POW SYST RES, V131, P159, DOI 10.1016/j.epsr.2015.10.015; Morozova N.S, 2015, MOSCOW U COMPUTATION, V39, P1, DOI [10.3103/S027864191504007X, DOI 10.3103/S027864191504007X]; Narvekar M., 2015, INT J COMPUTER APPL, V121, P9, DOI [10.5120/21830-5088, DOI 10.5120/21830-5088]; Qingrui TU, 2017, POWER SYSTEM PROTECT, V45, P157, DOI [10.7667/PSPC170027, DOI 10.7667/PSPC170027]; Riskiawan HY, 2017, ADV SCI LETT, V23, P2389, DOI 10.1166/asl.2017.8760; Subha NAM, 2015, IEEE T CONTR SYST T, V23, P619, DOI 10.1109/TCST.2014.2341617; Yorino N, 2015, IEEE T POWER SYST, V30, P2225, DOI 10.1109/TPWRS.2014.2364193; Zeng ZW, 2016, IET CONTROL THEORY A, V10, P1583, DOI 10.1049/iet-cta.2015.1068; [赵青春 Zhao Qingchun], 2015, [电力系统保护与控制, Power System Protection and Control], V43, P115; Zhu YK, 2015, IET CONTROL THEORY A, V9, P2548, DOI 10.1049/iet-cta.2014.0533	25	1	1	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0246403	10.1371/journal.pone.0246403	http://dx.doi.org/10.1371/journal.pone.0246403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826615	gold, Green Published			2022-12-26	WOS:000638119900035
J	Boehne, C; Behrendt, AK; Meyer-Bahlburg, A; Boettcher, M; Drube, S; Kamradt, T; Hansen, G				Boehne, Carolin; Behrendt, Ann-Kathrin; Meyer-Bahlburg, Almut; Boettcher, Martin; Drube, Sebastian; Kamradt, Thomas; Hansen, Gesine			Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma	PLOS ONE			English	Article							INDUCED AIRWAY HYPERREACTIVITY; REGULATORY T-CELLS; RECEPTORS; POLYMORPHISMS; EXHAUSTION; EXPRESSION; INNATE; ICOS	T cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) has been described as a transmembrane protein, expressed on the surface of various T cells as well as different cells of innate immunity. It has since been associated with Th1 mediated autoimmune diseases and transplantation tolerance studies, thereby indicating a possible role of this receptor in counter-regulation of Th2 immune responses. In the present study we therefore directly examined the role of Tim-3 in allergic inflammation and respiratory tolerance. First, Tim-3(-/-) mice and wild type controls were immunized and challenged with the model allergen ovalbumin (OVA) to induce an asthma-like phenotype. Analysis of cell numbers and distribution in the bronchoalveolar lavage (BAL) fluid as well as lung histology in H&E stained lung sections demonstrated a comparable degree of eosinophilic inflammation in both mouse strains. Th2 cytokine production in restimulated cell culture supernatants and serum IgE and IgG levels were equally increased in both genotypes. In addition, cell proliferation and the distribution of different T cell subsets were comparable. Moreover, analysis of both mouse strains in our respiratory tolerance model, where mucosal application of the model allergen before immunization, prevents the development of an asthma-like phenotype, revealed no differences in any of the parameters mentioned above. The current study demonstrates that Tim-3 is dispensable not only for the development of allergic inflammation but also for induction of respiratory tolerance in mice in an OVA-based model.	[Boehne, Carolin; Behrendt, Ann-Kathrin; Meyer-Bahlburg, Almut; Hansen, Gesine] Hannover Med Sch, Dept Pediat & Adolescent Med, Pediat Pulmonol Allergol & Neonatol, Lower Saxony, Germany; [Meyer-Bahlburg, Almut; Hansen, Gesine] Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Lower Saxony, Germany; [Boettcher, Martin; Drube, Sebastian; Kamradt, Thomas] Univ Hosp Jena, Inst Immunol, Jena, Thuringia, Germany; [Hansen, Gesine] Hannover Med Sch, Cluster Excellence Resist EXC 2155, Lower Saxony, Germany; [Behrendt, Ann-Kathrin; Meyer-Bahlburg, Almut] Univ Med Greifswald, Dept Pediat, Greifswald, Mecklenburg Wes, Germany; [Boettcher, Martin] Univ Erlangen Nurnberg, Dept Med Hematol & Oncolgy, Erlangen, Bavaria, Germany	Hannover Medical School; Hannover Medical School; Friedrich Schiller University of Jena; Hannover Medical School; Greifswald Medical School; University of Erlangen Nuremberg	Hansen, G (corresponding author), Hannover Med Sch, Dept Pediat & Adolescent Med, Pediat Pulmonol Allergol & Neonatol, Lower Saxony, Germany.; Hansen, G (corresponding author), Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Lower Saxony, Germany.; Hansen, G (corresponding author), Hannover Med Sch, Cluster Excellence Resist EXC 2155, Lower Saxony, Germany.	Hansen.Gesine@mh-hannover.de	Böttcher, Martin/AFQ-7409-2022	Böttcher, Martin/0000-0003-2911-8830				Albacker LA, 2013, MUCOSAL IMMUNOL, V6, P580, DOI 10.1038/mi.2012.100; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Avery L, 2018, P NATL ACAD SCI USA, V115, P2455, DOI 10.1073/pnas.1712107115; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1012, DOI 10.1111/j.1365-2222.2011.03728.x; Behrendt AK, 2012, CLIN EXP IMMUNOL, V168, P308, DOI 10.1111/j.1365-2249.2012.04572.x; Behrendt AK, 2010, IMMUNOL LETT, V133, P19, DOI 10.1016/j.imlet.2010.06.004; Berod L, 2011, EUR J IMMUNOL, V41, P833, DOI 10.1002/eji.201040504; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chae SC, 2004, HUM IMMUNOL, V65, P1427, DOI 10.1016/j.humimm.2004.07.002; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Coyle AJ, 2004, SPRINGER SEMIN IMMUN, V25, P349, DOI 10.1007/s00281-003-0154-y; Ferris RL, 2014, J IMMUNOL, V193, P1525, DOI 10.4049/jimmunol.1400557; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Frey O, 2010, ANN RHEUM DIS, V69, P1511, DOI 10.1136/ard.2009.123422; Gautron AS, 2014, EUR J IMMUNOL, V44, P2703, DOI 10.1002/eji.201344392; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hiraishi Y, 2016, ALLERGOL INT, V65, P459, DOI 10.1016/j.alit.2016.04.008; Hu WK, 2009, J ASTHMA, V46, P872, DOI 10.3109/02770900903199953; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jirmo AC, 2020, EUR J IMMUNOL, V50, P1019, DOI 10.1002/eji.201948409; Jirmo AC, 2016, J IMMUNOL, V197, P4219, DOI 10.4049/jimmunol.1601094; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee J, 2011, GENES IMMUN, V12, P595, DOI 10.1038/gene.2011.75; Lee SY, 2013, J IMMUNOL, V190, P4991, DOI 10.4049/jimmunol.1300083; Leitner J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003253; Li ZH, 2013, ALLERGY ASTHMA PROC, V34, pE21, DOI 10.2500/aap.2013.34.3646; Linhares AD, 2020, EUR J IMMUNOL, V50, P1126, DOI 10.1002/eji.201948400; Lu XX, 2013, INFLAMMATION, V36, P582, DOI 10.1007/s10753-012-9580-0; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Mosayebian A, 2018, IRAN J ALLERGY ASTHM, V17, P517; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Saresella M, 2014, FASEB J, V28, P5000, DOI 10.1096/fj.14-258194; Shi FM, 2012, CLIN IMMUNOL, V145, P230, DOI 10.1016/j.clim.2012.09.001; Tang F, 2015, INT J CLIN EXP MED, V8, P3809; Tang RH, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101302; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249605	10.1371/journal.pone.0249605	http://dx.doi.org/10.1371/journal.pone.0249605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822811	gold, Green Published			2022-12-26	WOS:000637879100001
J	Lin, YL; Zhou, XH; Yang, KF; Chen, YT; Wang, LZ; Luo, WX; Li, YJ; Liao, JR; Zhou, YT; Lei, YM; Zhang, YT; Wu, DH; Cai, LM				Lin, Yanling; Zhou, Xiaohan; Yang, Kaifan; Chen, Yuting; Wang, Lingzhi; Luo, Wenxiao; Li, Yujiang; Liao, Jinrong; Zhou, Yingtong; Lei, Yiming; Zhang, Yanting; Wu, Dehua; Cai, Longmei			Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via STAT3 dephosphorylation in nasopharyngeal carcinoma	ONCOGENE			English	Article								Radiotherapy is essential to the treatment of nasopharyngeal carcinoma (NPC) and acquired or innate resistance to this therapeutic modality is a major clinical problem. However, the underlying molecular mechanisms in the radiation resistance in NPC are not fully understood. Here, we reanalyzed the microarray data from public databases and identified the protein tyrosine phosphatase receptor type D (PTPRD) as a candidate gene. We found that PTPRD was downregulated in clinical NPC tissues and NPC cell lines with its promoter hypermethylated. Functional assays revealed that PTPRD overexpression sensitized NPC to radiation in vitro and in vivo. Importantly, miR-454-3p directly targets PTPRD to inhibit its expression and biological effect. Interestingly, mechanistic analyses indicate that PTPRD directly dephosphorylates STAT3 to enhance Autophagy-Related 5 (ATG5) transcription, resulting in triggering radiation-induced autophagy. The immunohistochemical staining of 107 NPC revealed that low PTPRD and high p-STAT3 levels predicted poor clinical outcome. Overall, we showed that PTPRD promotes radiosensitivity by triggering radiation-induced autophagy via the dephosphorylation of STAT3, thus providing a potentially useful predictive biomarker for NPC radiosensitivity and drug target for NPC radiosensitization.	[Lin, Yanling; Zhou, Xiaohan; Chen, Yuting; Luo, Wenxiao; Zhou, Yingtong; Wu, Dehua; Cai, Longmei] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China; [Yang, Kaifan] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Spine Surg, Guangzhou, Peoples R China; [Wang, Lingzhi; Lei, Yiming; Zhang, Yanting] Southern Med Univ, Nanfang Hosp, Clin Med Coll 1, Guangzhou, Peoples R China; [Li, Yujiang] Southern Med Univ, Huiqiao Med Ctr, Dept Thorac & Cardiovasc Surg, Guangzhou, Peoples R China; [Li, Yujiang] Southern Med Univ, Dongguan Peoples Hosp, Affiliated Dongguan Peoples Hosp, Dept Thorac & Cardiovasc Surg, Dongguan, Peoples R China; [Liao, Jinrong] Southern Med Univ, Zhujiang Hosp, Clin Med Coll 2, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Wu, DH; Cai, LM (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China.	wudehua.gd@gmail.com; cailongmeibestlove@163.com		Chen, Yuting/0000-0002-0262-9721; Wu, De-Hua/0000-0003-0560-0016; Yang, Kaifan/0000-0003-4166-0198	National Natural Science Foundation of China [81773111, 81702696]; Natural Science Foundation of Guangdong Province [2017A030310040]; Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2017J004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University	We are grateful to Prof. Musheng Zeng (Sun Yat-sen University Cancer Center, China) and Prof. George S.W. Tsao (University of Hong Kong, China) for their support. This work was supported by the National Natural Science Foundation of China (grant Nos. 81773111 and 81702696), the Natural Science Foundation of Guangdong Province (grant No. 2017A030310040), and the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (grant No. 2017J004).	Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Cai LM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00939; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Chai EZP, 2016, PHARMACOL THERAPEUT, V162, P86, DOI 10.1016/j.pharmthera.2015.10.004; Chan ATC, 2012, ANN ONCOL, V23, P83, DOI 10.1093/annonc/mds266; Chang LH, 2019, AM J CANCER RES, V9, P1922; Chen QP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00232; Chen YP, 2019, LANCET, V394, P64, DOI 10.1016/S0140-6736(19)30956-0; Cui DR, 2020, CELL REP, V30, P497, DOI 10.1016/j.celrep.2019.12.032; Digomann D, 2019, AUTOPHAGY, V15, P1850, DOI 10.1080/15548627.2019.1639302; Funato K, 2011, EXP THER MED, V2, P457, DOI 10.3892/etm.2011.231; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Jiang W, 2015, MOL CANCER THER, V14, P2864, DOI 10.1158/1535-7163.MCT-15-0260; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Kim M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092708; Kim W, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091105; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li H, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0618-0; Li L, 2020, CURR MOL PHARMACOL, V13, P31, DOI 10.2174/1874467212666190809154518; Li Y, 2019, BIOSCIENCE REP, V39, DOI [10.1038/s41388-021-01768-8, DOI 10.1038/S41388-021-01768-8]; Li YQ, 2018, CLIN CANCER RES, V24, P6495, DOI 10.1158/1078-0432.CCR-18-0532; Liu DD, 2018, J AGR FOOD CHEM, V66, P11757, DOI 10.1021/acs.jafc.8b04704; Liu YL, 2020, J CELL MOL MED, V24, P9135, DOI 10.1111/jcmm.15550; Luftig M, 2013, J CLIN INVEST, V123, P4999, DOI 10.1172/JCI73416; Meng J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2327-1; Nunez FJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaq1427; Peng H, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-018-0997-7; Peyser ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135750; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ren XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14053; Thilakasiri PS, 2021, SEMIN CANCER BIOL, V68, P31, DOI 10.1016/j.semcancer.2019.09.022; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Vehlow A, 2019, AUTOPHAGY, V15, P1487, DOI 10.1080/15548627.2019.1618540; Wang XH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01120; Wu AH, 2019, INT J CLIN EXP PATHO, V12, P4222; Yang SM, 2019, BIOCHEM CELL BIOL, V97, P364, DOI 10.1139/bcb-2017-0343; Yu HY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0660-4; Yu XT, 2017, ONCOTARGET, V8, P98798, DOI 10.18632/oncotarget.22000; Zhang J, 2019, NEOPLASIA, V21, P311, DOI 10.1016/j.neo.2019.01.006; Zhang J, 2019, CANCER RES, V79, P747, DOI 10.1158/0008-5472.CAN-18-1754; Zhu QW, 2021, AUTOPHAGY, V17, P1667, DOI 10.1080/15548627.2020.1781368	45	9	9	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3101	3117		10.1038/s41388-021-01768-8	http://dx.doi.org/10.1038/s41388-021-01768-8		APR 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33824475	hybrid, Green Published			2022-12-26	WOS:000637478800005
J	Palacios, AM; Freeland-Graves, JH; Dulience, SJL; Delnatus, JR; Iannotti, LL				Palacios, Ana M.; Freeland-Graves, Jeanne H.; Dulience, Sherlie Jean-Louis; Delnatus, Jacques Raymond; Iannotti, Lora L.			Differences in factors associated with anemia in Haitian children from urban and rural areas	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; FAMILY-STRUCTURE; IRON-DEFICIENCY; LATIN-AMERICA; POPULATIONS; PREVALENCE; COUNTRIES; INCOME; GROWTH; INTERVENTIONS	Background In Haiti, differences in the prevalence of anemia between urban and rural areas have been observed. Objective To identify moderating factors that may help explain the difference in the prevalence of anemia in children from poor urban vs. rural areas of Haiti. Methods This cross-sectional study used secondary data from urban and rural school-based trials that assessed the effectiveness of a nutrition intervention. The study was registered at ClinicalTrials.gov as NCT02747524. A total of 300 rural- and 981 urban- children between 2.5-13 years of age were included in this analysis. Effect modification in a binary logistic generalized linear mixed model was conducted using sample weights in SPSS(R) version 26. Models were adjusted for age and income. School cluster was included as random effect. Results In rural areas, stunting was more prevalent in children with anemia vs. no anemia, (16.6%, and 6.3%, P = 0.008), respectively. Also, rural children with anemia lived with fewer adults vs. rural children with no anemia, (x over bar = 2.83 +/- 1.29, and 3.30 +/- 1.54, P = 0.005), respectively. In poor urban areas, helminth morbidities were more frequent in children with anemia vs. no anemia, (21.9% vs. 13.9, P = 0.011), respectively. In the combined sample, stunting, [AOR = 2.05; 95%CI (1.32-3.18)], age [AOR = 0.89; 95%CI (0.85-0.93)], and households with more adults [AOR = 0.77; 95%CI (0.67-0.87)] were associated with anemia. Effect modification by place of residence was observed in households with more adults (t = 3.83, P<0.001). No other nutritional, dietary, sanitation or morbidity factors or effect modifiers were observed. Conclusions In this sample, factors associated with anemia differed in poor urban and rural children from Haiti including family structure and helminth morbidities. Stunting and lower age increased the odds of anemia in the combined sample. Family structure appears to have an important role in anemia, and further research understanding the influence of family structures in anemia is needed.	[Palacios, Ana M.; Freeland-Graves, Jeanne H.] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, Bloomington, IN 47405 USA; [Dulience, Sherlie Jean-Louis; Delnatus, Jacques Raymond] Meds & Food Kids, Guillaudeux Quartier Mor, Haiti; [Iannotti, Lora L.] Washington Univ, George Warren Brown Sch Social Work, Inst Publ Hlth, St Louis, MO 63130 USA	Indiana University System; Indiana University Bloomington; Washington University (WUSTL)	Palacios, AM (corresponding author), Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, Bloomington, IN 47405 USA.	anapalac@gmail.com		Palacios, Ana/0000-0002-9489-2219	United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program [FFE-5212012/034-00]	United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program	The original trials (LLI) were funded by the United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program FFE-5212012/034-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Akram R, 2018, FOOD NUTR BULL, V39, P521, DOI 10.1177/0379572118794770; [Anonymous], 2006, HOUSEHOLD DIETARY DI; Bester S., 2015, INT ENCY SOCIAL BEHA, VSecond, P438; Central Intelligence Agency, 2016, WORLD FACTBOOK 2016; Champetier de Ribes G, 2005, Bull Soc Pathol Exot, V98, P127; Cogill B, 2003, ANTHROPOMETRIC INDIC, V92; COHEN AR, 1988, AM J CLIN PATHOL, V90, P302, DOI 10.1093/ajcp/90.3.302; de Benoist, 2008, WORLDWIDE PREVALENCE; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Donohue RE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007455; ENGLE PL, 1993, SOC SCI MED, V37, P1303, DOI 10.1016/0277-9536(93)90160-6; Engle-Stone R, 2017, AM J CLIN NUTR, V106, p402S, DOI 10.3945/ajcn.116.142323; Esteve A, 2018, UNEQUAL FAMILY LIVES: CAUSES AND CONSEQUENCES IN EUROPE AND THE AMERICAS, P40; Fay M, 2005, DIR DEV, P1; Galicia L, 2016, REV PANAM SALUD PUBL, V40, P104; Ganz T, 2019, NEW ENGL J MED, V381, P1148, DOI 10.1056/NEJMra1804281; Golzarri-Arroyo L, 2020, CHILD OBES, V16, P65, DOI 10.1089/chi.2019.0142; Gosdin L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12597; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Harper KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006205; Heard HE, 2007, J FAM ISSUES, V28, P319, DOI 10.1177/0192513X06296307; Heidkamp RA, 2013, FOOD NUTR BULL, V34, P462, DOI 10.1177/156482651303400411; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Hurrell RF, 2006, J NUTR, V136, P2808, DOI 10.1093/jn/136.11.2808; Iannotti L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168121; Iannotti LL, 2015, AM J TROP MED HYG, V93, P1092, DOI 10.4269/ajtmh.15-0073; Iannotti LL, 2015, J NUTR, V145, P813, DOI 10.3945/jn.114.203182; Vazquez LI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010183; Institut Ha?tien de l'Enfance & ICF , 2018, ENQU TE MORTALIT MOR; Institut Haitien de Statistique et d'Informatique (IHSI), 2015, TOTAL POPULATION POP; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Jones AD, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12604; Kabaria CW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1694-2; Kraemer K, 2007, NUTR ANEMIA; Lam LF, 2017, CLIN NUTR, V36, P1007, DOI 10.1016/j.clnu.2016.06.013; Legason Ismail Dragon, 2017, BMC Hematol, V17, P10, DOI 10.1186/s12878-017-0081-0; Leininger LJ, 2008, HEALTH SERV RES, V43, P117, DOI 10.1111/j.1475-6773.2007.00758.x; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Malako BG, 2019, BMC NUTR, V5, DOI 10.1186/s40795-018-0268-1; Mujica-Coopman MF, 2015, FOOD NUTR BULL, V36, pS119, DOI 10.1177/0379572115585775; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; Ntshebe O, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7963-y; Paciorek CJ, 2013, LANCET GLOB HEALTH, V1, pE300, DOI 10.1016/S2214-109X(13)70109-8; Palacios AM, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12885; Penrose K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000631; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Rogawski ET, 2017, PEDIATR CLIN N AM, V64, P815, DOI 10.1016/j.pcl.2017.03.003; Rotz S, 2013, AM J HEMATOL, V88, P827, DOI 10.1002/ajh.23510; Shirley DAT, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy161; Simms TM, 2010, AM J PHYS ANTHROPOL, V142, P49, DOI 10.1002/ajpa.21194; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Tran TD, 2019, PUBLIC HEALTH NUTR, V22, P35, DOI 10.1017/S136898001800232X; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Vaumourin E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1167-9; Walker CLF, 2007, FOOD NUTR BULL, V28, pS454, DOI 10.1177/15648265070283S305; Weppelmann TA, 2017, AM J TROP MED HYG, V97, P1262, DOI 10.4269/ajtmh.16-0714; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2018, WHOCDSNTDWHOPES20180; World Bank, 2011, GUATEMALA NUTR GLANC; World Health Organization, 2009, MULTICENTRE GROWTH R	65	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0247975	10.1371/journal.pone.0247975	http://dx.doi.org/10.1371/journal.pone.0247975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ8VV	33822795	Green Published, gold			2022-12-26	WOS:000637879100024
J	Song, TJ; Park, CH; In, KR; Kim, JB; Kim, JH; Kim, M; Chang, HJ				Song, Tae-Jun; Park, Choon-Ho; In, Kyu-Ree; Kim, Jong-Bae; Kim, Joo Hee; Kim, Miran; Chang, Hye Jin			Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway	PLOS ONE			English	Article								Betulinic acid (BA) is a naturally arising pentacyclic triterpenoid that has anti-malarial, anti-retroviral, anti-inflammatory, and anti-cancer biological effects. More recently, it has been reported to possess anti-obesity activity mediated by the activation of AMP-activated protein kinase (AMPK). We further investigated antidiabetic activity of BA in mouse tissues at the cellular and systemic levels. We found that BA stimulated AMPK in a similar fashion to the known AMPK activators, such as 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin. Notably, the level of glucose uptake by BA was not altered by wortmannin, suggesting that this activation did not depend on phosphoinositide 3-kinase. Furthermore, BA diminished blood glucose levels in alloxane-treated ICR mice and in untreated mice during the glucose tolerance test. BA also stimulated mRNA expression of glucose transporter 4, which could partly explain increased glucose uptake. BA also increased AS160 phosphorylation by insulin-independent mechanisms in the extensor digitorum longus muscle. These results indicate that BA may serve as a promising therapeutic agent for diabetes by activating AMPK, like metformin. Notably, BA also enhanced mouse endurance capacity, indicating that it also affects metabolic regulation in addition to its antidiabetic activity.	[Song, Tae-Jun; Kim, Jong-Bae] Handong Global Univ, Grad Sch Life Sci, Pohang, South Korea; [Park, Choon-Ho] Ajou Univ, Grad Sch Clin Pharm & Pharmaceut, Suwon, South Korea; [In, Kyu-Ree] Ajou Univ, Coll Nat Sci, Dept Life Sci, Suwon, South Korea; [Kim, Joo Hee] Ajou Univ, Coll Pharm, Suwon, South Korea; [Kim, Miran; Chang, Hye Jin] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Obstet & Gynecol, Suwon, South Korea	Handong Global University; Ajou University; Ajou University; Ajou University; Ajou University; Ajou University Hospital	Chang, HJ (corresponding author), Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Obstet & Gynecol, Suwon, South Korea.	zzanga-94@hanmail.net						Ahangarpour A, 2018, RES PHARM SCI, V13, P142, DOI 10.4103/1735-5362.223796; Birgani GA, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000217171; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Gauthier C, 2006, BIOORGAN MED CHEM, V14, P6713, DOI 10.1016/j.bmc.2006.05.075; Gray AM, 1999, J ENDOCRINOL, V160, P409, DOI 10.1677/joe.0.1600409; Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13; Ha DT, 2009, BIOORG MED CHEM LETT, V19, P5556, DOI 10.1016/j.bmcl.2009.08.048; Heaf J, 2014, PERITON DIALYSIS INT, V34, P353, DOI 10.3747/pdi.2013.00344; Imachi J, 1973, Nippon Ganka Gakkai Zasshi, V77, P216; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim KD, 2019, NUTR METAB CARDIOVAS, V29, P409, DOI 10.1016/j.numecd.2018.12.001; Kim KW, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/703624; Ko BS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7836823; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kola B, 2008, FRONT HORM RES, V36, P198, DOI 10.1159/000115366; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mikhail N, 2006, SOUTH MED J, V99, P1271, DOI 10.1097/01.smj.0000240730.86237.b6; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pais I, 2007, EXP CLIN ENDOCR DIAB, V115, P42, DOI 10.1055/s-2007-957348; Roden M, 2019, NATURE, V576, P51, DOI 10.1038/s41586-019-1797-8; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Santos RC, 2009, BIOORGAN MED CHEM, V17, P6241, DOI 10.1016/j.bmc.2009.07.050; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Tan YM, 2003, CLIN CANCER RES, V9, P2866; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Xie R, 2017, FOOD FUNCT, V8, P299, DOI 10.1039/c6fo01601d; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Zhang X, 2016, MOL MED REP, V14, P4489, DOI 10.3892/mmr.2016.5792; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	35	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249109	10.1371/journal.pone.0249109	http://dx.doi.org/10.1371/journal.pone.0249109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819291	gold, Green Published			2022-12-26	WOS:000637647200003
J	Takahashi, K; Kamibayashi, K; Wakahara, T				Takahashi, Katsuki; Kamibayashi, Kiyotaka; Wakahara, Taku			Muscle size of individual hip extensors in sprint runners: Its relation to spatiotemporal variables and sprint velocity during maximal velocity sprinting	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; RUNNING SPEED; LIMB; ARCHITECTURE; PERFORMANCE; TRANSITION; MORPHOLOGY	Hip extensor muscle size is related to sprint running performance. However, the mechanisms underlying this relationship remain unclear. To gain insights into this issue, the present study examined the relationships between the individual hip extensor sizes, spatiotemporal variables (step frequency and length, and their determinants), and sprint velocity during maximal velocity sprinting. Magnetic resonance images of the hip and right thigh were obtained from 26 male sprinters to determine the volumes of the gluteus maximus, individual hamstrings and adductors, and gracilis. Muscle volumes were normalized to their respective body mass and recorded as relative muscle volumes. The sprinters performed a 100-m sprint with their maximal effort. Their sprint motions were recorded using cameras to calculate the mean sprint velocity and the spatiotemporal variables at 50-60 m interval. The sprint velocity was significantly correlated with the relative volume of the semitendinosus (r = 0.497, P = 0.010), but not with the volumes of the other examined muscles. The relative volume of semitendinosus significantly correlated with the stance distance (r = 0.414, P = 0.036) and the stance distance adjusted by the stance time (r = 0.490, P = 0.011). Moreover, there were significant correlations between the stance distance and step length (r = 0.592, P = 0.001), and between the step length and sprint velocity (r = 0.509, P = 0.008). These results suggest that the semitendinosus contributes to attaining long stance distance and thereby high sprint velocity during maximal velocity sprinting.	[Takahashi, Katsuki] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto, Japan; [Kamibayashi, Kiyotaka; Wakahara, Taku] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan; [Wakahara, Taku] Waseda Univ, Human Performance Lab, Saitama, Japan; [Takahashi, Katsuki] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan	Doshisha University; Doshisha University; Waseda University; Waseda University	Wakahara, T (corresponding author), Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan.; Wakahara, T (corresponding author), Waseda Univ, Human Performance Lab, Saitama, Japan.	twakahar@mail.doshisha.ac.jp		Takahashi, Katsuki/0000-0001-8534-0888; Wakahara, Taku/0000-0001-6864-7706; Kamibayashi, Kiyotaka/0000-0001-9849-8588				Ae M, 1992, NEW STUDIES ATHLETIC, V7, P47; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; BODINE SC, 1982, J NEUROPHYSIOL, V48, P192, DOI 10.1152/jn.1982.48.1.192; Bourne MN, 2017, BRIT J SPORT MED, V51, P469, DOI 10.1136/bjsports-2016-096130; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Contreras B, 2015, PEERJ, V3, DOI 10.7717/peerj.1261; Dorn TW, 2012, J EXP BIOL, V215, P1944, DOI 10.1242/jeb.064527; DOSTAL WF, 1986, PHYS THER, V66, P351, DOI 10.1093/ptj/66.3.351; Ema R, 2018, MED SCI SPORT EXER, V50, P2085, DOI 10.1249/MSS.0000000000001678; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; FUKUNAGA T, 1992, J ORTHOPAED RES, V10, P926, DOI 10.1002/jor.1100100623; Handsfield GG, 2017, SCAND J MED SCI SPOR, V27, P1050, DOI 10.1111/sms.12723; Hegyi A, 2019, MED SCI SPORT EXER, V51, P2274, DOI 10.1249/MSS.0000000000002060; Higashihara A, 2019, J SPORT SCI, V37, P2744, DOI 10.1080/02640414.2019.1664030; Higashihara A, 2018, J SPORT SCI, V36, P1313, DOI 10.1080/02640414.2017.1375548; Hunter JP, 2004, J BIOMECH, V37, P1439, DOI 10.1016/j.jbiomech.2003.12.018; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; IKAI MICHIO, 1968, INT Z ANGEW PHYSIOL ARBEITSPHYSIOL, V26, P26; Ishoi L, 2018, J SPORT SCI, V36, P1663, DOI 10.1080/02640414.2017.1409609; Ito A., 1998, TAIIKUGAKU KENKYU, V43, P260, DOI DOI 10.5432/JJPEHSS.KJ00003392100; Krommes K, 2017, BMC Res Notes, V10, P669, DOI 10.1186/s13104-017-2986-x; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Mann R, 1983, P INT S BIOM SPORTS, P305; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; Miller R, 2021, MED SCI SPORT EXER, V53, P804, DOI 10.1249/MSS.0000000000002522; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Nagahara R, 2014, BIOL OPEN, V3, P689, DOI 10.1242/bio.20148284; Nuell S, 2020, EUR J SPORT SCI, V20, P793, DOI 10.1080/17461391.2019.1668063; Okada J., 2011, INT J SPORT HLTH SCI, V9, P1, DOI [https://doi.org/10.5432/ijshs.20100018, DOI 10.5432/IJSHS.20100018, 10.5432/ijshs.20100018]; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627; STERN JT, 1972, AM J PHYS ANTHROPOL, V36, P315, DOI 10.1002/ajpa.1330360303; Sugisaki N, 2018, INT J SPORT PHYSIOL, V13, P214, DOI 10.1123/ijspp.2016-0703; Takizawa M, 2014, SCAND J MED SCI SPOR, V24, P197, DOI 10.1111/j.1600-0838.2012.01466.x; Wiemann K., 1995, NEW STUD ATHLET, V10, P29; Wilkau HCVU, 2020, J SPORT SCI, V38, P2359, DOI 10.1080/02640414.2020.1785193; Yasuda T., 2019, INT J CLIN MED, V10, P469	39	3	3	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249670	10.1371/journal.pone.0249670	http://dx.doi.org/10.1371/journal.pone.0249670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819316	Green Published, gold			2022-12-26	WOS:000637647200043
J	Li, Y; Gao, YZ; Liu, XG; Shi, J; Xia, JW; Yang, JC; Mao, LJ				Li, Yue; Gao, Yunzhe; Liu, Xinguo; Shi, Jian; Xia, Jiawen; Yang, Jiancheng; Mao, Lijun			The influence of beam delivery uncertainty on dose uniformity and penumbra for pencil beam scanning in carbon-ion radiotherapy	PLOS ONE			English	Article							FLUKA CODE; PROTON; SYSTEM; MODEL; IRRADIATION; PERFORMANCE; THERAPY; DESIGN	The dose uniformity and penumbra in the treatment field are important factors in radiotherapy, which affects the outcomes of radiotherapy. In this study, the integrated depth-dose-distributions (IDDDs) of 190 MeV/u and 260 MeV/u carbon beams in the active spot-scanning delivery system were measured and calculated by FLUKA Monte Carlo simulation based on the Heavy Ion Medical Machine (HIMM). Considering the dose distributions caused by secondary particles and scattering, we also used different types of pencil beam (PB) models to fit and compare the spatial distributions of PB. We superposed a bunch of PB to form a 20x20 cm(2) treatment field with the double Gaussian and double Gaussian logistic beam models and calculated the influence of beam delivery error on the field flatness and penumbra, respectively. The simulated IDDDs showed good agreement with the measured values. The triple Gaussian and double Gaussian logistic beam models have good fitness to the simulated dose distributions. There are different influences on dose uniformity and penumbra resulting from beam uncertainties. These results would be helpful for understanding carbon ion therapy, and physical therapists are more familiar with beam characteristics for active scanning therapy, which provides a reference for commissioning and optimization of treatment plans in radiotherapy.	[Li, Yue; Gao, Yunzhe; Liu, Xinguo; Shi, Jian; Xia, Jiawen; Yang, Jiancheng; Mao, Lijun] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China; [Li, Yue; Gao, Yunzhe; Xia, Jiawen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yunzhe; Xia, Jiawen] Huizhou Res Ctr Ion Sci, Huizhou, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mao, LJ (corresponding author), Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China.	maolijun@impcas.ac.cn		Mao, Lijun/0000-0002-0023-8217	Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06G373]	Guangdong Innovative and Entrepreneurial Research Team Program	Guangdong Innovative and Entrepreneurial Research Team Program (No. 2016ZT06G373).	Almhagen E, 2018, PHYS MEDICA, V52, P27, DOI 10.1016/j.ejmp.2018.06.007; [Anonymous], 2016, NUCL TECHNIQUES, DOI [DOI 10.11889/J.0253-3219.2016.HJS.39.090202, 10.11889/j.0253-3219.2016.hjs.39.090202]; Battistoni G, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00116; Battistoni G, 2015, ANN NUCL ENERGY, V82, P10, DOI 10.1016/j.anucene.2014.11.007; Bohlen TT, 2014, NUCL DATA SHEETS, V120, P211, DOI 10.1016/j.nds.2014.07.049; Chun-Hui Miao, 2017, Nuclear Science and Techniques, V28, DOI 10.1007/s41365-017-0324-6; Dai ZY, 2012, CHINESE PHYS C, V36, P784, DOI 10.1088/1674-1137/36/8/018; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; Dvorak P, 2018, CLIN RADIOTHERAPY PH; Furukawa T, 2007, MED PHYS, V34, P1085, DOI 10.1118/1.2558213; Furukawa T, 2010, MED PHYS, V37, P5672, DOI 10.1118/1.3501313; Grevillot L, 2015, PHYS MED BIOL, V60, P7985, DOI 10.1088/0031-9155/60/20/7985; Gudowska I, 2004, PHYS MED BIOL, V49, P1933, DOI 10.1088/0031-9155/49/10/008; HABERER T, 1993, NUCL INSTRUM METH A, V330, P296, DOI 10.1016/0168-9002(93)91335-K; Hara Y, 2014, MED PHYS, V41, DOI 10.1118/1.4860256; Lanca L, 2014, RADIOGRAPHY, V20, P333, DOI 10.1016/j.radi.2014.04.007; Liu HD, 2017, EPJ WEB CONF, V153, DOI 10.1051/epjconf/201715304018; Matsumoto S, 2019, MED PHYS, V46, P5824, DOI 10.1002/mp.13864; Mirandola A, 2018, MED PHYS, V45, P2266, DOI 10.1002/mp.12866; Mirandola A, 2015, MED PHYS, V42, P5287, DOI 10.1118/1.4928397; Parodi K, 2012, PHYS MED BIOL, V57, P3759, DOI 10.1088/0031-9155/57/12/3759; Parodi K, 2013, J RADIAT RES, V54, P91, DOI 10.1093/jrr/rrt051; Saini J, 2018, TRANSL LUNG CANCER R, V7, P171, DOI 10.21037/tlcr.2018.04.05; Schwaab J, 2011, PHYS MED BIOL, V56, P7813, DOI 10.1088/0031-9155/56/24/009; Titt U, 2010, PHYS MED BIOL, V55, P7097, DOI 10.1088/0031-9155/55/23/S10; Torikoshi M, 2007, J RADIAT RES, V48, pA15, DOI 10.1269/jrr.48.A15; Vlachoudis V., FLAIR POWERFUL USER; Xing Y, 2017, MED PHYS, V44, P6047, DOI 10.1002/mp.12569; Yan YL, 2017, CHINESE PHYS C, V41, DOI 10.1088/1674-1137/41/9/098201; Yonai S, 2012, MED PHYS, V39, P5028, DOI 10.1118/1.4736823; Yu J, 2014, MED PHYS, V41, P96, DOI 10.1118/1.4885956; Zhang H, 2018, PHYS MEDICA, V55, P15, DOI 10.1016/j.ejmp.2018.10.014; Zhou J, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab81ca	33	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249452	10.1371/journal.pone.0249452	http://dx.doi.org/10.1371/journal.pone.0249452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793680	Green Published, gold			2022-12-26	WOS:000636467000077
J	Vo, DH; Doan, B				Vo, Duc Hong; Doan, Bao			Effects from containment and closure policies to market quality: Do they really matter in Vietnam during Covid-19?	PLOS ONE			English	Article								During the Covid-19 pandemic, the Vietnamese government has actively implemented various policies to achieve dual objectives: (i) to minimize the loss of life due to the infection; and (ii) to support economic growth. This paper is conducted to examine the effect of the government's containment and closure policy on the stock market quality in Vietnam. Unlike other papers, we focus exclusively on market quality during the pandemic. We find that the policies appear to positively affect the market quality, except for closing-school policy (negative effect) and international travel (no effect). We argue that the government should sustain the policies until the wide availability of the vaccine to support the stock market quality in the near future.	[Vo, Duc Hong] Ho Chi Minh City Open Univ, CBER Res Ctr Business Econ & Resources, Ho Chi Minh City, Vietnam; [Doan, Bao] RMIT Univ, Dept Econ & Finance, Ho Chi Minh City, Vietnam	Ho Chi Minh City Open University; Royal Melbourne Institute of Technology (RMIT)	Vo, DH (corresponding author), Ho Chi Minh City Open Univ, CBER Res Ctr Business Econ & Resources, Ho Chi Minh City, Vietnam.	duc.vhong@ou.edu.vn		Doan, Bao Huy/0000-0003-3632-6371; Hong Vo, Duc/0000-0001-7823-0349				Ashraf BN, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101249; Ashraf BN, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100371; Bessembinder H, 2003, J FINANC QUANT ANAL, V38, P747, DOI 10.2307/4126742; Gubareva M, 2021, FINANC RES LETT, V41, DOI 10.1016/j.frl.2020.101826; Hale T., 2020, VARIATION GOVT RESPO; He Q, 2020, ECON POLIT STUD-EPS, V8, P275, DOI 10.1080/20954816.2020.1757570; Huang RD, 1997, REV FINANC STUD, V10, P995, DOI 10.1093/rfs/10.4.995; LEE CMC, 1991, J FINANC, V46, P733, DOI 10.2307/2328845; Narayan PK, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101732	9	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248703	10.1371/journal.pone.0248703	http://dx.doi.org/10.1371/journal.pone.0248703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793586	gold, Green Published			2022-12-26	WOS:000636467000042
J	Wang, QL; Mao, XY; Jiang, XS; Pei, DD; Shao, XH				Wang, Qilin; Mao, Xinyu; Jiang, Xiaosan; Pei, Dandan; Shao, Xiaohou			Digital image processing technology under backpropagation neural network and K-Means Clustering algorithm on nitrogen utilization rate of Chinese cabbages	PLOS ONE			English	Article							AGRONOMIC PARAMETERS; FEATURE-EXTRACTION; WINTER-WHEAT; MODEL; WATER	The purposes are to monitor the nitrogen utilization efficiency of crops and intelligently evaluate the absorption of nutrients by crops during the production process. The research object is Chinese cabbage. The Chinese cabbage population with different agricultural parameters is constructed through different densities and nitrogen fertilizer application rates based on digital image processing technology, and an estimation NC (Nitrogen Content) model is established. The population is classified through the K-Means Clustering algorithm using the feature extraction method, and the Chinese cabbage population quality BPNN (Backpropagation Neural Network) model is constructed. The nonlinear mapping relationship between different agricultural parameters and population quality, and the contribution rate of each indicator, are studied. The nitrogen utilization of Chinese cabbage is monitored effectively. Results demonstrate that the proposed NC estimation model has correlation coefficients above 0.70 in different growth stages. This model can accurately estimate the NC of the Chinese cabbage population. The results of the Chinese cabbage population quality BPNN model show that the population planting density based on the seedling number is reasonable. The constructed population quality evaluation model has a high R-2 value and a comparatively low RMSE (Root Mean Square Error) value for the quality evaluation of Chinese cabbage in different periods, showing that it applies to evaluate the population quality of Chinese cabbage in different growth stages. The constructed nitrogen utilization model and quality evaluation model can monitor the nutrient utilization of crops in different growth stages, ascertain the agricultural characteristics of other yield groups in different growth stages, and clarify the performance of agricultural parameters in different growth stages. The above results can provide some ideas for crop growth intelligent detection.	[Wang, Qilin; Mao, Xinyu; Pei, Dandan; Shao, Xiaohou] Hohai Univ, Coll Agr Sci & Engn, Nanjing, Peoples R China; [Jiang, Xiaosan] Nanjing Agr Univ, Taizhou Res Inst, Taizhou, Peoples R China	Hohai University; Nanjing Agricultural University	Mao, XY (corresponding author), Hohai Univ, Coll Agr Sci & Engn, Nanjing, Peoples R China.	mxy880731@163.com			Youth Foundation of the National Natural Science Foundation of China [51809076]; basic Scientific Research Service fee Project of the Central University [2019B08514]; special fund project of Taizhou municipal finance in 2020 [20201301]	Youth Foundation of the National Natural Science Foundation of China; basic Scientific Research Service fee Project of the Central University; special fund project of Taizhou municipal finance in 2020	Project supported by the Youth Foundation of the National Natural Science Foundation of China (no.51809076) The basic Scientific Research Service fee Project of the Central University (no.2019B08514) The special fund project of Taizhou municipal finance in 2020 (no.20201301).	Bengochea-Guevara JM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030276; Dechant B, 2017, REMOTE SENS ENVIRON, V196, P279, DOI 10.1016/j.rse.2017.05.019; Dhingra G, 2018, MULTIMED TOOLS APPL, V77, P19951, DOI 10.1007/s11042-017-5445-8; Dong DL, 2011, ACTA PHARM SIN B, V1, P1, DOI 10.1016/j.apsb.2011.04.010; El-Hendawy S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212294; El-Hendawy SE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01537; Feng DY, 2020, NEURAL COMPUT APPL, V32, P16833, DOI 10.1007/s00521-018-3932-0; Gupta N, 2021, J ASTHMA, V58, P893, DOI 10.1080/02770903.2020.1741612; Hartman D.J, 2019, J PATHOLOGY INFORN, P10; Hashimoto Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14586-5; He GH, 2019, J CLEAN PROD, V229, P739, DOI 10.1016/j.jclepro.2019.05.053; Liang H, 2018, ECOL MODEL, V367, P24, DOI 10.1016/j.ecolmodel.2017.10.016; Liang W, 2019, SUSTAIN COMPUT-INFOR, V21, P1, DOI 10.1016/j.suscom.2018.11.007; Lopez-Calderon MJ, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10100451; Madlikova M, 2018, J RADIOANAL NUCL CH, V317, P479, DOI 10.1007/s10967-018-5881-6; Mahalakshmi J., 2017, INT J ENG RES DEV, V13, P25; Mattila P, 2018, PLANT FOOD HUM NUTR, V73, P108, DOI 10.1007/s11130-018-0660-7; Meng YF, 2018, INFORM SCIENCES, V463, P166, DOI 10.1016/j.ins.2018.06.035; Pan HW, 2017, ENVIRON GEOCHEM HLTH, V39, P417, DOI 10.1007/s10653-016-9899-9; Sadeghi-Tehran P, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0253-8; Schirrmann M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090706; Siregar S. P., 2017, IJISTECH, V1, P34, DOI DOI 10.30645/IJISTECH.V1I1.4; Sun XX, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0212-9; Sun Z, 2020, ENVIRON SCI TECHNOL, V54, P15507, DOI 10.1021/acs.est.0c06354; Syakur MA, 2018, IOP CONF SER-MAT SCI, V336, DOI 10.1088/1757-899X/336/1/012017; Syed T.N., 2019, ARTIF INTELL AGR, V3, P18, DOI [10.1016/j.aiia.2019.09.001, DOI 10.1016/J.AIIA.2019.09.001]; Vasilaki V, 2018, WATER RES, V140, P387, DOI 10.1016/j.watres.2018.04.052; Wang L, 2021, ARCH AGRON SOIL SCI, V67, P1272, DOI 10.1080/03650340.2020.1789967; Wang ML, 2018, B ENVIRON CONTAM TOX, V100, P634, DOI 10.1007/s00128-018-2315-7; Zeng YR, 2017, ENERGY, V127, P381, DOI 10.1016/j.energy.2017.03.094; Zhang X, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17071474; Zhou CY, 2019, MEASUREMENT, V136, P478, DOI 10.1016/j.measurement.2018.12.088; Zhou JX, 2019, MULTIMED TOOLS APPL, V78, P6163, DOI 10.1007/s11042-018-6192-1; Zhou WJ, 2017, INFORM SCIENCES, V397, P1, DOI 10.1016/j.ins.2017.02.049	34	4	4	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248923	10.1371/journal.pone.0248923	http://dx.doi.org/10.1371/journal.pone.0248923			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788875	Green Published, gold			2022-12-26	WOS:000636354600019
J	Bengart, P; Gruendler, T; Vogt, B				Bengart, Paul; Gruendler, Theo; Vogt, Bodo			Acute tryptophan depletion in healthy subjects increases preferences for negative reciprocity	PLOS ONE			English	Article							DECISION-MAKING; GAME-THEORY; PSYCHOLOGICAL-RESEARCH; ALTRUISTIC PUNISHMENT; HUMAN COOPERATION; MOOD RESPONSE; SOCIAL NORMS; SEROTONIN; FAIRNESS; AVERSION	Reciprocity motivates to reward those who are kind (= positive reciprocity) and to punish those who are unkind (= negative reciprocity). The neurotransmitter serotonin (5-HT) modulates human behavior in numerous social situations, such as retaliation in response to perceived unfairness. In a placebo-controlled study, we used acute tryptophan depletion (ATD) to investigate the influence of available serotonin on choice behavior and reciprocity in the Hawk-Dove game. This game illustrates a conflict situation and incorporates two potential strategies: the cooperative Dove strategy and the uncooperative, more aggressive Hawk strategy. After strategic choices, we elicited the subjects' expectations (= beliefs) regarding the opponent's choices and controlled for risk preferences and current mood. We defined strategy choices as negative reciprocity when the participants opted for Hawk in response to an expected Hawk. We hypothesized that the ATD-induced reduction of 5-HT availability would increase participants' preferences for negative reciprocity. Generalized estimating equations reveal no significant main effect of ATD on assessed belief, mood, or risk attitude. But assessment of ATD's marginal effects over beliefs suggests that ATD significantly increases the tendency for negative reciprocity, whereas positive reciprocity (Dove in response to an expected Dove) is unaffected. We could therefore demonstrate that 5-HT availability mediates (negative) reciprocal behavior in social decision-making.	[Bengart, Paul; Vogt, Bodo] Otto von Guericke Univ, Inst Social Med & Hlth Syst Res, Magdeburg, Germany; [Gruendler, Theo; Vogt, Bodo] Otto von Guericke Univ, Dept Empir Econ, Magdeburg, Germany; [Gruendler, Theo] Mil Hosp Berlin, Ctr Mil Mental Hlth, Berlin, Germany	Otto von Guericke University; Otto von Guericke University	Bengart, P (corresponding author), Otto von Guericke Univ, Inst Social Med & Hlth Syst Res, Magdeburg, Germany.	paul.bengart@med.ovgu.de	Gruendler, Theo OJ/H-4486-2012	Gruendler, Theo OJ/0000-0002-5631-7352; Bengart, Paul/0000-0002-9169-7442				Andreoni J., 2014, NATL BUREAU EC RES W, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bilderbeck AC, 2014, PSYCHOL SCI, V25, P1303, DOI 10.1177/0956797614527830; Booij L, 2002, NEUROPSYCHOPHARMACOL, V27, P852, DOI 10.1016/S0893-133X(02)00361-5; Boone C, 2010, J CONFLICT RESOLUT, V54, P799, DOI 10.1177/0022002710372329; Burrows H., 2013, BIOL ACTIONS SEX HOR; Camerer CF, 1997, J ECON PERSPECT, V11, P167, DOI 10.1257/jep.11.4.167; Carpenter LL, 1998, NEUROPSYCHOPHARMACOL, V19, P26; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Crockett M.J., 2014, NEUROECONOMICS, P259, DOI [10.1016/B978-0-12-416008-8.00014-0, DOI 10.1016/B978-0-12-416008-8.00014-0]; Crockett MJ, 2013, J NEUROSCI, V33, P3505, DOI 10.1523/JNEUROSCI.2761-12.2013; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; de Heus P, 2010, J EXP SOC PSYCHOL, V46, P736, DOI 10.1016/j.jesp.2010.04.013; Decety Jean, 2015, AJOB Neurosci, V6, P3; Declerck C., 2016, COMPASSIONATE EGOIST; Di Tella R, 2015, AM ECON REV, V105, P3416, DOI 10.1257/aer.20141409; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Eisenberger R, 2004, PERS SOC PSYCHOL B, V30, P787, DOI 10.1177/0146167204264047; Ellenbogen MA, 1996, NEUROPSYCHOPHARMACOL, V15, P465, DOI 10.1016/S0893-133X(96)00056-5; Faulkner P, 2017, INT J NEUROPSYCHOPH, V20, DOI [10.1093/ijnp/pyw075, 10.1093/injp/pyw075]; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fershtman C, 2012, AM ECON J-MICROECON, V4, P131, DOI 10.1257/mic.4.4.131; Fischer AG, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00484; Gao XX, 2018, P NATL ACAD SCI USA, V115, pE7680, DOI 10.1073/pnas.1802523115; Ging-Jehli NR, 2020, GAME ECON BEHAV, V122, P341, DOI 10.1016/j.geb.2020.04.016; Green P, 2016, METHODS ECOL EVOL, V7, P493, DOI 10.1111/2041-210X.12504; Hammerstein P., 2006, HDB GAME THEORY, V3 rd ed, P929; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hess S, 2017, STATA J, V17, P630; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Homberg JR, 2012, NEUROSCI BIOBEHAV R, V36, P218, DOI 10.1016/j.neubiorev.2011.06.001; Krajbich I, 2015, CURR OPIN BEHAV SCI, V5, P51, DOI 10.1016/j.cobeha.2015.07.005; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lichters M, 2016, J MARKETING RES, V53, P183, DOI 10.1509/jmr.14.0482; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Muth C, 2016, EDUC PSYCHOL MEAS, V76, P64, DOI 10.1177/0013164415580432; Neugebauer T, 2008, J ECON BEHAV ORGAN, V66, P243, DOI 10.1016/j.jebo.2005.12.008; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nyarko Y, 2002, ECONOMETRICA, V70, P971, DOI 10.1111/1468-0262.00316; RABIN M, 1993, AM ECON REV, V83, P1281; Rabin M, 1998, J ECON LIT, V36, P11; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; Rubinow DR, 1998, BIOL PSYCHIAT, V44, P839, DOI 10.1016/S0006-3223(98)00162-0; Rubinstein A, 2016, JUDGM DECIS MAK, V11, P168; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Siegel JZ, 2013, ANN NY ACAD SCI, V1299, P42, DOI 10.1111/nyas.12229; SMITH JM, 1976, AM SCI, V64, P41; Steyer R., 1994, DIAGNOSTICA, V40, P320; Takahashi H, 2012, P NATL ACAD SCI USA, V109, P4281, DOI 10.1073/pnas.1118687109; van den Bos W, 2012, GROUP PROCESS INTERG, V15, P243, DOI 10.1177/1368430211418698; Wiech K, 2013, COGNITION, V126, P364, DOI 10.1016/j.cognition.2012.11.002; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Wood RM, 2006, NEUROPSYCHOPHARMACOL, V31, P1075, DOI 10.1038/sj.npp.1300932; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; YOUNG SN, 1989, PSYCHOPHARMACOLOGY, V98, P508, DOI 10.1007/BF00441950; Yuan KH, 2005, J EDUC BEHAV STAT, V30, P141, DOI 10.3102/10769986030002141	69	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249339	10.1371/journal.pone.0249339	http://dx.doi.org/10.1371/journal.pone.0249339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784350	Green Published, gold			2022-12-26	WOS:000636359600024
J	Yoshimura, T; Colley, N; Komizunai, S; Ninomiya, S; Kanai, S; Konno, A; Yasuda, K; Taguchi, H; Hashimoto, T; Shimizu, S				Yoshimura, Takaaki; Colley, Noriyo; Komizunai, Shunsuke; Ninomiya, Shinji; Kanai, Satoshi; Konno, Atsushi; Yasuda, Koichi; Taguchi, Hiroshi; Hashimoto, Takayuki; Shimizu, Shinichi			Construction of a detachable artificial trachea model for three age groups for use in an endotracheal suctioning training environment simulator	PLOS ONE			English	Article								Tracheal suctioning is an important procedure to maintain airway patency by removing secretions. Today, suctioning operators include not only medical staff, but also family caregivers. The use of a simulation system has been noted to be the most effective way to learn the tracheal suctioning technique for operators. While the size of the trachea varies across different age groups, the artificial trachea model in the simulation system has only one fixed model. Thus, this study aimed to construct multiple removable trachea models according to different age groups. We enrolled 20 patients who had previously received proton beam therapy in our institution and acquired the treatment planning computed tomography (CT) image data. To construct the artificial trachea model for three age groups (children, adolescents and young adults, and adults), we analyzed the three-dimensional coordinates of the entire trachea, tracheal carina, and the end of the main bronchus. We also analyzed the diameter of the trachea and main bronchus. Finally, we evaluated the accuracy of the model by analyzing the difference between the constructed model and actual measurements. The trachea model was 8 cm long for children and 12 cm for adolescents and young adults, and for adults. The angle between the trachea and bed was about 20 degrees, regardless of age. The mean model accuracy was less than 0.4 cm. We constructed detachable artificial trachea models for three age groups for implementation in the endotracheal suctioning training environment simulator (ESTE-SIM) based on the treatment planning CT image. Our constructed artificial trachea models will be able to provide a simulation environment for various age groups in the ESTE-SIM.	[Yoshimura, Takaaki] Hokkaido Univ, Fac Hlth Sci, Dept Hlth Sci & Technol, Sapporo, Hokkaido, Japan; [Yoshimura, Takaaki; Shimizu, Shinichi] Hokkaido Univ Hosp, Dept Med Phys, Sapporo, Hokkaido, Japan; [Colley, Noriyo] Hokkaido Univ, Fac Hlth Sci, Dept Comprehens Dev Nursing, Sapporo, Hokkaido, Japan; [Komizunai, Shunsuke; Kanai, Satoshi; Konno, Atsushi] Hokkaido Univ, Div Syst Sci & Informat, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Ninomiya, Shinji] Hiroshima Int Univ, Fac Hlth Sci, Dept Med Sci & Technol, Hiroshima, Japan; [Yasuda, Koichi; Taguchi, Hiroshi] Hokkaido Univ, Dept Radiat Oncol, Fac Med, Sapporo, Hokkaido, Japan; [Hashimoto, Takayuki; Shimizu, Shinichi] Hokkaido Univ, Fac Med, Dept Radiat Med Sci & Engn, Sapporo, Hokkaido, Japan; [Shimizu, Shinichi] Hokkaido Univ, Global Ctr Biomed Sci & Engn, Fac Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Colley, N (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Comprehens Dev Nursing, Sapporo, Hokkaido, Japan.	noriyo@med.hokudai.ac.jp	Colley, Noriyo/GMW-9944-2022; Yasuda, Koichi/ABE-6380-2021	Colley, Noriyo/0000-0002-4811-3499; Taguchi, Hiroshi/0000-0003-2348-4071	JSPS KAKENHI [JP19H03877]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP19H03877. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra L, 2004, CRIT CARE MED, V32, P2071, DOI 10.1097/01.CCM.0000142575.86468.9B; Colley N, 2020, J MED BIOL ENG, V40, P340, DOI 10.1007/s40846-020-00521-y; Dale CM, 2018, ANN AM THORAC SOC, V15, P357, DOI 10.1513/AnnalsATS.201708-663OC; de Christensen MR., 2019, CHEST IMAGING; Grant CA, 2006, BRIT J ANAESTH, V96, P127, DOI 10.1093/bja/aei282; GRISCOM NT, 1986, AM J ROENTGENOL, V146, P233, DOI 10.2214/ajr.146.2.233; GRISCOM NT, 1989, PEDIATR PULM, V6, P186; Hamaguchi S, 2012, J VASC SURG, V55, P545, DOI 10.1016/j.jvs.2011.08.006; JEANNERETGROSJEAN A, 1988, AM REV RESPIR DIS, V137, P707, DOI 10.1164/ajrccm/137.3.707; Keilty K, 2018, J CHILD HEALTH CARE, V22, P46, DOI 10.1177/1367493517746770; Komizunai S, 2019, INT J AUTO TECH-JPN, V13, P490, DOI 10.20965/ijat.2019.p0490; Konno A, 2020, 2020 IEEE SICE INT S; Min K., 2012, OPEN J MOL INTEGR PH, V02, P14, DOI 10.4236/ojmip.2012.21003; O'Neal PV, 2007, BIOL RES NURS, V8, P202, DOI 10.1177/1099800406295517; Safshekan F, 2016, MATERIALS, V9, DOI 10.3390/ma9060456; Sloane PD, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.06.008; Takizawa H, 2020, 2020 IEEEM SICE INT; Trouillet JL, 2018, ANAESTH CRIT CARE PA, V37, P281, DOI 10.1016/j.accpm.2018.02.012	18	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249010	10.1371/journal.pone.0249010	http://dx.doi.org/10.1371/journal.pone.0249010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780512	gold, Green Published			2022-12-26	WOS:000636336800017
J	Martin, PT; Zygmunt, DA; Ashbrook, A; Hamilton, S; Packer, D; Birch, SM; Bettis, AK; Balog-Alvarez, CJ; Guo, LJ; Nghiem, PP; Kornegay, JN				Martin, Paul T.; Zygmunt, Deborah A.; Ashbrook, Anna; Hamilton, Sonia; Packer, Davin; Birch, Sharla M.; Bettis, Amanda K.; Balog-Alvarez, Cynthia J.; Guo, Lee-Jae; Nghiem, Peter P.; Kornegay, Joe N.			Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength	PLOS ONE			English	Article								We have examined the effects of intravenous (IV) delivery of rAAVrh74.MHCK7.GALGT2 in the golden retriever muscular dystrophy (GRMD) model of Duchenne Muscular Dystrophy (DMD). After baseline testing, GRMD dogs were treated at 3 months of age and reassessed at 6 months. This 3-6 month age range is a period of rapid disease progression, thus offering a relatively short window to establish treatment efficacy. Measures analyzed included muscle AAV transduction, GALGT2 transgene expression, GALGT2-induced glycosylation, muscle pathology, and muscle function. A total of five dogs were treated, 4 at 2x10(14)vg/kg and one at 6x10(14)vgkg. The 2x10(14)vg/kg dose led to transduction of regions of the heart with 1-3 vector genomes (vg) per nucleus, while most skeletal muscles were transduced with 0.25-0.5vg/nucleus. GALGT2-induced glycosylation paralleled levels of myofiber vg transduction, with about 90% of cardiomyocytes having increased glycosylation versus 20-35% of all myofibers across the skeletal muscles tested. Conclusions from phenotypic testing were limited by the small number of dogs. Treated dogs had less pronounced fibrosis and overall lesion severity when compared to control groups, but surprisingly no significant changes in limb muscle function measures. GALGT2-treated skeletal muscle and heart had elevated levels of utrophin protein expression and GALGT2-induced expression of glycosylated alpha dystroglycan, providing further evidence of a treatment effect. Serum chemistry, hematology, and cardiac function measures were largely unchanged by treatment. Cumulatively, these data show that short-term intravenous treatment of GRMD dogs with rAAVrh74.MHCK7.GALGT2 at high doses can induce muscle glycosylation and utrophin expression and may be safe over a short 3-month interval, but that such treatments had only modest effects on muscle pathology and did not significantly improve muscle strength.	[Martin, Paul T.; Zygmunt, Deborah A.; Ashbrook, Anna] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA; [Martin, Paul T.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Hamilton, Sonia] Ohio State Univ, Neurosci Undergrad Program, Columbus, OH 43210 USA; [Packer, Davin] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA; [Birch, Sharla M.; Bettis, Amanda K.; Balog-Alvarez, Cynthia J.; Guo, Lee-Jae; Nghiem, Peter P.; Kornegay, Joe N.] Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station	Martin, PT (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA.; Martin, PT (corresponding author), Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA.	Paul.Martin@nationwidechildrens.org		Kornegay, Joe/0000-0002-5594-1882; Guo, Lee-Jae (Jack)/0000-0002-9633-1167	NIH [R01 AR049722, P50 AR070604]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grants R01 AR049722 and P50 AR070604 to PTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AR, 2016, NEUROMUSCULAR DISORD, V26, P865, DOI 10.1016/j.nmd.2016.09.024; Barraza-Flores P, 2019, HUM MOL GENET, V28, P2686, DOI 10.1093/hmg/ddz086; Bartlett RJ, 1996, AM J VET RES, V57, P650; Ceco E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010018; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Chicoine LG, 2014, MOL THER, V22, P338, DOI 10.1038/mt.2013.244; Chicoine LG, 2014, MOL THER, V22, P713, DOI 10.1038/mt.2013.246; Childers MK, 2011, JOVE-J VIS EXP, DOI 10.3791/2623; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Cramer ML, 2017, HUM GENE THER, V28, P493, DOI 10.1089/hum.2016.113; De la Porte S, 1999, INT REV CYTOL, V191, P99, DOI 10.1016/S0074-7696(08)60158-8; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; ERVASTI JM, 1994, FEBS LETT, V350, P173, DOI 10.1016/0014-5793(94)00748-9; Fine DM, 2011, NEUROMUSCULAR DISORD, V21, P453, DOI 10.1016/j.nmd.2011.03.010; Galvao JFD, 2017, VET CLIN N AM-SMALL, V47, P241, DOI 10.1016/j.cvsm.2016.10.016; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gregorevic P, 2009, MOL THER, V17, P1427, DOI 10.1038/mt.2009.116; Guo C, 2006, HUM MOL GENET, V15, P989, DOI 10.1093/hmg/ddl018; Guo LJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012443; Haaf P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0308-4; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoyte K, 2002, MOL BRAIN RES, V109, P146, DOI 10.1016/S0169-328X(02)00551-X; Jellis CL, 2014, CARDIOVASC DIAGN THE, V4, P126, DOI 10.3978/j.issn.2223-3652.2013.09.03; KAMAKURA K, 1994, J NEUROSCI RES, V37, P728, DOI 10.1002/jnr.490370607; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Koo T, 2011, J GENE MED, V13, P497, DOI 10.1002/jgm.1602; Kornegay JN, 1999, J NEUROL SCI, V166, P115, DOI 10.1016/S0022-510X(99)00118-5; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Kornegay JN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0124-z; Kornegay JN, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-18; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Kornegay JN, 2011, METHODS MOL BIOL, V709, P105, DOI 10.1007/978-1-61737-982-6_7; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Le Guiner C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16105; Le Guiner C, 2014, MOL THER, V22, P1923, DOI 10.1038/mt.2014.151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088226; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; Martin PT, 1999, MOL CELL NEUROSCI, V13, P105, DOI 10.1006/mcne.1999.0737; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Nghiem PP, 2019, HUM GENET, V138, P483, DOI 10.1007/s00439-019-01976-z; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Raith M, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-14; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Song YF, 2019, NAT MED, V25, P1505, DOI 10.1038/s41591-019-0594-0; Soslow JH, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0224-7; Spurney CF, 2015, J AM SOC ECHOCARDIOG, V28, P999, DOI 10.1016/j.echo.2015.03.003; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Su JB, 2012, CARDIOVASC RES, V95, P86, DOI 10.1093/cvr/cvs161; Tegeler CJ, 2010, MUSCLE NERVE, V42, P130, DOI 10.1002/mus.21699; Thomas PJ, 2016, AM J PATHOL, V186, P2429, DOI 10.1016/j.ajpath.2016.05.021; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TOME FMS, 1994, NEUROMUSCULAR DISORD, V4, P343, DOI 10.1016/0960-8966(94)90070-1; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; VALENTINE BA, 1990, J VET INTERN MED, V4, P140, DOI 10.1111/j.1939-1676.1990.tb00886.x; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Vo AH, 2015, CURR OPIN NEUROL, V28, P528, DOI 10.1097/WCO.0000000000000240; Wang ZJ, 2012, MOL THER, V20, P1501, DOI 10.1038/mt.2012.111; Wang ZJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00201; Wang ZJ, 2010, MOL THER, V18, P617, DOI 10.1038/mt.2009.294; Wess G, 2010, J VET INTERN MED, V24, P1069, DOI 10.1111/j.1939-1676.2010.0575.x; Xia B, 2002, DEV BIOL, V242, P58, DOI 10.1006/dbio.2001.0530; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xu R, 2007, AM J PATHOL, V171, P181, DOI 10.2353/ajpath.2007.060927; Xu R, 2007, NEUROMUSCULAR DISORD, V17, P209, DOI 10.1016/j.nmd.2006.12.004; Xu R, 2019, MOL THER, V27, P636, DOI 10.1016/j.ymthe.2019.01.005; Xu R, 2018, MOL THER-METH CLIN D, V10, P89, DOI 10.1016/j.omtm.2018.06.002; Xu R, 2015, AM J PATHOL, V185, P2668, DOI 10.1016/j.ajpath.2015.06.008; Xu R, 2009, AM J PATHOL, V175, P235, DOI 10.2353/ajpath.2009.080967; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013; Yue YP, 2008, MOL THER, V16, P1944, DOI 10.1038/mt.2008.207; Zygmunt DA, 2019, MOL THER-METH CLIN D, V15, P305, DOI 10.1016/j.omtm.2019.10.005; Zygmunt DA, 2017, HUM GENE THER, V28, P737, DOI 10.1089/hum.2016.141	82	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248721	10.1371/journal.pone.0248721	http://dx.doi.org/10.1371/journal.pone.0248721			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770101	gold, Green Published			2022-12-26	WOS:000634833500025
J	Puiseux, T; Sewonu, A; Moreno, R; Mendez, S; Nicoud, F				Puiseux, Thomas; Sewonu, Anou; Moreno, Ramiro; Mendez, Simon; Nicoud, Franck			Numerical simulation of time-resolved 3D phase-contrast magnetic resonance imaging	PLOS ONE			English	Article								A numerical approach is presented to efficiently simulate time-resolved 3D phase-contrast Magnetic resonance Imaging (or 4D Flow MRI) acquisitions under realistic flow conditions. The Navier-Stokes and Bloch equations are simultaneously solved with an Eulerian-Lagrangian formalism. A semi-analytic solution for the Bloch equations as well as a periodic particle seeding strategy are developed to reduce the computational cost. The velocity reconstruction pipeline is first validated by considering a Poiseuille flow configuration. The 4D Flow MRI simulation procedure is then applied to the flow within an in vitro flow phantom typical of the cardiovascular system. The simulated MR velocity images compare favorably to both the flow computed by solving the Navier-Stokes equations and experimental 4D Flow MRI measurements. A practical application is finally presented in which the MRI simulation framework is used to identify the origins of the MRI measurement errors.	[Puiseux, Thomas; Mendez, Simon; Nicoud, Franck] Univ Montpellier, CNRS, IMAG, Montpellier, France; [Puiseux, Thomas; Sewonu, Anou; Moreno, Ramiro] Spin Up, Strasbourg, France; [Puiseux, Thomas; Moreno, Ramiro] INSERM, I2MC, UMR 1297, Toulouse, France; [Moreno, Ramiro] ALARA Expertise, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Puiseux, T (corresponding author), Univ Montpellier, CNRS, IMAG, Montpellier, France.; Puiseux, T (corresponding author), Spin Up, Strasbourg, France.; Puiseux, T (corresponding author), INSERM, I2MC, UMR 1297, Toulouse, France.	tpuiseux@spin-up.fr		Puiseux, Thomas/0000-0002-3548-6085; Mendez, Simon/0000-0002-0863-2024	GENCI-CINES [2018-A0040307194, 2019-A0060307194]; High Performance Computing Platform MESO@LR - Occitanie/Pyrenees-Mediterranee Region, Montpellier Mediterranean Metropole; University of Montpellier; ALARA Expertise; LabEx Numev [ANR-10-LABX-0020]; Spin Up	GENCI-CINES; High Performance Computing Platform MESO@LR - Occitanie/Pyrenees-Mediterranee Region, Montpellier Mediterranean Metropole; University of Montpellier; ALARA Expertise; LabEx Numev; Spin Up	Simulations were performed using HPC resources from GENCI-CINES (Grants 2018-A0040307194 and 2019-A0060307194) and with the support of the High Performance Computing Platform MESO@LR, funded by the Occitanie/Pyrenees-Mediterranee Region, Montpellier Mediterranean Metropole and the University of Montpellier. This study was funded by ALARA Expertise (https://www.alara-expertise.fr/) and Spin Up (https://www.spin-up.fr/).Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. A. Fortin for his contribution to the development of 4D Flow MRI sequences and for providing the image reconstruction program. They also thank M. Garreau for her active involvement in this project. The authors are very grateful to Dr. V. Moureau and Dr. G. Lartigue (CORIA, UMR 6614) and the SUCCESS scientific group for providing the YALES2 code, which served as a basis for the development of YALES2BIO. The authors wish to thank Prof. M. Markl from the department of Radiology and Biomedical Engineering at Northwestern University for kindly providing 4D Flow MRI sequences and the scientific partnership department of SIEMENS HEALTHINEERS, France. Finally, the LabEx Numev (convention ANR-10-LABX-0020) is acknowledged.	Andria G, 2009, IEEE T INSTRUM MEAS, V58, P3140, DOI 10.1109/TIM.2009.2016888; Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027; BITTOUN J, 1984, Magnetic Resonance Imaging, V2, P113, DOI 10.1016/0730-725X(84)90065-1; Bittoun J, 2000, MAGN RESON MED, V44, P723, DOI 10.1002/1522-2594(200011)44:5<723::AID-MRM10>3.0.CO;2-5; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Chnafa C, 2016, ANN BIOMED ENG, V44, P3346, DOI 10.1007/s10439-016-1614-6; Ebbers T, 2001, MAGNET RESON MED, V45, P872, DOI 10.1002/mrm.1116; Fortin A, 2018, MAGN RESON MED, V80, P1655, DOI 10.1002/mrm.27114; FRAYNE R, 1995, JMRI-J MAGN RESON IM, V5, P207, DOI 10.1002/jmri.1880050217; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Gatehouse PD, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-5; Greil G, 2002, J MAGN RESON IMAGING, V15, P47, DOI 10.1002/jmri.10029; Haacke E. M., 1999, MAGNETIC RESONANCE I; Hazra A, 2018, APPL NUMER MATH, V123, P241, DOI 10.1016/j.apnum.2017.09.007; Jou LD, 1998, MED ENG PHYS, V20, P643, DOI 10.1016/S1350-4533(98)00075-7; Jurczuk K, 2014, IEEE T MED IMAGING, V33, P2191, DOI 10.1109/TMI.2014.2336756; Jurczuk K, 2013, MAGN RESON IMAGING, V31, P1163, DOI 10.1016/j.mri.2013.01.005; KIM J, 1985, J COMPUT PHYS, V59, P308, DOI 10.1016/0021-9991(85)90148-2; Klepaczko A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093689; Latta P, 2010, J MAGN RESON, V203, P44, DOI 10.1016/j.jmr.2009.11.019; Lorthois S, 2005, ANN BIOMED ENG, V33, P270, DOI 10.1007/s10439-005-1730-1; Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971; Malandain M, 2013, J COMPUT PHYS, V238, P32, DOI 10.1016/j.jcp.2012.11.046; Markl M, 2003, J MAGN RESON IMAGING, V18, P396, DOI 10.1002/jmri.10394; Markl M, 2010, MAGN RESON MED, V63, P1575, DOI 10.1002/mrm.22353; Marshall I, 2010, J MAGN RESON IMAGING, V31, P928, DOI 10.1002/jmri.22096; Mendez S, 2015, YALES2BIO COMPUTATIO; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Meyrignac O, 2020, RADIOLOGY, V295, P722, DOI 10.1148/radiol.2020192112; Moureau V, 2011, CR MECANIQUE, V339, P141, DOI 10.1016/j.crme.2010.12.001; Nicoud F, 2018, LECT NOTES APPL COMP, V84, P147, DOI 10.1007/978-3-319-59548-1_9; Nicoud F, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3623274; OLSSON MBE, 1995, MAGNET RESON MED, V34, P612, DOI 10.1002/mrm.1910340418; PELC NJ, 1991, JMRI-J MAGN RESON IM, V1, P405, DOI 10.1002/jmri.1880010404; Petersson S, 2010, MAGN RESON MED, V64, P1039, DOI 10.1002/mrm.22494; Potters WV, 2015, J MAGN RESON IMAGING, V41, P505, DOI 10.1002/jmri.24560; Puiseux T., 2019, NUMERICAL SIMULATION; Puiseux T, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4063; Rocchini C., 2000, Journal of Graphics Tools, V5, P9, DOI 10.1080/10867651.2000.10487528; Rojano RM, 2018, BIOMECH MODEL MECHAN, V17, P815, DOI 10.1007/s10237-017-0994-3; Sharp J, 2006, INTEGRATED MR CONSOL; Shkarin P, 1997, INT J IMAG SYST TECH, V8, P419, DOI 10.1002/(SICI)1098-1098(1997)8:5<419::AID-IMA1>3.0.CO;2-D; Steinman DA, 1997, J MAGN RESON IMAGING, V7, P339, DOI 10.1002/jmri.1880070214; Stocker T, 2010, MAGN RESON MED, V64, P186, DOI 10.1002/mrm.22406; Taraconat P, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3243; Thunberg P, 2000, MAGNET RESON MED, V43, P734, DOI 10.1002/(SICI)1522-2594(200005)43:5<734::AID-MRM16>3.0.CO;2-A; TORREY HC, 1956, PHYS REV, V104, P563, DOI 10.1103/PhysRev.104.563; Xanthis CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-48; Xanthis CG, 2014, IEEE T MED IMAGING, V33, P607, DOI 10.1109/TMI.2013.2292119; YUAN C, 1987, MED PHYS, V14, P914, DOI 10.1118/1.596129; ZUR Y, 1991, MAGNET RESON MED, V21, P251, DOI 10.1002/mrm.1910210210	52	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248816	10.1371/journal.pone.0248816	http://dx.doi.org/10.1371/journal.pone.0248816			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770130	Green Published, gold			2022-12-26	WOS:000634833500041
J	Schug, F; Frantz, D; van der Linden, S; Hostert, P				Schug, Franz; Frantz, David; van der Linden, Sebastian; Hostert, Patrick			Gridded population mapping for Germany based on building density, height and type from Earth Observation data using census disaggregation and bottom-up estimates	PLOS ONE			English	Article							SETTLEMENTS; EXPOSURE; LAND; MAPS	Gridded population data is widely used to map fine scale population patterns and dynamics to understand associated human-environmental processes for global change research, disaster risk assessment and other domains. This study mapped gridded population across Germany using weighting layers from building density, building height (both from previous studies) and building type datasets, all created from freely available, temporally and globally consistent Copernicus Sentinel-1 and Sentinel-2 data. We first produced and validated a nation-wide dataset of predominant residential and non-residential building types. We then examined the impact of different weighting layers from density, type and height on top-down dasymetric mapping quality across scales. We finally performed a nation-wide bottom-up population estimate based on the three datasets. We found that integrating building types into dasymetric mapping is helpful at fine scale, as population is not redistributed to non-residential areas. Building density improved the overall quality of population estimates at all scales compared to using a binary building layer. Most importantly, we found that the combined use of density and height, i.e. volume, considerably increased mapping quality in general and with regard to regional discrepancy by largely eliminating systematic underestimation in dense agglomerations and overestimation in rural areas. We also found that building density, type and volume, together with living floor area per capita, are suitable to produce accurate large-area bottom-up population estimates.	[Schug, Franz; Frantz, David; Hostert, Patrick] Humboldt Univ, Dept Geog, Berlin, Germany; [Schug, Franz; Hostert, Patrick] Humboldt Univ, Integrated Res Inst Transformat Human Environm Sy, Berlin, Germany; [van der Linden, Sebastian] Univ Greifswald, Inst Geographie & Geol, Greifswald, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Ernst Moritz Arndt Universitat Greifswald	Schug, F (corresponding author), Humboldt Univ, Dept Geog, Berlin, Germany.; Schug, F (corresponding author), Humboldt Univ, Integrated Res Inst Transformat Human Environm Sy, Berlin, Germany.	franz.schug@geo.hu-berlin.de	van der Linden, Sebastian/B-4516-2008	van der Linden, Sebastian/0000-0001-6576-8377; Schug, Franz/0000-0003-1534-5610	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (MAT_STOCKS) [741950]; German Research Foundation (DFG); HumboldtUniversitat zu Berlin	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (MAT_STOCKS)(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); HumboldtUniversitat zu Berlin	FS, DF and PH have received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (MAT_STOCKS, grant agreement No 741950). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of HumboldtUniversitat zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AUST J EMERG MANAG, V30, P9; Azar D, 2010, INT J REMOTE SENS, V31, P5635, DOI 10.1080/01431161.2010.496799; Bai ZQ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10051363; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Berlin Senate Dpt. for Urb. Dev. & Housing, 2019, LEBENSWELTLICH ORIEN; Biljecki F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156808; Bosco C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0825; Brown S, 2018, EARTHS FUTURE, V6, P583, DOI 10.1002/2017EF000738; Ceccherini G, 2017, NAT HAZARD EARTH SYS, V17, P115, DOI 10.5194/nhess-17-115-2017; Census db. from Fed. Stat. Offices, 2011, ZENSUS 2011; CIESIN, 2017, DOC GLOB RUR URB MAP; CIESIN, 2020, GLOB RUR URB MAPP PR; Corbane C, 2021, NEURAL COMPUT APPL, V33, P6697, DOI 10.1007/s00521-020-05449-7; Corbane C, 2019, BIG EARTH DATA, V3, P140, DOI 10.1080/20964471.2019.1625528; Deutsches Statistisches Bundesamt, 2019, FORTSCHREIBUNG BEV L; Dijkstra L., 2019, OECD REGIONAL DEV WO; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001; Ehrlich D, 2018, ENVIRON SCI POLICY, V90, P73, DOI 10.1016/j.envsci.2018.10.001; Eicher C. L., 2001, CARTOGR GEOGR INF SC, V28, P125, DOI [10.1559/152304001782173727, DOI 10.1559/152304001782173727]; Esch T, 2013, IEEE GEOSCI REMOTE S, V10, P1617, DOI 10.1109/LGRS.2013.2272953; European Commission, 2016, COMMUNICATION COMMIS; Eurostat, 2016, REN EN STAT; Frantz D., 2020, ZENODO; Frantz D, 2021, REMOTE SENS ENVIRON, V252, DOI 10.1016/j.rse.2020.112128; Gaughan AE, 2015, INT J DIGIT EARTH, V8, P989, DOI 10.1080/17538947.2014.965761; Gebaude und Wohnungen, 2019, BESTAND WOHNUNGEN WO; Ghosh T, 2020, FRONT SUSTAIN CITIES, V2, DOI 10.3389/frsc.2020.00037; Gunasekera R, 2015, EARTH-SCI REV, V150, P594, DOI 10.1016/j.earscirev.2015.08.012; Haberl H, 2019, NAT SUSTAIN, V2, P173, DOI 10.1038/s41893-019-0225-2; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hecht R, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8010002; Hostert P., 2021, GRIDDED POPULATION M; Hugo G, 2011, GLOBAL ENVIRON CHANG, V21, pS21, DOI 10.1016/j.gloenvcha.2011.09.008; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Jones B, 2015, NAT CLIM CHANGE, V5, P652, DOI [10.1038/NCLIMATE2631, 10.1038/nclimate2631]; JRC, 2020, GHS POPULATION GRID; Krunic N, 2015, LECT NOTES GEOINF CA, P137, DOI 10.1007/978-3-319-18407-4_12; Leyk S, 2019, EARTH SYST SCI DATA, V11, P1385, DOI 10.5194/essd-11-1385-2019; Li MM, 2020, REMOTE SENS ENVIRON, V245, DOI 10.1016/j.rse.2020.111859; Linard C, 2011, GEOJOURNAL, V76, P525, DOI 10.1007/s10708-010-9364-8; Marconcini M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00580-5; Melchiorri M, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8020096; Mennis J, 2003, PROF GEOGR, V55, P31; Nagle NN, 2014, ANN ASSOC AM GEOGR, V104, P80, DOI 10.1080/00045608.2013.843439; Nieves JJ., 2020, SSRN J, DOI [10.2139/ssrn.3599775, DOI 10.2139/SSRN.3599775]; OSM Foundation, 2020, OPENSTREETMAP; Palacios-Lopez D, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11216056; Reed FJ, 2018, DATA, V3, DOI 10.3390/data3030033; Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213; Schug F, 2020, REMOTE SENS ENVIRON, V246, DOI 10.1016/j.rse.2020.111810; Gine DS, 2016, CARTOGR GEOGR INF SC, V43, P442, DOI 10.1080/15230406.2015.1076737; Small C, 2018, GLOBAL PLANET CHANGE, V165, P62, DOI 10.1016/j.gloplacha.2018.03.005; Stevens FR, 2020, INT J DIGIT EARTH, V13, P78, DOI 10.1080/17538947.2019.1633424; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tobler W, 1997, Int J Popul Geogr, V3, P203; Tomas L, 2016, INT J REMOTE SENS, V37, P1, DOI 10.1080/01431161.2015.1121301; UN Prospects, 2019, A423 STESASER; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; van Soesbergen A, 2018, ECOSYST SERV, V33, P175, DOI 10.1016/j.ecoser.2018.08.005; Wardrop NA, 2018, P NATL ACAD SCI USA, V115, P3529, DOI 10.1073/pnas.1715305115; Weber EM, 2018, REMOTE SENS ENVIRON, V204, P786, DOI 10.1016/j.rse.2017.09.024; Wentz EA, 2018, LANDSCAPE URBAN PLAN, V179, P55, DOI 10.1016/j.landurbplan.2018.07.007; WorldPop UoS, 2020, WORLDPOP OPEN SPATIA; Wu Y, 2020, PSYCHOL MED, V50, P2816, DOI 10.1017/S0033291719002137; Zandbergen PA, 2010, CARTOGR GEOGR INF SC, V37, P199, DOI 10.1559/152304010792194985; Zhao Y, 2017, INT J REMOTE SENS, V38, P1180, DOI 10.1080/01431161.2017.1280634; Zhu Z, 2019, REMOTE SENS ENVIRON, V228, P164, DOI 10.1016/j.rse.2019.04.020	69	13	13	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249044	10.1371/journal.pone.0249044	http://dx.doi.org/10.1371/journal.pone.0249044			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770133	Green Published, gold			2022-12-26	WOS:000634833500011
J	Stien, N; Vereide, VA; Saeterbakken, AH; Hermans, E; Shaw, MP; Andersen, V				Stien, Nicolay; Vereide, Vegard Albert; Saeterbakken, Atle Hole; Hermans, Espen; Shaw, Matthew Peter; Andersen, Vidar			Upper body rate of force development and maximal strength discriminates performance levels in sport climbing	PLOS ONE			English	Article							MUSCLE STRENGTH; ROCK; DETERMINANTS; ENDURANCE; ELITE; LEAD	The aim of this study was to assess and compare the maximal force and rate of force development (RFD) between intermediate, advanced and elite climbers using several different methods for calculating RFD. Fifty-seven male climbers (17 intermediate, 25 advanced, and 15 elite) performed isometric pull-ups on a climbing-specific hold while the RFD was calculated using several absolute (50, 100, 150, 200, and 250 ms from onset of force) and relative time periods (25, 50, 75, 95, and 100% of time to peak force). The maximal force was higher among elite climbers compared to advanced (ES = 1.78, p < 0.001) and intermediate climbers (ES = 1.77, p < 0.001), while no difference was observed between intermediate and advanced climbers (P = 0.898). The elite group also showed higher RFD than the other two groups at all relative time periods (ES = 1.02-1.58, p < 0.001-0.002), whereas the absolute time periods only revealed differences between the elite vs. the other groups at 50, 100 and 150 ms from the onset of force (ES = 0.72-0.84, p = 0.032-0.040). No differences in RFD were observed between the intermediate and advanced groups at any time period (p = 0.942-1.000). Maximal force and RFD, especially calculated using the longer periods of the force curve, may be used to distinguish elite climbers from advanced and intermediate climbers. The authors suggest using relative rather than absolute time periods when analyzing the RFD of climbers.	[Stien, Nicolay; Vereide, Vegard Albert; Saeterbakken, Atle Hole; Hermans, Espen; Shaw, Matthew Peter; Andersen, Vidar] Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Bergen, Norway	Western Norway University of Applied Sciences	Stien, N (corresponding author), Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Bergen, Norway.	nicolay.stien@hvl.no		Stien, Nicolay/0000-0001-5161-9055				Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deyhle MR, 2015, J STRENGTH COND RES, V29, P2006, DOI 10.1519/JSC.0000000000000823; Draper N., 2015, SPORTS TECHNOL, V8, P88, DOI [10.1080/19346182.2015.1107081, DOI 10.1080/19346182.2015.1107081]; Draper N, 2008, J SPORT SCI MED, V7, P492; Draper N, 2011, J SPORT SCI, V29, P851, DOI 10.1080/02640414.2011.565362; Esposito F, 2009, EUR J APPL PHYSIOL, V105, P81, DOI 10.1007/s00421-008-0877-5; Fanchini M, 2013, J STRENGTH COND RES, V27, P310, DOI 10.1519/JSC.0b013e3182577026; Fryer S, 2015, INT J SPORTS MED, V36, P137, DOI 10.1055/s-0034-1385887; Grant S, 2001, J SPORT SCI, V19, P499, DOI 10.1080/026404101750238953; Gupta M, 2020, J THERM ANAL CALORIM, V142, P1545, DOI 10.1007/s10973-020-09453-w; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Laffaye G, 2016, SCAND J MED SCI SPOR, V26, P1151, DOI 10.1111/sms.12558; Levernier G, 2019, J STRENGTH COND RES, V33, P2471, DOI 10.1519/JSC.0000000000002230; Levernier G, 2021, SPORT BIOMECH, V20, P495, DOI 10.1080/14763141.2019.1584236; Limonta E, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00902; Macdonald JH, 2011, WILD ENVIRON MED, V22, P140, DOI 10.1016/j.wem.2010.11.012; MacLeod D, 2007, J SPORT SCI, V25, P1433, DOI 10.1080/02640410600944550; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Maffiuletti NA, 2010, CLIN ORTHOP RELAT R, V468, P191, DOI 10.1007/s11999-009-0978-4; Magiera A, 2013, J HUM KINET, V36, P107, DOI 10.2478/hukin-2013-0011; Mermier CM, 2000, BRIT J SPORT MED, V34, P359, DOI 10.1136/bjsm.34.5.359; Michailov ML, 2018, RES Q EXERCISE SPORT, V89, P246, DOI 10.1080/02701367.2018.1441484; Mirkov DM, 2004, EUR J APPL PHYSIOL, V91, P147, DOI 10.1007/s00421-003-0946-8; Orth D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01744; Ozimek M, 2016, J HUM KINET, V53, P249, DOI 10.1515/hukin-2016-0027; Roberts TJ, 2016, J EXP BIOL, V219, P266, DOI 10.1242/jeb.124446; Stien N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222529; Taylor N, 2020, INT J SPORT PHYSIOL, V15, P795, DOI 10.1123/ijspp.2019-0311; Tillin NA, 2013, J ELECTROMYOGR KINES, V23, P991, DOI 10.1016/j.jelekin.2013.04.015; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; Watts PB, 2004, EUR J APPL PHYSIOL, V91, P361, DOI 10.1007/s00421-003-1036-7; White DJ, 2010, J STRENGTH COND RES, V24, P1356, DOI 10.1519/JSC.0b013e3181cf75bd	34	3	3	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249353	10.1371/journal.pone.0249353	http://dx.doi.org/10.1371/journal.pone.0249353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770128	Green Published, gold			2022-12-26	WOS:000634833500054
J	Upadhyaya, G; Das, A; Basu, C; Agarwal, T; Basak, C; Chakraborty, C; Halder, T; Basu, G; Ray, S				Upadhyaya, Gouranga; Das, Arup; Basu, Chandradeep; Agarwal, Tanushree; Basak, Chandra; Chakraborty, Chandrima; Halder, Tanmoy; Basu, Gautam; Ray, Sudipta			Multiple copies of a novel amphipathic alpha-helix forming segment in Physcomitrella patens dehydrin play a key role in abiotic stress mitigation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; K-SEGMENTS; LACTATE-DEHYDROGENASE; WATER-STRESS; MAIZE DHN1; TOLERANCE; DEHYDRATION; MEMBRANE; FLUORESCENCE; SEQUENCES	Plants use a diverse set of proteins to mitigate various abiotic stresses. The intrinsically disordered protein dehydrin is an important member of this repertoire of proteins, characterized by a canonical amphipathic K-segment. It can also contain other stress-mitigating noncanonical segments-a likely reflection of the extremely diverse nature of abiotic stress encountered by plants. Among plants, the poikilohydric mosses have no inbuilt mechanism to prevent desiccation and therefore are likely to contain unique noncanonical stress-responsive motifs in their dehydrins. Here we report the recurring occurrence of a novel amphipathic helix-forming segment (D-segment: EG phi phi D(R/K)AKDA phi, where phi represents a hydrophobic residue) in Physcomitrella patens dehydrin (PpDHNA), a poikilohydric moss. NMR and CD spectroscopic experiments demonstrated the helix-forming tendency of the D-segment, with the shuffled D-segment as control. PpDHNA activity was shown to be size as well as D-segment dependent from in vitro, in vivo, and in planta studies using PpDHNA and various deletion mutants. Bimolecular fluorescence complementation studies showed that D-segment-mediated PpDHNA self-association is a requirement for stress abatement. The D-segment was also found to occur in two rehydrin proteins from Syntrichia ruralis, another poikilohydric plant like P. patens. Multiple occurrences of the D-segment in poikilohydric plant dehydrins/rehydrins, along with the experimental demonstration of the role of D-segment in stress abatement, implies that the D-segment mediates unique resurrection strategies, which may be employed by plant dehydrins that are capable of mitigating extreme stress.	[Upadhyaya, Gouranga; Das, Arup; Agarwal, Tanushree; Basak, Chandra; Chakraborty, Chandrima; Halder, Tanmoy; Ray, Sudipta] Univ Calcutta, Dept Bot, Plant Funct Genom Lab, Kolkata, India; [Basu, Chandradeep; Basu, Gautam] Bose Inst, Dept Biophys, Kolkata, India	University of Calcutta; Department of Science & Technology (India); Bose Institute	Ray, S (corresponding author), Univ Calcutta, Dept Bot, Plant Funct Genom Lab, Kolkata, India.	srbot@caluniv.ac.in	Upadhyaya, Gouranga/AAR-6911-2020	Upadhyaya, Gouranga/0000-0003-0816-0570	Department of Science and Technology, Government of India; University Grants Commission, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology, Government of India [SERB/SR/SO/PS-30/2010]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	G. U. and C. Basu thank the Department of Science and Technology, Government of India; A.D., C.C., and C. Basak thank the University Grants Commission, Government of India; T.H. thanks the Council of Scientific and Industrial Research, Government of India, for research fellowship. Department of Science and Technology, Government of India (Sanction No. SERB/SR/SO/PS-30/2010) provided financial support.	Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Agarwal T, 2017, PLANTA, V245, P101, DOI 10.1007/s00425-016-2596-1; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baryla A, 2000, ENVIRON POLLUT, V109, P131, DOI 10.1016/S0269-7491(99)00232-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charron AJ, 2009, MOL PLANT, V2, P478, DOI 10.1093/mp/ssp018; Clement CG, 2014, HUM PATHOL, V45, P1766, DOI 10.1016/j.humpath.2014.04.016; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuevas-Velazquez CL, 2016, J BIOL CHEM, V291, P10893, DOI 10.1074/jbc.M116.720318; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Drira M, 2015, APPL BIOCHEM BIOTECH, V175, P3310, DOI 10.1007/s12010-015-1502-9; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; Eriksson S, 2016, PLANT PHYSIOL, V171, P932, DOI 10.1104/pp.15.01531; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Gupta A, 2019, J BIOL CHEM, V294, P6468, DOI 10.1074/jbc.RA118.007163; Halder T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00136; Halder T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00918; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2017, J PLANT PHYSIOL, V210, P18, DOI 10.1016/j.jplph.2016.12.003; Hernandez-Sanchez I. E., 2017, SCI REP-UK, V7, P1; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hossain MA, 2019, OSMOPROTECTANT-MEDIATED ABIOTIC STRESS TOLERANCE IN PLANTS: RECENT ADVANCES AND FUTURE PERSPECTIVES, pV; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Li QL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01316; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lv AM, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1511-2; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Murvai N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081856; Nakayama K, 2007, PLANT PHYSIOL, V144, P513, DOI 10.1104/pp.106.094581; Rensing SA, 2020, PLANT CELL, V32, P1361, DOI 10.1105/tpc.19.00828; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rivera-Najera LY, 2014, J BIOL CHEM, V289, P31995, DOI 10.1074/jbc.M114.583369; Rosales R, 2014, PHYTOCHEMISTRY, V108, P17, DOI 10.1016/j.phytochem.2014.10.006; Ruibal C, 2012, PLANT SCI, V190, P89, DOI 10.1016/j.plantsci.2012.03.009; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Strimbeck GR, 2017, PLANTA, V245, P1061, DOI 10.1007/s00425-017-2679-7; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weigel D., 2006, CSH PROTOC, V2006; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yang WB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00406; Yokoyama T, 2020, ARCH BIOCHEM BIOPHYS, V691, DOI 10.1016/j.abb.2020.108510	63	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100596	10.1016/j.jbc.2021.100596	http://dx.doi.org/10.1016/j.jbc.2021.100596			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781743	gold, Green Published			2022-12-26	WOS:000672866400568
J	Padgett, LR; Robertson, MA; Anderson-Baucum, EK; Connors, CT; Wu, WT; Mirmira, RG; Mastracci, TL				Padgett, Leah R.; Robertson, Morgan A.; Anderson-Baucum, Emily K.; Connors, Craig T.; Wu, Wenting; Mirmira, Raghavendra G.; Mastracci, Teresa L.			Deoxyhypusine synthase, an essential enzyme for hypusine biosynthesis, is required for proper exocrine pancreas development	FASEB JOURNAL			English	Article						acinar cells; DHPS; eIF5A; exocrine pancreas; hypusine biosynthesis; mRNA translation; translational regulation	DIABETES-MELLITUS; POSTTRANSLATIONAL SYNTHESIS; TRANSLATION ELONGATION; PROMOTES TRANSLATION; CONTAINING PROTEIN; AMINO-ACID; BETA-CELLS; EIF5A; DIFFERENTIATION; IDENTIFICATION	Pancreatic diseases including diabetes and exocrine insufficiency would benefit from therapies that reverse cellular loss and/or restore cellular mass. The identification of molecular pathways that influence cellular growth is therefore critical for future therapeutic generation. Deoxyhypusine synthase (DHPS) is an enzyme that post-translationally modifies and activates the mRNA translation factor eukaryotic initiation factor 5A (eIF5A). Previous work demonstrated that the inhibition of DHPS impairs zebrafish exocrine pancreas development; however, the link between DHPS, eIF5A, and regulation of pancreatic organogenesis remains unknown. Herein we identified that the conditional deletion of either Dhps or Eif5a in the murine pancreas results in the absence of acinar cells. Because DHPS catalyzes the activation of eIF5A, we evaluated and uncovered a defect in mRNA translation concomitant with defective production of proteins that influence cellular development. Our studies reveal a heretofore unappreciated role for DHPS and eIF5A in the synthesis of proteins required for cellular development and function.	[Padgett, Leah R.; Anderson-Baucum, Emily K.; Mastracci, Teresa L.] Indiana Biosci Res Inst, Indianapolis, IN USA; [Robertson, Morgan A.; Connors, Craig T.; Mastracci, Teresa L.] Indiana Univ Purdue Univ Indianapolis, Dept Biol, 723 W Michigan St,SL 306, Indianapolis, IN 46202 USA; [Wu, Wenting; Mirmira, Raghavendra G.; Mastracci, Teresa L.] Indiana Univ, Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN USA; [Wu, Wenting] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Mastracci, Teresa L.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Univ Chicago, Kovler Diabet Ctr, Chicago, IL 60637 USA; [Mirmira, Raghavendra G.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago; University of Chicago	Mastracci, TL (corresponding author), Indiana Univ Purdue Univ Indianapolis, Dept Biol, 723 W Michigan St,SL 306, Indianapolis, IN 46202 USA.	tmastrac@iu.edu		Mastracci, Teresa L./0000-0003-1956-1951	Juvenile Diabetes Research Foundation International (JDRF) [5-CDA-2016-194-A-N]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK121987-01A1]	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Juvenile Diabetes Research Foundation International (JDRF), Grant/Award Number: 5--CDA--2016--194--A--N; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 1R01DK121987--01A1	Accili D, 2016, DIABETES OBES METAB, V18, P117, DOI 10.1111/dom.12723; Bergeron RJ, 1998, J MED CHEM, V41, P3901, DOI 10.1021/jm980390o; Campbell-Thompson M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0653-y; Castro-Gutierrez R, 2018, CURR OPIN ENDOCRINOL, V25, P251, DOI 10.1097/MED.0000000000000418; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Cleveland MH, 2012, SEMIN CELL DEV BIOL, V23, P711, DOI 10.1016/j.semcdb.2012.06.008; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Das SLM, 2014, GUT, V63, P818, DOI 10.1136/gutjnl-2013-305062; Dominguez-Munoz JE, 2018, CURR OPIN GASTROEN, V34, P349, DOI 10.1097/MOG.0000000000000459; Ganapathi M, 2019, AM J HUM GENET, V104, P287, DOI 10.1016/j.ajhg.2018.12.017; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hart PA, 2016, LANCET GASTROENTEROL, V1, P226, DOI 10.1016/S2468-1253(16)30106-6; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Levasseur EM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax0715; Li X, 2017, DIABETES CARE, V40, P577, DOI 10.2337/dc16-1774; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandal A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25795; Mastracci TL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230627; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; Mastracci TL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003278; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nair GG, 2019, NAT CELL BIOL, V21, P263, DOI 10.1038/s41556-018-0271-4; Nishiki Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-421; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Olesen HV, 2020, J CYST FIBROS, V19, P321, DOI 10.1016/j.jcf.2019.10.009; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Raman VS, 2011, J PEDIATR-US, V158, P612, DOI 10.1016/j.jpeds.2010.09.066; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sambathkumar R, 2018, PHYSIOLOGY, V33, P394, DOI 10.1152/physiol.00026.2018; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Sneddon JB, 2018, CELL STEM CELL, V22, P810, DOI 10.1016/j.stem.2018.05.016; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; TORRELIO BM, 1987, BIOCHEM BIOPH RES CO, V145, P1335, DOI 10.1016/0006-291X(87)91584-1; Uc A, 2016, PANCREAS, V45, P1365, DOI 10.1097/MPA.0000000000000713; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0	46	7	7	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21473	10.1096/fj.201903177R	http://dx.doi.org/10.1096/fj.201903177R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811703	Green Published, hybrid			2022-12-26	WOS:000645260100016
J	Voigt, AL; Kondro, DA; Powell, D; Valli-Pulaski, H; Ungrin, M; Stukenborg, JB; Klein, C; Lewis, IA; Orwig, KE; Dobrinski, I				Voigt, Anna Laura; Kondro, Douglas Andrew; Powell, Diana; Valli-Pulaski, Hanna; Ungrin, Mark; Stukenborg, Jan-Bernd; Klein, Claudia; Lewis, Ian A.; Orwig, Kyle E.; Dobrinski, Ina			Unique metabolic phenotype and its transition during maturation of juvenile male germ cells	FASEB JOURNAL			English	Article						maturation; metabolism; prepubertal spermatogonia; reactive oxygen species	SPERMATOGONIAL STEM-CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; ENERGY-METABOLISM; SELF-RENEWAL; MITOCHONDRIAL BIOGENESIS; FERTILITY PRESERVATION; POSTNATAL-DEVELOPMENT; SEMINIFEROUS TUBULES; ANTIOXIDANT ENZYMES; RESTORES FERTILITY	Human male reproductive development has a prolonged prepubertal period characterized by juvenile quiescence of germ cells with immature spermatogonial stem cell (SSC) precursors (gonocytes) present in the testis for an extended period of time. The metabolism of gonocytes is not defined. We demonstrate with mitochondrial ultrastructure studies via TEM and IHC and metabolic flux studies with UHPLC-MS that a distinct metabolic transition occurs during the maturation to SSCs. The mitochondrial ultrastructure of prepubertal human spermatogonia is shared with prepubertal pig spermatogonia. The metabolism of early prepubertal porcine spermatogonia (gonocytes) is characterized by the reliance on OXPHOS fuelled by oxidative decarboxylation of pyruvate. Interestingly, at the same time, a high amount of the consumed pyruvate is also reduced and excreted as lactate. With maturation, prepubertal spermatogonia show a metabolic shift with decreased OXHPOS and upregulation of the anaerobic metabolism-associated uncoupling protein 2 (UCP2). This shift is accompanied with stem cell specific promyelocytic leukemia zinc finger protein (PLZF) protein expression and glial cell-derived neurotropic factor (GDNF) pathway activation. Our results demonstrate that gonocytes differently from mature spermatogonia exhibit unique metabolic demands that must be attained to enable their maintenance and growth in vitro.	[Voigt, Anna Laura; Kondro, Douglas Andrew; Powell, Diana; Ungrin, Mark; Klein, Claudia; Dobrinski, Ina] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Valli-Pulaski, Hanna; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA USA; [Stukenborg, Jan-Bernd] Karolinska Inst, Dept Womens & Childrens Hlth, NORDFERTIL Res Lab Stockholm, Childhood Canc Res Unit, Solna, Sweden; [Stukenborg, Jan-Bernd] Karolinska Univ Hosp, Solna, Sweden; [Lewis, Ian A.] Univ Calgary, Fac Sci, Dept Biol Sci, Calgary, AB, Canada	University of Calgary; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Calgary	Dobrinski, I (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Dept Biochem & Mol Biol,Cumming Sch Med, 404 HMRB,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	Idobrins@ucalgary.ca		Dobrinski, Ina/0000-0002-0695-2606; Ungrin, Mark/0000-0002-7410-1491; Valli-Pulaski, Hanna/0000-0001-8092-0066; Voigt, Anna Laura/0000-0003-3970-6011; Stukenborg, Jan-bernd/0000-0002-2839-1870	HHS vertical bar National Institutes of Health (NIH) [OD016575, HD092084]; Barncancerfonden (Swedish Childhood Cancer Foundation) [TJ2020-0026, PR2019-0123]	HHS vertical bar National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barncancerfonden (Swedish Childhood Cancer Foundation)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: OD016575 and HD092084; Barncancerfonden (Swedish Childhood Cancer Foundation), Grant/Award Number: TJ2020-0026,PR2019-0123	Al-Ani A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204269; Barton LJ, 2016, CURR OPIN CELL BIOL, V42, P128, DOI 10.1016/j.ceb.2016.07.007; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Boussouar F, 2014, ANDROLOGY-US, V2, P351, DOI 10.1111/j.2047-2927.2014.00184.x; Brinster RL, 1998, SEMIN CELL DEV BIOL, V9, P401, DOI 10.1006/scdb.1998.0205; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; Butcher L, 1998, BIOL REPROD, V58, P1054, DOI 10.1095/biolreprod58.4.1054; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Lopez KGDC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01373; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; David S, 2020, UROL CLIN N AM, V47, P227, DOI 10.1016/j.ucl.2020.01.001; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eguizabal C, 2016, STEM CELLS, V34, P2418, DOI 10.1002/stem.2422; Fillmore N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120257; Flores A, 2017, NAT CELL BIOL, V19, P1017, DOI 10.1038/ncb3575; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Foster DL, 2015, KNOBIL NEILLS PHYSL, V2, DOI [10.1016/B978-0-12-397175-3.00031-4, DOI 10.1016/B978-0-12-397175-3.00031-4]; Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629; Galetzka D, 2007, MOL REPROD DEV, V74, P233, DOI 10.1002/mrd.20615; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Goossens E, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoaa016; Green DM, 2017, HUM REPROD, V32, P1192, DOI 10.1093/humrep/dex082; Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; Hayashi Y, 2017, P NATL ACAD SCI USA, V114, P8289, DOI 10.1073/pnas.1620915114; Helsel AR, 2017, STEM CELL REP, V8, P1430, DOI 10.1016/j.stemcr.2017.03.004; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Ito K, 2018, EXP HEMATOL, V64, P1, DOI 10.1016/j.exphem.2018.05.005; Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; JUTTE NHPM, 1983, J REPROD FERTIL, V68, P219, DOI 10.1530/jrf.0.0680219; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2016, GENE DEV, V30, P2637, DOI 10.1101/gad.287045.116; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kollin C, 2012, J CLIN ENDOCR METAB, V97, P4588, DOI 10.1210/jc.2012-2325; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KOSCO MS, 1989, J REPROD FERTIL, V87, P1, DOI 10.1530/jrf.0.0870001; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; LEGAC F, 1983, ARCH ANDROLOGY, V10, P149; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Li XL, 2017, ONCOTARGET, V8, P46363, DOI 10.18632/oncotarget.18199; Lord T, 2020, DEV CELL, V52, P399, DOI 10.1016/j.devcel.2020.01.014; Lu V, 2019, EMBO J, V38, DOI 10.15252/embj.2018100615; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Mauduit C, 1999, HUM REPROD UPDATE, V5, P535, DOI 10.1093/humupd/5.5.535; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mikedis MM, 2020, ELIFE, V9, DOI 10.7554/eLife.56523; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morimoto H, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900374; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAMURA M, 1982, J BIOL CHEM, V257, P3945; NAKAMURA M, 1984, AM J PHYSIOL, V247, pE234, DOI 10.1152/ajpendo.1984.247.2.E234; NOVI AM, 1968, Z ZELLFORSCH MIK ANA, V86, P313, DOI 10.1007/BF00332472; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Oliveira PF, 2015, MED RES REV, V35, P126, DOI 10.1002/med.21325; Oliveira PF, 2015, SERTOLI CELL METABOL, P41, DOI [10.1007/978-3-319-19791-3, DOI 10.1007/978-3-319-19791-3]; PANIAGUA R, 1984, J ANAT, V139, P535; PANIAGUA R, 1985, J ANAT, V143, P201; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Picut CA, 2018, BIRTH DEFECTS RES, V110, P190, DOI 10.1002/bdr2.1133; Pietila M, 2012, STEM CELLS DEV, V21, P575, DOI 10.1089/scd.2011.0023; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; Plant TM., 2015, KNOBIL NEILLS PHYSL, P1487, DOI DOI 10.1016/B978-0-12-397175-3.00032-6; Poganitsch-Korhonen M, 2017, LEUKEMIA, V31, P1460, DOI 10.1038/leu.2017.76; Pui HP, 2017, MECH DEVELOP, V144, P125, DOI 10.1016/j.mod.2017.03.002; Puszyk W, 2013, EMBO J, V32, P1941, DOI 10.1038/emboj.2013.118; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Richardson TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006308; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sakib S, 2019, JOVE-J VIS EXP, DOI 10.3791/60387; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Simkins C. L., 1923, Acta Zoologica Stockholm, V4, P241; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Snyder EM, 2010, BIOL REPROD, V83, P783, DOI 10.1095/biolreprod.110.085811; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Stukenborg JB, 2018, HUM REPROD, V33, P1677, DOI 10.1093/humrep/dey240; Sun YC, 2017, ONCOTARGET, V8, P57836, DOI 10.18632/oncotarget.18444; Tang L, 2018, MOL REPROD DEV, V85, P250, DOI 10.1002/mrd.22961; Tischler J, 2019, EMBO J, V38, DOI 10.15252/embj.201899518; TRAN D, 1981, BIOL REPROD, V24, P923, DOI 10.1095/biolreprod24.4.923; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Tsogtbaatar E, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00087; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wang XL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020399; Wang XL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700478; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Zagore LL, 2018, CELL REP, V25, P1225, DOI 10.1016/j.celrep.2018.10.012; Zeng Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040257; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	128	9	10	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21513	10.1096/fj.202002799R	http://dx.doi.org/10.1096/fj.202002799R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811704	Green Accepted			2022-12-26	WOS:000645260100008
J	Tamura, Y; Takata, K; Eguchi, A; Maeda, M; Kataoka, Y				Tamura, Yasuhisa; Takata, Kumi; Eguchi, Asami; Maeda, Mitsuyo; Kataoka, Yosky			Age-related changes in NG2-expressing telocytes of rat stomach	PLOS ONE			English	Article								NG2 immunoreactive cells (NG2 cells) are found in the brain and peripheral tissues including the skin, intestinal tracts, and bladder. In a previous study, we observed the presence of NG2 cells in the stomach using bioluminescence imaging techniques in NG2-firefly luciferase (fLuc) transgenic (Tg) rats. Here, we aimed to identify and characterize NG2 cells in the adult rat stomach. Immunohistochemical studies showed that NG2 cells were mainly present in the lamina propria and most of the cells were gastric telocytes, co-expressing CD34, and platelet-derived growth factor receptor alpha (PDGFR alpha), with a small oval-shaped cell body and extremely long and thin cellular prolongations. In the rat stomach, NG2-expressing telocytes comprised two subpopulations: NG2+/CD34+/PDGFR alpha+ and NG2+/CD34+/PDGFR alpha-. Furthermore, we showed that the expression of NG2 gene in the aged rat stomach decreased relative to that of the young rat stomach and the decline of NG2 expression in aged rats was mainly observed in NG2+/CD34+/PDGFR alpha+ telocytes. These findings suggested age-related alterations in NG2+/CD34+/PDGFR alpha+ telocytes of rat stomach.	[Tamura, Yasuhisa; Takata, Kumi; Eguchi, Asami; Maeda, Mitsuyo; Kataoka, Yosky] RIKEN Ctr Biosyst Dynam Res, Lab Cellular Funct Imaging, Chuo Ku, Kobe, Hyogo, Japan; [Tamura, Yasuhisa; Takata, Kumi; Eguchi, Asami; Maeda, Mitsuyo; Kataoka, Yosky] RIKEN JEOL Collaborat Ctr, Multimodal Microstruct Anal Unit, Chuo Ku, Kobe, Hyogo, Japan	RIKEN; RIKEN	Tamura, Y; Kataoka, Y (corresponding author), RIKEN Ctr Biosyst Dynam Res, Lab Cellular Funct Imaging, Chuo Ku, Kobe, Hyogo, Japan.; Tamura, Y; Kataoka, Y (corresponding author), RIKEN JEOL Collaborat Ctr, Multimodal Microstruct Anal Unit, Chuo Ku, Kobe, Hyogo, Japan.	tamuray@riken.jp; kataokay@riken.jp			Japan Society for the Promotion of Science (JSPS) [16K10232, 20K06883, 18H02724, 17K18774]; AMED [JP17ak0101059]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED	This study was supported by Grant-in-Aid for Scientific Research to YT (KAKENHI: 16K10232 and 20K06883) and to YK (KAKENHI: 18H02724), and Grant-in-Aid for Exploratory Research to YK (KAKENHI: 17K18774) from the Japan Society for the Promotion of Science (JSPS) and AMED (Grant Number JP17ak0101059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030637; Cretoiu Sanda M, 2014, Biomol Concepts, V5, P353, DOI 10.1515/bmc-2014-0029; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Gherghiceanu M, 2010, J CELL MOL MED, V14, P871, DOI 10.1111/j.1582-4934.2010.01060.x; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; HOLLANDER D, 1989, DIGEST DIS SCI, V34, P1692, DOI 10.1007/BF01540046; Jeong JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39848; Kadoya K, 2008, J HISTOCHEM CYTOCHEM, V56, P295, DOI 10.1369/jhc.7A7349.2007; Kim JE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14058-5; Kondo A, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175018; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Marini M, 2017, J CELL MOL MED, V21, P3602, DOI 10.1111/jcmm.13270; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2005, J CELL MOL MED, V9, P714, DOI 10.1111/j.1582-4934.2005.tb00502.x; Popescu LM, 2011, INT J BIOL BIOMED EN, V5, P83; Ramirez M, 2019, ADV EXP MED BIOL, V1122, P73, DOI 10.1007/978-3-030-11093-2_5; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Stallcup WB, 2018, ADV EXP MED BIOL, V1109, P5, DOI 10.1007/978-3-030-02601-1_2; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Tamura Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18763-3; Tamura Y, 2012, J CEREBR BLOOD F MET, V32, P1879, DOI 10.1038/jcbfm.2012.98; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; Vannucchi MG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124478; Vannucchi MG, 2014, J CELL MOL MED, V18, P2000, DOI 10.1111/jcmm.12375; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Xiong J, 2007, BIOCHEM BIOPH RES CO, V361, P960, DOI 10.1016/j.bbrc.2007.07.113; Ye L, 2017, J CELL MOL MED, V21, P2863, DOI 10.1111/jcmm.13199; Zhang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33554; Zhou J, 2014, SCI CHINA LIFE SCI, V57, P241, DOI 10.1007/s11427-013-4602-1; Zhu Guoli, 2021, Cell Regen, V10, P1, DOI 10.1186/s13619-020-00061-5	38	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249729	10.1371/journal.pone.0249729	http://dx.doi.org/10.1371/journal.pone.0249729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822814	gold, Green Published			2022-12-26	WOS:000637879100009
J	Blythe-Mallett, A; Aiken, KA; Segura-Garcia, I; Truelove, NK; Webber, MK; Roye, ME; Box, SJ				Blythe-Mallett, Azra; Aiken, Karl A.; Segura-Garcia, Iris; Truelove, Nathan K.; Webber, Mona K.; Roye, Marcia E.; Box, Stephen J.			Genetic composition of queen conch (Lobatus gigas) population on Pedro Bank, Jamaica and its use in fisheries management	PLOS ONE			English	Article							STROMBUS-GIGAS; SOFTWARE; CONNECTIVITY; PATTERNS; ALLELES; FLOW	The queen conch fishery in Jamaica is sustained by Pedro Bank, which is the main harvesting site located approximately 80 km south-west from Kingston. Due to its relative size, Pedro Bank has been subdivided into zones for management purposes by the Fisheries Division and the Veterinary Services Division. Understanding whether these sub-divisions reflect different sub-populations is critical for managing exploitation levels because fisheries management must demonstrate that harvesting does not endanger the future viability of the population as queen conch are on Appendix II of the Convention in Trade in Endangered Species of Wild Fauna and Flora (CITES). This determination is essential for the continued export to international markets such as the European Union. Two hundred and eight samples were collected across the entire Pedro Bank and were genetically characterized using nine polymorphic microsatellite loci. Population structure analysis for Lobatus gigas from Pedro Bank yielded low but significant values (F-ST = 0.009: p = 0.006) and suggested a high magnitude of gene flow indicative of a fit and viable population throughout the bank. Analysis of molecular variance (AMOVA) indicated a 100% variation within individual samples with little variation (0.9%) between populations. In contrast pairwise genetic comparisons identified significant differences between populations located to the south eastern and eastern region of the bank to those in the central and western locations. Bayesian clustering analysis also indicated the likelihood of two population sub-divisions (K = 2) on Pedro Bank. The results provided evidence of a weak but significant population structure which has crucial implications for the fishing industry as it suggests the use of ecosystem based management (EBM) in setting quotas to promote sustainable harvesting of L. gigas within each monitoring zone on Pedro Bank.	[Blythe-Mallett, Azra; Aiken, Karl A.] Univ West Indies, Dept Life Sci, Kingston, Jamaica; [Segura-Garcia, Iris; Truelove, Nathan K.; Box, Stephen J.] Smithsonian Natl Museum Natl Hist, Smithsonian Marine Stn, Ft Pierce, FL USA; [Webber, Mona K.] Univ West Indies, Ctr Marine Sci, Kingston, Jamaica; [Roye, Marcia E.] Univ West Indies, Biotechnol Ctr, Kingston, Jamaica; [Segura-Garcia, Iris] Harbor Branch Oceanog Inst FAU, Ft Pierce, FL USA; [Truelove, Nathan K.] Monterey Bay Aquarium Res Inst, Sandholdt Rd, Moss Landing, CA USA; [Box, Stephen J.] Rare, Arlington, VA USA	University West Indies Mona Jamaica; Smithsonian Institution; Smithsonian National Museum of Natural History; University West Indies Mona Jamaica; University West Indies Mona Jamaica; Monterey Bay Aquarium Research Institute	Blythe-Mallett, A (corresponding author), Univ West Indies, Dept Life Sci, Kingston, Jamaica.	azziemal@gmail.com		Segura-Garcia, Iris/0000-0003-3688-3557; Blythe-Mallett, Azra/0000-0001-6456-3521				Aiken K, 2006, OCEAN COAST MANAGE, V49, P332, DOI 10.1016/j.ocecoaman.2006.03.004; Aiken KA, 1999, OCEAN COAST MANAGE, V42, P1069, DOI 10.1016/S0964-5691(99)00063-0; Albert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130800; [Anonymous], 2000, OFFICIAL J EUROPEA L, V10, P64; Appeldoorn RS, 1995, STOCK ABUNDANCE POTE; Baldwin EK., 2014, P GULF CARIB FISH I, V67, P12; Berg C.J. Jr, 1989, P421; Blythe A, 1999, CFMC CFRAMP INT CONC; BROWNELL WN, 1981, MAR FISH REV, V43, P1; Bruckner A., 2012, KHALED BIN SULTAN LI, V8; CAMPTON DE, 1992, FISH B-NOAA, V90, P250; Causey DR, 2019, J PROTEOMICS, V192, P114, DOI 10.1016/j.jprot.2018.08.013; CFMC/CFRAMP, 1999, QUEEN CONCH STOCK AS; Chakalall B., 1997, P GULF CARIB FISH I, V49, P531; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CITES, 2016, 17 M C PART JOH S AF; Cochrane KL, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P1, DOI 10.1002/9781444316315; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Curik I, 2014, LIVEST SCI, V166, P26, DOI 10.1016/j.livsci.2014.05.034; Dalvit C, 2009, J ANIM SCI, V87, P3837, DOI 10.2527/jas.2008-1682; Davis M., 2005, MISSISSIPPI STATE U, V7203; Doborjeh MG, 2018, EVOL SYST-GER, V9, P195, DOI 10.1007/s12530-017-9178-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO/WECAFC/COPACO/CFMC, 2012, FAO FISHERIES AQUACU; Gjedrem T., 2014, Agricultural Sciences, V5, P1152, DOI 10.4236/as.2014.512125; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Heino M., 2003, IR03005 IIASA; Heller, 2007, THESIS U LONDON; Jones DB, 2010, CORAL REEFS, V29, P455, DOI 10.1007/s00338-010-0591-8; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kenney J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3337; Kim ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129967; Kitson-Walters KA, 2018, FISH RES, V199, P53, DOI 10.1016/j.fishres.2017.11.010; Mahon R., 1992, 8 CARICOM; Marquez E, 2013, P 56 ANN GULF CAR FI, P410; Meirmans PG, 2020, MOL ECOL RESOUR, V20, P1126, DOI 10.1111/1755-0998.13145; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Morales F., 2004, THESIS FLORIDA I TEC; Morris RA., 2016, PEDRO BANK JAMAICA Q; Morris RA., 2016, THESIS U ICELAND; Munro JL, 1973, ICLARM STUDIES REV, V7, P15; Murray A., 2012, ASSESSMENT 2012 CATC; NOAA, 2014, DAILY J US GOVT FED, P16; NOAA, 2015, QUEEN CONCH STROMB G; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Enriquez R, 2011, REV BIOL TROP, V59, P1115; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Prada M., 2008, NDF WORKSH CAS STUD; Pritchard JK, 2000, GENETICS, V155, P945; RANDALL JOHN E., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P246; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sampson JF, 2015, BOT J LINN SOC, V179, P319, DOI 10.1111/boj.12322; Schill SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144199; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smithen N, 2011, 47 CERMES U W IND; Stoner AW, 2019, REV FISH SCI AQUAC, V27, P51, DOI 10.1080/23308249.2018.1480008; Stoner AW, 2012, B MAR SCI, V88, P89, DOI 10.5343/bms.2011.1044; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; Stoner AW, 1998, J SHELLFISH RES, V17, P955; Szpiech ZA, 2011, THEOR POPUL BIOL, V80, P100, DOI 10.1016/j.tpb.2011.03.006; Tewfik A., 1998, 1997 QUEEN CONCH STR; Tewfik A, 1996, THESIS ACADIA U CANA; Theile S, 2001, QUEEN CONCH FISHERIE; Truelove NK, 2017, DIVERS DISTRIB, V23, P1292, DOI 10.1111/ddi.12626; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villegas-Sanchez CA, 2010, CORAL REEFS, V29, P1023, DOI 10.1007/s00338-010-0643-0; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Webber MK., 1993, THESIS U W INDIES MO; Yamamichi M, 2012, HEREDITY, V108, P362, DOI 10.1038/hdy.2011.83; Zamora-Bustillos R, 2007, MOL ECOL NOTES, V7, P597, DOI 10.1111/j.1471-8286.2007.01687.x	77	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0245703	10.1371/journal.pone.0245703	http://dx.doi.org/10.1371/journal.pone.0245703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819265	Green Submitted, Green Published, gold			2022-12-26	WOS:000637647200007
J	Sanchez-Gonzalez, G; Belak, ZR; Lozano, L; Conde, R				Sanchez-Gonzalez, Gilberto; Belak, Zachery R.; Lozano, Luis; Conde, Renaud			Probability of consolidation constrains novel serotype emergence in dengue fever virus	PLOS ONE			English	Article							AEGYPTI DIPTERA-CULICIDAE	Since their first sequencing 40 years ago, Dengue virus (DENV) genotypes have shown extreme coherence regarding the serotype class they encode. Considering that DENV is a ribonucleic acid (RNA) virus with a high mutation rate, this behavior is intriguing. Here, we explore the effect of various parameters on likelihood of new serotype emergence. In order to determine the time scales of such an event, we used a Timed Markov Transmission Model to explore the influences of sylvatic versus peri-urban transmission, viral mutation rate, and vertical transmission on the probabilities of novel serotype emergence. We found that around 1 000 years are required for a new serotype to emerge, consistent with phylogenetic analysis of extant dengue serotypes. Furthermore, we show that likelihood of establishing chains of mosquito-human-mosquito infection, known as consolidation, is the primary factor which constrains novel serotype emergence. Our work illustrates the restrictions on and provides a mechanistic explanation for the low probability of novel dengue virus serotype emergence and the low number of observed DENV serotypes.	[Sanchez-Gonzalez, Gilberto; Conde, Renaud] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Belak, Zachery R.] ZYUS Life Sci Inc, Saskatoon, SK, Canada; [Lozano, Luis] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico	Conde, R (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	Renaud.Conde@insp.mx		Conde, Renaud/0000-0001-9928-8937				Bazzi M, 2017, J TIME SER ANAL, V38, P458, DOI 10.1111/jtsa.12211; Bergamaschi G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081921; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Burke DS, 1998, EVOL COMPUT, V6, P387, DOI 10.1162/evco.1998.6.4.387; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chen WJ, 2003, INTERVIROLOGY, V46, P289, DOI 10.1159/000073208; Chong LC, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6311-z; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; CHU MC, 1989, J GEN VIROL, V70, P1701, DOI 10.1099/0022-1317-70-7-1701; Chua SK., 2006, SINGAPORE MED J; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; da Silva Voorham JM, 2014, NED TIJDSCHR GENEES; Gaye A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007043; Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG., 2000, LANCET, DOI [10.1016/S0140-6736%2800%2902303-5, DOI 10.1016/S0140-6736%2800%2902303-5]; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hamdy RF, 2015, J PEDIAT INF DIS SOC, V4, P389, DOI 10.1093/jpids/piv056; Hapuarachchi HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22592; Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158; Khan AM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S4; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931; Ly S, 2012, INT J INFECT DIS, V16, pE14, DOI 10.1016/j.ijid.2012.05.037; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259; Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011; Nishiura H, 2008, DENGUE BULL; RODHAIN F, 1991, COMP IMMUNOL MICROB, V14, P9, DOI 10.1016/0147-9571(91)90036-D; Rudnick A, 1978, ASIAN J INFECT DIS; Rudnick A, 1986, I MED RES MALAYS B, P51; Sanchez-Gonzalez G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196047; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760; Tang Y., 2010, AM J TROP MED HYG, DOI [10.4269/ajtmh.2010.10%26%23x2013%3B0052, DOI 10.4269/AJTMH.2010.10%26%23X2013%3B0052]; Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0; Thenmozhi V., 2007, JPN J INFECT DIS, DOI [10.1023/A%3A1013741325877, DOI 10.1023/A%3A1013741325877]; Thomas SJ, 2019, HUM VACC IMMUNOTHER, V15, P2295, DOI 10.1080/21645515.2019.1658503; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821; Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81; Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; Young KI, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2341-z	61	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0248765	10.1371/journal.pone.0248765	http://dx.doi.org/10.1371/journal.pone.0248765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819302	Green Published, gold			2022-12-26	WOS:000637647200038
J	Matthews, CJD; Lawson, JW; Ferguson, SH				Matthews, Cory J. D.; Lawson, Jack W.; Ferguson, Steven H.			Amino acid delta N-15 differences consistent with killer whale ecotypes in the Arctic and Northwest Atlantic	PLOS ONE			English	Article							NITROGEN ISOTOPIC COMPOSITION; TROPHIC ENRICHMENT FACTORS; PRINCE-WILLIAM-SOUND; ORCINUS-ORCA; PREY ABUNDANCE; MINKE WHALES; GRAY WHALES; PACIFIC; PREDATION; DIET	Ecotypes are groups within a species with different ecological adaptations than their conspecifics. Eastern North Pacific (ENP) killer whale (Orcinus orca) ecotypes differ in their diet, behavior, and morphology, but the same is not known for this species in the eastern Canadian Arctic (ECA) and Northwest Atlantic (NWA). Using compound-specific stable isotope analysis (CSIA) of amino acids (AAs), we compared delta N-15 patterns of the primary trophic and source AA pair, glutamic acid/glutamine (Glx) and phenylalanine (Phe), in dentine collagen of (1) sympatric ENP killer whale ecotypes with well-characterized diet differences and (2) ECA/NWA killer whales with unknown diets. delta N-15(Glx-Phe) was significantly higher in the ENP fish-eating (FE) than mammal-eating (ME) ecotype (19.2 +/- 0.4 parts per thousand vs. 13.5 +/- 0.7 parts per thousand, respectively). Similar bimodal variation in delta N-15(Glx-Phe) indicated analogous dietary divisions among ECA/NWA killer whales, with two killer whales having higher delta N-15(Glx-Phe) (16.5 +/- 0.0 parts per thousand) than the others (13.5 +/- 0.6 parts per thousand). Inferences of dietary divisions between these killer whales were supported by parallel differences in threonine delta N-15 (-33.5 +/- 1.6 parts per thousand and -40.4 +/- 1.1 parts per thousand, respectively), given the negative correlation between delta N-15(Thr) and TP across a range of marine consumers. CSIA-AA results for ECA/NWA whales, coupled with differences in tooth wear (a correlate for diet), are consistent with ecotype characteristics reported in ENP and other killer whale populations, thus adding to documented ecological divergence in this species worldwide.	[Matthews, Cory J. D.; Ferguson, Steven H.] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Lawson, Jack W.] Fisheries & Oceans Canada, St John, NF, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada	Matthews, CJD (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	Cory.Matthews@dfo-mpo.gc.ca			Fisheries and Oceans Canada (DFO); Nunavut General Monitoring Plan (NGMP); Nunavut Wildlife Management Board (NWMB); Natural Sciences and Engineering Research Council (NSERC)	Fisheries and Oceans Canada (DFO); Nunavut General Monitoring Plan (NGMP); Nunavut Wildlife Management Board (NWMB); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was received from Fisheries and Oceans Canada (DFO) (S.H.F. and C.J.D.M.), the Nunavut General Monitoring Plan (NGMP) (S.H.F. and C.J.D.M.), the Nunavut Wildlife Management Board (NWMB) (S.H.F. and C.J.D.M.), and the Natural Sciences and Engineering Research Council (NSERC) (S.H.F.).	Barrett-Lennard LG, 2011, MAR ECOL PROG SER, V421, P229, DOI 10.3354/meps08906; Best PB, 2010, AFR J MAR SCI, V32, P171, DOI 10.2989/1814232X.2010.501544; Bigg MA., 1987, KILLER WHALES STUDY, DOI [10.1159/000242703, DOI 10.1159/000242703]; Bolanos-Jimenez J, 2014, MAMMAL REV, V44, P177, DOI 10.1111/mam.12021; Bradley CJ, 2015, LIMNOL OCEANOGR-METH, V13, P476, DOI 10.1002/lom3.10041; Burdin AM., 2004, SC56SM15 IWC; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cronin MA, 2006, WILDLIFE SOC B, V34, P237, DOI 10.2193/0091-7648(2006)34[237:APTERT]2.0.CO;2; Dahlheim ME, 2008, MAR MAMMAL SCI, V24, P719, DOI 10.1111/j.1748-7692.2008.00206.x; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Durban JW, 2017, POLAR BIOL, V40, P231, DOI 10.1007/s00300-016-1942-x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Ferguson Steven H, 2012, Aquat Biosyst, V8, P3, DOI 10.1186/2046-9063-8-3; Filatova OA, 2015, BIOL BULL+, V42, P674, DOI 10.1134/S1062359015070043; Filatova OA, 2019, POLAR BIOL, V42, P931, DOI 10.1007/s00300-019-02484-6; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford JKB, 2005, MAR MAMMAL SCI, V21, P603, DOI 10.1111/j.1748-7692.2005.tb01254.x; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2011, AQUAT BIOL, V11, P213, DOI 10.3354/ab00307; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Fuller BT, 2017, RAPID COMMUN MASS SP, V31, P705, DOI 10.1002/rcm.7835; GAEBLER OH, 1966, CAN J BIOCHEM CELL B, V44, P1249, DOI 10.1139/o66-142; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; GOLEY PD, 1994, CAN J ZOOL, V72, P1528, DOI 10.1139/z94-202; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Guiry EJ, 2020, METHODS ECOL EVOL, V11, P1049, DOI 10.1111/2041-210X.13433; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; HEIDE-JORGENSEN M-P, 1988, Rit Fiskideildar, V11, P115; Higdon JW, 2012, MAR MAMMAL SCI, V28, pE93, DOI 10.1111/j.1748-7692.2011.00489.x; Higdon JW, 2009, ECOL APPL, V19, P1365, DOI 10.1890/07-1941.1; Hirons AC, 2001, OECOLOGIA, V129, P591, DOI 10.1007/s004420100756; Hoen DK, 2014, J EXP MAR BIOL ECOL, V453, P76, DOI 10.1016/j.jembe.2014.01.006; Ivkovich T, 2010, MAMM BIOL, V75, P198, DOI 10.1016/j.mambio.2009.03.006; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Jones IM, 2006, MAR MAMMAL SCI, V22, P198, DOI 10.1111/j.1748-7692.2006.00013.x; Krahn MM, 2007, MAR ENVIRON RES, V63, P91, DOI 10.1016/j.marenvres.2006.07.002; Lawson J., 2007, DFO CAN SCI ADVIS SE; Lawson JW, 2014, J MAR BIOL ASSOC UK, V94, P1253, DOI 10.1017/S0025315413001409; LIEN J, 1988, Rit Fiskideildar, V11, P194; Maniscalco JM, 2007, MAR MAMMAL SCI, V23, P306, DOI 10.1111/j.1748-7692.2007.00103.x; Matthews CJD, 2020, ECOL EVOL, V10, P3450, DOI 10.1002/ece3.6142; Matthews CJD, 2020, MAR MAMMAL SCI, V36, P1010, DOI 10.1111/mms.12674; Matthews CJD, 2014, J MAR BIOL ASSOC UK, V94, P1343, DOI 10.1017/S0025315413001379; Matthews CJD, 2011, POLAR BIOL, V34, P1091, DOI 10.1007/s00300-010-0958-x; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McMahon KW, 2015, LIMNOL OCEANOGR, V60, P1076, DOI 10.1002/lno.10081; McMahon KW, 2015, ECOL EVOL, V5, P1278, DOI 10.1002/ece3.1437; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; MYRICK A C JR, 1988, Rit Fiskideildar, V11, P285; Newsome SD, 2007, MAR ECOL PROG SER, V332, P211, DOI 10.3354/meps332211; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Nielsen JM, 2015, OECOLOGIA, V178, P631, DOI 10.1007/s00442-015-3305-7; Nordoy ES., 1995, FOOD REQUIREMENTS NE, P307; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pauly D., 1997, FISHBASE 97; Pedro S, 2017, SCI TOTAL ENVIRON, V601, P237, DOI 10.1016/j.scitotenv.2017.05.193; Pierce GJ, 2004, J MAR BIOL ASSOC UK, V84, P1241, DOI 10.1017/S0025315404010732h; Pitman RL, 2007, J MAMMAL, V88, P43, DOI 10.1644/06-MAMM-A-118R1.1; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; R Core Team, 2020, R LANG ENV STAT COMP; REEVES R R, 1988, Rit Fiskideildar, V11, P136; Riesch R, 2012, BIOL J LINN SOC, V106, P1, DOI 10.1111/j.1095-8312.2012.01872.x; Samarra FIP, 2017, MAR ECOL PROG SER, V564, P199, DOI 10.3354/meps11998; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; Schell DM, 1998, MAR ECOL PROG SER, V162, P11, DOI 10.3354/meps162011; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SERGEANT DE, 1957, J FISH RES BOARD CAN, V14, P83, DOI 10.1139/f57-003; Styring AK, 2010, GEOCHIM COSMOCHIM AC, V74, P241, DOI 10.1016/j.gca.2009.09.022; Nuche-Pascual MT, 2018, ECOL EVOL, V8, P9192, DOI 10.1002/ece3.4295; Toperoff AK., 2002, THESIS SAN JOSE STAT; Walsh RG, 2014, RAPID COMMUN MASS SP, V28, P96, DOI 10.1002/rcm.6761; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Yarnes CT, 2017, RAPID COMMUN MASS SP, V31, P693, DOI 10.1002/rcm.7832; Ylitalo GM, 2001, SCI TOTAL ENVIRON, V281, P183, DOI 10.1016/S0048-9697(01)00846-4	79	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249641	10.1371/journal.pone.0249641	http://dx.doi.org/10.1371/journal.pone.0249641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798257	gold, Green Published			2022-12-26	WOS:000636737700007
J	Prost, DM; Merenzon, MA; Gomez-Escalante, JI; Primavera, A; Benitez, MV; Gil, AS; Marenco, PM; Califano, MM; Cueto, CM; Dakoff, JMZ; Colonna, M; Mazzon, A; Zaninovich, RS; De Cristofaro, OR				Prost, Diego M.; Merenzon, Martin A.; Gomez-Escalante, Jose, I; Primavera, Andres; Vargas Benitez, Mara; Gil, Andres S.; Marenco, Pablo M.; Califano, Maria M.; Moughty Cueto, Carolina; Zaloff Dakoff, Juan M.; Colonna, Mario; Mazzon, Alejandro; Zaninovich, Roberto S.; De Cristofaro, Oscar R.			Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area	PLOS ONE			English	Article							ARGENTINA; CARE	High-Grade Gliomas (HGG) are the most frequent brain tumor in adults. The gold standard of clinical care recommends beginning chemoradiation within 6 weeks of surgery. Disparities in access to healthcare in Argentina are notorious, often leading to treatment delays. We conducted this retrospective study to evaluate if time to chemoradiation after surgery is correlated with progression-free survival (PFS). Our study included clinical cases with a histological diagnosis of Glioblastoma (GBM), Anaplastic Astrocytoma (AA) or High-Grade Glioma (HGG) in patients over 18 years of age from 2014 to 2020. We collected data on clinical presentation, type of resection, time to surgery, time to chemoradiation, location within the Buenos Aires Metropolitan Area (BAMA) and type of health insurance. We found 63 patients that fit our inclusion criteria, including 26 (41.3%) females and 37 (58.7%) males. Their median age was 54 years old (19-86). Maximal safe resection was achieved in 49.2% (n = 31) of the patients, incomplete resection in 34.9% (n = 22) and the other 15.9% (n = 10) received a biopsy, but no resection. The type of health care insurance was almost evenly divided, with 55.6% (n = 35) of the patients having public vs. 44.4% (n = 28) having private health insurance. Median time to chemoradiation after surgery was 8 (CI 6.68-9.9) weeks for the global population. When we ordered the patients PFS by time to chemoradiation we found that there was a statistically significant effect of time to chemoradiation on patient PFS. Patients had a PFS of 10 months (p = 0.014) (CI 6.89-13.10) when they received chemoradiation <5 weeks vs a PFS of 7 months (CI 4.93-9.06) when they received chemoradiation between 5 to 8 weeks and a PFS of 4 months (CI 3.76-4.26 HR 2.18 p = 0.006) when they received chemoradiation >8 weeks after surgery. Also, our univariate and multivariate analysis found that temporal lobe location (p = 0.03), GMB histology (p = 0.02) and biopsy as surgical intervention (p = 0.02) all had a statistically significant effect on patient PFS. Thus, time to chemoradiation is an important factor in patient PFS. Our data show that although an increase in HGG severity contributes to a decrease in patient PFS, there is also a large effect of time to chemoradiation. Our results suggest that we can improve patient PFS by making access to healthcare in Buenos Aires more equitable by reducing the average time to chemoradiation following tumor resection.	[Prost, Diego M.; De Cristofaro, Oscar R.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Med Oncol Dept, Neurooncol Unit, Buenos Aires, DF, Argentina; [Merenzon, Martin A.; Califano, Maria M.; Moughty Cueto, Carolina; Zaloff Dakoff, Juan M.; Colonna, Mario; Mazzon, Alejandro] Univ Buenos Aires, Inst Oncol Angel H Roffo, Surg Oncol Dept, Neurooncol Unit, Buenos Aires, DF, Argentina; [Gomez-Escalante, Jose, I] Univ Buenos Aires, Inst Oncol Angel H Roffo, Pathol Dept, Buenos Aires, DF, Argentina; [Primavera, Andres] Univ Buenos Aires, Inst Oncol Angel H Roffo, Med Imaging Dept, Buenos Aires, DF, Argentina; [Vargas Benitez, Mara] Ctr Privado Radioterapia, Radiat Oncol, Cordoba, Argentina; [Gil, Andres S.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Radiat Oncol Dept, Buenos Aires, DF, Argentina; [Marenco, Pablo M.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Psicooncol Dept, Buenos Aires, DF, Argentina; [Zaninovich, Roberto S.] Univ Buenos Aires, Hosp Clin Jose de San Martin, Neurosurg Dept, Buenos Aires, DF, Argentina; [De Cristofaro, Oscar R.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Clin Oncol Dept, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Prost, DM (corresponding author), Univ Buenos Aires, Inst Oncol Angel H Roffo, Med Oncol Dept, Neurooncol Unit, Buenos Aires, DF, Argentina.	dieprost@gmail.com		Prost, Diego/0000-0002-4962-8611; Merenzon, Martin/0000-0002-2181-9029				Brat DJ, 2020, ACTA NEUROPATHOL, V139, P603, DOI 10.1007/s00401-020-02127-9; Brat DJ, 2018, ACTA NEUROPATHOL, V136, P805, DOI 10.1007/s00401-018-1913-0; Chang S., 2016, NEURO ONCOL, P1; D'Amico RS, 2017, WORLD NEUROSURG, V103, P538, DOI 10.1016/j.wneu.2017.04.041; Geurts M, 2019, CANCER-AM CANCER SOC, V125, P174, DOI 10.1002/cncr.31834; Hervey-Jumper SL, 2016, J NEURO-ONCOL, V130, P269, DOI 10.1007/s11060-016-2110-4; Instituto Nacional de Estadistica, 2022, ESTIMACIONES PROYECC; Iriart C, 2006, INT J HEALTH SERV, V36, P177, DOI 10.2190/2DYU-E8ME-DG87-4JTH; Irwin C, 2007, J NEURO-ONCOL, V85, P339, DOI 10.1007/s11060-007-9426-z; Machado CV, 2018, CIENC SAUDE COLETIVA, V23, P2197, DOI 10.1590/1413-81232018237.08362018; Nam JY, 2017, J ONCOL PRACT, V13, P629, DOI 10.1200/JOP.2017.025536; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Pontes L, 2017, J GLOB ONCOL, V3, P157, DOI 10.1200/JGO.2016.004911; Rabadan AT., 2017, SURG NEUROL INT, V13, P1417, DOI [10.4103/sni.sni_497_16 28680737, DOI 10.4103/SNI.SNI_497_1628680737]; Rubinstein A, 2018, HEALTH SYST REFORM, V4, P203, DOI 10.1080/23288604.2018.1477537; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sulman EP, 2017, J CLIN ONCOL, V35, P361, DOI 10.1200/JCO.2016.70.7562; Warren KT, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00186; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wen PY, 2017, J CLIN ONCOL, V35, P2439, DOI 10.1200/JCO.2017.72.7511	20	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249486	10.1371/journal.pone.0249486	http://dx.doi.org/10.1371/journal.pone.0249486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798233	gold, Green Published			2022-12-26	WOS:000636737700008
J	Chu, FI; Racette, L				Chu, Fang-, I; Racette, Lyne			Characterizing and quantifying the temporal relationship between structural and functional change in glaucoma	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPY; VISUAL-FIELD PROGRESSION; OPTIC DISC; AUTOMATED PERIMETRY; LAYER THICKNESS; AFRICAN DESCENT; SENSITIVITY; DEFECTS; RETINA; MODEL	Purpose To characterize and quantify the temporal relationship between structural and functional change in glaucoma. Methods 120 eyes of 120 patients with ocular hypertension or primary open-angle glaucoma were selected from the Diagnostic Innovations in Glaucoma Study or the African Descent and Glaucoma Evaluation Study. Patients had 11 visits, separated by at least 3 months over 5 to 10 years. Each visit had rim area (RA) and mean sensitivity (MS) measurements taken within a 30-day period. The structure-function (SF) relationship was summarized using conventional and modified cross-correlation functions (CCFs), which identified the strongest absolute and positive correlation, respectively. Patients were categorized in one of the following three groups: RA and MS evolved simultaneously (lag = 0), RA preceded MS (lag<0), and MS preceded RA (lag>0). Lagging regression analysis was used to examine the variations of the SF relationship within groups. Results The number of participants, mean visit lag, and mean correlation (standard deviation) were, for the conventional and modified CCFs, respectively: lag = 0 [16, 0, 0.53 (0.10) and 16, 0, 0.46 (0.11)]; lag<0 [50, -2.94, 0.51 (0.11) and 55, -3.45, 0.44 (0.12)], and lag>0 [54, 3.35, 0.53 (0.13) and 49, 3.78, 0.45 (0.12)]. A significant difference of the visit lag relation within groups was identified using lagging regression analysis (p<0.0001). Conclusions The strongest relationship between structure and function was obtained at different visit lags in different patients. This finding also suggests that the SF relationship should be addressed at the subject level when using both measurements jointly to model glaucoma progression.	[Chu, Fang-, I; Racette, Lyne] Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA; [Chu, Fang-, I] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Racette, Lyne] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL 35487 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham	Racette, L (corresponding author), Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA.; Racette, L (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL 35487 USA.	lracette@uabmc.edu		Racette, Lyne/0000-0003-4550-124X	NIH [EY025756, R01 EY026574, R01 EY027510, R01 EY11008, R01 EY019869, R01 EY021818, U10 EY14267, P30 EY022589]; Research to Prevent Blindness; National Glaucoma Research, a program of BrightFocus Foundation [G2014096]; EyeSight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, NY	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Glaucoma Research, a program of BrightFocus Foundation(BrightFocus Foundation); EyeSight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, NY	This work was supported in part by NIH grant EY025756 (LR) and by an unrestricted grant from Research to Prevent Blindness. Acknowledgement is made to the donors of the National Glaucoma Research, a program of BrightFocus Foundation, for support of this research (G2014096) (LR). The DIGS and ADAGES studies were supported by NIH grants R01 EY026574, R01 EY027510, R01 EY11008, R01 EY019869, R01 EY021818, U10 EY14267, P30 EY022589; the EyeSight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, NY; unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes PH, 2005, PROG RETIN EYE RES, V24, P333, DOI 10.1016/j.preteyeres.2004.10.002; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Box G. E. P., 2016, TIME SERIES ANAL FOR; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Chauhan BC, 2001, ARCH OPHTHALMOL-CHIC, V119, P1492; Derrick TR, 2004, INNOVATIVE ANAL HUMA; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Fry LE, 2018, PROG RETIN EYE RES, V65, P77, DOI 10.1016/j.preteyeres.2018.04.001; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; Garway-Heath DF, 2002, INVEST OPHTH VIS SCI, V43, P2213; Girkin CA, 2000, ARCH OPHTHALMOL-CHIC, V118, P1231; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; Hot A, 2008, INVEST OPHTH VIS SCI, V49, P3049, DOI 10.1167/iovs.07-1205; Hu RR, 2014, INVEST OPHTH VIS SCI, V55, P8086, DOI 10.1167/iovs.14-14928; Jung KI, 2016, INVEST OPHTH VIS SCI, V57, P420, DOI 10.1167/iovs.15-18256; Kamal DS, 2000, BRIT J OPHTHALMOL, V84, P993, DOI 10.1136/bjo.84.9.993; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Lee JW, 2017, BRIT J OPHTHALMOL, V101, P1052, DOI 10.1136/bjophthalmol-2016-309208; Liebmann, 2005, ESSENTIAL HRT PRIMER; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; McKendrick AM, 2017, OPHTHALMOLOGY, V124, P554, DOI 10.1016/j.ophtha.2016.12.016; Medeiros FA, 2012, ARCH OPHTHALMOL-CHIC, V130, P1107, DOI 10.1001/archophthalmol.2012.827; Medeiros FA, 2012, AM J OPHTHALMOL, V153, P1197, DOI 10.1016/j.ajo.2011.11.015; Mohammadzadeh V, 2020, OPHTHALMOLOGY, V127, P888, DOI 10.1016/j.ophtha.2020.01.023; Nassiri N, 2012, ARCH OPHTHALMOL-CHIC, V130, P826, DOI 10.1001/archophthalmol.2012.1057; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Racette L, 2007, J GLAUCOMA, V16, P676, DOI 10.1097/IJG.0b013e31804d23c2; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; RCore Team, 2020, R LANG ENV STAT COMP; Reus NJ, 2005, INVEST OPHTH VIS SCI, V46, P4182, DOI 10.1167/iovs.04-1029; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Schlottmann PG, 2004, INVEST OPHTH VIS SCI, V45, P1823, DOI 10.1167/iovs.03-0692; Shafi A, 2011, OPTOMETRY VISION SCI, V88, P130, DOI 10.1097/OPX.0b013e3181fa38f4; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P5356, DOI 10.1167/iovs.05-1660; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P2904, DOI 10.1167/iovs.05-1584	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249212	10.1371/journal.pone.0249212	http://dx.doi.org/10.1371/journal.pone.0249212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793602	gold, Green Published			2022-12-26	WOS:000636467000074
J	Lee, YS; Heo, W; Choi, HJ; Cho, HR; Nam, JH; Ki, YG; Lee, HR; Son, WC; Park, YS; Kang, CD; Bae, J				Lee, Young Shin; Heo, Woong; Choi, Ho-Jung; Cho, Hae-Ryung; Nam, Ji Ho; Ki, Yong Gan; Lee, Hong-Rae; Son, Woo-Chang; Park, You-Soo; Kang, Chi-Dug; Bae, Jaeho			An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells	PLOS ONE			English	Article							FRACTIONATED RADIOTHERAPY; PEMBROLIZUMAB; IPILIMUMAB; ANTI-PD-1; SURVIVAL; SAFETY; EXPRESSION; PROGNOSIS; BLOCKADE; PD-L1	Since ionizing radiation has showed the dramatic effect to kill the cancer cells through direct DNA damage as well as triggering anti-cancer immune responses including induction of NKG2D ligands, it has used for long time to treat many cancer patients. However, it has been known that radiotherapy might promote the remnant cancer cells to escape immune system and metastasis. One of the suggested ways of immune evasion is induction of a ligand for programmed death-1 (PD-L1) in head and neck cancer, bladder cancer and lung cancer cells which engages the receptor, programmed death-1 (PD-1) in immune cells. PD-1/PD-L1 axis transduces the inhibitory signal and suppresses the adaptive immunity. However, their role in innate immunity remains poorly understood. Therefore, we investigated whether ionizing radiation could change the expression of PD-L1 in malignant melanoma cells and the receptor, programmed death-1 (PD-1), in NK-92 cells. Surface PD-L1 levels on melanoma cells were increased by ionizing radiation in a dose-independent manner but the level of PD-L1 was not changed significantly in NK-92 cells. Radiation-induced PD-L1 suppressed the activity of the NK-92 cells against melanoma cells despite of upregulation of NKG2D ligands. Furthermore, activated NK cells had high level of PD-1 and could not kill PD-L1+ melanoma cells effectively. When we used PD-L1 inhibitor or silenced PD-L1 gene, inhibited PD-1/PD-L1 axis reversed the activity of the suppressed NK cells. Through these results, we supposed that PD-1/PD-L1 blockade could enhance the immune responses of NK cells against melanoma cells after radiotherapy and might overcome the PD-L1 mediated radioresistance of cancer cells.	[Lee, Young Shin; Heo, Woong; Choi, Ho-Jung; Cho, Hae-Ryung; Kang, Chi-Dug; Bae, Jaeho] Pusan Natl Univ, Sch Med, Dept Biochem, Yangsan, South Korea; [Lee, Young Shin; Heo, Woong; Choi, Ho-Jung; Cho, Hae-Ryung; Kang, Chi-Dug; Bae, Jaeho] Pusan Natl Univ, Sch Med, Dept Mol Cell Biol & Genet, Plus Biomed Sci Educ Ctr, Yangsan, South Korea; [Nam, Ji Ho; Ki, Yong Gan] Pusan Natl Univ, Sch Med, Dept Radiat Oncol, Yangsan, South Korea; [Lee, Hong-Rae; Son, Woo-Chang; Park, You-Soo] Dongnam Inst Radiol & Med Sci, Dept Res Ctr, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Korea Institute of Radiological & Medical Sciences	Bae, J (corresponding author), Pusan Natl Univ, Sch Med, Dept Biochem, Yangsan, South Korea.; Bae, J (corresponding author), Pusan Natl Univ, Sch Med, Dept Mol Cell Biol & Genet, Plus Biomed Sci Educ Ctr, Yangsan, South Korea.	biosole@pusan.ac.kr			Pusan National University Research Grant	Pusan National University Research Grant(Pusan National University)	This work was supported by a Pusan National University Research Grant for 2 years.	Barcellos-Hoff MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005474; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dovedi SJ, 2014, CANCER RES, V74, P5458, DOI 10.1158/0008-5472.CAN-14-1258; Eggermont Alexander M M, 2018, Am Soc Clin Oncol Educ Book, V38, P197, DOI 10.1200/EDBK_201131; Ekinci T, 2014, GINEKOL POL, V85, P121; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0361-7; Grapin M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0634-9; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hayashi H, 2020, INT J CLIN ONCOL, V25, P818, DOI 10.1007/s10147-019-01548-1; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Lee HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09259-1; Liu S Z, 2001, BMC Immunol, V2, P8, DOI 10.1186/1471-2172-2-8; Liu Y, 2017, ONCOGENE, V36, P6143, DOI 10.1038/onc.2017.209; Park SS, 2015, CANCER IMMUNOL RES, V3, P610, DOI 10.1158/2326-6066.CIR-14-0138; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Robert C, 2018, J CLIN ONCOL, V36, P1668, DOI 10.1200/JCO.2017.75.6270; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Schulz Daniela, 2019, Oncotarget, V10, P573, DOI 10.18632/oncotarget.26542; Shen MJ, 2017, ONCOTARGET, V8, P80506, DOI 10.18632/oncotarget.19193; Son CH, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-49; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wu CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19740; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025	29	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248870	10.1371/journal.pone.0248870	http://dx.doi.org/10.1371/journal.pone.0248870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793576	Green Published, gold			2022-12-26	WOS:000636467000059
J	Berger, A; Nsoga, MTN; Perez-Rodriguez, FJ; Aad, YA; Sattonnet-Roche, P; Gayet-Ageron, A; Jaksic, C; Torriani, G; Boehm, E; Kronig, I; Sacks, JA; de Vos, M; Bausch, FJ; Chappuis, F; Renzoni, A; Kaiser, L; Schibler, M; Eckerle, I				Berger, Alice; Nsoga, Marie Therese Ngo; Perez-Rodriguez, Francisco Javier; Aad, Yasmine Abi; Sattonnet-Roche, Pascale; Gayet-Ageron, Angele; Jaksic, Cyril; Torriani, Giulia; Boehm, Erik; Kronig, Ilona; Sacks, Jilian A.; de Vos, Margaretha; Bausch, Frederique Jacquerioz; Chappuis, Francois; Renzoni, Adriana; Kaiser, Laurent; Schibler, Manuel; Eckerle, Isabella			Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers	PLOS ONE			English	Article								Objectives Determine the diagnostic accuracy of two antigen-detecting rapid diagnostic tests (Ag-RDT) for SARS-CoV-2 at the point of care and define individuals' characteristics providing best performance. Methods We performed a prospective, single-center, point of care validation of two Ag-RDT in comparison to RT-PCR on nasopharyngeal swabs. Results Between October 9(th) and 23(rd), 2020, 1064 participants were enrolled. The Panbio(TM) Covid-19 Ag Rapid Test device (Abbott) was validated in 535 participants, with 106 positive Ag-RDT results out of 124 positive RT-PCR individuals, yielding a sensitivity of 85.5% (95% CI: 78.0-91.2). Specificity was 100.0% (95% CI: 99.1-100) in 411 RT-PCR negative individuals. The Standard Q Ag-RDT (SD Biosensor, Roche) was validated in 529 participants, with 170 positive Ag-RDT results out of 191 positive RT-PCR individuals, yielding a sensitivity of 89.0% (95%CI: 83.7-93.1). One false positive result was obtained in 338 RT-PCR negative individuals, yielding a specificity of 99.7% (95%CI: 98.4-100). For individuals presenting with fever 1-5 days post symptom onset, combined Ag-RDT sensitivity was above 95%. Lower sensitivity of 88.2% was seen on the same day of symptom development (day 0). Conclusions We provide an independent validation of two widely available commercial Ag-RDTs, both meeting WHO criteria of >= 80% sensitivity and >= 97% specificity. Although less sensitive than RT-PCR, these assays could be beneficial due to their rapid results, ease of use, and independence from existing laboratory structures. Testing criteria focusing on patients with typical symptoms in their early symptomatic period onset could further increase diagnostic value.	[Berger, Alice; Nsoga, Marie Therese Ngo; Aad, Yasmine Abi; Boehm, Erik; Kronig, Ilona; Kaiser, Laurent; Schibler, Manuel; Eckerle, Isabella] Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland; [Perez-Rodriguez, Francisco Javier; Sattonnet-Roche, Pascale; Kaiser, Laurent; Schibler, Manuel; Eckerle, Isabella] Geneva Univ Hosp, Geneva Ctr Emerging Viral Dis, Geneva, Switzerland; [Gayet-Ageron, Angele; Jaksic, Cyril] Univ Geneva, CRC, Geneva, Switzerland; [Gayet-Ageron, Angele; Jaksic, Cyril] Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; [Gayet-Ageron, Angele; Jaksic, Cyril] Univ Hosp Geneva, Geneva, Switzerland; [Torriani, Giulia] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Sacks, Jilian A.; de Vos, Margaretha] Fdn Innovat New Diagnost, Geneva, Switzerland; [Bausch, Frederique Jacquerioz; Chappuis, Francois] Geneva Univ Hosp, Dept Primary Care, Geneva, Switzerland; [Renzoni, Adriana; Kaiser, Laurent; Schibler, Manuel; Eckerle, Isabella] Geneva Univ Hosp, Lab Virol, Div Lab Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Foundation For Innovative New Diagnostics; University of Geneva; University of Geneva	Eckerle, I (corresponding author), Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland.; Eckerle, I (corresponding author), Geneva Univ Hosp, Geneva Ctr Emerging Viral Dis, Geneva, Switzerland.; Eckerle, I (corresponding author), Geneva Univ Hosp, Lab Virol, Div Lab Med, Geneva, Switzerland.	Isabella.eckerle@hcuge.ch	Jaksic, Cyril/GXI-0084-2022	Jaksic, Cyril/0000-0001-5835-3480; de Vos, Margaretha/0000-0003-3059-2986; Chappuis, Francois/0000-0003-0442-7610; Perez Rodriguez, FRANCISCO JAVIER/0000-0003-0380-9625; Gayet-Ageron, Angele/0000-0002-6164-9693; Renzoni, Adriana/0000-0002-4897-5208; Eckerle, Isabella/0000-0002-4850-7172; Kaiser, Laurent/0000-0002-0857-2252	Foundation for Innovative New Diagnostics; Fondation privee des HUG; Pictet Charitable Foundation; Swiss confederation; humanitarian commission of the university hospitals of Geneva	Foundation for Innovative New Diagnostics; Fondation privee des HUG; Pictet Charitable Foundation; Swiss confederation; humanitarian commission of the university hospitals of Geneva	The study was supported by the Foundation for Innovative New Diagnostics (https://www.finddx.org/), the Fondation privee des HUG (https://www.fondationhug.org/) and Pictet Charitable Foundation (https://www.group.pictet/responsible-vision/pictet-group-foundation).M.T.Ngo Nsoga is a beneficiary of the excellence grant from the Swiss confederation (https://www.sbfi.admin.ch/sbfi/en/home/education/scholarshipsand-grants/swiss-government-excellence-scholarships.html) and the grant from the humanitarian commission of the university hospitals of Geneva (https://www.hug.ch/en/external-affairs-directorate).The Foundation for Innovative New Diagnostics provided rapid tests and elements of the study protocol. The funders had no other roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.004; Alemany A, 2021, J INFECTION, V82, P188, DOI 10.1016/j.jinf.2020.12.033; B.Wilder, 2020, medRxiv, DOI 10.1101/2020.06.22.20136309; Baggio S, 2021, CLIN INFECT DIS, V73, P148, DOI 10.1093/cid/ciaa1157; Broberg EK., 2020, 20195917 MEDRXIV; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; Cerutti F, 2020, J CLIN VIROL, V132, DOI 10.1016/j.jcv.2020.104654; Chaimayo C, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01452-5; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fenollar F, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02589-20; FIND. FIND Evaluation of SD Biosensor Inc, 2020, STANDARD TM Q COVID; Gremmels H, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100677; Guglielmi G, 2020, NATURE, V583, P506, DOI 10.1038/d41586-020-02140-8; Gupta A, 2021, INDIAN J MED RES, V153, P126, DOI 10.4103/ijmr.IJMR_3305_20; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Kampen JJAvan., 2020, 20125310 MEDRXIV; Krueger LJ., 2020, 20203836 MEDRXIV; L'Huillier AG, 2020, EMERG INFECT DIS, V26, P2494, DOI 10.3201/eid2610.202403; Lambert-Niclot S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00977-20; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Linares M, 2020, J CLIN VIROL, V133, DOI 10.1016/j.jcv.2020.104659; Masia M, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab059; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Nalumansi A, 2021, INT J INFECT DIS, V104, P282, DOI 10.1016/j.ijid.2020.10.073; Vetter P, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00827-20; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Zajac M., 2020, SENSITIVITY SARS COV, DOI DOI 10.1101/2020.11.23.20237198]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	30	55	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248921	10.1371/journal.pone.0248921	http://dx.doi.org/10.1371/journal.pone.0248921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788882	Green Published, Green Submitted, gold			2022-12-26	WOS:000636354600020
J	Sheng, G; Yuan, HY; Jin, L; Ranjit, S; Panov, J; Lu, X; Levi, M; Glazer, RI				Sheng, Gao; Yuan, Hongyan; Jin, Lu; Ranjit, Suman; Panov, Julia; Lu, Xun; Levi, Moshe; Glazer, Robert I.			Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist	PLOS ONE			English	Article							FLUORESCENCE LIFETIME; 2ND-HARMONIC GENERATION; PHASOR APPROACH; CANCER; DIFFERENTIATION; INFLAMMATION; FIBROBLASTS; EXPRESSION; REGULATORS; LANDSCAPE	One of the central challenges for cancer therapy is the identification of factors in the tumor microenvironment that increase tumor progression and prevent immune surveillance. One such element associated with breast cancer is stromal fibrosis, a histopathologic criterion for invasive cancer and poor survival. Fibrosis is caused by inflammatory factors and remodeling of the extracellular matrix that elicit an immune tolerant microenvironment. To address the role of fibrosis in tumorigenesis, we developed NeuT/ATTAC transgenic mice expressing a constitutively active NeuT/erbB2 transgene, and an inducible, fat-directed caspase-8 fusion protein, which upon activation results in selective and partial ablation of mammary fat and its replacement with fibrotic tissue. Induction of fibrosis in NeuT/ATTAC mice led to more rapid tumor development and an inflammatory and fibrotic stromal environment. In an effort to explore therapeutic options that could reduce fibrosis and immune tolerance, mice were treated with the oxysterol liver X receptor (LXR) pan agonist, N,N-dimethyl-3-beta-hydroxy-cholenamide (DMHCA), an agent known to reduce fibrosis in non-malignant diseases. DMHCA reduced tumor progression, tumor multiplicity and fibrosis, and improved immune surveillance by reducing infiltrating myeloid-derived suppressor cells and increasing CD4 and CD8 effector T cells. These effects were associated with downregulation of an LXR-dependent gene network related to reduced breast cancer survival that included Spp1, S100a9, Anxa1, Mfge8 and Cd14. These findings suggest that the use of DMHCA may be a potentially effective approach to reduce desmoplasia and immune tolerance and increase the efficacy of cancer therapy.	[Sheng, Gao; Yuan, Hongyan; Jin, Lu; Glazer, Robert I.] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA; [Sheng, Gao; Yuan, Hongyan; Jin, Lu; Glazer, Robert I.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Sheng, Gao] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Womens Hosp, Dept Breast, Nanjing, Peoples R China; [Ranjit, Suman; Levi, Moshe] Georgetown Univ, Dept Biochem & Mol Biol, Washington, DC USA; [Panov, Julia] Univ Haifa, Fac Nat Sci, Haifa, Israel; [Lu, Xun] George Washington Univ, Washington, DC USA	Georgetown University; Georgetown University; Nanjing Medical University; Georgetown University; University of Haifa; George Washington University	Glazer, RI (corresponding author), Georgetown Univ, Dept Oncol, Washington, DC 20057 USA.; Glazer, RI (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	glazerr@georgetown.edu		Panov, Julia/0000-0003-2392-4073; Glazer, Robert/0000-0001-6936-2980; Ranjit, Suman/0000-0003-3058-6332	Sher Award from the Lombardi Comprehensive Cancer Center from the National Cancer Institute, NIH [1P30CA051008]; NIH [R01 HL133545, R01 DK116567]	Sher Award from the Lombardi Comprehensive Cancer Center from the National Cancer Institute, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Sher Award from the Lombardi Comprehensive Cancer Center, 1P30CA051008 from the National Cancer Institute, NIH, to the Lombardi Comprehensive Cancer Center, and R01 HL133545 and R01 DK116567 from the NIH to M.L.	Alshetaiwi H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay6017; Astudillo AM, 2012, BBA-MOL CELL BIOL L, V1821, P249, DOI 10.1016/j.bbalip.2011.11.006; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Beyer C, 2015, ANN RHEUM DIS, V74, P1317, DOI 10.1136/annrheumdis-2013-204401; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cannon MV, 2015, EUR J HEART FAIL, V17, P273, DOI 10.1002/ejhf.243; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Cirri P, 2011, AM J CANCER RES, V1, P482; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crosignani V, 2014, MICROSC RES TECHNIQ, V77, P368, DOI 10.1002/jemt.22354; Datta R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09848; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dvornikov A, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2020053; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gailhouste L, 2010, J HEPATOL, V52, P398, DOI 10.1016/j.jhep.2009.12.009; Gaviola E, 1926, Z PHYS, V35, P748, DOI 10.1007/BF01386042; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gotwals P, 2017, NAT REV CANCER, V17, P286, DOI 10.1038/nrc.2017.17; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo YC, 1999, P NATL ACAD SCI USA, V96, P10854, DOI 10.1073/pnas.96.19.10854; Guy CT, 1996, J BIOL CHEM, V271, P7673, DOI 10.1074/jbc.271.13.7673; Hamilton JP, 2016, HEPATOLOGY, V63, P1828, DOI 10.1002/hep.28406; Hammer SS, 2017, EBIOMEDICINE, V22, P181, DOI 10.1016/j.ebiom.2017.07.008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lin CY, 2015, NAT REV CANCER, V15, P216, DOI 10.1038/nrc3912; Lv DD, 2013, CELL MOL IMMUNOL, V10, P303, DOI 10.1038/cmi.2012.69; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ortiz-Martinez F, 2014, HUM PATHOL, V45, P504, DOI 10.1016/j.humpath.2013.10.015; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Patel M, 2014, DIABETOLOGIA, V57, P435, DOI 10.1007/s00125-013-3095-6; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ranjit S, 2019, J PHYS CHEM A, V123, P9865, DOI 10.1021/acs.jpca.9b07880; Ranjit S, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0026-5; Ranjit S, 2017, BIOMED OPT EXPRESS, V8, P3143, DOI 10.1364/BOE.8.003143; Ranjit S, 2016, KIDNEY INT, V90, P1123, DOI 10.1016/j.kint.2016.06.030; Ranjit S, 2016, BIOMED OPT EXPRESS, V7, P3519, DOI 10.1364/BOE.7.003519; Ranjit S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13378; Roh JS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e27; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Saresella M, 2008, FASEB J, V22, P3500, DOI 10.1096/fj.08-110650; Shi Y, 2016, INT IMMUNOPHARMACOL, V41, P116, DOI 10.1016/j.intimp.2016.10.016; Spencer TA, 2001, J MED CHEM, V44, P886, DOI 10.1021/jm0004749; Stringari C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048014; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Tomic S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00475; Nguyen-Vu T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3443; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; van den Broek T, 2018, NAT REV IMMUNOL, V18, P363, DOI 10.1038/s41577-018-0001-y; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Wang XXX, 2018, J AM SOC NEPHROL, V29, P118, DOI 10.1681/ASN.2017020222; Wigler N, 2002, ISRAEL MED ASSOC J, V4, P940; Yuan Hongyan, 2018, Oncotarget, V9, P8042, DOI 10.18632/oncotarget.24233; Yuan HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24022-w; Yuan HY, 2013, CANCER RES, V73, P4349, DOI 10.1158/0008-5472.CAN-13-0322; Zhang Y, 2013, CELL RES, V23, P394, DOI 10.1038/cr.2012.178	75	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248996	10.1371/journal.pone.0248996	http://dx.doi.org/10.1371/journal.pone.0248996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780491	gold, Green Published			2022-12-26	WOS:000636336800003
J	Prang, P; Schuld, C; Rupp, R; Hensel, C; Weidner, N				Prang, Peter; Schuld, Christian; Rupp, Ruediger; Hensel, Cornelia; Weidner, Norbert			Influence of patient isolation due to colonization with multidrug-resistant organisms on functional recovery after spinal cord injury	PLOS ONE			English	Article								Study design Chart reviews were combined with neurological and functional outcome data obtained from the prospective European Multicenter Study on Spinal Cord Injury (EMSCI, www.emsci.org). Objectives To determine if strict physical isolation of multidrug-resistant organisms (MDRO)-positive patients negatively affects neurological recovery and functional outcome in the first year after acute spinal cord injury (SCI). Setting SCI Center Heidelberg University Hospital. Methods Individuals with acute (< 6 weeks) traumatic or ischemic SCI were included. During primary comprehensive care, isolated MDRO-positive patients (n = 13) were compared with a MDRO-negative control group (n = 13) matched for functional (Spinal Cord Independence Measure-SCIM) and neurological impairment (motor scores based on the International Standards for Neurological Classification of Spinal Cord Injury-ISNCSCI) at an early stage up to 40 days after SCI. SCIM scores and motor scores were obtained at 12 weeks (intermediate stage) and 24 or 48 weeks (late stage) after SCI. Results Isolated MDRO-positive (median duration of hospitalization: 175 days, 39% of inpatient stay under isolation measures) and non-isolated MDRO-negative (median duration of hospitalization: 161 days) patients showed functional and neurological improvements, which were not statistically different between groups at the intermediate and late stage. Conclusion Prolonged isolation due to MDRO colonization for over a third of the inpatient comprehensive care period does not appear to impair neurological recovery and functional outcome within the first year after SCI.	[Prang, Peter; Schuld, Christian; Rupp, Ruediger; Hensel, Cornelia; Weidner, Norbert] Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Weidner, N (corresponding author), Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany.	Norbert.weidner@med.uni-heidelberg.de						Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Balbale SN, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0318-x; Catalano G, 2003, SOUTH MED J, V96, P141, DOI 10.1097/01.SMJ.0000050683.36014.2E; Catz A, 2001, DISABIL REHABIL, V23, P263; Catz A, 2007, J REHABIL RES DEV, V44, P65, DOI 10.1682/JRRD.2005.07.0123; Chittick P, 2016, AM J INFECT CONTROL, V44, P657, DOI 10.1016/j.ajic.2015.12.033; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Evans ME, 2013, AM J INFECT CONTROL, V41, P422, DOI 10.1016/j.ajic.2012.06.006; Fitzpatrick MA, 2016, INFECT CONT HOSP EP, V37, P768, DOI 10.1017/ice.2016.60; Franz M, 2018, SPINAL CORD, V56, P158, DOI 10.1038/s41393-017-0007-5; Gasink LB, 2008, INFECT CONT HOSP EP, V29, P275, DOI 10.1086/527508; Hassouna H, 2008, ACTA ORTHOP BELG, V74, P528; Hogardt M, 2015, EUROSURVEILLANCE, V20, P23, DOI 10.2807/1560-7917.ES2015.20.26.21171; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Jakob W, 2009, J NEUROTRAUM, V26, P2037, DOI 10.1089/neu.2008.0824; Karam G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1320-7; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P535, DOI 10.1179/204577211X13207446293695; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO), 2014, BUNDESGESUNDHEITSBLA, V57, P695, DOI [10.1007/s00103-014-1980-x, DOI 10.1007/s00103-014-1980-x, DOI 10.1007/S00103-014-1980-X]; Manian FA, 2002, INFECT CONT HOSP EP, V23, P516, DOI 10.1086/502099; Maurer-Burkhard B, 2016, SPINAL CORD, V54, P619, DOI 10.1038/sc.2015.223; Minary-Dohen Patrica, 2003, BMC Geriatr, V3, P5, DOI 10.1186/1471-2318-3-5; Mylotte JM, 2000, AM J INFECT CONTROL, V28, P291, DOI 10.1067/mic.2000.107424; Nair R, 2020, CLIN MICROBIOL INFEC, V26, P684, DOI 10.1016/j.cmi.2020.01.022; Pike JH, 2002, ARCH PHYS MED REHAB, V83, P1028, DOI 10.1053/apmr.2002.33108; Rollnik JD, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0833-2; Rollnik JD, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-34; Schuld C, 2013, SPINAL CORD, V51, P282, DOI 10.1038/sc.2012.149; Schuld C, 2012, J NEUROTRAUM, V29, P453, DOI 10.1089/neu.2011.2085; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Torres K, 2013, AM J INFECT CONTROL, V41, P1043, DOI 10.1016/j.ajic.2013.02.013; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; van Langeveld SA, 2009, ARCH PHYS MED REHAB, V90, P1229, DOI 10.1016/j.apmr.2008.12.026; Wirz M, 2015, J NEUROTRAUM, V32, P194, DOI 10.1089/neu.2014.3335	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249295	10.1371/journal.pone.0249295	http://dx.doi.org/10.1371/journal.pone.0249295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770131	Green Published, Green Accepted, gold			2022-12-26	WOS:000634833500035
J	Takazaki, KAG; Quinaglia, T; Venancio, TD; Martinez, ARM; Shah, RV; Neilan, TG; Jerosch-Herold, M; Coelho, OR; Franca, MC				Takazaki, Karen A. G.; Quinaglia, Thiago; Venancio, Thiago D.; Martinez, Alberto R. M.; Shah, Ravi V.; Neilan, Tomas G.; Jerosch-Herold, Michael; Coelho-Filho, Otavio R.; Franca, Marcondes C., Jr.			Pre-clinical left ventricular myocardial remodeling in patients with Friedreich's ataxia: A cardiac MRI study	PLOS ONE			English	Article							MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME; CARDIOMYOPATHY; PROGRESSION; FIBROSIS; FRACTION; THERAPY; IRON; T1	Background Heart Failure (HF) is the most common cause of death in Friedreich's ataxia (FRDA), an inherited mitochondrial disease. Myocardial fibrosis and myocardial hypertrophy are well-documented autopsy features among FRDA patients with HF. Objectives To leverage the unique tissue characterization features of cardiac magnetic resonance (CMR) for characterizing myocardial remodeling in patients with genetically confirmed FRDA without HF and preserved left ventricular ejection fraction (LVEF > 55%). Methods Twenty-seven FRDA's patients (age 27.6 9.7 years, 15 women) and 10 healthy controls (32.67.3 years, 5 women) underwent a CMR for assessment of LV function, myocardial T1, late gadolinium enhancement (LGE), extracellular volume fraction (ECV), and intracellular water-lifetime (tau(ic)), a marker of cardiomyocyte size. Results As compared to controls, FRDA patients had a preserved LVEF (LVEF: 70.5 +/- 7.4% vs. 63.9 +/- 9.0%, P<0.058), larger LV mass index (LVMASSi: 61 +/- 21.7 vs. 45 +/- 4.2g/m(2), P<0.02), and decreased LV end-diastolic volume index (LVEDVi 53.1 +/- 12.0 vs. 75.7 +/- 16.1ml/m(2), P<0.001), compared with controls. Additionally, ECV and cardiomyocyte size (tau(ic),) were larger in FRDA patients (ECV: 0.36 +/- 0.05 vs. 0.25 +/- 0.02, P<0.001; tau(ic): 0.15 +/- 0.08 vs. 0.06 +/- 0.03 s, P = 0.02). ECV and tau(ic) were positively associated with LV mass-to-volume ratio (ECV: r = 0.57, P = 0.003; tau(ic): r = 0.39; P = 0.05). LVMASSi and cardiomyocyte mass-index [(1-ECV).LVMASSi] declined with age at the CMR exam, independent of the age at initial diagnosis. Conclusions LV hypertrophy and concentric LV remodeling in FRDA are associated at the tissue level with an expansion of the ECV and an increase in cardiomyocyte size. The adverse tissue remodeling assessed by ECV and tau(ic) is associated with more severe cardiomyopathy classification, suggesting a role for these markers in tracking disease progression.	[Takazaki, Karen A. G.; Venancio, Thiago D.; Martinez, Alberto R. M.; Franca, Marcondes C., Jr.] Univ Campinas UNICAMP, Sch Med Sci, Dept Neurol, Div Med,Sect Neurol, Campinas, SP, Brazil; [Quinaglia, Thiago; Coelho-Filho, Otavio R.] Univ Campinas UNICAMP, Sch Med Sci, Dept Internal Med, Div Med,Sect Cardiol,Div Med, Campinas, SP, Brazil; [Shah, Ravi V.; Neilan, Tomas G.] Harvard Med Sch, Massachusetts Gen Hosp, Sect Cardiovasc Imaging Res Program, Div Med, Boston, MA 02115 USA; [Shah, Ravi V.; Neilan, Tomas G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Cardiol, Cardiac MR PET CT Program, Boston, MA 02115 USA; [Jerosch-Herold, Michael] Brigham & Womens Hosp, Dept Radiol, Div Med, Sect MRI Phys, 75 Francis St, Boston, MA 02115 USA; [Jerosch-Herold, Michael] Harvard Med Sch, Boston, MA 02115 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Coelho, OR (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Internal Med, Div Med,Sect Cardiol,Div Med, Campinas, SP, Brazil.	orcfilho@unicamp.br	Coelho-Filho, Otavio/AAV-9557-2021	Coelho-Filho, Otavio/0000-0003-4428-5186; Takazaki, Karen Antonia Girotto/0000-0001-6828-3156	National Council for Scientific and Technological Development (CNPq) [303366/2015-0]; Sao Paulo Research Foundation (FAPESP) [2015/15402-2, 2016/26209-1, 2017/03708-5, 2013/01766-7]; National Institutes of Health/National Heart, Lung, and Blood Institute [1R01HL130539-01A1, 1R01HL137562-01A1, K24HL113128-06]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Council for Scientific and Technological Development (CNPq) in the form of a grant in research productivity awarded to ORCF (303366/2015-0), the Sao Paulo Research Foundation (FAPESP) in the form of grants awarded to ORCF (2015/15402-2, 2016/26209-1, 2017/03708-5) and MCF (2013/01766-7), National Institutes of Health/National Heart, Lung, and Blood Institute in the form of grants awarded to TGN (1R01HL130539-01A1, 1R01HL137562-01A1, K24HL113128-06).	Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Casazza F, 1990, Cardiologia, V35, P423; Coelho OR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000790; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; Coelho OR, 2018, INT J CARDIOVAS IMAG, V34, P15, DOI 10.1007/s10554-016-0937-6; de Souza TF, 2018, JACC-CARDIOVASC IMAG, V11, P1044, DOI 10.1016/j.jcmg.2018.05.012; Dedobbeleer C, 2012, EUR HEART J-CARD IMG, V13, P346, DOI 10.1093/ejechocard/jer267; Dolgin M, 1994, NOMENCLATURE CRITERI; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Koeppen AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116396; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kruger PC, 2016, AM J CARDIOL, V118, P127, DOI 10.1016/j.amjcard.2016.04.024; Landis CS, 1999, MAGNET RESON MED, V42, P467, DOI 10.1002/(SICI)1522-2594(199909)42:3<467::AID-MRM9>3.0.CO;2-0; McCormick A, 2017, ANN CLIN TRANSL NEUR, V4, P622, DOI 10.1002/acn3.439; Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8; Meyer C, 2007, MOVEMENT DISORD, V22, P1615, DOI 10.1002/mds.21590; Miettinen TP, 2017, TRENDS CELL BIOL, V27, P393, DOI 10.1016/j.tcb.2017.02.006; Neilan TG, 2013, JACC-CARDIOVASC IMAG, V6, P672, DOI 10.1016/j.jcmg.2012.09.020; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Reetz K, 2017, LANCET NEUROL, V16, P954, DOI 10.1016/S1474-4422(16)30287-3; Regner SR, 2012, AM J CARDIOL, V109, P401, DOI 10.1016/j.amjcard.2011.09.025; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Seyer L, 2015, ACTA NEUROL SCAND, V132, P7, DOI 10.1111/ane.12337; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Subramony SH, 2005, NEUROLOGY, V64, P1261, DOI 10.1212/01.WNL.0000156802.15466.79; Sutton MS, 2014, ECHOCARDIOGR-J CARD, V31, P50, DOI 10.1111/echo.12287; Todiere G, 2012, J AM COLL CARDIOL, V60, P922, DOI 10.1016/j.jacc.2012.03.076; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Weidemann F, 2013, J NEUROCHEM, V126, P88, DOI 10.1111/jnc.12217; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0246633	10.1371/journal.pone.0246633	http://dx.doi.org/10.1371/journal.pone.0246633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770103	gold, Green Published			2022-12-26	WOS:000634833500037
J	Wu, J; Zhang, Y; Lv, ZM; Yu, P; Shi, WQ				Wu, Jun; Zhang, Ying; Lv, Zhongming; Yu, Ping; Shi, Weiqing			Safety evaluation of Aloe vera soft capsule in acute, subacute toxicity and genotoxicity study	PLOS ONE			English	Article							VAR. NATALENSIS BERGER; XYLO-OLIGOSACCHARIDES; LIVER-INJURY; ANTIOXIDANT; MEDICINES; APOPTOSIS; RATS; FOOD	Aloe vera has been widely used in health and nutritional supplements in Chinese herbal medicine. Furthermore, Aloe vera production has been an emerging industry for making cosmetics and functional food. However, the reported adverse effects raised questions as to whether Aloe vera and its products were safe enough to be used in medicine and health care. In view of this, the safety evaluation of Aloe vera products before marketing is very important. The present study aimed to assess the toxicological profile of Aloe vera soft capsule (ASC), through acute, subacute toxicity and genotoxicity tests. Male and female ICR mice were received by oral gavage 15000 mg/kg bodyweight of ASC in the acute toxicity test. Male and female SD rats were fed on diet blended with different doses of ASC (equivalent to 832.5, 1665 and 3330 mg/kg bodyweight of ASC) for the subacute toxicity test. In the acute toxicity study, no mortality or behavioral changes were observed, indicating the LD50 was higher than 15000 mg/kg bodyweight. In the subacute toxicity test, no significant changes were observed in bodyweight, food consumption, hematological, biochemical or histopathological parameters in the rats exposed. These data suggested that ASC used in this study did not produce any marked subacute toxic effects up to a maximum concentration of 3330 mg/kg bodyweight. In the genotoxicity study, ASC showed no mutagenic activity in the Ames test and no evidence of potential to induce bone marrow micronucleus or testicular chromosome aberrations in ICR mice exposed to 10000 mg/kg bodyweight. Collectively, ASC could be considered safe before it was marketed as a laxative and moistening health food.	[Wu, Jun; Zhang, Ying; Lv, Zhongming; Yu, Ping; Shi, Weiqing] Jiangsu Prov Ctr Dis Control & Prevent, Inst Toxicol & Risk Assessment, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Wu, J (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Inst Toxicol & Risk Assessment, Nanjing, Jiangsu, Peoples R China.	wujun@jscdc.cn						Abbaszadegan A, 2016, J INVESTIG CLIN DENT, V7, P93, DOI 10.1111/jicd.12123; Budai MM, 2013, MOL IMMUNOL, V56, P471, DOI 10.1016/j.molimm.2013.05.005; Carvalho NC, 2018, J PHOTOCH PHOTOBIO B, V178, P348, DOI 10.1016/j.jphotobiol.2017.11.027; Chen T, 2017, INT J EXP PATHOL, V98, P248, DOI 10.1111/iep.12242; Cholongitas Evangelos, 2005, Eur J Intern Med, V16, P59, DOI 10.1016/j.ejim.2004.07.014; Christakopoulos P, 2003, INT J BIOL MACROMOL, V31, P171, DOI 10.1016/S0141-8130(02)00079-X; Cirillo C, 2015, PHYTOTHER RES, V29, P1488, DOI 10.1002/ptr.5410; Cui Y, 2014, ARCH PHARM RES, V37, P1624, DOI 10.1007/s12272-014-0370-0; Dat AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008762.pub2; Dong XX, 2017, CELL PHYSIOL BIOCHEM, V42, P685, DOI 10.1159/000477886; Dong XX, 2017, PHYTOTHER RES, V31, P927, DOI 10.1002/ptr.5820; Eshun K, 2004, CRIT REV FOOD SCI, V44, P91, DOI 10.1080/10408690490424694; GROOM QJ, 1987, PLANTA MED, P345, DOI 10.1055/s-2006-962735; Harlev E, 2012, PLANTA MED, V78, P843, DOI 10.1055/s-0031-1298453; IARC, 2015, SOM DRUGS HERB PROD, V108; Kim JH, 2017, J ENZYM INHIB MED CH, V32, P78, DOI 10.1080/14756366.2016.1235568; Klaikeaw N, 2020, WORLD J HEPATOL, V12, P363, DOI 10.4254/wjh.v12.i7.363; Luo X, 2018, MOLECULES, V23, DOI 10.3390/molecules23030517; Matsuda Y, 2008, FOOD CHEM TOXICOL, V46, P733, DOI 10.1016/j.fct.2007.09.107; Middleberg Robert A, 2012, Methods Mol Biol, V902, P157, DOI 10.1007/978-1-61779-934-1_14; Mueller SO, 1999, BBA-GEN SUBJECTS, V1428, P406, DOI 10.1016/S0304-4165(99)00064-1; Nabarlatz D, 2007, CARBOHYD RES, V342, P1122, DOI 10.1016/j.carres.2007.02.017; Parian A, 2016, CURR PHARM DESIGN, V22, P180, DOI 10.2174/1381612822666151112145033; Posadzki P, 2013, CLIN MED, V13, P7, DOI 10.7861/clinmedicine.13-1-7; Radha Maharjan H, 2015, J Tradit Complement Med, V5, P21, DOI 10.1016/j.jtcme.2014.10.006; Rahman S, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8010006; Salehi B, 2018, INT J MOL SCI, V19, DOI [10.3390/ijms19092843, 10]; Tanaka M, 2012, J FOOD SCI, V77, pT2, DOI 10.1111/j.1750-3841.2011.02452.x; Vijayalakshmi D, 2012, J ETHNOPHARMACOL, V141, P542, DOI 10.1016/j.jep.2012.02.040; Viljoen AM, 2001, BIOCHEM SYST ECOL, V29, P53, DOI 10.1016/S0305-1978(00)00024-7; Werawatganon D, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-229; Williams LD, 2010, REGUL TOXICOL PHARM, V57, P90, DOI 10.1016/j.yrtph.2010.01.002; Yokohira M, 2009, J FOOD SCI, V74, pT24, DOI 10.1111/j.1750-3841.2009.01070.x; Zhang J, 2018, BIORESOURCE TECHNOL, V249, P342, DOI 10.1016/j.biortech.2017.09.203	34	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249356	10.1371/journal.pone.0249356	http://dx.doi.org/10.1371/journal.pone.0249356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770149	gold, Green Published			2022-12-26	WOS:000634833500053
J	Li, SZ; Jiang, LQ; Beckmann, K; Hojen, JF; Pessara, U; Powers, NE; De Graaf, DM; Azam, T; Lindenberger, J; Eisenmesser, EZ; Fischer, S; Dinarello, CA				Li, Suzhao; Jiang, Liqiong; Beckmann, Karsten; Hojen, Jesper Falkesgaard; Pessara, Ulrich; Powers, Nicholas E.; de Graaf, Dennis M.; Azam, Tania; Lindenberger, Jared; Eisenmesser, Elan Z.; Fischer, Stephan; Dinarello, Charles A.			A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; BLOOD MONONUCLEAR-CELLS; GAMMA-INDUCING FACTOR; NECROSIS-FACTOR-ALPHA; CYTOKINES IN-VITRO; CANDIDA-ALBICANS; INTERFERON-GAMMA; BINDING-PROTEIN; TNF-ALPHA	Unchecked inflammation can result in severe diseases with high mortality, such as macrophage activation syndrome (MAS). MAS and associated cytokine storms have been observed in COVID-19 patients exhibiting systemic hyperinflammation. Interleukin-18 (IL-18), a proinflammatory cytokine belonging to the IL-1 family, is elevated in both MAS and COVID-19 patients, and its level is known to correlate with the severity of COVID-19 symptoms. IL-18 binds its specific receptor IL-1 receptor 5 (IL-1R5, also known as IL-18 receptor alpha chain), leading to the recruitment of the coreceptor, IL-1 receptor 7 (IL-1R7, also known as IL-18 receptor beta chain). This heterotrimeric complex then initiates downstream signaling, resulting in systemic and local inflammation. Here, we developed a novel humanized monoclonal anti-IL-1R7 antibody to specifically block the activity of IL-18 and its inflammatory signaling. We characterized the function of this antibody in human cell lines, in freshly obtained peripheral blood mononuclear cells (PBMCs) and in human whole blood cultures. We found that the anti-IL-1R7 antibody significantly suppressed IL-18-mediated NF kappa B activation, reduced IL-18-stimulated IFN gamma and IL-6 production in human cell lines, and reduced IL-18-induced IFN gamma, IL-6, and TNF alpha production in PBMCs. Moreover, the anti-IL-1R7 antibody significantly inhibited LPS- and Candida albicans-induced IFN gamma production in PBMCs, as well as LPS-induced IFN gamma production in whole blood cultures. Our data suggest that blocking IL-1R7 could represent a potential therapeutic strategy to specifically modulate IL-18 signaling and may warrant further investigation into its clinical potential for treating IL-18-mediated diseases, including MAS and COVID-19.	[Li, Suzhao; Jiang, Liqiong; Powers, Nicholas E.; de Graaf, Dennis M.; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80204 USA; [Jiang, Liqiong] Shenzhen Eye Hosp, Shenzhen, Guangdong, Peoples R China; [Beckmann, Karsten; Pessara, Ulrich; Fischer, Stephan] MAB Discovery GmbH, Neuried, Germany; [Hojen, Jesper Falkesgaard] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Lindenberger, Jared] Univ Colorado Denver, Biophys Core Facil, Anschutz Med Campus, Aurora, CO USA; [Eisenmesser, Elan Z.] Univ Colorado Denver, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Beckmann, Karsten] BioNTech SE, Mainz, Germany	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Aarhus University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; BioNTech SE	Li, SZ; Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80204 USA.	suzhao.li@cuanschutz.edu; cdinare333@aol.com		Powers, Nicholas/0000-0002-5403-4324; Hojen, Jesper Falkesgaard/0000-0002-2629-5391	National Institutes of Health [AI-015614, AI-128443, AI-151651]; Interleukin Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interleukin Foundation	This study was supported by National Institutes of Health Grants AI-015614 (to C. A. D.) and AI-128443 and AI-151651 (to S. L.) and Interleukin Foundation (to C.A.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banda NK, 2003, J IMMUNOL, V170, P2100, DOI 10.4049/jimmunol.170.4.2100; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bouali E, 2015, IMMUNOL LETT, V167, P87, DOI 10.1016/j.imlet.2015.08.001; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002; Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Chi YW, 2020, J MICROENCAPSUL, V37, P134, DOI 10.1080/02652048.2019.1705409; Dai SM, 2004, ARTHRITIS RHEUM-US, V50, P432, DOI 10.1002/art.20064; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Dinarello CA, 2000, EUR CYTOKINE NETW, V11, P483; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dinarello CA, 2019, NAT REV RHEUMATOL, V15, P612, DOI 10.1038/s41584-019-0277-8; Eisenmesser EZ, 2019, P NATL ACAD SCI USA, V116, P5514, DOI 10.1073/pnas.1819672116; Fischer CP, 2005, CLIN IMMUNOL, V117, P152, DOI 10.1016/j.clim.2005.07.008; Flament H, 2021, NAT IMMUNOL, V22, P322, DOI 10.1038/s41590-021-00870-z; Gabay C, 2018, ANN RHEUM DIS, V77, P840, DOI 10.1136/annrheumdis-2017-212608; Gao Z, 2019, MEDITERR J HEMATOL I, V11, DOI 10.4084/MJHID.2019.008; Gauglitz GG, 2012, ACTA DERM-VENEREOL, V92, P291, DOI 10.2340/00015555-1250; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GHEZZI P, 1988, J IMMUNOL, V140, P4238; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Girard C, 2016, RHEUMATOLOGY, V55, P2237, DOI 10.1093/rheumatology/kew300; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hojen JF, 2019, NAT IMMUNOL, V20, P1138, DOI 10.1038/s41590-019-0467-1; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Huithe j., 2006, ATHEROSCLEROSIS, V188, P450; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jiang JF, 2018, GYNECOL ENDOCRINOL, V34, P83, DOI 10.1080/09513590.2017.1354367; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Kaplanski G, 2018, IMMUNOL REV, V281, P138, DOI 10.1111/imr.12616; Kerget B, 2021, J MED VIROL, V93, P2090, DOI 10.1002/jmv.26589; Kim SH, 2001, J IMMUNOL, V166, P148; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Liu SS, 2020, J MOL BIOL, V432, P1169, DOI 10.1016/j.jmb.2020.01.012; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Maeno N, 2004, ARTHRITIS RHEUM, V50, P1935, DOI 10.1002/art.20268; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Manigold T, 2000, CYTOKINE, V12, P1788, DOI 10.1006/cyto.2000.0783; Maruyama J, 2010, J RHEUMATOL, V37, P967, DOI 10.3899/jrheum.090662; Mavragani Clio P, 2012, Int J Inflam, V2012, P879020, DOI 10.1155/2012/879020; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Monteleone G, 1999, J IMMUNOL, V163, P143; Naftali T, 2007, ISRAEL MED ASSOC J, V9, P504; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914; Ojala JO, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050055; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otsuka R, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00131-w; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Puren AJ, 1998, J INFECT DIS, V178, P1830, DOI 10.1086/314481; Put K, 2015, RHEUMATOLOGY, V54, P1507, DOI 10.1093/rheumatology/keu524; Ravelli A, 2012, GENES IMMUN, V13, P289, DOI 10.1038/gene.2012.3; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Satis H, 2021, CYTOKINE, V137, DOI 10.1016/j.cyto.2020.155302; Sawada M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054623; Shimizu M, 2015, CLIN IMMUNOL, V160, P277, DOI 10.1016/j.clim.2015.06.005; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; SIEGMUND B, 2001, AM J PHYSIOL-REG I, V281, pR126; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sonmez HE, 2018, CLIN RHEUMATOL, V37, P3329, DOI 10.1007/s10067-018-4095-1; Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Toldo S, 2014, AM J PHYSIOL-HEART C, V306, pH1025, DOI 10.1152/ajpheart.00795.2013; Toth A, 2013, J INFECT DIS, V208, P690, DOI 10.1093/infdis/jit188; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Van den Munckhof I, 2019, ATHEROSCLEROSIS, V287, pE75, DOI 10.1016/j.atherosclerosis.2019.06.217; Vecchie A, 2021, J CELL PHYSIOL, V236, P1638, DOI 10.1002/jcp.30008; Wada T, 2014, CYTOKINE, V65, P74, DOI 10.1016/j.cyto.2013.09.007; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Yasin S, 2020, RHEUMATOLOGY, V59, P442, DOI 10.1093/rheumatology/kez284; Yasin S, 2020, RHEUMATOLOGY, V59, P361, DOI 10.1093/rheumatology/kez282; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P2043, DOI 10.1161/ATVBAHA.107.149484	101	7	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100630	10.1016/j.jbc.2021.100630	http://dx.doi.org/10.1016/j.jbc.2021.100630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823154	gold, Green Published			2022-12-26	WOS:000672866400601
J	Sebastian-Valverde, M; Wu, H; Al Rahim, M; Sanchez, R; Kumar, K; De Vita, RJ; Pasinetti, GM				Sebastian-Valverde, Maria; Wu, Henry; Al Rahim, Md; Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.; Pasinetti, Giulio Maria			Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCURATE DOCKING; GASDERMIN D; INFLAMMATION; MICROGLIA; GLIDE; ASTROCYTES; ACTIVATION; RECEPTORS; SEVERITY; PROTEINS	Inflammasomes are macromolecular complexes involved in the host response to external and endogenous danger signals. Inflammasome-mediated sterile inflammation plays a central role in several human conditions such as autoimmune diseases, type-2 diabetes, and neurodegenerative disorders, indicating inflammasomes could be appealing therapeutic targets. Previous work has demonstrated that inhibiting the ATPase activity of the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3), disrupts inflammasome assembly and function. However, there is a necessity to find new potent compounds with therapeutic potential. Here we combine computational modeling of the target and virtual screening to discover a group of novel compounds predicted to inhibit NLRP3. We characterized the best compounds and determined their potency, specificity, and ability to inhibit processes downstream from NLRP3 activation. Moreover, we analyzed in mice the competence of a lead candidate to reduce lipopolysaccharide-induced inflammation. We also validated the active pharmacophore shared among all the NLRP3 inhibitors, and through computational docking, we clarify key structural features for compound positioning within the inflammasome ATP-binding site. Our study sets the basis for rational design and optimization of inflammasome-targeting probes and drugs.	[Sebastian-Valverde, Maria; Wu, Henry; Al Rahim, Md; Pasinetti, Giulio Maria] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.] Icahn Sch Med Mt Sinai, Drug Discovery Inst, New York, NY 10029 USA; [Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Pasinetti, GM (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA.	giulio.pasinetti@mssm.edu		Sebastian-Valverde, Maria/0000-0002-5593-8624; Pasinetti, Giulio/0000-0002-1524-5196	NIH's Office of Dietary Supplements (ODS) [AT008661]; National Center for Complementary and Integrative Health; Altschul Foundation; Senior VA Career Scientist Award	NIH's Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary and Integrative Health; Altschul Foundation; Senior VA Career Scientist Award	This research was supported by a grant (AT008661) from the NIH's Office of Dietary Supplements (ODS) and the National Center for Complementary and Integrative Health, awarded to G. M. P. The study was supported by the generous support of the Altschul Foundation to G. M. P. G. M. P. holds a Senior VA Career Scientist Award. We acknowledge that the contents of this study do not represent the views of the NCCIH, the ODS, the National Institutes of Health, the U.S. Department of Veterans Affairs, or the United States Government.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Bronstein R, 2013, JOVE-J VIS EXP, DOI 10.3791/50647; Chear CT, 2020, CLIN IMMUNOL, V211, DOI 10.1016/j.clim.2019.108328; Cocco M, 2017, J MED CHEM, V60, P3656, DOI 10.1021/acs.jmedchem.6b01624; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Debye B, 2018, BRAIN PATHOL, V28, P14, DOI 10.1111/bpa.12467; Deora V, 2020, GLIA, V68, P407, DOI 10.1002/glia.23728; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Duncan JA, 2018, IMMUNOL REV, V281, P115, DOI 10.1111/imr.12607; Fan Z, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1670-6; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kuemmerle-Deschner JB, 2011, ANN RHEUM DIS, V70, P2095, DOI 10.1136/ard.2011.152728; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lehmann S, 2018, NEUROPATH APPL NEURO, V44, P606, DOI 10.1111/nan.12483; Lempriere Sarah, 2020, Nat Rev Neurol, V16, P4, DOI 10.1038/s41582-019-0299-5; Liu L, 2014, AGEING RES REV, V15, P6, DOI 10.1016/j.arr.2013.12.007; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874; Perera AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26775-w; Platnich JM, 2019, ARCH BIOCHEM BIOPHYS, V670, P4, DOI 10.1016/j.abb.2019.02.008; Romberg N, 2017, CURR OPIN ALLERGY CL, V17, P398, DOI 10.1097/ACI.0000000000000396; Saadi M, 2020, BRAIN RES BULL, V154, P81, DOI 10.1016/j.brainresbull.2019.10.010; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shim DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15314-8; Soares JLS, 2019, MULT SCLER RELAT DIS, V29, P26, DOI 10.1016/j.msard.2019.01.023; Stancu IC, 2019, ACTA NEUROPATHOL, V137, P599, DOI 10.1007/s00401-018-01957-y; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; van Golen RF, 2019, BBA-MOL BASIS DIS, V1865, P1192, DOI 10.1016/j.bbadis.2019.01.014; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu JR, 2011, CURR ALLERGY ASTHM R, V11, P12, DOI 10.1007/s11882-010-0160-9; Zhang CX, 2019, DIABETES METAB SYNDR, V12, P1297, DOI 10.2147/DMSO.S199802; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789	68	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100597	10.1016/j.jbc.2021.100597	http://dx.doi.org/10.1016/j.jbc.2021.100597			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781745	gold, Green Published			2022-12-26	WOS:000672866400569
J	Wang, HX; Zhang, Q; Zhang, JY; Luan, R; Liang, ZF; Tan, L; Xu, YA; Zhang, P; Zheng, L; Zhao, Y; Qiu, YR				Wang, Hong-Xia; Zhang, Qian; Zhang, Jiayu; Luan, Rong; Liang, Zhanfeng; Tan, Liang; Xu, Yanan; Zhang, Peng; Zheng, Lei; Zhao, Yong; Qiu, Yu-Rong			CD74 regulates cellularity and maturation of medullary thymic epithelial cells partially by activating the canonical NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						CD74 (invariant chain); maturation; medullary thymic epithelial cells (mTECs); NF-kappa b; thymic epithelial cells (TECs)	SELF-ANTIGEN EXPRESSION; LACKING INVARIANT CHAIN; MICE LACKING; SURFACE EXPRESSION; HEMATOPOIETIC PROGENITORS; TOLERANCE; ALPHA; REQUIREMENT; SELECTION; ABSENCE	Thymic epithelial cells (TECs) are indispensable for T cell development, T cell receptor (TCR) repertoire selection, and specific lineage differentiation. Medullary thymic epithelial cells (mTECs), which account for the majority of TECs in adults, are critical for thymocyte selection and self-tolerance. CD74 is a nonpolymorphic transmembrane glycoprotein of major histocompatibility complex class II (MHCII) that is expressed in TECs. However, the exact role of CD74 in regulating the development of mTEC is poorly defined. In this research, we found that loss of CD74 resulted in a significant diminution in the medulla, a selective reduction in the cell number of mature mTECs expressing CD80 molecules, which eventually led to impaired thymic CD4(+) T cell development. Moreover, RNA-sequence analysis showed that CD74 deficiency obviously downregulated the canonical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling pathway in mTECs. Our results suggest that CD74 positively controls mTEC cellularity and maturation partially by activating the canonical NF-kappa B signaling pathway.	[Wang, Hong-Xia; Zheng, Lei; Qiu, Yu-Rong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Hong-Xia; Zhang, Qian; Zhang, Jiayu; Luan, Rong; Liang, Zhanfeng; Xu, Yanan; Zhang, Peng; Zhao, Yong] Chinese Acad Sci, Transplantat Biol Res Div, State Key Lab Membrane Biol, Inst Zool, Beichen West Rd 1-5, Beijing 100101, Peoples R China; [Tan, Liang] Cent South Univ, Dept Urol Organ Transplantat, Ctr Organ Transplantat, Xiangya Hosp 2, Changsha, Peoples R China	Southern Medical University - China; Chinese Academy of Sciences; Central South University	Qiu, YR (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Transplantat Biol Res Div, State Key Lab Membrane Biol, Inst Zool, Beichen West Rd 1-5, Beijing 100101, Peoples R China.	zhaoy@ioz.ac.cn			National Natural Science Foundation of China [81801390, 81871712, 31800754]; National Key Research and Development Program of China [2017YFA0105002, 2017YFA0104402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 81801390, 81871712 and 31800754; National Key Research and Development Program of China, Grant/Award Number: 2017YFA0105002 and 2017YFA0104402	Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Alexandropoulos K, 2012, IMMUNOL RES, V54, P177, DOI 10.1007/s12026-012-8301-y; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Bichele R, 2016, MOL IMMUNOL, V72, P92, DOI 10.1016/j.molimm.2016.02.015; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Binsky I, 2007, P NATL ACAD SCI USA, V104, P13408, DOI 10.1073/pnas.0701553104; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Ceman S, 1995, Semin Immunol, V7, P373, DOI 10.1006/smim.1995.0042; Cowan JE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13465-y; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Datta MW, 2000, APPL IMMUNOHISTO M M, V8, P210, DOI 10.1097/00022744-200009000-00007; De R, 2018, J BIOL CHEM, V293, P19740, DOI 10.1074/jbc.RA118.003935; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Gil-Yarom N, 2017, P NATL ACAD SCI USA, V114, P562, DOI 10.1073/pnas.1612195114; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; HENNE C, 1995, IMMUNOLOGY, V84, P177; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Irla M, 2013, J IMMUNOL, V190, P586, DOI 10.4049/jimmunol.1200119; Jenkinson SR, 2013, P NATL ACAD SCI USA, V110, P21107, DOI 10.1073/pnas.1314859111; Kenty G, 1998, J IMMUNOL, V160, P606; Klasen C, 2018, CELL SIGNAL, V46, P32, DOI 10.1016/j.cellsig.2018.02.010; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Levi D, 2013, CYTOKINE, V62, P433, DOI 10.1016/j.cyto.2013.03.026; Liang ZF, 2021, J CELL PHYSIOL, V236, P4725, DOI 10.1002/jcp.30192; Liang ZF, 2018, AUTOPHAGY, V14, P505, DOI 10.1080/15548627.2017.1376161; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin V, 2017, J HEPATOL, V67, P1018, DOI 10.1016/j.jhep.2017.06.014; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Riemann M, 2017, J AUTOIMMUN, V81, P56, DOI 10.1016/j.jaut.2017.03.007; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Shen H, 2019, P NATL ACAD SCI USA, V116, P19090, DOI 10.1073/pnas.1901056116; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Su HT, 2017, INFLAMM RES, V66, P209, DOI 10.1007/s00011-016-0995-1; Su M, 2018, IMMUNOL CELL BIOL, V96, P229, DOI 10.1111/imcb.1026; Sun LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/816979; Sun LN, 2013, J IMMUNOL, V191, P3210, DOI 10.4049/jimmunol.1300363; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Venables T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11879-2; Villegas JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01663; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; Wang HX, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03099; Wang HX, 2016, J IMMUNOL, V197, P141, DOI 10.4049/jimmunol.1502698; Wang HX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002370; Wei CN, 2018, PHYSIOL GENOMICS, V50, DOI 10.1152/physiolgenomics.00098.2017; Williams JA, 2014, J IMMUNOL, V192, P630, DOI 10.4049/jimmunol.1302550; Wong P, 1996, J IMMUNOL, V156, P2133; Wright RJ, 1998, IMMUNOLOGY, V95, P309, DOI 10.1046/j.1365-2567.1998.00595.x; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	64	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21535	10.1096/fj.202100139R	http://dx.doi.org/10.1096/fj.202100139R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817835				2022-12-26	WOS:000645260100086
J	Zhang, F; Li, Y; Gan, LP; Tong, XM; Qi, DD; Wang, QH; Ye, X				Zhang, Fang; Li, Yong; Gan, Lipeng; Tong, Xiaomei; Qi, Dandan; Wang, Qihui; Ye, Xin			HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA	FASEB JOURNAL			English	Article						cell proliferation; HBV; MAFG; MAFG-AS1; nonmuscle myosin IIA	LONG NONCODING RNA; CANCER; PHOSPHORYLATION; GENE; DNA	To identify hepatitis B virus (HBV)-related lncRNA(s), we previously examined the transcription profiles of the HBV-transgenic cell line HepG2-4D14 and parental HepG2 cells by RNA deep sequencing and identified 38 upregulated long noncoding RNAs (lncRNAs). In the present study, the lncRNA MAFG-AS1 is investigated in detail because its gene is located adjacent to the MAFG gene, which is an important transcription factor involved in cell proliferation. The level of MAFG-AS1 is significantly higher in HCC tissue than in nontumor tissues. TCGA data show that the expression level of MAFG-AS1 is negatively correlated with survival of HCC patients. GEO cohort data show that compared with healthy tissues, the expression level of MAFG-AS1 is significantly higher in HBV-infected liver tissues. Real-time PCR and luciferase reporter assay data show that HBx can enhance the transcription of MAFG-AS1. Gain-of-function and loss-of-function experiments indicate that MAFG-AS1 promotes proliferation, migration, and invasion of HCC cells. Tumor formation assay results demonstrate that knockdown of MAFG-AS1 significantly inhibits cell proliferation in nude mice. Furthermore, MAFG-AS1 enhances the transcription of adjacent MAFG via E2F1. Additionally, MAFG-AS1 interacts with three subunits (MYH9, MYL12B, and MYL6) of nonmuscle myosin IIA (NM IIA). Knockdown of MAFG-AS1 inhibits ATPase activity of MYH9, interaction of NM IIA subunits, and cell cycle progression. Thus, the lncRNA MAFG-AS1 is upregulated by HBV and promotes proliferation and migration of HCC cells. Our findings suggest that MAFG-AS1 is a potential oncogene that may contribute to HBV-related HCC development.	[Zhang, Fang; Li, Yong; Gan, Lipeng; Tong, Xiaomei; Qi, Dandan; Wang, Qihui; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhang, Fang; Li, Yong; Gan, Lipeng; Ye, Xin] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81772989, 31900143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81772989 and 31900143	Atanasovska B, 2017, HEPATOLOGY, V66, P794, DOI 10.1002/hep.29034; Chen JA, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0947-9; Cui SS, 2018, BIOCHEM BIOPH RES CO, V506, P251, DOI 10.1016/j.bbrc.2018.10.112; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Gao WW, 2020, HEPATOLOGY, V71, P1678, DOI 10.1002/hep.30947; Gao Y, 2017, HEPATOLOGY, V66, P1413, DOI 10.1002/hep.29316; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Huang PB, 2020, ONCOGENE, V39, P3774, DOI 10.1038/s41388-020-1254-z; Komatsu S, 2007, MOL BIOL CELL, V18, P5081, DOI 10.1091/mbc.E06-12-1076; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Liu NN, 2018, HEPATOLOGY, V68, P2130, DOI 10.1002/hep.30098; Liu PY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12971-3; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; Nguyen MH, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00046-19; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ouyang H, 2019, EXP THER MED, V18, P2547, DOI 10.3892/etm.2019.7850; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pei HL, 2018, CANCER RES, V78, P4563, DOI 10.1158/0008-5472.CAN-18-0988; Qin G, 2020, HEPATOLOGY, V71, P112, DOI 10.1002/hep.30793; Revill PA, 2020, NAT REV GASTRO HEPAT, V17, P618, DOI 10.1038/s41575-020-0296-6; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Salerno D, 2020, GUT, V69, P2016, DOI 10.1136/gutjnl-2019-319637; Singer RA, 2019, CELL METAB, V30, P1091, DOI 10.1016/j.cmet.2019.09.013; Sui Y, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172465; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Tang J, 2019, NAT COMMUN, V1, DOI DOI 10.1038/S41467-019-11447-824; Tong S., 2016, J HEPATOL, V64, pS4; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang M, 2019, CELL DEATH DIFFER, V26, P2329, DOI 10.1038/s41418-019-0304-y; Wang YQ, 2017, P NATL ACAD SCI USA, V114, P474, DOI 10.1073/pnas.1619917114; Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169	35	9	9	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21529	10.1096/fj.202002374R	http://dx.doi.org/10.1096/fj.202002374R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813778				2022-12-26	WOS:000645260100106
J	Zhang, YJ; Masters, L; Wang, YH; Wu, LY; Pei, YX; Guo, BQ; Parissenti, A; Lees, SJ; Wang, R; Yang, GD				Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Wu, Lingyun; Pei, Yanxi; Guo, Baoqing; Parissenti, Amadeo; Lees, Simon J.; Wang, Rui; Yang, Guangdong			Cystathionine gamma-lyase/H2S signaling facilitates myogenesis under aging and injury condition	FASEB JOURNAL			English	Article						aging; cystathionine gamma-lyase; H2S; MEF2c; myogenesis; S-sulfhydration	ENDOGENOUS HYDROGEN-SULFIDE; GAMMA-LYASE; S-SULFHYDRATION; LIFE-SPAN; MYOBLAST DIFFERENTIATION; DIETARY RESTRICTION; H2S; CYSTEINE; REGULATOR; INCREASES	Hydrogen sulfide (H2S) can be endogenously produced and belongs to the class of signaling molecules known as gasotransmitters. Cystathionine gamma-lyase (CSE)-derived H2S is implicated in the regulation of cell differentiation and the aging process, but the involvements of the CSE/H2S system in myogenesis upon aging and injury have not been explored. In this study, we demonstrated that CSE acts as a major H2S-generating enzyme in skeletal muscles and is significantly down-regulated in aged skeletal muscles in mice. CSE deficiency exacerbated the age-dependent sarcopenia and cardiotoxin-induced injury/regeneration in mouse skeletal muscle, possibly attributed to inefficient myogenesis. In contrast, supplement of NaHS (an H2S donor) induced the expressions of myogenic genes and promoted muscle regeneration in mice. In vitro, incubation of myoblast cells (C2C12) with H2S promoted myogenesis, as evidenced by the inhibition of cell cycle progression and migration, altered expressions of myogenic markers, elongation of myoblasts, and formation of multinucleated myotubes. Myogenesis was also found to upregulate CSE expression, while blockage of CSE/H2S signaling resulted in a suppression of myogenesis. Mechanically, H2S significantly induced the heterodimer formation between MEF2c and MRF4 and promoted the binding of MEF2c/MRF4 to myogenin promoter. MEF2c was S-sulfhydrated at both cysteine 361 and 420 in the C-terminal transactivation domain, and blockage of MEF2c S-sulfhydration abolished the stimulatory role of H2S on MEF2c/MRF4 heterodimer formation. These findings support an essential role for H2S in maintaining myogenesis, presenting it as a potential candidate for the prevention of age-related sarcopenia and treatment of muscle injury.	[Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Guo, Baoqing; Parissenti, Amadeo; Yang, Guangdong] Laurentian Univ, Dept Chem & Biochem, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada; [Zhang, Yanjie; Masters, Laura; Wang, Yuehong; Wu, Lingyun; Yang, Guangdong] Laurentian Univ, Cardiovasc & Metab Res Unit, Sudbury, ON, Canada; [Wu, Lingyun] Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada; [Wu, Lingyun; Guo, Baoqing; Parissenti, Amadeo] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Pei, Yanxi] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China; [Lees, Simon J.] Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Wang, Rui] York Univ, Dept Biol, Toronto, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Shanxi University; Northern Ontario School of Medicine; York University - Canada	Yang, GD (corresponding author), Laurentian Univ, Dept Chem & Biochem, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.	gyang2@laurentian.ca	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; Yang, Guangdong/0000-0003-3575-7786	Natural Sciences and Engineering Research Council of Canada [04051]; Heart and Stroke Foundation of Canada [G-18-0022098]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: 04051; Heart and Stroke Foundation of Canada, Grant/Award Number: G-18-0022098	Baghdadi MB, 2018, CELL STEM CELL, V23, P859, DOI 10.1016/j.stem.2018.09.017; Bitar MS, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6825452; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brunet A, 2014, J GERONTOL A-BIOL, V69, pS17, DOI 10.1093/gerona/glu042; Byun SK, 2017, MOL CELLS, V40, P667, DOI 10.14348/molcells.2017.0116; Chen YH, 2005, CHEST, V128, P3205, DOI 10.1378/chest.128.5.3205; Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008; Ding J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155349; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Gao XH, 2020, MOL CELL PROTEOMICS, V19, P852, DOI 10.1074/mcp.RA119.001910; Guo BQ, 2003, BREAST CANCER RES TR, V82, P125, DOI 10.1023/B:BREA.0000003969.21267.81; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Iciek M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150147; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Jin S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/758358; Ju YJ, 2015, BBA-GEN SUBJECTS, V1850, P2293, DOI 10.1016/j.bbagen.2015.08.003; Keller K, 2019, WIEN MED WOCHENSCHR, V169, P157, DOI 10.1007/s10354-018-0618-2; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Leslie M, 2008, SCIENCE, V320, P1155, DOI 10.1126/science.320.5880.1155; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Lu FP, 2020, J CELL MOL MED, V24, P9362, DOI 10.1111/jcmm.15587; Lu ZH, 2019, REJUV RES, V22, P513, DOI 10.1089/rej.2018.2166; Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, pC609, DOI 10.1152/ajpcell.00147.2018; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Matei IV, 2017, REGEN MED, V12, P125, DOI 10.2217/rme-2016-0142; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagpure BV, 2015, HANDB EXP PHARMACOL, V230, P193, DOI 10.1007/978-3-319-18144-8_10; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Ohtsubo H, 2017, INT J BIOCHEM CELL B, V85, P91, DOI 10.1016/j.biocel.2017.02.005; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Parsanathan R, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.07.019; Parsanathan R, 2018, FREE RADICAL RES, V52, P288, DOI 10.1080/10715762.2018.1431626; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Perridon BW, 2016, AGING-US, V8, P2264, DOI 10.18632/aging.101026; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Qabazard B, 2015, HANDB EXP PHARMACOL, V230, P269, DOI 10.1007/978-3-319-18144-8_14; Qabazard B, 2014, ANTIOXID REDOX SIGN, V20, P2621, DOI 10.1089/ars.2013.5448; Rizvi SI, 2008, REJUV RES, V11, P661, DOI 10.1089/rej.2007.0652; Sen N, 2017, J MOL BIOL, V429, P543, DOI 10.1016/j.jmb.2016.12.015; Sen U, 2012, AM J PHYSIOL-CELL PH, V303, pC41, DOI 10.1152/ajpcell.00398.2011; Shaposhnikov M, 2018, AGING-US, V10, P3260, DOI 10.18632/aging.101630; Shaposhnikov MV, 2021, BIOGERONTOLOGY, V22, P197, DOI 10.1007/s10522-021-09911-4; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Sinha-Hikim I, 2013, J GERONTOL A-BIOL, V68, P749, DOI 10.1093/gerona/gls334; Stokes E, 2018, LIFE SCI, V213, P116, DOI 10.1016/j.lfs.2018.10.031; Szczesny B, 2014, NITRIC OXIDE-BIOL CH, V41, P120, DOI 10.1016/j.niox.2014.04.008; Vellecco V, 2020, BRIT J PHARMACOL, V177, P810, DOI 10.1111/bph.14700; Vellecco V, 2018, BRIT J PHARMACOL, V175, P3090, DOI 10.1111/bph.14358; Wang PP, 2017, ANTIOXID REDOX SIGN, V27, P931, DOI 10.1089/ars.2016.6875; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang RX, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9752698; Wang WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30292; Wang XJ, 2017, GENE, V629, P68, DOI 10.1016/j.gene.2017.07.062; Wang YH, 2020, NITRIC OXIDE-BIOL CH, V103, P9, DOI 10.1016/j.niox.2020.07.002; Wetzel MD, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1753-7; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2018, BBA-MOL CELL BIOL L, V1863, P165, DOI 10.1016/j.bbalip.2017.11.008; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2012, J MOL CELL CARDIOL, V52, P677, DOI 10.1016/j.yjmcc.2011.12.004; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yang R, 2020, EXP BIOL MED, V245, P1280, DOI 10.1177/1535370220931038; Zhang YJ, 2020, ANTIOXID REDOX SIGN, V32, P583, DOI 10.1089/ars.2019.7824; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; Zhao KX, 2014, FRONT BIOSCI-LANDMRK, V19, P1355, DOI 10.2741/4286; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zivanovic J, 2019, CELL METAB, V30, P1152, DOI 10.1016/j.cmet.2019.10.007	79	9	9	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21511	10.1096/fj.202002675R	http://dx.doi.org/10.1096/fj.202002675R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826201				2022-12-26	WOS:000645260100010
J	Cunningham-Myrie, C; Theall, KP; Younger-Coleman, N; Greene, LG; Lyew-Ayee, P; Wilks, R				Cunningham-Myrie, Colette; Theall, Katherine P.; Younger-Coleman, Novie; Greene, Lisa-Gaye; Lyew-Ayee, Parris; Wilks, Rainford			Associations of neighborhood physical and crime environments with obesity-related outcomes in Jamaica	PLOS ONE			English	Article							BODY-MASS INDEX; BUILT ENVIRONMENT; WAIST CIRCUMFERENCE; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; RISK-FACTORS; SOCIAL-CLASS; HEALTH; OVERWEIGHT; WEIGHT	Objective To examine whether proximity and density of public open spaces, public parks, street connectivity, and serious and violent crimes were associated with Body Mass Index (BMI) and Waist Circumference (WC) within and across levels of urbanicity, sex and socioeconomic status (SES) in Jamaica, a small island developing state (SIDS). Methods Secondary analysis was conducted using data from the Jamaica Health and Lifestyle Survey 2008 (JHLS II). All respondents were geocoded to area of residence in Enumeration Districts (EDs). Intraclass correlation coefficients (ICCs) were derived and multilevel mixed effects regression models applied to 2529 participants nested within 101 EDs from all 14 parishes in Jamaica. Results There was significant clustering across neighborhoods for mean BMI (ICC = 4.16%) and mean WC (ICC = 4.42%). In fully adjusted models statistically significant associations included: increased mean BMI among men, with increased intersection density/ km(2) (beta = 0.02; 95% CI = 1.96 x10(-3), 0.04, p = 0.032); increased mean WC among urban residents with increased crimes/km(2)/yr (beta = 0.09; 95% CI = 0.03, 0.16, p<0.01) and among persons in the middle class, with further distance away from public parks (beta = 0.30; 95% CI = 0.08, 0.53, p<0.01). Conclusions Neighborhood physical and crime environments were associated with obesity-related outcomes in Jamaica. Policymakers in SIDS such as Jamaica should also note the important differences by urbanicity, sex and SES in prevention efforts designed to stem the growing obesity epidemic.	[Cunningham-Myrie, Colette] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica; [Theall, Katherine P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70112 USA; [Younger-Coleman, Novie; Wilks, Rainford] Univ West Indies, Caribbean Inst Hlth Res, Mona, Jamaica; [Greene, Lisa-Gaye; Lyew-Ayee, Parris] Univ West Indies, Mona GeoInformat Inst, Mona, Jamaica	University West Indies Mona Jamaica; Tulane University; University West Indies Mona Jamaica; University West Indies Mona Jamaica	Cunningham-Myrie, C (corresponding author), Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica.	colette.cunninghammyrie@uwimona.edu.jm						Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Angkurawaranon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113547; ASHCROFT MT, 1966, BRIT J PREV SOC MED, V20, P22; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Bonnefond C, 2014, SOC SCI MED, V112, P22, DOI 10.1016/j.socscimed.2014.04.021; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Caribbean Commission on Health and Development, 2006, REP CAR COMM HLTH DE, P37; Chauvet-Gelinier JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210507; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Pham DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105251; Felker-Kantor EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224516; Ferguson TS, 2010, W INDIAN MED J, V59, P259; Ferguson TS, 2018, PEERJ, V6, DOI 10.7717/peerj.4385; Forrester T, 1996, CIBA F SYMP, V201, P17; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Francis DK, 2009, PUBLIC HEALTH NUTR, V12, P1106, DOI 10.1017/S1368980009004960; Frank L, 2007, AM J HEALTH PROMOT, V21, P305, DOI 10.4278/0890-1171-21.4s.305; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Frank LD, 2005, INT REGIONAL SCI REV, V28, P193, DOI 10.1177/0160017604273853; Galaviz KI, 2016, J PHYS ACT HEALTH, V13, P1110, DOI 10.1123/jpah.2015-0557; Giles-Corti B, 2005, AM J PREV MED, V28, P169, DOI 10.1016/j.amepre.2004.10.018; Harrington DW, 2009, SOC SCI MED, V68, P593, DOI 10.1016/j.socscimed.2008.11.021; Jackson M, 2003, EUR J CLIN NUTR, V57, P621, DOI 10.1038/sj.ejcn.1601584; Jones, 2016, CRIME VIOLENCE JAMAI; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; LEORHYNIE E, 1982, SOC ECON STUD, V31, P35; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Martorell R, 2000, INT J OBESITY, V24, P959, DOI 10.1038/sj.ijo.0801264; Masood M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008173; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Oakes J Michael, 2007, Epidemiol Perspect Innov, V4, P16, DOI 10.1186/1742-5573-4-16; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Prince SA, 2012, OBESITY, V20, P2093, DOI 10.1038/oby.2011.392; Prince SA, 2011, INT J ENV RES PUB HE, V8, P3953, DOI 10.3390/ijerph8103953; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Samimi A, 2009, TRANSPORT RES D-TR E, V14, P67, DOI 10.1016/j.trd.2008.10.002; Saquib J, 2016, INT J HEALTH SCI-IJH, V10, P363; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; StataCorp, 2015, STAT REL 14 STAT SOF; Stringhini S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3589-5; Sugiyama T, 2010, AM J PUBLIC HEALTH, V100, P1752, DOI 10.2105/AJPH.2009.182006; The Statistical Institute of Jamaica (STATIN), 2011, CENS POP HOUS JAM; Traynor A, 2013, COMP EDUC REV, V57, P662, DOI 10.1086/671423; VanderWeele TJ, 2019, AM J EPIDEMIOL, V188, P617, DOI 10.1093/aje/kwy250; Wang FH, 2013, APPL GEOGR, V41, P1, DOI 10.1016/j.apgeog.2013.03.006; Wen LM, 2006, INT J OBESITY, V30, P782, DOI 10.1038/sj.ijo.0803199; Wikipedia, FREE ENCY; Wilks R., 2000, JAMAICAN HLTH LIFEST; Wilks R, 2008, TECHNICAL REPORT; Witten K, 2008, PREV MED, V47, P299, DOI 10.1016/j.ypmed.2008.04.010; World Health Organization, OB OV FACT SHEET NO; Xu YQ, 2015, HEALTH PLACE, V34, P19, DOI 10.1016/j.healthplace.2015.03.010; Yu E, 2016, SOCIOL COMPASS, V10, P187, DOI 10.1111/soc4.12356	66	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249619	10.1371/journal.pone.0249619	http://dx.doi.org/10.1371/journal.pone.0249619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819299	gold, Green Published			2022-12-26	WOS:000637647200032
J	Mwau, M; Danda, J; Mbugua, J; Handa, A; Fortunko, J; Worlock, A; Nair, SV				Mwau, Matilu; Danda, Jeff; Mbugua, Joseph; Handa, Allan; Fortunko, Jacqueline; Worlock, Andrew; Nair, Sangeetha Vijaysri			Prospective evaluation of accuracy of HIV viral load monitoring using the Aptima HIV Quant Dx assay with fingerstick and venous dried blood spots prepared under field conditions in Kenya	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERFORMANCE-CHARACTERISTICS; ANTIRETROVIRAL TREATMENT; RNA QUANTITATION; REALTIME HIV-1; V2.0 ASSAY; QUANTIFICATION; PLASMA; CHILDREN; SYSTEM	Quantification of HIV-1 RNA is essential for clinical management of HIV patients. The limited throughput and significant hands-on time required by most HIV Viral load (VL) tests makes it challenging for laboratories with high test volume, to turn around patient results quickly. The Hologic Aptima HIV-1 Quant Dx Assay (Aptima), has the potential to alleviate this burden as it is high throughput and fully automated. This assay is validated for both plasma and dried blood spots (DBS), which are commonly used in resource limited settings. The objective of this study was to compare the performance of Aptima to Abbott RealTime HIV-1 Assay (Abbott RT), which was used as reference. This was a cross-sectional prospective study where HIV VL in finger stick (FS) DBS, venous blood (VB) DBS and plasma, collected from 258 consenting adults visiting 5 medical facilities in Kenya, Africa were tested in Aptima. The results were compared to plasma VL in Abbott RT at the medical decision point (MDP) of 1000 copies/mL and across Aptima assay range. The total agreement at MDP between plasma HIV VL in Abbott RT and plasma, FS and VB DBS tested in Aptima were 97.7%, 92.2% and 95.3% respectively with kappa statistic of 0.95, 0.84 and 0.90. The positive and negative agreement for all 3 sample types were >92%. Regression analysis between VL in Abbott RT plasma and various sample types tested in Aptima had a Pearson's correlation coefficient >= 0.91 with systematic bias of < 0.20 log copies/mL on Bland-Altman analysis. The high level of agreement in Aptima HIV VL results for all 3 sample types with Abbott RT plasma VL along with the high throughput, complete automation, and ease of use of the Panther platform makes Aptima a good option for HIV VL monitoring for busy laboratories with high volume of testing.	[Mwau, Matilu; Danda, Jeff; Mbugua, Joseph; Handa, Allan] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Fortunko, Jacqueline; Worlock, Andrew; Nair, Sangeetha Vijaysri] Hol Inc, San Diego, CA USA	Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	matilu.mwau@gmail.com			Hologic, Inc	Hologic, Inc	Hologic, Inc (www.hologic.com) provided the funds and materials for the study. Hologic Inc. provided support in the form of salaries for authors SN, AW and JF. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amendola A, 2016, J MED VIROL, V88, P1535, DOI 10.1002/jmv.24493; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; [Anonymous], 2014, D770814 ASTM, DOI DOI 10.1520/D7708-14; ASTM International, 2016, STANDARD TEST METHOD, DOI DOI 10.1520/D5298-16; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bbosa N, 2019, CURR OPIN HIV AIDS, V14, P153, DOI 10.1097/COH.0000000000000534; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carlos S, 2015, SEX TRANSM INFECT, V91, P334, DOI 10.1136/sextrans-2014-051734; Chang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181054; Darcis G, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01902-19; Fajardo E, 2014, J CLIN MICROBIOL, V52, P1343, DOI 10.1128/JCM.03519-13; Gounder K, 2017, AIDS RES HUM RETROV, V33, P500, DOI [10.1089/AID.2016.0321, 10.1089/aid.2016.0321]; Hatzakis A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0627-y; Hopkins M, 2015, J CLIN VIROL, V69, P56, DOI 10.1016/j.jcv.2015.05.020; Kiptoo M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-517; Manak MM, 2016, J CLIN MICROBIOL, V54, P2575, DOI 10.1128/JCM.01350-16; Mavedzenge SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126878; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Nair SV, 2016, J CLIN VIROL, V77, P46, DOI 10.1016/j.jcv.2016.02.002; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Onsongo S, 2016, AIDS RES HUM RETROV, V32, P220, DOI 10.1089/aid.2015.0026; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Sahoo MK, 2016, J CLIN MICROBIOL, V54, P2597, DOI 10.1128/JCM.01569-16; Sam SS, 2016, J CLIN MICROBIOL, V54, P1036, DOI 10.1128/JCM.03289-15; Saune K, 2016, J CLIN VIROL, V84, P70, DOI 10.1016/j.jcv.2016.09.002; Schalasta G, 2016, CLIN CHEM LAB MED, V54, P493, DOI 10.1515/cclm-2015-0522; Schmitz ME, 2017, JAIDS-J ACQ IMM DEF, V74, P399, DOI [10.1097/QAI.0000000000001275, 10.1097/qai.0000000000001275]; Schonning K, 2017, J CLIN VIROL, V92, P14, DOI 10.1016/j.jcv.2017.05.006; Sloma CR, 2009, J CLIN MICROBIOL, V47, P889, DOI 10.1128/JCM.02231-08; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; UNAIDS, 2019, START FREE STAY FREE; Wiesmann F, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00292-18; Yek C, 2017, J CLIN MICROBIOL, V55, P2544, DOI 10.1128/JCM.00425-17; Zeh Clement, 2017, PLoS One, V12, pe0179316, DOI 10.1371/journal.pone.0179316	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249376	10.1371/journal.pone.0249376	http://dx.doi.org/10.1371/journal.pone.0249376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798221	gold, Green Published			2022-12-26	WOS:000636737700025
J	Han, CH; Kim, M; Kwak, JT				Han, Chang Hee; Kim, Misuk; Kwak, Jin Tae			Semi-supervised learning for an improved diagnosis of COVID-19 in CT images	PLOS ONE			English	Article							CORONAVIRUS	Coronavirus disease 2019 (COVID-19) has been spread out all over the world. Although a real-time reverse-transcription polymerase chain reaction (RT-PCR) test has been used as a primary diagnostic tool for COVID-19, the utility of CT based diagnostic tools have been suggested to improve the diagnostic accuracy and reliability. Herein we propose a semi-supervised deep neural network for an improved detection of COVID-19. The proposed method utilizes CT images in a supervised and unsupervised manner to improve the accuracy and robustness of COVID-19 diagnosis. Both labeled and unlabeled CT images are employed. Labeled CT images are used for supervised leaning. Unlabeled CT images are utilized for unsupervised learning in a way that the feature representations are invariant to perturbations in CT images. To systematically evaluate the proposed method, two COVID-19 CT datasets and three public CT datasets with no COVID-19 CT images are employed. In distinguishing COVID-19 from non-COVID-19 CT images, the proposed method achieves an overall accuracy of 99.83%, sensitivity of 0.9286, specificity of 0.9832, and positive predictive value (PPV) of 0.9192. The results are consistent between the COVID-19 challenge dataset and the public CT datasets. For discriminating between COVID-19 and common pneumonia CT images, the proposed method obtains 97.32% accuracy, 0.9971 sensitivity, 0.9598 specificity, and 0.9326 PPV. Moreover, the comparative experiments with respect to supervised learning and training strategies demonstrate that the proposed method is able to improve the diagnostic accuracy and robustness without exhaustive labeling. The proposed semi-supervised method, exploiting both supervised and unsupervised learning, facilitates an accurate and reliable diagnosis for COVID-19, leading to an improved patient care and management.	[Han, Chang Hee] Sejong Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kim, Misuk] Sejong Univ, Dept Data Sci, Seoul, South Korea; [Kwak, Jin Tae] Korea Univ, Sch Elect Engn, Seoul, South Korea	Sejong University; Sejong University; Korea University	Kwak, JT (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	jkwak@korea.ac.kr		Chang Hee, Han/0000-0003-2004-9146; Kim, Misuk/0000-0002-8623-3088; Kwak, Jin Tae/0000-0003-0287-4097	National Research Foundation of Korea (NRF) [NRF-2020K1A3A1A74114867]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF): NRF-2020K1A3A1A74114867.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Bai W., SEMISUPERVISED LEARN; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Fan DP, 2020, IEEE T MED IMAGING, V39, P2626, DOI 10.1109/TMI.2020.2996645; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; Han ZY, 2020, IEEE T MED IMAGING, V39, P2584, DOI 10.1109/TMI.2020.2996256; Huang Lu, 2020, Radiol Cardiothorac Imaging, V2, pe200075, DOI 10.1148/ryct.2020200075; Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330; Ko H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19569; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e223; Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954; Navab N., SEMISUPERVISED DEEP; Ouyang X, 2020, IEEE T MED IMAGING, V39, P2595, DOI 10.1109/TMI.2020.2995508; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]; Tan M, 2019, PR MACH LEARN RES; van Engelen JE, 2020, MACH LEARN, V109, P373, DOI 10.1007/s10994-019-05855-6; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang J, 2020, IEEE T MED IMAGING, V39, P2572, DOI 10.1109/TMI.2020.2994908; Wang S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00775-2020; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Wang XG, 2020, IEEE T MED IMAGING, V39, P2615, DOI 10.1109/TMI.2020.2995965; Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343; Xie YT, 2019, IEEE T MED IMAGING, V38, P991, DOI 10.1109/TMI.2018.2876510; Xu XW, 2020, ENGINEERING-PRC, V6, P1122, DOI 10.1016/j.eng.2020.04.010; Yan T, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110153; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249450	10.1371/journal.pone.0249450	http://dx.doi.org/10.1371/journal.pone.0249450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793650	gold, Green Published			2022-12-26	WOS:000636467000081
J	Kasztelewicz, B; Janiszewska, K; Burzynska, J; Szydlowska, E; Migdal, M; Dzierzanowska-Fangrat, K				Kasztelewicz, Beata; Janiszewska, Katarzyna; Burzynska, Julia; Szydlowska, Emilia; Migdal, Marek; Dzierzanowska-Fangrat, Katarzyna			Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland	PLOS ONE			English	Article								Data on the prevalence of the SARS-CoV-2 antibody in healthcare workers (HCWs) is scarce, especially in pediatric settings. The purpose of this study was to evaluate SARS-CoV-2 IgG-positivity among HCWs of a tertiary pediatric hospital. In addition, follow-up of the serological response in the subgroup of seropositive HCWs was analysed, to gain some insight on the persistence of IgG antibodies to SARS-CoV-2. We performed a retrospective analysis of voluntary SARS-CoV-2 IgG testing, which was made available free of charge to HCWs of the Children's Memorial Health Institute in Warsaw (Poland). Plasma samples were collected between July 1 and August 9, 2020, and tested using the Abbott SARS-CoV-2 IgG assay. Of 2,282 eligible participants, 1,879 (82.3%) HCWs volunteered to undergo testing. Sixteen HCWs tested positive for SARS-CoV-2 IgG, corresponding to a seroprevalence of 0.85%. Among seropositive HCWs, three HCWs had confirmed COVID-19. Nine (56.3%) of the seropositive HCWs reported neither symptoms nor unprotected contact with confirmed SARS-CoV-2 cases in the previous months. A decline in the IgG index was observed at a median time of 86.5 days (range:84-128 days) after symptom onset or RT-PCR testing. Further studies are necessary to elucidate the duration of persistence of anti-SARS-CoV-2 antibodies, as well as the correlation between seropositivity and protective immunity against reinfection. Regardless of the persistence of antibodies and their protective properties, such low prevalence indicates that this population is vulnerable to a second wave of the COVID-19 pandemic.	[Kasztelewicz, Beata; Janiszewska, Katarzyna; Burzynska, Julia; Szydlowska, Emilia; Dzierzanowska-Fangrat, Katarzyna] Childrens Mem Hlth Inst, Dept Clin Microbiol & Immunol, Warsaw, Poland; [Migdal, Marek] Childrens Mem Hlth Inst, Dept Anaesthesiol & Intens Care, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute	Kasztelewicz, B (corresponding author), Childrens Mem Hlth Inst, Dept Clin Microbiol & Immunol, Warsaw, Poland.	b.kasztelewicz@ipczd.pl	Kasztelewicz, Beata/L-8250-2019	Kasztelewicz, Beata/0000-0003-1504-5589				Alter G, 2020, NEW ENGL J MED, V383, P1782, DOI 10.1056/NEJMe2028079; Amendola A, 2020, INFECT CONT HOSP EP, V41, P1468, DOI 10.1017/ice.2020.401; [Anonymous], 2020, WEEK 42, VAvailable; Arevalo-Rodriguez Ingrid, 2020, PLoS One, V15, pe0242958, DOI 10.1371/journal.pone.0242958; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Contejean A, 2021, CLIN INFECT DIS, V72, P257, DOI 10.1093/cid/ciaa977; Dacosta-Urbieta A, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00547; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Patel AB, 2020, J PEDIAT INF DIS SOC, V9, P617, DOI 10.1093/jpids/piaa102; Patel MM, 2020, JAMA-J AM MED ASSOC, V324, P1781, DOI 10.1001/jama.2020.18796; Stromer A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101572; World Health Organization, 2020, ARCH WHO TIM COVID 1; Xiao J, 2020, J INFECT PUBLIC HEAL, V13, P843, DOI 10.1016/j.jiph.2020.05.019	14	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249550	10.1371/journal.pone.0249550	http://dx.doi.org/10.1371/journal.pone.0249550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793673	gold, Green Published, Green Submitted			2022-12-26	WOS:000636467000116
J	Onishi, Y; Kawamura, T; Higashino, T; Mimura, R; Tsukamoto, H; Sasaki, S				Onishi, Yasutaka; Kawamura, Tetsuji; Higashino, Takanori; Mimura, Rokuro; Tsukamoto, Hiroaki; Sasaki, Shin			Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases	PLOS ONE			English	Article								Background Acute fibrinous and organizing pneumonia (AFOP) is a rare histologic pattern of acute lung involvement with intra-alveolar fibrin deposition. However, the clinical significance of the pathological findings of AFOP remains unclear. This study aimed to explore the clinical significance of AFOP through a comprehensive clinical examination. Methods The medical records of patients with lung diseases accompanied by the pathological finding of intra-alveolar organization between January 2010 and December 2019 were retrospectively reviewed. The clinical and radiological findings were compared between the groups with and without the histologic pattern of AFOP. Results We identified 34 patients with AFOP (AFOP group) and 143 without AFOP (non-AFOP group). The underlying diseases of the AFOP group were as follows: 19 patients had cryptogenic organizing pneumonia (OP), 5 had connective tissue diseases, 3 had radiation pneumonitis, 3 had chronic eosinophilic pneumonia, 2 had myelodysplastic syndromes, and 2 had drug-induced pneumonia. Fever was more common, the time from symptom onset to biopsy was shorter, and the serum C-reactive protein level was higher in the AFOP group than in the non-AFOP group. On high-resolution computed tomography, 85% of patients had OP pattern, and halo sign was more common in the AFOP group. Corticosteroids were effective in 94% of the patients in the AFOP group; however, recurrences were more frequent, and a higher corticosteroid dose was needed during recurrence. Conclusions AFOP might be an early phase of a histologic pattern associated with known etiologies. In addition, it could be a marker indicating intense inflammatory diseases with a tendency of recurrence.	[Onishi, Yasutaka; Kawamura, Tetsuji; Tsukamoto, Hiroaki; Sasaki, Shin] Himeji Med Ctr, Natl Hosp Org, Dept Resp Med, Himeji, Hyogo, Japan; [Higashino, Takanori] Himeji Med Ctr, Natl Hosp Org, Dept Radiol, Himeji, Hyogo, Japan; [Mimura, Rokuro] Himeji Med Ctr, Natl Hosp Org, Dept Pathol, Himeji, Hyogo, Japan		Onishi, Y (corresponding author), Himeji Med Ctr, Natl Hosp Org, Dept Resp Med, Himeji, Hyogo, Japan.	oonishi.yasutaka.ab@mail.hosp.go.jp		Onishi, Yasutaka/0000-0001-9207-8785				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; AZZAM ZS, 1993, CHEST, V104, P1899, DOI 10.1378/chest.104.6.1899; Bardehle S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00354; Beasley MB, 2010, ARCH PATHOL LAB MED, V134, P719, DOI 10.1043/1543-2165-134.5.719; Beasley MB, 2002, ARCH PATHOL LAB MED, V126, P1064; Bucur M, 2019, EXP THER MED, V17, P982, DOI 10.3892/etm.2018.7063; COLBY TV, 1992, CHEST, V102, pS38, DOI 10.1378/chest.102.1_Supplement.38S; Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Dai JH, 2015, CHINESE MED J-PEKING, V128, P2701, DOI 10.4103/0366-6999.167293; DINA R, 1993, HISTOPATHOLOGY, V23, P541, DOI 10.1111/j.1365-2559.1993.tb01240.x; Faria IM, 2015, J BRAS PNEUMOL, V41, P231, DOI 10.1590/S1806-37132015000004544; Fischer A, 2009, RESP MED, V103, P1719, DOI 10.1016/j.rmed.2009.05.001; Gomes R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004073; Inoue Yukihisa, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P75; Ishikawa N, 2012, RESPIR INVESTIG, V50, P3, DOI 10.1016/j.resinv.2012.02.001; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Johkoh T, 2015, EUR J RADIOL, V84, P542, DOI 10.1016/j.ejrad.2014.11.032; Kashif M, 2017, AM J CASE REP, V18, P448, DOI 10.12659/AJCR.903540; Kim SJ, 2003, AM J ROENTGENOL, V180, P1251, DOI 10.2214/ajr.180.5.1801251; Kim Y, 1999, J COMPUT ASSIST TOMO, V23, P622, DOI 10.1097/00004728-199907000-00025; Lee YR, 2005, BRIT J RADIOL, V78, P862, DOI 10.1259/bjr/77712845; Lu JJ, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0861-3; Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468; Luyendyk JP, 2019, BLOOD, V133, P511, DOI 10.1182/blood-2018-07-818211; Miles LA, 2016, BLOOD, V127, P1079, DOI 10.1182/blood-2016-01-687673; Montagnese F, 2019, J NEUROL, V266, P1358, DOI 10.1007/s00415-019-09266-4; Motley MP, 2016, BLOOD, V127, P1085, DOI 10.1182/blood-2015-05-644260; Nagata N, 2015, LUNG, V193, P203, DOI 10.1007/s00408-015-9689-7; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085062; Nishino M, 2014, HUM PATHOL, V45, P342, DOI 10.1016/j.humpath.2013.09.010; Onishi Y, 2017, RESPIR INVESTIG, V55, P10, DOI 10.1016/j.resinv.2016.09.001; Otsuka M, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P298; Pajares V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239114; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paraskeva M, 2013, AM J RESP CRIT CARE, V187, P1360, DOI 10.1164/rccm.201210-1831OC; PEREZ RL, 1995, J IMMUNOL, V154, P1879; PEYROL S, 1990, AM J PATHOL, V137, P155; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sauter JL, 2014, HISTOPATHOLOGY, V65, P581, DOI 10.1111/his.12420; Tanaka T, 2018, ARCH PATHOL LAB MED, V142, P1069, DOI 10.5858/arpa.2017-0534-RA; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; YOSHINOUCHI T, 1995, RESP MED, V89, P271, DOI 10.1016/0954-6111(95)90087-X	43	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249300	10.1371/journal.pone.0249300	http://dx.doi.org/10.1371/journal.pone.0249300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793625	gold, Green Published			2022-12-26	WOS:000636467000089
J	Yow, KS; Aik, J; Tan, EYM; Ng, LC; Lai, YL				Yow, Kok-Siang; Aik, Joel; Tan, Eugene Yong-Meng; Ng, Lee-Ching; Lai, Yee-Ling			Rapid diagnostic tests for the detection of recent dengue infections: An evaluation of six kits on clinical specimens	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; NS1; SINGAPORE; OUTBREAK; SERUM	Introduction Early and rapid confirmation of dengue infections strengthens disease surveillance program and are critical to the success of vector control measures. Rapid diagnostics tests (RDTs) are increasingly used to confirm recent dengue infections due to their ease of use and short turnaround time for results. Several studies undertaken in dengue-endemic Southeast Asia have reported the performance of RDTs against enzyme-linked immunosorbent assay (ELISA), reverse transcriptase polymerase chain reaction (RT-PCR) and virus isolation methods. However, few studies have compared multiple RDTs for the detection of dengue NS1 antigen and IgM antibody in a single combo cassette. We evaluated six RDTs in Singapore for their utility in routine clinical testing to detect recent dengue infections. Methods The evaluation comprised two phases. The first phase sought to determine each RDT's specificity to dengue NS1 and IgM using zika and chikungunya virus supernatant and zika convalescent samples. RDTs that cross-reacted with zika or chikungunya were not further tested in phase 2. The second phase sought to determine the sensitivity and specificity of the remaining RDTs to dengue NS1 and IgM using pre-characterised dengue specimens and non-dengue/chikungunya febrile clinical specimens. Results None of the RDTs cross-reacted with zika IgM in Phase 1. Truquick and Quickprofile cross reacted with zika and chikungunya viruses and were not evaluated thereafter. Standard Q had the highest dengue NS1 and IgM sensitivity at 87.0% and 84.3% respectively whereas Bioline (68.5%) and Multisure (58.3%) had the lowest dengue NS1 and IgM sensitivity respectively. Combining dengue NS1/IgM detection results greatly improved the RDT ability to detect recent dengue infection; Standard Q had the highest sensitivity at 99.1% while Multisure had the lowest at 92.6%. All the RDTs were highly specific for dengue NS1 and IgM (96.7% to 100%). All the RDTs had high positive predictive values (98.4% to 100%) for NS1, IgM and combined NS1/IgM parameters whereas Standard Q had the highest negative predictive values at 68.2% (NS1), 63.8% (IgM) and 96.8% (NS1/IgM). For the RDTs, detection of NS1 declined from acute to convalescent phase of illness whereas IgM detection rate gradually increased over time. Conclusion In our study, several RDTs were evaluated for their diagnostic accuracy and capability in detecting recent dengue infection. Standard Q demonstrated a high degree of diagnostic accuracy and capability in the detection of NS1 and IgM biomarkers. RDTs can provide rapid and accurate confirmation of recent dengue infections and augment dengue surveillance and control programmes. Further studies are required to assess the usefulness of these RDTs in other epidemiology settings.	[Yow, Kok-Siang; Aik, Joel; Tan, Eugene Yong-Meng; Ng, Lee-Ching; Lai, Yee-Ling] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore		Yow, KS (corresponding author), Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.	yow_kok_siang@nea.gov.sg						Acosta POA, 2014, REV INST MED TROP SP, V56, P447, DOI 10.1590/S0036-46652014000500014; Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993; Argentieri MC, 2013, HISTOPATHOLOGY, V63, P869, DOI 10.1111/his.12225; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037; Gubler DJ, 2011, EXPERT REV VACCINES, V10, P563, DOI [10.1586/ERV.11.35, 10.1586/erv.11.35]; Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9; Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171; Johnson M, 2012, MAT METHODS; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Labrique AB, 2010, AM J OPHTHALMOL, V149, P878, DOI 10.1016/j.ajo.2010.01.001; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Rajarethinam J, 2018, AM J TROP MED HYG, V99, P204, DOI 10.4269/ajtmh.17-0819; Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7; Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; WHO, 2009, WHO TECH REP SER, V958, P1; Wiwanitkit V, 2010, EXPERT REV ANTI-INFE, V8, P841, DOI 10.1586/ERI.10.53; Wong PF, 2020, J INFECT PUBLIC HEAL, V13, P193, DOI 10.1016/j.jiph.2019.07.012; Woodrum D, 1996, UROLOGY, V48, P33, DOI 10.1016/S0090-4295(96)00607-3; Yan G, 2020, LANCET INFECT DIS, V20, P536, DOI 10.1016/S1473-3099(20)30158-4	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249602	10.1371/journal.pone.0249602	http://dx.doi.org/10.1371/journal.pone.0249602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793682	gold, Green Published			2022-12-26	WOS:000636467000060
J	Ansah, JP; Matchar, DB; Wei, SLS; Low, JG; Pourghaderi, AR; Siddiqui, FJ; Min, TLS; Wei-Yan, AC; Ong, MEH				Ansah, John P.; Matchar, David Bruce; Shao Wei, Sean Lam; Low, Jenny G.; Pourghaderi, Ahmad Reza; Siddiqui, Fahad Javaid; Min, Tessa Lui Shi; Wei-Yan, Aloysius Chia; Ong, Marcus Eng Hock			The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience	PLOS ONE			English	Article								Background In dealing with community spread of COVID-19, two active interventions have been attempted or advocated-containment, and mitigation. Given the extensive impact of COVID-19 globally, there is international interest to learn from best practices that have been shown to work in controlling community spread to inform future outbreaks. This study explores the trajectory of COVID-19 infection in Singapore had the government intervention not focused on containment, but rather on mitigation. In addition, we estimate the actual COVID-19 infection cases in Singapore, given that confirmed cases are publicly available. Methods and findings We developed a COVID-19 infection model, which is a modified SIR model that differentiate between detected (diagnosed) and undetected (undiagnosed) individuals and segments total population into seven health states: susceptible (S), infected asymptomatic undiagnosed (A), infected asymptomatic diagnosed (I), infected symptomatic undiagnosed (U), infected symptomatic diagnosed (E), recovered (R), and dead (D). To account for the infection stages of the asymptomatic and symptomatic infected individuals, the asymptomatic infected individuals were further disaggregated into three infection stages: (a) latent (b) infectious and (c) non-infectious; while the symptomatic infected were disaggregated into two stages: (a) infectious and (b) non-infectious. The simulation result shows that by the end of the current epidemic cycle without considering the possibility of a second wave, under the containment intervention implemented in Singapore, the confirmed number of Singaporeans infected with COVID-19 (diagnosed asymptomatic and symptomatic cases) is projected to be 52,053 (with 95% confidence range of 49,370-54,735) representing 0.87% (0.83%-0.92%) of the total population; while the actual number of Singaporeans infected with COVID-19 (diagnosed and undiagnosed asymptomatic and symptomatic infected cases) is projected to be 86,041 (81,097-90,986), which is 1.65 times the confirmed cases and represents 1.45% (1.36%-1.53%) of the total population. A peak in infected cases is projected to have occurred on around day 125 (27/05/2020) for the confirmed infected cases and around day 115 (17/05/2020) for the actual infected cases. The number of deaths is estimated to be 37 (34-39) among those infected with COVID-19 by the end of the epidemic cycle; consequently, the perceived case fatality rate is projected to be 0.07%, while the actual case fatality rate is estimated to be 0.043%. Importantly, our simulation model results suggest that there about 65% more COVID-19 infection cases in Singapore that have not been captured in the official reported numbers which could be uncovered via a serological study. Compared to the containment intervention, a mitigation intervention would have resulted in early peak infection, and increase both the cumulative confirmed and actual infection cases and deaths. Conclusion Early public health measures in the context of targeted, aggressive containment including swift and effective contact tracing and quarantine, was likely responsible for suppressing the number of COVID-19 infections in Singapore.	[Ansah, John P.; Matchar, David Bruce; Shao Wei, Sean Lam; Pourghaderi, Ahmad Reza; Siddiqui, Fahad Javaid; Min, Tessa Lui Shi; Wei-Yan, Aloysius Chia; Ong, Marcus Eng Hock] Duke NUS Med Sch, Programme Hlth Serv & Syst Res, Singapore, Singapore; [Ansah, John P.] Natl Univ Singapore, Residential Coll 4, Singapore, Singapore; [Matchar, David Bruce] Duke Univ, Dept Internal Med Gen Internal Med, Singapore, Singapore; [Matchar, David Bruce] Singapore Gen Hosp, Dept Internal Med, Singapore, Singapore; [Shao Wei, Sean Lam; Pourghaderi, Ahmad Reza] Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore; [Low, Jenny G.] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Low, Jenny G.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore; Singapore General Hospital	Ansah, JP (corresponding author), Duke NUS Med Sch, Programme Hlth Serv & Syst Res, Singapore, Singapore.; Ansah, JP (corresponding author), Natl Univ Singapore, Residential Coll 4, Singapore, Singapore.	john.ansah@duke-nus.edu.sg	Siddiqui, Fahad Javaid/ABB-1564-2021	Siddiqui, Fahad Javaid/0000-0002-9046-5105; Matchar, David/0000-0003-3020-2108; Pourghaderi, Ahmad Reza/0000-0003-2682-2160; Ong, Marcus/0000-0001-7874-7612; Chia, Wei-Yan Aloysius/0000-0003-0847-035X	Singapore Ministry of Health's National Medical Research Council	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	The production of this manuscript was funded by the Singapore Ministry of Health's National Medical Research Council.	Casella F, 2021, IEEE CONTR SYST LETT, V5, P1079, DOI 10.1109/LCSYS.2020.3009912; Chen DB, 2020, INT J INFECT DIS, V93, P297, DOI 10.1016/j.ijid.2020.03.003; Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Holmes A., 2020, BUSINESS INSIDER SIN; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kirkcaldy RD, 2020, JAMA-J AM MED ASSOC, V323, P2245, DOI 10.1001/jama.2020.7869; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Lim J., 2020, SINGAPORES EXPERIENC; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Luo L, 2020, MEDRXIV, V26, DOI [10.1101/2020.03.24.20042606, DOI 10.1101/2020.03.24.20042606]; National Centre for Infectious Diseases Singapore, 2020, PERIOD INFECTIVITY I; Ng YX, 2020, MMWR-MORBID MORTAL W, V69, P307, DOI 10.15585/mmwr.mm6911e1; Parodi SM, 2020, JAMA-J AM MED ASSOC, V323, P1441, DOI 10.1001/jama.2020.3882; Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Teo T., 2020, REUTERS; Walensky RP, 2020, JAMA-J AM MED ASSOC, V323, P1889, DOI 10.1001/jama.2020.6572; WHO, 2020, WHO DIRECTOR GEN OPE; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Wu J, 2020, NEUROCOMPUTING, V395, P78, DOI 10.1016/j.neucom.2020.02.017; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Zhang Z., 2020, EVOLVING EPIDEMIOLOG	27	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248742	10.1371/journal.pone.0248742	http://dx.doi.org/10.1371/journal.pone.0248742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784332	Green Published, gold			2022-12-26	WOS:000636359600062
J	Haedener, M; Weinmann, W; Eich, D; Liebrenz, M; Wuethrich, T; Buadze, A				Haedener, Marianne; Weinmann, Wolfgang; Eich, Dominique; Liebrenz, Michael; Wuethrich, Thomas; Buadze, Anna			Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; LISDEXAMFETAMINE DIMESYLATE; OPEN-LABEL; LIQUID-CHROMATOGRAPHY; D-AMPHETAMINE; MEDICATION ADHERENCE; TREATING ADHD; HUMAN URINE; ADULT ADHD	Considering the high clinical and forensic relevance of pharmaco-adherence during lisdexamphetamine (LDX) treatment for attention-deficit/hyperactivity disorder (ADHD), the aim here was to evaluate hair analysis as a tool for monitoring compliance in patients currently undergoing long term treatment with LDX, by detecting possible interruptions of medication intake or changes in dosage. For this purpose, a total of 24 patients from an outpatient clinic for ADHD were recruited. Hair and urine samples were taken after three consecutive therapy sessions over a 7-month period and analyzed for amphetamine (AMP) enantiomers and other drugs, using chiral and achiral liquid chromatography-tandem mass spectrometry (LC-MS/MS). Participants also provided information on the condition of their hair, the consumption of illegal psychotropic substances and the regularity of taking LDX. Two participants withdrew from the study early. Urine analyses were positive for D-AMP in all urine samples and therapy sessions, except in two patients who did not take LDX on a daily basis. D-AMP was detected in all hair samples; however, no correlation was found between prescribed dose/day and D-AMP concentrations in proximal hair segments. Qualitative interpretation of hair analysis showed that 18 of the 22 study completers were compliant concerning the intake of LDX without additional consumption of illegal D,L-AMP. Analysis of urine taken during the therapy sessions showed no correlation between D-AMP concentrations and prescribed dosage, with or without normalization for creatinine. In conclusion, chiral LC-MS/MS hair analysis might represent a non-invasive way to confirm LDX use within the approximate period covered by the hair segment tested, but it does not allow for quantitative therapeutic drug monitoring because of interindividual variability of concentrations in hair. Drug concentrations in hair at different stages of long-term treatment should thus be interpreted with caution by clinicians and forensic experts alike when making assessments of treatment adherence.	[Haedener, Marianne; Weinmann, Wolfgang; Wuethrich, Thomas] Univ Bern, Inst Forens Med, Dept Forens Toxicol & Chem, Bern, Switzerland; [Eich, Dominique; Buadze, Anna] Univ Zurich, Psychiat Hosp, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Liebrenz, Michael] Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland	University of Bern; University of Zurich; University of Bern	Buadze, A (corresponding author), Univ Zurich, Psychiat Hosp, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.	anna.buadze@puk.zh.ch		Buadze, Ana/0000-0002-8683-6807				Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; [Anonymous], Schweizerisches_Heilmittelinstitut S. Elvanse &REG; , Kapseln (Lisdexamphetamini dimesylas); Baciu T, 2015, ANAL CHIM ACTA, V856, P1, DOI 10.1016/j.aca.2014.06.051; Baeck S, 2011, FORENSIC SCI INT, V206, P77, DOI 10.1016/j.forsciint.2010.06.023; Baggio S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00331; Barbaresi WJ, 2018, J ATTEN DISORD, V22, P571, DOI 10.1177/1087054715618791; Barkley R. A., 2010, ATTENTION DEFICIT HY; Beckman_Coulter, CREAT OSR617 8OSR667; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Biederman J, 2007, BIOL PSYCHIAT, V62, P970, DOI 10.1016/j.biopsych.2007.04.015; Binz TM, 2018, DRUG TEST ANAL, V10, P254, DOI 10.1002/dta.2208; Boellner SW, 2010, CLIN THER, V32, P252, DOI 10.1016/j.clinthera.2010.02.011; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Burnier M., 2018, DRUG ADHERENCE HYPER, P1; Canela C, 2015, FORENS PSYCHIATR PSY, V9, P106, DOI 10.1007/s11757-014-0302-3; Castillo ED, 2011, INT J OFFENDER THER, V55, P98, DOI 10.1177/0306624X09359502; Chang Z, 2016, JAMA-J AM MED ASSOC, V316, P1798, DOI 10.1001/jama.2016.15380; Comiran E, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3812; Cone EJ, 2009, J ANAL TOXICOL, V33, P1, DOI 10.1093/jat/33.1.1; Cooke CE, 2006, J MANAG CARE PHARM, V12, P649, DOI 10.18553/jmcp.2006.12.8.649; Cooper D, 2007, J CLIN PSYCHIAT, V68, P818, DOI 10.4088/JCP.v68n0601; De Giovanni N, 2013, CURR MED CHEM, V20, P545; Douglas KS, 2014, HDB VIOLENCE RISK AS, P157; Dra MM, 2016, NEUROPSYCHIATRY, V6, P236, DOI [10.4172/Neuropsychiatry.1000145, DOI 10.4172/NEUROPSYCHIATRY.1000145]; Dussy F, 2014, DRUG TEST ANAL, V6, P5, DOI 10.1002/dta.1627; Eme R., 2012, CONT TRENDS ADHD RES, P183; Ermer J, 2016, THER DRUG MONIT, V38, P769, DOI 10.1097/FTD.0000000000000343; Ermer J, 2016, THER DRUG MONIT, V38, P546, DOI 10.1097/FTD.0000000000000296; Ermer J, 2010, J CLIN PHARMACOL, V50, P1001, DOI 10.1177/0091270009357346; Ermer JC, 2011, CLIN DRUG INVEST, V31, P357, DOI 10.2165/11588190-000000000-00000; EuropeanMedicinesAgency, GUIDELINE BIOANALYTI; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Friedman N, 2008, FACTORS CONTRIBUTING; Gammon G D, 1993, J Child Adolesc Psychopharmacol, V3, P1, DOI 10.1089/cap.1993.3.1; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Gelmi TJ., 2019, TOXICHEM KRIMTECH, V86, P195; Gerlach M, 2016, NEURO PSYCHOPHARMAKA; Hadener M, 2017, ANAL BIOANAL CHEM, V409, P1291, DOI 10.1007/s00216-016-0056-1; Hagen T, 2019, J OCCUP REHABIL, V29, P72, DOI 10.1007/s10926-018-9766-x; Hall RCW, 2016, J AM ACAD PSYCHIATRY, V44, P164; Haufroid V, 2015, CLIN TOXICOL, V53, P501, DOI 10.3109/15563650.2015.1049355; Heal DJ, 2013, J PSYCHOPHARMACOL, V27, P479, DOI 10.1177/0269881113482532; HENDERSON GL, 1993, FORENSIC SCI INT, V63, P19, DOI 10.1016/0379-0738(93)90256-A; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Koch SL, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23316; Kooij JJS, 2012, J ATTEN DISORD, V16, p3S, DOI 10.1177/1087054711435361; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Krishnan SM, 2008, CURR MED RES OPIN, V24, P33, DOI 10.1185/030079907X242737; Krishnan SM, 2008, CLIN DRUG INVEST, V28, P745, DOI 10.2165/0044011-200828120-00002; Kronstrand R, 1999, CLIN CHEM, V45, P1485; Kronstrand R, 2003, J ANAL TOXICOL, V27, P135, DOI 10.1093/jat/27.3.135; Kronstrand R, 2001, J ANAL TOXICOL, V25, P594, DOI 10.1093/jat/25.7.594; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Lam WY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/217047; Le Gallo J, 2017, J URBAN ECON, V97, P1, DOI 10.1016/j.jue.2016.10.003; Li LH, 2010, BRIT J CLIN PHARMACO, V69, P187, DOI 10.1111/j.1365-2125.2009.03576.x; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Love SA, 2016, J ANAL TOXICOL, V40, P659, DOI 10.1093/jat/bkw092; Martins LF, 2008, FORENSIC SCI INT, V176, P38, DOI 10.1016/j.forsciint.2007.06.023; Mattes JA, 2016, J AM ACAD PSYCHIATRY, V44, P151; McCarthy S, 2014, PATIENT PREFER ADHER, V8, P1317, DOI 10.2147/PPA.S42145; Meier U, 2017, DRUG TEST ANAL, V9, P1594, DOI 10.1002/dta.2186; Mulder E, 2011, INT J OFFENDER THER, V55, P118, DOI 10.1177/0306624X09356683; Poklis A, 1997, J ANAL TOXICOL, V21, P176, DOI 10.1093/jat/21.2.176; Poklis A, 1998, J ANAL TOXICOL, V22, P481, DOI 10.1093/jat/22.6.481; Polettini A, 2012, ANAL CHIM ACTA, V726, P35, DOI 10.1016/j.aca.2012.01.042; Raphael S, 2002, J URBAN ECON, V52, P109, DOI 10.1016/S0094-1190(02)00017-7; Ribeiro C, 2018, MOLECULES, V23, DOI 10.3390/molecules23020262; ROSS HL, 1988, ACCIDENT ANAL PREV, V20, P379, DOI 10.1016/0001-4575(88)90020-6; Sacher K., 2016, ANORDNUNG VOLLZUG ST; Sawada N, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-38; Sohoni T, 2020, J CRIME JUSTICE, V43, P307, DOI 10.1080/0735648X.2019.1690549; Steinau S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00680; Takayama N, 1999, BIOMED CHROMATOGR, V13, P257, DOI 10.1002/(SICI)1099-0801(199906)13:4<257::AID-BMC830>3.0.CO;2-V; Thevis M, 2014, RAPID COMMUN MASS SP, V28, P781, DOI 10.1002/rcm.6844; Vogliardi S, 2015, ANAL CHIM ACTA, V857, P1, DOI 10.1016/j.aca.2014.06.053; Wilens TE, 2004, PSYCHIAT CLIN N AM, V27, P283, DOI 10.1016/S0193-953X(03)00113-8; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Yoshimasu K, 2018, J ATTEN DISORD, V22, P535, DOI 10.1177/1087054716676342; Young S, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1858-9	80	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248747	10.1371/journal.pone.0248747	http://dx.doi.org/10.1371/journal.pone.0248747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784320	Green Published, gold			2022-12-26	WOS:000636359600054
J	Wang, YQ; Dong, LY; Jiang, XQ; Ma, XT; Li, YL; Zhang, H				Wang, YueQun; Dong, LiYan; Jiang, XiaoQuan; Ma, XinTao; Li, YongLi; Zhang, Hao			KG2Vec: A node2vec-based vectorization model for knowledge graph	PLOS ONE			English	Article								Since the word2vec model was proposed, many researchers have vectorized the data in the research field based on it. In the field of social network, the Node2Vec model improved on the basis of word2vec can vectorize nodes and edges in social networks, so as to carry out relevant research on social networks, such as link prediction, and community division. However, social network is a network with homogeneous structure. When dealing with heterogeneous networks such as knowledge graph, Node2Vec will lead to inaccurate prediction and unreasonable vector quantization data. Specifically, in the Node2Vec model, the walk strategy for homogeneous networks is not suitable for heterogeneous networks, because the latter has distinguishing features for nodes and edges. In this paper, a Heterogeneous Network vector representation method is proposed based on random walks and Node2Vec, called KG2vec (Heterogeneous Network to Vector) that solves problems related to the inadequate consideration of the full-text semantics and the contextual relations that are encountered by the traditional vector representation of the knowledge graph. First, the knowledge graph is reconstructed and a new random walk strategy is applied. Then, two training models and optimizing strategies are proposed, so that the contextual environment between entities and relations is obtained, semantically providing a full vector representation of the Heterogeneous Network. The experimental results show that the KG2VEC model solves the problem of insufficient context consideration and unsatisfactory results of one-to-many relationship in the vectorization process of the traditional knowledge graph. Our experiments show that KG2vec achieves better performance with higher accuracy than traditional methods.	[Wang, YueQun; Dong, LiYan; Jiang, XiaoQuan; Ma, XinTao; Zhang, Hao] Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Dong, LiYan; Zhang, Hao] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China; [Li, YongLi] Northeast Normal Univ, Sch Comp Sci & Technol, Changchun, Peoples R China	Jilin University; Jilin University; Northeast Normal University - China	Zhang, H (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China.; Zhang, H (corresponding author), Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China.	zhangh@jlu.edu.cn	Zhang, Hao/AAR-8325-2020	Zhang, Hao/0000-0002-2058-7123				Bordes A., 2013, ADV NEURAL INFORM PR, P1; Bordes A, 2014, MACH LEARN, V94, P233, DOI 10.1007/s10994-013-5363-6; Celikyilmaz A., 2015, 2015 AAAI SPRING S S, P39; Chang WB, 2018, FUTURE GENER COMP SY, V86, P656, DOI 10.1016/j.future.2018.04.059; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Dai HJ, 2017, BIOINFORMATICS, V33, P3575, DOI 10.1093/bioinformatics/btx480; De Winter S, 2018, 2018 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P1234; Dong YX, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P135, DOI 10.1145/3097983.3098036; Fu TY, 2017, CIKM'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P1797, DOI 10.1145/3132847.3132953; Gao J, 2018, 2018 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE (WI 2018), P81, DOI 10.1109/WI.2018.0-104; Grover A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P855, DOI 10.1145/2939672.2939754; Guan NN, 2019, KNOWL-BASED SYST, V164, P38, DOI 10.1016/j.knosys.2018.10.008; Ji GL, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P687; JIANG B, 1991, INFORM PROCESS LETT, V37, P143, DOI 10.1016/0020-0190(91)90034-F; Kenter T, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P941; Kipf Thomas N., 2017, P INT C LEARN REPR, DOI DOI 10.1051/0004-6361/201527329; Lazaridou A., 2015, P 2015 C N AM CHAPTE, P153, DOI DOI 10.3115/V1/N15-1016; Lin YK, 2015, AAAI CONF ARTIF INTE, P2181; Perozzi B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P701, DOI 10.1145/2623330.2623732; Rachman GH, 2018, J ICT RES APPL, V12, P168, DOI 10.5614/itbj.ict.res.appl.2018.12.2.5; Schlichtkrull M., 2018, EUR SEM WEB C, P593, DOI [10.1007/978-3-319-93417-4_38, DOI 10.1007/978-3-319-93417-4_38]; Shi Yu, 2018, Proc SIAM Int Conf Data Min, V2018, P144, DOI 10.1137/1.9781611975321.16; Smaili FZ, 2018, BIOINFORMATICS, V34, P52, DOI 10.1093/bioinformatics/bty259; Sunt YZ, 2011, PROC VLDB ENDOW, V4, P992; Tang J, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1165, DOI 10.1145/2783258.2783307; Tang J, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1067, DOI 10.1145/2736277.2741093; Wang HW, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2000, DOI 10.1145/3308558.3313411; Wang MX, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P803; Wang Z, 2014, AAAI CONF ARTIF INTE, P1112; Yih WT, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P1321; Zhang CX, 2019, PROCEEDINGS OF THE TWELFTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'19), P690, DOI 10.1145/3289600.3291001	32	4	4	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248552	10.1371/journal.pone.0248552	http://dx.doi.org/10.1371/journal.pone.0248552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784319	Green Published, gold			2022-12-26	WOS:000636359600010
J	Avesani, A; Marino, V; Zanzoni, S; Koch, KW; Dell'Orco, D				Avesani, Anna; Marino, Valerio; Zanzoni, Serena; Koch, Karl-Wilhelm; Dell'Orco, Daniele			Molecular properties of human guanylate cyclase-activating protein 2 (GCAP2) and its retinal dystrophy-associated variant G157R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; MUTATION; GUCA1A; EXPRESSION; MECHANISM; CLONING; FAMILY; RETGC; GENE; LOCALIZATION	In murine and bovine photoreceptors, guanylate cyclase-activating protein 2 (GCAP2) activates retinal guanylate cyclases (GCs) at low Ca2+ levels, thus contributing to the Ca2+/cGMP negative feedback on the cyclase together with its paralog guanylate cyclase-activating protein 1, which has the same function but different Ca2+ sensitivity. In humans, a GCAP2 missense mutation (G157R) has been associated with inherited retinal degeneration (IRD) via an unknown molecular mechanism. Here, we characterized the biochemical properties of human GCAP2 and the G157R variant, focusing on its dimerization and the Ca2+/Mg2+-binding processes in the presence or absence of N-terminal myristoylation. We found that human GCAP2 and its bovine/murine orthologs significantly differ in terms of oligomeric properties, cation binding, and GC regulation. Myristoylated GCAP2 endothermically binds up to 3 Mg2+ with high affinity and forms a compact dimer that may reversibly dissociate in the presence of Ca2+. Conversely, nonmyristoylated GCAP2 does not bind Mg2+ over the physiological range and remains as a monomer in the absence of Ca2+. Both myristoylated and nonmyristoylated GCAP2 bind Ca2+ with high affinity. At odds with guanylate cyclase-activating protein 1 and independently of myristoylation, human GCAP2 does not significantly activate retinal GC1 in a Ca2+-dependent fashion. The IRD-associated G157R variant is characterized by a partly misfolded, molten globule-like conformation with reduced affinity for cations and prone to form aggregates, likely mediated by hydrophobic interactions. Our findings suggest that GCAP2 might be mostly implicated in processes other than phototransduction in human photoreceptors and suggest a possible molecular mechanism for G157R-associated IRD.	[Avesani, Anna; Marino, Valerio; Dell'Orco, Daniele] Univ Verona, Dept Neurosci Biomed & Movement Sci, Biol Chem Sect, Verona, Italy; [Zanzoni, Serena] Univ Verona, Ctr Piattaforme Tecnol, Verona, Italy; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Div Biochem, Oldenburg, Germany	University of Verona; University of Verona; Carl von Ossietzky Universitat Oldenburg	Dell'Orco, D (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Biol Chem Sect, Verona, Italy.	daniele.dellorco@univr.it	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044; zanzoni, serena/0000-0003-0495-295X; DELL'ORCO, Daniele/0000-0002-3724-3044	Fondazione Telethon, Italy [GGP16010]; University of Verona [2018 JPVR184ZZ5]; Italian Ministry of University and Research [201744NR8S]	Fondazione Telethon, Italy(Fondazione Telethon); University of Verona; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was funded by Fondazione Telethon, Italy, Grant number GGP16010, a grant from the University of Verona (Joint Project 2018 JPVR184ZZ5), and a grant from the Italian Ministry of University and Research (PRIN 2017, 201744NR8S) to D. D.	Abbas S, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3580; Ames JB, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00397; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen X, 2017, GENET MED, V19, P945, DOI 10.1038/gim.2016.217; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dal Cortivo G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51573-3; Dell'Orco D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56606-5; Dell'Orco D, 2014, CELL MOL LIFE SCI, V71, P3829, DOI 10.1007/s00018-014-1593-4; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Huang L, 2013, NEUROSCI LETT, V541, P179, DOI 10.1016/j.neulet.2013.02.013; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BBA-PROTEINS PROTEOM, V1600, P111, DOI 10.1016/S1570-9639(02)00451-X; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Invergo BM, 2014, MOL BIOSYST, V10, P1481, DOI 10.1039/c3mb70584f; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Kamenarova K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/517570; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Koch KW, 2013, ACS CHEM NEUROSCI, V4, P909, DOI 10.1021/cn400027z; Koch Karl-Wilhelm, 2008, P121; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Lim S, 2016, J BIOL CHEM, V291, P4429, DOI 10.1074/jbc.M115.696161; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Lopez-Begines S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20893-1; Lopez-del Hoyo N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004480; Lopez-del Hoyo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042994; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Marino V, 2018, HUM MOL GENET, V27, P4204, DOI 10.1093/hmg/ddy311; Marino V, 2017, NANOSCALE, V9, P11773, DOI 10.1039/c7nr03288a; Marino V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34277; Marino V, 2015, HUM MOL GENET, V24, P6653, DOI 10.1093/hmg/ddv370; Marino V, 2015, BBA-MOL CELL RES, V1853, P2055, DOI 10.1016/j.bbamcr.2014.10.026; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Nong E, 2014, DOC OPHTHALMOL, V128, P59, DOI 10.1007/s10633-013-9420-z; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko I. V., 2004, BIOCHEMISTRY; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2020, J BIOL CHEM, V295, P18301, DOI 10.1074/jbc.RA120.015553; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pettelkau J, 2013, J AM SOC MASS SPECTR, V24, P1969, DOI 10.1007/s13361-013-0734-6; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Schmitz F, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00003; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Theisgen S, 2011, EUR BIOPHYS J BIOPHY, V40, P565, DOI 10.1007/s00249-011-0680-9; Vallone R, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00274; Vinberg F, 2018, J BIOL CHEM, V293, P7457, DOI 10.1074/jbc.RA117.001574; Viviano J, 2016, ANAL BIOCHEM, V494, P93, DOI 10.1016/j.ab.2015.11.005; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00348; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p	75	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100619	10.1016/j.jbc.2021.100619	http://dx.doi.org/10.1016/j.jbc.2021.100619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812995	Green Published, gold			2022-12-26	WOS:000672866400590
J	Boudko, SP; Bauer, R; Chetyrkin, SV; Ivanov, S; Smith, J; Voziyan, PA; Hudson, BG				Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Smith, Jarrod; Voziyan, Paul A.; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. II. Crystal structure of the alpha 345 hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOODPASTURE AUTOANTIGEN; IV COLLAGEN; STABILIZATION; ORGANIZATION; NETWORK; DOMAINS; ANTIGEN; CHAIN; AMBER	Our recent work identified a genetic variant of the alpha 345 hexamer of the collagen IV scaffold that is present in patients with glomerular basement membrane diseases, Goodpasture's disease (GP) and Alport syndrome (AS), and phenocopies of AS in knock-in mice. To understand the context of this "Zurich" variant, an 8-amino acid appendage, we developed a construct of the WT alpha 345 hexamer using the single-chain NC1 trimer technology, which allowed us to solve a crystal structure of this key connection module. The alpha 345 hexamer structure revealed a ring of 12 chloride ions at the trimer-trimer interface, analogous to the collagen alpha 121 hexamer, and the location of the 170 AS variants. The hexamer surface is marked by multiple pores and crevices that are potentially accessible to small molecules. Loop-crevice-loop features constitute bioactive sites, where pathogenic pathways converge that are linked to AS and GP, and, potentially, diabetic nephropathy. In Pedchenko et al., we demonstrate that these sites exhibit conformational plasticity, a dynamic property underlying assembly of bioactive sites and hexamer dysfunction. The alpha 345 hexamer structure is a platform to decipher how variants cause AS and how hypoepitopes can be triggered, causing GP. Furthermore, the bioactive sites, along with the pores and crevices on the hexamer surface, are prospective targets for therapeutic interventions.	[Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Voziyan, Paul A.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA; [Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Voziyan, Paul A.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA; [Boudko, Sergei P.; Smith, Jarrod; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Inst Chem Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Boudko, SP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA.; Boudko, SP (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA.; Boudko, SP (corresponding author), Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA.	Sergey.Budko@vumc.org	Ivanov, Sergey/GSD-3061-2022	Boudko, Sergei/0000-0003-3856-4859	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK18381-50, R24DK103067, R01DK065138, R01DK018381-49S]; Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center	This work was supported by Grants R01DK18381-50 and a supplement R01DK018381-49S (to B. G. H.), R24DK103067 (to B. G. H.), R01DK065138 (to B. G. H. and P. A. V.) from the National Institute of Diabetes and Digestive and Kidney Diseases. Additional support was provided by the Aspirnaut program from the Center for Matrix Biology at Vanderbilt University Medical Center. S. P. B. was supported, in part, by start-up funding from Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Casino P, 2018, IUCRJ, V5, P765, DOI 10.1107/S2052252518012459; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pedchenko V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100592; Pedchenko V, 2019, J BIOL CHEM, V294, P7968, DOI 10.1074/jbc.RA119.007426; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Pokidysheva EN, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100590; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Silk M, 2019, NUCLEIC ACIDS RES, V47, pW121, DOI 10.1093/nar/gkz457; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Xie LJ, 2017, IMMUNOLOGY, V151, P395, DOI 10.1111/imm.12736	36	6	6	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100591	10.1016/j.jbc.2021.100591	http://dx.doi.org/10.1016/j.jbc.2021.100591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775698	Green Published, gold			2022-12-26	WOS:000672866400563
J	Hornos, F; Feng, HZ; Rizzuti, B; Palomino-Schatzlein, M; Wieczorek, D; Neira, JL; Jin, JP				Hornos, Felipe; Feng, Han-Zhong; Rizzuti, Bruno; Palomino-Schatzlein, Martina; Wieczorek, David; Neira, Jose L.; Jin, J. -P.			The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PRESERVED EJECTION FRACTION; TRANSGENIC MOUSE MODEL; HUMAN CARDIAC TROPONIN; CIRCULAR-DICHROISM; FOLDING PROBLEM; DIASTOLIC DYSFUNCTION; HYDRODYNAMIC RADII; STRUCTURAL BASIS; HEART-FAILURE	The conserved C-terminal end segment of troponin I (TnI) plays a critical role in regulating muscle relaxation. This function is retained in the isolated C-terminal 27 amino acid peptide (residues 184-210) of human cardiac TnI (HcTnI-C27): When added to skinned muscle fibers, HcTnI-C27 reduces the Ca2+-sensitivity of activated myofibrils and facilitates relaxation without decreasing the maximum force production. However, the underlying mechanism of HcTnI-C27 function is unknown. We studied the conformational preferences of HcTnI-C27 and a myopathic mutant, Arg192His, (HcTnI-C27-H). Both peptides were mainly disordered in aqueous solution with a nascent helix involving residues from Trp191 to Ile195, as shown by NMR analysis and molecular dynamics simulations. The population of nascent helix was smaller in HcTnI-C27-H than in HcTnI-C27, as shown by circular dichroism (CD) titrations. Fluorescence and isothermal titration calorimetry (ITC) showed that both peptides bound tropomyosin (alpha Tm), with a detectably higher affinity (similar to 10 mu M) of HcTnI-C27 than that of HcTnI-C27-H (similar to 15 mu M), consistent with an impaired Ca2+-desensitization effect of the mutant peptide on skinned muscle strips. Upon binding to aTm, HcTnI-C27 acquired a weakly stable helix-like conformation involving residues near Trp191, as shown by transferred nuclear Overhauser effect spectroscopy and hydrogen/deuterium exchange experiments. With the potent Ca2+-desensitization effect of HcTnI-C27 on skinned cardiac muscle from a mouse model of hypertrophic cardiomyopathy, the data support that the C-terminal end domain of TnI can function as an isolated peptide with the intrinsic capacity of binding tropomyosin, providing a promising therapeutic approach to selectively improve diastolic function of the heart.	[Hornos, Felipe; Neira, Jose L.] Univ Miguel Hernandez, IDIBE, Alicante, Spain; [Feng, Han-Zhong; Jin, J. -P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Rizzuti, Bruno] Licryl UOS Cosenza, CNR NANOTEC, Cosenza, Italy; [Rizzuti, Bruno] Univ Calabria, Dept Phys, CEMIF Cal, Cosenza, Italy; [Palomino-Schatzlein, Martina] Ctr Invest Principe Felipe Valencia, Dept NMR, Valencia, Spain; [Wieczorek, David] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cinncinnnati, OH USA; [Neira, Jose L.] Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Wayne State University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Nanotecnologia (NANOTEC-CNR); University of Calabria; Prince Felipe Research Center; University System of Ohio; University of Cincinnati	Neira, JL (corresponding author), Univ Miguel Hernandez, IDIBE, Alicante, Spain.; Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.; Neira, JL (corresponding author), Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain.	jlneira@umh.es; jjin@med.wayne.edu	Neira, Jose/ABF-4210-2021; Rizzuti, Bruno/B-5781-2013	Rizzuti, Bruno/0000-0003-1110-764X; Jin, JP/0000-0001-9932-1063; Palomino-Schatzlein, Martina/0000-0001-7303-0743; Neira, Jose Luis/0000-0002-4933-0428	Spanish Ministry of Economy and Competitiveness; European ERDF Funds (MCIU/AEI/FEDER, EU) [RTI2018-097991-B-I00]; National Institutes of Health of USA [HL127691, HL138007]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European ERDF Funds (MCIU/AEI/FEDER, EU); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) [RTI2018-097991-B-I00 to J. L. N.] and National Institutes of Health of USA [Grants HL127691 and HL138007 to J. P. J.].	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Beckett D, 2011, METHOD ENZYMOL, P1, DOI 10.1016/B978-0-12-381268-1.00001-X; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; Bruix M, 1997, EUR J BIOCHEM, V243, P384, DOI 10.1111/j.1432-1033.1997.0384a.x; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132; Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018; Evoli S, 2014, PROTEINS, V82, P2609, DOI 10.1002/prot.24625; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng HZ, 2020, EXP PHYSIOL, V105, P1869, DOI 10.1113/EP088521; Gay GD, 1996, ARCH BIOCHEM BIOPHYS, V335, P1, DOI 10.1006/abbi.1996.0475; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Grande F, 2018, MOLECULES, V23, DOI 10.3390/molecules23040894; Guntert P, 1998, Q REV BIOPHYS, V31, P145, DOI 10.1017/S0033583598003436; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakob U, 2014, CHEM REV, V114, P6779, DOI 10.1021/cr400459c; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KEMMINK J, 1993, J MOL BIOL, V234, P861, DOI 10.1006/jmbi.1993.1631; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Launay H, 2018, J MOL BIOL, V430, P1218, DOI 10.1016/j.jmb.2018.02.020; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Melenovsky V, 2007, J AM COLL CARDIOL, V49, P198, DOI 10.1016/j.jacc.2006.08.050; Mitrea DM, 2013, FEBS LETT, V587, P1081, DOI 10.1016/j.febslet.2013.02.024; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; MUNOZ V, 1995, J MOL BIOL, V247, P648, DOI 10.1006/jmbi.1994.0170; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Neira JL, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.07.005; Neira JL, 2016, ARCH BIOCHEM BIOPHYS, V598, P18, DOI 10.1016/j.abb.2016.03.034; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Royer CA, 2008, METHOD ENZYMOL, V450, P79, DOI 10.1016/S0076-6879(08)03405-8; Sanches K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70034-w; SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3; Schultz JE, 2013, TRENDS BIOCHEM SCI, V38, P538, DOI 10.1016/j.tibs.2013.08.005; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Whitby FG, 2000, PROTEINS, V38, P49; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wong S, 2019, J MOL CELL CARDIOL, V136, P42, DOI 10.1016/j.yjmcc.2019.09.002; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yadahalli S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36589-5; Zhang ZL, 2011, FEBS J, V278, P3348, DOI 10.1111/j.1742-4658.2011.08250.x	73	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100228	10.1074/jbc.RA120.016012	http://dx.doi.org/10.1074/jbc.RA120.016012			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33814345	Green Published, gold			2022-12-26	WOS:000672866400206
J	Dumont, AA; Dumont, L; Zhou, DL; Giguere, H; Pileggi, C; Harper, ME; Blondin, DP; Scott, MS; Auger-Messier, M				Dumont, Audrey-Ann; Dumont, Lauralyne; Zhou, Delong; Giguere, Hugo; Pileggi, Chantal; Harper, Mary-Ellen; Blondin, Denis P.; Scott, Michelle S.; Auger-Messier, Mannix			Cardiomyocyte-specific Srsf3 deletion reveals a mitochondrial regulatory role	FASEB JOURNAL			English	Article						cardiomyocyte; mitochondria; oxidative phosphorylation; respiratory chain complex I; Srsf3	HIGH-FAT DIET; HIPPOCAMPAL NEUROGENESIS; PREFRONTAL CORTEX; MATERNAL OBESITY; NMDA; GLUTAMATE; MEMORY; EXPRESSION; PREGNANCY; BEHAVIOR	Serine-rich splicing factor 3 (SRSF3) was recently reported as being necessary to preserve RNA stability via an mTOR mechanism in a cardiac mouse model in adulthood. Here, we demonstrate the link between Srsf3 and mitochondrial integrity in an embryonic cardiomyocyte-specific Srsf3 conditional knockout (cKO) mouse model. Fifteen-day-old Srsf3 cKO mice showed dramatically reduced (below 50%) survival and reduced the left ventricular systolic performance, and histological analysis of these hearts revealed a significant increase in cardiomyocyte size, confirming the severe remodeling induced by Srsf3 deletion. RNA-seq analysis of the hearts of 5-day-old Srsf3 cKO mice revealed early changes in expression levels and alternative splicing of several transcripts related to mitochondrial integrity and oxidative phosphorylation. Likewise, the levels of several protein complexes of the electron transport chain decreased, and mitochondrial complex I-driven respiration of permeabilized cardiac muscle fibers from the left ventricle was impaired. Furthermore, transmission electron microscopy analysis showed disordered mitochondrial length and cristae structure. Together with its indispensable role in the physiological maintenance of mouse hearts, these results highlight the previously unrecognized function of Srsf3 in regulating the mitochondrial integrity.	[Dumont, Audrey-Ann; Dumont, Lauralyne; Giguere, Hugo; Blondin, Denis P.; Auger-Messier, Mannix] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Med,Serv Cardiol, Sherbrooke, PQ J1H 5N4, Canada; [Zhou, Delong] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ, Canada; [Pileggi, Chantal; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Scott, Michelle S.] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Biochim & Genom Fonct, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Ottawa; University of Sherbrooke	Auger-Messier, M (corresponding author), Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Sci Sante, Dept Med,Serv Cardiol, Sherbrooke, PQ J1H 5N4, Canada.	Mannix.Auger-Messier@USherbrooke.ca		Harper, Mary-Ellen/0000-0003-3864-5886; ZHOU, Delong/0000-0001-5397-3920; Auger-Messier, Mannix/0000-0001-8600-5440; Dumont, Lauralyne/0000-0002-7681-6212; Giguere, Hugo/0000-0001-7193-0051	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [301131, FDN143278]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 301131 and FDN143278	Abbott KN, 2019, NEUROSCI BIOBEHAV R, V107, P399, DOI 10.1016/j.neubiorev.2019.08.010; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Ashwood P, 2008, J AUTISM DEV DISORD, V38, P169, DOI 10.1007/s10803-006-0353-1; Beilharz JE, 2015, NUTRIENTS, V7, P6719, DOI 10.3390/nu7085307; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boitard C, 2012, HIPPOCAMPUS, V22, P2095, DOI 10.1002/hipo.22032; Cadena-Burbano EV, 2019, NUTR NEUROSCI, V22, P98, DOI 10.1080/1028415X.2017.1354958; Carpita B, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3717215; Cercato MC, 2014, J PHYSIOL-PARIS, V108, P263, DOI 10.1016/j.jphysparis.2014.08.001; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chin EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174030; Choi CS, 2015, J NUTR BIOCHEM, V26, P1520, DOI 10.1016/j.jnutbio.2015.07.018; Cohen JFW, 2018, AM J PREV MED, V54, P727, DOI 10.1016/j.amepre.2018.02.020; Cordner ZA, 2019, EXP NEUROL, V318, P92, DOI 10.1016/j.expneurol.2019.04.018; DeCapo M, 2019, BIOL PSYCHIAT, V85, P122, DOI 10.1016/j.biopsych.2018.08.006; Desai RA, 2009, CNS SPECTRUMS, V14, P372, DOI 10.1017/S1092852900023026; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Flores-Barrera E, 2014, BIOL PSYCHIAT, V75, P508, DOI 10.1016/j.biopsych.2013.07.033; Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344; Gao C, 2010, HIPPOCAMPUS, V20, P1072, DOI 10.1002/hipo.20705; Glendining KA, 2018, PSYCHONEUROENDOCRINO, V96, P132, DOI 10.1016/j.psyneuen.2018.06.015; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Hammerton G, 2014, INT J OBESITY, V38, P513, DOI 10.1038/ijo.2013.133; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Harraz Maged M, 2014, Mol Cell Ther, V2; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Hunsberger JG, 2009, NEUROMOL MED, V11, P173, DOI 10.1007/s12017-009-8070-5; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Kiyohara Chikako, 2009, Environmental Health and Preventive Medicine, V14, P71, DOI 10.1007/s12199-008-0073-6; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; de la Garza AL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030572; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Marcondes LA, 2020, NEUROBIOL LEARN MEM, V168, DOI 10.1016/j.nlm.2019.107153; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mendes-da-Silva C, 2015, INT J DEV NEUROSCI, V40, P35, DOI 10.1016/j.ijdevneu.2014.11.005; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mitchell S, 2015, BEST PRACT RES CL OB, V29, P289, DOI 10.1016/j.bpobgyn.2014.10.002; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Moutin E, 2012, J CELL SCI, V125, P2030, DOI 10.1242/jcs.098160; Mucellini AB, 2019, BRAIN RES, V1708, P138, DOI 10.1016/j.brainres.2018.12.021; Naef L, 2013, STRESS, V16, P540, DOI 10.3109/10253890.2013.805321; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Ogden CL., 2014, JAMA-J AM MED ASSOC, V312, p189; Page KC, 2014, AM J PHYSIOL-REG I, V306, pR527, DOI 10.1152/ajpregu.00319.2013; Panchenko PE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050948; Patterson PH, 2012, BRAIN BEHAV IMMUN, V26, P393, DOI 10.1016/j.bbi.2011.09.008; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Pilc A, 2008, BIOCHEM PHARMACOL, V75, P997, DOI 10.1016/j.bcp.2007.09.021; Qian Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00770; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Ray GT, 2009, MED CARE, V47, P105, DOI 10.1097/MLR.0b013e31817e18c0; Robb JL, 2017, BEHAV BRAIN RES, V326, P187, DOI 10.1016/j.bbr.2017.02.049; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Robinson M, 2013, J DEV ORIG HLTH DIS, V4, P42, DOI 10.1017/S2040174412000578; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Sarker G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53652-x; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sousa Fabio J, 2020, Brain Behav Immun Health, V5, P100075, DOI 10.1016/j.bbih.2020.100075; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Trujillo-Villarreal LA, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01157-x; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Baez MV, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5093048; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Vuong B, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0859-9; Weible AP, 2009, J NEUROPHYSIOL, V102, P2055, DOI 10.1152/jn.00214.2009; WHO, 2014, OB OV; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Winther G, 2018, NEUROSCIENCE, V388, P87, DOI 10.1016/j.neuroscience.2018.07.014; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2015, HIPPOCAMPUS, V25, P1274, DOI 10.1002/hipo.22435; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001; Zheng HH, 2016, MOL NEUROBIOL, V53, P1, DOI 10.1007/s12035-014-8981-5	93	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21544	10.1096/fj.202002293RR	http://dx.doi.org/10.1096/fj.202002293RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33819356	Green Submitted			2022-12-26	WOS:000645260100081
J	Eid, SA; Hinder, LM; Zhang, HY; Eksi, R; Nair, V; Eddy, S; Eichinger, F; Park, M; Saha, J; Berthier, CC; Jagadish, HV; Guan, YF; Pennathur, S; Hur, J; Kretzler, M; Feldman, EL; Brosius, FC				Eid, Stephanie A.; Hinder, Lucy M.; Zhang, Hongyu; Eksi, Ridvan; Nair, Viji; Eddy, Sean; Eichinger, Felix; Park, Meeyoung; Saha, Jharna; Berthier, Celine C.; Jagadish, Hosagrahar, V; Guan, Yuanfang; Pennathur, Subramaniam; Hur, Junguk; Kretzler, Matthias; Feldman, Eva L.; Brosius, Frank C.			Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects	FASEB JOURNAL			English	Article						diabetic kidney disease; diabetic peripheral neuropathy; genome-wide expression; RAS blockade; self-organizing map	NEPHROPATHY; PODOCYTE; DEFICIENCY; BIOLOGY; SYSTEM; CELLS	Diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN) are two common diabetic complications. However, their pathogenesis remains elusive and current therapies are only modestly effective. We evaluated genome-wide expression to identify pathways involved in DKD and DPN progression in db/db eNOS-/- mice receiving renin-angiotensin-aldosterone system (RAS)-blocking drugs to mimic the current standard of care for DKD patients. Diabetes and eNOS deletion worsened DKD, which improved with RAS treatment. Diabetes also induced DPN, which was not affected by eNOS deletion or RAS blockade. Given the multiple factors affecting DKD and the graded differences in disease severity across mouse groups, an automatic data analysis method, SOM, or self-organizing map was used to elucidate glomerular transcriptional changes associated with DKD, whereas pairwise bioinformatic analysis was used for DPN. These analyses revealed that enhanced gene expression in several pro-inflammatory networks and reduced expression of development genes correlated with worsening DKD. Although RAS treatment ameliorated the nephropathy phenotype, it did not alter the more abnormal gene expression changes in kidney. Moreover, RAS exacerbated expression of genes related to inflammation and oxidant generation in peripheral nerves. The graded increase in inflammatory gene expression and decrease in development gene expression with DKD progression underline the potentially important role of these pathways in DKD pathogenesis. Since RAS blockers worsened this gene expression pattern in both DKD and DPN, it may partly explain the inadequate therapeutic efficacy of such blockers.	[Eid, Stephanie A.; Hinder, Lucy M.; Park, Meeyoung; Feldman, Eva L.] Univ Michigan, Dept Neurol, Sch Med, 5017 AATBSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Zhang, Hongyu; Nair, Viji; Eddy, Sean; Eichinger, Felix; Saha, Jharna; Berthier, Celine C.; Pennathur, Subramaniam; Kretzler, Matthias; Brosius, Frank C.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Eksi, Ridvan; Jagadish, Hosagrahar, V; Guan, Yuanfang; Kretzler, Matthias] Univ Michigan, Dept Computat Med & Biol, Sch Med, Ann Arbor, MI 48109 USA; [Pennathur, Subramaniam; Brosius, Frank C.] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48109 USA; [Hur, Junguk] Univ North Dakota, Dept Biomed Sci, Grand Forks, ND USA; [Brosius, Frank C.] Univ Arizona, Dept Med, Tucson, AZ USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Dakota Grand Forks; University of Arizona	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Sch Med, 5017 AATBSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	efeldman@umich.edu			HHS | National Institutes of Health (NIH) [1DP3DK094292]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R24082841, U2CDK110768]; Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research) [NNF14OC0011633]; Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center [2P30DK081943]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center	HHS | National Institutes of Health (NIH), Grant/Award Number: 1DP3DK094292; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 1R24082841 and U2CDK110768; Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research), Grant/Award Number: NNF14OC0011633; The Nathan and Rose Milstein Research Fund; Neuronetwork for Emerging Therapies at the University of Michigan; the A. Alfred Taubman Medical Research Institute; University of Michigan O'Brien Kidney Translational Core Center, Grant/Award Number: 2P30DK081943	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azushima K, 2018, NAT REV NEPHROL, V14, P48, DOI 10.1038/nrneph.2017.142; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Bhatt LK, 2010, NEUROL SCI, V31, P705, DOI 10.1007/s10072-010-0243-3; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Callaghan BC, 2020, JAMA-J AM MED ASSOC, V324, P90, DOI 10.1001/jama.2020.0700; Callaghan BC, 2018, ANN CLIN TRANSL NEUR, V5, P397, DOI 10.1002/acn3.531; Chittka D, 2018, NEPHROL DIAL TRANSPL, V33, P1533, DOI 10.1093/ndt/gfx359; del Nogal M, 2012, APOPTOSIS, V17, P1261, DOI 10.1007/s10495-012-0769-3; Eid S, 2019, DIABETOLOGIA, V62, P1539, DOI 10.1007/s00125-019-4959-1; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Feldman EL, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0092-1; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Guo K, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00913-6; Gupta G, 2020, CHEM-BIOL INTERACT, V317, DOI 10.1016/j.cbi.2020.108975; Gurley SB, 2018, DIABETES, V67, P2096, DOI 10.2337/db17-1323; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hinder LM, 2018, EXP NEUROL, V305, P33, DOI 10.1016/j.expneurol.2018.03.011; Hinder LM, 2017, J CELL MOL MED, V21, P2140, DOI 10.1111/jcmm.13136; Hinder LM, 2017, DIS MODEL MECH, V10, P717, DOI 10.1242/dmm.028530; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Hur J, 2016, DIABETOLOGIA, V59, P1297, DOI 10.1007/s00125-016-3913-8; Hur J, 2015, DIABETES, V64, P3294, DOI 10.2337/db15-0133; Hur J, 2011, BRAIN, V134, P3222, DOI 10.1093/brain/awr228; Jiang GZ, 2016, KIDNEY INT, V89, P411, DOI 10.1016/j.kint.2015.09.001; Jurga AM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00048; Juster-Switlyk K., 2016, F1000RES, V5, P738, DOI [10.12688/f1000research.7898.1, DOI 10.12688/F1000RESEARCH.7898.1]; Kallenborn-Gerhardt W, 2014, PAIN, V155, P2161, DOI 10.1016/j.pain.2014.08.013; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Komorowsky CV, 2012, J CARDIOVASC TRANSL, V5, P491, DOI 10.1007/s12265-012-9382-7; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laboratory B., ANIMAL MODELS DIABET; Leoncini G, 2020, J NEPHROL, V33, P949, DOI 10.1007/s40620-020-00803-3; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Liu YF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00172; Maity S, 2020, J BIOL CHEM, V295, P14262, DOI 10.1074/jbc.RA120.014994; Manea SA, 2015, REDOX BIOL, V5, P358, DOI 10.1016/j.redox.2015.06.012; Matoba K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143393; McGregor BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36098-5; Mifsud SA, 2001, DIABETOLOGIA, V44, P878; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; O'Brien PD, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.042101; O'Brien PD, 2015, NEUROBIOL DIS, V73, P348, DOI 10.1016/j.nbd.2014.10.015; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Perlman AS, 2015, ANN CLIN LAB SCI, V45, P256; Roscioni SS, 2014, NAT REV NEPHROL, V10, P77, DOI 10.1038/nrneph.2013.251; Sanden SK, 2003, J AM SOC NEPHROL, V14, P2484, DOI 10.1097/01.ASN.0000089829.45296.7C; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Sas KM, 2018, J LIPID RES, V59, P173, DOI 10.1194/jlr.M077222; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shi Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67054-x; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; Sun L, 2015, KIDNEY INT, V88, P662, DOI 10.1038/ki.2015.250; Takahashi T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/590541; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Williams AS, 2017, DIABETES, V66, P325, DOI 10.2337/db16-0484; Wilson PC, 2019, P NATL ACAD SCI USA, V116, P19619, DOI 10.1073/pnas.1908706116; Zain M, 2014, PAK J PHARM SCI, V27, P1379; Zhang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1071, DOI 10.1152/ajprenal.90208.2008; Zhang HY, 2017, KIDNEY INT, V92, P909, DOI 10.1016/j.kint.2017.03.027; Zhang HY, 2010, AM J PHYSIOL-RENAL, V299, pF91, DOI 10.1152/ajprenal.00021.2010; Zhang MZ, 2012, AM J PHYSIOL-RENAL, V302, pF433, DOI 10.1152/ajprenal.00292.2011; Zhang Z, 2008, P NATL ACAD SCI USA, V105, P15896, DOI 10.1073/pnas.0803751105; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zheng XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185250	73	4	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21467	10.1096/fj.202002387R	http://dx.doi.org/10.1096/fj.202002387R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788970	Green Published			2022-12-26	WOS:000645260100029
J	Huang, DD; Ding, QH; Chen, SB; Lu, SQ; Zhang, Y; Long, MA				Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian			E-selectin negatively regulates polymorphonuclear neutrophil transmigration through altered endothelial junction integrity	FASEB JOURNAL			English	Article						cytoskeletal remodeling; endothelial integrity; E-selectin; neutrophil; transmigration	ARP2/3 COMPLEX; CELL-ADHESION; LEUKOCYTE ADHESION; ACTIN; DYNAMICS; LAMELLIPODIA; CORTACTIN; MOLECULES; MIGRATION; PROTEINS	Transendothelial migration (TEM) of neutrophils under blood flow is critical in the inflammatory cascade. However, the role of endothelial plasticity in this process is not fully understood. Therefore, we used an in vitro model to test the dynamics of human polymorphonuclear neutrophil (PMN) TEM across lipopolysaccharide-treated human umbilical vein endothelial cell (HUVEC) monolayers. Interestingly, shRNA-E-selectin knockdown in HUVECs destabilized endothelial junctional integrity by reducing actin branching and increasing stress fiber at cell-cell junctions. This process is accomplished by downregulating the activation of cortactin and Arp2/3, which in turn alters the adhesive function of VE-cadherin, enhancing PMN transmigration. Meanwhile, redundant P-selectins possess overlapping functions in E-selectin-mediated neutrophil adhesion, and transmigration. These results demonstrate, to our knowledge, for the first time, that E-selectins negatively regulate neutrophil transmigration through alterations in endothelial plasticity. Furthermore, it improves our understanding of the mechanisms underlying actin remodeling, and junctional integrity, in endothelial cells mediating leukocyte TEM.	[Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Ctr Biomech & Bioengn,Key Lab Micrograv, Beijing 100190, Peoples R China; [Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100190, Peoples R China; [Huang, Dandan; Ding, Qihan; Chen, Shenbao; Lu, Shouqin; Zhang, Yan; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y; Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Ctr Biomech & Bioengn,Key Lab Micrograv, Beijing 100190, Peoples R China.; Zhang, Y; Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100190, Peoples R China.	zhangyan@imech.ac.cn; mlong@imech.ac.cn			National Natural Science Foundation of China (NSFC) [31627804, 91642203, 11772345, 91539119]; National Key Rsearch and Development Program of China [2016YFA0501601]; Chinese Academy of Sciences Strategic Priority Research Program [XDB22040101]; Frontier Science Key Project [QYZDJ--SSW--JSC018]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Rsearch and Development Program of China; Chinese Academy of Sciences Strategic Priority Research Program; Frontier Science Key Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31627804, 91642203, 11772345 and 91539119; National Key Rsearch and Development Program of China, Grant/Award Number: 2016YFA0501601; Chinese Academy of Sciences Strategic Priority Research Program, Grant/Award Number: XDB22040101; Frontier Science Key Project, Grant/Award Number: QYZDJ--SSW--JSC018	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Alon R, 2017, TRENDS IMMUNOL, V38, P606; Belvitch P, 2017, PULM CIRC, V7, P200, DOI 10.1086/690307; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brodt P, 1997, INT J CANCER, V71, P612, DOI 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D; Dimchev G, 2017, MOL BIOL CELL, V28, P1311, DOI 10.1091/mbc.E16-05-0334; Eguiluz RCA, 2017, BIOMATERIALS, V140, P45, DOI 10.1016/j.biomaterials.2017.06.010; Gong YX, 2017, FASEB J, V31, P212, DOI 10.1096/fj.201600398RRR; Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438; Hu J, 2019, BIOPHYS REP, V6, P9; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Isac L, 2011, ANAL BIOANAL CHEM, V399, P2351, DOI 10.1007/s00216-010-3978-z; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Martinelli R, 2014, J CELL SCI, V127, P3720, DOI 10.1242/jcs.148619; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McEver RP, 2010, ANN REV, P363; Milstone DS, 1998, MICROCIRCULATION-LON, V5, P153, DOI 10.1080/713773857; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rajagopal V, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1407; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schnittler H, 2014, CELL TISSUE RES, V355, P529, DOI 10.1007/s00441-014-1856-2; Schnoor M, 2015, J IMMUNOL, V194, P3535, DOI 10.4049/jimmunol.1403250; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tilghman RW, 2002, FASEB J, V16, P1257, DOI 10.1096/fj.01-0969fje; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Xu YH, 2019, APL BIOENG, V3, DOI 10.1063/1.5045115; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445	51	2	2	8	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21521	10.1096/fj.202000662RR	http://dx.doi.org/10.1096/fj.202000662RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811691				2022-12-26	WOS:000645260100005
J	Ma, C; Teng, L; Lin, G; Guo, BB; Zhuo, R; Qian, XW; Guan, TC; Wu, RH; Liu, Y; Liu, M				Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei			L-leucine promotes axonal outgrowth and regeneration via mTOR activation	FASEB JOURNAL			English	Article						axonal outgrowth; CSPGs; L-Leucine; mTOR pathway; spinal cord injury	SPINAL-CORD; PTEN; SUPPLEMENTATION; SYSTEM; MICROTUBULES; LOCOMOTION; SURVIVAL; DELETION; 3-KINASE; PATHWAY	Discovering safe and effective drugs that promote neuron regeneration is an essential strategy for the recovery of central nervous system injuries. In this study, we found that L-leucine, an essential amino acid obtained from both supplements and food sources, could dramatically boost axonal outgrowth and regeneration. First, the effects of L-leucine on neurons were evaluated by cell apoptosis, survival, and death assays, and the results showed no changes in these processes after treatment. By live cell imaging, L-leucine was found to remarkably increase axonal length and growth velocity after axotomy. We also verified that L-leucine enhanced p-mTOR/p-S6K activation in neurons by testing with an mTOR inhibitor, rapamycin. Thereafter, we investigated the effects of L-leucine on the spinal cord injury in vivo. A mouse model of spinal cord hemi-section was established, and L-leucine was administered by tail intravenous injection. Basso mouse scale values revealed that L-leucine could improve functional recovery after injury. It was also notable that L-leucine treatment promoted axon growth across chondroitin sulfate proteoglycan (CSPG) areas. Furthermore, we used CSPGs as inhibitory environmental cues and clarified that L-leucine significantly enhanced axonal outgrowth and regeneration by promoting p-mTOR and p-S6K activation. Therefore, our study is the first to report that L-leucine promotes axonal regeneration in vitro and in vivo and could be candidate drug for axonal re-growth and nervous functional recovery.	[Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China; [Ma, Chao; Teng, Long; Lin, Ge; Guo, Beibei; Zhuo, Run; Qian, Xiaowei; Guan, Tuchen; Wu, Ronghua; Liu, Yan; Liu, Mei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Liu, Y; Liu, M (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Jiangsu, Peoples R China.; Liu, Y; Liu, M (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong 226001, Jiangsu, Peoples R China.	liuyan@ntu.edu.cn; liumei@ntu.edu.cn	; Liu, Mei/H-9415-2018	ma, chao/0000-0001-9478-1810; Guan, Tuchen/0000-0001-5929-5489; Liu, Mei/0000-0003-1168-6119	National Major Project of Research and Development [2017YFA0104701]; National Natural Science Foundation of China [31970412, 32070725]; Natural Science Foundation of Jiangsu Province [BK20191446]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Major Project of Research and Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This study was supported by the National Major Project of Research and Development (2017YFA0104701), the National Natural Science Foundation of China (31970412, 32070725), Natural Science Foundation of Jiangsu Province (BK20191446), and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	de Moraes WMAM, 2015, NUTRIENTS, V7, P3751, DOI 10.3390/nu7053751; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Berry M, 2016, NEUROBIOL DIS, V85, P99, DOI 10.1016/j.nbd.2015.10.002; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dhamija R, 2020, CLIN IMAG, V60, P180, DOI 10.1016/j.clinimag.2019.12.006; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Elghazi L, 2017, MOL METAB, V6, P560, DOI 10.1016/j.molmet.2017.03.010; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Hu ZL, 2017, MOL BIOL CELL, V28, P545, DOI 10.1091/mbc.E16-09-0628; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Ishizuka Y, 2008, J NEUROCHEM, V106, P934, DOI 10.1111/j.1471-4159.2008.05438.x; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Matamoros AJ, 2019, J NEUROSCI, V39, P2011, DOI 10.1523/JNEUROSCI.1888-18.2018; Morgan-Warren PJ, 2013, INVEST OPHTH VIS SCI, V54, P6903, DOI 10.1167/iovs.13-12803; Ohtake Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37152; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Pedroso JAB, 2015, NUTRIENTS, V7, P3914, DOI 10.3390/nu7053914; Pereira MG, 2014, NUTRIENTS, V6, P3981, DOI 10.3390/nu6103981; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Poulopoulos A, 2019, NATURE, V565, P356, DOI 10.1038/s41586-018-0847-y; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Teng L, 2020, BIOCHEM BIOPH RES CO, V534, P121; Tran AP, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113276; Wei XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091075; Wu RH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01303; Yang T, 2016, NEUROPHARMACOLOGY, V110, P343, DOI 10.1016/j.neuropharm.2016.06.015; Yang T, 2020, FASEB J, V34, P15504, DOI 10.1096/fj.202001657RR; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zanchi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35727; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	42	9	9	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21526	10.1096/fj.202001798RR	http://dx.doi.org/10.1096/fj.202001798RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33813773				2022-12-26	WOS:000645260100107
J	Tkacik, PT; Dahlberg, JL; Johnson, JE; Hoth, JJ; Szer, RA; Hellman, SE				Tkacik, Peter T.; Dahlberg, Jerry L.; Johnson, James E.; Hoth, James J.; Szer, Rebecca A.; Hellman, Samuel E.			Sizing of airborne particles in an operating room	PLOS ONE			English	Article								Medical procedures that produce aerosolized particles are under great scrutiny due to the recent concerns surrounding the COVID-19 virus and increased risk for nosocomial infections. For example, thoracostomies, tracheotomies and intubations/extubations produce aerosols that can linger in the air. The lingering time is dependent on particle size where, e.g., 500 mu m (0.5 mm) particles may quickly fall to the floor, while 1 mu m particles may float for extended lengths of time. Here, a method is presented to characterize the size of 600 mu m particles resulting from surgery in an operating room (OR). The particles are measured in-situ (next to a patient on an operating table) through a 75mm aperture in a similar to 400 mm rectangular enclosure with minimal flow restriction. The particles and gasses exiting a patient are vented through an enclosed laser sheet while a camera captures images of the side-scattered light from the entrained particles. A similar optical configuration was described by Anfinrud et al.; however, we present here an extended method which provides a calibration method for determining particle size. The use of a laser sheet with side-scattered light provides a large FOV and bright image of the particles; however, the particle image dilation caused by scattering does not allow direct measurement of particle size. The calibration routine presented here is accomplished by measuring fixed particle distribution ranges with a calibrated shadow imaging system and mapping these measurements to the in-situ imaging system. The technique used for generating and measuring these particles is described. The result is a three-part process where 1) particles of varying sizes are produced and measured using a calibrated, high-resolution shadow imaging method, 2) the same particle generators are measured with the in-situ imaging system, and 3) a correlation mapping is made between the (dilated) laser image size and the measured particle size. Additionally, experimental and operational details of the imaging system are described such as requirements for the enclosure volume, light management, air filtration and control of various laser reflections. Details related to the OR environment and requirements for achieving close proximity to a patient are discussed as well.	[Tkacik, Peter T.; Dahlberg, Jerry L.] Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA; [Johnson, James E.; Hoth, James J.] Wake Forest Sch Med, Dept Gen Surg, Winston Salem, NC 27101 USA; [Szer, Rebecca A.] West Virginia Sch Osteopath Med, Lewisburg, WV USA; [Hellman, Samuel E.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10021 USA	University of North Carolina; University of North Carolina Charlotte; Wake Forest University; Memorial Sloan Kettering Cancer Center	Tkacik, PT (corresponding author), Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA.	ptkacik@uncc.edu		Dahlberg, Jerry/0000-0003-2778-5349; Hellman, Samuel/0000-0002-5519-870X	Wake Forest School of Medicine; U.S. Office of Naval Research [N00014-18-1-2754]	Wake Forest School of Medicine; U.S. Office of Naval Research(Office of Naval Research)	This material is based upon research supported by, or in part by, a grant from Wake Forest School of Medicine (no award number) and the U.S. Office of Naval Research under award number N00014-18-1-2754. Other than CoAuthors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://school.wakehealth.edu/https://www.onr.navy.mil/.	Anfinrud P, 2020, NEW ENGL J MED, V382, P2061, DOI 10.1056/NEJMc2007800; [Anonymous], 2020, REDLAKE MOTIONXTRA H; [Anonymous], 2020, DANTEC DYNAMICS MEAS; [Anonymous], 2020, DMS500 CAMBUSTION; [Anonymous], 2020, RAYPOWER 5000 5000MW; [Anonymous], 2020, ARRI EB400575D HIGH; [Anonymous], 2020, MOTION STUDIO 64BIT; [Anonymous], 2020, V3528 MPY 11 35MM F2; [Anonymous], 2020, ARRILUX 400 LAMP; [Anonymous], 2020, AEROSOL; [Anonymous], 2020, 610N 6 SPRING TEMPER; [Anonymous], 2020, BROOKHAVEN INSTRUMEN; [Anonymous], 2020, IPAD PRO11 SPECIFICA; Artium, 2020, PDI PHASED DOPPLER I; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Baron P, GENERATION BEHAV AIR; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Dantec Dynamics, 2020, LASER DOPPLER ANEMOM; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; Hinds W.C., 2011, AEROSOL MEASUREMENT, P31; JACKSON TA, 1987, APPL OPTICS, V26, P2137, DOI 10.1364/AO.26.002137; Jankovic L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125204; LaVision, 2020, LASER IMAGING DENSE; TSI, 2020, PHASE DOPPLER PARTIC; TSI, 2020, VIBRATING ORIFICE GE; TSI, 2017, SCANN MOB PART SIZ 3; Wells WF, 1955, AIR HYG ECOL STUDY D; World Health Organization, 2005, JOINT ILO WHO GUID H, P79; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x	31	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249586	10.1371/journal.pone.0249586	http://dx.doi.org/10.1371/journal.pone.0249586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819294	gold, Green Published			2022-12-26	WOS:000637647200015
J	Iannone, LF; Roberti, R; Arena, G; Mammone, S; Pulitano, P; De Sarro, G; Mecarelli, O; Russo, E				Iannone, Luigi Francesco; Roberti, Roberta; Arena, Gabriele; Mammone, Simone; Pulitano, Patrizia; De Sarro, Giovambattista; Mecarelli, Oriano; Russo, Emilio			Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system	PLOS ONE			English	Article								Several studies have evidenced inadequate knowledge about epilepsy and inappropriate seizure management, influencing quality of life and social inclusion of patients with epilepsy. Aim of the study was to estimate the knowledge and the attitudes toward epilepsy in schoolteachers and students in Italy. Custom-designed and validated questionnaires in Italian on general and specific knowledge, and social impact of epilepsy have been administered in a random sample of schoolteachers and students. Overall, 667 schoolteachers and 672 students have been included. Among teachers and students, consider epilepsy a psychiatric disorder (16.8% and 26.5%) or an incurable disease (43.9% and 33%). The 47.5% of teachers declared to be unable to manage a seizing student, 55.8% thought it requires specific support and 21.6% reported issues in administer antiseizure medications in school. Healthcare professionals should have an active role in the educational system, dispelling myths, preparing educators and students with appropriate attitudes in the event of a seizure and prevent over limitations in patients with epilepsy. These findings highlight still poor knowledge and attitudes about epilepsy among teachers and students although the 99.4% claimed to have heard/read something about epilepsy. Therefore, improving existing dedicated educational/training interventions could be necessary.	[Iannone, Luigi Francesco; Roberti, Roberta; Arena, Gabriele; Mammone, Simone; De Sarro, Giovambattista; Russo, Emilio] Magna Graecia Univ Catanzaro, Sci Hlth Dept, Catanzaro, Italy; [Pulitano, Patrizia; Mecarelli, Oriano] Sapienza Univ, Human Neurosci Dept, Rome, Italy	Magna Graecia University of Catanzaro; Sapienza University Rome	Russo, E (corresponding author), Magna Graecia Univ Catanzaro, Sci Hlth Dept, Catanzaro, Italy.	erusso@unicz.it	Russo, Emilio/G-5241-2010	Russo, Emilio/0000-0002-1279-8123; Iannone, Luigi Francesco/0000-0003-3598-0195				Alamri S, 2018, EPILEPSY BEHAV, V89, P169, DOI 10.1016/j.yebeh.2018.10.024; Altowayan R, 2019, EPILEPSY BEHAV, V90, P66, DOI 10.1016/j.yebeh.2018.10.044; [Anonymous], SEIZURE 1 AID; Baker GA, 2008, EPILEPSY BEHAV, V12, P395, DOI 10.1016/j.yebeh.2007.11.001; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Benson A, 2016, PATIENT EDUC COUNS, V99, P1473, DOI 10.1016/j.pec.2016.06.009; Buccheri T, 2015, EPILEPSY BEHAV, V53, P43, DOI 10.1016/j.yebeh.2015.09.033; Galletti F, 2004, PATIENT EDUC COUNS, V55, P422, DOI 10.1016/j.pec.2003.06.004; Idrissi AJ, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106633; Jacoby A, 2002, EPILEPSY BEHAV, V3, pS10; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; Jones C, 2018, EPILEPSY BEHAV, V87, P59, DOI 10.1016/j.yebeh.2018.06.044; Mecarelli O, 2007, SEIZURE-EUR J EPILEP, V16, P313, DOI 10.1016/j.seizure.2007.01.005; Mecarelli O, 2015, EPILEPSY BEHAV, V42, P93, DOI 10.1016/j.yebeh.2014.07.022; Mecarelli O, 2014, EPILEPSY BEHAV, V32, P84, DOI 10.1016/j.yebeh.2014.01.009; Mecarelli O, 2011, EPILEPSY BEHAV, V22, P285, DOI 10.1016/j.yebeh.2011.06.019; Mecarelli O, 2010, EPILEPSY BEHAV, V18, P110, DOI 10.1016/j.yebeh.2010.03.004; Okumura A, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.06.005; Quintas R, 2012, EPILEPSY BEHAV, V25, P60, DOI 10.1016/j.yebeh.2012.05.016; Shawahna R, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106811; Uslu FI, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.04.014; Wait S, 2013, EUR J PAEDIATR NEURO, V17, P14, DOI 10.1016/j.ejpn.2012.07.002	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249681	10.1371/journal.pone.0249681	http://dx.doi.org/10.1371/journal.pone.0249681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798252	Green Published, gold			2022-12-26	WOS:000636737700017
J	Konno, RN; Nigam, N; Wakeling, JM				Konno, Ryan N.; Nigam, Nilima; Wakeling, James M.			Modelling extracellular matrix and cellular contributions to whole muscle mechanics	PLOS ONE			English	Article								Skeletal muscle tissue has a highly complex and heterogeneous structure comprising several physical length scales. In the simplest model of muscle tissue, it can be represented as a one dimensional nonlinear spring in the direction of muscle fibres. However, at the finest level, muscle tissue includes a complex network of collagen fibres, actin and myosin proteins, and other cellular materials. This study shall derive an intermediate physical model which encapsulates the major contributions of the muscle components to the elastic response apart from activation-related along-fibre responses. The micro-mechanical factors in skeletal muscle tissue (eg. connective tissue, fluid, and fibres) can be homogenized into one material aggregate that will capture the behaviour of the combination of material components. In order to do this, the corresponding volume fractions for each type of material need to be determined by comparing the stress-strain relationship for a volume containing each material. This results in a model that accounts for the micro-mechanical features found in muscle and can therefore be used to analyze effects of neuro-muscular diseases such as cerebral palsy or muscular dystrophies. The purpose of this study is to construct a model of muscle tissue that, through choosing the correct material parameters based on experimental data, will accurately capture the mechanical behaviour of whole muscle. This model is then used to look at the impacts of the bulk modulus and material parameters on muscle deformation and strain energy-density distributions.	[Konno, Ryan N.; Nigam, Nilima; Wakeling, James M.] Simon Fraser Univ, Dept Math, Burnaby, BC, Canada; [Wakeling, James M.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Konno, RN (corresponding author), Simon Fraser Univ, Dept Math, Burnaby, BC, Canada.	rkonno@sfu.ca		Konno, Ryan/0000-0003-1761-5266	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada for Discovery Grants to JW and NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1962, J PHYSIOL-LONDON, V161, P379, DOI 10.1113/jphysiol.1962.sp006893; Arndt D, 2017, J NUMER MATH, V25, P137, DOI 10.1515/jnma-2017-0058; Binder-Markey BI, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00293; Bleiler C, 2019, J MECH BEHAV BIOMED, V97, P171, DOI 10.1016/j.jmbbm.2019.05.012; Blemker SS, 2005, ANN BIOMED ENG, V33, P661, DOI 10.1007/s10439-005-1433-7; Bol M, 2008, COMPUT METHOD BIOMEC, V11, P489, DOI 10.1080/10255840701771750; Bol M, 2019, ACTA BIOMATER, V92, P277, DOI 10.1016/j.actbio.2019.05.015; Bolsterlee B, 2017, J APPL PHYSIOL, V122, P727, DOI 10.1152/japplphysiol.00976.2016; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Ceelen KK, 2008, BIOMECH MODEL MECHAN, V7, P277, DOI 10.1007/s10237-007-0097-7; Chui C, 2004, MED BIOL ENG COMPUT, V42, P787, DOI 10.1007/BF02345212; Dominguez S, 2020, THESIS SIMON FRASER; FINE RA, 1973, J CHEM PHYS, V59, P5529, DOI 10.1063/1.1679903; Gardiner JC, 2001, J BIOMECH ENG-T ASME, V123, P170, DOI 10.1115/1.1351891; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Karimi A, 2018, DIGEST DIS, V36, P150, DOI 10.1159/000481344; Lieber RL, 2013, AM J PHYSIOL-CELL PH, V305, pC241, DOI 10.1152/ajpcell.00173.2013; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; MAYNE R, 1985, COLLAGEN REL RES, V5, P449; Mohammadkhah M, 2016, J MECH BEHAV BIOMED, V62, P468, DOI 10.1016/j.jmbbm.2016.05.021; Oomens CWJ, 2003, PHILOS T ROY SOC B, V358, P1453, DOI 10.1098/rstb.2003.1345; Pierrat B, 2016, COMPUT METHOD BIOMEC, V19, P745, DOI 10.1080/10255842.2015.1061513; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Purslow PP, 2002, COMP BIOCHEM PHYS A, V133, P947, DOI 10.1016/S1095-6433(02)00141-1; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Rahemi H, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00298; Randhawa A, 2015, J THEOR BIOL, V382, P57, DOI 10.1016/j.jtbi.2015.06.001; Rohrle O, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00358; Ross SA, 2018, INTEGR COMP BIOL, V58, P232, DOI 10.1093/icb/icy021; Sharafi B, 2011, J BIOMECH, V44, P2031, DOI 10.1016/j.jbiomech.2011.04.038; Sharafi B, 2010, J BIOMECH, V43, P3207, DOI 10.1016/j.jbiomech.2010.07.020; SIMO JC, 1991, COMPUT METHOD APPL M, V85, P273, DOI 10.1016/0045-7825(91)90100-K; SIMO JC, 1992, COMPUT METHOD APPL M, V98, P41, DOI 10.1016/0045-7825(92)90170-O; Sleboda DA, 2020, J MORPHOL, V281, P160, DOI 10.1002/jmor.21088; Sleboda DA, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.209668; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Spyrou LA, 2019, J MECH BEHAV BIOMED, V92, P97, DOI 10.1016/j.jmbbm.2018.12.030; Spyrou LA, 2017, J THEOR BIOL, V414, P50, DOI 10.1016/j.jtbi.2016.11.018; Takaza M, 2013, J MECH BEHAV BIOMED, V17, P209, DOI 10.1016/j.jmbbm.2012.09.001; Trotter J A, 1995, Exerc Sport Sci Rev, V23, P167, DOI 10.1249/00003677-199500230-00008; Turrina A, 2013, J BODYW MOV THER, V17, P95, DOI 10.1016/j.jbmt.2012.06.001; Van Loocke M, 2009, J BIOMECH, V42, P1038, DOI 10.1016/j.jbiomech.2009.02.022; Virgilio KM, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0080; Wakeling JM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00813; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Willwacher S, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14414; Winters TM, 2011, J BIOMECH, V44, P109, DOI 10.1016/j.jbiomech.2010.08.033; YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343; Yucesoy CA, 2002, J BIOMECH, V35, P1253, DOI 10.1016/S0021-9290(02)00069-6; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	55	1	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249601	10.1371/journal.pone.0249601	http://dx.doi.org/10.1371/journal.pone.0249601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798249	Green Published, gold			2022-12-26	WOS:000636737700013
J	Asemu, MM; Yalew, AW; Kabeta, ND; Mekonnen, D				Asemu, Meseret Molla; Yalew, Alemayehu Worku; Kabeta, Negussie Deyessa; Mekonnen, Desalew			Prevalence and risk factors of hypertension among adults: A community based study in Addis Ababa, Ethiopia	PLOS ONE			English	Article							NORTHWEST ETHIOPIA; PREHYPERTENSION; POPULATION	Background In all areas of the World Health Organization, the prevalence of hypertension was highest in Africa. High blood pressure is a significant risk factor for coronary and ischemic diseases, as well as hemorrhagic stroke. However, there were scarce data concerning the magnitude and risk factors of hypertension. Thus, this study aimed to identify the prevalence and associated factors of hypertension among adults in Addis Ababa city. Method A community-based cross-sectional study was conducted from June to October 2018 in Addis Ababa city. Participants aged 18 years and older recruited using a multi-stage random sampling technique. Data were collected by face-to-face interview technique. All three WHO STEPS instruments were applied. Additionally, participants' weight, height, waist, hip, and blood pressure (BP) were measured according to standard procedures. Multiple logistic regressions were used and Odds ratios with 95% confidence intervals were also calculated to identify associated factors. Results In this study, a total of 3560 participants were included.The median age was 32 years (IQR 25, 45). More than half (57.3%) of the respondents were females. Almost all (96.2%) of participants consumed vegetables and or fruits less than five times per day. Eight hundred and sixty-five (24.3%) of respondents were overweight, while 287 (8.1%) were obese. One thousand forty-one 29.24% (95% CI: 27.75-30.74) were hypertensive, of whom two-thirds (61.95%) did not know that they had hypertension. Factors significantly associated with hypertension were age 30-49 and >= 50 years (AOR = 2.79, 95% CI: 1.39-5.56) and (AOR = 8.23, 95% CI: 4.09-16.55) respectively, being male (AOR = 1.88, 95% CI: 1.18-2.99), consumed vegetables less than or equal to 3 days per week (AOR = 2.44, 95% CI: 1.21-4.93), obesity (AOR = 2.05, 95%CI: 1.13-3.71), abdominal obesity (AOR = 1.70, 95% CI: 1.10-2.64) and high triglyceride level (AOR = 2.06, 95% CI: 1.38-3.07). Conclusion In Addis Ababa, around one in three adults are hypertensive. With a large proportion, unaware of their condition. We recommend integrating regular community-based screening programs as integral parts of the health promotion and disease prevention strategies. Lifestyle interventions shall target the modifiable risk factors associated with hypertension, such as weight loss and increased vegetable consumption.	[Asemu, Meseret Molla; Yalew, Alemayehu Worku; Kabeta, Negussie Deyessa] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Mekonnen, Desalew] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Asemu, MM (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	mesinebi@yahoo.com			Addis Ababa University, Addis Ababa, Ethiopia	Addis Ababa University, Addis Ababa, Ethiopia	This work was funded by Addis Ababa University, Addis Ababa, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdissa SG, 2015, ETHIOP J HEALTH DEV, V29, P22; Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Ajayi I.O., 2016, NIGERIAN J CARDIOLOG, V13, P67, DOI 10.4103/0189-7969.165168; [Anonymous], 2003, Saudi Med J, V24, P1154; Anteneh ZA, 2015, INT J GEN MED, V8, P175, DOI 10.2147/IJGM.S81513; Ausiello DA., 2003, ANN INTERN MED, V139; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bharati DR, 2012, NEPAL J EPIDEMIOL, V2, P191, DOI 10.3126/nje.v2i2.6576; Bushara SO, 2016, PREVALENCE RISK FACT, V5, DOI [10.4103/2249-4863.197317, DOI 10.4103/2249-4863.197317]; Chobanian AV., 2003, 7 REPORT JOINT NATL; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Ekpenyong CE, 2012, EUR J SUSTAIN DEV, V1, P249; Ethiopian Public Health Institute, 2016, ETH STEPS REP RISK F; Federal Democratic Republic of Ethiopia Addis Ababa City Administration, 2016, ETH TRANSP SYST IMPR; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POPULATION PROJECTIO; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Health. FMo, 2016, HLTH HLTH REL IND 20; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Heras-Molina A, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9090284; Islam Saeed KM, 2015, NANGARHAR PROVINCE A, V4; Khanam MA, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-015-1520-0, 10.1186/s12889-015-2471-1]; Maimela E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147926; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Muluneh AT, 2012, ETHIOP J HEALTH SCI, V22, P7; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Olivares DEV, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030251; Organization WH, 1996, WHOQOL BREF INTR ADM; Tesfaye F Byass P., 2009, BMC CARDIOVASC DISOR, V9; Wamala JF., 2009, AFR HEALTH SCI, V9, P153; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organization, 2005, WHO STEPWISE APPR CH; World Health Organization, 2014, BURD DIS AMB AIR POL; World Health Organization, 2013, HOUSEHOLD WATER TREA	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248934	10.1371/journal.pone.0248934	http://dx.doi.org/10.1371/journal.pone.0248934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793641	gold, Green Published			2022-12-26	WOS:000636467000029
J	Chimamise, C; Munjanja, SP; Machinga, M; Shiripinda, I				Chimamise, Chipo; Munjanja, Stephen Peter; Machinga, Mazvita; Shiripinda, Iris			Impact of Covid-19 pandemic on obstetric fistula repair program in Zimbabwe	PLOS ONE			English	Article								The advent of Covid-19 pandemic adversely affected many programs worldwide, public health, including programming for obstetric fistula were not spared. Obstetric fistula is an abnormal connection between the vagina and the bladder or the rectum resulting from obstetric causes, mainly prolonged obstructed labour. Zimbabwe has two obstetric fistula repair centers. Because the program uses specialist surgeons from outside the country, the repairs are organized in quarterly camps with a target to repair 90 women per quarter. This study aimed at assessing the impact of restrictions on movement and gathering of people brought about by the Cocid-19 pandemic and to characterize participants of the camp which was held in the midst of the Covid-19 pandemic at Mashoko Hospital. Specifically it looked at how Covid-19 pandemic affected programming for obstetric fistula repair and characterized participants of the fistula camp held in November to December 2020 at one of the repair centers. A review of the dataset and surgical log sheets for the camp and national obstetric fistula dataset was conducted. Variables of interest were extracted onto an excel spreadsheet and analyzed for frequencies and proportions. Data were presented in charts, tables and narratives. The study noted that Covid-19 pandemic negatively affected performance of fistula repairs greatly with only 25 women repaired in 2020 as compared to 313 in 2019. Ninety women were called to come for repairs but 52 did not manage to attend due to reasons related to the restriction of the Covid-19 pandemic lockdown. Two thirds of those women suffered from urinary incontinence while the other third had fecal incontinence. The successful repair rate was 92%. This study concluded that the pandemic greatly affected programming of fistula repair in the country and recommended the Ministry of Health and Child Care to institute measures to resume programming as soon as the situation allows.	[Chimamise, Chipo; Machinga, Mazvita; Shiripinda, Iris] Africa Univ, Coll Hlth Agr & Nat Sci, Dept Hlth Sci, Mutare, Zimbabwe; [Munjanja, Stephen Peter] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gyynaecol, Harare, Zimbabwe	University of Zimbabwe	Chimamise, C (corresponding author), Africa Univ, Coll Hlth Agr & Nat Sci, Dept Hlth Sci, Mutare, Zimbabwe.	chipochimamise@gmail.com		CHIMAMISE, CHIPO/0000-0002-8508-2142				Abokaiagana A., 2010, EXPERIENCES WOMEN OB; Ajibo H, 2020, SOC WORK PUBLIC HLTH, V35, P511, DOI 10.1080/19371918.2020.1806168; Hebbar S, 2015, INT J RES MED SCI, V3, P531, DOI DOI 10.5455/2320-6012.ijrms20150301; Ijaiya M A, 2004, West Afr J Med, V23, P7; Kay A, 2015, ANN GLOB HEALTH, V81, P636, DOI 10.1016/j.aogh.2015.12.005; Khisa AM, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0451-6; Khisa AM, 2012, REPROD HEALTH MATTER, V20, P59, DOI 10.1016/S0968-8080(12)40661-9; Kibe A, 2014, INT J APPL SCI TECHN, V4, P15; Ministry of Health and Child Care, 2016, ZIMB NAT HLTH STRAT; Mselle LT, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0267-1; Mwini-Nyaledzigbor PP, 2013, HEALTH CARE WOMEN IN, V34, P440, DOI 10.1080/07399332.2012.755981; Ramsey K, 2007, INT J GYNECOL OBSTET, V99, pS130, DOI 10.1016/j.ijgo.2007.06.034; Semere Luwam, 2008, Rev Obstet Gynecol, V1, P193; The World Health Organization, 2017, OBST FIST GUID PRINC; UNFPA, 2015, MAT HLTH THEM FUND 2; Wade S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8781; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; World Health Organization, 2019, 10 FACTS OBST FIST	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249398	10.1371/journal.pone.0249398	http://dx.doi.org/10.1371/journal.pone.0249398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793657	Green Published, gold			2022-12-26	WOS:000636467000109
J	Conneely, LJ; Mauleon, R; Mieog, J; Barkla, BJ; Kretzschmar, T				Conneely, Lee James; Mauleon, Ramil; Mieog, Jos; Barkla, Bronwyn J.; Kretzschmar, Tobias			Characterization of the Cannabis sativa glandular trichome proteome	PLOS ONE			English	Article							PLANT; BIOSYNTHESIS; REVEALS; HEMP; KINASES; LYCOPERSICON; ARCHITECTURE; METABOLISM; EVOLUTION; PATHWAYS	Cannabis sativa has been cultivated since antiquity as a source of fibre, food and medicine. The recent resurgence of C. sativa as a cash crop is mainly driven by the medicinal and therapeutic properties of its resin, which contains compounds that interact with the human endocannabinoid system. Compared to other medicinal crops of similar value, however, little is known about the biology of C. sativa. Glandular trichomes are small hair-like projections made up of stalk and head tissue and are responsible for the production of the resin in C. sativa. Trichome productivity, as determined by C. sativa resin yield and composition, is only beginning to be understood at the molecular level. In this study the proteomes of glandular trichome stalks and heads, were investigated and compared to the proteome of the whole flower tissue, to help further elucidate C. sativa glandular trichome biochemistry. The data suggested that the floral tissue acts as a major source of carbon and energy to the glandular trichome head sink tissue, supplying sugars which drive secondary metabolite biosynthesis. The trichome stalk seems to play only a limited role in secondary metabolism and acts as both source and sink.	[Conneely, Lee James; Mauleon, Ramil; Mieog, Jos; Barkla, Bronwyn J.; Kretzschmar, Tobias] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	Southern Cross University	Kretzschmar, T (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.	tobias.kretzschmar@scu.edu.au	Mauleon, Ramil/AAW-1697-2020; Mieog, Jos/AAV-3371-2021	Mauleon, Ramil/0000-0001-8512-144X; Mieog, Jos/0000-0002-2153-8956; kretzschmar, tobias/0000-0002-8227-0746; Conneely, Lee James/0000-0003-3471-5883	Cann Group LTD; Southern Cross University	Cann Group LTD; Southern Cross University	This work was co-funded by Cann Group LTD and Southern Cross University. first author LJK received a partial stipend from the commercial entity Cann Group Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Alun Jones, Manager, Mass Spectrometry Facility, IMB University Queensland for MS analysis, Maxine Dawes, SCU, for technical support for SEM, Nicolas Dimopoulos for contribution to (Fig 1[B]), Andrew Kavasilas for providing the hemp cultivar used in this research, Michael Karkkainen for his input on matters relating to compliance and handling of controlled substances, Qi Guo for support with proteomic data processing and Priyakshee Borpatra Gohain and Francine Gloerfelt-Tarp for help with maintaining the plants.	Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Balcke GU, 2017, PLANT CELL, V29, P960, DOI 10.1105/tpc.17.00060; Bergau N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00949; Bergau N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0678-z; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Brenneisen Rudolf, 2007, P17, DOI 10.1007/978-1-59259-947-9_2; Bridgeman Mary Barna, 2017, P T, V42, P180; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cascio MG, 2015, BRIT J PHARMACOL, V172, P1305, DOI 10.1111/bph.13000; Chang C, 2019, BIOINFORMATICS, V35, P898, DOI 10.1093/bioinformatics/bty727; Chye Y, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00063; Cotton CAR, 2018, CURR OPIN BIOTECH, V49, P49, DOI 10.1016/j.copbio.2017.07.014; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Deschamps C, 2010, METHODS MOL BIOL, V643, P263, DOI 10.1007/978-1-60761-723-5_18; Dolgin E, 2018, NATURE, V562, P327, DOI 10.1038/d41586-018-07037-1; Ebersbach P, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1481-4; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Flanagan JU, 2007, EVOL BIOINFORM, V3, P309; Fridman E, 2005, PLANT CELL, V17, P1252, DOI 10.1105/tpc.104.029736; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Geiger D, 2011, MOL PLANT, V4, P395, DOI 10.1093/mp/ssr029; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Glas JJ, 2012, INT J MOL SCI, V13, P17077, DOI 10.3390/ijms131217077; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; HAMMOND CT, 1978, AM J BOT, V65, P140, DOI 10.2307/2442447; Happyana N, 2016, PLANTA MED, V82, P1217, DOI 10.1055/s-0042-108058; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huchelmann A, 2017, PLANT PHYSIOL, V175, P6, DOI 10.1104/pp.17.00727; Ikram NKBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00129; Johnson SR, 2017, PLANT PHYSIOL, V175, P681, DOI 10.1104/pp.17.00551; Julius BT, 2017, PLANT CELL PHYSIOL, V58, P1442, DOI 10.1093/pcp/pcx090; Kang SK, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016679213; KIM ES, 1991, AM J BOT, V78, P220, DOI 10.2307/2445245; Koontz L, 2014, METHOD ENZYMOL, V541, P3, DOI 10.1016/B978-0-12-420119-4.00001-X; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lindahl AL, 2006, BIOTECHNOL LETT, V28, P571, DOI 10.1007/s10529-006-0015-6; Livingston SJ, 2020, PLANT J, V101, P37, DOI 10.1111/tpj.14516; Luo XZ, 2019, NATURE, V567, P123, DOI 10.1038/s41586-019-0978-9; Martinez-Barajas E, 2011, PLANT PHYSIOL, V156, P373, DOI 10.1104/pp.111.174524; MCCASKILL D, 1995, PLANTA, V197, P49, DOI 10.1007/BF00239938; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Moliterni VMC, 2004, EUPHYTICA, V140, P95, DOI 10.1007/s10681-004-4758-7; MOUNTFORT DO, 1978, BIOCHEM BIOPH RES CO, V85, P1346, DOI 10.1016/0006-291X(78)91151-8; Mudge EM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31120-2; Mukherjee A, 2008, GENET RESOUR CROP EV, V55, P481, DOI 10.1007/s10722-008-9343-9; Parker K.A., 2019, FINANCIAL MARKETS I, V28, P3, DOI [10.1111/fmii.12104, DOI 10.1111/FMII.12104]; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Pyne ME, 2019, PLANT PHYSIOL, V179, P844, DOI 10.1104/pp.18.01291; Raharjo Tri J, 2004, J Biomol Tech, V15, P97; Rea KA, 2019, PHYTOCHEMISTRY, V164, P162, DOI 10.1016/j.phytochem.2019.05.009; Riddick EW, 2014, PEST MANAG SCI, V70, P1655, DOI 10.1002/ps.3772; Rieder SA, 2010, IMMUNOBIOLOGY, V215, P598, DOI 10.1016/j.imbio.2009.04.001; Robertson, ROSALES 2017; Roka L, 2018, J PLANT PHYSIOL, V231, P210, DOI 10.1016/j.jplph.2018.09.016; Russo EB, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00051; Sallets A, 2014, J PROTEOME RES, V13, P3386, DOI 10.1021/pr5002548; Sasse J, 2016, PLANT CELL ENVIRON, V39, P2725, DOI 10.1111/pce.12828; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Schuurink R, 2020, NEW PHYTOL, V225, P2251, DOI 10.1111/nph.16283; Shannon Scott, 2019, Perm J, V23, P18, DOI 10.7812/TPP/18-041; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Small E, 2015, BOT REV, V81, P189, DOI 10.1007/s12229-015-9157-3; Spitzer-Rimon B, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00350; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Tissier A, 2018, CURR OPIN BIOTECH, V49, P73, DOI 10.1016/j.copbio.2017.08.003; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; Trosch R, 2015, BBA-BIOENERGETICS, V1847, P872, DOI 10.1016/j.bbabio.2015.01.002; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Vigli D, 2018, NEUROPHARMACOLOGY, V140, P121, DOI 10.1016/j.neuropharm.2018.07.029; Vincent D, 2019, MOLECULES, V24, DOI 10.3390/molecules24040659; VOIRIN B, 1993, PHYTOCHEMISTRY, V34, P85, DOI 10.1016/S0031-9422(00)90787-8; Vuerich M, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9070356; Weinhold A, 2011, P NATL ACAD SCI USA, V108, P7855, DOI 10.1073/pnas.1101306108; Werf H. M. G. van der, 1994, Industrial Crops and Products, V2, P219, DOI 10.1016/0926-6690(94)90039-6; Wong H, 2019, ARCH ORAL BIOL, V104, P33, DOI 10.1016/j.archoralbio.2019.05.028; Wu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041822; Wurzinger B, 2018, PLANT PHYSIOL, V176, P1085, DOI 10.1104/pp.17.01404; Xie Z, 2008, PLANT J, V54, P349, DOI 10.1111/j.1365-313X.2008.03429.x; Yang Y, 2017, CANNABIS CANNABINOID, V2, P274, DOI 10.1089/can.2017.0040; Zhang QY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01876; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	85	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0242633	10.1371/journal.pone.0242633	http://dx.doi.org/10.1371/journal.pone.0242633			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793557	Green Published, gold, Green Submitted			2022-12-26	WOS:000636467000094
J	Lin, CC; Hsu, KH; Shih, CP; Chang, GJ				Lin, Chih-Chuan; Hsu, Kuang-Hung; Shih, Chia-Pang; Chang, Gwo-Jyh			Hemodynamic and electromechanical effects of paraquat in rat heart	PLOS ONE			English	Article								Paraquat (PQ) is a highly lethal herbicide. Ingestion of large quantities of PQ usually results in cardiovascular collapse and eventual mortality. Recent pieces of evidence indicate possible involvement of oxidative stress- and inflammation-related factors in PQ-induced cardiac toxicity. However, little information exists on the relationship between hemodynamic and cardiac electromechanical effects involved in acute PQ poisoning. The present study investigated the effects of acute PQ exposure on hemodynamics and electrocardiogram (ECG) in vivo, left ventricular (LV) pressure in isolated hearts, as well as contractile and intracellular Ca2+ properties and ionic currents in ventricular myocytes in a rat model. In anesthetized rats, intravenous PQ administration (100 or 180 mg/kg) induced dose-dependent decreases in heart rate, blood pressure, and cardiac contractility (LV +dP/dt(max)). Furthermore, PQ administration prolonged the PR, QRS, QT, and rate-corrected QT (QTc) intervals. In Langendorff-perfused isolated hearts, PQ (33 or 60 mu M) decreased LV pressure and contractility (LV +dP/dt(max)). PQ (10-60 mu M) reduced the amplitudes of Ca2+ transients and fractional cell shortening in a concentration-dependent manner in isolated ventricular myocytes. Moreover, whole-cell patch-clamp experiments demonstrated that PQ decreased the current amplitude and availability of the transient outward K+ channel (I-to) and altered its gating kinetics. These results suggest that PQ-induced cardiotoxicity results mainly from diminished Ca2+ transients and inhibited K+ channels in cardiomyocytes, which lead to LV contractile force suppression and QTc interval prolongation. These findings should provide novel cues to understand PQ-induced cardiac suppression and electrical disturbances and may aid in the development of new treatment modalities.	[Lin, Chih-Chuan] Chang Gung Univ, Dept Emergency Med, Chang Gung Mem Hosp, Coll Med, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Lab Epidemiol, Dept Hlth Care Management, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Shih, Chia-Pang] Yuanpei Univ Med Technol, Dept Nursing, Hsinchu, Taiwan; [Chang, Gwo-Jyh] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Gwo-Jyh] Chang Gung Mem Hosp, Cardiovasc Div Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chang, GJ (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.; Chang, GJ (corresponding author), Chang Gung Mem Hosp, Cardiovasc Div Med, Taoyuan, Taiwan.	gjchang@mail.cgu.edu.tw	Lin, Chih-Chuan/AGI-4118-2022	Chang, Gwo-Jyh/0000-0001-6967-8758	Chang Gung Memorial Hospital, Taiwan [CMRPG 381571-3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by Chang Gung Memorial Hospital, Taiwan (grants CMRPG 381571-3) to C.C. Lin. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BISMUTH C, 1982, J TOXICOL-CLIN TOXIC, V19, P461, DOI 10.3109/15563658208992501; Chan YC, 2007, TOXICOL IN VITRO, V21, P595, DOI 10.1016/j.tiv.2006.12.007; Chang GJ, 2019, J PHARMACOL EXP THER, V368, P66, DOI 10.1124/jpet.118.252080; Chang GJ, 2014, BRIT J PHARMACOL, V171, P3918, DOI 10.1111/bph.12752; Chang ZS, 2019, AGING CELL, V18, DOI 10.1111/acel.12990; Davey P, 2000, EUR J HEART FAIL, V2, P265, DOI 10.1016/S1388-9842(00)00065-9; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2009, TOXICOLOGY, V255, P187, DOI 10.1016/j.tox.2008.10.015; Dong XS, 2013, TOXICOLOGY, V312, P115, DOI 10.1016/j.tox.2013.08.009; Fahim MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057651; Foroughi Mahnoosh, 2009, Asian Cardiovasc Thorac Ann, V17, P604, DOI 10.1177/0218492309349068; Gawarammana I, 2012, CLIN TOXICOL, V50, P278; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Horacek J. M., 2009, Experimental Oncology, V31, P115; JOSEPHSON IR, 1984, CIRC RES, V54, P157, DOI 10.1161/01.RES.54.2.157; Kmecova J, 2010, EUR J PHARMACOL, V641, P187, DOI 10.1016/j.ejphar.2010.05.038; Lee HL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-7; LEROY JP, 1982, ANN PATHOL, V2, P332; Li LR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008084.pub4; Lin CC, 2014, J EMERG MED, V47, P401, DOI 10.1016/j.jemermed.2014.02.026; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Malekinejad M, 2019, J CARDIOVASC PHARM, V74, P400, DOI 10.1097/FJC.0000000000000731; NABAUER M, 1993, CIRC RES, V73, P386, DOI 10.1161/01.RES.73.2.386; NAITO H, 1987, HUM TOXICOL, V6, P87, DOI 10.1177/096032718700600114; Noguchi N, 1990, Nihon Hoigaku Zasshi, V44, P6; ONYON LJ, 1987, HUM TOXICOL, V6, P19, DOI 10.1177/096032718700600104; Padmanabhan S, 2003, AM HEART J, V145, P132, DOI 10.1067/mhj.2003.59; PARKINSON C, 1980, HISTOPATHOLOGY, V4, P171, DOI 10.1111/j.1365-2559.1980.tb02910.x; Povoa R, 1992, Arq Bras Cardiol, V59, P95; PROUDFOOT AT, 1979, LANCET, V2, P330; Ren Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015441; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; Seok Su-Jin, 2009, Korean Journal of Internal Medicine, V24, P247, DOI 10.3904/kjim.2009.24.3.247; STAJER D, 1993, J ELECTROCARDIOL, V26, P333, DOI 10.1016/0022-0736(93)90054-H; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; VALE JA, 1987, HUM TOXICOL, V6, P41, DOI 10.1177/096032718700600107; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang JX, 2016, CARDIOVASC TOXICOL, V16, P235, DOI 10.1007/s12012-015-9331-1; Wu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087568; Yang CC, 1996, J TOXICOL-CLIN TOXIC, V34, P651, DOI 10.3109/15563659609013825; Zhang LP, 2018, CARDIOVASC TOXICOL, V18, P346, DOI 10.1007/s12012-017-9441-z	43	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0234591	10.1371/journal.pone.0234591	http://dx.doi.org/10.1371/journal.pone.0234591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793552	Green Published, gold, Green Submitted			2022-12-26	WOS:000636467000066
J	Nooroong, P; Trinachartvanit, W; Baimai, V; Anuracpreeda, P; Ahantarig, A				Nooroong, Pornpiroon; Trinachartvanit, Wachareeporn; Baimai, Visut; Anuracpreeda, Panat; Ahantarig, Arunee			Partial DnaK protein expression from Coxiella-like endosymbiont of Rhipicephalus annulatus tick	PLOS ONE			English	Article							Q-FEVER; BURNETII; THAILAND; AMBLYOMMA; BACTERIA; RICKETTSIA; ANAPLASMA	Q fever is one of the most important zoonotic diseases caused by the obligate intracellular bacteria, Coxiella burnetii. This bacterial infection has been frequently reported in both humans and animals, especially ruminants. Ticks are important ectoparasite and serve as reservoir hosts of Coxiella-like endosymbionts (CLEs). In this study, we have attempted to express chaperone-coding genes from CLEs of Rhipicephalus annulatus ticks collected fromcow path. The partial DnaK coding sequence has been amplified and expressed by Escherichia coli. Amino acid sequences have been analyzed by MS-MS spectrometry and the UniProt database. Despites nucleotide sequences indicating high nucleotide variation and diversity, many nucleotide substitutions are synonymous. In addition, amino acid substitutions compensate for the physicochemical properties of the original amino acids. Immune Epitope Database and Analysis Resource (IEDB-AR) was employed to indicate the antigenicity of the partial DnaK protein and predict the epitopes of B-and T-cells. Interestingly, some predicted HLA-A and B alleles of the MHC-I and HLA-DR alleles belonging to MHC-II were similar to T-cell responses to C. burnetii in Q fever patients. Therefore, the partial DnaK protein of CLE from R. annulatus could be considered a vaccine candidate and immunogenic marker with future prospects.	[Nooroong, Pornpiroon; Trinachartvanit, Wachareeporn; Baimai, Visut; Ahantarig, Arunee] Mahidol Univ, Fac Sci, Biodivers Res Cluster, Dept Biol, Bangkok, Thailand; [Anuracpreeda, Panat] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand; [Ahantarig, Arunee] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Mahidol University	Ahantarig, A (corresponding author), Mahidol Univ, Fac Sci, Biodivers Res Cluster, Dept Biol, Bangkok, Thailand.; Ahantarig, A (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand.	arunee.aha@mahidol.ac.th	Anuracpreeda, Panat/GLR-2244-2022		Royal Golden Jubilee Ph.D. (RGJ-PHD) Scholarship [PHD/0108/2557]; Mahidol University; Center of Excellence on Biodiversity (BDC) Office of Higher Education Commission [BDC-PG3-163005]	Royal Golden Jubilee Ph.D. (RGJ-PHD) Scholarship; Mahidol University; Center of Excellence on Biodiversity (BDC) Office of Higher Education Commission	Royal Golden Jubilee Ph.D. (RGJ-PHD) Scholarship [grant number PHD/0108/2557] to Pornpiroon Nooroong and Research Grants from Mahidol University and Center of Excellence on Biodiversity (BDC) Office of Higher Education Commission (grant number BDC-PG3-163005) to Assoc. Prof. Dr. Arunee Ahantarig.	[Anonymous], 2015, METHODS ECOL EVOL, DOI [DOI https://doi.org/10.1111/2041-210X.12410, 10.1111/2041-210x.12410]; [Anonymous], Discovery Studio Modeling Environment, Release 4.5. 2015; Arthan W, 2015, TICKS TICK-BORNE DIS, V6, P63, DOI 10.1016/j.ttbdis.2014.09.005; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Chmielewski T, 2012, POL J MICROBIOL, V61, P81, DOI 10.33073/pjm-2012-011; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Colombe S, 2018, ONE HEALTH-AMSTERDAM, V6, P37, DOI 10.1016/j.onehlt.2018.10.001; Contreras M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00307; Doung-Ngern P, 2017, AM J TROP MED HYG, V96, P786, DOI 10.4269/ajtmh.16-0336; Duron O, 2017, MOL ECOL, V26, P2905, DOI 10.1111/mec.14094; Duron O, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv132; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Galay RL., 2020, TROP MED INFECT DIS, V5, P54; Gerlach C, 2017, ACTA VIROL, V61, P377, DOI 10.4149/av_2017_320; Greiner AL., 2018, AM J TROP MED HYG, V98, P252, DOI [10.4269/ajtmh.17-0413, DOI 10.4269/AJTMH.17-0413]; Hall T., 2011, GERF B BIOSCI, V2, P60; Ihnatko R, 2012, ADV EXP MED BIOL, V984, P105, DOI 10.1007/978-94-007-4315-1_6; Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06; Khoo JJ, 2016, VECTOR-BORNE ZOONOT, V16, P744, DOI 10.1089/vbz.2016.1959; Kledmanee K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216652; Kowalczewska M, 2011, GENOME MED, V3, DOI 10.1186/gm266; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Muramatsu Y, 2014, SE ASIAN J TROP MED, V45, P1167; Nooroong P, 2018, TICKS TICK-BORNE DIS, V9, P963, DOI 10.1016/j.ttbdis.2018.03.027; Ogo NI, 2013, VET WORLD, V6, P818, DOI 10.14202/vetworld.2013.818-822; Opaschaitat P., 2018, KKU Veterinary Journal, V28, P19; Pachirat O, 2012, INFECT DIS REP, V4, P17, DOI 10.4081/idr.2012.e7; Papadioti A, 2011, J PROTEOMICS, V74, P1150, DOI 10.1016/j.jprot.2011.04.016; Rambaut A., 2009, FIGTREE VERSION 1 3; Rodtian P., 2016, OSIR J, V6, P8; Scholzen A, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00213-19; Scholzen A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00207; Smith TA, 2015, GENOME BIOL EVOL, V7, P831, DOI 10.1093/gbe/evv016; Sumrandee C, 2016, TICKS TICK-BORNE DIS, V7, P678, DOI 10.1016/j.ttbdis.2016.02.015; Suputtamongkol Y, 2003, EMERG INFECT DIS, V9, P1186; Trinachartvanit W, 2019, SE ASIAN J TROP MED, V50, P643; Trinachartvanit W, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3259-9; Tsementzi D, 2018, ENVIRON MICROBIOL, V20, P1751, DOI 10.1111/1462-2920.14104; Van den Brom R, 2015, VET MICROBIOL, V181, P119, DOI 10.1016/j.vetmic.2015.07.011; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Watt G, 2014, EMERG INFECT DIS, V20, P473, DOI 10.3201/eid2003.131059; Weber CC, 2019, MOL BIOL EVOL, V36, P679, DOI 10.1093/molbev/msz003; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yingst SL, 2013, EMERG INFECT DIS, V19, P2056, DOI 10.3201/eid1912.130624; Zhang GQ, 2012, ADV EXP MED BIOL, V984, P91, DOI 10.1007/978-94-007-4315-1_5; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249354	10.1371/journal.pone.0249354	http://dx.doi.org/10.1371/journal.pone.0249354			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793664	Green Published, gold			2022-12-26	WOS:000636467000046
J	Rahman, H; Pipinos, II; Johanning, JM; Myers, SA				Rahman, Hafizur; Pipinos, Iraklis I.; Johanning, Jason M.; Myers, Sara A.			Gait variability is affected more by peripheral artery disease than by vascular occlusion	PLOS ONE			English	Article							INTERMITTENT CLAUDICATION; DYNAMICS; RISK; ASSOCIATIONS; VENTILATION; PREVALENCE; KINEMATICS; STABILITY; PATTERNS; RECOVERY	Background Patients with peripheral artery disease with intermittent claudication (PAD-IC) have altered gait variability from the first step they take, well before the onset of claudication pain. The mechanisms underlying these gait alterations are poorly understood. Aims To determine the effect of reduced blood flow on gait variability by comparing healthy older controls and patients with PAD-IC. We also determined the diagnostic value of gait variability parameters to identify the presence of PAD. Methods A cross-sectional cohort design was used. Thirty healthy older controls and thirty patients with PAD-IC walked on a treadmill at their self-selected speed in pain free walking (normal walking for healthy older controls; prior to claudication onset for PAD) and reduced blood flow (post vascular occlusion with thigh tourniquet for healthy older controls; pain for PAD) conditions. Gait variability was assessed using the largest Lyapunov exponent, approximate entropy, standard deviation, and coefficient of variation of ankle, knee, and hip joints range of motion. Receiver operating characteristics curve analyses of the pain free walking condition were performed to determine the optimal cut-off values for separating individuals with PAD-IC from those without PAD-IC. Results and discussion Patients with PAD-IC have increased amount of variability for knee and hip ranges of motion compared with the healthy older control group. Regarding the main effect of condition, reduced blood flow demonstrated increased amount of variability compared with pain free walking. Significant interactions between group and condition at the ankle show increased values for temporal structure of variability, but a similar amount of variability in the reduced blood flow condition. This demonstrates subtle interactions in the movement patterns remain distinct between PAD-IC versus healthy older controls during the reduced blood flow condition. A combination of gait variability parameters correctly identifies PAD-IC disease 70% of the time or more. Conclusions Gait variability is affected both by PAD and by the mechanical induction of reduced blood flow. Gait variability parameters have potential diagnostic ability, as some measures had 90.0% probability of correctly identifying patients with PAD-IC.	[Rahman, Hafizur; Myers, Sara A.] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Rahman, Hafizur; Pipinos, Iraklis I.; Johanning, Jason M.; Myers, Sara A.] Vet Affairs Med Ctr Nebraska & Western Iowa, Dept Surg, Omaha, NE 68105 USA; [Pipinos, Iraklis I.; Johanning, Jason M.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA	University of Nebraska System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center	Myers, SA (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.; Myers, SA (corresponding author), Vet Affairs Med Ctr Nebraska & Western Iowa, Dept Surg, Omaha, NE 68105 USA.	samyers@unomaha.edu	; Myers, Sara/E-1460-2015	Rahman, Hafizur/0000-0003-1739-3544; Myers, Sara/0000-0002-2934-2624	National Institute of Health (nih.gov) grants [F31AG032788, R01HD090333, R01AG049868]; United States Department of Veterans Affairs Rehabilitation Research and Development Service (va.gov) [I01RX003266]	National Institute of Health (nih.gov) grants; United States Department of Veterans Affairs Rehabilitation Research and Development Service (va.gov)	This work was supported in part by National Institute of Health (nih.gov) grants F31AG032788 (SAM), R01HD090333 (SAM), R01AG049868 (IIP) and Merit Review Grant I01RX003266 (SAM) from the United States Department of Veterans Affairs Rehabilitation Research and Development Service (va.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Angeloni C., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P40, DOI 10.1109/86.296343; Antonellis P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205088; Bakir MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069500; Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Becker RA, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13161; Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109; Bruce SL, 2010, ATHLET THER TODAY, V15, P4, DOI 10.1123/att.15.2.4; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Celis R, 2009, J VASC SURG, V49, P127, DOI 10.1016/j.jvs.2008.08.013; Chen SJ, 2008, J BIOMECH, V41, P2506, DOI 10.1016/j.jbiomech.2008.05.011; Cluff K, 2013, AM J PHYSIOL-REG I, V305, pR291, DOI 10.1152/ajpregu.00525.2012; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Crowther RG, 2007, J VASC SURG, V45, P1172, DOI 10.1016/j.jvs.2007.01.060; DIENER HC, 1984, BRAIN RES, V296, P103, DOI 10.1016/0006-8993(84)90515-8; Ellis RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141694; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fuglestad MA, 2020, J VASC SURG, V71, P946, DOI 10.1016/j.jvs.2019.04.493; Gardner AW, 2001, VASC MED, V6, P223, DOI 10.1177/1358836X0100600404; Gardner AW, 2001, J GERONTOL A-BIOL, V56, pM454, DOI 10.1093/gerona/56.7.M454; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Gilat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066718; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Gommans LNM, 2016, J VASC SURG, V63, P664, DOI 10.1016/j.jvs.2015.09.045; Ha DM, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0790-3; HAOUZI P, 1993, RESP PHYSIOL, V94, P137, DOI 10.1016/0034-5687(93)90043-A; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hernandez H, 2019, ANN VASC SURG, V55, P112, DOI 10.1016/j.avsg.2018.06.017; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Jaffery Z, 2009, J INTERV CARDIOL, V22, P564, DOI 10.1111/j.1540-8183.2009.00505.x; Kjaer M, 1999, J APPL PHYSIOL, V86, P806; Koutakis P, 2015, J SURG RES, V196, P172, DOI 10.1016/j.jss.2015.02.011; Koutakis P, 2015, J HISTOCHEM CYTOCHEM, V63, P256, DOI 10.1369/0022155415569348; Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002; Koutakis P, 2010, J VASC SURG, V52, P340, DOI 10.1016/j.jvs.2010.03.005; Koutakis P, 2010, J VASC SURG, V51, P80, DOI 10.1016/j.jvs.2009.07.117; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Makris KI, 2007, VASCULAR, V15, P336, DOI 10.2310/6670.2007.00054; McDermott MM, 2007, J AM GERIATR SOC, V55, P400, DOI 10.1111/j.1532-5415.2007.01092.x; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Myers SA, 2013, ANN BIOMED ENG, V41, P1692, DOI 10.1007/s10439-012-0667-4; Myers SA, 2011, CLIN BIOMECH, V26, P729, DOI 10.1016/j.clinbiomech.2011.03.005; Myers SA, 2010, J SURG RES, V164, P6, DOI 10.1016/j.jss.2010.04.030; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Nicoloff AD, 1998, J VASC SURG, V27, P256, DOI 10.1016/S0741-5214(98)70356-8; NIGG BM, 1993, J BIOMECH, V26, P909, DOI 10.1016/0021-9290(93)90053-H; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Piersol A, 1966, MEASUREMENTS ANAL RA; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Pincus SM, 1998, APPLICATIONS OF NONLINEAR DYNAMICS TO DEVELOPMENTAL PROCESS MODELING, P243; Pincus SM, 2000, METHOD ENZYMOL, V321, P149; Pipinos II, 2002, J SURG RES, V102, P126, DOI 10.1006/jsre.2001.6292; Pipinos Iraklis I, 2007, Vasc Endovascular Surg, V41, P481, DOI 10.1177/1538574407311106; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003; REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413; Richardson JK, 2005, ARCH PHYS MED REHAB, V86, P1539, DOI 10.1016/j.apmr.2004.12.032; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; SARGEANT AJ, 1981, J APPL PHYSIOL, V50, P718, DOI 10.1152/jappl.1981.50.4.718; Schieber MN, 2017, J VASC SURG, V66, P178, DOI 10.1016/j.jvs.2017.01.051; Shu J, 2018, ATHEROSCLEROSIS, V275, P379, DOI 10.1016/j.atherosclerosis.2018.05.033; SKINNER JS, 1967, CIRCULATION, V36, P15, DOI 10.1161/01.CIR.36.1.15; Sprott J., 1992, CHAOS DATA ANALYZER; STAHLER C, 1967, ANGIOLOGY, V18, P237, DOI 10.1177/000331976701800406; STANLEY WC, 1985, EUR J APPL PHYSIOL O, V54, P269, DOI 10.1007/BF00426144; Stergiou N, 2004, CLIN BIOMECH, V19, P957, DOI 10.1016/j.clinbiomech.2004.06.008; Stergiou N., 2004, NONLINEAR TOOLS HUMA, P63; Stergiou N, 2002, P 4 WORLD; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Thrane Gyrd, 2007, BMC Geriatr, V7, P1, DOI 10.1186/1471-2318-7-1; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; Tokizawa K, 2004, J APPL PHYSIOL, V96, P981, DOI 10.1152/japplphysiol.00695.2003; Toursarkissian B, 2002, AM SURGEON, V68, P606; Tzagarakis GN, 2010, J INT MED RES, V38, P511, DOI 10.1177/147323001003800214; Vaughan C., 1999, DYNAMICS HUMAN GAIT; Weber F, 2002, MUSCLE NERVE, V26, P471, DOI 10.1002/mus.10235; Webster KE, 2006, ALZ DIS ASSOC DIS, V20, P37, DOI 10.1097/01.wad.0000201849.75578.de; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Zar JH, 1999, BIOSTATISTICAL ANAL	90	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0241727	10.1371/journal.pone.0241727	http://dx.doi.org/10.1371/journal.pone.0241727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788839	gold, Green Submitted, Green Published			2022-12-26	WOS:000636354600028
J	Al-Babtain, AA; Elbatal, I; Chesneau, C; Elgarhy, M				Al-Babtain, Abdulhakim A.; Elbatal, Ibrahim; Chesneau, Christophe; Elgarhy, Mohammed			Estimation of different types of entropies for the Kumaraswamy distribution	PLOS ONE			English	Article								The estimation of the entropy of a random system or process is of interest in many scientific applications. The aim of this article is the analysis of the entropy of the famous Kumaraswamy distribution, an aspect which has not been the subject of particular attention previously as surprising as it may seem. With this in mind, six different entropy measures are considered and expressed analytically via the beta function. A numerical study is performed to discuss the behavior of these measures. Subsequently, we investigate their estimation through a semi-parametric approach combining the obtained expressions and the maximum likelihood estimation approach. Maximum likelihood estimates for the considered entropy measures are thus derived. The convergence properties of these estimates are proved through a simulated data, showing their numerical efficiency. Concrete applications to two real data sets are provided.	[Al-Babtain, Abdulhakim A.] King Saud Univ, Dept Stat & Operat Res, Riyadh, Saudi Arabia; [Elbatal, Ibrahim] Imam Mohammad Ibn Saud Islamic Univ IMSIU, Coll Sci, Dept Math & Stat, Riyadh, Saudi Arabia; [Chesneau, Christophe] Univ Caen, Dept Math, LMNO, Campus 2,Sci 3, Caen, France; [Elgarhy, Mohammed] Higher Inst Commercial Sci, Al Mahalla Al Kubra, Algarbia, Egypt	King Saud University; Imam Mohammad Ibn Saud Islamic University (IMSIU); Universite de Caen Normandie	Chesneau, C (corresponding author), Univ Caen, Dept Math, LMNO, Campus 2,Sci 3, Caen, France.	christophe.chesneau@unicaen.fr	Albabtain, Abdulhakim ABDULMOHSEN/AAX-4497-2021	Albabtain, Abdulhakim ABDULMOHSEN/0000-0003-2189-2629; Elgarhy, Mohammed/0000-0002-1333-3862; chesneau, christophe/0000-0002-1522-9292	King Saud University, Riyadh, Saudi Arabia [RSP-2020/156]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project is supported by Researchers Supporting Project number (RSP-2020/156) King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Eleneen ZA, 2011, ENTROPY-SWITZ, V13, P437, DOI 10.3390/e13020437; Al-Babtain AA, 2021, AIMS MATH, V6, P3889, DOI 10.3934/math.2021231; Alzer H, 2001, INDAGAT MATH NEW SER, V12, P15, DOI 10.1016/S0019-3577(01)80002-1; Amigo JM, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20110813; ARIMOTO S, 1971, INFORM CONTROL, V19, P181, DOI 10.1016/S0019-9958(71)90065-9; AWAD AM, 1987, IMA J MATH CONTROL I, V4, P143, DOI 10.1093/imamci/4.2.143; Bader A., 2017, APPL MATH INFORM SCI, V11, P1811; Bantan RAR, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22060601; Basit A, 2017, ADV APPL STAT, V50, P477, DOI 10.17654/AS050060477; Bouzebda S, 2011, ELECTRON J STAT, V5, P440, DOI 10.1214/11-EJS614; Carrasco J, ARXIV10040911V1STATM; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chesneau C, 2017, COMMENT MATH UNIV CA, V58, P87, DOI 10.14712/1213-7243.2015.191; Cho Y, 2015, ENTROPY-SWITZ, V17, P102, DOI 10.3390/e17010102; Cho Y, 2014, ENTROPY-SWITZ, V16, P3655, DOI 10.3390/e16073655; Cordeiro GM, 2011, J STAT COMPUT SIM, V81, P883, DOI 10.1080/00949650903530745; Cordeiro GM, 2012, BRAZ J PROBAB STAT, V26, P88, DOI 10.1214/10-BJPS124; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; DUMONCEAUX R, 1973, TECHNOMETRICS, V15, P923, DOI 10.2307/1267401; EBRAHIMI N, 1994, STAT PROBABIL LETT, V20, P225, DOI 10.1016/0167-7152(94)90046-9; Golan A., 2006, FOUND TRENDS EC, V2, P1, DOI DOI 10.1561/0800000004; Harvda J, 1967, KYBERNETIKA, V3, P30; Hassan AS, 2019, J TAIBAH UNIV SCI, V13, P331, DOI 10.1080/16583655.2019.1576493; Huang HL, 2016, J TRANSP GEOGR, V54, P248, DOI 10.1016/j.jtrangeo.2016.06.012; Jones M., 2009, STAT METHODOL, V6, P70, DOI [10.1016/j.stamet.2008.04.001, DOI 10.1016/J.STAMET.2008.04.001]; Kayal S, 2013, STAT PROBABIL LETT, V83, P1127, DOI 10.1016/j.spl.2013.01.012; KUMARASWAMY P, 1980, J HYDROL, V46, P79, DOI 10.1016/0022-1694(80)90036-0; Namdari A, 2019, ADV MECH ENG, V11, DOI 10.1177/1687814019857350; Noorizadeh S, 2010, PHYS CHEM CHEM PHYS, V12, P4742, DOI 10.1039/b916509f; Noughabi HA, 2010, J STAT COMPUT SIM, V80, P1151, DOI 10.1080/00949650903005656; Renyi A., 1960, P 4 BERK S MATH STAT, V1, P47; Ribeiro M, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23020222; Seo JI, 2014, ENTROPY-SWITZ, V16, P443, DOI 10.3390/e16010443; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tahmasebi S., 2010, APPL MATH SCI, V4, P495; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; Zeng Q, 2022, J TRANSP SAF SECUR, V14, P323, DOI 10.1080/19439962.2020.1779422	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249027	10.1371/journal.pone.0249027	http://dx.doi.org/10.1371/journal.pone.0249027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784310	gold, Green Published			2022-12-26	WOS:000636359600050
J	Migenda, N; Moller, R; Schenck, W				Migenda, Nico; Moeller, Ralf; Schenck, Wolfram			Adaptive dimensionality reduction for neural network-based online principal component analysis	PLOS ONE			English	Article							PCA	"Principal Component Analysis" (PCA) is an established linear technique for dimensionality reduction. It performs an orthonormal transformation to replace possibly correlated variables with a smaller set of linearly independent variables, the so-called principal components, which capture a large portion of the data variance. The problem of finding the optimal number of principal components has been widely studied for offline PCA. However, when working with streaming data, the optimal number changes continuously. This requires to update both the principal components and the dimensionality in every timestep. While the continuous update of the principal components is widely studied, the available algorithms for dimensionality adjustment are limited to an increment of one in neural network-based and incremental PCA. Therefore, existing approaches cannot account for abrupt changes in the presented data. The contribution of this work is to enable in neural network-based PCA the continuous dimensionality adjustment by an arbitrary number without the necessity to learn all principal components. A novel algorithm is presented that utilizes several PCA characteristics to adaptivly update the optimal number of principal components for neural network-based PCA. A precise estimation of the required dimensionality reduces the computational effort while ensuring that the desired amount of variance is kept. The computational complexity of the proposed algorithm is investigated and it is benchmarked in an experimental study against other neural network-based and incremental PCA approaches where it produces highly competitive results.	[Migenda, Nico; Schenck, Wolfram] Bielefeld Univ Appl Sci, Fac Engn & Math, Ctr Appl Data Sci Gutersloh, Bielefeld, Germany; [Moeller, Ralf] Bielefeld Univ, Fac Technol, Comp Engn Grp, Bielefeld, Germany	Bielefeld University of Applied Sciences; University of Bielefeld	Migenda, N (corresponding author), Bielefeld Univ Appl Sci, Fac Engn & Math, Ctr Appl Data Sci Gutersloh, Bielefeld, Germany.	nico.migenda@fh-bielefeld.de		Migenda, Nico/0000-0002-7223-1735; Moller, Ralf/0000-0001-7389-3696; Schenck, Wolfram/0000-0003-3300-2048	"Europaischer Fonds fur regionale Entwicklung Nordrhein-Westfalen (EFRE-NRW) [34.EFRE0300119]	"Europaischer Fonds fur regionale Entwicklung Nordrhein-Westfalen (EFRE-NRW)	This work was supported by the "Europaischer Fonds fur regionale Entwicklung Nordrhein-Westfalen" (EFRE-NRW -https://www.efre.nrw.de) funding programme "Forschungsinfrastrukturen" (grant no. 34.EFRE0300119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artac M, 2002, INT C PATT RECOG, P781, DOI 10.1109/ICPR.2002.1048133; Balzano L, 2018, P IEEE, V106, P1293, DOI 10.1109/JPROC.2018.2847041; BANNOUR S, 1995, IEEE T NEURAL NETWOR, V6, P457, DOI 10.1109/72.363480; Bartecki K, 2012, LECT NOTES ARTIF INT, V7267, P3, DOI 10.1007/978-3-642-29347-4_1; Beatty M, 1997, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL II, P835, DOI 10.1109/ICIP.1997.638626; Brand M, 2006, LINEAR ALGEBRA APPL, V415, P20, DOI 10.1016/j.laa.2005.07.021; Cardot H, 2018, INT STAT REV, V86, P29, DOI 10.1111/insr.12220; Cunningham JP, 2015, J MACH LEARN RES, V16, P2859; Du K.-L., 2019, NEURAL NETWORKS STAT, DOI 10.1007/978-1-4471-7452-3_20; Eiteneuer B, 2019, IEEE INT CONF INDUST, P1286, DOI 10.1109/ICIT.2019.8755116; Evangelista PF, 2006, ADV SOFT COMP, V34, P425, DOI 10.1007/3-540-31662-0_33; Fujiwara T, 2020, IEEE T VIS COMPUT GR, V26, P418, DOI 10.1109/TVCG.2019.2934433; Gao LL, 2017, MULTIMEDIA SYST, V23, P303, DOI 10.1007/s00530-015-0494-1; Goebel K., 2008, **DATA OBJECT**; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Halpern T, 2018, LECT NOTES COMPUT SC, V10777, P3, DOI 10.1007/978-3-319-78024-5_1; HANCOCK PJB, 1992, NETWORK-COMP NEURAL, V3, P61, DOI 10.1088/0954-898X/3/1/008; Heikki H, 2019, CAREERCON 2019 HELP; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Karhunen J, 2000, Int J Neural Syst, V10, P439, DOI 10.1142/S0129065700000429; Katal A, 2013, INT CONF CONTEMP, P404, DOI 10.1109/IC3.2013.6612229; Kirsch A, 2009, VEKTORQUANTISIERER B; Kong X., 2017, PRINCIPAL COMPONENT; Kuang LW, 2014, IEEE T EMERG TOP COM, V2, P280, DOI 10.1109/TETC.2014.2330516; Lee JA, 2007, INFORM SCI STAT, P1; Lennon M, 2001, INT GEOSCI REMOTE SE, P2893, DOI 10.1109/IGARSS.2001.978197; Lv JC, 2007, IEEE T NEURAL NETWOR, V18, P910, DOI 10.1109/TNN.2007.891193; Martin R., 1998, P BRIT MACH VIS C, P1; Migenda N, 2019, LECT NOTES COMPUT SC, V11871, P76, DOI 10.1007/978-3-030-33607-3_9; Moller R, 2004, NEUROCOMPUTING, V62, P305, DOI 10.1016/j.neucom.2003.09.014; Moller R, 2004, IEEE T NEURAL NETWOR, V15, P214, DOI 10.1109/TNN.2003.820439; Moller R, 2002, NEUROCOMPUTING, V49, P429, DOI 10.1016/S0925-2312(02)00671-9; Oja E., 1989, International Journal of Neural Systems, V1, P61, DOI 10.1142/S0129065789000475; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Ouyang S, 2000, IEEE T NEURAL NETWOR, V11, P215, DOI 10.1109/72.822524; Pandey P, 2018, 2018 CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGY (CICT'18); PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Ruderman D. L, 1994, ADV NEURAL INFORM PR, P551; Sakurada M., MLSDA 14; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Schenck W., 2008, MPI SERIES BIOL CYBE, V1st; Schraudolph NN, 1999, ONLINE INDEPENDENT C; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Tharwat A, 2018, APPL COMPUT INFORM, V17, P1, DOI [10.1016/j.aci.2018.08.006, DOI 10.1016/J.ACI.2018.08.006]; Tharwat A, 2016, INT J APPL PATTERN R, V3, P197, DOI 10.1504/ijapr.2016.079733; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P66, DOI DOI 10.1080/13506280444000102; Wang J, 2006, IEEE T GEOSCI REMOTE, V44, P1586, DOI 10.1109/TGRS.2005.863297; Wang YS, 2016, NEUROCOMPUTING, V184, P232, DOI 10.1016/j.neucom.2015.08.104; Zhang TL, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON SMART CLOUD (SMARTCLOUD), P152, DOI 10.1109/SmartCloud.2016.33; Zhou AY, 2003, EIGHTH INTERNATIONAL CONFERENCE ON DATABASE SYSTEMS FOR ADVANCED APPLICATIONS, PROCEEDINGS, P285	51	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248896	10.1371/journal.pone.0248896	http://dx.doi.org/10.1371/journal.pone.0248896			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784333	gold, Green Published			2022-12-26	WOS:000636359600049
J	Chen, J; Tomasek, M; Cruz, A; Faron, ML; Liu, DK; Rodgers, WH; Gau, V				Chen, Jade; Tomasek, Michael; Cruz, Amorina; Faron, Matthew L.; Liu, Dakai; Rodgers, William H.; Gau, Vincent			Feasibility and potential significance of rapid in vitro qualitative phenotypic antimicrobial susceptibility testing of gram-negative bacilli with the ProMax system	PLOS ONE			English	Article							TRACT-INFECTIONS; RESISTANCE	The emergence and evolution of antibiotic resistance has been accelerated due to the widespread use of antibiotics and a lack of timely diagnostic tests that guide therapeutic treatment with adequate sensitivity, specificity, and antimicrobial susceptibility testing (AST) accuracy. Automated AST instruments are extensively used in clinical microbiology labs and provide a streamlined workflow, simplifying susceptibility testing for pathogenic bacteria isolated from clinical samples. Although currently used commercial systems such as the Vitek2 and BD Phoenix can deliver results in substantially less time than conventional methods, their dependence on traditional AST inoculum concentrations and optical detection limit their speed somewhat. Herein, we describe the GeneFluidics ProMax lab automation system intended for a rapid 3.5-hour molecular AST from clinical isolates. The detection method described utilizes a higher starting inoculum concentration and automated molecular quantification of species-specific 16S rRNA through the use of an electrochemical sensor to assess microbiological responses to antibiotic exposure. A panel of clinical isolates consisting of species of gram-negative rods from the CDC AR bank and two hospitals, New York-Presbyterian Queens and Medical College of Wisconsin, were evaluated against ciprofloxacin, gentamicin, and meropenem in a series of reproducibility and clinical studies. The categorical agreement and reproducibility for Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, and Pseudomonas aeruginosa were 100% and 100% for ciprofloxacin, 98.7% and 100% for gentamicin and 98.5% and 98.5% for meropenem, respectively.	[Chen, Jade; Tomasek, Michael; Gau, Vincent] GeneFluidics, Los Angeles, CA USA; [Cruz, Amorina; Faron, Matthew L.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Liu, Dakai; Rodgers, William H.] NewYork Presbyterian Queens, Dept Pathol & Clin Labs, Flushing, NY USA; [Rodgers, William H.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Medical College of Wisconsin; Cornell University	Gau, V (corresponding author), GeneFluidics, Los Angeles, CA USA.	vgau@genefluidics.com			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [RO1AI117059]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R44HD084033]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number RO1AI117059 and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R44HD084033. Both grants were received by VG. The NIAID website may be accessed here: https://www.niaid.nih.gov/.The NICHD website may be accessed here: https://www.nichd.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jade Chen, Michael Tomasek, and Vincent Gau are employed by GeneFluidics. As a non-academic, commercial company, the employer and funder provided support in the form of salaries for authors [J.C., M.T.,V.G.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2009, FONDLY WE HOPE FERVE; Barczak AK, 2012, P NATL ACAD SCI USA, V109, P6217, DOI 10.1073/pnas.1119540109; Cornejo-Juarez P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234684; Oliveira MGD, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-162; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; Franz M, 1999, NEPHROL DIAL TRANSPL, V14, P2746, DOI 10.1093/ndt/14.11.2746; Halford C, 2013, ANTIMICROB AGENTS CH, V57, P936, DOI 10.1128/AAC.00615-12; Hooton TM, 2003, INT J ANTIMICROB AG, V22, pS65, DOI 10.1016/S0924-8579(03)00238-3; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Li H, 2019, P NATL ACAD SCI USA, V116, P10270, DOI 10.1073/pnas.1819569116; Liao JC, 2006, J CLIN MICROBIOL, V44, P561, DOI 10.1128/JCM.44.2.561-570.2006; Liao JC, 2007, J MOL DIAGN, V9, P158, DOI 10.2353/jmoldx.2007.060052; MacCannell D., 2016, Clinical Microbiology Newsletter, V38, P169; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Ndir A, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0114-7; Nham E, 2020, INFECT CHEMOTHER, V52, P59, DOI 10.3947/ic.2020.52.1.59; Read Andrew F., 2014, Evolution Medicine and Public Health, P147, DOI 10.1093/emph/eou024; Savage RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154944; Schoepp NG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3693; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; Viswanathan VK, 2014, GUT MICROBES, V5, P3, DOI 10.4161/gmic.28027; Wojno KJ, 2020, UROLOGY, V136, P119, DOI 10.1016/j.urology.2019.10.018; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249203	10.1371/journal.pone.0249203	http://dx.doi.org/10.1371/journal.pone.0249203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770124	Green Published, gold			2022-12-26	WOS:000634833500008
J	Niemczyk, M; Danielewska, ME; Kostyszak, MA; Lewandowski, D; Iskander, DR				Niemczyk, Marcela; Danielewska, Monika E.; Kostyszak, Malgorzata A.; Lewandowski, Daniel; Robert Iskander, D.			The effect of intraocular pressure elevation and related ocular biometry changes on corneal OCT speckle distribution in porcine eyes	PLOS ONE			English	Article								The aim of this study was to evaluate the influence of increase in intraocular pressure (IOP) and cooccurring changes in ocular biometry parameters on the corneal optical coherence tomography (OCT) speckle distribution in ex-vivo experiments on porcine intact eyes. Twenty-three eyeballs were used in the inflation test where IOP in the anterior chamber was precisely set from 10 mmHg to 40 mmHg in steps of 5 mmHg and where eye biometry was utilized (IOL Master 700). To assess the influence of the duration of the experiment on the OCT speckle statistics, the second experiment was performed with 10 eyeballs at the constant IOP of 15 mmHg. Based on the OCT scans of central cornea (Copernicus REVO), spatial maps of the scale parameter (a) and the shape parameter (v) of the gamma distribution speckle model were estimated. The means of both parameters for each spatial map were computed within the 2 mm of the central stroma. Both distributional parameters statistically significantly varied with IOP and time (one way repeated measures ANOVA, all p-values < 0.001). The a parameter revealed a faster statistically significant increase in IOP up to 25 mmHg, regardless of time. Central corneal thickness (CCT), the anterior chamber depth, and the mean equivalent spherical power varied significantly with IOP, whereas CCT and axial length changed statistically significantly with time. Statistically significant correlation was found between CCT and the a parameter, after removing IOP as a confounding factor (r = -0.576, p < 0.001). The parameters of the gamma distribution can be used not only for identifying IOP induced changes in the optical scattering within the corneal stroma, but also in corneal geometry. The approach of corneal speckle analysis could be potentially utilized for an indirect and noninvasive assessment of some properties of corneal stroma.	[Niemczyk, Marcela; Danielewska, Monika E.; Kostyszak, Malgorzata A.; Robert Iskander, D.] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland; [Lewandowski, Daniel] Wroclaw Univ Sci & Technol, Dept Mech Mat & Biomed Engn, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology	Niemczyk, M (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland.	marcela.niemczyk@pwr.edu.pl	Lewandowski, Daniel/A-4324-2016; Niemczyk, Marcela/GQQ-3280-2022; Lewandowski, Daniel/AGY-1726-2022	Lewandowski, Daniel/0000-0002-5169-9021; Niemczyk, Marcela/0000-0001-8307-3413	National Science Centre, Poland, OPUS grant [2018/29/B/ST7/02451]; project "InterDokInterdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology"; Polish National Agency for Academic Exchange NAWA grant [PPI/APM/2019/1/00085/DEC/1]	National Science Centre, Poland, OPUS grant; project "InterDokInterdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology"; Polish National Agency for Academic Exchange NAWA grant(Polish National Agency for Academic Exchange (NAWA))	D. R. I., M. E. D., and M. A. K. have been funded by the National Science Centre, Poland, OPUS grant No 2018/29/B/ST7/02451. M. N. has been funded by the project "InterDokInterdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology". D. R. I. and M. N. acknowledge support from the Polish National Agency for Academic Exchange NAWA grant No PPI/APM/2019/1/00085/DEC/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2004, J R SOC INTERFACE, V1, P3, DOI 10.1098/rsif.2004.0002; Ang M, 2018, PROG RETIN EYE RES, V66, P132, DOI 10.1016/j.preteyeres.2018.04.002; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Benoit A, 2016, J MECH BEHAV BIOMED, V60, P93, DOI 10.1016/j.jmbbm.2015.12.031; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Bujang M. A, 2016, WORLD J SOC SCI RES, V3, P37, DOI [10.22158/wjssr.v3n1p37, DOI 10.22158/WJSSR.V3N1P37]; Chihara E, 2008, SURV OPHTHALMOL, V53, P203, DOI 10.1016/j.survophthal.2008.02.005; CHOI SC, 1969, TECHNOMETRICS, V11, P683, DOI 10.2307/1266892; Eliasy A, 2018, EXP EYE RES, V175, P98, DOI 10.1016/j.exer.2018.06.013; Goodman J. W., 1975, Laser speckle and related phenomena, P9; Grzywacz NM, 2010, IEEE T MED IMAGING, V29, P1224, DOI 10.1109/TMI.2009.2038375; Hatami-Marbini H, 2014, EXP EYE RES, V120, P103, DOI 10.1016/j.exer.2013.11.017; Hatami-Marbini H, 2013, CURR EYE RES, V38, P1124, DOI 10.3109/02713683.2013.809769; Iskander DR, 2020, OPTOMETRY VISION SCI, V97, P62, DOI 10.1097/OPX.0000000000001476; Jesus DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177180; Jesus DA, 2017, BIOMED OPT EXPRESS, V8, P162, DOI 10.1364/BOE.8.000162; Kazaili A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42789-4; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Lindenmaier AA, 2013, OPT LETT, V38, P1280, DOI 10.1364/OL.38.001280; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Lombardo M, 2015, BIOMED OPT EXPRESS, V6, P2803, DOI 10.1364/BOE.6.002803; Mcheik Ali, 2009, Proceedings of the Singaporean-French IPAL Symposium 2009 - SinFra'09, P86, DOI 10.1142/9789814277563_0009; McQuaid R, 2014, CORNEA, V33, P125, DOI 10.1097/ICO.0000000000000015; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Nguyen TM, 2014, INVEST OPHTH VIS SCI, V55, P7545, DOI 10.1167/iovs.14-15127; Nose RM, 2017, BURNS, V43, P424, DOI 10.1016/j.burns.2016.08.012; Pavlatos E, 2018, IEEE T MED IMAGING, V37, P663, DOI 10.1109/TMI.2017.2775146; Pierscionek K, 2007, BRIT J OPHTHALMOL, V91, P801, DOI 10.1136/bjo.2006.110221; Quantock AJ, 2015, EXP EYE RES, V133, P81, DOI 10.1016/j.exer.2014.07.018; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Rogala MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228920; Salmon TO, 2002, J OPT SOC AM A, V19, P657, DOI 10.1364/JOSAA.19.000657; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Shetty R, 2017, INVEST OPHTH VIS SCI, V58, P5695, DOI 10.1167/iovs.17-22864; STACY EW, 1965, TECHNOMETRICS, V7, P349, DOI 10.2307/1266594; Szczesna DH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431103; Szkulmowski M, 2012, OPT EXPRESS, V20, P1337, DOI 10.1364/OE.20.001337; Tan HY, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2012987; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; Vetter JM, 2012, J CATARACT REFR SURG, V38, P525, DOI 10.1016/j.jcrs.2011.09.045; Wang LK, 2018, ANN BIOMED ENG, V46, P247, DOI 10.1007/s10439-017-1973-7; Werkmeister RM, 2017, BIOMED OPT EXPRESS, V8, P1221, DOI 10.1364/BOE.8.001221; Wu KS, 2013, SOFT MATER, V11, P244, DOI 10.1080/1539445X.2011.622030; Wu QF, 2008, CORNEA, V27, P202, DOI 10.1097/ICO.0b013e318159221e; Yadav R, 2011, BIOMED OPT EXPRESS, V2, P3037, DOI 10.1364/BOE.2.003037; Yeh AT, 2002, OPT LETT, V27, P2082, DOI 10.1364/OL.27.002082	50	4	4	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249213	10.1371/journal.pone.0249213	http://dx.doi.org/10.1371/journal.pone.0249213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770135	Green Published, gold			2022-12-26	WOS:000634833500019
J	Temesgen, K; Wakgari, N; Debelo, BT; Tafa, B; Alemu, G; Wondimu, F; Gudisa, T; Gishile, T; Daba, G; Bulto, GA; Soboka, B				Temesgen, Kababa; Wakgari, Negash; Debelo, Bikila Tefera; Tafa, Belay; Alemu, Getu; Wondimu, Fikadu; Gudisa, Tolera; Gishile, Tolosa; Daba, Gurmesa; Bulto, Gizachew Abdissa; Soboka, Bikila			Maternal health care services utilization amidstCOVID-19 pandemic in West Shoa zone, central Ethiopia	PLOS ONE			English	Article							WOMENS AUTONOMY; DETERMINANTS	The novel coronavirus (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Despite strong efforts that have been taking place to control the pandemic globally, the virus is on the rise in many countries. Hence, this study assessed the maternal health care services utilization amidst the COVID-19 pandemic in West Shoa zone, Central Ethiopia. A community-based cross-sectional study was conducted among 844 pregnant women or those who gave birth in the last 6 months before the study. A multi-stage sampling technique was used to select the study participants. The data were collected through face-to-face interviews using a semi-structured questionnaire. Logistic regressions were performed to identify the presence of significant associations, and an adjusted odds ratio with 95%CI was employed for the strength and directions of association between the independent and outcome variables. A P-value of <0.05 was used to declare statistical significance. The prevalence of maternal health service utilization during the COVID-19 pandemic was 64.8%. The odds of maternal health service utilization was higher among mothers who had primary (AOR = 2.16, 95%CI: 1.29-3.60), secondary (AOR = 1.97, 95%CI: 1.13-3.44), and college and above education (AOR = 2.89, 95%CI: 1.34-6.22) than those who could not read and write. Besides, mothers who did travel 30-60 minutes (AOR = 0.37, 95%CI: 0.23-0.59) and 60-90minutes (AOR = 0.10, 95%CI: 0.05-0.19) to reach the health facility had a lower odds of maternal health service utilization than those who did travel <30 minutes. Moreover, mothers who earn 1000-2000 (AOR = 3.10, 95%CI: 1.73-5.55) and > 2000 birrs (AOR = 2.66 95%CI: 1.52-4.64) had higher odds of maternal health service utilization than those who earn <500 birrs. Similarly, the odds of utilizing maternal health service were higher among mothers who did not fear COVID-19 infection (AOR = 2.79, 95%CI: 1.85-4.20), who had not had to request permission from husband to visit the health facility (AOR = 7.24, 95%CI: 2.65-19.75), who had practicedCOVID-19 prevention measure (AOR = 5.82, 95%CI: 3.87-8.75), and used face mask (AOR = 2.06, 95% CI: 1.28-3.31) than their counterpart. Empowering mothers and creating awareness on COVID-19 preventionis recommended to improve maternal health service utilization during the COVID-19 pandemic.	[Temesgen, Kababa; Wakgari, Negash; Debelo, Bikila Tefera; Wondimu, Fikadu; Gudisa, Tolera; Daba, Gurmesa; Bulto, Gizachew Abdissa] Ambo Univ, Dept Midwifery, Coll Med & Hlth Sci, Ambo, Ethiopia; [Tafa, Belay] Ambo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Ambo, Ethiopia; [Alemu, Getu] Ambo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Ambo, Ethiopia; [Gishile, Tolosa] Ambo Univ, Dept Obstet & Gynecol, Referral Hosp, Ambo, Ethiopia; [Soboka, Bikila] Ethiopian Publ Hlth Inst, Hlth Syst & Reprod Hlth Res, Addis Ababa, Ethiopia	Ambo University; Ambo University; Ambo University; Ambo University	Wakgari, N (corresponding author), Ambo Univ, Dept Midwifery, Coll Med & Hlth Sci, Ambo, Ethiopia.	negashwakgari@yahoo.com		Wondimu Abdisa, Fikadu/0000-0002-5519-0089; Wakgari, Negash/0000-0002-3422-5836; Bulto, Gizachew Abdissa/0000-0003-4390-1418; Debelo, Bikila Tefera/0000-0003-1066-118X; Tafa, Belay/0000-0003-0751-9422	Ambo University, College of Medicine and Health Science	Ambo University, College of Medicine and Health Science	The authors are grateful to the Ambo University, College of Medicine and Health Science for funding the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbadee AY, 2020, EUR J CONTRACEP REPR, V25, P402, DOI 10.1080/13625187.2020.1768527; Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Akaba Godwin, 2020, F1000Res, V9, P1106, DOI 10.12688/f1000research.26283.2; Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bayeta A., 2018, MATERNAL HLTH SERVIC; Burgoyne Mary E, 2020, Case Rep Obstet Gynecol, V2020, P8847859, DOI 10.1155/2020/8847859; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021; Ethiopian Public Health Institute, FEDERAL MINISTRY HLT; Feyissa GT, 2020, AFR J REPROD HEALTH, V24, P24, DOI 10.29063/ajrh2020/v24i2s.3; Mahato P., 2020, EUROPASIAN J MED SCI, V2, P113, DOI [10.46405/ejms.v2i2.91, DOI 10.46405/EJMS.V2I2.91]; Mirzadeh M, 2022, J MATERN-FETAL NEO M, V35, P1377, DOI 10.1080/14767058.2020.1749257; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Pant S, 2020, EUROPASIAN J MED SCI, V2, P48, DOI [10.46405/ejms.v2i2.110, DOI 10.46405/EJMS.V2I2.110]; Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017; Saccone G, 2020, AM J OBSTET GYNECOL, V223, P293, DOI 10.1016/j.ajog.2020.05.003; Tiruneh FN, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2670-9; Tolu LB, GUIDELINES BEST PRAC; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0067-y; World Health Organization, 2013, CORONAVIRUS DIS COVI	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249214	10.1371/journal.pone.0249214	http://dx.doi.org/10.1371/journal.pone.0249214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770120	gold, Green Published			2022-12-26	WOS:000634833500029
J	Cassim, AM; Navon, Y; Gao, Y; Decossas, M; Fouillen, L; Grelard, A; Nagano, M; Lambert, O; Bahammou, D; Van Delft, P; Maneta-Peyret, L; Simon-Plas, F; Heux, L; Jean, B; Fragneto, G; Mortimer, JC; Deleu, M; Lins, L; Mongrand, S				Cassim, Adiilah Mamode; Navon, Yotam; Gao, Yu; Decossas, Marion; Fouillen, Laetitia; Grelard, Axelle; Nagano, Minoru; Lambert, Olivier; Bahammou, Delphine; Van Delft, Pierre; Maneta-Peyret, Lilly; Simon-Plas, Francoise; Heux, Laurent; Jean, Bruno; Fragneto, Giovanna; Mortimer, Jenny C.; Deleu, Magali; Lins, Laurence; Mongrand, Sebastien			Biophysical analysis of the plant-specific GIPC sphingolipids reveals multiple modes of membrane regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIPID RAFTS; MAGNETIC-RESONANCE; CHOLESTEROL; TOBACCO; ORGANIZATION; ARABIDOPSIS; BILAYERS; DYNAMICS; PHASES	The plant plasma membrane (PM) is an essential barrier between the cell and the external environment, controlling signal perception and transmission. It consists of an asymmetrical lipid bilayer made up of three different lipid classes: sphingolipids, sterols, and phospholipids. The glycosyl inositol phosphoryl ceramides (GIPCs), representing up to 40% of total sphingolipids, are assumed to be almost exclusively in the outer leaflet of the PM. However, their biological role and properties are poorly defined. In this study, we investigated the role of GIPCs in membrane organization. Because GIPCs are not commercially available, we developed a protocol to extract and isolate GIPC-enriched fractions from eudicots (cauliflower and tobacco) and monocots (leek and rice). Lipidomic analysis confirmed the presence of trihydroxylated long chain bases and 2-hydroxylated very long-chain fatty acids up to 26 carbon atoms. The glycan head groups of the GIPCs from monocots and dicots were analyzed by gas chromatograph-mass spectrometry, revealing different sugar moieties. Multiple biophysics tools, namely Langmuir monolayer, zeta-Potential, light scattering, neutron reflectivity, solid state 2H-NMR, and molecular modeling, were used to investigate the physical properties of the GIPCs, as well as their interaction with free and conjugated phytosterols. We showed that GIPCs increase the thickness and electronegativity of model membranes, interact differentially with the different phytosterols species, and regulate the gel-to-fluid phase transition during temperature variations. These results unveil the multiple roles played by GIPCs in the plant PM.	[Cassim, Adiilah Mamode; Fouillen, Laetitia; Nagano, Minoru; Bahammou, Delphine; Van Delft, Pierre; Maneta-Peyret, Lilly; Mongrand, Sebastien] Univ Bordeaux, Lab Biogenese Membranaire, CNRS, UMR 5200, Villenave Dornon, France; [Navon, Yotam; Heux, Laurent; Jean, Bruno] Univ Grenoble Alpes, Ctr Rech Macromol Vegetales CERMAV, CNRS, Grenoble, France; [Gao, Yu; Mortimer, Jenny C.] Joint BioEnergy Inst, Emeryville, CA USA; [Gao, Yu; Mortimer, Jenny C.] Lawrence Berkeley Natl Lab, Environm & Syst Genom, Berkeley, CA USA; [Decossas, Marion; Grelard, Axelle; Lambert, Olivier] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects UMR5248, Inst Polytech Bordeaux, CNRS, Pessac, France; [Nagano, Minoru] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Japan; [Cassim, Adiilah Mamode; Simon-Plas, Francoise] Univ Bourgogne Franche Comte, INRA, CNRS, AgroSup Dijon,Agroecol, F-21000 Dijon, France; [Fragneto, Giovanna] Inst Laue Langevin ILL, Grenoble, France; [Deleu, Magali; Lins, Laurence] Univ Liege, TERRA Res Ctr, Lab Biophys Mol Interfaces, GX ABT, Gembloux, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Ritsumeikan University; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Laue-Langevin (ILL); University of Liege	Mongrand, S (corresponding author), Univ Bordeaux, Lab Biogenese Membranaire, CNRS, UMR 5200, Villenave Dornon, France.	sebastien.mongrand@u-bordeaux.fr	Mortimer, Jenny C/AAY-6648-2021; FOUILLEN, Laetitia/AAV-9710-2020	Mortimer, Jenny C/0000-0001-6624-636X; FOUILLEN, Laetitia/0000-0002-1204-9296; Gao, Yu/0000-0002-8696-442X; Van Delft, Pierre/0000-0001-5839-8427; decossas, marion/0000-0003-0810-4309	French Ministry of Higher Education and Research (MESR); ANR PlayMobil [ANR-19-CE20-0016-02]; DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC0205CH11231]; Bordeaux Metabolome Facility-MetaboHUB [ANR-11-INBS-0010]	French Ministry of Higher Education and Research (MESR)(Ministry of Research, France); ANR PlayMobil(French National Research Agency (ANR)); DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Bordeaux Metabolome Facility-MetaboHUB	A. M. C. PhD project was funded by the French Ministry of Higher Education and Research (MESR). F. S. -P., S. M., L. L., L. F., and D. B. are funded by the ANR PlayMobil (ANR-19-CE20-0016-02). Y. G., J. C. M. were funded as was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC0205CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. We thank Bordeaux-Metabolome platform for lipid analysis supported by ANR PlayMobil (grant no. ANR-19-CE20-0016-02 to S. M., L. F., F. S. -P.) and Bordeaux Metabolome Facility-MetaboHUB (grant no. ANR-11-INBS-0010 to S. M. and L. F.).	Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Bure C, 2016, J MASS SPECTROM, V51, P305, DOI 10.1002/jms.3758; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Bure C, 2011, RAPID COMMUN MASS SP, V25, P3131, DOI 10.1002/rcm.5206; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; CARTER HE, 1969, J LIPID RES, V10, P356; CARTER HE, 1958, J BIOL CHEM, V233, P1309; CARTER HE, 1969, J LIPID RES, V10, P363; Cassim AM, 2019, PROG LIPID RES, V73, P1, DOI 10.1016/j.plipres.2018.11.002; Courtney KC, 2018, ELIFE, V7, DOI 10.7554/eLife.38493; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Deleu M, 2014, BBA-BIOMEMBRANES, V1838, P3171, DOI 10.1016/j.bbamem.2014.08.023; Eeman M, 2005, LANGMUIR, V21, P2505, DOI 10.1021/la0475775; Fang L, 2016, PLANT CELL, V28, P2991, DOI 10.1105/tpc.16.00186; Furt F, 2007, PLANT SIGNAL BEHAV, V2, P508, DOI 10.4161/psb.2.6.4636; Gerbeau-Pissot P, 2014, PLANT PHYSIOL, V164, P273, DOI 10.1104/pp.113.225755; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Gronnier J, 2018, TRENDS PLANT SCI, V23, P899, DOI 10.1016/j.tplants.2018.07.007; Grosjean K, 2015, J BIOL CHEM, V290, P5810, DOI 10.1074/jbc.M114.598805; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; Ishikawa T, 2018, PLANT PHYSIOL, V177, P938, DOI 10.1104/pp.18.00396; Jiang ZH, 2019, NATURE, V572, P341, DOI 10.1038/s41586-019-1449-z; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KANG SY, 1979, BIOCHEMISTRY-US, V18, P3268, DOI 10.1021/bi00582a011; KAUL K, 1978, BIOCHEMISTRY-US, V17, P3569, DOI 10.1021/bi00610a023; KAUL K, 1975, PLANT PHYSIOL, V55, P120, DOI 10.1104/pp.55.1.120; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Kubsch B, 2017, JOVE-J VIS EXP, DOI 10.3791/56034; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; Lenarcic T, 2017, SCIENCE, V358, P1431, DOI 10.1126/science.aan6874; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Luttgeharm KD, 2015, PHYTOCHEMISTRY, V115, P121, DOI 10.1016/j.phytochem.2015.02.019; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Markham JE, 2013, CURR OPIN PLANT BIOL, V16, P350, DOI 10.1016/j.pbi.2013.02.009; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Montis C, 2016, COLLOID SURFACE B, V137, P203, DOI 10.1016/j.colsurfb.2015.07.039; Moreau RA, 2018, PROG LIPID RES, V70, P35, DOI 10.1016/j.plipres.2018.04.001; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Morre DM, 2000, J CHROMATOGR B, V743, P377, DOI 10.1016/S0378-4347(00)00058-X; Mortimer JC, 2020, TRENDS PLANT SCI, V25, P522, DOI 10.1016/j.tplants.2020.03.007; Mortimer JC, 2013, PLANT CELL, V25, P1881, DOI 10.1105/tpc.113.111500; Nagano M, 2016, PLANT CELL, V28, P1966, DOI 10.1105/tpc.16.00201; Navon Y, 2017, BIOMACROMOLECULES, V18, P2918, DOI 10.1021/acs.biomac.7b00872; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Rennie EA, 2014, PLANT CELL, V26, P3314, DOI 10.1105/tpc.114.129171; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Rog T, 2004, BIOPHYS CHEM, V107, P151, DOI 10.1016/j.bpc.2003.09.002; Rog T, 2016, BBA-BIOMEMBRANES, V1858, P281, DOI 10.1016/j.bbamem.2015.12.003; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; Seneviratne V, 2003, ELECTROCHIM ACTA, V48, P2221, DOI 10.1016/S0013-4686(03)00208-1; Sibille E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168794; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Sipione S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.572965; Smondyrev AM, 2001, BIOPHYS J, V80, P1649, DOI 10.1016/S0006-3495(01)76137-1; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Tarazona P, 2015, PLANT J, V84, P621, DOI 10.1111/tpj.13013; Tellier F, 2014, PHYTOCHEMISTRY, V103, P50, DOI 10.1016/j.phytochem.2014.03.023; Tjellstrom H, 2010, FASEB J, V24, P1128, DOI 10.1096/fj.09-139410; Voxeur A, 2014, PLANT J, V79, P139, DOI 10.1111/tpj.12547; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; YEAGLE PL, 1977, P NATL ACAD SCI USA, V74, P4924, DOI 10.1073/pnas.74.11.4924; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b	77	14	14	10	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100602	10.1016/j.jbc.2021.100602	http://dx.doi.org/10.1016/j.jbc.2021.100602			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785359	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400574
J	Pokidysheva, EN; Seeger, H; Pedchenko, V; Chetyrkin, S; Bergmann, C; Abrahamson, D; Cui, ZW; Delpire, E; Fervenza, FC; Fidler, AL; Fogo, AB; Gaspert, A; Grohmann, M; Gross, O; Haddad, G; Harris, RC; Kashtan, C; Kitching, AR; Lorenzen, JM; McAdoo, S; Pusey, CD; Segelmark, M; Simmons, A; Voziyan, PA; Wagner, T; Wuthrich, RP; Zhao, MH; Boudko, SP; Kistler, AD; Hudson, BG				Pokidysheva, Elena N.; Seeger, Harald; Pedchenko, Vadim; Chetyrkin, Sergei; Bergmann, Carsten; Abrahamson, Dale; Cui, Zhao Wei; Delpire, Eric; Fervenza, Fernando C.; Fidler, Aaron L.; Fogo, Agnes B.; Gaspert, Ariana; Grohmann, Maik; Gross, Oliver; Haddad, George; Harris, Raymond C.; Kashtan, Clifford; Kitching, A. Richard; Lorenzen, Johan M.; McAdoo, Stephen; Pusey, Charles D.; Segelmark, Marten; Simmons, Alicia; Voziyan, Paul A.; Wagner, Timo; Wuethrich, Rudolf P.; Zhao, Ming-Hui; Boudko, Sergei P.; Kistler, Andreas D.; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; MOLECULAR-CLONING; ALPHA-3 CHAIN; X-CHROMOSOME; IDENTIFICATION; ANTIGEN; MODEL; GENE; LOCALIZATION; ORGANIZATION	Diseases of the glomerular basement membrane (GBM), such as Goodpasture's disease (GP) and Alport syndrome (AS), are a major cause of chronic kidney failure and an unmet medical need. Collagen IV alpha 345 is an important architectural element of the GBM that was discovered in previous research on GP and AS. How this collagen enables GBM to function as a permselective filter and how structural defects cause renal failure remain an enigma. We found a distinctive genetic variant of collagen IV alpha 345 in both a familial GP case and four AS kindreds that provided insights into these mechanisms. The variant is an 8-residue appendage at the C-terminus of the a3 subunit of the alpha 345 hexamer. A knock-in mouse harboring the variant displayed GBM abnormalities and proteinuria. This pathology phenocopied AS, which pinpointed the alpha 345 hexamer as a focal point in GBM function and dysfunction. Crystallography and assembly studies revealed underlying hexamer mechanisms, as described in Boudko et al. and Pedchenko et al. Bioactive sites on the hexamer surface were identified where pathogenic pathways of GP and AS converge and, potentially, that of diabetic nephropathy (DN). We conclude that the hexamer functions include signaling and organizing macromolecular complexes, which enable GBM assembly and function. Therapeutic modulation or replacement of alpha 345 hexamer could therefore be a potential treatment for GBM diseases, and this knock-in mouse model is suitable for developing gene therapies.	[Pokidysheva, Elena N.; Pedchenko, Vadim; Chetyrkin, Sergei; Fidler, Aaron L.; Fogo, Agnes B.; Harris, Raymond C.; Simmons, Alicia; Voziyan, Paul A.; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Pokidysheva, Elena N.; Pedchenko, Vadim; Chetyrkin, Sergei; Fidler, Aaron L.; Simmons, Alicia; Voziyan, Paul A.; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA; [Seeger, Harald; Haddad, George; Lorenzen, Johan M.; Wuethrich, Rudolf P.] Univ Hosp Zurich, Nephrol Div, Zurich, Switzerland; [Bergmann, Carsten] Univ Hosp Freiburg, Dept Med & Nephrol, Freiburg, Germany; [Bergmann, Carsten; Grohmann, Maik; Wagner, Timo] Limbach Genet, Med Genet Mainz, Mainz, Germany; [Abrahamson, Dale] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Cui, Zhao Wei; Zhao, Ming-Hui] Peking Univ First Hosp, Renal Div, Beijing, Peoples R China; [Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Fervenza, Fernando C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Fidler, Aaron L.; Simmons, Alicia; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Fogo, Agnes B.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Gaspert, Ariana] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Gross, Oliver] Univ Goettingen, Univ Med Ctr Goettingen, Clin Nephrol & Rheumatol, Gottingen, Germany; [Kashtan, Clifford] Univ Minnesota, Sch Med, Div Pediat Nephrol, Minneapolis, MN 55455 USA; [Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Monash Hlth, Dept Med,Nephrol, Clayton, Vic, Australia; [McAdoo, Stephen; Pusey, Charles D.] Imperial Coll London, Ctr Inflammatory Dis, London, England; [Segelmark, Marten; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Kistler, Andreas D.] Kantonsspital Frauenfeld, Dept Internal Med, Frauenfeld, Switzerland; [Hudson, Billy G.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; University of Zurich; University Zurich Hospital; University of Freiburg; University of Kansas; University of Kansas Medical Center; Vanderbilt University; Mayo Clinic; Vanderbilt University; Vanderbilt University; University of Zurich; University Zurich Hospital; University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities; Monash University; Imperial College London; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	billy.hudson@vumc.org	Kitching, A Richard/B-6947-2013; Cui, Zhao/ABZ-9262-2022; McAdoo, Stephen Paul/AAP-7427-2021; Fidler, Aaron/C-4031-2014	Kitching, A Richard/0000-0002-2713-2391; Cui, Zhao/0000-0002-5837-1926; McAdoo, Stephen Paul/0000-0001-8260-8770; Kistler, Andreas/0000-0002-4114-9560; Fidler, Aaron/0000-0002-2519-8864; Fervenza, Fernando/0000-0002-9952-209X; Boudko, Sergei/0000-0003-3856-4859; Gross, Oliver/0000-0002-8390-8852	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK18381-50, R01DK018381, R24DK103067, R01DK065138, R01DK93501, P30DK114809, RO1DK56942]; Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center; German Research Foundation DFG [GR 1852/6-1]; Federal Ministry of Education and Research (BMBF) [01GM1903I, 01GM1903G]; Deutsche Forschungsgemeinschaft (DFG) [BE 3910/8-1, BE 3910/9-1, 431984000 - SFB 1453]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center; German Research Foundation DFG(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Y Supported by grants R01DK18381-50 and a supplement R01DK018381 (to Dr Billy G Hudson), R24DK103067 (to Dr Raymond Harris and Dr Billy G Hudson), R01DK065138 (to Dr Billy G Hudson and Dr Paul Voziyan), R01DK93501 (to Dr Eric Delpire), and P30DK114809 (to Dr Raymond Harris), and RO1DK56942 (to Dr Agnes Fogo) from the National Institute of Diabetes and Digestive and Kidney Diseases. Additional support was provided by the Aspirnaut program from the Center for Matrix Biology at Vanderbilt University Medical Center. Dr Sergei Boudko was supported, in part, by start-up funding from Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center. Dr Oliver Gross is supported by the German Research Foundation DFG (GR 1852/6-1). Dr Carsten Bergmann is supported by the Deutsche Forschungsgemeinschaft (DFG) (BE 3910/8-1, BE 3910/9-1, and Project-ID 431984000 -SFB 1453) and the Federal Ministry of Education and Research (BMBF, 01GM1903I and 01GM1903G).	Abrahamson DR, 2012, SEMIN NEPHROL, V32, P342, DOI 10.1016/j.semnephrol.2012.06.005; Angioi A, 2017, CLIN NEPHROL, V88, P277, DOI 10.5414/CN109206; Backus KM, 2019, CURR TOP MICROBIOL, V420, P375, DOI 10.1007/82_2018_120; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; Bikbov B, 2018, NEPHRON, V139, P313, DOI 10.1159/000489897; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Boudko SP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100591; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cui Z, 2016, J AUTOIMMUN, V70, P1, DOI 10.1016/j.jaut.2016.04.001; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Groopman EE, 2019, NEW ENGL J MED, V380, P142, DOI 10.1056/NEJMoa1806891; Gross O, 2020, KIDNEY INT, V97, P1275, DOI 10.1016/j.kint.2019.12.015; Guin D, 2019, CHEM REV, V119, P10691, DOI 10.1021/acs.chemrev.8b00753; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; GUNWAR S, 1991, AM J RESP CELL MOL, V5, P107, DOI 10.1165/ajrcmb/5.2.107; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1972, J BIOL CHEM, V247, P4229; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; Kashtan CE, 2018, KIDNEY INT, V93, P1045, DOI 10.1016/j.kint.2017.12.018; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KEFALIDES NA, 1968, BIOCHEMISTRY-US, V7, P3103, DOI 10.1021/bi00849a012; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Lin MH, 2018, J AM SOC NEPHROL, V29, P1426, DOI 10.1681/ASN.2017060690; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; McAdoo SP, 2017, CLIN J AM SOC NEPHRO, V12, P1162, DOI 10.2215/CJN.01380217; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; MORRISON KE, 1991, AM J HUM GENET, V49, P545; Mott JD, 1997, KIDNEY INT, V52, P1302, DOI 10.1038/ki.1997.455; MYERS JC, 1990, AM J HUM GENET, V46, P1024; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Pedchenko V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100592; Pedchenko V, 2018, MATRIX BIOL, V71-72, P240, DOI 10.1016/j.matbio.2018.05.004; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Pirson Y, 1999, KIDNEY INT, V56, P760, DOI 10.1046/j.1523-1755.1999.00601.x; Polosukhin VV, 2005, ULTRASTRUCT PATHOL, V29, P53, DOI 10.1080/019131290882286; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; SAUS J, 1988, J BIOL CHEM, V263, P13374; Savige J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161802; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Seeger H. P., 2018, J AM SOC NEPHROLOGY, P692; SPIRO RG, 1973, NEW ENGL J MED, V288, P1337; SPIRO RG, 1967, J BIOL CHEM, V242, P1915; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; Xie LJ, 2017, IMMUNOLOGY, V151, P395, DOI 10.1111/imm.12736; Yamamura T, 2017, KIDNEY INT REP, V2, P850, DOI 10.1016/j.ekir.2017.04.011; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	65	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100590	10.1016/j.jbc.2021.100590	http://dx.doi.org/10.1016/j.jbc.2021.100590			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774048	Green Published, gold			2022-12-26	WOS:000672866400562
J	Wu, XZ; Brombacher, F; Chroneos, ZC; Norbury, CC; Gowda, DC				Wu, Xianzhu; Brombacher, Frank; Chroneos, Zissis C.; Norbury, Christopher C.; Gowda, D. Channe			IL-4R alpha signaling by CD8 alpha(+) dendritic cells contributes to cerebral malaria by enhancing inflammatory, Th1, and cytotoxic CD8(+) T cell responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; PATHOGENESIS; PARASITE; HISTORY	Persistent high levels of proinflammatory and Th1 responses contribute to cerebral malaria (CM). Suppression of inflammatory responses and promotion of Th2 responses prevent pathogenesis. IL-4 commonly promotes Th2 responses and inhibits inflammatory and Th1 responses. Therefore, IL-4 is widely considered as a beneficial cytokine via its Th2-promoting role that is predicted to provide protection against severe malaria by inhibiting inflammatory responses. However, IL-4 may also induce inflammatory responses, as the result of IL-4 action depends on the timing and levels of its production and the tissue environment in which it is produced. Recently, we showed that dendritic cells (DCs) produce IL-4 early during malaria infection in response to a parasite protein and that this IL-4 response may contribute to severe malaria. However, the mechanism by which IL-4 produced by DCs contributing to lethal malaria is unknown. Using Plasmodium berghei ANKA-infected C57BL/6 mice, a CM model, we show here that mice lacking IL-4R alpha only in CD8 alpha(+) DCs are protected against CM pathogenesis and survive, whereas WT mice develop CM and die. Compared with WT mice, mice lacking IL-4R alpha in CD11c(+) or CD8 alpha(+) DCs showed reduced inflammatory responses leading to decreased Th1 and cytotoxic CD8(+) T cell responses, lower infiltration of CD8(+) T cells to the brain, and negligible brain pathology. The novel results presented here reveal a paradoxical role of IL-4R alpha signaling in CM pathogenesis that promotes CD8 alpha(+) DC-mediated inflammatory responses that generate damaging Th1 and cytotoxic CD8(+) T cell responses.	[Wu, Xianzhu; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol ICGEB, Component, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol ICGEB, Div Immunol, Cape Town, South Africa; [Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Norbury, Christopher C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	gowda@psu.edu		Brombacher, Frank/0000-0001-8881-6781; Norbury, Christopher/0000-0001-7411-6987; Gowda, Channe/0000-0002-6860-5108; Wu, Xianzhu/0000-0002-6892-378X; , Zissis/0000-0002-9841-7917	National Institute of Allergy and Infectious Diseases, NIH [R01 AI41139]; Pennsylvania Department of Health [4100083097]	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health	This work was funded in parts by the grant R01 AI41139 from the National Institute of Allergy and Infectious Diseases, NIH, and the grant with the Pennsylvania Department of Health using Tobacco CURE Funds SAP#4100083097 (D. C. G. and C. C. N.). The Pennsylvania Department of Health specifically disclaims responsibility for any analysis, interpretations, or conclusions. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amorim KNS, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2926436; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Cabantous S, 2009, J INFECT DIS, V200, P1530, DOI 10.1086/644600; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; de Souza MC, 2016, CURRENT TOPICS IN MALARIA, P85, DOI 10.5772/65348; Deroost K, 2016, FEMS MICROBIOL REV, V40, P208, DOI 10.1093/femsre/fuv046; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Ghazanfari N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02016; Guenova E, 2008, EUR J IMMUNOL, V38, P3138, DOI 10.1002/eji.200838463; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; MAKGOBA MW, 1988, EUR J IMMUNOL, V18, P637, DOI 10.1002/eji.1830180423; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Mohrs M, 1999, J IMMUNOL, V162, P7302; Morris SC, 2009, J IMMUNOL, V182, P1429, DOI 10.4049/jimmunol.182.3.1429; Morrot A, 2004, INT J PARASITOL, V34, P1529, DOI 10.1016/j.ijpara.2004.10.001; Naves R, 2013, J IMMUNOL, V191, P2967, DOI 10.4049/jimmunol.1300419; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Renia L, 2020, J CLIN INVEST, V130, P1109, DOI 10.1172/JCI135510; Riggle BA, 2020, J CLIN INVEST, V130, P1128, DOI 10.1172/JCI133474; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Sebina I, 2018, IMMUNOLOGY, V155, P176, DOI 10.1111/imm.12971; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Storm J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00100; Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Verra F, 2004, ACTA TROP, V90, P205, DOI 10.1016/j.actatropica.2003.11.014; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Wu XZ, 2018, J BIOL CHEM, V293, P10425, DOI 10.1074/jbc.AC118.001720; Wu XZ, 2017, J BIOL CHEM, V292, P13615, DOI [10.1074/jbc.M116.770313, 10.1074/jbc.m116.770313]; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	36	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100615	10.1016/j.jbc.2021.100615	http://dx.doi.org/10.1016/j.jbc.2021.100615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798555	gold, Green Published			2022-12-26	WOS:000672866400586
J	Broatch, JR; O'Riordan, SF; Keske, MA; Betik, AC; Bishop, DJ; Halson, SL; Parker, L				Broatch, James R.; O'Riordan, Shane F.; Keske, Michelle A.; Betik, Andrew C.; Bishop, David J.; Halson, Shona L.; Parker, Lewan			Reduced post-exercise muscle microvascular perfusion with compression is offset by increased muscle oxygen extraction: Assessment by contrast-enhanced ultrasound	FASEB JOURNAL			English	Article						capillary-myocyte interface; ergogenic; microvasculature; NIRS; sprint-interval exercise	PRESERVED EJECTION FRACTION; BLOOD-FLOW RESPONSES; SKELETAL-MUSCLE; EXERCISE INTOLERANCE; LOWER-LIMB; PHYSIOLOGICAL-RESPONSES; EXTERNAL COMPRESSION; PROTEIN-SYNTHESIS; HEART-FAILURE; INSULIN	The microvasculature is important for both health and exercise tolerance in a range of populations. However, methodological limitations have meant changes in microvascular blood flow are rarely assessed in humans during interventions designed to affect skeletal muscle blood flow such as the wearing of compression garments. The aim of this study is, for the first time, to use contrast-enhanced ultrasound to directly measure the effects of compression on muscle microvascular blood flow alongside measures of femoral artery blood flow and muscle oxygenation following intense exercise in healthy adults. It was hypothesized that both muscle microvascular and femoral artery blood flows would be augmented with compression garments as compared with a control condition. Ten recreationally active participants completed two repeated-sprint exercise sessions, with and without lower-limb compression tights. Muscle microvascular blood flow, femoral arterial blood flow (2D and Doppler ultrasound), muscle oxygenation (near-infrared spectroscopy), cycling performance, and venous blood samples were measured/taken throughout exercise and the 1-hour post-exercise recovery period. Compared with control, compression reduced muscle microvascular blood volume and attenuated the exercise-induced increase in microvascular velocity and flow immediately after exercise and 1 hour post-exercise. Compression increased femoral artery diameter and augmented the exercise-induced increase in femoral arterial blood flow during exercise. Markers of blood oxygen extraction in muscle were increased with compression during and after exercise. Compression had no effect on blood lactate, glucose, or exercise performance. We provide new evidence that lower-limb compression attenuates the exercise-induced increase in skeletal muscle microvascular blood flow following exercise, despite a divergent increase in femoral artery blood flow. Decreased muscle microvascular perfusion is offset by increased muscle oxygen extraction, a potential mechanism allowing for the maintenance of exercise performance.	[Broatch, James R.; O'Riordan, Shane F.; Bishop, David J.] Victoria Univ, Inst Hlth & Sport IHES, POB 14428, Melbourne, Vic 8001, Australia; [Broatch, James R.; O'Riordan, Shane F.] Australia Inst Sport, Canberra, ACT, Australia; [Keske, Michelle A.; Betik, Andrew C.; Parker, Lewan] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr IPAN, Geelong, Vic, Australia; [Halson, Shona L.] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia	Victoria University; Australian Institute of Sport; Deakin University; Australian Catholic University	Broatch, JR (corresponding author), Victoria Univ, Inst Hlth & Sport IHES, POB 14428, Melbourne, Vic 8001, Australia.	james.broatch@vu.edu.au	Bishop, David John/X-9826-2019; Broatch, James R/AAC-3628-2019; Broatch, James R/N-9488-2018	Bishop, David John/0000-0002-6956-9188; Broatch, James R/0000-0002-0082-3168; Broatch, James R/0000-0002-0082-3168; O'Riordan, Shane/0000-0002-1022-4492; Keske, Michelle/0000-0003-4214-7628; Parker, Lewan/0000-0002-5372-1851	Deakin University; National Heart Foundation Early Career Fellowship [APP1157930]; compression garment manufacturer 2XU (Australia); Victoria University; NHMRC	Deakin University; National Heart Foundation Early Career Fellowship; compression garment manufacturer 2XU (Australia); Victoria University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by Deakin University and Victoria University. LP was supported by a NHMRC & National Heart Foundation Early Career Fellowship (APP1157930). JRB, SLH, and DJB received a research grant from compression garment manufacturer 2XU (Australia), which also supported JRB. 2XU had no input in study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the article for publication	Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Bangsbo J, 1998, ACTA PHYSIOL SCAND, V162, P305, DOI 10.1046/j.1365-201X.1998.0331e.x; Barrett EJ, 2012, DIABETES, V61, P2661, DOI 10.2337/db12-0271; Barstow TJ, 2019, J APPL PHYSIOL, V126, P1360; Betik AC, 2021, MED SCI SPORT EXER, V53, P375, DOI 10.1249/MSS.0000000000002463; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bochmann RP, 2005, J APPL PHYSIOL, V99, P2337, DOI 10.1152/japplphysiol.00965.2004; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broatch JR, 2018, INT J SPORT PHYSIOL, V13, P882, DOI 10.1123/ijspp.2017-0638; Broatch JR, 2014, MED SCI SPORT EXER, V46, P2139, DOI 10.1249/MSS.0000000000000348; Brophy-Williams N, 2015, J SPORT SCI, V33, P1403, DOI 10.1080/02640414.2014.990489; Brown F, 2017, SPORTS MED, V47, P2245, DOI 10.1007/s40279-017-0728-9; Buchheit M, 2011, EUR J APPL PHYSIOL, V111, P293, DOI 10.1007/s00421-010-1654-9; Clark MG, 2000, ACTA PHYSIOL SCAND, V168, P519, DOI 10.1046/j.1365-201x.2000.00704.x; CLARK MG, 1995, AM J PHYSIOL, V268, pE79; Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254; Coggins M, 2001, DIABETES, V50, P2682, DOI 10.2337/diabetes.50.12.2682; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CUI WJ, 1991, P SOC PHOTO-OPT INS, V1431, P180, DOI 10.1117/12.44189; Dhakal BP, 2015, CIRC-HEART FAIL, V8, P286, DOI 10.1161/CIRCHEARTFAILURE.114.001825; DORA KA, 1994, J APPL PHYSIOL, V77, P277, DOI 10.1152/jappl.1994.77.1.277; Durham WJ, 2010, FASEB J, V24, P4117, DOI 10.1096/fj.09-150177; Engel FA, 2016, SPORTS MED, P461939; FAULKNER JA, 1977, MED SCI SPORT EXER, V9, P148; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Fujita S, 2006, AM J PHYSIOL-ENDOC M, V291, pE745, DOI 10.1152/ajpendo.00271.2005; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Hellsten Y, 2016, COMPR PHYSIOL, V6, P1, DOI 10.1002/cphy.c140080; Hopker J, 2010, INT J SPORTS MED, V31, P731, DOI 10.1055/s-0030-1261968; Ilkka H, 2011, AM J PHYSIOL-HEART C, V300, pH1510, DOI 10.1152/ajpheart.00996.2010; Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013; Kerherve HA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00247; Keske MA, 2017, CLIN EXP PHARMACOL P, V44, P143, DOI 10.1111/1440-1681.12688; Keske MA, 2016, J PHYSIOL-LONDON, V594, P2223, DOI 10.1113/jphysiol.2014.283549; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; Kundi Rishi, 2017, J Vasc Endovasc Surg, V2; Laughlin M H, 1988, Adv Exp Med Biol, V227, P87; LAWRENCE D, 1980, BRIT J SURG, V67, P119, DOI 10.1002/bjs.1800670214; Lee DCW, 2020, INT J SPORTS MED, V41, P3, DOI 10.1055/a-0970-5399; Lee DCW, 2018, J SCI MED SPORT, V21, P1062, DOI 10.1016/j.jsams.2017.12.004; Lindner JR, 2008, JACC-CARDIOVASC IMAG, V1, P343, DOI 10.1016/j.jcmg.2008.04.001; Liu R, 2008, ADV THER, V25, P465, DOI 10.1007/s12325-008-0058-2; Mayrovitz HN, 1998, CLIN PHYSIOL, V18, P117; Mayrovitz HN, 1997, CLIN PHYSIOL, V17, P105, DOI 10.1046/j.1365-2281.1997.01616.x; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; Menetrier A, 2015, J SPORT MED PHYS FIT, V55, P258; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; Parker L, 2021, J PHYSIOL-LONDON, V599, P83, DOI 10.1113/JP280651; Parker L, 2020, AM J PHYSIOL-ENDOC M, V318, pE1014, DOI 10.1152/ajpendo.00540.2019; Rattigan S, 1996, AM J PHYSIOL-ENDOC M, V271, pE96, DOI 10.1152/ajpendo.1996.271.1.E96; Rendell M, 1998, CLIN PHYSIOL, V18, P426, DOI 10.1046/j.1365-2281.1998.00108.x; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Roseguini BT, 2019, MUSCLE AND EXERCISE PHYSIOLOGY, P379, DOI 10.1016/B978-0-12-814593-7.00017-7; Russell RD, 2018, AM J PHYSIOL-ENDOC M, V315, pE307, DOI 10.1152/ajpendo.00448.2017; Russell RD, 2017, DIABETES CARE, V40, P1256, DOI 10.2337/dc16-2750; Sacre JW, 2015, JACC-CARDIOVASC IMAG, V8, P913, DOI 10.1016/j.jcmg.2014.12.033; Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x; Samendinger S, 2019, J SPORT HEALTH SCI, V8, P289, DOI 10.1016/j.jshs.2018.08.003; SEGAL SS, 1995, MED SCI SPORT EXER, V27, P1158; Shen W, 2000, ACTA PHYSIOL SCAND, V168, P675, DOI 10.1046/j.1365-201x.2000.00719.x; Sjoberg KA, 2017, DIABETES, V66, P1501, DOI 10.2337/db16-1327; Sperlich B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060923; St-Pierre P, 2012, DIABETES OBES METAB, V14, P753, DOI 10.1111/j.1463-1326.2012.01598.x; Staub D, 2013, VASA, V42, P17, DOI 10.1024/0301-1526/a000244; Timmerman KL, 2010, DIABETES, V59, P2764, DOI 10.2337/db10-0415; Upadhya B, 2015, J GERIATR CARDIOL, V12, P294, DOI 10.11909/j.issn.1671-5411.2015.03.013; Vaile J, 2016, J SPINAL CORD MED, V39, P206, DOI 10.1179/2045772314Y.0000000287; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Vercruyssen F, 2014, EUR J SPORT SCI, V14, P144, DOI 10.1080/17461391.2012.730062; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Vincent MA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1191, DOI 10.1152/ajpendo.00497.2005; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; Womack L, 2009, J AM COLL CARDIOL, V53, P2175, DOI 10.1016/j.jacc.2009.02.042; Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x	79	5	5	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21499	10.1096/fj.202002205RR	http://dx.doi.org/10.1096/fj.202002205RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811697	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000645260100099
J	Chongchai, A; Waramit, S; Suwan, K; Al-Bahrani, M; Udomruk, S; Phitak, T; Kongtawelert, P; Pothacharoen, P; Hajitou, A				Chongchai, Aitthiphon; Waramit, Sajee; Suwan, Keittisak; Al-Bahrani, Mariam; Udomruk, Sasimol; Phitak, Thanyaluck; Kongtawelert, Prachya; Pothacharoen, Peraphan; Hajitou, Amin			Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNF alpha) gene	FASEB JOURNAL			English	Article						chondrosarcoma; integrins alpha v beta 3 and alpha v beta 5 apoptosis; phage-based particle; targeted gene therapy; tumor necrosis factor alpha (TNF alpha)	TARGETED DELIVERY; CANCER; VASCULATURE; PHAGE; DEATH	Chondrosarcoma is a cartilage-forming bone tumor, well known for intrinsic resistance to chemotherapy and radiotherapy. We have designed a targeted chondrosarcoma gene therapy using a bacteriophage (phage) particle to deliver therapeutic genes. Phage has no tropism for mammalian cells, allowing engineered phage to be targeted to specific cell surface receptors in cancer. We modified the phage capsid to display the RGD4C ligand on the pIII minor coat proteins to specifically bind to alpha v beta 3 or alpha v beta 5 integrin receptors. The endosomal escape peptide, H5WYG, was also displayed on recombinant pVIII major coat proteins to enhance gene delivery. Finally, a human tumor necrosis factor alpha (TNF alpha) therapeutic transgene expression cassette was incorporated into the phage genome. First, we found that human chondrosarcoma cells (SW1353) have high expression of alpha v beta 3, alpha v beta 5 integrin receptors, and both TNF alpha receptors. Targeted particle encoding a luciferase reporter gene efficiently and selectively mediated gene delivery to these cells. When SW1353 cells were treated with the targeted particle encoding a TNF alpha transgene, significant cell killing was evident and was associated with high expression of TNF alpha and apoptosis-related genes. In vivo, mice with established human chondrosarcoma showed suppression of tumors upon repetitive intravenous administrations of the targeted phage. These data show that our phage-based particle is a promising, selective, and efficient tool for targeted chondrosarcoma therapy.	[Chongchai, Aitthiphon; Udomruk, Sasimol; Phitak, Thanyaluck; Kongtawelert, Prachya; Pothacharoen, Peraphan] Chiang Mai Univ, Fac Med, Thailand Excellence Ctr Tissue Engn & Stem Cells, Dept Biochem, Chiang Mai, Thailand; [Chongchai, Aitthiphon; Waramit, Sajee; Suwan, Keittisak; Al-Bahrani, Mariam; Hajitou, Amin] Imperial Coll London, Fac Med, Dept Brain Sci, Canc Phage Therapy Grp, London, England	Chiang Mai University; Imperial College London	Hajitou, A (corresponding author), Imperial Coll London, Fac Med, Dept Brain Sci, Canc Phage Therapy, Hammersmith Hosp Campus,Burlington Danes Bldg, London W12 0NN, England.	a.hajitou@imperial.ac.uk	Pothacharoen, Peraphan/GZG-6521-2022	Pothacharoen, Peraphan/0000-0002-8560-553X; Hajitou, Amin/0000-0003-1119-5686; Suwan, Keittisak/0000-0001-6542-5841	The Royal Golden Jubilee PhD Program [PHD/0189/2557]; Newton-TRF [351404776]; UK Department of Business, Energy and Industrial Strategy (BEIS); Royal Golden Jubilee (RGJ) PhD program; UK Medical [G0701159]	The Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF)); Newton-TRF; UK Department of Business, Energy and Industrial Strategy (BEIS); Royal Golden Jubilee (RGJ) PhD program; UK Medical	This research was funded by The Royal Golden Jubilee PhD Program, grant No. PHD/0189/2557, a PhD Placement for Scholars 2017/18 grant, ID 351404776, under the Newton--TRF PhD Scholarship partnership. The grant is funded by the UK Department of Business, Energy and Industrial Strategy (BEIS) and the Royal Golden Jubilee (RGJ) PhD program and delivered by the British Council. For further information, please visit www.newtonfund. ac.uk, Phage Cancer Therapy Group, Department of Brain Sciences, Faculty of Medicine, Imperial College London, United Kingdom, The Graduate School of Chiang Mai University and Thailand Excellence Center for Tissue Engineering and Stem Cells. This study was also supported by a grant G0701159 of the UK Medical	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Asavarut P, 2014, LANCET INFECT DIS, V14, P686, DOI [10.1016/S1473-3099(14)70867-9, DOI 10.1016/S1473-3099(14)70867-9]; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayen A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071930; Chow Warren A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15953.1; Dobroff AS, 2016, P NATL ACAD SCI USA, V113, P12780, DOI 10.1073/pnas.1615288113; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Hajitou A, 2007, NAT PROTOC, V2, P523, DOI 10.1038/nprot.2007.51; Hemminki A, 2001, MOL THER, V4, P223, DOI 10.1006/mthe.2001.0446; Jiang YP, 2017, CELL DEATH DIFFER, V24, P660, DOI 10.1038/cdd.2016.162; Josephs SF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1611-7; Kamimura K, 2020, CANCERS, V12, DOI 10.3390/cancers12020472; Kia A, 2012, MOL CANCER THER, V11, P2566, DOI 10.1158/1535-7163.MCT-12-0587; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Kwiatkowska Aneta, 2013, Cancers (Basel), V5, P1271, DOI 10.3390/cancers5041271; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Libutti SK, 2019, CANCER GENE THER, V26, P345, DOI 10.1038/s41417-019-0121-y; Majhen D, 2009, VIRUS RES, V139, P64, DOI 10.1016/j.virusres.2008.10.004; Martinez-Reza I, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0398-9; Medler J, 2019, EXPERT OPIN THER TAR, V23, P295, DOI 10.1080/14728222.2019.1586886; Murphey MD, 2003, RADIOGRAPHICS, V23, P1245, DOI 10.1148/rg.235035134; Natsume A, 2008, CELL ADHES MIGR, V2, P186, DOI 10.4161/cam.2.3.6278; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Przystal JM, 2013, MOL ONCOL, V7, P55, DOI 10.1016/j.molonc.2012.08.001; Przystal JM, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708492; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Smith TL, 2016, P NATL ACAD SCI USA, V113, P2466, DOI 10.1073/pnas.1525709113; Stoneham CA, 2012, J BIOL CHEM, V287, P35849, DOI 10.1074/jbc.M112.369389; Sun WM, 2019, DISCOV MED, V27, P45; Suwan K, 2019, P NATL ACAD SCI USA, V116, P18571, DOI 10.1073/pnas.1906653116; Tandle A, 2009, CANCER-AM CANCER SOC, V115, P128, DOI 10.1002/cncr.24001; Van Oosterom A T, 1990, Curr Opin Oncol, V2, P495; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00091; Wang Z, 2019, J CANCER, V10, P2457, DOI 10.7150/jca.30388; Ye CL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008049; Yuan Z, 2013, CANCER GENE THER, V20, P46, DOI 10.1038/cgt.2012.83	41	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21487	10.1096/fj.202002539R	http://dx.doi.org/10.1096/fj.202002539R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811705	Green Published, hybrid			2022-12-26	WOS:000645260100002
J	de Guia, RM; Hassing, AS; Ma, T; Plucinska, K; Holst, B; Gerhart-Hines, Z; Emanuelli, B; Treebak, JT				de Guia, Roldan Medina; Hassing, Anna S.; Ma, Tao; Plucinska, Kaja; Holst, Birgitte; Gerhart-Hines, Zach; Emanuelli, Brice; Treebak, Jonas T.			Ablation of Nampt in AgRP neurons leads to neurodegeneration and impairs fasting-and ghrelin-mediated food intake	FASEB JOURNAL			English	Article						AgRP; arcuate nucleus; NAD(+); NAMPT; neurodegeneration	NAD(+) DEPLETION; NEUROPEPTIDE-Y; INSULIN SENSITIVITY; ENERGY HOMEOSTASIS; NPY/AGRP NEURONS; ADULT MICE; CELL-DEATH; AGOUTI; PROTEIN; BIOSYNTHESIS	Agouti-related protein (AgRP) neurons in the arcuate nucleus of the hypothalamus regulates food intake and whole-body metabolism. NAD(+) regulates multiple cellular processes controlling energy metabolism. Yet, its role in hypothalamic AgRP neurons to control food intake is poorly understood. Here, we aimed to assess whether genetic deletion of nicotinamide phosphoribosyltransferase (Nampt), a rate-limiting enzyme in NAD(+) production, affects AgRP neuronal function to impact whole-body metabolism and food intake. Metabolic parameters during fed and fasted states, and upon systemic ghrelin and leptin administration were studied in AgRP-specific Nampt knockout (ARNKO) mice. We monitored neuropeptide expression levels and density of AgRP neurons in ARNKO mice from embryonic to adult age. NPY cells were used to determine effects of NAMPT inhibition on neuronal viability, energy status, and oxidative stress in vitro. In these cells, NAD(+) depletion reduced ATP levels, increased oxidative stress, and promoted cell death. Agrp expression in the hypothalamus of ARNKO mice gradually decreased after weaning due to progressive AgRP neuron degeneration. Adult ARNKO mice had normal glucose and insulin tolerance, but exhibited an elevated respiratory exchange ratio (RER) when fasted. Remarkably, fasting-induced food intake was unaffected in ARNKO mice when evaluated in metabolic cages, but fasting-and ghrelin-induced feeding and body weight gain decreased in ARNKO mice when evaluated outside metabolic cages. Collectively, deletion of Nampt in AgRP neurons causes progressive neurodegeneration and impairs fasting and ghrelin responses in a context-dependent manner. Our data highlight an essential role of Nampt in AgRP neuron function and viability.	[de Guia, Roldan Medina; Hassing, Anna S.; Ma, Tao; Plucinska, Kaja; Gerhart-Hines, Zach; Emanuelli, Brice; Treebak, Jonas T.] Univ Copenhagen, Fac Hlth & Med Sci, Integrat Metab & Environm Influences, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Holst, Birgitte] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [de Guia, Roldan Medina] Czech Acad Sci, Vvi, Inst Mol Genet, Czech Ctr Phenogen BIOCEV IMG, Prumyslova 595, Vestec 25250, Czech Republic	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Treebak, JT (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic Metab Res, Novo Nordisk Fdn, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jttreebak@sund.ku.dk	de Guia, Roldan/AAL-8529-2020; Emanuelli, Brice/M-2097-2016; Treebak, Jonas Thue/B-4521-2017	de Guia, Roldan/0000-0002-4239-2407; Emanuelli, Brice/0000-0001-5795-5666; Treebak, Jonas Thue/0000-0003-1488-7012; Gerhart-Hines, Zachary/0000-0003-2981-4991; Hassing, Anna Skab/0000-0003-1650-8784; Plucinska, Kaja/0000-0002-2144-7712	Novo Nordisk Fonden (NNF) [NNF14OC0009315, NNF18CC0034900]; Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF) [DFF 4004-00235, DFF 6110-00132]	Novo Nordisk Fonden (NNF); Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF14OC0009315 and NNF18CC0034900; Sundhed og Sygdom, Det Frie Forskningsrad (FSS, DFF), Grant/Award Number: DFF 4004-00235 and DFF 6110-00132	Agerholm M, 2018, AM J PHYSIOL-ENDOC M, V314, pE377, DOI 10.1152/ajpendo.00213.2017; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Cea M, 2013, AUTOPHAGY, V9, P410, DOI 10.4161/auto.22866; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Corander MP, 2011, ENDOCRINOLOGY, V152, P1819, DOI 10.1210/en.2010-1450; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; Dall M, 2018, MOL CELL ENDOCRINOL, V473, P245, DOI 10.1016/j.mce.2018.01.025; de Guia RM, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13437; Denis RGP, 2015, CELL METAB, V22, P646, DOI 10.1016/j.cmet.2015.07.011; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kim ER, 2015, J NEUROSCI, V35, P10440, DOI 10.1523/JNEUROSCI.1110-15.2015; Lautrup S, 2019, CELL METAB, V30, P630, DOI 10.1016/j.cmet.2019.09.001; Li CH, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0438-1; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nielsen KN, 2018, MOL METAB, V11, P178, DOI 10.1016/j.molmet.2018.02.014; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Okur MN, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-019-0040-z; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027; Tan K, 2014, MOL METAB, V3, P694, DOI 10.1016/j.molmet.2014.07.002; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Wang XW, 2017, CELL REP, V20, P2184, DOI 10.1016/j.celrep.2017.08.022; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Wei CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00851-z; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216; Zhou MH, 2015, BRAIN, V138, P992, DOI 10.1093/brain/awv002	69	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21450	10.1096/fj.202002740R	http://dx.doi.org/10.1096/fj.202002740R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788980				2022-12-26	WOS:000645260100044
J	Ehinger, R; Kuret, A; Matt, L; Frank, N; Wild, K; Kabagema-Bilan, C; Bischof, H; Malli, R; Ruth, P; Bausch, AE; Lukowski, R				Ehinger, Rebekka; Kuret, Anna; Matt, Lucas; Frank, Nadine; Wild, Katharina; Kabagema-Bilan, Clement; Bischof, Helmut; Malli, Roland; Ruth, Peter; Bausch, Anne E.; Lukowski, Robert			Slack K+ channels attenuate NMDA-induced excitotoxic brain damage and neuronal cell death	FASEB JOURNAL			English	Article						BDNF; excitotoxicity; glutamate; Kcnt1; K(Na)1.1; neuroprotection; NMDA receptor; Slack; Slo2.2; TrkB	ACTIVATED POTASSIUM CHANNEL; CEREBELLAR GRANULE CELLS; MENTAL-RETARDATION PROTEIN; MIGRATING PARTIAL SEIZURES; METHYL-D-ASPARTATE; NA CHANNELS; AMPA RECEPTORS; NEUROTROPHIC FACTOR; IN-VITRO; GLUTAMATE NEUROTOXICITY	The neuronal Na+-activated K+ channel Slack (aka Slo2.2, K(Na)1.1, or Kcnt1) has been implicated in setting and maintaining the resting membrane potential and defining excitability and firing patterns, as well as in the generation of the slow afterhyperpolarization following bursts of action potentials. Slack activity increases significantly under conditions of high intracellular Na+ levels, suggesting this channel may exert important pathophysiological functions. To address these putative roles, we studied whether Slack K+ channels contribute to pathological changes and excitotoxic cell death caused by glutamatergic overstimulation of Ca2+-and Na+-permeable N-methyl-D-aspartic acid receptors (NMDAR). Slack-deficient (Slack KO) and wild-type (WT) mice were subjected to intrastriatal microinjections of the NMDAR agonist NMDA. NMDA-induced brain lesions were significantly increased in Slack KO vs WT mice, suggesting that the lack of Slack renders neurons particularly susceptible to excitotoxicity. Accordingly, excessive neuronal cell death was seen in Slack-deficient primary cerebellar granule cell (CGC) cultures exposed to glutamate and NMDA. Differences in neuronal survival between WT and Slack KO CGCs were largely abolished by the NMDAR antagonist MK-801, but not by NBQX, a potent and highly selective competitive antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type ionotropic glutamate receptors. Interestingly, NMDAR-evoked Ca2+ signals did not differ with regard to Slack genotype in CGCs. However, real-time monitoring of K+ following NMDAR activation revealed a significant contribution of this channel to the intracellular drop in K+. Finally, TrkB and TrkC neurotrophin receptor transcript levels were elevated in NMDA-exposed Slack-proficient CGCs, suggesting a mechanism by which this K+ channel contributes to the activation of the extracellular-signal-regulated kinase (Erk) pathway and thereby to neuroprotection. Combined, our findings suggest that Slack-dependent K+ signals oppose the NMDAR-mediated excitotoxic neuronal injury by promoting pro-survival signaling via the BDNF/TrkB and Erk axis.	[Ehinger, Rebekka; Kuret, Anna; Matt, Lucas; Frank, Nadine; Wild, Katharina; Kabagema-Bilan, Clement; Bischof, Helmut; Ruth, Peter; Bausch, Anne E.; Lukowski, Robert] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany; [Malli, Roland] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Medical University of Graz	Lukowski, R (corresponding author), Univ Tubingen, Inst Pharm, Expt Pharmacol, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany.	robert.lukowski@uni-tuebingen.de		Matt, Lucas/0000-0003-3235-5140; Bischof, Helmut/0000-0003-2380-600X	Deutsche Forschungsgemeinschaft; Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft; Doktor Robert Pfleger--Stiftung; Landesgraduiertenforderung Baden-Wurttemberg	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Alim I, 2013, J NEUROSCI, V33, P17264, DOI 10.1523/JNEUROSCI.1729-13.2013; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Ayata C, 1997, J NEUROSCI, V17, P6908; Babot Z, 2005, EUR J NEUROSCI, V21, P103, DOI 10.1111/j.1460-9568.2004.03848.x; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bausch AE, 2018, NEUROSCIENCE, V384, P361, DOI 10.1016/j.neuroscience.2018.05.040; Bausch AE, 2015, LEARN MEMORY, V22, P323, DOI 10.1101/lm.037820.114; BEAL MF, 1992, J NEUROL SCI, V108, P80; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; Berg AP, 2007, J NEUROSCI, V27, P8845, DOI 10.1523/JNEUROSCI.0551-07.2007; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Bischof H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01615-z; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brandoli C, 1998, J NEUROSCI, V18, P7953; Brown DR, 1999, MOL CELL NEUROSCI, V13, P379, DOI 10.1006/mcne.1999.0751; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Cebers G, 1997, BRAIN RES BULL, V43, P393, DOI 10.1016/S0361-9230(97)00025-7; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Evely KM, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806917714342; Finn R, 2010, J NEUROSCI RES, V88, P2648, DOI 10.1002/jnr.22433; Gao SB, 2008, ACTA PHARMACOL SIN, V29, P899, DOI 10.1111/j.1745-7254.2008.00842.x; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Guglielmi L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00034; Gururaj S, 2017, CELL REP, V21, P926, DOI 10.1016/j.celrep.2017.09.088; Gururaj S, 2016, NEUROPHARMACOLOGY, V103, P279, DOI 10.1016/j.neuropharm.2015.12.016; HACK NJ, 1995, DEV BRAIN RES, V87, P55, DOI 10.1016/0165-3806(95)00054-H; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Ikegami A, 2004, INT REV NEUROBIOL, V62, P45, DOI 10.1016/S0074-7742(04)62002-2; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Jiang XY, 2003, ANN NY ACAD SCI, V993, P134, DOI 10.1111/j.1749-6632.2003.tb07522.x; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Judge Susan I V, 2007, Recent Pat CNS Drug Discov, V2, P200, DOI 10.2174/157488907782411765; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; Kramer D, 2010, METHODS MOL BIOL, V633, P233, DOI 10.1007/978-1-59745-019-5_17; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015601; Lu RR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010405; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Mandir AS, 2000, J NEUROSCI, V20, P8005; MANEV H, 1989, MOL PHARMACOL, V36, P106; Martinez-Espinosa PL, 2015, ELIFE, V4, DOI 10.7554/eLife.10013; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Nanou E, 2007, EUR J NEUROSCI, V25, P445, DOI 10.1111/j.1460-9568.2006.05287.x; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Numakawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113650; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; OLNEY JW, 1989, J CHILD NEUROL, V4, P218, DOI 10.1177/088307388900400315; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ortuno-Sahagun D, 2014, J MOL NEUROSCI, V52, P366, DOI 10.1007/s12031-013-0157-7; Perez-Capote K, 2004, GLIA, V45, P258, DOI 10.1002/glia.10329; Pryce KD, 2019, FASEB J, V33, P7315, DOI 10.1096/fj.201802454RR; Quraishi IH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60028-z; Reijntjes DOJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39119-z; Rizzi S, 2016, J COMP NEUROL, V524, P2093, DOI 10.1002/cne.23934; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Shen Y, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0269-2; Soltysinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103402; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Uchino S, 2003, BIOCHEM BIOPH RES CO, V310, P1140, DOI 10.1016/j.bbrc.2003.09.133; Wallen P, 2007, J PHYSIOL-LONDON, V585, P75, DOI 10.1113/jphysiol.2007.138156; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Wu SN, 2003, CURR MED CHEM, V10, P649, DOI 10.2174/0929867033457863; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zhang JY, 2018, P NATL ACAD SCI USA, V115, pE9006, DOI 10.1073/pnas.1802567115; Zhang SC, 1996, ACTA NEUROPATHOL, V91, P385, DOI 10.1007/s004010050440; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012	104	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21568	10.1096/fj.202002308RR	http://dx.doi.org/10.1096/fj.202002308RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817875	hybrid			2022-12-26	WOS:000645260100055
J	Ekman, L; Lindholm, E; Brogren, E; Dahlin, LB				Ekman, Linnea; Lindholm, Eero; Brogren, Elisabeth; Dahlin, Lars B.			Normative values of the vibration perception thresholds at finger pulps and metatarsal heads in healthy adults	PLOS ONE			English	Article								Aims To establish normative values of vibration perception thresholds (VPTs), using multi-frequency vibrometry at finger pulps and at metatarsal heads of the foot in healthy adults. We also aimed to investigate factors that could potentially affect VPTs such as age, sex, height, weight, foot- or handedness and skin temperature. Methods VPTs were examined in 924 healthy and randomly selected subjects in the southern Sweden (mean 46 years; 628 women and 296 men). Inclusion criterias were adult subjects (>18 years) in considerable health without diabetes mellitus or other nerve affecting disorders. VPTs were measured at the finger pulps of index and little finger, as well as the first and fifth metatarsal heads of the foot, through multi-frequency vibrometry using the VibroSense Meter (R) I device. Patient characteristics were recorded and skin temperature was measured before assessment of VPTs. Results We present normative values of VPTs for a large population of both male and female subjects in various ages. VPTs detoriated as age increased (0.09-0.59 dB per year; p<0.001), i.e. progressing with normal aging. Increasing skin temperature affected VPTs in finger pulps, but not at metatarsal heads, with -0.2 to -1.6 dB, i.e. vibration perception improved with higher temperatures. Height was only found to affect the VPTs of metatarsal heads (250 Hz: 0.42 dB per cm). Sex, weight and handedness did not affect the VPTs. Conclusion We investigated the normative values of VPTs and presented affecting factors as age, skin temperature and height. With these results, VPT testing through multi-frequency vibrometry is enabled to be used in a clinical practice as a diagnostic tool when investigating neuropathy and other neurological disorders.	[Ekman, Linnea; Dahlin, Lars B.] Lund Univ, Dept Translat Med, Hand Surg, Malmo, Sweden; [Lindholm, Eero] Lund Univ, Dept Clin Sci, Endocrinol, Malmo, Sweden; [Brogren, Elisabeth; Dahlin, Lars B.] Skane Univ Hosp, Dept Hand Surg, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Ekman, L (corresponding author), Lund Univ, Dept Translat Med, Hand Surg, Malmo, Sweden.	linnea.ekman@med.lu.se		Ekman, Linnea/0000-0002-2016-4569; Lindholm, Eero/0000-0002-8869-681X	VINNOVA [2014-03422]; Skane University Hospital; Lund University; Diabetes Association in Malmo; Swedish Diabetes Foundation [DIA2016-117]	VINNOVA(Vinnova); Skane University Hospital; Lund University; Diabetes Association in Malmo; Swedish Diabetes Foundation	The work was supported by grants from VINNOVA (Grant number 2014-03422) (https://www.vinnova.se) (LD), Skane University Hospital (Grant number, URL N/A)(LD), Lund University (Grant number N/A) https://www.medicin.lu.se/(LD); the Diabetes Association in Malmo (Grant number N/A) (https://www.diabetes.se/om-oss/about-us/) (LD) and the Swedish Diabetes Foundation, grant nr: DIA2016-117, https://www.diabetes.se/diabetesfonden/(LD).The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Aimonetti JM, 2007, J PHYSIOL-LONDON, V580, P649, DOI 10.1113/jphysiol.2006.123075; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; [Anonymous], 2011, ISO 13091 1; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; BLOOM S, 1984, BRIT MED J, V288, P1793, DOI 10.1136/bmj.288.6433.1793; BRUCE MF, 1980, J NEUROL NEUROSUR PS, V43, P730, DOI 10.1136/jnnp.43.8.730; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Dahlin LB, 2020, ACTA DIABETOL, V57, P433, DOI 10.1007/s00592-019-01450-2; Dahlin LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119753; Ekman L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226371; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Fallon JB, 2005, J NEUROPHYSIOL, V94, P3795, DOI 10.1152/jn.00359.2005; Fujita Yoshihito, 2008, Diabetes Res Clin Pract, V80, pe16, DOI 10.1016/j.diabres.2007.12.011; Gandhi MS, 2011, J HAND THER, V24, P240, DOI 10.1016/j.jht.2011.01.001; Gerhardsson L, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/s12995-014-0038-1; GESCHEIDER GA, 1994, SOMATOSENS MOT RES, V11, P345, DOI 10.3109/08990229409028878; HAGE JJ, 1995, J HAND SURG-AM, V20A, P227; Iandolo R, 2019, SOMATOSENS MOT RES, V36, P162, DOI 10.1080/08990220.2019.1632184; Ishibashi F, 2019, DIABETES CARE, V42, P110, DOI 10.2337/dc18-1560; Ising E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196243; Iwasaki Teruko, 2003, Okajimas Folia Anatomica Japonica, V79, P185, DOI 10.2535/ofaj.79.185; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lindholm E, 2019, DIABETOLOGIA, V62, pS471; Lindholm E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212921; LUNDBORG G, 1986, J HAND SURG-AM, V11A, P693, DOI 10.1016/S0363-5023(86)80014-4; LUNDSTROM R, 1992, INT ARCH OCC ENV HEA, V64, P201, DOI 10.1007/BF00380910; MEH D, 1995, J NEUROL SCI, V134, P136, DOI 10.1016/0022-510X(95)00230-9; Mildren RL, 2016, J APPL PHYSIOL, V120, P855, DOI 10.1152/japplphysiol.00810.2015; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Nelander J, 2012, DIABETIC MED, V29, pe449, DOI 10.1111/dme.12024; OSULLIVAN DJ, 1968, J NEUROL NEUROSUR PS, V31, P464, DOI 10.1136/jnnp.31.5.464; Palve SS, 2018, J NEUROSCI RURAL PRA, V9, P112, DOI 10.4103/jnrp.jnrp_323_17; Peterson M, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120931640; Ricci PT, 1997, PERCEPT MOTOR SKILL, V85, P1091, DOI 10.2466/pms.1997.85.3.1091; Sorensen L, 2002, DIABETES RES CLIN PR, V57, P45, DOI 10.1016/S0168-8227(02)00010-4; Stevens JC, 1998, J GERONTOL B-PSYCHOL, V53, pP263, DOI 10.1093/geronb/53B.4.P263; Stromberg T, 1998, SCAND J WORK ENV HEA, V24, P495, DOI 10.5271/sjweh.374; Strzalkowski NDJ, 2018, J NEUROPHYSIOL, V120, P1233, DOI 10.1152/jn.00848.2017; Strzalkowski NDJ, 2017, J NEUROPHYSIOL, V118, P1931, DOI 10.1152/jn.00647.2016; Thomsen NOB, 2011, DIABETIC MED, V28, P1401, DOI 10.1111/j.1464-5491.2011.03308.x; Thomsen NOB, 2009, DIABETIC MED, V26, P100, DOI 10.1111/j.1464-5491.2008.02629.x; Thrainsdottir S, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2008.01118.x; Venkatesan L, 2015, SOMATOSENS MOT RES, V32, P44, DOI 10.3109/08990220.2014.958216; Yau JM, 2016, J NEUROPHYSIOL, V115, P631, DOI 10.1152/jn.00598.2015; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	46	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249461	10.1371/journal.pone.0249461	http://dx.doi.org/10.1371/journal.pone.0249461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822804	gold, Green Published			2022-12-26	WOS:000637879100023
J	Giti, R; Dabiri, S; Motamedifar, M; Derafshi, R				Giti, Rashin; Dabiri, Shima; Motamedifar, Mohammad; Derafshi, Reza			Surface roughness, plaque accumulation, and cytotoxicity of provisional restorative materials fabricated by different methods	PLOS ONE			English	Article								Fabricating method may affect the surface properties and biological characteristics of provisional restorations. This study aimed to evaluate the surface roughness, plaque accumulation, and cytotoxicity of provisional restorative materials fabricated by the conventional, digital subtractive and additive methods. Sixty-six bar-shaped specimens (2x4x10 mm) were fabricated by using provisional restorative materials through the conventional, digital subtractive and additive methods (n = 22 per group). Ten specimens of each group were used for surface roughness and plaque accumulation tests, 10 specimens for cytotoxicity assay, and 2 specimens of each group were used for qualitative assessment by scanning electron microscopy. The R-a (roughness average) and R-z (roughness height) values (mu m) were measured via profilometer, and visual inspection was performed through scanning electron microscopy. Plaque accumulation of Streptococcus mutans and cytotoxicity on human gingival fibroblast-like cells were evaluated. The data were analyzed with one-way ANOVA and Tukey's post hoc test (alpha = 0.05). Surface roughness, biofilm accumulation and cytotoxicity were significantly different among the groups (P<0.05). Surface roughness was significantly higher in the conventional group (P<0.05); however, the two other groups were not significantly different (P>0.05). Significantly higher bacterial attachment was observed in the additive group than the subtractive (P<0.001) and conventional group (P = 0.025); while, the conventional and subtractive groups were statistically similar (P = 0.111). Regarding the cytotoxicity, the additive group had significantly higher cell viability than the subtractive group (P = 0.006); yet, the conventional group was not significantly different from the additive (P = 0.354) and subtractive group (P = 0.101). Surface roughness was the highest in conventionally cured group; but, the additive group had the most plaque accumulation and lowest cytotoxicity.	[Giti, Rashin; Dabiri, Shima; Derafshi, Reza] Shiraz Univ Med Sci, Sch Dent, Dept Prosthodont, Biomat Res Ctr, Shiraz, Fars, Iran; [Motamedifar, Mohammad] Shiraz Univ Med Sci, Shiraz HIV AIDS Res Ctr, Inst Hlth, Dept Bacteriol & Virol,Med Sch, Shiraz, Fars, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science	Derafshi, R (corresponding author), Shiraz Univ Med Sci, Sch Dent, Dept Prosthodont, Biomat Res Ctr, Shiraz, Fars, Iran.	derafshi@sums.ac.ir	Giti, Rashin/H-5270-2016	Giti, Rashin/0000-0003-1091-9574; dabiri, shima/0000-0002-8532-8528	Vice-Chancellery of Research of Shiraz University of Medical Sciences [98-01-03-20246]	Vice-Chancellery of Research of Shiraz University of Medical Sciences	R.G.: Vice-Chancellery of Research of Shiraz University of Medical Sciences (grant #98-01-03-20246).	Abdullah AO, 2018, DENT MATER J, V37, P957, DOI 10.4012/dmj.2017-315; Alharbi N, 2016, J PROSTHET DENT, V115, P760, DOI 10.1016/j.prosdent.2015.12.002; Alp G, 2019, J PROSTHODONT, V28, pE491, DOI 10.1111/jopr.12755; Alt V, 2011, DENT MATER, V27, P339, DOI 10.1016/j.dental.2010.11.012; Atay A, 2019, J PROSTHODONT, V28, pE383, DOI 10.1111/jopr.12915; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Borzangy S, 2013, J PROSTHET DENT, V110, P296, DOI 10.1016/S0022-3913(13)60379-0; Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2; Campaner M, 2020, ARCH ORAL BIOL, V111, DOI 10.1016/j.archoralbio.2019.104643; Dantas LCD, 2016, INT J DENT, V2016, DOI 10.1155/2016/8685796; Deligeorgi V, 2001, Prim Dent Care, V8, P5, DOI 10.1308/135576101771799335; Digholkar Shruti, 2016, J Indian Prosthodont Soc, V16, P328; Engler MLPD, 2020, CLIN ORAL INVEST, V24, P277, DOI 10.1007/s00784-019-02947-4; Giti Rashin, 2020, Dent Res J (Isfahan), V17, P152; Giti R, 2019, SAUDI DENT J, V31, P284, DOI 10.1016/j.sdentj.2019.02.045; Hiramatsu Daniel Afonso, 2011, RPG REV POS GRAD, V18, P108; Ionescu A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5372-4; Ionescu A, 2012, EUR J ORAL SCI, V120, P458, DOI 10.1111/j.1600-0722.2012.00983.x; Jun SK, 2017, OPER DENT, V42, pE81, DOI 10.2341/16-137-L; Kessler A, 2019, DENT MATER, V35, P1805, DOI 10.1016/j.dental.2019.10.005; Koroglu A, 2016, J PROSTHET DENT, V115, P447, DOI 10.1016/j.prosdent.2015.10.005; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Lee JH, 2017, J PROSTHET DENT, V118, P524, DOI 10.1016/j.prosdent.2016.11.014; Lee WS, 2017, J ADV PROSTHODONT, V9, P265, DOI 10.4047/jap.2017.9.4.265; Lin CH, 2020, J PROSTHET DENT, V123, P349, DOI 10.1016/j.prosdent.2019.05.002; Meshni AA, 2018, J BIOMATER TISS ENG, V8, P228, DOI 10.1166/jbt.2018.1735; Ozel GS, 2017, J ADV PROSTHODONT, V9, P335, DOI 10.4047/jap.2017.9.5.335; Park JY, 2016, J PROSTHET DENT, V116, P536, DOI 10.1016/j.prosdent.2016.03.012; Peralta SL, 2018, J APPL ORAL SCI, V26, DOI 10.1590/1678-7757-2017-0562; Pituru SM, 2020, MATERIALS, V13, DOI 10.3390/ma13132894; Rayyan MM, 2015, J PROSTHET DENT, V114, P414, DOI 10.1016/j.prosdent.2015.03.007; Revilla-Leon M, 2019, J ESTHET RESTOR DENT, V31, P51, DOI 10.1111/jerd.12438; Reymus M, 2020, CLIN ORAL INVEST, V24, P701, DOI 10.1007/s00784-019-02952-7; Rizo-Gorrita M, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11091446; Scotti CK, 2020, J PROSTHET DENT, V124, DOI 10.1016/j.prosdent.2020.03.029; Shim JS, 2019, INT J ORAL MAX IMPL, V34, P390, DOI 10.11607/jomi.6707; Simoneti DM, 2022, J PROSTHET DENT, V127, P168, DOI 10.1016/j.prosdent.2020.06.026; Souza IR, 2020, J PROSTHET DENT, V124, DOI 10.1016/j.prosdent.2020.01.030; Yuan CY, 2016, J DENT, V54, P33, DOI 10.1016/j.jdent.2016.07.010; Zadeh PN, 2020, OPER DENT, V45, P407, DOI 10.2341/19-057-L; Zissis AJ, 2000, INT J PROSTHODONT, V13, P136	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249551	10.1371/journal.pone.0249551	http://dx.doi.org/10.1371/journal.pone.0249551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819292	Green Published, gold			2022-12-26	WOS:000637647200037
J	Ho, CL; Wu, WF				Ho, Ciao-Lin; Wu, Wei-Fong			Risk factor analysis of allergic rhinitis in 6-8 year-old children in Taipei	PLOS ONE			English	Article								The incidence of allergic rhinitis (AR) has increased rapidly in Taiwan during the past 30 years; however, potential risk factors of AR have yet to be examined. The purpose of this study is to explore the prevalence, personal and environmental risk factors of rhinitis. A cross-sectional survey was conducted in 26418 first graders (6-8 years old) in Taipei with a response rate of 94.6% (24999/26418). Modified International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires were completed by their parents or main caregivers. Logistic regression was used to examine possible personal and environmental (in early life and current) factors related to rhinitis. The prevalence of rhinitis in the past 12 months was 42.8% in 6-8 years old children. Multivariate logistic regression analysis for both males and females revealed that male gender, antibiotic use in first year of life, bronchiolitis before the age of two years, diagnosed asthma, and diagnosed eczema, having a cat the first year of life were associated with an increased risk of rhinitis. Having older siblings, on the other hand, may reduce the risk of rhinitis. Based on the present study, we may recommend less use of antibiotics the first year of life and not having a cat in the home in the child's first year of life as preventive measures to reduce the risk of rhinitis. From the subgroup analysis, we can take preventive measures for the different risk factors of rhinitis and the severity of rhinitis in each subgroup.	[Ho, Ciao-Lin] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wu, Wei-Fong] West Garden Hosp, Taipei City Hosp Ren Ai Branch, Dept Pediat, Dept Allergy & Immunol, Taipei, Taiwan	National Taiwan University; Taipei City Hospital	Wu, WF (corresponding author), West Garden Hosp, Taipei City Hosp Ren Ai Branch, Dept Pediat, Dept Allergy & Immunol, Taipei, Taiwan.	docweifong@yahoo.com.tw		Wu, Wei-Fong/0000-0002-0456-4466	Taipei Health Department	Taipei Health Department	Special thanks to Taipei Health Department for their support by awarding the study grant and communicating with the Educational Department of Taipei City. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Alm B, 2014, PEDIAT ALLERG IMM-UK, V25, P468, DOI 10.1111/pai.12244; Alm B, 2011, PEDIAT ALLERG IMM-UK, V22, P398, DOI 10.1111/j.1399-3038.2011.01153.x; Alsowaidi S, 2010, ALLERGY, V65, P208, DOI 10.1111/j.1398-9995.2009.02123.x; Baumann LM, 2015, CLIN EXP ALLERGY, V45, P192, DOI 10.1111/cea.12379; Bennett D, 2015, J IND ECON, V63, P371, DOI 10.1111/joie.12075; Bunyavanich S, 2010, ALLERGY, V65, P256, DOI 10.1111/j.1398-9995.2009.02159.x; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Eriksson J, 2010, ALLERGY, V65, P1397, DOI 10.1111/j.1398-9995.2010.02397.x; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Kao CC, 2005, PEDIAT ALLERG IMM-UK, V16, P408, DOI 10.1111/j.1399-3038.2005.00268.x; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kurukulaaratchy RJ, 2005, ALLERGY, V60, P1280, DOI 10.1111/j.1398-9995.2005.00890.x; Lee YL, 2007, CLIN EXP ALLERGY, V37, P543, DOI 10.1111/j.1365-2222.2007.02690.x; Lee YL, 2007, BRIT J DERMATOL, V157, P1217, DOI 10.1111/j.1365-2133.2007.08215.x; Liao PF, 2009, PEDIATR NEONATOL, V50, P18, DOI 10.1016/S1875-9572(09)60025-5; Mir E, 2012, ASIA PAC ALLERGY, V2, P93, DOI 10.5415/apallergy.2012.2.2.93; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Oymar K, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-23; Penaranda A, 2012, RHINOLOGY, V50, P122, DOI [10.4193/Rhin11.175, 10.4193/Rhino11.175]; Peroni DG, 2003, CLIN EXP ALLERGY, V33, P1349, DOI 10.1046/j.1365-2222.2003.01766.x; Raciborski F, 2012, INT J OCCUP MED ENV, V25, P470, DOI 10.2478/S13382-012-0056-0; Ramsey AC, 2011, J ALLERGY CLIN IMMUN, V128, P824, DOI 10.1016/j.jaci.2011.07.037; Seo JH, 2015, ALLERGY ASTHMA IMMUN, V7, P241, DOI 10.4168/aair.2015.7.3.241; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Sultesz M, 2010, INT J PEDIATR OTORHI, V74, P503, DOI 10.1016/j.ijporl.2010.02.008; Tamay Z, 2014, ALLERGOL INT, V63, P553, DOI 10.2332/allergolint.13-OA-0661; Tay YK, 2002, BRIT J DERMATOL, V146, P101, DOI 10.1046/j.1365-2133.2002.04566.x; Wang XY, 2016, INT J HYG ENVIR HEAL, V219, P220, DOI 10.1016/j.ijheh.2015.11.007; Wennergren G, 2010, PEDIAT ALLERG IMM-UK, V21, P806, DOI 10.1111/j.1399-3038.2010.01057.x; Yeh KW, 2011, ASIAN PAC J ALLERGY, V29, P34; YOUNG S, 1995, ARCH DIS CHILD, V72, P16, DOI 10.1136/adc.72.1.16; Zhang YM, 2013, LARYNGOSCOPE, V123, P28, DOI 10.1002/lary.23573	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249572	10.1371/journal.pone.0249572	http://dx.doi.org/10.1371/journal.pone.0249572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798255	gold, Green Published			2022-12-26	WOS:000636737700029
J	Fernandes, DLRD; Gomes, ECD; Bezerra, MF; Guimaraes, RJDSE; de Almeida, AMP				Reis da Silva Fernandes, Diego Leandro; de Souza Gomes, Elainne Christine; Bezerra, Matheus Filgueira; de Paula Souza e Guimaraes, Ricardo Jose; Paiva de Almeida, Alzira Maria			Spatiotemporal analysis of bubonic plague in Pernambuco, northeast of Brazil: Case study in the municipality of Exu	PLOS ONE			English	Article							YERSINIA-PESTIS; LESSONS; FLEAS; FOCI	Along with other countries in America, plague reached Brazil through the sea routes during the third pandemic. A brief ports phase was followed by an urban phase that took place in smaller inland cities and finally, it attained the rural area and established several foci where the ecological conditions were suitable for its continued existence. However, the geographic dispersion of plague in Brazil is still poorly studied. To better understand the disease dynamics, we accessed satellite-based data to trace the spatial occurrence and distribution of human plague cases in Pernambuco, Northeastern Brazil and using the municipality of Exu as study case area. Along with the satellite data, a historical survey using the Plague Control Program files was applied to characterize the spatial and temporal dispersion of cases in the period of 1945-1976. Kernel density estimation, spatial and temporal clusters with statistical significance and maximum entropy modeling were used for spatial data analysis, by means of the spatial analysis software packages. The use of geostatistical tools allowed evidencing the shift of the infection from the urban to the wild-sylvatic areas and the reemergence of cases after a period of quiescence, independent of the reintroduction from other plague areas.	[Reis da Silva Fernandes, Diego Leandro; Bezerra, Matheus Filgueira; Paiva de Almeida, Alzira Maria] Inst Aggeu Magalhaes Fiocruz PE, Dept Microbiol, Recife, PE, Brazil; [de Souza Gomes, Elainne Christine] Inst Aggeu Magalhaes Fiocruz PE, Dept Parasitol, Recife, PE, Brazil; [de Paula Souza e Guimaraes, Ricardo Jose] Evandro Chagas Inst SVS MS, Geoproc Lab, Belem, Para, Brazil	Instituto Evandro Chagas	de Almeida, AMP (corresponding author), Inst Aggeu Magalhaes Fiocruz PE, Dept Microbiol, Recife, PE, Brazil.	aalmeida@cpqam.fiocruz.br	de Paula Souza e Guimarães, Ricardo José/AAV-2973-2021; DE SOUZA GOMES, ELAINNE CHRISTINE/AAC-8261-2020; Bezerra, Matheus/GOG-9072-2022; Guimaraes, Ricardo J P S/F-7182-2015	de Paula Souza e Guimarães, Ricardo José/0000-0002-5767-4765; DE SOUZA GOMES, ELAINNE CHRISTINE/0000-0001-7836-6457; Guimaraes, Ricardo J P S/0000-0002-5767-4765; Bezerra, Matheus/0000-0001-7102-6804				Baltazard M, 2004, B SOC PATHOL EXOT S, V97, P93; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Bertherata E., 2019, Weekly Epidemiological Record, V94, P289; Blanc G., 1942, B ACAD NAT MED PARIS, V126, P448; Bramanti B, 2016, ADV EXP MED BIOL, V918, P1, DOI 10.1007/978-94-024-0890-4_1; Butler T, 2014, CLIN MICROBIOL INFEC, V20, P202, DOI 10.1111/1469-0691.12540; de Almeida AMP, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0136-2019; Demeure CE, 2019, GENES IMMUN, V20, P357, DOI 10.1038/s41435-019-0065-0; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Eisen RJ., 2008, AM J TROP MED HYG, V78, P949; Freitas CA., 1957, REV BRAS MALARIOL D, V9, P123; Gage KL, 2012, ADV EXP MED BIOL, V954, P79, DOI 10.1007/978-1-4614-3561-7_11; Giles J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000925; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2019, CONH CID EST BRAS; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; IPA-Instituto de Pesquisa Agropecuaria, 2019, CAD SEM; Jones SD., 2019, P NATL ACAD SCI USA, V116, P9155, DOI [10.1073/pnas.1817339116, DOI 10.1073/PNAS.1817339116]; KARIMI Y, 1974, ANN INST PASTEUR MIC, VA125, P243; Karimi Y., 1974, B SOC PATHOL EXOT, V67, P583; Laudisoit A, 2007, EMERG INFECT DIS, V13, P687, DOI 10.3201/eid1305.061084; Mead PS, 2018, NEW ENGL J MED, V378, P106, DOI 10.1056/NEJMp1713881; Meyer KF., 1965, SCI PUBL, V115; Pollitzer R., 1954, MONOGRAPH SERIES, V22; RAMALINGASWAMI V, 1995, NAT MED, V1, P1237, DOI 10.1038/nm1295-1237; Ratovonjato J, 2014, EMERG INFECT DIS, V20, P1414, DOI 10.3201/eid2008.130629; Reis Da Silva Fernandes DL, 2021, INTEGR ZOOL, V16, P810, DOI 10.1111/1749-4877.12480; Sousa LLF., 2017, REV SOC BRAS MED TRO, V50, P769, DOI [10.1590/0037-8682-0278-2017, DOI 10.1590/0037-8682-0278-2017]; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Tavares C, 2012, ADV EXP MED BIOL, V954, P69, DOI 10.1007/978-1-4614-3561-7_10; Zeppelini CG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004949	30	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249464	10.1371/journal.pone.0249464	http://dx.doi.org/10.1371/journal.pone.0249464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798208	Green Published, gold			2022-12-26	WOS:000636737700036
J	Bhowmik, T; Tirtha, SD; Iraganaboina, NC; Eluru, N				Bhowmik, Tanmoy; Tirtha, Sudipta Dey; Iraganaboina, Naveen Chandra; Eluru, Naveen			A comprehensive analysis of COVID-19 transmission and mortality rates at the county level in the United States considering socio-demographics, health indicators, mobility trends and health care infrastructure attributes	PLOS ONE			English	Article							DISEASE	Background Several research efforts have evaluated the impact of various factors including a) socio-demographics, (b) health indicators, (c) mobility trends, and (d) health care infrastructure attributes on COVID-19 transmission and mortality rate. However, earlier research focused only on a subset of variable groups (predominantly one or two) that can contribute to the COVID-19 transmission/mortality rate. The current study effort is designed to remedy this by analyzing COVID-19 transmission/mortality rates considering a comprehensive set of factors in a unified framework. Methods and findings We study two per capita dependent variables: (1) daily COVID-19 transmission rates and (2) total COVID-19 mortality rates. The first variable is modeled using a linear mixed model while the later dimension is analyzed using a linear regression approach. The model results are augmented with a sensitivity analysis to predict the impact of mobility restrictions at a county level. Several county level factors including proportion of African-Americans, income inequality, health indicators associated with Asthma, Cancer, HIV and heart disease, percentage of stay at home individuals, testing infrastructure and Intensive Care Unit capacity impact transmission and/or mortality rates. From the policy analysis, we find that enforcing a stay at home order that can ensure a 50% stay at home rate can result in a potential reduction of about 33% in daily cases. Conclusions The model framework developed can be employed by government agencies to evaluate the influence of reduced mobility on transmission rates at a county level while accommodating for various county specific factors. Based on our policy analysis, the study findings support a county level stay at home order for regions currently experiencing a surge in transmission. The model framework can also be employed to identify vulnerable counties that need to be prioritized based on health indicators for current support and/or preferential vaccination plans (when available).	[Bhowmik, Tanmoy; Tirtha, Sudipta Dey; Iraganaboina, Naveen Chandra; Eluru, Naveen] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Bhowmik, T (corresponding author), Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA.	tanmoy78@knights.ucf.edu	Eluru, Naveen/B-2965-2012; Iraganaboina, Naveen Chandra/AAV-6928-2021; Tirtha, Sudipta Dey/AAT-2868-2021	Eluru, Naveen/0000-0003-1221-4113; Iraganaboina, Naveen Chandra/0000-0002-1425-6897; Tirtha, Sudipta Dey/0000-0002-6228-0904; Bhowmik, Tanmoy/0000-0002-0258-1692				Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; [Anonymous], COVID 19 MAP JOHNS H; [Anonymous], MICHIGAN RADIO; [Anonymous], INCOME WEALTH INEQUA; [Anonymous], GLOBAL EC OUTLOOK CO; [Anonymous], COVID 19 TRACKING PR; [Anonymous], COMMON QUESTIONS NEW; Backer A., 2020, SSRN ELECT J; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013; Bilgin, 2020, SSRN ELECT J, DOI 10.2139/ssrn.3585921; Borjas GJ., 2020, DEMOGRAPHIC DETERMIN; Centers for Disease Control and Prevention (CDC) Division of Viral Diseases, 2020, CDC 2019 NOV COR 201, P1; Ci Chen, 2010, Proceedings 2010 Sixth International Conference on Natural Computation (ICNC 2010), P3768, DOI 10.1109/ICNC.2010.5583198; Couture V, NBER WORKING PAPER S, V27560; Engle S., 2020, SSRN ELECT J, DOI 10.2139/ssrn.3565703; Faghih-Imani A, 2014, J TRANSP GEOGR, V41, P306, DOI 10.1016/j.jtrangeo.2014.01.013; Herkenhoff K., 2020, SSRN ELECT J; Mateo JRSC., 2012, GREEN ENERGY TECHNOL; Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884; Mukandavire Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236003; Omori R, 2020, INT J INFECT DIS, V94, P116, DOI 10.1016/j.ijid.2020.04.021; Rehman S, 2017, INT J ADV COMPUT SC, V8, P128; Siedner MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003244; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; Triantaphyllou E, 1997, DECISION SCI, V28, P151, DOI 10.1111/j.1540-5915.1997.tb01306.x; Veenema TG, 2008, DISASTER MED PUBLIC, V2, P224, DOI 10.1097/DMP.0b013e31818a2b7a; Wiel T., 2020, FLATTEN CURVE MODELI; Wood G., 2020, CAUSAL EFFECT SOCIAL; Worldometer, 2020, COR CAS, DOI DOI 10.1101/2020.01.23.20018549V2; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Xie Z., 2020, HLTH DEMOGRAPHIC IMP, DOI 10.1101/2020.05.06.20093195; Yelowitz A., 2020, I STUDY FREE ENTERP, V4, P1; Yuan Xiaoling, 2020, Explor Res Hypothesis Med, V5, P1, DOI 10.14218/ERHM.2020.00023; Zhan CJ, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0234763, 10.1371/journal.pone.0234763.r001, 10.1371/journal.pone.0234763.r002, 10.1371/journal.pone.0234763.r003, 10.1371/journal.pone.0234763.r004]; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296	37	16	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249133	10.1371/journal.pone.0249133	http://dx.doi.org/10.1371/journal.pone.0249133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793611	Green Published, Green Submitted, gold			2022-12-26	WOS:000636467000016
J	Marashi, MY; Nicholson, E; Ogrodnik, M; Fenesi, B; Heisz, JJ				Marashi, Maryam Yvonne; Nicholson, Emma; Ogrodnik, Michelle; Fenesi, Barbara; Heisz, Jennifer J.			A mental health paradox: Mental health was both a motivator and barrier to physical activity during the COVID-19 pandemic	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; REACTIVE PROTEIN-LEVELS; EXERCISE; DEPRESSION; TIME; OUTBREAK; BEHAVIOR; PEOPLE; SLEEP	The COVID-19 pandemic has impacted the mental health, physical activity, and sedentary behavior of people worldwide. According to the Health Belief Model (HBM), health-related behavior is determined by perceived barriers and motivators. Using an online survey with 1669 respondents, we sought to understand why and how physical activity and sedentary behavior has changed by querying about perceived barriers and motivators to physical activity that changed because of the pandemic, and how those changes impacted mental health. The following results were statistically significant at p < .05. Consistent with prior reports, our respondents were less physically active (aerobic activity, -11%; strength-based activity, -30%) and more sedentary (+11%) during the pandemic as compared to 6-months before. The pandemic also increased psychological stress (+22%) and brought on moderate symptoms of anxiety and depression. Respondents' whose mental health deteriorated the most were also the ones who were least active (depression r = -.21, anxiety r = -.12). The majority of respondents were unmotivated to exercise because they were too anxious (+8%,), lacked social support (+6%), or had limited access to equipment (+23%) or space (+41%). The respondents who were able to stay active reported feeling less motivated by physical health outcomes such as weight loss (-7%) or strength (-14%) and instead more motivated by mental health outcomes such as anxiety relief (+14%). Coupled with previous work demonstrating a direct relationship between mental health and physical activity, these results highlight the potential protective effect of physical activity on mental health and point to the need for psychological support to overcome perceived barriers so that people can continue to be physically active during stressful times like the pandemic.	[Marashi, Maryam Yvonne; Nicholson, Emma; Ogrodnik, Michelle; Heisz, Jennifer J.] McMaster Univ, Hamilton, ON, Canada; [Fenesi, Barbara] Western Univ, London, ON, Canada	McMaster University; Western University (University of Western Ontario)	Heisz, JJ (corresponding author), McMaster Univ, Hamilton, ON, Canada.	heiszjj@mcmaster.ca	Fenesi, Barb/GLT-1155-2022; Heisz, Jennifer/AAD-9608-2022	Marashi, Maryam/0000-0002-3104-3148	Natural Sciences and Engineering Research Council of Canada (NSERC) [296518]; Social Sciences and Humanities Research Council (SSHRC) Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC) Canada Graduate Scholarship	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 296518 to JJH, and the Social Sciences and Humanities Research Council (SSHRC) Canada Graduate Scholarship to MYM.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2020, WHO GUIDELINES PHYS; [Anonymous], 2020, GUIDANCE ESSENTIAL S; Arbour KP, 2004, J APPL BIOBEHAV RES, V9, P172; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Casagrande M, 2020, SLEEP MED, V75, P12, DOI 10.1016/j.sleep.2020.05.011; Cheval B, 2021, J SPORT SCI, V39, P699, DOI 10.1080/02640414.2020.1841396; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Colley RC, 2020, HEALTH REP, V31, P3, DOI 10.25318/82-003-x202000600001-eng; Copeland WE, 2012, PSYCHOL MED, V42, P2641, DOI 10.1017/S0033291712000554; Fowles JR, 2017, APPL PHYSIOL NUTR ME, V42, P677, DOI 10.1139/apnm-2016-0412; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gibson AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185143; Glazer Kelly M, 2002, J Cardiopulm Rehabil, V22, P40, DOI 10.1097/00008483-200201000-00006; Hoare E, 2017, SPORTS, V5, DOI 10.3390/sports5030047; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Jungmann SM, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102239; Justine M, 2013, SINGAP MED J, V54, P581, DOI 10.11622/smedj.2013203; Keyes CLM, 2012, AGING MENT HEALTH, V16, P67, DOI 10.1080/13607863.2011.596811; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Lauder W, 2007, J PSYCHIATR MENT HLT, V14, P661, DOI 10.1111/j.1365-2850.2007.01156.x; Lesser IA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113899; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Mailey Emily L, 2016, Prev Med Rep, V4, P423, DOI 10.1016/j.pmedr.2016.08.010; Marcus B., 2009, MOTIVATING PEOPLE BE; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Morgan JA, 2019, BRAIN RES BULL, V148, P118, DOI 10.1016/j.brainresbull.2019.02.014; Netz Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00257; Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562; Paolucci EM, 2018, BIOL PSYCHOL, V133, P79, DOI 10.1016/j.biopsycho.2018.01.015; Pasanen TP, 2014, APPL PSYCHOL-HLTH WE, V6, P324, DOI 10.1111/aphw.12031; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rebar AL, 2015, HEALTH PSYCHOL REV, V9, P366, DOI 10.1080/17437199.2015.1022901; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Samara A, 2015, INT J WOMENS HEALTH, V7, P279, DOI 10.2147/IJWH.S80680; Slater SJ, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200204; Spinney J, 2010, SOC INDIC RES, V99, P341, DOI 10.1007/s11205-010-9585-8; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Statistics Canada, TABL 13 10 0096 01 H, DOI 10.25318/1310009601-eng; Stubbs B, 2017, PSYCHIAT RES, V249, P102, DOI 10.1016/j.psychres.2016.12.020; Stubbs B, 2015, SCHIZOPHR RES, V168, P461, DOI 10.1016/j.schres.2015.07.003; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Weinstein AA, 2017, GEN HOSP PSYCHIAT, V49, P11, DOI 10.1016/j.genhosppsych.2017.06.001; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8	50	26	26	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0239244	10.1371/journal.pone.0239244	http://dx.doi.org/10.1371/journal.pone.0239244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793550	gold, Green Published, Green Submitted			2022-12-26	WOS:000636467000067
J	Hagan, D; Tarkang, EE; Aku, FY				Hagan, Dorcas; Tarkang, Elvis E.; Aku, Fortress Yayra			Compliance of commercial motorcycle riders with road safety regulations in a peri-urban town of Ghana	PLOS ONE			English	Article								Background While motorcycles are essential for moving people and goods, they are also, a significant contributor to Road Traffic Accidents (RTAs), making it a public health issue of concern globally. The Hohoe Municipal Hospital records increasing RTAs due to commercial motorcycles. Determining motorcycle riders' compliance with road safety regulations is critical in helping to curb this menace. Method A cross-sectional study was employed involving a multistage sample of 238 motorcycle riders. Data were collected using a pretested structured questionnaire and entered into Epi Data version 3.2 software and exported to STATA software version 12 for analysis. Descriptive and inferential analyses were done while statistical significance was determined at 95% reliability interval and p-value of 0.05. Findings The level of compliance with road safety regulations among respondents was 59.2%. The mean age of respondents was 29.9 +/- 7.9 years, and all respondents were males. Respondents who did not own their motorbikes were 0.39 times less likely to comply with road safety regulations compared to their counterparts who owned one, while those without alternate occupations were 0.51times less likely to comply with road safety regulations compared to those with an additional occupation. Those aged between 30-39 years and 40-49 years were 2.37 and 4.1 times more likely to comply with road safety regulations, respectively, compared to those aged <= 29 years, and those who did not smoke were 3.15 times more likely to comply with road safety regulations than those who smoked. Conclusion Compliance to safety regulations are fairly low and although motorcycle usage on a commercial basis is yet to be legalised in Ghana, routine education targeting riders who smoke, do not have alternate occupations, do not own motorbikes and younger riders will improve their compliance. Also, riders should be encouraged to obtain their license from the appropriate authorities.	[Hagan, Dorcas; Aku, Fortress Yayra] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Tarkang, Elvis E.] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana		Aku, FY (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana.	yfortress@uhas.edu.gh		Aku, Fortress Yayra/0000-0002-9004-348X				Adeloye D, 2016, B WORLD HEALTH ORGAN, V94, P510, DOI 10.2471/BLT.15.163121; Aidoo EN, 2018, TRAFFIC INJ PREV, V19, P856, DOI 10.1080/15389588.2018.1509072; Anera RG, 2011, J REFRACT SURG, V27, P597, DOI 10.3928/1081597X-20110303-01; [Anonymous], 2005, J COMMUNITY MED PRIM; Arosanyin GT., 2007, 14 INT C SWED NAT RO; Baldi S, 2005, J SAFETY RES, V36, P19, DOI 10.1016/j.jsr.2004.11.001; Chang HL, 2006, J TRANSP ENG, V132, P227, DOI 10.1061/(ASCE)0733-947X(2006)132:3(227); Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Degu G, 2005, BIOSTATISTICS HLTH S; Dong CJ, 2018, ACCIDENT ANAL PREV, V113, P292, DOI 10.1016/j.aap.2018.01.039; Ghana Police Service, 2017, MOT TRAFF TRANSP DEP; Mannering F, 2014, ANAL METHODS ACCID R, V1, P1, DOI 10.1016/j.amar.2013.09.001; Nanga S, 2017, ACCIDENT ANAL PREV, V103, P92, DOI 10.1016/j.aap.2017.04.003; Ndagire M, 2019, INT J INJ CONTROL SA, V26, P315, DOI 10.1080/17457300.2019.1607395; Nyachieo G.M.M., 2013, RES J ORGAN PSYCHOL, V2, P154; Ogunkeyede OS, 2019, TRAFFIC INJ PREV, V20, pS174, DOI 10.1080/15389588.2019.1659584; Olumide AO, 2015, TRAFFIC INJ PREV, V16, P691, DOI 10.1080/15389588.2014.1001842; Osinowo O.A., 2017, INT J HLTH SCI, V7, P68; Ucho A., 2016, ASIA PAC J ED ARTS S, V3, P1; Walter AO, 372 IMPACT ROAD SAFE; Weng JX, 2021, J TRANSP SAF SECUR, V13, P822, DOI 10.1080/19439962.2019.1690086; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization Department of Violence & Injury Prevention & Disability (VIP), 2009, GLOB STAT REP ROAD S; Zeng Q, 2022, J TRANSP SAF SECUR, V14, P323, DOI 10.1080/19439962.2020.1779422	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0246965	10.1371/journal.pone.0246965	http://dx.doi.org/10.1371/journal.pone.0246965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784328	gold, Green Published			2022-12-26	WOS:000636359600055
J	Yoshioka, T; Tabuchi, T				Yoshioka, Takashi; Tabuchi, Takahiro			Combustible cigarettes, heated tobacco products, combined product use, and periodontal disease: A cross-sectional JASTIS study	PLOS ONE			English	Article								Background Combustible cigarettes have detrimental effects on periodontal disease. However, little evidence is available regarding new heated tobacco product (HTP) use and combined product use (both combustible cigarettes and HTPs). This study aimed to examine the association of combustible cigarettes, HTPs, and combined product use with periodontal disease simultaneously. Materials and methods This cross-sectional study was conducted using data from the 2019 arm of the longitudinal Japan "Society and New Tobacco" Internet Survey. Combustible cigarette users, HTP users, combined product users, never-users, and former users' data were separately obtained. In the present study, the primary outcome was self-reported periodontal disease. We estimated adjusted prevalence ratios (PRs) and confidence intervals (CIs) using multivariable modified Poisson regression analysis after adjusting for 12 confounders. Results Of the 10,439 JASTIS respondents, the numbers of users of combustible cigarettes only, HTPs only, and both products were 1,304, 437, and 1,049, respectively. Compared with never-users, HTP use was significantly associated with the prevalence of self-reported periodontal diseases (PR 1.43, 95% CI 1.03-1.62). Moreover, former users, combustible cigarette users, and combined product users also showed significant associations (PR 1.56, 95% CI 1.35-1.80; PR 1.29, 95% CI 1.03-1.62; and PR 1.55, 95% CI 1.20-1.99, respectively). Conclusions Users of HTPs, combustible cigarettes, and combined products as well as former users were all significantly associated with a higher prevalence of periodontal diseases compared to never-users.	[Yoshioka, Takashi] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence CiRC2LE, Fukushima, Fukushima, Japan; [Tabuchi, Takahiro] Osaka Int Canc Inst, Canc Control Ctr, Chuo Ku, Osaka, Osaka, Japan	Fukushima Medical University	Tabuchi, T (corresponding author), Osaka Int Canc Inst, Canc Control Ctr, Chuo Ku, Osaka, Osaka, Japan.	tabuchitak@gmail.com		Tabuchi, Takahiro/0000-0002-1050-3125	Health Labour Sciences Research Grants [20FA1005, 19FA0501, 19FA2001, 19FA1011]; Japan Society for the Promotion of Science (JSPS) KAKENHI [18H03062]	Health Labour Sciences Research Grants; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT was supported by Health Labour Sciences Research Grants (20FA1005; 19FA0501; 19FA2001; and 19FA1011; https://mhlw-grants.niph.go.jp/), and Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (18H03062; https://www.jsps.go.jp/english/e-grants/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuegwu NC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071263; Centers for Disease Control and Prevention (United States), SMOKING TOBACCO USE; Dietrich T, 2007, J PERIODONTOL, V78, P1421, DOI 10.1902/jop.2007.060212; Dietrich T, 2015, J DENT RES, V94, P1369, DOI 10.1177/0022034515598961; Hanioka T, 2007, J EPIDEMIOL, V17, P125, DOI 10.2188/jea.17.125; Hanioka T, 2019, JPN DENT SCI REV, V55, P88, DOI 10.1016/j.jdsr.2019.03.002; Heo HC, 2020, ANN OCCUP ENVIRON ME, V32, DOI 10.35371/aoem.2020.32.e2; Hirano T, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020202; Holmberg MJ, 2020, JAMA-J AM MED ASSOC, V324, P1098, DOI 10.1001/jama.2020.12698; Javed F, 2017, ORAL DIS, V23, P1052, DOI 10.1111/odi.12652; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Leigh NJ, 2018, TOB CONTROL, V27, pS26, DOI 10.1136/tobaccocontrol-2018-054317; Leite FRM, 2018, AM J PREV MED, V54, P831, DOI 10.1016/j.amepre.2018.02.014; Ministry of Health Labour and Welfare, COMPREHENSIVE SURVEY; Ministry of Health Labour and Welfare of Japan, NATL HLTH NUTR SURVE, DOI DOI 10900000/000687163.PDF; Mundt T, 2007, J PUBLIC HEALTH DENT, V67, P243, DOI 10.1111/j.1752-7325.2007.00041.x; National Cancer Institute (United States), DEFINITION PACK YEAR; Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Schwendicke F, 2018, J CLIN PERIODONTOL, V45, P2, DOI 10.1111/jcpe.12823; Simila T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3556-1; Simonavicius E, 2019, TOB CONTROL, V28, P582, DOI 10.1136/tobaccocontrol-2018-054419; St Helen G, 2018, TOB CONTROL, V27, pS30, DOI 10.1136/tobaccocontrol-2018-054321; Tabuchi T, 2019, J EPIDEMIOL, V29, P444, DOI 10.2188/jea.JE20180116; Tabuchi T, 2018, TOB CONTROL, V27, pE25, DOI 10.1136/tobaccocontrol-2017-053947; Tauras JA, 2014, TOB CONTROL, V23, P1, DOI 10.1136/tobaccocontrol-2014-051547; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248989	10.1371/journal.pone.0248989	http://dx.doi.org/10.1371/journal.pone.0248989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784312	gold, Green Published			2022-12-26	WOS:000636359600053
J	Afolabi, RF; Palamuleni, ME				Afolabi, Rotimi Felix; Palamuleni, Martin Enock			Multilevel analysis of unhealthy bodyweight among women in Malawi: Does urbanisation matter?	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; DOUBLE BURDEN; OVERWEIGHT; UNDERWEIGHT; OBESITY; MALNUTRITION; PREVALENCE; HEALTH; TRENDS	Background Underweight and overweight constitute unhealthy bodyweight and their coexistence is symptomatic of the dual burden of malnutrition (DBM) of high public health concern in many sub-Saharan Africa countries. Little is known about DBM and its correlates in Malawi, a country undergoing urbanisation. The study examined net effects of urban residence on unhealthy weights amidst individual- and community-level factors among women in Malawi. Methods Data on 7231 women aged 15-49 years nested within 850 communities extracted from 2015-16 Malawi Demographic and Health Survey were analysed. Women's weight status measured by body mass index, operationally categorised as underweight, normal and overweight, was the outcome variable while urban-rural residence was the main explanatory variable. Multilevel multinomial logistic regression analysis was employed at 5% significant level; the relative-risk ratio (RR) and its 95% confidence interval (CI) were presented. Results Urban residents had a significantly higher prevalence of overweight than rural (36.4% vs. 17.2%; p< 0.001) but a -non-significant lower prevalence of underweight (6.2% vs. 7.4%; p = 0.423). Having adjusted for both individual- and community-level covariates, compared to rural, living in urban (aRR = 1.25; CI: 1.02-1.53) accounted for about 25% higher risk of being overweight relative to normal weight. Higher education attainment, being married and belonging to Chewa, Lomwe or Mang'anja ethnic group significantly reduced the risk of being underweight but heightened the risk of being overweight. Being older and living in wealthier households respectively accounted for about 3- and 2-times higher likelihood of being overweight, while breastfeeding (aRR = 0.65; CI: 0.55-0.76) was protective against overweight. Living in communities with higher poverty and higher education levels reduced and increased the risk of being overweight, respectively. Evidence of community's variability in unhealthy weights was observed in that 11.1% and 3.0% respectively of the variance in the likelihood of being overweight and underweight occurred across communities. Conclusions The study demonstrated association between urban residence and women overweight. Other important associated factors of overweight included breastfeeding, community education- and poverty-level, while education attainment, marital status and ethnicity were associated with the dual unhealthy weight. Thus, both individual- and community-level characteristics are important considerations for policy makers in designing interventions to address DBM in Malawi.	[Afolabi, Rotimi Felix] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Afolabi, Rotimi Felix; Palamuleni, Martin Enock] North West Univ, Fac Humanities, Populat Studies & Demog Programme, Mmabatho, South Africa; [Afolabi, Rotimi Felix; Palamuleni, Martin Enock] North West Univ, Fac Humanities, Populat & Hlth Res Ent, Mmabatho, South Africa	University of Ibadan; North West University - South Africa; North West University - South Africa	Afolabi, RF (corresponding author), Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria.; Afolabi, RF (corresponding author), North West Univ, Fac Humanities, Populat Studies & Demog Programme, Mmabatho, South Africa.; Afolabi, RF (corresponding author), North West Univ, Fac Humanities, Populat & Hlth Res Ent, Mmabatho, South Africa.	rotimifelix@yahoo.com	Afolabi, Rotimi Felix/ABA-1796-2021	Afolabi, Rotimi Felix/0000-0002-0744-1787				Aarts E, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0228-5; Ackerson LK, 2008, ECON HUM BIOL, V6, P264, DOI 10.1016/j.ehb.2008.05.002; Al Kibria GM, 2019, GLOB HEALTH RES POL, V4, DOI 10.1186/s41256-019-0117-z; Amugsi DA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029545; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Colombo L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010048; Delbiso TD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30204; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Doku DT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2033-6; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J., 2012, NUTR CHALLENGE SUBSA; FAO IFAD UNICEF WFP WHO, 2019, STAT FOOD SEC NUTR; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Gondwe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206035; Gowshall M, 2018, INT J GEN MED, V11, P255, DOI 10.2147/IJGM.S157987; Hanandita W, 2015, SSM-POPUL HLTH, V1, P16, DOI 10.1016/j.ssmph.2015.10.002; Hashan MR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034321; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Hox JJ., 2010, MULTILEVEL ANALYISIS, VSecond; Jaacks LM, 2015, J NUTR, V145, P352, DOI 10.3945/jn.114.203562; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Kim R, 2018, LANCET GLOB HEALTH, V6, pE777, DOI 10.1016/S2214-109X(18)30232-8; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Lee K, 2009, GLOB INST, P1; Lima NP, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00122018, 10.1590/0102-311x00122018]; Madise Nyovani Janet, 2017, BMC Obes, V4, P5, DOI 10.1186/s40608-016-0141-1; Melaku YA, 2019, PUBLIC HEALTH NUTR, V22, P827, DOI 10.1017/S1368980018002975; Msyamboza KP, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.108.2622; Nandi A, 2014, AM J PUBLIC HEALTH, V104, pE162, DOI 10.2105/AJPH.2013.301392; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Nkoka O, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0700-2; Pengpid S, 2019, DIABETES METAB SYNDR, V12, P647, DOI 10.2147/DMSO.S206855; Phd K, 2018, J INT ACAD RES MULTI, V6, P66; Prentice AM, 2018, ANN NUTR METAB, V72, P47, DOI 10.1159/000487383; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Rahman MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219968; Ramsay M, 2018, GLOBAL HEALTH ACTION, V11, P90, DOI 10.1080/16549716.2018.1556561; Rawal LB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205912; Rhodes EC, 2020, J NUTR, V150, P1554, DOI 10.1093/jn/nxaa076; Roh L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-371; Singh S, 2020, INT J NEUROSCI, V130, P251, DOI 10.1080/00207454.2019.1667799; Smith L, 2016, OCCUP MED-OXFORD, V66, P185, DOI 10.1093/occmed/kqv164; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; Theall KP, 2011, J EPIDEMIOL COMMUN H, V65, P688, DOI 10.1136/jech.2009.097956; USAID, 2018, MAL NUTR PROF; WHO, 2017, DOUBLE BURDEN MALNUT; World Bank, 2016, MAL URB REV LEV URB; World Health Organization, GLOB HLTH OBS DAT RE	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249289	10.1371/journal.pone.0249289	http://dx.doi.org/10.1371/journal.pone.0249289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780505	gold, Green Published			2022-12-26	WOS:000636336800002
J	Han, WM; Mahikul, W; Pouplin, T; Lawpoolsri, S; White, LJ; Pan-Ngum, W				Han, Win Min; Mahikul, Wiriya; Pouplin, Thomas; Lawpoolsri, Saranath; White, Lisa J.; Pan-Ngum, Wirichada			Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; REGIMEN; THERAPY; HIV; BEDAQUILINE; DELAMANID; DECLINE; RATES	This study aimed to predict the impacts of shorter duration treatment regimens for multidrug-resistant tuberculosis (MDR-TB) on both MDR-TB percentage among new cases and overall MDR-TB cases in the WHO Southeast Asia Region. A deterministic compartmental model was constructed to describe both the transmission of TB and the MDR-TB situation in the Southeast Asia region. The population-level impacts of short-course treatment regimens were compared with the impacts of conventional regimens. Multi-way analysis was used to evaluate the impact by varying programmatic factors (eligibility for short-course MDR-TB treatment, treatment initiation, and drug susceptibility test (DST) coverage). The model predicted that overall TB incidence will be reduced from 246 (95% credible intervals (CrI), 221-275) per 100,000 population in 2020 to 239 (95% CrI, 215-267) per 100,000 population in 2035, with a modest reduction of 2.8% (95% CrI, 2.7%-2.9%). Despite the slight reduction in overall TB infections, the model predicted that the MDR-TB percentage among newly notified TB infections will remain steady, with 2.4% (95% CrI, 2.1-2.9) in 2020 and 2.5% (95% CrI, 2.3-3.1) in 2035, using conventional MDR-TB treatment. With the introduction of short-course regimens to treat MDR-TB, the development of resistance can be slowed by 38.6% (95% confidence intervals (CI), 35.9-41.3) reduction in MDR-TB case number, and 37.6% (95% CI, 34.9-40.3) reduction in MDR-TB percentage among new TB infections over the 30-year period compared with the baseline using the standard treatment regimen. The multi-way analysis showed eligibility for short-course treatment and treatment initiation greatly influenced the impacts of short-course treatment regimens on reductions in MDR-TB cases and percentage resistance among new infections. Policies which promote the expansion of short-course regimens and early MDR-TB treatment initiation should be considered along with other interventions to tackle antimicrobial resistance in the region.	[Han, Win Min; Lawpoolsri, Saranath; Pan-Ngum, Wirichada] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Han, Win Min] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Mahikul, Wiriya] Chulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok, Thailand; [Pouplin, Thomas] Mahidol Oxford Trop Med Res Unit MORU, Pharmacol Dept, Bangkok, Thailand; [Pouplin, Thomas; White, Lisa J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [White, Lisa J.] Univ Oxford, Big Data Inst, Nuffield Dept Med, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Pan-Ngum, Wirichada] Mahidol Oxford Trop Med Res Unit MORU, Math & Econ Modelling MAEMOD Res Grp, Bangkok, Thailand	Mahidol University; Thai Red Cross Society; Chulabhorn Royal Academy; HRH Princess Chulabhorn College of Medical Science; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Pan-Ngum, W (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.; Pan-Ngum, W (corresponding author), Mahidol Oxford Trop Med Res Unit MORU, Math & Econ Modelling MAEMOD Res Grp, Bangkok, Thailand.	pan@tropmedres.ac	Mahikul, Wiriya/GXF-4465-2022	Mahikul, Wiriya/0000-0001-5834-5173; Han, Win Min/0000-0003-3731-7960; pan-ngum, wirichada/0000-0002-9839-5359	Wellcome Trust [220211]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded in part by the Wellcome Trust [Grant number 220211]. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. The funder had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	Anderson LF, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.40.20601; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Becerra MC, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5894; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; COLLINS JJ, 1982, DEMOGRAPHY, V19, P409, DOI 10.2307/2060979; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Hartig F, 2019, R PACKAGE VERSION 01; Hartig g., 2019, R PACKAGE VERSION 01; He GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010799; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Houben RMGJ, 2012, AIDS, V26, P2233, DOI 10.1097/QAD.0b013e32835958ed; Kendall EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172748; Kendall EA, 2017, LANCET RESP MED, V5, P191, DOI 10.1016/S2213-2600(16)30423-4; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Knight GM, 2019, LANCET INFECT DIS, V19, P903, DOI 10.1016/S1473-3099(19)30307-X; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Lange C, 2018, RESPIROLOGY, V23, P656, DOI 10.1111/resp.13304; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Moosazadeh M, 2014, INT J PREVENTIVE MED, V5, P1005; Narendran G, 2014, CLIN INFECT DIS, V59, P1798, DOI 10.1093/cid/ciu674; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Nunn AJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-353; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015; RCore Team, 2020, R LANG ENV STAT COMP; Salvatore PP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54561-9; Shewade HD, 2018, T ROY SOC TROP MED H, V112, P500, DOI 10.1093/trstmh/try091; SNIDER DE, 1986, JAMA-J AM MED ASSOC, V255, P1579, DOI 10.1001/jama.255.12.1579; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Sun F, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01770-2018; Suthar AB, 2016, INT J TUBERC LUNG D, V20, P1148, DOI 10.5588/ijtld.16.0142; Tabarsi P, 2011, AM J THER, V18, P343, DOI 10.1097/MJT.0b013e3181dd60ec; Nguyen TVA, 2020, CLIN INFECT DIS, V71, P3252, DOI 10.1093/cid/ciaa755; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Trauer JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0723-2; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; WHO, 2020, WHO OPERATIONAL HDB; WHO, 2018, GLOBAL TUBERCULOSIS; Wollenberg KR, 2017, J CLIN MICROBIOL, V55, P457, DOI 10.1128/JCM.02116-16; World Health Organisation, 2016, SHORTER MDR TB REGIM; World Health Organization, GLOBAL TUBERCULOSIS; Zurcher K, 2019, LANCET INFECT DIS, V19, P298, DOI 10.1016/S1473-3099(18)30673-X	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248846	10.1371/journal.pone.0248846	http://dx.doi.org/10.1371/journal.pone.0248846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770104	gold, Green Published			2022-12-26	WOS:000634833500013
J	Kebede, T; Gadisa, E; Tufa, A				Kebede, Taye; Gadisa, Eshetu; Tufa, Abreham			Antimicrobial activities evaluation and phytochemical screening of some selected medicinal plants: A possible alternative in the treatment of multidrug-resistant microbes	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; THREAT; BURDEN	Background Four out of five individuals rely on traditional medicine for their primary healthcare needs. Medicinal plants are endowed with diverse bioactive compounds to treat multidrug-resistant (MDR) microbes. So far, a less thorough examination has been made in this regard. This study aimed to evaluate antimicrobial activity and phytochemical screening of selected medicinal plants against MDR microbes. Methods In vitro experimental study was carried out to evaluate antimicrobial effects and phytochemical screening of Rumex abyssinicus, Cucumis pustulatus, Discopodium penninervium, Lippia adoensis, Euphorbia depauperata, Cirsium englerianum, and Polysphaeria aethiopica against MDR bacteria and fungi. Aqueous and 80% methanolic extraction methods were employed for extraction. The susceptibility test, minimum inhibitory concentration, and minimum bactericidal or fungicidal concentration were measured using disc diffusion or broth micro-dilution as per the CLSI protocols. Result The 80% methanolic extraction method was a preferred method to aqueous. The phytochemical constituents identified were alkaloids, flavonoids, saponins, phenolic, tannins, terpenoidss, and cardiac glycosides. The hydroalcoholic extract demonstrated an appreciable antimicrobial role against MDR microbes with an MIC value of 1.0-128.0 mu g/ml and 11-29mm inhibition zone (IZ) in diameter. Extracts obtained from C. englerianum and E. depauperata showed a significant IZ ranged of 26-29mm on MRSA and Streptococcus pyogenes. MDR E. coli and K. pneumoniae showed 12-25mm and 23-28mm IZ in diameter, respectively. T. mentagraphytes was susceptible to all tested extracts. Moreover, S. pyogenes and K. pneumoniae were found the most susceptible bacteria to C. englerianum. Cirsium englerianum, L. adoensis, D. penninervium, and R. abyssinicus demonstrated remarkable antifungal effect against C. albicans and T. mentagrophytes, while R. abyssinicus showed the leading antifungal effect with 32 to 64 mu g/ml MIC values. Conclusion The plant extracts have shown appreciable antimicrobial activities comparable to the currently prescribed modern drugs tested. Accordingly, further studies on clinical efficacy trial, safety, toxicity and affordability analyses have to be instigated promptly, so as to head to the final step to synthesize precursor molecules for new effective antimicrobials.	[Kebede, Taye] Madda Walabu Univ, Nat Sci Coll, Dept Biomed Sci & Immunol, Bale Robe, Ethiopia; [Gadisa, Eshetu] Kotebe Metropolitan Univ, Menelik Med & Hlth Sci Coll, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Tufa, Abreham] Madda Walabu Univ, Nat Sci Coll, Dept Biochem, Bale Robe, Ethiopia		Kebede, T (corresponding author), Madda Walabu Univ, Nat Sci Coll, Dept Biomed Sci & Immunol, Bale Robe, Ethiopia.	tayekebede2012@gmail.com	Kebede, Taye/AAV-6699-2021	Kebede, Taye/0000-0001-8611-4946	Madda Walabu University (BaleRobe); Kotebe Metropolitan University (Addis Ababa), Ethiopia	Madda Walabu University (BaleRobe); Kotebe Metropolitan University (Addis Ababa), Ethiopia	The research has been funded collaboratively by Madda Walabu University (BaleRobe) and Kotebe Metropolitan University (Addis Ababa), Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal SN, 2017, EUR J MICROBIOL IMMU, V7, P92, DOI 10.1556/1886.2017.00001; C Abreu VG, 2012, SEARCH ANTIBACT AGEN; Chuah E., 2014, J MICROBIOLOGY RES, V4, P6, DOI [10.5923/J.MICROBIOLOGY.20140401.02, DOI 10.5923/J.MICROBIOLOGY.20140401.02]; Courvalin P, 2016, CLIN MICROBIOL INFEC, V22, P405, DOI 10.1016/j.cmi.2016.01.012; Dhami N, 2013, J HERB MED, V3, P123, DOI 10.1016/j.hermed.2013.06.001; Dholaria M., 2018, J EMERG TECHNOL INNO, V5, P581; Edeoga HO, 2005, AFR J BIOTECHNOL, V4, P685, DOI 10.5897/AJB2005.000-3127; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Falcone M, 2016, J ANTIMICROB CHEMOTH, V71, P2713, DOI 10.1093/jac/dkw239; Gadisa E, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2429-4; Habtamu Y, 2010, AFR J MICROBIOL RES, V4, P1230; Hecht D., 2011, PERFORMANCE STANDARD, V30; Kenneth-Obosi O., 2017, INT J HOMEOPATH NAT, V3, P1; Mohd Shahnawaz PHQ, 2017, J PHYTOPHARM, V6, P349; Morehead MS, 2018, PRIMARY CARE, V45, P467, DOI 10.1016/j.pop.2018.05.006; Motaleb MA., 2011, SELECTED MED PLANTS, P01; Niranjan PS., 2017, J DRUG DELIV THER, V7, P2685; Opperman TJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00421; Parvin S., 2014, J PHARM PHYTO, V2, P47; Pitout JDD, 2008, EXPERT REV ANTI-INFE, V6, P657, DOI 10.1586/14787210.6.5.657; Poulakou G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.29; Rahman MS., 2007, BANGLADESH J MICROBI, V24, P73; Raoult D, 2016, CLIN MICROBIOL INFEC, V22, P403, DOI 10.1016/j.cmi.2016.03.004; Rather IA, 2017, SAUDI J BIOL SCI, V24, P808, DOI 10.1016/j.sjbs.2017.01.004; Sasidharan S, 2011, AFR J TRADIT COMPLEM, V8, P1; Sharifi-Rad J, 2016, CELL MOL BIOL, V62, P75, DOI 10.14715/cmb/2016.62.9.12; Sharland M, 2015, J PEDIAT-BRAZIL, V91, P410, DOI 10.1016/j.jped.2015.06.001; Shehadeh MB, 2016, SAUDI PHARM J, V24, P611, DOI 10.1016/j.jsps.2015.03.025; Shriram V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02990; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Valli M, 2012, QUIM NOVA, V35, P2278, DOI 10.1590/S0100-40422012001100036; van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343; Wayne P., 2014, PERFORMANCE STANDARD, VTwenty-Fou; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zuo GY, 2008, J ETHNOPHARMACOL, V120, P287, DOI 10.1016/j.jep.2008.08.021	37	23	25	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249253	10.1371/journal.pone.0249253	http://dx.doi.org/10.1371/journal.pone.0249253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770121	Green Published, gold			2022-12-26	WOS:000634833500033
J	Shinjoh, M; Sugaya, N; Yamaguchi, Y; Ookawara, I; Nakata, Y; Narabayashi, A; Furuichi, M; Yoshida, N; Kamei, A; Kuramochi, Y; Shibata, A; Shimoyamada, M; Nakazaki, H; Maejima, N; Yuasa, E; Araki, E; Maeda, N; Ohnishi, T; Nishida, M; Taguchi, N; Yoshida, M; Tsunematsu, K; Shibata, M; Hirano, Y; Sekiguchi, S; Kawakami, C; Mitamura, K; Takahashi, T				Shinjoh, Masayoshi; Sugaya, Norio; Yamaguchi, Yoshio; Ookawara, Ichiro; Nakata, Yuji; Narabayashi, Atsushi; Furuichi, Munehiro; Yoshida, Naoko; Kamei, Akinobu; Kuramochi, Yuu; Shibata, Akimichi; Shimoyamada, Motoko; Nakazaki, Hisataka; Maejima, Naohiko; Yuasa, Erika; Araki, Eriko; Maeda, Naonori; Ohnishi, Takuma; Nishida, Mitsuhiro; Taguchi, Nobuhiko; Yoshida, Makoto; Tsunematsu, Kenichiro; Shibata, Meiwa; Hirano, Yasuhiro; Sekiguchi, Shinichiro; Kawakami, Chiharu; Mitamura, Keiko; Takahashi, Takao			Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season	PLOS ONE			English	Article								During influenza epidemics, Japanese clinicians routinely conduct rapid influenza diagnostic tests (RIDTs) in patients with influenza-like illness, and patients with positive test results are treated with anti-influenza drugs within 48 h after the onset of illness. We assessed the vaccine effectiveness (VE) of inactivated influenza vaccine (IIV) in children (6 months-15 years old, N = 4243), using a test-negative case-control design based on the results of RIDTs in the 2018/19 season. The VE against influenza A(H1N1)pdm and A(H3N2) was analyzed separately using an RIDT kit specifically for detecting A(H1N1)pdm09. The adjusted VE against combined influenza A (H1N1pdm and H3N2) and against A(H1N1)pdm09 was 39% (95% confidence interval [CI], 30%-46%) and 74% (95% CI, 39%-89%), respectively. By contrast, the VE against non-A(H1N1)pdm09 influenza A (presumed to be H3N2) was very low at 7%. The adjusted VE for preventing hospitalization was 56% (95% CI, 16%-77%) against influenza A. The VE against A(H1N1)pdm09 was consistently high in our studies. By contrast, the VE against A(H3N2) was low not only in adults but also in children in the 2018/19 season.	[Shinjoh, Masayoshi; Furuichi, Munehiro; Yoshida, Naoko; Sekiguchi, Shinichiro; Takahashi, Takao] Keio Univ, Dept Pediat, Sch Med, Tokyo, Japan; [Sugaya, Norio; Taguchi, Nobuhiko] Keiyu Hosp, Dept Pediat, Keiyu, Kanagawa, Japan; [Yamaguchi, Yoshio] Natl Hosp Org, Tochigi Hosp, Inst Clin Res, Tochigi, Japan; [Yamaguchi, Yoshio] Natl Hosp Org, Tochigi Hosp, Dept Infect & Allergy, Tochigi, Japan; [Ookawara, Ichiro] Japanese Red Cross Shizuoka Hosp, Dept Pediat, Shizuoka, Japan; [Nakata, Yuji] Nippon Koukan Hosp, Dept Pediat, Kawasaki, Kanagawa, Japan; [Narabayashi, Atsushi] Kawasaki Municipal Hosp, Dept Pediat, Kawasaki, Kanagawa, Japan; [Kamei, Akinobu] Yokohama Municipal Citizens Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Kuramochi, Yuu] Subaru Hlth Insurance Soc Ota Mem Hosp, Dept Pediat, Gunma, Japan; [Shibata, Akimichi; Araki, Eriko] Japanese Red Cross Ashikaga Hosp, Dept Pediat, Ashikaga, Tochigi, Japan; [Shimoyamada, Motoko] Saitama City Hosp, Dept Pediat, Saitama, Japan; [Nakazaki, Hisataka] Tokyo Dent Coll Ichikawa Gen Hosp, Dept Pediat, Chiba, Japan; [Maejima, Naohiko] Tokyo Metropolitan Otsuka Hosp, Dept Pediat, Tokyo, Japan; [Yuasa, Erika] Saiseikai Utsunomiya Hosp, Dept Pediat, Utsunomiya, Tochigi, Japan; [Maeda, Naonori] Natl Hosp Org Tokyo Med Ctr, Dept Pediat, Tokyo, Japan; [Ohnishi, Takuma] Natl Hosp Org Saitama Hosp, Dept Pediat, Saitama, Japan; [Nishida, Mitsuhiro] Shizuoka City Shimizu Hosp, Dept Pediat, Shizuoka, Japan; [Yoshida, Makoto] Sano Kosei Gen Hosp, Dept Pediat, Shin Oyama, Tochigi, Japan; [Tsunematsu, Kenichiro] Hino Municipal Hosp, Dept Pediat, Tokyo, Japan; [Shibata, Meiwa] Yokohama Rosai Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Hirano, Yasuhiro] Hiratsuka City Hosp, Dept Pediat, Hiratsuka, Kanagawa, Japan; [Kawakami, Chiharu] Yokohama City Inst Publ Hlth, Yokohama, Kanagawa, Japan; [Mitamura, Keiko] Eiju Gen Hosp, Dept Pediat, Tokyo, Japan	Keio University; Tokyo Dental College; Yokohama Rosai Hospital	Sugaya, N (corresponding author), Keiyu Hosp, Dept Pediat, Keiyu, Kanagawa, Japan.	sugaya-n@za2.so-net.ne.jp	Furuichi, Munehiro/GLT-6225-2022; Shinjoh, Masayoshi/ABF-3935-2021	Shinjoh, Masayoshi/0000-0002-6291-7186				Doyle JD, 2019, MMWR-MORBID MORTAL W, V68, P135, DOI 10.15585/mmwr.mm6806a2; Flannery B, 2020, J INFECT DIS, V221, P8, DOI 10.1093/infdis/jiz543; Harada D, 2012, SCAND J INFECT DIS, V44, P776, DOI 10.3109/00365548.2012.686670; Ip DKM, 2016, CLIN INFECT DIS, V62, P431, DOI 10.1093/cid/civ909; Ito K, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000011551, 10.1097/MD.0000000000011551]; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jefferson T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub5; Katayose M, 2011, VACCINE, V29, P1844, DOI 10.1016/j.vaccine.2010.12.049; Kimiya T, 2018, EUR J PEDIATR, V177, P1009, DOI 10.1007/s00431-018-3145-7; Kissling E, 2019, EUROSURVEILLANCE, V24, P31, DOI 10.2807/1560-7917.ES.2019.24.48.1900604; Kissling E, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.1900121; McCullers JA, 2019, FEIGIN CHERRYS TXB P, Veighth, P1729; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Ministry of Health Labour. and Japan Welfare, INFLUENZA VACCINATIO; Nakamura Y, 2010, JPN MED ASS J, V53, P259; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Pharmaceuticals and Medical Devices Agency (PMDA) Japan, JAP INT IN INFL VACC; Rockman S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111745; Segaloff HE, 2019, CLIN INFECT DIS, V69, P2153, DOI 10.1093/cid/ciz125; Seki Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231217; Shinjoh M, 2019, VACCINE, V37, P4047, DOI 10.1016/j.vaccine.2019.05.090; Shinjoh M, 2018, VACCINE, V36, P5510, DOI 10.1016/j.vaccine.2018.07.065; Shinjoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136539; Skowronski DM, 2019, EUROSURVEILLANCE, V24, P39, DOI 10.2807/1560-7917.ES.2019.24.46.1900585; Skowronski DM, 2019, EUROSURVEILLANCE, V24, P6, DOI 10.2807/1560-7917.ES.2019.24.4.1900055; Sugaya N, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.42.30377; Sugaya N, 2018, VACCINE, V36, P1063, DOI 10.1016/j.vaccine.2018.01.024; Sugaya N, 2011, J INFECT CHEMOTHER, V17, P595, DOI 10.1007/s10156-011-0288-0; Sugaya N, 2011, J INFECTION, V63, P288, DOI 10.1016/j.jinf.2011.06.008; The National Institute of Infectious Diseases, INFLUENZA 201819 SEA; Thompson MG, 2016, PEDIATR INFECT DIS J, V35, P299, DOI 10.1097/INF.0000000000001006; World Health Organization, 2017, WHO PUBLIC HLTH RES; World Health Organization, DATA SOURCE FLUNET	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249005	10.1371/journal.pone.0249005	http://dx.doi.org/10.1371/journal.pone.0249005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770132	Green Published, gold			2022-12-26	WOS:000634833500009
J	Gao, YG; Zhai, XH; Boldyrev, IA; Molotkovsky, JG; Patel, DJ; Malinina, L; Brown, RE				Gao, Yong-Guang; Zhai, Xiuhong; Boldyrev, Ivan A.; Molotkovsky, Julian G.; Patel, Dinshaw J.; Malinina, Lucy; Brown, Rhoderick E.			Ceramide-1-phosphate transfer protein (CPTP) regulation by phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID TRANSFER PROTEIN; LIPID-TRANSFER; WEB SERVER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; STRUCTURAL BASIS; MOLECULAR-BASIS; C2 DOMAINS; BINDING; TRANSPORT; CERAMIDE	Ceramide-1-phosphate transfer proteins (CPTPs) are members of the glycolipid transfer protein (GLTP) superfamily that shuttle ceramide-1-phosphate (C1P) between membranes. CPTPs regulate cellular sphingolipid homeostasis in ways that impact programmed cell death and inflammation. CPTP down-regulation specifically alters C1P levels in the plasma and trans-Golgi membranes, stimulating proinflammatory eicosanoid production and autophagy-dependent inflammasome-mediated cytokine release. However, the mechanisms used by CPTP to target the trans-Golgi and plasma membrane are not well understood. Here, we monitored C1P intervesicular transfer using fluorescence energy transfer (FRET) and showed that certain phosphoinositides (phosphatidylinositol 4,5 bisphosphate (PI(4,5)P-2) and phosphatidylinositol 4-phosphate (PI-4P)) increased CPTP transfer activity, whereas others (phosphatidylinositol 3-phosphate (PI-3P) and PI) did not. PIPs that stimulated CPTP did not stimulate GLTP, another superfamily member. Short-chain PI-(4,5)P-2, which is soluble and does not remain membrane-embedded, failed to activate CPTP. CPTP stimulation by physiologically relevant PI-(4,5)P-2 levels surpassed that of phosphatidylserine (PS), the only known non-PIP stimulator of CPTP, despite PI-(4,5)P-2 increasing membrane equilibrium binding affinity less effectively than PS. Functional mapping of mutations that led to altered FRET lipid transfer and assessment of CPTP membrane interaction by surface plasmon resonance indicated that di-arginine motifs located in the alpha-6 helix and the alpha 3-alpha 4 helix regulatory loop of the membrane-interaction region serve as PI-(4,5)P-2 headgroup-specific interaction sites. Haddock modeling revealed specific interactions involving the PI-(4,5)P-2 headgroup that left the acyl chains oriented favorably for membrane embedding. We propose that PI-(4,5)P-2 interaction sites enhance CPTP activity by serving as preferred membrane targeting/docking sites that favorably orient the protein for function.	[Gao, Yong-Guang; Zhai, Xiuhong; Malinina, Lucy; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Zhai, Xiuhong] Aveda Estee Lauder Co Inc, Res & Dev Dept, 4000 Pheast Ridge Dr NE, Blaine, MN 55449 USA	University of Minnesota System; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Memorial Sloan Kettering Cancer Center	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu		Brown, Rhoderick/0000-0002-7337-3604	NHLBI [HL125353]; NIGMS [GM45928]; NCI [CA121493]; Russian Foundation for Basic Research [015-0407415]; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation	The research presented here was supported by NHLBI HL125353, NIGMS GM45928, and NCI CA121493; the Russian Foundation for Basic Research 015-0407415; Abby Rockefeller Mauze Trust, the Maloris Foundation, and the Hormel Foundation.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERGELSON LD, 1985, CHEM PHYS LIPIDS, V37, P165, DOI 10.1016/0009-3084(85)90083-0; Boldyrev IA, 2013, RUSS J BIOORG CHEM+, V39, P539, DOI 10.1134/S106816201305004X; Brown R E, 1990, Subcell Biochem, V16, P333; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Collins MD, 2013, BIOPHYS J, V105, P2485, DOI 10.1016/j.bpj.2013.09.035; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Grabon A, 2019, J LIPID RES, V60, P242, DOI 10.1194/jlr.R089730; Guillen J, 2013, P NATL ACAD SCI USA, V110, P20503, DOI 10.1073/pnas.1316179110; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hirano Y, 2019, ELIFE, V8, DOI 10.7554/eLife.44760; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Johnson JL, 2012, J BIOL CHEM, V287, P5764, DOI 10.1074/jbc.M111.336487; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kenoth R, 2019, METHODS MOL BIOL, V1949, P237, DOI 10.1007/978-1-4939-9136-5_17; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kjellberg MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097263; Kumagai K, 2019, FEBS LETT, V593, P2366, DOI 10.1002/1873-3468.13511; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leon L, 2012, P NATL ACAD SCI USA, V109, P4357, DOI 10.1073/pnas.1200764109; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Lipp NF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00663; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2017, ANNU REV BIOCHEM, V86, P609, DOI 10.1146/annurev-biochem-061516-044445; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2016, CHEM PHYS LIPIDS, V194, P72, DOI 10.1016/j.chemphyslip.2015.07.018; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mishra SK, 2020, PROG LIPID RES, V78, DOI 10.1016/j.plipres.2020.101031; Mishra SK, 2019, BBA-MOL CELL BIOL L, V1864, P158, DOI 10.1016/j.bbalip.2018.11.002; Mishra SK, 2018, AUTOPHAGY, V14, P862, DOI 10.1080/15548627.2017.1393129; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Ochoa-Lizarralde B, 2018, J BIOL CHEM, V293, P16709, DOI 10.1074/jbc.RA117.000733; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picas L., 2016, F1000RESEARCH, V5, DOI [10.12688/f1000research.7537.1, DOI 10.12688/F1000RESEARCH.7537.1]; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Ran Y, 2009, BIOPHYS J, V97, P257, DOI 10.1016/j.bpj.2009.03.065; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Rovina P, 2006, BIOCHEM J, V400, P255, DOI 10.1042/BJ20060316; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Scacioc A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14337-5; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Teyton L, 2018, J LIPID RES, V59, P1367, DOI 10.1194/jlr.R083212; Thompson PM, 2017, STRUCTURE, V25, P264, DOI 10.1016/j.str.2016.12.002; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Ward KE, 2013, J LIPID RES, V54, P636, DOI 10.1194/jlr.M031088; Wen Y, 2018, BIOPHYS J, V114, P2630, DOI 10.1016/j.bpj.2018.04.048; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; WONG M, 1984, BIOCHEMISTRY-US, V23, P6498, DOI 10.1021/bi00321a035; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Zhai XH, 2017, J BIOL CHEM, V292, P2531, DOI 10.1074/jbc.M116.760256	85	3	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100600	10.1016/j.jbc.2021.100600	http://dx.doi.org/10.1016/j.jbc.2021.100600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781749	gold, Green Published			2022-12-26	WOS:000672866400572
J	Meier-Stephenson, V; Badmalia, MD; Mrozowich, T; Lau, KCK; Schultz, SK; Gemmill, DL; Osiowy, C; van Marle, G; Coffin, CS; Patel, TR				Meier-Stephenson, Vanessa; Badmalia, Maulik D.; Mrozowich, Tyler; Lau, Keith C. K.; Schultz, Sarah K.; Gemmill, Darren L.; Osiowy, Carla; van Marle, Guido; Coffin, Carla S.; Patel, Trushar R.			Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; HUMAN TELOMERASE; NATURAL-HISTORY; RNA; GENOME; TRANSCRIPTION; REPLICATION; PERSISTENCE; RECOGNITION; SCATTERING	Approximately 250 million people worldwide are chronically infected with the hepatitis B virus (HBV) and are at increased risk of developing cirrhosis and hepatocellular carcinoma. The HBV genome persists as covalently closed circular DNA (cccDNA), which serves as the template for all HBV mRNA transcripts. Current nucleos(t)ide analogs used to treat HBV do not directly target the HBV cccDNA genome and thus cannot eradicate HBV infection. Here, we report the discovery of a unique G-quadruplex structure in the pre-core promoter region of the HBV genome that is conserved among nearly all genotypes. This region is central to critical steps in the viral life cycle, including the generation of pregenomic RNA, synthesis of core and polymerase proteins, and genome encapsidation; thus, an increased understanding of the HBV pre-core region may lead to the identification of novel anti-HBV cccDNA targets. We utilized biophysical methods (circular dichroism and small-angle X-ray scattering) to characterize the HBV G-quadruplex and the effect of three distinct G to A mutants. We also used microscale thermophoresis to quantify the binding affinity of G-quadruplex and its mutants with a known quadruplex-binding protein (DHX36). To investigate the physiological relevance of HBV G-quadruplex, we employed assays using DHX36 to pull-down cccDNA and compared HBV infection in HepG2 cells transfected with wild-type and mutant HBV plasmids by monitoring the levels of genomic DNA, pregenomic RNA, and antigens. Further evaluation of this critical host-protein interaction site in the HBV cccDNA genome may facilitate the development of novel anti-HBV therapeutics against the resilient cccDNA template.	[Meier-Stephenson, Vanessa; Badmalia, Maulik D.; Mrozowich, Tyler; Schultz, Sarah K.; Gemmill, Darren L.; Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada; [Meier-Stephenson, Vanessa; Lau, Keith C. K.; van Marle, Guido; Coffin, Carla S.; Patel, Trushar R.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Meier-Stephenson, Vanessa; Coffin, Carla S.] Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Osiowy, Carla] Publ Hlth Agcy Canada, Natl Microbiol Lab, Viral Hepatitis & Bloodborne Pathogens, Winnipeg, MB, Canada; [Patel, Trushar R.] Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada	University of Lethbridge; University of Calgary; Public Health Agency of Canada; University of Alberta	Patel, TR (corresponding author), Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada.; Coffin, CS; Patel, TR (corresponding author), Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Coffin, CS (corresponding author), Cumming Sch Med, Dept Med, Calgary, AB, Canada.; Patel, TR (corresponding author), Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada.	cscoffin@ucalgary.ca; trushar.patel@uleth.ca	; Patel, Trushar/F-2776-2011	Lau, Keith/0000-0001-7870-6597; van Marle, Guido/0000-0002-5148-6229; Patel, Trushar/0000-0003-0627-2923; Gemmill, Darren/0000-0003-2834-9063	Canadian Network on Hepatitis C Postdoctoral Fellowship; Canada Foundation for Innovation infrastructure grant; Cumming School of Medicine Seed Grant; Alberta Innovates Strategic Research Program grant; NSERC [RGPIN-2017-04004]; NSERC PGS-D fellowship; MITACS fellowship	Canadian Network on Hepatitis C Postdoctoral Fellowship; Canada Foundation for Innovation infrastructure grant(Canada Foundation for Innovation); Cumming School of Medicine Seed Grant; Alberta Innovates Strategic Research Program grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS fellowship	V. M. S. acknowledges the Canadian Network on Hepatitis C Postdoctoral Fellowship. T. R. P. is a Canada Research Chair in RNA and Protein Biophysics and acknowledges the Canada Foundation for Innovation infrastructure grant. T.R. P. and C. C. acknowledge the Cumming School of Medicine Seed Grant and Alberta Innovates Strategic Research Program grant. T. M. and M. B. were hired using NSERC Discovery (RGPIN-2017-04004) and Alberta Innovates Strategic Research Program grant, respectively. T. M. and M. B. also acknowledge NSERC PGS-D and MITACS fellowships. HPLC-SAXS data were collected at the B21 beamline, DIAMOND synchrotron (BAG proposal: SM22113), United Kingdom.	Ariyo EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144510; Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016; Asamitsu S, 2019, MOLECULES, V24, DOI 10.3390/molecules24030429; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Biswas B, 2017, NUCLEIC ACIDS RES, V45, P11268, DOI 10.1093/nar/gkx823; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Buti M, 2005, J CLIN VIROL, V34, pS79, DOI 10.1016/S1386-6532(05)80015-0; Carvalho J, 2017, J CHEM EDUC, V94, P1547, DOI 10.1021/acs.jchemed.7b00160; Chauhan R, 2018, WORLD J HEPATOL, V10, P352, DOI 10.4254/wjh.v10.i3.352; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Coffin CS, 2018, CAN LIVER J, V1, P156, DOI 10.3138/canlivj.2018-0008; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Entzian C, 2016, METHODS, V97, P27, DOI 10.1016/j.ymeth.2015.08.023; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frasson I., 2020, TRANSCRIPTION FACTOR, DOI [10.1101/2020.07.14.202747, DOI 10.1101/2020.07.14.202747]; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao S, 2017, J CLIN VIROL, V94, P8, DOI 10.1016/j.jcv.2017.06.009; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hayer J, 2013, NUCLEIC ACIDS RES, V41, pD566, DOI 10.1093/nar/gks1022; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Konig Sebastian L B, 2010, Biomol Concepts, V1, P197, DOI 10.1515/bmc.2010.011; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Lau KCK, 2018, J VIRAL HEPATITIS, V25, P724, DOI 10.1111/jvh.12860; Lau KCK, 2020, CANCER LETT, V480, P39, DOI 10.1016/j.canlet.2020.03.022; Lau KCK, 2019, DIAGN MICR INFEC DIS, V93, P318, DOI 10.1016/j.diagmicrobio.2018.10.015; Lavezzo E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006675; Lee Hannah M, 2019, Curr Treat Options Gastroenterol, V17, P271, DOI 10.1007/s11938-019-00236-3; Li J, 2001, J VIROL, V75, P8400, DOI 10.1128/JVI.75.18.8400-8406.2001; Lin CL, 2017, BEST PRACT RES CL GA, V31, P249, DOI 10.1016/j.bpg.2017.04.010; Luo XY, 2019, J AM CHEM SOC, V141, P5182, DOI 10.1021/jacs.8b10265; Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038; Magnez R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17963-1; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Meier M, 2018, NUCLEIC ACIDS RES, V46, P5319, DOI 10.1093/nar/gky307; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Meier-Stephenson V, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110603; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Mitra B, 2019, J VIROL, V93, DOI 10.1128/JVI.00196-19; Monsen RC, 2020, NUCLEIC ACIDS RES, V48, P5720, DOI 10.1093/nar/gkaa107; Mrozowich T., 2019, BIOCHEMIST, V41, P8, DOI [10.1042/bio04102008, DOI 10.1042/BIO04102008]; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Osiowy C, 2008, J GEN VIROL, V89, P3009, DOI 10.1099/vir.0.2008/005124-0; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Qin YL, 2017, METHODS MOL BIOL, V1540, P219, DOI 10.1007/978-1-4939-6700-1_18; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Rambo R., 2017, SCATTER JAVA BASED A; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rigo R, 2017, BBA-GEN SUBJECTS, V1861, P1399, DOI 10.1016/j.bbagen.2016.12.024; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Song JW, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1244031; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka Y, 2008, VIROLOGY, V376, P408, DOI 10.1016/j.virol.2008.04.001; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippana R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09802-w; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Turton KL, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020160; van Bommel F, 2015, HEPATOLOGY, V61, P66, DOI 10.1002/hep.27381; van der Kuyl AC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-540; Vlasenok M, 2017, DATA BRIEF, V11, P258, DOI 10.1016/j.dib.2017.02.023; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Ward H, 2016, FUTURE MICROBIOL, V11, P1581, DOI 10.2217/fmb-2016-0128; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432; Yang HC, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.64; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015; Zoulim F, 2016, CURR OPIN VIROL, V18, P109, DOI 10.1016/j.coviro.2016.06.004	94	5	5	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100589	10.1016/j.jbc.2021.100589	http://dx.doi.org/10.1016/j.jbc.2021.100589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774051	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400561
J	Zhong, BR; Zhou, GF; Song, L; Wen, QX; Deng, XJ; Ma, YL; Hu, LT; Chen, GJ				Zhong, Bi-Rou; Zhou, Gui-Feng; Song, Li; Wen, Qi-Xin; Deng, Xiao-Juan; Ma, Yuan-Lin; Hu, Li-Tian; Chen, Guo-Jun			TUFM is involved in Alzheimer's disease-like pathologies that are associated with ROS	FASEB JOURNAL			English	Article						apoptosis; BACE1 translation; beta-amyloid protein; RNA stability; ROS; Tau; TUFM	KAPPA-B; TRANSLATIONAL REGULATION; COGNITIVE DECLINE; BACE1; EXPRESSION; ELONGATION; INHIBITION; MUTATION; PROTEIN; BETA	Mitochondrial Tu translation elongation factor (TUFM or EF-Tu) is part of the mitochondrial translation machinery. It is reported that TUFM expression is reduced in the brain of Alzheimer's disease (AD), suggesting that TUFM might play a role in the pathophysiology. In this study, we found that TUFM protein level was decreased in the hippocampus and cortex especially in the aged APP/PS1 mice, an animal model of AD. In HEK cells that stably express full-length human amyloid-beta precursor protein (HEK-APP), TUFM knockdown or overexpression increased or reduced the protein levels of beta-amyloid protein (A beta) and beta-amyloid converting enzyme 1 (BACE1), respectively. TUFM-mediated reduction of BACE1 was attenuated by translation inhibitor cycloheximide (CHX) or alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl] hydrazinylidene]-2-nitro-benzenepropanoic acid (4EGI1), and in cells overexpressing BACE1 constructs deleting the 5' untranslated region (5'UTR). TUFM silencing increased the half-life of BACE1 mRNA, suggesting that RNA stability was affected by TUFM. In support, transcription inhibitor Actinomycin D (ActD) and silencing of nuclear factor kappa B (NF kappa B) failed to abolish TUFM-mediated regulation of BACE1 protein and mRNA. We further found that the mitochondria-targeted antioxidant TEMPO diminished the effects of TUFM on BACE1, suggesting that reactive oxygen species (ROS) played an important role. Indeed, cellular ROS levels were affected by TUFM knockdown or overexpression, and TUFM-mediated regulation of apoptosis and Tau phosphorylation at selective sites was attenuated by TEMPO. Collectively, TUFM protein levels were decreased in APP/PS1 mice. TUFM is involved in AD pathology by regulating BACE1 translation, apoptosis, and Tau phosphorylation, in which ROS plays an important role.	[Zhong, Bi-Rou; Zhou, Gui-Feng; Song, Li; Wen, Qi-Xin; Deng, Xiao-Juan; Ma, Yuan-Lin; Hu, Li-Tian; Chen, Guo-Jun] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Hu, Li-Tian] Nanchong Cent Hosp, Dept Neurol, North Sichuan Med Coll, Clin Coll 2, Nanchong, Peoples R China	Chongqing Medical University; North Sichuan Medical University	Chen, GJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, 1 Youyi Rd, Chongqing 400016, Peoples R China.	woodchen2015@163.com		Chen, Guo-Jun/0000-0001-8148-9810	National Key R&D Program of China [2018YFC1314700]; NSFC [81971030]; Chongqing Science and Technology Commission [cstc2018jcyjAX0067]; Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government [18SXHZ0184]; Scientific Research Development Project of North Sichuan Medical College [CBY17-A-ZD03]; Sichuan Provincial Health and Family Planning Commission [18PJ335]	National Key R&D Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government; Scientific Research Development Project of North Sichuan Medical College; Sichuan Provincial Health and Family Planning Commission	National Key R&D Program of China, Grant/Award Number: 2018YFC1314700; NSFC, Grant/Award Number: 81971030; Chongqing Science and Technology Commission, Grant/Award Number: cstc2018jcyjAX0067; The Strategic Science & Technology Cooperation Project of North Sichuan Medical College; Nanchong Municipal Government, Grant/Award Number: 18SXHZ0184; Scientific Research Development Project of North Sichuan Medical College, Grant/Award Number: CBY17-A-ZD03; Sichuan Provincial Health and Family Planning Commission, Grant/Award Number: 18PJ335	Bilkei-Gorzo A, 2014, PHARMACOL THERAPEUT, V142, P244, DOI 10.1016/j.pharmthera.2013.12.009; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Cieslik M, 2020, MOL NEUROBIOL, V57, P1374, DOI 10.1007/s12035-019-01819-y; Dai CL, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0341-7; Di Nottia M, 2017, BBA-MOL BASIS DIS, V1863, P961, DOI 10.1016/j.bbadis.2017.01.022; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; He K, 2016, CELL MOL LIFE SCI, V73, P2105, DOI 10.1007/s00018-015-2122-9; Hershkovitz T, 2019, J HUM GENET, V64, P589, DOI 10.1038/s10038-019-0592-6; Imbimbo BP, 2019, EXPERT OPIN INV DRUG, V28, P967, DOI 10.1080/13543784.2019.1683160; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Labno A, 2016, BBA-MOL CELL RES, V1863, P3125, DOI 10.1016/j.bbamcr.2016.09.023; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; May PC, 2015, J NEUROSCI, V35, P1199, DOI 10.1523/JNEUROSCI.4129-14.2015; Min Z, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00198; Mitsunaga M, 2007, WORLD J GASTROENTERO, V13, P692, DOI 10.3748/wjg.v13.i5.692; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mori K, 2019, FEBS J, V286, P459, DOI 10.1111/febs.14671; Mostafavi S, 2018, NAT NEUROSCI, V21, P811, DOI 10.1038/s41593-018-0154-9; Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Tang Y, 2018, EXP NEUROL, V305, P89, DOI 10.1016/j.expneurol.2018.04.003; Thangavelu B, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00915; Thiadens KAMH, 2015, BIOCHEM SOC T, V43, P343, DOI 10.1042/BST20150009; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Wang J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00918-y; Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang YP, 2004, CELL RES, V14, P467, DOI 10.1038/sj.cr.7290249; Weller Jason, 2018, F1000Res, V7, DOI 10.12688/f1000research.14506.1; Weng XY, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12113; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wingo AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09613-z; Xiang XJ, 2019, EXP NEUROL, V318, P145, DOI 10.1016/j.expneurol.2019.05.006; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yang J, 2019, J MOL NEUROSCI, V69, P608, DOI 10.1007/s12031-019-01389-7; Yu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04389-0; Zeng T, 2019, J CHEM NEUROANAT, V98, P87, DOI 10.1016/j.jchemneu.2019.04.001; Zhu BL, 2019, BRAIN, V142, P176, DOI 10.1093/brain/awy305; Zhu BL, 2016, J NEUROL SCI, V360, P30, DOI 10.1016/j.jns.2015.11.041; Zottel A, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920915302; Zuo L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/604658	62	2	2	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21445	10.1096/fj.202002461R	http://dx.doi.org/10.1096/fj.202002461R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774866				2022-12-26	WOS:000645260100059
J	Hao, TS; Zhang, CX; Wang, ZQ; Buck, A; Vonderfecht, SL; Ermel, R; Kim, Y; Chen, WY				Hao, Taisen; Zhang, Chunxiao; Wang, Zhiqiang; Buck, Alison; Vonderfecht, Steven L.; Ermel, Richard; Kim, Young; Chen, WenYong			An aging mouse model of human chronic myeloid leukemia	ONCOGENE			English	Article								Chronic myeloid leukemia (CML) is an age-dependent blood malignancy. Like many other age-dependent human diseases, laboratory animal research of CML uses young mice that do not factor in the influence of aging. To understand how aging may impact animal modeling of human age-dependent diseases, we established the first aging mouse model of human CML in BALB/c mice in the advanced age defined by 75% survival. This model was developed by noncytotoxic depletion of bone marrow lineage-positive cells followed by BCR-ABL retroviral transduction and transplantation. CML developed in aging mice shared many similarities to that in young mice, but had increased incidence of anemia that is often seen in human CML. Importantly, we showed that aging of both donor hematopoietic stem cells and recipient bone marrow niche impacted BCR-ABL mediated leukemogenesis and leukemia spectrum. Optimal CML induction relied on age-matching for donors and recipients, and cross-transplantation between young and old mice produced a mixture of different leukemia. Therefore, our model provides initial evidence of the feasibility and merit of CML modeling in aging mice and offers a new tool for future studies of CML stem cell drug resistance and therapeutic intervention in which aging would be taken into consideration as an influencing factor.	[Hao, Taisen; Zhang, Chunxiao; Wang, Zhiqiang; Chen, WenYong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Buck, Alison] City Hope Natl Med Ctr, Eugene & Ruth Roberts Summer Student Acad, Duarte, CA USA; [Vonderfecht, Steven L.] Vet Pathol, Reno, NV USA; [Ermel, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Ctr Comparat Med, Duarte, CA USA; [Kim, Young] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Chen, WY (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	wechen@coh.org		Zhang, Chunxiao/0000-0001-5543-4509; Chen, WenYong/0000-0001-6913-5729	NIH National Cancer Institute and National Institute of Aging [UH2/3 CA213385]; NIH Office of the Director [3UH3CA213385-05S1]; City of Hope Center for Cancer and Aging; Norton Basic Research Fund; National Cancer Institute [P30CA33572]	NIH National Cancer Institute and National Institute of Aging; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope Center for Cancer and Aging; Norton Basic Research Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants UH2/3 CA213385 (co-sponsored by NIH National Cancer Institute and National Institute of Aging) and 3UH3CA213385-05S1 (sponsored by NIH Office of the Director), as well as institutional grants from the City of Hope Center for Cancer and Aging, and Norton Basic Research Fund to WYC. Research reported in this publication included work performed in the Animal Resources Center and Flow Cytometry Core supported by the National Cancer Institute under the award P30CA33572. The content is solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Alexander TB, 2018, NATURE, V562, P373, DOI 10.1038/s41586-018-0436-0; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Brubaker AL, 2013, J IMMUNOL, V190, P1746, DOI 10.4049/jimmunol.1201213; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; de Haan G, 2018, BLOOD, V131, P479, DOI 10.1182/blood-2017-06-746412; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Dell Ralph B, 2002, ILAR J, V43, P207; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Duarte D, 2018, BLOOD, V131, P1507, DOI 10.1182/blood-2017-12-784132; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hamamyh T, 2020, PHARMACOLOGY, V105, P630, DOI 10.1159/000507295; Hao T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48445-1; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Helbling PM, 2019, CELL REP, V29, P3313, DOI 10.1016/j.celrep.2019.11.004; Ho YH, 2020, HAEMATOLOGICA, V105, P38, DOI 10.3324/haematol.2018.211334; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Hsieh MY, 2014, BLOOD, V123, P2401, DOI 10.1182/blood-2014-01-547943; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; Ko PS, 2017, CURR MED RES OPIN, V33, P1737, DOI 10.1080/03007995.2017.1356708; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Liu ZY, 2020, HEMATOLOGY, V25, P181, DOI 10.1080/16078454.2020.1765563; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Moura MS, 2019, HEMATOL TRANSF CELL, V41, P329, DOI 10.1016/j.htct.2019.03.006; Nowell PC, 2007, J CLIN INVEST, V117, P2033, DOI 10.1172/JCI31771; Oyekunle AA, 2016, CLIN MED INSIGHTS-BL, V9, P9, DOI 10.4137/CMBD.S31562; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pophali PA, 2016, CANCER J, V22, P40, DOI 10.1097/PPO.0000000000000165; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1980, CLIN HAEMATOL, V9, P55; Smith, 2007, MOUSE BIOMEDICAL RES, P623, DOI [10.1016/B978-012369454-6/50053-4, DOI 10.1016/B978-012369454-6/50053-4)]; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang XF, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0574-7; Wang ZQ, 2015, STEM CELLS, V33, P3437, DOI 10.1002/stem.2218; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Wolach O, 2015, BLOOD, V125, P2477, DOI 10.1182/blood-2014-10-551465; Wolff NC, 2005, BLOOD, V105, P3995, DOI 10.1182/blood-2004-09-3534; Wolff NC, 2001, BLOOD, V98, P2808, DOI 10.1182/blood.V98.9.2808; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	56	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3152	3163		10.1038/s41388-021-01770-0	http://dx.doi.org/10.1038/s41388-021-01770-0		APR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33824471	Green Accepted			2022-12-26	WOS:000637478800002
J	Faye, M; Deme, A; Diongue, AK; Diouf, I				Faye, Mbaye; Deme, Abdoulaye; Diongue, Abdou Ka; Diouf, Ibrahima			Impact of different heat wave definitions on daily mortality in Bandafassi, Senegal	PLOS ONE			English	Article							TEMPERATURE EXTREMES; AIR-TEMPERATURE; TIME-SERIES; PATTERNS; CLIMATE; SUMMER; CHINA; AREA	Objective The aim of this study is to find the most suitable heat wave definition among 15 different ones and to evaluate its impact on total, age-, and gender-specific mortality for Bandafassi, Senegal. Methods Daily weather station data were obtained from Kedougou situated at 17 km from Bandafassi from 1973 to 2012. Poisson generalized additive model (GAM) and distributed lag non-linear model (DLNM) are used to investigate the effect of heat wave on mortality and to evaluate the nonlinear association of heat wave definitions at different lag days, respectively. Results Heat wave definitions, based on three or more consecutive days with both daily minimum and maximum temperatures greater than the 90(th) percentile, provided the best model fit. A statistically significant increase in the relative risk (RRs 1.4 (95% Confidence Interval (CI): 1.2-1.6), 1.7 (95% CI: 1.5-1.9), 1.21 (95% CI: 1.08-1.3), 1.2 (95% CI: 1.04-1.5), 1.5 (95% CI: 1.3-1.8), 1.4 (95% CI: 1.2-1.5), 1.5 (95% CI: 1.07-1.6), and 1.5 (95% CI: 1.3-1.8)) of total mortality was observed for eight definitions. By using the definition based on the 90(th) percentile of minimum and maximum temperature with a 3-day duration, we also found that females and people aged >= 55 years old were at higher risks than males and other different age groups to heat wave related mortality. Conclusion The impact of heat waves was associated with total-, age-, gender-mortality. These results are expected to be useful for decision makers who conceive of public health policies in Senegal and elsewhere. Climate parameters, including temperatures and humidity, could be used to forecast heat wave risks as an early warning system in the area where we conduct this research. More broadly, our findings should be highly beneficial to climate services, researchers, clinicians, end-users and decision-makers.	[Faye, Mbaye; Diongue, Abdou Ka] Univ Gaston Berger St Louis, LERSTAD UFR Sci Appl & Technol, St Louis, Senegal; [Deme, Abdoulaye] Univ Gaston Berger St Louis, LSAO UFR Sci Appl & Technol, St Louis, Senegal; [Diouf, Ibrahima] NOAA, Ctr Weather & Climate Predict, Climate Predict Ctr, College Pk, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA	Faye, M (corresponding author), Univ Gaston Berger St Louis, LERSTAD UFR Sci Appl & Technol, St Louis, Senegal.	faye.mbaye@ugb.edu.sn		Faye, Mbaye/0000-0002-0558-4629; Diouf, Dr. Ibrahima/0000-0002-3157-0925	ACASIS project [ANR-13-SENV-0007]	ACASIS project	This research was funded by ACASIS project (http://www.agence-nationale-recherche.fr/Projet-ANR-13-SENV-0007).ACASIS project had access to the Bandafassi Health and Demographic Surveillance System (HDSS) and provided us daily mortality count data, but had no other role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatan AA, 2019, THEOR APPL CLIMATOL, V137, P2077, DOI 10.1007/s00704-018-2713-0; Ahmadnezhad E, 2013, J RES HEALTH SCI, V13, P24; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Azhar GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091831; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basara JB, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/230365; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Can G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224348; Chau PH, 2009, INT J BIOMETEOROL, V53, P461, DOI 10.1007/s00484-009-0232-5; Chen K, 2015, SCI TOTAL ENVIRON, V506, P18, DOI 10.1016/j.scitotenv.2014.10.092; Collier P, 2008, OXFORD REV ECON POL, V24, P337, DOI 10.1093/oxrep/grn019; Cornforth R, 2019, B AM METEOROL SOC, V100, P2343, DOI 10.1175/BAMS-D-16-0273.1; Diouf I, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101119; Dong WT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090933; Fischer EM, 2010, NAT GEOSCI, V3, P398, DOI 10.1038/NGEO866; Fontaine B, 2013, J GEOPHYS RES-ATMOS, V118, P8536, DOI 10.1002/jgrd.50667; Gao JH, 2015, SCI TOTAL ENVIRON, V505, P535, DOI 10.1016/j.scitotenv.2014.10.028; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Gershunov A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052979; Guo YM, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1026; Habeeb D, 2015, NAT HAZARDS, V76, P1651, DOI 10.1007/s11069-014-1563-z; Ishigami A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-5; Khan N, 2020, ATMOS RES, V233, DOI 10.1016/j.atmosres.2019.104688; Khan N, 2019, ATMOS RES, V221, P1, DOI 10.1016/j.atmosres.2019.01.024; Khan N, 2019, STOCH ENV RES RISK A, V33, P287, DOI 10.1007/s00477-018-1605-2; Khan N, 2019, THEOR APPL CLIMATOL, V136, P899, DOI 10.1007/s00704-018-2520-7; Kysely J, 2009, CLIM RES, V38, P105, DOI 10.3354/cr00775; Lee WK, 2016, INT J BIOMETEOROL, V60, P719, DOI 10.1007/s00484-015-1067-x; Li Y, 2017, J METEOROL RES-PRC, V31, P455, DOI 10.1007/s13351-017-6150-2; Ma WJ, 2015, ENVIRON INT, V75, P103, DOI 10.1016/j.envint.2014.11.004; McGregor G.R., 2015, HEATWAVES HLTH GUIDA; Morabito M, 2012, SCI TOTAL ENVIRON, V441, P28, DOI 10.1016/j.scitotenv.2012.09.056; Moron V, 2016, J GEOPHYS RES-ATMOS, V121, P5298, DOI 10.1002/2015JD024303; Muggeo VM, 2009, OCCUP ENVIRON MED, V66, P584, DOI 10.1136/oem.2007.038653; Muggeo VMR, 2010, J STAT SOFTW, V32, P1; Mutiibwa D, 2015, J GEOPHYS RES-ATMOS, V120, P7378, DOI 10.1002/2015JD023598; Percic S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010173; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Perkins SE, 2015, ATMOS RES, V164, P242, DOI 10.1016/j.atmosres.2015.05.014; PISON G, 1985, Population Studies, V39, P387, DOI 10.1080/0032472031000141586; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; Schoetter R, 2015, CLIM DYNAM, V45, P1601, DOI 10.1007/s00382-014-2434-8; Seposo XT, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1368969; Serdeczny O, 2017, REG ENVIRON CHANGE, V17, P1585, DOI 10.1007/s10113-015-0910-2; Shiva JS, 2019, EARTHS FUTURE, V7, P300, DOI 10.1029/2018EF001085; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Son JY, 2012, ENVIRON HEALTH PERSP, V120, P566, DOI 10.1289/ehp.1103759; Stefanon M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014023; Sun XM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-76; Sun XM, 2014, SCI TOTAL ENVIRON, V493, P789, DOI 10.1016/j.scitotenv.2014.06.042; Tian ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077321; Tibshirani R, 1990, GEN ADDITIVE MODEL; Tong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037500; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wichmann J, 2017, SCI TOTAL ENVIRON, V587, P266, DOI 10.1016/j.scitotenv.2017.02.135; Wilson LA, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-98; Xu ZW, 2016, ENVIRON INT, V89-90, P193, DOI 10.1016/j.envint.2016.02.007; Xu ZW, 2014, INT J BIOMETEOROL, V58, P239, DOI 10.1007/s00484-013-0655-x; Zeng WL, 2014, SCI TOTAL ENVIRON, V482, P214, DOI 10.1016/j.scitotenv.2014.02.049; Zhang Yunquan, 2017, Glob Health Res Policy, V2, P10, DOI 10.1186/s41256-017-0030-2	69	8	8	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249199	10.1371/journal.pone.0249199	http://dx.doi.org/10.1371/journal.pone.0249199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819272	gold, Green Published			2022-12-26	WOS:000637647200036
J	Raza, MT; Mizan, S; Yasmin, F; Akash, AS; Shahik, SM				Raza, Md Thosif; Mizan, Shagufta; Yasmin, Farhana; Akash, Al-Shahriar; Shahik, Shah Md			Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1)	PLOS ONE			English	Article							CELL LEUKEMIA-LYMPHOMA; BLOOD MONONUCLEAR-CELLS; STRUCTURE PREDICTION; PROTEIN-STRUCTURE; TYPE-1 HTLV-1; TAX GENE; ENVELOPE GLYCOPROTEINS; TRANSCRIPTION FACTORS; HEPARAN-SULFATE; MESSENGER-RNA	Human T-cell leukemia virus type 1 (HTLV-1) was the first oncogenic human retrovirus identified in humans which infects at least 10-15 million people worldwide. Large HTLV-1 endemic areas exist in Southern Japan, the Caribbean, Central and South America, the Middle East, Melanesia, and equatorial regions of Africa. HTLV-1 TAX viral protein is thought to play a critical role in HTLV-1 associated diseases. We have used numerous bio-informatics and immuno-informatics implements comprising sequence and construction tools for the construction of a 3D model and epitope prediction for HTLV-1 Tax viral protein. The conformational linear B-cell and T-cell epitopes for HTLV-1 TAX viral protein have been predicted for their possible collective use as vaccine candidates. Based on in silico investigation two B cell epitopes, KEADDNDHEPQISPGGLEPPSEKHFR and DGTPMISGPCPKDGQPS spanning from 324-349 and 252-268 respectively; and T cell epitopes, LLFGYPVYV, ITWPLLPHV and GLLPFHSTL ranging from 11-19, 163-171 and 233-241 were found most antigenic and immunogenic epitopes. Among different vaccine constructs generated by different combinations of these epitopes our predicted vaccine construct was found to be most antigenic with a score of 0.57. T cell epitopes interacted strongly with HLA-A*0201 suggesting a significant immune response evoked by these epitopes. Molecular docking study also showed a high binding affinity of the vaccine construct for TLR4. The study was carried out to predict antigenic determinants of the Tax protein along with the 3D protein modeling. The study revealed a potential multi epitope vaccine that can raise the desired immune response against HTLV-1 and be useful in developing effective vaccines against Human T-lymphotropic virus.	[Raza, Md Thosif; Mizan, Shagufta; Yasmin, Farhana; Akash, Al-Shahriar] Univ Chittagong, Fac Biol Sci, Dept Genet Engn & Biotechnol, Chattogram, Bangladesh; [Shahik, Shah Md] Dis Biol & Mol Epidemiol Res Grp, Bioinformat Div, Chattogram, Bangladesh; [Shahik, Shah Md] AFC Agro Biotech Ltd, Mol Biol Dept, Dhahka, Bangladesh	University of Chittagong	Shahik, SM (corresponding author), Dis Biol & Mol Epidemiol Res Grp, Bioinformat Div, Chattogram, Bangladesh.; Shahik, SM (corresponding author), AFC Agro Biotech Ltd, Mol Biol Dept, Dhahka, Bangladesh.	sm.shahik@gmail.com		Mizan, Shagufta/0000-0002-4958-2537; Shahik, Shah Md./0000-0002-1433-5085; Akash, Al-Shahriar/0000-0003-0680-1936				Adhikari UK, 2017, INFECT GENET EVOL, V56, P75, DOI 10.1016/j.meegid.2017.10.022; Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Araujo AQC, 2006, LANCET NEUROL, V5, P1068, DOI 10.1016/S1474-4422(06)70628-7; Asquith B, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-75; Bartoe JT, 2000, J VIROL, V74, P1094, DOI 10.1128/JVI.74.3.1094-1100.2000; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bhattacharya D, 2016, NUCLEIC ACIDS RES, V44, pW406, DOI 10.1093/nar/gkw336; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Choi ES, 2015, BIOTECHNOL LETT, V37, P627, DOI 10.1007/s10529-014-1731-y; Clerc I, 2008, J BIOL CHEM, V283, P23903, DOI 10.1074/jbc.M803116200; Collins ND, 1998, BLOOD, V91, P4701, DOI 10.1182/blood.V91.12.4701.412k23_4701_4707; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Courgnaud V, 2004, J VIROL, V78, P4700, DOI 10.1128/JVI.78.9.4700-4709.2004; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Cruz BA, 2006, J RHEUMATOL, V33, P2300; Delamarre L, 1996, J ACQ IMMUN DEF SYND, V13, pS85, DOI 10.1097/00042560-199600001-00015; Derse D, 1997, VIROLOGY, V237, P123, DOI 10.1006/viro.1997.8781; Dimitrov I, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2278-5; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Enose-Akahata Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02563; Forlani G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00819; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GESSAIN A, 1991, J VIROL, V65, P1628, DOI 10.1128/JVI.65.3.1628-1633.1991; Gessain A, 2000, B SOC PATHOL EXOT, V93, P163; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Goon PKC, 2004, CLIN EXP IMMUNOL, V137, P234, DOI 10.1111/j.1365-2249.2004.02524.x; GOUBAU P, 1994, P NATL ACAD SCI USA, V91, P2848, DOI 10.1073/pnas.91.7.2848; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073/pnas.86.9.3351; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; HORAL P, 1991, P NATL ACAD SCI USA, V88, P5754, DOI 10.1073/pnas.88.13.5754; Hossein MU, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00246; Hyun J, 2015, J VIROL, V89, P4880, DOI 10.1128/JVI.02493-14; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Jin QW, 2006, VIROLOGY, V349, P184, DOI 10.1016/j.virol.2006.01.045; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; Kannagi M, 2019, RETROVIROLOGY, V16, DOI 10.1186/s12977-019-0484-z; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khatoon N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08842-w; Kimura I, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P787; KINOSHITA K, 1985, BLOOD, V66, P120; KINOSHITA K, 1982, GANN, V73, P684; KINOSHITA T, 1989, P NATL ACAD SCI USA, V86, P5620, DOI 10.1073/pnas.86.14.5620; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAIRMORE MD, 1992, CANCER LETT, V66, P11, DOI 10.1016/0304-3835(92)90274-Y; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P3856, DOI 10.1073/pnas.81.12.3856; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998; MATSUMOTO M, 1979, JPN J CLIN ONCOL, V9, P325; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meertens L, 2002, J VIROL, V76, P259, DOI 10.1128/JVI.76.1.259-268.2002; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Mota-Miranda ACA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-75; Nagpal G, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1560-1; NAKAO K, 1991, BRIT J OPHTHALMOL, V75, P76, DOI 10.1136/bjo.75.2.76; NAM SH, 1988, J VIROL, V62, P3718, DOI 10.1128/JVI.62.10.3718-3728.1988; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015; PAINE E, 1994, VIROLOGY, V199, P331, DOI 10.1006/viro.1994.1131; Palatnik-de-Sousa CB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00826; PALKER TJ, 1989, J IMMUNOL, V142, P971; Patwary NIA, 2016, BIOMED J, V39, P382, DOI 10.1016/j.bj.2016.11.004; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; PIQUE C, 1990, EMBO J, V9, P4243, DOI 10.1002/j.1460-2075.1990.tb07872.x; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rosenberg AR, 1998, J VIROL, V72, P7609, DOI 10.1128/JVI.72.9.7609-7614.1998; Ross TM, 1996, J VIROL, V70, P5194, DOI 10.1128/JVI.70.8.5194-5202.1996; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996; Salemi M, 2000, MOL BIOL EVOL, V17, P374, DOI 10.1093/oxfordjournals.molbev.a026317; Salemi M, 1999, AIDS REV, V1, P131; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Seki M, 1990, Virus Genes, V3, P235, DOI 10.1007/BF00393183; Shey RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40833-x; Slattery JP, 1999, GENOME RES, V9, P525; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Suemori K, 2009, J GEN VIROL, V90, P1806, DOI 10.1099/vir.0.010199-0; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Dooren S, 2004, J GEN VIROL, V85, P507, DOI 10.1099/vir.0.19630-0; van Montfoort N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00182; Van Regenmortel MH, 2019, INHIV AIDS IMMUNOCHE; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785; YAMAOKA S, 1992, ONCOGENE, V7, P433; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yokota S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/184328; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zavodszky M, 2001, PROTEIN SCI, V10, P149, DOI 10.1110/ps.26801	128	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248001	10.1371/journal.pone.0248001	http://dx.doi.org/10.1371/journal.pone.0248001			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798232	Green Published, gold			2022-12-26	WOS:000636737700026
J	Williams, VL; Coals, PG; de Bruyn, M; Naude, VN; Dalton, DL; Kotze, A				Williams, Vivienne L.; Coals, Peter G.; de Bruyn, Marli; Naude, Vincent N.; Dalton, Desire L.; Kotze, Antoinette			Monitoring compliance of CITES lion bone exports from South Africa	PLOS ONE			English	Article							POPULATION-STRUCTURE; PROGRAM; IDENTIFICATION; CONSERVATION; INFERENCE; LOCI; GENE	From 2008 to 2018, South Africa permitted the export of captive-bred African lion (Panthera leo) skeletons to Southeast Asia under CITES Appendix II. Legal exports rose from approximately 50 individuals in 2008 to a maximum of 1,771 skeletons in 2016, and has led to ongoing concerns over possible laundering of non-lion, multiple-source and wild-sourced bones. South Africa is required under its obligations to CITES to employ mechanisms for monitoring and reporting trade, and to limit the potential for illegal trade and laundering of lion and other large felid bones. Monitoring tools for legal trade are critical to compliance with CITES. Here we evaluate the CITES-compliance procedure implemented by South Africa for export of lion bones and identify six essential general points for consideration in the implementation of animal export quota compliance protocols. We provide specific insight into the South African lion bone export monitoring system through: i) outlining the protocols followed; ii) assessing the utility of cranial morphology to identify species; iii) evaluating skeleton consignment weight as a monitoring tool; and iv) presenting molecular (DNA) species assignment and pairwise-comparative sample matching of individuals. We describe irregularities and illicit behaviour detected in the 2017 and 2018 lion bone quotas. Notably, we report that the compliance procedure successfully identified and prevented the attempted laundering of a tiger (P. tigris) skeleton in 2018. We emphasise the utility of mixed-method protocols for the monitoring of compliance in CITES Appendix II export quota systems.	[Williams, Vivienne L.; Coals, Peter G.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Williams, Vivienne L.; Coals, Peter G.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [de Bruyn, Marli; Dalton, Desire L.; Kotze, Antoinette] South African Natl Biodivers Inst, Pretoria, South Africa; [Naude, Vincent N.] Univ Cape Town, Inst Communities & Wildlife Africa, Cape Town, South Africa; [Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, South Africa	University of Witwatersrand; University of Oxford; South African National Biodiversity Institute; University of Cape Town; University of the Free State	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.; Williams, VL (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England.	vivienne.williams@wits.ac.za	Williams, Vivienne Linda/M-1453-2019; Naude, Vincent Norman/ABC-5454-2021	Williams, Vivienne Linda/0000-0003-0698-6512; Naude, Vincent Norman/0000-0002-0275-1727; Coals, Peter/0000-0002-1735-5487; Dalton, Desire Lee/0000-0001-5975-6425	Africa Oxford (AfOx) Collaboration Fellowship programme in 2019	Africa Oxford (AfOx) Collaboration Fellowship programme in 2019	VW acknowledges the Africa Oxford (AfOx) Collaboration Fellowship programme in 2019, supported at All Souls College, and hosted by the Wildlife Conservation Research Unit (WildCRU), for funding and facilities to prepare this manuscript at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2020, CITES, DOI [10.1007/s10991-020-09267-8, DOI 10.1007/S10991-020-09267-8]; Bauer H., 2016, CAT NEWS, V64; Bauer H, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12444; CITES, 2016, 17 M C PART; CITES, 2009, MAN NAT EST EXP QUOT; Coals P, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11185085; Coals P, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9020052; Conrad K, 2012, TROP CONSERV SCI, V5, P245, DOI 10.1177/194008291200500302; Dalton DL, 2020, CONSERV GENET RESOUR, V12, P29, DOI 10.1007/s12686-018-1060-x; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; DeSalle R, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00302; Falush D, 2003, GENETICS, V164, P1567; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MenottiRaymond M, 1997, J FORENSIC SCI, V42, P1039; Miller SM, 2014, S AFR J WILDL RES, V44, P43, DOI 10.3957/056.044.0107; Ogden Rob, 2010, Endangered Species Research, V9, P179, DOI 10.3354/esr00144; Parson W, 2000, INT J LEGAL MED, V114, P23, DOI 10.1007/s004140000134; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phillips JD, 2019, ECOL EVOL, V9, P2996, DOI 10.1002/ece3.4757; Pickover M., 2019, LION BONE QUOTA; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Williams VL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217409; Williams VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185996; Williams VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135144; Williams VL., 2015, BONES CONTENTION ASS; Zhang WP, 2006, J GENET, V85, P107, DOI 10.1007/BF02729016	38	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249306	10.1371/journal.pone.0249306	http://dx.doi.org/10.1371/journal.pone.0249306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798210	Green Published, gold			2022-12-26	WOS:000636737700034
J	Fourniol, L; Madec, Y; Mousson, L; Vazeille, M; Failloux, AB				Fourniol, Lisa; Madec, Yoann; Mousson, Laurence; Vazeille, Marie; Failloux, Anna-Bella			A laboratory-based study to explore the use of honey-impregnated cards to detect chikungunya virus in mosquito saliva	PLOS ONE			English	Article								Mosquito control is implemented when arboviruses are detected in patients or in field-collected mosquitoes. However, mass screening of mosquitoes is usually laborious and expensive, requiring specialized expertise and equipment. Detection of virus in mosquito saliva using honey-impregnated filter papers seems to be a promising method as it is non-destructive and allows monitoring the viral excretion dynamics over time from the same mosquito. Here we test the use of filter papers to detect chikungunya virus in mosquito saliva in laboratory conditions, before proposing this method in large-scale mosquito surveillance programs. We found that 0.9 cm(2) cards impregnated with a 50% honey solution could replace the forced salivation technique as they offered a viral RNA detection until 7 days after oral infection of Aedes aegypti and Aedes albopictus mosquitoes with CHIKV.	[Fourniol, Lisa; Mousson, Laurence; Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors Unit, Paris, France; [Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Failloux, AB (corresponding author), Inst Pasteur, Arboviruses & Insect Vectors Unit, Paris, France.	anna-bella.failloux@pasteur.fr		FAILLOUX, Anna-Bella/0000-0001-6890-0820	European Union's Horizon 2020 research and innovation program under EVAg grant [653316]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62IBEID]	European Union's Horizon 2020 research and innovation program under EVAg grant; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	This study was supported by the European Union's Horizon 2020 research and innovation program under EVAg grant agreement no. 653316 (https://www.european-virus-archive.com/) and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62IBEID). The funders had no role in study design, data collection and interpretation, or decision to submit the work for publication.	Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741; Barredo E, 2020, TRENDS PARASITOL, V36, P473, DOI 10.1016/j.pt.2020.02.003; Calkins TL, 2017, J INSECT PHYSIOL, V103, P98, DOI 10.1016/j.jinsphys.2017.10.012; Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752; Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759; Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885; Gu WD, 2004, AM J TROP MED HYG, V71, P636, DOI 10.4269/ajtmh.2004.71.636; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237; Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lothrop HD, 2012, J MED ENTOMOL, V49, P1466, DOI 10.1603/ME12117; Moutailler S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100904; Omodior Oghenekaro, 2018, Prev Med Rep, V12, P336, DOI 10.1016/j.pmedr.2018.10.018; Ritchie SA, 2013, J MED ENTOMOL, V50, P185, DOI 10.1603/ME12112; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; van den Hurk AF, 2014, VECTOR-BORNE ZOONOT, V14, P66, DOI 10.1089/vbz.2013.1373; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249471	10.1371/journal.pone.0249471	http://dx.doi.org/10.1371/journal.pone.0249471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793656	Green Published, gold			2022-12-26	WOS:000636467000050
J	Sanchez, X; Orrico, M; Morillo, T; Manzano, A; Jimbo, R; Armijos, L				Sanchez, Xavier; Orrico, Maria; Morillo, Toa; Manzano, Andrea; Jimbo, Ruth; Armijos, Luciana			Reducing unnecessary antibiotic prescription through implementation of a clinical guideline on self-limiting respiratory tract infections	PLOS ONE			English	Article							PRIMARY-CARE; POPULATION; STRATEGIES; SETTINGS	Background Clinical guidelines (CG) are used to reduce variability in practice when the scientific evidence is sparse or when multiple therapies are available. The development and implementation of evidence-based CG is intended to organize and provide the best available evidence to support clinical decision making in order to improve quality of care. Upper respiratory tract infections (URTI) are the leading cause of misuse of antibiotics and a CG may reduce the unnecessary antibiotic prescription. Methods The aim of this quasi-experimental, before-after study was to analyze the short- and long-term effects of the implementation of a CG to decrease the rate of antibiotic prescription in URTI cases in the emergency department of a third level private hospital in Quito, Ecuador. The study included 444 patients with a main diagnosis of URTI. They were distributed in three groups: a baseline cohort 2011 (n = 114), a first post-implementation cohort 2011 (n = 114), and a later post-implementation cohort 2018 (n = 216). The implementation strategy consisted of five key steps: acceptance of the need for implementation of the CG, dissemination of the CG, an educational campaign, constant feedback, and sustainability of the strategy through continuous training. Results The results of this study show a 42.90% of antibiotic prescription rate before the CG implementation. After the implementation of the CG, the prescription rate of antibiotics was significantly reduced by 24.5% (42.9% vs 18.4%, p<0.0001) and the appropriate antibiotic prescription rate was significantly increased by 44.2% (22.4% vs 66.6%, p<0.0001) in the first post-implementation cohort 2011. There was not a significant difference in antibiotic prescription rate and appropriate antibiotic prescription rate between two post-implementation cohorts: 18.4% vs 25.9% (p = 0.125) and 66.6% vs 50% (p = 0.191), respectively. Conclusions The implementation of CGs decreases the rate of antibiotic prescription in URTI cases. The results are remarkable after early implementation, but the effect persists over time. The emphasis must shift from guideline development to strategy implementation.	[Sanchez, Xavier; Jimbo, Ruth] Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, Quito, Ecuador; [Sanchez, Xavier; Orrico, Maria; Morillo, Toa; Manzano, Andrea; Jimbo, Ruth; Armijos, Luciana] Pontificia Univ Catolica Ecuador, Postgrad Med Familiar & Comunitaria, Fac Med, Quito, Ecuador; [Sanchez, Xavier; Jimbo, Ruth] Univ Alcala Henares, Madrid, Spain; [Sanchez, Xavier] Pontificia Univ Catolica Ecuador, Fac Med, Quito, Ecuador; [Jimbo, Ruth] Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, Quito, Ecuador	Pontificia Universidad Catolica del Ecuador; Pontificia Universidad Catolica del Ecuador; Universidad de Alcala; Pontificia Universidad Catolica del Ecuador; Pontificia Universidad Catolica del Ecuador	Sanchez, X (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, Quito, Ecuador.; Sanchez, X (corresponding author), Pontificia Univ Catolica Ecuador, Postgrad Med Familiar & Comunitaria, Fac Med, Quito, Ecuador.; Sanchez, X (corresponding author), Univ Alcala Henares, Madrid, Spain.; Sanchez, X (corresponding author), Pontificia Univ Catolica Ecuador, Fac Med, Quito, Ecuador.	xavier.sanchez.c@gmail.com	Jimbo Sotomayor, Ruth/AHA-5476-2022	Jimbo Sotomayor, Ruth/0000-0001-5016-3834; Sanchez, Xavier/0000-0002-8258-8746				[Anonymous], 2002, PROMOTING RATIONAL U; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bagger K, 2015, EUR J GEN PRACT, V21, P118, DOI 10.3109/13814788.2014.1001361; Blumenthal KG, 2015, ANN ALLERG ASTHMA IM, V115, P294, DOI 10.1016/j.anai.2015.05.011; Boonacker CWB, 2010, INT J PEDIATR OTORHI, V74, P1113, DOI 10.1016/j.ijporl.2010.07.008; Butt AA, 2017, INT J INFECT DIS, V55, P20, DOI 10.1016/j.ijid.2016.12.004; Cordoba G, 2017, J ANTIMICROB CHEMOTH, V72, P305, DOI 10.1093/jac/dkw370; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; DeVries TPG, 1994, FRESLE DAAP EDHOED M; Doubova SV, 2015, B MED HOSP INFANT M, V72, P235, DOI 10.1016/j.bmhimx.2015.07.003; Durkin MJ, 2018, INFECT CONT HOSP EP, V39, P584, DOI 10.1017/ice.2018.26; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Gill JM, 2006, FAM MED, V38, P349; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Grimshaw Jeremy M, 2012, Proc Am Thorac Soc, V9, P298, DOI 10.1513/pats.201208-066ST; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Johnson DP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1630; Juzych NS, 2005, J GEN INTERN MED, V20, P901, DOI 10.1111/j.1525-1497.2005.0198.x; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kourlaba G, 2016, EUROSURVEILLANCE, V21, P20, DOI 10.2807/1560-7917.ES.2016.21.26.30266; Le JV, 2015, FAM PRACT, V32, P681, DOI 10.1093/fampra/cmv061; Le JV, 2017, DAN MED J, V64; Lee TH, 2017, BRIT J GEN PRACT, V67, pE168, DOI 10.3399/bjgp17X688885; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x; Malesker MA, 2017, CHEST, V152, P1021, DOI 10.1016/j.chest.2017.08.009; McKay R, 2016, ANTIMICROB AGENTS CH, V60, P4106, DOI 10.1128/AAC.00209-16; Monto AS, 2002, AM J MED, V112, p4S; Morgan SG, 2016, AGE AGEING, V45, P535, DOI 10.1093/ageing/afw074; Mortazhejri S, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01359-w; National Institute for Health and Care Excellence (NICE), 2008, SELF LIM RESP TRACT; O'Connor MN, 2012, DRUG AGING, V29, P437, DOI 10.2165/11632610-000000000-00000; Parikh K, 2014, PEDIATRICS, V133, pE1, DOI 10.1542/peds.2013-2005; Pollock M, 2007, AM FAM PHYSICIAN, V75, P231; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Rossignoli A, 2007, EUR J CLIN PHARMACOL, V63, P1099, DOI 10.1007/s00228-007-0376-3; Choez XS, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0237-y; Shamsuddin S, 2016, INT J INFECT DIS, V52, P16, DOI 10.1016/j.ijid.2016.09.013; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Spurling GKP, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub5; Thamlikitkul V, 2004, INT J INFECT DIS, V8, P47, DOI 10.1016/j.ijid.2003.09.001; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Vodicka TA, 2013, BRIT J GEN PRACT, V63, pE445, DOI 10.3399/bjgp13X669167; Wang ZC, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0763-4	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249475	10.1371/journal.pone.0249475	http://dx.doi.org/10.1371/journal.pone.0249475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793627	Green Published, gold			2022-12-26	WOS:000636467000045
J	Fiore, VG; DeFelice, N; Glicksberg, BS; Perl, O; Shuster, A; Kulkarni, K; O'Brien, M; Pisauro, MA; Chung, D; Gu, XS				Fiore, Vincenzo G.; DeFelice, Nicholas; Glicksberg, Benjamin S.; Perl, Ofer; Shuster, Anastasia; Kulkarni, Kaustubh; O'Brien, Madeline; Pisauro, M. Andrea; Chung, Dongil; Gu, Xiaosi			Containment of COVID-19: Simulating the impact of different policies and testing capacities for contact tracing, testing, and isolation	PLOS ONE			English	Article							CHINA	Efficient contact tracing and testing are fundamental tools to contain the transmission of SARS-CoV-2. We used multi-agent simulations to estimate the daily testing capacity required to find and isolate a number of infected agents sufficient to break the chain of transmission of SARS-CoV-2, so decreasing the risk of new waves of infections. Depending on the non-pharmaceutical mitigation policies in place, the size of secondary infection clusters allowed or the percentage of asymptomatic and paucisymptomatic (i.e., subclinical) infections, we estimated that the daily testing capacity required to contain the disease varies between 0.7 and 9.1 tests per thousand agents in the population. However, we also found that if contact tracing and testing efficacy dropped below 60% (e.g. due to false negatives or reduced tracing capability), the number of new daily infections did not always decrease and could even increase exponentially, irrespective of the testing capacity. Under these conditions, we show that population-level information about geographical distribution and travel behaviour could inform sampling policies to aid a successful containment, while avoiding concerns about government-controlled mass surveillance.	[Fiore, Vincenzo G.; Perl, Ofer; Shuster, Anastasia; Kulkarni, Kaustubh; O'Brien, Madeline; Gu, Xiaosi] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [DeFelice, Nicholas] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Glicksberg, Benjamin S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Glicksberg, Benjamin S.] Icahn Sch Med Mt Sinai, Hasso Plattner Inst Digital Hlth Mt Sinai, New York, NY 10029 USA; [Pisauro, M. Andrea] Univ Oxford, Dept Expt Psychol, Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Pisauro, M. Andrea] Univ Birmingham, Sch Psychol, Ctr Human Brain Hlth, Birmingham, W Midlands, England; [Chung, Dongil] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; University of Birmingham; Ulsan National Institute of Science & Technology (UNIST)	Fiore, VG (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.	vincenzo.fiore@mssm.edu	Pisauro, M.Andrea/ABC-5786-2021; Chung, Dongil/B-4284-2018; Fiore, Vincenzo/T-7379-2017	Pisauro, M.Andrea/0000-0001-6087-2597; Chung, Dongil/0000-0003-1999-0326; Kulkarni, Kaustubh/0000-0001-6526-4873; Fiore, Vincenzo/0000-0002-4865-5482	Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2) at the James J. Peter Veterans Affairs Medical Center, Bronx, NY; National Aeronautics and Space Administration [ECOSTRES18-0046]; National Institute Environmental health sciences [R24ES028522, UH3OD023337]; National Research Foundation of Korea [NRF-2018R1D1A1B07043582]; National Institute on Drug Abuse [R01DA043695, R21DA049243]; National Institute of Mental Health [R21MH120789, R01MH124115, R01MH122611]	Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2) at the James J. Peter Veterans Affairs Medical Center, Bronx, NY; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute Environmental health sciences; National Research Foundation of Korea(National Research Foundation of Korea); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	VGF is funded by the Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2) at the James J. Peter Veterans Affairs Medical Center, Bronx, NY. NDF is supported by National Aeronautics and Space Administration [ECOSTRES18-0046], National Institute Environmental health sciences [R24ES028522, UH3OD023337]. DC is supported by the National Research Foundation of Korea [NRF-2018R1D1A1B07043582]. XG is supported by National Institute on Drug Abuse [grant numbers: R01DA043695, R21DA049243] and National Institute of Mental Health [grant number: R21MH120789, R01MH124115, R01MH122611]. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aguilar J., 2020, MODEL DESCRIBING COV, DOI [10.1101/2020.03.18.20037994, DOI 10.1101/2020.03.18.20037994V3]; Arevalo-Rodriguez I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242958; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; BERTOZZI A, 2020, SCIENCE, V117, P16732, DOI DOI 10.1073/PNAS.2006520117; BONABEAU E, 2002, SCIENCE, V99, P7280, DOI DOI 10.1073/PNAS.082080899; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Centers for Disease Control and Prevention, 2020, INT GUID US POOL PRO; Cereda D., 2020, EARLY PHASE COVID 19, VarXiv, p2003.09320; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; European Centre for Disease Prevention and Controle (ECDC), 2020, COR DIS 2019 COVID 1; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Freedman, 1980, DETERMINISTIC MATH M, Vx; Grassly NC, 2020, LANCET INFECT DIS, V20, P1381, DOI 10.1016/S1473-3099(20)30630-7; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hellewell J., 2020, LANCET GLOB HEALTH, V8, pE488, DOI [10.1016/S2214-109X(20)30074-7, DOI 10.1101/2020.02.08.20021162, 10.1016/S2214-109X%2820%2930074-7, DOI 10.1016/S2214-109X(20)30074-7]; Hoch M., 2020, LANCET INFECT DIS, DOI [10.1016/S1473-3099%2820%2930314-5, DOI 10.1016/S1473-3099%2820%2930314-5]; HOERTEL N, 2020, P NATL ACAD SCI USA, V26, P1417, DOI DOI 10.1038/S41591-020-1001-6; ICNARC, 2020, ICNARC REP COVID 19; Kang M, 2016, EMERG INFECT DIS, V22, P1644, DOI 10.3201/eid2209.152116; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Langton CG., 1995, ARTIFICIAL LIFE OVER, Vxi, P340; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leung K, 2020, LANCET, DOI [10.1016/S0140-6736(20)30746-7, 10.1016/S0140-6736(20)30746-732277878, DOI 10.1016/S0140-6736(20)30746-7]; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Metcalf CJE, 2020, SCIENCE, V369, P368, DOI 10.1126/science.abd1668; Miller A. C., 2020, MEDRXIV, DOI DOI 10.1101/2020.05.07.20094441; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Nishiura H., 2009, MATH STAT ESTIMATION, P103, DOI [DOI 10.1007/978-90-481-2313-1_5, 10.1007/978-90-481-2313-1_5]; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; SETHURAMAN N, 2020, LANCET, DOI DOI 10.1001/JAMA.2020.8259; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Swanson KC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006762; USRDS, 2018, ANN DAT REP; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, P411, DOI 10.15585/mmwr.mm6914e1; Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI 10.1159/000505601; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, 2020, CONS ADJ PUBL HLTH S; World Health Organization, 2020, 190 WHO, V190; World Health Organization, 2020, DRAFT LANDSC COVID 1; ZHANG S, 2020, MMWR-MORBID MORTAL W, V93, P201, DOI DOI 10.1016/J.IJID.2020.02.033; Zhou T, 2020, J EVID-BASED MED, V13, P3, DOI 10.1111/jebm.12376; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0247614	10.1371/journal.pone.0247614	http://dx.doi.org/10.1371/journal.pone.0247614			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788852	Green Published, gold			2022-12-26	WOS:000636354600037
J	Vos, D; Stafford, R; Jenkins, EL; Garrard, A				Vos, Daniella; Stafford, Richard; Jenkins, Emma L.; Garrard, Andrew			A model based on Bayesian confirmation and machine learning algorithms to aid archaeological interpretation by integrating incompatible data	PLOS ONE			English	Article							ACTIVITY AREAS; CHEMICAL-ANALYSIS; HOUSE FLOORS; PHYTOLITHS; SOILS; METHODOLOGY; SEDIMENTS; RESIDUES; FUEL; TOOL	The interpretation of archaeological features often requires a combined methodological approach in order to make the most of the material record, particularly from sites where this may be limited. In practice, this requires the consultation of different sources of information in order to cross validate findings and combat issues of ambiguity and equifinality. However, the application of a multiproxy approach often generates incompatible data, and might therefore still provide ambiguous results. This paper explores the potential of a simple digital framework to increase the explanatory power of multiproxy data by enabling the incorporation of incompatible, ambiguous datasets in a single model. In order to achieve this, Bayesian confirmation was used in combination with decision trees. The results of phytolith and geochemical analyses carried out on soil samples from ephemeral sites in Jordan are used here as a case study. The combination of the two datasets as part of a single model enabled us to refine the initial interpretation of the use of space at the archaeological sites by providing an alternative identification for certain activity areas. The potential applications of this model are much broader, as it can also help researchers in other domains reach an integrated interpretation of analysis results by combining different datasets.	[Vos, Daniella; Jenkins, Emma L.] Bournemouth Univ, Fac Sci & Technol, Dept Archaeol & Anthropol, Poole, Dorset, England; [Stafford, Richard] Bournemouth Univ, Fac Sci & Technol, Dept Life & Environm Sci, Poole, Dorset, England; [Garrard, Andrew] UCL, Inst Archaeol, London, England; [Vos, Daniella] Univ Groningen, Fac Spatial Sci, Dept Cultural Geog, Groningen, Netherlands	Bournemouth University; Bournemouth University; University of London; University College London; University of Groningen	Vos, D (corresponding author), Bournemouth Univ, Fac Sci & Technol, Dept Archaeol & Anthropol, Poole, Dorset, England.; Vos, D (corresponding author), Univ Groningen, Fac Spatial Sci, Dept Cultural Geog, Groningen, Netherlands.	d.vos@rug.nl		Vos, Daniella/0000-0003-2938-8857	AHRC/Bournemouth University; Arts and Humanities Research Council (AHRC) [AH/K002902/1]	AHRC/Bournemouth University; Arts and Humanities Research Council (AHRC)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was supported by an AHRC/Bournemouth University (BU -https://www.bournemouth.ac.uk/) PhD studentship and by an Arts and Humanities Research Council (AHRC https://ahrc.ukri.org/) grant number AH/K002902/1 awarded to ELJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji A., 2014, AM J SCI IND RESEARC, V5, P67; Albert RM, 2000, J ARCHAEOL SCI, V27, P931, DOI 10.1006/jasc.2000.0507; Banerjea RY, 2015, ARCHAEOL ANTHROP SCI, V7, P89, DOI 10.1007/s12520-013-0160-5; Buck C.E., 1996, BAYESIAN APPROACH IN; Canti M, 2015, J ARCHAEOL SCI, V56, P96, DOI 10.1016/j.jas.2015.02.024; Carnelli AL, 2001, ANN BOT-LONDON, V87, P425, DOI 10.1006/anbo.2000.1355; Chase MW, 2004, AM J BOT, V91, P1645, DOI 10.3732/ajb.91.10.1645; Colledge S, 2001, BAR INT SERIES, VS986; Colledge S., 1996, ORIGINS SPREAD AGR P, P204; Cronquist A., 1981, INTEGRATED SYSTEM CL, DOI [10.1080/01616412.1981.11739595, DOI 10.1080/01616412.1981.11739595]; da Costa ML, 1999, J GEOCHEM EXPLOR, V66, P369, DOI 10.1016/S0375-6742(99)00038-2; Debeljak M, 2015, BIOL CONSERV, V184, P310, DOI 10.1016/j.biocon.2015.02.004; Fernandez FG, 2002, GEOARCHAEOLOGY, V17, P487, DOI 10.1002/gea.10026; Garrard A., 1994, LEVANT, V26, P73, DOI DOI 10.1179/lev.1994.26.1.73; Garrard A.N., 1988, Paleorient, V14, P40; Goldberg P, 2006, PRACTICAL THEORETICA; Howson C., 2006, SCI REASONING; Jenkins EL, 2017, ENVIRON ARCHAEOL, V22, P412, DOI 10.1080/14614103.2017.1362787; Jerina K, 2003, ECOL MODEL, V170, P453, DOI 10.1016/S0304-3800(03)00245-X; Kohler-Rollefson I., 1992, PASTORALISM LEVANT A, P11; Lancelotti C, 2017, VEG HIST ARCHAEOBOT, V26, P75, DOI 10.1007/s00334-016-0574-y; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Manzanilla Linda, 1990, ANCIENT MESOAM, V1, P41; Martin Louise, 2000, Paleorient, V25, P87, DOI 10.3406/paleo.1999.4689; Middleton WD, 2004, ARCHAEOMETRY, V46, P47, DOI 10.1111/j.1475-4754.2004.00143.x; Middleton WD, 1996, J ARCHAEOL SCI, V23, P673, DOI 10.1006/jasc.1996.0064; Milek KB, 2013, J ARCHAEOL SCI, V40, P1845, DOI 10.1016/j.jas.2012.10.031; Oonk S, 2009, ARCHAEOL PROSPECT, V16, P35, DOI 10.1002/arp.344; Parnell JJ, 2002, J ARCHAEOL SCI, V29, P379, DOI 10.1006/jasc.2002.0735; Peto A, 2015, VEG HIST ARCHAEOBOT, V24, P101, DOI 10.1007/s00334-014-0491-x; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Portillo M, 2014, J ARCHAEOL SCI, V42, P107, DOI 10.1016/j.jas.2013.10.038; Portillo M, 2009, QUATERN INT, V193, P174, DOI 10.1016/j.quaint.2007.06.002; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Rondelli B, 2014, J ARCHAEOL SCI, V41, P482, DOI 10.1016/j.jas.2013.09.008; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; Schiegl Solveig, 1994, Israel Journal of Earth Sciences, V43, P267; Shahack-Gross R, 2004, J ARCHAEOL SCI, V31, P1395, DOI 10.1016/j.jas.2004.03.003; Stafford R, 2020, ENVIRON SCI POLICY, V112, P340, DOI 10.1016/j.envsci.2020.07.008; Stafford R, 2015, OCEAN COAST MANAGE, V118, P88, DOI 10.1016/j.ocecoaman.2015.04.013; Sulas F, 2012, ARCHAEOL ANTHROP SCI, V4, P145, DOI 10.1007/s12520-012-0090-7; Sullivan KA, 2004, J ARCHAEOL SCI, V31, P1659, DOI 10.1016/j.jas.2004.04.007; Sunanta O., 2018, BAYESIAN INFERENCE O, P1; Tsartsidou G, 2008, J ARCHAEOL SCI, V35, P600, DOI 10.1016/j.jas.2007.05.008; Tsartsidou G, 2009, J ARCHAEOL SCI, V36, P2342, DOI 10.1016/j.jas.2009.06.017; Ullah II, 2015, J ARCHAEOL METHOD TH, V22, P1238, DOI 10.1007/s10816-014-9223-x; Vos D, 2017, OUT SIGHT NOT OUT MI; Vos D., 2020, LANDSCAPES SURVIVAL; Vos D, 2018, GEOARCHAEOLOGY, V33, P680, DOI 10.1002/gea.21685; Vyncke K, 2011, J ARCHAEOL SCI, V38, P2274, DOI 10.1016/j.jas.2011.03.034; Wilson CA, 2008, J ARCHAEOL SCI, V35, P412, DOI 10.1016/j.jas.2007.04.006	51	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248261	10.1371/journal.pone.0248261	http://dx.doi.org/10.1371/journal.pone.0248261			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788845	Green Accepted, gold, Green Published			2022-12-26	WOS:000636354600055
J	Jiao, J; Li, Z; Wu, XJ; Cao, J; Liu, G; Liu, Y; Li, FF; Zhu, C; Song, BY; Jin, JF; Liu, YL; Wen, XX; Cheng, SZ; Wan, X				Jiao, Jing; Li, Zhen; Wu, Xinjuan; Cao, Jing; Liu, Ge; Liu, Ying; Li, Fangfang; Zhu, Chen; Song, Baoyun; Jin, Jingfen; Liu, Yilan; Wen, Xianxiu; Cheng, Shouzhen; Wan, Xia			Risk factors for 3-month mortality in bedridden patients with hospital-acquired pneumonia: A multicentre prospective study	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; CLINICAL-PRACTICE GUIDELINES; ATTRIBUTABLE MORTALITY; IMMOBILE INPATIENTS; UNITED-STATES; END-POINTS; ADULTS; PREVALENCE; EPIDEMIOLOGY; TRIALS	Background Mortality among patients with hospital-acquired pneumonia (HAP) is quite high; however, information on risk factors for short-term mortality in this population remains limited. The aim of the current study was to identify the risk factors for mortality in bedridden patients with HAP during a 3-month observation period. Methods A secondary data analysis was conducted. In total, 1141 HAP cases from 25 hospitals were included in the analysis. Univariate and multilevel regression analyses were performed to identify the risk factors for mortality. Results During the 3-month observation period, there were 189 deaths among bedridden patients with HAP. The mortality rate in this study was 16.56%. Multilevel regression analysis showed that ventilator-associated pneumonia (OR = 2.034, 95%CI: 1.256, 3.296, p = 0.004), pressure injuries (OR = 2.202, 95%CI: 1.258, 3.852, p = 0.006), number of comorbidities (OR = 1.076, 95%CI: 1.016,1.140, p = 0.013) and adjusted Charlson Comorbidity Index score (OR = 1.210, 95%CI: 1.090, 1.343, p<0.001) were associated with an increased risk of mortality, while undergoing surgery with general anaesthesia (OR = 0.582, 95%CI: 0.368, 0.920, p = 0.021) was associated with a decreased risk of mortality. Conclusions The identification of risk factors associated with mortality is an important step towards individualizing care plans. Our findings may help healthcare workers select high-risk patients for specific interventions. Further study is needed to explore whether appropriate interventions against modifiable risk factors, such as reduced immobility complications or ventilator-associated pneumonia, could improve the prognoses.	[Jiao, Jing; Li, Zhen; Wu, Xinjuan; Cao, Jing; Liu, Ying; Zhu, Chen] Peking Union Med Coll Hosp, Dept Nursing, Beijing, Peoples R China; [Liu, Ge] Peking Union Med Coll Hosp, Dept Surg, Beijing, Peoples R China; [Li, Fangfang] Peking Union Med Coll Hosp, Dept Med, Beijing, Peoples R China; [Song, Baoyun] Henan Prov Peoples Hosp, Dept Nursing, Zhengzhou, Henan, Peoples R China; [Jin, Jingfen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Nursing, Hangzhou, Zhejiang, Peoples R China; [Liu, Yilan] Wuhan Union Hosp, Dept Nursing, Wuhan, Hubei, Peoples R China; [Wen, Xianxiu] Sichuan Prov Peoples Hosp, Dept Nursing, Chengdu, Sichuan, Peoples R China; [Cheng, Shouzhen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhengzhou University; Zhejiang University; Huazhong University of Science & Technology; Sichuan Provincial People's Hospital; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, XJ (corresponding author), Peking Union Med Coll Hosp, Dept Nursing, Beijing, Peoples R China.	wuxinjuan@sina.com		, Zhen/0000-0002-4052-199X	Special Scientific Research Fund of Public Welfare Profession of China [201502017]	Special Scientific Research Fund of Public Welfare Profession of China	This work was supported by the Special Scientific Research Fund of Public Welfare Profession of China [grant number 201502017]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand N, 2009, SEMIN RESP CRIT CARE, V30, P3, DOI 10.1055/s-0028-1119803; Barbier F, 2013, CURR OPIN PULM MED, V19, P216, DOI 10.1097/MCP.0b013e32835f27be; Cao J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228423; Chang CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148076; Feng DY, 2019, MED SCI MONITOR, V25, P7660, DOI 10.12659/MSM.916356; Feng DY, 2019, J INFECT PUBLIC HEAL, V12, P630, DOI 10.1016/j.jiph.2019.02.014; Haga T, 2018, INTERNAL MED, V57, P2473, DOI 10.2169/internalmedicine.0435-17; Hespanhol V, 2020, PULMONOLOGY, V26, P123, DOI 10.1016/j.pulmoe.2019.10.003; Iqbal N, 2020, CLIN RESPIR J, V14, P328, DOI 10.1111/crj.13137; Iwata K, 2012, J INFECT CHEMOTHER, V18, P734, DOI 10.1007/s10156-012-0411-x; Jiao J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00221; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Khor HM, 2014, ARCH GERONTOL GERIAT, V59, P536, DOI 10.1016/j.archger.2014.07.011; Kumar S, 2018, LUNG, V196, P469, DOI 10.1007/s00408-018-0117-7; Laessig KA, 2010, CLIN INFECT DIS, V51, pS117, DOI 10.1086/653059; Li GW, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0397-5; Liu Y, 2019, INT WOUND J, V16, P459, DOI 10.1111/iwj.13054; Magill SS, 2018, NEW ENGL J MED, V379, P1732, DOI 10.1056/NEJMoa1801550; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Morris CB, 2016, THORAX, V71, pA230, DOI 10.1136/thoraxjnl-2016-209333.407; Murillo-Zamora E, 2018, MED CLIN-BARCELONA, V150, P99, DOI 10.1016/j.medcli.2017.06.044; Muscedere JG, 2010, CLIN INFECT DIS, V51, pS120, DOI 10.1086/653060; Olivieri A, 2018, MINERVA ANESTESIOL, V84, P811, DOI 10.23736/S0375-9393.17.12198-X; Pessoa E, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-019-1045-x; Ramirez JA, 2017, CLIN INFECT DIS, V65, P1806, DOI 10.1093/cid/cix647; Rotstein C, 2008, CAN J INFECT DIS MED, V19, P19, DOI 10.1155/2008/593289; Shi Y, 2019, J THORAC DIS, V11, P2581, DOI 10.21037/jtd.2019.06.09; Song YP, 2019, INT WOUND J, V16, P1533, DOI 10.1111/iwj.13243; Stralin K, 2002, ARCH INTERN MED, V162, P2491, DOI 10.1001/archinte.162.21.2491; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Wu XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205729; Zhu C, 2020, J HOSP INFECT, V104, P538, DOI 10.1016/j.jhin.2019.11.018	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249198	10.1371/journal.pone.0249198	http://dx.doi.org/10.1371/journal.pone.0249198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784317	gold, Green Published			2022-12-26	WOS:000636359600065
J	Jiang, WW; Liu, L; Xiao, HL; Zhu, S; Li, WT; Liu, Y				Jiang, Weiwei; Liu, Lun; Xiao, Henglin; Zhu, Song; Li, Wentao; Liu, Ying			Composition and distribution of vegetation in the water level fluctuating zone of the Lantsang cascade reservoir system using UAV multispectral imagery	PLOS ONE			English	Article							DANJIANGKOU RESERVOIR; SEED BANK; DAMS; RIPARIAN	With the development of a large number of tall dams and large cascade reservoir projects in the Lantsang River Basin, a large water level fluctuating zone (WLFZ) containing cascading reservoirs has formed. This newborn ecosystem is related to the sustainable development of hydropower projects, and has become a new problem to be studied urgently. Taking WLFZs in the Huangdeng, Xiaowan and Nuozhadu Reservoirs in the Lantsang River Basin as study areas, this study used multi-spectral remote-sensing field data obtained with unmanned aerial vehicles (UAVs) to ascertain the species types, coverage, distribution characteristics, dominant species and pioneer species of naturally restored vegetation. The considered data were subjected to UAV data processing, vegetation classification using multi-spectral images and a geographic information system (GIS) terrain-distribution analysis. Results show that: Polygonum Plebeium, Cynodon dactylon, Xanthium sibiricum, Ageratum conyzoides, Eleusine indica, Digitaria sanguinalis and Verbena officinalis are the dominant species of vegetation that could be naturally restored in the WLFZ; the vegetation coverage and the number of species are significantly positively correlated with the age and restoration periods of the WLFZ; the vegetation coverage of each study area increases at first, and then decreases, as a function of elevation; gentle slopes about 0-25 degrees are more suitable for vegetation restoration. This study provides first-hand data on the natural restoration of vegetation in WLFZs, and gives a useful reference for its ecological restoration as a consequence of hydropower cascade development in the Lantsang River Basin. Finally, the study demonstrates that light UAV remote sensing is an attractive choice for investigating vegetation in reservoir WLFZs.	[Jiang, Weiwei; Liu, Lun; Xiao, Henglin; Zhu, Song; Li, Wentao; Liu, Ying] Hubei Univ Technol, Sch Civil Engn Architecture & Environm, Wuhan, Hubei, Peoples R China	Hubei University of Technology	Xiao, HL (corresponding author), Hubei Univ Technol, Sch Civil Engn Architecture & Environm, Wuhan, Hubei, Peoples R China.	xiao-henglin@163.com			National Key Research and Development Program of China [2016YFC0502208]; National Natural Science Foundation of China [41807297]; Natural Science Foundation of Science and Technology Department of Hubei Province [2020CFB409]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Science and Technology Department of Hubei Province	This research was supported by the National Key Research and Development Program of China (Grant No. 2016YFC0502208), the National Natural Science Foundation of China (Grant No. 41807297), and the Natural Science Foundation of Science and Technology Department of Hubei Province (Grant No. 2020CFB409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M., 2000, MULTIRESOLUTION SEGM, VXII, P12, DOI DOI 10.1016/J.ISPRSJPRS.2003.10.002; Baldeck CA, 2013, OECOLOGIA, V173, P1491, DOI 10.1007/s00442-013-2709-5; Bapiri A, 2010, MICROB ECOL, V60, P419, DOI 10.1007/s00248-010-9723-5; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Bourgoin C., 2020, UAV BASED CANOPY TEX, V115; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chen FQ, 2020, J FRESHWATER ECOL, V35, P57, DOI 10.1080/02705060.2019.1670744; Chen HS., 2018, JZHEJIANG U WAT RES, V6, P52, DOI [10.1016/j.nutres.2013.07.017, DOI 10.1016/J.NUTRES.2013.07.017]; Cheng RuiMei, 2010, Scientia Silvae Sinicae, V46, P111; Cui T, 2014, THESIS CAP NORMAL U; [党晨席 Dang Chenxi], 2015, [水土保持研究, Research of Soil and Water Conservation], V22, P324; Du Y, 2020, J CTGU, V42, P51, DOI DOI 10.13393/J.CNKI.ISSN.1672-948X.2020.03.010; [冯晶红 Feng Jinghong], 2020, [水土保持研究, Research of Soil and Water Conservation], V27, P305; Huylenbroeck L, 2020, J ENVIRON MANAGE, V267, DOI 10.1016/j.jenvman.2020.110652; Jiang W., 2020, 2019 IEEE 4 ADV INF; Krolova M, 2012, LIMNOLOGICA, V42, P165, DOI 10.1016/j.limno.2011.10.002; Kuhn M., 2013, CLASSIFICATION TREES; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Li J., 2012, RESERVOIR WATER LEVE; Li JP, 2013, ECOL INDIC, V34, P94, DOI 10.1016/j.ecolind.2013.04.016; Li JP, 2012, FOREST ECOL MANAG, V284, P251, DOI 10.1016/j.foreco.2012.07.050; Li XF, 2013, ACTA SCI CIRCUMST, V4, P1089; Liu Rui-xue, 2013, Yingyong Shengtai Xuebao, V24, P801; [吕明权 Lu Mingquan], 2015, [生态学报, Acta Ecologica Sinica], V35, P3504; LXW, 2017, PATTERN OPTIMIZATION; Miao CY, 2015, WATER-SUI, V7, P2349, DOI 10.3390/w7052349; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Puliti S, 2015, REMOTE SENS-BASEL, V7, P9632, DOI 10.3390/rs70809632; Qiu J., 2009, SCI TOTAL ENVIRON, V551, P16; Rasanen JV, 2013, ENVIRON POLLUT, V183, P64, DOI 10.1016/j.envpol.2013.05.015; Riis T, 2002, AQUAT BOT, V74, P133, DOI 10.1016/S0304-3770(02)00074-8; Rosenberg D. M., 1997, Environmental Reviews, V5, P27, DOI 10.1139/er-5-1-27; Rull V, 2012, COMMUNITY ECOL, V13, P102, DOI 10.1556/ComEc.13.2012.1.13; Stone R, 2008, SCIENCE, V321, P628, DOI 10.1126/science.321.5889.628; Sun ZP, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-3248-x; Suzuki T., 2020, J REMOTE SENSING SOC, V39, pS30; Wang M, 2017, IEEE J-STARS, V10, P628, DOI 10.1109/JSTARS.2016.2539239; Wang T, 2019, J FRESHWATER ECOL, V34, P1, DOI 10.1080/02705060.2018.1470041; Wang Weidong, 2008, Wetlands Ecology and Management, V16, P65, DOI 10.1007/s11273-007-9057-3; Willis KJ, 2007, PHILOS T R SOC B, V362, P175, DOI 10.1098/rstb.2006.1977; Yin J, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041025; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zhang WT., 2015, Effect and mechanism of nitrogen and phosphorus removal from agricultural runoff by the buffer zone of Erhai Lake; Zhu KW, 2020, GLOB ECOL CONSERV, V21, DOI 10.1016/j.gecco.2019.e00866	44	3	4	15	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247682	10.1371/journal.pone.0247682	http://dx.doi.org/10.1371/journal.pone.0247682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780473	Green Published, gold			2022-12-26	WOS:000636336800027
J	Taye, BT; Mihret, MS; Muche, HA				Taye, Birhan Tsegaw; Mihret, Muhabaw Shumye; Muche, Haymanot Alem			Risk factors of precancerous cervical lesions: The role of women's socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study	PLOS ONE			English	Article							CANCER PREVENTION; ASSOCIATION; OBESITY	Background Cervical cancer remains one of the major public health challenges in low and middle-income countries including Ethiopia. There was a scarce of evidence regarding the effect of woman's socio-demographic characteristics and body mass index on the development of precancerous cervical lesions in Ethiopia. Therefore, the current study aimed at identifying the risk factors of precancerous cervical lesions among women visiting referral hospitals for cervical cancer screening in Amhara national regional state. Methods A hospital-based case-control study was conducted from 22 December 2019 to 8 April 2020 among 200 women including 67 visual inspections with acetic acid (VIA) positive women (i.e., cases) and 133 visual inspections with acetic acid (VIA) negative women (i.e., controls). The study was conducted at randomly selected referral hospitals in Amhara national regional state. Data were collected mainly through face to face interview and chart review using structured questionnaire and checklist respectively. Data were then entered to EpiData version 4.6 and exported to SPSS version 25 for analysis. Binary logistic regression model was fitted and variables with p-value of < 0.2 at bivariable logistic regression analysis were candidates for the multivariable analysis. Level of significance was claimed based on adjusted odds ratio (AOR) with 95% confidence interval (CI) at p-value of <less than or equal to> 0.05. Results This study illustrates that the odds of being positive for precancerous cervical lesion (PCL) were higher among women who had body mass index (BMI) of <18.5 kg/m2 (AOR = 3.83; 95% CI: 1.26, 8.76), early coitarche (AOR = 3.15; 95% CI: 1.50, 11.49, history of using oral contraceptive pills (AOR = 2.74; 95% CI: 1.6, 7.4), lifetime sexual transmitted infections (AOR = 3.73; 95% CI: 2.5, 12.28) and multiple sexual partners (AOR = 3.23; 95% CI: 1.82, 9.29). On the other hand, participants' BMI of <greater than or equal to>25 kg/m2 (AOR = 0.46; 95% CI: 0.36, 0.75) and level of education of college and above (AOR = 0.29; 95% CI: 0.23, 0.77) were identified to be protective factors of PCL. Conclusion Most of the determinants of precancerous cervical lesions were modifiable and mainly related to women's socio-demographic characteristics, sexual behaviors and body mass index. Therefore, strengthening awareness on safe sexual practices and healthy life styles through information, education and communication (IEC), and behavioral change communication (BCC) would decrease the incidence of precancerous cervical lesions.	[Taye, Birhan Tsegaw] Debre Birhan Univ, Coll Med & Hlth Sci, Dept Midwifery, Debre Birhan, Ethiopia; [Mihret, Muhabaw Shumye; Muche, Haymanot Alem] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Clin Midwifery, Gondar, Ethiopia	University of Gondar	Taye, BT (corresponding author), Debre Birhan Univ, Coll Med & Hlth Sci, Dept Midwifery, Debre Birhan, Ethiopia.	tsegawbirhan2@gmail.com	Taye, Birhan Tsegaw/AAX-6617-2021	Taye, Birhan Tsegaw/0000-0003-2174-3797	University of Gondar, College of Medicine and Health Science	University of Gondar, College of Medicine and Health Science	The research was supported by a grant from University of Gondar, College of Medicine and Health Science. The granting agency did not have a role in the design, collection, analysis and interpretation of data; or writing the manuscript.	Asseffa NA., 2017, J GYNECOL WOMENS HEA, V5, P1, DOI [10.19080/JGWH.2017.05.555660, DOI 10.19080/JGWH.2017.05.555660]; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV; Das CM, 2013, J LIAQUAT UNIV MED H, V12, P44; Deksissa Zewdie Mulissa, 2015, BMC Res Notes, V8, P618, DOI 10.1186/s13104-015-1594-x; Denny L, 2012, INT J GYNECOL OBSTET, V119, pS80, DOI 10.1016/j.ijgo.2012.03.023; Federal Democratic Republic of Ethiopia M of H, 2015, GUID CERV CANC PREV; Federal Ministry of Health, 2015, NAT CANC CONTR PLAN; Feng YH, 2015, GYNECOL MINIM INVASI, V4, P102, DOI 10.1016/j.gmit.2015.03.003; Gessesse Zekariase, 2015, Ethiop Med J, VSuppl 2, P17; GLOBOCAN, 2018, EST NUMB NEW CAS 201, V876, P1; HaftomGebrehiwot W/aregay, 2017, EUR J PHARM MED RES, V4, P41; IARC, 2018, LATEST GLOBAL CANC D, V12; Kassa Roza Teshome, 2018, BMC Res Notes, V11, P145, DOI 10.1186/s13104-018-3244-6; Kebede Haile Misgina, 2017, Journal of Public Health and Epidemiology, V9, P46, DOI 10.5897/JPHE2016.0891; Lertcharernrit Jiraporn, 2016, Asian Pac J Cancer Prev, V17, P4163; Makuza JD, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.26.7116; Melkamu G., 2015, BMC CLIN PATHOL, V15, P1, DOI [10.1186/s12907-015, DOI 10.1186/S12907-015]; Monday NS., 2018, AM I SCI, V4, P87; Mulumba Richard., 2018, APPL MED SCI, V6, P818; Ntekim A, 2012, TOP CERVICAL CANC AD, P4, DOI [10.5772/27200, DOI 10.5772/27200]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Poorolajal J, 2016, EUR J CANCER PREV, V25, P232, DOI 10.1097/CEJ.0000000000000164; Puig-Tintore LM, 2008, J LOW GENIT TRACT DI, V12, P82, DOI 10.1097/LGT.0b013e3181599c16; Raghupathi V, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00402-5; Schaffer Joseph I, 2017, WLLIAMS GYNECOLOGY, V91, P399; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Sinayobye JD, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-40; Sokkary HH, 2017, INT J REPROD CONTRAC, V6, P54, DOI [DOI 10.18203/2320-1770.IJRCOG20164632, 10.18203/2320-1770.ijrcog20164632]; Tadesse SK, 2016, OPEN ACCESS, V1, P1; Teame H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191506; Tesfa A., 2011, BRIEF PATHFINDER INT, P8; Wee CC, 2008, OBESITY, V16, P2552, DOI 10.1038/oby.2008.394; World Health Organization, 2013, COMPR CERV CANC PREV	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249218	10.1371/journal.pone.0249218	http://dx.doi.org/10.1371/journal.pone.0249218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770125	gold, Green Published			2022-12-26	WOS:000634833500017
J	Tao, JH; Berthet, A; Citron, YR; Tsiolaki, PL; Stanley, R; Gestwicki, JE; Agard, DA; McConlogue, L				Tao, Jiahui; Berthet, Amandine; Citron, Y. Rose; Tsiolaki, Paraskevi L.; Stanley, Robert; Gestwicki, Jason E.; Agard, David A.; McConlogue, Lisa			Hsp70 chaperone blocks alpha-synuclein oligomer formation via a novel engagement mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; HEAT-SHOCK-PROTEIN-70 HSP70; FIBRIL FORMATION; AGGREGATION; BINDING; INHIBITION; TOXICITY; MODEL	Overexpression and aggregation of alpha-synuclein (ASyn) are linked to the onset and pathology of Parkinson's disease and related synucleinopathies. Elevated levels of the stress-induced chaperone Hsp70 protect against ASyn misfolding and ASyn-driven neurodegeneration in cell and animal models, yet there is minimal mechanistic understanding of this important protective pathway. It is generally assumed that Hsp70 binds to ASyn using its canonical and promiscuous substrate-binding cleft to limit aggregation. Here we report that this activity is due to a novel and unexpected mode of Hsp70 action, involving neither ATP nor the typical substrate-binding cleft. We use novel ASyn oligomerization assays to show that Hsp70 directly blocks ASyn oligomerization, an early event in ASyn misfolding. Using truncations, mutations, and inhibitors, we confirm that Hsp70 interacts with ASyn via an as yet unidentified, noncanonical interaction site in the C-terminal domain. Finally, we report a biological role for a similar mode of action in H4 neuroglioma cells. Together, these findings suggest that new chemical approaches will be required to target the Hsp70-ASyn interaction in synucleinopathies. Such approaches are likely to be more specific than targeting Hsp70's canonical action. Additionally, these results raise the question of whether other misfolded proteins might also engage Hsp70 via the same noncanonical mechanism.	[Tao, Jiahui; Citron, Y. Rose; Tsiolaki, Paraskevi L.; Agard, David A.; McConlogue, Lisa] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Berthet, Amandine; Stanley, Robert; McConlogue, Lisa] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Pharmaceut Chem, San Francisco, CA USA; [Gestwicki, Jason E.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA; McConlogue, L (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; McConlogue, L (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu; lisam@trp.ucsf.edu		McConlogue, Lisa/0000-0001-7319-3534	Rogers Family Foundation; Howard Hughes Medical Institute; EMBO long term fellowship [ALTF 154-2020]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS092897]	Rogers Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the Rogers Family Foundation (L. M., D. A. A.), by the Howard Hughes Medical Institute (D. A. A.), by an EMBO long term fellowship award number ALTF 154-2020 (P. L. T.) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R21NS092897 (L. M.). "The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."	Alam P, 2019, J NEUROCHEM, V150, P522, DOI 10.1111/jnc.14808; Aprile FA, 2017, BIOCHEMISTRY-US, V56, P1177, DOI 10.1021/acs.biochem.6b01178; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burmann BM, 2020, NATURE, V577, P127, DOI 10.1038/s41586-019-1808-9; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Cesa LC, 2018, J BIOL CHEM, V293, P2370, DOI 10.1074/jbc.RA117.000634; Chaari A, 2016, INT J BIOL MACROMOL, V83, P433, DOI 10.1016/j.ijbiomac.2015.10.089; Chen SW, 2018, METHODS MOL BIOL, V1779, P45, DOI 10.1007/978-1-4939-7816-8_4; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Clerico EM, 2019, BIOCHEM J, V476, P1653, DOI 10.1042/BCJ20170380; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hu F, 2019, CELL REP, V26, P168, DOI 10.1016/j.celrep.2018.12.032; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; Jones DR, 2014, THER ADV NEUROL DISO, V7, P33, DOI 10.1177/1756285613493469; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Levin J, 2016, BIOCHEM BIOPH RES CO, V477, P76, DOI 10.1016/j.bbrc.2016.06.023; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Morris M, 2015, ANN CLIN TRANSL NEUR, V2, P1012, DOI 10.1002/acn3.257; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Outeiro TF, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0306-8; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schneider M. M., 2020, HSC70 DISAGGREGATION, DOI [10.1101/2020.11.02.365825, DOI 10.1101/2020.11.02.365825]; Shao H, 2018, J MED CHEM, V61, P6163, DOI 10.1021/acs.jmedchem.8b00583; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner JA, 2018, CELL TISSUE RES, V373, P161, DOI 10.1007/s00441-018-2814-1; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Toth G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52598-4; Toth G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087133; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wu N, 2015, BBA-PROTEINS PROTEOM, V1854, P1392, DOI 10.1016/j.bbapap.2015.05.008; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	71	11	11	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100613	10.1016/j.jbc.2021.100613	http://dx.doi.org/10.1016/j.jbc.2021.100613			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798554	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400584
J	Gutierrez, J; Gonzalez, D; Escalona-Rivano, R; Takahashi, C; Brandan, E				Gutierrez, Jaime; Gonzalez, David; Escalona-Rivano, Rodrigo; Takahashi, Chiaki; Brandan, Enrique			Reduced RECK levels accelerate skeletal muscle differentiation, improve muscle regeneration, and decrease fibrosis	FASEB JOURNAL			English	Article						MMP; muscle fibrosis; RECK; regeneration; skeletal muscle differentiation	ACTIVATED PROTEIN-KINASE; MMP-REGULATOR RECK; MATRIX METALLOPROTEINASES; SATELLITE CELL; MYOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; STEM-CELLS; DYSTROPHIC MUSCLE; GENE-EXPRESSION; UP-REGULATION	The muscle regeneration process requires a properly assembled extracellular matrix (ECM). Its homeostasis depends on the activity of different matrix-metalloproteinases (MMPs). The reversion-inducing-cysteine-rich protein with kazal motifs (RECK) is a membrane-anchored protein that negatively regulates the activity of different MMPs. However, the role of RECK in the process of skeletal muscle differentiation, regeneration, and fibrosis has not been elucidated. Here, we show that during skeletal muscle differentiation of C2C12 myoblasts and in satellite cells on isolated muscle fibers, RECK is transiently up regulated. C2C12 myoblasts with reduced RECK levels are more prone to enter the differentiation program, showing an accelerated differentiation process. Notch-1 signaling was reduced, while p38 and AKT signaling were augmented in myoblasts with decreased RECK levels. Overexpression of RECK restores the normal differentiation process but diminished the ability to form myotubes. Transient up-regulation of RECK occurs during skeletal muscle regeneration, which was accelerated in RECK-deficient mice (Reck +/-). RECK, MMPs and ECM proteins augmented in chronically damaged WT muscle, a model of muscle fibrosis. In this model, RECK +/- mice showed diminished fibrosis compared to WT. These results strongly suggest that RECK is acting as a potential myogenic repressor during muscle formation and regeneration, emerging as a new player in these processes, and as a potential target to treat individuals with the muscle-wasting disease.	[Gutierrez, Jaime; Escalona-Rivano, Rodrigo] Univ San Sebastian, Hlth Sci Fac, Sch Med Technol, Cellular Signaling & Differentiat Lab CSDL, Santiago, Chile; [Gutierrez, Jaime; Gonzalez, David; Brandan, Enrique] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol, Santiago 8330025, Chile; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Oncol & Mol Biol, Kanazawa, Ishikawa, Japan; [Brandan, Enrique] Fdn Ciencia & Vida, Santiago, Chile	Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Kanazawa University	Gutierrez, J; Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol, Santiago 8330025, Chile.	jaime.gutierrez@uss.cl; ebrandan@bio.puc.cl			Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1190144]; Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [AFB170005]; FONDECYT [11110010, 1180935, CONICYT-79090027]; CONICYT	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1190144 and Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) AFB170005 to EB. FONDECYT 11110010, 1180935, and CONICYT-79090027 to JG. DG held a CONICYT PhD fellowship. Funding sources had no role in the design of the study, collection, analysis, and interpretation of data, writing of the report, nor in the decision to submit the article for publication	Alameddine Hala S, 2016, J Neuromuscul Dis, V3, P455; Barnes BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1501, DOI 10.1152/ajpcell.00217.2009; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bersini S, 2018, ADV DRUG DELIVER REV, V129, P64, DOI 10.1016/j.addr.2018.02.009; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cabrera D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-6; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; Chen X, 1999, MOL CELL BIOL, V19, P4695; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Chin JR, 1997, DEVELOPMENT, V124, P1519; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Contreras O, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232157; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; COUCH CB, 1983, CELL, V32, P257, DOI 10.1016/0092-8674(83)90516-0; Danisovic L, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120253; Darabi R, 2008, STEM CELL REV, V4, P217, DOI 10.1007/s12015-008-9023-3; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Demestre M, 2005, NEUROPATH APPL NEURO, V31, P545, DOI 10.1111/j.1365-2990.2005.00676.x; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; Fiore D, 2016, STEM CELL RES, V17, P161, DOI 10.1016/j.scr.2016.06.007; Fujimaki S, 2018, STEM CELLS, V36, P278, DOI 10.1002/stem.2743; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2013, CELL TISSUE RES, V353, P173, DOI 10.1007/s00441-013-1642-6; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gonzalez D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177649; Gutierrez J, 2017, PLACENTA, V59, P19, DOI 10.1016/j.placenta.2017.09.004; Gutierrez J, 2016, CURR VASC PHARMACOL, V14, P106, DOI 10.2174/1570161113666151014130746; Gutierrez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135005; Hong KJ, 2014, J CELL PHYSIOL, V229, P191, DOI 10.1002/jcp.24434; Jaiswal N, 2019, MOL METAB, V28, P1, DOI 10.1016/j.molmet.2019.08.001; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Acuna MJ, 2014, HUM MOL GENET, V23, P1237, DOI 10.1093/hmg/ddt514; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Karalaki M, 2009, IN VIVO, V23, P779; Kawashima S, 2008, J NEUROCHEM, V104, P376, DOI 10.1111/j.1471-4159.2007.04977.x; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Khurana A, 2002, MOL CELL BIOCHEM, V238, P27, DOI 10.1023/A:1019957602038; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Li HP, 2019, ISCIENCE, V19, P559, DOI 10.1016/j.isci.2019.08.009; Li YQ, 2000, CELL SIGNAL, V12, P751, DOI 10.1016/S0898-6568(00)00120-0; Li Y, 2011, J NEUROSCI, V31, P13191, DOI 10.1523/JNEUROSCI.2953-11.2011; Liu JM, 2008, AM J PHYSIOL-CELL PH, V294, pC627, DOI 10.1152/ajpcell.00329.2007; Lluri G, 2005, MUSCLE NERVE, V32, P492, DOI 10.1002/mus.20383; Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Mizuno S, 2015, J BIOL CHEM, V290, P28456, DOI 10.1074/jbc.M115.653477; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mullooly M, 2016, CANCER BIOL THER, V17, P870, DOI 10.1080/15384047.2016.1177684; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mummidi S, 2019, J CELL PHYSIOL, V234, P22242, DOI 10.1002/jcp.28792; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Nowak E, 2018, CELL BIOL INT, V42, P373, DOI 10.1002/cbin.10914; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Perdiguero E, 2007, CELL CYCLE, V6, P1298, DOI 10.4161/cc.6.11.4315; Pessina Patrizia, 2014, Skelet Muscle, V4, P7, DOI 10.1186/2044-5040-4-7; Pichavant Christophe, 2011, PLoS Curr, V3, pRRN1275, DOI 10.1371/currents.RRN1275; Rayagiri SS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03425-3; Rebolledo DL, 2019, MATRIX BIOL, V82, P20, DOI 10.1016/j.matbio.2019.01.002; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Smith LR, 2018, MATRIX BIOL, V68-69, P602, DOI 10.1016/j.matbio.2018.01.014; Snyman C, 2015, J MUSCLE RES CELL M, V36, P215, DOI 10.1007/s10974-015-9414-4; Son DJ, 2017, THERANOSTICS, V7, P2186, DOI 10.7150/thno.18407; TEDESCO D, 1995, J VIROL, V69, P6947, DOI 10.1128/JVI.69.11.6947-6957.1995; Valle-Tenney R, 2020, MATRIX BIOL, V87, P48, DOI 10.1016/j.matbio.2019.09.003; Vallon M, 2018, CELL REP, V25, P339, DOI 10.1016/j.celrep.2018.09.045; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yokoyama S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176376; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	111	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21503	10.1096/fj.202001646RR	http://dx.doi.org/10.1096/fj.202001646RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811686				2022-12-26	WOS:000645260100028
J	Jiang, J; Zhu, JH; Liu, Q; Zhang, TT; Wen, JK; Xia, JH; Deng, YQ				Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Xia, Jianhong; Deng, Yiqun			Role of DNA methylation-related chromatin remodeling in aryl hydrocarbon receptor-dependent regulation of T-2 toxin highly inducible Cytochrome P450 1A4 gene	FASEB JOURNAL			English	Article						AhR; chromatin remodeling; CYP1A4; DNA methylation; T-2 toxin	CYP1A1 PROMOTER; HISTONE; METABOLISM; DEOXYNIVALENOL; TRICHOTHECENES; TRANSCRIPTION; COACTIVATOR; PATHWAYS; PROTEINS; ENZYME	Mycotoxins are toxic secondary metabolites produced by food-contaminating fungi, which lead to global epigenetic changes and cause toxicity to both farm animals and humans. However, whether mycotoxins induce gene-specific epigenetic alterations associated with inducible downstream gene expression is unclear as are the underlying regulatory mechanisms. Here, we found that T-2 toxin and its deacetylated metabolites but not deoxynivalenol (DON) or other representative mycotoxins highly induced the expression of cytochrome P450 1A4 (CYP1A4) in both Leghorn male hepatoma (LMH) cells and chicken primary hepatocytes, and this effect was related to the regulation of both aryl hydrocarbon receptor (AhR) and DNA methylation. We used methylation-sensitive restriction enzyme digestion-qPCR (MSRE-qPCR) and chromatin immunoprecipitation (ChIP) assays and found that the binding of DNA methyltransferase 1 (DNMT1) and histone deacetylase 2 (HDAC2) to highly methylated CpG island 3-2 at the enhancer of CYP1A4 was accompanied by the recruitment of the repressive histone modification marker H3K27me3, inducing a silent state. In turn, T-2 toxin stimulation enriched the binding of AhR to demethylated CpG island 3-2, which facilitated p300 and H3K9ac recruitment and ultimately generated an activated chromatin structure at the enhancer by increasing the active histone modification markers, including H3K4me3, H3K27ac, and H3K14ac. Interestingly, T-2 toxin-induced AhR activation also facilitated RNA polymerase II binding to CpG island 2, which may form a transcriptionally active chromatin structure at the promoter and ultimately transactivate CYP1A4. Our findings provide novel insights into the epigenetic regulation of T-2 toxin-induced gene expression.	[Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China; [Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Guangzhou, Peoples R China; [Jiang, Jun; Zhu, Jiahui; Liu, Qian; Zhang, Tingting; Wen, Jikai; Deng, Yiqun] South China Agr Univ, Key Lab Zoonosis, Minist Agr & Rural Affairs, Guangzhou, Peoples R China; [Xia, Jianhong] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Deng, YQ (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn	Deng, Yiqun/K-7709-2013; wen, jikai/AAV-9818-2021	Deng, Yiqun/0000-0002-6838-3779; wen, jikai/0000-0002-4010-4416	Natural Science Foundation of Guangdong Province [2016A030313166, 2018A030313001]; National Natural Science Foundation of China [U1901207]; National Natural Science Foundation of Guangdong Province [U1901207]; Science and Technology Program of Guangzhou [201804020067]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou	the Natural Science Foundation of Guangdong Province, Grant/Award Number: 2018A030313001; the Joint Fund of National Natural Science Foundation of China and Guangdong Province, Grant/Award Number: U1901207; the Natural Science Foundation of Guangdong Province, Grant/Award Number: 2016A030313166; the Science and Technology Program of Guangzhou, Grant/Award Number: 201804020067	Amenya HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34989; Anttila S, 2003, CANCER RES, V63, P8623; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Dai CS, 2019, ARCH TOXICOL, V93, P3041, DOI 10.1007/s00204-019-02577-5; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gannon M, 2000, TOXICOL APPL PHARM, V164, P24, DOI 10.1006/taap.1999.8864; Han J, 2016, TOXICOL APPL PHARM, V300, P70, DOI 10.1016/j.taap.2016.03.006; Huang DY, 2019, FOOD CHEM TOXICOL, V123, P595, DOI 10.1016/j.fct.2018.10.059; Kikuchi Y, 2003, J BIOCHEM, V134, P83, DOI 10.1093/jb/mvg115; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kobayashi A, 1997, J BIOCHEM, V122, P703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruber P, 2011, TOXICOLOGY, V284, P34, DOI 10.1016/j.tox.2011.03.012; Liu AM, 2019, TOXICOLOGY, V425, DOI 10.1016/j.tox.2019.152246; Liu AM, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110661; Liu Q, 2019, BIOCHEM PHARMACOL, V168, P319, DOI 10.1016/j.bcp.2019.07.023; Liu XL, 2017, TOXICOLOGY, V392, P81, DOI 10.1016/j.tox.2017.10.013; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MORGAN JE, 1992, P NATL ACAD SCI USA, V89, P11622, DOI 10.1073/pnas.89.23.11622; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; OKINO ST, 1995, MOL CELL BIOL, V15, P3714; Okino ST, 2006, CANCER RES, V66, P7420, DOI 10.1158/0008-5472.CAN-06-0504; PICARDO M, 1982, COMP BIOCHEM PHYS B, V71, P689, DOI 10.1016/0305-0491(82)90482-5; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Santes-Palacios R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5341081; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Shang SF, 2013, INT J MOL SCI, V14, P10809, DOI 10.3390/ijms140610809; Sun Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44305-0; Taylor RT, 2009, TOXICOL SCI, V107, P1, DOI 10.1093/toxsci/kfn217; Wang X, 2012, TOXICOL SCI, V127, P412, DOI 10.1093/toxsci/kfs106; Wu QH, 2014, ARCH TOXICOL, V88, P1309, DOI 10.1007/s00204-014-1280-0; Wu QH, 2020, ARCH TOXICOL, V94, P3645, DOI 10.1007/s00204-020-02899-9; Wu QH, 2017, ARCH TOXICOL, V91, P3737, DOI 10.1007/s00204-017-2118-3; Yang X, 2020, J AGR FOOD CHEM, V68, P727, DOI 10.1021/acs.jafc.9b07880; Ye WC, 2019, TOXICOL LETT, V315, P77, DOI 10.1016/j.toxlet.2019.08.021; Zhang Y, 2017, THERIOGENOLOGY, V103, P110, DOI 10.1016/j.theriogenology.2017.07.052	42	0	0	6	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21469	10.1096/fj.202002570RR	http://dx.doi.org/10.1096/fj.202002570RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788981				2022-12-26	WOS:000645260100026
J	Li, ZK; Wang-Heaton, H; Cartwright, BM; Makinwa, Y; Hilton, BA; Musich, PR; Shkriabai, N; Kvaratskhelia, M; Guan, SH; Chen, Q; Yu, XC; Zou, Y				Li, Zhengke; Wang-Heaton, Hui; Cartwright, Brian M.; Makinwa, Yetunde; Hilton, Benjamin A.; Musich, Phillip R.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Guan, Shengheng; Chen, Qian; Yu, Xiaochun; Zou, Yue			ATR prevents Ca2+ overload-induced necrotic cell death through phosphorylation-mediated inactivation of PARP1 without DNA damage signaling	FASEB JOURNAL			English	Article						ATR; Ca2+ overload; necrosis; PARP1; PARP1 phosphorylation	MITOCHONDRIAL PERMEABILITY TRANSITION; NUCLEOTIDE EXCISION-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; ESSENTIAL KINASE; APOPTOSIS; CALCIUM; CHECKPOINT; ACTIVATION	Hyperactivation of PARP1 is known to be a major cause of necrotic cell death by depleting NAD(+)/ATP pools during Ca2+ overload which is associated with many ischemic diseases. However, little is known about how PARP1 hyperactivity is regulated during calcium overload. In this study we show that ATR kinase, well known for its role in DNA damage responses, suppresses ionomycin, glutamate, or quinolinic acid-induced necrotic death of cells including SH-SY5Y neuronal cells. We found that the inhibition of necrosis requires the kinase activity of ATR. Specifically, ATR binds to and phosphorylates PARP1 at Ser179 after the ionophore treatments. This site-specific phosphorylation inactivates PARP1, inhibiting ionophore-induced necrosis. Strikingly, all of this occurs in the absence of detectable DNA damage and signaling up to 8 hours after ionophore treatment. Furthermore, little AIF was released from mitochondria/cytoplasm for nuclear import, supporting the necrotic type of cell death in the early period of the treatments. Our results reveal a novel ATR-mediated anti-necrotic mechanism in the cellular stress response to calcium influx without DNA damage signaling.	[Li, Zhengke; Wang-Heaton, Hui; Cartwright, Brian M.; Hilton, Benjamin A.; Musich, Phillip R.; Zou, Yue] East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA; [Makinwa, Yetunde; Zou, Yue] Univ Toledo, Dept Canc Biol, Coll Med, Toledo, OH 43614 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Guan, Shengheng] Univ Calif San Francisco, Dept Pharmaceut Chem & Mass Spectrometry Facil, San Francisco, CA USA; [Chen, Qian; Yu, Xiaochun] City Hope Natl Med Ctr, Dept Canc Genet & Epigenet, Duarte, CA USA	East Tennessee State University; University System of Ohio; University of Toledo; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; City of Hope	Li, ZK; Zou, Y (corresponding author), East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA.; Zou, Y (corresponding author), Univ Toledo, Dept Canc Biol, Coll Med, Toledo, OH 43614 USA.	LIZ01@mail.etsu.edu; yue.zou@utoledo.edu			National Institutes of Health [R01CA219342, R01CA86927, R15GM112168]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01CA219342, R01CA86927 and R15GM112168	Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho YS, 2010, MOL CELLS, V29, P327, DOI 10.1007/s10059-010-0066-3; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Douglas DL, 2014, J CELL SCI, V127, P4134, DOI 10.1242/jcs.128009; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Francis RJ, 2013, J LEUKOCYTE BIOL, V93, P95, DOI 10.1189/jlb.0412212; Gagne JP, 2012, SCIENCE, V336, P678, DOI 10.1126/science.1221870; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han SI, 2008, BMB REP, V41, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hsu PC, 2019, ONCOGENE, V38, P1166, DOI 10.1038/s41388-018-0506-7; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim D, 2018, NUCLEIC ACIDS RES, V46, P8311, DOI 10.1093/nar/gky625; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Li GY, 2010, BIOMED ENVIRON SCI, V23, P371, DOI 10.1016/S0895-3988(10)60078-5; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Monassier JP, 2008, ARCH CARDIOVASC DIS, V101, P491, DOI 10.1016/j.acvd.2008.06.014; Muller GJ, 2004, BRAIN PATHOL, V14, P415; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park S, 2015, ANAT CELL BIOL, V48, P66, DOI 10.5115/acb.2015.48.1.66; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; PATEL R, 1989, J CELL SCI, P129; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Strom CE, 2012, BIOMOLECULES, V2, P635, DOI 10.3390/biom2040635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Visvanathan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067689; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yelamos J, 2011, AM J CANCER RES, V1, P328; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang FJ, 2014, TOXICOL SCI, V140, P118, DOI 10.1093/toxsci/kfu073; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	101	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21373	10.1096/fj.202001636RRR	http://dx.doi.org/10.1096/fj.202001636RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811702	Green Published, hybrid			2022-12-26	WOS:000645260100096
J	Lao, MY; Zhang, XZ; Ma, T; Xu, J; Yang, HS; Duan, Y; Ying, HG; Zhang, XY; Guo, CX; Qiu, JY; Bai, XL; Liang, TB				Lao, Mengyi; Zhang, Xiaozhen; Ma, Tao; Xu, Jian; Yang, Hanshen; Duan, Yi; Ying, Honggang; Zhang, Xiaoyu; Guo, Chengxiang; Qiu, Junyu; Bai, Xueli; Liang, Tingbo			Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells	ONCOGENE			English	Article								Therapeutic strategies to treat pancreatic ductal adenocarcinoma (PDAC) remain unsatisfying and limited. Therefore, it is imperative to fully determine the mechanisms underlying PDAC progression. In the present study, we report a novel role of regulator of calcineurin 1, isoform 4 (RCAN1.4) in regulating PDAC progression. We demonstrated that RCAN1.4 expression was decreased significantly in PDAC tissues compared with that in para-cancerous tissues, and correlated with poor prognosis of patients with pancreatic cancer. In vitro, stable high expression of RCAN1.4 could suppress the metastasis and proliferation and angiogenesis of pancreatic tumor cells. In addition, interferon alpha inducible protein 27 (IFI27) was identified as having a functional role in RCAN1.4-mediated PDAC migration and invasion, while VEGFA play a vital role in RCAN1.4-mediated PDAC angiogenesis. Analysis of mice with subcutaneously/orthotopic implanted xenograft tumors and liver metastasis model confirmed that RCAN1.4 could modulate the growth, metastasis, and angiogenesis of tumors via IFI27/VEGFA in vivo. In conclusion, our results suggested that RCAN1.4 suppresses the growth, metastasis, and angiogenesis of PDAC, functioning partly via IFI27 and VEGFA. Importantly, our results provided possible diagnostic criteria and therapeutic targets for PDAC.	[Lao, Mengyi; Zhang, Xiaozhen; Ma, Tao; Xu, Jian; Yang, Hanshen; Duan, Yi; Ying, Honggang; Zhang, Xiaoyu; Guo, Chengxiang; Qiu, Junyu; Bai, Xueli; Liang, Tingbo] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Lao, Mengyi; Zhang, Xiaozhen; Ma, Tao; Xu, Jian; Yang, Hanshen; Duan, Yi; Ying, Honggang; Zhang, Xiaoyu; Guo, Chengxiang; Qiu, Junyu; Bai, Xueli; Liang, Tingbo] Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China; [Lao, Mengyi; Zhang, Xiaozhen; Ma, Tao; Xu, Jian; Yang, Hanshen; Duan, Yi; Ying, Honggang; Zhang, Xiaoyu; Guo, Chengxiang; Qiu, Junyu; Bai, Xueli; Liang, Tingbo] Zhejiang Prov Innovat Ctr Study Pancreat Dis, Hangzhou, Peoples R China	Zhejiang University	Bai, XL; Liang, TB (corresponding author), Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China.; Bai, XL; Liang, TB (corresponding author), Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China.; Bai, XL; Liang, TB (corresponding author), Zhejiang Prov Innovat Ctr Study Pancreat Dis, Hangzhou, Peoples R China.	shirleybai@zju.edu.cn; liangtingbo@zju.edu.cn	Zhang, xiaoyu/GXA-3206-2022; Yang, Hanshen/HII-7604-2022	Yang, Hanshen/0000-0001-5220-1996; Zhang, Xiaozhen/0000-0003-3567-8789	National Natural Science Foundation of China [U20A20378, 81871925, 81672337, 82071867, 82071748]; National Key Research and Development Program [2019YFC1316000]; Key Research and Development Program of Zhejiang Province [2019C03019, 2020C03117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Key Research and Development Program of Zhejiang Province	We thank Mr. Minghua Sun for his technical support during sample processing. This study was supported by the National Natural Science Foundation of China (U20A20378, to T-BL; 81871925, 81672337, and 82071867 to X-LB; 82071748 to TM), the National Key Research and Development Program (2019YFC1316000 to T-BL), and the Key Research and Development Program of Zhejiang Province (2019C03019 to T-BL; 2020C03117 to X-LB).	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Chiaravalli M, 2017, CANCER TREAT REV, V60, P32, DOI 10.1016/j.ctrv.2017.08.007; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Hampton T, 2005, JAMA-J AM MED ASSOC, V293, P284, DOI 10.1001/jama.293.3.284; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Jang C, 2011, KOREAN J PHYSIOL PHA, V15, P299, DOI 10.4196/kjpp.2011.15.5.299; Jin HJ, 2017, GASTROENTEROLOGY, V153, P799, DOI 10.1053/j.gastro.2017.05.045; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Lee JC, 2013, BIOCHEM BIOPH RES CO, V440, P50, DOI 10.1016/j.bbrc.2013.09.033; Liu NL, 2014, ONCOTARGET, V5, P4959, DOI 10.18632/oncotarget.2067; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Mihalich A, 2012, GYNECOL ENDOCRINOL, V28, P216, DOI 10.3109/09513590.2011.588746; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Satge D, 2001, B ACAD NAT MED PARIS, V185, P1239, DOI 10.1016/S0001-4079(19)34447-4; Song ZS, 2018, EXP CELL RES, V372, P118, DOI 10.1016/j.yexcr.2018.09.017; Suomela S, 2004, J INVEST DERMATOL, V122, P717, DOI 10.1111/j.0022-202X.2004.22322.x; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang CJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90651; Wang H, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1371-0; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	25	4	4	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3136	3151		10.1038/s41388-021-01763-z	http://dx.doi.org/10.1038/s41388-021-01763-z		APR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33824473	Green Published, hybrid			2022-12-26	WOS:000637478800004
J	Jarvisalo, MJ; Hellman, T; Uusalo, P				Jarvisalo, Mikko J.; Hellman, Tapio; Uusalo, Panu			Mortality and associated risk factors in patients with blood culture positive sepsis and acute kidney injury requiring continuous renal replacement therapy-A retrospective study	PLOS ONE			English	Article								Objectives Septic acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) carries a mortality risk nearing 50%. Risk factors associated with mortality in AKI patients undergoing CRRT with blood culture positive sepsis remain unclear as sepsis has been defined according to consensus criteria in previous studies. Methods Risk factors associated with intensive care unit (ICU), 90-day and overall mortality were studied in a retrospective cohort of 126 patients with blood culture positive sepsis and coincident severe AKI requiring CRRT. Comprehensive laboratory and clinical data were gathered at ICU admission and CRRT initiation. Results 38 different causative pathogens for sepsis and associated AKI were identified. ICU mortality was 30%, 90-day mortality 45% and one-year mortality 50%. Immunosuppression, history of heart failure, APACHE II and SAPS II scores, C-reactive protein and lactate at CRRT initiation were independently associated with mortality in multivariable Cox proportional hazards models. Blood lactate showed good predictive power for ICU mortality in receiver operating characteristic curve analyses with AUCs of 0.76 (95%CI 0.66-0.85) for lactate at ICU admission and 0.84 (95%CI 0.72-0.95) at CRRT initiation. Conclusions Our study shows for the first time that lactate measured at CRRT initiation is predictive of ICU mortality and independently associated with overall mortality in patients with blood culture positive sepsis and AKI requiring CRRT. Microbial etiology for septic AKI requiring CRRT is diverse.	[Jarvisalo, Mikko J.; Hellman, Tapio] Turku Univ Hosp, Kidney Ctr, Turku, Finland; [Jarvisalo, Mikko J.; Hellman, Tapio] Univ Turku, Turku, Finland; [Jarvisalo, Mikko J.; Uusalo, Panu] Univ Turku, Dept Anaesthesiol & Intens Care, Turku, Finland; [Jarvisalo, Mikko J.; Uusalo, Panu] Turku Univ Hosp, Perioperat Serv, Intens Care & Pain Med, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Jarvisalo, MJ (corresponding author), Turku Univ Hosp, Kidney Ctr, Turku, Finland.; Jarvisalo, MJ (corresponding author), Univ Turku, Turku, Finland.; Jarvisalo, MJ (corresponding author), Univ Turku, Dept Anaesthesiol & Intens Care, Turku, Finland.; Jarvisalo, MJ (corresponding author), Turku Univ Hosp, Perioperat Serv, Intens Care & Pain Med, Turku, Finland.	mikko.jarvisalo@tyks.fi		Uusalo, Panu/0000-0001-5120-8854; Hellman, Tapio/0000-0001-9453-5687; Jarvisalo, Mikko/0000-0002-0507-2148				Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Chua HR, 2020, J INTENSIVE CARE MED, V35, P527, DOI 10.1177/0885066618764617; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Gupta S, 2016, CHEST, V150, P1251, DOI 10.1016/j.chest.2016.08.1460; Kethireddy S, 2018, CRIT CARE MED, V46, P506, DOI 10.1097/CCM.0000000000002924; Kim JS, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03421-4; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Nagata I, 2015, J CRIT CARE, V30, P998, DOI 10.1016/j.jcrc.2015.06.021; Oh HJ, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.08.001; Ostrowski J, 2012, ANAESTH INTENS CARE, V40, P813, DOI 10.1177/0310057X1204000509; Panday RSN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2431-8; Passos RD, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005112; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Phua J, 2013, CRIT CARE, V17, DOI 10.1186/cc12896; Rannikko J, 2017, INT J INFECT DIS, V58, P52, DOI 10.1016/j.ijid.2017.03.005; Romagnoli S, 2018, CURR OPIN CRIT CARE, V24, P483, DOI 10.1097/MCC.0000000000000544; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Thomas-Rueddel DO, 2015, J CRIT CARE, V30, P439, DOI 10.1016/j.jcrc.2014.10.027; Tian HH, 2014, INT UROL NEPHROL, V46, P2009, DOI 10.1007/s11255-014-0747-5; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11158; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Yamamoto S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007049	23	3	3	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249561	10.1371/journal.pone.0249561	http://dx.doi.org/10.1371/journal.pone.0249561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819306	gold, Green Published			2022-12-26	WOS:000637647200026
J	Chan, EYL; Smullin, C; Clavijo, S; Papp-Green, M; Park, E; Nelson, M; Giarratano, G; Wagman, JA				Chan, Elaine Y. L.; Smullin, Carolyn; Clavijo, Stephanie; Papp-Green, Melissa; Park, Eunhee; Nelson, Marlene; Giarratano, Gloria; Wagman, Jennifer A.			A qualitative assessment of structural barriers to prenatal care and congenital syphilis prevention in Kern County, California	PLOS ONE			English	Article								Congenital syphilis is the result of placental transmission from mother to fetus of Treponema pallidum. Although congenital syphilis is preventable through timely treatment, the rate of new infections in the United States (US) has increased each year since 2013, and is increasing at a noticeably greater pace in California (CA). Most research into congenital syphilis has focused on individual psychosocial and behavioral factors that contribute to maternal vulnerability for syphilis. The aim of this study was to evaluate structural barriers to prenatal care access and utilization and congenital syphilis prevention in Kern County, CA. Transcripts from 8 in-depth interviews with prenatal care providers and 5 focus group discussions with 42 pregnant and postpartum persons were examined using thematic analysis. Structural barriers experienced by pregnant and postpartum persons to prenatal care access and utilization included (1) burdens of poverty; (2) stigma around substance use in pregnancy; (3) citizenship status; (4) lack of healthcare coverage; (5) low sexual health literacy; and (6) gender inequality Structural barriers experienced by prenatal care providers in congenital syphilis prevention included (1) limited guidance on clinical management of syphilis in pregnancy; (2) decay in public health infrastructure; and (3) inadequate support for managing patients' social comorbidities. The response to congenital syphilis prevention will require an examination of the complex context of social determinants of health in which persons diagnosed with syphilis live in.	[Chan, Elaine Y. L.; Smullin, Carolyn; Clavijo, Stephanie] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Clavijo, Stephanie; Park, Eunhee; Wagman, Jennifer A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA; [Clavijo, Stephanie] Charles R Drew Univ Med & Sci, 1621 E 120th St, Los Angeles, CA 90059 USA; [Papp-Green, Melissa] Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA; [Nelson, Marlene] Calif State Univ Bakersfield, Sch Social Sci & Educ, Bakersfield, CA USA; [Giarratano, Gloria] Louisiana State Univ, Sch Nursing, Baton Rouge, LA 70803 USA; [Wagman, Jennifer A.] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Charles R. Drew University of Medicine & Science; Los Angeles County Department of Public Health; California State University System; California State University Bakersfield; Louisiana State University System; Louisiana State University; University of California System; University of California Los Angeles	Wagman, JA (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA.; Wagman, JA (corresponding author), Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	jennwagman@ucla.edu	Park, Eunee/CAF-4882-2022; Chan, Elaine/GRR-5490-2022	Smullin, Carolyn/0000-0002-0794-5790; Park, Eunhee/0000-0001-6442-8119	March of Dimes; Centers for Disease Control and Prevention [U380T000199-05-00]	March of Dimes(March of Dimes); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	JW received funding by March of Dimes (https://www.marchofdimes.org/) and the Centers for Disease Control and Prevention (https://www.cdc.gov/) (U380T000199-05-00). The views expressed in the report do not necessarily reflect the official policies of the Department of Health and Human Services; nor do they mention trade names, commercial practices, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein Kyle T, 2018, Sex Transm Dis, V45, pS1, DOI 10.1097/OLQ.0000000000000817; Biswas HH, 2018, SEX TRANSM DIS, V45, P435, DOI [10.1097/OLQ.0000000000000782, 10.1097/olq.0000000000000782]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bryant A., AMA J ETHICS, V20, P269; ( CDC) CfDC, 2015, MMWR RECOMM REP, V64; Centers for Disease Control and Prevention (CDC), 2019, SEXUALLY TRANSMITTED; DiOrio D, 2018, SEX TRANSM DIS, V45, P447, DOI [10.1097/OLQ.0000000000000783, 10.1097/olq.0000000000000783]; Health CDoP, 2018, CAL SEX TRANSM DIS S; Hollier LM, 2003, AM J OBSTET GYNECOL, V189, P1178, DOI 10.1067/S0002-9378(03)00547-7; Knight KR, 2019, NEW ENGL J MED, V381, P593, DOI 10.1056/NEJMp1907437; Kroeger KA, 2018, SEX TRANSM DIS, V45, P442, DOI [10.1097/OLQ.0000000000000787, 10.1097/olq.0000000000000787]; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Metzl JM, 2014, SOC SCI MED, V103, P126, DOI 10.1016/j.socscimed.2013.06.032; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Papp-Green M, 2018, SOLUTIONS SYPHILLS T, DOI [10.1080/10410236.2018.1431020, DOI 10.1080/10410236.2018.1431020]; Santis M. de, 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P430585, DOI 10.1155/2012/430585; Smullin C, 2020, SEX TRANS DIS; U.S. Census Bureau, 2018, 2018 NAT STAT POP ES	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249419	10.1371/journal.pone.0249419	http://dx.doi.org/10.1371/journal.pone.0249419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793630	Green Published, gold			2022-12-26	WOS:000636467000009
J	Clement, J; Jacobi, M; Greenwood, BN				Clement, Jeffrey; Jacobi, Maura; Greenwood, Brad N.			Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims	PLOS ONE			English	Article							ADHERENCE; THERAPY	Patient access and adherence to chronic medications is critical. In this work, we evaluate whether disruptions related to Covid-19 have affected new and existing patients' access to pharmacological therapies without interruption. We do so by performing a retrospective analysis on a dataset of 9.4 billion US prescription drug claims from 252 million patients from May, 2019 through August, 2020 (about 93% of prescriptions dispensed within those months). Using fixed effect (conditional likelihood) linear models, we evaluate continuity of care, how many days of supply patients received, and the likelihood of discontinuing therapy for drugs from classes with significant population health impacts. Findings indicate that more prescriptions were filled in March 2020 than in any prior month, followed by a significant drop in monthly dispensing. Compared to the pre-Covid era, a patient's likelihood of discontinuing some medications increased after the spread of Covid: norgestrel-ethinyl estradiol (hormonal contraceptive) discontinuation increased 0.62% (95% CI: 0.59% to 0.65%, p<0.001); dexmethylphenidate HCL (ADHD stimulant treatment) discontinuation increased 2.84% (95% CI: 2.79% to 2.89%, p<0.001); escitalopram oxalate (SSRI antidepressant) discontinuation increased 0.57% (95% CI: 0.561% to 0.578%, p<0.001); and haloperidol (antipsychotic) discontinuation increased 1.49% (95% CI: 1.41% to 1.57%, p<0.001). In contrast, the likelihood of discontinuing tacrolimus (immunosuppressant) decreased 0.15% (95% CI: 0.12% to 0.19%, p<0.001). The likelihood of discontinuing buprenorphine/naloxone (opioid addiction therapy) decreased 0.59% (95% CI: 0.55% to 0.62% decrease, p<0.001). We also observe a notable decline in new patients accessing these latter two therapies. Most US patients were able to access chronic medications during the early months of Covid-19, but still were more likely to discontinue their therapies than in previous months. Further, fewer than normal new patients started taking medications that may be vital to their care. Providers would do well to inquire about adherence and provide prompt, nonjudgmental, re-initiation of medications. From a policy perspective, opioid management programs seem to demonstrate a robust ability to manage existing patients in spite of disruption.	[Clement, Jeffrey] Univ Minnesota, Carlson Sch Management, Informat & Decis Sci, Minneapolis, MN 55455 USA; [Jacobi, Maura] Allina Hlth, United Family Med Residency, St Paul, MN USA; [Greenwood, Brad N.] George Mason Univ, Sch Business, Informat Syst & Operat Management, Arlington, VA USA	University of Minnesota System; University of Minnesota Twin Cities; Allina Health System; George Mason University	Clement, J (corresponding author), Univ Minnesota, Carlson Sch Management, Informat & Decis Sci, Minneapolis, MN 55455 USA.	cleme514@umn.edu	Clement, Jeffrey/J-6883-2019	Clement, Jeffrey/0000-0002-4500-7260				Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2020, SYMPHONY HEALTHCARE; Brancu M, 2016, PSYCHOL TRAUMA-US, V8, P222, DOI 10.1037/tra0000078; Chan SS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003072; Commission C of MHP, 2018, PRESCR DRUG COUP STU; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Degli Esposti L, 2020, RISK MANAG HEALTHC P, V13, P3179, DOI 10.2147/RMHP.S265264; Deke J., 2014, MATH POLICY RES REPO, V6, P1; Erin Fox, 2020, AM SOC HLTH SYSTEM P; Felt BT, 2014, AM FAM PHYSICIAN, V90, P456; Giavoli C, 2020, EUR J ENDOCRINOL, V183, pL13, DOI 10.1530/EJE-20-0481; Haley DF, 2020, JAMA-J AM MED ASSOC, V324, P1615, DOI 10.1001/jama.2020.18543; Kaye L, 2020, J ALLER CL IMM-PRACT, V8, P2384, DOI 10.1016/j.jaip.2020.04.053; Mahal SK, 2014, AM J GERIAT PSYCHIAT, V22, pS75, DOI 10.1016/j.jagp.2013.12.083; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rader R, 2009, AM FAM PHYSICIAN, V79, P657; Rosenbaum J, 2021, AM J EMERG MED, V41, P51, DOI 10.1016/j.ajem.2020.12.047; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Woolhandler S, 2020, ANN INTERN MED, V173, P63, DOI 10.7326/M20-1491; Yang PK, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.190440; Zhang JP, 2013, INT J NEUROPSYCHOPH, V16, P1205, DOI 10.1017/S1461145712001277; Ziedan E., 2020, 27621 NBER	22	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249453	10.1371/journal.pone.0249453	http://dx.doi.org/10.1371/journal.pone.0249453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793663	gold, Green Published			2022-12-26	WOS:000636467000075
J	Risica, PM; McCarthy, ML; Barry, KL; Oliverio, SP; Gans, KM; De Groot, AS				Risica, Patricia Markham; McCarthy, Meghan L.; Barry, Katherine L.; Oliverio, Susan P.; Gans, Kim M.; De Groot, Anne S.			Clinical outcomes of a community clinic-based lifestyle change program for prevention and management of metabolic syndrome: Results of the 'Vida Sana/Healthy Life' program	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; WEIGHT-LOSS; INTERVENTION; US; PREVALENCE; ADULTS; HISPANICS; KNOWLEDGE; OBESITY	Introduction As US Hispanic populations are at higher risk than non-Hispanics for cardiovascular disease and Type 2 diabetes targeted interventions are clearly needed. This paper presents the four years results of the Vida Sana Program (VSP), which was developed and is implemented by a small clinic serving mostly Spanish-speaking, limited literacy population. Methods The eight-week course of interactive two-hour sessions taught by Navegantes, bilingual/cultural community health workers, was delivered to participants with hypertension, or high lipids, BMI, waist circumference, glucose or hemoglobin A1C (A1C). Measures, collected by Navegantes and clinic nurses, included blood chemistries, blood pressure, anthropometry, and an assessment of healthy food knowledge. Results Most participants (67%) were female, Hispanic (95%), and all were 18 to 70 years of age. At baseline, close to half of participants were obese (48%), had high waist circumference (53%), or elevated A1C (52%), or fasting blood glucose (57%). About one third had high blood pressure (29%) or serum cholesterol (35%), and 22% scored low on the knowledge assessment. After the intervention, participants decreased in weight (-1.0 lb), BMI (-0.2 kg/m2), WC (-0.4 inches), and cholesterol (-3.5 mg/dl, all p<0.001). Systolic blood pressure decreased (-1.7 mm Hg, p<0.001), and the knowledge score increased (6.8 percent, p<0.001). Discussion VSP shows promising improvements in metabolic outcomes, similar to other programs with longer duration or higher intensity interventions. VSP demonstrates an important model for successful community-connected interventions.	[Risica, Patricia Markham; Gans, Kim M.] Brown Univ, Sch Publ Hlth, Ctr Hlth Equ Res, Providence, RI 02912 USA; [Risica, Patricia Markham; Gans, Kim M.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Risica, Patricia Markham] Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI 02903 USA; [McCarthy, Meghan L.; Barry, Katherine L.; De Groot, Anne S.] Hope Clin, Clin Esperanza, Providence, RI USA; [Oliverio, Susan P.] Brown Univ, Warren Alpert Sch Med, Dept Internal Med, Providence, RI 02912 USA; [Gans, Kim M.] Univ Connecticut, Dept Human Dev & Family Studies, Storrs, CT USA; [Gans, Kim M.] Univ Connecticut, Inst Collaborat Hlth Intervent & Policy, Storrs, CT USA; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA	Brown University; Brown University; Brown University; Brown University; University of Connecticut; University of Connecticut; University of Rhode Island	Risica, PM (corresponding author), Brown Univ, Sch Publ Hlth, Ctr Hlth Equ Res, Providence, RI 02912 USA.; Risica, PM (corresponding author), Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA.; Risica, PM (corresponding author), Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI 02903 USA.	Patricia_Risica@brown.edu	De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459; Risica, Patricia/0000-0002-2868-1931				Ali SH, 2021, CURR HYPERTENS REP, V23, DOI 10.1007/s11906-020-01121-6; Altman R, 2014, J WOMENS HEALTH, V23, P350, DOI 10.1089/jwh.2013.4570; Aviles-Santa ML, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00298; Buckley J, 2015, J COMMUN HEALTH, V40, P116, DOI 10.1007/s10900-014-9905-z; Campbell B, 2016, DIABETES METAB SYND, V10, P230, DOI 10.1016/j.dsx.2016.06.014; Cholestech L.D.X, 2002, SYSTEM USER MANUAL; Corona G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157915; Cortes-Bergoderi M, 2013, EUR J INTERN MED, V24, P791, DOI 10.1016/j.ejim.2013.09.003; Gans KM, 2002, J NUTR EDUC BEHAV, V34, P202, DOI 10.1016/S1499-4046(06)60094-8; Giambrone AE, 2016, ETHNIC DIS, V26, P339, DOI 10.18865/ed.26.3.339; Gurka MJ, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0024-2; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Jensen MD, 2014, JAMA-J AM MED ASSOC, V311, P23, DOI 10.1001/jama.2013.282546; Kato M, 2012, DIABETIC MED, V29, P905, DOI 10.1111/j.1464-5491.2012.03572.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lacara T, 2007, AM J CRIT CARE, V16, P336; Medina-Inojosa J, 2014, PROG CARDIOVASC DIS, V57, P286, DOI 10.1016/j.pcad.2014.09.001; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Nantsupawat N, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-0975-x; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Orchard TJ, 2005, ANN INTERN MED, V142, P611, DOI 10.7326/0003-4819-142-8-200504190-00009; Pedley CF, 2018, DIABETES METAB SYND, V12, P215, DOI 10.1016/j.dsx.2017.09.011; Reyes J, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617713097; Risica PM, 2018, CONT CLIN TRIAL COMM, V12, P123, DOI 10.1016/j.conctc.2018.10.002; Risica PM MM., 2018, SUBMISSION CONT CLIN, DOI [10.1016/j.cct.2017.12.005, DOI 10.1016/J.CCT.2017.12.005]; Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981; Rosas LG, 2018, CONTEMP CLIN TRIALS, V68, P23, DOI 10.1016/j.cct.2018.02.019; Rosas LG, 2016, CONTEMP CLIN TRIALS, V48, P30, DOI 10.1016/j.cct.2016.03.003; Rosas LG, 2015, J ACAD NUTR DIET, V115, P537, DOI 10.1016/j.jand.2014.10.020; Sellers TA, 2001, EPIDEMIOLOGY, V12, P420, DOI 10.1097/00001648-200107000-00012; Shaibi GQ, 2013, CTS-CLIN TRANSL SCI, V6, P429, DOI 10.1111/cts.12114; Speight J, 2001, DIABETIC MED, V18, P626, DOI 10.1046/j.1464-5491.2001.00537.x; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; XIAO OS, 1993, AM J EPIDEMIOL, V137, P155, DOI 10.1093/oxfordjournals.aje.a116655; Zhang P, 2005, DIABETES CARE, V28, P1321, DOI 10.2337/diacare.28.6.1321	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248473	10.1371/journal.pone.0248473	http://dx.doi.org/10.1371/journal.pone.0248473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793595	gold, Green Published			2022-12-26	WOS:000636467000058
J	Saeed, BQ; Al-Shahrabi, R; Bolarinwa, OA				Saeed, Balsam Qubais; Al-Shahrabi, Rula; Bolarinwa, Obasanjo Afolabi			Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study	PLOS ONE			English	Article								Since the World Health Organization (WHO) announced that the coronavirus disease (COVID-19) is a worldwide pandemic, many countries' authorities, including the Iraqi authorities, started responding and taking action to control the spread of the pandemic. The public's knowledge and practices play an important role in curbing the spreading of the virus by following the health guidelines. This study aimed to assess the socio-demographic correlate of knowledge and practices of Iraqi living in Mosul-Iraq towards COVID-19 during its rapid rise. A cross-sectional online survey of 909 participants was conducted among a sample of the Mosul-Iraq population between 20(th) June to 1(st) July 2020. The survey included three parts: 1) socio-demographic characteristics, 2) participants' knowledge, 3) participants' practices. T-test, ANOVA, chi-square, and binary logistic regression were used. A p-value less than 0.05 (p < 0.05) was considered statistically significant. The results showed a knowledge and practice mean score of (12.91 +/- 1.67) and (21.56 +/- 2.92) with cumulative knowledge and practice of 86% and 76% respectively towards COVID-19. Socio-demographic characteristics such as age, marital status, gender, level of education and employment were statistically related with a higher mean score of knowledge and practice towards the virus as P.05. We concluded that the majority of the respondents demonstrate a high level of knowledge and practices towards COVID-19 except for respondents with socio-demographic characteristics such as those who were younger, male respondents, those with lower education and those unemployed as such campaigns that will increase the knowledge and encourage adequate preventive practice towards COVID-19 should be targeted towards this group.	[Saeed, Balsam Qubais] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Saeed, Balsam Qubais; Al-Shahrabi, Rula] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Bolarinwa, Obasanjo Afolabi] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth Med, Durban, South Africa	University of Sharjah; University of Sharjah; University of Kwazulu Natal	Saeed, BQ (corresponding author), Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates.; Saeed, BQ (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	bsaeed@sharjah.ac.ae	Bolarinwa, Obasanjo/ABC-5499-2020	Bolarinwa, Obasanjo/0000-0002-9208-6408				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Al-Malkey MK, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101739; [Anonymous], 2020, REVITALISING COMMERC; [Anonymous], 2020, MOSUL MSF WORKS DUAL; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7; CDC, 2020, COR DIS 2019 COVID 1; CDC, 2020, GET FACTS COR; Conroy R., 2015, SAMPLE SIZE ROUGH GU; Garson GD., 2016, LOGISTIC REGRESSION; Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Hussain AM, 2019, SAUDI MED J, V40, P72, DOI 10.15537/smj.2019.1.23463; Israel G.D., 1992, FLORIDA COOPERATIVE; Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Mikhael EM., 2020, IRAQI SITUATION PUB, V1; Nunnally J.C., 1994, PSYCHOM THEORY; Rugarabamu S, 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.04.26.20080820.t, DOI 10.1101/2020.04.26.20080820.T]; Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; UN OCHA (United Nations Office for the Coordination of Humanitarian Affairs), 2020, UN OFF COORD HUM AFF; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Health Organization, NOV COR 2019 NCOV AD; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yun K, 2012, J COMMUN HEALTH, V37, P1110, DOI 10.1007/s10900-012-9552-1; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249310	10.1371/journal.pone.0249310	http://dx.doi.org/10.1371/journal.pone.0249310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788835	Green Published, gold			2022-12-26	WOS:000636354600042
J	Suzuki, Y				Suzuki, Yasuhiro			Risk factors for delayed encephalopathy following carbon monoxide poisoning: Importance of the period of inability to walk in the acute stage	PLOS ONE			English	Article								Objective Delayed neurological sequelae (DNS) is a serious complication that occurs after acute carbon monoxide (CO) intoxication. The study identified factors for predicting DNS development for the purpose of improving CO intoxication treatment strategies. Methods The medical records of 65 patients admitted to Shizuoka Saiseikai General Hospital between 2004 and 2020 due to CO poisoning were retrospectively reviewed. Univariate and multivariate logistic regression analyses were performed, using a range of evaluated items as explanatory variables and the development of DNS as the response variable. Results Patients who developed DNS were found to have higher peak creatine kinase (CK) (odds ratio, 1.0003; 95% CI, 1.0001-1.0005; P<0.001), and experienced a greater number of days during which walking was impossible in the acute stage following intoxication (odds ratio, 1.011; 95% CI, 1.005-1.018; P<0.001) according to the univariate analysis. Multivariate analyses indicated that DNS development was related to the score, peak CK (U/L) + 40 x the number of days in which walking was impossible. The model demonstrated an area under the receiver operating characteristic curve (AUC) of 0.96 (95% CI, 0.91-1.00), and DNS was predicted with 100% sensitivity and 82% specificity. Conclusion An indicator that incorporates the number of days that walking is impossible for a patient could be useful in planning therapeutic strategies.	[Suzuki, Yasuhiro] Shizuoka Saiseikai Gen Hosp, Dept Neurol, Shizuoka, Japan		Suzuki, Y (corresponding author), Shizuoka Saiseikai Gen Hosp, Dept Neurol, Shizuoka, Japan.	gbg00162@nifty.com						Cha YS, 2018, HUM EXP TOXICOL, V37, P240, DOI 10.1177/0960327117698544; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; Jeon SB, 2018, JAMA NEUROL, V75, P436, DOI 10.1001/jamaneurol.2017.4618; Kim H, 2018, CLIN EXP EMERG MED, V5, P185, DOI 10.15441/ceem.17.217; Kim YS, 2018, HUM EXP TOXICOL, V37, P587, DOI 10.1177/0960327117722821; Kitamoto T, 2016, ACUTE MED SURG, V3, P315, DOI 10.1002/ams2.197; Kudo K, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-3; Lee H, 2021, AM J EMERG MED, V43, P195, DOI 10.1016/j.ajem.2020.02.054; Liao SC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2543018; Lin MS, 2018, J CHIN MED ASSOC, V81, P682, DOI 10.1016/j.jcma.2017.12.006; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pepe G, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-16; Wang WQ, 2019, MED SCI MONITOR, V25, P7684, DOI 10.12659/MSM.917065; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	14	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249395	10.1371/journal.pone.0249395	http://dx.doi.org/10.1371/journal.pone.0249395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788891	gold, Green Published			2022-12-26	WOS:000636354600050
J	Shoji, M; Esumi, T; Tanaka, N; Takeuchi, M; Yamaji, S; Watanabe, M; Takahashi, E; Kido, H; Yamamoto, M; Kuzuhara, T				Shoji, Masaki; Esumi, Tomoyuki; Tanaka, Narue; Takeuchi, Misa; Yamaji, Saki; Watanabe, Mihiro; Takahashi, Etsuhisa; Kido, Hiroshi; Yamamoto, Masayuki; Kuzuhara, Takashi			Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D	PLOS ONE			English	Article							INFLUENZA-A VIRUS; BAKUCHIOL; NRF2; CELLS; GENE; EXPRESSION; INDUCTION; ACTIVATION; IMMUNITY; KEAP1	Novel antiviral agents for influenza, which poses a substantial threat to humans, are required. Cyclobakuchiols A and B have been isolated from Psoralea glandulosa, and cyclobakuchiol C has been isolated from P. corylifolia. The structural differences between cyclobakuchiol A and C arise due to the oxidation state of isopropyl group, and these compounds can be derived from (+)-(S)-bakuchiol, a phenolic isoprenoid compound present in P. corylifolia seeds. We previously reported that bakuchiol induces enantiospecific anti-influenza A virus activity involving nuclear factor erythroid 2-related factor 2 (Nrf2) activation. However, it remains unclear whether cyclobakuchiols A-C induce anti-influenza A virus activity. In this study, cyclobakuchiols A, B, and C along with cyclobakuchiol D, a new artificial compound derived from cyclobakuchiol B, were synthesized and examined for their anti-influenza A virus activities using Madin-Darby canine kidney cells. As a result, cyclobakuchiols A-D were found to inhibit influenza A viral infection, growth, and the reduction of expression of viral mRNAs and proteins in influenza A virus-infected cells. Additionally, these compounds markedly reduced the mRNA expression of the host cell influenza A virus-induced immune response genes, interferon-beta and myxovirus-resistant protein 1. In addition, cyclobakuchiols A-D upregulated the mRNA levels of NAD(P)H quinone oxidoreductase 1, an Nrf2-induced gene, in influenza A virus-infected cells. Notably, cyclobakuchiols A, B, and C, but not D, induced the Nrf2 activation pathway. These findings demonstrate that cyclobakuchiols have anti-influenza viral activity involving host cell oxidative stress response. In addition, our results suggest that the suitably spatial configuration between oxidized isopropyl group and phenol moiety in the structure of cyclobakuchiols is required for their effect.	[Shoji, Masaki; Tanaka, Narue; Takeuchi, Misa; Yamaji, Saki; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biochem, Tokushima, Japan; [Esumi, Tomoyuki; Watanabe, Mihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Inst Pharmacognosy, Tokushima, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Pathol & Metabolome Res Infect Dis & Host Def, Tokushima, Japan; [Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan	Tokushima Bunri University; Tokushima Bunri University; Tokushima University; Tohoku University; Tohoku University	Shoji, M; Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biochem, Tokushima, Japan.; Esumi, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Inst Pharmacognosy, Tokushima, Japan.	masaki-shoji@ph.bunri-u.ac.jp; esumi@ph.bunri-u.ac.jp; kuzuhara@ph.bunri-u.ac.jp		Kuzuhara, Takashi/0000-0003-0565-6060	Tokushima Bunri University for Educational Reform and Collaborative Research [TBU20202-1]; Japan Society for the Promotion of Science [18K15173]	Tokushima Bunri University for Educational Reform and Collaborative Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant from Tokushima Bunri University for Educational Reform and Collaborative Research (No. TBU20202-1) and was also supported in part by the Japan Society for the Promotion of Science, Grants-in-Aid for Young Scientists 18K15173 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2003, CHEM RES TOXICOL, V16, P1062, DOI 10.1021/tx034082r; BACKHOUSE CN, 1995, PHYTOCHEMISTRY, V40, P325, DOI 10.1016/0031-9422(95)00252-3; Backhouse CN, 2001, J ETHNOPHARMACOL, V78, P27, DOI 10.1016/S0378-8741(01)00309-9; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Checkmahomed L, 2020, J INFECT DIS, V221, P63, DOI 10.1093/infdis/jiz418; Chen Z, 2010, EUR J PHARMACOL, V643, P170, DOI 10.1016/j.ejphar.2010.06.025; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Esumi T, 2013, SYNLETT, V24, P1845, DOI 10.1055/s-0033-1338968; Fiore AE., 2011, MMWR RECOMM REP, V60, DOI 1-24.21248682; Haraguchi H, 2000, PLANTA MED, V66, P569, DOI 10.1055/s-2000-8605; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; HITI AL, 1981, VIROLOGY, V111, P113, DOI 10.1016/0042-6822(81)90658-9; HITI AL, 1982, J VIROL, V41, P730, DOI 10.1128/JVI.41.2.730-734.1982; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Johnson J, 2009, INVEST OPHTH VIS SCI, V50, P2398, DOI 10.1167/iovs.08-2088; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Katsura H, 2001, ANTIMICROB AGENTS CH, V45, P3009, DOI 10.1128/AAC.45.11.3009-3013.2001; Kawashima H, 2014, CHEM-EUR J, V20, P272, DOI 10.1002/chem.201303538; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kim JE, 2016, ONCOTARGET, V7, P14616, DOI 10.18632/oncotarget.7524; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lee SW, 2012, PLANTA MED, V78, P903, DOI 10.1055/s-0031-1298482; Lv L, 2017, MOL MED REP, V16, P8977, DOI 10.3892/mmr.2017.7696; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; MEHTA G, 1966, TETRAHEDRON LETT, P4561; Mizuno D, 2016, VACCINE, V34, P1881, DOI 10.1016/j.vaccine.2016.02.061; Pae HO, 2001, INT IMMUNOPHARMACOL, V1, P1849, DOI 10.1016/S1567-5769(01)00110-2; Palos I, 2018, MOLECULES, V23, DOI 10.3390/molecules23061453; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Sekine N, 2013, J WOOD SCI, V59, P229, DOI 10.1007/s10086-013-1327-5; Shoji M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1612-8; Shoji M, 2015, J BIOL CHEM, V290, P28001, DOI 10.1074/jbc.M115.669465; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Soto-Sanchez J, 2020, PARASITOL RES, V119, P695, DOI 10.1007/s00436-019-06580-8; Stuart-Harris CH, 1939, LANCET, V1, P497; Sun NJ, 1998, J NAT PROD, V61, P362, DOI 10.1021/np970488q; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Takashita E, 2019, EMERG INFECT DIS, V25, P2108, DOI 10.3201/eid2511.190757; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; WHO, INFL SEAS FACT SHEET; Wloch A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121594; Xin ZL, 2019, PHARMACOL RES, V141, P208, DOI 10.1016/j.phrs.2019.01.001; Yin S, 2007, J ASIAN NAT PROD RES, V9, P29, DOI 10.1080/10286020500289568	51	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248960	10.1371/journal.pone.0248960	http://dx.doi.org/10.1371/journal.pone.0248960			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770117	gold, Green Published			2022-12-26	WOS:000634833500022
J	Fan, C; An, H; Sharif, M; Kim, D; Park, Y				Fan, Chuandong; An, Hongjoo; Sharif, Mohamed; Kim, Dongkyeong; Park, Yungki			Functional mechanisms of MYRF DNA-binding domain mutations implicated in birth defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY FACTOR; DE-NOVO VARIANTS; TRANSCRIPTION FACTOR; MYELIN; CELLS	Myrf is a pleiotropic membrane-bound transcription factor that plays critical roles in diverse organisms, including in oligodendrocyte differentiation, embryonic development, molting, and synaptic plasticity. Upon autolytic cleavage, the Myrf N-terminal fragment enters the nucleus as a homo-trimer and functions as a transcription factor. Homo-trimerization is essential for this function because it imparts DNA-binding specificity and affinity. Recent exome sequencing studies have implicated four de novo MYRF DNA-binding domain (DBD) mutations (F387S, Q403H, G435R, and L479V) in novel syndromic birth defects involving the diaphragm, heart, and the urogenital tract. It remains unknown whether and how these four mutations alter the transcription factor function of MYRF. Here, we studied them by introducing homologous mutations to the mouse Myrf protein. We found that the four DBD mutations abolish the transcriptional activity of the Myrf N-terminal fragment by interfering with its homo-trimerization ability by perturbing the DBD structure. Since the Myrf N-terminal fragment strictly functions as a homo-trimer, any loss-of-function mutation has the potential to act as a dominant negative. We observed that one copy of Myrf-F387S, Myrf-Q403H, or Myrf-L479V, but not Myrf-G435R, was tolerated by the Myrf N-terminal homo-trimer for structural and functional integrity. These data suggest that F387S, Q403H, and L479V cause birth defects by haploinsufficiency, while G435R does so via dominant negative functionality.	[Fan, Chuandong; An, Hongjoo; Sharif, Mohamed; Kim, Dongkyeong; Park, Yungki] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Hunter James Kelly Res Inst, Dept Biochem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Park, Y (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Hunter James Kelly Res Inst, Dept Biochem, Buffalo, NY 14260 USA.	yungkipa@buffalo.edu			National Institutes of Health [R01NS094181, R21NS102558]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [R01NS094181 and R21NS102558 to Y. P.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57593-8; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Chen BH, 2018, J STRUCT BIOL, V203, P170, DOI 10.1016/j.jsb.2018.04.007; Choi JO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31477-4; Duncan GJ, 2017, ACTA NEUROPATHOL, V134, P403, DOI 10.1007/s00401-017-1741-7; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Garnai SJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008130; Hagedorn J, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01659-8; Hamanaka K, 2019, HUM MOL GENET, V28, P2319, DOI 10.1093/hmg/ddz066; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim D, 2017, NUCLEIC ACIDS RES, V45, P5112, DOI 10.1093/nar/gkx080; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Kurahashi H, 2018, ANN NEUROL, V83, P98, DOI 10.1002/ana.25125; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li ZH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001624; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Meng J, 2017, DEV CELL, V41, P180, DOI 10.1016/j.devcel.2017.03.022; Milan M, 2020, DEV CELL, V55, P398, DOI 10.1016/j.devcel.2020.09.011; Pinz H, 2018, AM J MED GENET A, V176, P969, DOI 10.1002/ajmg.a.38620; Qi HJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007822; Rossetti LZ, 2019, AM J MED GENET A, V179, P1376, DOI 10.1002/ajmg.a.61182; Russel S, 2011, DEV BIOL, V360, P297, DOI 10.1016/j.ydbio.2011.09.025; Schulz EC, 2010, NAT STRUCT MOL BIOL, V17, P210, DOI 10.1038/nsmb.1746; Senoo H, 2013, J CELL SCI, V126, P5247, DOI 10.1242/jcs.133231; Senoo H, 2012, INT J DEV BIOL, V56, P325, DOI 10.1387/ijdb.120030jw; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhen XK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03768-9	32	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100612	10.1016/j.jbc.2021.100612	http://dx.doi.org/10.1016/j.jbc.2021.100612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798553	gold, Green Published			2022-12-26	WOS:000672866400583
J	Gruner, K; Leissing, F; Sinitski, D; Thieron, H; Axstmann, C; Baumgarten, K; Reinstadler, A; Winkler, P; Altmann, M; Flatley, A; Jaouannet, M; Zienkiewicz, K; Feussner, I; Keller, H; Coustau, C; Falter-Braun, P; Feederle, R; Bernhagen, J; Panstruga, R				Gruner, Katrin; Leissing, Franz; Sinitski, Dzmitry; Thieron, Hannah; Axstmann, Christian; Baumgarten, Kira; Reinstadler, Anja; Winkler, Pascal; Altmann, Melina; Flatley, Andrew; Jaouannet, Maelle; Zienkiewicz, Krzysztof; Feussner, Ivo; Keller, Harald; Coustau, Christine; Falter-Braun, Pascal; Feederle, Regina; Bernhagen, Jurgen; Panstruga, Ralph			Chemokine-like MDL proteins modulate flowering time and innate immunity in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; SALICYLIC-ACID; PSEUDOMONAS-SYRINGAE; FACTOR MIF; ARABIDOPSIS; CYTOKINE; RESISTANCE; RECRUITMENT; REVEALS; MUTANT	Human macrophage migration inhibitory factor (MIF) is an atypical chemokine implicated in intercellular signaling and innate immunity. MIF orthologs (MIF/D-DT-like proteins, MDLs) are present throughout the plant kingdom, but remain experimentally unexplored in these organisms. Here, we provide an in planta characterization and functional analysis of the three-member gene/protein MDL family in Arabidopsis thaliana. Subcellular localization experiments indicated a nucleo-cytoplasmic distribution of MDL1 and MDL2, while MDL3 is localized to peroxisomes. Protein-protein interaction assays revealed the in vivo formation of MDL1, MDL2, and MDL3 homo-oligomers, as well as the formation of MDL1-MDL2 hetero-oligomers. Functionally, Arabidopsis mdl mutants exhibited a delayed transition from vegetative to reproductive growth (flowering) under long-day conditions, but not in a short-day environment. In addition, mdl mutants were more resistant to colonization by the bacterial pathogen Pseudomonas syringae pv. maculicola. The latter phenotype was compromised by the additional mutation of SALICYLIC ACID INDUCTION DEFICIENT 2 (SID2), a gene implicated in the defense-induced biosynthesis of the key signaling molecule salicylic acid. However, the enhanced antibacterial immunity was not associated with any constitutive or pathogen-induced alterations in the levels of characteristic phytohormones or defense-associated metabolites. Interestingly, bacterial infection triggered relocalization and accumulation of MDL1 and MDL2 at the peripheral lobes of leaf epidermal cells. Collectively, our data indicate redundant functionality and a complex interplay between the three chemokine-like Arabidopsis MDL proteins in the regulation of both developmental and immune-related processes. These insights expand the comparative cross-kingdom analysis of MIF/MDL signaling in human and plant systems.	[Gruner, Katrin; Leissing, Franz; Thieron, Hannah; Axstmann, Christian; Baumgarten, Kira; Reinstadler, Anja; Winkler, Pascal; Panstruga, Ralph] Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany; [Sinitski, Dzmitry; Bernhagen, Jurgen] Ludwig Maximilians Univ LMU, LMU Univ Hosp, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany; [Altmann, Melina; Falter-Braun, Pascal] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Network Biol INET, Munich, Germany; [Flatley, Andrew; Feederle, Regina] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Diabet & Obes, Monoclonal Antibody Core Facil, Munich, Germany; [Jaouannet, Maelle; Keller, Harald; Coustau, Christine] Univ Cote Azur, Inst Sophia Agrobiotech, INRAE, CNRS, Sophia Antipolis, France; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Albrecht von Haller Inst, Gottingen, Germany; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Goettingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Goettingen Ctr Mol Biosci GZMB, Serv Unit Metabol & Lipid, Gottingen, Germany; [Falter-Braun, Pascal] Ludwig Maximilians Univ LMU, Fac Biol, Chair Microbe Host Interact, Planegg Martinsried, Germany; [Feederle, Regina; Bernhagen, Jurgen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	RWTH Aachen University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; University of Gottingen; University of Gottingen; University of Gottingen; University of Munich; University of Munich	Panstruga, R (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany.; Bernhagen, J (corresponding author), Ludwig Maximilians Univ LMU, LMU Univ Hosp, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany.; Bernhagen, J (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	Juergen.Bernhagen@med.uni-muenchen.de; panstruga@bio1.rwth-aachen.de	Leissing, Franz/R-5496-2019	Leissing, Franz/0000-0002-9746-7162; Feederle, Regina/0000-0002-3981-367X; COUSTAU, Christine/0000-0001-7524-0947	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR); DFG [BE 1977/10-1, PA 861/15-1, 390857198, INST 186/822-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR) co-funded project "X-KINGDOM-MIF -Cross-kingdom analysis of macrophage migration inhibitory factor (MIF) functions". Respective DFG grants are BE 1977/10-1 to J. B., PA 861/15-1 to R. P. The monoclonal antibody facility and the Chair of Vascular Biology are funded by the DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy; ID 390857198). The Service Unit for Metabolomics and Lipidomics and the Department of Plant Biochemistry are supported by a grant of the DFG (INST 186/822-1) to I. F.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altmann Melina, 2018, Curr Protoc Plant Biol, V3, pe20067, DOI 10.1002/cppb.20067; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Campe R, 2016, NEW PHYTOL, V209, P294, DOI 10.1111/nph.13582; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Ding PT, 2020, TRENDS PLANT SCI, V25, P549, DOI 10.1016/j.tplants.2020.01.004; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ellis C, 2002, MOL PLANT MICROBE IN, V15, P1025, DOI 10.1094/MPMI.2002.15.10.1025; Fan CP, 2013, P NATL ACAD SCI USA, V110, P10994, DOI 10.1073/pnas.1221817110; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Feederle Regina, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P259, DOI 10.1089/mab.2016.0029; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Foley J. F., 2020, SCI SIGNAL, V13; Garcia AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05041-7; Gruner K, 2018, PLANT J, V94, P1064, DOI 10.1111/tpj.13920; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He Q, 2018, P NATL ACAD SCI USA, V115, pE7834, DOI 10.1073/pnas.1808585115; Herrfurth C, 2020, METHODS MOL BIOL, V2085, P169, DOI 10.1007/978-1-0716-0142-6_13; Holowka T, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5010046; Holowka T, 2016, FASEB J, V30, P2249, DOI 10.1096/fj.201500189R; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Jedd G, 2002, PLANT CELL PHYSIOL, V43, P384, DOI 10.1093/pcp/pcf045; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Kapurniotu A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00003; Kemen E., 2017, SCI REP-UK, V7, P27; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn Hannah, 2016, Arabidopsis Book, V14, pe0184, DOI 10.1199/tab.0184; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li HY, 2018, ELIFE, V7, DOI 10.7554/eLife.40039; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Li W, 2013, PLANT PHYSIOL, V161, P2062, DOI 10.1104/pp.112.211748; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Michelet C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100740; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Mohnike L., 2021, PLANT CELL; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Naessens E, 2015, CURR BIOL, V25, P1898, DOI 10.1016/j.cub.2015.05.047; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Ogawara T, 2003, J PLANT PHYSIOL, V160, P1335, DOI 10.1078/0176-1617-01129; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Pan RH, 2018, J INTEGR PLANT BIOL, V60, P1028, DOI 10.1111/jipb.12670; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Shao XL, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3237; Sinitski D, 2020, J BIOL CHEM, V295, P850, DOI 10.1074/jbc.RA119.009716; Sinitski D, 2020, METHODS MOL BIOL, V2080, P249, DOI 10.1007/978-1-4939-9936-1_22; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Sparkes A, 2017, IMMUNOBIOLOGY, V222, P473, DOI 10.1016/j.imbio.2016.10.006; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; Tilstam PV, 2017, EXPERT OPIN THER TAR, V21, P671, DOI 10.1080/14728222.2017.1336227; Turnbull D, 2019, PLANT PHYSIOL, V180, P571, DOI 10.1104/pp.18.01143; Tynan A, 2017, FASEB J, V31, P5102, DOI 10.1096/fj.201700463R; Underwood W, 2017, MOL PLANT, V10, P805, DOI 10.1016/j.molp.2017.04.003; Underwood W, 2013, P NATL ACAD SCI USA, V110, P12492, DOI 10.1073/pnas.1218701110; van Wersch R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01717; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	91	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100611	10.1016/j.jbc.2021.100611	http://dx.doi.org/10.1016/j.jbc.2021.100611			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798552	Green Published, gold			2022-12-26	WOS:000672866400582
J	Heier, JA; Pokutta, S; Dale, IW; Kim, SK; Hinck, AP; Weis, WI; Kwiatkowski, AV				Heier, Jonathon A.; Pokutta, Sabine; Dale, Ian W.; Kim, Sun Kyung; Hinck, Andrew P.; Weis, William, I; Kwiatkowski, Adam, V			Distinct intramolecular interactions regulate autoinhibition of vinculin binding in alpha T-catenin and alpha E-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING; BETA-CATENIN; MECHANICAL STABILITY; ADHERENS JUNCTION; AREA COMPOSITA; COMPLEX; CARDIOMYOPATHY; ACTIVATION; CADHERINS; ALTERS	alpha-Catenin binds directly to beta-catenin and connects the cadherin-catenin complex to the actin cytoskeleton. Tension regulates alpha-catenin conformation. Actomyosin-generated force stretches the middle (M)-region to relieve autoinhibition and reveal a binding site for the actin-binding protein vinculin. It is not known whether the intramolecular interactions that regulate epithelial (alpha E)-catenin binding are conserved across the alpha-catenin family. Here, we describe the biochemical properties of testes (alpha T)-catenin, an alpha-catenin isoform critical for cardiac function and how intramolecular interactions regulate vinculin-binding autoinhibition. Isothermal titration calorimetry showed that alpha T-catenin binds the beta-catenin-N-cadherin complex with a similar low nanomolar affinity to that of alpha E-catenin. Limited proteolysis revealed that the alpha T-catenin M-region adopts a more open conformation than alpha E-catenin. The alpha T-catenin M-region binds the vinculin N-terminus with low nanomolar affinity, indicating that the isolated alpha T-catenin Mregion is not autoinhibited and thereby distinct from alpha E-catenin. However, the alpha T-catenin head (N- and M-regions) binds vinculin 1000-fold more weakly (low micromolar affinity), indicating that the N-terminus regulates the M-region binding to vinculin. In cells, alpha T-catenin recruitment of vinculin to cell-cell contacts requires the actin-binding domain and actomyosin-generated tension, indicating that force regulates vinculin binding. Together, our results show that the alpha T-catenin N-terminus is required to maintain M-region autoinhibition and modulate vinculin binding. We postulate that the unique molecular properties of alpha T-catenin allow it to function as a scaffold for building specific adhesion complexes.	[Heier, Jonathon A.; Dale, Ian W.; Kwiatkowski, Adam, V] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Pokutta, Sabine; Weis, William, I] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Pokutta, Sabine; Weis, William, I] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Sun Kyung; Hinck, Andrew P.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwiatkowski, AV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	adamkwi@pitt.edu	Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150; Kwiatkowski, Adam/0000-0003-3997-7057; Heier, Jonathon/0000-0002-4898-0357	NIH [HL127711, GM131747, GM058670, CA233622, S10 OD023481]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grants HL127711 (A. V. K.), GM131747 (W. I. W.), GM058670 (A. P. H.), and CA233622 (A. P. H.). The Malvern MicroCal PEAQ-ITC calorimeter purchase was made possible through NIH Grant S10 OD023481. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrick S, 2018, MOL BIOL CELL, V29, P111, DOI 10.1091/mbc.E17-03-0168; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chiarella SE, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1463896; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Folmsbee Stephen Sai, 2016, J Mol Psychiatry, V4, P2, DOI 10.1186/s40303-016-0017-9; Folmsbee SS, 2015, AM J PHYSIOL-LUNG C, V308, pL253, DOI 10.1152/ajplung.00331.2014; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07481-7; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssens B, 2001, J CELL SCI, V114, P3177; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Li Y, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221606; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Maki K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20115-8; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Mege RM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028738; Mei L, 2020, ELIFE, V9, DOI 10.7554/eLife.62514; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Merkel CD, 2019, MOL BIOL CELL, V30, P2639, DOI 10.1091/mbc.E19-04-0216; Nieset JE, 1997, J CELL SCI, V110, P1013; Pang SM, 2019, MOL BIOL CELL, V30, P1930, DOI 10.1091/mbc.E19-02-0102; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Priest AV, 2017, EXP CELL RES, V358, P10, DOI 10.1016/j.yexcr.2017.03.015; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rubsam M, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029207; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469; Terekhova K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51816-3; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Vite A, 2014, CELL COMMUN ADHES, V21, P169, DOI 10.3109/15419061.2014.908853; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Wickline ED, 2016, J BIOL CHEM, V291, P15687, DOI 10.1074/jbc.M116.735423; Wood MN, 2017, J CELL BIOL, V216, P3767, DOI 10.1083/jcb.201612006; Xu XP, 2020, ELIFE, V9, DOI 10.7554/eLife.60878; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhao ZM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-198	57	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100582	10.1016/j.jbc.2021.100582	http://dx.doi.org/10.1016/j.jbc.2021.100582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771561	Green Published, gold			2022-12-26	WOS:000672866400554
J	Jiang, YC; Li, WT; Lindsey-Boltz, LA; Yang, YC; Li, Y; Sancar, A				Jiang, Yuchao; Li, Wentao; Lindsey-Boltz, Laura A.; Yang, Yuchen; Li, Yun; Sancar, Aziz			Super hotspots and super coldspots in the repair of UV-induced DNA damage in the human genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTORS; ESCHERICHIA-COLI; CHROMATIN-STATE; MUTATIONS; LANDSCAPE; DOMAINS; BINDING; MAPS; MECHANISMS	The formation of UV-induced DNA damage and its repair are influenced by many factors that modulate lesion formation and the accessibility of repair machinery. However, it remains unknown which genomic sites are prioritized for immediate repair after UV damage induction, and whether these prioritized sites overlap with hotspots of UV damage. We identified the super hotspots subject to the earliest repair for (6-4) pyrimidine-pyrimidone photoproduct by using the eXcision Repairsequencing (XR-seq) method. We further identified super coldspots for (6-4) pyrimidine-pyrimidone photoproduct repair and super hotspots for cyclobutane pyrimidine dimer repair by analyzing available XR-seq time-course data. By integrating datasets of XR-seq, Damage-seq, adductSeq, and cyclobutane pyrimidine dimer-seq, we show that neither repair super hotspots nor repair super coldspots overlap hotspots of UV damage. Furthermore, we demonstrate that repair super hotspots are significantly enriched in frequently interacting regions and superenhancers. Finally, we report our discovery of an enrichment of cytosine in repair super hotspots and super coldspots. These findings suggest that local DNA features together with large-scale chromatin features contribute to the orders of magnitude variability in the rates of UV damage repair.	[Jiang, Yuchao; Li, Yun] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Jiang, Yuchao; Yang, Yuchen; Li, Yun] Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA; [Jiang, Yuchao; Sancar, Aziz] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Li, Wentao; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Coll Arts & Sci, Chapel Hill, NC 27515 USA; [Li, Wentao] Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, Athens, GA 30602 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia	Jiang, YC (corresponding author), Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.; Jiang, YC (corresponding author), Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA.; Jiang, YC; Sancar, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.	yuchaoj@email.unc.edu; aziz_sancar@med.unc.edu	Yang, Yuchen/GZK-6062-2022	Jiang, Yuchao/0000-0001-6905-6377; Li, Wentao/0000-0003-2313-6384	National Institutes of Health [R35 GM118102, R01 ES027255, R35 GM138342, R00 ES030015]; University of North Carolina Computational Medicine Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Computational Medicine Program	This work was supported by the National Institutes of Health grants R35 GM118102 (to A. S.), R01 ES027255(to A. S.), R35 GM138342 (to Y. J.), R00 ES030015 (to W. L.), and a pilot award from the University of North Carolina Computational Medicine Program (to Y. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Akkose U., 2020, COMP ANAL 2 PRIMATE, DOI [10.1101/2020.04.06.027201, DOI 10.1101/2020.04.06.027201]; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Choul-Ii S, 2018, BIOSCI BIOTECH BIOCH, V82, P1753, DOI 10.1080/09168451.2018.1484276; Choul-li S, 2009, BIOCHEM BIOPH RES CO, V390, P839, DOI 10.1016/j.bbrc.2009.10.059; Crowley C., 2020, FIRECALLER DETECTING, DOI [10.1101/619288, DOI 10.1101/619288]; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007849; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Frigola J, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1219; Garcia-Nieto PE, 2017, EMBO J, V36, P2829, DOI 10.15252/embj.201796717; Giusti-Rodriguez P., 2019, USING 3 DIMENSIONAL; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Han CH, 2016, CARCINOGENESIS, V37, P129, DOI 10.1093/carcin/bgv247; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hauer MH, 2017, GENE DEV, V31, P2204, DOI 10.1101/gad.307702.117; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang YC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1363; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kaul A, 2020, NAT PROTOC, V15, P991, DOI 10.1038/s41596-019-0273-0; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Legrand AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055883; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2020, ENVIRON MOL MUTAGEN, V61, P664, DOI 10.1002/em.22365; Li WT, 2019, J BIOL CHEM, V294, P5914, DOI 10.1074/jbc.RA119.007861; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu F, 2016, BIOINFORMATICS, V32, P641, DOI 10.1093/bioinformatics/btv643; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Mao P, 2017, PHOTOCHEM PHOTOBIOL, V93, P216, DOI 10.1111/php.12646; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; Poulos RC, 2016, CELL REP, V17, P2865, DOI 10.1016/j.celrep.2016.11.055; Premi S, 2019, P NATL ACAD SCI USA, V116, P24196, DOI 10.1073/pnas.1907860116; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Roberts SA, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800152; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sanders JT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20047-w; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Selby CP, 2020, J BIOL CHEM, V295, P17374, DOI 10.1074/jbc.AC120.016325; Sobhy H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40770-9; TORNALETTI S, 1995, J MOL BIOL, V249, P714, DOI 10.1006/jmbi.1995.0331; van Eijk P, 2019, GENOME RES, V29, P74, DOI 10.1101/gr.237198.118; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yang YY, 2019, J BIOL CHEM, V294, P210, DOI 10.1074/jbc.RA118.006121; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4	75	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100581	10.1016/j.jbc.2021.100581	http://dx.doi.org/10.1016/j.jbc.2021.100581			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771559	Green Published, gold			2022-12-26	WOS:000672866400553
J	Nagashima, S; Ito, N; Kobayashi, R; Shiiba, I; Shimura, H; Fukuda, T; Hagihara, H; Miyakawa, T; Inatome, R; Yanagi, S				Nagashima, Shun; Ito, Naoki; Kobayashi, Reiki; Shiiba, Isshin; Shimura, Hiroki; Fukuda, Toshifumi; Hagihara, Hideo; Miyakawa, Tsuyoshi; Inatome, Ryoko; Yanagi, Shigeru			Forebrain-specific deficiency of the GTPase CRAG/Centaurin-gamma 3 leads to immature dentate gyri and hyperactivity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; EXPRESSION; PROTEIN; CRAG; MODELS; CELLS; SRF	Mouse models of various neuropsychiatric disorders, such as schizophrenia, often display an immature dentate gyrus, characterized by increased numbers of immature neurons and neuronal progenitors and a dearth of mature neurons. We previously demonstrated that the CRMP5-associated GTPase (CRAG), a short splice variant of Centaurin-gamma 3/AGAP3, is highly expressed in the dentate gyrus. CRAG promotes cell survival and antioxidant defense by inducing the activation of serum response factors at promyelocytic leukemia protein bodies, which are nuclear stress-responsive domains, during neuronal development. However, the physiological role of CRAG in neuronal development remains unknown. Here, we analyzed the role of CRAG using dorsal forebrain-specific CRAG/Centaurin-gamma 3 knockout mice. The mice revealed maturational abnormality of the hippocampal granule cells, including increased doublecortin-positive immature neurons and decreased calbindin-positive mature neurons, a typical phenotype of immature dentate gyri. Furthermore, the mice displayed hyperactivity in the open-field test, a common measure of exploratory behavior, suggesting that these mice may serve as a novel model for neuropsychiatric disorder associated with hyperactivity. Thus, we conclude that CRAG is required for the maturation of neurons in the dentate gyrus, raising the possibility that its deficiency might promote the development of psychiatric disorders in humans.	[Nagashima, Shun; Ito, Naoki; Kobayashi, Reiki; Shiiba, Isshin; Shimura, Hiroki; Fukuda, Toshifumi; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan; [Ito, Naoki; Shiiba, Isshin; Inatome, Ryoko; Yanagi, Shigeru] Gakushuin Univ, Fac Sci, Dept Life Sci, Lab Mol Biochem,Toshima Ku, Tokyo, Japan; [Hagihara, Hideo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan	Tokyo University of Pharmacy & Life Sciences; Gakushuin University; Fujita Health University	Nagashima, S; Yanagi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan.; Yanagi, S (corresponding author), Gakushuin Univ, Fac Sci, Dept Life Sci, Lab Mol Biochem,Toshima Ku, Tokyo, Japan.	nagashi@toyaku.ac.jp; syanagi@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663; Fukuda, Toshifumi/0000-0003-2400-5319	MEXT/JSPS KAKENHI [16K08246, 18H04869, 20H04911]; MEXT; Uehara Memorial Foundation; Naito Foundation; Takeda Foundation; Sumitomo Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation; AMED [17gm5010002, 18gm5010002, 19gm5010002, 20gm5010002]; Cosmetology Research Foundation;  [16H06276]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation; AMED; Cosmetology Research Foundation; 	This study was supported in part by MEXT/JSPS KAKENHI (16K08246 to S. N., 18H04869 and 20H04911 to S. Y.) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (to S. N., R. I., and S. Y.), The Uehara Memorial Foundation, The Naito Foundation (to S. N. and S. Y.), a Grant-in-Aid for Scientific Research on Innovative Areas-Platform for Advanced Technologies and Research Resources (16H06276 to T. M.), The Takeda Foundation, The Sumitomo Foundation, The Cosmetology Research Foundation, The Ono Medical Research Foundation, The Tokyo Biochemical Research Foundation and AMED under Grant Number 17gm5010002, 18gm5010002, 19gm5010002, and 20gm5010002 (to S. Y.).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hagihara H, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0522-8; Hagihara Hideo, 2019, Neuropsychopharmacology Reports, V39, P78, DOI 10.1002/npr2.12048; Hagihara H, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0378-3; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Imoto Y, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0288-9; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-12; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Nader K, 2019, BRAIN STRUCT FUNCT, V224, P2691, DOI 10.1007/s00429-019-01925-6; Nagashima S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56559-9; Nagashima S, 2011, J BIOL CHEM, V286, P33879, DOI 10.1074/jbc.M111.234997; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Terashima M, 2010, J NEUROSCI RES, V88, P1387, DOI 10.1002/jnr.22315; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100620	10.1016/j.jbc.2021.100620	http://dx.doi.org/10.1016/j.jbc.2021.100620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811862	gold, Green Published			2022-12-26	WOS:000672866400591
J	Vilalta, A; Zhou, Y; Sevalle, J; Griffin, JK; Satoh, K; Allendorf, DH; De, S; Puigdellivol, M; Bruzas, A; Burguillos, MA; Dodd, RB; Chen, FS; Zhang, YL; Flagmeier, P; Needham, LM; Enomoto, M; Qamar, S; Henderson, J; Walter, J; Fraser, PE; Klenerman, D; Lee, SF; St George-Hyslop, P; Brown, GC				Vilalta, Anna; Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Allendorf, David H.; De, Suman; Puigdellivol, Mar; Bruzas, Arturas; Burguillos, Miguel A.; Dodd, Roger B.; Chen, Fusheng; Zhang, Yalun; Flagmeier, Patrick; Needham, Lisa-Maria; Enomoto, Masahiro; Qamar, Seema; Henderson, James; Walter, Jochen; Fraser, Paul E.; Klenerman, David; Lee, Steven F.; St George-Hyslop, Peter; Brown, Guy C.			Wild-type sTREM2 blocks A beta aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases A beta aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREM2; DISEASE; PROTEIN; MICE; PROTOFIBRILS; VARIANTS; CLEAVAGE; PLAQUES; INFLUX	TREM2 is a pattern recognition receptor, expressed on microglia and myeloid cells, detecting lipids and A beta and inducing an innate immune response. Missense mutations (e.g., R47H) of TREM2 increase risk of Alzheimer's disease (AD). The soluble ectodomain of wild-type TREM2 (sTREM2) has been shown to protect against AD in vivo, but the underlying mechanisms are unclear. We show that A beta oligomers bind to cellular TREM2, inducing shedding of the sTREM2 domain. Wild-type sTREM2 bound to A beta oligomers (measured by single-molecule imaging, dot blots, and Bio-Layer Interferometry) inhibited A beta oligomerization and disaggregated preformed A beta oligomers and protofibrils (measured by transmission electron microscopy, dot blots, and size-exclusion chromatography). Wild-type sTREM2 also inhibited A beta fibrillization (measured by imaging and thioflavin T fluorescence) and blocked A beta-induced neurotoxicity (measured by permeabilization of artificial membranes and by loss of neurons in primary neuronal-glial cocultures). In contrast, the R47H AD-risk variant of sTREM2 is less able to bind and disaggregate oligomeric A beta but rather promotes A beta protofibril formation and neurotoxicity. Thus, in addition to inducing an immune response, wild-type TREM2 may protect against amyloid pathology by the A beta-induced release of sTREM2, which blocks A beta aggregation and neurotoxicity. In contrast, R47H sTREM2 promotes A beta aggregation into protofibril that may be toxic to neurons. These findings may explain how wild-type sTREM2 apparently protects against AD in vivo and why a single copy of the R47H variant gene is associated with increased AD risk.	[Vilalta, Anna; Allendorf, David H.; Puigdellivol, Mar; Bruzas, Arturas; Burguillos, Miguel A.; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge, England; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Hlth Network, Toronto, ON, Canada; [De, Suman; Dodd, Roger B.] AstraZeneca, Cambridge, England; [Burguillos, Miguel A.; Dodd, Roger B.; Qamar, Seema; Henderson, James; St George-Hyslop, Peter] Cambridge Inst Med Res, Cambridge, England; [Flagmeier, Patrick; Needham, Lisa-Maria; Klenerman, David; Lee, Steven F.] Univ Cambridge, Dept Chem, Cambridge, England; [Enomoto, Masahiro] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Biophys, Toronto, ON, Canada; [Walter, Jochen] Univ Bonn, Dept Neurol, Mol Cell Biol, Bonn, Germany; [Klenerman, David] Cambridge Dementia Res Inst, Cambridge Biomed Campus, Cambridge, England	University of Cambridge; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bonn	Brown, GC (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med Neurol, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Univ Hlth Network, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Cambridge Inst Med Res, Cambridge, England.	phs22@cam.ac.uk; gcb3@cam.ac.uk	Brown, Guy C./HHC-1102-2022; Burguillos, Miguel/N-4806-2019; Puigdellivol Canadell, Mar/E-6656-2019	Burguillos, Miguel/0000-0002-3165-9997; Vilalta, Anna/0000-0002-2183-072X; Satoh, Kanayo/0000-0001-9684-239X; Dodd, Roger/0000-0003-4268-1863; Puigdellivol Canadell, Mar/0000-0002-9955-3558; Enomoto, Masahiro/0000-0002-9411-2999	Canadian Institutes of Health Research; Canadian Consortium on Neurodegeneration in Aging; Wellcome Trust; Medical Research Council; Zenith Award Alzheimer Association; Innovative Medicines Initiative 2 [115976]; European Union; European Federation of Pharmaceutical Industries and Associations	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Consortium on Neurodegeneration in Aging; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Zenith Award Alzheimer Association; Innovative Medicines Initiative 2; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations	This project has received funding from the Canadian Institutes of Health Research (P. S. G.H. and P. E. F.), Canadian Consortium on Neurodegeneration in Aging, Wellcome Trust, Medical Research Council, Zenith Award Alzheimer Association (P. S. G.-H.). This project has received funding from the Innovative Medicines Initiative 2 joint undertaking under grant agreement no. 115976. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations (G. C. B., J. W., and P. S. G.-H.).	Bal-Price A, 2001, J NEUROSCI, V21, P6480; Chia S, 2017, P NATL ACAD SCI USA, V114, P8005, DOI 10.1073/pnas.1700239114; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; De S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0777-4; De S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09477-3; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Drews A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31910; Edwards FA, 2019, TRENDS NEUROSCI, V42, P310, DOI 10.1016/j.tins.2019.03.003; Ewers M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012308; Ewers M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav6221; Flagmeier P, 2017, ANGEW CHEM INT EDIT, V56, P7750, DOI 10.1002/anie.201700966; Franzmeier N, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00407-2; Gertsenstein Marina, 2018, Curr Protoc Mouse Biol, V8, P28, DOI 10.1002/cpmo.40; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Horrocks MH, 2016, ACS CHEM NEUROSCI, V7, P399, DOI 10.1021/acschemneuro.5b00324; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iljina M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0390-6; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Kober DL, 2021, ALZHEIMERS DEMENT, V17, P475, DOI 10.1002/alz.12194; Lessard CB, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809027; Ma LZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00374-8; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Suarez-Calvet M, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0301-5; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiang XY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0280-6; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhong L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09118-9; Zhong L, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0247-7	45	18	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100631	10.1016/j.jbc.2021.100631	http://dx.doi.org/10.1016/j.jbc.2021.100631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823153	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400602
J	Wanna-Udom, S; Terashima, M; Suphakhong, K; Ishimura, A; Takino, T; Suzuki, T				Wanna-Udom, Sasithorn; Terashima, Minoru; Suphakhong, Kusuma; Ishimura, Akihiko; Takino, Takahisa; Suzuki, Takeshi			KDM2B is involved in the epigenetic regulation of TGF-beta-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; POLYCOMB; PROGRESSION; EXPRESSION; CHROMATIN; PROTEIN; PRC2; MARK	Polycomb repressive complex-1 (PRC1) induces transcriptional repression by regulating monoubiquitination of lysine 119 of histone H2A (H2AK119) and as such is involved in a number of biological and pathological processes including cancer development. Previously we demonstrated that PRC2, which catalyzes the methylation of histone H3K27, has an essential function in TGF-beta-induced epithelial-mesenchymal transition (EMT) of lung and pancreatic cancer cell lines. Since the cooperative activities of PRC1 and PRC2 are thought to be important for transcriptional repression in EMT program, we investigated the role of KDM2B, a member of PRC1 complex, on TGF-beta-induced EMT in this study. Knockdown of KDM2B inhibited TGF-beta-induced morphological conversion of the cells and enhanced cell migration and invasion potentials as well as the expression changes of EMT-related marker genes. Overexpression of KDM2B influenced the expression of several epithelial marker genes such as CDH1, miR200a, and CGN and enhanced the effects of TGF-beta. Mechanistic investigations revealed that KDM2B specifically recognized the regulatory regions of CDH1, miR200a, and CGN genes and induced histone H2AK119 monoubiquitination as a component of PRC1 complex, thereby mediating the subsequent EZH2 recruitment and histone H3K27 methylation process required for gene repression. Studies using KDM2B mutants confirmed that its DNA recognition property but not its histone H3 demethylase activity was indispensable for its function during EMT. This study demonstrated the significance of the regulation of histone H2A ubiquitination in EMT process and provided the possibility to develop novel therapeutic strategies for the treatment of cancer metastasis.	[Wanna-Udom, Sasithorn; Terashima, Minoru; Suphakhong, Kusuma; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Div Funct Genom, Canc Res Inst, Kanazawa, Ishikawa, Japan; [Takino, Takahisa] Kanazawa Univ, Div Educ Global Stand, Inst Liberal Arts & Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Div Funct Genom, Canc Res Inst, Kanazawa, Ishikawa, Japan.	suzuki-t@staff.kanazawa-u.ac.jp		Suzuki, Takeshi/0000-0002-1737-0900; Wanna-udom, Sasithorn/0000-0002-8593-9126	Ministry of Education, Culture, Sports, Science and Technology of Japan [19K07346, 18K06057, 19K07686]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research C (grant numbers: 19K07346 to T. S., 18K06057 to M. T. and 19K07686 to A. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen JZ, 2014, CANCER RES, V74, P4353, DOI 10.1158/0008-5472.CAN-14-0181; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fursova NA, 2019, MOL CELL, V74, P1020, DOI 10.1016/j.molcel.2019.03.024; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kang JY, 2018, FASEB J, V32, P5737, DOI 10.1096/fj.201800242R; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Terashima M, 2018, J BIOL CHEM, V293, P18016, DOI 10.1074/jbc.RA118.004006; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Terashima M, 2017, J BIOL CHEM, V292, P82, DOI 10.1074/jbc.M116.750950; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zacharopoulou N, 2018, CELL PHYSIOL BIOCHEM, V47, P368, DOI 10.1159/000489917; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	44	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100213	10.1074/jbc.RA120.015502	http://dx.doi.org/10.1074/jbc.RA120.015502			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33779563	Green Published, gold			2022-12-26	WOS:000672866400191
J	Wiedmann, M; Dranchak, PK; Aitha, M; Queme, B; Collmus, CD; Kashipathy, MM; Kanter, L; Lamy, L; Rogers, JM; Tao, DY; Battaile, KP; Rai, G; Lovell, S; Suga, H; Inglese, J				Wiedmann, Mareike; Dranchak, Patricia K.; Aitha, Mahesh; Queme, Bryan; Collmus, Christopher D.; Kashipathy, Maithri M.; Kanter, Liza; Lamy, Laurence; Rogers, Joseph M.; Tao, Dingyin; Battaile, Kevin P.; Rai, Ganesha; Lovell, Scott; Suga, Hiroaki; Inglese, James			Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYTIC-ENZYMES; PROTEIN; METAL; MECHANISM; DESIGN	Catalysis of human phosphoglycerate mutase is dependent on a 2,3-bisphosphoglycerate cofactor (dPGM), whereas the nonhomologous isozyme in many parasitic species is cofactor independent (iPGM). This mechanistic and phylogenetic diversity offers an opportunity for selective pharmacologic targeting of glycolysis in disease-causing organisms. We previously discovered ipglycermide, a potent inhibitor of iPGM, from a large combinatorial cyclic peptide library. To fully delineate the ipglycermide pharmacophore, herein we construct a detailed structure-activity relationship using 280 substituted ipglycermide analogs. Binding affinities of these analogs to immobilized Caenorhabditis elegans iPGM, measured as fold enrichment relative to the index residue by deep sequencing of an mRNA display library, illuminated the significance of each amino acid to the pharmacophore. Using cocrystal structures and binding kinetics, we show that the high affinity of ipglycermide for iPGM orthologs, from Brugia malayi, Onchocerca volvulus, Dirofilaria immitis, and Escherichia coli, is achieved by a codependence between (1) the offrate mediated by the macrocycle Cys14 thiolate coordination to an active-site Zn2+ in the iPGM phosphatase domain and (2) shape complementarity surrounding the macrocyclic core at the phosphotransferase-phosphatase domain interface. Our results show that the high-affinity binding of ipglycermide to iPGMs freezes these structurally dynamic enzymes into an inactive, stable complex.	[Wiedmann, Mareike; Rogers, Joseph M.; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo, Japan; [Dranchak, Patricia K.; Aitha, Mahesh; Queme, Bryan; Collmus, Christopher D.; Kanter, Liza; Lamy, Laurence; Tao, Dingyin; Rai, Ganesha; Inglese, James] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Kashipathy, Maithri M.; Lovell, Scott] Univ Kansas, Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Argonne Natl Lab, IMCA CAT Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA; [Inglese, James] NHGRI, NIH, Bethesda, MD 20892 USA; [Wiedmann, Mareike] Bayer Pharmaceut, R&D Div, Wuppertal, Germany; [Kanter, Liza] Univ Florida, Coll Dent, Gainesville, FL 32610 USA; [Rogers, Joseph M.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Battaile, Kevin P.] Brookhaven Natl Lab, Beamline NYX, New York Struct Biol Ctr, NSLS 2 Synchrotron Brookhaven Ave, Upton, NY 11973 USA	University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Bayer AG; Bayer Healthcare Pharmaceuticals; State University System of Florida; University of Florida; University of Copenhagen; United States Department of Energy (DOE); Brookhaven National Laboratory	Suga, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo, Japan.; Inglese, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.; Inglese, J (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	hsuga@chem.s.u-tokyo.ac.jp; jinglese@mail.nih.gov	Rogers, Joseph/AGZ-9056-2022	Queme, Bryan/0000-0003-1509-9982; Aitha, Mahesh/0000-0003-0377-4792; Lamy, Laurence/0000-0002-6967-9969; Dranchak, Patricia/0000-0002-1349-4885; Rogers, Joseph/0000-0002-1313-4089; Kanter, Liza/0000-0002-8616-764X; Tao, Dingyin/0000-0001-6531-2740	Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH [1ZIATR000247]; Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) [JP19am0101090]; Japanese Society for the Promotion of Science	Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH; Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH, under project 1ZIATR000247 (J. I.). H. S. thanks the Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research), under JP19am0101090. M. W. was supported by the Japanese Society for the Promotion of Science as an International Research Fellow. Accession number 7KNG denotes 2.10 A resolution structure of independent phosphoglycerate mutase from C. elegans in complex with a macrocyclic peptide inhibitor (Ce-2 Y7F) and 7KNF denotes 1.80 A resolution structure of independent phosphoglycerate mutase from C. elegans in complex with a macrocyclic peptide inhibitor (Ce-1 NHOH). The E. coli expression plasmids enabling site-specific C-terminal biotinylation described in this study, pET21a Ce-iPGM-bio (ID 162559), pET21a Bm-iPGM-bio (ID 162565), and pET21a Ec-iPGM-bio (ID 162575) have been deposited into Addgene. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldrich C, 2017, J MED CHEM, V60, P2165, DOI 10.1021/acs.jmedchem.7b00229; Bashiruddin NK, 2015, CURR OPIN CHEM BIOL, V24, P131, DOI 10.1016/j.cbpa.2014.11.011; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHAN WWC, 1982, J BIOL CHEM, V257, P7955; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins JM, 2014, ORG LETT, V16, P940, DOI 10.1021/ol4036825; Crowther GJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002628; Darby JF, 2019, J AM CHEM SOC, V141, P15818, DOI 10.1021/jacs.9b06275; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dougherty PG, 2019, CHEM REV, V119, P10241, DOI 10.1021/acs.chemrev.9b00008; Dutow P, 2010, J MOL MICROB BIOTECH, V19, P134, DOI 10.1159/000321499; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Filipuzzi I, 2017, NAT CHEM BIOL, V13, P1239, DOI [10.1038/NCHEMBIO.2493, 10.1038/nchembio.2493]; Floyd CD, 1996, TETRAHEDRON LETT, V37, P8045, DOI 10.1016/0040-4039(96)01821-7; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI 10.1021/cb700233t; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Haanstra JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40406; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Harris MT, 2014, CURR MED CHEM, V21, P1668, DOI 10.2174/09298673113206660286; INGLESE J, 1989, J MED CHEM, V32, P937, DOI 10.1021/jm00125a002; Istvan ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14240; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh T, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz143; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Kim BK, 2014, CURR TOP MED CHEM, V14, P2759, DOI 10.2174/1568026615666141208105614; ledrzejas, 2000, EMBO J, V19, p1419 1431; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Mercaldi GF, 2012, FEBS J, V279, P2012, DOI 10.1111/j.1742-4658.2012.08586.x; Miao ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37024; Miller TW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218897; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Niemeyer CM, 1999, BIOCONJUGATE CHEM, V10, P708, DOI 10.1021/bc980150n; Nowicki MW, 2009, J MOL BIOL, V394, P535, DOI 10.1016/j.jmb.2009.09.041; Okuma R, 2020, CHEM-ASIAN J, V15, P2631, DOI 10.1002/asia.202000700; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raj M, 2013, BIOORGAN MED CHEM, V21, P4051, DOI 10.1016/j.bmc.2012.11.023; Rogers JM, 2018, P NATL ACAD SCI USA, V115, P10959, DOI 10.1073/pnas.1809901115; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Roychowdhury A, 2015, FEBS J, V282, P1097, DOI 10.1111/febs.13205; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; Straus OH, 1943, J GEN PHYSIOL, V26, P559, DOI 10.1085/jgp.26.6.559; Tautermann CS, 2014, BIOORG MED CHEM LETT, V24, P4073, DOI 10.1016/j.bmcl.2014.07.009; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Yang J, 2020, ACS OMEGA, V5, P3979, DOI 10.1021/acsomega.9b03493; Yu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14932; Zhang YH, 2004, J BIOL CHEM, V279, P37185, DOI 10.1074/jbc.M405877200; Zhang ZY, 2020, ACS CENTRAL SCI, V6, P1753, DOI 10.1021/acscentsci.0c00514	63	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100628	10.1016/j.jbc.2021.100628	http://dx.doi.org/10.1016/j.jbc.2021.100628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812994	Green Published, gold			2022-12-26	WOS:000672866400599
J	Okui, M; Murakami, T; Sun, H; Ikeshita, C; Kanamura, N; Taruno, A				Okui, Motoki; Murakami, Tatsuro; Sun, Hongxin; Ikeshita, Chiaki; Kanamura, Narisato; Taruno, Akiyuki			Posttranslational regulation of CALHM1/3 channel: N-linked glycosylation and S-palmitoylation	FASEB JOURNAL			English	Article						acylation; ATP; gustation; patch clamp	SURFACE EXPRESSION; ION-CHANNEL; IDENTIFICATION; SUBUNIT; STABILITY; SITES	Among calcium homeostasis modulator (CALHM) family members, CALHM1 and 3 together form a voltage-gated large-pore ion channel called CALHM1/3. CALHM1/3 plays an essential role in taste perception by mediating neurotransmitter release at channel synapses of taste bud cells. However, it is poorly understood how CALHM1/3 is regulated. Biochemical analyses of the two subunits following site-directed mutagenesis and pharmacological treatments established that both CALHM1 and 3 were N-glycosylated at single Asn residues in their second extracellular loops. Biochemical and electrophysiological studies revealed that N-glycan acquisition on CALHM1 and 3, respectively, controls the biosynthesis and gating kinetics of the CALHM1/3 channel. Furthermore, failure in subsequent remodeling of N-glycans decelerated the gating kinetics. Thus, the acquisition of N-glycans on both subunits and their remodeling differentially contribute to the functional expression of CALHM1/3. Meanwhile, metabolic labeling and acyl-biotin exchange assays combined with genetic modification demonstrated that CALHM3 was reversibly palmitoylated at three intracellular Cys residues. Screening of the DHHC protein acyltransferases identified DHHC3 and 15 as CALHM3 palmitoylating enzymes. The palmitoylation-deficient mutant CALHM3 showed a normal degradation rate and interaction with CALHM1. However, the same mutation markedly attenuated the channel activity but not surface localization of CALHM1/3, suggesting that CALHM3 palmitoylation is a critical determinant of CALHM1/3 activity but not its formation or forward trafficking. Overall, this study characterized N-glycosylation and S-palmitoylation of CALHM1/3 subunits and clarified their differential contributions to its functional expression, providing insights into the fine control of the CALHM1/3 channel and associated physiological processes.	[Okui, Motoki; Murakami, Tatsuro; Sun, Hongxin; Ikeshita, Chiaki; Taruno, Akiyuki] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, 465 Kajiicho Kamigyo Ward, Kyoto 6028566, Japan; [Okui, Motoki; Kanamura, Narisato] Kyoto Prefectural Univ Med, Dept Dent Med, Kyoto, Japan; [Taruno, Akiyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST)	Taruno, A (corresponding author), Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, 465 Kajiicho Kamigyo Ward, Kyoto 6028566, Japan.	taruno@koto.kpu-m.ac.jp			JST [JPMJPR1886]; JSPS [16K15181, 19H03819, 20K21505, 20H04908]; Salt Science Research Foundation [18C2, 19C2, 20C2]	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Salt Science Research Foundation	JST, Grant/Award Number: JPMJPR1886; JSPS, Grant/Award Number: 16K15181, 19H03819, 20K21505 and 20H04908; Salt Science Research Foundation, Grant/Award Number: 18C2, 19C2 and 20C2	Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Choi W, 2019, NATURE, V576, P163, DOI 10.1038/s41586-019-1781-3; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Demura K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8105; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Drozdzyk K, 2020, ELIFE, V9, DOI 10.7554/eLife.55853; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Hofherr A, 2014, J BIOL CHEM, V289, P14854, DOI 10.1074/jbc.M114.562264; Jun M, 2018, MOL PSYCHIATR, V23, P883, DOI 10.1038/mp.2017.229; Kashio M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39593-5; Lichnerova K, 2015, J BIOL CHEM, V290, P18379, DOI 10.1074/jbc.M115.656546; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Ma ZM, 2018, NEURON, V98, P547, DOI 10.1016/j.neuron.2018.03.043; Ma ZM, 2016, PFLUG ARCH EUR J PHY, V468, P395, DOI 10.1007/s00424-015-1757-6; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Nomura K, 2020, NEURON, V106, P816, DOI 10.1016/j.neuron.2020.03.006; Ren Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8161; Romanov RA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1815; Sclafani A, 2018, AM J PHYSIOL-REG I, V315, pR576, DOI 10.1152/ajpregu.00015.2018; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Suzuki M, 2015, MOL BIOL CELL, V26, P2333, DOI 10.1091/mbc.E14-11-1504; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Syrjanen JL, 2020, NAT STRUCT MOL BIOL, V27, P150, DOI 10.1038/s41594-019-0369-9; Taruno A, 2021, PFLUG ARCH EUR J PHY, V473, P3, DOI 10.1007/s00424-020-02464-4; Taruno A, 2017, J PHYSIOL-LONDON, V595, P6121, DOI 10.1113/JP274164; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Thayer DA, 2016, J PHYSIOL-LONDON, V594, P6701, DOI 10.1113/JP272394; Tordoff MG, 2014, CHEM SENSES, V39, P515, DOI 10.1093/chemse/bju020; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Weiss N, 2013, PFLUG ARCH EUR J PHY, V465, P1159, DOI 10.1007/s00424-013-1259-3; Yang WX, 2020, PROTEIN SCI, V29, P1803, DOI 10.1002/pro.3904; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016	39	1	1	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21527	10.1096/fj.202002632R	http://dx.doi.org/10.1096/fj.202002632R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788965				2022-12-26	WOS:000645260100108
J	Sato, T; Ishiwatari, C; Kaneko, YK; Ishikawa, Y; Kimura, Y; Watanabe, N; Aoshima, I; Matsuda, Y; Nakayama, T; Chiba, R; Fujinuki, T; Iwata, K; Lu, Q; Usuki, T; Sakane, F; Ishikawa, T				Sato, Taiji; Ishiwatari, Chihiro; Kaneko, Yukiko K.; Ishikawa, Yoko; Kimura, Yuki; Watanabe, Naoya; Aoshima, Ikumi; Matsuda, Yukari; Nakayama, Takahiro; Chiba, Rina; Fujinuki, Takahiro; Iwata, Kai; Lu, Qiang; Usuki, Takako; Sakane, Fumio; Ishikawa, Tomohisa			Diacylglycerol kinase delta functions as a proliferation suppressor in pancreatic beta-cells	FASEB JOURNAL			English	Article						diacylglycerol kinase delta; pancreatic beta-cell; proliferation; beta-cell mass	INSULIN-SECRETION; NUCLEAR DIACYLGLYCEROL; POSSIBLE INVOLVEMENT; SWISS 3T3-CELLS; PLASMA-MEMBRANE; ADULT-MOUSE; FATTY-ACID; PROTEIN; EXPRESSION; GLUCOSE	Although an aberrant reduction in pancreatic beta-cell mass contributes to the pathogenesis of diabetes, the mechanism underlying the regulation of beta-cell mass is poorly understood. Here, we show that diacylglycerol kinase delta (DGK delta) is a key enzyme in the regulation of beta-cell mass. DGK delta expression was detected in the nucleus of beta-cells. We developed beta-cell-specific DGK delta knockout (beta DGK delta KO) mice, which showed lower blood glucose, higher plasma insulin levels, and better glucose tolerance compared to control mice. Moreover, an increased number of small islets and Ki-67-positive islet cells, as well as elevated cyclin B1 expression in the islets, were detected in the pancreas of beta DGK delta KO mice. DGK delta knockdown in the beta-cell line MIN6 induced significant increases in bromodeoxyuridine (BrdU) incorporation and cyclin B1 expression. Finally, we confirmed that streptozotocin-induced hyperglycemia and beta-cell loss were alleviated in beta DGK delta KO mice. Thus, suppressing the expression or enzymatic activity of DGK delta that functions as a suppressor of beta-cell proliferation could be a novel therapeutic approach to increase beta-cell mass for the treatment of diabetes.	[Sato, Taiji; Ishiwatari, Chihiro; Kaneko, Yukiko K.; Ishikawa, Yoko; Kimura, Yuki; Watanabe, Naoya; Aoshima, Ikumi; Matsuda, Yukari; Nakayama, Takahiro; Chiba, Rina; Fujinuki, Takahiro; Ishikawa, Tomohisa] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacol, Shizuoka, Japan; [Iwata, Kai; Lu, Qiang; Usuki, Takako; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan	University of Shizuoka; Chiba University	Kaneko, YK (corresponding author), Univ Shizuoka, Dept Pharmacol, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ykaneko@u-shizuoka-ken.ac.jp	Sakane, Fumio/H-2693-2017; Kaneko, Yukiko/AAV-2701-2021	Sakane, Fumio/0000-0003-0857-0377; Kaneko, Yukiko/0000-0002-5930-5349	University of Shizuoka; Japan Society for the Promotion of Science JSPS KAKENHI [26750336, 17K01857, 20K11512, 15K12705, 17H02175]; Takeda Science Foundation; Suzuken Memorial Foundation	University of Shizuoka; Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation	This study was supported by grants for the research projects from the University of Shizuoka. This study was also supported in part by Grants-in-Aid for Young Scientists (YKK, 26750336) and Scientific Research (YKK, 17K01857, 20K11512, TI, 15K12705, 17H02175) from the Japan Society for the Promotion of Science JSPS KAKENHI Grant and grants from Takeda Science Foundation and Suzuken Memorial Foundation	Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Baldanzi Gianluca, 2014, Advances in Biological Regulation, V55, P39, DOI 10.1016/j.jbior.2014.02.001; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bonner-Weir S, 1989, DIABETES, V38, P49; Bonner-Weir S., 2000, TRENDS ENDOCRIN MET, V11, P375; Bonner-Weir Susan, 2012, Rev Diabet Stud, V9, P407, DOI 10.1900/RDS.2012.9.407; Briaud I, 2001, DIABETES, V50, P315; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Daniel P, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.21; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Eizirik DL, 2018, NAT REV ENDOCRINOL, V14, P629, DOI 10.1038/s41574-018-0101-6; Evangelisti C, 2006, EUR J HISTOCHEM, V50, P9; Evangelisti C, 2007, FASEB J, V21, P3297, DOI 10.1096/fj.07-8336com; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Jiang LQ, 2016, AM J PHYSIOL-ENDOC M, V310, pE51, DOI 10.1152/ajpendo.00209.2015; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko YK, 2015, BIOL PHARM BULL, V38, P669, DOI 10.1248/bpb.b15-00060; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Los AP, 2006, J BIOL CHEM, V281, P858, DOI 10.1074/jbc.M502693200; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Martelli AM, 2000, CANCER RES, V60, P815; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakayama Y, 2013, INT REV CEL MOL BIO, V305, P303, DOI 10.1016/B978-0-12-407695-2.00007-X; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Razavi R, 2015, DIABETES, V64, P1311, DOI 10.2337/db14-0070; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Takeuchi M, 2012, BBA-MOL CELL RES, V1823, P2210, DOI 10.1016/j.bbamcr.2012.08.019; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Togashi Y, 2014, ENDOCRINOLOGY, V155, P1643, DOI 10.1210/en.2013-1796; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Turban S, 2018, FEBS LETT, V585, P269; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Usuki T, 2016, BRAIN RES, V1648, P193, DOI 10.1016/j.brainres.2016.07.017; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Wrede CE, 2003, J MOL ENDOCRINOL, V30, P271, DOI 10.1677/jme.0.0300271; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	54	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21420	10.1096/fj.202001279RR	http://dx.doi.org/10.1096/fj.202001279RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774855	hybrid			2022-12-26	WOS:000645260100085
J	Mashimo, S; Yoshida, N; Hogan, T; Takegami, A; Nishida, S; Nagano, Y				Mashimo, Sonoko; Yoshida, Naruto; Hogan, Takaaki; Takegami, Ayaka; Nishida, Satoru; Nagano, Yasuharu			An update of the Japanese Oslo Sports Trauma Research Center questionnaires on overuse injuries and health problems	PLOS ONE			English	Article								Monitoring the health of athletes is important for their protection, and questionnaires such as those produced by the Oslo Sports Trauma Research Center (OSTRC) are a valuable tool in this process. In 2020, several changes were made to the OSTRC questionnaires (OSTRC-O, OSTRC-H), including changes to the wording, structure, and logic of the original questionnaires. In the present study, the Japanese versions of the OSTRC questionnaires (OSTRC-O.JP, OSTRC-H.JP) were revised to meet the requirements of the updated versions and to analyse new and previously collected data to illustrate the impact of the changes on Japanese athletes. Proposed changes were categorized as minor or more substantial; minor changes were effected to the questionnaire instructions and to the wording of all four questions, and more substantial changes were made to the wording of question 2. The updated questionnaires also included changes to questionnaire logic and answer categories. To assess the consequences of the changes to the wording of question 2, 101 athletes were asked to complete the OSTRC-H.JP, which included both the original and updated versions of question 2, over 10 consecutive weeks. We calculated the number of health problems identified when new gatekeeper logic was and was not applied, using 1585 OSTRC-H.JP responses to assess the consequences of the changes to the questionnaire logic. The kappa coefficient, which measures the level of agreement between the responses to question 2 of the original and updated versions, was high. By applying gatekeeper logic, there was a remarkable reduction in the number of injuries and illnesses among all health problems but less reduction in substantial health problems and time loss health problems. These changes will make it easier for Japanese athletes to complete the questionnaires and improve the quality of collected data.	[Mashimo, Sonoko] Osaka Electrocommun Univ, Inst Liberal Arts & Sci, Neyagawa, Osaka, Japan; [Yoshida, Naruto] Teikyo Heisei Univ, Fac Hlth Care, Toshima Ku, Tokyo, Japan; [Hogan, Takaaki] Osaka Electrocommun Univ, Media Commun Ctr, Neyagawa, Osaka, Japan; [Takegami, Ayaka] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Nishida, Satoru] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Fukuoka, Japan; [Nagano, Yasuharu] Japan Womens Coll Phys Educ, Dept Sports & Hlth Sci, Setagaya Ku, Tokyo, Japan	Osaka Electro-Communication University; Osaka Electro-Communication University; University of Tsukuba; Fukuoka University	Mashimo, S (corresponding author), Osaka Electrocommun Univ, Inst Liberal Arts & Sci, Neyagawa, Osaka, Japan.	mashimo@osakac.ac.jp	Nagano, Yasuharu/AAH-7814-2019	Nagano, Yasuharu/0000-0001-6964-2245; Mashimo, Sonoko/0000-0002-2982-3890	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K19813]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) KAKENHI, Grant Number JP19K19813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Beaton DE, 2007, RECOMMENDATIONS CROS; Bjorneboe J, 2014, SCAND J MED SCI SPOR, V24, P189, DOI 10.1111/j.1600-0838.2012.01476.x; Clarsen B, 2020, BRIT J SPORT MED, V54, P390, DOI 10.1136/bjsports-2019-101337; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Ekman E, 2015, SCAND J MED SCI SPOR, V25, P104, DOI 10.1111/sms.12157; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hirschmuller A, 2017, BRIT J SPORT MED, V51, P260, DOI 10.1136/bjsports-2016-096669; Jorgensen JE, 2016, SCAND J MED SCI SPOR, V26, P1391, DOI 10.1111/sms.12590; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mashimo S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242993; Murray A, 2020, BRIT J SPORT MED, V54, P1136, DOI 10.1136/bjsports-2020-102380; Nagano Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215352; Olsen OE, 2006, SCAND J MED SCI SPOR, V16, P426, DOI 10.1111/j.1600-0838.2005.00484.x; Stubbe JH, 2015, J ATHL TRAINING, V50, P211, DOI 10.4085/1062-6050-49.3.64; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249685	10.1371/journal.pone.0249685	http://dx.doi.org/10.1371/journal.pone.0249685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793679	gold, Green Published			2022-12-26	WOS:000636467000055
J	Smolinski, S; Denechaud, CM; von Leesen, G; Geffen, AJ; Gronkjaer, P; Godiksen, JA; Campana, SE				Smolinski, Szymon; Denechaud, Come; von Leesen, Gotje; Geffen, Audrey J.; Gronkjaer, Peter; Godiksen, Jane A.; Campana, Steven E.			Differences in metabolic rate between two Atlantic cod (Gadus morhua) populations estimated with carbon isotopic composition in otoliths	PLOS ONE			English	Article							STABLE CARBON; TROPHIC RELATIONSHIPS; AMBIENT-TEMPERATURE; MIGRATION PATTERNS; DELTA-C-13 VALUES; FISH OTOLITHS; GLOBAL OCEAN; GROWTH; STOCK; SEA	The isotopic composition of inorganic carbon in otoliths (delta C-13(oto)) can be a useful tracer of metabolic rates and a method to study ecophysiology in wild fish. We evaluated environmental and physiological sources of delta C-13(oto) variation in Icelandic and Northeast Arctic (NEA) cod (Gadus morhua) over the years 1914-2013. Individual annual growth increments of otoliths formed at age 3 and 8 were micromilled and measured by isotope-ratio mass spectrometry. Simultaneously, all annual increment widths of the otoliths were measured providing a proxy of fish somatic growth. We hypothesized that changes in the physiological state of the organism, reflected by the isotopic composition of otoliths, can affect the growth rate. Using univariate and multivariate mixed-effects models we estimated conditional correlations between carbon isotopic composition and growth of fish at different levels (within individuals, between individuals, and between years), controlling for intrinsic and extrinsic effects on both otolith measurements. delta C-13(oto) was correlated with growth within individuals and between years, which was attributed to the intrinsic effects (fish age or total length). There was no significant correlation between delta C-13(oto) and growth between individuals, which suggests that caution is needed when interpreting delta C-13(oto) signals. We found a significant decrease in delta C-13(oto) through the century which was explained by the oceanic Suess effect-admixture of isotopically light carbon from fossil fuel. We calculated the proportion of the respired carbon in otolith carbonate (C-resp) using carbon isotopic composition in diet and dissolved inorganic carbon of the seawater. This approach allowed us to correct the values for each stock in relation to these two environmental baselines. C-resp was on average 0.275 and 0.295 in Icelandic and NEA stock, respectively. Our results provide an insight into the physiological basis for differences in growth characteristics between these two cod stocks, and how that may vary over time.	[Smolinski, Szymon; Denechaud, Come; Geffen, Audrey J.; Godiksen, Jane A.] Nordnes, Inst Marine Res, Bergen, Norway; [Smolinski, Szymon] Natl Marine Fisheries Res Inst, Dept Fisheries Resources, Gdynia, Poland; [Denechaud, Come; Geffen, Audrey J.] Univ Bergen, Dept Biol Sci, Bergen, Norway; [von Leesen, Gotje; Campana, Steven E.] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Gronkjaer, Peter] Aarhus Univ, Dept Biosci, Aquat Biol, Aarhus, Denmark	Institute of Marine Research - Norway; National Marine Fisheries Research Institute; University of Bergen; University of Iceland; Aarhus University	Smolinski, S (corresponding author), Nordnes, Inst Marine Res, Bergen, Norway.; Smolinski, S (corresponding author), Natl Marine Fisheries Res Inst, Dept Fisheries Resources, Gdynia, Poland.	szymon.smolinski@hi.no	Smoliński, Szymon/AAZ-1088-2020; von Leesen, Gotje/AHB-8643-2022; Gronkjaer, Peter/A-3697-2008	Smoliński, Szymon/0000-0003-2715-984X; Denechaud, Come/0000-0002-8298-4423; Gronkjaer, Peter/0000-0003-1337-4661; von Leesen, Gotje/0000-0003-1795-9413	Icelandic Research Fund [173906-051]; Eimskip University Fund [1535-1533127]; Research Council of Norway [245907]	Icelandic Research Fund; Eimskip University Fund; Research Council of Norway(Research Council of Norway)	Funding for this work was provided by the Icelandic Research Fund (grant 173906-051) to SEC. This work was also supported by The Eimskip University Fund (project number: 1535-1533127) to GvL. Establishment funding for FARLAB (Facility for advanced isotopic research and monitoring of weather, climate, and biogeochemical cycling) by the Research Council of Norway (grant 245907) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, **DATA OBJECT**, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; [Anonymous], 2019, PACKAGE MUMIN MULTIM; Bardarson H, 2017, CAN J FISH AQUAT SCI, V74, P2122, DOI 10.1139/cjfas-2016-0307; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Begg GA, 2002, MAR ECOL PROG SER, V229, P245, DOI 10.3354/meps229245; Begg GA, 2001, MAR ECOL PROG SER, V216, P223, DOI 10.3354/meps216223; Bochkov Y.A., 1982, SB NAUCHN T PINRO, V46, P113; Bogstad B, 2000, NAMMCO SCI PUBL, V2, P98, DOI 10.7557/3.2975; Brand WA, 2014, PURE APPL CHEM, V86, P425, DOI 10.1515/pac-2013-1023; Brickman D, 2007, ICES J MAR SCI, V64, P49, DOI 10.1093/icesjms/fsl019; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Chabot D, 2016, J FISH BIOL, V88, P81, DOI 10.1111/jfb.12845; Chung MT, 2019, MAR FRESHWATER RES, V70, P1747, DOI 10.1071/MF18317; Chung MT, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0266-5; Denechaud C, 2020, ICES J MAR SCI, V77, P1043, DOI 10.1093/icesjms/fsz259; Denechaud C, 2020, GLOBAL CHANGE BIOL, V26, P5661, DOI 10.1111/gcb.15298; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dippner JW, 2001, CLIMATE RES, V17, P73, DOI 10.3354/cr017073; Dufour E, 2007, CAN J FISH AQUAT SCI, V64, P1736, DOI 10.1139/F07-132; Eide M, 2017, GLOBAL BIOGEOCHEM CY, V31, P515, DOI [10.1002/2016GB005473, 10.1002/2016GB005472]; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; Estrella-Martinez J, 2019, FISH FISH, V20, P537, DOI 10.1111/faf.12362; Filipsson HL, 2017, PALAEOGEOGR PALAEOCL, V483, P15, DOI 10.1016/j.palaeo.2016.11.031; Geffen AJ, 2012, ENVIRON BIOL FISH, V95, P419, DOI 10.1007/s10641-012-0033-2; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Grammer GL, 2017, ECOL MONOGR, V87, P487, DOI 10.1002/ecm.1264; Gronkjaer P, 2016, MAR FRESHWATER RES, V67, P881, DOI 10.1071/MF15155; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hadfield JD, 2010, AM NAT, V175, P116, DOI 10.1086/648604; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hanson NN, 2013, MAR ECOL PROG SER, V475, P249, DOI 10.3354/meps10066; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hoie H, 2003, J EXP MAR BIOL ECOL, V289, P41, DOI 10.1016/S0022-0981(03)00034-0; Holt RE, 2019, ICES J MAR SCI, V76, P1641, DOI 10.1093/icesjms/fsz082; Houslay TM, 2017, BEHAV ECOL, V28, P948, DOI 10.1093/beheco/arx023; Irgens C, 2020, CAN J FISH AQUAT SCI, V77, P113, DOI 10.1139/cjfas-2019-0033; Izzo C, 2018, FISH FISH, V19, P441, DOI 10.1111/faf.12264; Jamieson RE, 2004, FISH RES, V68, P83, DOI 10.1016/j.fishres.2004.02.009; Jonsdottir IG, 2006, J FISH BIOL, V69, P136, DOI 10.1111/j.1095-8649.2006.01271.x; KALISH JM, 1991, MAR ECOL PROG SER, V75, P191, DOI 10.3354/meps075191; Kalish JM, 2001, RADIOCARBON, V43, P843; KALISH JM, 1991, MAR BIOL, V110, P37, DOI 10.1007/BF01313090; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; Link JS, 2009, FISH FISH, V10, P58, DOI 10.1111/j.1467-2979.2008.00295.x; Lorrain A, 2020, GLOBAL CHANGE BIOL, V26, P458, DOI 10.1111/gcb.14858; Macdonald JI, 2020, REV FISH BIOL FISHER, V30, P173, DOI 10.1007/s11160-019-09591-x; Martino JC, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.217091; Martino JC, 2019, ECOL INDIC, V97, P10, DOI 10.1016/j.ecolind.2018.10.010; Meager JJ, 2018, REV FISH BIOL FISHER, V28, P153, DOI 10.1007/s11160-017-9505-y; Morinville GR, 2003, CAN J FISH AQUAT SCI, V60, P401, DOI [10.1139/f03-036, 10.1139/F03-036]; Morrongiello JR, 2015, ECOL MONOGR, V85, P93, DOI 10.1890/13-2355.1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Ottersen G, 1998, ICES J MAR SCI, V55, P67, DOI 10.1006/jmsc.1997.0232; Palsson OK, 2003, CAN J FISH AQUAT SCI, V60, P1409, DOI 10.1139/F03-117; Palsson OK, 2011, ICES J MAR SCI, V68, P1488, DOI 10.1093/icesjms/fsr057; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PINRO, 2019, PINRO OFFICIAL WEBSI; R Core Team, 2020, R LANG ENV STAT COMP; Reis-Santos P, 2018, MAR ENVIRON RES, V140, P332, DOI 10.1016/j.marenvres.2018.06.002; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; ROLLEFSEN G., 1933, FISKERIDIREK SKR SER HAVUNDERS REP NORWEGIAN FISH AND MAR INVEST, V4, P1; Rosenfeld J, 2015, J ANIM ECOL, V84, P4, DOI 10.1111/1365-2656.12260; Schwarcz HP, 1998, CAN J FISH AQUAT SCI, V55, P1798, DOI 10.1139/cjfas-55-8-1798; Sherwood GD, 2003, MAR ECOL PROG SER, V258, P283, DOI 10.3354/meps258283; Sherwood GD, 2007, DEEP-SEA RES PT II, V54, P2794, DOI 10.1016/j.dsr2.2007.08.007; Smolinski S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73652-6; Smolinski S, 2019, ECOL INDIC, V101, P420, DOI 10.1016/j.ecolind.2019.01.050; Smolinski S, 2017, ECOL INDIC, V79, P286, DOI 10.1016/j.ecolind.2017.04.028; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; Stensholt BK, 2001, ICES J MAR SCI, V58, P770, DOI 10.1006/jmsc.2001.1067; Stock BC, 2018, PEERJ, V6, DOI 10.7717/peerj.5096; Strand KO, 2017, FRONT MAR SCI, V4, DOI 10.3330/fmars.2017.00304; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tereshchenko VV, 1996, ICES 900 1996C11; Thompson DR, 1999, CONDOR, V101, P898, DOI 10.2307/1370085; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Treberg JR, 2016, COMP BIOCHEM PHYS A, V202, P10, DOI 10.1016/j.cbpa.2016.04.022; Vasilakopoulos P, 2015, GLOBAL CHANGE BIOL, V21, P1834, DOI 10.1111/gcb.12845; von Leesen G, 2020, ICES J MAR SCI, V77, P942, DOI 10.1093/icesjms/fsaa011; Weidel BC, 2007, CAN J FISH AQUAT SCI, V64, P1641, DOI 10.1139/F07-157; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; Weisberg S, 2010, CAN J FISH AQUAT SCI, V67, P269, DOI 10.1139/F09-181; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Wurster CM, 2003, PALEOBIOLOGY, V29, P492, DOI 10.1666/0094-8373(2003)029<0492:MROLHF>2.0.CO;2; Yanes Y, 2013, QUATERNARY RES, V80, P596, DOI 10.1016/j.yqres.2013.08.010; Zuur A, 2009, MIXED EFFECTS MODELS	89	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248711	10.1371/journal.pone.0248711	http://dx.doi.org/10.1371/journal.pone.0248711			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793572	Green Published, gold			2022-12-26	WOS:000636467000004
J	Van Acker, P; Van Biesen, W; Nagler, EV; Koobasi, M; Veys, N; Vanmassenhove, J				Van Acker, Paulien; Van Biesen, Wim; Nagler, Evi V.; Koobasi, Muguet; Veys, Nic; Vanmassenhove, Jill			Risk prediction models for acute kidney injury in adults: An overview of systematic reviews	PLOS ONE			English	Article							PROGNOSIS; OUTCOMES; SURGERY; QUALITY; BIAS; TOOL	Background The incidence of Acute Kidney Injury (AKI) and its human and economic cost is increasing steadily. One way to reduce the burden associated with AKI is to prevent the event altogether. An important step in prevention lies in AKI risk prediction. Due to the increasing number of available risk prediction models (RPMs) clinicians need to be able to rely on systematic reviews (SRs) to provide an objective assessment on which RPM can be used in a specific setting. Our aim was to assess the quality of SRs of RPMs in AKI. Methods The protocol for this overview was registered in PROSPERO. MEDLINE and Embase were searched for SRs of RPMs of AKI in any setting from 2003 till August 2020. We used the ROBIS tool to assess the methodological quality of the retrieved SRs. Results Eight SRs were retrieved. All studies were assessed as being at high risk for bias using the ROBIS tool. Eight reviews had a high risk of bias in study eligibility criteria (domain 1), five for study identification and selection (domain 2), seven for data collection and appraisal (domain 3) and seven for synthesis and findings (domain 4). Five reviews were scored at high risk of bias across all four domains. Risk of bias assessment with a formal risk of bias tool was only performed in five reviews. Primary studies were heterogeneous and used a wide range of AKI definitions. Only 19 unique RPM were externally validated, of which 11 had only 1 external validation report. Conclusion The methodological quality of SRs of RPMs of AKI is inconsistent. Most SRs lack a formal risk of bias assessment. SRs ought to adhere to certain standard quality criteria so that clinicians can rely on them to select a RPM for use in an individual patient.	[Van Acker, Paulien; Van Biesen, Wim; Nagler, Evi V.; Koobasi, Muguet; Veys, Nic; Vanmassenhove, Jill] Ghent Univ Hosp, Renal Div, Dept Internal Med, Ghent, Belgium	Ghent University; Ghent University Hospital	Van Acker, P (corresponding author), Ghent Univ Hosp, Renal Div, Dept Internal Med, Ghent, Belgium.	paulien.vanacker@ugent.be		Koobasi, Muguet/0000-0002-9576-9271; Van Acker, Paulien/0000-0001-7915-1810; Van Biesen, Wim/0000-0002-4782-5224; Nagler, Evi/0000-0002-8954-6397				Allen DW, 2017, CAN J CARDIOL, V33, P724, DOI 10.1016/j.cjca.2017.01.018; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Borrelli S., PRECISION NEPHROLOGY; Caragata R, 2016, ANAESTH INTENS CARE, V44, P251, DOI 10.1177/0310057X1604400212; Coca SG, 2017, KIDNEY INT, V92, P288, DOI 10.1016/j.kint.2017.03.044; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Coresh J., STRATEGIES IMPROVE M; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hodgson LE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016591; Huang Chao-Yuan, 2020, Rev. bras. ter. intensiva, V32, P123, DOI 10.5935/0103-507x.20200018; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacLeod A, 2009, LANCET, V374, P1405, DOI 10.1016/S0140-6736(09)61843-2; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Safari S, 2016, IRAN J KIDNEY DIS, V10, P101; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Silver SA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4395; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Vanmassenhove J, 2017, LANCET, V389, P2139, DOI 10.1016/S0140-6736(17)31329-6; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Wilson T, 2016, NEPHROL DIAL TRANSPL, V31, P231, DOI 10.1093/ndt/gfv415	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248899	10.1371/journal.pone.0248899	http://dx.doi.org/10.1371/journal.pone.0248899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793591	Green Published, gold			2022-12-26	WOS:000636467000030
J	Gong, ZH; Chen, JH; Wang, J; Liu, S; Ambrosone, CB; Higgins, MJ				Gong, Zhihong; Chen, Jianhong; Wang, Jie; Liu, Song; Ambrosone, Christine B.; Higgins, Michael J.			Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry	PLOS ONE			English	Article								Aggressive high-grade, estrogen receptor negative (ER-) breast cancer is more common among American women of African ancestry (AA) than those of European ancestry (EA). Epigenetic mechanisms, particularly DNA methylation and altered microRNA (miRNA) expression, may contribute to racial differences in breast cancer. However, few studies have specifically characterized genome-wide DNA methylation-based modifications at the miRNA level in relation to ER+ and ER- subtype, and their functional role in the regulation of miRNA expression, especially among high risk AA women. In this study, we evaluated DNA methylation patterns of miRNA encoding genes and their effect on expression in breast tumors from both AA and EA women. The genome-wide methylation screen identified a total of 7,191 unique CpGs mapped to 1,292 miRNA genes, corresponding to 2,035 unique mature miRNAs. We identified differentially methylated loci (DMLs: (|delta beta|)>0.10, FDR<0.05) between ER- and ER+ tumor subtypes, including 290 DMLs shared in both races, 317 and 136 were specific to AA and EA women, respectively. Integrated analysis identified certain DMLs whose methylation levels were significantly correlated with the expression of relevant miRNAs, such as multiple CpGs within miR-190b and miR-135b highly negatively correlated with their expression. These results were then validated in the TCGA dataset. Target prediction and pathway analysis showed that these DNA methylation-dysregulated miRNAs are involved in multiple cancer-related pathways, including cell cycle G1-S growth factor regulation, cytoskeleton remodeling, angiogenesis, EMT, and ESR1-mediated signaling pathways. In summary, our results suggest that DNA methylation changes within miRNA genes are associated with altered miRNA expression, which may contribute to the network of subtype- and race-related tumor biological differences in breast cancer. These findings support the involvement of epigenetic regulation of miRNA expression and provide insights into the relations of clinical-relevant miRNAs to their target genes, which may serve as potential preventative and therapeutic targets.	[Gong, Zhihong; Chen, Jianhong; Ambrosone, Christine B.] Roswell Park Comprehens Canc Ctr, Dept Canc Prevent & Control, Buffalo, NY 14203 USA; [Wang, Jie; Liu, Song] Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Higgins, Michael J.] Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Buffalo, NY USA		Gong, ZH (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Canc Prevent & Control, Buffalo, NY 14203 USA.	Zhihong.gong@roswellpark.org		Gong, Zhihong/0000-0003-1129-1774	National Institutes of Health/National Cancer Institute [K07 CA178293, R01CA1332641]	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from the National Institutes of Health/National Cancer Institute (K07 CA178293 to ZG, R01CA1332641 to CBA and MJH). The Roswell Park Pathology Network Shared Resource, Biomedical Data Science Shared Resource, Genetics Shared Resource, and Bioinformatics are Roswell Park CCSG Shared Resources (NIH P30 CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakula A, 2015, MOL ONCOL, V9, P1287, DOI 10.1016/j.molonc.2015.03.001; Ahmad A, 2017, BBA-REV CANCER, V1868, P16, DOI 10.1016/j.bbcan.2017.01.001; Ambrosone CB, 2014, ONCOTARGET, V5, P237, DOI 10.18632/oncotarget.1599; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Bardowell SA, 2013, BREAST CANCER RES TR, V142, P365, DOI 10.1007/s10549-013-2738-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cizeron-Clairac G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1505-5; Dai WZ, 2019, J BREAST CANCER, V22, P219, DOI 10.4048/jbc.2019.22.e19; Espinal AC, 2017, BREAST CANCER RES TR, V166, P559, DOI 10.1007/s10549-017-4418-y; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fassan M, 2019, TRANSL ONCOL, V12, P282, DOI 10.1016/j.tranon.2018.10.013; Frick Elisabet, 2019, Oncotarget, V10, P4664, DOI 10.18632/oncotarget.27083; Gan BL, 2018, ONCOL REP, V40, P3171, DOI 10.3892/or.2018.6766; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Gong ZH, 2019, CARCINOGENESIS, V40, P61, DOI 10.1093/carcin/bgy134; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Howard EW, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0082-9; Hua KY, 2016, INT J ONCOL, V48, P1997, DOI 10.3892/ijo.2016.3405; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lee KM, 2017, CELL METAB, V26, P633, DOI 10.1016/j.cmet.2017.09.009; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lehmann U, 2014, CELL TISSUE RES, V356, P657, DOI 10.1007/s00441-014-1793-0; Li LA, 2010, HUM MOL GENET, V19, P4273, DOI 10.1093/hmg/ddq351; Li S, 2018, ONCOL LETT, V15, P7069, DOI 10.3892/ol.2018.8245; Long MD, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010015; Luo SS, 2016, ONCOTARGETS THER, V9, P5643, DOI 10.2147/OTT.S111684; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Paszek S, 2017, GINEKOL POL, V88, P530, DOI 10.5603/GP.a2017.0097; Pu TJ, 2019, LAB INVEST, V99, P1296, DOI 10.1038/s41374-019-0258-1; Strmsek Ziga, 2015, Non-Coding RNA, V1, P44, DOI 10.3390/ncrna1010044; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Uva P, 2018, INT J MED SCI, V15, P536, DOI 10.7150/ijms.23402; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vijay GV, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1125-0; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037928; Williams KE, 2019, J CELL BIOCHEM, V120, P738, DOI 10.1002/jcb.27431; Yu P, 2016, CELL BIOL INT, V40, P1062, DOI 10.1002/cbin.10646; Zhang L, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/7378967; Zhang Xu, 2012, Frontiers in Genetics, V3, P73, DOI 10.3389/fgene.2012.00073	50	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249229	10.1371/journal.pone.0249229	http://dx.doi.org/10.1371/journal.pone.0249229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784351	Green Published, gold			2022-12-26	WOS:000636359600041
J	Villinger, K; Wahl, DR; Schupp, HT; Renner, B				Villinger, Karoline; Wahl, Deborah R.; Schupp, Harald T.; Renner, Britta			Memorable meals: The memory-experience gap in day-to-day experiences	PLOS ONE			English	Article							RETROSPECTIVE EVALUATIONS; REMEMBERED ENJOYMENT; DURATION NEGLECT; FOOD; ONLINE; PEAK; LIFE; RETENTION; PAIN; TIME	Research shows that retrospective memory is often more extreme than in-the-moment experiences. While investigations into this phenomenon have mostly focused on distinct, one-time experiences, we examined it with respect to recurring day-to-day experiences in the eating domain, focusing on variables of the snapshot model-i.e., the most intense and the final experience. We used a smartphone-based Ecological Momentary Assessment to assess the food intake and eating happiness of 103 participants (82.52% female, M-age = 21.97 years) over eight days, and then calculated their best (positive peak), worst (negative peak) and final experiences. Remembered eating happiness was assessed immediately after the study (immediate recall) and after four weeks (delayed recall). A significant memory-experience gap was revealed at immediate recall (d = .53). Remembered eating happiness was predicted by the worst eating experience (beta = .41, p < .001), but not by the best or final eating experience. Analyzing changes over time did not show a significant memory-experience gap at delayed recall, but did reveal a similar influence of the worst eating experience (beta = .39, p < .001). Findings indicate that, in the domain of eating, retrospective memory is mainly influenced by negative experiences. Overall, the results indicate that the snapshot model is a valid conceptualization to explain recall of both outstanding and day-to-day experiences.	[Villinger, Karoline; Wahl, Deborah R.; Renner, Britta] Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany; [Schupp, Harald T.] Univ Konstanz, Dept Psychol, Gen Psychol, Constance, Germany	University of Konstanz; University of Konstanz	Villinger, K (corresponding author), Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany.	Karoline.villinger@uni-konstanz.de		Villinger, Karoline/0000-0002-4103-0498	Federal Ministry of Education and Research within the SMARTACT research project (BMBF) [01EL1820A]	Federal Ministry of Education and Research within the SMARTACT research project (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was supported by the Federal Ministry of Education and Research within the SMARTACT research project (BMBF Grant 01EL1820A) granted to BR & HS. The funding source had no involvement in the study ' s design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit this article for publication.	[Anonymous], 2000, CHOICE VALUES FRAMES; Ariely D, 1998, J BEHAV DECIS MAKING, V11, P19, DOI 10.1002/(SICI)1099-0771(199803)11:1<19::AID-BDM277>3.0.CO;2-B; Blumenschein M, 2020, COMPUT GRAPH FORUM, V39, P565, DOI 10.1111/cgf.14002; Cohen J., 1988, STAT POWER SOCIAL SC, P98; Conner T.S., 2015, EMERGING TRENDS SOCI, P1, DOI [https://doi.org/10.1002/9781118900772.etrds0010, DOI 10.1002/9781118900772.ETRDS0010, 10.1002/9781118900772.etrds0010]; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; FREDRICKSON BL, 1993, J PERS SOC PSYCHOL, V65, P45, DOI 10.1037/0022-3514.65.1.45; Fredrickson BL, 2000, COGNITION EMOTION, V14, P577, DOI 10.1080/026999300402808; Geng XW, 2013, J BEHAV DECIS MAKING, V26, P225, DOI 10.1002/bdm.1755; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Jezior B. A., 1990, Food Quality and Preference, V2, P21, DOI 10.1016/0950-3293(90)90027-R; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; KEPPEL G, 1962, J VERB LEARN VERB BE, V1, P153, DOI 10.1016/S0022-5371(62)80023-1; Konig LM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030755; Lindeman R., 1980, INTRO BIVARIATE MULT; Miron-Shatz T, 2009, EMOTION, V9, P885, DOI 10.1037/a0017823; Mitchell TR, 1997, J EXP SOC PSYCHOL, V33, P421, DOI 10.1006/jesp.1997.1333; Montgomery NV, 2009, J CONSUM RES, V36, P83, DOI 10.1086/595278; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Robinson E, 2014, APPETITE, V74, P55, DOI 10.1016/j.appet.2013.11.012; Robinson E, 2012, BRIT J NUTR, V108, P1505, DOI 10.1017/S0007114511007021; Robinson E, 2011, APPETITE, V57, P207, DOI 10.1016/j.appet.2011.04.022; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Robinson MD, 2002, J PERS SOC PSYCHOL, V83, P198, DOI 10.1037//0022-3514.83.1.198; Rode E, 2007, APPETITE, V49, P18, DOI 10.1016/j.appet.2006.09.006; Rozin A, 2004, MUSIC PERCEPT, V22, P15, DOI 10.1525/mp.2004.22.1.15; Rozin P, 2005, J NUTR EDUC BEHAV, V37, pS107, DOI 10.1016/S1499-4046(06)60209-1; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Schreiber CA, 2000, J EXP PSYCHOL GEN, V129, P27, DOI 10.1037//0096-3445.129.1.27; Schwarz N., 2009, USING CALENDAR DIARY; Schwarz N., 2007, SCI REAL TIME DATA C; Schwarz N., 2012, HDB RES METHODS STUD, P22; Schwarz N, 2011, J CONSUM PSYCHOL, V21, P142, DOI 10.1016/j.jcps.2011.02.006; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Stone A.A., 1999, ECOLOGICAL MOMENTARY; Stone AA, 2007, SCI REAL TIME DATA C; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Tadic M, 2014, CHILD INDIC RES, V7, P21, DOI 10.1007/s12187-013-9194-6; Trull TJ, 2014, CURR DIR PSYCHOL SCI, V23, P466, DOI 10.1177/0963721414550706; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; UNDERWOOD BJ, 1957, PSYCHOL REV, V64, P49, DOI 10.1037/h0044616; Varey C., 1992, Journal of Behavioral Decision Making, V5, P169, DOI 10.1002/bdm.3960050303; Villinger K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01187; Wahl DR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17262-9; Wahl DR, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/13191; Walker WR, 2003, REV GEN PSYCHOL, V7, P203, DOI 10.1037/1089-2680.7.2.203; Walker WR, 1997, APPL COGNITIVE PSYCH, V11, P399, DOI 10.1002/(SICI)1099-0720(199710)11:5<399::AID-ACP462>3.3.CO;2-5; Wansink B, 2007, ENVIRON BEHAV, V39, P106, DOI 10.1177/0013916506295573; Wirtz D, 2003, PSYCHOL SCI, V14, P520, DOI 10.1111/1467-9280.03455; Ziesemer K, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15430	52	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249190	10.1371/journal.pone.0249190	http://dx.doi.org/10.1371/journal.pone.0249190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784338	Green Published, gold			2022-12-26	WOS:000636359600067
J	Moukarzel, S; Rehm, M; Caduff, A; del Fresno, M; Perez-Escamilla, R; Daly, AJ				Moukarzel, Sara; Rehm, Martin; Caduff, Anita; del Fresno, Miguel; Perez-Escamilla, Rafael; Daly, Alan J.			Real-time Twitter interactions during World Breastfeeding Week: A case study and social network analysis	PLOS ONE			English	Article							HEALTH; AWARENESS; MEDIA	Using Twitter to implement public health awareness campaigns is on the rise, but campaign monitoring and evaluation are largely dependent on basic Twitter Analytics. To establish the potential of social network theory-based metrics in better understanding public health campaigns, we analyzed real-time user interactions on Twitter during the 2020 World Breastfeeding Week (WBW) as an exemplar case. Social network analysis (SNA), including community and influencer identification, as well as topic modeling were used to compare the activity of n = 29,958 campaign participants and n = 10,694 reference users from the six-months pre-campaign period. Users formed more inter-connected relationships during the campaign, retweeting and mentioning each other 46,161 times compared to 10,662 times in the prior six months. Campaign participants formed identifiable communities that were not only based on their geolocation, but also based on interests and professional background. While influencers who dominated the WBW conversations were disproportionally members of the scientific community, the campaign did mobilize influencers from the general public who seemed to play a "bridging" role between the public and the scientific community. Users communicated about the campaign beyond its original themes to also discuss breastfeeding within the context of social and racial inequities. Applying SNA allowed understanding of the breastfeeding campaign's messaging and engagement dynamics across communities and influencers. Moving forward, WBW could benefit from improving targeting to enhance geographic coverage and user interactions. As this exemplar case indicates, social network theory and analysis can be used to inform other public health campaigns with data on user interactions that go beyond traditional metrics.	[Moukarzel, Sara] Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Moukarzel, Sara; Caduff, Anita; Daly, Alan J.] Univ Calif San Diego, Dept Educ Studies, La Jolla, CA 92093 USA; [Rehm, Martin] Univ Educ Weingarten, Inst Educ Consulting, Weingarten, Germany; [del Fresno, Miguel] Natl Distance Educ Univ, Dept Social Work, Madrid, Spain; [Perez-Escamilla, Rafael] Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Universidad Nacional de Educacion a Distancia (UNED); Yale University	Moukarzel, S (corresponding author), Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA.; Moukarzel, S (corresponding author), Univ Calif San Diego, Dept Educ Studies, La Jolla, CA 92093 USA.	smoukarzel@ucsd.edu		Caduff, Anita/0000-0002-2736-2170; Rehm, Martin/0000-0002-9553-7008	Larsson-Rosenquist Foundation; Yankelovich Center For Social Science Research at UC San Diego	Larsson-Rosenquist Foundation; Yankelovich Center For Social Science Research at UC San Diego	SM is supported by a fellowship from the Larsson-Rosenquist Foundation. This research was funded by the Yankelovich Center For Social Science Research at UC San Diego.	Ahlqvist T, 2010, FORESIGHT, V12, P3, DOI 10.1108/14636681011075687; Allen JD, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08824-0; Bahkali S, 2015, STUD HEALTH TECHNOL, V213, P247, DOI 10.3233/978-1-61499-538-8-247; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blei DM., 2009, TOPIC MODELS, V10; Borgatti SP, 2003, MANAGE SCI, V49, P432, DOI 10.1287/mnsc.49.4.432.14428; Buccafurri F, 2015, COMPUT HUM BEHAV, V52, P87, DOI 10.1016/j.chb.2015.05.045; Christakis NA., 2009, CONNECTED SURPRISING; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Conley CC, 2020, CARDIO-ONCOLOGY, V6, DOI 10.1186/s40959-020-00072-w; Cross R, 2001, SOC NETWORKS, V23, P215, DOI 10.1016/S0378-8733(01)00041-7; Daly A.J., 2018, LEADING HOLISTICALLY, V1st Edition; Daly AJ., 2020, SOCIAL NETWORK THEOR; Daly AJ, 2019, TEACH COLL REC, V121; Garcia MD, 2016, REV ESP INVESTIG SOC, P23, DOI 10.5477/cis/reis.153.23; Diddi P, 2017, J HEALTH COMMUN, V22, P243, DOI 10.1080/10810730.2016.1266716; Dunn AG, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0054-0; Edo-Osagie O, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103770; Giustini Dean, 2018, Online J Public Health Inform, V10, pe215, DOI 10.5210/ojphi.v10i2.8270; Grunspan DZ, 2014, CBE-LIFE SCI EDUC, V13, P167, DOI 10.1187/cbe.13-08-0162; Harding K, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12909; Kogan J, 2010, TEXT MINING, P183; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Makita M, 2021, ISSUES MENT HEALTH N, V42, P437, DOI 10.1080/01612840.2020.1814914; Litterio AM, 2017, EUR J MANAG BUS ECON, V26, P347, DOI 10.1108/EJMBE-10-2017-020; Moukarzel S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237471; Moukarzel S, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13053; Moukarzel S, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13025; Murphy G., 2004, BIG BOOK CONCEPTS; Nguyen J., 2019, JMIR DERMATOL, V2; Noack A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026102; Ostrowski DA., P IEEE 6 INT C SEM C, DOI [10.1109/ICSC.2012.52, DOI 10.1109/ICSC.2012.52]; Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512; Supovitz J., 2017, COMMONCORE PROJECT 2; Supovitz J, 2018, J EDUC CHANG, V19, P419, DOI 10.1007/s10833-018-9327-2; Valente TW, 2017, ANNU REV PUBL HEALTH, V38, P103, DOI 10.1146/annurev-publhealth-031816-044528; Ward MD, 2011, ANNU REV POLIT SCI, V14, P245, DOI 10.1146/annurev.polisci.12.040907.115949; World Alliance for Breastfeeding Action, 2020, WORLD BREASTFEEDING; Yoon SJ, 2014, COMPUT HUM BEHAV, V41, P295, DOI 10.1016/j.chb.2014.09.043	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249302	10.1371/journal.pone.0249302	http://dx.doi.org/10.1371/journal.pone.0249302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780502	Green Published, gold			2022-12-26	WOS:000636336800033
J	Horn, IP; Marks, DL; Koenig, AN; Hogenson, TL; Almada, LL; Goldstein, LE; Duran, PAR; Vera, R; Vrabel, AM; Cui, GF; Rabe, KG; Bamlet, WR; Mer, G; Sicotte, H; Zhang, C; Li, H; Petersen, GM; Fernandez-Zapico, ME				Horn, Isaac P.; Marks, David L.; Koenig, Amanda N.; Hogenson, Tara L.; Almada, Luciana L.; Goldstein, Lauren E.; Duran, Paola A. Romecin; Vera, Renzo; Vrabel, Anne M.; Cui, Gaofeng; Rabe, Kari G.; Bamlet, William R.; Mer, Georges; Sicotte, Hugues; Zhang, Cheng; Li, Hu; Petersen, Gloria M.; Fernandez-Zapico, Martin E.			A rare germline CDKN2A variant (47T > G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MELANOMA UPDATE; FAMILIAL MELANOMA; MOLECULAR-DYNAMICS; SKIN FIBROBLASTS; LINE MUTATIONS; PRONE FAMILIES; P16(INK4A); GENES; RISK; P16	Germline mutations in CDKN2A, encoding the tumor suppressor p16, are responsible for a large proportion of familial melanoma cases and also increase risk of pancreatic cancer. We identified four families through pancreatic cancer probands that were affected by both cancers. These families bore a germline missense variant of CDKN2A (47T>G), encoding a p16-L16R mutant protein associated with high cancer occurrence. Here, we investigated the biological significance of this variant. When transfected into p16-null pancreatic cancer cells, p16-L16R was expressed at lower levels than wild-type (WT) p16. In addition, p16-L16R was unable to bind CDK4 or CDK6 compared with WT p16, as shown by coimmunoprecipitation assays and also was impaired in its ability to inhibit the cell cycle, as demonstrated by flow cytometry analyses. In silico molecular modeling predicted that the L16R mutation prevents normal protein folding, consistent with the observed reduction in expression/stability and diminished function of this mutant protein. We isolated normal dermal fibroblasts from members of the families expressing WT or L16R proteins to investigate the impact of endogenous p16-L16R mutant protein on cell growth. In culture, p16-L16R fibroblasts grew at a faster rate, and most survived until later passages than p16-WT fibroblasts. Further, western blotting demonstrated that p16 protein was detected at lower levels in p16-L16R than in p16-WT fibroblasts. Together, these results suggest that the presence of a CDKN2A (47T>G) mutant allele contributes to an increased risk of pancreatic cancer as a result of reduced p16 protein levels and diminished p16 tumor suppressor function.	[Horn, Isaac P.; Marks, David L.; Koenig, Amanda N.; Hogenson, Tara L.; Almada, Luciana L.; Goldstein, Lauren E.; Duran, Paola A. Romecin; Vera, Renzo; Vrabel, Anne M.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55901 USA; [Cui, Gaofeng; Mer, Georges] Mayo Clin, Div Biochem & Mol Biol, Rochester, MN USA; [Rabe, Kari G.; Bamlet, William R.; Sicotte, Hugues] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Zhang, Cheng; Li, Hu] Mayo Clin, Div Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Petersen, Gloria M.] Mayo Clin, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55901 USA.	fernandezzapico.martin@mayo.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Romecin Duran, Paola Alejandra/0000-0001-6890-5883	Rolfe Pancreatic Cancer Foundation [R01CA208517, P50CA102701, R01CA97075]	Rolfe Pancreatic Cancer Foundation	Grant support: R01CA208517, P50CA102701, R01CA97075, Rolfe Pancreatic Cancer Foundation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khalaf HH, 2018, MOL CANCER RES, V16, P1299, DOI 10.1158/1541-7786.MCR-18-0017; AZZARONE B, 1984, INT J CANCER, V33, P759, DOI 10.1002/ijc.2910330608; AZZARONE B, 1988, MUTAT RES, V199, P313, DOI 10.1016/0027-5107(88)90211-4; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Boyle JM, 1999, BRIT J CANCER, V79, P1657, DOI 10.1038/sj.bjc.6690265; Brule CE, 2017, TRENDS GENET, V33, P283, DOI 10.1016/j.tig.2017.02.001; Buj R, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1677140; Byeon IJL, 1998, MOL CELL, V1, P421, DOI 10.1016/S1097-2765(00)80042-8; Chaffee KG, 2018, GENET MED, V20, P119, DOI 10.1038/gim.2017.85; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Unamuno B, 2018, MELANOMA RES, V28, P246, DOI 10.1097/CMR.0000000000000442; Del Rey MJ, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0169-4; Dickson MA, 2014, CLIN CANCER RES, V20, P3379, DOI 10.1158/1078-0432.CCR-13-1551; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan MY, 2013, ONCOTARGET, V4, P128, DOI 10.18632/oncotarget.786; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Funk JO, 1998, J CUTAN PATHOL, V25, P291, DOI 10.1111/j.1600-0560.1998.tb01748.x; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Goldstein AM, 2004, HUM MUTAT, V23, P630, DOI 10.1002/humu.9247; Goldstein AM, 2004, J MED GENET, V41, P421, DOI 10.1136/jmg.2004.019349; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hu CL, 2018, JAMA-J AM MED ASSOC, V319, P2401, DOI 10.1001/jama.2018.6228; Jenkins NC, 2013, J INVEST DERMATOL, V133, P1043, DOI 10.1038/jid.2012.401; Kannengiesser C, 2009, HUM MUTAT, V30, P564, DOI 10.1002/humu.20845; Lynch HT, 2002, CANCER-AM CANCER SOC, V94, P84, DOI 10.1002/cncr.10159; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKenzie HA, 2010, HUM MUTAT, V31, P692, DOI 10.1002/humu.21245; McWilliams RR, 2018, CANCER EPIDEM BIOMAR, V27, P1364, DOI 10.1158/1055-9965.EPI-17-1065; McWilliams RR, 2011, EUR J HUM GENET, V19, P472, DOI 10.1038/ejhg.2010.198; Middlebrooks CD, 2019, CANCER RES, V79, P2992, DOI 10.1158/0008-5472.CAN-18-1580; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Petersen GM, 2016, SEMIN ONCOL, V43, P548, DOI 10.1053/j.seminoncol.2016.09.002; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Solomon S, 2012, CANCER J, V18, P485, DOI 10.1097/PPO.0b013e318278c4a6; Soura E, 2016, J AM ACAD DERMATOL, V74, P395, DOI 10.1016/j.jaad.2015.08.038; Soura E, 2016, J AM ACAD DERMATOL, V74, P411, DOI 10.1016/j.jaad.2015.08.037	45	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100634	10.1016/j.jbc.2021.100634	http://dx.doi.org/10.1016/j.jbc.2021.100634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823155	Green Published, gold			2022-12-26	WOS:000672866400605
J	Zhang, X; Gao, T; Deng, SW; Shang, L; Chen, XC; Chen, K; Li, P; Cui, XJ; Zeng, J				Zhang, Xiao; Gao, Ting; Deng, Senwen; Shang, Lin; Chen, Xiaocui; Chen, Kai; Li, Ping; Cui, Xiaojuan; Zeng, Jia			Fasting induces hepatic lipid accumulation by stimulating peroxisomal dicarboxylic acid oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; BETA-OXIDATION; RAT-LIVER; OMEGA-OXIDATION; FATTY-ACIDS; CARNITINE ACYLTRANSFERASES; ACYL-COENZYME; SHORT-CHAIN; PIG-KIDNEY; PPAR-ALPHA	Fasting induces lipid accumulation in the liver, while the mechanisms by which fasting dysregulates liver fatty acid oxidation are not clear. Fatty acid omega-oxidation is induced in the fasting state, and administration of dicarboxylic acids to fasting animals decreases plasma ketone bodies. We hypothesized that endogenous dicarboxylic acids might play a role in controlling mitochondrial beta-oxidation in fasting animals. A peroxisome proliferator-activated receptor-alpha agonist and an inhibitor for peroxisomal beta-oxidation were administered to the fasting rats to investigate the role of dicarboxylic acids in liver fatty acid oxidation and lipid homeostasis. We observed that excessive beta-oxidation of endogenous dicarboxylic acids by peroxisomes generated considerable levels of succinate in the liver. Excessive succinate oxidation subsequently increased the mitochondrial NADH/NAD(+) ratio and led to an accumulation of 3-OH-CoA and 2-enoyl-CoA intermediates in the liver. This further induced feedback suppression of mitochondrial beta-oxidation and promoted hepatic lipid deposition and steatosis. Specific inhibition of peroxisomal beta-oxidation attenuated fasting-induced lipid deposition in the liver by reducing succinate production and enhancing mitochondrial fatty acid oxidation. We conclude that suppression of mitochondrial beta-oxidation by oxidation of dicarboxylic acids serves as a mechanism for fasting-induced hepatic lipid accumulation and identifies cross talk between peroxisomal and mitochondrial fatty acid oxidation.	[Zhang, Xiao; Gao, Ting; Deng, Senwen; Shang, Lin; Chen, Xiaocui; Chen, Kai; Li, Ping; Cui, Xiaojuan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of P. R. China [30900024]; Natural Science Fund of Hunan Province [2020JJ5157]; Distinguished Professor Funds from Hunan University of Science and Technology; Project of graduate innovation in Hunan province [CX20190814]	National Natural Science Fund of P. R. China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hunan Province; Distinguished Professor Funds from Hunan University of Science and Technology; Project of graduate innovation in Hunan province	This work was supported by the National Natural Science Fund of P. R. China (30900024), Natural Science Fund of Hunan Province (2020JJ5157), Distinguished Professor Funds from Hunan University of Science and Technology, and Project of graduate innovation in Hunan province (CX20190814).	Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antoni R, 2017, P NUTR SOC, V76, P361, DOI 10.1017/S0029665116002986; BERGSETH S, 1990, BIOCHIM BIOPHYS ACTA, V1042, P182, DOI 10.1016/0005-2760(90)90005-I; BJORKHEM I, 1976, J BIOL CHEM, V251, P5259; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloom K, 2018, J INHERIT METAB DIS, V41, P49, DOI 10.1007/s10545-017-0013-y; BREMER J, 1966, BIOCHIM BIOPHYS ACTA, V116, P1, DOI 10.1016/0005-2760(66)90087-7; BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAPUZZI DM, 1974, BIOCHEM BIOPH RES CO, V60, P1499, DOI 10.1016/0006-291X(74)90367-2; CEDERBAUM AI, 1974, BIOCHEM PHARMACOL, V23, P1985, DOI 10.1016/0006-2952(74)90257-3; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHOI YR, 1977, J BIOL CHEM, V252, P7930; CIMAN M, 1972, FEBS LETT, V22, P8, DOI 10.1016/0014-5793(72)80205-9; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Eaton S, 1996, CLIN SCI, V90, P307, DOI 10.1042/cs0900307; EATON S, 1994, EUR J BIOCHEM, V220, P671, DOI 10.1111/j.1432-1033.1994.tb18668.x; Erguven M, 2007, ANN NUTR METAB, V51, P331, DOI 10.1159/000107675; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; HE XY, 1992, ARCH BIOCHEM BIOPHYS, V298, P527, DOI 10.1016/0003-9861(92)90445-3; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Holden PR, 1999, J MOL ENDOCRINOL, V22, P1, DOI 10.1677/jme.0.0220001; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Khare P, 2016, BIOFACTORS, V42, P201, DOI 10.1002/biof.1265; KING MT, 1988, METHOD ENZYMOL, V166, P70; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; LATIPAA PM, 1988, ANAL BIOCHEM, V171, P67, DOI 10.1016/0003-2697(88)90125-X; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Liu XJ, 2004, PROTEIN EXPRES PURIF, V37, P344, DOI 10.1016/j.pep.2004.06.026; LUMENG L, 1976, J BIOL CHEM, V251, P277; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; MCGARRY JD, 1969, BIOCHIM BIOPHYS ACTA, V177, P35, DOI 10.1016/0304-4165(69)90061-0; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Moller L, 2008, CLIN SCI, V114, P547, DOI 10.1042/CS20070217; MORTENSEN PB, 1980, BIOCHIM BIOPHYS ACTA, V620, P177, DOI 10.1016/0005-2760(80)90199-X; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; NILSSON A, 1986, BIOCHIM BIOPHYS ACTA, V879, P209, DOI 10.1016/0005-2760(86)90104-9; OSMUNDSEN H, 1977, BIOCHEM J, V164, P621, DOI 10.1042/bj1640621; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; PEARSON DJ, 1964, NATURE, V202, P91, DOI 10.1038/202091a0; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pourfarzam M, 1997, METHOD ENZYMOL, V279, P240; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; PREISS B, 1964, J BIOL CHEM, V239, P85; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; QUANT PA, 1989, BIOCHEM J, V262, P159, DOI 10.1042/bj2620159; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REICH NO, 1986, BIOCHEM PHARMACOL, V35, P1227, DOI 10.1016/0006-2952(86)90264-9; Secor SM, 2016, COMPR PHYSIOL, V6, P773, DOI 10.1002/cphy.c150013; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; TEIJEMA HL, 1980, EUR J PEDIATR, V134, P51, DOI 10.1007/BF00442403; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; Tubbs P.K., 1969, METHODS ENZYMOL, V13, P535, DOI [10.1016/0076-6879(69)13079-7, DOI 10.1016/0076-6879(69)13079-7]; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; VAMECQ J, 1987, J BIOCHEM-TOKYO, V102, P225, DOI 10.1093/oxfordjournals.jbchem.a122035; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; Vamecq J, 1989, J BIOCH, V106, P216; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; WADA F, 1977, BIOCHIM BIOPHYS ACTA, V487, P261, DOI 10.1016/0005-2760(77)90002-9; WANG HY, 1991, ARCH BIOCHEM BIOPHYS, V289, P274, DOI 10.1016/0003-9861(91)90472-U; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; Wu L, 2008, ORG LETT, V10, P3355, DOI 10.1021/ol801267e; Yokota SI, 2014, FEBS OPEN BIO, V4, P905, DOI 10.1016/j.fob.2014.10.009; Zeevalk GD, 1995, J PHARMACOL EXP THER, V275, P1124; Zeng J, 2008, ORG LETT, V10, P4287, DOI 10.1021/ol801571n; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532	88	6	7	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100622	10.1016/j.jbc.2021.100622	http://dx.doi.org/10.1016/j.jbc.2021.100622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811861	Green Published, gold			2022-12-26	WOS:000672866400593
J	Zheng, YX; Huang, YP; Mencius, J; Li, YJ; Zhao, LJ; Luo, WT; Chen, Y; Quan, S				Zheng, Yongxin; Huang, Yinping; Mencius, Jun; Li, Yanjing; Zhao, Lijie; Luo, Wanting; Chen, Yong; Quan, Shu			Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; METHYLTRANSFERASE ACTIVITY; FAMILY; METABOLISM; MONOMETHYLATION; INHIBITION; EXPRESSION; CANCER; ROLES; ASSAY	The methyltransferases MLL3 and MLL4 primarily catalyze the monomethylation of histone H3 lysine 4 (H3K4) on enhancers to regulate cell-type-specific gene expression and cell fate transition. MLL3 and MLL4 share almost identical binding partners and biochemical activities, but perform specific and nonredundant functions. The features and functions that distinguish MLL3 and MLL4 remain elusive. Here, we characterize the kinetic mechanisms of MLL3 and MLL4 ternary complexes containing the catalytic SET domain from MLL3 or MLL4 (MLL3(SET) or MLL4(SET)), the SPRY domain of ASH2L (ASH2L(SPRY)), and a short fragment of RBBP5 (RBBP5(AS-ABM)) to search for possible explanations. Steady-state kinetic analyses and inhibition studies reveal that the MLL3 complex catalyzes methylation in a random sequential bi-bi mechanism. In contrast, the MLL4 complex adopts an ordered sequential bi-bi mechanism, in which the cofactor S-adenosylmethionine (AdoMet) binds to the enzyme prior to the H3 peptide, and the methylated H3 peptide dissociates from the enzyme before S-adenosylhomocysteine (AdoHcy) detaches after methylation. Substrate-binding assays using fluorescence polarization (FP) confirm that AdoMet binding is a prerequisite for H3 binding for the MLL4 complex but not for the MLL3 complex. Molecular dynamic simulations reveal that the binding of AdoMet exclusively induces conformational constraints on the AdoMet-binding groove and the H3 substrate-binding pocket of MLL4, therefore stabilizing a specific active conformation to ease entry of the substrate H3. The distinct kinetic mechanisms and conformational plasticities provide important insights into the differential functions of MLL3 and MLL4 and may also guide the development of selective inhibitors targeting MLL3 or MLL4.	[Zheng, Yongxin; Huang, Yinping; Mencius, Jun; Quan, Shu] East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg SCICB, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Li, Yanjing; Zhao, Lijie; Luo, Wanting; Chen, Yong] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Zhao, Lijie; Luo, Wanting; Chen, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Wanting; Chen, Yong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	East China University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Quan, S (corresponding author), East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg SCICB, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.; Chen, Y (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.; Chen, Y (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, Y (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	yongchen@sibcb.ac.cn; shuquan@ecust.edu.cn		Jun, Mencius/0000-0001-5959-4737; Lijie, Zhao/0000-0002-0490-0175; chen, yong/0000-0001-5857-6086; Li, Yanjing/0000-0002-0747-6947	National Natural Science Foundation of China [31670802, 31970576, 31900934]; Fundamental Research Funds for the Central Universities [22221818014]; Research Program of State Key Laboratory of Bioreactor Engineering	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Program of State Key Laboratory of Bioreactor Engineering	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 31670802 to S. Q., 31970576 to Y. C., and 31900934 to Y. L.), the Fundamental Research Funds for the Central Universities (Grant No. 22221818014), and the Research Program of State Key Laboratory of Bioreactor Engineering.	Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Ashokkumar D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186999; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOLHUIS PA, 1988, CLIN CHEM, V34, P1607; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Collins BE, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0251-8; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Faundes V, 2019, J HUM GENET, V64, P161, DOI 10.1038/s10038-018-0536-6; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hermes M, 2005, CELL PHYSIOL BIOCHEM, V15, P233, DOI 10.1159/000086410; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Ibanez G, 2010, ANAL BIOCHEM, V401, P203, DOI 10.1016/j.ab.2010.03.010; Jang Y, 2019, NUCLEIC ACIDS RES, V47, P607, DOI 10.1093/nar/gky982; Jang YH, 2017, J MOL BIOL, V429, P2046, DOI 10.1016/j.jmb.2016.12.016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Leskovac, 2003, COMPREHENSIVE ENZYME; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Liu YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07906-3; Longnecker DS, 2002, J NUTR, V132, p2373S, DOI 10.1093/jn/132.8.2373S; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marangoni A.G., 2003, ENZYME KINETICS MODE; Meeks JJ, 2017, ANNU REV CANC BIOL, V1, P425, DOI 10.1146/annurev-cancerbio-050216-034333; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Purich I., 2009, CONT ENZYME KINETICS; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Schapira M, 2016, CELL CHEM BIOL, V23, P1067, DOI 10.1016/j.chembiol.2016.07.014; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stein R.L., 2011, KINETICS ENZYME ACTI; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weinberg DN, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026443; Yan J, 2018, CELL RES, V28, P204, DOI 10.1038/cr.2018.1; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10324-8; Zhang Y, 2015, STRUCTURE, V23, P1921, DOI 10.1016/j.str.2015.07.018; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	59	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100635	10.1016/j.jbc.2021.100635	http://dx.doi.org/10.1016/j.jbc.2021.100635			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823156	Green Published, gold			2022-12-26	WOS:000672866400606
J	Ryl, M; Urbasik, A; Gierke, K; Babai, N; Joachimsthaler, A; Feigenspan, A; Frischknecht, R; Stallwitz, N; Fejtova, A; Kremers, J; von Wittgenstein, J; Brandstatter, JH				Ryl, Miriam; Urbasik, Alexander; Gierke, Kaspar; Babai, Norbert; Joachimsthaler, Anneka; Feigenspan, Andreas; Frischknecht, Renato; Stallwitz, Nina; Fejtova, Anna; Kremers, Jan; von Wittgenstein, Julia; Brandstaetter, Johann Helmut			Genetic disruption of bassoon in two mutant mouse lines causes divergent retinal phenotypes	FASEB JOURNAL			English	Article						active zone; bassoon; photoreceptor; photoreceptor death; ribbon synapse	CYTOMATRIX PROTEIN BASSOON; RIBBON SYNAPSES; ACTIVE ZONE; SYNAPTIC-TRANSMISSION; CA2+ CHANNELS; ROD; PLASTICITY; RELEASE; RIBEYE; CELLS	Bassoon (BSN) is a presynaptic cytomatrix protein ubiquitously present at chemical synapses of the central nervous system, where it regulates synaptic vesicle replenishment and organizes voltage-gated Ca2+ channels. In sensory photoreceptor synapses, BSN additionally plays a decisive role in anchoring the synaptic ribbon, a presynaptic organelle and functional extension of the active zone, to the presynaptic membrane. In this study, we functionally and structurally analyzed two mutant mouse lines with a genetic disruption of Bsn-Bsn(gt) and Bsn(ko)-using electrophysiology and high-resolution microscopy. In both Bsn mutant mouse lines, full-length BSN was abolished, and photoreceptor synaptic function was similarly impaired, yet synapse structure was more severely affected in Bsn(gt/gt) than in Bsn(ko/ko) photoreceptors. The synaptic defects in Bsn(gt/gt) retina coincide with remodeling of the outer retina-rod bipolar and horizontal cell sprouting, formation of ectopic ribbon synaptic sites-and death of cone photoreceptors, processes that did not occur in Bsn(ko/ko) retina. An analysis of Bsn(gt/ko) hybrid mice revealed that the divergent retinal phenotypes of Bsn(gt/gt) and Bsn(ko/ko) mice can be attributed to the expression of the Bsn(gt) allele, which triggers cone photoreceptor death and neurite sprouting in the outer retina. These findings shed new light on the existing Bsn mutant mouse models and might help to understand mechanisms that drive photoreceptor death.	[Ryl, Miriam; Urbasik, Alexander; Gierke, Kaspar; Babai, Norbert; Feigenspan, Andreas; Frischknecht, Renato; von Wittgenstein, Julia; Brandstaetter, Johann Helmut] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Staudtstr 5, D-91058 Erlangen, Germany; [Joachimsthaler, Anneka; Stallwitz, Nina; Kremers, Jan] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Fejtova, Anna] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Brandstatter, JH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Staudtstr 5, D-91058 Erlangen, Germany.	johann.helmut.brandstaetter@fau.de	Fejtova, Anna/AAZ-1024-2020	Fejtova, Anna/0000-0002-1815-4409	Deutsche Forschungsgemeinschaft (DFG) [270949263]; DFG [GRK2162/1, FE1335/3, GRK 2162]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) Grant 270949263; DFG GRK2162/1 and 2 to J.H.B. and DFG FE1335/3 to A.Fej. M.R. and A.U. are graduate students, and J.H.B. and A.Fej. are principal investigators of the DFG research training group GRK 2162 "Neurodevelopment and Vulnerability of the Central Nervous System"	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Annamneedi A, 2018, BRAIN STRUCT FUNCT, V223, P3423, DOI 10.1007/s00429-018-1692-3; Babai N, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13241; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Dieck ST, 2012, J NEUROSCI, V32, P12192, DOI 10.1523/JNEUROSCI.0752-12.2012; Feigenspan A, 2017, JOVE-J VIS EXP, DOI 10.3791/55173; Feigenspan A, 2015, EUR J NEUROSCI, V42, P2615, DOI 10.1111/ejn.13016; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagiwara A, 2018, J CELL BIOL, V217, P3993, DOI 10.1083/jcb.201704076; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Jing ZZ, 2013, J NEUROSCI, V33, P4456, DOI 10.1523/JNEUROSCI.3491-12.2013; Joachimsthaler A, 2017, VISION, V1, DOI [10.3390/vision1040023, DOI 10.3390/VISI0]; Kerov V, 2018, J NEUROSCI, V38, P6145, DOI 10.1523/JNEUROSCI.3818-16.2018; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lagnado L, 2015, ANNU REV VIS SCI, V1, P235, DOI 10.1146/annurev-vision-082114-035709; Maddox JW, 2020, ELIFE, V9, DOI 10.7554/eLife.62184; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Maxeiner S, 2016, EMBO J, V35, P1098, DOI 10.15252/embj.201592701; Moser T, 2020, PHYSIOL REV, V100, P103, DOI 10.1152/physrev.00026.2018; Muller TM, 2019, J NEUROSCI, V39, P2606, DOI 10.1523/JNEUROSCI.2038-18.2019; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Schattling B, 2019, NAT NEUROSCI, V22, P887, DOI 10.1038/s41593-019-0385-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schulz AM, 2014, EMBO J, V33, P512, DOI 10.1002/embj.201385887; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Wang YC, 2017, NEURON, V93, P1359, DOI 10.1016/j.neuron.2017.02.021	46	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21520	10.1096/fj.202001962R	http://dx.doi.org/10.1096/fj.202001962R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811381	hybrid, Green Published			2022-12-26	WOS:000645260100003
J	Hasan, SMM; Rahman, M; Nakamura, K; Tashiro, Y; Miyashita, A; Seino, K				Hasan, S. M. Mahmudul; Rahman, Mosiur; Nakamura, Keiko; Tashiro, Yuri; Miyashita, Ayano; Seino, Kaoruko			Relationship between diabetes self-care practices and control of periodontal disease among type2 diabetes patients in Bangladesh	PLOS ONE			English	Article							ORAL-HEALTH; TREATMENT NEEDS; PREVALENCE; HYGIENE; RELIABILITY; ASSOCIATION; ADOLESCENTS; KNOWLEDGE; AWARENESS; ADULTS	Introduction The prevalence of periodontal disease is high in diabetes patients worldwide, including Bangladesh. Although associations of periodontal disease outcomes and clinical determinants of diabetes have been investigated, few studies have reported on the relationship between periodontal diseases outcomes with modifiable factors, such as self-care and oral hygiene practices, in patients with diabetes. Moreover, in order to develop targeted strategies, it is also important to estimate their aggregated contribution separately from that of the established sociodemographic and diabetics related clinical determinates. Therefore, this study was performed to elucidate 1) the relationship of diabetes patients' self-care and oral hygiene practices to periodontal disease and 2) the relative contributions of selected factors to periodontal disease outcome in type 2 diabetes patients. Methods The data were obtained from the baseline survey of a multicentre, prospective cohort study. A total of 379 adult patients with type 2 diabetes from three diabetic centres in Dhaka, Rajshahi and Barishal, received periodontal examinations using the community periodontal index (CPI) probe, glycated haemoglobin examination, other clinical examinations, and structured questionnaires. Multiple logistics regression analyses were performed to assess the associations between selected factors and prevalence of any periodontal disease and its severity. Results More than half of the participants were female (53.8%) and 66.8% of the total participants was 21-50 years old. The prevalence of any (CPI code 2+3+4; 75.7%) and severe form (CPI code 4; 35.1%) of periodontal disease were high in type 2 diabetes patients. In multivariate analysis, the odds of periodontal disease increased with unfavourable glycaemic control indicated by HbA1c >= 7%, and decreased by 64%, 85% and 92% with adherence to recommended diet, physical activity, and oral hygiene practices, respectively. Diabetes self-care practice explained the highest proportion of the variance (13.9%) followed by oral hygiene practices (10.9%) by modelling any periodontal disease versus no disease. Variables of diabetes conditions and oral hygiene practices explained 10.9% and 7.3% of the variance by modelling severe (CPI code 4) or moderate (CPI code 3) forms of periodontal disease versus mild form of periodontal disease. Findings also conferred that while poor diabetes control had an individually adverse association with any form of periodontal diseases and its severity, the risk of diseases was moderated by oral hygiene practices. Conclusions This study suggested that, in addition to diabetes-related clinical determinants, self-care practices, and oral hygiene practices must be taken into consideration for prevention and control of periodontal disease in patients with diabetes.	[Hasan, S. M. Mahmudul; Rahman, Mosiur; Nakamura, Keiko; Tashiro, Yuri; Miyashita, Ayano; Seino, Kaoruko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Global Hlth Entrepreneurship, Div Publ Hlth, Tokyo, Japan; [Rahman, Mosiur] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh	Tokyo Medical & Dental University (TMDU); University of Rajshahi	Nakamura, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Global Hlth Entrepreneurship, Div Publ Hlth, Tokyo, Japan.	nakamura.ith@tmd.ac.jp		Hasan, S. M. Mahmudul/0000-0002-9902-7953	Japan Society of the Promotion of Science (JSPS) [17F17110, 17H02164]; Japan Agency for Medical Research and Development (AMED) [SU12]	Japan Society of the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	KN received funds from by Grant-in-Aid for Scientific Research (17F17110 and 17H02164) of the Japan Society of the Promotion of Science (JSPS) [https://www.jsps.go.jp/english/index.html] and GACD Collaborative Call (SU12) of Japan Agency for Medical Research and Development (AMED) [https://www.amed.go.jp/en/index.html].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINAMO J, 1984, INT DENT J, V34, P214; Akhter R, 2008, ORAL HLTH PREV DENT, V6, P199; Al Wesabi A, 2017, J ORAL RES, V6, P176, DOI DOI 10.17126/JORALRES.2017.055; Al-Zarea BK, 2013, INT J DENT, V2013, DOI 10.1155/2013/647397; Almerich-Silla Jose-Manuel, 2017, J Clin Exp Dent, V9, pe988, DOI 10.4317/jced.54033; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; ANDERSON JA, 1984, J R STAT SOC B, V46, P1; Apoorva S M, 2013, J Indian Soc Periodontol, V17, P25, DOI 10.4103/0972-124X.107470; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010]; Battancs E, 2020, DIABETES THER, V11, P2715, DOI 10.1007/s13300-020-00933-8; Benigeri M, 2000, J CLIN PERIODONTOL, V27, P308, DOI 10.1034/j.1600-051x.2000.027005308.x; Bowyer V, 2011, BRIT DENT J, V211, DOI 10.1038/sj.bdj.2011.769; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chowdhury A, 2017, MARMARA PHARM J, V21, P1010, DOI 10.12991/mpj.2017.24; Dalazen CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156231; Devanoorkar A, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/930206; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firatli E, 1997, J PERIODONTOL, V68, P136, DOI 10.1902/jop.1997.68.2.136; Gil GS, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0002-5; Gupta S, 2018, J NEPAL MED ASSOC, V56, P818, DOI 10.31729/jnma.3610; Han K, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006176, 10.1097/md.0000000000006176]; Haque SE, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0202-3; Hong M, 2016, KOREAN J INTERN MED, V31, P910, DOI 10.3904/kjim.2016.031; Imran AG., 2010, RSBO, V7, P325; Kahan David, 2015, Prev Med Rep, V2, P71, DOI 10.1016/j.pmedr.2014.12.007; Lamster IB, 2008, J AM DENT ASSOC, V139, p19S, DOI 10.14219/jada.archive.2008.0363; Lertpimonchai A, 2017, INT DENT J, V67, P332, DOI 10.1111/idj.12317; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Mahmud SZ, 2013, BIRDEM MED J, V3, P74; Mahtab H., 2003, GUIDELINES CARE TYPE; Marcopito LF, 2019, RGO REV GAUCHA ODONT, P67; Nand Khushboo Yamima, 2017, J Indian Soc Periodontol, V21, P309, DOI 10.4103/jisp.jisp_217_17; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; Poudel P, 2017, DIABETES RES CLIN PR, V130, P266, DOI 10.1016/j.diabres.2017.06.004; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rahman M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63253-8; Rahman M, 2015, J DIABETES COMPLICAT, V29, P788, DOI 10.1016/j.jdiacomp.2015.04.011; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Schulze A, 2016, OPEN DENT J, V10, P287, DOI 10.2174/1874210601610010287; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Van Dyke Thomas E, 2005, J Int Acad Periodontol, V7, P3; Van Palenstein Helderman W., 1996, PREVALENCE SEVERITY; Verhulst MJL, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00056; Vogt M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-3; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization, 2018, REC LEV PHYS ACT; World Health Organization (WHO), 2013, WHO OR HLTH ASS FORM	48	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249011	10.1371/journal.pone.0249011	http://dx.doi.org/10.1371/journal.pone.0249011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822810	gold, Green Published			2022-12-26	WOS:000637879100044
J	Koljonen, ML; Masuda, M; Kallio-Nyberg, I; Koskiniemi, J; Saloniemi, I				Koljonen, Marja-Liisa; Masuda, Michele; Kallio-Nyberg, Irma; Koskiniemi, Jarmo; Saloniemi, Irma			Large inter-stock differences in catch size-at-age of mature Atlantic salmon observed by using genetic individual origin assignment from catch data	PLOS ONE			English	Article							ANADROMOUS BROWN TROUT; LIFE-HISTORY TRAITS; POST-SMOLT GROWTH; SIMOJOKI RIVER; SALAR L.; WILD; MIGRATION; CLIMATE; SURVIVAL; PATTERN	Genetic individual assignment of river stock of origin of mixed stock catch fish offers a tool to analyze size differences among river stocks. Data on the genetically identified river stock of origin of individual fish from commercial mixed stock catches were used to compare the catch size-at-age of mature Atlantic salmon catch fish (Salmo salar) from different rivers in the Baltic Sea. In this application of genetic mixed stock modeling, individual assignments of the river stock of origin were analyzed together with length- and weight-at-age data for individual catch fish. The use of four genetic stock identification based methods was compared for defining the length distributions of caught mature salmon in different river stocks. The catch data included information on maturing salmon in the northern Baltic Sea over the years 2000-2013. DNA microsatellite data on 17 loci and information on the smoltification age were used to assign spawners to their stock of origin. All of the compared methods for using probabilistic stock of origin data in our case yielded very similar estimates of the final mean length distributions of the stocks. The Bayesian mixture model yielded slightly more conservative estimates than the direct probability method, threshold method, or the modified probability method. The catch size between spawners of a same sex and age from river stocks differed significantly and the differences were large. The mean catch weight of 1-sea-winter old mature males in different rivers varied from 1.9 kg to 2.9 kg, from 5.1 kg to 7.5 kg for 2-sea-winter old males, from 5.0 kg to 7.2 kg for 2-sea-winter old females, and from 8.2 kg to 10.8 kg for 3-sea-winter-old females. The mean size of caught wild salmon spawners in each year-class was on average smaller than that of the hatchery-reared and sea ranched stocks.	[Koljonen, Marja-Liisa] Nat Resources Inst Finland Luke, Prod Syst, Anim Genet, Helsinki, Finland; [Masuda, Michele] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK USA; [Kallio-Nyberg, Irma] Nat Resources Inst Finland Luke, Ecosyst & Ecol, Fish Stocks & Environm, Helsinki, Finland; [Koskiniemi, Jarmo] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Saloniemi, Irma] Univ Turku, Dept Biol, Turku, Finland	Natural Resources Institute Finland (Luke); National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Natural Resources Institute Finland (Luke); University of Helsinki; University of Turku	Koljonen, ML (corresponding author), Nat Resources Inst Finland Luke, Prod Syst, Anim Genet, Helsinki, Finland.	marja-liisa.koljonen@luke.fi		Koljonen, Marja-Liisa/0000-0002-6177-9447				Alm G., 1934, Rapport Conseil Exploration Mer Copenhague, V92, P1; Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; Barson NJ, 2015, NATURE, V528, P405, DOI 10.1038/nature16062; Beardmore, 1978, MAR ORG GENET ECOL E; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Bradbury IR, 2016, FISH RES, V174, P234, DOI 10.1016/j.fishres.2015.10.009; Bromaghin JF, 2011, T AM FISH SOC, V140, P235, DOI 10.1080/00028487.2011.558776; Crozier WW, 2004, ICES J MAR SCI, V61, P1344, DOI 10.1016/j.icesjms.2004.08.013; Fleming IA, 1998, CAN J FISH AQUAT SCI, V55, P59, DOI 10.1139/cjfas-55-S1-59; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Friedland KD, 2005, ICES J MAR SCI, V62, P1338, DOI 10.1016/j.icesjms.2005.04.013; Friedland KD, 2000, ICES J MAR SCI, V57, P419, DOI 10.1006/jmsc.1999.0639; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gelman A., 2004, TEXTS STAT SCI, V2nd ed.; Gjedrem T., 1988, Proceedings of the Second International Conference on Quantitative Genetics., P527; GJERDE B, 1984, AQUACULTURE, V38, P229, DOI 10.1016/0044-8486(84)90147-9; GJERDE B, 1984, AQUACULTURE, V36, P97, DOI 10.1016/0044-8486(84)90057-7; Hansen LP, 1998, CAN J FISH AQUAT SCI, V55, P104, DOI 10.1139/cjfas-55-S1-104; HANSEN LP, 1991, J FISH BIOL, V38, P251, DOI 10.1111/j.1095-8649.1991.tb03111.x; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; ICES, 2014, REP BALT SALM TROUT, V2014; Jarvi THJ., 1948, PERIODICITY SALMON R, V119, P1; Jokikokko E, 2006, J FISH BIOL, V68, P430, DOI 10.1111/j.0022-1112.2006.00892.x; Jonsson B, 2004, CAN J FISH AQUAT SCI, V61, P2369, DOI 10.1139/f04-215; Jonsson B, 2016, J FISH BIOL, V88, P618, DOI 10.1111/jfb.12854; Jonsson B, 2015, J FISH BIOL, V87, P187, DOI 10.1111/jfb.12704; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; JONSSON B, 1993, J FISH BIOL, V43, P1; Jonsson N, 2005, CAN J FISH AQUAT SCI, V62, P2502, DOI 10.1139/F05-154; JONSSON N, 1991, J ANIM ECOL, V60, P937, DOI 10.2307/5423; Jutila E, 2009, J APPL ICHTHYOL, V25, P190, DOI 10.1111/j.1439-0426.2009.01212.x; Kallio-Nyberg I, 1999, CAN J FISH AQUAT SCI, V56, P853, DOI 10.1139/cjfas-56-5-853; Kallio-Nyberg I, 2013, FISH RES, V145, P6, DOI 10.1016/j.fishres.2013.03.004; Kallio-Nyberg I, 2015, FISH RES, V165, P85, DOI 10.1016/j.fishres.2014.12.022; Kallio-Nyberg Irma, 2014, Open Fish Science Journal, V7, P46, DOI 10.2174/1874401X01407010046; Kallio-Nyberg I, 2013, AQUACULTURE, V402, P76, DOI 10.1016/j.aquaculture.2013.03.027; Kallio-Nyberg I, 2011, FISH RES, V109, P285, DOI 10.1016/j.fishres.2011.02.015; KALLIONYBERG I, 1992, ICES J MAR SCI, V49, P191, DOI 10.1093/icesjms/49.2.191; KallioNyberg I, 1997, AQUACULTURE, V153, P207, DOI 10.1016/S0044-8486(97)00023-9; Koljonen ML, 2006, ICES J MAR SCI, V63, P1274, DOI 10.1016/j.icesjms.2006.04.010; Koljonen ML, 1997, ICES J MAR SCI, V54, P1015, DOI 10.1006/jmsc.1997.0310; Koskiniemi J, 2020, U HELSINKI NATURAL R, DOI [10.17504/protocols.io.bp7umrnw, DOI 10.17504/PROTOCOLS.IO.BP7UMRNW]; McGinnity P, 2007, AQUACULTURE, V273, P257, DOI 10.1016/j.aquaculture.2007.10.008; Milot E, 2013, EVOL APPL, V6, P472, DOI 10.1111/eva.12028; Moran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098470; NAEVDAL G, 1978, J FISH RES BOARD CAN, V35, P145, DOI 10.1139/f78-021; Palm S, 2008, CAN J FISH AQUAT SCI, V65, P1738, DOI 10.1139/F08-088; Pella J, 2001, FISH B-NOAA, V99, P151; Saisa M, 2005, CAN J FISH AQUAT SCI, V62, P1887, DOI 10.1139/F05-094; Saisa M, 2003, CONSERV GENET, V4, P613, DOI 10.1023/A:1025680002296; Salminen M, 1997, J APPL ICHTHYOL, V13, P121, DOI 10.1111/j.1439-0426.1997.tb00111.x; Saloniemi I, 2004, ICES J MAR SCI, V61, P782, DOI 10.1016/j.icesjms.2004.03.032; SCHAFFER WM, 1975, ECOLOGY, V56, P577, DOI 10.2307/1935492; Sinclair-Waters M, 2020, GENET SEL EVOL, V52, DOI 10.1186/s12711-020-0529-8; Sower S, 1985, GENETIC VARIATION MA, P52; Taper ML, 2008, ONCOR COMPUTER PROGR; THORPE JE, 1981, CAN J FISH AQUAT SCI, V38, P1576, DOI 10.1139/f81-208; Todd CD, 2008, GLOBAL CHANGE BIOL, V14, P958, DOI 10.1111/j.1365-2486.2007.01522.x; Vaha JP, 2011, EVOL APPL, V4, P39, DOI 10.1111/j.1752-4571.2010.00131.x; Vainikka A, 2010, J FISH BIOL, V76, P622, DOI 10.1111/j.1095-8649.2009.02520.x; Vuori K, 2012, J FISH BIOL, V81, P1815, DOI 10.1111/j.1095-8649.2012.03386.x; Whitlock R, 2018, METHODS ECOL EVOL, V9, P1017, DOI 10.1111/2041-210X.12946	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0247435	10.1371/journal.pone.0247435	http://dx.doi.org/10.1371/journal.pone.0247435			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822799	Green Published, gold			2022-12-26	WOS:000637879100038
J	Yusuf, AA; Musa, BM; Galadanci, NA; Babashani, M; Mohammed, AZ; Ingles, DJ; Fogo, AB; Wester, CW; Aliyu, MH				Yusuf, Aminu Abba; Musa, Baba Maiyaki; Galadanci, Najibah Aliyu; Babashani, Musa; Mohammed, Aminu Zakari; Ingles, Donna J.; Fogo, Agnes B.; Wester, C. William; Aliyu, Muktar Hassan			HIV-associated nephropathy: Protocol and rationale for an exploratory genotype-phenotype study in a sub-Saharan African population	PLOS ONE			English	Article							MINIMUM INFORMATION; KIDNEY-DISEASE; VIRAL LOAD; IMMUNODEFICIENCY; EPIDEMIOLOGY; ACTIVATION	Background HIV-positive persons of African descent are disproportionately affected by chronic kidney disease (CKD). Deterioration to end-stage kidney disease (ESKD) also occurs in this population at a higher frequency. There remains a lot to learn about the genetic susceptibility to CKD in HIV positive patients, and the pathophysiology of progression to ESKD. Objectives We will conduct an exploratory genotype-phenotype study in HIV-positive persons with CKD in Aminu Kano Teaching Hospital, Nigeria, to determine blood-based differential gene expression biomarkers in different kidney risk groups according to the KDIGO 2012 criteria. Methods We will consecutively screen 150 HIV-positive adults (>= 18 years of age) attending the HIV clinic of Aminu Kano Teaching Hospital, Kano, Nigeria, for CKD based on proteinuria and elevation of estimated glomerular filtration rate. Among these, two separate groups of 16 eligible participants each (n = 32) will be selected in the four (4) KDIGO 2012 kidney risk categories. The groups will be matched for age, sex, viral suppression level and antiretroviral (ARV) regimen. In the first group (n = 16), we will determine differential gene expression markers in peripheral blood mononuclear cells using mRNA-sequencing (RNA-Seq). We will validate the differential expression markers in the second group (n = 16) using reverse transcription quantitative polymerase chain reaction (RT-qPCR). Using a systems-based approach, we will construct, visualize and analyze gene-gene interaction networks to determine the potential biological roles of identified differential expression markers based on published literature and publicly available databases. Results Our exploratory study will provide valuable information on the potential roles of differential expression biomarkers in the pathophysiology of HIV-associated kidney disease by identifying novel biomarkers in different risk categories of CKD in a sub-Saharan African population. The results of this study will provide the basis for population-based genome-wide association studies to guide future personalized medicine approaches. Conclusion Validated biomarkers can be potential targets for the development of stage-specific therapeutic interventions, an essential paradigm in precision medicine.	[Yusuf, Aminu Abba] Bayero Univ Kano, Aminu Kano Teaching Hosp, Dept Haematol & Blood Transfus, Kano, Nigeria; [Musa, Baba Maiyaki; Babashani, Musa] Bayero Univ Kano, Aminu Kano Teaching Hosp, Dept Med, Kano, Nigeria; [Musa, Baba Maiyaki] Africa Ctr Excellence Populat Hlth & Policy, Kano, Nigeria; [Galadanci, Najibah Aliyu] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Mohammed, Aminu Zakari] Bayero Univ Kano, Aminu Kano Teaching Hosp, Dept Histopathol, Kano, Nigeria; [Ingles, Donna J.; Wester, C. William; Aliyu, Muktar Hassan] Vanderbilt Inst Global Hlth VIGH, Nashville, TN USA; [Fogo, Agnes B.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Bayero University; Bayero University; University of Alabama System; University of Alabama Birmingham; Bayero University; Vanderbilt University	Yusuf, AA (corresponding author), Bayero Univ Kano, Aminu Kano Teaching Hosp, Dept Haematol & Blood Transfus, Kano, Nigeria.	aayusuf.hae@buk.edu.ng		Yusuf, Aminu Abba/0000-0002-6132-9534	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the VECD Fogarty Global Health Fellowship Program [D43TW009337]	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the VECD Fogarty Global Health Fellowship Program	This work was supported by the Fogarty International Center at the U.S. National Institutes of Health (NIH) through the VECD Fogarty Global Health Fellowship Program (D43TW009337), URL: https://www.vumc.org/vecd/.The results and interpretations of this work are those of the authors and do not represent the official views of the NIH or the VECD Program. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, KIDNEY INT SUPPL, V19, P1; Armenia D, 2018, J CLIN VIROL, V104, P61, DOI 10.1016/j.jcv.2018.04.001; Atta MG, 2012, KIDNEY INT, V82, P338, DOI 10.1038/ki.2012.111; Atta MG, 2010, ADV CHRONIC KIDNEY D, V17, P52, DOI 10.1053/j.ackd.2009.08.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Conaldi PG, 2002, AM J PATHOL, V161, P53, DOI 10.1016/S0002-9440(10)64156-9; Devadas K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147421; ESCAICH S, 1992, AIDS RES HUM RETROV, V8, P1833, DOI 10.1089/aid.1992.8.1833; FERRE F, 1995, J ACQ IMMUN DEF SYND, V10, pS51; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Husain Nazik Elmalaika, 2018, J Clin Med Res, V10, P1, DOI 10.14740/jocmr3235w; Izzedine H, 2005, NEW ENGL J MED, V353, P1072, DOI 10.1056/NEJMc051607; Izzedine H, 2011, NEPHROL DIAL TRANSPL, V26, P580, DOI 10.1093/ndt/gfq414; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; MONTOYA JG, 1993, J CLIN MICROBIOL, V31, P2692, DOI 10.1128/JCM.31.10.2692-2696.1993; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Ross MJ, 2014, KIDNEY INT, V86, P266, DOI 10.1038/ki.2014.167; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma M, 2010, AIDS, V24, P2161, DOI 10.1097/QAD.0b013e32833dbc31; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Swanepoel CR, 2018, KIDNEY INT, V93, P545, DOI 10.1016/j.kint.2017.11.007; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005	26	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249567	10.1371/journal.pone.0249567	http://dx.doi.org/10.1371/journal.pone.0249567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822824	gold, Green Published			2022-12-26	WOS:000637879100018
J	Aguirre-Camacho, A; Hidalgo, B; Gonzalez-Cuevas, G				Aguirre-Camacho, Aldo; Hidalgo, Beatriz; Gonzalez-Cuevas, Gustavo			Fear of breast cancer among young Spanish women: Factor structure and psychometric properties of the Champion breast cancer fear scale	PLOS ONE			English	Article							HEALTH ANXIETY INVENTORY; MAMMOGRAPHY SELF-EFFICACY; INFORMATION AVOIDANCE; FAMILY-HISTORY; MORTALITY; MEDIA; WORRY; FATALISM; DISEASE; TRENDS	Heightened fear of breast cancer (FBC) has been linked to increased distress following breast cancer diagnosis and to avoidance of mammography screening. To our knowledge, however, no studies have examined the nature of FBC exclusively among young females, even though they are overrepresented in media stories of breast cancer. Given that no instruments are available to assess FBC in the Spanish language, we sought to 1) evaluate the psychometric properties and factor structure of the Champion Breast Cancer Fear Scale (CBCFS), and 2) offer preliminary data on the nature of FBC among young women. Participants (N = 442, mean age = 21.17, range 17-35) completed the translated CBCFS (CBCFS-es) and the Spanish version of the Short Health Anxiety Inventory. The CBCFS-es demonstrated good concurrent validity, internal consistency, and test-retest reliability. Confirmatory factor analysis showed adequate fit to a one-factor solution. The majority of participants reported considerably high levels of FBC, as 25.34% and 59.73% of them scored above the moderate- and high-FBC cut-offs, respectively. Moreover, FBC could not be explained by general concerns regarding health and illness, given that levels of health anxiety were low. Implications for health education, research, and clinical practice are discussed.	[Aguirre-Camacho, Aldo; Hidalgo, Beatriz] European Univ Madrid, Sch Biomed Sci, Dept Psychol, Madrid, Spain; [Hidalgo, Beatriz] Autonomous Univ Madrid, Dept Psychol, Madrid, Spain; [Gonzalez-Cuevas, Gustavo] Idaho State Univ, Coll Pharm, Meridian, ID USA	European University of Madrid; Autonomous University of Madrid; Idaho; Idaho State University	Aguirre-Camacho, A (corresponding author), European Univ Madrid, Sch Biomed Sci, Dept Psychol, Madrid, Spain.	aldo.aguirre.c@gmail.com	Hidalgo, Beatriz/AAI-7032-2021; Aguirre-Camacho, Aldo/C-2242-2015	Hidalgo, Beatriz/0000-0003-1111-6634; Aguirre-Camacho, Aldo/0000-0002-9632-8777				Abramowitz JS, 2007, BEHAV THER, V38, P86, DOI 10.1016/j.beth.2006.05.001; Alberts NM, 2013, J ANXIETY DISORD, V27, P68, DOI 10.1016/j.janxdis.2012.10.009; Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314; Ascunce N., 2017, PREVENCION CANC MAMA, P196; Atkin CK, 2008, J HEALTH COMMUN, V13, P3, DOI 10.1080/10810730701806912; Beeken RJ, 2011, CANCER EPIDEM BIOMAR, V20, P2127, DOI 10.1158/1055-9965.EPI-11-0437; Berry TR., 2016, HEALTH PSYCHOL OPEN, V3; Blanchard D, 2002, PREV MED, V35, P343, DOI 10.1006/pmed.2002.1088; BORLAND R, 1994, AUST J PUBLIC HEALTH, V18, P366; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Burke W, 2001, Eff Clin Pract, V4, P58; Carioli G, 2017, BREAST, V36, P89, DOI 10.1016/j.breast.2017.06.003; Caruso A, 2018, CANCER NURS, V41, P311, DOI 10.1097/NCC.0000000000000511; Chae J, 2015, J HEALTH COMMUN, V20, P1133, DOI 10.1080/10810730.2015.1018633; Champion C, 2016, HEALTH COMMUN, V31, P1242, DOI 10.1080/10410236.2015.1050082; Champion VL, 2004, J HEALTH PSYCHOL, V9, P753, DOI 10.1177/1359105304045383; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; DiLorenzo T, 2006, J BEHAV MED, V29, P37, DOI 10.1007/s10865-005-9039-y; Epstein J, 2015, J CLIN EPIDEMIOL, V68, P435, DOI 10.1016/j.jclinepi.2014.11.021; Erblich J, 2000, PREV MED, V31, P714, DOI 10.1006/pmed.2000.0765; Fobair P, 2006, PSYCHO-ONCOL, V15, P579, DOI 10.1002/pon.991; Gottlieb N, 2001, J NATL CANCER I, V93, P1520, DOI 10.1093/jnci/93.20.1520; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jatoi I, 2003, LANCET ONCOL, V4, P251, DOI 10.1016/S1470-2045(03)01037-4; Jensen JD, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2011.01549.x; Kobayashi LC, 2016, HEALTH EDUC BEHAV, V43, P461, DOI 10.1177/1090198115604616; Labrie NHM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3180-1; Leung DYP, 2014, EUR J ONCOL NURS, V18, P281, DOI 10.1016/j.ejon.2014.01.007; MacKenzie R, 2010, J CANCER EDUC, V25, P565, DOI 10.1007/s13187-010-0083-0; Markus KA, 2012, STRUCT EQU MODELING, V19, P509, DOI 10.1080/10705511.2012.687667; Miles A, 2008, CANCER EPIDEM BIOMAR, V17, P1872, DOI 10.1158/1055-9965.EPI-08-0074; Morales A, 2015, J HEALTH PSYCHOL, V20, P123, DOI 10.1177/1359105313500095; Moshki M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4404-7; Nelissen S, 2015, J CANCER EDUC, V30, P68, DOI 10.1007/s13187-014-0705-z; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Revelle W., 2020, PSYCH PROCEDURES PER; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Secginli S, 2012, CANCER NURS, V35, P365, DOI 10.1097/NCC.0b013e3182331a9a; Swaine-Verdier A, 2004, VALUE HEALTH, V7, P27; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Umeh K, 2001, BRIT J HEALTH PSYCH, V6, P361, DOI 10.1348/135910701169269; Vraga EK, 2018, J HEALTH COMMUN, V23, P181, DOI 10.1080/10810730.2017.1421730; Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008; Zhang LR, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/545062	48	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249562	10.1371/journal.pone.0249562	http://dx.doi.org/10.1371/journal.pone.0249562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819298	Green Published, gold			2022-12-26	WOS:000637647200019
J	Basheti, IA; Mhaidat, QN; Mhaidat, HN				Basheti, Iman A.; Mhaidat, Qassim N.; Mhaidat, Hala N.			Prevalence of anxiety and depression during COVID-19 pandemic among healthcare students in Jordan and its effect on their learning process: A national survey	PLOS ONE			English	Article							HOSPITAL ANXIETY; OUTBREAK; STRESS	Rational During pandemics, including the most recent COVID-19 pandemic, the mental health of university healthcare students' is expected to be affected negatively, impacting the students' learning process. Objectives The aim of this study was to assess the level of anxiety and depression of healthcare students living in Jordan, and the effect on their learning process during the COVID-19 pandemic. Methods This descriptive cross-sectional study was conducted via an online survey completed by students studying a healthcare-oriented degree in a university in Jordan. Participants were recruited through social media (Facebook and WhatsApp). The validated previously published Hospital Anxiety and Depression Scale (HADS) questionnaire was used as a part of the online survey to assess students' anxiety/depression scores. Students' responses regarding their learning process during the COVID-19 was also assessed. Results The mean age of participants was 21.62 (SD = 4.90), with the majority being females (67.1%). The HADs' assessment revealed that 43.8% and 40.0% of participants had normal anxiety and depression scores, while 22.4% showed borderline abnormal anxiety/depression scores (33.8%). Many students (33.8%) were classified to have abnormal anxiety scores, while a smaller proportion (26.2%) was classified to have abnormal depression scores. Smoking (p = 0.022), lower family income (p = 0.039), and use of medications (p = 0.032) were positively associated with higher (worse) anxiety scores. Ranking the learning process during COVID-19 showed that 45.8% of the participants believed it was a 'good/very good/excellent' process. Conclusions Anxiety and depression levels amongst university healthcare students in Jordan were found to be high when assessed during the COVID-19 pandemic. In addition, the learning process during the pandemic was not accepted by more than half of the students. Implementing psychological interventions for healthcare students during pandemics is strongly recommended in order to optimize students' mental health and their learning process alike.	[Basheti, Iman A.] Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan; [Mhaidat, Qassim N.; Mhaidat, Hala N.] Jordan Univ Sci & Technol, Sch Med, Irbid, Jordan	Jordan University of Science & Technology	Basheti, IA (corresponding author), Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan.	dr_iman@asu.edu.jo	Basheti, Iman/Q-8917-2017	Basheti, Iman/0000-0002-8460-1158				Abdelaziz B, 2017, HEALTH PROMOT INT, V32, P7, DOI 10.1093/heapro/daw103; Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Al-Mamlaka TV, LAUNCHING HELLO PHAR; Al-Tammemi AaB, IS IT JUST ABOUT PHY; Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Bates I, 2020, INT J PHARM PRACT, V28, P173, DOI 10.1111/ijpp.12611; Billy MJAaS, 2020, INFLUENCE DYNAMIC OR; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bukhari EE, 2016, J INFECT DEV COUNTR, V10, P845, DOI 10.3855/jidc.6925; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Choi B, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02117-1; Cornine A, 2020, NURS EDUC PERSPECT, V41, P229, DOI 10.1097/01.NEP.0000000000000633; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; Araujo FJD, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112977; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Elias H, 2011, PROCD SOC BEHV, V29, DOI 10.1016/j.sbspro.2011.11.288; Ferrel MN, 2020, CUREUS, V12, DOI 10.7759/cureus.7492; Gewin V, 2020, NATURE, V580, P295, DOI 10.1038/d41586-020-00896-7; Gonzalez T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239490; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hyland P, 2020, ACTA PSYCHIAT SCAND, V142, P249, DOI 10.1111/acps.13219; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kapasia N, 2020, CHILD YOUTH SERV REV, V116, DOI 10.1016/j.childyouth.2020.105194; Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Mak WWS, 2009, PSYCHOL HEALTH, V24, P161, DOI 10.1080/08870440701447649; Marelli S, 2021, J NEUROL, V268, P8, DOI 10.1007/s00415-020-10056-6; Matsuishi K, 2012, PSYCHIAT CLIN NEUROS, V66, P353, DOI 10.1111/j.1440-1819.2012.02336.x; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Mei SL., 2011, MED SOC, V24, P84; Ministry of Higher Education, DAT PEL MAL LUAR NEG; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Romero-Blanco C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145222; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541; Sallam M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243264; The Ministry of Health at the Hashemite Kingdom of Jordan, HLTH SATATISTICS; van Santen A, 2011, PSYCHONEUROENDOCRINO, V36, P240, DOI 10.1016/j.psyneuen.2010.07.014; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Voitsidis P, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113076; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Watson GR., 2010, CHEATING DIGITAL AGE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249716	10.1371/journal.pone.0249716	http://dx.doi.org/10.1371/journal.pone.0249716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819301	gold, Green Published			2022-12-26	WOS:000637647200030
J	Huang, KS; Pan, BL; Lai, WA; Bin, PJ; Yang, YH; Chou, CP				Huang, Kun-Siang; Pan, Bo-Lin; Lai, Wei-An; Bin, Pin-Jie; Yang, Yao-Hsu; Chou, Chia-Pei			Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study	PLOS ONE			English	Article								Background Some studies have indicated that the use of prokinetic agents may reduce pneumonia risk in some populations. Nasogastric tube insertion is known to increase the risk of pneumonia because it disrupts lower esophageal sphincter function. The aim of this study was to evaluate whether prokinetic agents could protect long-term nasogastric tube-dependent patients in Taiwan from being hospitalized for pneumonia. Methods A case-crossover study design was applied in this study. Long-term nasogastric tube-dependent patients who had a first-time admission to a hospital due to pneumonia from 1996 to 2013 that was recorded in the Taiwan National Health Insurance Research Database were included. The case period was set to be 30 days before admission, and two control periods were selected for analysis. Prokinetic agent use during those three periods was then assessed for the included patients. Conditional logistic regression was used to calculate the odds ratio (OR) for pneumonia admission with the use of prokinetic agents. Results A total of 639 first-time hospitalizations for pneumonia among patients with long-term nasogastric tube dependence were included. After adjusting the confounding factors for pneumonia, no negative association between prokinetic agent use and pneumonia hospitalization was found, and the adjusted OR was 1.342 (95% CI 0.967-1.86). In subgroup analysis, the adjusted ORs were 1.401 (0.982-1.997), 1.256 (0.87-1.814), 0.937 (0.607-1.447) and 2.222 (1.196-4.129) for elderly, stroke, diabetic and parkinsonism patients, respectively. Conclusion Prokinetic agent use had no negative association with pneumonia admission among long-term nasogastric tube-dependent patients in Taiwan.	[Huang, Kun-Siang; Pan, Bo-Lin; Lai, Wei-An; Bin, Pin-Jie; Chou, Chia-Pei] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Kun-Siang; Pan, Bo-Lin; Lai, Wei-An; Bin, Pin-Jie; Chou, Chia-Pei] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chou, CP (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan.; Chou, CP (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	libra760924@cgmh.org.tw			Chang Gung Memorial Hospital [CFRPG8H0321]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from Chang Gung Memorial Hospital (CFRPG8H0321).	Arai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169300; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Barone JA, 1999, ANN PHARMACOTHER, V33, P429, DOI 10.1345/aph.18003; Blumenstein I, 2014, WORLD J GASTROENTERO, V20, P8505, DOI 10.3748/wjg.v20.i26.8505; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; Chen TY, 2018, CHEST, V153, P161, DOI 10.1016/j.chest.2017.07.030; Curran MP, 2008, DRUGS, V68, P981, DOI 10.2165/00003495-200868070-00007; Delaney JA, 2009, STAT METHODS MED RES, V18, P53, DOI 10.1177/0962280208092346; DIPALMA JR, 1990, AM FAM PHYSICIAN, V41, P919; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Faillie JL, 2015, BRIT J CLIN PHARMACO, V80, P779, DOI 10.1111/bcp.12705; Gomes GF, 2003, CURR OPIN CLIN NUTR, V6, P327, DOI 10.1097/01.mco.0000068970.34812.8b; Grief SN, 2018, PRIMARY CARE, V45, P485, DOI 10.1016/j.pop.2018.04.001; Hall JE., 2020, GUYTON HALL TXB MED, V14, P587; Heetun ZS, 2012, PARKINSONISM RELAT D, V18, P433, DOI 10.1016/j.parkreldis.2011.12.004; Hiyama T, 2009, J GASTROEN HEPATOL, V24, P537, DOI 10.1111/j.1440-1746.2009.05780.x; Jackson ML, 2009, J AM GERIATR SOC, V57, P882, DOI 10.1111/j.1532-5415.2009.02223.x; Janda M, 2006, BEST PRACT RES-CLIN, V20, P409, DOI 10.1016/j.bpa.2006.02.006; Jaynes M, 2018, THER ADV DRUG SAF, V10, DOI 10.1177/2042098618809927; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; Kyriacou DN, 2016, JAMA-J AM MED ASSOC, V316, P1818, DOI 10.1001/jama.2016.16435; Lambert AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128004; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; Lewis K, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1441-z; Lin SM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024180; Liu YJ, 2017, ASIA PAC J CLIN NUTR, V26, P820, DOI 10.6133/apjcn.102016.01; Luk JKH, 2014, HONG KONG MED J, V20, P421, DOI 10.12809/hkmj144251; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mandell LA, 2018, HARRISONS PRINCIPLES, V20e; Marrinan S, 2014, MOVEMENT DISORD, V29, P23, DOI 10.1002/mds.25708; Masiero S, 2008, NEUROL SCI, V29, P139, DOI 10.1007/s10072-008-0925-2; Mukherjee A, 2016, WORLD J GASTROENTERO, V22, P5742, DOI 10.3748/wjg.v22.i25.5742; Nassaji M., 2010, Eastern Mediterranean Health Journal, V16, P371; Novack V, 2012, CAN MED ASSOC J, V184, pE367, DOI 10.1503/cmaj.111017; Pareek N, 2007, AM J MENT RETARD, V112, P467, DOI 10.1352/0895-8017(2007)112[467:PTRAPI]2.0.CO;2; Tanaka Y, 2011, J NEUROL, V258, P421, DOI 10.1007/s00415-010-5769-z; Tolppanen AM, 2016, CHEST, V150, P1233, DOI 10.1016/j.chest.2016.06.004; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Vinogradova Y, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606654; Wang CH, 2019, EXPERT OPIN DRUG SAF, V18, P163, DOI 10.1080/14740338.2019.1577820; Wang MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179472; Warusevitane A, 2015, STROKE, V46, P454, DOI 10.1161/STROKEAHA.114.006639; Welfare MoHa, 2018, CAUS DEATH STAT; WISEMAN LR, 1994, DRUGS, V47, P116, DOI 10.2165/00003495-199447010-00008; Yavagal DR, 2000, CRIT CARE MED, V28, P1408, DOI 10.1097/00003246-200005000-00025	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249645	10.1371/journal.pone.0249645	http://dx.doi.org/10.1371/journal.pone.0249645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819293	gold, Green Published			2022-12-26	WOS:000637647200021
J	Mulugeta, H; Tamene, A; Ashenafi, T; Thygerson, SM; Baxter, ND				Mulugeta, Hailemichael; Tamene, Aiggan; Ashenafi, Tesfaye; Thygerson, Steven M.; Baxter, Nathaniel D.			Workplace stress and associated factors among vehicle repair workers in Hawassa City, Southern Ethiopia	PLOS ONE			English	Article								Introduction Workplace stress is a public health problem worldwide. Studies focusing on work-related stress among vehicle repair workers are scarce in African countries. The current study aimed to determine the prevalence of self-reported workplace stress and associated factors among vehicle repair workers in Hawassa City, South Ethiopia. Methods and findings A cross-sectional study design was employed among 347 vehicle repair workers from January 25 to February 22, 2019. Questionnaires were administered using interviews. Additional tools were used for weight and height measurements. The main findings were analyzed using descriptive statistics, bivariable, and multivariable logistic regression. The strength of association of variables was presented by odds ratio along with its 95% CI. The statistical assessments were considered significant at p<0.05. A total of 344 workers participated in the study. The prevalence of workplace stress among participants was 41.6% with 95% CI: (36.3-47.1). Factors associated with workplace stress were more than 10 years of work experience [AOR: 2.40; 95% CI (1.29-4.50)], work-related musculoskeletal disorder [AOR: 3.39; 95% CI (1.99-5.78)], squatting and lying work posture [AOR: 4.63; 95% CI (1.61-13.3)] and servicing large vehicles [AOR: 1.96; 95% CI (1.14-3.38)]. Conclusion and recommendations This study showed that the overall prevalence of work-related stress was substantially high. The independently associated factors were workers' service years, symptoms of body pain, and the work environment. Preventive measures need to be implemented in vehicle repair workshops by focusing on work environment improvements.	[Mulugeta, Hailemichael] Debre Berhan Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Berhan, Ethiopia; [Tamene, Aiggan] Wachemo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Shewa, Ethiopia; [Ashenafi, Tesfaye] Hawassa Univ, Dept Environm Hlth, Coll Med & Hlth Sci, Awasa, Ethiopia; [Thygerson, Steven M.; Baxter, Nathaniel D.] Brigham Young Univ, Dept Publ Hlth, Coll Life Sci, Provo, UT 84602 USA	Hawassa University; Brigham Young University	Mulugeta, H (corresponding author), Debre Berhan Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Berhan, Ethiopia.	hailumary464@gmail.com	Tamene, Aiggan/ABB-7893-2021; Mulugeta, Hailemichael/ABB-1289-2020	Tamene, Aiggan/0000-0001-5504-0905; Mulugeta, Hailemichael/0000-0003-0350-205X				Abera K., 2016, ETHIOPIA J HLTH DEV, V30; Aiggan T., 2020, J ENVIRON PUBLIC HEA, V2020; Andargachew K., 2016, AFR HEALTH SCI, V16; [Anonymous], 2019, DAT VEH REP WO UNPUB; Ataro Z, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119846792; Ataro Z, 2018, RISK MANAG HEALTHC P, V11, P35, DOI 10.2147/RMHP.S154611; Attwa E, 2009, J EUR ACAD DERMATOL, V23, P138, DOI 10.1111/j.1468-3083.2008.02952.x; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cecatto SB, 2015, BRAZ J OTORHINOLAR, V81, P394, DOI 10.1016/j.bjorl.2014.09.009; Chien-Hsun W., 2019, HELIYON, V5; Crawford JO, 2007, OCCUP MED-OXFORD, V57, P300, DOI 10.1093/occmed/kqm036; Dawson AP, 2009, J PAIN, V10, P517, DOI 10.1016/j.jpain.2008.11.008; Demewoz H., 2015, PLOS ONE, V10; Dereje D., 2020, ENVIRON HEALTH PREV, V25; Drieskens S, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0255-7; Elise P.L., 2014, BMC PEDIATR, V14; Elke S., 2010, OSH FIGURES WORK REL; Eva B., 2013, PLOS ONE, V8; Evan S., 2020, J SOC SERV RES, V46; Fahad S.A., 2020, BIOMED RES INT, V2020; Gebisa G., 2020, BMC RES NOTES, V13; Gebrekiros G., 2015, OCCUPATIONAL MED HLT, P3; George M., 2008, RELATIONSHIP WORKPLA, P315; Hailemichael M., 2020, J ENVIRON PUBLIC HEA, V2020; International Labor Organization (ILO), 2016, WORK PLAC STRESS COL; Irie M, 2016, EUR RESPIR J, V48, P495, DOI 10.1183/13993003.01939-2015; Jaradat Y, 2016, APPL NURS RES, V32, P190, DOI 10.1016/j.apnr.2016.07.014; Jin W., 2020, CHINA CDC WEEKLY, V2; Kabito GG, 2020, ETHIOP J HEALTH SCI, V30, P223, DOI 10.4314/ejhs.v30i2.10; Keer S, 2016, NEUROTOXICOLOGY, V57, P223, DOI 10.1016/j.neuro.2016.10.005; Kitronza Panda Lukongo, 2015, Trop Med Health, V43, P223, DOI 10.2149/tmh.2015-24; Liu JT, 2013, J FORMOS MED ASSOC, V112, P287, DOI 10.1016/j.jfma.2011.12.006; Mathangi V., 2017, J ORG HUMAN BEHAV, V6; Mohammad D.H., 2018, PLOS ONE, V13; Morke M., 2018, BMC RES NOTES, V11; National Academy of Sciences, MUSCULOSKELETAL DISO; NIH, 2013, DRUG FACTS; Nuwayhid IA, 2004, AM J PUBLIC HEALTH, V94, P1916, DOI 10.2105/AJPH.94.11.1916; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Othman Zahiruddin&Sivasubramaniam, 2019, INT MED J, V26, P71, DOI [10.5281/zenodo.2586221, DOI 10.5281/ZENODO.2586221]; Paul H.L., 2016, BMC MED RES METHODOL, V16; Philip Mathew, 2014, Indian J Occup Environ Med, V18, P9, DOI 10.4103/0019-5278.134946; Ri W.A., 2017, PLOS ONE, V12; Sakhvidi MJZ, 2019, AIMS PUBLIC HEALTH, V6, P577, DOI 10.3934/publichealth.2019.4.577; Salilih SZ, 2014, WORKPLACE HEALTH SAF, V62, P326, DOI 10.3928/21650799-20140708-02; Samuel K., 2017, PLOS ONE, V12; Scott Macdonald P., 1997, EMPLOYEE ASSISTANCE, V13; Seema D., 2012, STRESS MED ED PROFES, V19, P404; Selam G., 2019, BMC RES NOTES, V12; Shatakshi K., 2020, J SEYBOLD REPORT, V15; Shubhangi J., 2018, INT J HLTH SCI RES, V8; Shukriah A., 2017, J FUNDAM APPL SCI, V9; Sina TT., 2020, J ERGON, V9, P257, DOI [10.35248/2165-7556.20.9.257, DOI 10.35248/2165-7556.20.9.257]; Solomon M.A., 2015, BMC CARDIOVASC DISOR, V12; Soltan M.R., 2020, MIDDLE E CURRENT PSY, V27; Takele Tadesse, 2007, Ethiopian Journal of Health Development, V21, P25; Tesfaye H.M., 2019, PAIN RES MANAG, V2019; Tesfaye H.M., 2020, BMC PUBLIC HEALTH, V20; The American Institute of Stress, 2001, MARL CO ATT AM WORKP; The British Medical Association, 2013, ILL MED DICT; Torp S, 1996, OCCUP MED-OXFORD, V46, P407, DOI 10.1093/occmed/46.6.407; Ukachukwu A., 2016, WORK, V53; University of Oxford, 2007, OXF HDB OCC HLTH, V1st Edition ed; Vyas H, 2011, IND HEALTH, V49, P642; World Health Organization (WHO), 2021, OCC HLTH STRESS WORK; Yalemsew A., 2012, J OCCUP MED TOXICOL, V7	67	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249640	10.1371/journal.pone.0249640	http://dx.doi.org/10.1371/journal.pone.0249640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819287	gold, Green Published			2022-12-26	WOS:000637647200017
J	Kreh, A; Brancaleoni, R; Magalini, SC; Chieffo, DPR; Flad, B; Ellebrecht, N; Juen, B				Kreh, Alexander; Brancaleoni, Rachele; Magalini, Sabina Chiara; Chieffo, Daniela Pia Rosaria; Flad, Barbara; Ellebrecht, Nils; Juen, Barbara			Ethical and psychosocial considerations for hospital personnel in the Covid-19 crisis: Moral injury and resilience	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PSYCHOLOGICAL IMPACT; PANDEMIC INFLUENZA; COPING STRATEGIES; SARS; EXPOSURE; TORONTO; WORKING; STAFF; QUARANTINE	This study aims at investigating the nature of resilience and stress experience of health care workers during the COVID-19 pandemic. Thirteen healthcare workers from Italian and Austrian hospitals specifically dealing with COVID-19 patients during the first phase of the pandemic were interviewed. Data was analysed using grounded theory methodology. Psychosocial effects on stress experience, stressors and resilience factors were identified. We generated three hypotheses. Hypothesis one is that moral distress and moral injury are main stressors experienced by healthcare workers. Hypothesis two states that organisational resilience plays an important part in how healthcare workers experience the crisis. Organisational justice and decentralized decision making are essential elements of staff wellbeing. Hypothesis three refers to effective psychosocial support: Basic on scene psychosocial support based on the Hobfoll principles given by trusted and well-known mental health professionals and peers in an integrated approach works best during the pandemic.	[Kreh, Alexander; Juen, Barbara] Univ Innsbruck, Innsbruck, Austria; [Brancaleoni, Rachele; Chieffo, Daniela Pia Rosaria] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Magalini, Sabina Chiara] Univ Cattolica Sacro Cuore, Rome, Italy; [Flad, Barbara] Ao Krankenhaus St Vinzenz, Zams, Austria; [Ellebrecht, Nils] Albert Ludwigs Univ, Freiburg, Germany	University of Innsbruck; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Freiburg	Kreh, A (corresponding author), Univ Innsbruck, Innsbruck, Austria.	alexander.kreh@uibk.ac.at		Brancaleoni, Rachele/0000-0002-2307-7161	European Union's Horizon 2020 research and innovation programme [786670]	European Union's Horizon 2020 research and innovation programme	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 786670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Bobbitt P., 1978, TRAGIC CHOICES; Bohlken J., 2020, PSYCHIAT PRAX, V47, P190, DOI [10.1055/a-1159-5551, DOI 10.1055/A-1159-5551]; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171; Comitato Nazionale per la Bioetica, 2020, COVID 19 CLIN DECISI; Dong ZQ, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.59; Duckers MLA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193285; Dunham AM, 2020, J AM ACAD ORTHOP SUR, V28, P471, DOI 10.5435/JAAOS-D-20-00371; Ellebrecht N, 2020, DISASTER MED PUBLIC, V14, P563, DOI 10.1017/dmp.2019.74; Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; IFRC reference center for Psychosocial support, 2009, PARTICIPANTS HDB; Ives J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-56; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Juen B., 2015, TRAUMA 1 MEHR ALS TR, P163; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lancee WJ, 2008, PSYCHIAT SERV, V59, P91, DOI 10.1176/ps.2008.59.1.91; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Maguire B, 2007, AUST J EMERG MANAG, V22, P16; Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012; Matsuishi K, 2012, PSYCHIAT CLIN NEUROS, V66, P353, DOI 10.1111/j.1440-1819.2012.02336.x; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; Maunder RG, 2008, CAN J PUBLIC HEALTH, V99, P486, DOI 10.1007/BF03403782; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Palazzani L., 2020, COVID 19 ETHICAL IMP; Palazzani L, 2020, BIOLAW J, P359; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Robertson E, 2004, CAN J PSYCHIAT, V49, P403; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Rubin GJ, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30933; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Shay J, 2014, PSYCHOANAL PSYCHOL, V31, P182, DOI 10.1037/a0036090; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; STRUTZEL E, 1968, NURS RES, V17, P364; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Thieken AH, 2014, NAT HAZARD EARTH SYS, V14, P33, DOI 10.5194/nhess-14-33-2014; Williams Roger D, 2020, J Health Serv Psychol, V46, P65, DOI 10.1007/s42843-020-00011-4; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1; Yuan, 2020, PSYCHOL IMPACT CORON, DOI DOI 10.1101/2020.03.03.20030874	50	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249609	10.1371/journal.pone.0249609	http://dx.doi.org/10.1371/journal.pone.0249609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798251	Green Published, Green Submitted, gold			2022-12-26	WOS:000636737700004
J	Anteneh, ZA; Van Geertruyden, JP				Anteneh, Zelalem Alamrew; Van Geertruyden, Jean-Pierre			Spatial variations and determinants of anemia among under-five children in Ethiopia, EDHS 2005-2016	PLOS ONE			English	Article							BIRTH-WEIGHT; MATERNAL AGE; PREVALENCE; DISTRICT; HEALTH; REGRESSION; IRON	Background Anemia has severe public health significance in sub-Saharan Africa. In Ethiopia, anemia has been increasing in the last two decades, reaching the highest national level in 2016, however, the geospatial distribution and determinants of anemia in children weren't well explored at a national level. Methods We used the Ethiopian Demographic and Health Survey(EDHS) data from 2005-2016. The data consists of samples of households (HHs) obtained through a two-stage stratified sampling procedure. Our analysis included 19,699 children. Descriptive statistics, geospatial analysis, and Generalized Linear Mixed Model (GLMMs) were used. Results The overall prevalence of anemia was 51.5%; the spatial distribution of anemia significantly different across clusters in each survey. Children from 6 to 11 months had higher odds of anemia compared to 24-59 months (Adjusted Odds ratio (AOR) = 3.4, 95%Confidence level (CI): 2.99-3.76). Children with the first and second birth order were less likely to be anemic compared to fifth and above (AOR = 0.60, 95%CI: 0.38-0.95, and AOR = 0.83, 95%C: 0.73-0.93) respectively. Mothers' age 15 to 24 years was associated with higher odds of anemia compared to 35 to 49 years (AOR = 1.37, 95%CI: 1.20-1.55). Children from HHs with the poorest and poorer wealth category showed a higher odds of anemia compared to the richest (AOR = 1.67, 95%CI: 1.45-1.93, and AOR = 1.25, 95%CI: 1.08-1.45) respectively. Moreover, children from HHs with one to two under-five children were less likely to be anemic compared to those three and more (AOR = 0.83, 95%CI: 0.76-0.91). Conclusions The geospatial distribution of anemia among children varies in Ethiopia; it was highest in the East, Northeast, and Western regions of the country. Several factors were associated with anemia; therefore, interventions targeting the hotspots areas and specific determinant factors should be implemented by the concerned bodies to reduce the consequences of anemia on the generation.	[Anteneh, Zelalem Alamrew] Bahir Dar Univ, Dept Epidemiol, Bahir Dar, Ethiopia; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium	Bahir Dar University; University of Antwerp	Anteneh, ZA (corresponding author), Bahir Dar Univ, Dept Epidemiol, Bahir Dar, Ethiopia.	kzolam@gmail.com	Anteneh, Zelalem Alamrew/AAD-1052-2022	Anteneh, Zelalem Alamrew/0000-0003-4879-675X				Afeworki R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131897; Aimone AM, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-1; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Aras RY., 2013, ARCH MED HEALTH SCI, V1, P33, DOI [10.4103/2321-4848.113558, DOI 10.4103/2321-4848.113558]; Bandyopadhyay S, 2017, BLOOD TRANSFUS-ITALY, V15, P158, DOI 10.2450/2017.0349-16; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Baranwal A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00196; Batra J, 2005, INDIAN J CLIN BIOCHE, V20, P119, DOI 10.1007/BF02867410; Betebo B, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/6373595; Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC, DOI [10.15620/cdc:82532, DOI 10.15620/CDC:82532]; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2005, ETH DEM HLTH SURV; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2011, ETH DEM HLTH SURV ED; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2017, ETH DEM HLTH SURV; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Cusick SE, 2016, J PEDIATR-US, V175, P16, DOI 10.1016/j.jpeds.2016.05.013; Davis Charles Patrick, 2019, ANEMIA SYMPTOMS SIGN; Dennis JA, 2013, SOC SCI J, V50, P625, DOI 10.1016/j.soscij.2013.09.008; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Federal Republic of Ethiopia, 2019, REG STAT ETH ADDIS A; Feleke BE, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/1962128; Ferri C, 2014, J TROP PEDIATRICS, V60, P53, DOI 10.1093/tropej/fmt077; Gebreegziabiher G, 2014, ANEMIA, V2014, DOI 10.1155/2014/245870; Getaneh Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190151; Girma Nega., 2017, NE ETHIOPIA ADV PUBL, V2017; Gutema Bekele, 2014, BMC Hematol, V14, P13, DOI 10.1186/2052-1839-14-13; Habyarimana F, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060652; Hammerly C, 2022, LINGUIST INQ, V53, P823, DOI 10.1162/ling_a_00422; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Huynh G, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6921312; Vazquez LI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010183; Institute of Medicine (US) Panel on Micronutrients, 2001, DIET REF INT VIT A V; Kamal MM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007538; Kanan MOS., 2016, SUDANESE J PAEDIAT, V16; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Kejo D, 2018, PEDIATR HEALTH MED T, V9, P9, DOI 10.2147/PHMT.S148515; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Kuziga F, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0782-3; Larson LM, 2017, ANN NUTR METAB, V71, P25, DOI 10.1159/000480742; Malako BG, 2019, BMC NUTR, V5, DOI 10.1186/s40795-018-0268-1; Melku M, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0547-0; Mohammed SH, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1476-9; Moschovis PP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019654; Nesti MMM, 2007, J PEDIAT-BRAZIL, V83, P299, DOI [10.2223/JPED.1649, 10.1590/S0021-75572007000500004]; Ntenda PAM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5568-5; Ny Pernilla, 2006, Health Care Women Int, V27, P131, DOI 10.1080/07399330500457945; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Osazuwa F, 2010, N AM J MED SCI, V2, P532, DOI 10.4297/najms.2010.2532; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Prieto-Patron A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091269; Queensland Government, DIET EAT IR TODDL CH; Rana MJ., 2017, INDIAN J HUMAN DEV, V11, P56, DOI [10.1177/0973703017712392, DOI 10.1177/0973703017712392]; Restrepo-Mendez MC, 2015, PAEDIATR PERINAT EP, V29, P31, DOI 10.1111/ppe.12162; da Silva LLS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204504; Sop M. M. K., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P925; Tassew AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203098; The DHS Program, 2005, SPAT DAT REP SUBN RE; United Nations Children's Fund (UNICEF), 2019, LEVELS TRENDS CHILD; United Nations. Sustainable Development Goals (SDGs), 2019, GOAL 2 END HUNG ACH; United States Agency for International Development (USAID), 2019, FOOD ASS FACT SHEET; USAIDS, INT AN PREV CONTR TO; Viana Marcos Borato, 2011, Rev. Bras. Hematol. Hemoter., V33, P90, DOI 10.5581/1516-8484.20110024; Weatherhead JE, 2015, PEDIATR REV, V36, P341, DOI 10.1542/pir.36-8-341; WHO, 2011, WHO TECH REP SER, V959, P1; Woldemichael A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022923; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; Yang WF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1127	68	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249412	10.1371/journal.pone.0249412	http://dx.doi.org/10.1371/journal.pone.0249412			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793640	Green Published, gold			2022-12-26	WOS:000636467000023
J	Hiramitsu, T; Tomosugi, T; Okada, M; Futamura, K; Goto, N; Narumi, S; Watarai, Y; Tominaga, Y; Ichimori, T				Hiramitsu, Takahisa; Tomosugi, Toshihide; Okada, Manabu; Futamura, Kenta; Goto, Norihiko; Narumi, Shunji; Watarai, Yoshihiko; Tominaga, Yoshihiro; Ichimori, Toshihiro			Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study	PLOS ONE			English	Article								Persistent or recurrent renal hyperparathyroidism may occur after total parathyroidectomy and transcervical thymectomy with forearm autograft under continuous stimulation due to uremia. Parathyroid hormone (PTH) levels may reflect persistent or recurrent renal hyperparathyroidism because of the enlarged autografted parathyroid glands in the forearm or remnant parathyroid glands in the neck or mediastinum. Detailed imaging requires predictive localization of causative parathyroid glands. Casanova and simplified Casanova tests may be convenient. However, these methods require avascularization of the autografted forearm for >10 min with a tourniquet or Esmarch. The heavy pressure during avascularization can be incredibly painful and result in nerve damage. An easier method that minimizes the burden on patients in addition to predicting the localization of causative parathyroid glands was developed in this study. Ninety patients who underwent successful re-parathyroidectomy for persistent or recurrent renal hyperparathyroidism after parathyroidectomy between January 2000 and July 2019 were classified according to the localization of causative parathyroid glands (63 and 27 patients in the autografted forearm and the neck or mediastinum groups, respectively). Preoperatively, intact PTH levels were measured from bilateral forearm blood samples following a 5-min avascularization of the autografted forearm. Cutoff values of the intact PTH ratio (intact PTH level obtained from the non-autografted forearm before re-parathyroidectomy/intact PTH level obtained from the autografted forearm before re-parathyroidectomy) were investigated with receiver operating characteristic curves to localize the causative parathyroid glands. Intact PTH ratios of <0.310 with an area under the curve (AUC) of 0.913 (95% confidence interval [CI]: 0.856-0.970; P < 0.001) and >0.859 with an AUC 0.744 (95% CI: 0.587-0.901; P = 0.013) could predict causative parathyroid glands in the autografted forearm and the neck or mediastinum with diagnostic accuracies of 81.1% and 83.3%, respectively. Therefore, we propose that the intact PTH ratio is useful for predicting the localization of causative parathyroid glands for re-parathyroidectomy.	[Hiramitsu, Takahisa; Tomosugi, Toshihide; Okada, Manabu; Futamura, Kenta; Goto, Norihiko; Narumi, Shunji; Watarai, Yoshihiko; Tominaga, Yoshihiro; Ichimori, Toshihiro] Nagoya Daini Red Cross Hosp, Dept Transplant & Endocrine Surg, Nagoya, Aichi, Japan	Japanese Red Cross Nagoya Daini Hospital	Hiramitsu, T (corresponding author), Nagoya Daini Red Cross Hosp, Dept Transplant & Endocrine Surg, Nagoya, Aichi, Japan.	thira@nagoya2.jrc.or.jp		Hiramitsu, Takahisa/0000-0003-1600-640X				Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; CASANOVA D, 1991, WORLD J SURG, V15, P546, DOI 10.1007/BF01675660; Chou FF, 2002, ANN SURG, V235, P99, DOI 10.1097/00000658-200201000-00013; de Andrade JSC, 2014, BRAZ J OTORHINOLAR, V80, P29, DOI 10.5935/1808-8694.20140008; Dotzenrath C, 2003, LANGENBECK ARCH SURG, V387, P348, DOI 10.1007/s00423-002-0322-x; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; HERGAN K, 1995, JMRI-J MAGN RESON IM, V5, P541; Hibi Y, 2002, WORLD J SURG, V26, P1301, DOI 10.1007/s00268-002-6731-8; Hiramitsu T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51265-y; Hiramitsu T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001213; Itoh K, 2003, ANN NUCL MED, V17, P315, DOI 10.1007/BF02988528; Karipineni F, 2018, SURGERY, V163, P35, DOI 10.1016/j.surg.2017.07.035; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Lorenz K, 2015, LANGENBECK ARCH SURG, V400, P907, DOI 10.1007/s00423-015-1344-5; Masri Bassam A, 2020, BMC Biomed Eng, V2, P7, DOI 10.1186/s42490-020-00041-5; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; Numano M, 1998, WORLD J SURG, V22, P1098, DOI 10.1007/s002689900524; Puccini M, 2010, BIOMED PHARMACOTHER, V64, P359, DOI 10.1016/j.biopha.2009.06.006; Schlosser K, 2004, WORLD J SURG, V28, P583, DOI 10.1007/s00268-004-7321-8; Schlosser K, 2016, ANN SURG, V264, P745, DOI 10.1097/SLA.0000000000001875; Schneider R, 2013, WORLD J SURG, V37, P2155, DOI 10.1007/s00268-013-2091-9; Stracke S, 1999, AM J KIDNEY DIS, V33, P304, DOI 10.1016/S0272-6386(99)70305-7; Taieb D, 2013, CLIN NUCL MED, V38, P630, DOI 10.1097/RLU.0b013e31829af5bf; Tominaga Y, 2003, NEPHROL DIAL TRANSPL, V18, P65, DOI 10.1093/ndt/gfg1017; Tominaga Y., 2012, SURG THYROID PARATHY, V2nd ed, P639; Tominaga Y, 2009, WORLD J SURG, V33, P2335, DOI 10.1007/s00268-009-9943-3; Tominaga Y, 2008, THER APHER DIAL, V12, pS21, DOI 10.1111/j.1744-9987.2008.00627.x; Uludag M, 2011, BRATISL MED J, V112, P385; van der Plas WY, 2019, SURGERY, V165, P135, DOI 10.1016/j.surg.2018.04.092; Zitt E, 2011, NEPHROL DIAL TRANSPL, V26, P1956, DOI 10.1093/ndt/gfq641	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248366	10.1371/journal.pone.0248366	http://dx.doi.org/10.1371/journal.pone.0248366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793603	Green Published, gold			2022-12-26	WOS:000636467000073
J	Bahado-Singh, RO; Vishweswaraiah, S; Aydas, B; Yilmaz, A; Metpally, RP; Carey, DJ; Crist, RC; Berrettini, WH; Wilson, GD; Imam, K; Maddens, M; Bisgin, H; Graham, SF; Radhakrishna, U				Bahado-Singh, Ray O.; Vishweswaraiah, Sangeetha; Aydas, Buket; Yilmaz, Ali; Metpally, Raghu P.; Carey, David J.; Crist, Richard C.; Berrettini, Wade H.; Wilson, George D.; Imam, Khalid; Maddens, Michael; Bisgin, Halil; Graham, Stewart F.; Radhakrishna, Uppala			Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease	PLOS ONE			English	Article							DNA METHYLATION DIFFERENCES; COGNITIVE DECLINE; WIDE; ASSOCIATION; DEMENTIA; COMMON; HEALTH; GENES; BLOOD; ROLES	We evaluated the utility of leucocyte epigenomic-biomarkers for Alzheimer's Disease (AD) detection and elucidates its molecular pathogeneses. Genome-wide DNA methylation analysis was performed using the Infinium MethylationEPIC BeadChip array in 24 late-onset AD (LOAD) and 24 cognitively healthy subjects. Data were analyzed using six Artificial Intelligence (AI) methodologies including Deep Learning (DL) followed by Ingenuity Pathway Analysis (IPA) was used for AD prediction. We identified 152 significantly (FDR p<0.05) differentially methylated intragenic CpGs in 171 distinct genes in AD patients compared to controls. All AI platforms accurately predicted AD with AUCs >= 0.93 using 283,143 intragenic and 244,246 intergenic/extragenic CpGs. DL had an AUC = 0.99 using intragenic CpGs, with both sensitivity and specificity being 97%. High AD prediction was also achieved using intergenic/extragenic CpG sites (DL significance value being AUC = 0.99 with 97% sensitivity and specificity). Epigenetically altered genes included CR1L & CTSV (abnormal morphology of cerebral cortex), S1PR1 (CNS inflammation), and LTB4R (inflammatory response). These genes have been previously linked with AD and dementia. The differentially methylated genes CTSV & PRMT5 (ventricular hypertrophy and dilation) are linked to cardiovascular disease and of interest given the known association between impaired cerebral blood flow, cardiovascular disease, and AD. We report a novel, minimally invasive approach using peripheral blood leucocyte epigenomics, and AI analysis to detect AD and elucidate its pathogenesis.	[Bahado-Singh, Ray O.; Vishweswaraiah, Sangeetha; Yilmaz, Ali; Graham, Stewart F.; Radhakrishna, Uppala] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, Royal Oak, MI 48067 USA; [Aydas, Buket] Meridian Hlth Plans, Dept Healthcare Analyt, Detroit, MI USA; [Metpally, Raghu P.; Carey, David J.] Geisinger, Dept Mol & Funct Genom, Danville, PA USA; [Crist, Richard C.; Berrettini, Wade H.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wilson, George D.] Oakland Univ, William Beaumont Sch Med, Dept Radiat Oncol, Rochester, MI 48063 USA; [Imam, Khalid; Maddens, Michael] Oakland Univ, William Beaumont Sch Med, Dept Internal Med, Rochester, MI 48063 USA; [Bisgin, Halil] Univ Michigan, Dept Comp Sci, Flint, MI 48503 USA	Oakland University; University of Pennsylvania; Pennsylvania Medicine; Oakland University; Oakland University; University of Michigan System; University of Michigan; University of Michigan Flint	Radhakrishna, U (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, Royal Oak, MI 48067 USA.	radhakrishna.uppala@unige.ch						Aberg KA, 2013, EPIGENOMICS-UK, V5, P367, DOI [10.2217/epi.13.36, 10.2217/EPI.13.36]; Alakwaa FM, 2018, J PROTEOME RES, V17, P337, DOI 10.1021/acs.jproteome.7b00595; Altorok N, 2015, ANN RHEUM DIS, V74, P1612, DOI 10.1136/annrheumdis-2014-205303; Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; [Anonymous], WORLD ALZHEIMER REPO; Bahado-Singh RO, 2019, ULTRASOUND OBST GYN, V54, P110, DOI 10.1002/uog.20168; Bahado-Singh RO, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146510; Bahado-Singh RO, 2019, BRAIN RES, V1724, DOI 10.1016/j.brainres.2019.146457; Bahado-Singh RO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092075; Bahado-Singh RO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214121; Bakkour A, 2013, NEUROIMAGE, V76, P332, DOI 10.1016/j.neuroimage.2013.02.059; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Bazan NG, 2018, MOL ASPECTS MED, V64, P18, DOI 10.1016/j.mam.2018.09.003; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Candel A, DEEP LEARNING H2O201; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Cluett C, 2010, NEUROBIOL AGING, V31, P1563, DOI 10.1016/j.neurobiolaging.2008.08.020; Cure S, 2014, J ALZHEIMERS DIS, V42, P169, DOI 10.3233/JAD-131559; Daviglus Martha L, 2010, NIH Consens State Sci Statements, V27, P1; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Ferrer I, 2001, NEUROPATH APPL NEURO, V27, P343, DOI 10.1046/j.1365-2990.2001.00348.x; Foulquier S, 2018, PHARMACOL REV, V70, P68, DOI 10.1124/pr.117.013896; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Grinan-Ferre C, 2018, J ALZHEIMERS DIS, V62, P943, DOI 10.3233/JAD-170664; Hampel H, 2017, CLIMACTERIC, V20, P107, DOI 10.1080/13697137.2017.1287866; Hansmannel F, 2010, J ALZHEIMERS DIS, V21, P1013, DOI 10.3233/JAD-2010-100630; Huang C, 2014, DEV CELL, V30, P479, DOI 10.1016/j.devcel.2014.06.011; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Itoh N, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00110; Jannot AS, 2015, J CLIN EPIDEMIOL, V68, P460, DOI 10.1016/j.jclinepi.2015.01.001; Kauwe JSK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077087; Kim JO, 2014, MOL MED REP, V9, P2459, DOI 10.3892/mmr.2014.2072; Kim S, 2018, GLIA, V66, P654, DOI 10.1002/glia.23272; Konki M, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0729-7; Kucukkilic E, 2018, HUM GENET, V137, P305, DOI 10.1007/s00439-018-1883-2; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kusdra L, 2000, IMMUNOBIOLOGY, V202, P26, DOI 10.1016/S0171-2985(00)80049-2; Lee HC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110428; Leenen FAD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0256-8; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Li HD, 2016, ONCOTARGET, V7, P19089, DOI 10.18632/oncotarget.7862; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Liu JY, 2014, SCHIZOPHRENIA BULL, V40, P769, DOI 10.1093/schbul/sbt080; Luu BC, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120953404; Mamoshina P, 2016, MOL PHARMACEUT, V13, P1445, DOI 10.1021/acs.molpharmaceut.5b00982; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mirza B, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020087; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Muthusamy N, 2015, J NEUROCHEM, V132, P20, DOI 10.1111/jnc.12989; Nasoohi S, 2018, MOL NEUROBIOL, V55, P7900, DOI 10.1007/s12035-018-0917-z; Prince M, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Rezai-Zadeh K, 2009, EXPERT REV NEUROTHER, V9, P1623, DOI 10.1586/ERN.09.118; Richartz-Salzburger E, 2007, J PSYCHIATR RES, V41, P174, DOI 10.1016/j.jpsychires.2006.01.010; Rustenhoven J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0277-1; Sajda P, 2006, ANNU REV BIOMED ENG, V8, P537, DOI 10.1146/annurev.bioeng.8.061505.095802; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Savasan ZA, 2019, METABOLITES, V9, DOI 10.3390/metabo9020027; Schjeide BM, 2009, NEUROGENETICS, V10, P19, DOI 10.1007/s10048-008-0151-3; Scuteri A, 2009, EUR HEART J, V30, P1525, DOI 10.1093/eurheartj/ehp133; Sherva R, 2011, J ALZHEIMERS DIS, V23, P349, DOI 10.3233/JAD-2010-100714; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Tindi JO, 2015, J NEUROSCI, V35, P8986, DOI 10.1523/JNEUROSCI.4029-14.2015; Torres VI, 2019, PHARMACOL THERAPEUT, V198, P34, DOI 10.1016/j.pharmthera.2019.02.009; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Vallee A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00459; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Wolfram JA, 2011, THER ADV CHRONIC DIS, V2, P133, DOI 10.1177/2040622310393059; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143; Zhang Q, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18534-1	75	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248375	10.1371/journal.pone.0248375	http://dx.doi.org/10.1371/journal.pone.0248375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788842	gold, Green Published			2022-12-26	WOS:000636354600033
J	Dorjdagva, J; Batbaatar, E; Svensson, M; Dorjsuren, B; Togtmol, M; Kauhanen, J				Dorjdagva, Javkhlanbayar; Batbaatar, Enkhjargal; Svensson, Mikael; Dorjsuren, Bayarsaikhan; Togtmol, Munkhsaikhan; Kauhanen, Jussi			Does social health insurance prevent financial hardship in Mongolia? Inpatient care: A case in point	PLOS ONE			English	Article							CHALLENGES	Background Protecting people from financial hardship and impoverishment due to health care costs is one of the fundamental purposes of the Mongolian health system. However, the inefficient, oversized hospital sector is considered one of the main shortcomings of the system. The aim of this study is to contribute to policy discussions by estimating the extent of catastrophic health expenditure and impoverishment due to inpatient care at secondary-level and tertiary-level public hospitals and private hospitals. Methods Data were derived from a nationally representative survey, the Household Socio-Economic Survey 2012, conducted by the National Statistical Office of Mongolia. A total of 12,685 households were involved in the study. "Catastrophic health expenditure" is defined as out-of-pocket payments for inpatient care that exceed a threshold of 40% of households' non-discretionary expenditure. The "impoverishment" effect of out-of-pocket payments for inpatient care was estimated as the difference between the poverty level before health care payments and the poverty level after these payments. Results At the threshold of 40% of capacity to pay, 0.31%, 0.07%, and 0.02% of Mongolian households suffered financially as a result of their member(s) staying in tertiary-level and secondary-level public hospitals and private hospitals respectively. About 0.13% of the total Mongolian population was impoverished owing to out-of-pocket payments for inpatient care at tertiary-level hospitals. Out-of-pocket payments for inpatient care at secondary-level hospitals and private hospitals were responsible for 0.10% and 0.09% respectively of the total population being pushed into poverty. Conclusions Although most inpatient care at public hospitals is covered by the social health insurance benefit package, patients who utilized inpatient care at tertiary-level public hospitals were more likely to push their households into financial hardship and poverty than the inpatients at private hospitals. Improving the hospital sector's efficiency and financial protection for inpatients would be a crucial means of attaining universal health coverage in Mongolia.	[Dorjdagva, Javkhlanbayar; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Fac Hlth Sci, Kuopio, Finland; [Batbaatar, Enkhjargal] Univ Eastern Finland, Fac Social Sci & Business Studies, Dept Social Sci, Kuopio, Finland; [Svensson, Mikael] Univ Gothenburg, Inst Med, Sch Publ Hlth & Community Med, Gothenburg, Sweden; [Dorjsuren, Bayarsaikhan] WHO, Dept Hlth Syst Governance & Financing, Geneva, Switzerland; [Togtmol, Munkhsaikhan] Minist Hlth, Ulaanbaatar, Mongolia	University of Eastern Finland; University of Eastern Finland; University of Gothenburg; World Health Organization; Ministry of Health Mongolia	Dorjdagva, J (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Fac Hlth Sci, Kuopio, Finland.	javkhlanbayar.dorjdagva@uef.fi	Kauhanen, Jussi/ABC-4064-2021	Batbaatar, Enkhjargal/0000-0002-8806-2841				Asian Development Bank, 2008, MONG HLTH SOCI PROT; Bayarsaikhan D, 2015, INT SOC SECUR REV, V68, P93, DOI 10.1111/issr.12089; Bayarsaikhan D, 2005, INT SOC SECUR REV, V58, P27, DOI 10.1111/j.1468-246X.2005.00224.x; Bredenkamp C, 2012, HLTH EQUITY FINANCIA; Center for Global Development Hospitals for Health Working Group, 2015, BETT HOSP BETT HLTH; Center for Health Development, 2017, HLTH IND 2016; Center for Health Development, 2018, HLTH IND 2017; Customer Rights Association of Gobi-Altai Province, 2010, REP EV MON SOC HLTH; Daramragchaa A., 2011, HOSP SERVICES COSTIN; Dorjdagva J, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0572-4; Dorjdagva J, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0395-8; Dorjdagva J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0281-9; Dorjdagva J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0185-8; Dorjsuren B., 2017, DEV NATL HLTH FINANC; Jigjidsuren A., 2019, FREE UNIVERSAL ACCES, V19; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Ministry of Health and Sports and Ministry of Finance, 2015, 498345 MIN HLTH SPOR; National Statistical Office of Mongolia, 2013, HOUS SOC SURV 2012; O'Donnell O, 2007, ANAL HLTH EQUITY USI, DOI [10.1596/978-0-8213-6933-3, DOI 10.1596/978-0-8213-6933-3]; Qingyue M, 2011, ALLIANCE HLTH POLICY, P1; Somanathan A, 2015, ASSESSMENT SYSTEMS P; Tandon A., 2000, GPE DISCUSSION PAPER; The State Great Hural (Parliament) of Mongolia, LAW SOCIAL HLTH INSU; The World Bank, HOSP BEDS 1000 PEOPL; The World Bank HD sector, 2007, MONG HLTH SYST CROSS; Tsevelvaanchig U, 2017, HEALTH POLICY PLANN, V32, P476, DOI 10.1093/heapol/czw157; Tsilaajav T, 2013, MONGOLIA HLTH SYSTEM, V3; United Nations, 2015, SUST DEV KNOWL PLATF; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WOR HEALT REP, P1; World Bank, INT COMP PROGR DAT; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248518	10.1371/journal.pone.0248518	http://dx.doi.org/10.1371/journal.pone.0248518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788865	Green Published, gold			2022-12-26	WOS:000636354600004
J	Varpio, L; Bader-Larsen, K; Hamwey, M; Durning, S; Meyer, H; Cruthirds, D; Artino, A				Varpio, Lara; Bader-Larsen, Karlen; Hamwey, Meghan; Durning, Steven; Meyer, Holly; Cruthirds, Danette; Artino, Anthony			Delivering patient care during large-scale emergency situations: Lessons from military care providers	PLOS ONE			English	Article							MASS CASUALTY	Background Today, physicians are at the front lines of a pandemic response. Military physicians are uniquely trained to excel in such large-scale emergency situations. Civilian physicians can harness military know-how, but it will require research into military healthcare responses-specifically, we need to learn lessons from military interprofessional healthcare teams (MIHTs). Methods This research answers two questions: What are the characteristics of successful MIHTs? Why are those characteristics important to MIHT success in large-scale emergency situations? Using a Grounded Theory approach, 30 interviews were conducted soliciting perspectives from the broadest range of healthcare professionals who had experiences working in and leading MIHTs. Purposive sampling was used to recruit participants broadly across: contexts where MIHTs work; military branches; ranks; genders; and healthcare professions. Data were iteratively collected and analyzed. Results 30 participants were interviewed (18 male (60%); 21 officers (70%); 9 enlisted (30%)) who held various healthcare occupations (medic/tech/corpsman (9); nurse (7); physician (7); dentist (2); occupational therapist (2); chaplain (1); physician's assistant (1); and psychiatrist (1)). Six characteristics of successful MIHTs that are directly applicable to large-scale emergency situations were identified thatthat clustered into two themes: own your purposes and responsibilities (through mission focus and ethical bearing) and get it done, safely (via situational awareness, adaptability, and leadership with followership). Conclusions This study provides insights, informed by decades of military service and training, to help civilian physicians succeed in large-scale emergency situations. These experiences from the war front can support today's pandemic responses on the home front.	[Varpio, Lara; Durning, Steven] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Bader-Larsen, Karlen; Hamwey, Meghan; Meyer, Holly] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Cruthirds, Danette] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Bethesda, MD 20814 USA; [Artino, Anthony] George Washington Univ, Sch Med & Hlth Sci, Dept Hlth Human Funct & Rehabil Sci, Washington, DC 20052 USA	Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA; George Washington University	Bader-Larsen, K (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	karlen.bader.ctr@usuhs.edu		Bader Larsen, Karlen/0000-0003-3233-8703	Uniformed Services University	Uniformed Services University	This study was funded to LV by the Uniformed Services University (www.usuhs.edu).	[Anonymous], 2019, ACTIVE SHOOTER INCID; Cornett E, 2016, BOARD HLTH SCI POLIC; Crawford Juanita, 2014, Nurs Manage, V45, P30, DOI 10.1097/01.NUMA.0000451999.41720.30; Elster EA, 2013, JAMA-J AM MED ASSOC, V310, P475, DOI 10.1001/jama.2013.167481; Hunt R, 2015, WHITE HOUSE INITIATI; King DR, 2015, J TRAUMA ACUTE CARE, V78, P594, DOI 10.1097/TA.0000000000000561; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Leung C, 2018, J CRIT CARE, V46, P99, DOI 10.1016/j.jcrc.2018.05.001; Lozada MJ, 2019, J TRAUMA ACUTE CARE, V86, P128, DOI 10.1097/TA.0000000000002089; Patton M, 2002, QUALITATIVE RES EVAL, V3rd ed., P339; Pereira BMT, 2010, J CRANIOFAC SURG, V21, P982, DOI 10.1097/SCS.0b013e3181e1e791; RAND Corporation, 2019, DOMESTIC TERRORISM; Raux M, 2019, INTENS CARE MED, V45, P1231, DOI 10.1007/s00134-019-05724-9; Ries J, 2020, THERE ISNT ENOUGH ME; Sohn VY, 2007, J SURG RES, V138, P25, DOI 10.1016/j.jss.2006.09.006; STRUTZEL E, 1968, NURS RES, V17, P364; The Defense Health Agency, MEDICAL ED TRAINING; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tschannen D, 2018, INT J MED EDUC, V9, P182, DOI 10.5116/ijme.5b30.9a84; Varpio L., 2018, MIL MED, V183, P448, DOI [10.1093/milmed/usy08729741728, DOI 10.1093/MILMED/USY08729741728]; Varpio L, 2021, MED TEACH, V43, P32, DOI 10.1080/0142159X.2020.1791318; Varpio L, 2021, J INTERPROF CARE, V35, P55, DOI 10.1080/13561820.2020.1711718	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248286	10.1371/journal.pone.0248286	http://dx.doi.org/10.1371/journal.pone.0248286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788854	gold, Green Published			2022-12-26	WOS:000636354600024
J	Kim, EJ; Ellison, B; McFadden, B; Prescott, MP				Kim, Elizabeth Jiyoon; Ellison, Brenna; McFadden, Brandon; Prescott, Melissa Pflugh			Consumers' decisions to access or avoid added sugars information on the updated Nutrition Facts label	PLOS ONE			English	Article							KNOWLEDGE; PERCEPTIONS; BEHAVIORS; BEVERAGES; ADULTS; PANEL	The Nutrition Facts (NF) label was recently updated and now includes the added sugars content in an effort to reduce added sugars consumption. This study investigated whether consumers wanted to access or avoid the added sugars content using an online experiment and five product categories (yogurt, cereal, fruit juice, snack bar, ice cream). We recruited a sample of 490 U.S. adults (49% female; 73% White/Caucasian). Respondents were randomly assigned to an information treatment (simple or full) before making decisions on whether to access or avoid the added sugars content. The simple information treatment explained that added sugars information was now available on the NF label, while the full information treatment included additional details (e.g., how to interpret the added sugars content and associated diseases). After making the access or avoid decisions for each product category, respondents rated their likelihood of purchase for ten products (two per category). Rates of information avoidance were much lower than what has been observed in previous studies, and rates of avoidance did not vary by information treatment. The majority of respondents (75-87% across the five product categories) preferred to access the added sugars content. Still, we found some consumers preferred to avoid this information, with higher rates of avoidance for the ice cream product category. Additionally, we found significant differences in likelihood of purchase ratings between information accessors and avoiders. Respondents who chose to access the added sugars information exhibited healthier purchasing behaviors for all product categories; they were more likely to purchase low added sugars products and less likely to purchase high added sugars products relative to information avoiders. Given consumers' demonstrated interest in accessing the added sugars content, it is important that the new changes to the NF label be broadly communicated to promote healthy eating behaviors.	[Kim, Elizabeth Jiyoon; Ellison, Brenna] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA; [McFadden, Brandon] Univ Delaware, Dept Appl Econ & Stat, Newark, DE USA; [Prescott, Melissa Pflugh] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Delaware; University of Illinois System; University of Illinois Urbana-Champaign	Ellison, B (corresponding author), Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA.	brennae@illinois.edu		Ellison, Brenna/0000-0002-4042-0056	National Institute of Food and Agriculture, U.S. Department of Agriculture at the University of Illinois at Urbana-Champaign [ILLU-470-334]	National Institute of Food and Agriculture, U.S. Department of Agriculture at the University of Illinois at Urbana-Champaign	This research was supported by funding from the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number ILLU-470-334 at the University of Illinois at Urbana-Champaign (BE). USDA was not involved in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bailey RL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010102; Centers for Disease Control and Prevention (CDC), 2020, PREVALENCE OVERWEIGH; Cho C., 2018, USDA EC RES SERVICE, V196; Food and Drug Administration (FDA), 2020, ADD SUG NEW NUTR FAC; Food and Drug Administration (FDA), 2020, NEW NUTR FACTS LAB W; Food and Drug Administration (FDA), 2015, FED REG, P44303; Food and Drug Administration HHS, 2016, Fed Regist, V81, P33741; Golman R, 2017, J ECON LIT, V55, P96, DOI 10.1257/jel.20151245; Grebitus C, 2017, FOOD POLICY, V73, P119, DOI 10.1016/j.foodpol.2017.10.002; Greene W.H., 2003, ECONOMETRIC ANAL, P07458; GUTHRIE JF, 1995, J NUTR EDUC, V27, P163, DOI 10.1016/S0022-3182(12)80422-5; Hales Craig M, 2017, NCHS Data Brief, P1; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Khandpur N, 2020, J ACAD NUTR DIET, V120, P197, DOI 10.1016/j.jand.2019.10.008; Khandpur N, 2017, APPETITE, V114, P38, DOI 10.1016/j.appet.2017.03.015; Kim EJ, 2021, AM J HEALTH PROMOT, V35, P648, DOI 10.1177/0890117120983128; Laquatra I, 2015, J ACAD NUTR DIET, V115, P1758, DOI 10.1016/j.jand.2015.04.017; Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6; Neuhofer Z, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100867; Ollberding NJ, 2011, J AM DIET ASSOC, V111, pS47, DOI 10.1016/j.jada.2011.03.009; Palan S, 2018, J BEHAV EXP FINANC, V17, P22, DOI 10.1016/j.jbef.2017.12.004; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Rampersaud GC, 2014, NUTR RES, V34, P134, DOI 10.1016/j.nutres.2013.11.004; Rivard C, 2012, PUBLIC HEALTH NUTR, V15, P1355, DOI 10.1017/S1368980011002898; Speirs KE, 2012, J HEALTH CARE POOR U, V23, P1082, DOI 10.1353/hpu.2012.0113; Sweeny K, 2010, REV GEN PSYCHOL, V14, P340, DOI 10.1037/a0021288; Thunstrom L, 2019, JUDGM DECIS MAK, V14, P11; Thunstrom L, 2016, J RISK UNCERTAINTY, V52, P117, DOI 10.1007/s11166-016-9236-9; Tierney M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010037; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20, V9th; United States Census Bureau, 2021, J WOMENS HEALTH; Weaver D, 2003, FOOD POLICY, V28, P213, DOI 10.1016/S0306-9192(03)00028-9	32	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0249355	10.1371/journal.pone.0249355	http://dx.doi.org/10.1371/journal.pone.0249355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780506	gold, Green Published			2022-12-26	WOS:000636336800044
J	Zhang, ZY; Zhou, Q; Liu, R; Liu, L; Shen, WJ; Azhar, S; Qu, YF; Guo, ZG; Hu, ZG				Zhang, Ziyu; Zhou, Qian; Liu, Rui; Liu, Li; Shen, Wen-Jun; Azhar, Salman; Qu, Yan-Fu; Guo, Zhigang; Hu, Zhigang			The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; PDZ DOMAIN PROTEIN; SR-BI; LIPOPROTEIN; HDL; METABOLISM; EXPRESSION; TRANSPORT	The scavenger receptor class B type 1 (SR-B1), a high-density lipoprotein (HDL) receptor, is a membrane glycoprotein that mediates selective uptake of HDL-cholesterol and cholesterol ester (CE) into cells. SR-B1 is subject to posttranslational regulation; however, the underlying mechanisms still remain obscure. Here, we identified a novel SR-B1-interacting protein, GIPC1 (GAIP-interacting protein, C terminus 1) that interacts with SR-B1 and stabilizes SR-B1 by negative regulation of its proteasomal and lysosomal degradation pathways. The physiological interaction between SR-B1 and GIPC1 was supported by co-immunoprecipitation of wild-type and mutant GIPC1 constructs in SR-B1 +/- GIPC1 overexpressing cells, in native liver cells, and in mouse liver tissues. Overexpression of GIPC1 increased endogenous SR-B1 protein levels, subsequently increasing selective HDL-cholesterol/CE uptake and cellular triglyceride (TG) and total cholesterol (TC) levels, whereas silencing of GIPC1 in the mouse liver was associated with blunted hepatic SR-B1 levels, elevated plasma TG and TC, and attenuated hepatic TG and TC content. A positive correlation was identified between GIPC1 and SR-B1 expression, and both expressions of GIPC1 and SR-B1 from human liver samples were inversely correlated with body mass index (BMI) from human subjects. We therefore conclude that GIPC1 plays a key role in the stability and function of SR-B1 and can also effectively regulate hepatic lipid and cholesterol metabolism. These findings expand our knowledge of the regulatory roles of GIPC1 and suggest that GIPC1 exerts a major effect on cell surface receptors such as SR-B1 and its associated hepatic lipid and cholesterol metabolic processes.	[Zhang, Ziyu; Zhou, Qian; Liu, Rui; Qu, Yan-Fu; Guo, Zhigang; Hu, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China; [Liu, Li] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Peoples R China; [Shen, Wen-Jun; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Shen, Wen-Jun; Azhar, Salman] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA	Nanjing Normal University; Nanjing Medical University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hu, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China.	huzg_2000@126.com		Shen, Wen-Jun/0000-0001-5150-1698	Natural Science Fund of Colleges and Universities in Jiangsu Province [19KJA180010]; National Natural Science Foundation of China [31400659]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Fund of Colleges and Universities in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by Natural Science Fund of Colleges and Universities in Jiangsu Province (19KJA180010), National Natural Science Foundation of China (31400659) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Carretero-Ortega J, 2019, ELIFE, V8, DOI 10.7554/eLife.30454; Cui XW, 2018, J BIOL CHEM, V293, P4097, DOI 10.1074/jbc.M117.812818; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Gutierrez-Pajares JL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00338; Hu ZG, 2016, DNA CELL BIOL, V35, P280, DOI 10.1089/dna.2015.3185; Hu ZG, 2015, BIOCHEMISTRY-US, V54, P6917, DOI 10.1021/acs.biochem.5b00147; Hu ZG, 2013, J BIOL CHEM, V288, P11416, DOI 10.1074/jbc.M112.437368; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Katoh M, 2002, INT J MOL MED, V9, P585; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Kent AP, 2011, HEPATIC MED-EVID RES, V3, P29, DOI 10.2147/HMER.S7860; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Langlois AC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70468-2; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Liu R, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158640; Lu X, 2017, BIOCHEM BIOPH RES CO, V490, P1168, DOI 10.1016/j.bbrc.2017.06.175; Mizutani T, 2000, J BIOL CHEM, V275, P22512, DOI 10.1074/jbc.M001631200; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Rajora MA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00326; Ren K, 2018, ATHEROSCLEROSIS, V270, P57, DOI 10.1016/j.atherosclerosis.2018.01.045; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen WJ, 2018, J LIPID RES, V59, P1114, DOI 10.1194/jlr.R083121; Shen WJ, 2018, ANNU REV PHYSIOL, V80, P95, DOI 10.1146/annurev-physiol-021317-121550; Shen WJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00042; Shen WJ, 2014, METABOLISM, V63, P875, DOI 10.1016/j.metabol.2014.03.011; Trigatti BL, 2017, CURR OPIN LIPIDOL, V28, P201, DOI 10.1097/MOL.0000000000000396; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Tsugita M, 2017, CELL REP, V18, P1298, DOI 10.1016/j.celrep.2017.01.004; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wang MN, 2018, GENE, V668, P196, DOI 10.1016/j.gene.2018.05.072; Wang W, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158554; Wei CW, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00324-0; Westhaus S, 2017, J HEPATOL, V67, P237, DOI 10.1016/j.jhep.2017.03.020; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007	38	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100616	10.1016/j.jbc.2021.100616	http://dx.doi.org/10.1016/j.jbc.2021.100616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811857	gold, Green Published			2022-12-26	WOS:000672866400587
J	Hanna, AD; Lee, CS; Babcock, L; Wang, H; Recio, J; Hamilton, SL				Hanna, Amy D.; Lee, Chang Seok; Babcock, Lyle; Wang, Hui; Recio, Joseph; Hamilton, Susan L.			Pathological mechanisms of vacuolar aggregate myopathy arising from a Casq1 mutation	FASEB JOURNAL			English	Article						calsequestrin; EC coupling; ER stress; myopathy; sarcoplasmic reticulum	SARCOPLASMIC-RETICULUM CONNECTION; INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; PROTEASOME INHIBITION; PROTEIN-SYNTHESIS; ER-STRESS; CALSEQUESTRIN; CA2+; CALCIUM	Mice with a mutation (D244G, DG) in calsequestrin 1 (CASQ1), analogous to a human mutation in CASQ1 associated with a delayed onset human myopathy (vacuolar aggregate myopathy), display a progressive myopathy characterized by decreased activity, decreased ability of fast twitch muscles to generate force and low body weight after one year of age. The DG mutation causes CASQ1 to partially dissociate from the junctional sarcoplasmic reticulum (SR) and accumulate in the endoplasmic reticulum (ER). Decreased junctional CASQ1 reduces SR Ca2+ release. Muscles from older DG mice display ER stress, ER expansion, increased mTOR signaling, inadequate clearance of aggregated proteins by the proteasomes, and elevation of protein aggregates and lysosomes. This study suggests that the myopathy associated with the D244G mutation in CASQ1 is driven by CASQ1 mislocalization, reduced SR Ca2+ release, CASQ1 misfolding/aggregation and ER stress. The subsequent maladaptive increase in protein synthesis and decreased protein aggregate clearance are likely to contribute to disease progression.	[Hanna, Amy D.; Lee, Chang Seok; Babcock, Lyle; Wang, Hui; Recio, Joseph; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA	Baylor College of Medicine	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.	susanh@bcm.edu	Wang, Hui J./AAT-7096-2020	Wang, Hui J./0000-0003-2654-0243; Hanna, Amy/0000-0001-6418-6666	Muscular Dystrophy Association (MDA) [548809]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [NIH AR072475, NIH AR053349]; HHS | National Institutes of Health (NIH) [T32HL007676]	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Muscular Dystrophy Association (MDA), Grant/Award Number: 548809; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: NIH AR072475 and NIH AR053349; HHS | National Institutes of Health (NIH), Grant/Award Number: T32HL007676	An H, 2019, MOL CELL, V74, P891, DOI 10.1016/j.molcel.2019.03.034; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Babcock LW, 2011, J GEN PHYSIOL; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bohm J, 2018, ACTA NEUROPATHOL, V135, P149, DOI 10.1007/s00401-017-1775-x; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Di Blasi C, 2015, J MED GENET, V52, P617, DOI 10.1136/jmedgenet-2014-102882; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; Fuqua JD, 2019, FASEB J, V33, P11735, DOI 10.1096/fj.201900766R; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Goebel HH, 2000, MOL GENET METAB, V71, P267, DOI 10.1006/mgme.2000.3064; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Kaakinen M, 2008, EXP CELL RES, V314, P237, DOI 10.1016/j.yexcr.2007.10.009; Kaisto T, 2003, EXP CELL RES, V289, P47, DOI 10.1016/S0014-4827(03)00231-3; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Lamboley CR, 2013, J PHYSIOL-LONDON, V591, P6053, DOI 10.1113/jphysiol.2013.265900; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Lavorato M, 2017, MICROS TODAY, V25, P40; Lee CS, 2014, J BIOL CHEM, V289, P25556, DOI 10.1074/jbc.M114.586289; Lee CY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15502; Lewis KM, 2015, J BIOL CHEM, V290, P28665, DOI 10.1074/jbc.M115.686261; Manno C, 2017, P NATL ACAD SCI USA, V114, pE638, DOI 10.1073/pnas.1620265114; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michelucci A, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.202012617; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Rossi D, 2008, TRAFFIC, V9, P1044, DOI 10.1111/j.1600-0854.2008.00717.x; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Samant RS, 2018, NATURE, V563, P407, DOI 10.1038/s41586-018-0678-x; Sanchez EJ, 2012, J BIOL CHEM, V287, P3042, DOI 10.1074/jbc.M111.326363; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Semplicini C, 2018, NEUROLOGY, V91, pE1629, DOI 10.1212/WNL.0000000000006387; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Tomelleri G, 2006, BRAIN, V129, P2085, DOI 10.1093/brain/awl128; VILLA A, 1993, EXP CELL RES, V209, P140, DOI 10.1006/excr.1993.1294; VOLPE P, 1992, P NATL ACAD SCI USA, V89, P6142, DOI 10.1073/pnas.89.13.6142; Wang HY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17937-4; Wang LM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11349; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zito E, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101232	71	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21349	10.1096/fj.202001653RR	http://dx.doi.org/10.1096/fj.202001653RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33786938	Green Accepted			2022-12-26	WOS:000645260100030
J	Tan, F; Rui, XQ; Xiang, X; Yu, ZR; Al-Rubeai, M				Tan, Fei; Rui, Xiaoqing; Xiang, Xue; Yu, Zuoren; Al-Rubeai, Mohamed			Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration	FASEB JOURNAL			English	Article						angiogenesis; atmospheric plasma; cell attachment; cell differentiation; cell migration; cell proliferation; cold plasma; EA.hy926; FGF; L-929; neurogenesis; neurite; nonthermal plasma; osteogenesis; PC-12; plasma-activated medium; plasma medicine; Saos-2; wound healing	ESTROGEN-RECEPTOR-ALPHA; OVIDUCTAL TRANSPORT; FACTOR-I; CELL; PROTEIN; EXPRESSION; ESTRADIOL; PROLIFERATION; HYDROSALPINX; DISRUPTION	Cold atmospheric plasma (CAP) is an emerging technology for biomedical applications, exemplified by its antimicrobial and antineoplastic potentials. On the contrary, acidic fibroblast growth factor (aFGF) has been a long-standing potent mitogen for cells from various origins. In this study, we are the first to develop a multimodal treatment combining the aforementioned physicochemical and pharmacological treatments and investigated their individual and combined effects on wound healing, angiogenesis, neurogenesis, and osteogenesis. This work was performed at the tissue, cellular, protein, and gene levels, using histochemical staining, flow cytometry, ELISA, and PCR, respectively. Depending on the type of target tissue, various combinations of aforementioned methods were used. The results showed that the enhancement on would healing and angiogenesis by CAP and aFGF were synergistic. The former was manifested by increased murine fibroblast proliferation and reduced cutaneous tissue inflammation, whereas the latter by upregulated proangiogenic markers in vivo, for example, CD31, VEGF, and TGF-beta, and downregulated antiangiogenic proteins in vitro, for example, angiostatin and angiopoietin-2, respectively. In addition, aFGF outperformed CAP during neurogenesis, which was evidenced by superior neurite outgrowth, while CAP exceeded aFGF in osteogenesis which was demonstrated by more substantial bone nodule formation. These novel findings not only support the fact that CAP and aFGF are both multipotent agents during tissue regeneration, but also highlight the potential of our multimodal treatment combining the individual advantages of CAP and aFGF. The versatile administration route, that is, topical and/or systemic, might further broaden its applications.	[Tan, Fei; Rui, Xiaoqing] Shanghai East Hosp, Dept ORL HNS, Shanghai, Peoples R China; [Tan, Fei; Yu, Zuoren] Tongji Univ, Sch Med, Shanghai, Peoples R China; [Tan, Fei] Royal Coll Surgeons England, London, England; [Xiang, Xue; Yu, Zuoren] Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China; [Al-Rubeai, Mohamed] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland	Tongji University; Royal College of Surgeons of England; University College Dublin	Tan, F (corresponding author), Shanghai East Hosp, Dept ORL HNS, Shanghai, Peoples R China.	iatrologist@163.com		Tan, Fei/0000-0003-1010-0163	Fundamental Research Funds for the Central Universities; Shanghai Pujiang Program [19PJ1408800]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work is sponsored by the Fundamental Research Funds for the Central Universities. It is also sponsored by Shanghai Pujiang Program (project no. 19PJ1408800).	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Alminana C, 2017, REPRODUCTION, V154, P253, DOI 10.1530/REP-17-0054; Barton BE, 2020, REPRODUCTION, V159, pR125, DOI 10.1530/REP-19-0189; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Beyler SA, 1997, HUM REPROD, V12, P2724, DOI 10.1093/humrep/12.12.2724; Bonilla AQS, 2011, MOL CELL ENDOCRINOL, V332, P170, DOI 10.1016/j.mce.2010.10.009; Borel F, 2018, P NATL ACAD SCI USA, V115, P2788, DOI 10.1073/pnas.1713689115; BRENNER RM, 1969, FERTIL STERIL, V20, P599; Chronopoulou E, 2015, HUM REPROD UPDATE, V21, P39, DOI 10.1093/humupd/dmu040; Croxatto H.B., 1991, ARCH BIOL MED EXP, V24, P403; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; DOHERTY AS, 1994, MOL REPROD DEV, V37, P21, DOI 10.1002/mrd.1080370104; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Ford MJ., 2020, OVIDUCT EPITHELIAL C, DOI [10.1101/2020.08.21.261016, DOI 10.1101/2020.08.21.261016]; FREEMAN DA, 1992, J REPROD FERTIL, V95, P535, DOI 10.1530/jrf.0.0950535; Harris EA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218280; HARVEY MB, 1992, MECH DEVELOP, V38, P169, DOI 10.1016/0925-4773(92)90050-T; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hong SH, 2004, MOL CELLS, V17, P477; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Lee KF, 2006, ENDOCRINOLOGY, V147, P79, DOI 10.1210/en.2005-0596; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; Li S, 2017, FASEB J, V31, P1595, DOI 10.1096/fj.201601128R; Li S, 2017, J ENDOCRINOL, V232, pR1, DOI [10.1530/JOE-16-0302, 10.1530/joe-16-0302]; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; McInnes L, UMAP UNIFORM MANIFOL; Mukherjee T, 1996, FERTIL STERIL, V66, P851, DOI 10.1016/S0015-0282(16)58652-X; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Orihuela PA, 2003, BIOL REPROD, V68, P1225, DOI 10.1095/biolreprod.102.011395; Orihuela PA, 2001, BIOL REPROD, V65, P1238, DOI 10.1095/biolreprod65.4.1238; Orostica ML, 2014, REPRODUCTION, V148, P285, DOI 10.1530/REP-14-0128; ORTIZ ME, 1989, BIOL REPROD, V41, P381, DOI 10.1095/biolreprod41.3.381; ORTIZ ME, 1986, BIOL REPROD, V34, P777, DOI 10.1095/biolreprod34.4.777; Ozmen B, 2007, REPROD BIOMED ONLINE, V14, P235, DOI 10.1016/S1472-6483(10)60792-4; Pillai VV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188105; Polanski K, 2020, BIOINFORMATICS, V36, P964, DOI 10.1093/bioinformatics/btz625; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Reuquen P, 2015, REPRODUCTION, V150, P331, DOI 10.1530/REP-15-0137; Saraiya M, 1998, AM J OBSTET GYNECOL, V178, P493, DOI 10.1016/S0002-9378(98)70427-2; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Velazquez MA, 2012, THERIOGENOLOGY, V78, P517, DOI 10.1016/j.theriogenology.2012.02.034; Velazquez MA, 2009, REPRODUCTION, V137, P161, DOI 10.1530/REP-08-0362; WEBER JA, 1991, BIOL REPROD, V45, P540, DOI 10.1095/biolreprod45.4.540; WEBER JA, 1991, BIOL REPROD, V45, P544, DOI 10.1095/biolreprod45.4.544; Winuthayanon W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07728-1; Winuthayanon W, 2015, ELIFE, V4, DOI 10.7554/eLife.10453; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wolf A., SCANPY TUTORIALS; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	59	4	4	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21442	10.1096/fj.202002611R	http://dx.doi.org/10.1096/fj.202002611R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774850				2022-12-26	WOS:000645260100071
J	Bozinovic, G; Shea, D; Feng, ZY; Hinton, D; Sit, T; Oleksiak, MF				Bozinovic, Goran; Shea, Damian; Feng, Zuying; Hinton, David; Sit, Tim; Oleksiak, Marjorie F.			PAH-pollution effects on sensitive and resistant embryos: Integrating structure and function with gene expression	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PERSISTENT ORGANIC POLLUTANTS; SEMIPERMEABLE-MEMBRANE DEVICES; FUNDULUS-HETEROCLITUS; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL-POLLUTANTS; TUMOR-SUPPRESSOR; BIRTH OUTCOMES; DNA-ADDUCTS; EXPOSURE	Polycyclic aromatic hydrocarbons (PAHs) are among the most widespread natural and anthropogenic pollutants, and some PAHs are proven developmental toxicants. We chemically characterized clean and heavily polluted sites and exposed fish embryos to PAH polluted sediment extracts during four critical developmental stages. Embryos were collected from Fundulus heteroclitus populations inhabiting the clean and heavily polluted Superfund estuary. Embryos of parents from the clean sites are sensitive to PAH pollutants while those of parents from the heavily polluted site are resistant. Chemical analysis of embryos suggests PAH accumulation and pollution-induced toxicity among sensitive embryos during development that ultimately kills all sensitive embryos before hatching, while remarkably, the resistant embryos develop normally. The adverse effects on sensitive embryos are manifested as developmental delays, reduced heart rates, and severe heart, liver, and kidney morphological abnormalities. Gene expression analysis of early somitogenesis, heartbeat initiation, late organogenesis, and pre-hatching developmental stages reveals genes whose expression significantly differs between sensitive and resistant embryo populations and helps to explain mechanisms of sensitivity and resistance to polluted environments during vertebrate animal development.	[Bozinovic, Goran; Shea, Damian; Oleksiak, Marjorie F.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Bozinovic, Goran; Feng, Zuying] Boz Life Sci Res & Teaching Inst, San Diego, CA 92109 USA; [Hinton, David] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Sit, Tim] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA; [Bozinovic, Goran] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Oleksiak, Marjorie F.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of North Carolina; North Carolina State University; Duke University; University of North Carolina; North Carolina State University; University of California System; University of California San Diego; University of Miami	Bozinovic, G (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Bozinovic, G (corresponding author), Boz Life Sci Res & Teaching Inst, San Diego, CA 92109 USA.; Bozinovic, G (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	gbozinovic@ucsd.edu	; Shea, Damian/K-1360-2014	Feng, Zuying/0000-0002-3314-7418; Bozinovic, Goran/0000-0001-8934-7884; Shea, Damian/0000-0003-1348-6639; Sit, Tim/0000-0001-7302-823X	National Institute of Health [R01 ES011588, P42 ES007381, 2P42 ES010356]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health grants R01 ES011588 and P42 ES007381 to MFO and 2P42 ES010356 to MFO and RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden R.W, 1995, REGIONAL ACTION PLAN; Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; ARMSTRON.PB, 1965, BIOL BULL, V128, P143, DOI 10.2307/1539545; Bozinovic G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-779; Bozinovic G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-132; Bozinovic G, 2011, ENVIRON TOXICOL CHEM, V30, P283, DOI 10.1002/etc.403; Bozinovic G, 2010, AQUAT TOXICOL, V98, P221, DOI 10.1016/j.aquatox.2010.02.022; Darras VM, 2008, CEREBELLUM, V7, P26, DOI 10.1007/s12311-008-0004-5; Daugulis AJ, 2003, BIOTECHNOL LETT, V25, P1441, DOI 10.1023/A:1025007729355; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Gonzalez JF, 2009, MAR ENVIRON RES, V67, P183, DOI 10.1016/j.marenvres.2009.01.002; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Greaves J, 1990, ELIZABETH RIVER LONG, V222; Hertz-Picciotto I, 2008, BASIC CLIN PHARMACOL, V102, P146, DOI 10.1111/j.1742-7843.2007.00190.x; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Hofelt CS, 1997, ENVIRON SCI TECHNOL, V31, P154, DOI 10.1021/es9602509; Holm J, 2005, ENVIRON TOXICOL CHEM, V24, P2373, DOI 10.1897/04-402R1.1; Iconomidou VA, 2000, J STRUCT BIOL, V132, P112, DOI 10.1006/jsbi.2000.4307; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Jacobson JL, 1997, NEUROTOXICOLOGY, V18, P415; JACOBSON JL, 1990, NEUROTOXICOL TERATOL, V12, P319, DOI 10.1016/0892-0362(90)90050-M; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2001, GENET RES, V77, P123; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; LANDRUM PF, 1991, ENVIRON TOXICOL CHEM, V10, P35, DOI 10.1002/etc.5620100105; Lauenborg B, 2010, APMIS, V118, P719, DOI 10.1111/j.1600-0463.2010.02669.x; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lim S, 2010, ANN NY ACAD SCI, V1201, P166, DOI 10.1111/j.1749-6632.2010.05622.x; Luellen DR, 2002, ENVIRON SCI TECHNOL, V36, P1791, DOI 10.1021/es0113504; Meyer JN, 2003, ECOL APPL, V13, P490, DOI 10.1890/1051-0761(2003)013[0490:HAAFCI]2.0.CO;2; Meyer JN, 2002, TOXICOL SCI, V68, P69, DOI 10.1093/toxsci/68.1.69; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nakai K, 2004, TOHOKU J EXP MED, V202, P227, DOI 10.1620/tjem.202.227; Nock NL, 2007, CANCER EPIDEM BIOMAR, V16, P1236, DOI 10.1158/1055-9965.EPI-06-0736; Ownby DR, 2002, ENVIRON TOXICOL CHEM, V21, P1897, DOI 10.1897/1551-5028(2002)021&lt;1897:FFHPWD&gt;2.0.CO;2; Patandin S, 1998, PEDIATR RES, V44, P538, DOI 10.1203/00006450-199810000-00012; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perera FP, 1999, ENVIRON HEALTH PERSP, V107, P451, DOI 10.1289/ehp.99107s3451; Perera FP, 2011, ENVIRON HEALTH PERSP, V119, P1176, DOI 10.1289/ehp.1002705; Powell WH, 2000, TOXICOL SCI, V57, P229, DOI 10.1093/toxsci/57.2.229; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; RICE JM, 1982, ANN NY ACAD SCI, V381, P274, DOI 10.1111/j.1749-6632.1982.tb50392.x; Shi Z, 2015, ONCOGENE, V34, P2538, DOI 10.1038/onc.2014.171; Tan J, 2009, CHEMOSPHERE, V74, P428, DOI 10.1016/j.chemosphere.2008.09.045; Thorsen WA, 2004, ENVIRON SCI TECHNOL, V38, P2029, DOI 10.1021/es0306056; USEPA, 2007, EC SOIL SCREEN LEV P, P7; Vasseur P, 2006, CHEMOSPHERE, V62, P1033, DOI 10.1016/j.chemosphere.2005.05.043; Vesselinovitch S D, 1979, Natl Cancer Inst Monogr, P239; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Wang L, 2010, AQUAT TOXICOL, V99, P439, DOI 10.1016/j.aquatox.2010.06.002; WEIS P, 1977, TERATOLOGY, V16, P317, DOI 10.1002/tera.1420160311; Weisbrod AV, 2001, MAR ENVIRON RES, V51, P29, DOI 10.1016/S0141-1136(00)00032-5; Weisbrod AV, 2000, ENVIRON TOXICOL CHEM, V19, P667, DOI [10.1897/1551-5028(2000)019<0667:BPOPBA>2.3.CO;2, 10.1897/1551-5028(2000)019&lt;0667:BPOPBA&gt;2.3.CO;2, 10.1002/etc.5620190319]; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Xu XL, 2016, SCI CHINA LIFE SCI, V59, P656, DOI 10.1007/s11427-016-0018-0	66	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249432	10.1371/journal.pone.0249432	http://dx.doi.org/10.1371/journal.pone.0249432			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822796	gold, Green Published			2022-12-26	WOS:000637879100031
J	Gao, YP; Xu, XF; Wei, Y				Gao, Yanpeng; Xu, Xiaofei; Wei, Ye			Analysis on the imbalance of population flow network during the Spring Festival travel rush in China in 2015	PLOS ONE			English	Article							FLOATING POPULATION; EQUILIBRIUM; MIGRATION; DISEQUILIBRIUM; PATTERN	This paper analyzes the imbalance of interprovincial population flow during the Spring Festival travel rush in China, using big data obtained through Baidu Migration, in terms of population flow during the festival and the normalized unbalanced coefficients of edge and node method for analysis, from which the following findings emerge: (1). The imbalance in population flow network during the Spring Festival travel rush is significant, with unbalanced coefficients and relevant frequencies of the population flow network in the Eastern and Western Regions being significantly higher than in other regions. The unbalanced coefficients in the Central Region are lower, followed by corresponding frequencies, while the unbalanced coefficients in the Northeast Region are evenly distributed with the lowest frequencies. The population flow toward the West and Northwest are relatively concentrated, while the population flow toward the South and Southwest are relatively scattered. (2). The regional imbalance during the Spring Festival travel rush has characteristics of spatial agglomeration, where a strongly-connected Southeast Subsystem and a weakly-connected Western Subsystem are formed; there is a significant leverage effect in Guangdong Province, which greatly affects the regional imbalance. Three characteristics emerge in the distribution of regional population flow-the outflow, inflow, and outflow along the Eastern, Central and Western strips/lines, respectively. The paper emphasizes the importance of researching imbalance issues, clarifies the difference between the imbalance of the population flow network and the imbalance involved in previous population research fields, and discusses the Spring Festival Effect in terms of population flow and deficiencies in research.	[Gao, Yanpeng] Northeastern Univ, Sch Architecture, Shenyang, Liaoning, Peoples R China; [Xu, Xiaofei] Northeastern Univ, Grammar Sch, Shenyang, Liaoning, Peoples R China; [Wei, Ye] Northeast Normal Univ, Sch Geog Sci, Changchun, Jilin, Peoples R China	Northeastern University - China; Northeastern University - China; Northeast Normal University - China	Xu, XF (corresponding author), Northeastern Univ, Grammar Sch, Shenyang, Liaoning, Peoples R China.	442964430@qq.com		WEI, YE/0000-0001-8931-0926				BRENNAN EM, 1989, INT REGIONAL SCI REV, V12, P117, DOI 10.1177/016001768901200201; Cao Z, 2018, HABITAT INT, V82, P72, DOI 10.1016/j.habitatint.2018.09.006; [陈明星 Chen Mingxing], 2021, [地理科学进展, Progress in Geography], V40, P50; Chen MX, 2019, J GEOGR SCI, V29, P1681, DOI 10.1007/s11442-019-1685-z; [段平忠 Duan Pingzhong], 2008, [中国人口·资源与环境, China Population·Resources and Environment], V18, P27; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; HARRIGAN FJ, 1993, J REGIONAL SCI, V33, P49, DOI 10.1111/j.1467-9787.1993.tb00210.x; HUNT GL, 1993, REG STUD, V27, P341, DOI 10.1080/00343409312331347605; Jin SH, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104070; Lessmann C, 2014, J DEV ECON, V106, P35, DOI 10.1016/j.jdeveco.2013.08.011; Li D, 2017, BIG DATA SUPPORT URB, P63, DOI [10.1007/978-3-319-51929-6%5F4, DOI 10.1007/978-3-319-51929-6%5F4]; Li XL, 2016, INT J RES SOCIAL SCI, V6; Li Y., COMPUT ENVIRON URBAN, P80; Liang Z, 2004, POPUL DEV REV, V30, P467, DOI 10.1111/j.1728-4457.2004.00024.x; Liu SH, 2011, J GEOGR SCI, V21, P35, DOI 10.1007/s11442-011-0827-8; Pan JH, 2019, CITIES, V94, P55, DOI 10.1016/j.cities.2019.05.022; Salvati L, 2016, LAND USE POLICY, V51, P229, DOI 10.1016/j.landusepol.2015.11.013; SCHACHTER J, 1989, J REGIONAL SCI, V29, P143, DOI 10.1111/j.1467-9787.1989.tb01229.x; Shen JF, 1996, PROG PLANN, V45, P125, DOI 10.1016/0305-9006(96)00002-5; Wang G., 2016, CHINA POPULATION TOD, V33, P39; Wei Y, 2018, APPL GEOGR, V96, P77, DOI 10.1016/j.apgeog.2018.05.009; [薛冰 Xue Bing], 2019, [地理与地理信息科学, Geography and Geo-information Science], V35, P51; Yang J, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082943; Yang J, 2018, CHINESE GEOGR SCI, V28, P505, DOI 10.1007/s11769-018-0954-6	24	1	1	11	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249520	10.1371/journal.pone.0249520	http://dx.doi.org/10.1371/journal.pone.0249520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ5NA	33819315	Green Published, gold			2022-12-26	WOS:000637647200016
J	Anders, P; Song, XF; Gyorgy, B; Szentmary, N; Seitz, B; Gatzioufas, Z				Anders, Philipp; Song, Xuefei; Gyorgy, Bence; Szentmary, Nora; Seitz, Berthold; Gatzioufas, Zisis			Effect of prolactin on normal and keratoconus human corneal stromal fibroblasts in vitro	PLOS ONE			English	Article								Purpose To examine the effect of prolactin (PRL) on human corneal stromal fibroblasts (CSFs), derived from healthy individuals and from keratoconus (KC) patients, in vitro, specifically assessing physiological and elevated PRL concentrations as apparent during pregnancy. Methods Eye bank corneas of 3 female and 3 male healthy individuals as well as the corneal buttons of 3 female and 3 male KC patients were utilized for this study. The endothelium of the cornea was removed with sterile surgical scalpels, the probes were washed repeatedly with Dulbecco's PBS and corneoscleral rims were trimmed off. Subsequently the corneal stroma was digested with collagenase type I and the harvested CSFs were cultured. We then examined (1) cell proliferation, (2) cell viability and (3) cytokine release of CSFs upon exposure to prolactin in vitro. Results With respect to viability and proliferation our experiments did not show significant differences between CSFs exposed to different PRL concentrations. Our data show a significantly lower IL-8 concentration in normal CSFs exposed to 10ng/ml PRL compared to 0ng/ml and 1000ng/ml at 5 hours post exposition. Moreover, we can report significantly lower secretion of IL-8, IL-6, HGF, VEGF and FGFb in KC CSFs compared to normal CSFs, independent of PRL exposure, as determined by cytokine ELISA. Conclusion Our data in part points towards corneal cytokine secretion as a possible link between altered stromal PRL concentrations and KC progression. However, in our small dataset a significant influence of PRL concentration on cytokine secretion can only be described for IL-8 in normal CSFs. Further our results contribute to existing reports on the importance of cytokines in KC development, with an emphasis on significantly lower cytokine secretion in KC CSFs compared to normal controls.	[Anders, Philipp; Gyorgy, Bence; Gatzioufas, Zisis] Univ Hosp Basel, Dept Ophthalmol, Basel, Switzerland; [Anders, Philipp; Gyorgy, Bence] Inst Mol & Clin Ophthalmol Basel, Basel, Switzerland; [Song, Xuefei] Shanghai Ninth Peoples Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Song, Xuefei; Seitz, Berthold] Saarland Univ, Med Ctr, Dept Ophthalmol, Homburg, Germany; [Szentmary, Nora] Saarland Univ, Dr Rolf M Schwiete Ctr Limbal Stem Cell Deficienc, Homburg, Germany	University of Basel; Shanghai Jiao Tong University; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Anders, P (corresponding author), Univ Hosp Basel, Dept Ophthalmol, Basel, Switzerland.; Anders, P (corresponding author), Inst Mol & Clin Ophthalmol Basel, Basel, Switzerland.	philipp.niggemann@usb.ch	Szentmary, Nora/AAE-7643-2022; Seitz, Berthold/AAB-8546-2019	Anders, Philipp/0000-0003-1690-9043; Seitz, Berthold/0000-0001-9701-8204				Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Baniwal SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062361; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; El-Massry A, 2020, J REFRACT SURG, V36, P253, DOI 10.3928/1081597X-20200226-03; Engler C, 2011, AM J OPHTHALMOL, V151, P752, DOI 10.1016/j.ajo.2010.11.008; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; Gatzioufas Z, 2008, J ENDOCRINOL INVEST, V31, P262, DOI 10.1007/BF03345600; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P497, DOI 10.1111/j.1365-2826.2008.01661.x; Grossman A., 2000, ENDOTEXT; Hanet MS, 2018, J OPHTHALMIC INFLAMM, V8, DOI 10.1186/s12348-018-0146-7; Hoogewoud F, 2013, J REFRACT SURG, V29, P144, DOI 10.3928/1081597X-20130117-11; Ionescu IC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4285268; Khaled ML, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7803029; Loh IP, 2022, OCUL IMMUNOL INFLAMM, V30, P246, DOI 10.1080/09273948.2020.1780271; MAURICE DM, 1994, EXP EYE RES, V58, P409, DOI 10.1006/exer.1994.1033; McKay TB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25534; Myrna KE, 2009, VET OPHTHALMOL, V12, P25, DOI 10.1111/j.1463-5224.2009.00742.x; Naderan M, 2017, ACTA OPHTHALMOL, V95, pE291, DOI 10.1111/aos.13296; Padmanabhan P, 2010, CORNEA, V29, P569, DOI 10.1097/ICO.0b013e3181bd9f2d; Pahuja N, 2016, INVEST OPHTH VIS SCI, V57, P5372, DOI 10.1167/iovs.16-19677; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Sharif R, 2019, EXP EYE RES, V179, P55, DOI 10.1016/j.exer.2018.10.015; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Shetty R, 2015, MOL VIS, V21, P12; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Stachon T, 2017, CURR EYE RES, V42, P842, DOI 10.1080/02713683.2016.1256413; Tabibian D, 2017, AM J OPHTHALMOL, V184, P129, DOI 10.1016/j.ajo.2017.10.001; Thanos S, 2016, CORNEA, V35, P1338, DOI 10.1097/ICO.0000000000000988; Torres-Netto EA, 2019, J CATARACT REFR SURG, V45, P101, DOI 10.1016/j.jcrs.2018.08.036; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249344	10.1371/journal.pone.0249344	http://dx.doi.org/10.1371/journal.pone.0249344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793669	Green Published, gold			2022-12-26	WOS:000636467000032
J	Habibi, SA; Salim, L				Habibi, Sarah A.; Salim, Lidya			Static vs. dynamic methods of delivery for science communication: A critical analysis of user engagement with science on social media	PLOS ONE			English	Article								Science communication has been increasingly viewed as a necessity and obligation of scientists in recent years. The rise of Web 2.0 technologies, such as social media, has made communication of science to the public more accessible as a whole. While one of the primary goals of science communication is to increase public engagement, there is very little research to show the type of communication that fosters the highest levels of engagement. Here we evaluate two social medial platforms, Instagram and TikTok, and assess the type of educational science content (ESC) that promotes user awareness and overall engagement. Specifically, we measured the level of engagement between static and dynamic posts on Instagram, and lecture-style and experimental videos on TikTok. User engagement is measured through the analysis of relative number of likes, comments, shares, saves, and views of each post in the various categories. We found that users interact with ESC significantly more (p<0.05) when the content is presented in dynamic ways with a component of experimentation. Together, we took the findings of this study and provided a series of suggestions for conducting science communication on social media, and the type of ESC that should be used to promote better user outcomes.	[Habibi, Sarah A.] Ontario Tech Univ, Fac Sci, Oshawa, ON, Canada; [Salim, Lidya] Ontario Tech Univ, Fac Sci, Appl Biosci Grad Program, Oshawa, ON, Canada		Habibi, SA (corresponding author), Ontario Tech Univ, Fac Sci, Oshawa, ON, Canada.	Habibi.Sarah11@gmail.com		Habibi, Sarah/0000-0002-4888-7830				[Anonymous], 2006, J SCI EDUC TECHNOL, DOI DOI 10.1007/S10956-006-9015-5; Baram-Tsabari A, 2015, J RES SCI TEACH, V52, P135, DOI 10.1002/tea.21202; Besley JC, 2015, SCI PUBL POLICY, V42, P201, DOI 10.1093/scipol/scu042; Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Brossard D, 2013, SCIENCE, V339, P40, DOI 10.1126/science.1232329; Brownell Sara E, 2013, J Undergrad Neurosci Educ, V12, pE6; Brumfiel G, 2009, NATURE, V458, P274, DOI 10.1038/458274a; Burns TW, 2003, PUBLIC UNDERST SCI, V12, P183, DOI 10.1177/09636625030122004; Chester Ann, 2018, J STEM Outreach, V1, DOI 10.15695/jstem/v1i1.17; Collins K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162680; Council N. R., 2009, LEARNING SCI INFORMA; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; Dragseth MR, 2020, J POLITICAL SCI EDUC, V16, P243, DOI 10.1080/15512169.2018.1550421; Dudo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148867; Dudo A, 2013, SCI COMMUN, V35, P476, DOI 10.1177/1075547012460845; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; Hitchcock L.I., 2013, J BACCALAUREATE SOCI, V18, P33, DOI [https://doi.org/10.5555/basw.18.suppl-1.3751j3g390xx3g56, DOI 10.5555/BASW.18.SUPPL-1.3751J3G390XX3G56]; Howell EL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216274; Jarreau PB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216625; Jones AL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001692; Knox K.L., 2003, J SCI EDUC TECHNOL, V12, P471, DOI DOI 10.1023/B:JOST.0000006306.97336.C5; Leshner AI, 2003, SCIENCE, V299, P977, DOI 10.1126/science.299.5609.977; Liberatore A., 2018, CITIZEN SCI THEORY P, V3, P3, DOI DOI 10.5334/CSTP.108; Maltese AV, 2014, SCI EDUC, V98, P937, DOI 10.1002/sce.21132; Osborne J., 2000, PUPILS PARENTSVIEWS; Osterrieder A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-26; Pavlov AK, 2018, B AM METEOROL SOC, V99, P1135, DOI 10.1175/BAMS-D-17-0195.1; Rosenthal-von der Putten AM, 2019, COMPUT HUM BEHAV, V92, P76, DOI 10.1016/j.chb.2018.10.017; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Sivan A, 2000, INNOV EDUC TRAIN INT, V37, P381, DOI 10.1080/135580000750052991; Tess PA, 2013, COMPUT HUM BEHAV, V29, pA60, DOI 10.1016/j.chb.2012.12.032; Zheng H, 2017, HYDROL EARTH SYST SC, V21, P949, DOI 10.5194/hess-21-949-2017	32	8	8	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248507	10.1371/journal.pone.0248507	http://dx.doi.org/10.1371/journal.pone.0248507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788841	gold, Green Published			2022-12-26	WOS:000636354600039
J	Boyd, P; Molyneux, J				Boyd, Peter; Molyneux, James			Assessing the contagiousness of mass shootings with nonparametric Hawkes processes	PLOS ONE			English	Article								Gun violence and mass shootings are high-profile epidemiological issues facing the United States with questions regarding their contagiousness gaining prevalence in news media. Through the use of nonparametric Hawkes processes, we examine the evidence for the existence of contagiousness within a catalog of mass shootings and highlight the broader benefits of using such nonparametric point process models in modeling the occurrence of such events.	[Boyd, Peter; Molyneux, James] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University	Molyneux, J (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	molyneuj@oregonstate.edu						Bauchner H, 2017, JAMA PSYCHIAT, V74, P1195, DOI 10.1001/jamapsychiatry.2017.3616; Bremaud P., 1981, POINT PROCESSES QUEU; Clements RA, 2012, ENVIRONMETRICS, V23, P606, DOI 10.1002/env.2168; Daley DJ., 2004, INTRO THEORY POINT P; DeBonis Mike, 2018, WASH POST; Dzau VJ, 2018, ANN INTERN MED, V168, P876, DOI 10.7326/M18-0579; Federal Bureau of Investigation, 2016, 2000 2018 ACT SHOOT; Fox EW, 2016, ANN APPL STAT, V10, P1725, DOI 10.1214/16-AOAS957; Gerhard F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005390; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; HAWKES AG, 1971, BIOMETRIKA, V58, P83, DOI 10.2307/2334319; Jetter M., 2018, IZA DISCUSSION PAPER; Marsan D, 2008, SCIENCE, V319, P1076, DOI 10.1126/science.1148783; Meindl JN, 2017, AM J PUBLIC HEALTH, V107, P368, DOI 10.2105/AJPH.2016.303611; Meyer S, 2012, BIOMETRICS, V68, P607, DOI 10.1111/j.1541-0420.2011.01684.x; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Ogata Y, 1998, ANN I STAT MATH, V50, P379, DOI 10.1023/A:1003403601725; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Porter MD, 2012, ANN APPL STAT, V6, P106, DOI 10.1214/11-AOAS513; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Rostron A, 2018, AM J PUBLIC HEALTH, V108, P865, DOI 10.2105/AJPH.2018.304450; Schoenberg FP, 2003, J AM STAT ASSOC, V98, P789, DOI 10.1198/016214503000000710; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117259; Utsu T., 1961, GEOPHYS MAG, V30, P521, DOI DOI 10.1007/BF01592930; Zhao QY, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1513, DOI 10.1145/2783258.2783401	26	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248437	10.1371/journal.pone.0248437	http://dx.doi.org/10.1371/journal.pone.0248437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784326	Green Submitted, gold, Green Published			2022-12-26	WOS:000636359600002
J	Hardouin, M; Searle, CE; Strampelli, P; Smit, J; Dickman, A; Lobora, AL; Rowcliffe, JM				Hardouin, Marie; Searle, Charlotte E.; Strampelli, Paolo; Smit, Josephine; Dickman, Amy; Lobora, Alex L.; Rowcliffe, J. Marcus			Density responses of lesser-studied carnivores to habitat and management strategies in southern Tanzania's Ruaha-Rungwa landscape	PLOS ONE			English	Article							CAPTURE-RECAPTURE; POPULATION-DENSITY; ACTIVITY PATTERNS; NATIONAL-PARK; TOP PREDATORS; CAMERA TRAPS; CONSERVATION; DESIGNS; EXTINCTION; CONFLICT	Compared to emblematic large carnivores, most species of the order Carnivora receive little conservation attention despite increasing anthropogenic pressure and poor understanding of their status across much of their range. We employed systematic camera trapping and spatially explicit capture-recapture modelling to estimate variation in population density of serval, striped hyaena and aardwolf across the mixed-use Ruaha-Rungwa landscape in southern Tanzania. We selected three sites representative of different habitat types, management strategies, and levels of anthropogenic pressure: Ruaha National Park's core tourist area, dominated by Acacia-Commiphora bushlands and thickets; the Park's miombo woodland; and the neighbouring community-run MBOMIPA Wildlife Management Area, also covered in Acacia-Commiphora. The Park's miombo woodlands supported a higher serval density (5.56 [Standard Error = +/- 2.45] individuals per 100 km(2)) than either the core tourist area (3.45 [+/- 1.04] individuals per 100 km(2)) or the Wildlife Management Area (2.08 [+/- 0.74] individuals per 100 km(2)). Taken together, precipitation, the abundance of apex predators, and the level of anthropogenic pressure likely drive such variation. Striped hyaena were detected only in the Wildlife Management Area and at low density (1.36 [+/- 0.50] individuals per 100 km(2)), potentially due to the location of the surveyed sites at the edge of the species' global range, high densities of sympatric competitors, and anthropogenic edge effects. Finally, aardwolf were captured in both the Park's core tourist area and the Wildlife Management Area, with a higher density in the Wildlife Management Area (13.25 [+/- 2.48] versus 9.19 [+/- 1.66] individuals per 100 km(2)), possibly as a result of lower intraguild predation and late fire outbreaks in the area surveyed. By shedding light on three understudied African carnivore species, this study highlights the importance of miombo woodland conservation and community-managed conservation, as well as the value of by-catch camera trap data to improve ecological knowledge of lesser-studied carnivores.	[Hardouin, Marie; Rowcliffe, J. Marcus] Imperial Coll London, Fac Nat Sci, Ascot, Berks, England; [Searle, Charlotte E.; Strampelli, Paolo; Dickman, Amy] Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, England; [Smit, Josephine] Southern Tanzania Elephant Program, Iringa, Tanzania; [Smit, Josephine] Univ Stirling, Dept Psychol, Stirling, Scotland; [Lobora, Alex L.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Rowcliffe, J. Marcus] Zool Soc London, Inst Zool, London, England	Imperial College London; University of Oxford; University of Stirling; Zoological Society of London	Hardouin, M (corresponding author), Imperial Coll London, Fac Nat Sci, Ascot, Berks, England.	marie.acx.hardouin@gmail.com	; Rowcliffe, Marcus/G-3713-2018	Smit, Josephine Belia/0000-0003-2974-6140; Lobora, Alex/0000-0002-6067-4539; Rowcliffe, Marcus/0000-0002-4286-6887	University of Oxford NERC Environmental Research DTP; Recanati-Kaplan Fellowship; Research England; National Geographic Society Early Career Grants; Cleveland Metroparks Zoo Africa Seed Grants; Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund; Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund	University of Oxford NERC Environmental Research DTP; Recanati-Kaplan Fellowship; Research England(UK Research & Innovation (UKRI)); National Geographic Society Early Career Grants(National Geographic Society); Cleveland Metroparks Zoo Africa Seed Grants; Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund; Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund	Scholarship funding for CS and PS is provided by the University of Oxford NERC Environmental Research DTP (https://www.environmental-research.ox.ac.uk).AD is funded by a Recanati-Kaplan Fellowship (https://www.wildcru.org).JMR is supported by Research England funding to the Institute of Zoology (https://re.ukri.org/funding/).Additional funding was awarded to CS for this research from National Geographic Society Early Career Grants (https://www.nationalgeographic.org/fundingopportunities/grants), Cleveland Metroparks Zoo Africa Seed Grants (https://www.clevelandmetroparks.com/zoo), Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund (https://www.czs.org/Chicago[1]Zoological-Society/Conservation% 20Leadership/CBOT-Endangered-Species-Fund/), and Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund (https://www.pittsburghzoo.org/conservation/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah J.M., 2007, WORKING PAPERS FINNI; Anderson MD, 2013, MAMMALS AFRICA CARNI, P282; Bjornstad A., 1976, VEGETATION RUAHA NAT; Bohm T, 2018, AFR J ECOL, V56, P841, DOI 10.1111/aje.12520; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Brink AB, 2009, APPL GEOGR, V29, P501, DOI 10.1016/j.apgeog.2008.10.004; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Clark JD, 2019, POPUL ECOL, V61, P93, DOI 10.1002/1438-390X.1011; COATON W. G. H., 1948, Bull. Dep. agric. S. Afr.; Dibyendu Mandal, 2017, Journal of Zoology Studies, V4, P34; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Doherty PF, 2003, ANN ZOOL FENN, V40, P145; Dupont P, 2019, METHODS ECOL EVOL, V10, P661, DOI 10.1111/2041-210X.13158; Edwards S, 2018, AFR J ECOL, V56, P831, DOI 10.1111/aje.12540; Efford MG, 2019, METHODS ECOL EVOL, V10, P1529, DOI 10.1111/2041-210X.13239; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; European Commission Directorate-General for International Cooperation and Development, 2016, LARGER ELEPHANTS INP, P120; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Ford WM, 2014, THESIS FISH WILDLIF; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Green D.S., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-2.RLTS.T1 8372A45195681.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T18372A45195681.EN]; Gupta Shilpi, 2009, Journal of the Bombay Natural History Society, V106, P284; Harmsen BJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227468; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hunter L., 2013, MAMMALS AFRICA, P180; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Knapp EJ, 2017, CONSERV SOC, V15, P24, DOI 10.4103/0972-4923.201393; Kruuk H., 1972, East African Wildlife Journal, V10, P211; KRUUK H, 1976, East African Wildlife Journal, V14, P91; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Loock DJE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34936-0; Mazzamuto MV, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-019-1310-6; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Miller Brian, 2001, Endangered Species Update, V18, P202; Mtahiko M. G. G., 2006, Wetlands Ecology and Management, V14, P489, DOI 10.1007/s11273-006-9002-x; Noss A, 2013, EVALUATING JAGUAR DE; O'Brien TG, 2011, ECOL APPL, V21, P2908, DOI 10.1890/10-2284.1; O'Brien TG, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P71, DOI 10.1007/978-4-431-99495-4_6; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ramesh T, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2271-y; Ramesh T, 2016, J MAMMAL, V97, P554, DOI 10.1093/jmammal/gyv201; Ramesh T, 2013, J MAMMAL, V94, P1460, DOI 10.1644/13-MAMM-A-063.1; Ribeiro N, 2015, BIODIVERSITY ECOSYST, DOI [10.5772/58494, DOI 10.5772/58494]; Rich LN, 2019, BIOL CONSERV, V233, P12, DOI 10.1016/j.biocon.2019.02.018; Rich LN, 2014, J MAMMAL, V95, P382, DOI 10.1644/13-MAMM-A-126; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Royle J.A., 2013, SPATIAL CAPTURE RECA, Vfirst, P612; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Ruaha Carnivore Project, RUAHA RUNGWA LARGE C; Satter CB, 2019, J WILDLIFE MANAGE, V83, P283, DOI 10.1002/jwmg.21598; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Singh R, 2014, ACTA THERIOL, V59, P521, DOI 10.1007/s13364-014-0187-8; Small Ernest, 2011, BIODIVERSITY-OTTAWA, V12, P232, DOI 10.1080/14888386.2011.642663; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Suryawanshi KR, 2019, POPUL ECOL, V61, P268, DOI 10.1002/1438-390X.1027; Tanzania National Parks (TANAPA), 2019, NYERERE NATL PARK; Tanzania Wildlife Research Institute (TAWIRI), 2019, TAWIRI AERIAL SURVEY; Thiel C, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-3.RLTS.T11638A156536762.en, DOI 10.2305/IUCN.UK.2019-3.RLTS.T11638A156536762.EN]; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Watson F, 2013, BIOL CONSERV, V168, P1, DOI 10.1016/j.biocon.2013.09.003; Williams B.K., 2002, ANAL MANAGEMENT ANIM; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; World Wildlife Fund (WWF), TANZANIAS WILDLIFE M	74	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0242293	10.1371/journal.pone.0242293	http://dx.doi.org/10.1371/journal.pone.0242293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784297	Green Published, Green Submitted, gold			2022-12-26	WOS:000636359600005
J	Birihane, BM; Bayih, WA; Alemu, AY; Belay, DM; Demis, A				Minuye Birihane, Binyam; Alebachew Bayih, Wubet; Yeshambel Alemu, Abebaw; Belay, Demeke Mesfin; Demis, Asmamaw			The burden of hyaline membrane disease, mortality and its determinant factors among preterm neonates admitted at Debre Tabor General Hospital, North Central Ethiopia: A retrospective follow up study	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LUNG ULTRASOUND; RISK-FACTORS; INFANTS; CARE	Background Hyaline membrane disease (HMD) is a leading cause of morbidity and mortality in preterm newborn babies. Though, there are studies related to Hyaline membrane disease inclusive of all neonates, studies related to the burden among preterm neonates were limited. In addition, increasing neonatal mortality in Ethiopia could be related to increase in the burden of hyaline membrane disease among preterm neonates. Therefore, this study was aimed to assess the burden of hyaline membrane disease, mortality and its associated factors among preterm neonate admitted at neonatal intensive care unit, North Central Ethiopia. Methodology An institution-based retrospective follow-up study was conducted among 535 preterm neonates admitted at neonatal intensive care unit from January 1, 2014-December 30, 2017. Data were entered into EPi-data 4.2.0.0 and transferred to STATA version 14 statistical software for statistical analysis. Binary logistic regression was used for the analysis. All variables with P-value < 0.25 during bi-variable analysis were considered for multivariable logistic regression. Level of statistical significance was declared at P value <= 0.05. Results In the current study, proportion of hyaline membrane disease was 40% (95% CI; 35.8, 44.3) of which 49.5% died. Preterm neonate born with Gestational age of less than 34 weeks of age (Adjusted odd ratio (AOR = 2.64; 95 CI: 1.49, 4.66)), 5(th) minute Apgar score less than 7 (AOR = 2.2; 95% CI: 1.20, 4.07), and newborn with birth weight of less than 1500 gram (AOR = 2.4, 95% CI: 1.3, 4.3) were predictors of hyaline membrane disease. Conclusions The mean gestational age (+/-) was 33.46 (+/- 2.55) weeks. The incidence of hyaline membrane disease among preterm admissions was high. Preterm neonate born with gestational age of less than 34 weeks of age, asphyxiated newborns and newborn with birth weight of less than 1500 gram were predictors of hyaline membrane disease. So, emphasis should be given on early screening, follow up and timely interventions for preterm neonate.	[Minuye Birihane, Binyam; Alebachew Bayih, Wubet; Yeshambel Alemu, Abebaw; Belay, Demeke Mesfin] Debretabor Univ, Coll Hlth Sci, Debretabor, Ethiopia; [Demis, Asmamaw] Woldia Univ, Dept Nursing, Coll Hlth Sci, Woldia, Ethiopia		Birihane, BM (corresponding author), Debretabor Univ, Coll Hlth Sci, Debretabor, Ethiopia.	biniamminuye@yahoo.com	Belay, Demeke Mesfin/ABD-7714-2021; Alemu, Abebaw Yeshambel/GYQ-8000-2022; Bayih, Wubet Alebachew/AAF-5099-2019; Bizuneh, Asmamaw Demis/ABA-1868-2021	Belay, Demeke Mesfin/0000-0003-4786-2866; Bayih, Wubet Alebachew/0000-0003-1439-4402; Minuye, Binyam/0000-0002-9338-0334; Alemu, Abebaw Yeshambel/0000-0001-5722-250X				Abdelazim I, 2017, ARCH MED SCI, V13, P629, DOI 10.5114/aoms.2017.67292; Abdelaziz N, 2018, EGYPT EGYPTIAN J COM, V36; Adebami O.J., 2017, INT J RES MED SCI, V5, P1487; Ahn KH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207061; Ajeli M.H.A., 2019, KARBALA J MED, V12, P2199; Al Riyami Nihal, 2020, Oman Med J, V2020, pe133, DOI 10.5001/omj.2020.51; Al-Beltagi M, 2020, PEDIATR PULM, V55, P108, DOI 10.1002/ppul.24552; Alebel A, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1963-z; Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Aynalem YA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235544; Baseer KAA, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2739; Bayana E., PATTERN DIS ASS FACT; BERGMAN B, 1978, ACTA OBSTET GYN SCAN, V57, P217, DOI 10.3109/00016347809154885; Condo V, 2017, J MATERN-FETAL NEO M, V30, P1267, DOI 10.1080/14767058.2016.1210597; Delara M, 2019, ARCH DIS CHILD-FETAL, V104, pF137, DOI 10.1136/archdischild-2017-314046; Dhaded SM, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S6; Di Mauro A, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0438-9; DTH, 2017, DEBR GEN HOSP REP 20; Dyer Janet, 2019, P T, V44, P12; Ehrenstein Vera, 2009, Clin Epidemiol, V1, P45; Gagrani S., 2017, INT J CONT PEDIAT, V4, P993; Gupta V, 2017, J NEPALGUNJ MED COLL, V15, P5; Hadgu FB, 2020, PEDIATR HEALTH MED T, V11, P29, DOI 10.2147/PHMT.S235591; Hiles M, 2017, ULTRASOUND, V25, P80, DOI 10.1177/1742271X16689374; Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1; Johansson J, 2019, J INTERN MED, V285, P165, DOI 10.1111/joim.12845; Kliegman R., 2016, NELSON TXB PEDIAT, V20th ed.; Kolobo HA, 2019, J CLIN NEONATOL, V8, P232, DOI 10.4103/jcn.JCN_23_19; Li Y, 2019, ACTA DIABETOL, V56, P729, DOI 10.1007/s00592-019-01327-4; Lim CM, 2001, INTENS CARE MED, V27, P477, DOI 10.1007/s001340000848; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Manhar S.R., 2018, BIRAT J HLTH SCI, V3, P537; Mihaylova A., 2016, WORLD J PHARM PHARM, P9; Monica N.F., 2017, SCI LETT, V5, P70; Mortier I, 2017, ARCH GYNECOL OBSTET, V296, P1071, DOI 10.1007/s00404-017-4505-7; Muhe LM, 2019, LANCET GLOB HEALTH, V7, pE1130, DOI 10.1016/S2214-109X(19)30220-7; Pang HQ, 2019, EUR J RADIOL, V116, P186, DOI 10.1016/j.ejrad.2019.05.004; Qari S.A., 2018, EGYPTIAN J HOSP MED, V70, P257; Rennie JM., 2012, RENNIE ROBERTONS TXB, V5th edition; Requejo J, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S4; Rijal Prashant, 2018, J Nepal Health Res Counc, V16, P131; Sabol BA, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.035; Sahoo T, 2020, J PERINATOL, V40, P743, DOI 10.1038/s41372-020-0604-6; Seikku L, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3334; Shen CL, 2016, J PEDIATR-US, V172, P69, DOI 10.1016/j.jpeds.2016.01.031; Shrestha S, 2010, J NEPAL MED ASSOC, V49, P286; Spillane NT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201266; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Tochie JN, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.152.7066; Wang J., 2019, INT J CLIN EXP MED, V12, P60; Wolde HF, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4668-3; World Health Organization, WHO REC INT IMPR PRE; Yismaw AE, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-018-0597-3	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249365	10.1371/journal.pone.0249365	http://dx.doi.org/10.1371/journal.pone.0249365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784349	gold, Green Published			2022-12-26	WOS:000636359600011
J	Beier, N; Kucklick, M; Fuchs, S; Mustafayeva, A; Behringer, M; Hartig, E; Jahn, D; Engelmann, S				Beier, Nicole; Kucklick, Martin; Fuchs, Stephan; Mustafayeva, Ayten; Behringer, Maren; Hartig, Elisabeth; Jahn, Dieter; Engelmann, Susanne			Adaptation of Dinoroseobacter shibae to oxidative stress and the specific role of RirA	PLOS ONE			English	Article							ESCHERICHIA-COLI; RHODOPSEUDOMONAS-SPHEROIDES; TRANSCRIPTIONAL RESPONSE; HYDROGEN-PEROXIDE; OXYR; IRON; RESISTANCE; DEHYDROGENASE; SUPEROXIDE; EXPRESSION	Dinoroseobacter shibae living in the photic zone of marine ecosystems is frequently exposed to oxygen that forms highly reactive species. Here, we analysed the adaptation of D. shibae to different kinds of oxidative stress using a GeLC-MS/MS approach. D. shibae was grown in artificial seawater medium in the dark with succinate as sole carbon source and exposed to hydrogen peroxide, paraquat or diamide. We quantified 2580 D. shibae proteins. 75 proteins changed significantly in response to peroxide stress, while 220 and 207 proteins were differently regulated by superoxide stress and thiol stress. As expected, proteins like thioredoxin and peroxiredoxin were among these proteins. In addition, proteins involved in bacteriochlophyll biosynthesis were repressed under disulfide and superoxide stress but not under peroxide stress. In contrast, proteins associated with iron transport accumulated in response to peroxide and superoxide stress. Interestingly, the iron-responsive regulator RirA in D. shibae was downregulated by all stressors. A rirA deletion mutant showed an improved adaptation to peroxide stress suggesting that RirA dependent proteins are associated with oxidative stress resistance. Altogether, 139 proteins were upregulated in the mutant strain. Among them are proteins associated with protection and repair of DNA and proteins (e. g. ClpB, Hsp20, RecA, and a thioredoxin like protein). Strikingly, most of the proteins involved in iron metabolism such as iron binding proteins and transporters were not part of the upregulated proteins. In fact, rirA deficient cells were lacking a peroxide dependent induction of these proteins that may also contribute to a higher cell viability under these conditions.	[Beier, Nicole; Kucklick, Martin; Mustafayeva, Ayten; Behringer, Maren; Hartig, Elisabeth; Jahn, Dieter; Engelmann, Susanne] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany; [Beier, Nicole; Kucklick, Martin; Mustafayeva, Ayten; Engelmann, Susanne] Helmholtzzentrum Infekt Forsch, Microbial Prote, Braunschweig, Germany; [Fuchs, Stephan] Robert Koch Inst, Berlin, Germany; [Jahn, Dieter; Engelmann, Susanne] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany	Braunschweig University of Technology; Robert Koch Institute; Braunschweig University of Technology	Engelmann, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany.; Engelmann, S (corresponding author), Helmholtzzentrum Infekt Forsch, Microbial Prote, Braunschweig, Germany.; Engelmann, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany.	Susanne.Engelmann@helmholtz-hzi.de			Deutsche Forschungsgemeinschaft [TRR51, INST 188/365-1 FUGG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft TRR51 to S.E. and D.J. and INST 188/365-1 FUGG to S.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Behringer M, 2020, BIOCHEM J, V477, P191, DOI 10.1042/BCJ20180734; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Berghoff BA, 2011, ENVIRON MICROBIOL, V13, P775, DOI 10.1111/j.1462-2920.2010.02381.x; Bichara M, 2007, MOL MICROBIOL, V65, P218, DOI 10.1111/j.1365-2958.2007.05790.x; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Crack JC, 2008, BIOCHEM SOC T, V36, P1144, DOI 10.1042/BST0361144; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Engelmann S, 1996, FEMS MICROBIOL LETT, V145, P63, DOI 10.1111/j.1574-6968.1996.tb08557.x; Ezraty B, 2017, NAT REV MICROBIOL, V15, P385, DOI 10.1038/nrmicro.2017.26; Fuchs S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070669; Glaeser J, 2007, J PROTEOME RES, V6, P2460, DOI 10.1021/pr060624p; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Laass S, 2014, J BIOL CHEM, V289, P13219, DOI 10.1074/jbc.M113.545004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASCELLES J, 1971, BIOCHIM BIOPHYS ACTA, V226, P328, DOI 10.1016/0005-2728(71)90100-9; LASCELLES J, 1959, BIOCHEM J, V72, P508, DOI 10.1042/bj0720508; Lassek C, 2015, MOL CELL PROTEOMICS, V14, P989, DOI 10.1074/mcp.M114.043463; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; LOEWEN PC, 1994, ANNU REV MICROBIOL, V48, P53, DOI 10.1146/annurev.mi.48.100194.000413; Maass S, 2011, ANAL CHEM, V83, P2677, DOI 10.1021/ac1031836; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Reder A, 2012, J BACTERIOL, V194, P3601, DOI 10.1128/JB.00528-12; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schindel HS, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000081; Soora M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00233; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; TAO K, 1995, J BACTERIOL, V177, P6740, DOI 10.1128/jb.177.23.6740-6744.1995; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Tretter L, 2000, J NEUROSCI, V20, P8972; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	53	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0248865	10.1371/journal.pone.0248865	http://dx.doi.org/10.1371/journal.pone.0248865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780465	Green Published, gold			2022-12-26	WOS:000636336800051
J	Pedchenko, V; Boudko, SP; Barber, M; Mikhailova, T; Saus, J; Harmange, JC; Hudson, BG				Pedchenko, Vadim; Boudko, Sergei P.; Barber, Mary; Mikhailova, Tatiana; Saus, Juan; Harmange, Jean-Christophe; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. III. A functional framework for alpha 345 hexamer assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; GOODPASTURE AUTOANTIGEN; CRYPTIC EPITOPES; IDENTIFICATION; GENE; ORGANIZATION; DOMAIN; SITES; CHAIN	We identified a genetic variant, an 8-residue appendage, of the alpha 345 hexamer of collagen IV present in patients with glomerular basement membrane diseases, Goodpasture's disease and Alport syndrome, and determined the long-awaited crystal structure of the hexamer. We sought to elucidate how variants cause glomerular basement membrane disease by exploring the mechanism of the hexamer assembly. Chloride ions induced in vitro hexamer assembly in a composition-specific manner in the presence of equimolar concentrations of alpha 3, alpha 4, and alpha 5 NC1 monomers. Chloride ions, together with sulfilimine crosslinks, stabilized the assembled hexamer. Furthermore, the chloride ion-dependent assembly revealed the conformational plasticity of the loop-crevice-loop bioactive sites, a critical property underlying bioactivity and pathogenesis. We explored the native mechanism by expressing recombinant alpha 345 miniprotomers in the cell culture and characterizing the expressed proteins. Our findings revealedNC1-directed trimerization, forming protomers inside the cell; hexamerization, forming scaffolds outside the cell; and a Cl gradient-signaled hexamerization. This assembly detail, along with a crystal structure, provides a framework for understanding hexamer dysfunction. Restoration of the native conformation of bioactive sites and alpha 345 hexamer replacement are prospective approaches to therapeutic intervention.	[Pedchenko, Vadim; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA; [Pedchenko, Vadim; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA; [Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA; [Barber, Mary; Mikhailova, Tatiana; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN 37235 USA; [Saus, Juan] Univ Valencia, Fac Med & Odontol, Dept Bioquim & Biol Mol, Valencia, Spain; [Harmange, Jean-Christophe] Goldfinch Bio, Cambridge, MA USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Valencia; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA.	billy.hudson@vumc.org		Barber, Mary/0000-0001-5394-8071; Mikhailova, Tatiana/0000-0003-4169-1322; Boudko, Sergei/0000-0003-3856-4859	Universidad de Buenos Aires [UBACYT 20020170100454BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2017-2971]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Universidad de Buenos Aires grant [UBACYT 20020170100454BA] to S. E. H. and S. L. L. and by Agencia Nacional de Promocion Cientifica y Tecnologica, grant [PICT-2017-2971] to S. L. L.	BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Boudko SP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100591; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; Hong P, 2012, J LIQ CHROMATOGR R T, V35, P2923, DOI 10.1080/10826076.2012.743724; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kang JS, 2008, J BIOL CHEM, V283, P35070, DOI 10.1074/jbc.M806396200; Keene DR, 2018, METHOD CELL BIOL, V143, P1, DOI 10.1016/bs.mcb.2017.08.002; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MYERS JC, 1990, AM J HUM GENET, V46, P1024; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Pedchenko V, 2019, J BIOL CHEM, V294, P7968, DOI 10.1074/jbc.RA119.007426; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Pokidysheva EN, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100590; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	26	9	9	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100592	10.1016/j.jbc.2021.100592	http://dx.doi.org/10.1016/j.jbc.2021.100592			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775696	gold, Green Published			2022-12-26	WOS:000672866400564
J	Rios, SC; Saez, JOC; Quesada, O; Figueroa, KQ; Dominicci, JAL				Rios, Sonnieliz Cotto; Saez, Jose O. Colon; Quesada, Orestes; Figueroa, Katherine Quiroz; Dominicci, Jose A. Lasalde			Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120(JRFL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; NECROSIS-FACTOR-ALPHA; SMOKING-CESSATION; MACROPHAGE HETEROGENEITY; INFLAMMATORY RESPONSE; BUPROPION LOWERS; IMMUNE-SYSTEM; SUBTYPE C; VIRUS; GP120	Despite current pharmacological intervention strategies, patients with HIV still suffer from chronic inflammation. The nicotinic acetylcholine receptors (nAChRs) are widely distributed throughout the nervous and immune systems. In macrophages, activation of alpha7-nAChR (alpha 7-nAChR) controls inflammatory processes through the cholinergic anti-inflammatory response (CAR). Given that this innate immune response controls inflammation and alpha 7-nAChR plays a critical role in the regulation of systemic inflammation, we investigated the effects of an R5-tropic HIV soluble component, gp120(JRFL), on the CAR functioning. We previously demonstrated that X4-tropic HIV-1 gp120(IIIB) disrupts the CAR as well as inducing upregulation of the alpha 7-nAChR in vitro in monocyte-derived macrophages (MDMs), which correlates with the upregulation observed in monocytes, T-lymphocytes, and MDMs recovered from HIV-infected people. We demonstrate here using imaging and molecular assays that the R5-tropic HIV-1 glycoprotein gp120(JRFL) upregulates the alpha 7-nAChR in MDMs dependent on CD4 and/or CCR5 activation. This upregulation was also dependent on MEK1 since its inhibition attenuates the upregulation of alpha 7-nAChR induced by gp120(JRFL) and was concomitant with an increase in basal calcium levels, which did not result in apoptosis. Moreover, the CAR was determined to be disrupted, since alpha 7-nAChR activation in MDMs did not reduce the production of the proinflammatory cytokines IL-6, GRO-alpha, or I-309. Furthermore, a partial antagonist of alpha 7-nAChR, bupropion, rescued IL-6 but not GRO-alpha or I-309 production. Together, these results demonstrate that gp120(JRFL) disrupts the CAR in MDMs. Other medications targeting the alpha 7-nAChR need to be tested to reactivate the CAR to ameliorate inflammation in HIV-infected subjects.	[Rios, Sonnieliz Cotto; Dominicci, Jose A. Lasalde] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA; [Saez, Jose O. Colon] Univ Puerto Rico, Dept Pharmaceut Sci, Med Sci Campus, San Juan, PR 00936 USA; [Quesada, Orestes] Univ Puerto Rico, Dept Phys Sci, Rio Piedras Campus, San Juan, PR 00936 USA; [Figueroa, Katherine Quiroz; Dominicci, Jose A. Lasalde] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA; [Dominicci, Jose A. Lasalde] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Dominicci, Jose A. Lasalde] Univ Puerto Rico, Mol Sci Res Ctr, San Juan, PR 00936 USA; [Figueroa, Katherine Quiroz] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Pennsylvania	Dominicci, JAL (corresponding author), Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Mol Sci Res Ctr, San Juan, PR 00936 USA.	jose.lasalde@upr.edu			RISE-MBRS-NIH Program [2R25GM061151]	RISE-MBRS-NIH Program	S. C. R. was supported by the RISE-MBRS-NIH Program (2R25GM061151).	Alexander JK, 2010, J NEUROSCI, V30, P10112, DOI 10.1523/JNEUROSCI.6344-09.2010; Altschuler EL, 2003, PSYCHOSOM MED, V65, P719, DOI 10.1097/01.PSY.0000073874.55003.EE; Anderson G., 2020, MELATONIN RES, V3, P322, DOI [10.32794/mr11250066, DOI 10.32794/MR11250066]; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brumme ZL, 2005, ANTIVIR THER, V10, P849; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Camara-Lemarroy CR, 2013, TRANSPL P, V45, P2502, DOI 10.1016/j.transproceed.2013.04.010; Capo-Velez CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20271-x; Castellano P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12758-w; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Chernyavsky AI, 2010, INT IMMUNOPHARMACOL, V10, P308, DOI 10.1016/j.intimp.2009.12.001; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Criado M, 1997, J NEUROSCI, V17, P6554; Cummins NW, 2013, CELL MOL LIFE SCI, V70, P3355, DOI 10.1007/s00018-012-1239-3; Currier MB, 2003, PSYCHOSOMATICS, V44, P120, DOI 10.1176/appi.psy.44.2.120; de Almeida SM, 2017, J NEUROVIROL, V23, P460, DOI 10.1007/s13365-017-0518-z; de Almeida SM, 2016, J NEUROVIROL, V22, P715, DOI 10.1007/s13365-016-0437-4; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Delgado-Velez M, 2008, J NEUROIMMUNOL, V196, P94, DOI 10.1016/j.jneuroim.2008.03.004; Delgado-Velez M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051473; Delgado-Velez M, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.31; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Drach L, 2010, AIDS PATIENT CARE ST, V24, P139, DOI 10.1089/apc.2009.0274; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; GILBERT M, 1991, J CLIN MICROBIOL, V29, P142, DOI 10.1128/JCM.29.1.142-147.1991; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hileman CO, 2017, CURR HIV-AIDS REP, V14, P93, DOI 10.1007/s11904-017-0356-x; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Huecker M. R., 2020, BUPROPION STAT PEARL; Islas-Weinstein L, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.581911; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kane SV, 2003, GASTROENTEROLOGY, V125, P1290, DOI 10.1016/j.gastro.2003.02.004; Kast RE, 2003, GEN HOSP PSYCHIAT, V25, P495, DOI 10.1016/S0163-8343(03)00093-8; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; King JR, 2018, MOL PHARMACOL, V93, P601, DOI 10.1124/mol.117.111401; King JR, 2017, FEBS OPEN BIO, V7, P1350, DOI 10.1002/2211-5463.12270; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Liu QH, 2000, P NATL ACAD SCI USA, V97, P4832, DOI 10.1073/pnas.090521697; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Maciel IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077227; Malnati MS, 1997, J BIOL REG HOMEOS AG, V11, P40; Massanella M, 2016, CURR OPIN HIV AIDS, V11, P234, DOI 10.1097/COH.0000000000000230; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Murakami K, 2013, NEUROSCIENCE, V252, P443, DOI 10.1016/j.neuroscience.2013.08.024; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Padilla A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11586-2; Park-Wyllie LY, 2003, AIDS, V17, P638, DOI 10.1097/00002030-200303070-00025; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pedrol-Clotet E, 2006, ENFERM INFEC MICR CL, V24, P509, DOI 10.1157/13092468; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; RAFF HV, 1980, J EXP MED, V152, P581, DOI 10.1084/jem.152.3.581; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; Rashidian A, 2020, INFLAMMATION, V43, P1999, DOI 10.1007/s10753-020-01273-2; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shahrir S, 2020, PROG CARDIOVASC DIS, V63, P118, DOI 10.1016/j.pcad.2020.01.003; Siniavin AE, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040507; Slemmer JE, 2000, J PHARMACOL EXP THER, V295, P321; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Tindle HA, 2020, NICOTINE TOB RES, V22, P1669, DOI 10.1093/ntr/ntaa077; Trumpfheller C, 1998, CLIN EXP IMMUNOL, V112, P92; Ugolini S, 1997, J IMMUNOL, V159, P3000; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; WITSELL AL, 1991, P NATL ACAD SCI USA, V88, P1963, DOI 10.1073/pnas.88.5.1963; Xiao XD, 2000, EXP MOL PATHOL, V68, P133, DOI 10.1006/exmp.1999.2300; Yi YJ, 1999, J VIROL, V73, P7117, DOI 10.1128/JVI.73.9.7117-7125.1999; Yuan ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42028; Zanetti SR, 2016, J BIOL CHEM, V291, P16541, DOI 10.1074/jbc.M115.710574; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602	88	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100618	10.1016/j.jbc.2021.100618	http://dx.doi.org/10.1016/j.jbc.2021.100618			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	TI5TQ	33811859	gold, Green Published			2022-12-26	WOS:000672866400589
J	Alderfer, L; Russo, E; Archilla, A; Coe, B; Hanjaya-Putra, D				Alderfer, Laura; Russo, Elizabeth; Archilla, Adriana; Coe, Brian; Hanjaya-Putra, Donny			Matrix stiffness primes lymphatic tube formation directed by vascular endothelial growth factor-C	FASEB JOURNAL			English	Article						hyaluronic acid; lymphatic networks; matrix stiffness; mechanoregulation; VEGF-C	NUCLEOTIDE EXCISION-REPAIR; MITOCHONDRIAL PERMEABILITY TRANSITION; NECROTIC CELL-DEATH; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; ESSENTIAL KINASE; ATR KINASE; S PHASE	Dysfunction of the lymphatic system is associated with a wide range of disease phenotypes. The restoration of dysfunctional lymphatic vessels has been hypothesized as an innovative method to rescue healthy phenotypes in diseased states including neurological conditions, metabolic syndromes, and cardiovascular disease. Compared to the vascular system, little is known about the molecular regulation that controls lymphatic tube morphogenesis. Using synthetic hyaluronic acid (HA) hydrogels as a chemically and mechanically tunable system to preserve lymphatic endothelial cell (LECs) phenotypes, we demonstrate that low matrix elasticity primes lymphatic cord-like structure (CLS) formation directed by a high concentration of vascular endothelial growth factor-C (VEGF-C). Decreasing the substrate stiffness results in the upregulation of key lymphatic markers, including PROX-1, lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), and VEGFR-3. Consequently, higher levels of VEGFR-3 enable stimulation of LECs with VEGF-C which is required to both activate matrix metalloproteinases (MMPs) and facilitate LEC migration. Both of these steps are critical in establishing CLS formation in vitro. With decreases in substrate elasticity, we observe increased MMP expression and increased cellular elongation, as well as formation of intracellular vacuoles, which can further merge into coalescent vacuoles. RNAi studies demonstrate that MMP-14 is required to enable CLS formation and that LECs sense matrix stiffness through YAP/TAZ mechanosensors leading to the activation of their downstream target genes. Collectively, we show that by tuning both the matrix stiffness and VEGF-C concentration, the signaling pathways of CLS formation can be regulated in a synthetic matrix, resulting in lymphatic networks which will be useful for the study of lymphatic biology and future approaches in tissue regeneration.	[Alderfer, Laura; Hanjaya-Putra, Donny] Univ Notre Dame, Bioengn Grad Program, Notre Dame, IN USA; [Russo, Elizabeth; Coe, Brian; Hanjaya-Putra, Donny] Univ Notre Dame, Aerosp & Mech Engn, 141 Multidisciplinary Res Bldg, Notre Dame, IN 46556 USA; [Archilla, Adriana; Hanjaya-Putra, Donny] Univ Notre Dame, Notre Dame Nanosci & Technol NDnano, Notre Dame, IN USA; [Hanjaya-Putra, Donny] Univ Notre Dame, Chem & Biomol Engn, Notre Dame, IN USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Notre Dame	Hanjaya-Putra, D (corresponding author), Univ Notre Dame, Aerosp & Mech Engn, 141 Multidisciplinary Res Bldg, Notre Dame, IN 46556 USA.	dputra1@nd.edu		HanjayaPutra, Donny/0000-0002-5403-544X	American Heart Association (AHA) [19-CDA-34630012]; American Cancer Society (ACS) [IRG-17-182-04]; Walther Cancer Foundation (WCF) [0180.01]; HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS) [ULITR001108]	American Heart Association (AHA)(American Heart Association); American Cancer Society (ACS)(American Cancer Society); Walther Cancer Foundation (WCF); HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	American Heart Association (AHA), Grant/Award Number: 19-CDA-34630012; American Cancer Society (ACS), Grant/Award Number: IRG-17-182-04; Walther Cancer Foundation (WCF): 0180.01; HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/Award Number: ULITR001108	Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho YS, 2010, MOL CELLS, V29, P327, DOI 10.1007/s10059-010-0066-3; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Douglas DL, 2014, J CELL SCI, V127, P4134, DOI 10.1242/jcs.128009; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Francis RJ, 2013, J LEUKOCYTE BIOL, V93, P95, DOI 10.1189/jlb.0412212; Gagne JP, 2012, SCIENCE, V336, P678, DOI 10.1126/science.1221870; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han SI, 2008, BMB REP, V41, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hsu PC, 2019, ONCOGENE, V38, P1166, DOI 10.1038/s41388-018-0506-7; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim D, 2018, NUCLEIC ACIDS RES, V46, P8311, DOI 10.1093/nar/gky625; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Li GY, 2010, BIOMED ENVIRON SCI, V23, P371, DOI 10.1016/S0895-3988(10)60078-5; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Monassier JP, 2008, ARCH CARDIOVASC DIS, V101, P491, DOI 10.1016/j.acvd.2008.06.014; Muller GJ, 2004, BRAIN PATHOL, V14, P415; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park S, 2015, ANAT CELL BIOL, V48, P66, DOI 10.5115/acb.2015.48.1.66; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; PATEL R, 1989, J CELL SCI, P129; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Strom CE, 2012, BIOMOLECULES, V2, P635, DOI 10.3390/biom2040635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Visvanathan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067689; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yelamos J, 2011, AM J CANCER RES, V1, P328; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang FJ, 2014, TOXICOL SCI, V140, P118, DOI 10.1093/toxsci/kfu073; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	101	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21498	10.1096/fj.202002426RR	http://dx.doi.org/10.1096/fj.202002426RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774872	Green Accepted			2022-12-26	WOS:000645260100098
J	Parial, R; Li, H; Li, J; Archacki, S; Yang, ZC; Wang, IZ; Chen, QY; Xu, CQ; Wang, QK				Parial, Ramendu; Li, Hui; Li, Jia; Archacki, Stephen; Yang, Zhongcheng; Wang, Isabel Z.; Chen, Qiuyun; Xu, Chengqi; Wang, Qing K.			Role of epigenetic m(6)A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling	FASEB JOURNAL			English	Article						mettl3; m6A methylation; PHLPP2; mTOR-AKT; vascular development; zebrafish	GENE-EXPRESSION; MESSENGER-RNA; ENDOTHELIAL-CELL; DIFFERENTIATION; IDENTIFICATION; SPECIFICATION; ANGIOGENESIS; MATURATION; ADTRP; AKT1	N-6-methyladenosine (m6A) methylation is the most prevalent RNA modification, and it emerges as an important regulatory mechanism of gene expression involved in many cellular and biological processes. However, the role of m6A methylation in vascular development is not clear. The m(6)A RNA methylation is regulated by dynamic interplay among methyltransferases, binding proteins, and demethylases. Mettl3 is a member of the mettl3-mettl14 methyltransferase complex, referred to as writers that catalyze m(6)A RNA methylation. Here, we used CRISPR-Cas9 genome editing to develop two lines of knockout (KO) zebrafish for mettl3. Heterozygous mettl(3+/-) KO embryos show defective vascular development, which is directly visible in fli-EGFP and flk-EGFP zebrafish. Alkaline phosphatase staining and whole mount in situ hybridization with cdh5, and flk markers demonstrated defective development of intersegmental vessels (ISVs), subintestinal vessels (SIVs), interconnecting vessels (ICVs) and dorsal longitudinal anastomotic vessels (DLAV) in both heterozygous mettl(3+/-) and homozygous mettl(3-/-) KO zebrafish embryos. Similar phenotypes were observed in zebrafish embryos with morpholino knockdown (KD) of mettl3; however, the vascular defects were rescued fully by overexpression of constitutively active AKT1. KD of METTL3 in human endothelial cells inhibited cell proliferation, migration, and capillary tube formation. Mechanistically, mettl3 KO and KD significantly reduced the levels of m(6)A RNA methylation, and AKT phosphorylation (S473) by an increase in the expression of phosphatase enzyme PHLPP2 and reduction in the phosphorylation of mTOR (S2481), a member of the phosphatidylinositol 3-kinase-related kinase family of protein kinases. These data suggest that m(6)A RNA methylation regulates vascular development via PHLPP2/mTOR--AKT signaling.	[Parial, Ramendu; Li, Hui; Li, Jia; Yang, Zhongcheng; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Peoples R China; [Parial, Ramendu; Li, Hui; Li, Jia; Yang, Zhongcheng; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Peoples R China; [Archacki, Stephen; Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA; [Archacki, Stephen; Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH USA; [Wang, Isabel Z.] Stanford Univ, Symbol Syst Program, Stanford, CA USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Stanford University; Case Western Reserve University	Xu, CQ; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Peoples R China.; Xu, CQ; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Peoples R China.; Chen, QY; Wang, QK (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.	chenq_2003@yahoo.com; cqxu@hust.edu.cn; qingwang118@qq.com		Wang, Qing Kenneth/0000-0002-2235-6572; Wang, Isabel/0000-0002-2209-308X; Li, Jia/0000-0001-7132-2574; Xu, Chengqi/0000-0002-4269-6830	China National Natural Science Foundation [81630002, 31430047]; Hubei Province Natural Science Program Innovative Team [2017CFA014]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Science Program Innovative Team	China National Natural Science Foundation, Grant/Award Number: 81630002 and 31430047; Hubei Province Natural Science Program Innovative Team, Grant/Award Number: 2017CFA014	Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gu Y, 2021, PLACENTA, V103, P43, DOI 10.1016/j.placenta.2020.10.016; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P1640, DOI 10.1016/j.bbadis.2017.03.010; Luo CY, 2016, PHYSIOL GENOMICS, V48, P554, DOI 10.1152/physiolgenomics.00028.2016; Lv JH, 2018, CELL RES, V28, P249, DOI 10.1038/cr.2017.143; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ozkurede U, 2019, J MOL ENDOCRINOL, V63, P123, DOI 10.1530/JME-19-0021; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Tian C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030551; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tobia C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01092; Vejnar CE, 2016, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot086850, DOI 10.1101/PDB.PR0T086850]; Wang Qing K., 2005, Lymphatic Research and Biology, V3, P226, DOI 10.1089/lrb.2005.3.226; Wang XJ, 2018, FEBS J, V285, P4071, DOI 10.1111/febs.14653; Xia H, 2018, GENETICS, V208, P729, DOI 10.1534/genetics.117.300574; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yao MD, 2020, MOL THER, V28, P2191, DOI 10.1016/j.ymthe.2020.07.022; Yao YF, 2019, DIABETES, V68, P1635, DOI 10.2337/db18-1178; Yao YF, 2019, PULM PHARMACOL THER, V55, P38, DOI 10.1016/j.pupt.2019.01.007; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883	36	7	7	8	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21465	10.1096/fj.202000516RR	http://dx.doi.org/10.1096/fj.202000516RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33788967				2022-12-26	WOS:000645260100037
J	Niedringhaus, KD; Nemeth, NM; Gibbs, S; Zimmerman, J; Shender, L; Slankard, K; Fenton, H; Charlie, B; Dalton, MF; Elsmo, EJ; Poppenga, R; Millsap, B; Ruder, MG				Niedringhaus, Kevin D.; Nemeth, Nicole M.; Gibbs, Samantha; Zimmerman, Jared; Shender, Lisa; Slankard, Kate; Fenton, Heather; Charlie, Bahnson; Dalton, Martha Frances; Elsmo, Elizabeth J.; Poppenga, Robert; Millsap, Brian; Ruder, Mark G.			Anticoagulant rodenticide exposure and toxicosis in bald eagles (Haliaeetus leucocephalus) and golden eagles (Aquila chrysaetos) in the United States	PLOS ONE			English	Article								Raptors, including eagles, are geographically widespread and sit atop the food chain, thereby serving an important role in maintaining ecosystem balance. After facing population declines associated with exposure to organochlorine insecticides such as dichlorodiphenyltrichloroethane (DDT), bald eagles (Haliaeetus leucocephalus) have recovered from the brink of extinction. However, both bald and golden eagles (Aquila chrysaetos) are exposed to a variety of other toxic compounds in the environment that could have population impacts. Few studies have focused on anticoagulant rodenticide (AR) exposure in eagles. Therefore, the purpose of this study was to determine the types of ARs that eagles are exposed to in the USA and better define the extent of toxicosis (i.e., fatal illness due to compound exposure). Diagnostic case records from bald and golden eagles submitted to the Southeastern Cooperative Wildlife Disease Study (University of Georgia) 2014 through 2018 were reviewed. Overall, 303 eagles were examined, and the livers from 116 bald eagles and 17 golden eagles were tested for ARs. The percentage of AR exposure (i.e., detectable levels but not associated with mortality) in eagles was high; ARs were detected in 109 (82%) eagles, including 96 (83%) bald eagles and 13 (77%) golden eagles. Anticoagulant rodenticide toxicosis was determined to be the cause of mortality in 12 (4%) of the 303 eagles examined, including 11 bald eagles and 1 golden eagle. Six different AR compounds were detected in these eagles, with brodifacoum and bromadiolone most frequently detected (81% and 25% of eagles tested, respectively). These results suggest that some ARs, most notably brodifacoum, are widespread in the environment and are commonly consumed by eagles. This highlights the need for research to understand the pathways of AR exposure in eagles, which may help inform policy and regulatory actions to mitigate AR exposure risk.	[Niedringhaus, Kevin D.; Nemeth, Nicole M.; Fenton, Heather; Charlie, Bahnson; Dalton, Martha Frances; Elsmo, Elizabeth J.; Ruder, Mark G.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Gibbs, Samantha] US Fish & Wildlife Serv, Natl Wildlife Refuge Syst, Chiefland, FL USA; [Zimmerman, Jared; Shender, Lisa] Florida Fish & Wildlife Conservat Commiss, Gainesville, FL USA; [Slankard, Kate] Kentucky Dept Fish & Wildlife Resources, Frankfort, KY USA; [Poppenga, Robert] Univ Calif Davis, Sch Vet Med, Calif Anim Hlth & Food Safety Labs, Davis, CA 95616 USA; [Millsap, Brian] US Fish & Wildlife Serv, Div Migratory Bird Management, Albuquerque, NM USA; [Niedringhaus, Kevin D.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Fenton, Heather] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Charlie, Bahnson] North Dakota Game & Fish Dept, Bismarck, ND USA; [Dalton, Martha Frances] Mississippi State Univ, Coll Vet Med, Mississippi Vet & Res Diagnost Lab, Pearl, MI USA; [Elsmo, Elizabeth J.] Univ Wisconsin, Wisconsin Vet Diagnost Lab, Madison, WI USA	University System of Georgia; University of Georgia; United States Department of the Interior; US Fish & Wildlife Service; Florida Fish & Wildlife Conservation Commission; University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Ruder, MG (corresponding author), Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	mgruder@uga.edu		Fenton, Heather/0000-0002-0190-8921; Nemeth, Nicole/0000-0001-5931-175X; Niedringhaus, Kevin/0000-0002-9560-5621	SCWDS in Alabama; SCWDS in Arkansas; SCWDS in Florida; SCWDS in Georgia; SCWDS in Kentucky; SCWDS in Kansas; SCWDS in Louisiana; SCWDS in Maryland; SCWDS in Mississippi; SCWDS in Missouri; SCWDS in Nebraska; SCWDS in North Carolina; SCWDS in Oklahoma; SCWDS in Pennsylvania; SCWDS in South Carolina; SCWDS in Tennessee; SCWDS in Virginia; SCWDS in West Virginia; United States Department of Interior [F15PX01848]; United States Geological Survey Ecosystems Mission Area, United States Department of Interior [G18AC00319]	SCWDS in Alabama; SCWDS in Arkansas; SCWDS in Florida; SCWDS in Georgia; SCWDS in Kentucky; SCWDS in Kansas; SCWDS in Louisiana; SCWDS in Maryland; SCWDS in Mississippi; SCWDS in Missouri; SCWDS in Nebraska; SCWDS in North Carolina; SCWDS in Oklahoma; SCWDS in Pennsylvania; SCWDS in South Carolina; SCWDS in Tennessee; SCWDS in Virginia; SCWDS in West Virginia; United States Department of Interior; United States Geological Survey Ecosystems Mission Area, United States Department of Interior	We are grateful for funding provided by member state wildlife management agencies of SCWDS in Alabama, Arkansas, Florida, Georgia, Kentucky, Kansas, Louisiana, Maryland, Mississippi, Missouri, Nebraska, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Virginia, and West Virginia provided by the Federal Aid to Wildlife Restoration Act (50 Stat.917). Further, we thank our partnering federal agencies, including the United States Fish and Wildlife Service National Wildlife Refuge System, United States Department of Interior (F15PX01848) and the United States Geological Survey Ecosystems Mission Area, United States Department of Interior (G18AC00319). The funders had no role in study design, data collection and data analysis, decision to publish, or preparation of the manuscript.	Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; BACHMANN KA, 1983, PHARMACOLOGY, V27, P281, DOI 10.1159/000137881; Bradbury S, 2008, FINAL RISK MITIGATIO; Christensen TK, 2012, ARCH ENVIRON CON TOX, V63, P437, DOI 10.1007/s00244-012-9771-6; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; Eason CT, 1999, NEW ZEAL J ECOL, V23, P219; Elliott JE, 2014, ENVIRON MONIT ASSESS, V186, P895, DOI 10.1007/s10661-013-3422-x; Erickson W., 2004, POTENTIAL RISKS 9 RO; GRIER JW, 1982, SCIENCE, V218, P1232, DOI 10.1126/science.7146905; Harris MC, 2007, J ZOO WILDLIFE MED, V38, P62, DOI 10.1638/05-099.1; Herring G, 2017, J RAPTOR RES, V51, P273, DOI 10.3356/JRR-16-19.1; Hindmarch S, 2018, ANTICOAGULANT RODENT, P228; Hindmarch S, 2019, SCI TOTAL ENVIRON, V657, P1205, DOI 10.1016/j.scitotenv.2018.11.485; Hosea RC, 2000, PROC VERTEBR PEST C, P236; Kirk DA, 1998, BIOL CONSERV, V83, P91, DOI 10.1016/S0006-3207(97)00051-7; Lambert O, 2007, B ENVIRON CONTAM TOX, V79, P91, DOI 10.1007/s00128-007-9134-6; Langford KH, 2013, SCI TOTAL ENVIRON, V450, P205, DOI 10.1016/j.scitotenv.2013.01.100; Lemus JA, 2011, SCI TOTAL ENVIRON, V409, P4729, DOI 10.1016/j.scitotenv.2011.07.007; Martinez-Padilla J, 2017, PEST MANAG SCI, V73, P364, DOI 10.1002/ps.4435; MENDENHALL V M, 1980, Wildlife Society Bulletin, V8, P311; Millsap BA, 2013, J WILDLIFE MANAGE, V77, P1436, DOI 10.1002/jwmg.588; Murray M, 2020, ENVIRON TOXICOL CHEM, V39, P2325, DOI 10.1002/etc.4853; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Quinn N, 2019, HUM-WILDL INTERACT, V13, P200; Rattner BA, 2021, PEST MANAG SCI, V77, P604, DOI 10.1002/ps.6137; Rattner BA, 2020, ENVIRON TOXICOL CHEM, V39, P468, DOI 10.1002/etc.4629; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Russell RE, 2014, WILDLIFE SOC B, V38, P697, DOI 10.1002/wsb.469; Slankard KG, 2019, J WILDLIFE DIS, V55, P432, DOI 10.7589/2018-03-073; Smith LL, 2017, J AGR FOOD CHEM, V65, P6682, DOI 10.1021/acs.jafc.7b02280; Stansley W, 2014, B ENVIRON CONTAM TOX, V92, P6, DOI 10.1007/s00128-013-1135-z; Stone WB, 2003, B ENVIRON CONTAM TOX, V70, P34, DOI 10.1007/s00128-002-0152-0; Stone WB, 1999, J WILDLIFE DIS, V35, P187, DOI 10.7589/0090-3558-35.2.187; Thomas PJ, 2011, ENVIRON INT, V37, P914, DOI 10.1016/j.envint.2011.03.010; US Environmental Protection Agency, 2014, FED REGISTER, V79; US Environmental Protection Agency, 2008, DAILY J US GOVT, V73, P31868; Walker LA, 2013, ANTICOAGULANT RODENT, P29; Ward MR, 2006, J WILDLIFE DIS, V42, P92, DOI 10.7589/0090-3558-42.1.92; Wayland M, 2003, J RAPTOR RES, V37, P8	39	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0246134	10.1371/journal.pone.0246134	http://dx.doi.org/10.1371/journal.pone.0246134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826627	Green Published, gold			2022-12-26	WOS:000638119900008
J	Listik, E; Horst, B; Choi, AS; Lee, NY; Gyorffy, B; Mythreye, K				Listik, Eduardo; Horst, Ben; Choi, Alex Seok; Lee, Nam. Y.; Gyorffy, Balazs; Mythreye, Karthikeyan			A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors	PLOS ONE			English	Article								Inhibins and activins are dimeric ligands belonging to the TGF beta superfamily with emergent roles in cancer. Inhibins contain an alpha-subunit (INHA) and a beta-subunit (either INHBA or INHBB), while activins are mainly homodimers of either beta(A) (INHBA) or beta(B) (INHBB) subunits. Inhibins are biomarkers in a subset of cancers and utilize the coreceptors betaglycan (TGFBR3) and endoglin (ENG) for physiological or pathological outcomes. Given the array of prior reports on inhibin, activin and the coreceptors in cancer, this study aims to provide a comprehensive analysis, assessing their functional prognostic potential in cancer using a bioinformatics approach. We identify cancer cell lines and cancer types most dependent and impacted, which included p53 mutated breast and ovarian cancers and lung adenocarcinomas. Moreover, INHA itself was dependent on TGFBR3 and ENG/CD105 in multiple cancer types. INHA, INHBA, TGFBR3, and ENG also predicted patients' response to anthracycline and taxane therapy in luminal A breast cancers. We also obtained a gene signature model that could accurately classify 96.7% of the cases based on outcomes. Lastly, we cross-compared gene correlations revealing INHA dependency to TGFBR3 or ENG influencing different pathways themselves. These results suggest that inhibins are particularly important in a subset of cancers depending on the coreceptor TGFBR3 and ENG and are of substantial prognostic value, thereby warranting further investigation.	[Listik, Eduardo; Horst, Ben; Choi, Alex Seok; Mythreye, Karthikeyan] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Horst, Ben] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Lee, Nam. Y.] Univ Arizona, Coll Med, Div Pharmacol Chem & Biochem, Tucson, AZ USA; [Gyorffy, Balazs] Inst Enzymol, TTK Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Bioinformat, Budapest, Hungary; [Gyorffy, Balazs] 2nd Dept Pediat, Budapest, Hungary	University of Alabama System; University of Alabama Birmingham; University of South Carolina System; University of South Carolina Columbia; University of Arizona; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Mythreye, K (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.	mythreye@uab.edu	Gyorffy, Balazs/AAA-9135-2021; Listik, Eduardo/X-7521-2019	Gyorffy, Balazs/0000-0002-5772-3766; Listik, Eduardo/0000-0002-2586-8282; Karthikeyan, Mythreye/0000-0001-5478-0098	NCI [R01CA219495]; National Research, Development and Innovation Office Hungary [2018-2.1.17-TET-KR-00001, 2018-1.3.1-VKE-2018-00032]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research, Development and Innovation Office Hungary	KM, R01CA219495, NCI https://www.cancer.gov and BG, 2018-2.1.17-TET-KR-00001, 2018-1.3.1-VKE-2018-00032 National Research, Development and Innovation Office Hungary (https://ec.europa.eu/growth/tools-databases/regional-innovation-monitor/organisation/national-research-development-and-innovation-office).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao-Machado LF, 2016, WORLD J GASTROENTERO, V22, P4619, DOI 10.3748/wjg.v22.i19.4619; Allain EP, 2020, BRIT J CANCER, V122, P1277, DOI 10.1038/s41416-019-0722-0; Alzahrani A, 2018, J CELL COMMUN SIGNAL, V12, P379, DOI 10.1007/s12079-018-0461-7; [Anonymous], EVALUATION TRC105 TR; [Anonymous], BEVACIZUMAB TRC105 T; [Anonymous], TRC105 ADULTS ADVANC; [Anonymous], SORAFENIB TRC105 HEP; [Anonymous], TRC105 RECURRENT GLI; [Anonymous], PHASE 2 EVALUATION T; [Anonymous], TRC105 COMBINED STAN; [Anonymous], OPEN LABEL CONTINUAT; [Anonymous], STUDY TRC105 BEVACIZ; [Anonymous], STUDY CAROTUXIMAB TR; [Anonymous], STUDY TRC105 COMBINA; [Anonymous], PREOPERATIVE COMBINA; [Anonymous], PHASE 1B DOSE ESCALA; [Anonymous], OPEN LABEL PHASE 1 D; [Anonymous], 1990, HDB EXPT PHARM, V95; [Anonymous], RANDOMIZED PHASE 2 T; [Anonymous], TRC105 LIVER CANC HA; [Anonymous], TRIAL TRC105 PAZOPAN; [Anonymous], STUDY TRC105 COMBINE; [Anonymous], OPEN LABEL DOSE FIND; [Anonymous], STUDY TRC105 PACLITA; [Anonymous], TRIAL TRC105 SORAFEN; [Anonymous], STUDY TRC105 ABIRATE; [Anonymous], A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC).; [Anonymous], BEVACIZUMAB ANTIENDO; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Arora DS, 1997, J PATHOL, V181, P413, DOI 10.1002/(SICI)1096-9896(199704)181:4<413::AID-PATH789>3.0.CO;2-U; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bai SM, 2019, CANCERS, V11, DOI 10.3390/cancers11111710; Balanathan P, 2009, BRIT J CANCER, V100, P1784, DOI 10.1038/sj.bjc.6605089; Baldewijns MM, 2007, BRIT J CANCER, V96, P1888, DOI 10.1038/sj.bjc.6603796; Ball EMA, 2004, CYTOKINE GROWTH F R, V15, P291, DOI 10.1016/j.cytogfr.2004.04.004; Bandyopadhyay A, 2005, PROSTATE, V63, P81, DOI 10.1002/pros.20166; Bandyopadhyay A, 2002, CANCER RES, V62, P4690; Bashir M, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.7; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bitu CC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-146; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chen CY, 2018, FASEB J, V32; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen ZL, 2019, J CELL PHYSIOL, V234, P18065, DOI 10.1002/jcp.28439; Chong HR, 2000, ENDOCRINOLOGY, V141, P2600, DOI 10.1210/en.141.7.2600; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; Cook LM, 2019, ONCOGENE, V38, P6959, DOI 10.1038/s41388-019-0913-4; Das S, 2013, NEW ENGL J MED, V369, P1561, DOI 10.1056/NEJMcibr1309402; de la Fuente-Granada M, 2019, FEBS OPEN BIO, V9, P137, DOI 10.1002/2211-5463.12555; De Robertis M, 2017, CLIN CANCER RES, V23, P159, DOI 10.1158/1078-0432.CCR-16-0709; DEJONG FH, 1976, NATURE, V263, P71, DOI 10.1038/263071a0; Dempster J.M.R.J., 2019, BIORXIV, P720243, DOI [10.1101/720243, DOI 10.1101/720243]; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; Fekete JT, 2019, INT J CANCER, V145, P3140, DOI 10.1002/ijc.32369; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Frias AE, 1999, CANCER-AM CANCER SOC, V85, P465, DOI 10.1002/(SICI)1097-0142(19990115)85:2<465::AID-CNCR26>3.0.CO;2-W; GADDYKURTEN D, 1995, J BIOL CHEM, V270, P28733, DOI 10.1074/jbc.270.48.28733; Gallo-Oller G, 2016, CANCER LETT, V381, P67, DOI 10.1016/j.canlet.2016.07.029; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gatza CE, 2011, NEOPLASIA, V13, P758, DOI 10.1593/neo.11528; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gong Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202449; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Han QG, 2017, MOL MED REP, V16, P6290, DOI 10.3892/mmr.2017.7369; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2014, ONCOGENE, V33, P2737, DOI 10.1038/onc.2013.238; Huang JJ, 2016, BIOCHEM SOC T, V44, P1441, DOI 10.1042/BST20160065; Jarosz M, 2013, GENE THER, V20, P262, DOI 10.1038/gt.2012.28; Jenkins LM, 2018, CYTOKINE GROWTH F R, V39, P124, DOI 10.1016/j.cytogfr.2017.12.003; Jenkins LM, 2016, J BIOL CHEM, V291, P25716, DOI 10.1074/jbc.M116.748624; Jovanovic B, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3684; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katayama Y, 2017, IN VIVO, V31, P565, DOI 10.21873/invivo.11095; Kauer J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54767-x; KEOGH EJ, 1976, ENDOCRINOLOGY, V98, P997, DOI 10.1210/endo-98-4-997; Kim CY, 2020, J CANCER, V11, P3416, DOI 10.7150/jca.38728; Kim SY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-177; Kim SK, 2019, EXP BIOL MED, V244, P1547, DOI 10.1177/1535370219881160; Kim SK, 2019, STRUCTURE, V27, P1427, DOI 10.1016/j.str.2019.06.010; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kita A, 2017, J CANCER, V8, P2033, DOI 10.7150/jca.18714; Knelson EH, 2013, J CLIN INVEST, V123, P4786, DOI 10.1172/JCI69657; Lee JD, 2010, CARCINOGENESIS, V31, P175, DOI 10.1093/carcin/bgp271; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li J, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2147397; Li YN, 2018, ENDOCRINOLOGY, V159, P4077, DOI 10.1210/en.2018-00770; LING N, 1986, BIOCHEM BIOPH RES CO, V138, P1129, DOI 10.1016/S0006-291X(86)80400-4; Llopiz D, 2009, INT J CANCER, V125, P2614, DOI 10.1002/ijc.24656; Longui CA, 2004, J MED GENET, V41, P354, DOI 10.1136/jmg.2004.018978; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Makanji Y, 2007, ENDOCRINOLOGY, V148, P2309, DOI 10.1210/en.2006-1612; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; McCluggage WG, 1997, HISTOPATHOLOGY, V30, P518, DOI 10.1046/j.1365-2559.1997.5580774.x; McLean S, 2013, CELL SIGNAL, V25, P319, DOI 10.1016/j.cellsig.2012.10.001; Mellor SL, 2000, J CLIN ENDOCR METAB, V85, P4851, DOI 10.1210/jc.85.12.4851; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; MIYAMOTO K, 1985, BIOCHEM BIOPH RES CO, V129, P396, DOI 10.1016/0006-291X(85)90164-0; Mom CH, 2007, GYNECOL ONCOL, V105, P365, DOI 10.1016/j.ygyno.2006.12.034; Moyano-Galceran L, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911177; Mythreye K, 2013, ONCOGENE, V32, P1416, DOI 10.1038/onc.2012.157; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Naumann U, 2008, INT J ONCOL, V33, P759, DOI 10.3892/ijo_00000062; Nikiteas NI, 2007, GASTRIC CANCER, V10, P12, DOI 10.1007/s10120-006-0401-8; Nishida J, 2018, ONCOGENE, V37, P2197, DOI 10.1038/s41388-017-0084-0; Okano M, 2013, ONCOL REP, V30, P2903, DOI 10.3892/or.2013.2761; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Oxmann D, 2008, ONCOGENE, V27, P3567, DOI 10.1038/sj.onc.1211025; Paauwe M, 2016, ONCOGENE, V35, P4069, DOI 10.1038/onc.2015.509; Paauwe M, 2018, CLIN CANCER RES, V24, P6331, DOI 10.1158/1078-0432.CCR-18-0329; Risbridger GP, 2004, MOL CELL ENDOCRINOL, V225, P73, DOI 10.1016/j.mce.2004.02.015; RIVIER J, 1985, BIOCHEM BIOPH RES CO, V133, P120, DOI 10.1016/0006-291X(85)91849-2; Robertson DN, 2007, CANCER LETT, V249, P14, DOI 10.1016/j.canlet.2006.12.017; ROBERTSON DM, 1985, BIOCHEM BIOPH RES CO, V126, P220, DOI 10.1016/0006-291X(85)90594-7; Ruiz EML, 2020, SURGERY, V167, P73, DOI 10.1016/j.surg.2019.06.058; Schoonderwoerd MJA, 2020, CLIN CANCER RES, V26, P3831, DOI 10.1158/1078-0432.CCR-19-2889; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; SETCHELL BP, 1974, J ENDOCRINOL, V62, P675, DOI 10.1677/joe.0.0620675; SHANBHAG SA, 1985, BRIT J CANCER, V51, P877, DOI 10.1038/bjc.1985.133; Singh P, 2018, CANCER RES, V78, P2978, DOI 10.1158/0008-5472.CAN-17-2316; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Suzuki Y, 2008, PANCREAS, V36, pE40, DOI 10.1097/mpa.0b013e3181584643; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vogiatzi F, 2016, P NATL ACAD SCI USA, V113, pE8433, DOI 10.1073/pnas.1612711114; Walentowicz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090575; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Wardwell-Ozgo J, 2014, ONCOGENE, V33, P1017, DOI 10.1038/onc.2013.30; Wiater E, 2009, MOL ENDOCRINOL, V23, P1033, DOI 10.1210/me.2009-0021; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Woszczyk D, 2004, MED SCI MONITOR, V10, pCR33; Xiong SY, 2015, ONCOTARGET, V6, P31659, DOI 10.18632/oncotarget.5229; Yang H, 2017, PEERJ, V5, DOI 10.7717/peerj.3089; Zhang J, 2019, ONCOL LETT, V17, P5351, DOI 10.3892/ol.2019.10221; Zhang Jinguo, 2018, Oncotarget, V9, P7660, DOI 10.18632/oncotarget.23546; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhu J, 2012, J BIOL CHEM, V287, P8060, DOI 10.1074/jbc.M111.293381; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845; Zimmer BM, 2016, HORM CANCER-US, V7, P260, DOI 10.1007/s12672-016-0268-z	173	4	4	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249558	10.1371/journal.pone.0249558	http://dx.doi.org/10.1371/journal.pone.0249558			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819300	Green Published, gold			2022-12-26	WOS:000637647200040
J	Kumar, M; Huang, KY				Kumar, Manasi; Huang, Keng Yen			Impact of being an adolescent mother on subsequent maternal health, parenting, and child development in Kenyan low-income and high adversity informal settlement context	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; SUB-SAHARAN AFRICA; MENTAL-HEALTH; PERINATAL DEPRESSION; SOCIAL DETERMINANTS; SINGLE MOTHERHOOD; PREGNANCY; NAIROBI	Background Women who have experienced adolescent pregnancy and early motherhood are disproportionately affected in terms of their health and parenting capabilities, as well as their offspring's health. Guided by Stress Process and Social Determinants of Health (SDH) Frameworks, which posit that multiple sources of stressors and structural determinants of adolescent pregnancy influence adolescent mothers' subsequent health and quality of parenting (Xavier et al 2018, McLoyd 1998, Conger et al 2010, Gipson et al 2008). These dynamics then further impact offspring's outcomes. Using an Integrated Stress-SDH Process for Health Disparities model and we test on whether early motherhood is associated with and subsequent maternal and child health from two informal settlements in Nairobi. Methods A cross-sectional design with 394 mothers of 2-16 years old children who sought maternal and child health services at Kariobangi and Kangemi public health centers between October 2015 to April 2016 were recruited. Participating mothers were asked questions related to their adolescent pregnancy history, their current health, wellbeing, and parenting practices, and their child's health. Structural equation modeling (SEM) was utilized to examine hypothesized mediational pathways that adolescent pregnancy history has negative influences on women's health and parenting during adulthood, which also influence their child's health and development. Results Our study supports that women with a history of adolescent motherhood have poor physical and mental health outcomes as adults after adjusting for demographic confounders. SEM results partially support the Stress-SDH Process model that history of adolescent pregnancy had negative consequences on women's adulthood health, which also negatively impacted offspring's physical and mental health. Conclusion Consistent with the Stress Process and SDH literature, we found consistent cross-cultural literature that adolescent pregnancy set the stage for, subsequent poor maternal health and child outcomes. Although history of adolescent pregnancy and motherhood was not necessarily associated with negative parenting, consistent with parenting literature, negative parenting was associated with poor child mental health. Findings suggest importance of providing integrated care that address health and parenting needs to optimize offspring's development in instances of early motherhood.	[Kumar, Manasi] Univ Nairobi, Dept Psychiat, London, England; [Kumar, Manasi] UCL, London, England; [Huang, Keng Yen] NYU, Sch Med, Dept Populat Hlth, New York, NY USA	University of London; University College London; New York University	Kumar, M (corresponding author), Univ Nairobi, Dept Psychiat, London, England.; Kumar, M (corresponding author), UCL, London, England.	m.kumar@ucl.ac.uk		Huang, Keng-Yen/0000-0003-3245-7614	Fogarty International Center/NIH [K43 TW010716]; National Institutes of Mental Health [U19 MH110001-01]	Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Fogarty International Center/NIH K43 TW010716 award to Manasi Kumar from 2018-2023 National Institutes of Mental Health U19 MH110001-01-award to Manasi Kumar and Keng Yen Huang.	Agnafors S, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2082-y; Aitken Z, 2016, SOC SCI MED, V157, P9, DOI 10.1016/j.socscimed.2016.03.037; Amartya Sen., 1991, DEV FREEDOM AMARTYA; Ballard Terri, 2011, HOUSEHOLD HUNGER SCA; Bilszta JLC, 2008, AUST NZ J PSYCHIAT, V42, P56, DOI 10.1080/00048670701732731; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Comim F, 2012, CAMB J EDUC, V42, P441, DOI 10.1080/0305764X.2012.706392; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Donkin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000603; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Henretta JC, 2008, AGING MENT HEALTH, V12, P605, DOI 10.1080/13607860802343084; Herpertz-Dahlmann B., 2013, KINDER JUGENDPSYCHIA, V41, P407; Huang KY, 2018, CHILD PSYCHIAT HUM D, V49, P833, DOI 10.1007/s10578-018-0799-3; Huang KY, 2017, CHILD PSYCHIAT HUM D, V48, P517, DOI 10.1007/s10578-016-0679-7; Hymas R, 2019, J AFFECT DISORDERS, V246, P873, DOI 10.1016/j.jad.2018.12.041; Kabiru CW, 2012, CHILD YOUTH SERV, V33, P12, DOI 10.1080/0145935X.2012.665321; Kabiru CW, 2010, J YOUTH STUD, V13, P453, DOI 10.1080/13676261003801754; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kimbui E, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0222-2; Kumar M, 2018, GLOB SOC WELFARE, V5, P11, DOI 10.1007/s40609-017-0102-8; Lempp H, 2018, EPIDEMIOL PSYCH SCI, V27, P29, DOI 10.1017/S2045796017000634; Lieberman K, 2014, J ADOLESCENCE, V37, P1227, DOI 10.1016/j.adolescence.2014.08.004; Maness SB, 2016, J ADOLESCENT HEALTH, V58, P636, DOI 10.1016/j.jadohealth.2016.02.006; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; McPeak KE, 2015, CURR OPIN PEDIATR, V27, P138, DOI 10.1097/MOP.0000000000000185; Muthen LK, 2010, MPLUS; National Bureau of Statistics-Kenya and ICF International, 2015, KEN 2014 DEM HLTH SU, V6, P24; National Council for Population and Development, 2020, TEEN PREGN KENY NAT; Ntoimo LFC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1145; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Neal CR, 2005, DEV PSYCHOPATHOL, V17, P467, DOI 10.1017/S0954579405050224; Osok J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1706-y; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Pianta R.C., 1992, CHILD PARENT RELATIO; Pilkington PD, 2015, J AFFECT DISORDERS, V178, P165, DOI 10.1016/j.jad.2015.02.023; Recto P, 2017, ISSUES MENT HEALTH N, V38, P633, DOI 10.1080/01612840.2017.1330908; Schneider M, 2018, GLOB MENT HEALTH, V5, DOI 10.1017/gmh.2018.1; Schrecker T., 2010, CONCEPTUAL FRAMEWORK; UNFPA, 2017, TEEN MOTH KEN POW AD; UNICEF, 2019, EARL CHILDB UNICEF D; Webster-Stratton C, 1998, J CONSULT CLIN PSYCH, V66, P715, DOI 10.1037/0022-006X.66.5.715; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO AA-HA, GLOB ACC ACT HLTH AD; World Health Organization, 2018, MENTAL HLTH PRIMARY; World Health Organization (WHO), 2008, INT MENT HLTH PRIM C; Xavier C, 2018, J EPIDEMIOL COMMUN H, V72, P451, DOI 10.1136/jech-2017-209923; Xu FZ, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00819; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248836	10.1371/journal.pone.0248836	http://dx.doi.org/10.1371/journal.pone.0248836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793592	gold, Green Published			2022-12-26	WOS:000636467000002
J	Lee, SO; Lee, JE; Lee, S; Lee, SH; Kang, JS				Lee, Soon Ok; Lee, Jeong Eun; Lee, Shinwon; Lee, Sun Hee; Kang, Jin Suk			Prevalence and patterns of illicit drug use in people with human immunodeficiency virus infection in Korea	PLOS ONE			English	Article								Background Data on illicit drug use by Korean people infected with HIV are lacking. Here, we examined the prevalence and patterns of illicit drug use among people infected with HIV in Korea. Material and methods In this cross-sectional study, we included all patients infected with HIV who visited a tertiary care hospital in Korea from January 1990 to May 2020. Sociodemographic data of patients, including drug use, were collected at the first visit and during follow-up. Results Among 1,267 patients, 5.13% reported the use of an illicit drug in their lifetime, and 2.61% were users of injection drugs. The most commonly used drugs were cannabis/marijuana and methamphetamine, followed by nitrite inhalants, cocaine, dextromethorphan, carisoprodol, and 3,4-methylenedioxymethamphetamine. The illicit drug users tended to be younger than non-users, homosexuals/bisexuals, and infected with hepatitis C virus (HCV); they had a higher CD4(+) cell count than non-users. Among 65 users of illicit drugs, only 24.6% revealed their drug use at the first visit interview, and 24.6% reported using two or more drugs in their lifetime. Individuals who used injection drugs were more likely to be arrested for drug-related charges than the users of non-injection drugs. Moreover, they tended to be heavy users of illicit drugs, to report using two or more drugs in their lifetime, and to be HCV seropositive. In contrast, the users of non-injection drugs were more likely to be experimental users and to start using drugs overseas for the first time, but less likely to report their drug use at the first interview. Conclusions The prevalence of illicit drug use in people with HIV infection in Korea may have been underestimated. Further research based on more accurate measurements are warranted.	[Lee, Soon Ok; Lee, Jeong Eun; Lee, Shinwon; Lee, Sun Hee] Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Internal Med,Sch Med, Busan, South Korea; [Kang, Jin Suk] Inje Univ, Busan Paik Hosp, Coll Med, Div Infect Dis,Dept Internal Med, Busan, South Korea	Pusan National University; Pusan National University Hospital; Inje University	Lee, SH (corresponding author), Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Internal Med,Sch Med, Busan, South Korea.	zzanmery@gmail.com	LEE, SUN HEE/AAB-5714-2022	LEE, SUN HEE/0000-0003-2093-3628; Lee, Soon Ok/0000-0002-0399-2135				BI C, 2004, DRUG CONTROL POLICY; Choi Y, 2019, EPIDEMIOL HEALTH, V41, DOI 10.4178/epih.e2019037; Cofrancesco J, 2008, AIDS, V22, P357, DOI 10.1097/QAD.0b013e3282f3cc21; Feng LY, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0078-x; Garin N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00690; Grabovac I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26413-5; Hser YI, 2016, J NEUROIMMUNE PHARM, V11, P383, DOI 10.1007/s11481-016-9665-x; Huang MB, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010030; Hyman SM, 2009, J SUBST ABUSE TREAT, V36, P400, DOI 10.1016/j.jsat.2008.08.005; JOHNSTON LD, 1986, J DRUG ISSUES, V16, P29, DOI 10.1177/002204268601600103; Fuster-RuizdeApodaca MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211252; Kim E, 2016, FORENSIC SCI INT, V269, P50, DOI 10.1016/j.forsciint.2016.10.024; Korea SPsoRo, DRUG CRIM WHIT PAP 2; Lee S, 2016, KOREAN J INTERN MED, V31, P772, DOI 10.3904/kjim.2015.353; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Min JA, 2013, J MED VIROL, V85, P575, DOI 10.1002/jmv.23523; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072310; Park S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2731-8; prevention KCfDCa, 2017 HIV AIDS ANN RE; Swartz JA, 2018, AIDS BEHAV, V22, P1395, DOI 10.1007/s10461-017-2008-y; T MKM, 2003, TRENDS ISSUES CRIME; Yun M, 2015, INT J OFFENDER THER, V59, P1166, DOI 10.1177/0306624X14530671; Zhang Z, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4696-7	24	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249361	10.1371/journal.pone.0249361	http://dx.doi.org/10.1371/journal.pone.0249361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH8NB	33793637	gold, Green Published			2022-12-26	WOS:000636467000008
J	Nabity, SA; Gunde, LJ; Surie, D; Shiraishi, RW; Kirking, HL; Maida, A; Auld, AF; Odo, M; Jahn, A; Nyirenda, RK; Oeltmann, JE				Nabity, Scott A.; Gunde, Laurence J.; Surie, Diya; Shiraishi, Ray W.; Kirking, Hannah L.; Maida, Alice; Auld, Andrew F.; Odo, Michael; Jahn, Andreas; Nyirenda, Rose K.; Oeltmann, John E.			Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017)	PLOS ONE			English	Article								Background Isoniazid preventive therapy (IPT) against tuberculosis (TB) is a life-saving intervention for people living with HIV (PLHIV). In September 2017, Malawi began programmatic scale-up of IPT to eligible PLHIV in five districts with high HIV and TB burden. We measured the frequency and timeliness of early-phase IPT implementation to inform quality-improvement processes. Methods and findings We applied a two-stage cluster design with systematic, probability-proportional-to-size sampling of six U.S. Centers for Disease Control and Prevention (CDC)-affiliated antiretroviral therapy (ART) centers operating in the urban areas of Lilongwe and Blantyre, Malawi (November 2017). ART clinic patient volume determined cluster size. Within each cluster, we sequentially sampled approximately 50 PLHIV newly enrolled in ART care. We described a quality-of-care cascade for intensive TB case finding (ICF) and IPT in PLHIV. PLHIV newly enrolled in ART care were eligibility-screened for hepatitis and peripheral neuropathy, as well as for TB disease using a standardized four-symptom screening tool. Among eligible PLHIV, the overall weighted IPT initiation rate was 70% (95% CI: 46%-86%). Weighted IPT initiation among persons aged <15 years (30% [95% CI: 12%-55%]) was significantly lower than among persons aged >= 15 years (72% [95% CI: 47%-89%]; Rao-Scott chi-square P = 0.03). HIV-positive children aged <5 years had a weighted initiation rate of only 13% (95% CI: 1%-79%). For pregnant women, the weighted initiation rate was 67% (95% CI: 32%-90%), similar to non-pregnant women aged >= 15 years (72% [95% CI: 49%-87%]). Lastly, 95% (95% CI: 92%-97%) of eligible PLHIV started ART within one week of HIV diagnosis, and 92% (95% CI: 73%-98%) of patients receiving IPT began on the same day as ART. Conclusions Early-phase IPT uptake among adults at ART centers in Malawi was high. Child uptake needed improvement. National programs could adapt this framework to evaluate their ICF-IPT care cascades.	[Nabity, Scott A.; Surie, Diya; Shiraishi, Ray W.; Kirking, Hannah L.; Oeltmann, John E.] US Ctr Dis Control & Prevent, Global TB Prevent & Control Branch, Atlanta, GA 30333 USA; [Gunde, Laurence J.; Maida, Alice; Auld, Andrew F.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Lilongwe, Malawi; [Odo, Michael; Jahn, Andreas; Nyirenda, Rose K.] Malawi Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA	Nabity, SA (corresponding author), US Ctr Dis Control & Prevent, Global TB Prevent & Control Branch, Atlanta, GA 30333 USA.	hjq5@cdc.gov	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Gunde, Laurence Josofati/0000-0003-4281-8612; Shiraishi, Ray/0000-0001-7640-0666; Odo, Michael/0000-0001-6986-0226; Auld, Andrew/0000-0001-5089-9163	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)	This project was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of a nonresearch determination. CDC developed the study protocol; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2017, INT J TUBERC LUNG D, V21, P1127, DOI 10.5588/ijtld.16.0946; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; Ayele HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142290; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Birungi Francine Mwayuma, 2018, Tuberc Res Treat, V2018, P8690714, DOI 10.1155/2018/8690714; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chihana ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207656; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Harries AD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3620-x; Harries AD, 2012, HEALTH CARE MANAG SC, V15, P197, DOI 10.1007/s10729-011-9187-2; Jahn A, 2016, B WORLD HEALTH ORGAN, V94, P772, DOI 10.2471/BLT.15.166074; Kanyerere H, 2016, PUBLIC HEALTH ACTION, V6, P247, DOI 10.5588/pha.16.0053; LaCourse SM, 2017, JAIDS-J ACQ IMM DEF, V76, P74, DOI 10.1097/QAI.0000000000001461; Little KM, 2018, INT J TUBERC LUNG D, V22, P371, DOI 10.5588/ijtld.16.0836; Malawi Ministry of Health, 2016, CLIN MAN HIV CHILDR; Malawi Ministry of Health, INT HIV PROGR REP AP; Malawi Ministry of Health, 2014, CLIN MAN HIV CHILDR; Malawi Ministry of Health, 2018, MALAWI POPULATION BA; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Mueller Y, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007740, 10.1097/md.0000000000007740]; Okwara FN, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2719-8; Osman M, 2013, PUBLIC HEALTH ACTION, V3, P199, DOI 10.5588/pha.13.0034; Pathmanathan I, 2018, INT J TUBERC LUNG D, V22, P596, DOI 10.5588/ijtld.17.0758; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Saito S, 2018, JAIDS-J ACQ IMM DEF, V78, pS134, DOI [10.1097/QAI.0000000000001739, 10.1097/qai.0000000000001739]; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Semu M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2109-7; Tadesse Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155525; Takarinda KC, 2017, PUBLIC HEALTH ACTION, V7, P55, DOI 10.5588/pha.16.0102; Thindwa D, 2018, INT J TUBERC LUNG D, V22, P273, DOI 10.5588/ijtld.17.0370; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Uyei J, 2011, LANCET INFECT DIS, V11, P855, DOI 10.1016/S1473-3099(11)70145-1; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2015, REC 36 MONTHS IS PRE; World Health Organization, TUB COUNTR PROF MAL; World Health Organization, 2018, LAT TB INF UPD CONS; World Health Organization, 2016, US ANT DRUGS TREAT P; World Health Organization (WHO), 2015, GUID MON EV COLL TB	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248115	10.1371/journal.pone.0248115	http://dx.doi.org/10.1371/journal.pone.0248115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793577	Green Published, gold			2022-12-26	WOS:000636467000062
J	Suenaga, R; Suka, M; Hirao, T; Hidaka, I; Sakaida, I; Ishida, H				Suenaga, Riichiro; Suka, Machi; Hirao, Tomohiro; Hidaka, Isao; Sakaida, Isao; Ishida, Haku			Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; DACLATASVIR PLUS ASUNAPREVIR; TREATMENT-NAIVE; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; CAUSE MORTALITY; INTERFERON; THERAPY; HCV	Aim To evaluate the cost-effectiveness of therapeutic strategies initiated at different stages of liver fibrosis using three direct-acting antivirals (DAAs), sofosbuvir-ledipasvir (SL), glecaprevir-pibrentasvir (GP), and elbasvir plus grazoprevir (E/G), for Japanese patients with chronic hepatitis C (CHC) genotype 1. Methods We created an analytical decision model reflecting the progression of liver fibrosis stages to evaluate the cost-effectiveness of alternative therapeutic strategies applied at different fibrosis stages. We compared six treatment strategies: treating all patients regardless of fibrosis stage (TA), treating individual patients with one of four treatments starting at four respective stages of liver fibrosis progression (F1S: withholding treatment at stage F0 and starting treatment from stage F1 or higher, and three successive options, F2S, F3S, and F4S), and administering no antiviral treatment (NoRx). We adopted a lifetime horizon and Japanese health insurance payers' perspective. Results The base case analysis showed that the incremental quality-adjusted life years (QALY) gain of TA by SL, GP, and E/G compared with the strategies of starting treatments for patients with the advanced fibrosis stage, F2S, varied from 0.32 to 0.33, and the incremental cost-effectiveness ratios (ICERs) were US$24,320, US$18,160 and US$17,410 per QALY, respectively. On the cost-effectiveness acceptability curve, TA was most likely to be cost-effective, with the three DAAs at the willingness to pay thresholds of US$50,000. Conclusions Our results suggested that administration of DAA treatment for all Japanese patients with genotype 1 CHC regardless of their liver fibrosis stage would be cost-effective under ordinary conditions.	[Suenaga, Riichiro] Japanese Red Cross Yamaguchi Hosp, Yamaguchi, Yamaguchi, Japan; [Suka, Machi] Jikei Univ Med, Dept Publ Hlth & Environm Med, Minato Ku, Tokyo, Japan; [Hirao, Tomohiro] Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa, Japan; [Hidaka, Isao; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan; [Ishida, Haku] Yamaguchi Univ, Grad Sch Med, Dept Med Informat & Decis Sci, Ube, Yamaguchi, Japan	Kagawa University; Yamaguchi University; Yamaguchi University	Ishida, H (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Med Informat & Decis Sci, Ube, Yamaguchi, Japan.	hishida@yamaguchi-u.ac.jp		Suenaga, Riichiro/0000-0002-4023-9628; Ishida, Haku/0000-0002-7773-2555	Ministry of Health, Labour and Welfare of Japan [K8026002]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	TH, HI and MS received grant from Ministry of Health, Labour and Welfare of Japan. Grant number is K8026002. https://mhlw-grants.niph.go.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ISHOKU, V46, P524; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Backus LI, 2018, HEPATOLOGY, V68, P827, DOI 10.1002/hep.29811; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chahal HS, 2016, JAMA INTERN MED, V176, P65, DOI 10.1001/jamainternmed.2015.6011; Chayama K, 2018, J GASTROENTEROL, V53, P557, DOI 10.1007/s00535-017-1391-5; Chidi AP, 2016, HEPATOLOGY, V63, P428, DOI 10.1002/hep.28327; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cipriano Lauren E, 2018, MDM Policy Pract, V3, p2381468318776634, DOI 10.1177/2381468318776634; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Corman S, 2017, VALUE HEALTH, V20, P1110, DOI 10.1016/j.jval.2017.05.003; Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology, 2013, Hepatol Res, V43, P1, DOI 10.1111/hepr.12020; Fukuda T., 2013, Journal of the National Institute of Public Health, V62, P625; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Ichikawa T, 2018, HEPATOL RES, V48, pE232, DOI 10.1111/hepr.12974; Igarashi A, 2017, CURR MED RES OPIN, V33, P11, DOI 10.1080/03007995.2016.1222513; Igarashi A, 2017, CURR MED RES OPIN, V33, P1, DOI 10.1080/03007995.2016.1222512; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Ishida K, 2006, HEPATO-GASTROENTEROL, V53, P588; Jakobsen JC, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012143.pub2, 10.1002/14651858.CD012143.pub3]; Jhaveri MA, 2018, DRUG AGING, V35, P117, DOI 10.1007/s40266-017-0515-1; Ji F, 2018, ALIMENT PHARM THER, V47, P550, DOI 10.1111/apt.14507; Kasahara A, 2004, J VIRAL HEPATITIS, V11, P148, DOI 10.1046/j.1365-2893.2003.00481.x; Kawaguchi I, 2020, ADV THER, V37, P457, DOI 10.1007/s12325-019-01166-3; Kumada H, 2017, J GASTROENTEROL, V52, P520, DOI 10.1007/s00535-016-1285-y; Kumada H, 2016, J GASTROEN HEPATOL, V31, P14, DOI 10.1111/jgh.13073; Ledesma F, 2020, REV ESP QUIM, V33, P240, DOI 10.37201/req/030.2020; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Liakina V, 2015, J VIRAL HEPATITIS, V22, P4, DOI 10.1111/jvh.12475; Matsushita H, 2014, J GASTROEN HEPATOL, V29, P337, DOI 10.1111/jgh.12337; McEwan P, 2016, HEPATOL RES, V46, P423, DOI 10.1111/hepr.12570; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Nguyen J, 2019, J PEDIATR-US, V207, P90, DOI 10.1016/j.jpeds.2018.12.012; Oza N, 2017, HEPATOL RES, V47, P487, DOI 10.1111/hepr.12897; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Popping S, 2019, J VIRUS ERAD, V5, P179; Rattay T, 2017, GASTROENTEROLOGY, V153, P1531, DOI 10.1053/j.gastro.2017.10.016; Razavi H, 2020, LIVER INT, V40, P522, DOI 10.1111/liv.14324; Shimoda S., 2014, MED COST RELATED VIR; Spengler U, 2018, PHARMACOL THERAPEUT, V183, P118, DOI 10.1016/j.pharmthera.2017.10.009; Sugimori H., 2014, STUDY UTILITY HEPATI; Suka M, STUDY COST EFFECTIVE; Suzuki M, 2016, EXP THER MED, V12, P3353, DOI 10.3892/etm.2016.3785; Szilberhorn L, 2019, ANTIVIR THER, V24, P247, DOI 10.3851/IMP3290; The Japan Society of Hepatology, 2018, PRACTICAL GUIDELINES; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Virabhak S, 2016, J MED ECON, V19, P1144, DOI 10.1080/13696998.2016.1206908; Westerhoff Maria, 2018, Surg Pathol Clin, V11, P287, DOI 10.1016/j.path.2018.02.002; World Health Organisation, 2016, GLOB HLTH SECT STRAT; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Younossi Z, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0598-8	56	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248748	10.1371/journal.pone.0248748	http://dx.doi.org/10.1371/journal.pone.0248748			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793594	gold, Green Published			2022-12-26	WOS:000636467000102
J	Wang, Y; Zhao, HN				Wang, Yan; Zhao, Henan			Digital data-based strategies: A novel form of better understanding COVID-19 pandemic and international scientific collaboration	PLOS ONE			English	Article							HEALTH; EPIDEMIOLOGY	International scientific collaborations have always been regarded as critical actions to address global pandemics, however, there was an obvious uncertainty between international collaboration and the COVID-19 control. We aim to combine digital data-based strategies to produce meaningful and advanced insights into the imbalance between COVID-19 and international collaboration, as well as reveal possible influencing factors, and ultimately enhance global collaboration. We conducted three retrospective cohort studies using respectively COVID-19 data from WHO, a complete dataset of scientific publications on coronavirus-related research from WoS, and daily data from Google Trends (GT). The results of geovisualization and spatiotemporal analysis revealed that the global COVID19 pandemic still remains serious. The global issue of imbalance between international collaborations and pandemic does exit, and the nations with good pandemic control had their own characteristics in above-mentioned correlation. Digital epidemiology provides, at least in part, evidence-based assessment and scientific advice to understand the imbalance between international collaborations and COVID-19. Our investigation demonstrates that transdisciplinary conversation through digital data-based strategies can help us fully understand the complex factors influencing the effectiveness of international scientific collaboration, thus facilitating the global response to COVID-19.	[Wang, Yan] Dalian Med Univ, Hosp 2, Sci Res Ctr, Dalian, Liaoning, Peoples R China; [Zhao, Henan] Dalian Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University	Wang, Y (corresponding author), Dalian Med Univ, Hosp 2, Sci Res Ctr, Dalian, Liaoning, Peoples R China.; Zhao, HN (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Dalian, Liaoning, Peoples R China.	zhaohenan@dmu.edu.cn; yanzi941026@126.com			Liaoning Education Department Program [LZ2019031]; Liaoning Provincial Program for Top Discipline of Basic Medical Sciences	Liaoning Education Department Program; Liaoning Provincial Program for Top Discipline of Basic Medical Sciences	Henan Zhao: This work was supported by Liaoning Education Department Program (LZ2019031) and Liaoning Provincial Program for Top Discipline of Basic Medical Sciences.	Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bell BP, 2016, MMWR-MORBID MORTAL W, V65, P4, DOI 10.15585/mmwr.su6503a2; Bowers KW, 2007, B HIST MED, V81, P335, DOI 10.1353/bhm.2007.0020; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Eckmanns T, 2019, LIFE SCI SOC POLICY, V15, DOI 10.1186/s40504-019-0091-8; Fry CV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236307; Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135; Khan A, 2016, OBES REV, V17, P377, DOI 10.1111/obr.12372; Kinsella CM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008902; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Makri A, 2017, LANCET, V390, P833, DOI 10.1016/S0140-6736(17)32278-X; Park HA, 2018, HEALTHC INFORM RES, V24, P253, DOI 10.4258/hir.2018.24.4.253; Salathe M, 2018, LIFE SCI SOC POLICY, V14, DOI 10.1186/s40504-017-0065-7; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Sgro A, 2019, WORLD J SURG, V43, P2689, DOI 10.1007/s00268-019-05112-w; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	18	3	3	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249280	10.1371/journal.pone.0249280	http://dx.doi.org/10.1371/journal.pone.0249280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793613	Green Published, gold			2022-12-26	WOS:000636467000064
J	Feldman, O; Samuel, N; Kvatinsky, N; Idelman, R; Diamand, R; Shavit, I				Feldman, Oren; Samuel, Nir; Kvatinsky, Noa; Idelman, Ravit; Diamand, Raz; Shavit, Itai			Endotracheal intubation of COVID-19 patients by paramedics using a box barrier: A randomized crossover manikin study	PLOS ONE			English	Article							TRACHEAL INTUBATION; AIRWAY MANAGEMENT; AEROSOL BOXES; PROTECTION	Background In the prehospital setting, endotracheal intubation (ETI) may be required to secure the coronavirus disease 2019 (COVID-19) patient airway. It has been suggested that the use of a protective barrier can reduce possible aerosol delivery from patients to clinicians during ETI. We sought to assess the performance of ETI by paramedics wearing personal protective equipment with and without the use of a box barrier. Methods A randomized, crossover simulation study was performed in a simulation laboratory. Study participants were 18 paramedics actively working in the clinical environment. Participants' performance of ETI via direct laryngoscopy (DL) with and without the use of a box barrier was assessed. The sequence of intubation was randomized to either BoxDL-first or DL-first. The primary outcome was the success rate of ETI on first-attempt. The secondary and tertiary outcomes were ETI success rates on three attempts and total intubation time, respectively. Results There were no differences between the DL group and the BoxDL group in one-attempt success rates (14/18 vs 12/18; P = 0.754), and in overall success rates (16/18 vs 14/18; P = 0.682). The mean (standard deviation) of the total intubation times for the DL group and the BoxDL group were 27.3 (19.7) seconds and 36.8 (26.2) seconds, respectively (P < 0.015). Conclusions The findings of this pilot study suggest that paramedics wearing personal protective equipment can successfully perform ETI using a barrier box, but the intubation time may be prolonged. The applicability of these findings to the care of COVID-19 patients remain to be investigated.	[Feldman, Oren; Samuel, Nir; Kvatinsky, Noa; Idelman, Ravit; Diamand, Raz; Shavit, Itai] Rambam Hlth Care Campus, Pediat Emergency Dept, Haifa, Israel; [Samuel, Nir] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel	Rambam Health Care Campus; Weizmann Institute of Science	Shavit, I (corresponding author), Rambam Hlth Care Campus, Pediat Emergency Dept, Haifa, Israel.	itai@pem-database.org						Adir Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01017-2020; Begley JL, 2020, ANAESTHESIA, V75, P1014, DOI 10.1111/anae.15115; Brown H, 2020, ANESTHESIOLOGY, V133, P683, DOI 10.1097/ALN.0000000000003422; Canelli R, 2020, NEW ENGL J MED, V382, P1957, DOI 10.1056/NEJMc2007589; Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9; Clariot S, 2020, ANAESTH CRIT CARE PA, V39, P461, DOI 10.1016/j.accpm.2020.06.005; Cubillos J, 2020, BRIT J ANAESTH, V125, pE179, DOI 10.1016/j.bja.2020.04.059; Fang PH, 2020, ANN EMERG MED, V75, P787, DOI 10.1016/j.annemergmed.2020.04.004; Feldman O, 2020, JAMA-J AM MED ASSOC, V323, P2091, DOI 10.1001/jama.2020.6633; Gore RK, 2020, IEEE J TRANSL ENG HE, V8, DOI 10.1109/JTEHM.2020.2993531; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hsu SH, 2020, EMERG MED J, V37, P400, DOI 10.1136/emermed-2020-209829; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Koyama J, 2010, RESUSCITATION, V81, P1172, DOI 10.1016/j.resuscitation.2010.05.020; Leong YC, 2020, RESUSC PLUS, V4, DOI 10.1016/j.resplu.2020.100027; Otten D, 2014, ANN EMERG MED, V63, P6, DOI 10.1016/j.annemergmed.2013.07.014; Perlini S, 2020, INTERN EMERG MED, V15, P825, DOI 10.1007/s11739-020-02390-4; Saito T, 2020, BRIT J ANAESTH, V125, pE284, DOI 10.1016/j.bja.2020.06.002; Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049; Sorbello M, 2020, BRIT J ANAESTH, V125, P880, DOI 10.1016/j.bja.2020.08.038; Spina S, 2020, LANCET, V395, pE49, DOI 10.1016/S0140-6736(20)30493-1; Timmermann A, 2007, RESUSCITATION, V73, P412, DOI 10.1016/j.resuscitation.2006.10.019	23	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248383	10.1371/journal.pone.0248383	http://dx.doi.org/10.1371/journal.pone.0248383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788837	Green Published, gold			2022-12-26	WOS:000636354600049
J	Huang, S; Lyu, YJ; Xiu, LW; Sha, H				Huang, Shuai; Lyu, Yuejun; Xiu, Liwei; Sha, Haijun			Seismic performance analysis of a wind turbine tower subjected to earthquake and ice actions	PLOS ONE			English	Article							DESIGN	Sea ice is one of the main loads acting on a wind turbine tower in areas prone to icing, and this threatens safe working life of the wind turbine tower. In our study, a simplified calculated model of ice, wind turbine tower, and water dynamic interaction under earthquake action was proposed, which could avoid to solve a large number of nonlinear equations. Then, the seismic behaviour of the wind turbine tower with and without the influence of sea ice was investigated, and we found that the influence of the greater mass of the sea ice on the seismic response of a wind turbine tower should be considered when the wind turbine tower is designed in an area with thick ice. With the influence of the most unfavourable ice mass, the deformation and energy dissipation capacity of the wind turbine tower are decreased, and the wall thickness or stiffening rib thickness should be increased to improve the seismic performance and ductility of the wind turbine tower; the shear force and bending moment increased significantly on the wind turbine tower, and the shear force changes at the bottom of the wind turbine tower and position of action of the sea ice: attention should be paid to the wind turbine tower design at these positions. Finally, we conducted the shaking table test, and verified the rationality of our proposed simplified model.	[Huang, Shuai; Lyu, Yuejun; Xiu, Liwei; Sha, Haijun] China Earthquake Adm, Inst Crustal Dynam, Beijing, Peoples R China	China Earthquake Administration	Huang, S (corresponding author), China Earthquake Adm, Inst Crustal Dynam, Beijing, Peoples R China.	huangshuai3395@163.com			Institute of Crustal Dynamics, China Earthquake Administration [ZDJ2017-14]; CAST's Young Elite Scientists Sponsorship Programme [2018QNRC001]; National Key R&D Programme of China [2017YFC1500404]	Institute of Crustal Dynamics, China Earthquake Administration; CAST's Young Elite Scientists Sponsorship Programme; National Key R&D Programme of China	This work is financially supported by research grants from the Institute of Crustal Dynamics, China Earthquake Administration (Grant No.ZDJ2017-14), CAST's Young Elite Scientists Sponsorship Programme (2018QNRC001), and the National Key R&D Programme of China (2017YFC1500404).	American Petroleum Institute (AP, 1993, RECOMMENDED PRACTICE; [Anonymous], 19982 EN; [Anonymous], 2012, GB500092012; [Anonymous], 2002, SPECIFICATIONS HIGHW; [Anonymous], 2019, GB501352019; BRAND L, 1957, ARCH RATION MECH AN, V1, P35, DOI 10.1007/BF00297994; Canadian Standards Association (CSA, 1992, CANCSAS47192C; Croteau P., 1983, DYNAMIC INTERACTIONS, DOI [10.1016/0003-9861%2883%2990389-2, DOI 10.1016/0003-9861%2883%2990389-2]; De Risi R, 2018, SOIL DYN EARTHQ ENG, V109, P154, DOI 10.1016/j.soildyn.2018.03.015; Huang S, 2021, ENG STRUCT, V227, DOI 10.1016/j.engstruct.2020.111426; Huang Shuai., 2021, EXTREME MECH LETT, V43, P82021; Jia LL, 2011, ADV MATER RES-SWITZ, V163-167, P4072, DOI 10.4028/www.scientific.net/AMR.163-167.4072; Kaynia AM, 2019, SOIL DYN EARTHQ ENG, V124, P399, DOI 10.1016/j.soildyn.2018.04.038; Kiyokawa T., 2002, P CIVIL ENG OCEAN, V18, P761; MORISON JR, 1950, PETROLEUM T AIME, V189, P149, DOI DOI 10.2118/950149-G; Paavilainen J, 2012, COLD REG SCI TECHNOL, V81, P1, DOI 10.1016/j.coldregions.2012.04.005; Paquette E, 2017, COLD REG SCI TECHNOL, V142, P55, DOI 10.1016/j.coldregions.2017.07.010; Petersen W., 2015, INT C PORT OC ENG AR; Qi Fuqiang., 2014, CHINA CIVIL ENG J, V47, P215; SATO Kouichi NAKANISHI Mitsukazu etc, 2001, ANN M ARCH I JAP, P265; Timco GW, 2010, COLD REG SCI TECHNOL, V60, P107, DOI 10.1016/j.coldregions.2009.10.003; Xiong Feng., 2009, STRUCTURES 2009 DONT, P48; Xu ZQ, 2018, PROCEEDINGS OF 2018 IEEE WORLD SYMPOSIUM ON COMMUNICATION ENGINEERING (WSCE), P1, DOI 10.1109/WSCE.2018.8690540; Yamauchi Y., 2002, P CIVIL ENG OCEAN, V18, P755; Zhao B, 2018, WIND ENERGY, V21, P1309, DOI 10.1002/we.2256; Zheng XY, 2015, MAR STRUCT, V44, P125, DOI 10.1016/j.marstruc.2015.08.003	26	0	0	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0247557	10.1371/journal.pone.0247557	http://dx.doi.org/10.1371/journal.pone.0247557			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788860	Green Published, gold			2022-12-26	WOS:000636354600021
J	Lusczek, ER; Ingraham, NE; Karam, BS; Proper, J; Siegel, L; Helgeson, ES; Lotfi-Emran, S; Zolfaghari, EJ; Jones, E; Usher, MG; Chipman, JG; Dudley, RA; Benson, B; Melton, GB; Charles, A; Lupei, MI; Tignanelli, CJ				Lusczek, Elizabeth R.; Ingraham, Nicholas E.; Karam, Basil S.; Proper, Jennifer; Siegel, Lianne; Helgeson, Erika S.; Lotfi-Emran, Sahar; Zolfaghari, Emily J.; Jones, Emma; Usher, Michael G.; Chipman, Jeffrey G.; Dudley, R. Adams; Benson, Bradley; Melton, Genevieve B.; Charles, Anthony; Lupei, Monica I.; Tignanelli, Christopher J.			Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles	PLOS ONE			English	Article								Purpose Heterogeneity has been observed in outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19). Identification of clinical phenotypes may facilitate tailored therapy and improve outcomes. The purpose of this study is to identify specific clinical phenotypes across COVID-19 patients and compare admission characteristics and outcomes. Methods This is a retrospective analysis of COVID-19 patients from March 7, 2020 to August 25, 2020 at 14 U.S. hospitals. Ensemble clustering was performed on 33 variables collected within 72 hours of admission. Principal component analysis was performed to visualize variable contributions to clustering. Multinomial regression models were fit to compare patient comorbidities across phenotypes. Multivariable models were fit to estimate associations between phenotype and in-hospital complications and clinical outcomes. Results The database included 1,022 hospitalized patients with COVID-19. Three clinical phenotypes were identified (I, II, III), with 236 [23.1%] patients in phenotype I, 613 [60%] patients in phenotype II, and 173 [16.9%] patients in phenotype III. Patients with respiratory comorbidities were most commonly phenotype III (p = 0.002), while patients with hematologic, renal, and cardiac (all p<0.001) comorbidities were most commonly phenotype I. Adjusted odds of respiratory, renal, hepatic, metabolic (all p<0.001), and hematological (p = 0.02) complications were highest for phenotype I. Phenotypes I and II were associated with 7.30-fold (HR:7.30, 95% CI:(3.11-17.17), p<0.001) and 2.57-fold (HR:2.57, 95% CI:(1.10-6.00), p = 0.03) increases in hazard of death relative to phenotype III. Conclusion We identified three clinical COVID-19 phenotypes, reflecting patient populations with different comorbidities, complications, and clinical outcomes. Future research is needed to determine the utility of these phenotypes in clinical practice and trial design.	[Lusczek, Elizabeth R.; Jones, Emma; Chipman, Jeffrey G.; Melton, Genevieve B.; Tignanelli, Christopher J.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Ingraham, Nicholas E.; Lotfi-Emran, Sahar; Dudley, R. Adams] Univ Minnesota, Dept Med, Div Pulm & Crit Care, Box 736 UMHC, Minneapolis, MN 55455 USA; [Karam, Basil S.] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Proper, Jennifer; Siegel, Lianne; Helgeson, Erika S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Zolfaghari, Emily J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Usher, Michael G.; Benson, Bradley] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Dudley, R. Adams; Melton, Genevieve B.; Tignanelli, Christopher J.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA; [Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Charles, Anthony] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Lupei, Monica I.] Univ Minnesota, Dept Anesthesiol, Minneapolis, MN 55455 USA; [Tignanelli, Christopher J.] North Mem Hlth Hosp, Dept Surg, Robbinsdale, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Ingraham, NE (corresponding author), Univ Minnesota, Dept Med, Div Pulm & Crit Care, Box 736 UMHC, Minneapolis, MN 55455 USA.	ingra107@umn.edu	Lotfi-Emran, Sahar/AGY-2353-2022	Lotfi-Emran, Sahar/0000-0002-8650-6779; Lusczek, Elizabeth/0000-0003-4680-965X; Ingraham, Nicholas/0000-0002-0292-0594; Tignanelli, Christopher/0000-0002-8079-5565; Melton-Meaux, Genevieve/0000-0001-5193-1663	NIH National Heart, Lung, and Blood Institute [T32HL129956, T32HL07741]; Agency for Healthcare Research and Quality (AHRQ); Patient-Centered Outcomes Research Institute (PCORI) [K12HS026379]; National Institutes of Health's National Center for Advancing Translational Sciences [UL1TR002494]	NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health's National Center for Advancing Translational Sciences	1. NIH National Heart, Lung, and Blood Institute T32HL07741 (NEI) 2. This research was supported by the Agency for Healthcare Research and Quality (AHRQ) and Patient-Centered Outcomes Research Institute (PCORI), grant K12HS026379 (CJT) and the National Institutes of Health's National Center for Advancing Translational Sciences, grant UL1TR002494. 3. NIH National Heart, Lung, and Blood Institute T32HL129956 (JP, LS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Atkins JC., 2020, COVID 19 SEVERITY IS, DOI [10.1007/s00134-020-06120-4, DOI 10.1007/s00134-020-06120-4]; Azoulay E, 2020, INTENS CARE MED, V46, P1651, DOI 10.1007/s00134-020-06120-4; Bramante Carolyn T, 2020, medRxiv, DOI 10.1101/2020.06.19.20135095; Chiu Derek., 2020, **DATA OBJECT**; Diehl JL, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00716-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ingraham Nicholas E, 2020, medRxiv, DOI 10.1101/2020.09.02.20185983; Ingraham NE, 2020, LANCET RESP MED, V8, P544, DOI 10.1016/S2213-2600(20)30226-5; Ingraham Nicholas E, 2020, Crit Care Explor, V2, pe0108, DOI 10.1097/CCE.0000000000000108; Ingraham NE, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00912-2020; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9; Little RJA., 1987, STAT ANAL MISSING DA, Vxiv, P278; Nassiri V, 2018, BEHAV RES METHODS, V50, P501, DOI [10.3758/s13428-017-1013-4, 10.3758/s13428-017-1000-9]; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; R Core Team, 2020, R LANG ENV STAT COMP; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Tian WJ, 2020, J MED VIROL, V92, P1875, DOI 10.1002/jmv.26050; Tignanelli CJ, 2020, LANCET RESP MED, V8, pE30, DOI 10.1016/S2213-2600(20)30153-3; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19534-4; Ye WJ, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01428-7; Yu Y., 2020, LANCET RESP MED, V8, P481; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	32	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248956	10.1371/journal.pone.0248956	http://dx.doi.org/10.1371/journal.pone.0248956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788884	Green Published, gold, Green Submitted			2022-12-26	WOS:000636354600001
J	Morad, S; Pitches, D; Girling, A; Taylor, B; Fradd, V; MacArthur, C; Kenyon, S				Morad, Sharon; Pitches, David; Girling, Alan; Taylor, Beck; Fradd, Vikki; MacArthur, Christine; Kenyon, Sara			24 hour consultant obstetrician presence on the labour ward and intrapartum outcomes in a large unit in England: A time series analysis	PLOS ONE			English	Article							HOSPITAL DELIVERY	Objectives To explore the effect of introducing 24/7 resident labour ward consultant presence on neonatal and maternal outcomes in a large obstetric unit in England. Design Retrospective time sequence analysis of routinely collected data. Setting Obstetric unit of large teaching hospital in England. Participants Women and babies delivered between1 July 2011 and 30 June 2017. Births Main outcome measures The primary composite outcome comprised intrapartum stillbirth, neonatal death, babies requiring therapeutic hypothermia, or admission to neonatal intensive care within three hours of birth. Secondary outcomes included markers of neonatal and maternal morbidity. Planned subgroup analyses investigated gestation (<34 weeks; 34-36 weeks; >= 37 weeks) and time of day. Results 17324 babies delivered before and 16110 after 24/7 consultant presence. The prevalence of the primary outcome increased by 0.65%, from 2.07% (359/17324) before 24/7 consultant presence to 2.72% (438/16110, P < 0.001) after 24/7 consultant presence which was consistent with an upward trend over time already well established before 24/7 consultant presence began (OR 1.09 p.a.; CI 1.04 to 1.13). Overall, there was no change in this trend associated with the transition to 24/7. However, in babies born >= 37 weeks gestation, the upward trend was reversed after implementation of 24/7 (OR 0.67 p.a.; CI 0.49 to 0.93; P = 0.017). No substantial differences were shown in other outcomes or subgroups. Conclusions Overall, resident consultant obstetrician presence 24/7 on labour ward was not associated with a change in a pre-existing trend of increasing adverse infant outcomes. However, 24/7 presence was associated with a reversal in increasing adverse outcomes for term babies.	[Morad, Sharon] Birmingham Womens Hosp, Birmingham, W Midlands, England; [Pitches, David] Dudley Metropolitan Borough Council, Directorate Publ Hlth & Wellbeing, Dudley, England; [Girling, Alan; Taylor, Beck; MacArthur, Christine; Kenyon, Sara] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Fradd, Vikki] Univ Hosp Birmingham, Birmingham Heartlands Hosp, Neonatal Unit, Birmingham, W Midlands, England	Birmingham Women's Hospital; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham	Morad, S (corresponding author), Birmingham Womens Hosp, Birmingham, W Midlands, England.	sharon.morad@nhs.net	MacArthur, Christine/ABA-8601-2021	MacArthur, Christine/0000-0003-0434-2158; Kenyon, Sara/0000-0002-0756-9617; Girling, Alan/0000-0003-2022-045X; Taylor, Beck/0000-0002-3559-7922	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) West Midlands, UK; Applied Research Collaboration	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) West Midlands, UK(National Institute for Health Research (NIHR)); Applied Research Collaboration	CMcA, SK, AG and BT were funded by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) West Midlands, UK and Applied Research Collaboration, https://warwick.ac.uk/fac/sci/med/about/centres/arc-wm/.The views expressed are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2015, LANCET, V386, P951, DOI 10.1016/S0140-6736(15)00058-6; [Anonymous], 2017, BJOG, V124, pe106, DOI 10.1111/1471-0528.14178; Bourne T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030968; Braun V., 2022, THEMATIC ANAL PRACTI; British Association of Perinatal Medicine, 2011, CATEGORIES CARE 2011; Caughey AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.046; Cook T.D., 2002, EXPT QUASIEXPERIMENT; de Graaf JP, 2010, BJOG-INT J OBSTET GY, V117, P1098, DOI 10.1111/j.1471-0528.2010.02611.x; Department of Health Maternity Safety Programme Team, 2016, SAFER MATERNITY CARE; Ewusie JE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016018; Gijsen R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-92; Henderson J, 2017, BJOG-INT J OBSTET GY, V124, P1311, DOI 10.1111/1471-0528.14527; JISC, ONL SURV; Knight M, 2019, SAVING LIVES IMPROVI; MBRRACE-UK, 2015, PERINATAL MORTALITY; National Collaborating Centre for Mental Health (Great Britain) & National Institute for Health & Clinical Excellence (Great Britain), 2011, ALCOHOL USE DISORDER; National Patient Safety Association, 2007, 2006 QUOTED RCOG SAF; NPEU, MBRRACE UK MOTHERS B; Palmer WL, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5774; RCOG, 2007, SAFER CHILDBIRTH MIN; RCOG, 2017, GREEN TOP GUID MAN B; RCOG, 2010, LABOUR WARD SOLUTION; RCOG, 2005, FUTURE ROLE CONSULTA; RCOG, 2009, RESPONSIBILITY CONSU; RCOG, 2016, PROVIDING QUALITY CA; Reid HE, 2017, BJOG-INT J OBSTET GY, V124, P1321, DOI 10.1111/1471-0528.14649; Reid HE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019977; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Walker SP, 2016, BJOG-INT J OBSTET GY, V123, P1378, DOI 10.1111/1471-0528.13755; Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249233	10.1371/journal.pone.0249233	http://dx.doi.org/10.1371/journal.pone.0249233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788880	Green Published, gold			2022-12-26	WOS:000636354600043
J	Margraf, J; Brailovskaia, J; Schneider, S				Margraf, Jurgen; Brailovskaia, Julia; Schneider, Silvia			Adherence to behavioral Covid-19 mitigation measures strongly predicts mortality	PLOS ONE			English	Article							HEALTH	In the absence of vaccines or causal therapies, behavioral measures such as wearing face masks and maintaining social distance are central to fighting Covid-19. Yet, their benefits are often questioned by the population and the level of adherence to the measures is variable. We examined in representative samples across eight countries (N = 7,568) whether adherence reported around June 1, 2020 predicted the increase in Covid-19 mortality by August 31, 2020. Mortality increased 81.3% in low adherence countries (United States, Sweden, Poland, Russia), 8.4% in high adherence countries (Germany, France, Spain, United Kingdom). Across countries adherence and subsequent mortality increases correlated with r = -0.91. No African or South American countries were included in the present study, which limits the generalizability of the findings. While reported Covid-19 mortality is likely to be influenced by other factors, the almost tenfold difference in additional mortality is significant, and may inform decisions when choosing whether to prioritize individual liberty rights or health-protective measures.	[Margraf, Jurgen; Brailovskaia, Julia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany; [Schneider, Silvia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Child & Adolescent Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Margraf, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany.	Juergen.Margraf@rub.de	Margraf, Jürgen/A-6873-2008; Brailovskaia, Julia/AAN-7333-2021; Schneider, Silvia/C-5229-2015	Margraf, Jürgen/0000-0001-5207-7016; Brailovskaia, Julia/0000-0001-7607-1305; Schneider, Silvia/0000-0003-0698-8411				Ali ST, 2020, SCIENCE, V369, P1106, DOI 10.1126/science.abc9004; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Atalan A, 2020, ANN MED SURG, V56, P38, DOI 10.1016/j.amsu.2020.06.010; Blayac T, 2021, LANCET PUBLIC HEALTH, V6, pE9, DOI 10.1016/S2468-2667(20)30285-1; Brailovskaia J, 2021, J Affect Disord Rep, V3, P100067, DOI 10.1016/j.jadr.2020.100067; Brailovskaia J, 2020, INT J CLIN HLTH PSYC, V20, P183, DOI 10.1016/j.ijchp.2020.06.002; Brailovskaia J, 2020, CURR PSYCHOL, V39, P2192, DOI 10.1007/s12144-018-9911-x; Brailovskaia J, 2018, DRUG ALCOHOL DEPEN, V192, P324, DOI 10.1016/j.drugalcdep.2018.08.027; Chan KH, 2020, INT J EPIDEMIOL, V49, P1063, DOI 10.1093/ije/dyaa044; Cuello-Garcia C, 2020, J CLIN EPIDEMIOL, V127, P198, DOI 10.1016/j.jclinepi.2020.06.028; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Folkhalsomyndigheten, 2020, COVID 19 STAT RAPP; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Gournement France, 2020, COVID 19 TOUT INF ES; GOV.UK, 2020, COR COVID 19; Government of Poland, 2020, KOR INF ZAL; Government of United States, 2020, GOVT RESPONSE CORONA; Hasell J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00688-8; Haushofer J, 2020, SCIENCE, V368, P1063, DOI 10.1126/science.abb6144; Holman EA, 2020, CLIN PSYCHOL SCI, V8, P111, DOI 10.1177/2167702619858300; Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110; Keeton CP, 2008, J FAM PSYCHOL, V22, P212, DOI 10.1037/0893-3200.22.2.212; Konrath S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103469; Liang LL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68862-x; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Ministerio de Sanidad, 2020, INF CORONAVIRUS; Nichols AL, 2013, PERS INDIV DIFFER, V55, P189, DOI 10.1016/j.paid.2013.02.018; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Riordan BC, 2020, CURR PSYCHOL, V39, P1215, DOI 10.1007/s12144-018-9824-8; Scholten S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194642; Scholten S, 2017, SSM-POPUL HLTH, V3, P639, DOI 10.1016/j.ssmph.2017.07.010; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Sood Shivani, 2020, Curr Pharmacol Rep, V6, P212, DOI 10.1007/s40495-020-00229-2; Sunjaya AP, 2020, RESPIROLOGY, V25, P678, DOI 10.1111/resp.13834; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thompson RR, 2017, CLIN PSYCHOL SCI, V5, P513, DOI 10.1177/2167702617692030; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Tso RV, 2020, CLIN INFECT DIS, V71, P2195, DOI 10.1093/cid/ciaa593; undesministerium fur Gesundheit, 2020, CORONAVIRUS SARS COV; World Health Organization, CONS ADJ PUBL HLTH S; Xafis V, 2020, ASIAN BIOETHICS REV, V12, P65, DOI 10.1007/s41649-020-00125-3; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	44	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249392	10.1371/journal.pone.0249392	http://dx.doi.org/10.1371/journal.pone.0249392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784361	Green Published, gold			2022-12-26	WOS:000636359600063
J	Mukherjee, S; Mahapatra, B; Saggurti, N				Mukherjee, Saradiya; Mahapatra, Bidhubhusan; Saggurti, Niranjan			Why women do not use contraceptives: Exploring the role of male out-migration	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; INDIA; STIGMA; RISK	Introduction Contextual understanding of reasons for non-use of contraceptives is key to devising family planning (FP) strategies. This study aimed to understand the reasons for non-use of contraceptives among women in the context of male out-migration. Methods Focus Group Discussions (FGDs) were conducted in two high male out-migration districts in Bihar, namely Nawada and Gopalganj. Twenty-five FGDs were conducted with currently married women with migrant husbands, currently married men and Accredited Social Health Activists (ASHAs) during April-June 2019. Data were analysed by using a thematic approach through Atlas.ti-6.2. Results The reasons for contraceptive non-use in areas with high male out-migration were complex, as this included barriers to contraceptive use unique to high-migration areas and reasons commonly found in other rural settings. Non-use of contraceptives among women with migrant husbands was mostly driven by lack of contraceptive preparedness before husband's arrival, inability to procure contraceptives due to inaccessibility to health facilities and stigma to procure when husband was away. Other migration environment related factors included low ASHA outreach, myths and side effects of contraceptives, community fertility norms and poor spousal communications around FP. Conclusion The reasons for non-use of contraceptives are multifaceted, complex and interlinked. Exploration of these reasons in migration context suggest that FP programs in migration affected areas need to address a range of barriers to contraceptive use at multiple levels.	[Mukherjee, Saradiya; Mahapatra, Bidhubhusan; Saggurti, Niranjan] Populat Council, New Delhi, India		Mahapatra, B (corresponding author), Populat Council, New Delhi, India.	bbmahapatra@popcouncil.org		Mahapatra, Bidhubhusan/0000-0003-0240-7026	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Data for this study was collected with support from the David and Lucile Packard Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the David and Lucile Packard foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban B, 2012, INT PERSPECT SEX R H, V38, P43, DOI 10.1363/3804312; Banerjee A., 2020, ATTITUDE MEN CONTRAC, P3; Becker S, 2001, STUD FAMILY PLANN, V32, P111, DOI 10.1111/j.1728-4465.2001.00111.x; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Diamond-Smith N, 2008, CULT HEALTH SEX, V10, P697, DOI 10.1080/13691050802061665; Diamond-Smith N, 2012, CULT HEALTH SEX, V14, P421, DOI 10.1080/13691058.2012.664659; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Ghule Mohan, 2015, Asian J Res Soc Sci Humanit, V5, P18, DOI 10.5958/2249-7315.2015.00132.X; Hall KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195163; Halli SS, 2007, CULT HEALTH SEX, V9, P85, DOI 10.1080/13691050600963898; Hameed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104633; Heckert J, 2016, J BIOSOC SCI, V48, P723, DOI 10.1017/S002193201500036X; Hussain W., 2015, INT J REPROD MED, P2015; International Institute for Population Sciences, 2017, NATL FAMILY HLTH SUR; Jain A, 2019, J BIOSOC SCI, V51, P505, DOI 10.1017/S0021932018000305; Joshi A., 2001, ASIA PACIFIC POPULAT, V16, P177; Khanal MN., 2013, MINISTRY HLTH POPULA; Koiri P., 2014, ASIAN J MULTIDISCIPL, V2, P28; Mahapatra B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09906-9; Makleff S, 2019, SEX REPROD HLTH MATT, V27, P50, DOI 10.1080/26410397.2019.1661753; Miskinzod D., 2015, IMPACT MENS LABOR MI; Muttreja Poonam, 2018, Indian J Med Res, V148, pS1, DOI 10.4103/ijmr.IJMR_2067_17; Nayak S, 2017, J HEALTH MANAG, V19, P109, DOI 10.1177/0972063416682889; NFHP I. CREHPA, 2012, FAMILY PLANNING NEED; Nyblade L, 2017, CULT HEALTH SEX, V19, P1092, DOI 10.1080/13691058.2017.1293844; Pachauri S, 2014, INDIAN J MED RES, V140, P137; Ranjan A., 2013, HIV PREVALENCE AWARE; Ranjan A, 2019, J FAM MED PRIM CARE, V8, P1637, DOI 10.4103/jfmpc.jfmpc_180_19; Rao M, 2000, EC POLIT WEEKLY, V35, P4317; Roosen I, 2018, PUBLIC HEALTH, V158, P183, DOI 10.1016/j.puhe.2018.03.014; Roy AK., 2005, MIGRATION HLTH ASIA, V209; Saggurti N, 2011, MIGRATION HIV INDIA; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043222; Shakya HB, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0636-7; Shattuck D, 2019, SEX REPROD HLTH MATT, V27, P248, DOI 10.1080/26410397.2019.1647398	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249177	10.1371/journal.pone.0249177	http://dx.doi.org/10.1371/journal.pone.0249177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784370	gold, Green Published			2022-12-26	WOS:000636359600031
J	Xu, F; Tian, LL; Li, Y; Zhang, XL; Qi, YY; Jing, ZG; Pan, YY; Zhang, L; Fan, XX; Wang, M; Zeng, QY; Fan, WX				Xu, Fang; Tian, Lili; Li, Yan; Zhang, Xuelian; Qi, Yayin; Jing, Zhigang; Pan, Yangyang; Zhang, Li; Fan, Xiaoxu; Wang, Meng; Zeng, Qiaoying; Fan, Weixing			High prevalence of extrapulmonary tuberculosis in dairy farms: Evidence for possible gastrointestinal transmission	PLOS ONE			English	Article								Bovine tuberculosis (bTB) caused by Mycobacterium bovis (M. bovis) represents one of major zoonotic diseases among cattle, it also affects the health of human, other domestic animals and wild life populations. Inhalation of infected aerosol droplets is considered as the most frequent route of the infection. This study aims to investigate the current forms of tuberculosis in cattle and identify the possible transmission modes in dairy farms of China. 13,345 cows from eight dairy farms in three provinces were comprehensively diagnosed by a multitude of assays, including SIT, CIT, IFN-gamma assay and ELISA. It has been indicated that advanced infection of bTB was found in 752 (5.64%) cattle, suggesting a high prevalence of tuberculosis in these dairy farms. In the necropsy examination of 151 positive cattle, typical bTB lesions were observed in 131 cattle (86.75%), of which, notably, 90.84% lesions appeared in liver, spleen, mesenteric lymph nodes, mammary lymph nodes and other organs, taking up a large proportion among cattle with advanced bTB infection. 71.26% extrapulmonary tuberculosis (EPTB) was related to gastrointestinal system. M. bovis nucleic acid was further found in milk and feces samples and M. bovis was even isolated from milk samples. Phylogenetic analysis based on whole genome sequencing unraveled that six isolates were closely related to M. bovis AF2122/97 originated from UK, whereas four isolates shared close relation to M. bovis 30 from China, respectively. Our data demonstrate that the increase of EPTB transmitted by digestive tract is implicated in the current high prevalence rate of bTB in China, which also provides leads for bTB control in other countries with high prevalence of bTB in the future.	[Xu, Fang; Pan, Yangyang; Wang, Meng; Zeng, Qiaoying] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China; [Xu, Fang; Tian, Lili; Jing, Zhigang; Fan, Xiaoxu; Fan, Weixing] China Anim Hlth & Epidemiol Ctr, Div Zoonoses Surveillance, Natl Anim TB Reference Lab, Qingdao, Shandong, Peoples R China; [Li, Yan; Zhang, Li] Xinjiang Prod & Construct Corps, Anim Husb & Vet Stn, Urumqi, Xinjiang, Peoples R China; [Zhang, Xuelian] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China; [Qi, Yayin] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China	Gansu Agricultural University; China Animal Health & Epidemiology Center; Fudan University; Shihezi University	Zeng, QY (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.; Fan, WX (corresponding author), China Anim Hlth & Epidemiol Ctr, Div Zoonoses Surveillance, Natl Anim TB Reference Lab, Qingdao, Shandong, Peoples R China.; Zhang, XL (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.	xuelianzhang@fudan.edu.cn; zengqy@gsau.edu.cn; fanweixing@cahec.cn			Gansu Agriculture Research System [GARS-CS-5]; China Agriculture Research System [CARS-36]; National Natural Science Foundation of China [81673482, 81971898]	Gansu Agriculture Research System; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Gansu Agriculture Research System (GARS-CS-5); China Agriculture Research System (CARS-36); and the National Natural Science Foundation of China (81673482, 81971898).	Abdelaal HFM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48106-3; Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Barasona JA, 2017, TRANSBOUND EMERG DIS, V64, P1148, DOI 10.1111/tbed.12480; Barbier E, 2016, J APPL MICROBIOL, V120, P1193, DOI 10.1111/jam.13090; Ciaravino G, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00202; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Good M, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00059; Gormley E, 2014, RES VET SCI, V97, pS30, DOI 10.1016/j.rvsc.2014.04.010; Gormley E, 2013, TRANSBOUND EMERG DIS, V60, P128, DOI 10.1111/tbed.12095; Jenkins HE, 2008, EPIDEMIOL INFECT, V136, P1350, DOI 10.1017/S0950268807009909; Kaneene JB, 2006, MYCOBACTERIUM BOVIS, P34, DOI [DOI 10.1002/9780470344538.CH5, 10.1002/9780470344538.ch5]; Lehane R., 1996, BEATING ODDS BIG IND; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Michel AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129926; Milian-Suazo F, 2000, AM J VET RES, V61, P86, DOI 10.2460/ajvr.2000.61.86; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Narnaware SD, 2015, TROP ANIM HEALTH PRO, V47, P1633, DOI 10.1007/s11250-015-0905-5; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; OIE, 2018, MANUAL DIAGNOSTIC TE; Serrano M, 2018, VET RES, V49, DOI 10.1186/s13567-018-0566-2; Sun ZG, 2012, RES VET SCI, V92, P236, DOI 10.1016/j.rvsc.2011.03.012; Thoen C., 2006, MYCOBACTERIUM BOVIS, P18; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; Xu Fang, 2017, Chinese Journal of Veterinary Science, V37, P2402	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249341	10.1371/journal.pone.0249341	http://dx.doi.org/10.1371/journal.pone.0249341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784364	Green Published, gold			2022-12-26	WOS:000636359600051
J	Thanee, M; Dokduang, H; Kittirat, Y; Phetcharaburanin, J; Klanrit, P; Titapun, A; Namwat, N; Khuntikeo, N; Wangwiwatsin, A; Saya, H; Loilome, W				Thanee, Malinee; Dokduang, Hasaya; Kittirat, Yingpinyapat; Phetcharaburanin, Jutarop; Klanrit, Poramate; Titapun, Attapol; Namwat, Nisana; Khuntikeo, Narong; Wangwiwatsin, Arporn; Saya, Hideyuki; Loilome, Watcharin			CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROSPECTIVE IDENTIFICATION; REDOX REGULATION; CANCER-CELLS; GLUTAMINE; METASTASIS; TUMOR; ACTIVATION; EXPRESSION; TARGET	CD44 is a transmembrane glycoprotein, the phosphorylation of which can directly trigger intracellular signaling, particularly Akt protein, for supporting cell growth, motility and invasion. This study examined the role of CD44 on the progression of Cholangiocarcinoma (CCA) using metabolic profiling to investigate the molecular mechanisms involved in the Akt signaling pathway. Our results show that the silencing of CD44 decreases Akt and mTOR phosphorylation resulting in p21 and Bax accumulation and Bcl-2 suppression that reduces cell proliferation. Moreover, an inhibition of cell migration and invasion regulated by CD44. Similarly, the silencing of CD44 showed an alteration in the epithelial-mesenchymal transition (EMT), e.g. an upregulation of E-cadherin and a downregulation of vimentin, and the reduction of the matrix metalloproteinase (MMP)-9 signal. Interestingly, a depletion of CD44 leads to metabolic pathway changes resulting in redox status modification and Trolox (anti-oxidant) led to the recovery of the cancer cell functions. Based on our findings, the regulation of CCA progression and metastasis via the redox status-related Akt signaling pathway depends on the alteration of metabolic profiling synchronized by CD44.	[Thanee, Malinee; Dokduang, Hasaya; Phetcharaburanin, Jutarop; Klanrit, Poramate; Titapun, Attapol; Namwat, Nisana; Khuntikeo, Narong; Wangwiwatsin, Arporn; Loilome, Watcharin] Khon Kaen Univ, Cholangiocarcinoma Screening & Care Program CASCA, Khon Kaen, Thailand; [Thanee, Malinee; Dokduang, Hasaya; Kittirat, Yingpinyapat; Phetcharaburanin, Jutarop; Klanrit, Poramate; Titapun, Attapol; Namwat, Nisana; Khuntikeo, Narong; Wangwiwatsin, Arporn; Loilome, Watcharin] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand; [Thanee, Malinee] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen, Thailand; [Kittirat, Yingpinyapat; Phetcharaburanin, Jutarop; Klanrit, Poramate; Namwat, Nisana; Wangwiwatsin, Arporn; Loilome, Watcharin] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand; [Titapun, Attapol; Khuntikeo, Narong] Khon Kaen Univ, Dept Surg, Fac Med, Khon Kaen, Thailand; [Saya, Hideyuki] Keio Univ, Inst Adv Med Res IAMR, Div Gene Regulat, Sch Med, Tokyo, Japan	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Keio University	Loilome, W (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Screening & Care Program CASCA, Khon Kaen, Thailand.; Loilome, W (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand.; Loilome, W (corresponding author), Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand.	watclo@kku.ac.th	Loilome, Watcharin/AAW-6203-2021	Wangwiwatsin, Arporn/0000-0003-4536-4492; Klanrit, Poramate/0000-0003-0209-3901	Thailand Research Fund [RSA5980013]; Khon Kaen University through the Cholangiocarcinoma Screening Care Program [CASCAP-09]; Terumo Foundation for Life Sciences and Arts, Japan	Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University through the Cholangiocarcinoma Screening Care Program; Terumo Foundation for Life Sciences and Arts, Japan	This research was supported by the Thailand Research Fund (Grant No. RSA5980013) and Khon Kaen University through the Cholangiocarcinoma Screening Care Program (Grant No. CASCAP-09) as well as a grant from the Terumo Foundation for Life Sciences and Arts, Japan to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	Abraham AG, 2014, BIOCHEM SOC T, V42, P798, DOI 10.1042/BST20140070; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Botta D, 2008, DRUG METAB REV, V40, P465, DOI [10.1080/03602530802186587, 10.1080/03602530802186587 ]; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chen L, 2015, INT J MOL SCI, V16, P22830, DOI 10.3390/ijms160922830; Chen R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08436-6; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Duan GH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21831-x; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; IDZERDA RL, 1989, P NATL ACAD SCI USA, V86, P4659, DOI 10.1073/pnas.86.12.4659; Jacque N, 2015, BLOOD, V126, P1346, DOI 10.1182/blood-2015-01-621870; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kunlabut K, 2012, ASIAN PAC J CANCER P, V13, P95, DOI 10.7314/APJCP.2012.13.KKSuppl.95; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lee SY, 2017, INT J ONCOL, V50, P329, DOI 10.3892/ijo.2016.3801; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Liu SL, 2017, CANCER RES, V77, P3791, DOI 10.1158/0008-5472.CAN-16-2545; Marhaba R, 2004, J MOL HISTOL, V35, P211; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Mielgo A, 2006, CELL DEATH DIFFER, V13, P465, DOI 10.1038/sj.cdd.4401763; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nam K, 2016, BIOCHEM J, V473, P3013, DOI 10.1042/BCJ20160613; Ni J, 2014, PROSTATE, V74, P602, DOI 10.1002/pros.22775; Ohmura M, 2015, NITRIC OXIDE-BIOL CH, V46, P102, DOI 10.1016/j.niox.2014.11.005; Okoh VO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054206; OZOLS RF, 1990, CANCER TREAT REV, V17, P45, DOI 10.1016/0305-7372(90)90015-8; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pongcharoen P, 2011, CLIN EXP METASTAS, V28, P827, DOI 10.1007/s10585-011-9414-8; Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Schmitz KJ, 2007, WORLD J GASTROENTERO, V13, P6470, DOI 10.3748/wjg.13.6470; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sriamporn S, 2004, TROP MED INT HEALTH, V9, P588, DOI 10.1111/j.1365-3156.2004.01234.x; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Thanee M, 2016, CANCER SCI, V107, P991, DOI 10.1111/cas.12967; Thanee Malinee, 2015, Asian Pac J Cancer Prev, V16, P3043; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Vazquez A, 2016, J CELL SCI, V129, P3367, DOI 10.1242/jcs.181016; Wu ST, 2011, EXP BIOL MED, V236, P1022, DOI 10.1258/ebm.2011.011058; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yothaisong S, 2013, TUMOR BIOL, V34, P3637, DOI 10.1007/s13277-013-0945-2; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0245871	10.1371/journal.pone.0245871	http://dx.doi.org/10.1371/journal.pone.0245871			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780455	gold, Green Published			2022-12-26	WOS:000636336800049
J	Zungu, T; Mdala, S; Manda, C; Twabi, HS; Kayange, P				Zungu, Thokozani; Mdala, Shaffi; Manda, Chatonda; Twabi, Halima Sumayya; Kayange, Petros			Characteristics and visual outcome of ocular trauma patients at Queen Elizabeth Central Hospital in Malawi	PLOS ONE			English	Article							EYE INJURIES; EPIDEMIOLOGY	Background To describe the epidemiology and visual outcome of patients with ocular trauma treated at Queen Elizabeth Central hospital in Malawi. Methods A prospective, observational study was undertaken from September 2017 to December 2017. Data on socio-demographic features, aetiology of trauma, type of ocular injury pre-referral pathway and treatment of ocular trauma was collected as the exposure variables. The main outcome variable was best corrected visual acuity at 8 weeks following initial visit. Results A total of 102 patients (103 eyes) with ocular trauma were recruited with loss of follow up of 11 participants at 8 weeks following recruitment. The most affected age group were children under 11 years old (35.3%), followed by young adults of age between 21-30 years (22.5%). The male-to-female ratio for ocular injury was 2.8:1. Most participants had closed globe injuries (n = 72, 70.6%), with over half the population injured by blunt objects (n = 62, 60.8%). Furthermore, among the adult population, majority (n = 19 38%) were injured on the road during assaults (n = 24, 48%), while most paediatric injuries (n = 32, 61.5%) occurred at home during play. The incidence of monocular blindness was 25.3% at eight weeks after the first presentation. Factors that were associated with monocular blindness on multivariate analysis were living in rural areas and open globe injuries. Conclusion Ocular trauma led to monocular blindness in a quarter of the study population. There is need for preventive education of ocular injuries at both family and community level.	[Zungu, Thokozani; Mdala, Shaffi; Manda, Chatonda; Kayange, Petros] Univ Malawi, Coll Med, Blantyre, Malawi; [Zungu, Thokozani; Mdala, Shaffi; Manda, Chatonda; Kayange, Petros] Queen Elizabeth Cent Hosp, Lions Eye Unit, Blantyre, Malawi; [Twabi, Halima Sumayya] Univ Malawi, Math Sci Dept, Chancellor Coll, Zomba, Malawi	University of Malawi; University of Malawi; University of Malawi	Zungu, T (corresponding author), Univ Malawi, Coll Med, Blantyre, Malawi.; Zungu, T (corresponding author), Queen Elizabeth Cent Hosp, Lions Eye Unit, Blantyre, Malawi.	thokzungu@gmail.com	Mdala, Shaffi Yusuf/ACV-0748-2022	Mdala, Shaffi Yusuf/0000-0002-3581-523X; Zungu, Thokozani/0000-0001-9537-8679; Twabi, Halima/0000-0002-0166-9393	University of Malawi, Department of surgery	University of Malawi, Department of surgery	This work received funding from the University of Malawi, Department of surgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe BM, 2001, COMMUNITY EYE HEAL J, V14, P75; Abraham D I, 1999, Ophthalmic Epidemiol, V6, P85, DOI 10.1076/opep.6.2.85.1560; Addisu Z, 2011, ETHIOP J HEALTH DEV, V25, P150; Ajayi IA., 2014, PAKISTAN J OPHTHALMO, V30, P137; Alemayehu W., 2014, J OPHTHALMOL E CENT, P27; [Anonymous], Population projections for Malawi.; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bonsaana GB., 2015, J OPHTHALMOL E CENT, V19, P75; Dutoit N., 2015, INT J OPHTHALMOL-CHI, V8, P1229, DOI [10.3980/j.issn.2222-3959.2015.06.28, DOI 10.3980/J.ISSN.2222-3959.2015.06.28]; Fasasi Monsudi K., 2013, AM J MED SCI MED INT, V1, P66; Gebril M., 2017, LIBYAN INT MED U J, V2, P40; Grieshaber MC, 2006, EYE, V20, P789, DOI 10.1038/sj.eye.6702003; Gyasi Me, 2007, Ghana Med J, V41, P171; Hooi S H, 2003, Med J Malaysia, V58, P405; ILSAR M, 1982, BRIT J OPHTHALMOL, V66, P145, DOI 10.1136/bjo.66.2.145; Karaman K, 2004, CROAT MED J, V45, P304; Khatry SK, 2004, BRIT J OPHTHALMOL, V88, P456, DOI 10.1136/bjo.2003.030700; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Kuhn F., 2008, OCULAR TRAUMATOLOGY, P4; Kushwaha RN, 2013, J EVOL MED DENT SCI-, V2, P4903; Malawi population, 2020, TRADING EC; Mallika Ps, 2008, Malays Fam Physician, V3, P140; McGwin G., 2005, ARCH OPHTHALMOL-CHIC, V123, DOI [10.1001/archopht.123.7.970, DOI 10.1001/ARCHOPHT.123.7.970]; Moyo V., 2011, PATTERN SURGICAL EYE; Mustak H, 2014, S AFR FAM PRACT, V56, P88, DOI 10.1080/20786204.2014.10855344; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okoye O. I., 2006, Nigerian Journal of Surgical Research, V8, P34; Patel D, 2017, COMMUNITY EYE HEAL, V28, P41; Qi Y., 2015, INT J OPHTHALMOL INT, V8, P162, DOI [10.3980/j, DOI 10.3980/J]; Roberts Helen, 2015, Community Eye Health, V28, P50; Sii F, 2018, CLIN OPHTHALMOL, V12, P105, DOI 10.2147/OPTH.S155611; Sukati VN, 2012, AFR VIS EYE HEALTH J, V71, P159; Sukati VN., 2013, AFR VIS EYE HEALTH J, V72, P119; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; THYLEFORS B, 1992, AUST NZ J OPHTHALMOL, V20, P95, DOI 10.1111/j.1442-9071.1992.tb00718.x	36	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0246155	10.1371/journal.pone.0246155	http://dx.doi.org/10.1371/journal.pone.0246155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780448	Green Published, gold			2022-12-26	WOS:000636336800026
J	Puri, MC; Huber-Krum, S; Canning, D; Guo, MQ; Shah, IH				Puri, Mahesh Chandra; Huber-Krum, Sarah; Canning, David; Guo, Muqi; Shah, Iqbal H.			Does family planning counseling reduce unmet need for modern contraception among postpartum women: Evidence from a stepped-wedge cluster randomized trial in Nepal	PLOS ONE			English	Article								Background Postpartum women have high rates of unmet need for modern contraception in the two years following birth in Nepal. We assessed whether providing contraceptive counseling during pregnancy and/or prior to discharge from the hospital for birth or after discharge from the hospital for birth was associated with reduced postpartum unmet need in Nepal. Methods We used data from a larger a stepped-wedge, cluster randomized trial, including contraceptive counselling in six tertiary hospitals. Group 1 hospitals (three hospitals) initiated the intervention after three months of baseline data collection, while Group 2 hospitals (three hospitals) initiated the same intervention after nine months. We have enrolled 21,280 women in the baseline interviews and conducted two follow-up interviews with them, one and two years after they had delivered in one of our study hospitals. We estimated the effect of counseling and its timing (pre-discharge, post- discharge, both, or neither) on unmet need for modern contraception in the postpartum period, using random-effects logistic regressions. Results Unmet need for modern contraception was high (54% at one year and 50% at two years). Women counseled in either the pre-discharge period (Odds ratio [OR] 0.86; 95% CI: 0.80, 0.93) or in the post-discharge period (OR 0.86; 95% CI: 0.79, 0.93) were less likely to have an unmet need in the postpartum period compared to women with no counseling. However, women who received counseling in both the pre- and post-discharge period were 27% less likely than women who had not received counseling to have unmet need (OR 0.73; 95% CI: 0.67, 0.80). Conclusions Counseling women either before or after discharge reduces unmet need for postpartum contraception but counseling in both periods is most effective.	[Puri, Mahesh Chandra] Ctr Res Environm Hlth & Populat Act CREHPA, Kathmandu, Nepal; [Huber-Krum, Sarah; Canning, David; Guo, Muqi; Shah, Iqbal H.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Puri, MC (corresponding author), Ctr Res Environm Hlth & Populat Act CREHPA, Kathmandu, Nepal.	mahesh@crehpa.org.np		Puri, Mahesh/0000-0002-2913-1480; Huber-Krum, Sarah/0000-0003-0938-252X	Susan Thompson Buffett Foundation	Susan Thompson Buffett Foundation	The main study was funded by Susan Thompson Buffett Foundation. The funder of the study had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript. In addition, no funding support had received to prepare this manuscript.	Abdel-Tawab NG, 2008, FRONTIERS FINAL REPO; Achyut P, 2016, J FAM PLAN REPROD H, V42, P107, DOI 10.1136/jfprhc-2015-101271; Adeyemi AB, 2005, EUR J CONTRACEP REPR, V10, P229, DOI 10.1080/13625180500279763; Akman M, 2010, J INT MED RES, V38, P1243, DOI 10.1177/147323001003800405; Barber SL, 2007, INT FAM PLAN PERSPEC, V33, P6, DOI 10.1363/3300607; Canning D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1160-0; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; CBS, 2012, STAT NCBO; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; de Caestecker L, 2018, INT J GYNECOL OBSTET, V143, P4, DOI 10.1002/ijgo.12598; Dockalova B, 2016, USTAINABLE DEV GOALS, P1; FishelJoy D, 2012, DHS ANAL STUDIES, V25; Foreit KG, 1993, INT FAMILY PLANNING, V19, P19, DOI DOI 10.2307/2133378; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Hubacher D, 2015, CONTRACEPTION, V92, P420, DOI 10.1016/j.contraception.2015.08.008; Mehata S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/649567; Ministry of Health and Population (MoHP) Nepal., 2015, NATL FAMILY PLANNING; MoH Nepal New ERA ICF, 2017, NEPAL DEMOGRAPHIC HL; Morel RS., 2006, ACHIEVING MILLENNIUM; Pandey J.P., 2013, MATERNAL CHILD HLTH; Pasha O, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S11; Pfitzer A, 2015, INT J GYNECOL OBSTET, V130, pS54, DOI 10.1016/j.ijgo.2015.03.008; Puri MC, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00904-y; Puri MC, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3777-3; Rajan S, 2016, INT PERSPECT SEX R H, V42, P167, DOI 10.1363/42e2816; Ross JA, 2001, INT FAM PLAN PERSPEC, V27, P20, DOI 10.2307/2673801; Rutstein SO., 2011, TRENDS BIRTH SPACING, V28; Shattuck D, 2019, SEX REPROD HLTH MATT, V27, P248, DOI 10.1080/26410397.2019.1647398; Shrestha D R, 2012, J Nepal Health Res Counc, V10, P108; Singh S, 2009, ADDING IT COSTS BENE; Singh S., 2014, ADD COSTS BEN INV SE; Smith KB, 2002, CONTRACEPTION, V65, P237, DOI 10.1016/S0010-7824(01)00308-0; Sully E, 2020, ADDING IT INVESTING; Vernon R, 2009, STUD FAMILY PLANN, V40, P235, DOI 10.1111/j.1728-4465.2009.00206.x; WHO/USAID, 2012, STAT COLL ACT POSTP; World Health Organization (WHO, 2013, PROGR STRAT POSTP FA; Zerai A, 2001, Afr J Reprod Health, V5, P68, DOI 10.2307/3583432	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249106	10.1371/journal.pone.0249106	http://dx.doi.org/10.1371/journal.pone.0249106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770114	gold, Green Published			2022-12-26	WOS:000634833500046
J	Siragy, T; Hill, A; Nantel, J				Siragy, Tarique; Hill, Allen; Nantel, Julie			Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease	PLOS ONE			English	Article							ANTICIPATORY CONTROL; BODY BALANCE; GAIT; FALLS; VARIABILITY; PREVALENCE; DISORDERS; ASYMMETRY; RESPONSES; WALKING	The arm elevation strategy assists in recovering stability during slips in healthy young and elderly individuals. However, in people with Parkinson's Disease, one of the main motor symptoms affecting the upper limbs is reduced arm swing which intensifies throughout the course of the disease before becoming absent. This holds direct implications for these individuals when encountering slips as the arm elevation strategy is an integral component in the interlimb slip response to restore stability. Arm swing's effect in recovering from slips in people with Parkinson's Disease though remains unexamined. Twenty people with Parkinson's Disease (63.78 +/- 8.97 years) walked with restricted and unrestricted arm swing conditions on a dual-belt treadmill where slips were induced on the least and most affected sides. Data were collected on the CAREN Extended System (Motek Medical, Amsterdam, NL). The Margin of Stability, linear and angular trunk velocities, as well as step length, time, and width were calculated. Data were examined during the slipped step and recovery step. The restricted arm swing condition, compared to unrestricted, caused a faster step time during the slipped step. Compared to the most affected leg, the least affected had a wider step width during the slipped step. During the recovery step, the least affected leg had a larger anteroposterior Margin of Stability and longer step time than the most affected. No differences between our arm swing conditions suggests that the normal arm swing in our participants was not more effective at restoring stability after an induced slip compared to when their arm motion was restricted. This may be due to the arm elevation strategy being ineffective in counteracting the slip's backward destabilization in these individuals. Differences between the legs revealed that our participants were asymmetrically impaired in their slip recovery response.	[Siragy, Tarique; Hill, Allen; Nantel, Julie] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	University of Ottawa	Nantel, J (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	jnantel@uottawa.ca		Siragy, Tarique/0000-0002-0808-0450; Nantel, Julie/0000-0001-7253-9222; Hill, Allen/0000-0003-0939-0765	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04928]; NSERC [RGPAS 493045-2016]; Ontario Ministry of Research, Innovation and Science Early Researcher Award [16-12-206]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research, Innovation and Science Early Researcher Award	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC: https://www.nserccrsng.gc.ca/index_eng.asp) Discovery grant RGPIN-2016-04928, NSERC Accelerator supplement RGPAS 493045-2016 and by the Ontario Ministry of Research, Innovation and Science Early Researcher Award (ERA: https://www.ontario.ca/page/early-researcher-awards) 16-12-206. All funding was granted to Julie Nantel (JN).	Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bekkers EMJ, 2018, NEUROSCI BIOBEHAV R, V94, P113, DOI 10.1016/j.neubiorev.2018.08.008; Bhatt T, 2006, EXP BRAIN RES, V170, P61, DOI 10.1007/s00221-005-0189-5; Bhatt T, 2012, ARCH PHYS MED REHAB, V93, P557, DOI 10.1016/j.apmr.2011.10.027; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; GABELL A, 1985, ERGONOMICS, V28, P965, DOI 10.1080/00140138508963219; Gholizadeh H, 2019, J BIOMECH, V95, DOI 10.1016/j.jbiomech.2019.07.013; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082842; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hill A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218644; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Jehu D, 2018, GAIT POSTURE, V65, P246, DOI 10.1016/j.gaitpost.2018.07.181; Jinnah R., 1995, CLIN ORTHOPAEDICS, V7; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Lowry KA, 2009, MOVEMENT DISORD, V24, P261, DOI 10.1002/mds.22352; Luukinen H, 2000, OSTEOPOROSIS INT, V11, P631, DOI 10.1007/s001980070086; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; Mak MKY, 2010, J NEUROL, V257, P1543, DOI 10.1007/s00415-010-5573-9; Marigold DS, 2009, NEUROSCIENTIST, V15, P36, DOI 10.1177/1073858408322674; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; Marigold DS, 2002, J NEUROPHYSIOL, V88, P339, DOI 10.1152/jn.00691.2001; Mirelman A, 2016, MOVEMENT DISORD, V31, P1527, DOI 10.1002/mds.26720; Oates AR, 2010, EXP BRAIN RES, V201, P47, DOI 10.1007/s00221-009-2011-2; PRINCE F, 1994, GAIT POSTURE, V2, P19, DOI 10.1016/0966-6362(94)90013-2; Ricciardi L, 2015, NEUROL SCI, V36, P1337, DOI 10.1007/s10072-015-2082-8; Siragy T, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00213; Siragy T, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109529; Siragy T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00387; Stolze H, 2005, MOVEMENT DISORD, V20, P89, DOI 10.1002/mds.20266; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Swart SB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66305-1; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Yogev-Seligmann G, 2013, EXP BRAIN RES, V226, P81, DOI 10.1007/s00221-013-3412-9	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249303	10.1371/journal.pone.0249303	http://dx.doi.org/10.1371/journal.pone.0249303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822806	gold, Green Published			2022-12-26	WOS:000637879100020
J	Nehe, AS; Foulkes, MJ; Ozturk, I; Rasheed, A; York, L; Kefauver, SC; Ozdemir, F; Morgounov, A				Nehe, A. S.; Foulkes, M. J.; Ozturk, I.; Rasheed, A.; York, L.; Kefauver, S. C.; Ozdemir, F.; Morgounov, A.			Root and canopy traits and adaptability genes explain drought tolerance responses in winter wheat	PLOS ONE			English	Article							TRITICUM-AESTIVUM; SYSTEM ARCHITECTURE; SPRING WHEAT; DURUM-WHEAT; YIELD COMPONENTS; GRAIN-YIELD; STAY-GREEN; LEAF-AREA; WATER; GROWTH	Bread wheat (Triticum aestivum L) is one of the three main staple crops worldwide contributing 20% calories in the human diet. Drought stress is the main factor limiting yields and threatening food security, with climate change resulting in more frequent and intense drought. Developing drought-tolerant wheat cultivars is a promising way forward. The use of holistic approaches that include high-throughput phenotyping and genetic markers in selection could help in accelerating genetic gains. Fifty advanced breeding lines were selected from the CIMMYT Turkey winter wheat breeding program and studied under irrigated and semiarid conditions in two years. High-throughput phenotyping was done for wheat crown root traits and canopy senescence dynamics using vegetation indices (green area using RGB images and Normalized Difference Vegetation Index using spectral reflectance). In addition, genotyping by KASP markers for adaptability genes was done. Overall, under semiarid conditions yield reduced by 3.09 t ha(-1) (-46.8%) compared to irrigated conditions. Genotypes responded differently under drought stress and genotypes 39 (VORONA/HD24-12//GUN/7/VEE#8// horizontal ellipsis /8/ALTAY), 18 (BiII98) and 29 (NIKIFOR//KROSHKA) were the most drought tolerant. Root traits including shallow nodal root angle under irrigated conditions and root number per shoot under semiarid conditions were correlated with increased grain yield. RGB based vegetation index measuring canopy green area at anthesis was better correlated with GY than NDVI was with GY under drought. The markers for five established functional genes (PRR73.A1 -flowering time, TEF-7A -grain size and weight, TaCwi.4A - yield under drought, Dreb1- drought tolerance, and ISBW11.GY.QTL.CANDIDATE- grain yield) were associated with different drought-tolerance traits in this experiment. We conclude that-genotypes 39, 18 and 29 could be used for drought tolerance breeding. The trait combinations of canopy green area at anthesis, and root number per shoot along with key drought adaptability makers (TaCwi.4A and Dreb1) could be used in screening drought tolerance wheat breeding lines.	[Nehe, A. S.; Ozturk, I.] Int Maize & Wheat Improvement Ctr CIMMYT, Ankara, Turkey; [Foulkes, M. J.] Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Nottingham, England; [Rasheed, A.] China Off, Int Maize & Wheat Improvement Ctr CIMMYT, Beijing, Peoples R China; [York, L.] Noble Res Inst, Ardmore, OK USA; [Kefauver, S. C.] Univ Barcelona, Integrat Crop Ecophysiol Grp, Barcelona, Spain; [Ozdemir, F.] Bahri Dagdas Int Agr Res Inst, Konya, Turkey; [Morgounov, A.] Omsk State Agr Univ, Omsk, Russia	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Ministry of Food, Agriculture & Livestock - Turkey; University of Nottingham; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Noble Research Institute; University of Barcelona; Ministry of Food, Agriculture & Livestock - Turkey; Omsk State Agrarian University	Nehe, AS (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Ankara, Turkey.	ajit.nehe@gmail.com	Morgunov, Alexey/AGD-7910-2022; Kefauver, Shawn Carlisle/AAK-8461-2020	Morgunov, Alexey/0000-0001-7082-5655; Kefauver, Shawn Carlisle/0000-0002-1687-1965; Nehe, Ajit/0000-0002-1409-9297	CGIAR Research Program on Wheat; Bill and Melinda Gates Foundation (BMGF) [OPP1133199]; UK Department for International Development (DFID) [OPP1133199]; Republic of Turkey Ministry of Agriculture and Forestry	CGIAR Research Program on Wheat(CGIAR); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Republic of Turkey Ministry of Agriculture and Forestry	CIMMYT-Turkey is supported by the CGIAR Research Program on Wheat and the Republic of Turkey Ministry of Agriculture and Forestry. CIMMYT thanks the Bill and Melinda Gates Foundation (BMGF) and the UK Department for International Development (DFID) for providing financial support through the grant OPP1133199 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven S, 2015, PLANT SOIL, V395, P45, DOI 10.1007/s11104-015-2533-2; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Brdar MD, 2008, CENT EUR J BIOL, V3, P75, DOI 10.2478/s11535-007-0050-x; Briese C, 2015, INT SOC ROOT RES S P; Burridge J, 2016, FIELD CROP RES, V192, P21, DOI 10.1016/j.fcr.2016.04.008; Casadesus J, 2014, J INTEGR PLANT BIOL, V56, P7, DOI 10.1111/jipb.12117; Christopher JT, 2008, AUST J AGR RES, V59, P354, DOI 10.1071/AR07193; Duggan BL, 2005, AUST J AGR RES, V56, P179, DOI 10.1071/AR04153; El Hassouni K, 2018, CROP SCI, V58, P2331, DOI 10.2135/cropsci2018.01.0076; Fan JL, 2016, FIELD CROP RES, V189, P68, DOI 10.1016/j.fcr.2016.02.013; Fernandez-Gallego JA, 2019, EUR J AGRON, V105, P146, DOI 10.1016/j.eja.2019.02.007; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Foulkes MJ, 2007, FIELD CROP RES, V103, P11, DOI 10.1016/j.fcr.2007.04.007; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Foulkes MJ, 2004, EUPHYTICA, V135, P63, DOI 10.1023/B:EUPH.0000009542.06773.13; Gao YZ, 2016, J EXP BOT, V67, P4545, DOI 10.1093/jxb/erw243; Gautam T, 2021, J PLANT BIOCHEM BIOT, V30, P172, DOI 10.1007/s13562-020-00553-0; GIUNTA F, 1993, FIELD CROP RES, V33, P399, DOI 10.1016/0378-4290(93)90161-F; Gorny Andrzej G., 2002, Journal of Applied Genetics, V43, P145; GREGORY PJ, 1978, J AGR SCI, V91, P91, DOI 10.1017/S0021859600056653; Grogan SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152852; Harikrishna LT, 2020, INDIAN J GENET PL BR, V80, P209, DOI 10.31742/IJGPB.80.2.12; Hodgkinson L, 2017, EUR J AGRON, V91, P74, DOI 10.1016/j.eja.2017.09.014; K/pke, 1979, THESIS U GOTTINGEN; Kefauver S.C., 2015, RGB PICTURE VEGETATI; Khalid M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00717; Kumar BNA, 2011, J AGR SCI-CAMBRIDGE, V149, P257, DOI 10.1017/S0021859610000730; Le Treut H, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P93; Leng GY, 2019, SCI TOTAL ENVIRON, V654, P811, DOI 10.1016/j.scitotenv.2018.10.434; Li PC, 2020, CROP J, V8, P645, DOI 10.1016/j.cj.2019.12.006; Li XX, 2019, J EXP BOT, V70, P4963, DOI 10.1093/jxb/erz232; Liu Q, 2000, CHINESE SCI BULL, V45, P970, DOI 10.1007/BF02884972; Lopes MS, 2012, J EXP BOT, V63, P3789, DOI 10.1093/jxb/ers071; Lopes MS, 2010, FUNCT PLANT BIOL, V37, P147, DOI 10.1071/FP09121; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Maccaferri M, 2016, J EXP BOT, V67, P1161, DOI 10.1093/jxb/erw039; Manschadi AM, 2010, PLANT BIOSYST, V144, P458, DOI 10.1080/11263501003731805; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Nehe AS, 2020, FIELD CROP RES, V251, DOI 10.1016/j.fcr.2020.107778; Nehe AS, 2018, FIELD CROP RES, V225, P152, DOI 10.1016/j.fcr.2018.06.002; Nehe A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219432; Olivares-Villegas JJ, 2007, FUNCT PLANT BIOL, V34, P189, DOI 10.1071/FP06148; Perez-Lara E, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0627-7; Rasheed A, 2016, THEOR APPL GENET, V129, P1843, DOI 10.1007/s00122-016-2743-x; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Richard CAI, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0055-9; Richards RA, 2006, AGR WATER MANAGE, V80, P197, DOI 10.1016/j.agwat.2005.07.013; Rouse J.W, 1974, MONITORING VERNAL AD, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Sheoran S., 2013, ICAR; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Trnka M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau2406; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; van Noordwijk M, 1983, FUNCTIONAL INTERPRET; Verma V, 2004, EUPHYTICA, V135, P255, DOI 10.1023/B:EUPH.0000013255.31618.14; Vijayalakshmi K, 2010, MOL BREEDING, V26, P163, DOI 10.1007/s11032-009-9366-8; Wang HY, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1901-0; Wasaya A, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8110241; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Wu XL, 2018, PLANT PROD SCI, V21, P358, DOI 10.1080/1343943X.2018.1518722; York LM, 2015, J EXP BOT, V66, P5493, DOI 10.1093/jxb/erv241; Yoshida S., 1982, Drought resistance in crops with emphasis on rice, P97; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang JJ, 2009, NEW PHYTOL, V181, P843, DOI 10.1111/j.1469-8137.2008.02713.x; Zhang WP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00772; Zheng J, 2014, J EXP BOT, V65, P5351, DOI 10.1093/jxb/eru306	74	4	4	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0242472	10.1371/journal.pone.0242472	http://dx.doi.org/10.1371/journal.pone.0242472			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819270	gold, Green Published			2022-12-26	WOS:000637647200005
J	Ziayee, F; Ullrich, T; Blondin, D; Irmer, H; Arsov, C; Antoch, G; Quentin, M; Schimmoller, L				Ziayee, Farid; Ullrich, Tim; Blondin, Dirk; Irmer, Hannes; Arsov, Christian; Antoch, Gerald; Quentin, Michael; Schimmoeller, Lars			Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection	PLOS ONE			English	Article								Dynamic contrast enhanced imaging (DCE) as an integral part of multiparametric prostate magnet resonance imaging (mpMRI) can be evaluated using qualitative, semi-quantitative, or quantitative assessment methods. Aim of this study is to analyze the clinical benefits of these evaluations of DCE regarding clinically significant prostate cancer (csPCa) detection and grading. 209 DCE data sets of 103 consecutive patients with mpMRI (T2, DWI, and DCE) and subsequent MRI-(in-bore)-biopsy were retrospectively analyzed. Qualitative DCE evaluation according to PI-RADS v2.1, semi-quantitative (curve type; DCE score according to PI-RADS v1), and quantitative Tofts analyses (K-trans, k(ep,) and v(e)) as well as PI-RADS v1 and v2.1 overall classification of 209 lesions (92 PCa, 117 benign lesions) were performed. Of each DCE assessment method, cancer detection, discrimination of csPCa, and localization were assessed and compared to histopathology findings. All DCE analyses (p<0.01-0.05), except v(e) (p = 0.02), showed significantly different results for PCa and benign lesions in the peripheral zone (PZ) with area under the curve (AUC) values of up to 0.92 for PI-RADS v2.1 overall classification. In the transition zone (TZ) only the qualitative DCE evalulation within PI-RADS (v1 and v2.1) could distinguish between PCa and benign lesions (p<0.01; AUC = 0.95). None of the DCE parameters could differentiate csPCa from non-significant (ns) PCa (p >= 0.1). Qualitative analysis of DCE within mpMRI according to PI-RADS version 2.1 showed excellent results regarding (cs)PCa detection. Semi-quantitative and quantitative parameters provided no additional improvements. DCE alone wasn't able to discriminate csPCa from nsPCa.	[Ziayee, Farid; Ullrich, Tim; Blondin, Dirk; Irmer, Hannes; Antoch, Gerald; Quentin, Michael; Schimmoeller, Lars] Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Arsov, Christian] Univ Dusseldorf, Med Fac, Dept Urol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Quentin, M (corresponding author), Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	michael.quentin@gmx.de		Quentin, Michael/0000-0002-6254-5618				Mirak SA, 2020, ABDOM RADIOL, V45, P2225, DOI 10.1007/s00261-019-02234-6; Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Arsov C, 2015, EUR UROL, V68, P713, DOI 10.1016/j.eururo.2015.06.008; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bonekamp David, 2008, Top Magn Reson Imaging, V19, P273, DOI 10.1097/RMR.0b013e3181aacdc2; Chesnais AL, 2013, CLIN RADIOL, V68, pE323, DOI 10.1016/j.crad.2013.01.018; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Haas GP, 2008, CAN J UROL, V15, P3866; Hansford BG, 2015, RADIOLOGY, V275, P448, DOI 10.1148/radiol.14140847; Johnson LM, 2014, NAT REV CLIN ONCOL, V11, P346, DOI 10.1038/nrclinonc.2014.69; Mehrabian H, 2015, MAGN RESON IMAGING, V33, P1236, DOI 10.1016/j.mri.2015.08.009; Mottet N, EAU GUIDELINES PROST; Niu XK, 2018, AM J ROENTGENOL, V211, P369, DOI 10.2214/AJR.17.18946; Ocak I, 2007, AM J ROENTGENOL, V189, pW192, DOI 10.2214/AJR.06.1329; Quentin M, 2014, J UROLOGY, V192, P1374, DOI 10.1016/j.juro.2014.05.090; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, pW471, DOI 10.2214/AJR.12.9737; Sanz-Requena R, 2015, J MAGN RESON IMAGING, V42, P477, DOI 10.1002/jmri.24805; Schimmoller L, 2016, AM J ROENTGENOL, V206, P92, DOI 10.2214/AJR.15.14579; Scialpi M, 2018, AM J ROENTGENOL, V211, P379, DOI 10.2214/AJR.17.19014; Scialpi M, 2017, TRANSL ANDROL UROL, V6, P499, DOI 10.21037/tau.2017.05.31; Sun Y, 2019, ACTA ONCOL, V58, P1118, DOI 10.1080/0284186X.2019.1598576; Tan CH, 2015, AM J ROENTGENOL, V204, pW439, DOI 10.2214/AJR.14.13373; Tofts P S, 2010, MAGNETOM FLASH, V3, P30; Turkbey B, 2019, EUR UROL, V76, P340, DOI 10.1016/j.eururo.2019.02.033; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2021	16	4							e0249532	10.1371/journal.pone.0249532	http://dx.doi.org/10.1371/journal.pone.0249532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ5NA	33819295	gold, Green Published			2022-12-26	WOS:000637647200033
J	Donnelly, RE; Prots, A; Donnelly, CA				Donnelly, Roarke E.; Prots, Alex; Donnelly, Christl A.			Better educational signage could reduce disturbance of resting dolphins	PLOS ONE			English	Article							STENELLA-LONGIROSTRIS; SPINNER DOLPHIN; BEHAVIOR; MANAGEMENT; KNOWLEDGE; WILDLIFE; IMPACT; CONSERVATION; MESSAGES	Spinner dolphins on Hawai'i Island's west coast (Stenella longirostris longirostris) rest by day in protected bays that are increasingly popular for recreation. Because more frequent interactions of people with these dolphins is likely to reduce rest for dolphins and to explain recent decline in dolphin abundance, the National Oceanic and Atmospheric Administration (NOAA) proposed stricter rules regarding interactions with spinner dolphins near the main Hawaiian Islands and plans to increase enforcement. Simultaneous investment in public education about both interaction rules and their biological rationale has been and is likely to be relatively low. To test the hypothesis that more educational signage will reduce human-generated disturbance of dolphins, a paper questionnaire was distributed to 351 land-based, mostly unguided visitors at three dolphin resting bays on Hawai'i Island's west coast. Responses indicated that visitors wanted to see dolphins, were ignorant of interaction rules, were likely to read signs explaining rules and their biological rationales, and were likely to follow known rules. Therefore, investment in effective educational signage at dolphin resting bays is recommended as one way to support conservation of spinner dolphins on Hawai'i Island's west coast and similar sites in the Hawaiian archipelago.	[Donnelly, Roarke E.; Prots, Alex] Oglethorpe Univ, Biol Program, Atlanta, GA 30319 USA; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England; [Donnelly, Christl A.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England	University of Oxford; Imperial College London	Donnelly, RE (corresponding author), Oglethorpe Univ, Biol Program, Atlanta, GA 30319 USA.	rdonnelly@oglethorpe.edu			Oglethorpe University	Oglethorpe University	Oglethorpe University (https://oglethorpe.edu) provided RD funds to cover expenses during data collection. There was no associated grant number. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock D., 1991, Australian Parks & Recreation, V27, P15; Alder J, 1996, ENVIRON MANAGE, V20, P541, DOI 10.1007/BF01474654; Andrews KR, 2010, MOL ECOL, V19, P732, DOI 10.1111/j.1365-294X.2010.04521.x; Ardoin NM, 2015, J SUSTAIN TOUR, V23, P838, DOI 10.1080/09669582.2015.1024258; Bailey K.D., 1994, METHODS SOCIAL RES, V4th; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bradford LEA, 2007, J PARK RECREAT ADM, V25, P1; Cong L, 2017, CURR ISSUES TOUR, V20, P1116, DOI 10.1080/13683500.2014.948811; Courbis S, 2007, TOURISM MARINE ENV, V4, P1, DOI DOI 10.3727/154427307784835697; Draugalis JR, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720111; Filby NE, 2015, MAR POLICY, V51, P40, DOI 10.1016/j.marpol.2014.07.010; French SS, 2017, BIOL CONSERV, V210, P37, DOI 10.1016/j.biocon.2017.04.006; Garrod B, 2004, ANN TOURISM RES, V31, P334, DOI 10.1016/j.annals.2003.12.003; Girasek DC, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-019-0222-y; Global Change Data Lab, 2020, GEND RAT; Hawaii Tourism Authority, 2021, MONTHL VIS STAT; Heenehan HL, 2017, MAR POLICY, V75, P84, DOI 10.1016/j.marpol.2016.10.015; Hu WY, 2009, MAR RESOUR ECON, V24, P61, DOI 10.1086/mre.24.1.42629645; Hughes K, 2013, J SUSTAIN TOUR, V21, P42, DOI 10.1080/09669582.2012.681788; KELLERT SR, 1985, J WILDLIFE MANAGE, V49, P528, DOI 10.2307/3801568; Kelly C, 2004, OCEAN COAST MANAGE, V47, P1, DOI 10.1016/j.ocecoaman.2004.03.001; Maguire GS, 2015, J COAST CONSERV, V19, P73, DOI 10.1007/s11852-014-0361-9; Marschall S, 2017, J OUTDOOR REC TOUR, V17, P11, DOI 10.1016/j.jort.2016.11.001; Martin CL, 2015, MAR POLICY, V56, P78, DOI 10.1016/j.marpol.2015.03.002; National Oceanic and Atmospheric Administration (NOAA), 2020, ENH PROT HAW SPINN D; National Oceanic and Atmospheric Administration (NOAA), 2016, HAWAIIAN SPINNER DOL; National Oceanic and Atmospheric Administration (NOAA), DOLPH SMART UNKN YEA; National Oceanic and Atmospheric Administration (NOAA), SPINN DOLPH OV UNKN; National Oceanic and Atmospheric Administration (NOAA), 2020, PROT SPEC ED SIGNS; NORRIS KS, 1980, FISH B-NOAA, V77, P821; Ormsby Alison A., 2010, Human Dimensions of Wildlife, V15, P119, DOI 10.1080/10871200903428366; Park LO, 2008, J PARK RECREAT ADM, V26, P97; Rea L.M., 2005, DESIGNING CONDUCTING, V3rd ed.; Saunders R, 2019, J OUTDOOR REC TOUR, V25, P132, DOI 10.1016/j.jort.2018.01.006; Schultz PW, 2014, EUR PSYCHOL, V19, P107, DOI 10.1027/1016-9040/a000163; Shroter-Schlaack C, 2011, INSTRUMENT MIXES BIO, P14; Stack SH, 2020, MAR ECOL PROG SER, V644, P187, DOI 10.3354/meps13347; State of Hawai'i, 2018, HAW POP CHAR; Timmel Gregory, 2008, Aquatic Mammals, V34, P402, DOI 10.1578/AM.34.4.2008.402; Tyne JA, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171506; Tyne JA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160626; Tyne JA, 2015, J APPL ECOL, V52, P621, DOI 10.1111/1365-2664.12434; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; United Nations Environmental Program, 2006, STUD BEN RISKS FAST; Weber A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00001; Wiener C, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00660; Wilson C, 2005, BIRD CONSERV INT, V15, P225, DOI 10.1017/S0959270905000419	47	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248732	10.1371/journal.pone.0248732	http://dx.doi.org/10.1371/journal.pone.0248732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798220	Green Published, gold			2022-12-26	WOS:000636737700038
J	Mirzazadeh, A; Chen, YH; Lin, J; Burk, K; Wilson, EC; Miller, D; Veloso, D; McFarland, W; Morris, MD				Mirzazadeh, Ali; Chen, Yea-Hung; Lin, Jess; Burk, Katie; Wilson, Erin C.; Miller, Desmond; Veloso, Danielle; McFarland, Willi; Morris, Meghan D.			Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco	PLOS ONE			English	Article							DRIVEN SAMPLING DATA; PREVENTION; BARRIERS	Background People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV). Data tracking the engagement of PWID in the continuum of HCV care are needed to assess the reach, target the response, and gauge impact of HCV elimination efforts. Methods We analyzed data from the National HIV Behavioral Surveillance (NHBS) surveys of PWID recruited via respondent driven sampling (RDS) in San Francisco in 2018. We calculated the number and proportion who self-reported ever: (1) tested for HCV, (2) tested positive for HCV antibody, (3) diagnosed with HCV, (4) received HCV treatment, (5) and attained sustained viral response (SVR). To assess temporal changes, we compared 2018 estimates to those from the 2015 NHBS sample. Results Of 456 PWID interviewed in 2018, 88% had previously been tested for HCV, 63% tested antibody positive, and 50% were diagnosed with HCV infection. Of those diagnosed, 42% received treatment. Eighty-one percent of those who received treatment attained SVR. In 2015 a similar proportion of PWID were tested and received an HCV diagnosis, compared to 2018. However, HCV treatment was more prevalent in the 2018 sample (19% vs. 42%, P-value 0.01). Adjusted analysis of 2018 survey data showed having no health insurance (APR 1.6, P-value 0.01) and having no usual source of health care (APR 1.5, P-value 0.01) were significantly associated with untreated HCV prevalence. Conclusion While findings indicate an improvement in HCV treatment uptake among PWID in San Francisco, more than half of PWID diagnosed with HCV infection had not received HCV treatment in 2018. Policies and interventions to increase coverage are necessary, particularly among PWID who are uninsured and outside of regular care.	[Mirzazadeh, Ali; Chen, Yea-Hung; Morris, Meghan D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mirzazadeh, Ali; McFarland, Willi] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Lin, Jess; Wilson, Erin C.; Miller, Desmond; Veloso, Danielle; McFarland, Willi] San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA USA; [Burk, Katie] San Francisco Dept Publ Hlth, Community Hlth Equ & Promot Branch, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco Department of Public Health	Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	Ali.Mirzazadeh@ucsf.edu		Lin, Jessica/0000-0002-6533-666X; Mirzazadeh, Ali/0000-0002-0478-3220	Centers for Disease Control and Prevention (CDC) [5U1BPS003247]; National Institute on Drug Abuse [5R37DA015612-170, R21DA046809]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Centers for Disease Control and Prevention (CDC) funded the collection of data for the National HIV Behavioral Surveillance 2015 and 2018 round (WM supported by grant number 5U1BPS003247). The funder had no role in the analysis or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. AM was supported by National Institute on Drug Abuse (grant number 5R37DA015612-170 and MDM by National Institute on Drug Abuse (grant number R21DA046809).	Arias E, 2019, NATL VITAL STAT REPO, V68; Avery L, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0842-5; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buckley GJ, 2017, ANN INTERN MED, V166, P895, DOI 10.7326/M17-0766; Bull-Otterson L, 2020, J INFECT DIS, V222, P940, DOI 10.1093/infdis/jiaa017; Chou JW, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3956-x; Facente SN, 2018, INFECT DIS CLIN N AM, V32, P313, DOI 10.1016/j.idc.2018.02.012; Facente SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195575; Falade-Nwulia O, 2019, J SUBST ABUSE TREAT, V100, P45, DOI 10.1016/j.jsat.2019.01.021; Fraser H, 2019, AM J EPIDEMIOL, V188, P1539, DOI 10.1093/aje/kwz097; Gile KJ, 2012, **DATA OBJECT**; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Kim N, 2019, AIDS BEHAV, V23, P1586, DOI 10.1007/s10461-018-2284-1; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Molinaro S, 2019, DRUG ALCOHOL REV, V38, P644, DOI 10.1111/dar.12978; Morris MD, 2019, DRUG ALCOHOL DEPEN, V198, P133, DOI 10.1016/j.drugalcdep.2019.02.008; Paz-Bailey G, 2014, AIDS BEHAV, V18, pS233, DOI 10.1007/s10461-014-0738-7; Schackman BR, 2018, DRUG ALCOHOL DEPEN, V185, P411, DOI 10.1016/j.drugalcdep.2017.11.031; Skeer MR, 2018, DRUG ALCOHOL DEPEN, V190, P246, DOI 10.1016/j.drugalcdep.2018.06.013; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249585	10.1371/journal.pone.0249585	http://dx.doi.org/10.1371/journal.pone.0249585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RI2KE	33798243	Green Published, gold			2022-12-26	WOS:000636737700037
J	Dawicki, W; Huang, H; Ma, YN; Town, J; Zhang, XB; Rudulier, CD; Gordon, JR				Dawicki, Wojciech; Huang, Hui; Ma, Yanna; Town, Jennifer; Zhang, Xiaobei; Rudulier, Chris D.; Gordon, John R.			CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells	PLOS ONE			English	Article								CD40 expressed on stimulatory dendritic cells (DC) provides an important accessory signal for induction of effector T cell responses. It is also expressed at lower levels on regulatory DC (DCreg), but there is little evidence that CD40 signaling contributes to the tolerogenic activity of these cells. Indeed, CD40 silencing within DCreg has been reported to induce T cell tolerance in multiple disease models, suggesting that CD40 is superfluous to DC-induced tolerance. We critically assessed whether CD40 does have a role in tolerance induced by IL-10-differentiated DC (DC10) by using DC10 generating from the bone marrow of wild-type (w.t.) or CD40(-/-) donor mice, or IL-10-complemented CD40(-/-) DC10 to treat asthmatic mice. Wild-type DC10 ablated the OVA-asthma phenotype via induction of Foxp3(+) Treg responses, but CD40(-/-) DC10 had no discernible effects on primary facets of the phenotype (e.g., IL-5, IL-9, IL-13 levels, IgE & IgG1 antibodies; p>0.05) and were <= 40% effective in reversal of others. Foxp3(+) T cells from the lungs of CD40(-/-) DC10-treated mice expressed reduced levels of a panel of six Treg-specific activation markers relative to Treg from w.t. DC10-treated mice. Coculture with effector T cells from asthmatic mice induced a marked upregulation of cell surface CD40 on w.t. DC10. While untreated CD40(-/-) and w.t. DC10 secreted equally low levels of IL-10, stimulation of w.t. DC10 with anti-CD40 for 72 h increased their expression of IL-10 by approximate to 250%, with no parallel induction of IL-12. Complementing IL-10 expression in CD40(-/-) DC10 by IL-10 mRNA transfection fully restored the cells' abilities to suppress the asthma phenotype. In summary, CD40 signaling in DC10 contributes importantly to their expression of IL-10 and to a robust induction of tolerance, including activation of induced Treg.	[Dawicki, Wojciech; Ma, Yanna; Zhang, Xiaobei; Rudulier, Chris D.; Gordon, John R.] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Huang, Hui; Town, Jennifer] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Gordon, JR (corresponding author), Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada.	john.gordon@usask.ca			Canadian Institutes for Medical Research grant [MOP 53167]	Canadian Institutes for Medical Research grant(Canadian Institutes of Health Research (CIHR))	John Gordon held the grant that funded this research - Canadian Institutes for Medical Research grant MOP 53167 (https://cihr-irsc.gc.ca/e/193.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Barthels C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14715; Boks MA, 2010, SCAND J IMMUNOL, V72, P158, DOI 10.1111/j.1365-3083.2010.02414.x; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Dawicki W, 2017, J ALLERGY CLIN IMMUN, V139, P1608, DOI 10.1016/j.jaci.2016.07.042; Demangel C, 2001, INFECT IMMUN, V69, P2456, DOI 10.1128/IAI.69.4.2456-2461.2001; Gonzalez-Rey E, 2006, BLOOD, V107, P3632, DOI 10.1182/blood-2005-11-4497; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Hochweller K, 2004, EUR J IMMUNOL, V34, P990, DOI 10.1002/eji.200324782; Huang H, 2013, ALLERGY, V68, P1126, DOI 10.1111/all.12203; Huang H, 2013, J IMMUNOL, V191, P1136, DOI 10.4049/jimmunol.1201899; Huang H, 2010, J IMMUNOL, V185, P5003, DOI 10.4049/jimmunol.0903446; Kaneko Y, 1996, EUR J IMMUNOL, V26, P3061, DOI 10.1002/eji.1830261236; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li XL, 2010, AM J RESP CELL MOL, V42, P190, DOI 10.1165/rcmb.2009-0023OC; Lu M, 2011, ALLERGY, V66, P612, DOI 10.1111/j.1398-9995.2010.02526.x; Luft T, 2002, INT IMMUNOL, V14, P367, DOI 10.1093/intimm/14.4.367; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Nabe T, 2013, BRIT J PHARMACOL, V169, P462, DOI 10.1111/bph.12154; Nayyar A, 2009, THERAPEUTIC IMMUNOMO; Nayyar A, 2012, J IMMUNOL, V189, P72, DOI 10.4049/jimmunol.1103286; Rea D, 2000, BLOOD, V95, P3162, DOI 10.1182/blood.V95.10.3162.010k18_3162_3167; Lenicov FR, 2012, J IMMUNOL, V189, P4777, DOI 10.4049/jimmunol.1202089; Schneider AM, 2001, CELL IMMUNOL, V212, P101, DOI 10.1006/cimm.2001.1854; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Suzuki M, 2009, ALLERGY, V64, P387, DOI 10.1111/j.1398-9995.2008.01839.x; Suzuki M, 2008, J IMMUNOL, V180, P8461, DOI 10.4049/jimmunol.180.12.8461; Suzuki M, 2018, J ALLERGY CLIN IMMUN, V142, P1994, DOI 10.1016/j.jaci.2018.07.031; Suzuki M, 2010, J ALLERGY CLIN IMMUN, V125, P737, DOI 10.1016/j.jaci.2009.11.042; Teh BK, 2011, MOL IMMUNOL, V48, P1128, DOI 10.1016/j.molimm.2011.02.006; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; VIJAYARAGHAVAN R, 1994, ARCH TOXICOL, V68, P490, DOI 10.1007/s002040050101; VIJAYARAGHAVAN R, 1993, ARCH TOXICOL, V67, P478, DOI 10.1007/BF01969919; Volchenkov R, 2013, SCAND J IMMUNOL, V77, P246, DOI 10.1111/sji.12039; Warren KJ, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1015-0; Yamanishi Y, 2016, SEMIN IMMUNOPATHOL, V38, P615, DOI 10.1007/s00281-016-0568-y; Yoshimoto T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00716	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248290	10.1371/journal.pone.0248290	http://dx.doi.org/10.1371/journal.pone.0248290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793599	Green Published, gold			2022-12-26	WOS:000636467000098
J	Gartner, L; Lenarz, T; Buchner, A				Gaertner, Lutz; Lenarz, Thomas; Buechner, Andreas			Measurements of the local evoked potential from the cochlear nucleus in patients with an auditory brainstem implant and its implication to auditory perception and audio processor programming	PLOS ONE			English	Article								The measurement of the electrically evoked compound action potential (ECAP) in cochlear implant (CI) patients is widely used to provide evidence of a functioning electrode-nerve interface, to confirm proper location of the electrode array and to program the sound processor. In patients with an auditory brainstem implant (ABI), a likewise versatile measurement would be desirable. The ECAP measurement paradigm "Alternating Polarity" was utilized to record responses via the implanted ABI electrode array placed on the cochlear nucleus. Emphasizing on the different location of stimulation and recording, these responses are called local evoked potentials (LEP). LEP measurements were conducted during the clinical routine in 16 ABI patients (12 children and 4 adults), corresponding to 191 electrode contacts. A retrospective analysis of these data revealed, that LEP responses were observed in 64.9% of all measured electrode contacts. LEP responses predicted auditory perception with a sensitivity of 90.5%. False-positive rate was 33.7%. Objective LEP thresholds were highly significantly (p < 0.001) correlated both to behavioral thresholds (Pearson's r = 0.697) and behavioral most comfortable levels (r = 0.840). Therefore, LEP measurements have the potential to support fitting in ABI patients.	[Gaertner, Lutz; Lenarz, Thomas; Buechner, Andreas] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany	Hannover Medical School	Gartner, L (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	gaertner.lutz@mh-hannover.de		Gartner, Lutz/0000-0003-2280-9487; Buechner, Andreas/0000-0001-6788-3985				Archbold S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P312; Azadpour M, 2021, HEARING RES, V401, DOI 10.1016/j.heares.2020.108163; Bahmer A, 2018, ACTA ACUST UNITED AC, V104, P900, DOI 10.3813/AAA.919250; Colletti V., 2014, OTOLARYNG HEAD NECK, V151, P1008, DOI [10.1177/0194599814551151, DOI 10.1177/0194599814551151]; de Vos JJ, 2018, EAR HEARING, V39, P401, DOI 10.1097/AUD.0000000000000495; Dietz A, 2016, EUR ARCH OTO-RHINO-L, V273, P1411, DOI 10.1007/s00405-015-3716-4; Gartner L, 2014, LARYNGO RHINO OTOL, V93, P398, DOI 10.1055/s-0034-1372590; Gartner L, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0588-z; Guex AA, 2019, HEARING RES, V377, P339, DOI 10.1016/j.heares.2019.02.010; HALL RD, 1990, HEARING RES, V49, P155, DOI 10.1016/0378-5955(90)90102-U; He SM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00339; HITSELBERGER WE, 1984, OTOLARYNG HEAD NECK, V92, P52, DOI 10.1177/019459988409200111; Illg A, 2013, OTOL NEUROTOL, V34, P682, DOI 10.1097/MAO.0b013e31828bb75e; Kuchta J, 2010, CENTRAL AUDITORY IMP; McKay CM, 2017, HEARING RES, V346, P62, DOI 10.1016/j.heares.2017.02.009; Otto Steven R, 2005, J Am Acad Audiol, V16, P219, DOI 10.3766/jaaa.16.4.3; Polak M, 2018, EUR ANN OTORHINOLARY, V135, P403, DOI 10.1016/j.anorl.2017.10.005; Svirsky M., 2017, C IMPL AUD PROSTH CI; van der Marel KS, 2012, AUDIOL NEURO-OTOL, V17, P275, DOI 10.1159/000338475; Wong K, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00010	20	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249535	10.1371/journal.pone.0249535	http://dx.doi.org/10.1371/journal.pone.0249535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793674	Green Published, gold			2022-12-26	WOS:000636467000021
J	Huntley, JW; Scarponi, D				Huntley, John Warren; Scarponi, Daniele			Parasitism and host behavior in the context of a changing environment: The Holocene record of the commercially important bivalve Chamelea gallina, northern Italy	PLOS ONE			English	Article							PEARL RIVER DELTA; PO COASTAL-PLAIN; CLIMATE-CHANGE; MANIPULATION HYPOTHESIS; COMMUNITY STRUCTURE; AYTHYA-FERINA; ADRIATIC SEA; TEMPERATURE; PATTERNS; RESOLUTION	Rapid warming and sea-level rise are predicted to be major driving forces in shaping coastal ecosystems and their services in the next century. Though forecasts of the multiple and complex effects of temperature and sea-level rise on ecological interactions suggest negative impacts on parasite diversity, the effect of long term climate change on parasite dynamics is complex and unresolved. Digenean trematodes are complex life cycle parasites that can induce characteristic traces on their bivalve hosts and hold potential to infer parasite host-dynamics through time and space. Previous work has demonstrated a consistent association between sea level rise and increasing prevalence of trematode traces, but a number of fundamental questions remain unanswered about this paleoecological proxy. Here we examine the relationships of host size, shape, and functional morphology with parasite prevalence and abundance, how parasites are distributed across hosts, and how all of these relationships vary through time, using the bivalve Chamelea gallina from a Holocene shallow marine succession in the Po coastal plain. Trematode prevalence increased and decreased in association with the transition from a wave-influenced estuarine system to a wave-dominated deltaic setting. Prevalence and abundance of trematode pits are associated with large host body size, reflecting ontogenetic accumulation of parasites, but temporal trends in median host size do not explain prevalence trends. Ongoing work will test the roles of temperature, salinity, and nutrient availability on trematode parasitism. Parasitized bivalves in one sample were shallower burrowers than their non-parasitized counterparts, suggesting that hosts of trematodes can be more susceptible to their predators, though the effect is ephemeral. Like in living parasite-host systems, trematode-induced malformations are strongly aggregated among hosts, wherein most host individuals harbor very few parasites while a few hosts have many. We interpret trace aggregation to support the assumption that traces are a reliable proxy for trematode parasitism in the fossil record.	[Huntley, John Warren] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; [Scarponi, Daniele] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy	University of Missouri System; University of Missouri Columbia; University of Bologna	Huntley, JW (corresponding author), Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA.; Scarponi, D (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	huntleyj@missouri.edu; daniele.scarponi@unibo.it		Huntley, John/0000-0001-9955-8853	Institute for Advanced Studies, University of Bologna; Alexander von Humboldt Stiftung; MU Faculty Research Leave; NSF CAREER [EAR-1650745]	Institute for Advanced Studies, University of Bologna; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); MU Faculty Research Leave; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	Institute for Advanced Studies, University of Bologna (JWH) http://www.isa.unibo.it/en, Alexander von Humboldt Stiftung (JWH) https://www.humboldt-foundation.de/en/, MU Faculty Research Leave (JWH) https://missouri.edu/, NSF CAREER EAR-1650745 (JWH) https://www.nsf.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addino M, 2010, J SEA RES, V63, P102, DOI 10.1016/j.seares.2009.11.001; Albano PG, 2018, BIOL INVASIONS, V20, P1417, DOI 10.1007/s10530-017-1634-7; Alberti M, 2013, PALAEOBIO PALAEOENV, V93, P327, DOI 10.1007/s12549-012-0101-9; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Amorosi A, 2004, GLOBAL PLANET CHANGE, V40, P55, DOI 10.1016/S0921-8181(03)00098-5; Amorosi A, 2019, SEDIMENTOLOGY, V66, P3029, DOI 10.1111/sed.12621; Amorosi A, 2016, EARTH-SCI REV, V153, P212, DOI 10.1016/j.earscirev.2015.10.010; Arizaga J, 2014, EUR J WILDLIFE RES, V60, P171, DOI 10.1007/s10344-013-0761-4; Arnold JB, **DATA OBJECT**; Azzarone M, 2020, B SOC PALEONTOL ITAL, V59, P9, DOI 10.4435/BSPI.2020.03; Bartoli P, 2007, J NAT HIST, V41, P1553, DOI 10.1080/00222930701500142; Berrilli F, 2000, B EUR ASSOC FISH PAT, V20, P199; Bruno L, 2017, SEDIMENTOLOGY, V64, P1792, DOI 10.1111/sed.12374; Campo B, 2020, QUATERNARY SCI REV, V237, DOI 10.1016/j.quascirev.2020.106300; CARBONE C, 1994, ANIM BEHAV, V48, P457, DOI 10.1006/anbe.1994.1259; Carlson CJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602422; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Cizauskas CA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160535; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Cremonte F, 2015, PARASITOL INT, V64, P202, DOI 10.1016/j.parint.2014.12.003; De Baets K, 2015, ADV PARASIT, V90, P93, DOI 10.1016/bs.apar.2015.06.002; Edelaar P, 2003, OECOLOGIA, V134, P66, DOI 10.1007/s00442-002-1038-x; Garnier S, 2018, **DATA OBJECT**; Granroth-Wilding HMV, 2014, ECOL EVOL, V4, P3408, DOI 10.1002/ece3.1192; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Henkes GA, 2013, GEOCHIM COSMOCHIM AC, V106, P307, DOI 10.1016/j.gca.2012.12.020; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Huntley JW, 2007, J SHELLFISH RES, V26, P253, DOI 10.2983/0730-8000(2007)26[253:TEAMBF]2.0.CO;2; Huntley JW, 2018, PALEOBIOLOGY, V44, P530, DOI 10.1017/pab.2018.14; Huntley JW, 2015, PALEOBIOLOGY, V41, P134, DOI 10.1017/pab.2014.9; Huntley JW, 2014, P NATL ACAD SCI USA, V111, P18150, DOI 10.1073/pnas.1416747111; Huntley JW, 2012, PALEOBIOLOGY, V38, P40, DOI 10.1666/10051.1; Huntley JW., EVOLUTION FOSSIL REC, V50; Ituarte C, 2005, INVERTEBR BIOL, V124, P220, DOI 10.1111/j.1744-7410.2005.00021.x; Ituarte CF, 2001, DIS AQUAT ORGAN, V48, P47, DOI 10.3354/dao048047; Ituarte C, 2009, J MAR BIOL ASSOC UK, V89, P569, DOI 10.1017/S0025315408001793; Ivany LC., 2012, PALEONTOLOGICAL SOC, V18; Lauckner G., 1983, P477; Legendre P, 2018, **DATA OBJECT**; Lei FY, 2011, MAR BIOL, V158, P995, DOI 10.1007/s00227-011-1625-7; Leung TLF, 2007, PARASITOLOGY, V134, P247, DOI 10.1017/S0031182006001478; LILJEDAHL L, 1985, LETHAIA, V18, P53, DOI 10.1111/j.1502-3931.1985.tb00684.x; Marcogliese DJ, 2016, INTEGR COMP BIOL, V56, P611, DOI 10.1093/icb/icw036; Montagna P, 2014, GEOCHIM COSMOCHIM AC, V132, P288, DOI 10.1016/j.gca.2014.02.005; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Mouritsen KN, 2002, PARASITOLOGY, V124, pS101, DOI 10.1017/S0031182002001476; Mouritsen KN, 1997, OIKOS, V79, P513, DOI 10.2307/3546895; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Muller K, 2019, **DATA OBJECT**; Mundt F, 2017, **DATA OBJECT**; Neubauer TA, 2013, BIOL J LINN SOC, V110, P320, DOI 10.1111/bij.12120; Paradiznik V, 2007, ACTA ADRIAT, V48, P115; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Paull SH, 2011, FRESHWATER BIOL, V56, P767, DOI 10.1111/j.1365-2427.2010.02547.x; Polley L, 2009, TRENDS PARASITOL, V25, P285, DOI 10.1016/j.pt.2009.03.007; Poloczanska E., 2019, IPCC SPECIAL REPORT; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2000, PARASITOLOGY, V121, P289, DOI 10.1017/S0031182099006289; R Core Team, 2020, R LANG ENV STAT COMP; Rogers RR, 2018, GEOLOGY, V46, P431, DOI 10.1130/G40035.1; RUIZ GM, 1991, AM ZOOL, V31, P831; RUIZ GM, 1989, LETHAIA, V22, P431, DOI 10.1111/j.1502-3931.1989.tb01447.x; Scarponi D, 2004, GEOLOGY, V32, P989, DOI 10.1130/G20808.1; Scarponi D, 2017, MAR PETROL GEOL, V87, P128, DOI 10.1016/j.marpetgeo.2017.03.031; Scarponi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05979-6; Scarponi D, 2013, GEOLOGY, V41, P239, DOI 10.1130/G33849.1; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Stanley SM., 1970, GEOLOGICAL SOC AM, V125, P296; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Studer A, 2010, MAR ECOL PROG SER, V415, P11, DOI 10.3354/meps08742; Stunkard HW, 1938, BIOL BULL-US, V75, P145, DOI 10.2307/1537680; Swennen C., 1969, Netherlands Journal of Sea Research, V4, P376, DOI 10.1016/0077-7579(69)90009-X; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; Thieltges DW, 2007, OECOLOGIA, V150, P569, DOI 10.1007/s00442-006-0557-2; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; Todd JA, 2011, LETHAIA, V44, P214, DOI 10.1111/j.1502-3931.2010.00237.x; Tomasovych A, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0695; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilson K., 2002, P6; WINFIELD IJ, 1994, FRESHWATER BIOL, V32, P467, DOI 10.1111/j.1365-2427.1994.tb01140.x; Wittmer JM, 2014, J GEOL, V122, P649, DOI 10.1086/677901; Zong Y, 2009, HOLOCENE, V19, P129, DOI 10.1177/0959683608098957	85	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0247790	10.1371/journal.pone.0247790	http://dx.doi.org/10.1371/journal.pone.0247790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793588	gold, Green Published			2022-12-26	WOS:000636467000083
J	Ito, RE; Oneyama, C; Aoki, K				Ito, Reina E.; Oneyama, Chitose; Aoki, Kazuhiro			Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction	PLOS ONE			English	Article								Oncogene addiction is a cellular property by which cancer cells become highly dependent on the expression of oncogenes for their survival. Oncogene addiction can be exploited to design molecularly targeted drugs that kill only cancer cells by inhibiting the specific oncogenes. Genes and cell lines exhibiting oncogene addiction, as well as the mechanisms by which cell death is induced when addicted oncogenes are suppressed, have been extensively studied. However, it is still not fully understood how oncogene addiction is acquired in cancer cells. Here, we take a synthetic biology approach to investigate whether oncogenic mutation or oncogene expression suffices to confer the property of oncogene addiction to cancer cells. We employed human mammary epithelium-derived MCF-10A cells expressing the oncogenic KRAS or BRAF. MCF-10A cells harboring an oncogenic mutation in a single-allele of KRAS or BRAF showed weak transformation activity, but no characteristics of oncogene addiction. MCF-10A cells overexpressing oncogenic KRAS demonstrated the transformation activity, but MCF-10A cells overexpressing oncogenic BRAF did not. Neither cell line exhibited any oncogene addiction properties. These results indicate that the introduction of oncogenic mutation or the overexpression of oncogenes is not sufficient for cells to acquire oncogene addiction, and that oncogene addiction is not associated with transformation activity.	[Ito, Reina E.; Aoki, Kazuhiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Quantitat Biol Res Grp, Okazaki, Aichi, Japan; [Ito, Reina E.; Aoki, Kazuhiro] Natl Inst Nat Sci, Div Quantitat Biol, Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Oneyama, Chitose] Aichi Canc Ctr Res Inst, Div Canc Cell Regulat, Nagoya, Aichi, Japan; [Aoki, Kazuhiro] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Aichi Cancer Center; Graduate University for Advanced Studies - Japan	Aoki, K (corresponding author), Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Quantitat Biol Res Grp, Okazaki, Aichi, Japan.; Aoki, K (corresponding author), Natl Inst Nat Sci, Div Quantitat Biol, Natl Inst Basic Biol, Okazaki, Aichi, Japan.; Aoki, K (corresponding author), SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	k-aoki@nibb.ac.jp	Aoki, Kazuhiro/I-5483-2019	Aoki, Kazuhiro/0000-0001-7263-1555	JST, CREST [JPMJCR1654]; MEXT/JSPS KAKENHI [16KT0069, 16H01425, 18H04754, 18H02444, 19H05798]	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	K.A. is supported by JST, CREST Grant No. JPMJCR1654; and by MEXT/JSPS KAKENHI Grant No. 16KT0069, 16H01425 "Resonance Bio", 18H04754 "Resonance Bio", 18H02444, and 19H05798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yusuke Miyanari for the use of the bioruptor; Emi Ebine, and Kaori Onoda for their assistance; and all members of the K.A. laboratory for helpful discussions. This work was supported by the Functional Genomics Facility, NIBB Core Research Facilities.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Cheng H, 2016, ONCOGENE, V35, P2961, DOI 10.1038/onc.2015.377; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Hingorani SR, 2003, CANCER RES, V63, P5198; Horibata S, 2015, JOVE-J VIS EXP, DOI 10.3791/52727; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kawabata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167940; Khaliq M, 2019, CANCERS, V11, DOI 10.3390/cancers11101480; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Liu Z, 2016, ONCOTARGET, V7, P39097, DOI 10.18632/oncotarget.9772; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MUKHOPADHYAY T, 1991, CANCER RES, V51, P1744; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Rambow F, 2018, CELL, V174, P843, DOI 10.1016/j.cell.2018.06.025; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; SOULE HD, 1990, CANCER RES, V50, P6075; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	45	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249388	10.1371/journal.pone.0249388	http://dx.doi.org/10.1371/journal.pone.0249388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793658	Green Submitted, Green Published, gold			2022-12-26	WOS:000636467000090
J	Tsuji, T; Maeda, Y; Kita, K; Murakami, K; Saya, H; Takemura, H; Inaki, N; Oshima, M; Oshima, H				Tsuji, Toshikatsu; Maeda, Yusuke; Kita, Kenji; Murakami, Kazuhiro; Saya, Hideyuki; Takemura, Hirofumi; Inaki, Noriyuki; Oshima, Masanobu; Oshima, Hiroko			FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; PROSTAGLANDIN E-2; ACTIVATION; RESISTANCE; AKT; METASTASIS; SURVIVAL; PATHWAY; WNT	FOXO3 is a member of the FOXO transcription factors thought to play a tumor-suppressor role in gastrointestinal cancer, while tumor-promoting function of FOXO3 has also been reported. These results suggest a context-dependent function of FOXO3 in tumor development. However, the relationship between the FOXO3 expression pattern and its role in tumorigenesis has not been elucidated. We examined the FOXO3 expression in 65 human primary gastric cancer and patient-derived xenograft tissues by immunohistochemistry and identified three subtypes according to subcellular localization: FOXO3-nuclear accumulated (FOXO3-Nuc), FOXO3-nuclear/cytoplasmic or cytoplasmic distributed (FOXO3-Cyt), and FOXO3-negative. In the FOXO3-Cyt gastric cancer cells, the expression of the constitutive active mutant FOXO3 (Act-ER FOXO3) induced the nuclear accumulation of FOXO3 and significantly suppressed colony formation and proliferation. The inhibition of the PI3K-AKT pathway by inhibitor treatment also suppressed the proliferation of FOXO3-Cyt gastric cancer cells, which was associated with the nuclear accumulation of endogenous FOXO3. Furthermore, the expression of Act-ER FOXO3 by an endogenous promoter significantly suppressed gastric tumorigenesis in Gan mice, a model of gastric cancer. Finally, treatment of FOXO3-Cyt human gastric cancer-derived organoids with an AKT inhibitor significantly suppressed the survival and proliferation. These results indicate that FOXO3 is a latent tumor suppressor for FOXO3-Cyt-type gastric cancer cells and that activation of the PI3K-AKT pathway protects this type of gastric cancer cell from FOXO3-mediated growth suppression via constitutive nuclear export. Thus, the inhibition of the PI3K-AKT pathway and nuclear translocation of endogenous FOXO3 may have therapeutic applications in the treatment of FOXO3-positive and cytoplasmic-type gastric cancer.	[Tsuji, Toshikatsu; Maeda, Yusuke; Oshima, Masanobu; Oshima, Hiroko] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa, Japan; [Tsuji, Toshikatsu; Takemura, Hirofumi] Kanazawa Univ, Dept Thorac Cardiovasc & Gen Surg, Kanazawa, Ishikawa, Japan; [Tsuji, Toshikatsu] Ishikawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Kanazawa, Ishikawa, Japan; [Maeda, Yusuke; Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res IAMR, Tokyo, Japan; [Kita, Kenji] Kanazawa Univ, Canc Res Inst, Cent Res Resource Branch, Kanazawa, Ishikawa, Japan; [Murakami, Kazuhiro] Kanazawa Univ, Canc Res Inst, Div Stem Cell Biol, Kanazawa, Ishikawa, Japan; [Inaki, Noriyuki] Kanazawa Univ, Dept Surg Gastroenterol, Kanazawa, Ishikawa, Japan; [Oshima, Masanobu; Oshima, Hiroko] Kanazawa Univ, WPI Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Ishikawa Prefectural Central Hospital; Keio University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Oshima, H (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa, Japan.; Oshima, H (corresponding author), Kanazawa Univ, WPI Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan.	hoshima@staff.kanazawa-u.ac.jp	Inaki, Noriyuki/B-4361-2018; Oshima, Masanobu/F-9958-2014; Kita, Kenji/D-8437-2015	Inaki, Noriyuki/0000-0002-4241-5015; Oshima, Masanobu/0000-0002-3304-0004; Murakami, Kazuhiro/0000-0003-1759-9542; Saya, Hideyuki/0000-0001-6610-1902; Kita, Kenji/0000-0002-4622-6633	Ministry of Education, Culture, Sports, Science and Technology of Japan [18H04030, 19H03498]; AMED from the Japan Agency for Medical Research and Development, Japan [20ck0106541h0001]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED from the Japan Agency for Medical Research and Development, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank, Manami Watanabe, Ayako Tsuda, and Yoshie Jomen for their technical assistance. This work was supported by Grants-in-Aid for Scientific Research (A) (18H04030) and (B) (19H03498) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; AMED (20ck0106541h0001) from the Japan Agency for Medical Research and Development, Japan; Takeda Science Foundation.	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bullock MD, 2013, BRIT J CANCER, V109, P387, DOI 10.1038/bjc.2013.355; de Brachene AC, 2016, CELL MOL LIFE SCI, V73, P1159, DOI 10.1007/s00018-015-2112-y; Echizen K, 2019, ONCOGENE, V38, P4250, DOI 10.1038/s41388-019-0702-0; Echizen K, 2016, CANCER SCI, V107, P391, DOI 10.1111/cas.12901; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Hornsveld M, 2018, SEMIN CANCER BIOL, V50, P90, DOI 10.1016/j.semcancer.2017.11.017; Hornsveld M, 2016, CELL DEATH DIFFER, V23, P1483, DOI 10.1038/cdd.2016.33; Hornsveld M, 2018, CANCER RES, V78, P2356, DOI 10.1158/0008-5472.CAN-17-2511; Jiramongkol Y, 2020, CANCER METAST REV, V39, P681, DOI 10.1007/s10555-020-09883-w; Li L, 2019, J CLIN INVEST, V129, P2374, DOI 10.1172/JCI122256; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LIU Y, 2018, MOL CANCER, V17; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima H, 2011, CANCER SCI, V102, P713, DOI 10.1111/j.1349-7006.2011.01847.x; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Oshima H, 2009, CANCER SCI, V100, P1779, DOI 10.1111/j.1349-7006.2009.01258.x; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Penrose HM, 2019, CELL MOL GASTROENTER, V7, P391, DOI 10.1016/j.jcmgh.2018.10.003; Putker M, 2015, ANTIOXID REDOX SIGN, V22, P15, DOI 10.1089/ars.2014.6056; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Tan SH, 2020, NATURE, V578, P437, DOI 10.1038/s41586-020-1973-x; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Yu S, 2015, INT J CLIN EXP PATHO, V8, P2963	41	7	7	4	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3072	3086		10.1038/s41388-021-01757-x	http://dx.doi.org/10.1038/s41388-021-01757-x		APR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33795838	hybrid, Green Published			2022-12-26	WOS:000635873300002
J	Ghanbar, KD; Rezaii, TY; Farzamnia, A; Saad, I				Darvish Ghanbar, Khatereh; Yousefi Rezaii, Tohid; Farzamnia, Ali; Saad, Ismail			Correlation-based common spatial pattern (CCSP): A novel extension of CSP for classification of motor imagery signal	PLOS ONE			English	Article							SINGLE-TRIAL EEG; COMPONENTS; FEATURES	Common spatial pattern (CSP) is shown to be an effective pre-processing algorithm in order to discriminate different classes of motor-based EEG signals by obtaining suitable spatial filters. The performance of these filters can be improved by regularized CSP, in which available prior information is added in terms of regularization terms into the objective function of conventional CSP. Variety of prior information can be used in this way. In this paper, we used time correlation between different classes of EEG signal as the prior information, which is clarified similarity between different classes of signal for regularizing CSP. Furthermore, the proposed objective function can be easily extended to more than two-class problems. We used three different standard datasets to evaluate the performance of the proposed method. Correlation-based CSP (CCSP) outperformed original CSP as well as the existing regularized CSP, Principle Component Cnalysis (PCA) and Fisher Discriminate Analysis (FDA) in both two-class and multi-class scenarios. The simulation results showed that the proposed method outperformed conventional CSP by 6.9% in 2-class and 2.23% in multi-class problem in term of mean classification accuracy.	[Darvish Ghanbar, Khatereh; Yousefi Rezaii, Tohid] Univ Tabriz, Dept Biomed Engn, Tabriz, East Azarbijan, Iran; [Farzamnia, Ali; Saad, Ismail] Univ Malaysia Sabah, Fac Engn, Kota Kinabalu, Sabah, Malaysia	University of Tabriz; Universiti Malaysia Sabah	Rezaii, TY (corresponding author), Univ Tabriz, Dept Biomed Engn, Tabriz, East Azarbijan, Iran.; Farzamnia, A (corresponding author), Univ Malaysia Sabah, Fac Engn, Kota Kinabalu, Sabah, Malaysia.	ali-farzamnia@ieee.org; yousefi@tabrizu.ac.ir	Saad, Ismail/GVR-8748-2022; Farzamnia, Ali/W-6446-2019	Saad, Ismail/0000-0002-8633-3505; Farzamnia, Ali/0000-0001-8618-7256	Research and Innovation Management Center, Universiti Malaysia Sabah (UMS) [TBP0002]	Research and Innovation Management Center, Universiti Malaysia Sabah (UMS)	Research and Innovation Management Center, Universiti Malaysia Sabah (UMS)"award number = "TBP0002".	Aghaei AS, 2016, IEEE T BIO-MED ENG, V63, P15, DOI 10.1109/TBME.2015.2487738; Blankertz B., 2008, ADV NEURAL INFORM PR, V20, P113; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Chakraborty B, 2020, IEEE T BIO-MED ENG, V67, P2064, DOI 10.1109/TBME.2019.2954470; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Dornhege G, 2004, ADV NEUR IN, V16, P733; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Elmahdi RE., 2020, J CLIN ENG, V45, P45, DOI [10.1097/JCE.0000000000000385, DOI 10.1097/JCE.0000000000000385]; Garcia-Laencina PJ, 2014, EXPERT SYST APPL, V41, P5285, DOI 10.1016/j.eswa.2014.02.043; Ghanbar KD, 2019, IRAN CONF ELECTR ENG, P1770, DOI 10.1109/IranianCEE.2019.8786490; Jin J, 2019, NEURAL NETWORKS, V118, P262, DOI 10.1016/j.neunet.2019.07.008; Khan J, 2019, EURASIP J WIREL COMM, DOI 10.1186/s13638-019-1497-y; KOLES ZJ, 1991, ELECTROEN CLIN NEURO, V79, P440, DOI 10.1016/0013-4694(91)90163-X; Thang LQ, 2015, INT SYM MED INFORM, P180, DOI 10.1109/ISMICT.2015.7107524; Thang LQ, 2014, INT CONF COMP INFO; Li D, 2018, BIOMED SIGNAL PROCES, V41, P222, DOI 10.1016/j.bspc.2017.11.014; Li PY, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-77; Li XM, 2016, BIOMED SIGNAL PROCES, V26, P52, DOI 10.1016/j.bspc.2015.12.005; Li YQ, 2009, IEEE T BIO-MED ENG, V56, P2439, DOI 10.1109/TBME.2009.2025866; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Mahmood A, 2017, IEEE ENG MED BIO, P1034, DOI 10.1109/EMBC.2017.8037003; Meisheri H., 2018, ARXIV PREPRINT ARXIV; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Nicolas-Alonso Luis F., 2014, 2014 6th Computer Science and Electronic Engineering Conference (CEEC). Proceedings, P79, DOI 10.1109/CEEC.2014.6958559; Park SH, 2018, IEEE T NEUR SYS REH, V26, P498, DOI 10.1109/TNSRE.2017.2757519; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Qiu ZY, 2016, NEUROCOMPUTING, V207, P519, DOI 10.1016/j.neucom.2016.05.035; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Sanei S, 2013, ADAPTIVE PROCESSING OF BRAIN SIGNALS, P1, DOI 10.1002/9781118622162; Talukdar U, 2020, BIOMED SIGNAL PROCES, V58, DOI 10.1016/j.bspc.2019.101829; Nguyen T, 2018, IEEE ACCESS, V6, P27873, DOI 10.1109/ACCESS.2018.2841051; Townsend G, 2006, IEEE T BIO-MED ENG, V53, P642, DOI 10.1109/TBME.2006.870237; Wang J, 2018, COMPUT BIOL MED, V97, P161, DOI 10.1016/j.compbiomed.2018.04.022; Wei LF, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON E-COMMERCE AND CONTEMPORARY ECONOMIC DEVELOPMENT (ECED 2015), P1; Wu W, 2005, P ANN INT IEEE EMBS, P2387; Weston J., 1999, 7th European Symposium on Artificial Neural Networks. ESANN'99. Proceedings, P219; Zhang R, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/591216	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248511	10.1371/journal.pone.0248511	http://dx.doi.org/10.1371/journal.pone.0248511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788862	gold, Green Published			2022-12-26	WOS:000636354600015
J	Nogami, M; Zeng, FB; Inukai, J; Watanabe, Y; Nishio, M; Kanda, T; Ueno, YR; Sofue, K; Kono, AK; Hori, M; Ohnishi, A; Kubo, K; Kurimoto, T; Murakami, T				Nogami, Munenobu; Zeng, Feibi; Inukai, Junko; Watanabe, Yoshiaki; Nishio, Mizuho; Kanda, Tomonori; Ueno, Yoshiko R.; Sofue, Keitaro; Kono, Atsushi K.; Hori, Masatoshi; Ohnishi, Akihito; Kubo, Kazuhiro; Kurimoto, Takako; Murakami, Takamichi			Physiological skin FDG uptake: A quantitative and regional distribution assessment using PET/MRI	PLOS ONE			English	Article								Purpose To retrospectively assess the repeatability of physiological F-18 labeled fluorodeoxyglucose (FDG) uptake in the skin on positron emission tomography/magnetic resonance imaging (PET/MRI) and explore its regional distribution and relationship with sex and age. Methods Out of 562 examinations with normal FDG distribution on whole-body PET/MRI, 74 repeated examinations were evaluated to assess the repeatability and regional distribution of physiological skin uptake. Furthermore, 224 examinations were evaluated to compare differences in the uptake due to sex and age. Skin segmentation on PET was performed as body-surface contouring on an MR-based attenuation correction map using an off-line reconstruction software. Bland-Altman plots were created for the repeatability assessment. Kruskal-Wallis test was performed to compare the maximum standardized uptake value (SUVmax) with regional distribution, age, and sex. Results The limits of agreement for the difference in SUVmean and SUVmax of the skin were less than 30%. The highest SUVmax was observed in the face (3.091.04), followed by the scalp (2.07 +/- 0.53). The SUVmax in the face of boys aged 0-9 years and 10-20 years (1.33 +/- 0.64 and 2.05 +/- 1.00, respectively) and girls aged 0-9 years (0.98 +/- 0.38) was significantly lower than that of men aged >= 20 years and girls aged >= 10 years (p<0.001). In women, the SUVmax of the face (2.31<plus/minus>0.71) of >= 70-year-olds was significantly lower than that of 30-39-year-olds (3.83 +/- 0.82) (p<0.05). Conclusion PET/MRI enabled the quantitative analysis of skin FDG uptake with repeatability. The degree of physiological FDG uptake in the skin was the highest in the face and varied between sexes. Although attention to differences in body habitus between age groups is needed, skin FDG uptake also depended on age.	[Nogami, Munenobu; Zeng, Feibi; Inukai, Junko; Watanabe, Yoshiaki; Nishio, Mizuho; Kanda, Tomonori; Ueno, Yoshiko R.; Sofue, Keitaro; Kono, Atsushi K.; Hori, Masatoshi; Kubo, Kazuhiro; Murakami, Takamichi] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan; [Ohnishi, Akihito] Kakogawa Cent City Hosp, Dept Radiol, Kakogawa, Hyogo, Japan; [Kurimoto, Takako] GE Healthcare, Hino, Tokyo, Japan	Kobe University; General Electric	Nogami, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan.	aznogami@med.kobe-u.ac.jp	Nishio, Mizuho/ACC-0897-2022; Kono, Atsushi/N-2697-2019; Nogami, Munenobu/AAV-4883-2021	Kono, Atsushi/0000-0002-0963-7433; Nogami, Munenobu/0000-0002-4846-5662; kanda, Tomonori/0000-0003-2719-8283				Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Avril N, 2004, J NUCL MED, V45, P930; Bai WJ, 2011, IEEE T MED IMAGING, V30, P351, DOI 10.1109/TMI.2010.2078514; Bakshi A, 2015, CLIN NUCL MED, V40, P727, DOI 10.1097/RLU.0000000000000851; Barnhart HX, 2009, TRANSL ONCOL, V2, P231, DOI 10.1593/tlo.09268; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bleckmann C, 1999, J NUCL MED, V40, P2021; BLUME U, 1991, BRIT J DERMATOL, V124, P21, DOI 10.1111/j.1365-2133.1991.tb03277.x; Brendle CB, 2013, RADIOLOGY, V268, P190, DOI 10.1148/radiol.13121838; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Gillman A, 2017, MED PHYS, V44, pE430, DOI 10.1002/mp.12577; Grant AM, 2016, MED PHYS, V43, DOI 10.1118/1.4945416; Ceruti JM, 2018, MOL CELL ENDOCRINOL, V465, P122, DOI 10.1016/j.mce.2017.09.009; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Mukherjee JM, 2016, MED PHYS, V43, DOI 10.1118/1.4946814; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; PAGNONI A, 1994, BRIT J DERMATOL, V131, P862, DOI 10.1111/j.1365-2133.1994.tb08590.x; Qian R, 2012, IEEE NUCL SCI CONF R, P2773; Rauber AA, 1922, RAUBER KOPSCH LEHRBU; Rook A, 2004, ROOKS TXB DERMATOLOG; String S, 2015, GRAYS ANATOMY ANATOM, V41st ed.; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Tur E, 1997, CLIN DERMATOL, V15, P5, DOI 10.1016/S0738-081X(96)00105-8; Wagatsuma K, 2017, PHYS MEDICA, V42, P203, DOI 10.1016/j.ejmp.2017.09.124; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wollenweber SD, 2013, IEEE T NUCL SCI, V60, P3391, DOI 10.1109/TNS.2013.2278759; Wurslin C, 2013, J NUCL MED, V54, P464, DOI 10.2967/jnumed.112.105296; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249304	10.1371/journal.pone.0249304	http://dx.doi.org/10.1371/journal.pone.0249304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770111	Green Published, gold			2022-12-26	WOS:000634833500047
J	Pedroza-Gutierrez, C; Lopez-Rocha, JA				Pedroza-Gutierrez, Carmen; Lopez-Rocha, Jorge A.			Ungovernable systems: The strength of informal institutions in the sea cucumber fishery in Yucatan, Mexico	PLOS ONE			English	Article							GOVERNANCE; MANAGEMENT; COMMUNITIES; POPULATION; PENINSULA; DENSITY; TRENDS	Formal and informal institutions govern fisheries around the world. Yucatan's sea cucumber fishery is not an exemption, the sudden and fast development of the fishery in 2010 has motivated the creation of informal and illegal forms of organization. The prices, buyers' interest and the fishing effort substantially increased, being followed by illegal fishing-fishers and traders, creating informal fishing-trade channels and severe social and biological concerns. This article aims to give account of the emergence and dynamics of the informal institutions which currently dominate this fishery. It was sought to identify the extent to which rules and regulations are not being respected and how they are affecting fish resources and coastal communities. We considered the case of the port of Sisal, Yucatan, Mexico to illustrate our argument and here we applied a mixture of qualitative and quantitative methodologies including informal and in-depth interviews applied to 17 key informants, a questionnaire applied to 47 fishers and an estimation of the degree of compliance from three of the main management measures. Socio-biological negative impacts were identified in Yucatan's coastal communities and its fisheries. Foreign buyers and local middlemen exert high pressure on fishers to exceed the quota and catch the highest possible volumes facilitating the fisheries decline. This and the growing economic interest motivated the development of strong informal institutions supporting illegal fishing and informal trade. Social problems emerged and women were particularly affected. The economic power of the fishery is likely to overcome any type of governance structure. The enforcement of entry rules was not effective, so the governance base was around informality and illegal actions. Local and foreign buyers are exerting pressure to increase the catch volume thus it is recommended that rules and regulations be directed at buyers and exporting companies rather than at fishers.	[Pedroza-Gutierrez, Carmen] Univ Nacl Auonoma Mexico, Escuela Nacl Estudios Super, Unidad Merida, Ucu, Yucatan, Mexico; [Lopez-Rocha, Jorge A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Lab Anal Espacial Zonas Costeras, Unidad Multidisciplinaria Docencia & Invest, Sisal, Yucatan, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Pedroza-Gutierrez, C (corresponding author), Univ Nacl Auonoma Mexico, Escuela Nacl Estudios Super, Unidad Merida, Ucu, Yucatan, Mexico.	pedrozacarmen@yahoo.com	Pedroza-Gutiérrez, Carmen/D-1267-2017; López-Rocha, Jorge Alberto/AFD-8323-2022; López-Rocha, Jorge A./AAR-8928-2021; López-Rocha, Jorge Alberto/AAE-9368-2022	López-Rocha, Jorge Alberto/0000-0001-6300-0022; López-Rocha, Jorge Alberto/0000-0001-6300-0022; Pedroza-Gutierrez, Carmen/0000-0002-1048-434X	Universidad Nacional Autonoma de Mexico (UNAM) [PAPIIT IN210915, IN223418, IN301719]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	The study was funded by the Universidad Nacional Autonoma de Mexico (UNAM) under grants PAPIIT IN210915, IN223418 and IN301719 which financed the field study and the publication of the article.	Agarwal B., 1997, 5 EC INTERNET, V3, P1, DOI [10.1080/135457097338799, DOI 10.1080/135457097338799]; Anderson J.L., 2003, INT SEAFOOD TRADE; Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; Gamboa-Alvarez MA, 2020, OCEAN COAST MANAGE, V184, DOI 10.1016/j.ocecoaman.2019.105011; Baker A., 2005, GOVERNING FINANCIAL; BERKES F, 1986, MAR POLICY, V10, P215, DOI 10.1016/0308-597X(86)90054-0; Bernard R., 2006, RES METHODS ANTHR QU; Boyle M., 2001, ENCY GLOBAL ENV CHAN, V4, P116; Carter CR, 2015, J SUPPLY CHAIN MANAG, V51, P89, DOI 10.1111/jscm.12073; Caviglia-Harris JL, 2003, ECOL ECON, V45, P119, DOI 10.1016/S0921-8009(03)00009-0; Lopez MC, 2012, ECON INQ, V50, P131, DOI 10.1111/j.1465-7295.2010.00344.x; Daliri M, 2016, OCEAN COAST MANAGE, V120, P127, DOI 10.1016/j.ocecoaman.2015.11.020; Dana L.P., 2015, INT J ENTREPRENEURSH, V26, P154; Ekawaty R, 2020, FISH RES, V223, DOI 10.1016/j.fishres.2019.105436; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; Eriksson H, 2015, MAR POLICY, V56, P16, DOI 10.1016/j.marpol.2015.02.005; Ertor-Akyazi P, 2019, MAR POLICY, V109, DOI 10.1016/j.marpol.2019.103673; Etiegni CA, 2017, ENVIRON DEV SUSTAIN, V19, P1557, DOI 10.1007/s10668-016-9799-2; Evans LS, 2009, MAR POLICY, V33, P784, DOI 10.1016/j.marpol.2009.02.013; Franco-Torres M, 2021, UTIL POLICY, V68, DOI 10.1016/j.jup.2020.101159; Glockner-Fagetti A, 2016, OCEAN COAST MANAGE, V121, P49, DOI 10.1016/j.ocecoaman.2015.12.009; Greene R., 1999, POWER 48 LAWS; HELMKE G, 2004, PERSPECTIVES POLITIC, V0002; Hernandez-Flores A, 2015, FISH RES, V172, P114, DOI 10.1016/j.fishres.2015.07.005; Hodgson GM, 2006, J ECON ISSUES, V40, P1, DOI 10.1080/00213624.2006.11506879; Jentoft S, 2007, MAR POLICY, V31, P360, DOI 10.1016/j.marpol.2006.11.003; Kia TT, 2019, AFR REV-ABINGDON, V11, P77, DOI 10.1080/09744053.2018.1538681; Kooiman J., 2003, GOVERNING GOVERNANCE; Lebel L, 2006, ECOL SOC, V11; Lopez-Rocha JA, 2019, REG STUD MAR SCI, V27, DOI 10.1016/j.rsma.2019.100547; McGarvey R, 2003, MAR POLICY, V27, P207, DOI 10.1016/S0308-597X(02)00058-1; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ochiewo J, 2010, OCEAN COAST MANAGE, V53, P192, DOI 10.1016/j.ocecoaman.2010.01.010; OSTROM E, 1986, PUBLIC CHOICE, V48, P3; Ostrom E, UNDERSTANDING I DIVE; Ostrom E., 2015, GOVERNING COMMONS, DOI DOI 10.1017/CBO9781316423936; Pedroza C, 2013, MAR POLICY, V39, P135, DOI 10.1016/j.marpol.2012.10.011; Pellowe KE, 2020, MAR POLICY, V121, DOI 10.1016/j.marpol.2020.104179; Purcell SW, 2018, REG STUD MAR SCI, V17, P127, DOI 10.1016/j.rsma.2017.12.003; Purcell SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165633; Purcell SW, 2016, FISH RES, V183, P99, DOI 10.1016/j.fishres.2016.05.010; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Ramirez-Soberon G., 2002, SPC BECHE DE MER INF, V17, P33; Rhodes RAW, 1996, POLIT STUD-LONDON, V44, P652, DOI 10.1111/j.1467-9248.1996.tb01747.x; Salgari E, 1916, PESCADORES T PANG; Symes D, 1997, FISH RES, V32, P107, DOI 10.1016/S0165-7836(97)00052-0; Symes D, 2006, FISH RES, V81, P113, DOI 10.1016/j.fishres.2006.06.015; Trotter II R. T., 1998, HDB METHODS CULTURAL, P691; Van Assche K, 2020, MAR POLICY, V112, DOI 10.1016/j.marpol.2019.01.002; Vidal-Hernandez L, 2019, OCEAN COAST MANAGE, V168, P226, DOI 10.1016/j.ocecoaman.2018.10.036; Visser M, 2015, J ECON BEHAV ORGAN, V118, P95, DOI 10.1016/j.jebo.2015.03.009; Walker D. H. T., 2005, MANAG DECIS, V43, P649, DOI DOI 10.1108/00251740510597680; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; Weller S. C., 1998, HDB METHODS CULTURAL, P365; YIN RK, 1994, EVAL PRACT, V15, P283, DOI 10.1016/0886-1633(94)90023-X; Yukl G., 1998, LEADERSHIP ORG	56	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249132	10.1371/journal.pone.0249132	http://dx.doi.org/10.1371/journal.pone.0249132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770139	gold, Green Published			2022-12-26	WOS:000634833500032
J	Sengupta, M; Abuirqeba, S; Kameric, A; Cecile-Valfort, A; Chatterjee, A; Griffett, K; Burris, TP; Flaveny, CA				Sengupta, Monideepa; Abuirqeba, Suomia; Kameric, Amina; Cecile-Valfort, Aurore; Chatterjee, Arindam; Griffett, Kristine; Burris, Thomas P.; Flaveny, Colin A.			A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis	PLOS ONE			English	Article								Alcoholic liver disease (ALD) is responsible for an average of 50.4% and 44.2%of liver disease deaths among males and females respectively. Driven by alcohol misuse, ALD is often reversible by cessation of consumption. However, abstinence programs can have limited success at curtailing abuse, and the loss of life. ALD, therefore, remains a significant clinical challenge. There is a need for effective treatments that prevent or reverse alcohol-induced liver damage to complement or supplant behavioral interventions. Metabolic syndrome, which is disproportionally prevalent in ALD patients, accelerates the progression of ALD and increases liver disease mortality. Current rodent models of ALD unfortunately do not account for the contribution of the western diet to ALD pathology. To address this, we have developed a rodent model of ALD that integrates the impact of the western diet and alcohol; the WASH-diet model. We show here that the WASH diet, either chronically or in small time-restricted bouts, accelerated ALD pathology with severe steatohepatitis, elevated inflammation and increased fibrosis compared to mice receiving chronic alcohol alone. We also validated our WASH-diet model as an in vivo system for testing the efficacy of experimental ALD treatments. The efficacy of the inverse-agonist SR9238, previously shown to inhibit both non-alcohol and alcohol-induced steatohepatitis progression, was conserved in our WASH-diet model. These findings suggested that the WASH-diet may be useful for in vivo pre-clinical assessment of novel therapies.	[Sengupta, Monideepa; Abuirqeba, Suomia; Kameric, Amina; Chatterjee, Arindam; Flaveny, Colin A.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO 63103 USA; [Cecile-Valfort, Aurore; Griffett, Kristine; Burris, Thomas P.] Washington Univ, Ctr Clin Pharmacol, St Louis, MO 63110 USA; [Cecile-Valfort, Aurore; Griffett, Kristine; Burris, Thomas P.] St Louis Coll Pharm, St Louis, MO USA; [Flaveny, Colin A.] Washington Univ, Sch Med, Alvin J Siteman Comprehens Canc Ctr, St Louis, MO 63130 USA	Saint Louis University; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Flaveny, CA (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO 63103 USA.; Flaveny, CA (corresponding author), Washington Univ, Sch Med, Alvin J Siteman Comprehens Canc Ctr, St Louis, MO 63130 USA.	colin.flaveny@health.slu.edu	Griffett, Kristine/ABU-5754-2022	Griffett, Kristine/0000-0002-6747-2518	National Institutes of Health [R21 CA205096, F32 DK105845]; National Institute of Diabetes Digestive and Kidney diseases; National Cancer Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes Digestive and Kidney diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.A.F: R21 CA205096 -The National Institutes of Health. National Cancer Institute https://www.cancer.gov/T.P.B: F32 DK105845 -The National Institutes of Health. National Institute of Diabetes Digestive and Kidney diseases https://www.niddk.nih.gov/.	Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Chang BX, 2015, HEPATOLOGY, V62, P1070, DOI 10.1002/hep.27921; Chiang DJ, 2014, CLIN LIVER DIS, V18, P157, DOI 10.1016/j.cld.2013.09.006; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Everitt H, 2013, AM J PHYSIOL-GASTR L, V304, pG38, DOI 10.1152/ajpgi.00309.2012; Griffett K, 2015, MOL METAB, V4, P353, DOI 10.1016/j.molmet.2015.01.009; Guo FF, 2018, ALCOHOL CLIN EXP RES, V42, P1828, DOI 10.1111/acer.13840; Hao FJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.532; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Hwang S, 2020, CLIN MOL HEPATOL, V26, P586, DOI 10.3350/cmh.2020.0100; Jump DB, 2016, P NUTR SOC, V75, P1, DOI 10.1017/S002966511500244X; Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Sengupta M, 2018, ACS PHARMACOL TRANSL, V1, P50, DOI 10.1021/acsptsci.8b00003; Shen H, 2019, J CLIN INVEST, V129, P2305, DOI 10.1172/JCI124376; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553; Yamada K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191026	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249316	10.1371/journal.pone.0249316	http://dx.doi.org/10.1371/journal.pone.0249316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770118	Green Published, gold			2022-12-26	WOS:000634833500056
J	Brzezinska, P; Simpson, NJ; Hubert, F; Jacobs, AN; Umana, MB; MacKeil, JL; Burke-Kleinman, J; Payne, DM; Ferguson, AV; Maurice, DH				Brzezinska, Paulina; Simpson, Nicholas J.; Hubert, Fabien; Jacobs, Ariana N.; Umana, M. Bibiana; MacKeil, Jodi L.; Burke-Kleinman, Jonah; Payne, Darrin M.; Ferguson, Alastair, V; Maurice, Donald H.			Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CAPACITATIVE CA2+ ENTRY; CA2+-INHIBITABLE ADENYLYL-CYCLASE; PROTEIN-KINASE-A; PDE1C; PROLIFERATION; ACTIVATION; VARIANTS; ORAI1; LOOP	In addition to maintaining cellular ER Ca2+ stores, store-operated Ca2+ entry (SOCE) regulates several Ca2+-sensitive cellular enzymes, including certain adenylyl cyclases (ADCYs), enzymes that synthesize the secondary messenger cyclic AMP (cAMP). Ca2+, acting with calmodulin, can also increase the activity of PDE1-family phosphodiesterases (PDEs), which cleave the phosphodiester bond of cAMP. Surprisingly, SOCE-regulated cAMP signaling has not been studied in cells expressing both Ca2+-sensitive enzymes. Here, we report that depletion of ER Ca2+ activates PDE1C in human arterial smooth muscle cells (HASMCs). Inhibiting the activation of PDE1C reduced the magnitude of both SOCE and subsequent Ca2+/calmodulin-mediated activation of ADCY8 in these cells. Because inhibiting or silencing Ca2+-insensitive PDEs had no such effects, these data identify PDE1C-mediated hydrolysis of cAMP as a novel and important link between SOCE and its activation of ADCY8. Functionally, we showed that PDE1C regulated the formation of leading-edge protrusions in HASMCs, a critical early event in cell migration. Indeed, we found that PDE1C populated the tips of newly forming leading-edge protrusions in polarized HASMCs, and co-localized with ADCY8, the Ca2+ release activated Ca2+ channel subunit, Orai1, the cAMP-effector, protein kinase A, and an A-kinase anchoring protein, AKAP79. Because this polarization could allow PDE1C to control cAMP signaling in a hyper-localized manner, we suggest that PDE1C-selective therapeutic agents could offer increased spatial specificity in HASMCs over agents that regulate cAMP globally in cells. Similarly, such agents could also prove useful in regulating crosstalk between Ca2+/cAMP signaling in other cells in which dysregulated migration contributes to human pathology, including certain cancers.	[Brzezinska, Paulina; Simpson, Nicholas J.; Hubert, Fabien; Jacobs, Ariana N.; Umana, M. Bibiana; MacKeil, Jodi L.; Burke-Kleinman, Jonah; Ferguson, Alastair, V; Maurice, Donald H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Payne, Darrin M.] Queens Univ, Dept Surg, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Maurice, DH (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	mauriced@queensu.ca	Hubert, Fabien/ABE-6866-2021	Hubert, Fabien/0000-0003-1360-4092; Burke-Kleinman, Jonah/0000-0003-3399-3339	Canadian Institutes of Health Research (CIHR) [PJT-156283]; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by funds from the Canadian Institutes of Health Research (CIHR) (PJT-156283) to D. H. M and P. B. is a recipient of an Ontario Graduate Scholarship.	Ahuja M, 2014, CELL CALCIUM, V55, P385, DOI 10.1016/j.ceca.2014.01.006; Avila-Medina J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00257; Bender AT, 2005, P NATL ACAD SCI USA, V102, P497, DOI 10.1073/pnas.0408535102; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Brzezinska P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121473; Chen YF, 2019, CANCERS, V11, DOI 10.3390/cancers11070899; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cooper DMF, 2015, CELL CALCIUM, V58, P368, DOI 10.1016/j.ceca.2015.04.004; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Espinosa-Tanguma R, 2011, AM J PHYSIOL-HEART C, V301, pH315, DOI 10.1152/ajpheart.00355.2010; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Gao XH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0594-7; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Gueguen M, 2010, J PATHOL, V221, P331, DOI 10.1002/path.2716; Hashimoto T, 2018, CIRCULATION, V138, P1974, DOI 10.1161/CIRCULATIONAHA.117.030490; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Jia L, 2013, AM J RESP CELL MOL, V49, P601, DOI 10.1165/rcmb.2013-0040OC; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Knight WE, 2016, P NATL ACAD SCI USA, V113, pE7116, DOI 10.1073/pnas.1607728113; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Maiellaro I, 2012, J CELL MOL MED, V16, P2715, DOI 10.1111/j.1582-4934.2012.01592.x; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Michelucci A, 2018, CELL CALCIUM, V76, P101, DOI 10.1016/j.ceca.2018.10.004; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Moss SC, 2007, OCHSNER J, V7, P133; Motiani RK, 2018, EMBO J, V37, DOI 10.15252/embj.201797597; Palmer D, 1998, CIRC RES, V82, P852; Parker T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43821-3; Putney JW, 2017, ADV EXP MED BIOL, V981, P205, DOI 10.1007/978-3-319-55858-5_9; Putney James W., 2018, Advances in Biological Regulation, V68, P88, DOI 10.1016/j.jbior.2017.11.006; Putney JW, 2017, BBA-MOL CELL RES, V1864, P900, DOI 10.1016/j.bbamcr.2016.11.028; Raymond DR, 2009, AM J PHYSIOL-HEART C, V296, pH263, DOI 10.1152/ajpheart.00425.2008; Rowther FB, 2016, MOL CARCINOGEN, V55, P268, DOI 10.1002/mc.22276; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Spirli C, 2017, J HEPATOL, V66, P571, DOI 10.1016/j.jhep.2016.10.032; Thompson W J, 1974, Methods Enzymol, V38, P205; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zhang XX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09593-0; Zhang YS, 2018, CIRCULATION, V138, P1988, DOI 10.1161/CIRCULATIONAHA.118.034189	49	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100606	10.1016/j.jbc.2021.100606	http://dx.doi.org/10.1016/j.jbc.2021.100606			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789162	Green Published, gold			2022-12-26	WOS:000672866400578
J	Chen, XY; He, XY; Guo, Y; Liu, LH; Li, H; Tan, JF; Feng, WD; Guan, HY; Cao, XP; Xiao, HP; Li, YB				Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Tan, Jinfu; Feng, Weidong; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing			Glucose-dependent insulinotropic polypeptide modifies adipose plasticity and promotes beige adipogenesis of human omental adipose-derived stem cells	FASEB JOURNAL			English	Article						cellular research; drug mechanism; energy regulation; GIP; obesity therapy	ADIPOCYTE DIFFERENTIATION; FAT-CELL; TISSUE; OBESITY; WHITE; BROWN; EXPANSION; GIP; PROLIFERATION; MECHANISMS	The adipocyte precursors (APs) located in white adipose tissue (WAT) are functionally significant in adipose plasticity and browning. Modifying adipogenesis or WAT browning targeted on APs is a promising mechanism for anti-obesity drug. We herein explored the in vitro actions and mechanisms of glucose-dependent insulinotropic polypeptide (GIP), a gut-derived peptide, in human adipose-derived mesenchymal stem cells (hADSCs) isolated from omentum. The hADSCs were cotreated with 100 nM GIP with or without equimolar concentration of GIP3-42 (a GIP receptor antagonist), and subsequently examined in vitro. CCK-8, EdU incorporation, and flow cytometry assays were used to assess cellular proliferation. Annexin V FTIC/PI double stain, TUNEL staining, and Western blot were applied for apoptosis evaluation. Adipogenesis was reflected by Western blot, real-time PCR, Oil Red O staining, mitochondrial staining, and mitochondrial DNA analysis. Results showed that GIP promoted proliferation and inhibited apoptosis of hADSCs via pleiotropic effects. Besides, GIP facilitated de novo beige adipogenesis, by accelerating mitotic clonal expansion (MCE), upregulating core adipogenic regulators (C/EBP alpha and PPAR gamma), augmenting beige-related genes (UCP1, PGC1 alpha, and PRDM16), increasing mitochondrial content and improving beige adipocyte functionalities. Above all, our study expands knowledge on the mechanisms of GIP modifying adipogenesis especially in inducing beige adipogenesis, and thus provides a theoretical support for clinical usage of GIP on obesity treatment.	[Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China; [Chen, Xueying; He, Xiaoying; Guo, Yan; Liu, Liehua; Li, Hai; Guan, Hongyu; Cao, Xiaopei; Xiao, Haipeng; Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Diabet Ctr, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China; [Tan, Jinfu; Feng, Weidong] Sun Yat Sen Univ, Ctr Gastrointestinal Surg, Affiliated Hosp 1, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China.; Li, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Diabet Ctr, 58 Zhongshan Rd II, Guangzhou 510080, Peoples R China.	liyb@mail.sysu.edu.cn	li, yan/GTI-4638-2022		State Key Research and Development Program of China [2018YFC1314100]; National Natural Science Foundation of China [81870557, 81572623, 81572624, 81800716]; Key Field Research and Development Program of Guangdong Province, China [2019B020230001]; Natural Science Foundation of Guangdong Province, China [2016A030310169]; Guangdong Basic and Applied Basic Research Foundation [2019A1515012046, 2019A1515011248]; Medicine Technology Foundation of Guangdong Province [201811393557793]; Sun Yat-sen University Outstanding Graduate Innovation Development Project [19ykyjs09]	State Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Field Research and Development Program of Guangdong Province, China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangdong Basic and Applied Basic Research Foundation; Medicine Technology Foundation of Guangdong Province; Sun Yat-sen University Outstanding Graduate Innovation Development Project	State Key Research and Development Program of China, Grant/Award Number: 2018YFC1314100; National Natural Science Foundation of China, Grant/Award Number: 81870557, 81572623, 81572624 and 81800716; Key Field Research and Development Program of Guangdong Province, China, Grant/Award Number: 2019B020230001; Natural Science Foundation of Guangdong Province, China, Grant/Award Number: 2016A030310169; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2019A1515012046 and 2019A1515011248; Medicine Technology Foundation of Guangdong Province, Grant/Award Number: 201811393557793; Sun Yat--sen University Outstanding Graduate Innovation Development Project, Grant/Award Number: 19ykyjs09	Beaudry JL, 2019, MOL METAB, V28, P14; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cefalu WT, 2019, DIABETES CARE, V42, pS90, DOI 10.2337/dc19-S009; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Goedecke JH, 2011, J CLIN ENDOCR METAB, V96, pE2029, DOI 10.1210/jc.2011-1576; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Ha J, 2015, MOL ASPECTS MED, V46, P46, DOI 10.1016/j.mam.2015.08.002; He XY, 2018, INT J OBESITY, V42, P1051, DOI 10.1038/s41366-018-0024-2; Inoue N, 2008, J BIOL CHEM, V283, P21220, DOI 10.1074/jbc.M801824200; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Liang WW, 2015, ONCOTARGET, V6, P31780, DOI 10.18632/oncotarget.5566; Lopez-Mejia IC, 2018, CELL MOL LIFE SCI, V75, P975, DOI 10.1007/s00018-017-2668-9; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McIntosh CHS, 2012, J DIABETES INVEST, V3, P96, DOI 10.1111/j.2040-1124.2012.00196.x; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Montanari T, 2017, OBES REV, V18, P495, DOI 10.1111/obr.12520; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Ng SYA, 2014, EXPERT OPIN BIOL TH, V14, P1215, DOI 10.1517/14712598.2014.925870; Panina YA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01656; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Preston KJ, 2019, FASEB J, V33, P11993, DOI 10.1096/fj.201802637RR; Quang MDX, 2013, CYTOM PART A, V83, P933, DOI 10.1002/cyto.a.22333; Rose F, 2019, EXPERT OPIN DRUG DIS, V14, P1151, DOI 10.1080/17460441.2019.1646243; Rui LY, 2017, COMPR PHYSIOL, V7, P1281, DOI 10.1002/cphy.c170001; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schrover IM, 2018, EUR J PREV CARDIOL, V25, P1548, DOI 10.1177/2047487318790722; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srivastava G, 2018, NAT REV ENDOCRINOL, V14, P12, DOI 10.1038/nrendo.2017.122; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Wilkins HM, 2016, J NEUROCHEM, V137, P76, DOI 10.1111/jnc.13545; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang Y, 2018, J CLIN INVEST, V128, P4898, DOI 10.1172/JCI98353; Zhang Z, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110970	53	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21534	10.1096/fj.201903253R	http://dx.doi.org/10.1096/fj.201903253R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33817830				2022-12-26	WOS:000645260100089
J	Fang, ZF; Yi, F; Peng, Y; Zhang, JF; Zhang, LT; Deng, Z; Chen, FG; Li, CH; He, YW; Huang, CQ; Zhang, QL; Lai, KF; Xie, JX				Fang, Zhangfu; Yi, Fang; Peng, Yang; Zhang, Junfeng (Jim); Zhang, Liting; Deng, Zheng; Chen, Fagui; Li, Chenhui; He, Yaowei; Huang, Chuqin; Zhang, Qingling; Lai, Kefang; Xie, Jiaxing			Inhibition of TRPA1 reduces airway inflammation and hyperresponsiveness in mice with allergic rhinitis	FASEB JOURNAL			English	Article						airway inflammation; allergic rhinitis; asthma; TRPA1; vagal sensory neurons	SPLICING FACTOR SRSF3; MESSENGER-RNA; MITOCHONDRIAL DYNAMICS; SKELETAL-MUSCLE; GENE-EXPRESSION; HEART; CARDIOMYOPATHY; TRANSLATION; PROTEINS; HYPERTROPHY	This study was conducted to investigate whether a transient receptor potential ankyrin 1 (TRPA1) antagonist (HC-030031) can reduce airway inflammation and hyperresponsiveness in a murine allergic rhinitis (AR) model. BALB/c mice were sensitized and challenged by ovalbumin (OVA) to induce AR. HC-030031 or vehicle was administrated to mice via intraperitoneal injection prior to OVA challenges. Nose-scratching events, histopathologic alterations of the airways, and bronchial hyperresponsiveness (BHR) were assessed. Differential cells and proinflammatory cytokines in the nasal lavage (NAL) and bronchoalveolar lavage (BAL) fluid were measured. Expressions of TRPA1 in nasal mucosa were examined by immunohistochemistry. TRPA1-expressing vagal neurons were labeled by immunofluorescent staining. HC-030031-treated AR mice had markedly reduced type-2 inflammation in nasal mucosa and ameliorated-nose-scratching events than AR mice received vehicle. HC-030031 treatment also dramatically reduced leucocyte numbers and IL-8 level in the BAL fluid, inhibited lower airway remodeling and fibrosis, and nearly abolished BHR. HC-0300031 treatment significantly inhibited the upregulated number of TRPA1 expressing nasal epithelial cells and TRPA1 expressing sensory neurons, leading to downregulation of SP in both upper and lower airways. Targeting TRPA1 may represent a promising strategy for treating AR and AR-related asthma.	[Fang, Zhangfu; Yi, Fang; Peng, Yang; Zhang, Junfeng (Jim); Zhang, Liting; Deng, Zheng; He, Yaowei; Huang, Chuqin; Lai, Kefang] Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China; [Zhang, Junfeng (Jim)] Duke Univ, Nicholas Sch Environm, Global Hlth Inst, Durham, NC 27708 USA; [Chen, Fagui] Shantou Cent Hosp, Dept Resp Med, Shantou, Peoples R China; [Li, Chenhui] Shenzhen Peoples Hosp, Dept Resp & Crit Care Med, Shenzhen, Peoples R China; [Zhang, Qingling; Xie, Jiaxing] Guangzhou Med Univ, Affiliated Hosp 1, Dept Allergy & Clin Immunol,Guangzhou Inst Resp H, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Duke University; Jinan University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Lai, KF; Xie, JX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Hlth, 151 Yanjiang Rd, Guangzhou 510120, Peoples R China.	klai@163.com; jiaxingxie@126.com	Fang, Zhangfu/GVU-6797-2022; Xie, Jiaxing/B-5795-2012	Deng, Zheng/0000-0002-2203-6384; Zhang, Junfeng/0000-0003-3759-6672; Xie, Jiaxing/0000-0001-6462-6676	National Natural Science Foundation of China (NSFC) [81100028, 81270151, 82000024]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81100028, 81270151 and 82000024	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ajiro M, 2016, NUCLEIC ACIDS RES, V44, P1854, DOI 10.1093/nar/gkv1500; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Beqqali A, 2018, Biophys Rev, V10, P1061, DOI 10.1007/s12551-018-0439-y; Boengler K, 2006, J MOL CELL CARDIOL, V41, P426, DOI 10.1016/j.yjmcc.2006.05.015; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0; Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031; Boucher L, 2001, RNA, V7, P1693; Boutej H, 2017, CELL REP, V21, P3220, DOI 10.1016/j.celrep.2017.11.058; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Carlson SM, 2017, J BIOL CHEM, V292, P13381, DOI 10.1074/jbc.M117.784371; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chen J, 1998, DEVELOPMENT, V125, P1943; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Datta K, 2005, MOL BIOL CELL, V16, P954, DOI 10.1091/mbc.E04-07-0622; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; de Groot NE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64667-0; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorn GW, 2020, J MOL CELL CARDIOL, V142, P146, DOI 10.1016/j.yjmcc.2020.04.016; Dumont AA, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118557; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fang X, 2017, J CLIN INVEST, V127, P3189, DOI 10.1172/JCI94310; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gao C, 2016, J CLIN INVEST, V126, P195, DOI 10.1172/JCI84015; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Garrido-Martin D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006360; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Han H, 2017, MOL CELL, V65, P539, DOI 10.1016/j.molcel.2017.01.011; He XL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0422-1; Hoshino A, 2014, CIRC-HEART FAIL, V7, P500, DOI 10.1161/CIRCHEARTFAILURE.113.001062; Howard JM, 2015, WIRES RNA, V6, P93, DOI 10.1002/wrna.1260; Jeong S, 2017, MOL CELLS, V40, P1, DOI 10.14348/molcells.2017.2319; Jia R, 2010, INT J BIOL SCI, V6, P806; Kaizuka T, 2016, MOL CELL BIOL, V36, P585, DOI 10.1128/MCB.01005-15; Kanaan GN, 2018, REDOX BIOL, V14, P509, DOI 10.1016/j.redox.2017.10.019; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim HK, 2018, PFLUG ARCH EUR J PHY, V470, P995, DOI 10.1007/s00424-018-2136-x; Kim J, 2014, CELL DEATH DIFFER, V21, P481, DOI 10.1038/cdd.2013.171; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Kumar D, 2019, J CLIN INVEST, V129, P4477, DOI 10.1172/JCI127374; Kurokawa K, 2014, ONCOGENE, V33, P1407, DOI 10.1038/onc.2013.86; Lara-Pezzi E, 2013, J CARDIOVASC TRANSL, V6, P945, DOI 10.1007/s12265-013-9482-z; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lee HC, 2012, CLIN GENET, V81, P394, DOI 10.1111/j.1399-0004.2011.01659.x; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu J, 2019, PROTEIN CELL, V10, P405, DOI 10.1007/s13238-018-0578-8; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lupu I., 2019, THESIS U OXFORD; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mirtschink P, 2015, NATURE, V522, P444, DOI 10.1038/nature14508; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Opie LH., 1997, HEART PHYSL CELL CIR; Ortiz-Sanchez P, 2019, CIRC RES, V125, P170, DOI 10.1161/CIRCRESAHA.118.314515; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Piquereau J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00959; Pircher H, 2015, J BIOL CHEM, V290, P6755, DOI 10.1074/jbc.M114.609305; Rawcliffe DFR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165453; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Sabbah HN, 2016, CIRC-HEART FAIL, V9, P1, DOI 10.1161/CIRCHEARTFAILURE.115.002206; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; Sanchez-Diaz M, 2020, TRENDS ENDOCRIN MET, V31, P308, DOI 10.1016/j.tem.2020.01.006; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Semmler AL, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0121-9; Sen S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2342; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Simon MT, 2017, MITOCHONDRION, V34, P84, DOI 10.1016/j.mito.2017.02.004; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song X, 2019, CANCER RES, V79, P5288, DOI 10.1158/0008-5472.CAN-19-1504; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; Stopp S, 2017, P NATL ACAD SCI USA, V114, P8029, DOI 10.1073/pnas.1703406114; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Tang K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004346; Tapial J, 2017, GENOME RES, V27, P1759, DOI 10.1101/gr.220962.117; Tunster SJ, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0154-6; Tyrakis PA, 2017, CELL REP, V21, P1036, DOI 10.1016/j.celrep.2017.09.092; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35520; Wang RX, 2018, INT J MOL MED, V41, P311, DOI 10.3892/ijmm.2017.3234; Wei CL, 2015, CELL REP, V10, P1521, DOI 10.1016/j.celrep.2015.02.013; Weiss AKH, 2018, BIOCHEM SOC T, V46, P295, DOI 10.1042/BST20170518; Whitcomb J, 2020, IUBMB LIFE, V72, P53, DOI 10.1002/iub.2163; Wong J, 2012, J NEUROCHEM, V123, P159, DOI 10.1111/j.1471-4159.2012.07873.x; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	112	2	2	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21428	10.1096/fj.201902627R	http://dx.doi.org/10.1096/fj.201902627R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33774861				2022-12-26	WOS:000645260100082
J	Bergeron, P; Page, A; Trempe, M				Bergeron, Patrick; Page, Ariane; Trempe, Maxime			Integrating humans into pace-of-life studies: The Big Five personality traits and metabolic rate in young adults	PLOS ONE			English	Article								The pace-of-life syndrome (POLS) predicts that personality and metabolism should be correlated if they function as an integrated unit along a slow-fast continuum. Over the last decade, this conceptual framework has been tested in several empirical studies over a wide array of non-human animal taxa, across multiple personality traits and using standardized measures of metabolism. However, studies associating metabolic rate and personality in humans have been surprisingly scarce. Here, we tested whether there was covariation among personality scores, measured using the Big Five Inventory test, resting metabolic rate (RMR) and preferred walking speed (PWS) in a cohort of young human adults aged between 18 and 27 years old. We found a significant, negative relationship between RMR and Extraversion; less extraverted individuals had a 30% higher RMR than the most extraverted ones. No other personality traits correlated with RMR and none correlated with PWS. The negative correlation between Extraversion and RMR may suggest an allocation energy trade-off between personality and basal metabolism. Our results yielded equivocal support for the POLS and emphasized the need for more research on human to test the generality of this conceptual framework and further assess its validity.	[Bergeron, Patrick; Page, Ariane; Trempe, Maxime] Bishops Univ, Sherbrooke, PQ, Canada	Bishops University	Bergeron, P (corresponding author), Bishops Univ, Sherbrooke, PQ, Canada.	pbergero@ubishops.ca			Bishop's University institutional grant	Bishop's University institutional grant	This research was funded by a Bishop's University institutional grant to MT and PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvergne A, 2010, P NATL ACAD SCI USA, V107, P11745, DOI 10.1073/pnas.1001752107; Biro PA., 2019, ETHOLOGY, P1; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Brooks G. A., 2004, EXERCISE PHYSL HUMAN; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2019, PHYSIOL BEHAV, V199, P173, DOI 10.1016/j.physbeh.2018.11.023; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Carter NT, 2016, J PERS, V84, P510, DOI 10.1111/jopy.12177; Connelly BS, 2010, PSYCHOL BULL, V136, P1092, DOI 10.1037/a0021212; Dammhahn M, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2473-y; DeYoung CG, 2015, J RES PERS, V56, P33, DOI 10.1016/j.jrp.2014.07.004; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; HOGAN J, 1989, J PERS SOC PSYCHOL, V56, P284, DOI 10.1037/0022-3514.56.2.284; John OP, 1999, HDB PERSONALITY THEO; Johnson JA, 2014, J RES PERS, V51, P78, DOI 10.1016/j.jrp.2014.05.003; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Lehmann A, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2465-y; Lukaszewski AW, 2015, PERS INDIV DIFFER, V77, P186, DOI 10.1016/j.paid.2015.01.005; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; McMurray RG, 2014, MED SCI SPORT EXER, V46, P1352, DOI 10.1249/MSS.0000000000000232; Montiglio PO, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2526-2; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Niemela PT, 2018, ANIM BEHAV, V145, P99, DOI 10.1016/j.anbehav.2018.09.012; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Royaute R, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2472-z; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Soto CJ, 2009, J RES PERS, V43, P84, DOI 10.1016/j.jrp.2008.10.002; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Terracciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054746	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248876	10.1371/journal.pone.0248876	http://dx.doi.org/10.1371/journal.pone.0248876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ8VV	33822789	Green Published, gold			2022-12-26	WOS:000637879100014
J	Hudecz, D; Sigurdardottir, SB; Christensen, SC; Hempel, C; Urquhart, AJ; Andresen, TL; Nielsen, MS				Hudecz, Diana; Sigurdardottir, Sara Bjork; Christensen, Sarah Christine; Hempel, Casper; Urquhart, Andrew J.; Andresen, Thomas Lars; Nielsen, Morten S.			Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells	PLOS ONE			English	Article								The blood-brain barrier (BBB) is one of the main obstacles for therapies targeting brain diseases. Most macromolecules fail to pass the tight BBB, formed by brain endothelial cells interlinked by tight junctions. A wide range of small, lipid-soluble molecules can enter the brain parenchyma via diffusion, whereas macromolecules have to transcytose via vesicular transport. Vesicular transport can thus be utilized as a strategy to deliver brain therapies. By conjugating BBB targeting antibodies and peptides to therapeutic molecules or nanoparticles, it is possible to increase uptake into the brain. Previously, the synthetic peptide GYR and a peptide derived from melanotransferrin (MTfp) have been suggested as candidates for mediating transcytosis in brain endothelial cells (BECs). Here we study uptake, intracellular trafficking, and translocation of these two peptides in BECs. The peptides were synthesized, and binding studies to purified endocytic receptors were performed using surface plasmon resonance. Furthermore, the peptides were conjugated to a fluorophore allowing for live-cell imaging studies of their uptake into murine brain endothelial cells. Both peptides bound to low-density lipoprotein receptor-related protein 1 (LRP-1) and the human transferrin receptor, while lower affinity was observed against the murine transferrin receptor. The MTfp showed a higher binding affinity to all receptors when compared to the GYR peptide. The peptides were internalized by the bEnd.3 mouse endothelial cells within 30 min of incubation and frequently co-localized with endo-lysosomal vesicles. Moreover, our in vitro Transwell translocation experiments confirmed that GYR was able to cross the murine barrier and indicated the successful translocation of MTfp. Thus, despite binding to endocytic receptors with different affinities, both peptides are able to transcytose across the murine BECs.	[Hudecz, Diana; Christensen, Sarah Christine; Nielsen, Morten S.] Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus, Denmark; [Sigurdardottir, Sara Bjork; Hempel, Casper; Urquhart, Andrew J.; Andresen, Thomas Lars] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark	Aarhus University; Technical University of Denmark	Nielsen, MS (corresponding author), Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus, Denmark.	mn@biomed.au.dk	Nielsen, Morten Schallburg/G-9498-2016; Urquhart, Andrew/B-8194-2014; Hempel, Casper/C-9511-2013	Nielsen, Morten Schallburg/0000-0001-9863-9694; Urquhart, Andrew/0000-0002-5322-0002; Christensen, Sarah Christine/0000-0002-2873-7974; Sigurdardottir, Sara Bjork/0000-0003-2936-1152; Andresen, Thomas Lars/0000-0002-1048-127X; Hempel, Casper/0000-0002-9816-4673	Lundbeck foundation [R155-2013-14113]	Lundbeck foundation(Lundbeckfonden)	The Authors has been supported by a grant from the Lundbeck foundation (grant number R155-2013-14113) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Akita H, 2016, SMALL, V12, P1212, DOI 10.1002/smll.201500909; Brinkhuis RP., 2011, Patent No. [WO 2011/005098 A1, 2011005098]; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; DANIELSEN EM, 1995, J CELL BIOL, V131, P939, DOI 10.1083/jcb.131.4.939; Deli MA, 2011, SOLUBILITY, DELIVERY AND ADME PROBLEMS OF DRUGS AND DRUG CANDIDATES, P144; Demeule M, 2002, J NEUROCHEM, V83, P924, DOI 10.1046/j.1471-4159.2002.01201.x; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Eyford BA., 2019, BIORXIV, DOI [10.1101/871186, DOI 10.1101/871186]; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hudecz D, 2020, ACS NANO, V14, P1111, DOI 10.1021/acsnano.9b08870; Jensen KJ, 2013, METHODS MOL BIOL, V1047, P1, DOI 10.1007/978-1-62703-544-6_1; Johnsen KB, 2018, THERANOSTICS, V8, P3416, DOI 10.7150/thno.25228; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; Lajoie JM, 2015, ANNU REV PHARMACOL, V55, P613, DOI 10.1146/annurev-pharmtox-010814-124852; MERZOUK A, 1992, TETRAHEDRON LETT, V33, P477, DOI 10.1016/S0040-4039(00)93973-X; Michaud-Levesque J, 2012, EXP CELL RES, V318, P925, DOI 10.1016/j.yexcr.2012.02.017; Nakamasu K, 1999, BBA-GENE STRUCT EXPR, V1447, P258, DOI 10.1016/S0167-4781(99)00173-6; Nielsen MS, 1997, J BIOL CHEM, V272, P5821, DOI 10.1074/jbc.272.9.5821; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oller-Salvia B, 2016, CHEM SOC REV, V45, P4690, DOI 10.1039/c6cs00076b; Pardridge William M, 2005, NeuroRx, V2, P3; Rahmanto YS, 2012, BBA-GEN SUBJECTS, V1820, P237, DOI 10.1016/j.bbagen.2011.09.003; Shao Y, 2016, ONCOTARGET, V7, P34011, DOI [10.18632/oncotarget.8514, 10.18632/oncotarget.12708]; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Tang FHF, 2019, P NATL ACAD SCI USA, V116, P2300, DOI 10.1073/pnas.1809483116; Thieriet N, 1997, TETRAHEDRON LETT, V38, P7275, DOI 10.1016/S0040-4039(97)01690-0; Thom G, 2019, J CEREBR BLOOD F MET, V39, P2074, DOI 10.1177/0271678X18772998; van Rooy I, 2011, J CONTROL RELEASE, V150, P30, DOI 10.1016/j.jconrel.2010.11.014; van Rooy I, 2010, PHARM RES-DORDR, V27, P673, DOI 10.1007/s11095-010-0053-6; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vieira DB, 2016, INT J NANOMED, V11, P5381, DOI 10.2147/IJN.S117210; Villasenor R, 2017, CELL REP, V21, P3256, DOI 10.1016/j.celrep.2017.11.055; Villasenor R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25658; Watts RJ, 2013, CURR OPIN CHEM BIOL, V17, P393, DOI 10.1016/j.cbpa.2013.03.023; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wu LP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12554-2; Ye D, 2013, NANOSCALE, V5, P11153, DOI 10.1039/c3nr02905k; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Yuan W, 2010, ANN BIOMED ENG, V38, P1463, DOI 10.1007/s10439-010-9920-x; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	46	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0249686	10.1371/journal.pone.0249686	http://dx.doi.org/10.1371/journal.pone.0249686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798235	Green Published, gold			2022-12-26	WOS:000636737700006
J	Mbuagbaw, L; Logie, CH; Thabane, L; Smaill, F; Smieja, M; Burchell, AN; Rachlis, B; Tarride, JE; Kroch, A; Mazzulli, T; Alvarez, E; Lawson, DO; Nguyen, F; Perez, R; Seow, H				Mbuagbaw, Lawrence; Logie, Carmen H.; Thabane, Lehana; Smaill, Fiona; Smieja, Marek; Burchell, Ann N.; Rachlis, Beth; Tarride, Jean-Eric; Kroch, Abigail; Mazzulli, Tony; Alvarez, Elizabeth; Lawson, Daeria O.; Nguyen, Francis; Perez, Richard; Seow, Hsien			The impact of routine HIV drug resistance testing in Ontario: A controlled interrupted time series study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; EPIDEMIOLOGY; TRANSMISSION; ASSOCIATION; GUIDELINES	Background Knowledge of HIV drug resistance informs the choice of regimens and ensures that the most efficacious options are selected. In January 2014, a policy change to routine resistance testing was implemented in Ontario, Canada. The objective of this study was to investigate the policy change impact of routine resistance testing in people with HIV in Ontario, Canada since January 2014. Methods We used data on people with HIV living in Ontario from administrative databases of the Institute for Clinical Evaluative Sciences (ICES) and Public Health Ontario (PHO), and ran ordinary least squares (OLS) models of interrupted time series to measure the levels and trends of 2-year mortality, 2-year hospitalizations and 2-year emergency department visits before (2005-2013) and after the policy change (2014-2017). Outcomes were collected in biannual periods, generating 18 periods before the intervention and 8 periods after. We included a control series of people who did not receive a resistance test within 3 months of HIV diagnosis. Results Data included 12,996 people with HIV, of which 8881 (68.3%) were diagnosed between 2005 and 2013, and 4115 (31.7%) were diagnosed between 2014 and 2017. Policy change to routine resistance testing within 3 months of HIV diagnosis led to a decreasing trend in 2-year mortality of 0.8% every six months compared to the control group. No significant differences in hospitalizations or emergency department visits were noted. Interpretation The policy of routine resistance testing within three months of diagnosis is beneficial at the population level.	[Mbuagbaw, Lawrence; Smaill, Fiona; Smieja, Marek; Tarride, Jean-Eric; Alvarez, Elizabeth; Lawson, Daeria O.; Seow, Hsien] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Mbuagbaw, Lawrence] St Josephs Healthcare, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada; [Mbuagbaw, Lawrence] Yaounde Cent Hosp, Ctr Dev Best Practices Hlth CDBPH, Yaounde, Cameroon; [Logie, Carmen H.] Womens Coll Res, Toronto, ON, Canada; [Logie, Carmen H.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Paediat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Anaesthesia, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON, Canada; [Thabane, Lehana] Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Burchell, Ann N.] Univ Toronto, Fac Med, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth Toronto, Ctr Res Inner City Hlth, Toronto, ON, Canada; [Kroch, Abigail] Ontario HIV Treatment Network, Toronto, ON, Canada; [Rachlis, Beth] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada; [Tarride, Jean-Eric] McMaster Univ, McMaster Chair Hlth Technol Management, Hamilton, ON, Canada; [Mazzulli, Tony] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mazzulli, Tony] Univ Hlth Network, Dept Microbiol, Sinai Hlth Syst, Toronto, ON, Canada; [Mazzulli, Tony] Publ Hlth Ontario Lab, Toronto, ON, Canada; [Alvarez, Elizabeth] McMaster Univ, Ctr Hlth Econ & Policy Anal CHEPA, Hamilton, ON, Canada; [Nguyen, Francis; Perez, Richard] McMaster Univ, ICES McMaster, Hamilton, ON, Canada; [Seow, Hsien] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON, Canada	McMaster University; University of Toronto; McMaster University; McMaster University; McMaster University; Population Health Research Institute; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; McMaster University; McMaster University; McMaster University	Mbuagbaw, L (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Mbuagbaw, L (corresponding author), St Josephs Healthcare, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada.; Mbuagbaw, L (corresponding author), Yaounde Cent Hosp, Ctr Dev Best Practices Hlth CDBPH, Yaounde, Cameroon.	mbuagblc@mcmaster.ca	Seow, Hsien/AAQ-1438-2021	Seow, Hsien/0000-0001-6701-1714; Lawson, Daeria O./0000-0002-6487-3367	Ontario HIV Treatment Network (OHTN) [EFP-1096-Junior Inv]; Constantine Douketis New Researcher Award of The Research Institute of St. Joe's Hamilton; Institute for Clinical Evaluative Sciences (ICES); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); OHTN Leader Award; Canada Research Chair in Sexually Transmitted Infections; University of Toronto Department of Family and Community Medicine Non-Clinician Scientist Award; Canada Research Chair in Global Health Equity and Social Justice with Marginalized Populations; Ontario Ministry of Research Innovation	Ontario HIV Treatment Network (OHTN); Constantine Douketis New Researcher Award of The Research Institute of St. Joe's Hamilton; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); OHTN Leader Award; Canada Research Chair in Sexually Transmitted Infections; University of Toronto Department of Family and Community Medicine Non-Clinician Scientist Award; Canada Research Chair in Global Health Equity and Social Justice with Marginalized Populations; Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by The Ontario HIV Treatment Network (OHTN) grant number EFP-1096-Junior Inv. This study was supported by an award from Constantine Douketis New Researcher Award of The Research Institute of St. Joe's Hamilton. The study's analysis was supported by the Institute for Clinical Evaluative Sciences (ICES). Parts of this material are based on data and information compiled and provided by the MOHLTC CIHI and PHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This analysis was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by the MOHLTC CIHI and PHO. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended.; Ann N. Burchell is supported by an OHTN Leader Award, Canada Research Chair in Sexually Transmitted Infections and University of Toronto Department of Family and Community Medicine Non-Clinician Scientist Award. Carmen H. Logie is supported by a Canada Research Chair in Global Health Equity and Social Justice with Marginalized Populations and the Ontario Ministry of Research & Innovation.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; Bernal JL, 2018, INT J EPIDEMIOL, V47, P2082, DOI 10.1093/ije/dyy135; Beyrer C, 2017, NEW ENGL J MED, V377, P1605, DOI 10.1056/NEJMp1710608; Burchell Ann N, 2019, CMAJ Open, V7, pE1, DOI 10.9778/cmajo.20180159; Burchell AN, 2012, J ANTIMICROB CHEMOTH, V67, P2755, DOI 10.1093/jac/dks287; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; CATIE, EP HIV CAN 2017; CATIE, PROGR ONT HIV CAR CA; EACS, EUROPEAN GUIDELINES; Eyawo O, 2011, AIDS CARE, V23, P42, DOI 10.1080/09540121.2010.498871; Frentz D, 2012, AIDS REV, V14, P17; Gibas KM, 2019, DRUGS, V79, P609, DOI 10.1007/s40265-019-01108-x; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Haddad N, 2018, Can Commun Dis Rep, V44, P348, DOI 10.14745/ccdr.v44i12a03; Hyle EP, 2020, CLIN INFECT DIS, V70, P1353, DOI 10.1093/cid/ciz372; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kronfli N, 2017, AIDS CARE, V29, P1235, DOI 10.1080/09540121.2017.1338658; Lodi S, 2019, JAIDS-J ACQ IMM DEF, V82, P314, DOI 10.1097/QAI.0000000000002135; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Matheson FI., 2012, ONTARIO MARGINALIZAT; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Palella FJ, 2009, ANN INTERN MED, V151, P73, DOI 10.7326/0003-4819-151-2-200907210-00003; PHO, HIV GEN RES TROP HLA; Raffi F, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-110; Rocheleau G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184848; RUBIN A, 1985, SOC SERV REV, V59, P518, DOI 10.1086/644316; Tannenbaum C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0247-7; UNAIDS, GLOB HIV AIDS STAT 2; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHO, HIV AIDS TREATM CAR; Wilton J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210096; World Health Organization, GUID PUBL HLTH RESP; World Health Organization, 2019, HIV DRUG RES REP 201; Zash R, 2018, NEW ENGL J MED, V379, P979, DOI 10.1056/NEJMc1807653	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0246766	10.1371/journal.pone.0246766	http://dx.doi.org/10.1371/journal.pone.0246766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798201	Green Published, gold			2022-12-26	WOS:000636737700043
J	McAlister, FA; Lethebe, BC; Leung, AA; Padwal, RS; Williamson, T				McAlister, Finlay A.; Lethebe, Brendan Cord; Leung, Alexander A.; Padwal, Rajdeep S.; Williamson, Tyler			Visit-to-visit blood pressure variability is common in primary care patients: Retrospective cohort study of 221,803 adults	PLOS ONE			English	Article								Objective Although high visit-to-visit blood pressure variability (BPV) is an independent risk factor for cardiovascular events, the frequency of high BPV is unknown. We conducted this study to define the frequency of high BPV in primary care patients, clinical correlates, and association with antihypertensive therapies. Methods Retrospective cohort study using electronic medical record data (with previously validated case definitions based on billing codes, free text analysis of progress notes, and prescribing data) from the Canadian Primary Care Sentinel Surveillance Network of 221,803 adults with multiple clinic visits over a 2-year period. We a priori defined a standard deviation>13.0 mm Hg in visit-to-visit systolic blood pressure (SBP) as "high BPV" based on prior literature. Results Overall, 85,455 (38.5%) patients had hypertension (mean 6.56 visits with SBP measurement, mean SBP 134.4 with Standard Deviation [SD] 11.3, 33.2% exhibited high BPV) and 136,348 did not (mean 3.96 visits with SBP measurement, mean SBP 120.9 with SD 8.2, 16.5% had high BPV). BPV increased with age regardless of whether individuals had hypertension or not; at all ages BPV varied across antihypertensive treatment regimens and was greater in those receiving renin angiotensin blockers or beta-blockers (p<0.001). High BPV was more frequent in patients with diabetes, chronic kidney disease, dementia, depression, chronic obstructive pulmonary disease, or Parkinson's disease. Conclusions High visit-to-visit BPV is present in one sixth of non-hypertensive adults and one third of hypertensive individuals and is more common in those with comorbidities. The frequency of high BPV varies across antihypertensive treatment regimens.	[McAlister, Finlay A.; Padwal, Rajdeep S.] Univ Alberta, Fac Med & Dent, Div Gen Internal Med, Edmonton, AB, Canada; [Lethebe, Brendan Cord; Williamson, Tyler] Univ Calgary, Cumming Sch Med, Clin Res Unit, Calgary, AB, Canada; [Leung, Alexander A.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Williamson, Tyler] Univ Calgary, Cumming Sch Med, Div Community Med, Calgary, AB, Canada	University of Alberta; University of Calgary; University of Calgary; University of Calgary	McAlister, FA (corresponding author), Univ Alberta, Fac Med & Dent, Div Gen Internal Med, Edmonton, AB, Canada.	Finlay.McAlister@ualberta.ca	McAlister, Finlay/C-4151-2013; Leung, Alexander/L-9856-2018	McAlister, Finlay/0000-0001-7435-3341; Leung, Alexander/0000-0002-7536-8497	Alberta Health Services Chair in Cardiovascular Outcomes Research	Alberta Health Services Chair in Cardiovascular Outcomes Research	No project specific funding but FAM is supported by the Alberta Health Services Chair in Cardiovascular Outcomes Research.	Armstrong PW, 2016, J AM COLL CARDIOL, V68, P802, DOI 10.1016/j.jacc.2016.06.006; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Garies S, 2017, INT J EPIDEMIOL, V46, P1091, DOI 10.1093/ije/dyw248; Gosmanova EO, 2016, J AM COLL CARDIOL, V68, P1375, DOI 10.1016/j.jacc.2016.06.054; Kronish IM, 2016, HYPERTENSION, V68, P39, DOI 10.1161/HYPERTENSIONAHA.115.06960; Laurent S, 2018, EUR HEART J, V39, P2252, DOI 10.1093/eurheartj/ehy011; Lim HM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025322; Mancia G, 2016, HYPERTENSION, V68, P32, DOI 10.1161/HYPERTENSIONAHA.116.07139; Mehlum MH, 2018, EUR HEART J, V39, P2243, DOI 10.1093/eurheartj/ehx760; Messerli FH, 2019, J AM COLL CARDIOL, V73, P2596, DOI 10.1016/j.jacc.2019.02.063; Mezue K, 2018, J CLIN HYPERTENS, V20, P1247, DOI 10.1111/jch.13346; Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803; Muntner P, 2014, J CLIN HYPERTENS, V16, P323, DOI 10.1111/jch.12290; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Queenan John A, 2016, CMAJ Open, V4, pE28, DOI 10.9778/cmajo.20140128; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Suchard MA, 2019, LANCET, V394, P1816, DOI 10.1016/S0140-6736(19)32317-7; Takashima N, 2019, J HUM HYPERTENS, V33, P229, DOI 10.1038/s41371-018-0129-z; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; Vishram JKK, 2015, J HYPERTENS, V33, P2422, DOI 10.1097/HJH.0000000000000739; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Williamson T, 2014, ANN FAM MED, V12, P367, DOI 10.1370/afm.1644	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2021	16	4							e0248362	10.1371/journal.pone.0248362	http://dx.doi.org/10.1371/journal.pone.0248362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RI2KE	33798213	Green Published, gold			2022-12-26	WOS:000636737700030
J	Broll, S; Urbanek, J; Buchanan, D; Chun, E; Muschelli, J; Punjabi, NM; Gaynanova, I				Broll, Steven; Urbanek, Jacek; Buchanan, David; Chun, Elizabeth; Muschelli, John; Punjabi, Naresh M.; Gaynanova, Irina			Interpreting blood GLUcose data with R package iglu	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; QUALITY; INDEX	Continuous Glucose Monitoring (CGM) data play an increasing role in clinical practice as they provide detailed quantification of blood glucose levels during the entire 24-hour period. The R package iglu implements a wide range of CGM-derived metrics for measuring glucose control and glucose variability. The package also allows one to visualize CGM data using time-series and lasagna plots. A distinct advantage of iglu is that it comes with a point-and-click graphical user interface (GUI) which makes the package widely accessible to users regardless of their programming experience. Thus, the open-source and easy to use iglu package will help advance CGM research and CGM data analyses. R package iglu is publicly available on CRAN and at https://github.com/irinagain/iglu.	[Broll, Steven; Buchanan, David; Gaynanova, Irina] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Urbanek, Jacek; Punjabi, Naresh M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Chun, Elizabeth] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Muschelli, John] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Broll, Steven] Cornell Univ, Dept Stat & Data Sci, Ithaca, NY USA; [Punjabi, Naresh M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; University of Miami	Gaynanova, I (corresponding author), Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA.	irinag@stat.tamu.edu	Punjabi, Naresh/EMH-1007-2022	Broll, Steve/0000-0002-0765-0941; Gaynanova, Irina/0000-0002-4116-0268	National Institutes of Health [HL11716, HL146709]; Johns Hopkins University [80045538]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University)	This work was supported by the National Institutes of Health [HL11716, HL146709 to N.P.]; and an agreement from the Johns Hopkins University [80045538 to I.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; Battelino T, 2019, DIABETES CARE, V42, P1593, DOI 10.2337/dci19-0028; Bergenstal RM, 2018, DIABETES CARE, V41, P2275, DOI 10.2337/dc18-1581; Clarke W, 2009, DIABETES TECHNOL THE, V11, pS45, DOI 10.1089/dia.2008.0138; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; Fabris Chiara, 2015, J Diabetes Sci Technol, V10, P119, DOI 10.1177/1932296815596173; Fabris C, 2014, DIABETES TECHNOL THE, V16, P644, DOI 10.1089/dia.2013.0252; Gaynanova I, 2022, BIOSTATISTICS, V23, P223, DOI 10.1093/biostatistics/kxaa023; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hill NR, 2007, DIABETIC MED, V24, P753, DOI 10.1111/j.1464-5491.2007.02119.x; Hill NR, 2011, DIABETES TECHNOL THE, V13, P921, DOI 10.1089/dia.2010.0247; Johnson ML, 2019, DIABETES TECHNOL THE, V21, pS17, DOI 10.1089/dia.2019.0034; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Leelarathna Lalantha, 2020, J Diabetes Sci Technol, V14, P277, DOI 10.1177/1932296819838525; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Muller K, 2020, **DATA OBJECT**; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Peyser TA, 2018, DIABETES TECHNOL THE, V20, P6, DOI 10.1089/dia.2017.0187; Riddlesworth TD, 2018, DIABETES TECHNOL THE, V20, P314, DOI 10.1089/dia.2017.0455; Rodbard D, 2016, DIABETES TECHNOL THE, V18, P3, DOI 10.1089/dia.2015.0417; Rodbard David, 2009, J Diabetes Sci Technol, V3, P1395; Rodbard David, 2009, J Diabetes Sci Technol, V3, P1388; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; SCHLICHTKRULL J, 1965, ACTA MED SCAND, V177, P95; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; Suh S, 2015, DIABETES METAB J, V39, P273, DOI 10.4093/dmj.2015.39.4.273; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; Umpierrez GE, 2018, AM J MED SCI, V356, P518, DOI 10.1016/j.amjms.2018.09.010; Vigers T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216851; WOJCICKI JM, 1995, HORM METAB RES, V27, P41, DOI 10.1055/s-2007-979906; Zhang XD, 2018, BIOINFORMATICS, V34, P1609, DOI 10.1093/bioinformatics/btx826	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248560	10.1371/journal.pone.0248560	http://dx.doi.org/10.1371/journal.pone.0248560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793578	gold, Green Published, Green Submitted			2022-12-26	WOS:000636467000027
J	Song, SR; Park, KM; Jung, BY				Song, Seung-rye; Park, Kyeong-Mee; Jung, Bock-Young			Fracture strength analysis of titanium insert-reinforced zirconia abutments according to the axial height of the titanium insert with an internal connection	PLOS ONE			English	Article							BITE FORCE; IMPLANT ABUTMENTS; CERAMIC ABUTMENTS; IN-VITRO; LOAD; RESTORATIONS	This study aimed to analyze fracture strength in vitro by varying the axial height of the titanium insert and the labial height of the zirconia abutment in an internal connection implant to identify the titanium insert axial height with optimal mechanical stability. Sixty implants with an internal connection system were used. Two-piece zirconia abutments were used with the titanium inserts. Combinations of different titanium insert axial heights (mm) and zirconia abutment labial heights (mm) constituted five groups: Gr1 (1-3), Gr2 (3-3), Gr3 (3-5), Gr4 (5-3), and Gr5 (5-5). After thermocycling, a fracture load test was performed with a universal testing machine. The initial deformation load and the fracture load were measured and analyzed. The fractured surface and cross-section of the specimens were examined by scanning electron microscopy (SEM). The groups of titanium inserts with axial heights of 3 mm and 5 mm showed significantly greater initial deformation load and fracture load than the group with an axial height of 1 mm (p < 0.05), but there was no significant difference between the two groups with axial heights of 3 mm and 5 mm. The labial height of the zirconia abutment had no significant influence on the initial deformation load and fracture load. In some specimens in Gr4 and Gr5, cracking or bending of the titanium insert and abutment screw was observed on SEM. The axial height of the titanium insert should be designed to not be less than 3 mm to increase the fracture strength and promote the long-term stability of implants.	[Song, Seung-rye] Dankook Univ, Coll Dent, Dept Adv Gen Dent, Cheonan, South Korea; [Park, Kyeong-Mee] Yonsei Univ, Coll Dent, Human Identificat Res Inst, Dept Adv Gen Dent, Seoul, South Korea; [Jung, Bock-Young] Yonsei Univ, Coll Dent, Dept Adv Gen Dent, Seoul, South Korea	Dankook University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, BY (corresponding author), Yonsei Univ, Coll Dent, Dept Adv Gen Dent, Seoul, South Korea.	jby1004@yuhs.ac		Jung, Bock-Young/0000-0002-8186-2109	Yonsei University College of Dentistry [6-2018-0027]	Yonsei University College of Dentistry	This study was supported by a faculty research grant from the Yonsei University College of Dentistry (No 6-2018-0027).	Aboushelib MN, 2009, INT J PROSTHODONT, V22, P616; Att W, 2006, J ORAL REHABIL, V33, P380, DOI 10.1111/j.1365-2842.2005.01571.x; Baldassarri M, 2012, INT J ORAL MAX IMPL, V27, P537; Bindl A, 2006, J ORAL REHABIL, V33, P520, DOI 10.1111/j.1365-2842.2005.01588.x; Bottino MA, 2016, EUR J PROSTHODONT RE, V24, P164, DOI 10.1922/EJPRD_01556Bottino05; Choi JW, 2018, MATERIALS, V11, DOI 10.3390/ma11040564; Chun HJ, 2015, INT J ORAL MAX IMPL, V30, P346, DOI 10.11607/jomi.3768; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Gehrke SA, 2016, J PROSTHET DENT, V116, P529, DOI 10.1016/j.prosdent.2016.02.015; GIBBS CH, 1986, J PROSTHET DENT, V56, P226, DOI 10.1016/0022-3913(86)90480-4; HARALDSON T, 1979, ACTA ODONTOL SCAND, V37, P195, DOI 10.3109/00016357909027582; Hebel KS, 1997, J PROSTHET DENT, V77, P28, DOI 10.1016/S0022-3913(97)70203-8; Hjerppe J, 2011, INT J ORAL MAX IMPL, V26, P132; Iso, 2018, DENT POLYM BASED CRO, V3rd ed; Iso, 2007, DENT IMPL DYN FAT TE, V2nd ed; Joo HS, 2015, J ADV PROSTHODONT, V7, P183, DOI 10.4047/jap.2015.7.3.183; Kerstein RB, 2008, INT J ORAL MAX IMPL, V23, P1029; Kil JK., 2010, THESIS YONSEI U SEOU; Kim Young-Ho, 2016, [The Journal of Korean Academy of Prosthodontics, 대한치과보철학회지], V54, P93, DOI 10.4047/jkap.2016.54.2.93; Kohal RJ, 2008, PERIODONTOL 2000, V47, P224, DOI 10.1111/j.1600-0757.2007.00243.x; Koutayas SO, 2012, INT J ORAL MAX IMPL, V27, P839; 신홍수, 2013, [Korean Journal of Dental Materials, 대한치과재료학회지], V40, P223; Lin YT, 2020, J PROSTHET DENT, V123, P449, DOI 10.1016/j.prosdent.2019.01.006; Mascarenhas F, 2017, J PROSTHET DENT, V117, P749, DOI 10.1016/j.prosdent.2016.09.008; Mehl C, 2012, INT J ORAL MAX IMPL, V27, P1106; Misch CE, 2015, DENT IMPLANTS PROSTH, V11; Mitsias M, 2014, CLIN ORAL IMPLAN RES, V25, P675, DOI 10.1111/clr.12058; Moon S-J., 2015, J KOREAN ACAD PROSTH, V53; Paphangkorakit J, 1997, ARCH ORAL BIOL, V42, P11, DOI 10.1016/S0003-9969(96)00106-9; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; RITTER JE, 1995, DENT MATER, V11, P147, DOI 10.1016/0109-5641(95)80051-4; Sailer I, 2018, CLIN ORAL IMPLAN RES, V29, P411, DOI 10.1111/clr.13139; Sailer I, 2009, INT J ORAL MAX IMPL, V24, P850; Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292; Stimmelmayr M, 2013, INT J ORAL MAX IMPL, V28, P488, DOI 10.11607/jomi.2772; Truninger TC, 2012, CLIN ORAL IMPLAN RES, V23, P12, DOI 10.1111/j.1600-0501.2010.02141.x; WALTIMO A, 1993, SCAND J DENT RES, V101, P171	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249208	10.1371/journal.pone.0249208	http://dx.doi.org/10.1371/journal.pone.0249208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793622	Green Published, gold			2022-12-26	WOS:000636467000052
J	Stefanescu, S; Cocos, R; Turcu-Stiolica, A; Mahler, B; Meca, AD; Giura, AMC; Bogdan, M; Shelby, ES; Zamfirescu, G; Pisoschi, CG				Stefanescu, Simona; Cocos, Relu; Turcu-Stiolica, Adina; Mahler, Beatrice; Meca, Andreea-Daniela; Giura, Ana Maria Cristina; Bogdan, Maria; Shelby, Elena-Silvia; Zamfirescu, Georgeta; Pisoschi, Catalina-Gabriela			Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; PERIPHERAL-BLOOD; DISTRIBUTION WIDTH; PLATELET COUNT; NEUTROPHIL; RISK; BIOMARKERS; PARAMETERS; DIAGNOSIS; INFLAMMATION	We evaluated in this cohort study the predictive ability of 23 peripheral blood parameters and ratios for treatment outcomes after the 2-month intensive phase in patients with PTB. In 63 patients out of 90 that turned culture negative, a significant decrease in white blood cell count, neutrophils, monocyte, hemoglobin, platelet, plateletcrit, erythrocyte sedimentation rate, MLR, NLR, PLR and SII values after anti-TB therapy compared to pretreatment was observed (p <0.001). Logistic regression analysis generated a model of predictors consisting of nine covariates. Spearman's correlation analysis revealed significant positive correlations between NLR with NEU (r = 0.79, p<0.01), SII with NEU (r = 0.846, p<0.01), PLT with SII (r = 0.831, p<0.01), PLT with PCT (r = 0.71, p<0.01) and MPV with P-LCR (r = 0,897, p<0.01) in 63 patients out of 90 that turned culture negative after 2 months of treatment. ROC curve analysis indicated that all areas under the curve (AUC) revealed no statistically significant results, except lymphocyte for culture conversion. In summary, here we observed a set of hematological parameters that declined significantly as the disease was treated in patients that turned culture negative. Despite some limitations, our findings are useful for further studies aiming to identify hematological profiles that could predict the treatment outcome.	[Stefanescu, Simona] Clin Emergency Cty Hosp Craiova, Clin Anal Lab, Craiova, Romania; [Cocos, Relu] Univ Med & Pharm Carol Davila, Dept Med Genet, Bucharest, Romania; [Cocos, Relu; Mahler, Beatrice] Inst Pneumophtisiol Marius Nasta, Bucharest, Romania; [Turcu-Stiolica, Adina] Univ Med & Pharm Craiova, Dept Pharmacoecon, Craiova, Romania; [Mahler, Beatrice] Univ Med & Pharm Carol Davila, Dept Pneumol 2, Bucharest, Romania; [Meca, Andreea-Daniela; Bogdan, Maria] Univ Med & Pharm Craiova, Dept Pharmacol, Craiova, Romania; [Giura, Ana Maria Cristina] Univ Med & Pharm Carol Davila, Dept Prevent Dent, Bucharest, Romania; [Shelby, Elena-Silvia] Dr Nicolae Robanescu Natl Clin Ctr Childrens Neur, Sci Res Nucleus, Bucharest, Romania; [Zamfirescu, Georgeta] Leamna Pneumophtisiol Hosp, Clin Anal Lab, Craiova, Romania; [Pisoschi, Catalina-Gabriela] Univ Med & Pharm Craiova, Dept Biochem, Craiova, Romania	Carol Davila University of Medicine & Pharmacy; "Marius Nasta" Pneumophtisiology Institute; University of Medicine & Pharmacy of Craiova; Carol Davila University of Medicine & Pharmacy; University of Medicine & Pharmacy of Craiova; Carol Davila University of Medicine & Pharmacy; University of Medicine & Pharmacy of Craiova	Cocos, R (corresponding author), Univ Med & Pharm Carol Davila, Dept Med Genet, Bucharest, Romania.; Cocos, R (corresponding author), Inst Pneumophtisiol Marius Nasta, Bucharest, Romania.	relu_cocos@yahoo.com	Shelby, Elena-Silvia/AAJ-4543-2021; Meca, Andreea-Daniela/AAQ-2380-2021; Cocoș, Relu/O-4134-2017; Cocos, Relu/AAS-3810-2021; Turcu-Stiolica, Adina/C-5968-2017	Shelby, Elena-Silvia/0000-0003-4658-2416; Meca, Andreea-Daniela/0000-0002-6890-049X; Cocoș, Relu/0000-0002-6209-2305; Turcu-Stiolica, Adina/0000-0003-1374-276X; Bogdan, Maria/0000-0001-8089-1787				Amaral EP, 2021, ANTIOXID REDOX SIGN, V34, P471, DOI 10.1089/ars.2020.8124; [Anonymous], 2014, LANCET RESP MED, V2, P943, DOI 10.1016/S2213-2600(14)70277-2; [Anonymous], 2018, WHO GLOBAL TUBERCULO; [Anonymous], 2019, WHO GLOBAL TUBERCULO; BAYNES RD, 1986, AM J CLIN PATHOL, V85, P226, DOI 10.1093/ajcp/85.2.226; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; do Socorro Nantua Evangelista Maria, 2018, BMC Res Notes, V11, P414, DOI 10.1186/s13104-018-3522-3; Fest J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28646-w; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Gil-Santana L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37860-5; GOODMAN DA, 1995, AM SURGEON, V61, P257; Gunluoglu G, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-11; Gurol G, 2015, J MICROBIOL BIOTECHN, V25, P521, DOI 10.4014/jmb.1408.08060; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Huang HP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39150-0; Javed I, 2018, EUR J INFLAMM, V16, DOI 10.1177/2058739218818684; Jeon YL, 2019, LAB MED, V50, P286, DOI 10.1093/labmed/lmy083; Kahase D, 2020, J BLOOD MED, V11, P115, DOI 10.2147/JBM.S237317; Kassa Eyuel, 2016, BMC Hematol, V16, P1, DOI 10.1186/s12878-015-0037-1; Kroon EE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02637; Kullaya V, 2018, TUBERCULOSIS, V111, P86, DOI 10.1016/j.tube.2018.05.002; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Li Chan, 2018, Oncotarget, V9, P35293, DOI 10.18632/oncotarget.24293; Li K, 2019, J INT MED RES, V47, P2993, DOI 10.1177/0300060519851673; Liu QD, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4525-y; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Mesquita EDD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1736-3; Miyahara R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4292-9; Muefong CN, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00962; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Package WeiT., 2016, CORRPLOT; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; Ramarokoto H, 2002, INT J TUBERC LUNG D, V6, P909; Rohini K, 2016, INDIAN J CLIN BIOCHE, V31, P332, DOI 10.1007/s12291-015-0535-8; Russell CD, 2019, J INFECTION, V78, P339, DOI 10.1016/j.jinf.2019.02.006; Sahin F, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-38; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sampath P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01726; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Torrelles JB, 2017, TRENDS MICROBIOL, V25, P688, DOI 10.1016/j.tim.2017.03.007; Tozkoparan E, 2007, CLIN CHEM LAB MED, V45, P1009, DOI 10.1515/CCLM.2007.194; Ulukent SC, 2016, INT J CLIN EXP MED, V9, P11871; Vinhaes CL, 2019, CYTOKINE, V123, DOI 10.1016/j.cyto.2019.154759; Robert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125403; Wallis RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071116; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Wang W, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3270393; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2017, GUIDELINES TREATMENT; World Health Organization, 2018, COMP WHO GUID ASS ST, V2nd; Yin YM, 2017, ARCH MED SCI, V13, P404, DOI 10.5114/aoms.2016.60822; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Zhang HB, 2016, EXP THER MED, V12, P2215, DOI 10.3892/etm.2016.3583; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249301	10.1371/journal.pone.0249301	http://dx.doi.org/10.1371/journal.pone.0249301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793598	gold, Green Published			2022-12-26	WOS:000636467000088
J	Taman, H; Fenton, CG; Anderssen, E; Florholmen, J; Paulssen, RH				Taman, Hagar; Fenton, Christopher G.; Anderssen, Endre; Florholmen, Jon; Paulssen, Ruth H.			DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis	PLOS ONE			English	Article								Severe ulcerative colitis (UC) is a potentially life-threatening disease with a potential colorectal cancer (CRC) risk. The aim of this study was to explore the relationship between transcriptomic and genome-wide DNA methylation profiles in a well-stratified, treatment-naive severe UC patient population in order to define specific epigenetic changes that could be responsible for the grade of disease severity. Mucosal biopsies from treatment-naive severe UC patients (n = 8), treatment-naive mild UC (n = 8), and healthy controls (n = 8) underwent both whole transcriptome RNA-Seq and genome-wide DNA bisulfite- sequencing, and principal component analysis (PCA), cell deconvolutions and diverse statistical methods were applied to obtain a dataset of significantly differentially expressed genes (DEGs) with correlation to DNA methylation for severe UC. DNA hypo-methylation correlated with approximately 80% of all DEGs in severe UC when compared to mild UC. Enriched pathways of annotated hypo-methylated genes revealed neutrophil degranulation, and immuno-regulatory interactions of the lymphoid system. Specifically, hypo-methylated anti-inflammatory genes found for severe UC were IL10, SIGLEC5, CD86, CLMP and members of inflammasomes NLRP3 and NLRC4. Hypo-methylation of anti-inflammatory genes during severe UC implies an interplay between the epithelium and lamina propria in order to mitigate inflammation in the gut. The specifically DNA hypo-methylated genes found for severe UC can potentially be useful biomarkers for determining disease severity and in the development of new targeted treatment strategies for severe UC patients.	[Taman, Hagar; Paulssen, Ruth H.] UiT Arctic Univ Norway, Clin Bioinformat Res Grp, Dept Clin Med, Tromso, Norway; [Taman, Hagar; Fenton, Christopher G.; Anderssen, Endre; Paulssen, Ruth H.] UiT Arctic Univ Norway, Genom Support Ctr Tromso GSCT, Dept Clin Med, Tromso, Norway; [Florholmen, Jon] UiT Arctic Univ Norway, Gastroenterol & Nutr Res Grp, Dept Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Paulssen, RH (corresponding author), UiT Arctic Univ Norway, Clin Bioinformat Res Grp, Dept Clin Med, Tromso, Norway.; Paulssen, RH (corresponding author), UiT Arctic Univ Norway, Genom Support Ctr Tromso GSCT, Dept Clin Med, Tromso, Norway.	ruth.h.paulssen@uit.no			Northern Norway Regional Health Authority HelseNord [SFP-1209-14]	Northern Norway Regional Health Authority HelseNord	THis work was supported by the Northern Norway Regional Health Authority HelseNord (SFP-1209-14).s	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690; Choi JK, 2016, J CANCER, V7, P681, DOI 10.7150/jca.14264; Choy MC, 2019, INFLAMM BOWEL DIS, V25, P1169, DOI 10.1093/ibd/izy383; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; De Vries LCS, 2017, J CROHNS COLITIS, V11, P885, DOI 10.1093/ecco-jcc/jjx003; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dulai PS, 2018, THER ADV CHRONIC DIS, V9, P65, DOI 10.1177/2040622317742095; Engelhardt KR, 2014, CURR TOP MICROBIOL, V380, P1, DOI 10.1007/978-3-662-43492-5_1; Fernandes SR, 2016, REV ESP ENFERM DIG, V108, P697, DOI 10.17235/reed.2016.4470/2016; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gloria L, 1996, CANCER, V78, P2300, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2300::AID-CNCR5>3.0.CO;2-Q; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Harris RA, 2012, INFLAMM BOWEL DIS, V18, P2334, DOI 10.1002/ibd.22956; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hindryckx P, 2016, NAT REV GASTRO HEPAT, V13, P654, DOI 10.1038/nrgastro.2016.116; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jain S, 2019, POSTGRAD MED J, V95, P32, DOI 10.1136/postgradmedj-2018-136072; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karatzas PS, 2014, ANN GASTROENTEROL, V27, P125; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Lissner D, 2011, THESCIENTIFICWORLDJO, V11, P1536, DOI 10.1100/tsw.2011.139; Lopez-Posadas R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01240; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; McDermott E, 2016, J CROHNS COLITIS, V10, P77, DOI 10.1093/ecco-jcc/jjv176; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moustafa A, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/ctg.2017.58; Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Olsen T, 2007, SCAND J GASTROENTERO, V42, P1312, DOI 10.1080/00365520701409035; Paulssen RH, 2018, AM J GASTROENTEROL, V113, P050; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Peters FS, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0519-7; Ringel-Scaia VM, 2016, CRIT REV IMMUNOL, V36, P283, DOI 10.1615/CritRevImmunol.2017019158; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Sheaffer KL, 2016, CANCER PREV RES, V9, P534, DOI 10.1158/1940-6207.CAPR-15-0349; Tahara T, 2010, DIGEST DIS SCI, V55, P54, DOI 10.1007/s10620-008-0701-4; Tahara T, 2009, CANCER SCI, V100, P1192, DOI 10.1111/j.1349-7006.2009.01175.x; Taman H, 2018, J CROHNS COLITIS, V12, P1338, DOI 10.1093/ecco-jcc/jjy117; Taman H, 2018, J CROHNS COLITIS, V12, P327, DOI 10.1093/ecco-jcc/jjx139; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zmora N, 2017, MUCOSAL IMMUNOL, V10, P865, DOI 10.1038/mi.2017.19	60	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0248905	10.1371/journal.pone.0248905	http://dx.doi.org/10.1371/journal.pone.0248905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793617	Green Published, gold			2022-12-26	WOS:000636467000106
J	Yin, WC; Mendoza, L; Monzon-Sandoval, J; Urrutia, AO; Gutierrez, H				Yin, Wencheng; Mendoza, Luis; Monzon-Sandoval, Jimena; Urrutia, Araxi O.; Gutierrez, Humberto			Emergence of co-expression in gene regulatory networks	PLOS ONE			English	Article								Transcriptomes are known to organize themselves into gene co-expression clusters or modules where groups of genes display distinct patterns of coordinated or synchronous expression across independent biological samples. The functional significance of these co-expression clusters is suggested by the fact that highly coexpressed groups of genes tend to be enriched in genes involved in common functions and biological processes. While gene co-expression is widely assumed to reflect close regulatory proximity, the validity of this assumption remains unclear. Here we use a simple synthetic gene regulatory network (GRN) model and contrast the resulting co-expression structure produced by these networks with their known regulatory architecture and with the co-expression structure measured in available human expression data. Using randomization tests, we found that the levels of co-expression observed in simulated expression data were, just as with empirical data, significantly higher than expected by chance. When examining the source of correlated expression, we found that individual regulators, both in simulated and experimental data, fail, on average, to display correlated expression with their immediate targets. However, highly correlated gene pairs tend to share at least one common regulator, while most gene pairs sharing common regulators do not necessarily display correlated expression. Our results demonstrate that widespread co-expression naturally emerges in regulatory networks, and that it is a reliable and direct indicator of active co-regulation in a given cellular context.	[Yin, Wencheng] Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England; [Mendoza, Luis] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico; [Monzon-Sandoval, Jimena] Cardiff Univ, UK Dementia Res Inst, Cardiff, Wales; [Urrutia, Araxi O.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Urrutia, Araxi O.] Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Bath, Avon, England; [Gutierrez, Humberto] Inst Nacl Med Genom, Mexico City, DF, Mexico	University of Birmingham; Universidad Nacional Autonoma de Mexico; Cardiff University; Universidad Nacional Autonoma de Mexico; University of Bath; Instituto Nacional de Medicina Genomica	Mendoza, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico.; Gutierrez, H (corresponding author), Inst Nacl Med Genom, Mexico City, DF, Mexico.	lmendoza@biomedicas.unam.mx; hgutierrez@inmegen.gob.mx	Mendoza, Luis/A-3167-2009	Mendoza, Luis/0000-0002-3321-3083; Gutierrez, Humberto/0000-0002-5021-8636	grant UNAM-DGAPA-PAPIIT [IN 200918]; Royal Society Dorothy Hodgkin Research Fellowship [DH071902]; Royal Society [RG0870644, RG080272]	grant UNAM-DGAPA-PAPIIT; Royal Society Dorothy Hodgkin Research Fellowship(Royal Society of London); Royal Society(Royal Society of London)	This work was supported in part by grant UNAM-DGAPA-PAPIIT IN 200918 to LM; a Royal Society Dorothy Hodgkin Research Fellowship (DH071902), Royal Society Research Grants (RG0870644) and a Royal Society Research Grant for fellows (RG080272) to AOU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bodaker M, 2014, BIOINFORMATICS, V30, P406, DOI 10.1093/bioinformatics/btt685; Bolouri H, 2014, TRENDS GENET, V30, P182, DOI 10.1016/j.tig.2014.02.005; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; De Bleser PJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r83; Farahbod M, 2020, GENOME RES, V30, P849, DOI 10.1101/gr.256735.119; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hurst LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0413-3; Jiang LH, 2020, CELL, V183, P269, DOI 10.1016/j.cell.2020.08.036; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Knabe J., 2006, EVOLVING BIOL CLOCKS; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462; Michailidis G, 2013, MATH BIOSCI, V246, P326, DOI 10.1016/j.mbs.2013.10.003; Monzon-Sandoval J, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0111-3; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Payne JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13015; Payne JL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003071; Perco P, 2005, BIOSYSTEMS, V82, P235, DOI 10.1016/j.biosystems.2005.08.001; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Stead JDH, 2006, J NEUROSCI, V26, P345, DOI 10.1523/JNEUROSCI.2755-05.2006; Sterner KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037714; Vohradsky J, 2001, J BIOL CHEM, V276, P36168, DOI 10.1074/jbc.M104391200; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	33	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0247671	10.1371/journal.pone.0247671	http://dx.doi.org/10.1371/journal.pone.0247671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793561	Green Accepted, gold, Green Published			2022-12-26	WOS:000636467000076
J	Ono, Y; Hirosawa, T; Hasegawa, C; Ikeda, T; Kudo, K; Naito, N; Yoshimura, Y; Kikuchi, M				Ono, Yasuki; Hirosawa, Tetsu; Hasegawa, Chiaki; Ikeda, Takashi; Kudo, Kiwamu; Naito, Nobushige; Yoshimura, Yuko; Kikuchi, Mitsuru			Influence of oxytocin administration on somatosensory evoked magnetic fields induced by median nerve stimulation during hand action observation in healthy male volunteers	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; INTRANASAL OXYTOCIN; ASPERGER-SYNDROME; POTENTIALS; QUOTIENT; MODULATION; DISORDER; CORTICES; CONTEXT; ADULTS	Watching another person's hand movement modulates somatosensory evoked magnetic fields (SEFs). Assuming that the mirror neuron system may have a role in this phenomenon, oxytocin should enhance these effects. This single-blinded, placebo-controlled, crossover study therefore used magnetoencephalography (MEG) to investigate SEFs following electrical stimulation of the right median nerve in 20 healthy male participants during hand movement observation, which were initially presented as static images followed by moving images. The participants were randomly assigned to receive either oxytocin or saline during the first trial, with the treatment being reversed during a second trial. Log-transformed ratios of the N20 and N30 amplitudes were calculated and compared between moving and static images observations. Phase locking (calculated using intertrial phase coherence) of brain oscillations was also analyzed to evaluate alpha, beta and gamma rhythm changes after oxytocin administration. Log N30 ratios showed no significant changes after placebo administration but showed a decreasing tendency (albeit not significant) after placebo administration, which may suggest mirror neuron system involvement. In contrast, log N20 ratios were increased after placebo administration, but showed no significant change after oxytocin administration. Interestingly, the gamma band activity around N20 increased after placebo administration, suggesting that oxytocin exerted an analgesic effect on median nerve stimulation, and inhibited the gamma band increase. Oxytocin might therefore modulate not only the mirror neuron system, but also the sensory processing associated with median nerve stimulation.	[Ono, Yasuki] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Ono, Yasuki; Hirosawa, Tetsu; Naito, Nobushige; Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Hasegawa, Chiaki; Ikeda, Takashi; Yoshimura, Yuko] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Kudo, Kiwamu] Ricoh Co Ltd, Kanazawa, Ishikawa, Japan	Hirosaki University; Kanazawa University; Kanazawa University; Ricoh Company, Ltd.	Ono, Y (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.; Ono, Y (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.	spfy7ff9@wish.ocn.ne.jp	Hasegawa, Chiaki/HHS-2658-2022	Hasegawa, Chiaki/0000-0001-8730-8769	Center of Innovation Program from Japan Science and Technology Agency, JST, Japan	Center of Innovation Program from Japan Science and Technology Agency, JST, Japan	This study was supported by the Center of Innovation Program from Japan Science and Technology Agency, JST, Japan in the form of research materials for author MK and YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.neuroimage.2007.05.038; Boll S, 2018, NEUROSCIENCE, V387, P149, DOI 10.1016/j.neuroscience.2017.09.041; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Braadbaart L, 2013, INT J PSYCHOPHYSIOL, V89, P99, DOI 10.1016/j.ijpsycho.2013.05.019; Brambilla M, 2016, EUR NEUROPSYCHOPHARM, V26, P1619, DOI 10.1016/j.euroneuro.2016.08.001; Cebolla AM, 2014, NEUROIMAGE, V95, P48, DOI 10.1016/j.neuroimage.2014.03.039; Coll MP, 2017, J NEUROSCI, V37, P5936, DOI 10.1523/JNEUROSCI.3393-16.2017; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Festante F, 2020, PSYCHONEUROENDOCRINO, V111, DOI 10.1016/j.psyneuen.2019.104467; Fukuda M, 2008, BRAIN, V131, P1793, DOI 10.1093/brain/awn100; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Hadoush H, 2010, NEUROREPORT, V21, P108, DOI 10.1097/WNR.0b013e3283349a17; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Han Y, 2009, NEUROSCI LETT, V454, P101, DOI 10.1016/j.neulet.2009.02.062; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Hirosawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00384; Hobson HM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160662; Hoshiyama M, 2001, BRAIN RES, V908, P140, DOI 10.1016/S0006-8993(01)02623-3; Khan S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00255; Khan S, 2015, BRAIN, V138, P1394, DOI 10.1093/brain/awv043; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Levy J, 2016, NEUROIMAGE, V124, P923, DOI 10.1016/j.neuroimage.2015.09.066; Munesue T, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00002; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Paloyelis Y, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12347; Perry A, 2010, PSYCHONEUROENDOCRINO, V35, P1446, DOI 10.1016/j.psyneuen.2010.04.011; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rossi S, 2002, CLIN NEUROPHYSIOL, V113, P16, DOI 10.1016/S1388-2457(01)00725-8; Rossini PM, 1998, BRAIN RES, V782, P153, DOI 10.1016/S0006-8993(97)01274-2; Rossiter HE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00362; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; Singh F, 2016, EUR NEUROPSYCHOPHARM, V26, P626, DOI 10.1016/j.euroneuro.2015.12.026; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; van Zuiden M, 2017, BIOL PSYCHIAT, V81, P1030, DOI 10.1016/j.biopsych.2016.11.012	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249167	10.1371/journal.pone.0249167	http://dx.doi.org/10.1371/journal.pone.0249167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788881	Green Published, gold			2022-12-26	WOS:000636354600006
J	Hernandez, CJ; Trujillo, D; Sicro, S; Meza, J; Bella, M; Daza, E; Torres, F; McFarland, W; Turner, CM; Wilson, EC				Hernandez, Christopher J.; Trujillo, Dillon; Sicro, Sofia; Meza, Joaquin; Bella, Mackie; Daza, Emperatriz; Torres, Francisco; McFarland, Willi; Turner, Caitlin M.; Wilson, Erin C.			High hepatitis C virus seropositivity, viremia, and associated risk factors among trans women living in San Francisco, California	PLOS ONE			English	Article							TRANSGENDER WOMEN; UNITED-STATES; HIV RISK; DRUG-USE; INFECTION; PREVENTION; STRATEGIES; HOMELESS; COHORT; HEALTH	Trans women have been understudied in the Hepatitis C virus (HCV) epidemic, yet data suggest they may be at elevated risk of the disease. Using data collected from the Centers for Disease Control and Prevention's (CDC) National HIV Behavioral Surveillance (NHBS) survey, we measured HCV seropositivity, viremia, and associated risk factors for HCV infection among trans women in San Francisco from June 2019 to February 2020. Respondent-driven sampling (RDS) was used to obtain a diverse, community-based sample of 201 trans women, of whom 48 (23.9%, 95% CI 17.9% - 30.0%) were HCV seropositive. HCV seropositivity significantly increased with increasing age (adjusted prevalence ratio [APR] 1.04 per year, 95% CI 1.01-1.07) and history of injection drug use (APR 4.44, 95% CI 2.15-9.18). We also found that many had HCV viremia as twelve (6.0% of the total sample, 95% CI 2.7% - 9.3%) were RNA-positive for HCV. Trans women are highly impacted by HCV and could benefit from access to regular and frequent HCV screening and treatment access. HCV screening could be offered regularly in trans-specific health services, in the community, in jails and prisons, and integrated syringe exchange programs where treatment access or referral are also available.	[Hernandez, Christopher J.; Trujillo, Dillon; Sicro, Sofia; Meza, Joaquin; Bella, Mackie; Daza, Emperatriz; Torres, Francisco; McFarland, Willi; Turner, Caitlin M.; Wilson, Erin C.] Ctr Publ Hlth Res, San Francisco, CA 94143 USA; [McFarland, Willi; Turner, Caitlin M.; Wilson, Erin C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hernandez, CJ (corresponding author), Ctr Publ Hlth Res, San Francisco, CA 94143 USA.	chrishernandezb@berkeley.edu		Hernandez, Christopher/0000-0002-6478-7856	Centers for Disease Control [ECW PS005077-2]	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	ECW PS005077-2 Centers for Disease Control https://www.cdc.gov/hiv/statistics/systems/nhbs/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; [Anonymous], 2021, ADD POP; [Anonymous], 2019, HEPATITIS C RNA QUAL; Association of Public Health Laboratories (APHL), 2019, INT HEP C VIR TEST R; Baguso GN, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25270; Brennan J, 2012, AM J PUBLIC HEALTH, V102, P1751, DOI 10.2105/AJPH.2011.300433; Coffin PO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217471; Deacon RM, 2013, HEALTH SOC CARE COMM, V21, P402, DOI 10.1111/hsc.12026; DeBeck K, 2009, ADDICTION, V104, P69, DOI 10.1111/j.1360-0443.2008.02387.x; Facente SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195575; Feld JJ, 2017, CURR DRUG TARGETS, V18, P851, DOI 10.2174/1389450116666150825111314; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Grov C, 2020, AIDS CARE, V32, pS74, DOI 10.1080/09540121.2020.1739204; Hayes B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-645; Lauer GM, 2006, CLIN INFECT DIS, V42, P953, DOI 10.1086/500944; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Moore KJ, 2019, J INFECT PUBLIC HEAL, V12, P32, DOI 10.1016/j.jiph.2018.08.003; Morano JP, 2014, J COMMUN HEALTH, V39, P922, DOI 10.1007/s10900-014-9932-9; Norton BL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-74; Nyamathi A, 2013, J FORENSIC NURS, V9, P162, DOI 10.1097/JFN.0b013e31827a5908; Page K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4102-5; Perlman DC, 2018, CURR HIV-AIDS REP, V15, P96, DOI 10.1007/s11904-018-0390-3; Rapues J, 2013, AM J PUBLIC HEALTH, V103, P1485, DOI 10.2105/AJPH.2012.301109; Raymond C., 2019, HARVARD HLTH BLOG; Raymond HF, 2017, AM J PUBLIC HEALTH, V107, pE12, DOI 10.2105/AJPH.2017.303964; Raymond HF, 2013, JAIDS-J ACQ IMM DEF, V62, P584, DOI 10.1097/QAI.0b013e318285febf; Reback CJ, 2015, INT J TRANSGENDERISM, V16, P209, DOI 10.1080/15532739.2015.1081085; Ryerson AB, 2020, MMWR-MORBID MORTAL W, V69, P399, DOI 10.15585/mmwr.mm6914a2; Spach DH., 2020, HEP C; Staton-Tindall M, 2015, PSYCHIATR REHABIL J, V38, P45, DOI 10.1037/prj0000107; Stone J, 2018, LANCET INFECT DIS, V18, P1397, DOI 10.1016/S1473-3099(18)30469-9; TIBBS CJ, 1995, J VIRAL HEPATITIS, V2, P113, DOI 10.1111/j.1365-2893.1995.tb00016.x; Wilson EC, 2019, J VIRAL HEPATITIS, V26, P923, DOI 10.1111/jvh.13089; Wolf ECM, 2012, J LGBT ISS COUNS, V6, P237, DOI 10.1080/15538605.2012.727743	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249219	10.1371/journal.pone.0249219	http://dx.doi.org/10.1371/journal.pone.0249219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784365	Green Published, gold			2022-12-26	WOS:000636359600023
J	Malik, J; Malik, A; Javaid, M; Zahid, T; Ishaq, U; Shoaib, M				Malik, Jahanzeb; Malik, Asmara; Javaid, Muhammad; Zahid, Tayyaba; Ishaq, Uzma; Shoaib, Muhammad			Thyroid function analysis in COVID-19: A retrospective study from a single center	PLOS ONE			English	Article								Background and objective Coronavirus disease 2019 (COVID-19) is an on-going epidemic with a multitude of long-ranging effects on the physiological balance of the human body. It can cause several effects on thyroid functions as well. We aimed to assess the lasting sequelae of COVID-19 on thyroid hormone and the clinical course of the disease as a result. Methods Out of 76 patients, 48 patients of COVID-19 positive and 28 patients of COVID-19 negative polymerase chain reaction (PCR) were assessed for thyroid functions, IL-6, and Procalcitonin between moderate, severe, and critical pneumonia on HRCT. Results Seventy-five percent of patients with COVID-19 had thyroid abnormalities and higher IL-6 levels (76.10 +/- 82.35 vs. 6.99 +/- 3.99, 95% CI 52.18-100.01, P-value <0.01). Logistic regression analysis suggested TT3 (P-value 0.01), IL-6 (P-value <0.01), and Procalcitonin (P-value 0.03) as independent risk factors for COVID-19. ROC curve demonstrated IL-6 as the most sensitive marker (P-value <0.01), and TT3, and Procalcitonin as the predictor for COVID-19 disease. Conclusion This pilot study from Pakistan demonstrates that changes in serum TSH and TT3 levels may be important manifestations of the courses of COVID-19 pneumonia.	[Malik, Jahanzeb; Javaid, Muhammad; Zahid, Tayyaba] Rawalpindi Inst Cardiol, Dept Cardiol, Rawalpindi, Pakistan; [Malik, Asmara] Natl Univ Med Sci, Dept Publ Hlth, Saddar, Rawalpindi, Pakistan; [Ishaq, Uzma] Fdn Univ Med Coll, Dept Pathol, Islamabad, Pakistan; [Shoaib, Muhammad] Pakistan Inst Med Sci, Dept Cardiol, Islamabad, Pakistan	Pakistan Institute of Medical Sciences	Malik, J (corresponding author), Rawalpindi Inst Cardiol, Dept Cardiol, Rawalpindi, Pakistan.	Heartdoc86@gmail.com	Malik, Jahanzeb/AAU-5877-2020	Malik, Jahanzeb/0000-0002-9343-4187; Malik, Dr Asmara Ahmed/0000-0002-4175-7689				Abid K, 2020, ASIA-PAC J PUBLIC HE, V32, P154, DOI 10.1177/1010539520927259; Alam Khan V., J MED SCI, V2, P89, DOI [10.3923/jms.2002.89.94, DOI 10.3923/JMS.2002.89.94]; Bellastella G, 2020, J ENDOCRINOL INVEST, V43, P1169, DOI 10.1007/s40618-020-01311-8; Brancatella A, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa537; Brancatella A, 2020, J CLIN ENDOCR METAB, V105, P2367, DOI 10.1210/clinem/dgaa276; Chen M, 2021, THYROID, V31, P8, DOI 10.1089/thy.2020.0363; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Dasgupta A, 2020, J PAK MED ASSOC, V70, pS131, DOI 10.5455/JPMA.32; Dworakowska D, 2020, ENDOCRINE, V68, P471, DOI 10.1007/s12020-020-02364-8; Lania A, 2020, EUR J ENDOCRINOL, V183, P381, DOI 10.1530/EJE-20-0335; Lee S, 2016, COMPR PHYSIOL, V6, P1071, DOI 10.1002/cphy.c150017; Leow MKS, 2005, CLIN ENDOCRINOL, V63, P197, DOI 10.1111/j.1365-2265.2005.02325.x; Noor AU, 2020, PAK J MED SCI, V36, pS79, DOI 10.12669/pjms.36.COVID19-S4.2660; Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772; Scappaticcio L, 2021, REV ENDOCR METAB DIS, V22, P803, DOI 10.1007/s11154-020-09615-z; Schwarz Y, 2021, ENDOCR PRACT, V27, P101, DOI 10.1016/j.eprac.2021.01.001; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Unnikrishnan Ambika Gopalakrishnan, 2011, Indian J Endocrinol Metab, V15, pS78, DOI 10.4103/2230-8210.83329; Wang W., 2003, CHIN J ANTITUBERCULO, V25, P232; Zou RM, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.566439	20	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249421	10.1371/journal.pone.0249421	http://dx.doi.org/10.1371/journal.pone.0249421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784355	Green Published, Green Submitted, gold			2022-12-26	WOS:000636359600044
J	Song, X; Vilares, I				Song, Xin; Vilares, Iris			Assessing the relationship between the human learned helplessness depression model and anhedonia	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANIMAL-MODELS; GENDER-DIFFERENCES; VALIDITY; SENSITIVITY; VALIDATION; GUIDELINES; VETERANS; BEHAVIOR; FAILURE	The learned helplessness (LH) model is one of the most commonly used acute stress models to explain depression and it has shown good face and predictive validity. However, despite being able to induce depressed-like behaviors and corresponding psychophysiological changes, there is little evidence showing that the LH paradigm can produce anhedonia, a core symptom seen in all forms of depression in humans. So far a couple of studies showed that rodents bred for helplessness develop anhedonic-like behaviors in response to stress; yet, to the best of our knowledge, no similar human research has tried to investigate the direct relationship between the LH model and anhedonia. In the present study, we use a modified version of the original LH task to experimentally and temporarily induce learned helplessness in college students and then examine if the human LH paradigm induces anhedonia. We aim to 1: address the ill-defined connection between the LH model and anhedonia, and 2: directly assess helplessness in humans as opposed to the majority of non-human animal subjects used in the helplessness literature. We believe that our study will fill an important gap in the learned helplessness model literature, and will advance our understanding of the relationship between depression and perceived control, as well as place limitations to what can and cannot be inferred from non-human animal data in this topic.	[Song, Xin; Vilares, Iris] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Song, X (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	songx953@umn.edu		SONG, XIN/0000-0003-3491-5324; Vilares, Iris/0000-0003-1500-3864				Abelaira HM, 2013, REV BRAS PSIQUIATR, V35, pS112, DOI 10.1590/1516-4446-2013-1098; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; ADRIEN J, 1991, PHYSIOL BEHAV, V49, P257, DOI 10.1016/0031-9384(91)90041-L; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENSON JS, 1976, J PERS SOC PSYCHOL, V34, P138, DOI 10.1037/0022-3514.34.1.138; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; BUCHWALD AM, 1978, J ABNORM PSYCHOL, V87, P180; Caldarone BJ, 2000, PHARMACOL BIOCHEM BE, V66, P811, DOI 10.1016/S0091-3057(00)00271-9; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FAWCETT J, 1983, ARCH GEN PSYCHIAT, V40, P79; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; GATCHEL RJ, 1976, J ABNORM PSYCHOL, V85, P27, DOI 10.1037/0021-843X.85.1.27; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Gotlib I.H., 2008, HDB DEPRESSION; GREENBERG L, 1989, BIOL PSYCHIAT, V26, P530, DOI 10.1016/0006-3223(89)90074-7; Hammack SE, 2012, NEUROPHARMACOLOGY, V62, P565, DOI 10.1016/j.neuropharm.2011.02.024; HEDBERG AG, 1972, PROF PSYCHOL, V3, P389, DOI 10.1037/h0020743; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Henn Fritz A, 2002, World Psychiatry, V1, P115; HIROTO DS, 1974, J EXP PSYCHOL, V102, P187, DOI 10.1037/h0035910; HIROTO DS, 1975, J PERS SOC PSYCHOL, V31, P311, DOI 10.1037/h0076270; Job RFS, 2002, INTEGR PHYS BEH SCI, V37, P59; Kashdan TB, 2006, BEHAV RES THER, V44, P457, DOI 10.1016/j.brat.2005.03.001; Kashdan TB, 2007, PERS INDIV DIFFER, V43, P725, DOI 10.1016/j.paid.2007.01.013; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kim Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00003; Lee K, 2009, GLOB INST, P1; Lieder A., 2013, LEARNED HELPLESSNESS, P35; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Maier SF, 2016, PSYCHOL REV, V123, P349, DOI 10.1037/rev0000033; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; MCCARTHY D, 1979, J EXP ANAL BEHAV, V32, P373, DOI 10.1901/jeab.1979.32-373; MCKINNEY WT, 1969, ARCH GEN PSYCHIAT, V21, P240; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; OVERMIER JB, 1968, J EXP PSYCHOL, V78, P340, DOI 10.1037/h0026365; Overmier JB., 2017, ENCYCL ANIM COGN BEH, P1; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Rizvi SJ, 2015, PSYCHIAT RES, V229, P109, DOI 10.1016/j.psychres.2015.07.062; RYCKMAN DB, 1987, J EDUC RES, V81, P120, DOI 10.1080/00220671.1987.10885808; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Sanchis-Segura C, 2005, BEHAV PHARMACOL, V16, P267, DOI 10.1097/01.fbp.0000171772.61669.6f; Su CL, 2016, J PSYCHIATR RES, V76, P101, DOI 10.1016/j.jpsychires.2016.02.008; THORNTON JW, 1971, J EXP PSYCHOL, V87, P367, DOI 10.1037/h0030529; Tracy M, 2011, DEPRESS ANXIETY, V28, P666, DOI 10.1002/da.20838; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Trindade IA, 2020, J CONTEXT BEHAV SCI, V15, P68, DOI 10.1016/j.jcbs.2019.12.001; Tripp G, 1999, J CLIN CHILD PSYCHOL, V28, P366, DOI 10.1207/S15374424jccp280309; TURNER LH, 1962, PSYCHOL MONOGR, V76, P1; Valas H., 2001, SCAND J EDUC RES, V45, P71, DOI [10.1080/00313830020042689, DOI 10.1080/00313830020042689]; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; WEISS JM, 1981, BRAIN RES REV, V3, P167, DOI 10.1016/0165-0173(81)90005-9; WILLNER P, 1986, PROG NEURO-PSYCHOPH, V10, P677, DOI 10.1016/0278-5846(86)90051-5; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Zinbarg R, 1996, CURRENT THEORY RES M	68	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249056	10.1371/journal.pone.0249056	http://dx.doi.org/10.1371/journal.pone.0249056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6XT	33784324	gold, Green Published			2022-12-26	WOS:000636359600030
J	Regan, EW; Handlery, R; Stewart, JC; Pearson, JL; Wilcox, S; Fritz, S				Regan, Elizabeth W.; Handlery, Reed; Stewart, Jill C.; Pearson, Joseph L.; Wilcox, Sara; Fritz, Stacy			Feasibility of integrating survivors of stroke into cardiac rehabilitation: A mixed methods pilot study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; PHYSICAL-ACTIVITY; PREVENTION PROGRAMS; SECONDARY PREVENTION; EXERCISE; PARTICIPATION; POSTSTROKE; STATEMENT	Background Survivors of stroke are often deconditioned and have limited opportunities for exercise post-rehabilitation. Cardiac Rehabilitation (CR), a structured exercise program offered post-cardiac event in the United States (U.S.), may provide an opportunity for continued exercise. The purpose of this study was to examine the feasibility of integrating survivors of stroke into an existing, hospital-based CR program through an assessment of (1) recruitment, uptake and retention, (2) adherence and fidelity, (3) acceptability and (4) safety. Methods A mixed methods design combined a single group, pre-post design, pilot feasibility study with an imbedded qualitative inquiry. Survivors of stroke were recruited into a standard 12-week, 36 visit CR program. Results Fifty-three survivors were referred, 29 started and 24 completed the program. Program uptake rate was 55% and completion rate was 83%. Eleven completers and one non-completer participated in the qualitative interviews. Program completers attended an average of 25.25 (SD 5.82) sessions with an average of 38.93 (SD 5.64) exercise minutes per session while reaching targeted rate of perceived exertion levels. Qualitative themes included perceived benefits of an individualized program in a group setting, positive interactions with qualified staff, opportunities for socialization, and regular monitoring and staff attentiveness promoting feelings of safety. Conclusions Survivors of stroke were able to meet Medicare standard dosage (frequency and session duration) and rate of perceived intensity goals, and perceived the program as needed regardless of their mobility limitations or previous exercise experience. Primary challenges included managing referrals and uptake. Results support feasibility and benefit for survivors to integrate into U.S. CR programs.	[Regan, Elizabeth W.; Handlery, Reed; Stewart, Jill C.; Wilcox, Sara; Fritz, Stacy] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Pearson, Joseph L.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Regan, EW (corresponding author), Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA.	eregan@email.sc.edu		Handlery, Reed/0000-0003-0064-6808; Regan, Elizabeth/0000-0003-2820-717X	University of South Carolina (USC) Behavioral-Biomedical Interface Program-NIGMS/NIH-T32 [2T326M081740-11A1]; 2019 American Heart Association (AHA) Pre-Doctoral Fellowship; 2018 American Physical Therapy Association Health Policy and Administration Research Grant; 2019 USC Support to Promote Advancement of Research and Creativity Grant; AHA [15SDG24970011]; Promotion of Doctoral Studies (PODS)-Level I Scholarship from the Foundation for Physical Therapy Research; Arnold Fellowship from the Arnold School of Public Health, USC	University of South Carolina (USC) Behavioral-Biomedical Interface Program-NIGMS/NIH-T32; 2019 American Heart Association (AHA) Pre-Doctoral Fellowship; 2018 American Physical Therapy Association Health Policy and Administration Research Grant; 2019 USC Support to Promote Advancement of Research and Creativity Grant; AHA(American Heart Association); Promotion of Doctoral Studies (PODS)-Level I Scholarship from the Foundation for Physical Therapy Research; Arnold Fellowship from the Arnold School of Public Health, USC	This work was supported by the University of South Carolina (USC) Behavioral-Biomedical Interface Program-NIGMS/NIH-T32 2T326M081740-11A1, bbip.sc.edu (ER); 2019 American Heart Association (AHA) Pre-Doctoral Fellowship, Heart.org (ER); 2018 American Physical Therapy Association Health Policy and Administration Research Grant aptahpa.org (ER); 2019 USC Support to Promote Advancement of Research and Creativity Grant, sc.edu (ER); AHA Grant 15SDG24970011, Heart.org (JS); Promotion of Doctoral Studies (PODS)-Level I Scholarship from the Foundation for Physical Therapy Research, foundation4pt.org (RH); the Arnold Fellowship from the Arnold School of Public Health, USC (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2017, MAYO CLIN PROC, V92, P234, DOI 10.1016/j.mayocp.2016.10.014; Anderson S, 2011, TOP STROKE REHABIL, V18, P509, DOI 10.1310/tsr1805-509; Astley CM, 2017, J CARDIOVASC NURS, V32, P236, DOI 10.1097/JCN.0000000000000332; Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Balady GJ, 2000, CIRCULATION, V102, P1069, DOI 10.1161/01.CIR.102.9.1069; Biasin L, 2014, PHYS THER, V94, P1796, DOI 10.2522/ptj.20130404; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Boisgontier MP, 2020, PHYS THER, V100, P743, DOI 10.1093/ptj/pzaa011; Boss HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-007065; Boss HM, 2014, NEUROREHABILITATION, V34, P401, DOI 10.3233/NRE-141049; Boyne P, 2017, J NEUROL PHYS THER, V41, P119, DOI 10.1097/NPT.0000000000000177; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Clark AM, 2013, EUR J PREV CARDIOL, V20, P692, DOI 10.1177/2047487312447846; Clark AM, 2012, AM HEART J, V164, P835, DOI 10.1016/j.ahj.2012.08.020; Cuccurullo SJ, 2019, AM J PHYS MED REHAB, V98, P953, DOI 10.1097/PHM.0000000000001214; Curnier Daniel Y, 2005, J Cardiopulm Rehabil, V25, P80, DOI 10.1097/00008483-200503000-00006; Damush TM, 2007, REHABIL NURS, V32, P253, DOI 10.1002/j.2048-7940.2007.tb00183.x; Dixon G, 2007, CLIN REHABIL, V21, P230, DOI 10.1177/0269215506071784; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Eldridge SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150205; Ellis JM, 2018, J CARDIOPULM REHABIL, V38, P309, DOI 10.1097/HCR.0000000000000295; Hansen TB, 2015, EUR J PREV CARDIOL, V22, P710, DOI 10.1177/2047487314536364; Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9; Herber OR, 2017, J CLIN NURS, V26, P3529, DOI 10.1111/jocn.13722; Hubbard G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009284; Kaushik V, 2019, SOC SCI-BASEL, V8, DOI 10.3390/socsci8090255; Kirk H, 2014, CLIN REHABIL, V28, P339, DOI 10.1177/0269215513502211; Kono Y, 2015, INT J STROKE, V10, P219, DOI 10.1111/ijs.12392; Kuys S, 2006, PHYSIOTHER RES INT, V11, P219, DOI 10.1002/pri.344; Lee J, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104498; Lennon O, 2008, CLIN REHABIL, V22, P125, DOI 10.1177/0269215507081580; Lennon O, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-9; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lindsay MP, 2019, WORLD STROKE ORG WSO; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Lynggaard V, 2017, INT J CARDIOL, V236, P65, DOI 10.1016/j.ijcard.2017.02.051; MacKay-Lyons M, 2020, PHYS THER, V100, P149, DOI 10.1093/ptj/pzz153; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1378, DOI 10.1053/apmr.2002.35089; Martin JJ, 2013, DISABIL REHABIL, V35, P2030, DOI 10.3109/09638288.2013.802377; Marzolini S, 2018, CAN J CARDIOL, V34, pS240, DOI 10.1016/j.cjca.2018.06.017; Marzolini S, 2014, J STROKE CEREBROVASC, V23, P1648, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.008; Marzolini S, 2012, J CARDIOPULM REHABIL, V32, P127, DOI 10.1097/HCR.0b013e31824d2ab3; MedPac, 2019, REPORT C MEDICARE HE; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Moore SA, 2015, NEUROREHAB NEURAL RE, V29, P623, DOI 10.1177/1545968314562116; Morris JH, 2014, ARCH PHYS MED REHAB, V95, P956, DOI 10.1016/j.apmr.2013.12.016; Neubeck L, 2012, EUR J PREV CARDIOL, V19, P494, DOI 10.1177/1741826711409326; Newitt R, 2016, DISABIL REHABIL, V38, P1, DOI 10.3109/09638288.2014.996676; Orsmond GI, 2015, OTJR-OCCUP PART HEAL, V35, P169, DOI 10.1177/1539449215578649; Pio CSD, 2020, INT J CARDIOL, V298, P1, DOI 10.1016/j.ijcard.2019.06.064; Regan E., 2020, INTEGRATING STROKE S; Regan EW, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.017907; Regan EW., 2020, CIRC-CARDIOVASC QUAL, V13, pA279; Rimmer J, 2017, DISABIL REHABIL, V39, P173, DOI 10.3109/09638288.2015.1047967; Robinson CA, 2011, PHYS THER, V91, P1865, DOI 10.2522/ptj.20100216; Rouleau CR, 2018, DISABIL REHABIL, V40, P469, DOI 10.1080/09638288.2016.1261417; Sebastian LA, 2015, J CARDIOVASC NURS, V30, P164, DOI 10.1097/JCN.0000000000000154; Services CfMM, MEDICARE CLAIMS PROC; Shaughnessy M, 2006, REHABIL NURS, V31, P15, DOI 10.1002/j.2048-7940.2006.tb00005.x; Shiran A, 1997, CARDIOLOGY, V88, P207, DOI 10.1159/000177331; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; Thomas RJ, 2018, J AM COLL CARDIOL, V71, P1814, DOI 10.1016/j.jacc.2018.01.004; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	65	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0247178	10.1371/journal.pone.0247178	http://dx.doi.org/10.1371/journal.pone.0247178			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6OZ	33780477	gold, Green Published			2022-12-26	WOS:000636336800046
J	Fraga, AZ; Louveau, I; Campos, PHRF; Hauschild, L; Le Floc'h, N				Zem Fraga, Alicia; Louveau, Isabelle; Campos, Paulo Henrique Reis Furtado; Hauschild, Luciano; Le Floc'h, Nathalie			Selection for feed efficiency elicits different postprandial plasma metabolite profiles in response to poor hygiene of housing conditions in growing pigs	PLOS ONE			English	Article							DIVERGENT SELECTION; AMINO-ACIDS; HEALTH; ENERGY; STIMULATION; INSULIN; IMPACT; GROWTH; MODEL; LINES	This study was conducted to compare postprandial plasma concentrations of insulin, energy-related metabolites, and amino acids measured after a 6-week challenge consisting of exposure to good or poor hygiene of housing conditions of 24 growing pigs divergently selected for low-RFI (LRFI) and high-RFI (HRFI). Blood indicators of immune responses were assessed from samples collected before 0 (W0), and 3 (W3), and 6 weeks (W6) after pigs transfer to their respective hygiene of housing conditions. Plasma haptoglobin concentrations and blood neutrophil granulocyte numbers were greater in poor than in good hygiene of housing conditions at W3. Plasma concentrations of total immunoglobulin G were greater (p = 0.04) in poor than in good hygiene of housing conditions at W6. At W6, pigs were fitted with an intravenous catheter for serial blood samplings. Low-RFI pigs had greater insulin (p < 0.001) and lower triglyceride (p = 0.04) average plasma concentrations than HRFI pigs in both conditions. In poor hygiene of housing conditions, the peaks of insulin and glucose were observed earlier and that of insulin was greater in LRFI than in HRFI pigs. Irrespective of genetic line, average plasma concentrations of histidine, isoleucine, leucine, methionine, threonine, valine, and alanine were greater in poor compared with good hygiene of housing conditions. Only HRFI pigs had greater lysine, asparagine, proline, and tyrosine plasma concentrations in poor than in good hygiene of housing conditions. Conversely, arginine, tryptophan, proline, and tyrosine plasma concentrations were lower only for LRFI pigs housed in poor hygiene conditions. Our results suggest that, contrary to HRFI, LRFI pigs increase or maintain their utilization of tryptophan, arginine, and lysine when housed in poor hygiene conditions. This indicates that this difference may contribute to the better capacity of LRFI to cope with poor hygiene of housing conditions.	[Zem Fraga, Alicia; Hauschild, Luciano] Sao Paulo State Univ, Sch Agr & Vet Sci, Dept Anim Sci, Jaboticabal, SP, Brazil; [Zem Fraga, Alicia; Louveau, Isabelle; Le Floc'h, Nathalie] Inst Agro, INRAE, PEGASE, St Gilles, France; [Campos, Paulo Henrique Reis Furtado] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Estadual Paulista; INRAE; Institut Agro; Universidade Federal de Vicosa	Le Floc'h, N (corresponding author), Inst Agro, INRAE, PEGASE, St Gilles, France.	nathalie.lefloch@inrae.fr		Fraga, Alicia/0000-0002-3056-7441	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [613574]; Sao Paulo Research Foundation (FAPESP-Brazil) [2018/15559-7, 2018/11807-6]	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration; Sao Paulo Research Foundation (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration (grant number 613574, PROHEALTH project). Ali ' cia Zem Fraga was supported by a scholarship from the Sao Paulo Research Foundation (FAPESP-Brazil; grant number 2018/15559-7 and fellowship number 2018/11807-6).	Barea R, 2010, J ANIM SCI, V88, P2062, DOI 10.2527/jas.2009-2395; Breuille D, 1999, INFECT IMMUN, V67, P1079, DOI 10.1128/IAI.67.3.1079-1085.1999; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chatelet A, 2018, ANIMAL, V12, P350, DOI 10.1017/S1751731117001379; Cvitkovic S, 2004, PEDIATR RES, V55, P630, DOI 10.1203/01.PDR.0000113788.85515.7E; Davis TA, 1998, J NUTR, V128, p347S, DOI 10.1093/jn/128.2.347S; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Faure J, 2013, MEAT SCI, V93, P37, DOI 10.1016/j.meatsci.2012.07.006; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Gilbert H, 2017, ANIMAL, V11, P1427, DOI 10.1017/S175173111600286X; Gloaguen M, 2012, J ANIM SCI, V90, P3135, DOI 10.2527/jas.2011-4956; Knap PW, 2009, VOLUNTARY FEED INTAKE IN PIGS, P13; Labussiere E, 2015, ANIMAL, V9, P1653, DOI 10.1017/S1751731115000932; Le Floc'h N, 2014, ANIMAL, V8, P1632, DOI 10.1017/S1751731114001608; Le Floc'h N, 2019, ARCH ANIM NUTR, V73, P255, DOI 10.1080/1745039X.2019.1627836; Le Floc'h N, 2018, ANIM FEED SCI TECH, V245, P104, DOI 10.1016/j.anifeedsci.2018.09.007; Le Floc'h N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104605; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Le Naou T, 2012, J ANIM SCI, V90, P4771, DOI 10.2527/jas.2012-5226; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; MATIS JH, 1989, BIOMETRICS, V45, P703, DOI 10.2307/2531678; McGilvray WD, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060323; McGilvray WD, 2019, J ANIM SCI, V97, P2479, DOI 10.1093/jas/skz120; Merlot E, 2016, J ANIM SCI, V94, P563, DOI 10.2527/jas.2015-9445; Meunier-Salaun MC, 2014, ANIMAL, V8, P1898, DOI 10.1017/S1751731114001839; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; ODINK J, 1990, J ANIM SCI, V68, P163; Rakhshandeh A, 2012, J ANIM SCI, V90, P233, DOI 10.2527/jas.53976; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; Campos PHRF, 2019, J ANIM SCI, V97, P3354, DOI 10.1093/jas/skz204; Renaudeau D, 2013, J ANIM SCI, V91, P1162, DOI 10.2527/jas.2012-5689; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y	32	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2021	16	3							e0246216	10.1371/journal.pone.0246216	http://dx.doi.org/10.1371/journal.pone.0246216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6OZ	33780478	gold, Green Published, Green Submitted			2022-12-26	WOS:000636336800001
J	Dennison, CA; Legge, SE; Bracher-Smith, M; Menzies, G; Escott-Price, V; Smith, DJ; Doherty, AR; Owen, MJ; O'Donovan, MC; Walters, JTR				Dennison, Charlotte A.; Legge, Sophie E.; Bracher-Smith, Matthew; Menzies, Georgina; Escott-Price, Valentina; Smith, Daniel J.; Doherty, Aiden R.; Owen, Michael J.; O'Donovan, Michael C.; Walters, James T. R.			Association of genetic liability for psychiatric disorders with accelerometer-assessed physical activity in the UK Biobank	PLOS ONE			English	Article							MENTAL-DISORDERS; HEALTH-BENEFITS; INACTIVITY; ADULTS; METAANALYSIS; DEPRESSION; DISEASES; PEOPLE; RISK; LOCI	Levels of activity are often affected in psychiatric disorders and can be core symptoms of illness. Advances in technology now allow the accurate assessment of activity levels but it remains unclear whether alterations in activity arise from shared risk factors for developing psychiatric disorders, such as genetics, or are better explained as consequences of the disorders and their associated factors. We aimed to examine objectively-measured physical activity in individuals with psychiatric disorders, and assess the role of genetic liability for psychiatric disorders on physical activity. Accelerometer data were available on 95,529 UK Biobank participants, including measures of overall mean activity and minutes per day of moderate activity, walking, sedentary activity, and sleep. Linear regressions measured associations between psychiatric diagnosis and activity levels, and polygenic risk scores (PRS) for psychiatric disorders and activity levels. Genetic correlations were calculated between psychiatric disorders and different types of activity. Having a diagnosis of schizophrenia, bipolar disorder, depression, or autism spectrum disorders (ASD) was associated with reduced overall activity compared to unaffected controls. In individuals without a psychiatric disorder, reduced overall activity levels were associated with PRS for schizophrenia, depression, and ASD. ADHD PRS was associated with increased overall activity. Genetic correlations were consistent with PRS findings. Variation in physical activity is an important feature across psychiatric disorders. Whilst levels of activity are associated with genetic liability to psychiatric disorders to a very limited extent, the substantial differences in activity levels in those with psychiatric disorders most likely arise as a consequences of disorder-related factors.	[Dennison, Charlotte A.; Legge, Sophie E.; Bracher-Smith, Matthew; Escott-Price, Valentina; Owen, Michael J.; O'Donovan, Michael C.; Walters, James T. R.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Div Psychiat & Clin Neurosci, Cardiff, Wales; [Menzies, Georgina] Cardiff Univ, Dementia Res Inst, Sch Biosci, Cardiff, Wales; [Escott-Price, Valentina] Cardiff Univ, Dementia Res Inst, Sch Med, Div Psychiat & Clin Neurosci, Cardiff, Wales; [Smith, Daniel J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Doherty, Aiden R.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England; [Doherty, Aiden R.] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England	Cardiff University; Cardiff University; Cardiff University; University of Glasgow; University of Oxford; University of Oxford	Walters, JTR (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Div Psychiat & Clin Neurosci, Cardiff, Wales.	WaltersJT@cardiff.ac.uk	Walters, James/HCH-8835-2022	Escott-Price, Valentina/0000-0003-1784-5483; Menzies, Georgina/0000-0002-6600-6507; Doherty, Aiden/0000-0003-1840-0451; Smith, Daniel/0000-0002-2267-1951; Dennison, Charlotte A/0000-0002-7493-2041	Medical Research Council (MRC) Mental Health Data Pathfinder Award [MC_PC_17212]; MRC [G0800509]; MRC Mental Health Data Pathfinder Award [MC_PC_17217]; MRC Centre grant [MR/L010305/1]; National Institute of Mental Health [1U01MH109514-01]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC); British Heart Foundation Centre of Research Excellence; Alan Turing Institute; British Heart Foundation [SP/18/4/33803]; Health Data Research UK - UK Research and Innovation, Department of Health and Social Care (England)	Medical Research Council (MRC) Mental Health Data Pathfinder Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Mental Health Data Pathfinder Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); British Heart Foundation Centre of Research Excellence(British Heart Foundation); Alan Turing Institute; British Heart Foundation(British Heart Foundation); Health Data Research UK - UK Research and Innovation, Department of Health and Social Care (England)	JTRW and MJO are supported by funding from the Medical Research Council (MRC) Mental Health Data Pathfinder Award (MC_PC_17212). JTRW, MOD, and MJO are supported by funding from the MRC Program grant (G0800509). DJS is supported by funding from MRC Mental Health Data Pathfinder Award (MC_PC_17217). MJO is in receipt of an MRC Centre grant (MR/L010305/1). https://mrc.ukri.org/MOD is supported by funding from the National Institute of Mental Health (1U01MH109514-01). https://www.nimh.nih.gov/index.shtml AD is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the British Heart Foundation Centre of Research Excellence, the Alan Turing Institute and the British Heart Foundation (grant number SP/18/4/33803), and Health Data Research UK, an initiative funded by UK Research and Innovation, Department of Health and Social Care (England) and the devolved administrations, and leading medical research charities. https://www.turing.ac.uk/collaborateturing/current-partnerships-and-collaborations/british-heart-foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker J, 2019, INT J EPIDEMIOL, V48, P1167, DOI [10.1093/ije/dyy294, 10.1093/ije/dyz148]; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C., 2017, BIORXIV, P166298, DOI DOI 10.1136/heartjnl-2013-303950; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Choi KW, 2020, DEPRESS ANXIETY, V37, P106, DOI 10.1002/da.22967; Choi KW, 2019, JAMA PSYCHIAT, V76, P399, DOI 10.1001/jamapsychiatry.2018.4175; Chwastiak LA, 2011, PSYCHOSOMATICS, V52, P230, DOI 10.1016/j.psym.2010.12.009; Collier S, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0921-z; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Davis KAS, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2019.100; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Doherty A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07743-4; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Firth J, 2018, SCHIZOPHRENIA BULL, V44, P1293, DOI 10.1093/schbul/sbx149; Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Janney CA, 2014, J AFFECT DISORDERS, V152, P498, DOI 10.1016/j.jad.2013.09.009; Kendall KM, 2017, BIOL PSYCHIAT, V82, P103, DOI 10.1016/j.biopsych.2016.08.014; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Legge SE, 2019, JAMA PSYCHIAT, V76, P1256, DOI 10.1001/jamapsychiatry.2019.2508; Lyall LM, 2018, LANCET PSYCHIAT, V5, P507, DOI 10.1016/S2215-0366(18)30139-1; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Momen NC, 2020, NEW ENGL J MED, V382, P1721, DOI 10.1056/NEJMoa1915784; O'Donovan, 2020, MAPPING GENOMIC LOCI, DOI [10.1101/2020.09.12.20192922, DOI 10.1101/2020.09.12.20192922]; Papiol S, 2021, JAMA PSYCHIAT, V78, P441, DOI 10.1001/jamapsychiatry.2020.3946; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Stubbs B, 2017, PSYCHIAT RES, V247, P208, DOI 10.1016/j.psychres.2016.11.033; Stubbs B, 2016, SCHIZOPHR RES, V176, P431, DOI 10.1016/j.schres.2016.05.017; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; VanKim NA, 2013, AM J HEALTH PROMOT, V28, P7, DOI 10.4278/ajhp.111101-QUAN-395; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3	44	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0249189	10.1371/journal.pone.0249189	http://dx.doi.org/10.1371/journal.pone.0249189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770123	Green Accepted, Green Published, gold			2022-12-26	WOS:000634833500043
J	Huang, YM; Xu, XX; Arvan, P; Liu, M				Huang, Yumeng; Xu, Xiaoxi; Arvan, Peter; Liu, Ming			Deficient endoplasmic reticulum translocon-associated protein complex limits the biosynthesis of proinsulin and insulin	FASEB JOURNAL			English	Article						diabetes; insulin secretion; pancreatic beta cell; preproinsulin; translocation	TRAP; CONTRIBUTES	The conserved endoplasmic reticulum (ER) membrane protein TRAP alpha (translocon-associated protein, also known as signal sequence receptor 1, SSR1) has been reported to play a critical but unclear role in insulin biosynthesis. TRAP alpha/SSR1 is one component of a four-protein complex including TRAP beta/SSR2, TRAP gamma/SSR3, and TRAP delta/SSR4. The TRAP complex topologically has a small exposure on the cytosolic side of the ER via its TRAP gamma/SSR3 subunit, whereas TRAP beta/SSR2 and TRAP delta/SSR4 function along with TRAP alpha/SSR1 largely on the luminal side of the ER membrane. Here, we have examined pancreatic beta-cells with deficient expression of either TRAP beta/SSR2 or TRAP delta/SSR4, which does not perturb mRNA expression levels of other TRAP subunits, or insulin mRNA. However, deficient protein expression of TRAP beta/SSR2 and, to a lesser degree, TRAPd/SSR4, diminishes the protein levels of other TRAP subunits, concomitant with deficient steady-state levels of proinsulin and insulin. Deficient TRAP beta/SSR2 or TRAP delta/SSR4 is not associated with any apparent defect of exocytotic mechanism but rather by a decreased abundance of the proinsulin and insulin that accompanies glucose-stimulated secretion. Amino acid pulse labeling directly establishes that much of the steady-state deficiency of intracellular proinsulin can be accounted for by diminished proinsulin biosynthesis, observed in a pulse-labeling as short as 5 minutes. The proinsulin and insulin levels in TRAP beta/SSR2 or TRAP delta/SSR4 null mutant beta-cells are notably recovered upon re-expression of the missing TRAP subunit, accompanying a rebound of proinsulin biosynthesis. Remarkably, overexpression of TRAP alpha/SSR1 can also suppress defects in beta-cells with diminished expression of TRAP beta/SSR2, strongly suggesting that TRAP beta/SSR2 is needed to support TRAP alpha/SSR1 function.	[Huang, Yumeng; Xu, Xiaoxi; Liu, Ming] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Huang, Yumeng; Xu, Xiaoxi; Arvan, Peter; Liu, Ming] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA	Tianjin Medical University; University of Michigan System; University of Michigan	Arvan, P; Liu, M (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.	parvan@umich.edu; mingliu@tmu.edu.cn						Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Dittner-Moormann S., 2020, J MED GENET; Nguyen D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06188-z; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Gemmer M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.231340; Guo H, 2018, J BIOL CHEM, V293, P1899, DOI 10.1074/jbc.RA117.000922; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; HOLTHUIS JCM, 1995, BIOCHEM J, V312, P205, DOI 10.1042/bj3120205; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kriegler T, 2020, J MOL BIOL, V432, DOI 10.1016/j.jmb.2020.10.028; Lang S, 2019, SUBCELL BIOCHEM, V93, P83, DOI 10.1007/978-3-030-28151-9_4; Li X., 2019, SCI ADV, V5, P1; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2018, DIABETES OBES METAB, V20, P28, DOI 10.1111/dom.13378; Losfeld ME, 2014, HUM MOL GENET, V23, P1602, DOI 10.1093/hmg/ddt550; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Ng BG, 2019, J INHERIT METAB DIS, V42, P993, DOI 10.1002/jimd.12091; Pfeffer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14516; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211; Yamaguchi J, 2006, J BIOL CHEM, V281, P27063, DOI 10.1074/jbc.M606809200	25	4	4	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21515	10.1096/fj.202002774R	http://dx.doi.org/10.1096/fj.202002774R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33811688	Green Accepted, Green Published			2022-12-26	WOS:000645260100013
J	Mamadjonov, N; Jung, YH; Jeung, KW; Lee, HY; Lee, BK; Youn, CS; Jeong, IS; Heo, T; Min, YI				Mamadjonov, Najmiddin; Jung, Yong Hun; Jeung, Kyung Woon; Lee, Hyoung Youn; Lee, Byung Kook; Youn, Chun Song; Jeong, In Seok; Heo, Tag; Min, Yong Il			Pralidoxime improves the hemodynamics and survival of rats with peritonitis-induced sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; CONTINUOUS-INFUSION; HEART-RATE; NOREPINEPHRINE; VASOPRESSIN; PEROXYNITRITE; BUTORPHANOL; TACHYCARDIA; HYPOTENSION; METABOLISM	Several studies have suggested that sympathetic overstimulation causes deleterious effects in septic shock. A previous study suggested that pralidoxime exerted a pressor effect through a mechanism unrelated to the sympathetic nervous system; this effect was buffered by the vasodepressor action of pralidoxime mediated through sympathoinhibition. In this study, we explored the effects of pralidoxime on hemodynamics and survival in rats with peritonitis-induced sepsis. This study consisted of two sub-studies: survival and hemodynamic studies. In the survival study, 66 rats, which survived for 10 hours after cecal ligation and puncture (CLP), randomly received saline placebo, pralidoxime, or norepinephrine treatment and were monitored for up to 24 hours. In the hemodynamic study, 44 rats were randomly assigned to sham, CLP-saline placebo, CLP-pralidoxime, or CLP-norepinephrine groups, and hemodynamic measurements were performed using a conductance catheter placed in the left ventricle. In the survival study, 6 (27.2%), 15 (68.1%), and 5 (22.7%) animals survived the entire 24-hour monitoring period in the saline, pralidoxime, and norepinephrine groups, respectively (log-rank test P = 0.006). In the hemodynamic study, pralidoxime but not norepinephrine increased end-diastolic volume (P <0.001), stroke volume (P = 0.002), cardiac output (P = 0.003), mean arterial pressure (P = 0.041), and stroke work (P <0.001). The pressor effect of norepinephrine was short-lived, such that by 60 minutes after the initiation of norepinephrine infusion, it no longer had any significant effect on mean arterial pressure. In addition, norepinephrine significantly increased heart rate (P <0.001) and the ratio of arterial elastance to ventricular end-systolic elastance (P = 0.010), but pralidoxime did not. In conclusion, pralidoxime improved the hemodynamics and 24-hour survival rate in rats with peritonitis-induced sepsis, but norepinephrine did not.	[Mamadjonov, Najmiddin] Chonnam Natl Univ, Dept Med Sci, Grad Sch, Gwangju, South Korea; [Jung, Yong Hun; Jeung, Kyung Woon; Lee, Hyoung Youn; Lee, Byung Kook; Heo, Tag; Min, Yong Il] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea; [Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Heo, Tag; Min, Yong Il] Chonnam Natl Univ, Dept Emergency Med, Med Sch, Gwangju, South Korea; [Youn, Chun Song] Catholic Univ Korea, Dept Emergency Med, Seoul St Marys Hosp, Seoul, South Korea; [Jeong, In Seok] Chonnam Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Catholic University of Korea; Seoul St. Mary's Hospital; Chonnam National University; Chonnam National University Hospital	Jeung, KW (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.; Jeung, KW (corresponding author), Chonnam Natl Univ, Dept Emergency Med, Med Sch, Gwangju, South Korea.	neoneti@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF2018R1A2B6001388, NRF2020R1A2C1013332]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF2018R1A2B6001388 [recipient: KWJ] and NRF2020R1A2C1013332 [recipient: YHJ]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Barrett LK, 2007, CRIT CARE MED, V35, P2337, DOI 10.1097/01.CCM.0000281861.72907.17; BENEDICT CR, 1992, CIRC SHOCK, V38, P165; Bennett T, 2004, BRIT J ANAESTH, V93, P400, DOI 10.1093/bja/aeh214; Blet A, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0255-0; Bombardini T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/235194; Brand DA, 2017, J PAIN SYMPTOM MANAG, V53, P938, DOI 10.1016/j.jpainsymman.2016.12.333; Bucher M, 2003, CRIT CARE MED, V31, P566, DOI 10.1097/01.CCM.0000048621.36569.69; CARRIER GO, 1975, J PHARMACOL EXP THER, V193, P218; Chen SJ, 2010, SHOCK, V33, P473, DOI 10.1097/SHK.0b013e3181bea334; Chopra M, 2010, LIFE SCI, V87, P672, DOI 10.1016/j.lfs.2010.09.029; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Conrad M, 2015, J CRIT CARE, V30, P739, DOI 10.1016/j.jcrc.2015.03.029; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; DEEGAN R, 1993, ANESTH ANALG, V77, P49; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Domizi R, 2020, J CRIT CARE, V57, P185, DOI 10.1016/j.jcrc.2020.02.014; dos Santos PSP, 2011, VET ANAESTH ANALG, V38, P467, DOI 10.1111/j.1467-2995.2011.00644.x; Ducrocq N, 2012, ANESTHESIOLOGY, V116, P1083, DOI 10.1097/ALN.0b013e31824f9669; Fries M, 2006, CRIT CARE MED, V34, P446, DOI 10.1097/01.CCM.0000196205.23674.23; Fries M, 2008, CRIT CARE MED, V36, P1886, DOI 10.1097/CCM.0b013e31817cede9; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Guarracino F, 2014, CRIT CARE, V18, DOI 10.1186/cc13842; Hofstetter C, 2007, INT J MOL MED, V20, P597; Hollenberg SM, 1997, CRIT CARE MED, V25, P869, DOI 10.1097/00003246-199705000-00025; Jung YH, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015076; Jung YH, 2020, CLIN EXP PHARMACOL P, V47, P236, DOI 10.1111/1440-1681.13198; Jung YH, 2019, CLIN EXP EMERG MED, V6, P204, DOI 10.15441/ceem.18.036; Kimmoun A, 2015, CRIT CARE MED, V43, pE332, DOI 10.1097/CCM.0000000000001078; Landesberg G, 2012, EUR HEART J, V33, P895, DOI 10.1093/eurheartj/ehr351; Leibovici L, 2007, QJM-INT J MED, V100, P629, DOI 10.1093/qjmed/hcm074; Levy MM, 2018, CRIT CARE MED, V46, P997, DOI 10.1097/CCM.0000000000003119; Mathieu C, 2018, CRIT CARE MED, V46, pE684, DOI 10.1097/CCM.0000000000003146; Maurer MS, 2009, CIRC-HEART FAIL, V2, P189, DOI 10.1161/CIRCHEARTFAILURE.108.806240; Garcia MIM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.04.10; Morelli A, 2013, JAMA-J AM MED ASSOC, V310, P1683, DOI 10.1001/jama.2013.278477; MULDOON S, 1983, ANESTH ANALG, V62, P21; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; Ramchandra R, 2009, AM J PHYSIOL-REG I, V297, pR1247, DOI 10.1152/ajpregu.00437.2009; Rhodes A., 2017, INTENSIVE CARE MED, V43, P304, DOI [10.1007/s00134-017-4683-6, DOI 10.1007/S00134-017-4683-6]; Sano Y, 2016, AM J PHYSIOL-HEART C, V311, pH1360, DOI 10.1152/ajpheart.00181.2016; Schexnayder S, 1998, J TOXICOL-CLIN TOXIC, V36, P549, DOI 10.3109/15563659809028048; Schmittinger CA, 2013, SHOCK, V39, P329, DOI 10.1097/SHK.0b013e318289376b; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; STAVINOH.WB, 1970, ARCH INT PHARMACOD T, V187, P52; Takakura K, 2003, ANESTH ANALG, V97, P1492, DOI 10.1213/01.ANE.0000082248.30437.0B; Takakura K, 2003, ANESTHESIOLOGY, V98, P928, DOI 10.1097/00000542-200304000-00020; Takakura K, 2002, CRIT CARE MED, V30, P894, DOI 10.1097/00003246-200204000-00030; Tang WC, 1996, CRIT CARE MED, V24, P125, DOI 10.1097/00003246-199601000-00021; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/201614; Wilson J, 2013, CRIT CARE, V17, DOI 10.1186/cc12889; Xiao XD, 2015, J SURG RES, V195, P568, DOI 10.1016/j.jss.2015.02.022; ZARRO VJ, 1965, J PHARMACOL EXP THER, V147, P153	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0249794	10.1371/journal.pone.0249794	http://dx.doi.org/10.1371/journal.pone.0249794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8VV	33822820	Green Published, gold			2022-12-26	WOS:000637879100033
J	Sato, Y; Shiba, K				Sato, Yasuhiro; Shiba, Keita			The impact of Tsunamis on land appraisals: Evidence from Western Japan	PLOS ONE			English	Article								This paper estimates the impact of the tsunami caused by the Great East Japan earthquake on land appraisals of various locations outside of directly damaged areas. The focus is on locations that are expected to be extensively damaged by a tsunami if the Nankai Trough earthquake occurs. We use the DID and DDD approaches and show that locations with low elevation and close to the sea experienced decreases in appraised land prices compared to locations with high elevation and far from the sea. Especially, locations with less than 3.6m elevation and within 1.46km of the coastline experienced significant decreases in appraised land prices. This result implies that people have changed their location preferences regarding elevation and distance from the sea.	[Sato, Yasuhiro] Univ Tokyo, Fac Econ, Tokyo, Japan; [Shiba, Keita] Univ Shinshu, Res Ctr Social Syst, Nagano, Japan	University of Tokyo	Shiba, K (corresponding author), Univ Shinshu, Res Ctr Social Syst, Nagano, Japan.	kshiba@shinshu-u.ac.jp		Shiba, Keita/0000-0003-1368-5806	Japan Society for the Promotion of Science [19K23192, 18H00842, 18H00841]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Keita Shiba 19K23192 Japan Society for the Promotion of Science https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-19K23192/Yasuhiro Sato 18H00842 Japan Society for the Promotion of Science https://kaken.nii.ac.jp/en/grant/KAKENHIPROJECT-18H00842/Yasuhiro Sato 18H00841 Japan Society for the Promotion of Science https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT18H00841/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya A, 2015, RISK ANAL, V35, P828, DOI 10.1111/risa.12307; Atreya A, 2013, LAND ECON, V89, P577, DOI 10.3368/le.89.4.577; Beron KJ, 1997, LAND ECON, V73, P101, DOI 10.2307/3147080; Bin O, 2004, LAND ECON, V80, P490, DOI 10.2307/3655805; Driscoll JC, 1998, REV ECON STAT, V80, P549, DOI 10.1162/003465398557825; Ferreira S, 2018, J ENVIRON ECON MANAG, V92, P251, DOI 10.1016/j.jeem.2018.08.006; Kawaguchi D, 2017, J URBAN ECON, V99, P148, DOI 10.1016/j.jue.2017.02.005; Nakanishi H, 2017, EMPIR ECON, V52, P869, DOI 10.1007/s00181-016-1084-6; Sato K., 2016, ESRI DISCUSS PAPER S, V327, P1, DOI [11513838/www.esri.go.jp/jp/archive/e_dis/e_dis327/e_dis327.html, DOI 11513838/WWW.ESRI.GO.JP/JP/ARCHIVE/E_DIS/E_DIS327/E_DIS327.HTML]; Tanaka K, 2016, SINGAP ECON REV, V61, DOI 10.1142/S0217590816400038; Yamane F, 2013, RISK ANAL, V33, P2023, DOI 10.1111/risa.12045; Yi DG, 2020, J REAL ESTATE FINANC, V61, P55, DOI 10.1007/s11146-019-09704-0	12	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2021	16	4							e0248860	10.1371/journal.pone.0248860	http://dx.doi.org/10.1371/journal.pone.0248860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RJ8VV	33822787	Green Published, gold			2022-12-26	WOS:000637879100030
J	Ariya, M; Koohpayeh, F; Ghaemi, A; Osati, S; Davoodi, SH; Razzaz, JM; Javedan, G; Ehrampoush, E; Homayounfar, R				Ariya, Mohammad; Koohpayeh, Farbod; Ghaemi, Alireza; Osati, Saeed; Davoodi, Sayed Hossain; Razzaz, Jalaledin Mirzay; Javedan, Gholamali; Ehrampoush, Elham; Homayounfar, Reza			Assessment of the association between body composition and risk of non-alcoholic fatty liver	PLOS ONE			English	Article								Non-alcoholic fatty liver disease (NAFLD) is defined as the condition of fat accumulation in the liver. This cross-sectional study aimed to investigate the relationship between body composition and fatty liver and determine of cut-off point for predicting NAFLD. Samples were selected from the nutrition clinic from 2016 to 2017 in Tehran, Iran. The liver steatosis was calculated using the CAP score through the FiroScan((TM)) and body composition was measured using the dual-energy X-ray absorptiometry scan method. A total of 2160 patients participated in this study, 745 (34.5%) subjects had NAFLD. We found that fat-free tissue was inversely and fat tissue was directly correlated with the risk of NAFLD in almost all factors and the risk of developing NAFLD increases if the total fat exceeds 32.23% and 26.73% in women and men and abdominal fat exceeds 21.42% and 13.76% in women and men, respectively. Finally, we realized that the total fat percent had the highest AUC (0.932 for men and 0.917 for women) to predict the risk of NAFLD. Overall, the likelihood of NAFLD development rose significantly with increasing the amount of total fat and abdominal fat from the cut-off point level.	[Ariya, Mohammad; Ehrampoush, Elham; Homayounfar, Reza] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Ariya, Mohammad; Ehrampoush, Elham; Homayounfar, Reza] Fasa Univ Med Sci, Dept Nutr, Fasa, Iran; [Koohpayeh, Farbod] Fasa Univ Med Sci, Students Res Comm, Fasa, Iran; [Ghaemi, Alireza] Mazandaran Univ Med Sci, Addict Inst, Fac Publ Hlth, Dept Basic Sci & Nutr,Hlth Sci Res Ctr, Sari, Iran; [Osati, Saeed; Davoodi, Sayed Hossain; Razzaz, Jalaledin Mirzay; Homayounfar, Reza] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Tehran, Iran; [Javedan, Gholamali] Hormozgan Univ Med Sci, Food Hlth Res Ctr, Bandar Abbas, Iran; [Javedan, Gholamali] Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran	Mazandaran University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences	Homayounfar, R (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.; Homayounfar, R (corresponding author), Fasa Univ Med Sci, Dept Nutr, Fasa, Iran.; Homayounfar, R (corresponding author), Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Tehran, Iran.	r_homayounfar@yahoo.com	Javedan, Gholamali/AAS-2371-2021; Davoodi, Sayed Hossein/AHE-7436-2022	Davoodi, Sayed Hossein/0000-0002-6404-8367; ariya, mohammad/0000-0002-6732-1867	Fasa University of Medical Sciences [97107]	Fasa University of Medical Sciences	The study was supported by the Fasa University of Medical Sciences (Grant No.: 97107).	Abenavoli Ludovico, 2016, J Lifestyle Med, V6, P47, DOI 10.15280/jlm.2016.6.1.47; Alferink LJM, 2019, J BONE MINER RES, V34, P1254, DOI 10.1002/jbmr.3713; Aller R, 2009, DIGEST DIS SCI, V54, P1772, DOI 10.1007/s10620-008-0539-9; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bouchi R, 2016, J DIABETES INVEST, V7, P607, DOI 10.1111/jdi.12443; Brambilla P, 2013, INT J OBESITY, V37, P943, DOI 10.1038/ijo.2013.32; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Byrne CD, 2016, DIABETOLOGIA, V59, P1141, DOI 10.1007/s00125-016-3910-y; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Choudhary NS, 2012, ANN HEPATOL, V11, P478, DOI 10.1016/S1665-2681(19)31461-9; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glass LM, 2015, DIGEST DIS SCI, V60, P1024, DOI 10.1007/s10620-014-3380-3; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Hsing JC, 2019, HEPATOL COMMUN, V3, P1061, DOI 10.1002/hep4.1392; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Ko YH, 2017, METAB SYNDR RELAT D, V15, P304, DOI 10.1089/met.2017.0001; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Lu FB, 2018, EXPERT REV GASTROENT, V12, P491, DOI 10.1080/17474124.2018.1460202; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P7236, DOI 10.3748/wjg.v22.i32.7236; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Monsour Howard P Jr, 2012, Methodist Debakey Cardiovasc J, V8, P21; Monteiro PA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-25; Motamed N, 2016, WORLD J GASTROENTERO, V22, P3023, DOI 10.3748/wjg.v22.i10.3023; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P1081, DOI 10.1210/jc.2005-1056; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Park SH, 2007, J AM COLL NUTR, V26, P321, DOI 10.1080/07315724.2007.10719618; Parker R., 2018, LIVER RES, V2, P35, DOI [10.1016/j.livres.2018.02.002, DOI 10.1016/J.LIVRES.2018.02.002]; Raymond JL, 2016, KRAUSES FOOD NUTR CA; Saida T, 2014, J GASTROEN HEPATOL, V29, P128, DOI 10.1111/jgh.12377; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Sogabe M, 2014, HEPATOL RES, V44, P515, DOI 10.1111/hepr.12146; Sogabe M, 2012, J GASTROENTEROL, V47, P293, DOI 10.1007/s00535-011-0489-4; Sookoian S, 2018, ALIMENT PHARM THER, V47, P16, DOI 10.1111/apt.14401; Sookoian S, 2017, ALIMENT PHARM THER, V46, P85, DOI 10.1111/apt.14112; Tang TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081949; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; WHO, 2004, LANCET, V363, P902; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yang HR, 2016, ASIA PAC J CLIN NUTR, V25, P126, DOI 10.6133/apjcn.2016.25.1.15; Yoo HJ, 2010, LIVER INT, V30, P1189, DOI 10.1111/j.1478-3231.2010.02300.x; Zhou YN, 2019, J RENAL NUTR, V29, P33, DOI 10.1053/j.jrn.2018.05.003	53	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249223	10.1371/journal.pone.0249223	http://dx.doi.org/10.1371/journal.pone.0249223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793621	gold, Green Published			2022-12-26	WOS:000636467000033
J	Deane, JA; Lim, AKP; McGregor, AH; Strutton, PH				Deane, Janet A.; Lim, Adrian K. P.; McGregor, Alison H.; Strutton, Paul H.			Understanding the impact of lumbar disc degeneration and chronic low back pain: A cross-sectional electromyographic analysis of postural strategy during predicted and unpredicted postural perturbations	PLOS ONE			English	Article							SYSTEM-IMPAIRMENT TREATMENTS; ACTIVATION PATTERNS; MUSCLE-ACTIVITY; MRI FINDINGS; RISK-FACTORS; RESPONSES; INDIVIDUALS; ADJUSTMENTS; STABILITY; MOVEMENT	People with chronic low back pain (LBP) exhibit changes in postural control. Stereotypical muscle activations resulting from external perturbations include anticipatory (APAs) and compensatory (CPAs) postural adjustments. The aim and objective of this study was to determine differences in postural control strategies (peak amplitude, APAs and CPAs) between symptomatic and asymptomatic adults with and without Lumbar Disc Degeneration (LDD) using surface electromyography during forward postural perturbation. Ninety-seven subjects participated in the study (mean age 50 years (SD 12)). 3T MRI was used to acquire T2 weighted images (L1-S1). LDD was determined using Pfirrmann grading. A bespoke translational platform was designed to deliver horizontal perturbations in sagittal and frontal planes. Electromyographic activity was analysed bilaterally from 8 trunk and lower limb muscles during four established APA and CPA epochs. A Kruskal-Wallis H test with Bonferroni correction for multiple comparisons was conducted. Four groups were identified: no LDD no pain (n = 19), LDD no pain (n = 38), LDD pain (n = 35) and no LDD pain (n = 5). There were no significant differences in age or gender between groups. The most significant difference between groups was observed during forward perturbation. In the APA and CPA phases of predictable forward perturbation there were significant differences ankle strategy between groups (p = 0.007-0.008); lateral gastrocnemius and tibialis anterior activity was higher in the LDD pain than the LDD no pain group. There were no significant differences in the unpredictable condition (p>0.05). These findings were different from the remaining groups, where significant differences in hip strategy were observed during both perturbation conditions (p = 0.004-0.006). Symptomatic LDD patients exhibit different electromyographic strategies to asymptomatic LDD controls. Future LBP electromyographic research should benefit from considering assessment of both lower limbs in addition to the spine. This approach could prevent underestimation of postural control deficits and guide targeted rehabilitation.	[Deane, Janet A.; Lim, Adrian K. P.; McGregor, Alison H.; Strutton, Paul H.] Imperial Coll London, Dept Surg & Canc, London, England; [Deane, Janet A.] Univ Manchester, Dept Hlth Sci, Manchester, Lancs, England; [Deane, Janet A.] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Lim, Adrian K. P.] Imperial Coll Healthcare NHS Trust, Dept Imaging, London, England; [Deane, Janet A.; Lim, Adrian K. P.; McGregor, Alison H.; Strutton, Paul H.] Imperial Coll London, Sir Michael Uren Hub, Sackler Musculoskeletal Lab, London, England; [Deane, Janet A.] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England; [Lim, Adrian K. P.] Hammersmith, Charing Cross Hosp, London, England	Imperial College London; University of Manchester; Imperial College London; Imperial College London; University of Manchester; Imperial College London	Deane, JA (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.; Deane, JA (corresponding author), Univ Manchester, Dept Hlth Sci, Manchester, Lancs, England.; Deane, JA (corresponding author), Manchester Univ NHS Fdn Trust, Manchester, Lancs, England.; Deane, JA (corresponding author), Imperial Coll London, Sir Michael Uren Hub, Sackler Musculoskeletal Lab, London, England.; Deane, JA (corresponding author), Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England.	j.deane@manchester.ac.uk		Deane, Janet A/0000-0002-0710-2881	Versus Arthritis [20172]	Versus Arthritis(Versus Arthritis)	JD was funded by Versus Arthritis (grant number 20172) (https://www.versusarthritis.org).Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge David Buckwell, Dr Clement Favier, Dr Megan Sperry and Dr Andrew Phillips for their expert advice and support in designing and developing the perturbation platform used in this study. Thanks to Dr Djordje Brujic for his generous support with the development and creation of bespoke MATLAB scripts and to Lesley Honeyfield (Lead Research Radiographer, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London) for assisting with imaging optimisation and the acquisition of MR images. Finally, many thanks to the participants in this study and to the National Institute for Health Research (NIHR) for supporting recruitment.	Adkin AL, 2006, EXP BRAIN RES, V172, P85, DOI 10.1007/s00221-005-0310-9; Adkin AL, 2008, NEUROSCI LETT, V435, P120, DOI 10.1016/j.neulet.2008.02.018; Allison GT, 2003, J ELECTROMYOGR KINES, V13, P209, DOI 10.1016/S1050-6411(03)00019-1; Arampatzis A, 2017, EUR J APPL PHYSIOL, V117, P2547, DOI 10.1007/s00421-017-3742-6; BELEN'KII V. E., 1967, BIOFIZIKA, V12, P135; Boudreau S, 2011, EXP BRAIN RES, V210, P259, DOI 10.1007/s00221-011-2629-8; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; Cai XY, 2020, ORTHOP SURG, V12, P917, DOI 10.1111/os.12703; Chen CL, 2009, P I MECH ENG H, V223, P87, DOI 10.1243/09544119JEIM482; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chiou SY, 2014, EUR J PAIN, V18, P794, DOI 10.1002/j.1532-2149.2013.00428.x; Cholewicki J, 2005, SPINE, V30, P2614, DOI 10.1097/01.brs.0000188273.27463.bc; Claeys K, 2015, J ELECTROMYOGR KINES, V25, P329, DOI 10.1016/j.jelekin.2014.10.013; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Favier Clement D., 2019, Journal of Medical Engineering & Technology, V43, DOI 10.1080/03091902.2019.1673845; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hancock MJ, 2015, SPINE J, V15, P2360, DOI 10.1016/j.spinee.2015.07.007; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Henry SM, 2006, CLIN BIOMECH, V21, P881, DOI 10.1016/j.clinbiomech.2006.04.016; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jacobs JV, 2016, MANUAL THER, V21, P210, DOI 10.1016/j.math.2015.08.006; Jacobs JV, 2011, J NEUROPHYSIOL, V106, P2506, DOI 10.1152/jn.00296.2011; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; Jones SL, 2012, EXP BRAIN RES, V221, P413, DOI 10.1007/s00221-012-3183-8; Jones SL, 2012, J ELECTROMYOGR KINES, V22, P13, DOI 10.1016/j.jelekin.2011.10.006; Knox MF, 2018, SPINE J, V18, P1934, DOI 10.1016/j.spinee.2018.06.008; Knox MF, 2017, J ELECTROMYOGR KINES, V37, P117, DOI 10.1016/j.jelekin.2017.10.009; Koch C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00586; Lariviere C, 2003, J ELECTROMYOGR KINES, V13, P305, DOI 10.1016/S1050-6411(03)00039-7; Liebetrau A, 2013, HUM MOVEMENT SCI, V32, P954, DOI 10.1016/j.humov.2013.03.006; Lima M, 2018, GAIT POSTURE, V61, P250, DOI 10.1016/j.gaitpost.2018.01.021; Lin YC, 2018, GAIT POSTURE, V64, P159, DOI 10.1016/j.gaitpost.2018.06.021; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Lomond KV, 2015, SPINE J, V15, P596, DOI 10.1016/j.spinee.2014.10.020; MacDonald D, 2010, SPINE, V35, P818, DOI 10.1097/BRS.0b013e3181bc98f1; Mansfield Avril, 2007, BMC Geriatr, V7, P12, DOI 10.1186/1471-2318-7-12; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McDowel C, 2018, J ELECTROMYOGR KINES, V43, P68, DOI 10.1016/j.jelekin.2018.09.005; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; Mok NW, 2013, EXP BRAIN RES, V231, P305, DOI 10.1007/s00221-013-3692-0; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Moseley GL, 2004, BRAIN, V127, P2339, DOI 10.1093/brain/awh248; Muthukrishnan R, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-13; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Newcomer KL, 2002, ARCH PHYS MED REHAB, V83, P816, DOI 10.1053/apmr.2002.32826; Qie SY, 2020, J BACK MUSCULOSKELET, V33, P589, DOI 10.3233/BMR-181308; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; Rohlmann A, 2006, J BIOMECH, V39, P2484, DOI 10.1016/j.jbiomech.2005.07.026; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P398, DOI 10.1016/j.jelekin.2010.01.002; Shiratori T, 2001, CLIN NEUROPHYSIOL, V112, P1250, DOI 10.1016/S1388-2457(01)00553-3; Steffens D, 2016, EUR SPINE J, V25, P1170, DOI 10.1007/s00586-015-4195-4; Stokes IAF, 2006, EUR SPINE J, V15, P658, DOI 10.1007/s00586-005-0893-7; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Sung PS, 2018, MUSCULOSKEL SCI PRAC, V33, P84, DOI 10.1016/j.msksp.2017.12.005; Takatalo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056244; Thigpen MT, 2009, GAIT POSTURE, V29, P113, DOI 10.1016/j.gaitpost.2008.07.009; Truszczynska A, 2016, ACTA BIOENG BIOMECH, V18, P71, DOI 10.5277/ABB-00555-2016-03; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	66	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2021	16	4							e0249308	10.1371/journal.pone.0249308	http://dx.doi.org/10.1371/journal.pone.0249308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH8NB	33793605	Green Published, gold			2022-12-26	WOS:000636467000086
J	Mulaga, AN; Kamndaya, MS; Masangwi, SJ				Mulaga, Atupele N.; Kamndaya, Mphatso S.; Masangwi, Salule J.			Examining the incidence of catastrophic health expenditures and its determinants using multilevel logistic regression in Malawi	PLOS ONE			English	Article							OF-POCKET PAYMENTS; CARE; PROTECTION	Background Despite a free access to public health services policy in most sub-Saharan African countries, households still contribute to total health expenditures through out-of-pocket expenditures. This reliance on out-of-pocket expenditures places households at a risk of catastrophic health expenditures and impoverishment. This study examined the incidence of catastrophic health expenditures, impoverishing effects of out-of-pocket expenditures on households and factors associated with catastrophic expenditures in Malawi. Methods We conducted a secondary analysis of the most recent nationally representative integrated household survey conducted by the National Statistical Office between April 2016 to 2017 in Malawi with a sample size of 12447 households. Catastrophic health expenditures were estimated based on household annual nonfood expenditures and total household annual expenditures. We estimated incidence of catastrophic health expenditures as the proportion of households whose out-of-pocket expenditures exceed 40% threshold level of non-food expenditures and 10% of total annual expenditures. Impoverishing effect of out-of-pocket health expenditures on households was estimated as the difference between poverty head count before and after accounting for household health payments. We used a multilevel binary logistic regression model to assess factors associated with catastrophic health expenditures. Results A total of 167 households (1.37%) incurred catastrophic health expenditures. These households on average spend over 52% of household nonfood expenditures on health care. 1.6% of Malawians are impoverished due to out-of-pocket health expenditures. Visiting a religious health facility (AOR = 2.27,95% CI:1.24-4.15), hospitalization (AOR = 6.03,95% CI:4.08-8.90), larger household size (AOR = 1.20,95% CI:1.24-1.34), higher socioeconomic status (AOR = 2.94,95% CI:1.39-6.19), living in central region (AOR = 3.54,95% CI:1.79-6.97) and rural areas (AOR = 5.13,95% CI:2.14-12.29) increased the odds of incurring catastrophic expenditures. Conclusion The risk of catastrophic health expenditures and impoverishment persists in Malawi. This calls for government to improve the challenges faced by the free public health services and design better prepayment mechanisms to protect more vulnerable groups of the population from the burden of out-of-pocket payments.	[Mulaga, Atupele N.; Kamndaya, Mphatso S.; Masangwi, Salule J.] Univ Malawi, Fac Sci Appl, Dept Math & Stat, Blantyre, Malawi; [Masangwi, Salule J.] Univ Malawi, Ctr Water Sanitat Hlth & Appropriate Technol Dev, Blantyre, Malawi	University of Malawi; University of Malawi	Mulaga, AN (corresponding author), Univ Malawi, Fac Sci Appl, Dept Math & Stat, Blantyre, Malawi.	atupelemulaga@gmail.com		Kamndaya, Mphatso/0000-0002-7597-3339	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100113]; DELTAS Africa Initiative [107768/Z/15/Z]; Deutscher Akademischer Austauschdienst (DAAD); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	ANM was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100113), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z) and Deutscher Akademischer Austauschdienst (DAAD). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the Fellow.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Ahmed S, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0757-5; Akazili J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1289735; Akinkugbe O, 2012, AFR DEV REV, V24, P358, DOI 10.1111/1467-8268.12006; [Anonymous], 2017, MDHS 2015 2016 MAL D; Ataguba JE, 2018, OXFORD RES ENCYCL EC; Ataguba JEO, 2012, HEALTH ECON POLICY L, V7, P309, DOI 10.1017/S1744133110000356; Atake EH, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2974-4; Barasa EW, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0526-x; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; Buigut S, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0168-9; Chansa C., 2018, Expanding health care provision in a low-income country: the experience of Malawi; Chansa C, 2018, HEALTH SYST REFORM, V4, P324, DOI 10.1080/23288604.2018.1506643; Chirwa ML, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-27; Ekman B, 2007, HEALTH POLICY, V83, P304, DOI 10.1016/j.healthpol.2007.02.004; Ghimire M, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0736-x; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Government of Malawi, 2017, HLTH SECT STRAT PLAN; Khan JAM, 2017, HEALTH POLICY PLANN, V32, P1102, DOI 10.1093/heapol/czx048; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Li XH, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-506; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Amaya-Lara JL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0472-z; Manthalu G, 2016, HEALTH POLICY PLANN, V31, P1184, DOI 10.1093/heapol/czw050; Masiye F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146508; Mchenga M, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0515-0; Ministry of Health M, 2020, MAL NAT HLTH ACC SUM; Myint CY, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1018-y; Ngcamphalala C, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1428473; O'Donnell O, 2007, ANAL HLTH EQUITY USI, P1; Oudmane M., 2019, INT J HEAL PLANN MGM, P1, DOI [10.1002/hpm.284831332829, DOI 10.1002/HPM.284831332829]; Qosaj FA, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0111-1; Sene LM, 2015, INT J HEALTH ECON MA, V15, P307, DOI 10.1007/s10754-015-9170-4; The National Statistical Office of Malawi, 2017, INT HOUS SURV 2016 2; The National Statistical Office of Malawi The World Bank Poverty and Equity Global Practice, 2018, METH POV MEAS MAL 20; The World Bank, 2015, J EC; Tomini SM, 2013, HEALTH POLICY PLANN, V28, P419, DOI 10.1093/heapol/czs073; UNICEF, 2019, 2018 19 HLTH BUDG BR; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/S2214-109X(17)30429-1, 10.1016/s2214-109x(17)30486-2]; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization The World Bank, 2020, GLOB MON REP FIN PRO; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K., 2005, DESIGNING HLTH FINAN; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	46	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0248752	10.1371/journal.pone.0248752	http://dx.doi.org/10.1371/journal.pone.0248752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RH6VV	33788900	Green Published, gold			2022-12-26	WOS:000636354600010
J	Wang, JJ; Yin, YP; Song, JZ; Hu, SJ; Cheng, W; Qiu, L				Wang, Juan-Juan; Yin, Ya-Ping; Song, Ji-Zheng; Hu, Shun-Juan; Cheng, Wen; Qiu, Lei			A p53-like transcription factor, BbTFO1, contributes to virulence and oxidative and thermal stress tolerances in the insect pathogenic fungus, Beauveria bassiana	PLOS ONE			English	Article								The p53-like transcription factor (TF) NDT80 plays a vital role in the regulation of pathogenic mechanisms and meiosis in certain fungi. However, the effects of NDT80 on entomopathogenic fungi are still unknown. In this paper, the NDT80 orthologue BbTFO1 was examined in Beauveria bassiana, a filamentous entomopathogenic fungus, to explore the role of an NDT80-like protein for fungal pest control potential. Disruption of BbTFO1 resulted in impaired resistance to oxidative stress (OS) in a growth assay under OS and a 50% minimum inhibitory concentration experiment. Intriguingly, the oxidation resistance changes were accompanied by transcriptional repression of the two key antioxidant enzyme genes cat2 and cat5. Delta BbTFO1 also displayed defective conidial germination, virulence and heat resistance. The specific supplementation of BbTFO1 reversed these phenotypic changes. As revealed by this work, BbTFO1 can affect the transcription of catalase genes and play vital roles in the maintenance of phenotypes associated with the biological control ability of B. bassiana.	[Wang, Juan-Juan; Yin, Ya-Ping] Jinan Univ, Sch Biol Sci & Technol, Jinan, Peoples R China; [Song, Ji-Zheng; Hu, Shun-Juan; Qiu, Lei] Qilu Univ Technol, Shandong Acad Sci, State Key Lab Biobased Mat & Green Papermaking, Jinan, Peoples R China; [Song, Ji-Zheng; Cheng, Wen] Shandong Acad Agr Sci, Maize Res Inst, Jinan, Peoples R China	University of Jinan; Qilu University of Technology; Shandong Academy of Agricultural Sciences	Wang, JJ (corresponding author), Jinan Univ, Sch Biol Sci & Technol, Jinan, Peoples R China.; Qiu, L (corresponding author), Qilu Univ Technol, Shandong Acad Sci, State Key Lab Biobased Mat & Green Papermaking, Jinan, Peoples R China.	wjj880414@163.com; qiulei.2005@163.com	wang, juanjuan/GYV-5540-2022		National Natural Science Foundation of China [31800062, 31600063]; Qilu University of Technology, Shandong Academy of Sciences [2019BSHZ0030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qilu University of Technology, Shandong Academy of Sciences	National Natural Science Foundation of China (Grants 31800062), Lei Qiu; National Natural Science Foundation of China (Grants 31600063), Juan-Juan Wang; Youth Doctor Cooperation Fund Project (2019BSHZ0030), Qilu University of Technology, Shandong Academy of Sciences, Lei Qiu.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Chantasingh D, 2013, BIOL CONTROL, V67, P85, DOI 10.1016/j.biocontrol.2013.08.004; Chen CG, 2004, ANTIMICROB AGENTS CH, V48, P4505, DOI 10.1128/AAC.48.12.4505-4512.2004; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; Ding JL, 2020, ENVIRON MICROBIOL, V22, P584, DOI 10.1111/1462-2920.14868; Fernandes EKK, 2015, CURR GENET, V61, P427, DOI 10.1007/s00294-015-0492-z; Glazier VE, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006948; He ZJ, 2020, ENVIRON MICROBIOL, V22, P2514, DOI 10.1111/1462-2920.14910; Hutchison EA, 2010, GENETICS, V185, P1271, DOI 10.1534/genetics.110.117184; Kappel L, 2016, MOL MICROBIOL, V99, P640, DOI 10.1111/mmi.13256; Katz ME, 2019, FUNGAL GENET BIOL, V124, P8, DOI 10.1016/j.fgb.2018.12.007; Katz ME, 2015, G3-GENES GENOM GENET, V5, P2783, DOI 10.1534/g3.115.021378; Katz Margaret E, 2013, F1000Res, V2, P72, DOI 10.12688/f1000research.2-72.v1; Keyhani NO, 2018, FUNGAL BIOL-UK, V122, P420, DOI 10.1016/j.funbio.2017.07.003; Keyser CA, 2014, J INVERTEBR PATHOL, V120, P67, DOI 10.1016/j.jip.2014.05.008; Li F, 2015, FUNGAL GENET BIOL, V81, P160, DOI 10.1016/j.fgb.2014.09.006; Li GH, 2017, ENVIRON MICROBIOL, V19, P4365, DOI 10.1111/1462-2920.13932; Lovett B, 2018, PEST MANAG SCI, V74, P781, DOI 10.1002/ps.4734; Mashamaite LN, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140157; Min K, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00545-18; Ortiz-Urquiza A, 2015, CURR GENET, V61, P239, DOI 10.1007/s00294-014-0439-9; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Perez-Guzman D, 2016, J APPL MICROBIOL, V121, P453, DOI 10.1111/jam.13156; Qiu L, 2020, PESTIC BIOCHEM PHYS, V163, P185, DOI 10.1016/j.pestbp.2019.11.016; Qiu L, 2015, ENVIRON MICROBIOL, V17, P1119, DOI 10.1111/1462-2920.12530; Qiu L, 2014, ENVIRON MICROBIOL, V16, P2316, DOI 10.1111/1462-2920.12486; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Sellam A, 2010, EUKARYOT CELL, V9, P634, DOI 10.1128/EC.00325-09; Shahi S, 2016, FUNGAL GENET BIOL, V95, P49, DOI 10.1016/j.fgb.2016.08.005; Shao W, 2019, ENVIRON MICROBIOL, V21, P2772, DOI 10.1111/1462-2920.14616; Sheehan G, 2018, VIRULENCE, V9, P163, DOI 10.1080/21505594.2017.1370174; Shemesh E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02490; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; Tong SM, 2020, APPL MICROBIOL BIOT, V104, P5711, DOI 10.1007/s00253-020-10659-z; Trevijano-Contador N, 2019, J FUNGI, V5, DOI 10.3390/jof5010003; Wang CS, 2017, ANNU REV ENTOMOL, V62, P73, DOI 10.1146/annurev-ento-031616-035509; Wang JJ, 2018, APPL MICROBIOL BIOT, V102, P1343, DOI 10.1007/s00253-017-8703-9; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Zhang LB, 2018, APPL MICROBIOL BIOT, V102, P4995, DOI 10.1007/s00253-018-9033-2; Zhang LB, 2016, APPL MICROBIOL BIOT, V100, P10363, DOI 10.1007/s00253-016-7688-0; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zhao X, 2019, ENVIRON MICROBIOL, V21, P3392, DOI 10.1111/1462-2920.14629; Zhu XG, 2018, APPL MICROBIOL BIOT, V102, P9221, DOI 10.1007/s00253-018-9302-0	45	3	3	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2021	16	3							e0249350	10.1371/journal.pone.0249350	http://dx.doi.org/10.1371/journal.pone.0249350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6VV	33788872	Green Published, gold			2022-12-26	WOS:000636354600053
J	Laursen, K; Moller, AP				Laursen, Karsten; Moller, Anders Pape			Brain mass explains prey size selection better than beak, gizzard and body size in a benthivorous duck species	PLOS ONE			English	Article							SOMATERIA-MOLLISSIMA; MYTILUS-EDULIS; COMMON EIDERS; BLUE MUSSELS; GAPE WIDTH; HEAD SIZE; DISPLACEMENT; PERFORMANCE; STRATEGIES; EVOLUTION	Prey size selection in some bird species is determined by the size of the beak. However, we assumed for bird species swallowing whole prey that a cognitive process may be involved. As cognitive feature, brain mass was used. We hypothesized that the mass of the brain was more strongly positively correlated with prey size than morphological features such as beak volume, gizzard mass and body mass. We tested this hypothesis on eiders Somateria mollissima that swallow the prey whole, by using mean and maximum size of nine prey categories. Eiders were collected at the main wintering grounds in Denmark. As index of brain mass we used head volume, which is positively correlated with brain mass (r(2) = 0.73). Head volume of eiders was significantly, positive correlated with mean and maximum size of blue mussels Mytilus edulis, razor clams Ensis directus and all prey sizes combined and the maximum size of draft whelk Hinia reticulata and conch Buccinum undatum. Gizzard mass was also significantly positively correlated with maximum size of draft whelk and conch. Beak volume and body mass was not significantly correlated with the size of any of the nine food items. Analyses of effect size for organs showed that head volume was positively related to prey size, whereas beak volume, gizzard mass and body mass did not show a significant positive relationship. These results indicate that cognitive processes connected to brain mass may be involved in prey size selection by eiders.	[Laursen, Karsten] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Moller, Anders Pape] Univ Paris Saclay, Univ Paris Sud, AgroParisTech, Ecol Syst Evolut,CNRS, Orsay, France	Aarhus University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Laursen, K (corresponding author), Aarhus Univ, Dept Biosci, Ronde, Denmark.	kl@bios.au.dk			 [2015-B-132];  [2019-J-3]	; 	This work was supported by The 15.June Foundation, Denmark (Ref. 2015-B-132 and 2019-J-3) received by KL (http://www.15junifonden.dk/).The funder had no role in any aspects of the study or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bonaparte KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023775; Bright JA, 2016, P NATL ACAD SCI USA, V113, P5352, DOI 10.1073/pnas.1602683113; Bustnes JO, 1998, CAN J ZOOL, V76, P1787, DOI 10.1139/cjz-76-9-1787; Cervencl A, 2015, MAR BIOL, V162, P153, DOI 10.1007/s00227-014-2594-4; Chappell J, 2017, LEARN BEHAV, V45, P1, DOI 10.3758/s13420-016-0247-9; Coulson J., 2015, THE COMMON EIDER, V1st; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; Druijns S, THESIS U GRONINGEN G; Edmunds NB, 2016, ECOL LETT, V19, P948, DOI 10.1111/ele.12633; FJELDSA J, 1982, Ornis Fennica, V59, P84; Forstmeier W, 2001, P ROY SOC B-BIOL SCI, V268, P1583, DOI 10.1098/rspb.2001.1692; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; HESPENHEIDE HA, 1966, WILSON BULL, V78, P191; Hobson KA, 2015, AUK, V132, P624, DOI 10.1642/AUK-14-294.1; Jaatinen K., 2019, SCI REP-UK, V9, P1187, DOI [10.1038/s41598-019-48153-w30718542, DOI 10.1038/S41598-019-48153-W30718542]; Jaatinen K, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0157-x; Kats R., 2007, THESIS U GRONINGEN N; Krebs JR, 1996, IBIS, V138, P34; Larsen JK, 2000, MAR ECOL PROG SER, V201, P301, DOI 10.3354/meps201301; Laursen K, 2016, J ZOOL, V299, P213, DOI 10.1111/jzo.12337; Laursen K, 2019, J SEA RES, V144, P49, DOI 10.1016/j.seares.2018.11.005; Laursen K, 2016, WILDLIFE BIOL, V22, P174, DOI 10.2981/wlb.00197; Laursen K, 2009, J SEA RES, V62, P22, DOI 10.1016/j.seares.2009.02.004; Madsen F. J., 1954, Danish Review of Game Biology, V2, P157; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Moller AP, 2019, ECOL EVOL, V9, P8580, DOI 10.1002/ece3.5384; Moller AP, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161040; Navalon G, 2019, EVOLUTION, V73, P422, DOI 10.1111/evo.13655; Nehls G., 1995, THESIS U KIEL; Ost M, 2015, BEHAV ECOL, V26, P1371, DOI 10.1093/beheco/arv093; Petersen IK, 2010, TECHNICAL REPORT DMU; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; PULLIAM HR, 1971, ECOLOGY, V52, P557, DOI 10.2307/1934143; Rao XD, 2018, AVIAN RES, V9, DOI 10.1186/s40657-018-0103-z; Richman SE, 2008, J COMP PHYSIOL B, V178, P321, DOI 10.1007/s00360-007-0225-9; Rigou Y, 2010, WATERBIRDS, V33, P314, DOI 10.1675/063.033.0307; Samia DSM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11913; SAS, 2012, MP VERSION 100; Saunders ASJ, 1995, EMU, V95, P297, DOI 10.1071/MU9950297; Shaw RC, 2019, CURR BIOL, V29, P1498, DOI 10.1016/j.cub.2019.03.027; Stephens D., 2007, FORAGING BEHAV ECOLO; Varennes E, 2015, CAN J ZOOL, V93, P655, DOI 10.1139/cjz-2015-0046; Waser AM, 2016, BIOL CONSERV, V202, P39, DOI 10.1016/j.biocon.2016.08.007; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Zhang SD, 2019, J AVIAN BIOL, V50, DOI 10.1111/jav.02255; Zhang SD, 2019, ECOL EVOL, V9, P3868, DOI 10.1002/ece3.5013	49	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0248615	10.1371/journal.pone.0248615	http://dx.doi.org/10.1371/journal.pone.0248615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784342	Green Published, gold			2022-12-26	WOS:000636359600039
J	Li, H; Yang, WN; Lei, JJ; She, JX; Zhou, XS				Li, Hong; Yang, Wunian; Lei, Junjie; She, Jinxing; Zhou, Xiangshan			Estimation of leaf water content from hyperspectral data of different plant species by using three new spectral absorption indices	PLOS ONE			English	Article								The leaf equivalent water thickness (EWT, g cm(-2)) and fuel moisture content (FMC, %) are key variables in ecological and environmental monitoring. Although a variety of hyperspectral vegetation indices have been developed to estimate the leaf EWT and FMC, most of these indices are defined considered two or three specific bands for a specific plant species, which limits their applicability. In this study, we proposed three new spectral absorption indices (SAI(970), SAI(1200), and SAI(1660)) for various plant types by considering the symmetry of the spectral absorption at 970 nm, 1200 nm and 1660 nm and spectral heterogeneity of different leaves. The indices were calculated considering the absorption peak and shoulder bands of each leaf instead of the same specific bands for all leaves. A pooled dataset of three tree species (camphor (VX), capricorn (VJ), and red-leaf plum (VL)) was used to test the performance of the SAIs in terms of the leaf EWT and FMC estimation. The results indicated that, first, SAI(1200) was more suitable for estimating the EWT than FMC, whereas SAI(970) and SAI(1660) were more suitable for estimating the FMC. Second, SAI(1200) achieved the most accurate estimation of the EWT with a cross-validation coefficient of determination (R-cv(2)) of 0.845 and relative cross-validation root mean square error (rRMSE(cv)) of 8.90%. Third, SAI(1660) outperformed the other indices in estimating the FMC at the leaf level, with an R-cv(2) of 0.637 and rRMSE(cv) of 8.56%. Fourth, SAI(970) achieved a moderate accuracy in estimating the EWT (R-cv(2) of 0.25 and rRMSE(cv) of 19.68%) and FMC (R-cv(2) of 0.275 and rRMSE(cv) of 12.10%) at the leaf level. These results can enrich the application of the SAIs and demonstrate the potential of using SAI(1200) to determine the leaf EWT and SAI(1660) to obtain the leaf FMC among various plant types.	[Li, Hong; Yang, Wunian; Lei, Junjie; She, Jinxing; Zhou, Xiangshan] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China; [Li, Hong] Chongqing Vocat Inst Engn, Geol & Surveying Engn Sch, Chongqing, Peoples R China	Chengdu University of Technology; Chongqing Vocational Institute of Engineering	Yang, WN (corresponding author), Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China.	ywn@cdut.edu.cn		Li, Hong/0000-0002-1555-0422	National Natural Science Foundation of China [41671432]; Science and Technology Research Project of Chongqing Education Commission [KJQN201803402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Chongqing Education Commission	This study was financially supported by the National Natural Science Foundation of China (Grant No. 41671432) and Science and Technology Research Project of Chongqing Education Commission (Grant No. KJQN201803402).	Arshad M, 2018, J APPL REMOTE SENS, V12, DOI 10.1117/1.JRS.12.022203; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P188, DOI 10.1016/S0034-4257(02)00037-8; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P198, DOI [10.1016/S0034-4257(02)00036-6, 10.1016/S0034-4257(02)00037-8]; Cernicharo J, 2013, REMOTE SENS-BASEL, V5, P5265, DOI 10.3390/rs5105265; Chakroun H, 2015, REMOTE SENS-BASEL, V7, P1937, DOI 10.3390/rs70201937; Chen SB, 2020, INT J REMOTE SENS, V41, P4389, DOI 10.1080/01431161.2020.1718234; Clevers JGPW, 2010, INT J APPL EARTH OBS, V12, P119, DOI 10.1016/j.jag.2010.01.007; Colombo R, 2008, REMOTE SENS ENVIRON, V112, P1820, DOI 10.1016/j.rse.2007.09.005; DANSON FM, 1992, INT J REMOTE SENS, V13, P461, DOI 10.1080/01431169208904049; Danson FM, 2004, REMOTE SENS ENVIRON, V92, P309, DOI 10.1016/j.rse.2004.03.017; Deffet S, 2020, MED PHYS, V47, P509, DOI 10.1002/mp.13917; El-Hendawy SE, 2019, AGR WATER MANAGE, V217, P356, DOI 10.1016/j.agwat.2019.03.006; El-Hendawy SE, 2019, AGR WATER MANAGE, V212, P358, DOI 10.1016/j.agwat.2018.09.009; Fang MH, 2017, REMOTE SENS ENVIRON, V196, P13, DOI 10.1016/j.rse.2017.04.029; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hunt ER, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10020273; Hunt ER, 2016, INT J REMOTE SENS, V37, P388, DOI 10.1080/01431161.2015.1128575; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Garcia-Haro FJ, 2020, ISPRS J PHOTOGRAMM, V162, P77, DOI 10.1016/j.isprsjprs.2020.02.007; Jin XL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00721; Kawamura Kensuke, 2008, Grassland Science, V54, P131, DOI 10.1111/j.1744-697X.2008.00116.x; Kokaly RF, 2003, REMOTE SENS ENVIRON, V84, P437, DOI 10.1016/S0034-4257(02)00133-5; Kovar M, 2019, WATER-SUI, V11, DOI 10.3390/w11030443; Lei JJ, 2019, J APPL REMOTE SENS, V13, DOI 10.1117/1.JRS.13.034517; Li Z, 2017, SPECTROSC SPECT ANAL, V37, P859, DOI 10.3964/j.issn.1000-0593(2017)03-0859-06; Liu LY, 2016, INT J REMOTE SENS, V37, P3384, DOI 10.1080/01431161.2016.1199083; Ma J, 2016, FOOD CHEM, V197, P848, DOI 10.1016/j.foodchem.2015.11.023; Ma JW, 2017, IEEE GEOSCI REMOTE S, V14, P364, DOI 10.1109/LGRS.2016.2643004; Myoung B, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010087; Neinavaz E, 2017, AGR FOREST METEOROL, V247, P365, DOI 10.1016/j.agrformet.2017.08.020; Arganaraz JP, 2016, IEEE J-STARS, V9, P5339, DOI 10.1109/JSTARS.2016.2575366; Pasqualotto N, 2018, INT J APPL EARTH OBS, V67, P69, DOI 10.1016/j.jag.2018.01.002; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Penuelas J, 1996, INT J REMOTE SENS, V17, P373, DOI 10.1080/01431169608949012; Pu R, 2004, INT J REMOTE SENS, V25, P4267, DOI 10.1080/01431160410001705114; Pu R, 2003, INT J REMOTE SENS, V24, P1799, DOI 10.1080/01431160210155965; Rodriguez-Perez JR, 2018, BIOSYST ENG, V165, P36, DOI 10.1016/j.biosystemseng.2017.08.017; Rollin EM, 1998, REMOTE SENS ENVIRON, V65, P86, DOI 10.1016/S0034-4257(98)00013-3; Stimson HC, 2005, REMOTE SENS ENVIRON, V96, P108, DOI 10.1016/j.rse.2004.12.007; Tian Q, 2001, INT J REMOTE SENS, V22, P2329, DOI 10.1080/014311601300229845; TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6; Verrelst J, 2015, ISPRS J PHOTOGRAMM, V108, P260, DOI 10.1016/j.isprsjprs.2015.04.013; Vohland M, 2008, J APPL REMOTE SENS, V2, DOI 10.1117/1.2937937; Wang J.-N., 1996, REMOTE SENS ENVIRON, V11, P20, DOI DOI 10.1007/BF02951625); Wang LL, 2013, REMOTE SENS ENVIRON, V129, P103, DOI 10.1016/j.rse.2012.10.027; Wocher M, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10121924; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9; Zhang C, 2018, IEEE J-STARS, V11, P112, DOI 10.1109/JSTARS.2017.2773625; Zhang F, 2019, BMC ECOL, V19, DOI 10.1186/s12898-019-0233-0; Zhang JH, 2010, SCI CHINA TECHNOL SC, V53, P1159, DOI 10.1007/s11431-010-0131-3; Zhang L, 2014, EUR J REMOTE SENS, V47, P593, DOI 10.5721/EuJRS20144733; Zhang L, 2012, EUR J AGRON, V41, P103, DOI 10.1016/j.eja.2012.04.003; Zhao CJ, 2004, INT J REMOTE SENS, V25, P2575, DOI [10.1080/01431160310001619571, 10.1080/01431160310001618419]	54	7	7	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2021	16	3							e0249351	10.1371/journal.pone.0249351	http://dx.doi.org/10.1371/journal.pone.0249351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH6XT	33784352	gold, Green Published			2022-12-26	WOS:000636359600066
